{"comparison_id":"48acc5f8-7efb-4026-bd09-c6c7b176c1d9","query_id":"51","doc_a_id":"45638119","doc_b_id":"17021845","presented_order":["45638119","17021845"],"winner_id":"45638119","reasoning":"Doc A directly addresses ALDH1 in breast cancer and reports it predicts poor clinical outcome, directly relevant to the claim.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229745Z"}
{"comparison_id":"90648801-87dd-414d-96f3-46ff70773a02","query_id":"51","doc_a_id":"8963413","doc_b_id":"17021845","presented_order":["17021845","8963413"],"winner_id":"8963413","reasoning":"Document B is more relevant — it discusses expression of a biomarker (PD-L1) and its association with better outcomes in breast cancer, whereas Document A concerns Nanog in lung cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229769Z"}
{"comparison_id":"9643beee-3170-4a37-bf31-a9be5fb4101e","query_id":"51","doc_a_id":"22401720","doc_b_id":"17021845","presented_order":["22401720","17021845"],"winner_id":"22401720","reasoning":"Document A is more relevant — it deals with markers and prognosis in primary breast cancer, whereas Document B concerns Nanog in lung cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229778Z"}
{"comparison_id":"4240f507-bcb3-4b61-b14f-146595257809","query_id":"51","doc_a_id":"21439640","doc_b_id":"17021845","presented_order":["21439640","17021845"],"winner_id":"21439640","reasoning":"Document A — it concerns breast cancer biology (though not ALDH1 specifically), while Document B addresses Nanog in lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229785Z"}
{"comparison_id":"fc753e24-330b-48e9-95c0-51f35688d7ec","query_id":"51","doc_a_id":"12762485","doc_b_id":"17021845","presented_order":["12762485","17021845"],"winner_id":"12762485","reasoning":"Document A is about breast cancer and stem-cell–related phenotypes (more relevant to ALDH1's role in breast cancer outcomes), while B is about Nanog in lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229793Z"}
{"comparison_id":"b9599600-8bac-4ca2-bd15-eae9cfe68600","query_id":"51","doc_a_id":"23830488","doc_b_id":"17021845","presented_order":["17021845","23830488"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem cell marker and prognosis (conceptually closer to ALDH1 and breast cancer outcomes) whereas Document B concerns circadian genes in colorectal cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229800Z"}
{"comparison_id":"0f716816-98fc-4413-8fe3-fc92a36ae502","query_id":"51","doc_a_id":"7821634","doc_b_id":"17021845","presented_order":["17021845","7821634"],"winner_id":"7821634","reasoning":"Document B is more relevant — it concerns breast cancer outcomes and prognostic markers, whereas Document A is about Nanog in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229807Z"}
{"comparison_id":"8e981cf0-8f99-48e5-9b0f-1383a4b4cc83","query_id":"51","doc_a_id":"4429932","doc_b_id":"17021845","presented_order":["4429932","17021845"],"winner_id":"4429932","reasoning":"Document A — it discusses breast cancer patient outcomes (though not ALDH1 specifically), while Document B is about Nanog in lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229813Z"}
{"comparison_id":"d1c00d3a-d18a-4f20-9dc0-fbf9961c7a02","query_id":"51","doc_a_id":"24341590","doc_b_id":"17021845","presented_order":["24341590","17021845"],"winner_id":"24341590","reasoning":"Doc A is about breast cancer outcomes (though a different biomarker), while Doc B concerns Nanog in lung cancer and is unrelated to ALDH1 or breast cancer.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229820Z"}
{"comparison_id":"713b7942-f11b-4d5e-8be5-d9993bfa4e41","query_id":"51","doc_a_id":"13007205","doc_b_id":"17021845","presented_order":["13007205","17021845"],"winner_id":"13007205","reasoning":"Document A is more relevant — it discusses breast cancer biology (though not ALDH1), whereas Document B addresses Nanog in lung cancer which is not relevant to breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229827Z"}
{"comparison_id":"10bf60f5-74b4-4811-9f5e-eeda7173e07c","query_id":"51","doc_a_id":"32001951","doc_b_id":"17021845","presented_order":["17021845","32001951"],"winner_id":"32001951","reasoning":"Document B is more relevant — it concerns regulation of an enzyme marker in a human breast cancer cell line, whereas Document A discusses Nanog in lung cancer (different tissue and marker). \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229834Z"}
{"comparison_id":"fe7e3f26-5117-494f-bbc0-5f4eb3fa9028","query_id":"51","doc_a_id":"24349992","doc_b_id":"17021845","presented_order":["17021845","24349992"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses stem cell marker expression and prognosis (though in lung cancer), which is closer to ALDH1's role in cancer outcomes than the stromal/metabolism focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229841Z"}
{"comparison_id":"334c9546-6ada-4196-a78a-bf892e521e9d","query_id":"51","doc_a_id":"20886584","doc_b_id":"17021845","presented_order":["20886584","17021845"],"winner_id":"20886584","reasoning":"Doc A — it concerns breast cancer (though not ALDH1 specifically), while Doc B is about Nanog in lung cancer and is less relevant to a breast cancer outcome claim.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229849Z"}
{"comparison_id":"fe2e6310-be20-4574-a889-dcbb86c217f0","query_id":"51","doc_a_id":"29124963","doc_b_id":"17021845","presented_order":["29124963","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a stem-cell marker's association with cancer prognosis, which is conceptually closer to ALDH1's role than a study on an ALK translocation in lung adenocarcinoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229856Z"}
{"comparison_id":"319d30bb-781d-4db3-82aa-ead1b0897c92","query_id":"51","doc_a_id":"7583725","doc_b_id":"17021845","presented_order":["7583725","17021845"],"winner_id":"7583725","reasoning":"Document A is more relevant — it addresses breast cancer outcomes (though a different marker), while B studies Nanog in lung cancer.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229863Z"}
{"comparison_id":"f027f101-c3e6-4cd6-9c8c-5b1e1cf2c3eb","query_id":"51","doc_a_id":"15113221","doc_b_id":"17021845","presented_order":["17021845","15113221"],"winner_id":"15113221","reasoning":"Document B — it addresses gene expression signatures linked to prognosis in carcinomas (more relevant to a claim about marker expression and cancer outcomes), whereas A concerns Nanog in lung cancer only.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229870Z"}
{"comparison_id":"4b095ee9-8777-4f82-bcd6-4fc88970f180","query_id":"51","doc_a_id":"9486930","doc_b_id":"17021845","presented_order":["9486930","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it examines a stem cell marker's (Nanog) association with cancer diagnosis and prognosis, which is conceptually closer to ALDH1's prognostic role than the glioblastoma resistance focus in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229877Z"}
{"comparison_id":"53a0fdee-1352-447f-a87e-4780ce4bcf86","query_id":"51","doc_a_id":"4820792","doc_b_id":"17021845","presented_order":["4820792","17021845"],"winner_id":"4820792","reasoning":"Document A is more relevant — it concerns breast cancer biology (where ALDH1 would be relevant), whereas Document B studies Nanog in lung cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229884Z"}
{"comparison_id":"fb6f1d73-e333-4743-ba19-60a18c8b188b","query_id":"51","doc_a_id":"22963769","doc_b_id":"17021845","presented_order":["17021845","22963769"],"winner_id":"17021845","reasoning":"Document A — it discusses a stem cell marker (Nanog) in cancer, which is more related to ALDH1 (also a stem cell marker) than the adhesion-protein focus in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229891Z"}
{"comparison_id":"3623f6af-f0b6-43f7-a245-2ea043b5d0df","query_id":"51","doc_a_id":"42731834","doc_b_id":"17021845","presented_order":["17021845","42731834"],"winner_id":"17021845","reasoning":"Document A — it discusses a stem-cell marker and prognosis (though in lung cancer), which is closer to ALDH1 and breast-cancer outcomes than Document B on AIM2 in colorectal cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229898Z"}
{"comparison_id":"b3bd29ff-0b90-4c1f-8979-00f5c3557606","query_id":"51","doc_a_id":"25832301","doc_b_id":"17021845","presented_order":["25832301","17021845"],"winner_id":"17021845","reasoning":"Doc B is slightly more relevant because it discusses a stem-cell marker's association with cancer prognosis (conceptually closer to ALDH1's prognostic role) whereas A concerns a different marker and cancer type. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229905Z"}
{"comparison_id":"42d373f6-06b6-47e6-95c4-86cb7f919182","query_id":"51","doc_a_id":"27240667","doc_b_id":"17021845","presented_order":["17021845","27240667"],"winner_id":"27240667","reasoning":"Document B — it concerns breast cancer outcomes (though not ALDH1), while A is about Nanog in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229911Z"}
{"comparison_id":"891638ae-b313-4d9e-ab31-53284d89899e","query_id":"51","doc_a_id":"8037453","doc_b_id":"17021845","presented_order":["17021845","8037453"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem cell marker's expression and prognosis in cancer (though in lung), which is closer to ALDH1 and outcome associations than bone turnover markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229919Z"}
{"comparison_id":"fc41d77b-3cc4-44f8-86e6-20196d7d304a","query_id":"51","doc_a_id":"15721252","doc_b_id":"17021845","presented_order":["15721252","17021845"],"winner_id":"15721252","reasoning":"Document A is about breast cancer and molecular markers, while Document B concerns Nanog in lung cancer; A is therefore more relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229926Z"}
{"comparison_id":"edb6646b-14e9-4253-8098-7ee59b188f93","query_id":"51","doc_a_id":"17648235","doc_b_id":"17021845","presented_order":["17021845","17648235"],"winner_id":"17648235","reasoning":"Document B — it concerns breast cancer (though not ALDH1 specifically), while Document A is about Nanog in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229932Z"}
{"comparison_id":"eb8dc8b0-22f3-48a0-b3bc-0b64d43f11f4","query_id":"51","doc_a_id":"15081770","doc_b_id":"17021845","presented_order":["15081770","17021845"],"winner_id":"15081770","reasoning":"Document A is slightly more relevant because it discusses enzyme expression linked to patient outcomes and prognostic significance in cancer, whereas Document B concerns Nanog in lung cancer only. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229940Z"}
{"comparison_id":"1e08abb6-7759-4534-9ce2-08345927fbc7","query_id":"51","doc_a_id":"31591262","doc_b_id":"17021845","presented_order":["17021845","31591262"],"winner_id":"17021845","reasoning":"Document A is marginally more relevant because it discusses a stem cell marker (Nanog) and prognosis, which is conceptually closer to ALDH1 as a stem-cell marker, though neither document addresses ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229947Z"}
{"comparison_id":"945593c6-c347-4199-b807-81b2637258e1","query_id":"51","doc_a_id":"16734530","doc_b_id":"17021845","presented_order":["16734530","17021845"],"winner_id":"16734530","reasoning":"Document A is more relevant — it studies breast cancer (same disease) whereas B is about Nanog in lung cancer, so A is closer to the claim context.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229954Z"}
{"comparison_id":"024bead0-1bb6-466a-8d18-879c1ad73545","query_id":"51","doc_a_id":"8512633","doc_b_id":"17021845","presented_order":["17021845","8512633"],"winner_id":"17021845","reasoning":"Document A — it discusses a stem cell marker's expression and prognosis in cancer (similar topic). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229961Z"}
{"comparison_id":"993b8f9f-f7b1-402b-a5e7-5fada8ef1314","query_id":"51","doc_a_id":"3285322","doc_b_id":"17021845","presented_order":["17021845","3285322"],"winner_id":"3285322","reasoning":"B is more relevant — it concerns breast cancer clinical outcomes (though doesn't mention ALDH1), whereas A is about Nanog in lung cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229967Z"}
{"comparison_id":"bc8b59f6-62c1-4bbb-acc2-4cab520d2c53","query_id":"51","doc_a_id":"2140497","doc_b_id":"17021845","presented_order":["2140497","17021845"],"winner_id":"2140497","reasoning":"Document A is more relevant because it concerns breast cancer risk factors (breast tissue features), whereas Document B addresses Nanog in lung cancer and is unrelated to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229974Z"}
{"comparison_id":"b5d25b0a-53b2-4991-8911-7f3e40f3a08e","query_id":"51","doc_a_id":"20839751","doc_b_id":"17021845","presented_order":["20839751","17021845"],"winner_id":"20839751","reasoning":"Document A is more relevant — it discusses breast cancer pathology (where ALDH1 would be relevant), whereas Document B concerns Nanog in lung cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229981Z"}
{"comparison_id":"88b2698c-d100-46a4-8bc6-5c5dbab73f75","query_id":"51","doc_a_id":"13906581","doc_b_id":"17021845","presented_order":["13906581","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a cancer stem-cell marker's expression and its association with prognosis, which is closer to the query about ALDH1 and breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229988Z"}
{"comparison_id":"fe86d16a-0008-4a1e-9bf0-d7ab429539c3","query_id":"51","doc_a_id":"23304931","doc_b_id":"17021845","presented_order":["17021845","23304931"],"winner_id":"17021845","reasoning":"A is more relevant because it studies a stem cell marker's expression and prognostic association (though in lung cancer), which is closer to ALDH1's role in cancer outcomes than the lymphoma-focused immunophenotyping in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.229995Z"}
{"comparison_id":"2e7f17b3-7084-49e8-8154-38aaf4218d66","query_id":"51","doc_a_id":"16701509","doc_b_id":"17021845","presented_order":["16701509","17021845"],"winner_id":"16701509","reasoning":"Document A is more relevant — it concerns breast cancer (though not ALDH1), while Document B is about Nanog in lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230001Z"}
{"comparison_id":"c7562b49-933b-4efa-b1d2-760c08de4190","query_id":"51","doc_a_id":"13030852","doc_b_id":"17021845","presented_order":["13030852","17021845"],"winner_id":"13030852","reasoning":"Document A is more relevant — it concerns biomarkers and outcomes in breast cancer, whereas Document B is about Nanog in lung cancer.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230007Z"}
{"comparison_id":"53d0a40b-0bd3-46b9-a703-d964b56ebfac","query_id":"51","doc_a_id":"7795952","doc_b_id":"17021845","presented_order":["17021845","7795952"],"winner_id":"17021845","reasoning":"Document A — it discusses marker gene expression and prognosis (though in lung cancer), which is closer to the query about a marker (ALDH1) and cancer outcomes than Document B's mechanistic study of fascin. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230014Z"}
{"comparison_id":"99e7f8f7-74ef-49f0-8d45-d0945721cd2c","query_id":"51","doc_a_id":"13069283","doc_b_id":"17021845","presented_order":["17021845","13069283"],"winner_id":"13069283","reasoning":"Document B — it concerns breast cancer (tamoxifen metabolism and outcomes), while Document A is about Nanog in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230021Z"}
{"comparison_id":"19e9d55e-c56e-4932-a914-6ef5a689967f","query_id":"51","doc_a_id":"37480103","doc_b_id":"17021845","presented_order":["37480103","17021845"],"winner_id":"37480103","reasoning":"Document A is more relevant because it concerns breast cancer (even though it doesn't address ALDH1 expression), while Document B is about Nanog in lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230028Z"}
{"comparison_id":"77c6f7bb-4e06-4339-83a4-f2549b457747","query_id":"51","doc_a_id":"4999633","doc_b_id":"17021845","presented_order":["17021845","4999633"],"winner_id":"4999633","reasoning":"Document B — it's about breast cancer (MCF-7 cells), so more related to the query than Document A, which concerns Nanog in lung cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230035Z"}
{"comparison_id":"3d98ab8c-47a4-485d-8604-d9177906a28b","query_id":"51","doc_a_id":"9600826","doc_b_id":"17021845","presented_order":["17021845","9600826"],"winner_id":"9600826","reasoning":"Document B is more relevant — it discusses mechanisms in breast cancer (though not ALDH1), while Document A is about Nanog in lung cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230041Z"}
{"comparison_id":"aa5cf803-d7ad-42dc-a276-69f471a79522","query_id":"51","doc_a_id":"15335331","doc_b_id":"17021845","presented_order":["15335331","17021845"],"winner_id":"15335331","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it links marker expression to cancer outcomes (albeit in oral SCC), whereas B discusses Nanog in lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230048Z"}
{"comparison_id":"95ba8622-0ebb-4fa9-9bfd-eaa0c8b49549","query_id":"51","doc_a_id":"43385013","doc_b_id":"17021845","presented_order":["43385013","17021845"],"winner_id":"43385013","reasoning":"Document A is more relevant — it concerns breast epithelial/mesenchymal subpopulations and stem/progenitor markers in breast cancer context, whereas B is about Nanog in lung cancer.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230055Z"}
{"comparison_id":"fbfc9dae-06fd-46f8-a09d-092c3747a7e3","query_id":"51","doc_a_id":"1171121","doc_b_id":"17021845","presented_order":["1171121","17021845"],"winner_id":"1171121","reasoning":"Document A is more relevant — it concerns prognostic markers in breast cancer (though not ALDH1), whereas Document B is about Nanog in lung cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230063Z"}
{"comparison_id":"dea12013-e166-4b66-9fc6-7bcd1b198c3e","query_id":"51","doc_a_id":"25732836","doc_b_id":"17021845","presented_order":["17021845","25732836"],"winner_id":"25732836","reasoning":"Document B is more relevant — it concerns prognostic markers and outcomes in metastatic breast cancer, whereas A is about Nanog in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230070Z"}
{"comparison_id":"88b8941c-632f-479b-8169-f3bb8d624130","query_id":"51","doc_a_id":"23665162","doc_b_id":"17021845","presented_order":["17021845","23665162"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem cell marker and prognosis (closer in topic to ALDH1 and outcomes) while Document B concerns LINE-1 methylation and liver cancer risk. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230077Z"}
{"comparison_id":"faa06bcc-d1e6-4bce-a6c0-cf4db50bce9a","query_id":"51","doc_a_id":"25973484","doc_b_id":"17021845","presented_order":["17021845","25973484"],"winner_id":"25973484","reasoning":"Document B is more relevant — it discusses breast cancer risk and prognosis (though it doesn't mention ALDH1). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230084Z"}
{"comparison_id":"f9df5e2d-3939-4b22-a80f-563c0c5b3bec","query_id":"51","doc_a_id":"29366489","doc_b_id":"17021845","presented_order":["29366489","17021845"],"winner_id":"29366489","reasoning":"Document A is more relevant — it discusses a cancer prognostic marker and tumor suppressor across cancers (more likely to relate to breast cancer outcomes) while Document B focuses on Nanog in lung cancer.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230091Z"}
{"comparison_id":"d56de4ba-79a0-4e8b-9a66-68883105cfe6","query_id":"51","doc_a_id":"24205118","doc_b_id":"17021845","presented_order":["17021845","24205118"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem-cell marker (Nanog) and prognosis, which is closer to ALDH1's role as a stem-cell marker in cancer prognosis than the cervical-cancer Bmi-1 study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230100Z"}
{"comparison_id":"e4fb6cd6-f1a7-44bb-a048-58ba1a56b715","query_id":"51","doc_a_id":"4414547","doc_b_id":"17021845","presented_order":["4414547","17021845"],"winner_id":"4414547","reasoning":"Document A is more relevant because it discusses breast cancer (where ALDH1's association would be evaluated), while Document B concerns lung cancer and a different marker. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230110Z"}
{"comparison_id":"365ff769-e914-47f9-bf78-230ef749f484","query_id":"51","doc_a_id":"19047331","doc_b_id":"17021845","presented_order":["19047331","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it addresses a stem cell marker's expression and its association with cancer prognosis (like ALDH1's proposed role), whereas A focuses on miR551b/STAT3 in ovarian cancer unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230118Z"}
{"comparison_id":"2868e59f-d5af-4a81-868d-77eead1c8bdb","query_id":"51","doc_a_id":"24249915","doc_b_id":"17021845","presented_order":["17021845","24249915"],"winner_id":"24249915","reasoning":"Document B — discusses expression changes in breast cancer (though not ALDH1), while A is about Nanog in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230125Z"}
{"comparison_id":"b4e0fa0a-f83f-4d0b-931b-373802325be2","query_id":"51","doc_a_id":"313403","doc_b_id":"17021845","presented_order":["313403","17021845"],"winner_id":"313403","reasoning":"Document A is more relevant — it addresses prognostic factors in breast cancer, whereas Document B concerns Nanog in lung cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230131Z"}
{"comparison_id":"2d51a395-d0c4-4d9d-8870-3b1fce5d9b9c","query_id":"51","doc_a_id":"52180874","doc_b_id":"17021845","presented_order":["17021845","52180874"],"winner_id":"52180874","reasoning":"Document B is more relevant — it examines how expression status of a tumor marker (PD-L1) relates to patient outcomes across cancers, which is conceptually closer to the query about ALDH1 expression and breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230139Z"}
{"comparison_id":"0538d9a2-cd0e-4a64-b92d-c071098dbe50","query_id":"51","doc_a_id":"195680777","doc_b_id":"17021845","presented_order":["195680777","17021845"],"winner_id":"195680777","reasoning":"Document A is more relevant — it concerns breast cancer outcomes (though not ALDH1 specifically), whereas B is about Nanog in lung cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230145Z"}
{"comparison_id":"d7228ae9-7e92-4e27-a738-ac72091cdf6b","query_id":"51","doc_a_id":"38551172","doc_b_id":"17021845","presented_order":["17021845","38551172"],"winner_id":"38551172","reasoning":"Document B is more relevant because it deals with breast cancer (even though it doesn't mention ALDH1), while Document A is about Nanog in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230153Z"}
{"comparison_id":"8b73a3c3-e0b7-4ab1-b415-a71acf35d35c","query_id":"51","doc_a_id":"1389264","doc_b_id":"17021845","presented_order":["17021845","1389264"],"winner_id":"1389264","reasoning":"Document B is more relevant because it concerns breast cancer therapeutic outcomes, while Document A addresses Nanog in lung cancer and is unrelated to breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230160Z"}
{"comparison_id":"4c4329da-e38e-4d1f-8473-18459bb17ef1","query_id":"51","doc_a_id":"22509015","doc_b_id":"17021845","presented_order":["17021845","22509015"],"winner_id":"22509015","reasoning":"Document B is more relevant because it concerns breast cancer biology, whereas Document A is about Nanog in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230166Z"}
{"comparison_id":"ceb5e15e-a7af-4533-ab89-0f654de44cc3","query_id":"51","doc_a_id":"7165938","doc_b_id":"17021845","presented_order":["17021845","7165938"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem cell marker (Nanog) and cancer prognosis, which is conceptually closer to ALDH1 and breast cancer outcomes than a circadian gene study in colorectal cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230173Z"}
{"comparison_id":"c638a8c1-e866-4c16-bc63-e92850ccb7e5","query_id":"51","doc_a_id":"2727303","doc_b_id":"17021845","presented_order":["17021845","2727303"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem‑cell marker's expression and association with cancer prognosis (though in lung cancer), which is closer to the ALDH1 prognostic claim than B's mechanistic HDAC6/STIM1 study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230180Z"}
{"comparison_id":"54e93228-2dca-43ca-b84a-45253af7cc93","query_id":"51","doc_a_id":"10169908","doc_b_id":"17021845","presented_order":["17021845","10169908"],"winner_id":"17021845","reasoning":"Reason: Both documents concern lung cancer and not breast cancer, but Document A discusses a stem cell marker (Nanog), which is thematically closer to ALDH1 (also a stem cell marker) than Document B's metabolic transporter focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230188Z"}
{"comparison_id":"98a59492-b3ce-417a-a395-831cebb4de0e","query_id":"51","doc_a_id":"17450673","doc_b_id":"17021845","presented_order":["17021845","17450673"],"winner_id":"17450673","reasoning":"Document B is more relevant — it concerns breast cancer (though not ALDH1 specifically), whereas Document A is about Nanog in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230195Z"}
{"comparison_id":"db06d1af-21a9-4be5-a342-a6e3e59a50da","query_id":"51","doc_a_id":"1782201","doc_b_id":"17021845","presented_order":["17021845","1782201"],"winner_id":"17021845","reasoning":"Document A is more relevant — it examines a stem cell marker's expression and prognostic significance (though in lung cancer), which is closer to ALDH1's role in cancer outcomes than Document B's focus on integrin signaling in pancreatic tumors.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230203Z"}
{"comparison_id":"54a031bb-63a5-46bc-8443-304ca9ba9bb6","query_id":"51","doc_a_id":"2130391","doc_b_id":"17021845","presented_order":["17021845","2130391"],"winner_id":"2130391","reasoning":"Document B is more relevant because it concerns breast cancer biology, whereas Document A focuses on Nanog in lung cancer and is unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230209Z"}
{"comparison_id":"f251e56f-a57a-409a-b501-ed403c58f28a","query_id":"51","doc_a_id":"8677721","doc_b_id":"17021845","presented_order":["17021845","8677721"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem-cell marker and its association with cancer prognosis (though in lung cancer), which is closer to ALDH1 and breast cancer outcomes than the hepatocellular carcinoma signaling study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230216Z"}
{"comparison_id":"95591b04-35a8-49d4-8636-c330af9695ef","query_id":"51","doc_a_id":"39580129","doc_b_id":"17021845","presented_order":["17021845","39580129"],"winner_id":"17021845","reasoning":"Document A — discusses a stem cell marker (Nanog) and cancer stem cells, which is conceptually closer to ALDH1 (another stem cell marker), whereas Document B concerns a microRNA in colorectal cancer, unrelated to ALDH1 or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230224Z"}
{"comparison_id":"83e2cdba-005b-4fb7-97e6-9b4e15c6a141","query_id":"51","doc_a_id":"18340282","doc_b_id":"17021845","presented_order":["18340282","17021845"],"winner_id":"18340282","reasoning":"Document A is more relevant — it concerns breast cancer (while B is about a lung cancer marker), though neither mentions ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230231Z"}
{"comparison_id":"28ddee18-e500-4dcb-b314-3537089c7993","query_id":"51","doc_a_id":"7736860","doc_b_id":"17021845","presented_order":["7736860","17021845"],"winner_id":"17021845","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer; Document B is marginally more relevant because it addresses a stem-cell marker and prognosis, which is conceptually closer to ALDH1's role.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230238Z"}
{"comparison_id":"33e653bf-f663-4fbb-b45c-de8ef1462ad7","query_id":"51","doc_a_id":"8671456","doc_b_id":"17021845","presented_order":["8671456","17021845"],"winner_id":"8671456","reasoning":"Document A is more relevant — it concerns breast cancer (the claim's disease), whereas Document B is about Nanog in lung cancer, unrelated to ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230245Z"}
{"comparison_id":"c0a9536c-89eb-49c6-92e9-14129979db3f","query_id":"51","doc_a_id":"1554348","doc_b_id":"17021845","presented_order":["1554348","17021845"],"winner_id":"1554348","reasoning":"Document A is more relevant — it concerns breast cancer (MCF-7) cell biology, whereas B addresses Nanog in lung cancer; neither mentions ALDH1 but A is closer to the query topic.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230252Z"}
{"comparison_id":"3a0877d5-20c3-4f0b-9764-ab51d142d2c7","query_id":"51","doc_a_id":"20454006","doc_b_id":"17021845","presented_order":["20454006","17021845"],"winner_id":"20454006","reasoning":"Document A is more relevant because it concerns breast cancer (the disease in the query), whereas Document B is about a different marker (Nanog) in lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230258Z"}
{"comparison_id":"64ef273f-bd9c-4bc0-b904-4e652651b45b","query_id":"51","doc_a_id":"36950726","doc_b_id":"17021845","presented_order":["17021845","36950726"],"winner_id":"17021845","reasoning":"Document A — both discuss a stem cell marker's expression and prognosis (though in lung cancer), making it slightly closer to the query about marker expression and cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230265Z"}
{"comparison_id":"fb678ed1-b25f-4d02-8efc-5be419981590","query_id":"51","doc_a_id":"27123743","doc_b_id":"17021845","presented_order":["27123743","17021845"],"winner_id":"27123743","reasoning":"Doc A is more relevant — it addresses breast cancer etiology (though not ALDH1), whereas Doc B concerns Nanog in lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230272Z"}
{"comparison_id":"52a077a6-c084-4898-8dc3-0dbe3d63e932","query_id":"51","doc_a_id":"3684342","doc_b_id":"17021845","presented_order":["3684342","17021845"],"winner_id":"17021845","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document B discusses a stem-cell marker's expression and prognostic significance, making it marginally more related.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230278Z"}
{"comparison_id":"431f6156-7b37-419a-8390-769c6f1c08bd","query_id":"51","doc_a_id":"20280410","doc_b_id":"17021845","presented_order":["20280410","17021845"],"winner_id":"20280410","reasoning":"Document A is more relevant because it concerns breast cancer (though not ALDH1), while Document B addresses lung cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230285Z"}
{"comparison_id":"f243a978-0786-474d-bb5e-78d9187ee492","query_id":"51","doc_a_id":"22482820","doc_b_id":"17021845","presented_order":["22482820","17021845"],"winner_id":"22482820","reasoning":"Document A is more relevant — it addresses breast cancer (treatment/biology), whereas Document B concerns Nanog in lung cancer and is not about breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230292Z"}
{"comparison_id":"9fa2cac7-17a5-4cda-83c3-dc26677a0f07","query_id":"51","doc_a_id":"2389574","doc_b_id":"17021845","presented_order":["17021845","2389574"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem cell marker and its association with cancer diagnosis/prognosis (closer to ALDH1 as a stem cell marker) whereas B addresses a different marker in endometrial cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230299Z"}
{"comparison_id":"1c9dd2b0-20fa-4ae9-8630-51d3f25101dc","query_id":"51","doc_a_id":"10024681","doc_b_id":"17021845","presented_order":["17021845","10024681"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem-cell marker and its association with cancer prognosis, which is thematically closer to ALDH1 and breast cancer outcomes than the prostate/microRNA study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230306Z"}
{"comparison_id":"6e68bfed-e823-46c4-bff1-6eaf5c6867f5","query_id":"51","doc_a_id":"24980622","doc_b_id":"17021845","presented_order":["17021845","24980622"],"winner_id":"17021845","reasoning":"Document A — it discusses a stem-cell marker and prognosis in cancer, which is more thematically related to ALDH1 and outcome associations than the hypoxia/colorectal-metastasis focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230314Z"}
{"comparison_id":"cd176918-6e9e-46f2-941a-7b56c486c31d","query_id":"51","doc_a_id":"25576204","doc_b_id":"17021845","presented_order":["17021845","25576204"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses cancer stem cell markers (Nanog, CD44+) which are conceptually closer to ALDH1 as a stem cell marker, whereas Document B focuses on autophagy/beclin 1 and tumor suppression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230321Z"}
{"comparison_id":"c149752e-b9ee-4814-a146-ddc5343e789e","query_id":"51","doc_a_id":"25523969","doc_b_id":"17021845","presented_order":["25523969","17021845"],"winner_id":"17021845","reasoning":"B — It discusses a stem-cell marker's expression and prognosis (Nanog), which is more conceptually related to ALDH1 as a prognostic stem-cell marker than a miRNA metastasis profiling study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230328Z"}
{"comparison_id":"1a68caea-5a53-43a0-8748-04e28bb220c3","query_id":"51","doc_a_id":"14471161","doc_b_id":"17021845","presented_order":["17021845","14471161"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem cell marker (Nanog, and CD44+ cells), which is conceptually closer to ALDH1 as a stem-cell-related marker, whereas Document B concerns meal timing and pancreatic tumors. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230335Z"}
{"comparison_id":"c1e1828e-f362-40df-addf-663ffcaa1a45","query_id":"51","doc_a_id":"4418878","doc_b_id":"17021845","presented_order":["4418878","17021845"],"winner_id":"4418878","reasoning":"Document A is more relevant — it discusses gene expression signatures and their links to prognosis across cancers (which could include markers like ALDH1), while Document B focuses on Nanog in lung cancer, not ALDH1 or breast cancer.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230342Z"}
{"comparison_id":"070a5c78-cf90-4751-b24d-82c7433b91a3","query_id":"51","doc_a_id":"9239963","doc_b_id":"17021845","presented_order":["17021845","9239963"],"winner_id":"17021845","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document A discusses a stem-cell marker (Nanog) and prognosis, making it marginally more relevant than Document B which focuses on steroidogenesis in endometrial cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230349Z"}
{"comparison_id":"f33397ce-c248-48eb-a798-8f0a2c5e0c95","query_id":"51","doc_a_id":"67045088","doc_b_id":"17021845","presented_order":["17021845","67045088"],"winner_id":"67045088","reasoning":"Document B is more relevant — it discusses tumor control in breast cancer models (where outcomes are assessed), while A concerns Nanog in lung cancer and is unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230356Z"}
{"comparison_id":"7638bf8a-4f86-4962-9ce9-87c649f10f91","query_id":"51","doc_a_id":"5864770","doc_b_id":"17021845","presented_order":["5864770","17021845"],"winner_id":"5864770","reasoning":"Document A is more relevant because it discusses breast cancer (where ALDH1 expression would be relevant); Document B is about Nanog in lung cancer and unrelated to ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230364Z"}
{"comparison_id":"5b411a02-3572-4fc7-9c0a-03dd193ad40d","query_id":"51","doc_a_id":"23863551","doc_b_id":"17021845","presented_order":["23863551","17021845"],"winner_id":"23863551","reasoning":"Document A is more relevant — it concerns breast cancer (while Document B is about lung cancer), so A is more likely to provide evidence related to ALDH1 and breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230371Z"}
{"comparison_id":"d2273194-fdb0-4076-8784-36ec712e822d","query_id":"51","doc_a_id":"19358586","doc_b_id":"17021845","presented_order":["19358586","17021845"],"winner_id":"19358586","reasoning":"Document A is more relevant because it deals with breast cancer biology and patient outcomes, while Document B focuses on Nanog in lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230377Z"}
{"comparison_id":"1f944b43-b28f-4d1b-9e53-3da47f813b93","query_id":"51","doc_a_id":"17088791","doc_b_id":"17021845","presented_order":["17088791","17021845"],"winner_id":"17088791","reasoning":"Doc A is more relevant because it concerns breast cancer outcomes; Doc B addresses lung cancer and is not related to ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230383Z"}
{"comparison_id":"bd084ce3-1830-4d04-aa7e-50bccdc06f12","query_id":"51","doc_a_id":"1379127","doc_b_id":"17021845","presented_order":["17021845","1379127"],"winner_id":"1379127","reasoning":"Document B — it concerns breast cancer (though not ALDH1), while Document A is about Nanog in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230390Z"}
{"comparison_id":"71ed21a1-d47c-413d-abb1-eb21271e4403","query_id":"51","doc_a_id":"1866911","doc_b_id":"17021845","presented_order":["17021845","1866911"],"winner_id":"1866911","reasoning":"Document B — it concerns breast epithelial cell populations and breast cancer origins (more related to ALDH1 and outcomes) while Document A is about Nanog in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230397Z"}
{"comparison_id":"50d34869-8047-409e-bd47-c1bd7f5e5d3f","query_id":"51","doc_a_id":"5774746","doc_b_id":"17021845","presented_order":["17021845","5774746"],"winner_id":"17021845","reasoning":"Doc A — it discusses a stem cell marker and its association with cancer prognosis (though in lung cancer), which is closer to ALDH1/prognosis in breast cancer than Doc B's focus on SAA/S100A4 in colorectal metastasis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230403Z"}
{"comparison_id":"952ee58c-4aba-4911-9386-63a3f4b2c4d0","query_id":"51","doc_a_id":"31311495","doc_b_id":"17021845","presented_order":["31311495","17021845"],"winner_id":"31311495","reasoning":"Document A is more relevant — it concerns breast cancer (MCF7 cells), whereas Document B discusses Nanog in lung cancer and is unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230410Z"}
{"comparison_id":"0f0dd8a9-f0e4-443f-946d-520cf39d67dd","query_id":"51","doc_a_id":"11271123","doc_b_id":"17021845","presented_order":["11271123","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem-cell marker's expression and prognostic significance in cancer, which is more conceptually related to ALDH1 and outcomes than Document A's endometrial mutation analysis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230417Z"}
{"comparison_id":"8bad0085-92f0-4208-ac79-481933dfa9c4","query_id":"51","doc_a_id":"6790197","doc_b_id":"17021845","presented_order":["17021845","6790197"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem cell marker's expression and its association with cancer prognosis, which is conceptually closer to ALDH1 and breast cancer outcomes than prostate biopsy profiling.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230425Z"}
{"comparison_id":"97c0197d-3fc2-426c-b122-b88aeb10a04f","query_id":"51","doc_a_id":"12438901","doc_b_id":"17021845","presented_order":["17021845","12438901"],"winner_id":"12438901","reasoning":"Document B — it concerns breast cancer outcomes (tamoxifen duration) whereas Document A is about Nanog in lung cancer, so B is more relevant to the query. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230431Z"}
{"comparison_id":"6aff1492-fa39-495a-997c-348f0c397415","query_id":"51","doc_a_id":"4462079","doc_b_id":"17021845","presented_order":["4462079","17021845"],"winner_id":"17021845","reasoning":"Document B — it addresses cancer stem-cell marker expression and prognosis (though in lung cancer), which is more related to a claim about a marker's association with cancer outcomes than Document A about vitamin D. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230439Z"}
{"comparison_id":"3edfbe3b-4b3a-4f19-85af-5a59c15ff958","query_id":"51","doc_a_id":"3329824","doc_b_id":"17021845","presented_order":["3329824","17021845"],"winner_id":"3329824","reasoning":"Reason: Document A concerns breast cancer (though not ALDH1 directly), while Document B concerns lung cancer and a different marker (Nanog), so A is more relevant to the breast cancer claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230445Z"}
{"comparison_id":"687ee0eb-daa8-490e-aa03-982e39850722","query_id":"51","doc_a_id":"1507222","doc_b_id":"17021845","presented_order":["1507222","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem-cell marker and prognosis in cancer (closer to a claim about marker expression and outcomes) while A concerns uncoupling proteins and cachexia, unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230453Z"}
{"comparison_id":"c7e3fa90-8c1f-4ae5-bd25-2655047d2363","query_id":"51","doc_a_id":"24349430","doc_b_id":"17021845","presented_order":["24349430","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a stem cell marker's association with cancer prognosis, which is closer to a claim about marker expression and outcomes than Document A's mechanistic lung cell study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230460Z"}
{"comparison_id":"782d3144-127d-496d-8100-f7d3307c0186","query_id":"51","doc_a_id":"9394119","doc_b_id":"17021845","presented_order":["17021845","9394119"],"winner_id":"9394119","reasoning":"Document B — it concerns breast cancer (BRCA mutation-associated risks), whereas Document A is about Nanog in lung cancer and not relevant to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230467Z"}
{"comparison_id":"5fe35820-d376-4ee3-a80f-6f8e258879c3","query_id":"51","doc_a_id":"15559582","doc_b_id":"17021845","presented_order":["15559582","17021845"],"winner_id":"15559582","reasoning":"Document A is more relevant — it concerns breast cancer (same disease context as the claim), while Document B discusses Nanog in lung cancer and is unrelated to ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230473Z"}
{"comparison_id":"afc60329-d99e-4cd6-ae57-0ad6cef72f4c","query_id":"51","doc_a_id":"13831842","doc_b_id":"17021845","presented_order":["13831842","17021845"],"winner_id":"13831842","reasoning":"Document A is more relevant — it concerns breast cancer (though not ALDH1 specifically), while B is about Nanog in lung cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230480Z"}
{"comparison_id":"c6f9f73f-3d13-486e-a186-48d3278dad11","query_id":"51","doc_a_id":"31439189","doc_b_id":"17021845","presented_order":["31439189","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem cell marker's expression and its association with cancer prognosis (though in lung cancer), which is closer to the query about a marker's association with breast cancer outcomes than Document A's focus on prostate cell line clonogenicity.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230487Z"}
{"comparison_id":"471ef8ea-0632-48c3-9be3-efc26f822273","query_id":"51","doc_a_id":"13964633","doc_b_id":"17021845","presented_order":["13964633","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a stem cell marker's expression and its association with cancer prognosis (though in lung cancer, not ALDH1 or breast). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230494Z"}
{"comparison_id":"d0cc1a64-a0ae-4176-80c0-1b43cd5c5537","query_id":"51","doc_a_id":"31313782","doc_b_id":"17021845","presented_order":["17021845","31313782"],"winner_id":"17021845","reasoning":"Document A — it discusses a stem cell marker and its prognostic significance (closer to ALDH1/prognosis topic) while Document B focuses on TLR expression in lung/IPF. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230501Z"}
{"comparison_id":"07eee27b-dd0e-4123-a9bd-8051650611ed","query_id":"51","doc_a_id":"21181273","doc_b_id":"17021845","presented_order":["17021845","21181273"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem-cell marker and its link to cancer prognosis (though in lung cancer), while Document B concerns a different enzyme in colorectal cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230508Z"}
{"comparison_id":"6c2e62d6-6b26-457d-987d-7db5ac2f3a40","query_id":"51","doc_a_id":"12358173","doc_b_id":"17021845","presented_order":["17021845","12358173"],"winner_id":"17021845","reasoning":"Document A is more relevant because it discusses a stem cell marker (Nanog) and its association with diagnosis/prognosis, which is closer to ALDH1 (a stem cell marker) and cancer outcomes than PD-ECGF angiogenesis in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230515Z"}
{"comparison_id":"dcd431e7-c207-4137-8a1e-a59a44d36d22","query_id":"51","doc_a_id":"5222182","doc_b_id":"17021845","presented_order":["17021845","5222182"],"winner_id":"5222182","reasoning":"Document B is more relevant because it concerns breast cancer-related measures (mammographic density) while Document A is about Nanog in lung cancer, not breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230521Z"}
{"comparison_id":"9880f9cd-d7a6-424e-9ff6-df0a0b0eb552","query_id":"51","doc_a_id":"6550579","doc_b_id":"17021845","presented_order":["17021845","6550579"],"winner_id":"6550579","reasoning":"Document B is more relevant — it concerns breast cancer, while Document A is about Nanog in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230528Z"}
{"comparison_id":"c18055b3-ae55-48f0-b06e-a7aac71937a7","query_id":"51","doc_a_id":"13831558","doc_b_id":"17021845","presented_order":["17021845","13831558"],"winner_id":"13831558","reasoning":"Document B — it concerns breast cancer (risk/detection), while A is about lung cancer and Nanog, so B is more relevant. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230536Z"}
{"comparison_id":"0b59b659-619b-426e-bdeb-20c5ef95ed9e","query_id":"51","doc_a_id":"4828631","doc_b_id":"17021845","presented_order":["17021845","4828631"],"winner_id":"4828631","reasoning":"B is more relevant — it addresses breast cancer (risk) whereas A is about Nanog in lung cancer, not breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230543Z"}
{"comparison_id":"0f07abb9-f18f-4d59-bfd0-ee75fee6be46","query_id":"51","doc_a_id":"15946643","doc_b_id":"17021845","presented_order":["15946643","17021845"],"winner_id":"15946643","reasoning":"Document A is more relevant — it concerns breast cancer biology and factors affecting outcomes (chemoresistance/metastasis), whereas Document B addresses Nanog in lung cancer, not breast or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230550Z"}
{"comparison_id":"37759d6d-21f0-421d-833a-e31aa4a4cf84","query_id":"51","doc_a_id":"16630996","doc_b_id":"17021845","presented_order":["16630996","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a stem-cell marker's expression and its association with cancer prognosis, which is conceptually closer to a claim about marker (ALDH1) and outcomes than a study on gemcitabine transport in pancreatic cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230558Z"}
{"comparison_id":"4092c1c0-5df0-426c-af11-9c668d23bb12","query_id":"51","doc_a_id":"32721137","doc_b_id":"17021845","presented_order":["32721137","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a stem-cell marker's expression and its association with cancer prognosis (though different marker and cancer type), which is closer to the ALDH1–breast cancer prognosis claim than an endometrial PI3K study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230566Z"}
{"comparison_id":"5aa64f33-7878-4d55-aef6-f042526cae0e","query_id":"51","doc_a_id":"2272614","doc_b_id":"17021845","presented_order":["17021845","2272614"],"winner_id":"17021845","reasoning":"Document A is slightly more relevant because it discusses a stem cell marker's expression and prognostic significance (though in lung cancer, not ALDH1 or breast cancer). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230572Z"}
{"comparison_id":"053493ae-ff86-4c43-8248-effeceda7fbd","query_id":"51","doc_a_id":"36212758","doc_b_id":"17021845","presented_order":["17021845","36212758"],"winner_id":"17021845","reasoning":"Document A — it discusses a stem cell marker's expression and prognosis in cancer (conceptually closer to ALDH1 and outcome associations) whereas B focuses on genomic pathway profiles in NSCLC. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230580Z"}
{"comparison_id":"fa297b13-4dcf-40d5-b0b6-797bae0834f6","query_id":"51","doc_a_id":"3355397","doc_b_id":"17021845","presented_order":["3355397","17021845"],"winner_id":"17021845","reasoning":"Reason: Document B discusses a cancer stem cell marker and its prognostic significance (though in lung cancer and a different marker), making it more relevant to a claim about a stem cell marker (ALDH1) and cancer outcomes than Document A, which is about drug use and cancer risk.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230587Z"}
{"comparison_id":"20d8e949-e1f0-459f-9f19-9e4e1840d7ea","query_id":"51","doc_a_id":"5649538","doc_b_id":"17021845","presented_order":["5649538","17021845"],"winner_id":"5649538","reasoning":"Document A is more relevant — it concerns breast cancer gene expression (where ALDH1 would be measured), whereas Document B concerns Nanog in lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230594Z"}
{"comparison_id":"43b0319b-db1e-4b2d-a334-b0f236bccf00","query_id":"51","doc_a_id":"32852283","doc_b_id":"17021845","presented_order":["17021845","32852283"],"winner_id":"17021845","reasoning":"Document A is about a cancer stem-cell marker (Nanog) and its association with prognosis, which is more relevant to a claim about ALDH1 (another stem-cell marker) and outcomes than Document B's drug/NSCLC treatment focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230601Z"}
{"comparison_id":"f4d777c7-a902-44fe-8d1f-015006445a26","query_id":"51","doc_a_id":"4702639","doc_b_id":"17021845","presented_order":["17021845","4702639"],"winner_id":"4702639","reasoning":"Reason: Document B discusses tumor stemness markers and therapy resistance in carcinomas, which is closer to biomarkers and outcomes in cancer than Document A (Nanog in lung cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230609Z"}
{"comparison_id":"770f5018-caa9-4e5e-8a38-0d31de6da915","query_id":"51","doc_a_id":"24396137","doc_b_id":"17021845","presented_order":["17021845","24396137"],"winner_id":"17021845","reasoning":"Document A — it discusses a cancer stem cell marker (Nanog), which is thematically closer to ALDH1 and tumor outcomes than the Tai Chi blood pressure study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230615Z"}
{"comparison_id":"a12164cd-af83-4604-8dd1-6b669ecb6ad8","query_id":"51","doc_a_id":"33370","doc_b_id":"17021845","presented_order":["33370","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it addresses a stem cell marker's expression and prognosis in cancer (though lung, not breast), while A focuses on A20 in glioma. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230622Z"}
{"comparison_id":"a07359de-1784-426c-8668-d8787f511b2c","query_id":"51","doc_a_id":"39929509","doc_b_id":"17021845","presented_order":["17021845","39929509"],"winner_id":"17021845","reasoning":"Document A is more relevant because it discusses a cancer stem cell marker's expression and its association with prognosis (conceptually closer to ALDH1 and breast cancer outcomes) whereas Document B is about a specific RNA–protein interaction unrelated to ALDH1 or cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230630Z"}
{"comparison_id":"47de6106-add6-4aba-8236-9504511abb7f","query_id":"51","doc_a_id":"22521091","doc_b_id":"17021845","presented_order":["22521091","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a stem cell marker (Nanog) and its prognostic significance in cancer, which is conceptually closer to ALDH1 as a stem cell marker tied to outcomes than a study on NRAGE in liver cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230638Z"}
{"comparison_id":"5b08a205-0256-400e-8e5c-b28ffad932fe","query_id":"51","doc_a_id":"19673227","doc_b_id":"17021845","presented_order":["17021845","19673227"],"winner_id":"19673227","reasoning":"Document B is more relevant — it addresses prognostic/predictive markers and outcomes in epithelial tumors (potentially including breast), whereas Document A concerns Nanog in lung cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230645Z"}
{"comparison_id":"3675a6e3-013e-4c04-a37a-8d39ccd9eb51","query_id":"51","doc_a_id":"14180565","doc_b_id":"17021845","presented_order":["14180565","17021845"],"winner_id":"17021845","reasoning":"Document B is slightly more relevant because it concerns a stem-cell–related marker and prognosis in cancer, whereas A studies Aloe emodin effects in glioblastoma cells (unrelated gene/tissue). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230652Z"}
{"comparison_id":"5dcd4920-daf5-4192-bfcb-0dc5e5d7dc70","query_id":"51","doc_a_id":"31616203","doc_b_id":"17021845","presented_order":["31616203","17021845"],"winner_id":"31616203","reasoning":"Document A — it concerns breast cancer (though not ALDH1), while Document B is about lung cancer stem cell marker Nanog and is unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230659Z"}
{"comparison_id":"86c945ee-e35d-48e4-8c9b-2fb219b80c4a","query_id":"51","doc_a_id":"38808600","doc_b_id":"17021845","presented_order":["17021845","38808600"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem cell marker and prognosis (albeit in lung cancer), which is closer to the ALDH1–breast cancer outcomes topic than Document B's glioma imaging focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230666Z"}
{"comparison_id":"2ed82971-0a1d-4227-9489-b61e5d88cc88","query_id":"51","doc_a_id":"26079071","doc_b_id":"17021845","presented_order":["17021845","26079071"],"winner_id":"17021845","reasoning":"Document A is more relevant because it discusses cancer stem cell markers (Nanog, CD44+) which are conceptually closer to ALDH1 as a stem-cell marker linked to prognosis, whereas Document B is about a targeted therapy for ROS1-rearranged NSCLC. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230673Z"}
{"comparison_id":"a5877443-05a6-40fc-8d4a-7c9a93365492","query_id":"51","doc_a_id":"12869200","doc_b_id":"17021845","presented_order":["17021845","12869200"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem cell marker and prognosis (though in lung, not breast), which is closer to ALDH1's role than the metabolic biomarker/endometrial cancer focus of B.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230680Z"}
{"comparison_id":"7219800e-bbae-4440-bdb7-b7e0e63fccf9","query_id":"51","doc_a_id":"4886637","doc_b_id":"17021845","presented_order":["4886637","17021845"],"winner_id":"4886637","reasoning":"Document A is more relevant — it discusses breast cancer (population and outcomes context), while Document B concerns Nanog in lung cancer and is unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230687Z"}
{"comparison_id":"ba9fafb9-104f-4fed-8a28-51c1a768972b","query_id":"51","doc_a_id":"16098747","doc_b_id":"17021845","presented_order":["17021845","16098747"],"winner_id":"16098747","reasoning":"Document B — it concerns breast cancer (risk factors and breast density), while Document A is about Nanog in lung cancer and unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230695Z"}
{"comparison_id":"26c06839-0d2c-4f53-8b38-da2051d5bd18","query_id":"51","doc_a_id":"52925737","doc_b_id":"17021845","presented_order":["52925737","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem cell marker's expression and its association with cancer prognosis (closer conceptually to ALDH1 and outcomes) even though it’s a different marker and cancer type.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230702Z"}
{"comparison_id":"8c5514e5-0bca-40ac-86e1-2bacebe6e1da","query_id":"51","doc_a_id":"4455466","doc_b_id":"17021845","presented_order":["17021845","4455466"],"winner_id":"4455466","reasoning":"Document B — it discusses a breast cancer prognostic marker and outcomes, whereas A is about Nanog in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230708Z"}
{"comparison_id":"f10c0056-5f65-49b6-a653-f233c0cb0762","query_id":"51","doc_a_id":"38623601","doc_b_id":"17021845","presented_order":["38623601","17021845"],"winner_id":"38623601","reasoning":"Document A is more relevant because it concerns breast cancer (the same cancer type as the query), whereas Document B focuses on Nanog in lung cancer rather than ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230714Z"}
{"comparison_id":"e846a0fc-b4f1-4b2e-864c-7eb1d87d9573","query_id":"51","doc_a_id":"1032372","doc_b_id":"17021845","presented_order":["1032372","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem cell marker's expression and its prognostic significance (though in lung cancer), which is closer to the query about a stem cell marker (ALDH1) and breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230721Z"}
{"comparison_id":"a59fb75e-afde-45ec-9f62-0aa7ed38c2e0","query_id":"51","doc_a_id":"2931832","doc_b_id":"17021845","presented_order":["17021845","2931832"],"winner_id":"2931832","reasoning":"Document B is more relevant — it addresses prognostic markers in breast cancer (though not ALDH1), while Document A is about Nanog in lung cancer.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230728Z"}
{"comparison_id":"ee1cc179-447c-473f-ba49-37bfc1ee8f3b","query_id":"51","doc_a_id":"20127522","doc_b_id":"17021845","presented_order":["20127522","17021845"],"winner_id":"20127522","reasoning":"Document A is more relevant because it discusses breast cancer outcomes (though not ALDH1 specifically), whereas Document B is about Nanog in lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230734Z"}
{"comparison_id":"211640c0-22f8-4a67-b535-886148365c62","query_id":"51","doc_a_id":"5386514","doc_b_id":"17021845","presented_order":["5386514","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a cancer stem cell marker (Nanog), which is more closely related to ALDH1's role as a stem cell marker, while Document A covers NLRP3 inflammasome/immune response unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230741Z"}
{"comparison_id":"a9229081-eee1-4902-9ee5-dadbee674d07","query_id":"51","doc_a_id":"23509593","doc_b_id":"17021845","presented_order":["17021845","23509593"],"winner_id":"17021845","reasoning":"Document A is more relevant because it discusses stem cell marker expression and prognosis in cancer (though in lung, not breast), whereas Document B concerns androgen regulation in prostate stromal cells and is unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230748Z"}
{"comparison_id":"4e2590fa-6e40-484a-8a20-e20bfec31a36","query_id":"51","doc_a_id":"22975806","doc_b_id":"17021845","presented_order":["22975806","17021845"],"winner_id":"22975806","reasoning":"Doc A is more relevant because it concerns breast cancer (the query concerns ALDH1 in breast cancer), while Doc B is about Nanog in lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230756Z"}
{"comparison_id":"50b92e9a-e2e8-4d54-8248-ee7c6b34165c","query_id":"51","doc_a_id":"1976183","doc_b_id":"17021845","presented_order":["17021845","1976183"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem cell marker and prognosis (conceptually closer to ALDH1 and cancer outcomes) whereas B focuses on a microRNA in oral cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230763Z"}
{"comparison_id":"c80798bc-0a2d-4840-a8e0-d78ac63c5920","query_id":"51","doc_a_id":"16322674","doc_b_id":"17021845","presented_order":["17021845","16322674"],"winner_id":"16322674","reasoning":"Document B — it concerns breast cancer (though not ALDH1), whereas Document A is about Nanog in lung cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230769Z"}
{"comparison_id":"2b33d510-0ae5-49cf-82a8-0cc1cdcc6476","query_id":"51","doc_a_id":"46617075","doc_b_id":"17021845","presented_order":["17021845","46617075"],"winner_id":"17021845","reasoning":"Document A — discusses a stem-cell marker's expression and prognostic association (though in lung cancer and a different marker), so it's more topically related than B's focus on Rb-p16 pathway.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230776Z"}
{"comparison_id":"aaba546c-c956-46a4-913f-370b75f87edf","query_id":"51","doc_a_id":"22007333","doc_b_id":"17021845","presented_order":["22007333","17021845"],"winner_id":"22007333","reasoning":"Document A is more relevant — it concerns breast cancer–related factors (mammographic density) while Document B is about Nanog in lung cancer, not ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230783Z"}
{"comparison_id":"c5b1cdd3-32dd-4633-9ed0-f56d236c3ce5","query_id":"51","doc_a_id":"25298276","doc_b_id":"17021845","presented_order":["17021845","25298276"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem cell marker (Nanog) and prognosis, which is conceptually closer to ALDH1’s role in cancer outcomes than bisphosphonate therapy. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230790Z"}
{"comparison_id":"404088ac-e917-408a-b224-6ab2aa7b9498","query_id":"51","doc_a_id":"3067015","doc_b_id":"17021845","presented_order":["3067015","17021845"],"winner_id":"3067015","reasoning":"Document A is slightly more relevant because it mentions an ALDH gene (ALDH2), whereas Document B discusses Nanog in lung cancer and does not relate to ALDH or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230797Z"}
{"comparison_id":"344f0e4f-da32-4bf8-9d09-2ba014b59433","query_id":"51","doc_a_id":"53211308","doc_b_id":"17021845","presented_order":["53211308","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a cancer stem‑cell marker and prognosis, which is more conceptually related to ALDH1's role in prognosis than Document A's miRNA/ovarian invasion study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230804Z"}
{"comparison_id":"12fe589a-92de-4087-8fbc-0fcb598309c8","query_id":"51","doc_a_id":"9211173","doc_b_id":"17021845","presented_order":["9211173","17021845"],"winner_id":"17021845","reasoning":"Document B — it addresses a cancer stem-cell marker and prognosis (conceptually closer to ALDH1 and breast cancer outcomes) whereas Document A focuses on ARID1A in ovarian carcinoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230811Z"}
{"comparison_id":"5f7228a6-fcb6-4126-91ed-725ea309945c","query_id":"51","doc_a_id":"27306942","doc_b_id":"17021845","presented_order":["27306942","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem-cell marker's expression and prognostic association (though in lung cancer), while A concerns CRLF2 in pediatric ALL and is unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230819Z"}
{"comparison_id":"ac69f47d-2587-4eb8-8527-d40354da5021","query_id":"51","doc_a_id":"21033230","doc_b_id":"17021845","presented_order":["21033230","17021845"],"winner_id":"21033230","reasoning":"Document A is more relevant — it deals with molecular markers and prognostic information in breast cancer, while B is about Nanog in lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230825Z"}
{"comparison_id":"fa4bd041-e5c4-4a35-b367-d04d3762b959","query_id":"51","doc_a_id":"23577867","doc_b_id":"17021845","presented_order":["17021845","23577867"],"winner_id":"17021845","reasoning":"Reason: Both documents are unrelated to ALDH1 or breast cancer, but Document A discusses a cancer stem cell marker and prognosis, making it marginally closer in topic.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230832Z"}
{"comparison_id":"c6cc1871-7995-4c0a-946d-897cb692afe3","query_id":"51","doc_a_id":"34066665","doc_b_id":"17021845","presented_order":["17021845","34066665"],"winner_id":"34066665","reasoning":"Document B is more relevant because it concerns breast cancer biology and clinical outcomes, whereas Document A discusses Nanog in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230839Z"}
{"comparison_id":"9ae708bc-5ecb-4a56-a13e-d50c1e23d178","query_id":"51","doc_a_id":"11880289","doc_b_id":"17021845","presented_order":["17021845","11880289"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses expression of a cancer stem‑cell marker and its prognostic significance (though in lung cancer), which is closer to ALDH1’s role than a screening trial. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230846Z"}
{"comparison_id":"40d95ef8-392e-420c-b1d3-1d944cdb5f26","query_id":"51","doc_a_id":"5377642","doc_b_id":"17021845","presented_order":["17021845","5377642"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem cell marker's expression and its association with cancer prognosis (though in lung cancer), which is closer to the query about a marker's expression and breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230853Z"}
{"comparison_id":"6a77252b-5a78-4b73-9cac-1fdc69772275","query_id":"51","doc_a_id":"4688340","doc_b_id":"17021845","presented_order":["17021845","4688340"],"winner_id":"17021845","reasoning":"Document A is more relevant because it examines a stem cell marker's expression and its association with cancer prognosis (though in lung cancer and a different marker), whereas Document B focuses on therapy in head and neck cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230860Z"}
{"comparison_id":"1510f46d-39e2-47c4-a196-e6fdc69124e1","query_id":"51","doc_a_id":"16086778","doc_b_id":"17021845","presented_order":["16086778","17021845"],"winner_id":"16086778","reasoning":"Document A is more relevant because it addresses breast cancer biology (though not ALDH1 directly), while Document B concerns Nanog in lung cancer and is unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230890Z"}
{"comparison_id":"654f83e1-58c4-4b7e-af7d-db065a89e3f3","query_id":"51","doc_a_id":"24144677","doc_b_id":"17021845","presented_order":["24144677","17021845"],"winner_id":"24144677","reasoning":"Document A is about breast cancer (though not ALDH1), while B concerns Nanog in lung cancer and is unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230901Z"}
{"comparison_id":"ce054575-e73b-4291-8f31-2e7342992fc2","query_id":"51","doc_a_id":"2061878","doc_b_id":"17021845","presented_order":["17021845","2061878"],"winner_id":"2061878","reasoning":"Document B — it discusses a cancer-related prognostic marker across multiple solid tumors (more general relevance to prognosis) while A is specific to Nanog in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230910Z"}
{"comparison_id":"e24ba3e7-5b51-4c60-b041-e90200cab27f","query_id":"51","doc_a_id":"33638477","doc_b_id":"17021845","presented_order":["33638477","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it addresses a stem cell marker's expression and its association with cancer prognosis (though in lung cancer), which is conceptually closer to ALDH1 as a stem cell marker than Document A's focus on BCL9 oncogene mechanisms.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230918Z"}
{"comparison_id":"2c9e3fcf-4996-4dd6-9fbb-f1405fd0d880","query_id":"51","doc_a_id":"2015126","doc_b_id":"17021845","presented_order":["17021845","2015126"],"winner_id":"2015126","reasoning":"Document B is more relevant because it concerns breast cancer, whereas Document A discusses Nanog in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230924Z"}
{"comparison_id":"fcb0c47e-f65a-4c67-a4f0-e8001a6740e8","query_id":"51","doc_a_id":"21902400","doc_b_id":"17021845","presented_order":["17021845","21902400"],"winner_id":"21902400","reasoning":"Document B is more relevant — it discusses prognostic factors in cancer (though not ALDH1 or breast cancer specifically), whereas A focuses on Nanog in lung cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230932Z"}
{"comparison_id":"57d1a064-5861-4562-a413-9868f2f0bcf7","query_id":"51","doc_a_id":"20738970","doc_b_id":"17021845","presented_order":["17021845","20738970"],"winner_id":"17021845","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it discusses a stem cell marker (Nanog), whereas B focuses on a tyrosine kinase in SCLC apoptosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230938Z"}
{"comparison_id":"844e5d06-45a3-40cf-aa01-1d3d5621228e","query_id":"51","doc_a_id":"3210545","doc_b_id":"17021845","presented_order":["17021845","3210545"],"winner_id":"17021845","reasoning":"Document A is more related because it discusses a stem-cell marker's expression and its prognostic significance (though in lung cancer), which is closer to ALDH1 prognostic claims than KRAS in endometrial cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230945Z"}
{"comparison_id":"ad026fc8-dc11-406a-80e1-aae9fe0bb182","query_id":"51","doc_a_id":"23557241","doc_b_id":"17021845","presented_order":["17021845","23557241"],"winner_id":"23557241","reasoning":"Document B — it concerns breast cancer (though not ALDH1 specifically), whereas A is about lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230951Z"}
{"comparison_id":"b7068205-1b91-44b5-b489-cb05894f0dc2","query_id":"51","doc_a_id":"878526","doc_b_id":"17021845","presented_order":["878526","17021845"],"winner_id":"878526","reasoning":"Document A is more relevant — it concerns breast cancer metastasis and metastasis-initiating cells (related to stem-cell markers like ALDH1), whereas B is about Nanog in lung cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230958Z"}
{"comparison_id":"e64b2332-ae7b-4740-8558-796bee3f5959","query_id":"51","doc_a_id":"39758684","doc_b_id":"17021845","presented_order":["39758684","17021845"],"winner_id":"17021845","reasoning":"Document B is more related: it discusses a stem-cell marker's expression and prognostic significance in cancer (though a different marker and in lung cancer, not ALDH1 or breast cancer). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230964Z"}
{"comparison_id":"03d1adac-e3fc-4ebb-87a7-85249a552b26","query_id":"51","doc_a_id":"26848994","doc_b_id":"17021845","presented_order":["26848994","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a stem cell marker's expression and its association with cancer prognosis, which is conceptually closer to a claim about ALDH1 and breast cancer outcomes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230972Z"}
{"comparison_id":"20f3725a-23af-4116-a02e-252d15993f88","query_id":"51","doc_a_id":"36432234","doc_b_id":"17021845","presented_order":["36432234","17021845"],"winner_id":"36432234","reasoning":"Document A is more relevant because it concerns breast cancer (the claim is about breast cancer), whereas Document B deals with Nanog in lung cancer and is unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230979Z"}
{"comparison_id":"954fc3c3-1206-46a8-ae61-6cc5c0eb897b","query_id":"51","doc_a_id":"30226988","doc_b_id":"17021845","presented_order":["30226988","17021845"],"winner_id":"30226988","reasoning":"Document A is more relevant — it discusses breast cancer survival/outcomes (though not ALDH1), while Document B is about Nanog in lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230987Z"}
{"comparison_id":"fff1be75-cdec-4680-8e65-f8567496b09c","query_id":"51","doc_a_id":"25121903","doc_b_id":"17021845","presented_order":["17021845","25121903"],"winner_id":"17021845","reasoning":"Document A — it discusses stem cell marker expression and prognosis (though in lung cancer), which is more relevant to a claim about ALDH1 and breast cancer outcomes than general survivor statistics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.230995Z"}
{"comparison_id":"ba7cf8cf-27cf-4577-ae52-bd1e7f051c23","query_id":"51","doc_a_id":"21502234","doc_b_id":"17021845","presented_order":["21502234","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it addresses a cancer stem cell marker and prognosis (conceptually closer to ALDH1's role) whereas A concerns mismatch repair in endometrial cancer, unrelated to stem cell markers or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231002Z"}
{"comparison_id":"e797a747-08c6-4031-aa30-3bd90a4c1e0d","query_id":"51","doc_a_id":"3222187","doc_b_id":"17021845","presented_order":["17021845","3222187"],"winner_id":"3222187","reasoning":"Document B is more relevant — it concerns a breast cancer study population (though about vitamin D), while Document A addresses Nanog in lung cancer, not breast cancer or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231010Z"}
{"comparison_id":"e11b510b-e3df-4f7e-967a-a2d406503fab","query_id":"51","doc_a_id":"24834968","doc_b_id":"17021845","presented_order":["17021845","24834968"],"winner_id":"24834968","reasoning":"Document B — it's about biological markers and breast cancer outcomes, whereas A is about Nanog in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231016Z"}
{"comparison_id":"6df318cd-012f-4948-bbe5-3f6e247c2725","query_id":"51","doc_a_id":"14938990","doc_b_id":"17021845","presented_order":["14938990","17021845"],"winner_id":"17021845","reasoning":"Document B — it addresses cancer marker expression and prognosis (though in lung cancer), which is closer to a claim about ALDH1 and breast cancer outcomes than a study on PD-1 and SLE.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231024Z"}
{"comparison_id":"48a0b7bb-2ee9-4607-ae00-af2a2c63af0c","query_id":"51","doc_a_id":"20183360","doc_b_id":"17021845","presented_order":["20183360","17021845"],"winner_id":"20183360","reasoning":"Document A is more relevant — it concerns breast cancer biology, while Document B discusses Nanog in lung cancer, unrelated to ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231030Z"}
{"comparison_id":"cbae1a2a-6677-43db-a3e1-77a858f42099","query_id":"51","doc_a_id":"5500086","doc_b_id":"17021845","presented_order":["5500086","17021845"],"winner_id":"5500086","reasoning":"Document A is more relevant because it discusses factors correlated with breast cancer clinical outcomes, whereas Document B concerns Nanog in lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231037Z"}
{"comparison_id":"12954396-4eec-4613-a6df-3a63bf2642bf","query_id":"51","doc_a_id":"25628793","doc_b_id":"17021845","presented_order":["17021845","25628793"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem cell marker and prognosis in cancer, which is closer to ALDH1 and breast cancer outcomes than the endometriosis/CYP enzyme focus in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231044Z"}
{"comparison_id":"06c50459-0943-44a3-b187-82db59410131","query_id":"51","doc_a_id":"26735905","doc_b_id":"17021845","presented_order":["17021845","26735905"],"winner_id":"17021845","reasoning":"Document A. It discusses expression of a cancer stem cell marker and its association with prognosis (though in lung cancer and a different marker), so it's more thematically relevant than Document B. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231052Z"}
{"comparison_id":"876683d3-b2c1-45a8-871f-8c8bea0b4491","query_id":"51","doc_a_id":"7875158","doc_b_id":"17021845","presented_order":["7875158","17021845"],"winner_id":"7875158","reasoning":"Document A is more relevant — it addresses breast carcinoma, whereas Document B concerns Nanog in lung cancer and is unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231058Z"}
{"comparison_id":"2e951a5b-ae3d-4af8-bdff-f4c2628d4f73","query_id":"51","doc_a_id":"52188256","doc_b_id":"17021845","presented_order":["17021845","52188256"],"winner_id":"52188256","reasoning":"Document B — it mentions breast cancer specifically (Document A is about Nanog in lung cancer). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231065Z"}
{"comparison_id":"cc919b3c-ec4e-42c9-92fa-e47cfb0d2fe3","query_id":"51","doc_a_id":"4889228","doc_b_id":"17021845","presented_order":["4889228","17021845"],"winner_id":"4889228","reasoning":"Document A is more relevant because it concerns breast cancer prognosis (even though it doesn't mention ALDH1), while Document B addresses Nanog in lung cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231075Z"}
{"comparison_id":"0240235d-5ce1-4d82-8d72-adc781847d0d","query_id":"51","doc_a_id":"17876040","doc_b_id":"17021845","presented_order":["17021845","17876040"],"winner_id":"17021845","reasoning":"Document A is slightly more relevant because it discusses a stem cell marker's expression and its association with cancer prognosis (though in lung cancer), whereas B focuses on an AML drug and is unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231082Z"}
{"comparison_id":"76e692f1-f37f-42bd-b6d4-d3ffd5f0e180","query_id":"51","doc_a_id":"3052213","doc_b_id":"17021845","presented_order":["17021845","3052213"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem cell marker and prognosis (though in lung cancer), which is closer to ALDH1 and breast cancer outcomes than an adipocyte epigenetics study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231090Z"}
{"comparison_id":"2c1ef90b-5173-4eda-923d-45671842920f","query_id":"51","doc_a_id":"26902591","doc_b_id":"17021845","presented_order":["17021845","26902591"],"winner_id":"17021845","reasoning":"Document A — it discusses expression of a cancer stem cell marker and its prognostic significance (though in lung cancer and for Nanog, not ALDH1/breast cancer), so it's closer in topic than the cachexia-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231097Z"}
{"comparison_id":"af442db8-a365-4627-85f5-c0f90f311369","query_id":"51","doc_a_id":"32534305","doc_b_id":"17021845","presented_order":["17021845","32534305"],"winner_id":"32534305","reasoning":"Document B — it concerns breast cancer (though not ALDH1), whereas A is about Nanog in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231103Z"}
{"comparison_id":"6e33cdec-53c2-40a8-b6e4-e85edbe0e4f7","query_id":"51","doc_a_id":"13765757","doc_b_id":"17021845","presented_order":["17021845","13765757"],"winner_id":"13765757","reasoning":"Document B — it concerns breast cancer (risk/outcomes), whereas Document A discusses Nanog in lung cancer and is unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231111Z"}
{"comparison_id":"4a4ed1a0-d014-4dc1-96fb-d9719c7c261d","query_id":"51","doc_a_id":"6517763","doc_b_id":"17021845","presented_order":["17021845","6517763"],"winner_id":"17021845","reasoning":"Reason: Document A discusses a cancer stem cell marker (Nanog) and prognosis, which is more related to ALDH1 as a stem cell marker than Document B's glioblastoma genomics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231117Z"}
{"comparison_id":"73430170-242c-4a02-9460-8920d391908f","query_id":"51","doc_a_id":"17163294","doc_b_id":"17021845","presented_order":["17021845","17163294"],"winner_id":"17163294","reasoning":"Document B is more relevant — it includes breast cancer data (whereas A is about Nanog in lung cancer and unrelated to ALDH1 or breast outcomes).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231125Z"}
{"comparison_id":"a0c42ec1-8b0e-41cc-9c10-5bcbca4847b7","query_id":"51","doc_a_id":"293661","doc_b_id":"17021845","presented_order":["293661","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it deals with a stem cell marker's expression and its association with cancer prognosis, which is conceptually closer to ALDH1's role than arginine metabolism. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231131Z"}
{"comparison_id":"21242410-98ec-49f1-8ce5-c01000fcc5e4","query_id":"51","doc_a_id":"16691520","doc_b_id":"17021845","presented_order":["16691520","17021845"],"winner_id":"16691520","reasoning":"Document A is more relevant — it deals with breast cancer genomic regulation, whereas Document B covers Nanog in lung cancer (unrelated tissue/gene). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231137Z"}
{"comparison_id":"c05e21c4-dddc-4016-a274-82a79be30e82","query_id":"51","doc_a_id":"16532419","doc_b_id":"17021845","presented_order":["16532419","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it examines the prognostic significance of a stem cell marker in cancer, which aligns with the claim about marker expression and outcomes, whereas A focuses on induction of stem-like cells and tumorigenicity.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231144Z"}
{"comparison_id":"c6aeefae-aa36-4046-a716-56ce9b5b6a3a","query_id":"51","doc_a_id":"26488879","doc_b_id":"17021845","presented_order":["17021845","26488879"],"winner_id":"17021845","reasoning":"Document A is more relevant — it's about cancer stem cell markers (Nanog) and prognosis, which is conceptually related to ALDH1 and cancer outcomes; Document B is unrelated to cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231151Z"}
{"comparison_id":"8087cec4-45fc-4ac7-b3f9-c01bed434296","query_id":"51","doc_a_id":"2360905","doc_b_id":"17021845","presented_order":["17021845","2360905"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses stem-cell markers in cancer (though in lung), which is more closely related to ALDH1 and cancer outcomes than a pediatric glioma genomic study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231158Z"}
{"comparison_id":"5faa1138-64b5-4b8c-a20f-8e503e1c9818","query_id":"51","doc_a_id":"16390264","doc_b_id":"17021845","presented_order":["17021845","16390264"],"winner_id":"16390264","reasoning":"Document B is more relevant — it addresses breast cancer patient outcomes/access, whereas Document A concerns Nanog in lung cancer, not ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231165Z"}
{"comparison_id":"c4c45b09-340b-49c8-8474-7f366014d79e","query_id":"51","doc_a_id":"515489","doc_b_id":"17021845","presented_order":["17021845","515489"],"winner_id":"17021845","reasoning":"Doc A is somewhat more relevant because it discusses a stem-cell marker (Nanog) and its association with cancer prognosis, whereas Doc B focuses on lncRNA PVT1 in hepatocellular carcinoma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231172Z"}
{"comparison_id":"ddf0a715-4353-4e29-bc4a-a0c749e898a9","query_id":"51","doc_a_id":"663464","doc_b_id":"17021845","presented_order":["17021845","663464"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem cell marker and prognosis (though in lung cancer), which is closer to ALDH1 and breast cancer outcomes than an aging microRNA study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231178Z"}
{"comparison_id":"c6285375-15c6-43be-a52c-1c4449d47725","query_id":"51","doc_a_id":"7228140","doc_b_id":"17021845","presented_order":["7228140","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem-cell marker (Nanog) and prognosis, which is closer to the query about ALDH1 and cancer outcomes than Document A's focus on PDAC subtypes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231184Z"}
{"comparison_id":"70399517-ab5b-440f-9eb3-ee823a50bcab","query_id":"51","doc_a_id":"3524352","doc_b_id":"17021845","presented_order":["17021845","3524352"],"winner_id":"3524352","reasoning":"Document B is more relevant because it concerns breast cancer outcomes (mortality), while Document A addresses Nanog in lung cancer, not breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231190Z"}
{"comparison_id":"b1d4c896-d6d0-47fd-a3c4-c8256768db47","query_id":"51","doc_a_id":"520579","doc_b_id":"17021845","presented_order":["17021845","520579"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem-cell marker's expression and its relation to cancer prognosis, whereas Document B is unrelated (vitamin D and colorectal cancer risk).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231197Z"}
{"comparison_id":"9acb2c5e-c0c7-4d23-a333-f6072c7c393f","query_id":"51","doc_a_id":"3559136","doc_b_id":"17021845","presented_order":["3559136","17021845"],"winner_id":"3559136","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer specifically, but Document A relates to tumor biology and treatment effects (more directly tied to cancer outcomes) whereas Document B concerns Nanog in lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231203Z"}
{"comparison_id":"5018f31a-4dcd-4ffd-b8d9-dbedb74aa615","query_id":"51","doc_a_id":"24873253","doc_b_id":"17021845","presented_order":["24873253","17021845"],"winner_id":"17021845","reasoning":"B is more relevant — it discusses the prognostic significance of a cancer stem-cell marker (Nanog), which is conceptually closer to a claim about ALDH1 expression and breast cancer outcomes than A's focus on bisphosphonate treatment.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231210Z"}
{"comparison_id":"1292a6be-67ce-474d-97b2-1b30eea75d96","query_id":"51","doc_a_id":"17755060","doc_b_id":"17021845","presented_order":["17021845","17755060"],"winner_id":"17021845","reasoning":"Doc A is more relevant because it discusses a stem cell marker's expression and its association with cancer prognosis (even though it's Nanog in lung cancer, it's closer in topic than the metabolic focus of B). \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231217Z"}
{"comparison_id":"5e776b79-5f6b-45dc-9d4f-cde12e01b801","query_id":"51","doc_a_id":"4729644","doc_b_id":"17021845","presented_order":["17021845","4729644"],"winner_id":"17021845","reasoning":"Doc A discusses a stem-cell marker's expression and its link to cancer prognosis (though in lung cancer), which is closer to the query about marker expression and outcomes than Doc B's focus on lncRNA-driven drug resistance in NPC.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231223Z"}
{"comparison_id":"c7fbc77f-5b69-497a-9453-bc99f7e3dc95","query_id":"51","doc_a_id":"3805841","doc_b_id":"17021845","presented_order":["3805841","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it addresses expression of a stem-cell marker and its association with cancer prognosis (though in lung cancer), whereas Document A discusses MYC and circadian disruption, not marker expression or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231230Z"}
{"comparison_id":"ab61c3f5-7230-4b15-82af-9603921007e6","query_id":"51","doc_a_id":"25488034","doc_b_id":"17021845","presented_order":["25488034","17021845"],"winner_id":"25488034","reasoning":"Document A — it discusses enzyme systems and cancer-related enzyme regulation (more relevant to an enzyme marker like ALDH1) whereas B addresses Nanog in lung cancer, not ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231237Z"}
{"comparison_id":"d64dec55-2091-4c0c-b893-8ef0a5be4e4f","query_id":"51","doc_a_id":"3376731","doc_b_id":"17021845","presented_order":["17021845","3376731"],"winner_id":"17021845","reasoning":"Document A — it discusses a stem-cell marker's expression and prognostic significance (though in lung cancer), which is closer to the ALDH1/breast cancer prognosis topic than Document B's IL6/CXCR7 chemoresistance focus. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231244Z"}
{"comparison_id":"7022efd4-cb6f-4468-9717-f1c68fc3903e","query_id":"51","doc_a_id":"21551568","doc_b_id":"17021845","presented_order":["17021845","21551568"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses expression of a stem cell marker and its link to diagnosis/prognosis (though in lung cancer), whereas B focuses on PI3K/Akt genetic changes in thyroid cancer and is unrelated to marker expression or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231251Z"}
{"comparison_id":"0356b1a0-6dca-491f-ab60-c7e85cc314d3","query_id":"51","doc_a_id":"11968641","doc_b_id":"17021845","presented_order":["17021845","11968641"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem cell marker (Nanog) and stem cell-associated expression, which is closer to ALDH1's role in cancer prognosis than circadian-clock effects in melanoma/colon cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231258Z"}
{"comparison_id":"9741a903-9e52-490b-bece-a6b7d29ecb98","query_id":"51","doc_a_id":"38243984","doc_b_id":"17021845","presented_order":["38243984","17021845"],"winner_id":"17021845","reasoning":"Document B — it examines a stem-cell marker's expression and prognosis in cancer (closer to ALDH1’s role) while A is about pancreatic tumor engraftment and gemcitabine resistance. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231264Z"}
{"comparison_id":"d0b85633-0d31-4a38-b368-c9d173fef33e","query_id":"51","doc_a_id":"15600979","doc_b_id":"17021845","presented_order":["17021845","15600979"],"winner_id":"15600979","reasoning":"Document B is more relevant — it discusses mechanisms related to breast cancer, whereas Document A concerns Nanog in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231270Z"}
{"comparison_id":"67615390-da38-418f-ba26-c5f69680bc83","query_id":"51","doc_a_id":"4468861","doc_b_id":"17021845","presented_order":["17021845","4468861"],"winner_id":"17021845","reasoning":"Document A is slightly more relevant because it discusses a stem cell marker's expression and prognostic association (though in lung, not breast, and a different marker). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.231277Z"}
{"comparison_id":"c60ff87f-a324-4d0c-bc9c-a8999e074e52","query_id":"51","doc_a_id":"29806339","doc_b_id":"17021845","presented_order":["29806339","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a cancer stem cell marker and prognosis (related concept), whereas A focuses on mitotic exit mechanisms and tumor regression without addressing ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.264935Z"}
{"comparison_id":"acf4b10c-eaff-44bb-8f84-3fbb82b85c29","query_id":"51","doc_a_id":"8891333","doc_b_id":"17021845","presented_order":["8891333","17021845"],"winner_id":"8891333","reasoning":"Document A is more relevant — it discusses cancer stem cells in breast cancer (even though it doesn't mention ALDH1 specifically), whereas Document B is about Nanog in lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.265136Z"}
{"comparison_id":"ab98b371-0500-4738-a696-baf4daebef1c","query_id":"51","doc_a_id":"33030946","doc_b_id":"17021845","presented_order":["33030946","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses cancer stem cell markers and prognosis, which is closer to ALDH1's role in cancer outcomes than Document A's focus on macrophage/osteoclast biology.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.265279Z"}
{"comparison_id":"267e30a2-e693-4145-93f8-1ac5c78f0918","query_id":"51","doc_a_id":"1065627","doc_b_id":"17021845","presented_order":["17021845","1065627"],"winner_id":"1065627","reasoning":"Document B — it concerns breast cancer biology (though not ALDH1 specifically), whereas Document A is about Nanog in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.265440Z"}
{"comparison_id":"be159f19-82d6-481b-9222-9a326cc81957","query_id":"51","doc_a_id":"38355793","doc_b_id":"17021845","presented_order":["38355793","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem cell marker and its prognostic significance in cancer, which is more conceptually related to ALDH1 and cancer outcomes than Document A about A20 in glioma.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.265571Z"}
{"comparison_id":"adbc7a31-0f31-4ac3-821a-5b55e158e556","query_id":"51","doc_a_id":"24974080","doc_b_id":"17021845","presented_order":["17021845","24974080"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses stem cell marker expression and prognosis (though in lung cancer and a different marker), which is closer to the query than a VEGF/angiogenesis therapy paper.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.265702Z"}
{"comparison_id":"5f864736-f076-4a7e-86a8-c0f4a9353f58","query_id":"51","doc_a_id":"9648896","doc_b_id":"17021845","presented_order":["17021845","9648896"],"winner_id":"17021845","reasoning":"Doc A is slightly more relevant because it discusses a stem cell marker (Nanog) and cancer prognosis, which is closer to ALDH1's role as a cancer stem cell marker and outcome associations than Doc B's CAF/microRNA focus. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.265827Z"}
{"comparison_id":"a0717838-c6dd-4fbe-9840-a9c50e651efd","query_id":"51","doc_a_id":"16016673","doc_b_id":"17021845","presented_order":["16016673","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses expression of a stem-cell marker and its relation to cancer prognosis (though in lung cancer and a different marker), whereas A is about bladder DNA methylation markers unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.265932Z"}
{"comparison_id":"528f62db-3784-4cef-ac8e-ceaf96e7e353","query_id":"51","doc_a_id":"23934390","doc_b_id":"17021845","presented_order":["17021845","23934390"],"winner_id":"17021845","reasoning":"Neither document addresses ALDH1 or breast cancer, but Document A discusses a stem-cell marker (Nanog) and prognosis, making it marginally more relevant than B (miR-203/Bmi1 in NSCLC). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.265973Z"}
{"comparison_id":"5266c880-72e1-45b2-a908-b66780170c1f","query_id":"51","doc_a_id":"4841908","doc_b_id":"17021845","presented_order":["17021845","4841908"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem-cell marker and prognosis (though different marker and cancer type), while B concerns metabolomics and longevity unrelated to ALDH1 or breast cancer.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266007Z"}
{"comparison_id":"f4cfac55-f5c9-4bed-ab82-01eb90402e33","query_id":"51","doc_a_id":"1780819","doc_b_id":"17021845","presented_order":["1780819","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses expression of a stem-cell marker (Nanog) and its association with cancer diagnosis/prognosis, which is conceptually closer to ALDH1 expression and outcomes than a paper on HAND2 methylation in endometrial cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266041Z"}
{"comparison_id":"5694c091-6967-41fd-a993-fbeb871d5710","query_id":"51","doc_a_id":"16806763","doc_b_id":"17021845","presented_order":["17021845","16806763"],"winner_id":"17021845","reasoning":"Document A is slightly more relevant because it discusses a stem cell marker's expression and prognosis in cancer (though in lung, not breast); Document B concerns lncRNA signatures in colorectal cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266073Z"}
{"comparison_id":"2a3c9aac-8429-4ffb-861f-bddec8fd0001","query_id":"51","doc_a_id":"4387494","doc_b_id":"17021845","presented_order":["17021845","4387494"],"winner_id":"17021845","reasoning":"Document A is slightly more relevant because it discusses expression of a stem cell marker and its association with cancer prognosis (though in lung cancer and a different marker), whereas Document B concerns a drug study in AML unrelated to marker expression or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266106Z"}
{"comparison_id":"6ce1e9c2-1b37-4f42-98ea-bcc5e265dd8f","query_id":"51","doc_a_id":"8496132","doc_b_id":"17021845","presented_order":["17021845","8496132"],"winner_id":"17021845","reasoning":"Neither document discusses ALDH1 or breast cancer, but Document A covers a stem‑cell marker (Nanog) and its prognostic role in cancer, making it more conceptually relevant than Document B (HuR/Bcl-2 in leukemia/carcinoma cells).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266138Z"}
{"comparison_id":"2189adff-a287-49a7-893e-bd3d46dc541a","query_id":"51","doc_a_id":"14241418","doc_b_id":"17021845","presented_order":["17021845","14241418"],"winner_id":"14241418","reasoning":"Document B is more relevant because it concerns cancer treatment and mechanisms (including trastuzumab-resistant cells relevant to breast cancer), while A discusses Nanog in lung cancer and not ALDH1 or breast outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266174Z"}
{"comparison_id":"db9fc7fb-a3c6-4eab-b575-93f92ee7cffe","query_id":"51","doc_a_id":"21414718","doc_b_id":"17021845","presented_order":["21414718","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem cell marker and its association with cancer diagnosis/prognosis, which is more analogous to a claim about a marker (ALDH1) and breast cancer outcomes than Document A. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266206Z"}
{"comparison_id":"a6dcb779-b95b-44b9-9a7b-3a3e5c95ce76","query_id":"51","doc_a_id":"23601616","doc_b_id":"17021845","presented_order":["23601616","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses cancer stem cell marker expression and prognosis, whereas A is about hippocampal effects of liraglutide in mice. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266236Z"}
{"comparison_id":"b4067b5b-8a92-48c7-81d6-0ecacd9b69c7","query_id":"51","doc_a_id":"18987782","doc_b_id":"17021845","presented_order":["18987782","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it addresses expression of a stem-cell marker and its association with cancer prognosis (though in lung cancer, not ALDH1 or breast).  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266267Z"}
{"comparison_id":"7c78ff83-ef26-44fe-ac32-a027900d1a93","query_id":"51","doc_a_id":"2014909","doc_b_id":"17021845","presented_order":["17021845","2014909"],"winner_id":"2014909","reasoning":"Document B is more relevant — it analyzes primary breast cancers (while A is about Nanog in lung cancer), so B is likelier to address markers like ALDH1 and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266298Z"}
{"comparison_id":"aad02813-9762-45fe-8535-0ae75719ea9a","query_id":"51","doc_a_id":"13519661","doc_b_id":"17021845","presented_order":["17021845","13519661"],"winner_id":"13519661","reasoning":"Document B is more relevant because it concerns breast cancer (while Document A is about lung cancer); neither mentions ALDH1, but B is closer to the query topic.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266329Z"}
{"comparison_id":"949b1d02-9ca9-43ba-aedc-ed82e3c1a7f9","query_id":"51","doc_a_id":"14663842","doc_b_id":"17021845","presented_order":["17021845","14663842"],"winner_id":"17021845","reasoning":"Document A is more relevant because it discusses expression of a cancer stem-cell marker and its association with prognosis (though in lung cancer), whereas Document B is about IDH1 metabolic effects and unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266361Z"}
{"comparison_id":"e7edf526-d21e-4344-b075-62df9834c73b","query_id":"51","doc_a_id":"22267225","doc_b_id":"17021845","presented_order":["17021845","22267225"],"winner_id":"22267225","reasoning":"Reason: Neither abstract mentions ALDH1, but Document B discusses breast cancer in a broad outcomes/prevention context, making it slightly more relevant than a lung cancer–focused Nanog study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266393Z"}
{"comparison_id":"8e3e57f4-50aa-472b-9adf-559f8ba9ccf1","query_id":"51","doc_a_id":"5278233","doc_b_id":"17021845","presented_order":["17021845","5278233"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem cell marker's expression and its association with diagnosis/prognosis, which is closer to ALDH1 and breast cancer outcomes than the imprinting/Beckwith-Wiedemann topic in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266424Z"}
{"comparison_id":"25fb57ea-504f-4c1b-be44-cbd56f14a1d7","query_id":"51","doc_a_id":"6807122","doc_b_id":"17021845","presented_order":["6807122","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem cell marker's expression and prognostic significance (though in lung cancer), which is closer to the query about ALDH1 and breast cancer outcomes than Document A's focus on EndMT and fibroblasts.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266456Z"}
{"comparison_id":"cba7c209-28c0-4791-901e-4725943a1bba","query_id":"51","doc_a_id":"38784540","doc_b_id":"17021845","presented_order":["17021845","38784540"],"winner_id":"38784540","reasoning":"Document B — it's about breast cancer (risk factors and breast density), whereas A is about Nanog in lung cancer and unrelated to ALDH1 or breast outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266487Z"}
{"comparison_id":"bd31a3d5-e3a3-43ea-8a41-dd430bcbd59b","query_id":"51","doc_a_id":"20568364","doc_b_id":"17021845","presented_order":["20568364","17021845"],"winner_id":"17021845","reasoning":"Both documents are irrelevant to ALDH1 in breast cancer, but B is slightly more relevant because it examines a cancer stem‑cell marker's association with prognosis (though it's Nanog in lung cancer, not ALDH1 in breast cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266519Z"}
{"comparison_id":"6f69ea12-2503-423e-9563-bf8d194d4502","query_id":"51","doc_a_id":"11481946","doc_b_id":"17021845","presented_order":["17021845","11481946"],"winner_id":"17021845","reasoning":"Document A — it discusses a cancer stem cell marker and prognosis (though in lung cancer), which is more thematically related to ALDH1 and outcome than the metabolic/diabetes focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266551Z"}
{"comparison_id":"c699db03-defa-42f6-ad0c-6b5efeaf8033","query_id":"51","doc_a_id":"21382907","doc_b_id":"17021845","presented_order":["17021845","21382907"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem cell marker and prognosis (though different marker and cancer type), whereas B concerns integrin-targeted therapy in head and neck cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266582Z"}
{"comparison_id":"1361c564-3a55-484d-845e-2ba7aeb064ad","query_id":"51","doc_a_id":"23269537","doc_b_id":"17021845","presented_order":["17021845","23269537"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem cell marker's expression and its prognostic significance, which is closer to ALDH1 and breast cancer outcomes than a cyclin D1 epigenetics study in B‑cell malignancy.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266614Z"}
{"comparison_id":"f5f3fcb9-9b3a-4016-bb41-64ece67cbec1","query_id":"51","doc_a_id":"23078022","doc_b_id":"17021845","presented_order":["17021845","23078022"],"winner_id":"23078022","reasoning":"Document B is more relevant — it discusses an oncoprotein active in human carcinomas (including breast), whereas A is specific to Nanog in lung cancer and unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266646Z"}
{"comparison_id":"579aa919-4c31-4d0b-bf88-1d0663cdecd5","query_id":"51","doc_a_id":"23013317","doc_b_id":"17021845","presented_order":["17021845","23013317"],"winner_id":"17021845","reasoning":"Document A — it discusses cancer stem-cell marker expression and prognosis (though in lung cancer and for Nanog, it's closer to the claim than B, which is unrelated). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266677Z"}
{"comparison_id":"377c0d57-6155-4da8-8454-9517f18ccfb5","query_id":"51","doc_a_id":"5487448","doc_b_id":"17021845","presented_order":["17021845","5487448"],"winner_id":"5487448","reasoning":"Document B is more relevant because it concerns breast cancer risk factors, whereas Document A concerns Nanog in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266708Z"}
{"comparison_id":"5572c98f-61d2-4800-b0b2-533664bb9651","query_id":"51","doc_a_id":"43334921","doc_b_id":"17021845","presented_order":["43334921","17021845"],"winner_id":"17021845","reasoning":"Reason: Document B discusses a cancer stem cell marker's expression and its association with prognosis (though in lung cancer and for Nanog), which is closer in topic to ALDH1 expression and breast cancer outcomes than Document A's focus on NSAIDs and colorectal cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266725Z"}
{"comparison_id":"665c3fbb-2b3d-4df5-9009-df17a279db24","query_id":"51","doc_a_id":"13070316","doc_b_id":"17021845","presented_order":["13070316","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem cell marker and prognosis (though in lung cancer), which is closer to ALDH1's role in cancer outcomes than Document A's focus on macrophage-driven angiogenesis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266753Z"}
{"comparison_id":"e197697c-a4ec-4557-81a5-2bc8d8f9bfb3","query_id":"51","doc_a_id":"57783564","doc_b_id":"17021845","presented_order":["17021845","57783564"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem cell marker's expression and its association with cancer prognosis (though in lung cancer), which is closer to ALDH1 and breast cancer outcomes than Document B's focus on CDX2 and colon cancer.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266858Z"}
{"comparison_id":"1fb57605-4a9b-446b-91ac-d12115370fa3","query_id":"51","doc_a_id":"6363093","doc_b_id":"17021845","presented_order":["6363093","17021845"],"winner_id":"17021845","reasoning":"Document B — discusses a stem cell marker's expression and its association with cancer prognosis (though in lung cancer and a different marker), so it's more topically related than the glioblastoma signaling study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266895Z"}
{"comparison_id":"d85e095c-7ff9-499a-bf71-4ea5e6feca35","query_id":"51","doc_a_id":"40234452","doc_b_id":"17021845","presented_order":["40234452","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses stem cell marker expression in cancer prognosis (though in lung cancer and Nanog, not ALDH1 or breast cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266927Z"}
{"comparison_id":"449db5c3-5eaf-4702-9919-448b1c17ffad","query_id":"51","doc_a_id":"2328272","doc_b_id":"17021845","presented_order":["17021845","2328272"],"winner_id":"17021845","reasoning":"Document A — it discusses a stem-cell marker's expression and prognostic significance in cancer (though different marker and cancer type), which is closer to the query than Document B's trial recruitment/survivorship topic.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266958Z"}
{"comparison_id":"445d3c9f-09a1-4e0d-95bd-3eb312b7a875","query_id":"51","doc_a_id":"9558539","doc_b_id":"17021845","presented_order":["9558539","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it addresses a stem cell marker's expression and prognostic significance (though in lung cancer), whereas A focuses on CD44v6 in colorectal metastasis and is less related to marker-outcome associations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.266990Z"}
{"comparison_id":"1bb61b3a-647c-4b02-b14e-42e1ff1cfeac","query_id":"51","doc_a_id":"3848469","doc_b_id":"17021845","presented_order":["3848469","17021845"],"winner_id":"3848469","reasoning":"Neither document addresses ALDH1 or breast cancer. If forced to choose, DOCUMENT A is slightly more relevant because it discusses stemness and expression of stem-cell markers (which could include ALDH1), whereas B focuses specifically on Nanog in lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267021Z"}
{"comparison_id":"4a7bef44-e112-4cd6-8ccb-c7f7a3e4476e","query_id":"51","doc_a_id":"3590806","doc_b_id":"17021845","presented_order":["17021845","3590806"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem cell marker (Nanog) and its association with diagnosis/prognosis, which is closer to the query about ALDH1 and breast cancer outcomes than Document B's focus on NRIP2/Wnt in colorectal cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267053Z"}
{"comparison_id":"f0549a70-184d-4f0a-afe0-fcc578b8fcef","query_id":"51","doc_a_id":"7046487","doc_b_id":"17021845","presented_order":["7046487","17021845"],"winner_id":"7046487","reasoning":"Document A is more relevant — it addresses cancer biology broadly (including mechanisms that can impact tumor markers and outcomes), whereas Document B is specific to Nanog in lung cancer and unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267085Z"}
{"comparison_id":"a76c1a1a-adcb-4152-a0ba-b6ea2a63dd65","query_id":"51","doc_a_id":"9095394","doc_b_id":"17021845","presented_order":["9095394","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it examines a stem-cell marker's expression and prognostic significance in cancer, which is conceptually closer to ALDH1 and outcomes than Document A's focus on keratins in oral neoplasms.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267116Z"}
{"comparison_id":"5544f03c-7f08-4457-bce7-30257fb72758","query_id":"51","doc_a_id":"3710557","doc_b_id":"17021845","presented_order":["3710557","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a stem-cell marker's expression and its association with cancer prognosis (though in lung cancer and for Nanog, not ALDH1/breast). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267147Z"}
{"comparison_id":"77102b43-c859-4917-8aca-562bac4e3681","query_id":"51","doc_a_id":"4429118","doc_b_id":"17021845","presented_order":["4429118","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem cell marker's expression and prognostic significance (though in lung cancer), which is more related to ALDH1 as a stem cell/prognostic marker than the general inflammation topic in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267179Z"}
{"comparison_id":"d828230d-b9fb-4719-822b-cdd8b6f68425","query_id":"51","doc_a_id":"7639744","doc_b_id":"17021845","presented_order":["7639744","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses expression of a cancer stem cell marker and its prognostic significance, which is more related to the query about marker expression and outcomes than a smoking-cessation prognosis study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267211Z"}
{"comparison_id":"c66e0a40-bcf5-4c01-a02f-bc0a3b62168f","query_id":"51","doc_a_id":"8764879","doc_b_id":"17021845","presented_order":["17021845","8764879"],"winner_id":"17021845","reasoning":"Document A is more related: it discusses a stem cell marker's expression and association with cancer prognosis (though in lung cancer and a different marker), which is closer to ALDH1 and breast cancer outcomes than the AML/CSF1R focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267242Z"}
{"comparison_id":"3ca93afa-a44f-4e5b-b8c3-3d9555dddad4","query_id":"51","doc_a_id":"12337611","doc_b_id":"17021845","presented_order":["12337611","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a stem cell marker's association with cancer prognosis (though in lung cancer), which is more analogous to ALDH1's proposed prognostic role than Document A on neuroblastoma. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267273Z"}
{"comparison_id":"9de9e3ad-8576-4ac1-8e7e-286b75f4647d","query_id":"51","doc_a_id":"20333864","doc_b_id":"17021845","presented_order":["20333864","17021845"],"winner_id":"20333864","reasoning":"Document A is more relevant — it deals with breast cancer biology and tumor progression, whereas Document B focuses on Nanog in lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267304Z"}
{"comparison_id":"5d2a3cea-1993-4c76-bdca-ee2f67af931a","query_id":"51","doc_a_id":"38485364","doc_b_id":"17021845","presented_order":["38485364","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem cell marker and prognosis associations (though for Nanog in lung cancer), which is more thematically related to ALDH1 and outcomes than the invasion-focused paper in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267335Z"}
{"comparison_id":"1ff02746-d6aa-4a6e-8bb6-b9e25bbafd72","query_id":"51","doc_a_id":"2494748","doc_b_id":"17021845","presented_order":["17021845","2494748"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem cell marker (Nanog) and stem-cell–positive populations (CD44+) related to cancer prognosis, which is closer to ALDH1 stem-cell–marker and outcome associations than the gastric methylation study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267368Z"}
{"comparison_id":"a206e9b3-1c55-451d-aa31-a741e8b61543","query_id":"51","doc_a_id":"12903921","doc_b_id":"17021845","presented_order":["17021845","12903921"],"winner_id":"17021845","reasoning":"Document A is more relevant because it discusses cancer stem cell markers and prognosis (though in lung cancer), whereas B is unrelated (leukemia in rats and oxidative stress).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267399Z"}
{"comparison_id":"245c343a-aa4f-4188-aa54-c5875c8f539a","query_id":"51","doc_a_id":"26561572","doc_b_id":"17021845","presented_order":["17021845","26561572"],"winner_id":"17021845","reasoning":"Doc A—discusses a stem cell marker's expression and prognosis (conceptually related to ALDH1 as a stem-cell/prognostic marker), whereas Document B focuses on kinase fusions unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267430Z"}
{"comparison_id":"7e98c5bf-70ac-4ad0-a368-44b0362da422","query_id":"51","doc_a_id":"12650610","doc_b_id":"17021845","presented_order":["17021845","12650610"],"winner_id":"17021845","reasoning":"Document A is more relevant because it discusses a cancer stem cell marker's expression and its association with prognosis, which is closer in topic to ALDH1 and breast cancer outcomes than a signaling study in oral cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267461Z"}
{"comparison_id":"ebc55afe-6d7b-41dc-82df-59e9d6172aa0","query_id":"51","doc_a_id":"9196472","doc_b_id":"17021845","presented_order":["9196472","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a cancer stem-cell marker and prognosis, which is more related to ALDH1's role in cancer outcomes than a monocyte transcriptome study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267492Z"}
{"comparison_id":"e9fa337b-4279-48d0-a132-c4a2ed1753b5","query_id":"51","doc_a_id":"41548287","doc_b_id":"17021845","presented_order":["17021845","41548287"],"winner_id":"17021845","reasoning":"Document A is more relevant — it links expression of a stem-cell marker to cancer prognosis (though in lung cancer), whereas B addresses DNMT1/miRNA in pancreatic CSCs and not marker–outcome associations. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267524Z"}
{"comparison_id":"d4224e4d-3992-48b7-b265-18fa151ad0e7","query_id":"51","doc_a_id":"6121668","doc_b_id":"17021845","presented_order":["6121668","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it deals with a stem cell marker's expression and prognosis in cancer, which is conceptually closer to ALDH1's prognostic role than Document A's focus on COX-2/survivin in endometrial carcinoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267556Z"}
{"comparison_id":"d6fdaf41-87f8-475a-99cd-815f0a996779","query_id":"51","doc_a_id":"7808055","doc_b_id":"17021845","presented_order":["17021845","7808055"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem-cell marker (Nanog) and prognosis, which is closer to ALDH1's role in cancer outcomes than the DNA methylation age study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267587Z"}
{"comparison_id":"2cdb6e5b-3f60-4b7d-8789-202ce589e455","query_id":"51","doc_a_id":"6121555","doc_b_id":"17021845","presented_order":["17021845","6121555"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem-cell marker's expression and its association with cancer prognosis, which is conceptually closer to an ALDH1–breast cancer outcomes question than a glioma signaling study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267619Z"}
{"comparison_id":"45e1a287-a985-479b-bfe3-b5dbfe7895da","query_id":"51","doc_a_id":"15832146","doc_b_id":"17021845","presented_order":["15832146","17021845"],"winner_id":"15832146","reasoning":"Document A is more relevant — it concerns breast cancer biology (tumor microenvironment and progression), whereas B covers Nanog in lung cancer and doesn't relate to ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267650Z"}
{"comparison_id":"c202ad7a-d8ae-4689-bb1f-191181236313","query_id":"51","doc_a_id":"8774475","doc_b_id":"17021845","presented_order":["8774475","17021845"],"winner_id":"8774475","reasoning":"Document A is more relevant — it concerns mammary (breast) tumor biology, whereas Document B is about Nanog in lung cancer and not breast-related. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267681Z"}
{"comparison_id":"44fa5e4d-f727-47f4-94fc-c9335e2dccd7","query_id":"51","doc_a_id":"5406411","doc_b_id":"17021845","presented_order":["5406411","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a stem cell marker and prognosis, which is conceptually closer to ALDH1's role as a cancer stem cell marker and outcome associations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267712Z"}
{"comparison_id":"5879b17e-9584-4edd-a8f8-bb6c0babfe22","query_id":"51","doc_a_id":"85665741","doc_b_id":"17021845","presented_order":["85665741","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it deals with expression of a stem-cell marker and its association with cancer prognosis (similar topic), whereas A is about BRAF/MEK in NSCLC. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267743Z"}
{"comparison_id":"a7bfb8c9-51a7-4ed5-bed6-eecc42a663b3","query_id":"51","doc_a_id":"13400643","doc_b_id":"17021845","presented_order":["17021845","13400643"],"winner_id":"17021845","reasoning":"Document A — it discusses a stem cell marker's expression and its association with cancer prognosis, which is closer to the query about ALDH1 and breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267774Z"}
{"comparison_id":"3aa56c5e-0515-44f9-9a2b-380b5949058f","query_id":"51","doc_a_id":"24624992","doc_b_id":"17021845","presented_order":["24624992","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it examines a cancer stem-cell marker and prognosis, which is closer to ALDH1 and breast cancer outcome than A's leukemia-focused gene study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267805Z"}
{"comparison_id":"770ae04d-b897-4ac4-b280-7785d64ffbfe","query_id":"51","doc_a_id":"16346504","doc_b_id":"17021845","presented_order":["16346504","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a cancer stem‑cell marker and prognosis (though in lung cancer), which is more related conceptually to ALDH1 and outcome than Document A's endometrial GAS5/PTEN mechanism.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267837Z"}
{"comparison_id":"bfd95b86-86dd-420a-bed7-ca70c4a08542","query_id":"51","doc_a_id":"4583180","doc_b_id":"17021845","presented_order":["17021845","4583180"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem cell marker and its association with prognosis (though in lung cancer), whereas B focuses on pH/SREBP2 and cholesterol, unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267868Z"}
{"comparison_id":"cc37f671-0274-4cc0-87d5-e6d2238f7bf7","query_id":"51","doc_a_id":"14315749","doc_b_id":"17021845","presented_order":["14315749","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — although neither discusses ALDH1 or breast cancer, B addresses a stem cell marker (Nanog) and its association with cancer prognosis, which is more conceptually related to ALDH1's prognostic role than A's colorectal hClock study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267900Z"}
{"comparison_id":"e908eba4-0a9d-4caf-85bc-41054faade60","query_id":"51","doc_a_id":"29190724","doc_b_id":"17021845","presented_order":["17021845","29190724"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem cell marker and its association with diagnosis/prognosis, which is closer to ALDH1 and outcome associations than a review of methylation in gastric cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267932Z"}
{"comparison_id":"72a9ba8d-30e8-4372-bbee-ee7036619da4","query_id":"51","doc_a_id":"24916604","doc_b_id":"17021845","presented_order":["24916604","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem cell marker's expression and its association with cancer prognosis (though in lung cancer and a different marker), whereas Document A is about treatment policy and not biomarkers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267963Z"}
{"comparison_id":"374dc78f-03e1-4dcf-a889-6d74ce651187","query_id":"51","doc_a_id":"33677323","doc_b_id":"17021845","presented_order":["17021845","33677323"],"winner_id":"17021845","reasoning":"Document A is about a cancer stem cell marker and prognosis (though in lung cancer), which is more relevant to ALDH1's prognostic role than Document B's focus on miR-22 in hematopoietic malignancies.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.267994Z"}
{"comparison_id":"48f7718e-3e44-4343-b50d-f35aee5c25e6","query_id":"51","doc_a_id":"1456068","doc_b_id":"17021845","presented_order":["17021845","1456068"],"winner_id":"17021845","reasoning":"Document A discusses a stem-cell marker's expression and its prognostic significance in cancer (though Nanog in lung cancer rather than ALDH1 in breast), so it's more relevant than B which focuses on lifestyle and mortality.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268025Z"}
{"comparison_id":"8505bb5a-4d1e-445b-bdc1-e5ace96be8ab","query_id":"51","doc_a_id":"25738896","doc_b_id":"17021845","presented_order":["17021845","25738896"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem cell marker and prognosis (though in lung cancer and a different marker), whereas Document B concerns immune tolerance in melanoma and is unrelated to marker expression or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268057Z"}
{"comparison_id":"90ceb0aa-2d06-4707-b9fe-5bf627f36609","query_id":"51","doc_a_id":"16853734","doc_b_id":"17021845","presented_order":["17021845","16853734"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem-cell marker and its association with diagnosis/prognosis, which is thematically closer to ALDH1 and breast cancer outcomes than a study on MMP1-driven MSC migration in glioma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268089Z"}
{"comparison_id":"58812515-7d53-4598-8771-95e60a947232","query_id":"51","doc_a_id":"19541444","doc_b_id":"17021845","presented_order":["19541444","17021845"],"winner_id":"19541444","reasoning":"Document A — it discusses a tumor suppressor and cancer-related expression changes (more generally relevant to cancer outcomes) while Document B focuses specifically on Nanog in lung cancer, not breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268120Z"}
{"comparison_id":"2e40a516-0ef2-47d0-ac61-31acc77d9e22","query_id":"51","doc_a_id":"28334217","doc_b_id":"17021845","presented_order":["28334217","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem cell marker's association with cancer prognosis (though in lung cancer and for Nanog, not ALDH1 or breast cancer), so it's more thematically relevant than Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268152Z"}
{"comparison_id":"cad39b8e-39fa-4d63-a930-32c082fd9c0b","query_id":"51","doc_a_id":"9226649","doc_b_id":"17021845","presented_order":["17021845","9226649"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem cell marker (Nanog), which is conceptually closer to ALDH1 as a stem cell marker, whereas B addresses inflammasome-driven colon tumorigenesis.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268184Z"}
{"comparison_id":"f561bba1-03dd-49d1-918d-747bd42699ba","query_id":"51","doc_a_id":"9171913","doc_b_id":"17021845","presented_order":["9171913","17021845"],"winner_id":"9171913","reasoning":"Document A is more relevant because it concerns breast cancer outcomes (though it does not discuss ALDH1), whereas Document B is about Nanog in lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268214Z"}
{"comparison_id":"dd792351-bdf6-4bf6-aa95-774be51902aa","query_id":"51","doc_a_id":"3545805","doc_b_id":"17021845","presented_order":["17021845","3545805"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem cell marker's expression and its association with cancer prognosis (similar topic to ALDH1 and outcomes), while B is about T cell therapy in melanoma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268245Z"}
{"comparison_id":"95f6be87-5a01-4360-9ac6-9abb9cf26140","query_id":"51","doc_a_id":"5372432","doc_b_id":"17021845","presented_order":["5372432","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses stem cell marker expression and prognosis (though in lung cancer), which is closer to the claim about a marker's association with cancer outcomes than Document A about healthcare access. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268277Z"}
{"comparison_id":"16c0a1d3-d236-4d86-aec7-1701f562fb89","query_id":"51","doc_a_id":"8702697","doc_b_id":"17021845","presented_order":["8702697","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a stem cell marker's expression and its association with cancer prognosis (though in lung cancer), which is closer to the ALDH1–breast cancer outcome topic than a prostate miR-205 study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268308Z"}
{"comparison_id":"d4cc655e-7f4a-437a-9f57-58cbf0c87837","query_id":"51","doc_a_id":"4959368","doc_b_id":"17021845","presented_order":["4959368","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses stem cell marker expression and cancer prognosis, which is more conceptually relevant than Document A's focus on BCAAs and pancreatic cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268339Z"}
{"comparison_id":"84ea4e73-ee66-434a-9197-49c90ac82c90","query_id":"51","doc_a_id":"6948886","doc_b_id":"17021845","presented_order":["17021845","6948886"],"winner_id":"17021845","reasoning":"Document A — it discusses a stem cell marker's expression and prognosis in cancer (though lung cancer, not breast or ALDH1), so it's closer in topic. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268369Z"}
{"comparison_id":"8ae6c94d-ec05-43f4-b34c-f888619b8611","query_id":"51","doc_a_id":"27167110","doc_b_id":"17021845","presented_order":["27167110","17021845"],"winner_id":"17021845","reasoning":"Document B is slightly more relevant because it concerns stem cell markers in cancer (though in lung cancer and a different marker), while Document A addresses miRNAs in prostate cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268400Z"}
{"comparison_id":"280d9495-06b4-493e-8ca7-64b8391d7d14","query_id":"51","doc_a_id":"25513319","doc_b_id":"17021845","presented_order":["25513319","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it studies a stem cell marker's expression and prognostic significance in cancer (though lung, not breast), which is closer in topic to ALDH1's role as a stem/prognostic marker than a prostate metabolism study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268432Z"}
{"comparison_id":"abf20313-4d15-4b33-b143-04a12cee2e08","query_id":"51","doc_a_id":"34189936","doc_b_id":"17021845","presented_order":["34189936","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a stem-cell marker's expression and prognostic significance in cancer (though a different marker and cancer type), whereas A is unrelated.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268463Z"}
{"comparison_id":"5999998d-f0fe-4be4-96f1-e53457721c43","query_id":"51","doc_a_id":"15928989","doc_b_id":"17021845","presented_order":["17021845","15928989"],"winner_id":"17021845","reasoning":"Document A — it relates to cancer and stem-cell markers (though in lung cancer/Nanog), so it's more germane than the pregnancy-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268494Z"}
{"comparison_id":"f3d3e884-1008-4445-9500-98ce90c4be91","query_id":"51","doc_a_id":"29473081","doc_b_id":"17021845","presented_order":["17021845","29473081"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem cell marker and prognosis (though in lung cancer and a different gene), whereas Document B concerns glycosylation in multiple myeloma and is unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268526Z"}
{"comparison_id":"6c50482f-fb95-48fc-872c-24100a95ba7e","query_id":"51","doc_a_id":"17671145","doc_b_id":"17021845","presented_order":["17021845","17671145"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses cancer stem‑cell marker expression and prognosis (closer to ALDH1/breast cancer marker topic) while B is about ROR-γ in prostate cancer and unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268557Z"}
{"comparison_id":"480837b0-0d8b-4b1b-8c8f-c327b2608ef8","query_id":"51","doc_a_id":"1285713","doc_b_id":"17021845","presented_order":["1285713","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a cancer stem cell marker and its association with prognosis (though in lung cancer and for Nanog, not ALDH1 or breast cancer). \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268599Z"}
{"comparison_id":"f4986e23-03a9-4a4c-8922-6292eb5c8524","query_id":"51","doc_a_id":"654735","doc_b_id":"17021845","presented_order":["17021845","654735"],"winner_id":"17021845","reasoning":"Document A is more relevant — it concerns a stem cell marker (Nanog) and prognosis, which is closer in topic to ALDH1 and cancer outcomes than a glioma miRNA study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268630Z"}
{"comparison_id":"515f79b4-4bd0-457e-9df2-2c40450bdefe","query_id":"51","doc_a_id":"5270265","doc_b_id":"17021845","presented_order":["17021845","5270265"],"winner_id":"5270265","reasoning":"Document B — it discusses breast cancer treatment/outcomes, whereas A is about Nanog in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268661Z"}
{"comparison_id":"db197847-1d80-4fe4-9694-30dcfa77855d","query_id":"51","doc_a_id":"25452937","doc_b_id":"17021845","presented_order":["25452937","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a stem-cell marker's expression and prognostic association (though in lung cancer and for Nanog, not ALDH1/breast cancer). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268692Z"}
{"comparison_id":"4b36477e-719f-4e17-b8cb-2f6d872bf1c3","query_id":"51","doc_a_id":"22901758","doc_b_id":"17021845","presented_order":["17021845","22901758"],"winner_id":"17021845","reasoning":"Document A is more relevant — it addresses stem cell marker expression and prognosis in cancer (though in lung), while Document B focuses on Hedgehog signaling in glioblastoma, which is less related to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268723Z"}
{"comparison_id":"830d8bc5-6bca-4abf-b989-039ffc551dbb","query_id":"51","doc_a_id":"42150015","doc_b_id":"17021845","presented_order":["17021845","42150015"],"winner_id":"17021845","reasoning":"Document A is more relevant because it discusses cancer stem cell marker expression and prognosis (though in lung cancer), whereas Document B concerns reproductive hormones and is unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268755Z"}
{"comparison_id":"0ad964d3-0e7b-4ee4-9e8c-6400f9f77f24","query_id":"51","doc_a_id":"15215393","doc_b_id":"17021845","presented_order":["17021845","15215393"],"winner_id":"17021845","reasoning":"Document A discusses a stem cell marker's expression and prognostic significance in cancer (though in lung cancer), which is closer to the ALDH1–breast cancer outcome topic than Document B's glioblastoma therapy study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268786Z"}
{"comparison_id":"f16c76a6-9fdc-435f-8841-7d39af7a3ef7","query_id":"51","doc_a_id":"3765739","doc_b_id":"17021845","presented_order":["17021845","3765739"],"winner_id":"17021845","reasoning":"Reason: Document A discusses a stem cell marker's expression and its association with cancer prognosis, which is more thematically related to ALDH1 and breast cancer outcomes than Document B's EBV/lymphoma focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268818Z"}
{"comparison_id":"7e686f7e-38a4-4660-94b0-376e23565e40","query_id":"51","doc_a_id":"21521236","doc_b_id":"17021845","presented_order":["17021845","21521236"],"winner_id":"17021845","reasoning":"Reason: Document A discusses a stem cell marker's expression and its association with cancer prognosis (though in lung cancer), which is more thematically related to ALDH1 and breast cancer outcomes than Document B's focus on NEAT1 and replication stress.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268849Z"}
{"comparison_id":"32c9e4b9-11a8-4edb-8a82-d9804a0a2e69","query_id":"51","doc_a_id":"12145359","doc_b_id":"17021845","presented_order":["17021845","12145359"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses expression of a stem-cell marker and its association with cancer diagnosis/prognosis, which is conceptually closer to a claim about marker expression and cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268881Z"}
{"comparison_id":"8003052c-09aa-48ca-a499-cfa67d524555","query_id":"51","doc_a_id":"11359243","doc_b_id":"17021845","presented_order":["17021845","11359243"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses expression of a cancer stem cell marker and its association with diagnosis/prognosis in cancer, whereas Document B is about EBV-related methylation in B-cells and unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268912Z"}
{"comparison_id":"c33bbccc-6743-4746-8276-66f78eee09b5","query_id":"51","doc_a_id":"21692235","doc_b_id":"17021845","presented_order":["17021845","21692235"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem-cell marker and prognosis (albeit Nanog in lung cancer), which is closer to ALDH1 and breast cancer outcomes than a glioblastoma genomic classification.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268943Z"}
{"comparison_id":"aabca253-4f82-49f3-9267-6c138635bc8d","query_id":"51","doc_a_id":"23576165","doc_b_id":"17021845","presented_order":["17021845","23576165"],"winner_id":"17021845","reasoning":"Document A — it discusses expression of a stem-cell marker and its link with cancer prognosis (though in lung cancer, not ALDH1/breast), which is more related than Document B's focus on tumor metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.268975Z"}
{"comparison_id":"6f09361a-31c6-4b57-98b3-58cf2c5da6c9","query_id":"51","doc_a_id":"23286603","doc_b_id":"17021845","presented_order":["23286603","17021845"],"winner_id":"17021845","reasoning":"Document B — it concerns cancer stem-cell marker expression and prognosis (though in lung cancer), so it's closer to the claim about a marker and cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269006Z"}
{"comparison_id":"1e4f514b-ef2f-4253-a9f8-05fd1285adc8","query_id":"51","doc_a_id":"5123516","doc_b_id":"17021845","presented_order":["17021845","5123516"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem-cell marker and prognosis (though in lung cancer), which is closer to ALDH1 and breast cancer outcomes than a glioblastoma EphA3 study. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269038Z"}
{"comparison_id":"e458c702-1a97-4350-b975-567e1166659b","query_id":"51","doc_a_id":"37204802","doc_b_id":"17021845","presented_order":["37204802","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it examines a cancer stem cell marker and its association with prognosis, which is closer to ALDH1's role than Document A's colon p53 mechanism.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269069Z"}
{"comparison_id":"7b9905bd-4051-42ed-8295-5e6a028a38ec","query_id":"51","doc_a_id":"22180793","doc_b_id":"17021845","presented_order":["17021845","22180793"],"winner_id":"17021845","reasoning":"Document A — it discusses a stem cell marker's expression and prognostic association (though in lung cancer), which is closer to ALDH1's prognostic topic than B's prostate N-cadherin therapy.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269100Z"}
{"comparison_id":"f20d2c70-4f2b-4e3c-b8bd-84b6898cbc4e","query_id":"51","doc_a_id":"5468807","doc_b_id":"17021845","presented_order":["17021845","5468807"],"winner_id":"17021845","reasoning":"Document A is more relevant because it examines a stem cell marker's expression and its association with cancer prognosis (closer in topic to ALDH1 and outcome), while Document B focuses on ARID1A/HDAC6 in ovarian cancer unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269131Z"}
{"comparison_id":"4f16e6c0-1c42-4dec-85c2-a51b9bf3c994","query_id":"51","doc_a_id":"10165723","doc_b_id":"17021845","presented_order":["17021845","10165723"],"winner_id":"17021845","reasoning":"Document A is slightly more relevant because it discusses a stem-cell marker and prognosis in cancer (though different marker and cancer type); Document B concerns methylation in melanoma and is less related to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269163Z"}
{"comparison_id":"d79f012c-06b3-40df-b0a8-2a27cc031242","query_id":"51","doc_a_id":"22049489","doc_b_id":"17021845","presented_order":["22049489","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it concerns a stem cell marker's expression and association with cancer prognosis (though in lung cancer), which is closer to the query about ALDH1 and breast cancer outcomes than Document A's gastric cancer/miRNA topic.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269195Z"}
{"comparison_id":"c8acf7da-8baf-4cf6-85f2-7db5c729d75d","query_id":"51","doc_a_id":"3730196","doc_b_id":"17021845","presented_order":["17021845","3730196"],"winner_id":"17021845","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it discusses a stem cell marker and prognostic associations, whereas Document B focuses on an lncRNA in small cell lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269226Z"}
{"comparison_id":"785ea154-5e35-4a3f-b64b-b7edbcaac7df","query_id":"51","doc_a_id":"22059387","doc_b_id":"17021845","presented_order":["17021845","22059387"],"winner_id":"17021845","reasoning":"Document A is about a cancer stem-cell marker and its association with prognosis (though in lung cancer), whereas Document B concerns infection-induced DNA damage in hamsters and cholangiocarcinoma — A is closer to the claim context.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269257Z"}
{"comparison_id":"a953fa35-4d5e-4a1e-abac-90dfbc20d75e","query_id":"51","doc_a_id":"3619931","doc_b_id":"17021845","presented_order":["3619931","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a stem cell marker and its association with cancer prognosis, which is closer to ALDH1 as a prognostic marker than a study on thyroid hormone and lung fibrosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269288Z"}
{"comparison_id":"cfa0678a-17e4-48bf-a15a-d0c88d94b410","query_id":"51","doc_a_id":"6650933","doc_b_id":"17021845","presented_order":["6650933","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a cancer stem‑cell marker's expression and prognostic significance (though in lung cancer), which is more related to ALDH1's role as a stem‑cell marker and outcome association than Document A's EGCG/oxidative stress focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269319Z"}
{"comparison_id":"faf7b727-cbaa-4548-ad88-3c0e0d94a6db","query_id":"51","doc_a_id":"3899896","doc_b_id":"17021845","presented_order":["17021845","3899896"],"winner_id":"17021845","reasoning":"Document A is slightly more relevant because it discusses a cancer stem cell marker and prognosis (analogous to ALDH1's role), whereas Document B addresses RDW in rectal cancer unrelated to ALDH1 or breast cancer.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269350Z"}
{"comparison_id":"37b2ab39-194c-4f8f-a638-501a9abe4ffc","query_id":"51","doc_a_id":"32423829","doc_b_id":"17021845","presented_order":["17021845","32423829"],"winner_id":"32423829","reasoning":"Document B — it concerns breast cancer outcomes (screening and improved outcomes), while A is about Nanog in lung cancer and not relevant to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269381Z"}
{"comparison_id":"dc750120-0289-4d79-abe4-48f8383e2b7d","query_id":"51","doc_a_id":"9791313","doc_b_id":"17021845","presented_order":["17021845","9791313"],"winner_id":"17021845","reasoning":"DOCUMENT A is slightly more relevant — it discusses a stem cell marker's expression and prognosis in cancer (though in lung, not breast, and a different marker). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269412Z"}
{"comparison_id":"502d1333-89ac-4c23-a8d0-b138eda1881f","query_id":"51","doc_a_id":"10279084","doc_b_id":"17021845","presented_order":["17021845","10279084"],"winner_id":"10279084","reasoning":"Document B — it discusses a molecular variant implicated in breast cancer dysregulation, whereas A is about Nanog in lung cancer (unrelated marker and tumor type).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269443Z"}
{"comparison_id":"12b6f948-d649-4f24-8c00-396aa339b7d7","query_id":"51","doc_a_id":"4434951","doc_b_id":"17021845","presented_order":["17021845","4434951"],"winner_id":"17021845","reasoning":"Document A is more relevant because it discusses cancer stem cell marker expression and prognosis (though in lung cancer), whereas Document B is unrelated to cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269474Z"}
{"comparison_id":"9e7cd916-90cd-432c-8bec-25ee1729e5d2","query_id":"51","doc_a_id":"3831884","doc_b_id":"17021845","presented_order":["17021845","3831884"],"winner_id":"17021845","reasoning":"Both documents are about different markers/cancers, but Document A discusses a stem cell marker's expression and prognosis (similar topic), so it's more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269505Z"}
{"comparison_id":"eda41865-18eb-4026-b040-9956db97053a","query_id":"51","doc_a_id":"38009906","doc_b_id":"17021845","presented_order":["38009906","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a cancer stem-cell marker and prognosis (though in lung and a different marker), so it's more thematically related to ALDH1 and outcomes than Document A. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269536Z"}
{"comparison_id":"eb4ff721-e51e-45eb-820b-55953753bb77","query_id":"51","doc_a_id":"54561709","doc_b_id":"17021845","presented_order":["17021845","54561709"],"winner_id":"54561709","reasoning":"Reason: Document B concerns breast cancer (MCF-7) cell line issues, making it marginally closer to the query than Document A, which is about Nanog in lung cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269566Z"}
{"comparison_id":"6e8e77a2-97a3-4b19-bf7a-01dee8d89fb6","query_id":"51","doc_a_id":"18810195","doc_b_id":"17021845","presented_order":["18810195","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it addresses cancer stem cell markers and prognosis (though in lung cancer), which is closer to ALDH1 as a prognostic stem-cell marker than Document A's PGAM1 metabolic mechanism. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269598Z"}
{"comparison_id":"4b2ad7ce-71a5-48f5-8071-a0d67c0d66c5","query_id":"51","doc_a_id":"35993767","doc_b_id":"17021845","presented_order":["17021845","35993767"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem cell marker and its association with cancer diagnosis/prognosis (though in lung cancer and a different marker), whereas B focuses on fibroblasts and metastasis in liver cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269629Z"}
{"comparison_id":"e1819c2a-0a98-4d43-bc8f-2bfbc014256b","query_id":"51","doc_a_id":"14672919","doc_b_id":"17021845","presented_order":["14672919","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a cancer stem cell marker and prognosis (though in lung cancer), which is closer to ALDH1's role than platelet measures in esophageal cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269660Z"}
{"comparison_id":"bc5109d2-463c-4e7a-9f34-72f32c797c6d","query_id":"51","doc_a_id":"1686997","doc_b_id":"17021845","presented_order":["17021845","1686997"],"winner_id":"17021845","reasoning":"Document A is about a stem cell marker and prognosis in cancer (though lung, not breast), so it's closer to ALDH1 expression and outcomes than the metabolic tumor-growth study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269691Z"}
{"comparison_id":"48bcc3d6-0417-4f8d-82c1-9a369d06e57c","query_id":"51","doc_a_id":"3756384","doc_b_id":"17021845","presented_order":["17021845","3756384"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses expression of a stem cell marker (Nanog) and its association with cancer prognosis, which is conceptually closer to ALDH1's prognostic role than the HBV/EpCAM hepatocyte study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269723Z"}
{"comparison_id":"bdda720c-cf44-4a4d-b9c1-c253bbb94bf0","query_id":"51","doc_a_id":"11484808","doc_b_id":"17021845","presented_order":["11484808","17021845"],"winner_id":"11484808","reasoning":"Document A is more relevant — it addresses endocrine-related cancers (which include breast cancer) and clinical biomarkers, whereas Document B is focused on Nanog in lung cancer, unrelated to ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269754Z"}
{"comparison_id":"f8100309-b58a-4a79-a3cb-ca8749d88a18","query_id":"51","doc_a_id":"36838958","doc_b_id":"17021845","presented_order":["17021845","36838958"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses cancer stem cell markers and prognosis, which is closer to ALDH1 and breast cancer outcomes than a paper on adipose tissue thermogenesis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269785Z"}
{"comparison_id":"a6e9b48d-1f18-4612-96eb-829c91c3e0ea","query_id":"51","doc_a_id":"27647593","doc_b_id":"17021845","presented_order":["17021845","27647593"],"winner_id":"17021845","reasoning":"Doc A discusses a stem cell marker's expression and its prognostic significance (albeit Nanog in lung cancer), which is conceptually closer to a claim about ALDH1 and breast cancer outcomes than Document B's focus on stromal metabolism. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269819Z"}
{"comparison_id":"3d8152f8-c01b-4a66-8220-2c832fa0ca1a","query_id":"51","doc_a_id":"13205096","doc_b_id":"17021845","presented_order":["17021845","13205096"],"winner_id":"17021845","reasoning":"Document A — it discusses a cancer stem-cell marker (Nanog) and prognosis in cancer, which is more related to ALDH1 and cancer outcomes than an AML gene-profiling study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269851Z"}
{"comparison_id":"ddca3848-a5a0-4fbc-bef6-9a35da7cdc7e","query_id":"51","doc_a_id":"24323369","doc_b_id":"17021845","presented_order":["17021845","24323369"],"winner_id":"17021845","reasoning":"Document A — it discusses stem cell marker expression in cancer (though lung cancer), while Document B is unrelated (PCOS/ovulation). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269881Z"}
{"comparison_id":"a045c761-f8a2-448d-8a09-15c61bda9763","query_id":"51","doc_a_id":"26231129","doc_b_id":"17021845","presented_order":["17021845","26231129"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem cell marker's expression and its association with cancer prognosis (though different marker and cancer type). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269912Z"}
{"comparison_id":"0c88eea9-57c1-46eb-816b-24a5e27958bb","query_id":"51","doc_a_id":"33387953","doc_b_id":"17021845","presented_order":["33387953","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a cancer stem-cell marker's expression and its association with prognosis (though in lung cancer), which is more related to marker-expression and outcomes than Document A. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269944Z"}
{"comparison_id":"9a5294df-71c8-4d69-a6bf-543f149600fb","query_id":"51","doc_a_id":"3504761","doc_b_id":"17021845","presented_order":["3504761","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses cancer stem cell marker expression and prognosis (though in lung cancer), which is closer to the query about a marker's association with cancer outcomes than Document A's liver metabolism focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.269975Z"}
{"comparison_id":"ffc36494-5743-444e-9fbf-d300bc9ab85e","query_id":"51","doc_a_id":"7869794","doc_b_id":"17021845","presented_order":["7869794","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a stem cell marker's expression and its association with cancer prognosis, which is conceptually closer to ALDH1 and outcome studies than Document A's focus on neutrophil calcium signaling.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270006Z"}
{"comparison_id":"106cd274-4643-4304-b35b-b1406024caea","query_id":"51","doc_a_id":"5783785","doc_b_id":"17021845","presented_order":["17021845","5783785"],"winner_id":"17021845","reasoning":"Document A is slightly more relevant because it discusses a cancer stem cell marker (Nanog), which is conceptually closer to ALDH1 as a stem/progenitor marker, whereas Document B concerns miRNA methylation in gastric cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270037Z"}
{"comparison_id":"958cbe16-a4bf-426b-b0e4-d3f8b7396788","query_id":"51","doc_a_id":"12685434","doc_b_id":"17021845","presented_order":["12685434","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem-cell marker and prognosis (though in lung cancer), which is more thematically related to ALDH1 and cancer outcomes than Document A about GBP1 in glioblastoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270069Z"}
{"comparison_id":"7e277671-2d73-4bad-9ef5-4511c400a2e2","query_id":"51","doc_a_id":"22478394","doc_b_id":"17021845","presented_order":["17021845","22478394"],"winner_id":"17021845","reasoning":"Document A is more relevant because it discusses cancer stem cell marker expression (though in lung cancer), whereas Document B is about liver PPAR-γ in obesity and unrelated to cancer biomarkers.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270100Z"}
{"comparison_id":"bf413819-b342-4e56-8ec9-82d0ad3a10ba","query_id":"51","doc_a_id":"31803596","doc_b_id":"17021845","presented_order":["31803596","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it studies a stem-cell marker's expression and its relation to cancer prognosis (though in lung cancer), whereas A is an OSCC gene-expression survey that doesn't address stem-cell markers or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270131Z"}
{"comparison_id":"f8463280-1d97-4ff3-a381-bccfa2c19689","query_id":"51","doc_a_id":"22712546","doc_b_id":"17021845","presented_order":["17021845","22712546"],"winner_id":"22712546","reasoning":"Document B is more relevant — it profiles enzymatic/metabolic activities in breast cancer tissue (potentially including ALDH1), whereas Document A discusses Nanog in lung cancer, not ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270163Z"}
{"comparison_id":"97e650ee-cfd4-4645-9bc8-9eda26aa2017","query_id":"51","doc_a_id":"864491","doc_b_id":"17021845","presented_order":["17021845","864491"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem cell marker's expression and its association with cancer prognosis (even though different marker and cancer type). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270194Z"}
{"comparison_id":"74a6782d-acb0-47f7-8338-09fb1490cac1","query_id":"51","doc_a_id":"18358026","doc_b_id":"17021845","presented_order":["18358026","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem cell marker's expression and its association with cancer prognosis (though in lung cancer and for Nanog, not ALDH1 or breast cancer), so it's more topically related than Document A. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270225Z"}
{"comparison_id":"e4f50d6b-8580-4924-95d0-75fe2ca96409","query_id":"51","doc_a_id":"4467129","doc_b_id":"17021845","presented_order":["4467129","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem-cell marker's prognostic role in cancer, which is closer to ALDH1's role in breast cancer than Document A's neuroblastoma/microRNA focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270256Z"}
{"comparison_id":"5621b4d0-92f1-4a4d-86e3-2c0c58b5adf3","query_id":"51","doc_a_id":"7028976","doc_b_id":"17021845","presented_order":["17021845","7028976"],"winner_id":"17021845","reasoning":"Document A — it discusses a stem cell marker and its association with cancer prognosis (closer to ALDH1/prognosis context) whereas B is about EGFR in glioblastoma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270287Z"}
{"comparison_id":"039d8a9f-9ed1-45bb-8102-c23d5580600b","query_id":"51","doc_a_id":"40735046","doc_b_id":"17021845","presented_order":["17021845","40735046"],"winner_id":"40735046","reasoning":"Document B — it concerns breast cancer outcomes (screening and mortality), which is more related to the query than a lung-cancer Nanog study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270317Z"}
{"comparison_id":"d38754c2-e05f-4781-ad1d-17b15c65aba9","query_id":"51","doc_a_id":"10542877","doc_b_id":"17021845","presented_order":["10542877","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a stem cell marker's expression and prognosis, which is conceptually closer to ALDH1's role than a drug targeting STAT3 in other cancers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270349Z"}
{"comparison_id":"eaa05ab7-40e2-4f6a-8577-ddd61e952380","query_id":"51","doc_a_id":"6259170","doc_b_id":"17021845","presented_order":["6259170","17021845"],"winner_id":"6259170","reasoning":"Document A is slightly more relevant because it discusses cancer-related pathways (Nrf2/Keap1) and treatment resistance that could relate to biomarkers and outcomes, whereas Document B focuses specifically on Nanog in lung cancer and not on ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270380Z"}
{"comparison_id":"c2d55c62-f868-4d8f-9e5d-14288a21df7e","query_id":"51","doc_a_id":"16361581","doc_b_id":"17021845","presented_order":["16361581","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem-cell marker's association with cancer diagnosis/prognosis (though in lung cancer and for Nanog, not ALDH1/breast). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270411Z"}
{"comparison_id":"83e0fb08-49f1-43cb-8c3b-da15ceede7ec","query_id":"51","doc_a_id":"24783597","doc_b_id":"17021845","presented_order":["17021845","24783597"],"winner_id":"17021845","reasoning":"Document A — it discusses a cancer stem cell marker and prognosis (though in lung cancer), so it's more relevant to a claim about ALDH1 and breast cancer outcomes than the IBD-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270443Z"}
{"comparison_id":"a3272d7b-bc67-4544-bdb1-8135721aa596","query_id":"51","doc_a_id":"667451","doc_b_id":"17021845","presented_order":["667451","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses expression of a stem-cell marker and its association with cancer prognosis (though in lung cancer and for Nanog, not ALDH1), whereas A is about subclonal mutations in CLL and unrelated.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270474Z"}
{"comparison_id":"f9fa848a-c71b-4bcf-a9c3-2c0b5eae6c62","query_id":"51","doc_a_id":"5691302","doc_b_id":"17021845","presented_order":["5691302","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a stem-cell marker's expression and association with cancer prognosis (although in lung cancer and Nanog, not ALDH1 or breast cancer). \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270505Z"}
{"comparison_id":"00a2c0e5-ec73-4bbf-a070-af1086191b21","query_id":"51","doc_a_id":"3858268","doc_b_id":"17021845","presented_order":["17021845","3858268"],"winner_id":"17021845","reasoning":"Document A — it discusses a stem cell marker (Nanog) and prognosis, which is more thematically related to ALDH1 and breast cancer outcomes than a metabolic study in ovarian CSCs.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270536Z"}
{"comparison_id":"5ba76acf-96cf-45c3-969b-5d06921e51b8","query_id":"51","doc_a_id":"1836154","doc_b_id":"17021845","presented_order":["1836154","17021845"],"winner_id":"17021845","reasoning":"Document B is slightly more relevant because it discusses stem cell markers in cancer (though in lung, not breast, and not ALDH1). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270612Z"}
{"comparison_id":"a880ec56-cfd6-45f5-8236-f369537e3e57","query_id":"51","doc_a_id":"24190159","doc_b_id":"17021845","presented_order":["17021845","24190159"],"winner_id":"17021845","reasoning":"Document A discusses a stem-cell marker's expression and its association with cancer prognosis (albeit in lung cancer), which is conceptually closer to ALDH1 and breast cancer outcomes than Document B's focus on KRAS-driven changes in rectal cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270647Z"}
{"comparison_id":"c0fa5db2-4c4b-424b-aef5-776d7cba391b","query_id":"51","doc_a_id":"23599024","doc_b_id":"17021845","presented_order":["17021845","23599024"],"winner_id":"17021845","reasoning":"Document A is more relevant — it concerns a stem-cell marker and its association with cancer prognosis (though in lung and for Nanog), whereas Document B addresses SP-B signaling in NSCLC and not stem-cell markers or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270679Z"}
{"comparison_id":"f5ccb885-9c93-4654-b982-474a1e341a1e","query_id":"51","doc_a_id":"13905670","doc_b_id":"17021845","presented_order":["13905670","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it concerns cancer stem-cell marker expression and prognosis, which is closer to the claim about a prognostic marker in cancer than Document A's inflammatory-disease/FOXO3 topic.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270712Z"}
{"comparison_id":"cd1cd519-26f7-495c-872f-085910ff3abe","query_id":"51","doc_a_id":"18882947","doc_b_id":"17021845","presented_order":["18882947","17021845"],"winner_id":"17021845","reasoning":"Reason: Document B discusses a stem cell marker's expression and prognosis in cancer (though lung and Nanog, not ALDH1 or breast), so it's marginally more related than Document A, which is about Tcf1 and lymphomas.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270744Z"}
{"comparison_id":"26e33766-dbda-4d1d-ae40-412a6b8bff04","query_id":"51","doc_a_id":"19427410","doc_b_id":"17021845","presented_order":["19427410","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant—it's about cancer biomarkers and prognosis (though in lung cancer), whereas A discusses IL-33 in adipocytes unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270776Z"}
{"comparison_id":"cc2d7141-2a13-4d5d-aada-0332a71132a4","query_id":"51","doc_a_id":"8538916","doc_b_id":"17021845","presented_order":["17021845","8538916"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem-cell marker and its association with cancer prognosis, whereas B focuses on a molecular chaperone unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270807Z"}
{"comparison_id":"eeb42d50-1cc4-47bf-a970-ad32a0c38d4c","query_id":"51","doc_a_id":"25036988","doc_b_id":"17021845","presented_order":["25036988","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a stem-cell marker's expression and its association with cancer prognosis, which is conceptually closer to ALDH1 and breast cancer outcomes than Document A's molecular study in colon cells.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270838Z"}
{"comparison_id":"f867ee96-1b9d-4555-ad2a-5c99e105e373","query_id":"51","doc_a_id":"19800147","doc_b_id":"17021845","presented_order":["17021845","19800147"],"winner_id":"17021845","reasoning":"Document A is more relevant because it discusses a stem cell marker's expression and prognostic significance in cancer (though lung, not breast), whereas Document B focuses on exosomal miRNA in colon cancer and is less related to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270870Z"}
{"comparison_id":"255b3694-f437-4aa7-bcea-d7a15be06b38","query_id":"51","doc_a_id":"5573975","doc_b_id":"17021845","presented_order":["5573975","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a cancer stem-cell marker and its prognostic association (though in lung cancer), whereas Document A is about kidney regeneration/fibrosis and unrelated to cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270901Z"}
{"comparison_id":"b0cc7bd4-631d-493b-a6bc-901302b83d40","query_id":"51","doc_a_id":"11578459","doc_b_id":"17021845","presented_order":["11578459","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem cell marker's expression and prognostic significance (though in lung cancer), which is more closely related to the ALDH1/breast cancer prognosis claim than the glioblastoma HOX-signature study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270933Z"}
{"comparison_id":"742feec0-27d0-46da-ab00-2f29b8b9ed1c","query_id":"51","doc_a_id":"6290112","doc_b_id":"17021845","presented_order":["6290112","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a stem cell marker's expression and its association with cancer prognosis, which is conceptually closer to ALDH1 and breast cancer outcomes than an obesity/AMY1 study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270965Z"}
{"comparison_id":"26a2d7e4-7547-4a90-a768-8b6b9697cf5a","query_id":"51","doc_a_id":"33740844","doc_b_id":"17021845","presented_order":["17021845","33740844"],"winner_id":"17021845","reasoning":"Document A is more relevant — it concerns cancer stem cell marker expression and prognosis (though in lung cancer and for Nanog rather than ALDH1 in breast cancer), whereas Document B is unrelated to cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.270996Z"}
{"comparison_id":"1c6b3f0b-2e4f-4da4-9675-b7ef193154f7","query_id":"51","doc_a_id":"67787658","doc_b_id":"17021845","presented_order":["67787658","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem cell marker's association with cancer prognosis, which is more related to ALDH1 and outcome associations than Document A's glioblastoma/miRNA chemoresistance focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271028Z"}
{"comparison_id":"22599742-70c9-4592-b87b-b47ec94236d7","query_id":"51","doc_a_id":"13398997","doc_b_id":"17021845","presented_order":["17021845","13398997"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses expression of a stem cell marker and its association with cancer prognosis (though in lung cancer), whereas Document B is about T cell immunology in transplantation. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271059Z"}
{"comparison_id":"08b9746d-5789-4325-8ae9-685a20c1686c","query_id":"51","doc_a_id":"10669939","doc_b_id":"17021845","presented_order":["17021845","10669939"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem cell marker's expression and its association with cancer prognosis (closer to ALDH1/prognosis topic) while B is about imaging methodology unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271091Z"}
{"comparison_id":"41695085-67c8-43b3-afc5-72973a404a77","query_id":"51","doc_a_id":"13889430","doc_b_id":"17021845","presented_order":["17021845","13889430"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses cancer stem cell marker expression (Nanog, CD44) and prognosis, which is closer to a claim about marker expression and outcomes than Document B's focus on exosome-mediated fibroblast differentiation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271122Z"}
{"comparison_id":"0dc885b2-0edd-4bdd-9430-86b8421c215b","query_id":"51","doc_a_id":"18682109","doc_b_id":"17021845","presented_order":["18682109","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a stem cell marker's expression and its association with cancer prognosis, which is closer to the query about marker expression and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271154Z"}
{"comparison_id":"d1ccfc87-0d29-4382-9cd8-51b0f36e5105","query_id":"51","doc_a_id":"31851367","doc_b_id":"17021845","presented_order":["31851367","17021845"],"winner_id":"31851367","reasoning":"Document A — it addresses estrogen receptor coregulators relevant to breast cancer biology; Document B is about Nanog in lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271185Z"}
{"comparison_id":"bf09baf9-3ad5-4cd3-af0e-3c92a3b37015","query_id":"51","doc_a_id":"5254463","doc_b_id":"17021845","presented_order":["5254463","17021845"],"winner_id":"17021845","reasoning":"Reason: Document B addresses expression of a stem-cell marker and its association with cancer diagnosis/prognosis, which is closer to a claim about a marker's association with outcomes than Document A (mouse intestinal tumorigenesis).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271217Z"}
{"comparison_id":"43e46b1e-d0e4-4710-9f11-049d5d3cfb30","query_id":"51","doc_a_id":"20659283","doc_b_id":"17021845","presented_order":["17021845","20659283"],"winner_id":"17021845","reasoning":"Document A is more relevant because it discusses a cancer stem-cell marker and prognosis, which is closer to ALDH1's role in cancer outcomes than the unrelated enzyme regulation study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271248Z"}
{"comparison_id":"16e4abd0-b7a5-4431-9d86-e2e76378e47e","query_id":"51","doc_a_id":"2576811","doc_b_id":"17021845","presented_order":["2576811","17021845"],"winner_id":"2576811","reasoning":"Document A is more relevant — it concerns breast epithelial cells (breast cancer context), whereas Document B discusses Nanog in lung cancer, not ALDH1 or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271279Z"}
{"comparison_id":"de628d00-2789-4600-85cd-ee87847dc57d","query_id":"51","doc_a_id":"15512462","doc_b_id":"17021845","presented_order":["17021845","15512462"],"winner_id":"15512462","reasoning":"Reason: Document B mentions breast cancer (though not ALDH1 or outcomes), while Document A is about Nanog in lung cancer and is unrelated to breast cancer or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271310Z"}
{"comparison_id":"eb8d7f8e-bbe0-4bf7-a532-f5ed12653e72","query_id":"51","doc_a_id":"195689757","doc_b_id":"17021845","presented_order":["17021845","195689757"],"winner_id":"17021845","reasoning":"Document A — it discusses a cancer stem cell marker (Nanog), which is more related to ALDH1's role as a stem cell marker than Document B's metabolic focus in glioblastoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271342Z"}
{"comparison_id":"7b11125d-e262-4fa9-879c-b3c1e00eb4cf","query_id":"51","doc_a_id":"831167","doc_b_id":"17021845","presented_order":["831167","17021845"],"winner_id":"831167","reasoning":"Document A is more relevant because it addresses gene expression associations with survival prognosis (though in glioblastoma rather than breast cancer); Document B focuses on Nanog in lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271373Z"}
{"comparison_id":"43799c4e-a294-4ba3-8042-4e2711f468b4","query_id":"51","doc_a_id":"15727984","doc_b_id":"17021845","presented_order":["17021845","15727984"],"winner_id":"17021845","reasoning":"Document A is more related: although neither mentions ALDH1 or breast cancer, A discusses a stem-cell marker (Nanog) and its association with prognosis, which is conceptually closer to the query than B's focus on secreted proteins in lung tumor microenvironment.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271404Z"}
{"comparison_id":"b601b209-85c1-4ffa-b844-b94b258232f7","query_id":"51","doc_a_id":"21063817","doc_b_id":"17021845","presented_order":["17021845","21063817"],"winner_id":"17021845","reasoning":"Document A is more relevant — it addresses a cancer stem cell marker (Nanog), which is conceptually closer to ALDH1 and cancer prognosis than keratin changes in oral carcinoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271436Z"}
{"comparison_id":"94ffdfd5-ded2-4bb9-b1db-277df969135e","query_id":"51","doc_a_id":"7975937","doc_b_id":"17021845","presented_order":["7975937","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a stem cell marker's expression and its association with cancer prognosis (though in lung cancer), which is nearer in topic to ALDH1 as a stem cell/prognostic marker than Document A's COX/immunity focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271468Z"}
{"comparison_id":"1a852470-d23f-40a4-b1b2-d392120cc26c","query_id":"51","doc_a_id":"10365787","doc_b_id":"17021845","presented_order":["17021845","10365787"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem-cell marker and prognosis (analogous to ALDH1 as a stem-cell marker), whereas Document B covers a cell-cycle regulator unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271499Z"}
{"comparison_id":"cfe11d70-4e4d-45a0-8236-31d473c8244c","query_id":"51","doc_a_id":"4325398","doc_b_id":"17021845","presented_order":["17021845","4325398"],"winner_id":"17021845","reasoning":"Document A — it discusses stem-cell marker expression and prognosis (though in lung cancer, not ALDH1/breast), so it's more relevant than the pancreatic genomics paper.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271530Z"}
{"comparison_id":"bee05246-5379-42d3-aeb8-7409a20c4502","query_id":"51","doc_a_id":"17717391","doc_b_id":"17021845","presented_order":["17021845","17717391"],"winner_id":"17021845","reasoning":"Reason: Document A discusses a stem cell marker and its association with cancer diagnosis/prognosis, which is more related to ALDH1 and breast cancer outcomes than Document B's focus on a p16 reporter model in mice.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271561Z"}
{"comparison_id":"49eb2576-e67a-492a-b721-06b22592a45d","query_id":"51","doc_a_id":"33076846","doc_b_id":"17021845","presented_order":["33076846","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses stem cell marker expression in cancer (though in lung), which is more related to ALDH1's role as a cancer/stem-cell marker than Document A's megakaryocyte/GEF focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271593Z"}
{"comparison_id":"97238bee-c01b-4fff-945b-0566a8124534","query_id":"51","doc_a_id":"13235609","doc_b_id":"17021845","presented_order":["13235609","17021845"],"winner_id":"17021845","reasoning":"Reason: Document B discusses a stem cell marker's expression and its association with cancer prognosis (though in lung cancer and for Nanog), which is closer to ALDH1/prognosis than Document A's VEGF/MET/GBM focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271624Z"}
{"comparison_id":"9fe46bab-e36f-47f9-8d45-3958e136e350","query_id":"51","doc_a_id":"2547636","doc_b_id":"17021845","presented_order":["17021845","2547636"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem cell marker and its association with cancer prognosis (though in lung cancer and a different marker), closer to the claim's topic than Document B's circadian stem cell function.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271656Z"}
{"comparison_id":"b023b5f9-6921-4e9c-9f60-d0e0be5ce133","query_id":"51","doc_a_id":"9478135","doc_b_id":"17021845","presented_order":["17021845","9478135"],"winner_id":"17021845","reasoning":"Document A — it discusses a cancer stem cell marker and prognosis (though in lung cancer), which is closer to ALDH1's role in cancer outcomes than the leukemia genetics paper.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271687Z"}
{"comparison_id":"6b221ede-3541-4132-9827-4a83fc6a221b","query_id":"51","doc_a_id":"28644298","doc_b_id":"17021845","presented_order":["17021845","28644298"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses stem cell marker expression and cancer prognosis (though in lung cancer and about Nanog, not ALDH1 or breast cancer), whereas Document B concerns NF-kappa B in EBV-infected lymphoid cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271719Z"}
{"comparison_id":"d9659a4d-8c70-44c4-b3fe-18ca4868ff62","query_id":"51","doc_a_id":"6374918","doc_b_id":"17021845","presented_order":["17021845","6374918"],"winner_id":"17021845","reasoning":"Reason: Document A discusses a cancer stem cell marker's expression and prognostic significance, which is more conceptually related to ALDH1 and breast cancer outcomes than Document B's AML treatment focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271751Z"}
{"comparison_id":"3bd6a359-6cfe-4f7c-9fc1-e6a9d9df03ac","query_id":"51","doc_a_id":"2374637","doc_b_id":"17021845","presented_order":["2374637","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it studies a stem-cell marker's expression linked to prognosis (though in lung cancer, not ALDH1/breast cancer), whereas A is a general methods paper.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271782Z"}
{"comparison_id":"d4932809-f319-4565-bdaa-5a149373146a","query_id":"51","doc_a_id":"24294572","doc_b_id":"17021845","presented_order":["17021845","24294572"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem cell marker's expression and prognostic association (though in lung cancer), which is closer to the ALDH1–breast cancer outcome topic than the PI lipid signaling focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271814Z"}
{"comparison_id":"2697ad28-08e8-4ac2-a497-02962bacdd16","query_id":"51","doc_a_id":"1727493","doc_b_id":"17021845","presented_order":["17021845","1727493"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem cell marker (Nanog) and prognosis, which is conceptually closer to ALDH1 and breast cancer outcomes than the exosome/miR21 ovarian cancer study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271845Z"}
{"comparison_id":"98b1e929-69fe-4e29-a041-04f7152c20c9","query_id":"51","doc_a_id":"14972169","doc_b_id":"17021845","presented_order":["14972169","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it examines a stem cell marker's expression and its relation to cancer diagnosis/prognosis, which is closer to the query about a marker (ALDH1) and cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271876Z"}
{"comparison_id":"3f05c50b-fc7e-4a7a-99ce-6cd53568124d","query_id":"51","doc_a_id":"17973161","doc_b_id":"17021845","presented_order":["17021845","17973161"],"winner_id":"17021845","reasoning":"Document A is more relevant because it discusses cancer stem cell markers and prognosis (though in lung cancer), which is closer to a claim about a biomarker and breast cancer outcomes than the metabolic adipocyte study. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271908Z"}
{"comparison_id":"c2f4526f-48f2-4ab2-bbb0-790cbf2d34a8","query_id":"51","doc_a_id":"6766459","doc_b_id":"17021845","presented_order":["6766459","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses cancer stem cell markers and prognosis (though in lung cancer and for Nanog), which is more related to ALDH1 as a prognostic cancer marker than Document A about fever regulation.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271939Z"}
{"comparison_id":"25af43bf-700a-40be-8872-c18af3c81e81","query_id":"51","doc_a_id":"825728","doc_b_id":"17021845","presented_order":["17021845","825728"],"winner_id":"825728","reasoning":"Document B — it discusses cancer cell stemness, EMT, and links to patient survival and metastasis, which is more relevant to outcome associations than a lung-cancer Nanog study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.271971Z"}
{"comparison_id":"de202f50-b008-4662-9eea-4a10808abb6f","query_id":"51","doc_a_id":"16364639","doc_b_id":"17021845","presented_order":["16364639","17021845"],"winner_id":"17021845","reasoning":"Reason: Document B deals with cancer stem cell markers and prognosis associations (though in lung cancer), which is closer to the query about a marker's association with outcomes than Document A's glioblastoma microRNA network.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272002Z"}
{"comparison_id":"f7a6c5ee-66db-4452-80ee-be69c1799d95","query_id":"51","doc_a_id":"952111","doc_b_id":"17021845","presented_order":["17021845","952111"],"winner_id":"17021845","reasoning":"Document A — it discusses a stem-cell marker's expression and its association with cancer prognosis, which is more similar to the claim about ALDH1 and outcomes than the CAF-focused review in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272033Z"}
{"comparison_id":"18ea6d49-26ee-478a-a0c2-8cb2b774d5b6","query_id":"51","doc_a_id":"27822315","doc_b_id":"17021845","presented_order":["27822315","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem cell marker's expression and prognostic significance in cancer, which is conceptually closer to ALDH1's role than Document A's focus on LRH-1 and steroidogenesis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272064Z"}
{"comparison_id":"9f86a0cd-a667-4b7c-94ff-c5beb5a2cac3","query_id":"51","doc_a_id":"1649738","doc_b_id":"17021845","presented_order":["1649738","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a cancer stem-cell marker's expression and its prognostic significance (closer in topic to ALDH1 as a stem-cell marker), whereas A is unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272096Z"}
{"comparison_id":"d81031e2-220a-438e-94b9-d5fb5fbc32ca","query_id":"51","doc_a_id":"15322518","doc_b_id":"17021845","presented_order":["15322518","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem-cell marker's expression and its association with cancer prognosis, which is more thematically related to marker expression and outcomes than Document A. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272127Z"}
{"comparison_id":"41725f47-fe5c-45dd-92bb-19222f1f3063","query_id":"51","doc_a_id":"14019636","doc_b_id":"17021845","presented_order":["14019636","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it addresses expression of a stem-cell marker and its prognostic significance in cancer (though in lung, not breast), whereas A discusses rDNA copy number unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272159Z"}
{"comparison_id":"0238bf91-9f3e-41c4-8ce9-7f87010a6435","query_id":"51","doc_a_id":"4464565","doc_b_id":"17021845","presented_order":["17021845","4464565"],"winner_id":"17021845","reasoning":"Document A is more relevant — it addresses cancer stem-cell markers and prognosis (though in lung cancer and for Nanog, not ALDH1 in breast cancer), whereas B is about cocoa effects in intestinal cells and is unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272191Z"}
{"comparison_id":"0432028c-e56d-49cc-a7d9-eb68bd535a0c","query_id":"51","doc_a_id":"14768471","doc_b_id":"17021845","presented_order":["17021845","14768471"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem cell marker and prognosis (though in lung cancer and not ALDH1/breast cancer), whereas Document B concerns renal CSC-derived EVs and tumor-supporting stromal changes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272222Z"}
{"comparison_id":"ca7c9b9a-a7b5-47ed-bcc8-a7dd330c6166","query_id":"51","doc_a_id":"18953920","doc_b_id":"17021845","presented_order":["18953920","17021845"],"winner_id":"18953920","reasoning":"Document A is more relevant — it concerns mammary epithelial cells and stem-cell markers in breast cancer context, whereas B is about Nanog in lung cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272253Z"}
{"comparison_id":"c2973225-7537-4999-a0a2-955e05c72c5a","query_id":"51","doc_a_id":"3701541","doc_b_id":"17021845","presented_order":["17021845","3701541"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem-cell marker and its association with cancer prognosis, which is closer to ALDH1’s role in cancer outcomes than Document B’s focus on p62/VDR in liver disease. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272285Z"}
{"comparison_id":"23b809b0-c4a9-4b58-9215-3a5be74b9c0f","query_id":"51","doc_a_id":"9513785","doc_b_id":"17021845","presented_order":["17021845","9513785"],"winner_id":"17021845","reasoning":"Document A discusses stem cell marker expression and its association with cancer prognosis (though in lung cancer), making it more relevant than B, which is about maternal protein restriction and lifespan in mice.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272316Z"}
{"comparison_id":"8341f72d-3f8f-4f04-a4da-df236c33c98c","query_id":"51","doc_a_id":"19408393","doc_b_id":"17021845","presented_order":["17021845","19408393"],"winner_id":"17021845","reasoning":"Reason: Document A discusses cancer stem cell marker expression and prognosis (though in lung cancer and Nanog, not ALDH1/breast), so it's marginally more related than Document B which addresses brain re-irradiation outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272348Z"}
{"comparison_id":"037cf1d8-2bfd-4222-91ce-083bf9ac92cb","query_id":"51","doc_a_id":"30543439","doc_b_id":"17021845","presented_order":["30543439","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it addresses cancer stem cell markers and prognosis (though for Nanog in lung cancer), whereas A discusses nucleotide‑sanitizing enzymes unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272379Z"}
{"comparison_id":"80ea9a83-2e44-4beb-9c98-1d15df6d5031","query_id":"51","doc_a_id":"2613411","doc_b_id":"17021845","presented_order":["17021845","2613411"],"winner_id":"17021845","reasoning":"Document A is about a stem cell marker's expression and prognostic significance (similar topic to ALDH1 and outcomes), while B is a general review of CDKs unrelated to ALDH1/breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272410Z"}
{"comparison_id":"90a14a53-4c45-442d-93cd-afb1f18565c0","query_id":"51","doc_a_id":"25725663","doc_b_id":"17021845","presented_order":["25725663","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses cancer stem cell marker expression and prognosis (though in lung cancer), which is closer to the claim about ALDH1 and breast cancer outcomes than Document A's lung epithelial oxidative-stress study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272441Z"}
{"comparison_id":"989a35b1-d134-479b-ae85-ae3491f059e1","query_id":"51","doc_a_id":"4993011","doc_b_id":"17021845","presented_order":["4993011","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a cancer stem cell marker and its prognostic significance (though in lung cancer), which is more related to the claim about ALDH1 and cancer outcomes than Document A's ATRX/rDNA topic.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272473Z"}
{"comparison_id":"0a5dcdfd-0d89-4ca8-8b7b-cbce9115e9ec","query_id":"51","doc_a_id":"15491308","doc_b_id":"17021845","presented_order":["17021845","15491308"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem cell marker and prognosis (though in lung cancer), which is closer to ALDH1 and breast cancer outcomes than a study on SIRT1 in mesenchymal stem cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272504Z"}
{"comparison_id":"02e4f35d-a4f0-4566-9c7f-8013826b3c94","query_id":"51","doc_a_id":"21372171","doc_b_id":"17021845","presented_order":["17021845","21372171"],"winner_id":"17021845","reasoning":"Document A is more relevant — it concerns a cancer stem-cell marker and prognosis, which is thematically closer to a claim about marker expression and cancer outcomes than a study of HMGB1 in peripheral artery disease.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272536Z"}
{"comparison_id":"e6a5d1be-4a70-48c5-a9dd-82af656371ce","query_id":"51","doc_a_id":"15803282","doc_b_id":"17021845","presented_order":["17021845","15803282"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem cell marker and prognosis (though in lung cancer, not breast), while Document B is about somatic cell nuclear transfer and not cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272567Z"}
{"comparison_id":"7c98ac5c-0342-4c71-8a74-cfa766aa0197","query_id":"51","doc_a_id":"25022826","doc_b_id":"17021845","presented_order":["17021845","25022826"],"winner_id":"17021845","reasoning":"Document A — it discusses a stem cell marker’s expression and its association with cancer diagnosis/prognosis (though in lung cancer), which is more related to the query about a marker’s expression and cancer outcomes than Document B. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272609Z"}
{"comparison_id":"a5e44ccd-6285-48ec-8288-c711427c16a5","query_id":"51","doc_a_id":"19644821","doc_b_id":"17021845","presented_order":["19644821","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem cell marker's expression and its association with cancer prognosis, which is conceptually closer to ALDH1 and breast cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272640Z"}
{"comparison_id":"1af02926-5c28-4bd6-81ae-ecf5993347af","query_id":"51","doc_a_id":"219475","doc_b_id":"17021845","presented_order":["219475","17021845"],"winner_id":"219475","reasoning":"Document A — it concerns mammary (breast) tumors, so it's more relevant to breast cancer outcomes than Document B, which is about Nanog in lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272671Z"}
{"comparison_id":"1606f913-5b1d-4d25-83d6-c5b38efccc2a","query_id":"51","doc_a_id":"36653415","doc_b_id":"17021845","presented_order":["36653415","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a cancer stem cell marker and prognosis (closer to ALDH1/prognosis) while A is about lung tumor metabolism unrelated to marker expression. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272702Z"}
{"comparison_id":"ddcbb9e6-9766-4362-89f0-bc5a0ab1bc2b","query_id":"51","doc_a_id":"32742683","doc_b_id":"17021845","presented_order":["32742683","17021845"],"winner_id":"17021845","reasoning":"Document B is slightly more relevant because it discusses a stem cell marker's association with cancer prognosis (though in lung and a different marker). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272733Z"}
{"comparison_id":"fcd213b1-91d8-4d11-bc39-19fc3f54cd4c","query_id":"51","doc_a_id":"20501163","doc_b_id":"17021845","presented_order":["17021845","20501163"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses stem cell marker expression and cancer prognosis, which is closer to ALDH1 as a prognostic stem cell marker than Document B's metabolic/IL-6 immunology focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272765Z"}
{"comparison_id":"9f3a1bd3-9055-4eb6-b7b0-fabce4ca3c80","query_id":"51","doc_a_id":"8994465","doc_b_id":"17021845","presented_order":["8994465","17021845"],"winner_id":"17021845","reasoning":"Reason: Both documents are unrelated to ALDH1 or breast cancer, but Document B studies a stem-cell marker's association with cancer prognosis (closer in topic) while A focuses on melanoma cell cycling.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272796Z"}
{"comparison_id":"bc17006c-f432-434f-a811-dc807c679ccb","query_id":"51","doc_a_id":"19343151","doc_b_id":"17021845","presented_order":["17021845","19343151"],"winner_id":"17021845","reasoning":"Document A is more related (it discusses cancer and stem cell marker expression, whereas B concerns skin aging and not cancer). \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272826Z"}
{"comparison_id":"0514942c-990d-4e26-b6fe-b004f5492b4f","query_id":"51","doc_a_id":"42106119","doc_b_id":"17021845","presented_order":["42106119","17021845"],"winner_id":"42106119","reasoning":"Document A is slightly more relevant — it discusses stem cell factors and links to cancer biology (more likely to bear on markers like ALDH1), whereas Document B concerns Nanog in lung cancer specifically, not ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272858Z"}
{"comparison_id":"c94d887d-de93-4c2d-b458-ef101733900b","query_id":"51","doc_a_id":"8724666","doc_b_id":"17021845","presented_order":["17021845","8724666"],"winner_id":"17021845","reasoning":"Reason: Document A discusses a cancer stem cell marker and prognosis (though in lung cancer), which is closer to ALDH1 as a stem cell/prognostic marker in breast cancer than the leukemia metabolism focus in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272890Z"}
{"comparison_id":"a74e19f6-30ce-4b5b-a152-51a4514bec46","query_id":"51","doc_a_id":"31624828","doc_b_id":"17021845","presented_order":["17021845","31624828"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem cell marker and prognosis (though for Nanog in lung cancer), which is closer to ALDH1 and breast cancer outcomes than the p53/apoptotic-clearance topic in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272921Z"}
{"comparison_id":"2d08883a-29ae-4d99-81b4-3b0dcf0f059d","query_id":"51","doc_a_id":"164985","doc_b_id":"17021845","presented_order":["17021845","164985"],"winner_id":"164985","reasoning":"Document B is more relevant because it involves mammary (breast) carcinoma biology, whereas Document A concerns Nanog in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272952Z"}
{"comparison_id":"9568ab00-8d01-48f3-8707-3a68f16e6c64","query_id":"51","doc_a_id":"20460020","doc_b_id":"17021845","presented_order":["17021845","20460020"],"winner_id":"17021845","reasoning":"Reason: Document A discusses a stem cell marker's expression and its association with cancer prognosis (though in lung cancer), which is closer to ALDH1 and breast cancer outcome than Document B's wound-healing/ERα macrophage study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.272984Z"}
{"comparison_id":"cf5adc14-e14a-4634-a8db-c56afbba2775","query_id":"51","doc_a_id":"32372280","doc_b_id":"17021845","presented_order":["17021845","32372280"],"winner_id":"17021845","reasoning":"Document A is more related because it discusses cancer stem cell marker expression and prognosis (though in lung cancer), whereas Document B concerns glaucoma.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273015Z"}
{"comparison_id":"8d6cc07d-c3ca-40dc-9020-7a894d942bd6","query_id":"51","doc_a_id":"22896384","doc_b_id":"17021845","presented_order":["17021845","22896384"],"winner_id":"17021845","reasoning":"Document A — it discusses a cancer stem-cell marker and prognosis (though in lung cancer), which is more related to marker expression and outcomes than developmental TFs in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273046Z"}
{"comparison_id":"83648dbb-7e4b-4445-b1a8-cc7aa604afe4","query_id":"51","doc_a_id":"38025907","doc_b_id":"17021845","presented_order":["17021845","38025907"],"winner_id":"17021845","reasoning":"Document A is slightly more relevant because it discusses cancer stem cell markers (though in lung cancer), whereas Document B concerns liver disease in mice and is unrelated to cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273078Z"}
{"comparison_id":"a050f0ea-df32-482c-964d-4574a931ffe1","query_id":"51","doc_a_id":"14149065","doc_b_id":"17021845","presented_order":["14149065","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem cell marker and cancer prognosis (though in lung cancer), which is more related to marker expression and outcomes than Document A's cell‑adhesion/proliferation focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273109Z"}
{"comparison_id":"4f5b1cb0-20d4-41b0-840e-5747bb5458b6","query_id":"51","doc_a_id":"25344732","doc_b_id":"17021845","presented_order":["17021845","25344732"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses expression of a stem-cell marker and its association with cancer prognosis, whereas Document B concerns PHC3 in osteosarcoma and is unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273141Z"}
{"comparison_id":"8d9480c4-a831-43f7-b3bb-ec952a96d9c7","query_id":"51","doc_a_id":"26059876","doc_b_id":"17021845","presented_order":["17021845","26059876"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a cancer stem cell marker and its prognostic significance (analogous to ALDH1), whereas Document B concerns Ku70 in colorectal homeostasis and is unrelated to stem cell markers or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273172Z"}
{"comparison_id":"4be00caa-2bf6-4fd7-a1fa-ddc2b01e97d5","query_id":"51","doc_a_id":"8417211","doc_b_id":"17021845","presented_order":["17021845","8417211"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses stem cell marker expression and cancer prognosis (albeit Nanog in lung cancer), whereas Document B is about Drosophila HP1 phosphorylation and unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273203Z"}
{"comparison_id":"a93fb413-76a0-4596-b5ff-ac358870a165","query_id":"51","doc_a_id":"23887844","doc_b_id":"17021845","presented_order":["17021845","23887844"],"winner_id":"17021845","reasoning":"Document A — it discusses a stem-cell marker and prognosis in cancer (though Nanog and lung cancer), which is closer to ALDH1 and breast cancer outcomes than the metabolic mechanism in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273235Z"}
{"comparison_id":"9583baf4-6078-4fc7-abb0-5450eecb23d5","query_id":"51","doc_a_id":"28249680","doc_b_id":"17021845","presented_order":["17021845","28249680"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem cell marker and prognosis (though in lung cancer), which is closer to ALDH1's role in cancer outcomes than the cell-death mechanism in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273267Z"}
{"comparison_id":"c580e7a5-18ed-4094-827a-ca8489ba8418","query_id":"51","doc_a_id":"4920376","doc_b_id":"17021845","presented_order":["17021845","4920376"],"winner_id":"17021845","reasoning":"Reason: Document A discusses a cancer stem cell marker and its association with diagnosis/prognosis, which is more conceptually related to ALDH1 and outcome associations than Document B's topic (ERK inhibition in pancreatic cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273298Z"}
{"comparison_id":"ba724d19-5f46-459e-8707-2e4a729e9508","query_id":"51","doc_a_id":"2919030","doc_b_id":"17021845","presented_order":["2919030","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem-cell marker's expression and prognosis in cancer, which is more related to ALDH1's role as a cancer stem-cell marker and outcomes than Document A's metabolic/yeast focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273330Z"}
{"comparison_id":"4892a7db-9ebc-42f9-84f4-a0f8071be4dd","query_id":"51","doc_a_id":"6137330","doc_b_id":"17021845","presented_order":["6137330","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses tumor stem cell marker expression and prognosis in cancer, which is closer to the claim about ALDH1 and breast cancer outcomes than general pulmonary nodule guidelines.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273361Z"}
{"comparison_id":"4db846bc-a22a-4da9-8560-94297e4ee368","query_id":"51","doc_a_id":"17775228","doc_b_id":"17021845","presented_order":["17021845","17775228"],"winner_id":"17021845","reasoning":"Document A — it discusses a stem-cell marker (Nanog) and prognosis in cancer, which is conceptually closer to ALDH1 and outcome associations than the colorectal imprinting study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273392Z"}
{"comparison_id":"097c2448-d636-417e-abe7-883ff10125ee","query_id":"51","doc_a_id":"6828370","doc_b_id":"17021845","presented_order":["17021845","6828370"],"winner_id":"17021845","reasoning":"Reason: Document A discusses a stem cell marker's expression and its association with cancer prognosis (though in lung cancer), which is more directly related to ALDH1 as a stem cell marker and clinical outcomes than Document B's general mRNA/pseudogene regulatory mechanism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273424Z"}
{"comparison_id":"0cd6e1dd-37b5-47fc-9c4d-3ff1b6e05704","query_id":"51","doc_a_id":"12737132","doc_b_id":"17021845","presented_order":["12737132","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem-cell marker's expression and its association with cancer prognosis, which is conceptually closer to ALDH1's prognostic role than the YAP/TEAD pathway in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273455Z"}
{"comparison_id":"7bf4bfab-357f-45f8-aee3-bf6dcdac7727","query_id":"51","doc_a_id":"4641348","doc_b_id":"17021845","presented_order":["17021845","4641348"],"winner_id":"17021845","reasoning":"Document A is more relevant — it's about a stem cell marker's expression and prognosis in cancer (though for Nanog in lung cancer, not ALDH1 in breast cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273486Z"}
{"comparison_id":"57eba22b-03f9-4257-a79d-900d298a48ce","query_id":"51","doc_a_id":"20179918","doc_b_id":"17021845","presented_order":["20179918","17021845"],"winner_id":"17021845","reasoning":"Document B is slightly more relevant because it discusses a stem cell marker's association with cancer prognosis, whereas Document A focuses on STAT3 regulation of SALL4 in embryonic stem cells and not cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273518Z"}
{"comparison_id":"87259cb7-c0f5-45b0-81eb-89ec2f6a39d1","query_id":"51","doc_a_id":"756887","doc_b_id":"17021845","presented_order":["17021845","756887"],"winner_id":"17021845","reasoning":"Document A — discusses a stem cell marker's expression and prognostic significance (though in lung cancer), which is more relevant to a claim about marker expression and cancer outcomes than B's screening-rate topic.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273550Z"}
{"comparison_id":"86deafb9-3035-43d2-b0e6-d8b1eb2a7ec0","query_id":"51","doc_a_id":"2359152","doc_b_id":"17021845","presented_order":["17021845","2359152"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem cell marker's expression and prognostic association in cancer, which is closer to ALDH1 and breast cancer outcomes than a genetic survey of MDS. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273581Z"}
{"comparison_id":"209e53ab-f123-4f44-a6c1-e7dd0ad265f7","query_id":"51","doc_a_id":"36547290","doc_b_id":"17021845","presented_order":["17021845","36547290"],"winner_id":"17021845","reasoning":"Neither document addresses ALDH1 or breast cancer directly. Document A is marginally more relevant because it discusses a cancer stem cell marker and prognosis, whereas B is a mechanistic study of BRG1/STAT3 unrelated to cancer outcome markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273613Z"}
{"comparison_id":"c2e215d2-4679-415a-86ef-8ffcb515f150","query_id":"51","doc_a_id":"39481265","doc_b_id":"17021845","presented_order":["17021845","39481265"],"winner_id":"17021845","reasoning":"Document A — it discusses a cancer stem cell marker and its association with diagnosis/prognosis in cancer (closer to ALDH1 and breast cancer outcomes than a review on lung fibrosis epigenetics).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273644Z"}
{"comparison_id":"55f13848-3279-4f8f-83e7-ae7115990a03","query_id":"51","doc_a_id":"22483580","doc_b_id":"17021845","presented_order":["22483580","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses cancer stem cell markers and prognosis (though in lung cancer and about Nanog, not ALDH1/breast cancer), while Document A is unrelated (bipolar disorder/IL-6).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273676Z"}
{"comparison_id":"0aca2c33-ca04-41d4-9c38-418bc80caced","query_id":"51","doc_a_id":"8842332","doc_b_id":"17021845","presented_order":["17021845","8842332"],"winner_id":"17021845","reasoning":"Neither document addresses ALDH1 or breast cancer directly, but Document A discusses a cancer stem-cell marker and prognosis (more related to cancer biomarker–outcome links) so it's more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273707Z"}
{"comparison_id":"5ca3cf84-31ca-48ac-a179-6c641bdd09d9","query_id":"51","doc_a_id":"5765455","doc_b_id":"17021845","presented_order":["5765455","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a cancer stem cell marker and prognosis (though in lung cancer), which is more related to ALDH1's role in prognosis than Document A's focus on ROS and myeloid leukemia.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273738Z"}
{"comparison_id":"ac640f89-e666-4887-abd7-6c0c219172e9","query_id":"51","doc_a_id":"24586989","doc_b_id":"17021845","presented_order":["24586989","17021845"],"winner_id":"17021845","reasoning":"Document B — it's about cancer and stem cell marker expression (though in lung, not breast, and a different marker), whereas A is about heart failure and unrelated genes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273769Z"}
{"comparison_id":"24c85892-7d8c-4dd7-9ff9-83c92ecf2e8e","query_id":"51","doc_a_id":"12152977","doc_b_id":"17021845","presented_order":["17021845","12152977"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem cell marker's expression and its association with cancer prognosis (though in lung cancer), whereas B focuses on chromatin regulation in embryonic stem cells and not cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273801Z"}
{"comparison_id":"fba43cd7-5c8e-42e4-a7d8-7ddc400b0c80","query_id":"51","doc_a_id":"5939172","doc_b_id":"17021845","presented_order":["17021845","5939172"],"winner_id":"17021845","reasoning":"Document A — it discusses cancer stem cell marker expression and prognosis (closer in topic to ALDH1 and breast cancer outcomes) whereas B is about drinking patterns and mortality. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273832Z"}
{"comparison_id":"981f725a-4eaa-4bd8-a576-71ae18858998","query_id":"51","doc_a_id":"1871499","doc_b_id":"17021845","presented_order":["17021845","1871499"],"winner_id":"17021845","reasoning":"Document A is more relevant because it deals with cancer biomarker expression (though in lung cancer) while Document B concerns Huntington's disease and is unrelated to cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273863Z"}
{"comparison_id":"044cf72b-2c0f-4657-aea6-481f1f505adb","query_id":"51","doc_a_id":"17412260","doc_b_id":"17021845","presented_order":["17021845","17412260"],"winner_id":"17021845","reasoning":"Document A is slightly more relevant — it concerns cancer stem-cell marker expression and prognosis (though in lung cancer and for Nanog, not ALDH1 or breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273894Z"}
{"comparison_id":"dce594c0-2a42-4892-94cc-45224a96494b","query_id":"51","doc_a_id":"3727986","doc_b_id":"17021845","presented_order":["3727986","17021845"],"winner_id":"3727986","reasoning":"Document A is more relevant — it addresses cancer cell behavior and tumor invasion mechanisms (more likely related to breast cancer biology) while Document B concerns Nanog in lung cancer, which is unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273926Z"}
{"comparison_id":"296b9f5d-d11b-493b-a310-bd7379c1d35a","query_id":"51","doc_a_id":"12580014","doc_b_id":"17021845","presented_order":["17021845","12580014"],"winner_id":"17021845","reasoning":"Document A is slightly more relevant because it discusses a cancer stem cell marker and prognosis, which is closer to ALDH1's role in cancer outcomes than the skin-specific keratin/Aire study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273957Z"}
{"comparison_id":"a8508244-9f67-4565-b01f-9d917404ea89","query_id":"51","doc_a_id":"13048272","doc_b_id":"17021845","presented_order":["13048272","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a stem cell marker's expression and its association with cancer prognosis, which is closer to the query about ALDH1 and breast cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.273988Z"}
{"comparison_id":"0093f9eb-243f-4820-85d2-db8a7ab8717b","query_id":"51","doc_a_id":"8290760","doc_b_id":"17021845","presented_order":["8290760","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem-cell marker's diagnostic/prognostic significance in cancer (though lung cancer and Nanog, not ALDH1/breast), so it's more relevant than A, which is about cellular reprogramming. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274019Z"}
{"comparison_id":"c12e95e2-3694-4088-9096-43139e238b8d","query_id":"51","doc_a_id":"28390999","doc_b_id":"17021845","presented_order":["17021845","28390999"],"winner_id":"17021845","reasoning":"Document A deals with cancer stem cell marker expression and prognosis (though in lung cancer), making it more relevant to a claim about a cancer marker and outcomes than Document B, which is about chicken gonad development.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274051Z"}
{"comparison_id":"1ff198cf-c8f4-4d7a-87a0-be2cc6c74479","query_id":"51","doc_a_id":"5579368","doc_b_id":"17021845","presented_order":["17021845","5579368"],"winner_id":"5579368","reasoning":"Reason: Document B concerns genomic analysis and breast cancer biomarkers (linking methylation and gene expression), which is more relevant to ALDH1 expression and breast cancer outcomes than Document A (Nanog in lung cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274082Z"}
{"comparison_id":"df2f202f-c591-412a-9329-20ee75a81b7d","query_id":"51","doc_a_id":"1791714","doc_b_id":"17021845","presented_order":["1791714","17021845"],"winner_id":"17021845","reasoning":"Document B — it concerns a stem-cell marker's expression and prognosis (though in lung cancer), which is more conceptually related to ALDH1 as a stem-cell marker and outcomes than Document A's EMT/squamous carcinoma focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274114Z"}
{"comparison_id":"69e32d67-4517-4a80-9383-db7a0b5cbaa7","query_id":"51","doc_a_id":"3202143","doc_b_id":"17021845","presented_order":["17021845","3202143"],"winner_id":"17021845","reasoning":"Document A is more relevant because it addresses cancer and stem cell markers (though in lung cancer), whereas Document B is unrelated (C. elegans memory study). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274145Z"}
{"comparison_id":"63dd7d6a-461b-4fc6-89b6-edf00dbd17e3","query_id":"51","doc_a_id":"2485101","doc_b_id":"17021845","presented_order":["17021845","2485101"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses expression of a stem-cell marker and its association with cancer prognosis (though in lung cancer and for Nanog, not ALDH1/breast). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274176Z"}
{"comparison_id":"6a336776-f8b4-490c-89ec-19792c5619ab","query_id":"51","doc_a_id":"25748308","doc_b_id":"17021845","presented_order":["25748308","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a stem-cell marker's expression and its association with cancer prognosis, which is conceptually closer to ALDH1 as a prognostic stem-cell marker than a paper about GAPDH.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274208Z"}
{"comparison_id":"924a34d4-448e-40ac-931c-dfda1f201644","query_id":"51","doc_a_id":"7225911","doc_b_id":"17021845","presented_order":["17021845","7225911"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses a stem-cell marker and its association with cancer prognosis (even though it's lung cancer and a different marker), whereas Document B focuses on lncRNA-p53 regulation unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274239Z"}
{"comparison_id":"3d20a5b3-5334-4c4c-99d0-7e8b4d11905c","query_id":"51","doc_a_id":"2356950","doc_b_id":"17021845","presented_order":["17021845","2356950"],"winner_id":"17021845","reasoning":"Doc A is more relevant because it discusses cancer and stem-cell markers (though in lung cancer), whereas Doc B is about neural stem cell regulation and not cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274270Z"}
{"comparison_id":"f21a6146-7f26-4d15-86d0-1acb7d099928","query_id":"51","doc_a_id":"20381484","doc_b_id":"17021845","presented_order":["17021845","20381484"],"winner_id":"17021845","reasoning":"Reason: Document A discusses a stem cell marker and its association with cancer prognosis (though in lung cancer, not breast), so it is more relevant than Document B, which is about GAPDH nitrosylation and not cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274301Z"}
{"comparison_id":"9c58a1be-78fd-424b-9fbb-c18beb3cc4fc","query_id":"51","doc_a_id":"885056","doc_b_id":"17021845","presented_order":["17021845","885056"],"winner_id":"885056","reasoning":"Document B — it discusses SLIRP's modulation of tamoxifen effects and nuclear receptor signaling (relevant to breast cancer treatment), whereas A is about Nanog in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274332Z"}
{"comparison_id":"a0ee9694-52f3-40a2-ab0a-2f99771c7dd9","query_id":"51","doc_a_id":"13980338","doc_b_id":"17021845","presented_order":["13980338","17021845"],"winner_id":"17021845","reasoning":"Document B — it addresses a stem-cell-associated marker's role in cancer diagnosis and prognosis, which is closer to the query about marker expression and cancer outcomes than Document A's methods-focused HSC study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274364Z"}
{"comparison_id":"a036ca46-7e63-4e93-8fed-d1c71614a25b","query_id":"51","doc_a_id":"4378885","doc_b_id":"17021845","presented_order":["17021845","4378885"],"winner_id":"17021845","reasoning":"Document A is more relevant because it discusses cancer stem cell marker expression and prognosis (though in lung cancer), whereas Document B is a methods/genetics study in cell lines unrelated to cancer outcomes. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274395Z"}
{"comparison_id":"73459538-0a62-4197-a92d-54084a6f4f15","query_id":"51","doc_a_id":"38028419","doc_b_id":"17021845","presented_order":["17021845","38028419"],"winner_id":"17021845","reasoning":"Document A is more relevant — it discusses cancer stem cell markers and prognosis (though in lung cancer and for Nanog, not ALDH1 or breast cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274426Z"}
{"comparison_id":"d60ad3b1-35f7-4cdb-aed3-ccb178c6ac51","query_id":"51","doc_a_id":"11255504","doc_b_id":"17021845","presented_order":["11255504","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem cell marker's association with cancer prognosis (though in lung cancer), whereas A is unrelated (liver cancer genetics). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274457Z"}
{"comparison_id":"87a1b589-6f01-47c5-84e8-946b23de0c44","query_id":"51","doc_a_id":"13791206","doc_b_id":"17021845","presented_order":["13791206","17021845"],"winner_id":"13791206","reasoning":"Document A is more relevant — it deals with BRCA1-related mechanisms in breast cancer cells, whereas Document B is about Nanog in lung cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274488Z"}
{"comparison_id":"a9aa17c2-7634-4afe-9ae7-e85ad3e7f0bb","query_id":"51","doc_a_id":"4795303","doc_b_id":"17021845","presented_order":["4795303","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a cancer stem-cell marker and prognosis associations, which is closer to ALDH1's role in cancer outcomes than the unrelated neuroprotection study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274519Z"}
{"comparison_id":"d27a63c3-03fc-41b1-9c94-5cf4e557ee15","query_id":"51","doc_a_id":"3621011","doc_b_id":"17021845","presented_order":["3621011","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses stem cell marker expression and cancer prognosis (though in lung cancer, not ALDH1 or breast cancer), whereas A is unrelated (adipose biology). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274550Z"}
{"comparison_id":"304f4eb1-61f8-4e94-aa5b-e35116fdb26d","query_id":"51","doc_a_id":"42484543","doc_b_id":"17021845","presented_order":["42484543","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a stem cell marker's expression and its association with cancer diagnosis/prognosis (though in lung cancer), which is closer to the query about ALDH1 and breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274648Z"}
{"comparison_id":"ff7dac21-05fc-47b2-8f6a-9f2a84d6566e","query_id":"51","doc_a_id":"9641846","doc_b_id":"17021845","presented_order":["9641846","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses a stem-cell marker and cancer prognosis (closer to ALDH1’s role) whereas A is about Rb-family function and cell-cycle in embryos. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274685Z"}
{"comparison_id":"97b5f81e-9efc-472b-baf1-e528b56d400a","query_id":"51","doc_a_id":"2829179","doc_b_id":"17021845","presented_order":["2829179","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a cancer stem cell marker and prognosis, which is closer to ALDH1's role in cancer outcomes than a paper on pre-eclampsia.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274717Z"}
{"comparison_id":"812220aa-da73-4528-8cbb-ab308fd33495","query_id":"51","doc_a_id":"40901687","doc_b_id":"17021845","presented_order":["17021845","40901687"],"winner_id":"17021845","reasoning":"Document A is slightly more relevant because it discusses cancer stem cell markers and prognosis, whereas Document B addresses DNA damage signaling unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274749Z"}
{"comparison_id":"09ec897f-7bf5-423f-bb82-93df3f331666","query_id":"51","doc_a_id":"21602220","doc_b_id":"17021845","presented_order":["21602220","17021845"],"winner_id":"17021845","reasoning":"Document B — it discusses cancer stem-cell markers and prognosis (though in lung cancer, not breast), which is more related to the query than an E. coli fermentation study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274780Z"}
{"comparison_id":"80b3448c-1020-4402-8bc3-60b3e0384487","query_id":"51","doc_a_id":"1982286","doc_b_id":"17021845","presented_order":["1982286","17021845"],"winner_id":"17021845","reasoning":"Document B is more relevant — it discusses a stem-cell marker's association with cancer prognosis, whereas A is about T-ALL transcriptional networks unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274811Z"}
{"comparison_id":"31c0e891-6804-4c6c-8c76-cbe59e86fb28","query_id":"51","doc_a_id":"14848619","doc_b_id":"17021845","presented_order":["14848619","17021845"],"winner_id":"17021845","reasoning":"Document B is marginally more relevant because it discusses a stem cell marker's association with cancer prognosis, whereas Document A addresses hypoxia-induced cell death unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274842Z"}
{"comparison_id":"57e3ac9b-84de-423d-b4c6-e92d5f7e2839","query_id":"51","doc_a_id":"22914228","doc_b_id":"17021845","presented_order":["17021845","22914228"],"winner_id":"17021845","reasoning":"Reason: Document A discusses a stem cell marker's expression and its association with cancer prognosis (though in lung cancer), which is more thematically related to ALDH1 and breast cancer outcomes than Document B's focus on pancreatic cancer metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:29:41.274873Z"}
{"comparison_id":"a56be5ff-1fa2-4c80-a387-bfc5b3053996","query_id":"51","doc_a_id":"45638119","doc_b_id":"31616203","presented_order":["31616203","45638119"],"winner_id":"45638119","reasoning":"Document B — it directly studies ALDH1 in breast tissue and states ALDH1 correlates with poor clinical outcome, which is directly relevant to the claim. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.434798Z"}
{"comparison_id":"66b66a18-ed6f-4695-9498-724da032ab98","query_id":"51","doc_a_id":"8963413","doc_b_id":"31616203","presented_order":["8963413","31616203"],"winner_id":"8963413","reasoning":"Document A is more relevant — it discusses how expression of a tumor marker (PD-L1) relates to breast cancer outcomes, which is analogous to the claim about ALDH1 as a prognostic marker. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.434819Z"}
{"comparison_id":"61fa698a-93d3-42d8-b9a2-2a4a2415af51","query_id":"51","doc_a_id":"22401720","doc_b_id":"31616203","presented_order":["22401720","31616203"],"winner_id":"22401720","reasoning":"Document A is more relevant — it examines expression of tumor markers and their relation to prognosis in breast cancer, while B is a therapy trial for brain metastases and doesn't address biomarker–outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.434828Z"}
{"comparison_id":"e083a95e-2d09-447b-b56a-7af85800bbbf","query_id":"51","doc_a_id":"21439640","doc_b_id":"31616203","presented_order":["31616203","21439640"],"winner_id":"21439640","reasoning":"Both documents do not mention ALDH1, but Document B discusses tumor-promoting molecular pathways in breast cancer (more relevant to biomarker/prognosis context) while Document A is a therapy trial for HER2 brain metastases. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.434836Z"}
{"comparison_id":"b1a150d4-6f81-448f-bca1-4b7873dd49e0","query_id":"51","doc_a_id":"12762485","doc_b_id":"31616203","presented_order":["12762485","31616203"],"winner_id":"12762485","reasoning":"Document A — it discusses breast cancer phenotypes and stem-cell–like markers relevant to ALDH1's role in prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.434843Z"}
{"comparison_id":"267a9fca-80a0-451c-9edd-86ff08150471","query_id":"51","doc_a_id":"7821634","doc_b_id":"31616203","presented_order":["7821634","31616203"],"winner_id":"7821634","reasoning":"Document A is more relevant — it discusses how a biomarker's expression (DUSP4) correlates with breast cancer outcomes, which is conceptually closer to the query about ALDH1 expression and outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.434850Z"}
{"comparison_id":"9c8c4dd0-0dc4-4be4-9ac7-0c3c66f01a97","query_id":"51","doc_a_id":"4429932","doc_b_id":"31616203","presented_order":["4429932","31616203"],"winner_id":"4429932","reasoning":"Document A is more relevant — it discusses a molecular marker (LOX) linked to breast cancer outcomes, whereas B is a clinical trial of lapatinib in brain metastases and doesn't address biomarker-outcome associations. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.434857Z"}
{"comparison_id":"bc6a34cc-8237-4477-b69a-713fd6bb3358","query_id":"51","doc_a_id":"24341590","doc_b_id":"31616203","presented_order":["24341590","31616203"],"winner_id":"24341590","reasoning":"Document A is more relevant — it discusses a biomarker/genetic factor associated with breast cancer outcomes, which is closer to the query about ALDH1 expression and outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.434864Z"}
{"comparison_id":"d9405435-346d-4e89-8d8a-c6c7818175c3","query_id":"51","doc_a_id":"13007205","doc_b_id":"31616203","presented_order":["31616203","13007205"],"winner_id":"13007205","reasoning":"Document B is more relevant — it discusses tumor biological factors and invasion that relate to prognosis, whereas A is a treatment trial unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.434871Z"}
{"comparison_id":"eae39092-be1d-432f-83bb-a4cb7bb58576","query_id":"51","doc_a_id":"32001951","doc_b_id":"31616203","presented_order":["31616203","32001951"],"winner_id":"32001951","reasoning":"Document B is more relevant — it concerns expression regulation of an enzyme in breast cancer cells, which is closer to a claim about a biomarker's expression and outcomes than a clinical trial of lapatinib.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.434878Z"}
{"comparison_id":"ea5ba390-a46d-4c03-903c-1281775185e5","query_id":"51","doc_a_id":"20886584","doc_b_id":"31616203","presented_order":["31616203","20886584"],"winner_id":"31616203","reasoning":"Document A is more relevant — it reports breast cancer treatment outcomes, whereas Document B focuses on genetic predictors of chemotherapy neurotoxicity, unrelated to ALDH1 or outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.434885Z"}
{"comparison_id":"972bb28c-2f6d-4fae-9f26-55b217126c0c","query_id":"51","doc_a_id":"7583725","doc_b_id":"31616203","presented_order":["7583725","31616203"],"winner_id":"7583725","reasoning":"Document A is more relevant — it addresses how expression of a tumor marker (TRPM7) correlates with breast cancer outcomes, which is conceptually closer to ALDH1 expression–outcome associations than the lapatinib trial in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.434892Z"}
{"comparison_id":"9bcdfd11-43fd-43d4-afdb-b2ea5931e567","query_id":"51","doc_a_id":"15113221","doc_b_id":"31616203","presented_order":["15113221","31616203"],"winner_id":"15113221","reasoning":"Document A is more relevant because it discusses a gene expression signature linked to prognosis in carcinoma, which is closer to evaluating biomarker (like ALDH1) associations with breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.434900Z"}
{"comparison_id":"efea8501-ed3e-49ba-8063-4edc179024d9","query_id":"51","doc_a_id":"4820792","doc_b_id":"31616203","presented_order":["31616203","4820792"],"winner_id":"4820792","reasoning":"Document B is more relevant — it deals with cellular survival pathways and therapy resistance, which relate more to markers like ALDH1 and outcome than a clinical lapatinib trial. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.434907Z"}
{"comparison_id":"dca12ea1-c0b6-4a4d-bca6-06111c3a54b7","query_id":"51","doc_a_id":"27240667","doc_b_id":"31616203","presented_order":["27240667","31616203"],"winner_id":"27240667","reasoning":"Document A is more relevant — it discusses breast cancer outcomes and mortality trends, which relate to the claim about a biomarker's association with outcomes. Document B is a specific treatment trial for HER2+ brain metastases and not about prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.434915Z"}
{"comparison_id":"ecf39fd4-3afb-454c-96c6-d9c3ac0770ad","query_id":"51","doc_a_id":"15721252","doc_b_id":"31616203","presented_order":["31616203","15721252"],"winner_id":"31616203","reasoning":"Document A is slightly more relevant because it reports clinical breast cancer outcomes (whereas B focuses on cell-line drug sensitivity markers); however, neither document mentions ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.434922Z"}
{"comparison_id":"ebb6f810-cc95-4d8b-bae9-c169e0a0e299","query_id":"51","doc_a_id":"17648235","doc_b_id":"31616203","presented_order":["17648235","31616203"],"winner_id":"17648235","reasoning":"Document A is more relevant — it addresses breast cancer molecular biology and pathways tied to tumor behavior, whereas Document B is a clinical trial of lapatinib in brain metastases and does not address biomarker–outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.434929Z"}
{"comparison_id":"83e49f28-9e08-4898-954b-cec4890a05b2","query_id":"51","doc_a_id":"15081770","doc_b_id":"31616203","presented_order":["31616203","15081770"],"winner_id":"31616203","reasoning":"Document A is more relevant because it concerns breast cancer outcomes (though not ALDH1), while Document B discusses a different enzyme in lymphomas. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.434935Z"}
{"comparison_id":"5e77612b-7603-49dc-89fe-6eeb57ea00a1","query_id":"51","doc_a_id":"16734530","doc_b_id":"31616203","presented_order":["31616203","16734530"],"winner_id":"16734530","reasoning":"Document B is more relevant — it analyzes genetic/molecular associations with breast cancer clinical features, whereas A is a treatment trial unrelated to biomarker expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.434942Z"}
{"comparison_id":"299737f7-7390-4c3b-9a3b-17df56d99e5c","query_id":"51","doc_a_id":"3285322","doc_b_id":"31616203","presented_order":["3285322","31616203"],"winner_id":"3285322","reasoning":"Document A is more relevant — it addresses clinical/pathologic tumor characteristics and outcome-related differences (biomarker-associated features), whereas Document B focuses on a specific treatment trial for HER2 brain metastases and doesn't relate to biomarker expression. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.434950Z"}
{"comparison_id":"3aee59dc-5125-4246-a314-f852f09751ae","query_id":"51","doc_a_id":"2140497","doc_b_id":"31616203","presented_order":["31616203","2140497"],"winner_id":"2140497","reasoning":"Document B — it concerns associations between breast tissue features and cancer risk/prognosis, so it's marginally closer to a claim about a prognostic marker like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.434957Z"}
{"comparison_id":"0daa721f-3a1b-42e0-98bf-3b8a8273614d","query_id":"51","doc_a_id":"20839751","doc_b_id":"31616203","presented_order":["20839751","31616203"],"winner_id":"20839751","reasoning":"Document A is more relevant — it addresses prognostic markers and outcomes in breast cancer (though it doesn’t mention ALDH1 specifically).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.434964Z"}
{"comparison_id":"2a0150f4-ab50-4cab-ad52-19f023c818bc","query_id":"51","doc_a_id":"16701509","doc_b_id":"31616203","presented_order":["16701509","31616203"],"winner_id":"31616203","reasoning":"Document B is more relevant because it reports on treatment outcomes/response in breast cancer, which relates to prognosis, whereas Document A addresses risk factors for developing breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.434973Z"}
{"comparison_id":"6efc65e7-4ff3-4692-a6e3-462d64dfbdae","query_id":"51","doc_a_id":"13030852","doc_b_id":"31616203","presented_order":["31616203","13030852"],"winner_id":"13030852","reasoning":"Document B is more relevant — it concerns biomarkers and their association with metastasis/outcomes, whereas A reports a drug trial unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.434980Z"}
{"comparison_id":"67f106fc-4fcd-4745-954e-d381dd40379f","query_id":"51","doc_a_id":"13069283","doc_b_id":"31616203","presented_order":["13069283","31616203"],"winner_id":"13069283","reasoning":"Document A is more relevant — it concerns treatment metabolism and outcomes in breast cancer patients (ER+), whereas Document B focuses narrowly on lapatinib in HER2+ brain metastases; neither mentions ALDH1 but A is closer to outcome-related factors. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435031Z"}
{"comparison_id":"0bd92774-7fc6-4e0b-b53f-5e15ef78a8b9","query_id":"51","doc_a_id":"37480103","doc_b_id":"31616203","presented_order":["37480103","31616203"],"winner_id":"31616203","reasoning":"Reason: Document B discusses breast cancer treatment outcomes, which is closer to a claim about markers associated with outcomes; Document A is about pregnancy-related risk, not marker expression or outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435046Z"}
{"comparison_id":"a07c61f0-9bd4-4d1d-8bed-a33896c0c3bf","query_id":"51","doc_a_id":"4999633","doc_b_id":"31616203","presented_order":["4999633","31616203"],"winner_id":"4999633","reasoning":"Document A is more relevant — it deals with expression of a receptor and tumor cell behavior, which is closer to biomarker-outcome associations than a drug trial for HER2 brain metastases. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435056Z"}
{"comparison_id":"594b7240-df39-4572-9aa5-3eaddafbb316","query_id":"51","doc_a_id":"9600826","doc_b_id":"31616203","presented_order":["9600826","31616203"],"winner_id":"9600826","reasoning":"Doc A is slightly more relevant because it discusses breast cancer molecular pathways and tumor biology, whereas Doc B focuses on a clinical trial for HER2 brain metastases and does not address molecular markers like ALDH1.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435064Z"}
{"comparison_id":"f7272d12-ac55-47ae-8919-b6c1eb23a16e","query_id":"51","doc_a_id":"15335331","doc_b_id":"31616203","presented_order":["31616203","15335331"],"winner_id":"31616203","reasoning":"Document A is more relevant — it concerns breast cancer (albeit about lapatinib in HER2+ brain mets), whereas Document B is about oral squamous cell carcinoma and unrelated to ALDH1 or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435072Z"}
{"comparison_id":"603af489-5cd4-4022-b3d8-c3c4df484334","query_id":"51","doc_a_id":"43385013","doc_b_id":"31616203","presented_order":["43385013","31616203"],"winner_id":"43385013","reasoning":"Document A is more relevant — it discusses stem cell/progenitor properties in breast cell subpopulations (related to markers like ALDH1), whereas Document B is a drug trial unrelated to ALDH1 or prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435080Z"}
{"comparison_id":"3f376756-4826-47a0-a22a-c91b7b7c8792","query_id":"51","doc_a_id":"1171121","doc_b_id":"31616203","presented_order":["31616203","1171121"],"winner_id":"1171121","reasoning":"Reason: Document B discusses prognostic biomarkers and associations with breast cancer outcomes, which is more conceptually related to ALDH1 as a prognostic marker than Document A (treatment trial for brain metastases).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435087Z"}
{"comparison_id":"eda17f6a-60f5-4db0-975c-3ce7a8b01001","query_id":"51","doc_a_id":"25732836","doc_b_id":"31616203","presented_order":["25732836","31616203"],"winner_id":"25732836","reasoning":"Document A is slightly more relevant because it addresses prognostic biomarkers and outcomes in breast cancer, whereas Document B is a drug trial for brain metastases and does not concern biomarkers. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435094Z"}
{"comparison_id":"631a9e1e-1173-4b05-a22b-845fa44e03c0","query_id":"51","doc_a_id":"25973484","doc_b_id":"31616203","presented_order":["25973484","31616203"],"winner_id":"25973484","reasoning":"Document A is more relevant — it discusses factors linked to breast cancer prognosis and outcomes, whereas Document B focuses on a treatment trial for HER2 brain metastases and not biomarkers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435102Z"}
{"comparison_id":"75209e03-b9b5-422c-9076-7a2cc75dd57f","query_id":"51","doc_a_id":"29366489","doc_b_id":"31616203","presented_order":["31616203","29366489"],"winner_id":"31616203","reasoning":"Document A is more relevant — it specifically concerns breast cancer outcomes, whereas Document B discusses a different tumor suppressor (DLC-1) and not ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435112Z"}
{"comparison_id":"05d8abf7-be5f-4d41-9d0b-83fbf90b79e4","query_id":"51","doc_a_id":"4414547","doc_b_id":"31616203","presented_order":["31616203","4414547"],"winner_id":"31616203","reasoning":"Document A discusses breast cancer treatment outcomes, whereas Document B concerns genetic predisposition; A is therefore more related to a claim about expression and outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435120Z"}
{"comparison_id":"531cd52f-8bc5-432e-a25f-26996ae5d323","query_id":"51","doc_a_id":"24249915","doc_b_id":"31616203","presented_order":["24249915","31616203"],"winner_id":"24249915","reasoning":"Doc A is more relevant — it addresses marker expression changes in breast cancer (like ALDH1 expression would) and links expression to cancer progression, whereas Document B is a drug trial unrelated to marker expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435128Z"}
{"comparison_id":"47d853b9-9f1d-4c20-98cb-d4a24c63241a","query_id":"51","doc_a_id":"313403","doc_b_id":"31616203","presented_order":["31616203","313403"],"winner_id":"313403","reasoning":"Document B — it discusses markers predicting breast cancer prognosis and survival, which is more relevant to a claim about a biomarker (ALDH1) and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435134Z"}
{"comparison_id":"c9db3054-2d0e-48a1-8365-4eed5fd19eff","query_id":"51","doc_a_id":"52180874","doc_b_id":"31616203","presented_order":["31616203","52180874"],"winner_id":"31616203","reasoning":"Document A is about breast cancer (HER2-positive) outcomes, while Document B concerns PD-1/PD-L1 across cancers; neither mentions ALDH1 but A is closer in topic. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435141Z"}
{"comparison_id":"127d64c5-ca6e-43cc-906c-8013557c007e","query_id":"51","doc_a_id":"195680777","doc_b_id":"31616203","presented_order":["31616203","195680777"],"winner_id":"195680777","reasoning":"Document B is more relevant — it addresses breast cancer outcomes and mortality broadly, while A reports a specific drug trial in HER2 brain metastases unrelated to ALDH1 expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435148Z"}
{"comparison_id":"5824adb9-b9b9-4cd7-b5aa-3a7b89c0e342","query_id":"51","doc_a_id":"38551172","doc_b_id":"31616203","presented_order":["38551172","31616203"],"winner_id":"38551172","reasoning":"Document A is more relevant — it discusses breast cancer risk/outcomes in a general population context, whereas Document B focuses narrowly on a specific treatment for HER2+ brain metastases and doesn't address biomarkers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435155Z"}
{"comparison_id":"8101f9b6-c216-4180-8949-70700498c5af","query_id":"51","doc_a_id":"1389264","doc_b_id":"31616203","presented_order":["1389264","31616203"],"winner_id":"1389264","reasoning":"Reason: Neither abstract mentions ALDH1, but Document A discusses biomarker-linked therapeutic response and tumor biology, making it slightly more relevant to a claim about marker-associated outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435162Z"}
{"comparison_id":"117629b9-71af-4864-913b-258dff14086f","query_id":"51","doc_a_id":"22509015","doc_b_id":"31616203","presented_order":["31616203","22509015"],"winner_id":"22509015","reasoning":"Document B is more relevant — it addresses molecular features of breast cancer subtypes (basal-like) and metastasis, which is closer to biomarker associations like ALDH1 than a clinical drug trial. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435169Z"}
{"comparison_id":"5181966e-e7c8-4220-a4e7-5ac56357761a","query_id":"51","doc_a_id":"17450673","doc_b_id":"31616203","presented_order":["17450673","31616203"],"winner_id":"31616203","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it addresses breast cancer clinical outcomes/treatment response, whereas A focuses on perinatal risk factors.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435176Z"}
{"comparison_id":"cb0d953f-8ed7-4b31-9526-11f8d9706f0a","query_id":"51","doc_a_id":"2130391","doc_b_id":"31616203","presented_order":["2130391","31616203"],"winner_id":"31616203","reasoning":"Reason: Neither document mentions ALDH1; Document B discusses breast cancer treatment outcomes directly (response rates), so it is slightly more relevant to a claim about outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435182Z"}
{"comparison_id":"130929fd-7c23-453b-a386-2dbd5168bc54","query_id":"51","doc_a_id":"18340282","doc_b_id":"31616203","presented_order":["18340282","31616203"],"winner_id":"18340282","reasoning":"Document A is more relevant — it addresses genetic/biomarker factors in breast cancer, whereas B is a treatment trial for HER2 brain metastases and unrelated to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435189Z"}
{"comparison_id":"4f25991a-d102-4780-9ebf-03db5bce3236","query_id":"51","doc_a_id":"8671456","doc_b_id":"31616203","presented_order":["8671456","31616203"],"winner_id":"31616203","reasoning":"Reason: Neither abstract mentions ALDH1, but Document B reports clinical outcomes in breast cancer (HER2+), making it slightly more relevant to a claim about expression linked to outcomes than a preclinical virotherapy study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435197Z"}
{"comparison_id":"a0cf77b8-6dfa-43e6-9db2-e6a882af0c6c","query_id":"51","doc_a_id":"1554348","doc_b_id":"31616203","presented_order":["1554348","31616203"],"winner_id":"31616203","reasoning":"Document B discusses clinical outcomes in breast cancer patients (though not ALDH1-specific), whereas Document A reports cell-line biochemical responses unrelated to ALDH1 or patient outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435204Z"}
{"comparison_id":"dd6c9f86-9a75-4fe8-bb45-cb685151e9e4","query_id":"51","doc_a_id":"20454006","doc_b_id":"31616203","presented_order":["20454006","31616203"],"winner_id":"20454006","reasoning":"Document A is more relevant — it concerns breast cancer biomarker modulation, whereas Document B reports a drug trial for brain metastases and does not address biomarkers like ALDH1.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435211Z"}
{"comparison_id":"9d6c3692-77e0-43ae-bf61-166de0607d05","query_id":"51","doc_a_id":"27123743","doc_b_id":"31616203","presented_order":["31616203","27123743"],"winner_id":"27123743","reasoning":"Document B is more relevant — it discusses breast cancer etiology and mentions effects on stem cells, which is closer to ALDH1 (a stem-cell marker) than a clinical trial of lapatinib. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435217Z"}
{"comparison_id":"9feb056d-98e1-48ae-a7fa-f803bdf5694c","query_id":"51","doc_a_id":"20280410","doc_b_id":"31616203","presented_order":["20280410","31616203"],"winner_id":"31616203","reasoning":"Document B is slightly more relevant because it discusses breast cancer outcomes, whereas Document A covers a BRCA2 variant and prenatal viability not related to ALDH1 or outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435224Z"}
{"comparison_id":"ff61148f-7e49-41ff-b01c-25b55b89b4df","query_id":"51","doc_a_id":"22482820","doc_b_id":"31616203","presented_order":["31616203","22482820"],"winner_id":"22482820","reasoning":"Document B is more relevant — it discusses breast cancer classification and treatment strategies where biomarkers like ALDH1 would be considered, whereas A focuses narrowly on lapatinib for HER2+ brain metastases.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435231Z"}
{"comparison_id":"8026d524-158e-4843-b844-bbee8e144939","query_id":"51","doc_a_id":"4418878","doc_b_id":"31616203","presented_order":["4418878","31616203"],"winner_id":"4418878","reasoning":"Document A is about gene expression signatures and their links to prognosis and therapy response, which is relevant to claims about ALDH1 expression and outcomes; Document B is a clinical trial unrelated to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435238Z"}
{"comparison_id":"e8027e47-2fe5-48ee-8f60-c6f9fe6dc9ae","query_id":"51","doc_a_id":"67045088","doc_b_id":"31616203","presented_order":["67045088","31616203"],"winner_id":"31616203","reasoning":"Document B is more relevant — it reports clinical outcomes in breast cancer patients, which is closer to assessing associations with prognosis than the preclinical immunology focus of Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435245Z"}
{"comparison_id":"b094478c-5ca4-4480-9f9f-69a9b746c37f","query_id":"51","doc_a_id":"5864770","doc_b_id":"31616203","presented_order":["5864770","31616203"],"winner_id":"5864770","reasoning":"Document A is more relevant — it discusses hormonal and molecular influences on breast cancer and mentions need for research into molecular mechanisms, whereas B focuses on a drug trial for HER2 brain metastases and not biomarkers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435252Z"}
{"comparison_id":"4fd7c5e4-d516-45ec-a3a8-ff40902739ff","query_id":"51","doc_a_id":"23863551","doc_b_id":"31616203","presented_order":["23863551","31616203"],"winner_id":"31616203","reasoning":"Document B is more relevant — it reports clinical outcomes in breast cancer (while A is mechanistic); however, neither document mentions ALDH1.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435258Z"}
{"comparison_id":"7786da7a-c59b-4c45-9995-05fa7141a51a","query_id":"51","doc_a_id":"19358586","doc_b_id":"31616203","presented_order":["31616203","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant — it discusses protein/miRNA markers linked to survival outcomes in breast cancer, whereas A is a drug trial for brain metastases and doesn't address prognostic markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435266Z"}
{"comparison_id":"16ca452e-1189-42fb-8149-366732a0e9cc","query_id":"51","doc_a_id":"17088791","doc_b_id":"31616203","presented_order":["31616203","17088791"],"winner_id":"17088791","reasoning":"Reason: Neither abstract mentions ALDH1, but Document B concerns genetic associations with breast cancer risk/outcomes, making it marginally more related to an expression–outcome association than a drug trial in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435273Z"}
{"comparison_id":"511f1172-0601-4022-9599-d90cb7bd7d5d","query_id":"51","doc_a_id":"1379127","doc_b_id":"31616203","presented_order":["31616203","1379127"],"winner_id":"1379127","reasoning":"Document B is more relevant — it addresses tumor cell migration and metastasis (factors tied to outcomes), whereas Document A reports a treatment trial unrelated to biomarker expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435280Z"}
{"comparison_id":"bea00fa6-eca7-4b22-8030-c2867140e521","query_id":"51","doc_a_id":"1866911","doc_b_id":"31616203","presented_order":["1866911","31616203"],"winner_id":"1866911","reasoning":"Document A is more relevant — it addresses breast epithelial progenitor/stem cell populations and marker expression related to tumor biology, which is closer to ALDH1 (a stem/progenitor marker) and outcome associations than a clinical drug trial. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435287Z"}
{"comparison_id":"f7892751-991f-405d-8880-c8c89c058266","query_id":"51","doc_a_id":"31311495","doc_b_id":"31616203","presented_order":["31311495","31616203"],"winner_id":"31311495","reasoning":"Document A is more relevant — it discusses molecular changes linked to tumor aggressiveness and prognosis, whereas Document B is a treatment trial for brain metastases unrelated to ALDH1 expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435294Z"}
{"comparison_id":"21c55e4d-90de-4a1a-b0fc-98964c071663","query_id":"51","doc_a_id":"12438901","doc_b_id":"31616203","presented_order":["31616203","12438901"],"winner_id":"12438901","reasoning":"Document B is slightly more relevant because it addresses long-term breast cancer outcomes and prognostic treatment effects, whereas Document A focuses on a drug trial for HER2+ brain metastases — neither mentions ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435301Z"}
{"comparison_id":"b12a318b-2859-4471-8dc8-b280b314333d","query_id":"51","doc_a_id":"3329824","doc_b_id":"31616203","presented_order":["31616203","3329824"],"winner_id":"31616203","reasoning":"Neither document addresses ALDH1 expression. Document A is marginally more relevant because it discusses treatment outcomes in breast cancer (response rates), whereas Document B focuses on CNS recurrence risk with trastuzumab. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435308Z"}
{"comparison_id":"a2d173cf-c90d-4b0b-9d8d-cbc85e88cd24","query_id":"51","doc_a_id":"9394119","doc_b_id":"31616203","presented_order":["9394119","31616203"],"winner_id":"31616203","reasoning":"Document B is more relevant — it reports treatment outcomes in breast cancer (clinical outcomes), whereas Document A focuses on BRCA mutation risk regions, not outcome associations tied to biomarkers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435315Z"}
{"comparison_id":"3c1d7018-fb67-45fa-aae9-246f2929e5d1","query_id":"51","doc_a_id":"15559582","doc_b_id":"31616203","presented_order":["15559582","31616203"],"winner_id":"15559582","reasoning":"Document A is slightly more relevant because it discusses biomarkers and their associations with breast cancer characteristics, whereas Document B is a treatment trial unrelated to biomarker expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435322Z"}
{"comparison_id":"3ca93963-b2f6-4508-99e9-d70feb038eec","query_id":"51","doc_a_id":"13831842","doc_b_id":"31616203","presented_order":["13831842","31616203"],"winner_id":"31616203","reasoning":"Document B is more relevant — it reports on outcomes in breast cancer patients (treatment response), whereas Document A addresses height/weight and cancer risk, not biomarker expression or outcomes. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435329Z"}
{"comparison_id":"ee0c6e51-80b5-43c3-a1ff-b9e17fe746bf","query_id":"51","doc_a_id":"5222182","doc_b_id":"31616203","presented_order":["31616203","5222182"],"winner_id":"31616203","reasoning":"Neither document mentions ALDH1; both are irrelevant. Document A is slightly more relevant because it deals directly with breast cancer outcomes, while B focuses on mammographic density risk factors.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435336Z"}
{"comparison_id":"52bfa624-4230-4eac-bd4c-5b46f847ef6a","query_id":"51","doc_a_id":"6550579","doc_b_id":"31616203","presented_order":["31616203","6550579"],"winner_id":"6550579","reasoning":"Document B is more relevant — it addresses molecular drivers and biomarker-related therapy implications in HER2-amplified breast cancer, which is closer to an ALDH1–outcome association than a brain-metastasis drug trial.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435355Z"}
{"comparison_id":"67521309-b6ae-48ee-a4c6-812f6f0a766f","query_id":"51","doc_a_id":"13831558","doc_b_id":"31616203","presented_order":["13831558","31616203"],"winner_id":"31616203","reasoning":"Neither abstract mentions ALDH1; however, Document B reports treatment outcomes in breast cancer (response rates), so it's marginally more relevant to a claim about associations with outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435372Z"}
{"comparison_id":"06de2f50-8e7b-4239-97b4-793b57924191","query_id":"51","doc_a_id":"4828631","doc_b_id":"31616203","presented_order":["4828631","31616203"],"winner_id":"4828631","reasoning":"Reason: Neither abstract mentions ALDH1, but Document A addresses breast cancer associations (population outcomes) while B focuses on a HER2+ brain-metastasis drug trial; A is marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435382Z"}
{"comparison_id":"4d97c9b9-28bd-4b92-a516-91a3d3a6231c","query_id":"51","doc_a_id":"15946643","doc_b_id":"31616203","presented_order":["15946643","31616203"],"winner_id":"15946643","reasoning":"Document A is more relevant — it deals with breast cancer biology, chemoresistance and metastasis where markers like ALDH1 are more likely discussed as prognostic indicators; Document B is a HER2 brain-metastasis drug trial and unrelated to ALDH1 expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435390Z"}
{"comparison_id":"13e7ca92-f2c7-4961-8a94-32717874d6cd","query_id":"51","doc_a_id":"5649538","doc_b_id":"31616203","presented_order":["31616203","5649538"],"winner_id":"5649538","reasoning":"Document B — it deals with gene expression markers in breast cancer (more related to ALDH1 expression) while Document A focuses on a HER2+ lapatinib trial unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435397Z"}
{"comparison_id":"aa469d75-dc1c-4da4-b553-4c807d5125b3","query_id":"51","doc_a_id":"4702639","doc_b_id":"31616203","presented_order":["4702639","31616203"],"winner_id":"4702639","reasoning":"Document A is more relevant — it discusses tumour stemness markers and their impact on prognosis and therapy, which relates to ALDH1 as a stem-cell marker; Document B is a clinical trial of lapatinib without marker data. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435405Z"}
{"comparison_id":"00467158-e991-471b-baf0-9d1300eec68b","query_id":"51","doc_a_id":"19673227","doc_b_id":"31616203","presented_order":["31616203","19673227"],"winner_id":"19673227","reasoning":"Document B — it addresses prognostic/predictive biomarkers and links profiles to survival outcomes, which is more relevant to a claim about marker expression and breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435412Z"}
{"comparison_id":"c9413453-bb33-43b5-b944-a9a6b7d50bd1","query_id":"51","doc_a_id":"13791206","doc_b_id":"31616203","presented_order":["31616203","13791206"],"winner_id":"31616203","reasoning":"Document A is about breast cancer clinical outcomes (treatment response), whereas Document B is a molecular DNA-repair study unrelated to ALDH1 or clinical prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435419Z"}
{"comparison_id":"0a979211-b926-49b3-be49-8c433417fc9a","query_id":"51","doc_a_id":"4886637","doc_b_id":"31616203","presented_order":["31616203","4886637"],"winner_id":"31616203","reasoning":"Document A is more relevant — it reports treatment outcomes in breast cancer (where ALDH1's prognostic association would pertain), while Document B focuses on diabetes/metabolic risk rather than cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435426Z"}
{"comparison_id":"7e85c2e2-c047-4aab-b731-2881d58476ca","query_id":"51","doc_a_id":"16098747","doc_b_id":"31616203","presented_order":["16098747","31616203"],"winner_id":"31616203","reasoning":"Reason: Document B discusses breast cancer treatment outcomes, which is more relevant to a claim about prognostic associations than Document A's focus on breast density risk factors.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435433Z"}
{"comparison_id":"bdd16ea8-cca8-4a8d-8ae4-62a10b982c4b","query_id":"51","doc_a_id":"4455466","doc_b_id":"31616203","presented_order":["4455466","31616203"],"winner_id":"4455466","reasoning":"Document A is more relevant — it discusses gene expression linked to breast cancer prognosis (though not ALDH1), whereas Document B is a clinical trial unrelated to biomarker expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435440Z"}
{"comparison_id":"3ffb3f23-4116-4521-a668-90d43a1a27b7","query_id":"51","doc_a_id":"38623601","doc_b_id":"31616203","presented_order":["38623601","31616203"],"winner_id":"31616203","reasoning":"Document B is more relevant — it reports clinical outcomes in breast cancer patients (treatment response), whereas Document A focuses on cell-line metabolic mechanisms unrelated to ALDH1 or patient outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435448Z"}
{"comparison_id":"aa2a04ce-5860-46f9-b37e-bb4b95ecc688","query_id":"51","doc_a_id":"2931832","doc_b_id":"31616203","presented_order":["31616203","2931832"],"winner_id":"2931832","reasoning":"Document B is more relevant — it discusses prognostic biomarkers in breast cancer, whereas Document A is about lapatinib treatment for brain metastases and not biomarker expression. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435454Z"}
{"comparison_id":"3753aa12-acf9-4b16-8f60-2293cd2c6236","query_id":"51","doc_a_id":"20127522","doc_b_id":"31616203","presented_order":["31616203","20127522"],"winner_id":"20127522","reasoning":"Document B — it discusses a biomarker (CTCs) linked to breast cancer outcomes, so it's more relevant to a claim about a biomarker (ALDH1) and prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435461Z"}
{"comparison_id":"2e640ed6-e87a-42dc-b928-208d6ae3ffa3","query_id":"51","doc_a_id":"22975806","doc_b_id":"31616203","presented_order":["31616203","22975806"],"winner_id":"22975806","reasoning":"Neither document discusses ALDH1. Document B is slightly more relevant because it addresses molecular/genetic factors in breast tumorigenesis (biomarker–outcome context), whereas Document A is a drug trial for HER2 brain metastases.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435469Z"}
{"comparison_id":"cf4fd258-6b10-48c5-96ae-b3c2d47b65c2","query_id":"51","doc_a_id":"16322674","doc_b_id":"31616203","presented_order":["16322674","31616203"],"winner_id":"16322674","reasoning":"Neither document discusses ALDH1. Document A is slightly more relevant because it addresses breast cancer risk/outcomes broadly, whereas B is a narrow treatment trial for HER2 brain metastases. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435475Z"}
{"comparison_id":"8b87e850-dd85-4f68-bdcb-9e762cfad240","query_id":"51","doc_a_id":"22007333","doc_b_id":"31616203","presented_order":["31616203","22007333"],"winner_id":"31616203","reasoning":"Document A is somewhat more related because it discusses breast cancer outcomes, whereas Document B addresses mammographic density and reproductive factors (breast cancer risk), not outcomes or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435482Z"}
{"comparison_id":"e223346d-2806-4c15-bd69-bcefdd79a2b5","query_id":"51","doc_a_id":"3067015","doc_b_id":"31616203","presented_order":["3067015","31616203"],"winner_id":"31616203","reasoning":"Document B is more relevant — it concerns breast cancer clinical outcomes (though not ALDH1 specifically), whereas Document A is about ALDH2 and blood pressure.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435488Z"}
{"comparison_id":"230d824e-9ae5-457a-9e89-650fbb442aea","query_id":"51","doc_a_id":"21033230","doc_b_id":"31616203","presented_order":["31616203","21033230"],"winner_id":"21033230","reasoning":"Document B is more relevant — it addresses molecular marker profiling and prognostic value in breast cancer, which is closer to ALDH1 outcome associations than a drug trial for brain metastases.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435495Z"}
{"comparison_id":"da1d9e44-70a1-46ca-a02f-38e217481d1f","query_id":"51","doc_a_id":"34066665","doc_b_id":"31616203","presented_order":["34066665","31616203"],"winner_id":"34066665","reasoning":"Document A is more relevant — it discusses molecular pathways and markers in breast cancer that could relate to prognostic markers like ALDH1; Document B is a specific drug trial for HER2 brain metastases and not relevant to ALDH1 expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435503Z"}
{"comparison_id":"4b00e828-f588-490e-8a90-ce968da29758","query_id":"51","doc_a_id":"16086778","doc_b_id":"31616203","presented_order":["16086778","31616203"],"winner_id":"16086778","reasoning":"Document A is more relevant because it discusses molecular pathways and tumor biology in breast cancer, which is closer to biomarker/outcome studies than a clinical trial of lapatinib for brain metastases. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435509Z"}
{"comparison_id":"38c0654c-585b-45b7-9d5a-fc2c55de2295","query_id":"51","doc_a_id":"24144677","doc_b_id":"31616203","presented_order":["31616203","24144677"],"winner_id":"31616203","reasoning":"Document A is more relevant because it concerns breast cancer treatment outcomes, whereas Document B addresses genetic risk of developing breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435516Z"}
{"comparison_id":"81c62352-c7c2-4e0b-b456-7d7769cc2a7f","query_id":"51","doc_a_id":"2061878","doc_b_id":"31616203","presented_order":["2061878","31616203"],"winner_id":"2061878","reasoning":"Reason: Document A discusses gene expression and its correlation with cancer prognosis (biomarker–outcome association), which is more relevant to a claim about ALDH1 expression and breast cancer outcomes than a treatment trial.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435523Z"}
{"comparison_id":"7ee9c76d-df25-464e-9398-655e25225df4","query_id":"51","doc_a_id":"2015126","doc_b_id":"31616203","presented_order":["31616203","2015126"],"winner_id":"31616203","reasoning":"Document A — it reports breast cancer treatment outcomes (though not about ALDH1), so it's marginally more relevant to a claim about markers and outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435530Z"}
{"comparison_id":"319bf719-f979-41f5-a353-5c72d8b2bf8a","query_id":"51","doc_a_id":"21902400","doc_b_id":"31616203","presented_order":["21902400","31616203"],"winner_id":"21902400","reasoning":"Document A is more relevant — it discusses prognostic indicators and clinical outcomes in cancer, which relates to a claim about a biomarker's association with breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435537Z"}
{"comparison_id":"c08058d9-1e38-4638-94de-d0a5bb77e73d","query_id":"51","doc_a_id":"23557241","doc_b_id":"31616203","presented_order":["23557241","31616203"],"winner_id":"31616203","reasoning":"Document B is more relevant — it addresses breast cancer treatment outcomes, whereas Document A concerns prenatal risk factors and not prognosis or biomarkers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435544Z"}
{"comparison_id":"ba0c2e3b-b064-411f-ae5d-0f7a8cc4f985","query_id":"51","doc_a_id":"878526","doc_b_id":"31616203","presented_order":["878526","31616203"],"winner_id":"31616203","reasoning":"Neither paper addresses ALDH1; Document B is slightly more relevant because it reports clinical breast cancer outcomes, while A focuses on neutrophil-driven metastasis mechanisms in mice.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435550Z"}
{"comparison_id":"3cbb3cc6-72da-4943-8e75-9f275093f239","query_id":"51","doc_a_id":"36432234","doc_b_id":"31616203","presented_order":["36432234","31616203"],"winner_id":"31616203","reasoning":"Reason: Neither mentions ALDH1, but Document B reports clinical outcome data in breast cancer, making it marginally more relevant than Document A (which is limited to estrogen receptor signaling in cell lines).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435557Z"}
{"comparison_id":"b59a2eb4-4609-4f3e-9b28-aaa57d282aeb","query_id":"51","doc_a_id":"30226988","doc_b_id":"31616203","presented_order":["31616203","30226988"],"winner_id":"30226988","reasoning":"Document B is more relevant — it discusses breast cancer survival outcomes (though it doesn't mention ALDH1), while Document A concerns a drug trial for HER2+ brain metastases unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435566Z"}
{"comparison_id":"78003fc9-d4be-47a1-9424-9aa3320424e6","query_id":"51","doc_a_id":"3222187","doc_b_id":"31616203","presented_order":["3222187","31616203"],"winner_id":"31616203","reasoning":"Document B is more relevant — it discusses breast cancer treatment outcomes, while Document A focuses on vitamin D genetics and not on ALDH1 or clinical outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435572Z"}
{"comparison_id":"2968d033-243f-4a3a-96da-ee039b4f729d","query_id":"51","doc_a_id":"24834968","doc_b_id":"31616203","presented_order":["24834968","31616203"],"winner_id":"24834968","reasoning":"Document A discusses biological markers in primary breast cancer (though not ALDH1 specifically), so it's more relevant than a drug trial for HER2 brain metastases.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435579Z"}
{"comparison_id":"9b44ae16-f5c4-47ea-9fe7-4730de97909e","query_id":"51","doc_a_id":"20183360","doc_b_id":"31616203","presented_order":["31616203","20183360"],"winner_id":"20183360","reasoning":"Document B is more relevant — it addresses molecular regulators of tumor invasiveness and biology, which is closer to marker–outcome associations than a clinical drug trial.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435586Z"}
{"comparison_id":"d13171c7-8cbc-47ac-a2e4-86e9786d44e4","query_id":"51","doc_a_id":"5500086","doc_b_id":"31616203","presented_order":["31616203","5500086"],"winner_id":"5500086","reasoning":"Document B — it discusses molecular signatures correlating with breast cancer clinical outcomes (though not ALDH1 specifically). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435592Z"}
{"comparison_id":"b85e43a3-cd72-4a38-91b2-b752f423604c","query_id":"51","doc_a_id":"7875158","doc_b_id":"31616203","presented_order":["31616203","7875158"],"winner_id":"31616203","reasoning":"Document A is more relevant because it reports clinical outcomes in breast cancer patients, whereas Document B is an in vitro study on glucose deprivation and oxidative stress that does not address clinical prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435598Z"}
{"comparison_id":"5b59e375-fafb-4626-94ef-28c174319fcf","query_id":"51","doc_a_id":"52188256","doc_b_id":"31616203","presented_order":["52188256","31616203"],"winner_id":"52188256","reasoning":"Document A is more relevant — it discusses breast cancer incidence and outcomes broadly, whereas Document B focuses narrowly on a drug trial for HER2 brain metastases and doesn't address biomarkers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435605Z"}
{"comparison_id":"46f0fed3-ea9c-4434-b1ea-b0c58ddbe553","query_id":"51","doc_a_id":"4889228","doc_b_id":"31616203","presented_order":["31616203","4889228"],"winner_id":"4889228","reasoning":"Document B — it discusses expression of molecular markers and their correlation with prognosis in breast cancer, so it's more relevant to a claim about ALDH1 expression and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435611Z"}
{"comparison_id":"7e52b0a4-4dfb-4ae6-8556-be55fa1336de","query_id":"51","doc_a_id":"32534305","doc_b_id":"31616203","presented_order":["32534305","31616203"],"winner_id":"31616203","reasoning":"Document B is more relevant — it reports treatment outcomes in breast cancer (closer to \"outcomes\" than an incidence/diabetes study).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435618Z"}
{"comparison_id":"aa51946b-bed7-46c6-8b8d-302fb7e62424","query_id":"51","doc_a_id":"13765757","doc_b_id":"31616203","presented_order":["13765757","31616203"],"winner_id":"13765757","reasoning":"Neither document discusses ALDH1; both are irrelevant. Document A is slightly more relevant because it addresses breast cancer risk and tumor outcomes, whereas B focuses narrowly on a drug trial for HER2+ brain metastases.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435624Z"}
{"comparison_id":"1ca735a5-1cd4-42de-974f-b05cdc76e0a0","query_id":"51","doc_a_id":"17163294","doc_b_id":"31616203","presented_order":["31616203","17163294"],"winner_id":"31616203","reasoning":"Document A is more relevant because it addresses breast cancer patient outcomes, whereas Document B focuses on metabolite-based cancer-type discrimination and not clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435630Z"}
{"comparison_id":"77e360fa-3a16-46e9-ba24-30314024f2d5","query_id":"51","doc_a_id":"16691520","doc_b_id":"31616203","presented_order":["16691520","31616203"],"winner_id":"16691520","reasoning":"Document A is more relevant — it examines genomic regulation and target genes in breast cancer (more likely to address biomarkers like ALDH1), while Document B is a drug trial unrelated to ALDH1 expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435637Z"}
{"comparison_id":"bc6d9e28-a0a5-49d2-b324-f7f29d663371","query_id":"51","doc_a_id":"16390264","doc_b_id":"31616203","presented_order":["31616203","16390264"],"winner_id":"31616203","reasoning":"Neither document discusses ALDH1 expression. Document A is slightly more relevant because it reports breast cancer treatment outcomes; Document B focuses on access to care rather than molecular markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435644Z"}
{"comparison_id":"7da6d1d2-ede5-40a8-a516-c915f2550afb","query_id":"51","doc_a_id":"3524352","doc_b_id":"31616203","presented_order":["31616203","3524352"],"winner_id":"31616203","reasoning":"Neither document mentions ALDH1. Document A is slightly more relevant because it directly addresses clinical breast cancer outcomes, while B is an ecological geographic mortality analysis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435651Z"}
{"comparison_id":"2407f394-ac8d-4bf2-bfca-bedd1ed9524b","query_id":"51","doc_a_id":"3559136","doc_b_id":"31616203","presented_order":["31616203","3559136"],"winner_id":"31616203","reasoning":"Document A is more relevant — it directly concerns breast cancer outcomes, whereas Document B focuses on tumor microenvironment mechanisms not specific to breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435658Z"}
{"comparison_id":"9f7420cb-05c7-4851-88a3-0bf2cc6b7617","query_id":"51","doc_a_id":"25488034","doc_b_id":"31616203","presented_order":["31616203","25488034"],"winner_id":"25488034","reasoning":"Document B is slightly more relevant because it discusses enzyme-mediated detoxification and oxidative-stress responses, which is closer to ALDH1's enzymatic role than a clinical trial of lapatinib.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435665Z"}
{"comparison_id":"bcab8195-cc43-4eb5-abc2-54fa69f1ba4e","query_id":"51","doc_a_id":"15600979","doc_b_id":"31616203","presented_order":["15600979","31616203"],"winner_id":"31616203","reasoning":"Document B is more relevant — it reports clinical outcomes in breast cancer patients (treatment response), whereas Document A focuses on molecular BRCA2/RAD51 mechanisms and not on ALDH1 or clinical outcomes.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435672Z"}
{"comparison_id":"9f2b8b83-9bcc-4150-abe0-feeb29c01cb8","query_id":"51","doc_a_id":"8891333","doc_b_id":"31616203","presented_order":["31616203","8891333"],"winner_id":"8891333","reasoning":"Document B is more relevant — it discusses cancer stem cells in breast cancer and pathways/transporters relevant to stem-cell markers like ALDH1, whereas A focuses on lapatinib treatment for brain metastases. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435679Z"}
{"comparison_id":"4b98af8e-03db-4459-b4b8-c769703ef28c","query_id":"51","doc_a_id":"1065627","doc_b_id":"31616203","presented_order":["31616203","1065627"],"winner_id":"31616203","reasoning":"Document A is slightly more relevant because it reports clinical breast cancer outcomes, whereas Document B focuses on preclinical mechanisms of drug resistance not directly related to prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435686Z"}
{"comparison_id":"015eab84-4593-4804-ad86-5b031b085a35","query_id":"51","doc_a_id":"14241418","doc_b_id":"31616203","presented_order":["31616203","14241418"],"winner_id":"14241418","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it addresses molecular signaling and biomarkers in breast cancer, whereas A is a clinical trial of lapatinib in brain metastases.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435693Z"}
{"comparison_id":"40ca8d17-f78a-4b16-90ce-e2f73f9dcec2","query_id":"51","doc_a_id":"2014909","doc_b_id":"31616203","presented_order":["2014909","31616203"],"winner_id":"2014909","reasoning":"Document A is more relevant — it discusses tumor-initiating cells and analyses of primary breast cancers (ALDH1 is a tumor‑initiating/cancer stem cell marker), whereas B is a clinical trial of lapatinib unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435701Z"}
{"comparison_id":"f31a4f4b-dbc2-4cb8-96a1-86ddb29fec89","query_id":"51","doc_a_id":"13519661","doc_b_id":"31616203","presented_order":["31616203","13519661"],"winner_id":"31616203","reasoning":"Document A — it discusses treatment outcomes in breast cancer patients (clinical outcomes), which is more related to a claim about markers being associated with outcomes than a genetic risk study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435708Z"}
{"comparison_id":"22b24483-70a9-4c3b-9853-415bd547b5c6","query_id":"51","doc_a_id":"22267225","doc_b_id":"31616203","presented_order":["22267225","31616203"],"winner_id":"22267225","reasoning":"Document A is more relevant — it discusses broad breast cancer outcomes and prevention where biomarker associations like ALDH1 are more likely to be addressed; Document B focuses narrowly on lapatinib treatment for HER2+ brain metastases. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435714Z"}
{"comparison_id":"57da9757-3fba-4c8c-8fc7-a777c4ffad16","query_id":"51","doc_a_id":"38784540","doc_b_id":"31616203","presented_order":["31616203","38784540"],"winner_id":"31616203","reasoning":"Document A is more related because it discusses breast cancer treatment outcomes, whereas B focuses on mammographic density and risk factors, not prognosis or molecular markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435721Z"}
{"comparison_id":"a305be0a-a55b-45b2-b01c-d321e7ee639b","query_id":"51","doc_a_id":"23078022","doc_b_id":"31616203","presented_order":["23078022","31616203"],"winner_id":"31616203","reasoning":"Document B is more relevant because it discusses breast cancer patient outcomes, whereas Document A focuses on MUC1 signaling and not on ALDH1 or prognostic associations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435728Z"}
{"comparison_id":"68fa3af6-a933-4b12-8811-a2223c53d553","query_id":"51","doc_a_id":"5487448","doc_b_id":"31616203","presented_order":["31616203","5487448"],"winner_id":"31616203","reasoning":"Document A is more relevant — it concerns breast cancer treatment outcomes, whereas Document B addresses birth weight and mammographic density (risk), not outcomes or ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435734Z"}
{"comparison_id":"50b81fa8-1201-46d3-a0d0-b3aac8730dc3","query_id":"51","doc_a_id":"3848469","doc_b_id":"31616203","presented_order":["3848469","31616203"],"winner_id":"31616203","reasoning":"Document B is more relevant — it reports clinical outcomes in breast cancer patients, whereas Document A is a lung cancer cell-line study unrelated to breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435741Z"}
{"comparison_id":"41c008fd-0f56-4c19-a78a-cecbd5156b8d","query_id":"51","doc_a_id":"7046487","doc_b_id":"31616203","presented_order":["31616203","7046487"],"winner_id":"7046487","reasoning":"Document B — it discusses cancer-related molecular pathways and tumor biology, which is more related to biomarker expression than a clinical trial of lapatinib for brain metastases. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435747Z"}
{"comparison_id":"d5ea40df-c40a-4495-83a2-fb5ba8cd27bd","query_id":"51","doc_a_id":"20333864","doc_b_id":"31616203","presented_order":["20333864","31616203"],"winner_id":"20333864","reasoning":"Document A is more relevant — it addresses tumor progression and molecular factors in breast cancer, which is closer to biomarker-outcome associations than a drug trial for HER2 brain metastases.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435755Z"}
{"comparison_id":"5dcefe95-28e5-4adc-a782-60eb2f0ac0e3","query_id":"51","doc_a_id":"15832146","doc_b_id":"31616203","presented_order":["15832146","31616203"],"winner_id":"31616203","reasoning":"Document B is more relevant — it reports clinical outcomes in breast cancer patients, whereas Document A focuses on stromal fibroblasts and tumor-promoting mechanisms without addressing ALDH1 or patient outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435761Z"}
{"comparison_id":"1dd49236-91e7-40af-bada-c7c5ec95a2a7","query_id":"51","doc_a_id":"8774475","doc_b_id":"31616203","presented_order":["8774475","31616203"],"winner_id":"8774475","reasoning":"Document A is more relevant — it addresses molecular mechanisms in breast cancer (closer to biomarker-related findings), whereas B focuses on a clinical trial for HER2 brain metastases and not biomarker expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435768Z"}
{"comparison_id":"af5815ab-66af-4cbc-bce2-b2e9f4e00744","query_id":"51","doc_a_id":"19541444","doc_b_id":"31616203","presented_order":["19541444","31616203"],"winner_id":"19541444","reasoning":"Document A is more relevant — it discusses gene expression and tumor suppressor roles (biomarker-related biology) which is closer to a claim about ALDH1 expression and outcomes than a drug trial for HER2+ brain metastases.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435775Z"}
{"comparison_id":"1cff91f8-322d-4a05-a65f-77f45c41208a","query_id":"51","doc_a_id":"9171913","doc_b_id":"31616203","presented_order":["9171913","31616203"],"winner_id":"31616203","reasoning":"Document B — it reports treatment outcomes in breast cancer patients (more directly related to outcomes), whereas A addresses risk factors. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435782Z"}
{"comparison_id":"3ff1e7bb-0e64-4bbb-a04e-5b7896e9cea9","query_id":"51","doc_a_id":"5270265","doc_b_id":"31616203","presented_order":["31616203","5270265"],"winner_id":"5270265","reasoning":"Document B is more relevant — it addresses molecular mechanisms and markers linked to treatment response and outcomes, whereas A is a clinical trial unrelated to biomarker expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435789Z"}
{"comparison_id":"61eaeb5c-8c3a-4306-8334-490e2af0c736","query_id":"51","doc_a_id":"32423829","doc_b_id":"31616203","presented_order":["31616203","32423829"],"winner_id":"32423829","reasoning":"Document B is more relevant — it reports on breast cancer outcomes (screening and treatment effects), whereas Document A focuses on lapatinib efficacy in HER2 brain metastases and not on ALDH1 or general outcome associations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435795Z"}
{"comparison_id":"e37b733c-c325-4020-a7be-7cda718086b9","query_id":"51","doc_a_id":"10279084","doc_b_id":"31616203","presented_order":["10279084","31616203"],"winner_id":"10279084","reasoning":"Document A is more relevant — it discusses molecular biology and expression changes in breast cancer (closer to topics of marker expression and outcomes) while B is a clinical trial of lapatinib for brain metastases. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435802Z"}
{"comparison_id":"dac04b35-bf12-4f77-8828-ef77afa20cb8","query_id":"51","doc_a_id":"54561709","doc_b_id":"31616203","presented_order":["31616203","54561709"],"winner_id":"31616203","reasoning":"Document A is more relevant — it reports clinical outcomes in breast cancer patients, whereas B concerns cell line variability and not clinical outcome data.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435809Z"}
{"comparison_id":"a9f4f3fa-a56c-4245-ab44-15817cd7f1e2","query_id":"51","doc_a_id":"11484808","doc_b_id":"31616203","presented_order":["11484808","31616203"],"winner_id":"11484808","reasoning":"Document A is more likely to discuss molecular biomarkers and their prognostic implications in endocrine-related breast cancers, whereas Document B is a trial of lapatinib for HER2+ brain metastases and does not address ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435816Z"}
{"comparison_id":"2a88c975-0aa6-45f7-8f38-b61e695311d7","query_id":"51","doc_a_id":"22712546","doc_b_id":"31616203","presented_order":["22712546","31616203"],"winner_id":"22712546","reasoning":"Document A — it studies enzymatic activities and metabolic interactions in breast cancer tissue, which is directly relevant to ALDH1 (an enzyme) expression and its association with outcomes.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435822Z"}
{"comparison_id":"a5bcedaa-9a0d-485d-ba05-49a083215bf4","query_id":"51","doc_a_id":"40735046","doc_b_id":"31616203","presented_order":["40735046","31616203"],"winner_id":"31616203","reasoning":"Neither document mentions ALDH1 or its association with outcomes. Document B is slightly more relevant because it deals with molecularly defined breast cancer (HER2) and treatment outcomes, whereas A is about screening.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435829Z"}
{"comparison_id":"42ab51c6-198a-4c6a-9970-f01c27690aaf","query_id":"51","doc_a_id":"6259170","doc_b_id":"31616203","presented_order":["31616203","6259170"],"winner_id":"31616203","reasoning":"Document A is more relevant because it concerns breast cancer clinical outcomes (though it doesn't mention ALDH1); Document B focuses on Nrf2/Keap1 and mitochondria, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435836Z"}
{"comparison_id":"45227e7a-0d64-4433-b125-3d669484564e","query_id":"51","doc_a_id":"31851367","doc_b_id":"31616203","presented_order":["31616203","31851367"],"winner_id":"31616203","reasoning":"Document A is more relevant — it reports clinical outcomes in breast cancer patients, whereas Document B focuses on ER coregulators and not clinical outcome markers like ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435842Z"}
{"comparison_id":"f9e4d679-6f5f-40d2-9295-d301be975c4a","query_id":"51","doc_a_id":"2576811","doc_b_id":"31616203","presented_order":["2576811","31616203"],"winner_id":"2576811","reasoning":"Document A is more relevant — it discusses molecular markers and pathways in breast epithelial cells, which is closer to biomarker-expression links than a clinical trial of lapatinib in HER2 brain metastases.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435850Z"}
{"comparison_id":"1728ba7e-9090-40c0-8a81-61dd57370a2d","query_id":"51","doc_a_id":"15512462","doc_b_id":"31616203","presented_order":["15512462","31616203"],"winner_id":"31616203","reasoning":"Document B is more relevant — it reports outcomes in breast cancer patients (treatment response), whereas A concerns cancer risk after pre-eclampsia and not molecular markers or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435856Z"}
{"comparison_id":"af954849-c734-44e7-879e-30aa8b089271","query_id":"51","doc_a_id":"831167","doc_b_id":"31616203","presented_order":["31616203","831167"],"winner_id":"31616203","reasoning":"Document A is more relevant — it concerns breast cancer outcomes, whereas Document B focuses on glioblastoma and is not about breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435863Z"}
{"comparison_id":"5fc1792d-6931-4b0e-b624-c00ebd6b9975","query_id":"51","doc_a_id":"825728","doc_b_id":"31616203","presented_order":["825728","31616203"],"winner_id":"825728","reasoning":"Doc A is more relevant — it links EMT, acquisition of stem-cell properties and patient survival (more likely to discuss stem cell markers like ALDH1). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435869Z"}
{"comparison_id":"047b402b-4025-4fd1-ba1d-e2e07f755292","query_id":"51","doc_a_id":"18953920","doc_b_id":"31616203","presented_order":["31616203","18953920"],"winner_id":"18953920","reasoning":"Document B is more relevant — it addresses breast epithelial cells acquiring stem-cell markers (related to ALDH1 as a stem cell marker), whereas Document A is about lapatinib in HER2+ brain metastases and unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435876Z"}
{"comparison_id":"9c12b170-bc79-4cb8-a02e-558cefe5f89f","query_id":"51","doc_a_id":"219475","doc_b_id":"31616203","presented_order":["31616203","219475"],"winner_id":"31616203","reasoning":"Neither document addresses ALDH1. Document A is marginally more relevant because it reports clinical breast cancer outcomes, whereas B is a murine study of premetastatic immune cells and not about clinical prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435884Z"}
{"comparison_id":"4b9babd3-c123-4fe5-b3d5-0e4d7fe0b6e1","query_id":"51","doc_a_id":"42106119","doc_b_id":"31616203","presented_order":["31616203","42106119"],"winner_id":"42106119","reasoning":"Document B — it discusses stem cell factors and links to cancer biology (more relevant to ALDH1 as a stem-cell marker), whereas A is a clinical trial of lapatinib unrelated to ALDH1 or outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435891Z"}
{"comparison_id":"00d012f6-1f8f-46ae-be92-c0872409db4b","query_id":"51","doc_a_id":"164985","doc_b_id":"31616203","presented_order":["164985","31616203"],"winner_id":"164985","reasoning":"Document A is more relevant — it addresses molecular/tumor microenvironment biology in mammary carcinoma, which is closer to biomarker (ALDH1) associations than a clinical trial of lapatinib for brain metastases. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435898Z"}
{"comparison_id":"32baa845-8dd7-4ed8-9a4a-f784d3af5b88","query_id":"51","doc_a_id":"3727986","doc_b_id":"31616203","presented_order":["3727986","31616203"],"winner_id":"31616203","reasoning":"Reason: Document B reports clinical outcomes in breast cancer patients, so it is marginally more relevant to a claim about associations with breast cancer outcomes; Document A is a mechanistic invasion study unrelated to ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435906Z"}
{"comparison_id":"d0639937-96b4-4f30-ba7c-20d2b19e75a0","query_id":"51","doc_a_id":"5579368","doc_b_id":"31616203","presented_order":["5579368","31616203"],"winner_id":"5579368","reasoning":"Document A is more relevant — it deals with DNA methylation and gene expression analysis for breast cancer biomarkers, which could include ALDH1 expression associations. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435912Z"}
{"comparison_id":"10bb1f84-8bbb-4236-93e0-8d36f9ff1fd0","query_id":"51","doc_a_id":"885056","doc_b_id":"31616203","presented_order":["885056","31616203"],"winner_id":"885056","reasoning":"Document A is more relevant — it discusses molecular markers and gene regulation in breast cancer (closer to ALDH1 expression) while Document B is a clinical trial of lapatinib for HER2 brain metastases and unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:30:57.435919Z"}
{"comparison_id":"c13ab92d-5a5d-4d25-9808-a39323763bc5","query_id":"51","doc_a_id":"45638119","doc_b_id":"15559582","presented_order":["15559582","45638119"],"winner_id":"45638119","reasoning":"Document B — it directly evaluates ALDH1 in breast cancer and reports its association with poor clinical outcome, which is directly relevant to the claim. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843062Z"}
{"comparison_id":"8c6a8d9f-c63e-4ead-9469-c31927dc2b05","query_id":"51","doc_a_id":"8963413","doc_b_id":"15559582","presented_order":["8963413","15559582"],"winner_id":"8963413","reasoning":"Document A is more relevant — it discusses expression of a tumor marker (PD-L1) and its association with breast cancer outcomes, which is conceptually closer to the ALDH1 expression–outcome claim than Document B's focus on lipids and prolactin.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843082Z"}
{"comparison_id":"c3d8c416-bb01-479f-a7fb-7c16e910fdf9","query_id":"51","doc_a_id":"22401720","doc_b_id":"15559582","presented_order":["15559582","22401720"],"winner_id":"22401720","reasoning":"Document B is more relevant — it discusses tumor marker expression and links expression levels to prognosis, whereas A concerns lipids and prolactin unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843091Z"}
{"comparison_id":"6afc4159-2ff1-408d-9546-29f3c319592b","query_id":"51","doc_a_id":"21439640","doc_b_id":"15559582","presented_order":["15559582","21439640"],"winner_id":"21439640","reasoning":"Neither document mentions ALDH1, but Document B discusses mechanisms of tumor progression and potential prognostic pathways, making it slightly more relevant to a claim about markers and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843099Z"}
{"comparison_id":"38580f69-79ee-46ec-a371-6d226e47d535","query_id":"51","doc_a_id":"12762485","doc_b_id":"15559582","presented_order":["12762485","15559582"],"winner_id":"12762485","reasoning":"Document A — it discusses stem cell phenotypes and tumor markers relevant to ALDH1's role in breast cancer biology. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843106Z"}
{"comparison_id":"672a7de3-b227-477c-abcb-a5dfc38c2824","query_id":"51","doc_a_id":"7821634","doc_b_id":"15559582","presented_order":["7821634","15559582"],"winner_id":"7821634","reasoning":"Document A is more relevant — it discusses molecular markers and associations with breast cancer outcomes, whereas Document B concerns lipids and prolactin unrelated to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843113Z"}
{"comparison_id":"c817efa2-9b43-47e8-b020-db8988cb865c","query_id":"51","doc_a_id":"4429932","doc_b_id":"15559582","presented_order":["4429932","15559582"],"winner_id":"4429932","reasoning":"Document A is more relevant — it discusses a molecular marker (LOX) linked to patient outcomes in breast cancer, whereas B covers lipids/prolactin and not marker–outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843119Z"}
{"comparison_id":"800a7ef1-cef2-49d9-ac07-7c5a3748fa47","query_id":"51","doc_a_id":"24341590","doc_b_id":"15559582","presented_order":["15559582","24341590"],"winner_id":"24341590","reasoning":"Document B is more relevant — it examines the relationship between a molecular biomarker (CYP2D6) and clinical outcomes in breast cancer, which is closer to the query about ALDH1 expression and prognosis; Document A addresses lipids/prolactin and is unrelated.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843126Z"}
{"comparison_id":"08c3f015-dc05-4aa4-a2db-7a747f8945cf","query_id":"51","doc_a_id":"13007205","doc_b_id":"15559582","presented_order":["15559582","13007205"],"winner_id":"13007205","reasoning":"Document B is slightly more relevant because it addresses tumor biology and factors influencing breast cancer progression, whereas Document A discusses plasma lipids and prolactin unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843134Z"}
{"comparison_id":"713ad9b2-2828-414a-a9fa-6de48d9ea3af","query_id":"51","doc_a_id":"32001951","doc_b_id":"15559582","presented_order":["15559582","32001951"],"winner_id":"32001951","reasoning":"Document B is more relevant — it concerns regulation of protein expression in breast cancer cells, whereas A discusses plasma lipids and prolactin unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843140Z"}
{"comparison_id":"5bc1f18b-85f3-4b44-9cb3-7228101161a1","query_id":"51","doc_a_id":"7583725","doc_b_id":"15559582","presented_order":["15559582","7583725"],"winner_id":"7583725","reasoning":"Document B is more relevant — it discusses a protein's expression level predicting patient outcomes in breast cancer, which is conceptually closer to the query about marker expression and prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843147Z"}
{"comparison_id":"f54ac775-b2a3-4f3f-bcfc-f76cb11e14ef","query_id":"51","doc_a_id":"15113221","doc_b_id":"15559582","presented_order":["15113221","15559582"],"winner_id":"15113221","reasoning":"Document A is more relevant — it discusses a gene expression signature linked to prognosis, which is closer to evaluating marker expression and clinical outcomes than a lipid/prolactin study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843153Z"}
{"comparison_id":"02229c2b-cf8d-4c26-bff1-d9c4e7ecc226","query_id":"51","doc_a_id":"4820792","doc_b_id":"15559582","presented_order":["15559582","4820792"],"winner_id":"4820792","reasoning":"Neither document mentions ALDH1. Document B is slightly more related to breast cancer outcomes (therapy resistance and survival pathways) than A, which focuses on lipids and prolactin.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843160Z"}
{"comparison_id":"fc01e00b-827d-4d46-b2b9-1a468ccc9779","query_id":"51","doc_a_id":"27240667","doc_b_id":"15559582","presented_order":["15559582","27240667"],"winner_id":"27240667","reasoning":"Document B is more relevant — it discusses breast cancer outcomes (mortality trends) whereas A focuses on lipids and prolactin without linking to prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843166Z"}
{"comparison_id":"82e8c9f7-8859-4f5b-8399-d4dda0a2fad2","query_id":"51","doc_a_id":"17648235","doc_b_id":"15559582","presented_order":["17648235","15559582"],"winner_id":"15559582","reasoning":"Neither document mentions ALDH1 or provides evidence about its association with breast cancer outcomes, so neither is relevant. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843173Z"}
{"comparison_id":"d2f3ee9e-42fc-46ee-9dd4-dc31fd3c7139","query_id":"51","doc_a_id":"16734530","doc_b_id":"15559582","presented_order":["15559582","16734530"],"winner_id":"16734530","reasoning":"Neither document discusses ALDH1. Document B is slightly more relevant because it examines genetic/molecular markers associated with breast cancer prognosis, whereas A focuses on lipids and prolactin. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843180Z"}
{"comparison_id":"b72d839d-4f10-4845-b46d-b1ab6607c200","query_id":"51","doc_a_id":"3285322","doc_b_id":"15559582","presented_order":["3285322","15559582"],"winner_id":"3285322","reasoning":"Document A — it discusses clinical/pathologic features and outcomes in breast cancer (more related to expression/outcome associations) while B focuses on lipids/prolactin. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843186Z"}
{"comparison_id":"c528e90d-d52a-4c1f-a84b-4fbb8089a1dc","query_id":"51","doc_a_id":"2140497","doc_b_id":"15559582","presented_order":["2140497","15559582"],"winner_id":"2140497","reasoning":"Document A is more relevant — it concerns breast tissue changes and breast cancer risk/outcomes, whereas Document B deals with plasma lipids and prolactin unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843193Z"}
{"comparison_id":"59017b43-89d8-4db9-9cfb-c1cbf8e410fd","query_id":"51","doc_a_id":"20839751","doc_b_id":"15559582","presented_order":["20839751","15559582"],"winner_id":"20839751","reasoning":"Document A is more relevant — it discusses prognostic/pathological factors in breast cancer (outcomes), whereas Document B addresses lipids and prolactin and is unrelated to prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843200Z"}
{"comparison_id":"cae9e0f5-d738-43ed-b620-579d916cd341","query_id":"51","doc_a_id":"13030852","doc_b_id":"15559582","presented_order":["13030852","15559582"],"winner_id":"13030852","reasoning":"Document A is more relevant — it discusses an enzyme biomarker and its relation to metastases/outcomes in breast cancer, which is closer to ALDH1 expression than lipid/prolactin levels.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843206Z"}
{"comparison_id":"52b65335-2527-4fe0-ba1d-cbeed6944ed2","query_id":"51","doc_a_id":"13069283","doc_b_id":"15559582","presented_order":["15559582","13069283"],"winner_id":"13069283","reasoning":"Document B is more relevant — it concerns genetic biomarkers and their effect on treatment-related outcomes in breast cancer, whereas A only reports plasma lipids and prolactin levels without addressing tumor biomarker expression or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843213Z"}
{"comparison_id":"8f815508-5259-47d2-8875-69d0c0416fc7","query_id":"51","doc_a_id":"4999633","doc_b_id":"15559582","presented_order":["15559582","4999633"],"winner_id":"15559582","reasoning":"Document A is more clinically focused on patient biomarkers and cancer characteristics, making it slightly more relevant to a claim about prognosis than a cell-line signaling study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843221Z"}
{"comparison_id":"285069c9-f30e-4f8f-8aec-fd7e0214fcb2","query_id":"51","doc_a_id":"9600826","doc_b_id":"15559582","presented_order":["9600826","15559582"],"winner_id":"9600826","reasoning":"Document A is more focused on molecular pathways affecting breast cancer progression and outcomes, making it slightly more relevant to a claim about a biomarker's association with prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843229Z"}
{"comparison_id":"ab680155-4102-4bac-af16-defa52c6e0e9","query_id":"51","doc_a_id":"43385013","doc_b_id":"15559582","presented_order":["43385013","15559582"],"winner_id":"43385013","reasoning":"Document A is more relevant — it addresses stem cell/progenitor properties in breast cells (where ALDH1 is a stem cell marker), whereas Document B is about lipids and prolactin unrelated to ALDH1 or outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843236Z"}
{"comparison_id":"010141e8-35f7-458a-a9ae-3726db5757d3","query_id":"51","doc_a_id":"1171121","doc_b_id":"15559582","presented_order":["15559582","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant — it addresses prognostic markers and associations with disease-free survival in breast cancer, whereas A discusses lipids and prolactin without prognostic implications.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843243Z"}
{"comparison_id":"c7235ea0-61dc-4b18-b4ef-5720ab8dd51e","query_id":"51","doc_a_id":"25732836","doc_b_id":"15559582","presented_order":["25732836","15559582"],"winner_id":"25732836","reasoning":"Document A is more relevant — it concerns prognostic biomarkers and outcome prediction in breast cancer, which is closer to an ALDH1–outcome association than the lipid/prolactin focus in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843250Z"}
{"comparison_id":"9bbee39f-6ad8-4390-a983-50ee6d3d96de","query_id":"51","doc_a_id":"25973484","doc_b_id":"15559582","presented_order":["25973484","15559582"],"winner_id":"25973484","reasoning":"Document A — discusses breast cancer prognosis and factors affecting outcomes, making it marginally more relevant than B, which focuses on lipids/prolactin.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843257Z"}
{"comparison_id":"fa271c09-c46a-49bd-8ac7-c482a1b6c47b","query_id":"51","doc_a_id":"24249915","doc_b_id":"15559582","presented_order":["24249915","15559582"],"winner_id":"24249915","reasoning":"Document A is more relevant — it addresses expression of a molecular marker in breast cancer (ERβ) and its clinical loss/mechanism, which is closer to a claim about marker expression and outcomes than a plasma lipid/prolactin study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843266Z"}
{"comparison_id":"f8e9e14e-3f61-44dc-8c71-0c3b95e73084","query_id":"51","doc_a_id":"313403","doc_b_id":"15559582","presented_order":["15559582","313403"],"winner_id":"313403","reasoning":"Document B is more relevant — it discusses a prognostic marker (TAM infiltration) and clinical outcomes in breast cancer, which is closer to the claim about a marker (ALDH1) and prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843273Z"}
{"comparison_id":"e6d0dceb-8df4-410c-bb97-2439ddccc38a","query_id":"51","doc_a_id":"195680777","doc_b_id":"15559582","presented_order":["15559582","195680777"],"winner_id":"195680777","reasoning":"Neither document discusses ALDH1. Document B is marginally more relevant because it addresses breast cancer outcomes (mortality) directly, while A focuses on lipids and prolactin.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843280Z"}
{"comparison_id":"1ac7514a-2bf0-4438-888b-c289a9db3caa","query_id":"51","doc_a_id":"38551172","doc_b_id":"15559582","presented_order":["15559582","38551172"],"winner_id":"15559582","reasoning":"Document A is more relevant — it discusses biomarkers and tumor characteristics in breast cancer patients (closer to prognosis/outcomes) while B addresses vitamin D, mammographic density, and risk. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843287Z"}
{"comparison_id":"f3f6c422-cec0-4a16-9e94-d26b91a6ff6f","query_id":"51","doc_a_id":"1389264","doc_b_id":"15559582","presented_order":["15559582","1389264"],"winner_id":"1389264","reasoning":"Document B is slightly more relevant because it deals with biomarkers and therapeutic outcomes in breast cancer, whereas A only addresses lipids and prolactin. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843294Z"}
{"comparison_id":"d148afb7-5695-4982-ac44-8594786b8820","query_id":"51","doc_a_id":"22509015","doc_b_id":"15559582","presented_order":["15559582","22509015"],"winner_id":"22509015","reasoning":"Document B is more relevant — it addresses molecular signaling and metastasis in breast cancer (closer to biomarker-related outcomes) while A concerns plasma lipids and prolactin, which are unrelated to ALDH1 expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843301Z"}
{"comparison_id":"a1c8a493-2c6a-4b47-a300-76dfee60db8f","query_id":"51","doc_a_id":"18340282","doc_b_id":"15559582","presented_order":["18340282","15559582"],"winner_id":"18340282","reasoning":"Document A — it addresses genetic factors in breast cancer (closer to molecular markers like ALDH1) while B focuses on plasma lipids/prolactin. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843308Z"}
{"comparison_id":"a3b4b3c6-02c7-4719-8025-e462d9a7331e","query_id":"51","doc_a_id":"20454006","doc_b_id":"15559582","presented_order":["15559582","20454006"],"winner_id":"20454006","reasoning":"Reason: Both abstracts don't mention ALDH1, but Document B deals with molecular biomarkers in breast cancer, so it's slightly more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843315Z"}
{"comparison_id":"0f04ac0a-bea8-46ea-99ef-fe25c510b0d9","query_id":"51","doc_a_id":"27123743","doc_b_id":"15559582","presented_order":["15559582","27123743"],"winner_id":"27123743","reasoning":"Document B — it discusses stem-cell–related mechanisms (growth factors affecting stem cells), which is more related to ALDH1 (a cancer stem cell marker) than Document A's focus on lipids/prolactin. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843322Z"}
{"comparison_id":"ccebe9f5-eaf6-4a1a-8214-6e26c9d0c87a","query_id":"51","doc_a_id":"22482820","doc_b_id":"15559582","presented_order":["22482820","15559582"],"winner_id":"22482820","reasoning":"Doc A is more relevant because it discusses molecular classification and therapeutic markers in breast cancer, which is closer to a claim about a specific marker's association with outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843334Z"}
{"comparison_id":"3d830e1e-0b20-4d9d-a524-557c70ef1c10","query_id":"51","doc_a_id":"4418878","doc_b_id":"15559582","presented_order":["15559582","4418878"],"winner_id":"4418878","reasoning":"Reason: Document B discusses gene expression signatures and their links to prognosis in cancers, which is directly relevant to assessing whether expression of a gene (like ALDH1) is associated with breast cancer outcomes. Document A discusses lipids and prolactin, not gene expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843342Z"}
{"comparison_id":"ffc18df6-e104-423e-986b-edc1050343ce","query_id":"51","doc_a_id":"5864770","doc_b_id":"15559582","presented_order":["5864770","15559582"],"winner_id":"5864770","reasoning":"Document A is more relevant — it discusses molecular/hormonal influences on breast cancer cell biology, which is closer to marker-expression and outcome associations than plasma lipid/prolactin levels.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843349Z"}
{"comparison_id":"6dd1c8fc-0245-4408-9173-142b141be369","query_id":"51","doc_a_id":"19358586","doc_b_id":"15559582","presented_order":["15559582","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant — it discusses molecular markers and survival/prognosis in breast cancer, whereas A focuses on lipids and prolactin unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843356Z"}
{"comparison_id":"03a22b43-7064-43ee-a5b8-a2b84a4627db","query_id":"51","doc_a_id":"17088791","doc_b_id":"15559582","presented_order":["17088791","15559582"],"winner_id":"17088791","reasoning":"Neither abstract mentions ALDH1. Document A is marginally more relevant because it concerns genetic/molecular markers linked to breast cancer outcomes, whereas B focuses on lipids and prolactin.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843363Z"}
{"comparison_id":"49bebad8-3cb1-4c6f-add4-e4e1f77cb4ee","query_id":"51","doc_a_id":"1379127","doc_b_id":"15559582","presented_order":["15559582","1379127"],"winner_id":"1379127","reasoning":"Document B is more relevant — it addresses mechanisms (migration/metastasis) directly tied to cancer outcomes, whereas A discusses lipids/prolactin without prognosis or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843369Z"}
{"comparison_id":"54f352df-f021-45e9-8e25-6f7579d86d87","query_id":"51","doc_a_id":"1866911","doc_b_id":"15559582","presented_order":["1866911","15559582"],"winner_id":"1866911","reasoning":"Document A is more relevant — it discusses mammary progenitor/stem cell populations and markers related to tumor origin, which is closer to ALDH1 (a stem/progenitor marker) than a study on lipids/prolactin. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843377Z"}
{"comparison_id":"4c0811f6-0d2e-473a-ae96-16acc89bc27b","query_id":"51","doc_a_id":"31311495","doc_b_id":"15559582","presented_order":["15559582","31311495"],"winner_id":"31311495","reasoning":"Document B is more relevant — it addresses cellular/molecular tumor behavior and treatment resistance (closer to ALDH1's role as a cellular marker) whereas A discusses plasma lipids/prolactin unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843384Z"}
{"comparison_id":"212ddac6-7e29-4c0a-b51c-3795395569e9","query_id":"51","doc_a_id":"12438901","doc_b_id":"15559582","presented_order":["15559582","12438901"],"winner_id":"12438901","reasoning":"Document B is more relevant — it addresses breast cancer outcomes (treatment effects on recurrence and mortality), whereas Document A discusses lipids and prolactin and doesn't pertain to ALDH1 or outcomes. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843391Z"}
{"comparison_id":"c18a5eb0-d319-412e-8a42-4cece844e322","query_id":"51","doc_a_id":"885056","doc_b_id":"15559582","presented_order":["15559582","885056"],"winner_id":"885056","reasoning":"Document B is more relevant — it discusses molecular/gene-regulatory factors and tamoxifen effects, which is closer to a claim about a protein biomarker's association with breast cancer outcomes than a study on plasma lipids/prolactin.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843398Z"}
{"comparison_id":"8f22b39a-31d4-4c8a-a8f5-784ae0436827","query_id":"51","doc_a_id":"6550579","doc_b_id":"15559582","presented_order":["15559582","6550579"],"winner_id":"6550579","reasoning":"Reason: Document B discusses molecular markers and treatment implications in breast cancer, making it more related to biomarker–outcome associations than Document A's focus on lipids and prolactin.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843404Z"}
{"comparison_id":"c4293e00-bb15-4a66-b271-5851e817f5b1","query_id":"51","doc_a_id":"4828631","doc_b_id":"15559582","presented_order":["4828631","15559582"],"winner_id":"15559582","reasoning":"Doc B discusses biomarkers in breast cancer patients and is more directly related to breast cancer biology than Doc A, which focuses on BMI and cancer risk. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843411Z"}
{"comparison_id":"698177ab-4d75-4b99-8530-fdbc84889809","query_id":"51","doc_a_id":"15946643","doc_b_id":"15559582","presented_order":["15946643","15559582"],"winner_id":"15946643","reasoning":"Document A is more relevant — it addresses tumor cell properties, chemoresistance and metastasis in breast cancer (contexts where ALDH1 expression and outcome associations are discussed). Document B is about plasma lipids/prolactin and is unrelated.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843419Z"}
{"comparison_id":"dd8b5ebc-0994-4740-ad50-39742dc07cc3","query_id":"51","doc_a_id":"5649538","doc_b_id":"15559582","presented_order":["15559582","5649538"],"winner_id":"5649538","reasoning":"Document B is more relevant — it deals with gene expression markers in breast cancer (though not specifically ALDH1), whereas A discusses lipids/prolactin and is unrelated to gene-expression or outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843425Z"}
{"comparison_id":"a6cf7a92-0243-4f57-8dab-3bebbbd55141","query_id":"51","doc_a_id":"4702639","doc_b_id":"15559582","presented_order":["4702639","15559582"],"winner_id":"4702639","reasoning":"Document A is more relevant — it discusses tumour stemness and markers/drivers of stem-like properties, which relate to ALDH1's role as a cancer stem cell marker. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843432Z"}
{"comparison_id":"6d88fbea-8bfa-4359-9155-5aeefd1ef2a8","query_id":"51","doc_a_id":"19673227","doc_b_id":"15559582","presented_order":["15559582","19673227"],"winner_id":"19673227","reasoning":"Document B is more relevant — it discusses prognostic/predictive biomarkers and correlations with disease-free survival/time to progression, which relates to associations with breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843439Z"}
{"comparison_id":"334c9cb5-533c-4983-bdc3-124ccb57c4a8","query_id":"51","doc_a_id":"4455466","doc_b_id":"15559582","presented_order":["15559582","4455466"],"winner_id":"4455466","reasoning":"Document B — it discusses how expression level of a gene (ZMYND11) is associated with breast cancer prognosis, which is conceptually relevant to a claim about biomarker expression and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843446Z"}
{"comparison_id":"f186e48b-0929-4dab-bf81-1bdeb8cd4394","query_id":"51","doc_a_id":"2931832","doc_b_id":"15559582","presented_order":["2931832","15559582"],"winner_id":"2931832","reasoning":"Document A is more relevant because it discusses prognostic biomarkers and outcomes in breast cancer, which relates to the claim about a marker (ALDH1) and prognosis.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843453Z"}
{"comparison_id":"7b020536-fcd6-44f9-aec8-204f62184a5e","query_id":"51","doc_a_id":"20127522","doc_b_id":"15559582","presented_order":["20127522","15559582"],"winner_id":"20127522","reasoning":"Document A — it discusses a biomarker (CTC levels) linked to breast cancer outcomes, so it's more relevant to a claim about biomarker expression and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843459Z"}
{"comparison_id":"204bab51-69b7-4458-93f7-c171f6e54eef","query_id":"51","doc_a_id":"22975806","doc_b_id":"15559582","presented_order":["22975806","15559582"],"winner_id":"22975806","reasoning":"Document A is more relevant — it addresses molecular/genetic factors in breast tumorigenesis and clinical implications, which is closer to biomarker/prognostic questions than a study on plasma lipids and prolactin.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843466Z"}
{"comparison_id":"c6dd668c-58ed-4a2e-8a78-efd51090dca0","query_id":"51","doc_a_id":"16322674","doc_b_id":"15559582","presented_order":["16322674","15559582"],"winner_id":"15559582","reasoning":"Reason: Neither document mentions ALDH1; Document B discusses tumor-related biomarkers and patient cancer characteristics (invasive/poorly differentiated), so it is marginally more related to breast cancer outcomes than Document A, which addresses birth size and future risk.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843473Z"}
{"comparison_id":"4455c1d3-d894-45c8-bc3f-635ee3132d7e","query_id":"51","doc_a_id":"21033230","doc_b_id":"15559582","presented_order":["15559582","21033230"],"winner_id":"21033230","reasoning":"Reason: Document B discusses molecular profiling of tumor cells and prognostic markers related to outcomes, which is more conceptually relevant to a claim about a biomarker's association with breast cancer prognosis than Document A's focus on lipids and prolactin.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843480Z"}
{"comparison_id":"47beb8f7-651e-4b14-bb48-6e7bca6b46eb","query_id":"51","doc_a_id":"34066665","doc_b_id":"15559582","presented_order":["34066665","15559582"],"winner_id":"34066665","reasoning":"Document A is more relevant because it discusses molecular markers and clinical implications for breast cancer outcomes and therapy resistance, whereas Document B focuses on plasma lipids and prolactin without linking to prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843488Z"}
{"comparison_id":"90b5a09c-356b-415f-81d9-3ffc784623b4","query_id":"51","doc_a_id":"16086778","doc_b_id":"15559582","presented_order":["16086778","15559582"],"winner_id":"16086778","reasoning":"Document A is more relevant — it addresses molecular markers and pathways tied to breast cancer behavior and outcomes, whereas B concerns plasma lipids/prolactin unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843495Z"}
{"comparison_id":"8ddb5453-eb4e-4ff6-9171-4815254bf771","query_id":"51","doc_a_id":"2061878","doc_b_id":"15559582","presented_order":["2061878","15559582"],"winner_id":"2061878","reasoning":"Document A discusses tumor marker expression and its correlation with prognosis, which is more directly related to the claim about a biomarker's association with breast cancer outcomes than the lipid/prolactin study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843502Z"}
{"comparison_id":"8a31d151-9f3e-47da-a1a4-996f91ec74bf","query_id":"51","doc_a_id":"21902400","doc_b_id":"15559582","presented_order":["21902400","15559582"],"winner_id":"21902400","reasoning":"Document A is more relevant — it discusses prognostic markers and clinical outcomes in cancer, which is closer to a claim about ALDH1 and breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843509Z"}
{"comparison_id":"c3330ffb-f03f-4caa-9fcc-5db131d44188","query_id":"51","doc_a_id":"30226988","doc_b_id":"15559582","presented_order":["15559582","30226988"],"winner_id":"15559582","reasoning":"Document A is more relevant — it's about biomarkers in breast cancer (though not ALDH1), whereas B covers broad population survival trends without molecular markers. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843515Z"}
{"comparison_id":"cd47e6c4-0e9c-4cd9-9f41-a1f2e550f17b","query_id":"51","doc_a_id":"24834968","doc_b_id":"15559582","presented_order":["15559582","24834968"],"winner_id":"24834968","reasoning":"Document B is more relevant — it evaluates tumor biological markers as predictors of outcome/response, whereas A focuses on lipids and prolactin unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843522Z"}
{"comparison_id":"4a2f6e84-1001-40e4-bac7-36f21a3c0629","query_id":"51","doc_a_id":"20183360","doc_b_id":"15559582","presented_order":["15559582","20183360"],"winner_id":"20183360","reasoning":"Reason: Document B addresses molecular mechanisms of breast cancer progression and invasiveness, which is more related to markers tied to outcomes than Document A's focus on plasma lipids and prolactin.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843529Z"}
{"comparison_id":"ec5f3366-4c60-40cd-b90d-c1bf0edbc1a0","query_id":"51","doc_a_id":"5500086","doc_b_id":"15559582","presented_order":["15559582","5500086"],"winner_id":"5500086","reasoning":"Doc B is more relevant — it discusses tumor-intrinsic molecular signaling and correlates a molecular signature with breast cancer outcomes, whereas Doc A focuses on lipids and prolactin unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843535Z"}
{"comparison_id":"dffa85ef-7829-4c2c-a913-96a7fea33e2f","query_id":"51","doc_a_id":"52188256","doc_b_id":"15559582","presented_order":["15559582","52188256"],"winner_id":"15559582","reasoning":"Reason: Document A discusses biomarkers in breast cancer patients and is more directly related to tumor biology and outcomes than global incidence statistics in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843542Z"}
{"comparison_id":"135cacf8-c494-4a09-b7aa-c0dd3b67b65d","query_id":"51","doc_a_id":"4889228","doc_b_id":"15559582","presented_order":["15559582","4889228"],"winner_id":"4889228","reasoning":"Document B is more relevant — it links expression of a molecular marker (TDP43) to breast cancer prognosis, whereas A addresses lipids and prolactin. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843548Z"}
{"comparison_id":"efb74b35-c729-4450-99b2-426d26a55f9d","query_id":"51","doc_a_id":"13765757","doc_b_id":"15559582","presented_order":["13765757","15559582"],"winner_id":"15559582","reasoning":"Document B is more relevant — it addresses biomarkers associated with tumor invasiveness/grade (which relate to outcomes), whereas Document A concerns reproductive timing and cancer risk rather than tumor markers or outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843555Z"}
{"comparison_id":"da751327-6ebb-41f4-9d44-4aa9bf1d84c4","query_id":"51","doc_a_id":"16691520","doc_b_id":"15559582","presented_order":["15559582","16691520"],"winner_id":"16691520","reasoning":"Document B is more relevant — it investigates genome-wide gene regulation and target genes in breast cancer, which could include ALDH1, whereas Document A discusses lipids and prolactin unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843562Z"}
{"comparison_id":"b3e3120d-7f08-4f01-8539-56997448295d","query_id":"51","doc_a_id":"25488034","doc_b_id":"15559582","presented_order":["15559582","25488034"],"winner_id":"15559582","reasoning":"Document A is more relevant — it addresses clinical breast cancer patient data (outcomes context), whereas Document B discusses glutathione-related enzymes and oxidative stress without linking to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843569Z"}
{"comparison_id":"a7ce6f77-26f2-498b-81cf-9f89505502b6","query_id":"51","doc_a_id":"8891333","doc_b_id":"15559582","presented_order":["15559582","8891333"],"winner_id":"8891333","reasoning":"Doc B is more relevant — it discusses cancer stem cells in breast cancer (where ALDH1 is a known stem-cell marker and linked to outcomes), while Document A focuses on lipids and prolactin unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843576Z"}
{"comparison_id":"79b66619-0452-4818-8749-c6b783d831c0","query_id":"51","doc_a_id":"14241418","doc_b_id":"15559582","presented_order":["15559582","14241418"],"winner_id":"15559582","reasoning":"Reason: Document A discusses biomarkers and clinical findings in breast cancer patients (patient outcomes context), whereas Document B focuses on a targeted drug and cell-line signaling; neither mentions ALDH1 but A is closer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843582Z"}
{"comparison_id":"4c791cbb-0ed9-4715-8441-de6b6b338179","query_id":"51","doc_a_id":"2014909","doc_b_id":"15559582","presented_order":["15559582","2014909"],"winner_id":"2014909","reasoning":"Document B is more relevant — it addresses tumor-initiating cells and breast cancer biology (closely related to ALDH1 as a stem/tumor-initiating cell marker), whereas A concerns plasma lipids and prolactin unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843589Z"}
{"comparison_id":"35c77f58-ac84-4c8c-93f9-8ebf377ecb55","query_id":"51","doc_a_id":"22267225","doc_b_id":"15559582","presented_order":["22267225","15559582"],"winner_id":"15559582","reasoning":"Document B is more relevant — it reports a biomarker study in breast cancer patients (closer to associations with outcomes), whereas A is a general chemoprevention overview and does not address tumor biomarkers like ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843596Z"}
{"comparison_id":"dfb5b226-14ce-4f17-bbc7-cd8a3a6f6766","query_id":"51","doc_a_id":"7046487","doc_b_id":"15559582","presented_order":["7046487","15559582"],"winner_id":"7046487","reasoning":"Document A is more relevant — it discusses transcriptional pathways (NF-κB) involved in tumor behavior, which is closer to biomarker and outcome associations than a study on lipids/prolactin.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843604Z"}
{"comparison_id":"5203b8f6-ae66-48ce-a5f9-149354805e00","query_id":"51","doc_a_id":"20333864","doc_b_id":"15559582","presented_order":["20333864","15559582"],"winner_id":"20333864","reasoning":"Document A is more relevant because it discusses molecular and cellular factors involved in breast cancer progression and invasiveness, which is closer to evaluating marker expression and outcomes than lipid/prolactin levels. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843610Z"}
{"comparison_id":"a9ff0fc4-7418-4484-b22d-be21bb291c0a","query_id":"51","doc_a_id":"8774475","doc_b_id":"15559582","presented_order":["8774475","15559582"],"winner_id":"8774475","reasoning":"Document A is more relevant — it addresses molecular/cellular factors in breast cancer tumorigenesis, which is closer to marker expression and outcomes than a study on plasma lipids/prolactin. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843617Z"}
{"comparison_id":"4594aac9-9a8e-44a1-a824-885be68b98d0","query_id":"51","doc_a_id":"19541444","doc_b_id":"15559582","presented_order":["19541444","15559582"],"winner_id":"19541444","reasoning":"Document A is more relevant — it addresses gene expression and tumorigenesis (biomarker/gene-expression context), whereas Document B covers plasma lipids and prolactin unrelated to ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843624Z"}
{"comparison_id":"d4f53e8f-fa8d-4d8f-9177-285bab42814d","query_id":"51","doc_a_id":"5270265","doc_b_id":"15559582","presented_order":["5270265","15559582"],"winner_id":"5270265","reasoning":"Doc A is more relevant — it addresses treatment resistance and outcomes in breast cancer (biomarker/treatment context), whereas Doc B focuses on lipids and prolactin and not on prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843632Z"}
{"comparison_id":"c65aa1a0-505a-4b69-a278-ad3dddff36fe","query_id":"51","doc_a_id":"32423829","doc_b_id":"15559582","presented_order":["32423829","15559582"],"winner_id":"32423829","reasoning":"Document A is more relevant — it reports on breast cancer outcomes (downstaging and improved treatment outcomes), which is closer to the claim about ALDH1 and outcomes than a study on plasma lipids and prolactin.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843639Z"}
{"comparison_id":"75965514-18d8-4be7-8656-841888c3c11a","query_id":"51","doc_a_id":"10279084","doc_b_id":"15559582","presented_order":["15559582","10279084"],"winner_id":"10279084","reasoning":"Document B is more relevant — it discusses molecular alterations in cancer cells (including breast cancer) that relate to protein expression and tumor behavior, which is closer to a claim about marker expression and outcomes than plasma lipid/prolactin levels.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843646Z"}
{"comparison_id":"3a544bbb-764d-4ebd-b532-910d392da565","query_id":"51","doc_a_id":"11484808","doc_b_id":"15559582","presented_order":["15559582","11484808"],"winner_id":"11484808","reasoning":"Reason: Document B discusses molecular biomarkers and mechanisms affecting cancer outcomes (ncRNAs and survival), making it more relevant to a claim about a molecular marker's association with prognosis than Document A, which focuses on lipids and prolactin.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843653Z"}
{"comparison_id":"d900e0ca-e0d9-4be1-80d9-5848d093efc4","query_id":"51","doc_a_id":"22712546","doc_b_id":"15559582","presented_order":["22712546","15559582"],"winner_id":"22712546","reasoning":"Document A — it studies enzymatic activities and metabolic interactions in breast cancer tissue and is more likely to address markers like ALDH1. Document B concerns plasma lipids and prolactin and is unrelated.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843661Z"}
{"comparison_id":"1437519e-5dcc-4e24-9059-01f6eb6810b4","query_id":"51","doc_a_id":"2576811","doc_b_id":"15559582","presented_order":["15559582","2576811"],"winner_id":"15559582","reasoning":"Reason: Neither discusses ALDH1, but Document A addresses clinical biomarkers and patient outcomes in breast cancer, making it slightly more relevant than a mechanistic cell biology study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843668Z"}
{"comparison_id":"cd803f7f-619a-4bad-b722-c0cc0292f345","query_id":"51","doc_a_id":"825728","doc_b_id":"15559582","presented_order":["825728","15559582"],"winner_id":"825728","reasoning":"Document A is more relevant — it links EMT, stem-cell properties and patient survival/metastasis, which is related to ALDH1 (a stem-cell marker) and breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843674Z"}
{"comparison_id":"f1846889-732a-408a-a058-a01736b9321c","query_id":"51","doc_a_id":"18953920","doc_b_id":"15559582","presented_order":["15559582","18953920"],"winner_id":"18953920","reasoning":"Document B — it discusses breast epithelial cells acquiring stem-cell markers and increased tumorigenicity, which is relevant to ALDH1 as a stem-cell marker and its association with outcomes. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843681Z"}
{"comparison_id":"7bd003a4-c007-47fe-be30-64eb219592e5","query_id":"51","doc_a_id":"42106119","doc_b_id":"15559582","presented_order":["15559582","42106119"],"winner_id":"42106119","reasoning":"Document B — it discusses stem cell factors and cancer biology (more likely to relate to ALDH1, a stem-cell marker), whereas A addresses lipids/prolactin and not ALDH1 or outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843688Z"}
{"comparison_id":"c8d585a2-c671-43d3-879e-f28f888ca769","query_id":"51","doc_a_id":"164985","doc_b_id":"15559582","presented_order":["164985","15559582"],"winner_id":"164985","reasoning":"Document A is slightly more relevant because it addresses tumor progression and mechanisms affecting outcomes, whereas Document B focuses on lipids and prolactin without linking to tumor biology markers like ALDH1.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843694Z"}
{"comparison_id":"8fb429be-029e-49fb-867d-e4a9b44608f6","query_id":"51","doc_a_id":"5579368","doc_b_id":"15559582","presented_order":["15559582","5579368"],"winner_id":"5579368","reasoning":"Document B is more relevant — it deals with DNA methylation and gene expression analysis for breast cancer biomarkers, which is directly related to evaluating ALDH1 expression; Document A discusses lipids/prolactin, not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:31:46.843701Z"}
{"comparison_id":"ca9d6a1a-3320-419b-be96-5457400873df","query_id":"51","doc_a_id":"45638119","doc_b_id":"1379127","presented_order":["1379127","45638119"],"winner_id":"45638119","reasoning":"Document B — it directly addresses ALDH1 and its association with clinical outcome (predicting poor prognosis), which is relevant to the claim. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225207Z"}
{"comparison_id":"b077618d-361e-4102-a01d-321e2077cbfc","query_id":"51","doc_a_id":"8963413","doc_b_id":"1379127","presented_order":["8963413","1379127"],"winner_id":"8963413","reasoning":"Document A is more relevant — it discusses expression of an immune marker being associated with better breast cancer outcomes, which is conceptually closer to a claim about a biomarker (ALDH1) and outcomes. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225229Z"}
{"comparison_id":"ea2140cf-088e-49bb-bcee-215983953f80","query_id":"51","doc_a_id":"22401720","doc_b_id":"1379127","presented_order":["22401720","1379127"],"winner_id":"22401720","reasoning":"Document A — it examines biomarker expression and relates factors (e.g., VEGF) to prognosis, so it's closer to a claim about marker expression and outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225238Z"}
{"comparison_id":"623e20f9-7ba0-45b5-bf8d-5c3930f80b76","query_id":"51","doc_a_id":"21439640","doc_b_id":"1379127","presented_order":["1379127","21439640"],"winner_id":"1379127","reasoning":"Document A — it discusses breast tumor cell migration and metastasis (directly related to outcomes), whereas Document B focuses on macrophage-driven COX-2 signaling without a direct link to prognosis or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225245Z"}
{"comparison_id":"de072561-d50c-4b5c-ac35-8ca162cdbd6c","query_id":"51","doc_a_id":"12762485","doc_b_id":"1379127","presented_order":["1379127","12762485"],"winner_id":"12762485","reasoning":"Document B is more relevant — it discusses stem cell phenotypes and prognostic markers in breast cancer, which is related to ALDH1 (a stem cell marker), whereas A focuses on calcium channels and metastasis unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225253Z"}
{"comparison_id":"4f3390a3-f4ac-41f8-9f13-7387fff8e141","query_id":"51","doc_a_id":"7821634","doc_b_id":"1379127","presented_order":["7821634","1379127"],"winner_id":"7821634","reasoning":"Document A is more relevant — it discusses a biomarker (DUSP4) tied to tumor behavior and patient outcomes, which is closer to the claim about ALDH1 and breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225260Z"}
{"comparison_id":"5ae736c2-b0f5-4027-b22f-81390b3d5bde","query_id":"51","doc_a_id":"4429932","doc_b_id":"1379127","presented_order":["1379127","4429932"],"winner_id":"4429932","reasoning":"Document B — it mentions associations with patient outcomes in breast cancer (though for LOX, not ALDH1), so it's more related to the query about expression and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225267Z"}
{"comparison_id":"f87f1c00-cd7c-4b43-ad05-8b85aaabe11b","query_id":"51","doc_a_id":"24341590","doc_b_id":"1379127","presented_order":["24341590","1379127"],"winner_id":"24341590","reasoning":"Reason: Document A concerns clinical outcomes in breast cancer (treatment and recurrence), so it's more related to an outcome-associated marker than Document B, which focuses on migration/metastasis mechanisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225275Z"}
{"comparison_id":"3979a62a-6486-42c4-a5d4-d483e6e5554f","query_id":"51","doc_a_id":"13007205","doc_b_id":"1379127","presented_order":["1379127","13007205"],"winner_id":"1379127","reasoning":"Document A is slightly more relevant because it addresses tumor migration and metastasis (clinical outcomes), whereas Document B focuses on fibroblast genotype and MMP-3–driven invasion. Neither mentions ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225282Z"}
{"comparison_id":"d898558c-9080-4316-ab5b-6fd91151d73b","query_id":"51","doc_a_id":"32001951","doc_b_id":"1379127","presented_order":["32001951","1379127"],"winner_id":"32001951","reasoning":"Document A is more relevant — it discusses regulation of enzyme expression in a breast cancer cell line (whereas Document B focuses on calcium entry proteins unrelated to ALDH1). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225289Z"}
{"comparison_id":"441c339d-10ea-4f9c-96ad-ba599611d8be","query_id":"51","doc_a_id":"7583725","doc_b_id":"1379127","presented_order":["1379127","7583725"],"winner_id":"7583725","reasoning":"Neither document addresses ALDH1, but Document B at least links a protein's expression to patient outcomes (while A does not), so B is slightly more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225296Z"}
{"comparison_id":"a9a14173-15cc-4d95-b267-729684658cc3","query_id":"51","doc_a_id":"15113221","doc_b_id":"1379127","presented_order":["15113221","1379127"],"winner_id":"15113221","reasoning":"Doc A is more relevant — it discusses gene expression signatures linked to prognosis in carcinoma, which is closer to evaluating marker-outcome associations than Doc B's focus on calcium channels and metastasis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225303Z"}
{"comparison_id":"c3195e94-e188-4b10-aac8-6ac826870242","query_id":"51","doc_a_id":"4820792","doc_b_id":"1379127","presented_order":["4820792","1379127"],"winner_id":"1379127","reasoning":"Neither abstract mentions ALDH1. Document B is slightly more relevant because it addresses tumor cell migration and metastasis, which relates to clinical outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225310Z"}
{"comparison_id":"7bd4ca73-34b5-4869-baf9-92448e41fe78","query_id":"51","doc_a_id":"27240667","doc_b_id":"1379127","presented_order":["27240667","1379127"],"winner_id":"27240667","reasoning":"Document A is more relevant because it addresses breast cancer outcomes (mortality) directly, whereas Document B focuses on migration/metastasis mechanisms without outcome data.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225317Z"}
{"comparison_id":"22e663ea-078b-468f-aead-48058cefcdd6","query_id":"51","doc_a_id":"16734530","doc_b_id":"1379127","presented_order":["16734530","1379127"],"winner_id":"16734530","reasoning":"Neither document mentions ALDH1. Document A is slightly more relevant because it studies biomarker–breast cancer associations (clinical features/outcomes), whereas B focuses on calcium channels and metastasis mechanisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225325Z"}
{"comparison_id":"3b7a9864-7e16-4742-a027-3c7a7477d802","query_id":"51","doc_a_id":"3285322","doc_b_id":"1379127","presented_order":["3285322","1379127"],"winner_id":"3285322","reasoning":"Document A is more relevant — it addresses clinical and pathologic features and outcomes in breast cancer patients, which is closer to evaluating associations of markers like ALDH1 with prognosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225331Z"}
{"comparison_id":"f191047a-e3cd-44ca-b3a5-de7aee9ac591","query_id":"51","doc_a_id":"2140497","doc_b_id":"1379127","presented_order":["1379127","2140497"],"winner_id":"1379127","reasoning":"Neither abstract mentions ALDH1, but Document A addresses tumor metastasis and mechanisms affecting cancer outcomes, while B concerns risk factors for developing cancer. Therefore A is more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225339Z"}
{"comparison_id":"d554d3ed-6827-4b56-9557-c20f45a5c240","query_id":"51","doc_a_id":"20839751","doc_b_id":"1379127","presented_order":["20839751","1379127"],"winner_id":"20839751","reasoning":"Document A is more relevant because it discusses prognostic factors and outcomes in breast cancer, whereas Document B focuses on calcium channels and metastasis without addressing prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225346Z"}
{"comparison_id":"671aded8-2e0f-48e6-ae2d-1b50df475407","query_id":"51","doc_a_id":"13030852","doc_b_id":"1379127","presented_order":["1379127","13030852"],"winner_id":"13030852","reasoning":"Document B is slightly more relevant because it deals with biomarkers and their relation to metastasis and patient management, whereas Document A focuses on calcium channel proteins unrelated to biomarker expression. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225353Z"}
{"comparison_id":"0b5fed41-0d13-46e2-ac9f-4a82db4e1ba3","query_id":"51","doc_a_id":"13069283","doc_b_id":"1379127","presented_order":["1379127","13069283"],"winner_id":"1379127","reasoning":"Document A is more relevant — it discusses breast tumor migration and metastasis (clinical outcomes), whereas Document B focuses on tamoxifen metabolism genetics unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225360Z"}
{"comparison_id":"b788ec23-5b0d-4442-8246-76355dbc0c52","query_id":"51","doc_a_id":"9600826","doc_b_id":"1379127","presented_order":["9600826","1379127"],"winner_id":"9600826","reasoning":"Document A is marginally more relevant because it directly discusses breast cancer pathways and outcomes (invasion/angiogenesis), whereas Document B focuses narrowly on calcium entry and migration. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225368Z"}
{"comparison_id":"285c1e58-d4eb-4a46-9a53-592084a2ff13","query_id":"51","doc_a_id":"43385013","doc_b_id":"1379127","presented_order":["1379127","43385013"],"winner_id":"43385013","reasoning":"Document B — it discusses stem cell/progenitor properties in breast cell subpopulations (relevant to ALDH1 as a stem cell marker), while A addresses calcium channels and metastasis unrelated to ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225376Z"}
{"comparison_id":"4ff148e6-9274-46f1-9510-25dfa82c3a18","query_id":"51","doc_a_id":"1171121","doc_b_id":"1379127","presented_order":["1379127","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant — it discusses prognostic biomarkers and associations with disease-free survival in breast cancer, which is closely related to the claim about ALDH1 and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225383Z"}
{"comparison_id":"e47658c1-4c9c-4a63-a817-36ad6df53fd4","query_id":"51","doc_a_id":"25732836","doc_b_id":"1379127","presented_order":["1379127","25732836"],"winner_id":"25732836","reasoning":"Document B — it evaluates prognostic markers and outcome prediction in breast cancer, whereas A focuses on migration/metastasis mechanisms and does not address prognostic biomarkers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225390Z"}
{"comparison_id":"822d91f9-af60-43b5-ab57-125210909da2","query_id":"51","doc_a_id":"25973484","doc_b_id":"1379127","presented_order":["1379127","25973484"],"winner_id":"25973484","reasoning":"Document B is more relevant — it discusses factors affecting breast cancer prognosis, whereas Document A focuses on calcium channels and metastasis mechanisms without addressing prognostic markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225397Z"}
{"comparison_id":"4015a3a0-6ce6-404b-91cf-2354da126ba3","query_id":"51","doc_a_id":"24249915","doc_b_id":"1379127","presented_order":["24249915","1379127"],"winner_id":"24249915","reasoning":"Document A is more relevant — it examines expression of a breast cancer marker (ERβ) and its change with invasive disease, which is closer to studies of marker expression and outcomes than Document B's focus on calcium channels and migration.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225406Z"}
{"comparison_id":"d9c37272-02a0-424f-a9a3-e4aa1bf1fa10","query_id":"51","doc_a_id":"313403","doc_b_id":"1379127","presented_order":["313403","1379127"],"winner_id":"313403","reasoning":"Document A is more relevant — it directly addresses prognostic markers and clinical outcomes in breast cancer, whereas Document B focuses on cell migration mechanisms unrelated to ALDH1 expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225414Z"}
{"comparison_id":"5aa1e400-cfcd-4413-9f62-36c94c548420","query_id":"51","doc_a_id":"195680777","doc_b_id":"1379127","presented_order":["195680777","1379127"],"winner_id":"1379127","reasoning":"Document B is more relevant — it discusses molecular factors affecting tumor behavior and metastasis (closer to biomarker–outcome links) while A focuses on chemotherapy regimen comparisons and not biomarkers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225421Z"}
{"comparison_id":"0dfff41d-69c9-4de5-b161-71996d9843f9","query_id":"51","doc_a_id":"1389264","doc_b_id":"1379127","presented_order":["1379127","1389264"],"winner_id":"1389264","reasoning":"Neither document mentions ALDH1 or provides evidence about its association with outcomes. Both are irrelevant; B is slightly more related because it discusses biomarkers and treatment response.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225428Z"}
{"comparison_id":"a73728f8-bcf2-4b30-af15-67a9d9b348b8","query_id":"51","doc_a_id":"22509015","doc_b_id":"1379127","presented_order":["22509015","1379127"],"winner_id":"22509015","reasoning":"Reason: Neither mentions ALDH1, but Document A discusses basal-like breast cancer and metastasis (more related to markers/clinical outcomes) whereas B focuses on calcium channels and migration.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225435Z"}
{"comparison_id":"4541d0c4-98a4-4b12-af09-d2f1d5c02d13","query_id":"51","doc_a_id":"18340282","doc_b_id":"1379127","presented_order":["18340282","1379127"],"winner_id":"1379127","reasoning":"Neither abstract mentions ALDH1. Document B is slightly more relevant because it addresses tumor metastasis, a clinical outcome, whereas A focuses on gene–environment interactions for breast cancer risk. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225442Z"}
{"comparison_id":"291f84f2-b315-4acf-88c7-d741955ceb92","query_id":"51","doc_a_id":"20454006","doc_b_id":"1379127","presented_order":["20454006","1379127"],"winner_id":"20454006","reasoning":"Document A is about breast cancer biomarker modulation (even though not ALDH1 specifically), so it's more relevant than Document B, which focuses on calcium channels and metastasis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225449Z"}
{"comparison_id":"2dcd624f-d107-45f6-bab5-77fa37c5e0a4","query_id":"51","doc_a_id":"27123743","doc_b_id":"1379127","presented_order":["1379127","27123743"],"winner_id":"27123743","reasoning":"Reason: Neither document discusses ALDH1; Document B mentions stem cells (ALDH1 is a stem-cell marker), so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225456Z"}
{"comparison_id":"9ca75d47-523e-40bb-87eb-dfa88b5befbe","query_id":"51","doc_a_id":"22482820","doc_b_id":"1379127","presented_order":["22482820","1379127"],"winner_id":"22482820","reasoning":"Neither document mentions ALDH1, but Document A discusses breast cancer classification and treatment strategies (more likely to address biomarkers/outcomes) whereas B focuses on calcium channels and metastasis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225463Z"}
{"comparison_id":"2164c7af-44c5-4a8a-8a01-5d49ccfa1419","query_id":"51","doc_a_id":"4418878","doc_b_id":"1379127","presented_order":["4418878","1379127"],"winner_id":"4418878","reasoning":"Document A is more relevant — it discusses gene expression signatures and their link to prognosis in cancers, which could include markers like ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225470Z"}
{"comparison_id":"15b623c6-7d94-45f8-b763-fe10e66b96ee","query_id":"51","doc_a_id":"5864770","doc_b_id":"1379127","presented_order":["1379127","5864770"],"winner_id":"1379127","reasoning":"Document A is more relevant — it discusses factors affecting breast tumor metastasis and outcomes, whereas Document B focuses on hormones and risk without addressing markers like ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225477Z"}
{"comparison_id":"7dc54ae7-c232-4f5d-8c7f-4d5d1caa9051","query_id":"51","doc_a_id":"19358586","doc_b_id":"1379127","presented_order":["1379127","19358586"],"winner_id":"19358586","reasoning":"Reason: Document B discusses prognostic protein signatures and survival in breast cancer, so it's more related to associations between markers and outcomes than Document A, which focuses on cell migration/metastasis mechanisms.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225484Z"}
{"comparison_id":"7eb643cc-4676-4da9-a82e-db1ef2d47793","query_id":"51","doc_a_id":"17088791","doc_b_id":"1379127","presented_order":["17088791","1379127"],"winner_id":"1379127","reasoning":"Document B is more relevant — it addresses factors (migration/metastasis) related to breast cancer outcomes, whereas A discusses BRCA1 polymorphisms and susceptibility rather than marker expression or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225491Z"}
{"comparison_id":"70989af2-31b7-4c8e-817f-38f22875b289","query_id":"51","doc_a_id":"5579368","doc_b_id":"1379127","presented_order":["1379127","5579368"],"winner_id":"5579368","reasoning":"Document B is more relevant — it deals with genomic/methylation analysis and gene expression of breast cancer biomarkers (which could include ALDH1), whereas Document A discusses calcium channels unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225499Z"}
{"comparison_id":"0e23d86c-1c4a-43c6-9c5f-fafd5c6d9f6a","query_id":"51","doc_a_id":"1866911","doc_b_id":"1379127","presented_order":["1866911","1379127"],"winner_id":"1866911","reasoning":"Document A is more relevant — it discusses progenitor/stem-like cell populations in breast cancer (markers and origins), which is closer to ALDH1 (a stem/progenitor marker) than Document B's focus on calcium channels and metastasis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225506Z"}
{"comparison_id":"a945b107-1529-46fa-b5d6-74e465dcfd08","query_id":"51","doc_a_id":"31311495","doc_b_id":"1379127","presented_order":["31311495","1379127"],"winner_id":"31311495","reasoning":"Neither document mentions ALDH1. Document A is slightly more relevant because it discusses EMT and tumor progression factors tied to prognosis, whereas B focuses on calcium-entry channels and metastasis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225512Z"}
{"comparison_id":"d0bfce66-26db-4f87-a658-d34e731cfa11","query_id":"51","doc_a_id":"12438901","doc_b_id":"1379127","presented_order":["12438901","1379127"],"winner_id":"12438901","reasoning":"Document A is more relevant because it directly addresses breast cancer outcomes, whereas Document B focuses on calcium-channel proteins and metastasis mechanisms unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225519Z"}
{"comparison_id":"848bd269-4f3c-4a77-8ebd-1a38f34e442f","query_id":"51","doc_a_id":"885056","doc_b_id":"1379127","presented_order":["885056","1379127"],"winner_id":"1379127","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it addresses breast cancer metastasis (an outcome), whereas A focuses on SLIRP and mitochondrial/regulatory effects. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225527Z"}
{"comparison_id":"d93642d1-35e8-4aae-ab46-2e9d66927800","query_id":"51","doc_a_id":"6550579","doc_b_id":"1379127","presented_order":["6550579","1379127"],"winner_id":"1379127","reasoning":"Neither paper mentions ALDH1, but Document B relates to tumor migration/metastasis (clinical outcome relevance) while A focuses on HER3-targeted therapy. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225533Z"}
{"comparison_id":"0e533f19-1be1-4fdd-8ef4-f6544e98ec06","query_id":"51","doc_a_id":"15946643","doc_b_id":"1379127","presented_order":["1379127","15946643"],"winner_id":"15946643","reasoning":"Document B — it discusses pathways linking chemoresistance and metastasis (more directly related to cancer outcomes) while Document A focuses narrowly on calcium-entry proteins and cell migration. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225540Z"}
{"comparison_id":"bfec1ffb-d6af-4150-8f8d-69c5709593e7","query_id":"51","doc_a_id":"5649538","doc_b_id":"1379127","presented_order":["5649538","1379127"],"winner_id":"1379127","reasoning":"Reason: Document B discusses factors affecting breast cancer metastasis (a clinical outcome), so it's slightly more relevant to a claim about expression being associated with outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225547Z"}
{"comparison_id":"86554c64-8d5f-48e4-be95-0a9f270c7003","query_id":"51","doc_a_id":"4702639","doc_b_id":"1379127","presented_order":["4702639","1379127"],"winner_id":"4702639","reasoning":"Document A is more relevant — it discusses tumor stemness markers and pathways related to stem-like cancer cells (ALDH1 is a stemness marker), whereas Document B focuses on calcium channels and metastasis with no link to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225554Z"}
{"comparison_id":"f28d4dcd-5820-4bae-96f7-b054edf7fe7e","query_id":"51","doc_a_id":"19673227","doc_b_id":"1379127","presented_order":["19673227","1379127"],"winner_id":"19673227","reasoning":"Document A discusses prognostic value and links to disease-free survival and time to progression, which is more directly related to clinical outcomes than Document B's mechanistic metastasis study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225561Z"}
{"comparison_id":"f3c8311e-97a8-40ee-b88f-1dc9f91048b3","query_id":"51","doc_a_id":"4455466","doc_b_id":"1379127","presented_order":["4455466","1379127"],"winner_id":"4455466","reasoning":"Document A — it discusses gene expression linked to breast cancer prognosis (outcomes), which is more relevant to the claim about marker expression and outcomes than Document B's focus on calcium channels and metastasis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225569Z"}
{"comparison_id":"08721062-6e6e-4aad-846f-405f3d8bf180","query_id":"51","doc_a_id":"2931832","doc_b_id":"1379127","presented_order":["1379127","2931832"],"winner_id":"2931832","reasoning":"Document B is more relevant — it concerns prognostic biomarkers and patient outcomes in breast cancer, whereas Document A focuses on migration/metastasis mechanisms unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225576Z"}
{"comparison_id":"8799d0d4-5b41-445f-891b-66611541bebf","query_id":"51","doc_a_id":"20127522","doc_b_id":"1379127","presented_order":["20127522","1379127"],"winner_id":"20127522","reasoning":"Document A is more relevant — it addresses biomarkers linked to breast cancer outcomes (treatment efficacy and progression), whereas Document B focuses on calcium-entry proteins and metastasis without discussion of prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225584Z"}
{"comparison_id":"2d39ea2e-7a9b-4ee0-912e-601509802684","query_id":"51","doc_a_id":"22975806","doc_b_id":"1379127","presented_order":["22975806","1379127"],"winner_id":"22975806","reasoning":"Document A is more relevant — it discusses breast tumorigenesis and clinical implications, whereas Document B focuses on calcium channels and metastasis rather than prognostic marker expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225590Z"}
{"comparison_id":"b235faad-8047-4615-8c25-f5856c822f11","query_id":"51","doc_a_id":"21033230","doc_b_id":"1379127","presented_order":["21033230","1379127"],"winner_id":"21033230","reasoning":"Document A is more relevant — it discusses molecular profiling and prognostic markers in breast cancer (though it does not mention ALDH1 specifically). \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225597Z"}
{"comparison_id":"2b7867ce-4dbe-4cc0-8116-9aa5f4b0a5a3","query_id":"51","doc_a_id":"34066665","doc_b_id":"1379127","presented_order":["1379127","34066665"],"winner_id":"34066665","reasoning":"Neither document mentions ALDH1, but document B (ER–HER crosstalk and therapy resistance) is slightly more related to clinical outcomes in breast cancer than A (calcium channels and metastasis). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225604Z"}
{"comparison_id":"2575f228-a8a9-4312-b311-9fc1ad2eb40b","query_id":"51","doc_a_id":"16086778","doc_b_id":"1379127","presented_order":["1379127","16086778"],"winner_id":"16086778","reasoning":"Document B is more relevant — it discusses molecular regulation and prognosis-related mechanisms in breast cancer, which is closer to biomarkers/outcomes than Document A's focus on calcium channels and migration.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225611Z"}
{"comparison_id":"39e40c97-4191-4ced-aefd-ac8ef46c4114","query_id":"51","doc_a_id":"2061878","doc_b_id":"1379127","presented_order":["1379127","2061878"],"winner_id":"1379127","reasoning":"Document A is more relevant — it concerns breast tumor biology and metastasis, whereas Document B discusses a lncRNA across cancers without focus on breast cancer or ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225618Z"}
{"comparison_id":"e0a80640-a4dc-44ed-b6c0-ba705718f662","query_id":"51","doc_a_id":"21902400","doc_b_id":"1379127","presented_order":["1379127","21902400"],"winner_id":"1379127","reasoning":"Document A is more relevant — it specifically addresses breast tumor behavior and metastasis, which relates directly to breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225624Z"}
{"comparison_id":"86280206-6eb7-4e8a-bc47-18b0ed523b80","query_id":"51","doc_a_id":"24834968","doc_b_id":"1379127","presented_order":["1379127","24834968"],"winner_id":"24834968","reasoning":"Document B is more relevant — it evaluates biological markers as predictors of breast cancer response/outcomes, whereas Document A focuses on calcium-entry proteins unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225631Z"}
{"comparison_id":"b5cec92c-ec4d-4b15-ba22-d951f9c34f04","query_id":"51","doc_a_id":"20183360","doc_b_id":"1379127","presented_order":["1379127","20183360"],"winner_id":"20183360","reasoning":"Neither document mentions ALDH1; Document B is slightly more relevant because it addresses factors (invasion/progression) that relate to breast cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225638Z"}
{"comparison_id":"bfff7fc5-b111-4316-94ae-d66c2f14b649","query_id":"51","doc_a_id":"5500086","doc_b_id":"1379127","presented_order":["5500086","1379127"],"winner_id":"5500086","reasoning":"Document A — it links a molecular signature to breast cancer clinical outcomes, which is more relevant to a claim about a biomarker-outcome association than Document B's focus on calcium channels and metastasis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225644Z"}
{"comparison_id":"5fe6d21f-d75a-4be9-9403-1c00b6e46c95","query_id":"51","doc_a_id":"4889228","doc_b_id":"1379127","presented_order":["1379127","4889228"],"winner_id":"4889228","reasoning":"Document B is more relevant — it discusses gene expression levels correlated with prognosis in breast cancer, which is closer to the claim about ALDH1 expression and outcomes.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225651Z"}
{"comparison_id":"ddf10907-3f66-43f8-8a32-05dd3c3220a9","query_id":"51","doc_a_id":"16691520","doc_b_id":"1379127","presented_order":["1379127","16691520"],"winner_id":"16691520","reasoning":"Neither abstract mentions ALDH1 or links its expression to clinical outcomes; both are unrelated. Document B is slightly more relevant because genome-wide ER binding studies are more likely to address gene-expression–outcome relationships than a paper focused narrowly on migration mechanisms.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225659Z"}
{"comparison_id":"c6449fc1-fddd-4207-889a-475109937ff3","query_id":"51","doc_a_id":"8891333","doc_b_id":"1379127","presented_order":["8891333","1379127"],"winner_id":"8891333","reasoning":"Document A is more relevant — it discusses cancer stem cells in breast cancer (where ALDH1 is a known stem-cell marker) and therapy-related implications, whereas Document B focuses on calcium channels and metastasis unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225666Z"}
{"comparison_id":"08059fd1-9b65-4a79-89dd-1692e00caa59","query_id":"51","doc_a_id":"2014909","doc_b_id":"1379127","presented_order":["1379127","2014909"],"winner_id":"2014909","reasoning":"Document B is more relevant — it includes analyses of primary breast cancers and tumor progression pathways, so it's more likely to address biomarker–outcome associations. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225673Z"}
{"comparison_id":"9b23c0b3-40d5-42c8-bc44-3d110b5a5bcf","query_id":"51","doc_a_id":"7046487","doc_b_id":"1379127","presented_order":["1379127","7046487"],"winner_id":"1379127","reasoning":"Document A is more relevant because it specifically addresses mechanisms affecting breast tumor metastasis and outcomes, whereas Document B discusses NF-κB broadly in inflammation and cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225680Z"}
{"comparison_id":"92b13b1e-dc1d-444b-83d8-679228ac4740","query_id":"51","doc_a_id":"20333864","doc_b_id":"1379127","presented_order":["1379127","20333864"],"winner_id":"20333864","reasoning":"Document B is more relevant — it addresses mechanisms of tumor progression and cellular states (in situ to invasive transition), which is closer to biomarkers like ALDH1 than a study focused narrowly on calcium channels and metastasis. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225687Z"}
{"comparison_id":"342a2bef-4d82-4db6-8ec0-5bfb9debfc9b","query_id":"51","doc_a_id":"8774475","doc_b_id":"1379127","presented_order":["1379127","8774475"],"winner_id":"1379127","reasoning":"Document A is more relevant — it addresses breast tumor cell migration and metastasis, which relate directly to clinical outcomes, whereas Document B focuses on cell polarity and tumorigenesis mechanisms without linking to markers or outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225694Z"}
{"comparison_id":"a42c2826-7325-4829-8a0b-4370251bc89c","query_id":"51","doc_a_id":"19541444","doc_b_id":"1379127","presented_order":["19541444","1379127"],"winner_id":"1379127","reasoning":"Document B is more relevant — it addresses breast tumor behavior (migration/metastasis) which relates to outcomes, whereas A discusses MEG3 broadly without link to ALDH1 or breast outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225701Z"}
{"comparison_id":"e8ea9f1d-9b0b-4eca-8f27-b0d1ac9f6747","query_id":"51","doc_a_id":"5270265","doc_b_id":"1379127","presented_order":["5270265","1379127"],"winner_id":"1379127","reasoning":"Document B is more relevant — it addresses tumor cell migration and metastasis (clinical outcomes related to prognosis), whereas neither paper mentions ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225708Z"}
{"comparison_id":"c113a439-4a2c-434c-8611-a22532094147","query_id":"51","doc_a_id":"32423829","doc_b_id":"1379127","presented_order":["1379127","32423829"],"winner_id":"1379127","reasoning":"Document A is more relevant — it deals with molecular factors affecting breast tumor behavior (migration/metastasis), whereas Document B covers screening trial methods/outcomes and neither mentions ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225715Z"}
{"comparison_id":"037a5836-b3b0-49a8-8852-bf229908a717","query_id":"51","doc_a_id":"10279084","doc_b_id":"1379127","presented_order":["1379127","10279084"],"winner_id":"1379127","reasoning":"Document A is more relevant — neither mentions ALDH1, but A addresses breast tumor migration/metastasis and thus relates more directly to factors affecting breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225722Z"}
{"comparison_id":"e7ab9abc-8e19-4d07-b7a5-4427d1bc58dc","query_id":"51","doc_a_id":"11484808","doc_b_id":"1379127","presented_order":["11484808","1379127"],"winner_id":"11484808","reasoning":"Reason: Neither abstract mentions ALDH1, but Document A discusses clinical markers and prognostic implications in endocrine-related (including breast) cancers, so it's more likely to address ALDH1 than the mechanistic study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225729Z"}
{"comparison_id":"9cc4592e-eda0-427b-94c5-8725ed2a8b57","query_id":"51","doc_a_id":"22712546","doc_b_id":"1379127","presented_order":["22712546","1379127"],"winner_id":"22712546","reasoning":"Document A is more relevant because it examines enzymatic/metabolic activities in breast cancer tissue (potentially including ALDH1), whereas Document B focuses on calcium channels unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225735Z"}
{"comparison_id":"b5f74b04-fd1b-42c5-b14f-cead5494039d","query_id":"51","doc_a_id":"825728","doc_b_id":"1379127","presented_order":["825728","1379127"],"winner_id":"825728","reasoning":"Document A is more relevant — it links EMT/stem-cell properties and patient survival (topics related to ALDH1 as a stem-cell marker and outcomes). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225742Z"}
{"comparison_id":"e7075d80-8fd4-4f53-98c8-8b6ce9f36abc","query_id":"51","doc_a_id":"18953920","doc_b_id":"1379127","presented_order":["18953920","1379127"],"winner_id":"18953920","reasoning":"Document A is more relevant — it discusses breast epithelial cells acquiring stem-cell markers and tumorigenic potential (context for ALDH1 as a stem-cell marker). Document B focuses on calcium channels unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225749Z"}
{"comparison_id":"0ad9ba01-c17a-4abe-aa2d-ecdf649bd7b9","query_id":"51","doc_a_id":"42106119","doc_b_id":"1379127","presented_order":["1379127","42106119"],"winner_id":"1379127","reasoning":"Document A is more relevant — it concerns breast tumor behavior (migration/metastasis), which is closer to breast cancer outcomes than an Oct4 network in embryonic stem cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225756Z"}
{"comparison_id":"2dea0cdd-3ab3-4387-818e-3d608eb5add8","query_id":"51","doc_a_id":"164985","doc_b_id":"1379127","presented_order":["1379127","164985"],"winner_id":"1379127","reasoning":"Document A is more relevant — it discusses factors affecting breast cancer metastasis and outcomes, which is closer to the claim about ALDH1 and clinical outcomes than the macrophage/IL-6 focus in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:27.225763Z"}
{"comparison_id":"54a1565f-96ef-42be-86e4-66a62c1f54e5","query_id":"51","doc_a_id":"45638119","doc_b_id":"4418878","presented_order":["4418878","45638119"],"winner_id":"45638119","reasoning":"Document B directly studies ALDH1 in breast cancer and links its expression to clinical outcome (specifically poor prognosis), whereas Document A is a general paper on pathway signatures and does not address ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692153Z"}
{"comparison_id":"c9e196c2-fd09-424e-9ed9-5e4099d2c2fd","query_id":"51","doc_a_id":"8963413","doc_b_id":"4418878","presented_order":["8963413","4418878"],"winner_id":"8963413","reasoning":"Document A is more relevant — it discusses expression of a specific marker and its association with outcomes in breast cancer, which is closer to the claim about ALDH1 than the generic pathway-signature discussion in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692175Z"}
{"comparison_id":"34d47eb6-6496-4743-adb4-12c94a30d690","query_id":"51","doc_a_id":"22401720","doc_b_id":"4418878","presented_order":["4418878","22401720"],"winner_id":"4418878","reasoning":"Document A is more relevant — it discusses gene expression signatures and their links to prognosis and therapy, which is directly related to claims about a specific marker's (ALDH1) association with breast cancer outcomes. Document B focuses on angiogenic factors not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692185Z"}
{"comparison_id":"9ea76aa1-aa34-4118-ac2e-702b407f6c07","query_id":"51","doc_a_id":"12762485","doc_b_id":"4418878","presented_order":["12762485","4418878"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses a breast cancer \"stem cell phenotype\" (ALDH1 is a stem cell marker) and its associations with prognostic features, which bears on outcomes. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692192Z"}
{"comparison_id":"c72f9e4a-beea-415c-839c-9c82bf4766a4","query_id":"51","doc_a_id":"7821634","doc_b_id":"4418878","presented_order":["4418878","7821634"],"winner_id":"4418878","reasoning":"Document A — it addresses gene expression signatures and their links to prognosis/outcomes broadly, while Document B focuses specifically on DUSP4 and chemotherapy resistance, not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692199Z"}
{"comparison_id":"908935cf-6179-4af2-9986-d2ad303b8a7d","query_id":"51","doc_a_id":"4429932","doc_b_id":"4418878","presented_order":["4429932","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it discusses gene expression signatures and their association with prognosis, which is closer to evaluating ALDH1 expression and breast cancer outcomes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692206Z"}
{"comparison_id":"fd6ce26a-eed1-4a8f-9517-0226864f5f41","query_id":"51","doc_a_id":"24341590","doc_b_id":"4418878","presented_order":["24341590","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it discusses gene expression signatures and their links to prognosis in cancer, which is directly related to associations between a gene marker's expression (like ALDH1) and outcomes. Document A concerns CYP2D6 polymorphisms and tamoxifen, not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692214Z"}
{"comparison_id":"e4a8f0c7-92bf-481e-86bd-a96bf1e727a6","query_id":"51","doc_a_id":"32001951","doc_b_id":"4418878","presented_order":["32001951","4418878"],"winner_id":"4418878","reasoning":"Document B — it discusses gene expression signatures and their links to prognosis in cancers, which is more directly relevant to associations between a specific gene's expression (like ALDH1) and breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692221Z"}
{"comparison_id":"86cce2a8-3a10-4696-9d4f-429b8cc5bed6","query_id":"51","doc_a_id":"7583725","doc_b_id":"4418878","presented_order":["7583725","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it addresses gene expression signatures and their links to prognosis, which is directly related to evaluating whether ALDH1 expression associates with breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692228Z"}
{"comparison_id":"111bb9fc-32d6-46b0-870e-603d3146152b","query_id":"51","doc_a_id":"15113221","doc_b_id":"4418878","presented_order":["15113221","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it discusses gene expression/biomarker signatures and their relation to prognosis across cancers, which is more directly related to assessing ALDH1's association with breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692235Z"}
{"comparison_id":"16daa427-0c8f-462f-b836-74d93f0eb7d0","query_id":"51","doc_a_id":"27240667","doc_b_id":"4418878","presented_order":["4418878","27240667"],"winner_id":"4418878","reasoning":"Document A is more relevant — it discusses gene expression signatures and their links to prognosis and therapy, which pertains to studies of markers like ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692241Z"}
{"comparison_id":"81000915-27f9-4fc7-b5b5-2bfaebcd12aa","query_id":"51","doc_a_id":"16734530","doc_b_id":"4418878","presented_order":["4418878","16734530"],"winner_id":"4418878","reasoning":"Reason: Document A discusses gene expression signatures and their links to cancer prognosis, which is directly relevant to a claim about ALDH1 (a gene expression marker) and breast cancer outcomes; Document B focuses on ORAI1 SNPs, not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692249Z"}
{"comparison_id":"4f2ae30e-d532-4bbf-9f7d-fceb16e10b39","query_id":"51","doc_a_id":"3285322","doc_b_id":"4418878","presented_order":["4418878","3285322"],"winner_id":"4418878","reasoning":"Doc A is more relevant — it discusses gene expression signatures and their links to cancer prognosis and outcomes, which is directly related to assessing biomarkers like ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692256Z"}
{"comparison_id":"1d69cc83-7f5e-49fd-a488-f916f2b359b4","query_id":"51","doc_a_id":"20839751","doc_b_id":"4418878","presented_order":["4418878","20839751"],"winner_id":"4418878","reasoning":"Document A is more relevant — it discusses gene expression signatures and prognosis, which could include markers like ALDH1, whereas Document B focuses on apoptosis indices unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692263Z"}
{"comparison_id":"28709d6e-8084-45cf-9dd8-f68ec10727b0","query_id":"51","doc_a_id":"13030852","doc_b_id":"4418878","presented_order":["13030852","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it discusses gene expression signatures and their links to prognosis and cancer subtypes, which relates to ALDH1 expression's association with breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692270Z"}
{"comparison_id":"25b97a4d-b1fe-49a6-9179-6d4410c38bcd","query_id":"51","doc_a_id":"9600826","doc_b_id":"4418878","presented_order":["4418878","9600826"],"winner_id":"4418878","reasoning":"Document A is more relevant — it discusses how gene expression signatures relate to cancer prognosis and outcomes, which pertains to evaluating markers like ALDH1. Document B focuses on an invasion/angiogenesis pathway not related to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692278Z"}
{"comparison_id":"524f9a65-dd76-450f-b172-6d74fc0d9916","query_id":"51","doc_a_id":"43385013","doc_b_id":"4418878","presented_order":["4418878","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it studies stem cell/progenitor properties in breast cell subpopulations, which relates to ALDH1 as a stem cell marker and its link to outcomes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692285Z"}
{"comparison_id":"7f2050ae-ed5f-45cc-8b5a-654ba49e55fb","query_id":"51","doc_a_id":"1171121","doc_b_id":"4418878","presented_order":["1171121","4418878"],"winner_id":"4418878","reasoning":"Reason: Document B addresses gene expression signatures and their links to prognosis, which is directly relevant to assessing whether expression of a marker like ALDH1 associates with breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692292Z"}
{"comparison_id":"1580d41c-2fd0-41da-94b2-8ba97cd071ca","query_id":"51","doc_a_id":"25732836","doc_b_id":"4418878","presented_order":["25732836","4418878"],"winner_id":"4418878","reasoning":"Reason: Document B discusses gene expression signatures and their links to prognosis, which is directly relevant to a claim about ALDH1 (a gene expression marker) and outcomes; Document A focuses on CTCs and PET imaging, not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692299Z"}
{"comparison_id":"a89c549a-d9fb-4740-8ad1-905c9a4221b1","query_id":"51","doc_a_id":"25973484","doc_b_id":"4418878","presented_order":["25973484","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it discusses gene expression signatures and their link to prognosis and therapy, which relates to whether expression of markers like ALDH1 associates with outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692306Z"}
{"comparison_id":"7b842f60-9b5f-46d9-858c-5c4a40396275","query_id":"51","doc_a_id":"24249915","doc_b_id":"4418878","presented_order":["4418878","24249915"],"winner_id":"4418878","reasoning":"Document A is more relevant — it discusses gene expression signatures and their link to prognosis in cancers, which relates to claims about marker expression and outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692313Z"}
{"comparison_id":"fd678bb2-dfe2-45b5-aae2-a561fbe5bf90","query_id":"51","doc_a_id":"313403","doc_b_id":"4418878","presented_order":["313403","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it discusses gene expression signatures and their link to prognosis, which is conceptually related to ALDH1 expression as a prognostic marker. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692320Z"}
{"comparison_id":"7e09a0f1-060a-4ff6-beb8-cd37c0d39db5","query_id":"51","doc_a_id":"1389264","doc_b_id":"4418878","presented_order":["4418878","1389264"],"winner_id":"4418878","reasoning":"Document A deals with gene expression signatures linked to prognosis and response, so it's more likely to address ALDH1's association with outcomes; Document B focuses on targeted therapy in HER2+ brain metastases and not ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692327Z"}
{"comparison_id":"9826f4d3-bbb1-4337-a7a8-cb8183b83412","query_id":"51","doc_a_id":"22509015","doc_b_id":"4418878","presented_order":["22509015","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it discusses gene expression signatures and their links to prognosis and outcomes, which relates to whether a marker like ALDH1 associates with breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692334Z"}
{"comparison_id":"79fa6f6a-23f2-4203-83a6-76fb829ec66c","query_id":"51","doc_a_id":"20454006","doc_b_id":"4418878","presented_order":["20454006","4418878"],"winner_id":"4418878","reasoning":"Document B — it addresses gene expression signatures and their links to prognosis and outcomes, which is directly relevant to associations between a marker like ALDH1 and breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692341Z"}
{"comparison_id":"e4b29f7d-a1a7-47ab-b24d-efaa8fababfb","query_id":"51","doc_a_id":"27123743","doc_b_id":"4418878","presented_order":["27123743","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it addresses gene expression signatures and their link to prognosis and treatment response, which pertains to ALDH1 expression and breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692348Z"}
{"comparison_id":"3987b6e2-ff54-4462-8e63-183593810ad7","query_id":"51","doc_a_id":"22482820","doc_b_id":"4418878","presented_order":["22482820","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it deals with gene expression signatures and their links to prognosis and therapy response, which is directly related to assessing associations between expression of markers like ALDH1 and breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692355Z"}
{"comparison_id":"f576135a-eb07-4477-a1db-75b3f577324c","query_id":"51","doc_a_id":"18953920","doc_b_id":"4418878","presented_order":["4418878","18953920"],"winner_id":"18953920","reasoning":"Document B is more relevant — it discusses stem-cell markers in mammary epithelial cells (like ALDH1) and their link to tumorigenic potential. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692363Z"}
{"comparison_id":"42aa78ec-98d3-4ecf-85af-9da5eba9a964","query_id":"51","doc_a_id":"19358586","doc_b_id":"4418878","presented_order":["19358586","4418878"],"winner_id":"4418878","reasoning":"Document B — it discusses gene expression signatures and their links to prognosis in cancer, which is more directly related to a claim about ALDH1 expression and outcomes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692370Z"}
{"comparison_id":"23160ac0-306b-4e13-bb86-f928d4d4236e","query_id":"51","doc_a_id":"5579368","doc_b_id":"4418878","presented_order":["5579368","4418878"],"winner_id":"5579368","reasoning":"Document A is more relevant — it specifically addresses methods linking DNA methylation and gene expression in breast cancer biomarkers, which could directly relate to ALDH1 expression and outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692377Z"}
{"comparison_id":"adb18e2b-1af2-44f8-81f2-aad337d5248b","query_id":"51","doc_a_id":"1866911","doc_b_id":"4418878","presented_order":["4418878","1866911"],"winner_id":"4418878","reasoning":"Document A is more relevant — it addresses gene expression signatures and their links to prognosis and therapy response, which could include markers like ALDH1 and breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692384Z"}
{"comparison_id":"f0cf6b4a-187f-4fba-9f32-db9a423248fb","query_id":"51","doc_a_id":"31311495","doc_b_id":"4418878","presented_order":["31311495","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it addresses gene expression signatures and their links to prognosis and cancer subtypes, which is directly related to assessing whether markers like ALDH1 associate with outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692391Z"}
{"comparison_id":"ed86ea7b-e15a-4645-8d81-30b629bbba9e","query_id":"51","doc_a_id":"12438901","doc_b_id":"4418878","presented_order":["4418878","12438901"],"winner_id":"4418878","reasoning":"Document A is more relevant — it discusses gene expression signatures and their links to cancer prognosis, which relates to ALDH1 expression as a prognostic marker.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692398Z"}
{"comparison_id":"8f3d249c-6f9e-45b9-9f35-b2892be9a94c","query_id":"51","doc_a_id":"15946643","doc_b_id":"4418878","presented_order":["4418878","15946643"],"winner_id":"4418878","reasoning":"Document A is more relevant — it focuses on gene expression signatures linked to cancer subtype and prognosis, which pertains to biomarkers like ALDH1; Document B discusses CXCL1-driven chemoresistance/metastasis, not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692405Z"}
{"comparison_id":"dee730fa-958e-4823-968a-69895dbd92d2","query_id":"51","doc_a_id":"4702639","doc_b_id":"4418878","presented_order":["4418878","4702639"],"winner_id":"4418878","reasoning":"Document A is more relevant — it addresses gene expression signatures linked to prognosis and outcomes in cancers, which pertains to associations between marker expression (like ALDH1) and breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692411Z"}
{"comparison_id":"2a936480-7c5d-499a-85fa-51d3c7bc5319","query_id":"51","doc_a_id":"19673227","doc_b_id":"4418878","presented_order":["4418878","19673227"],"winner_id":"4418878","reasoning":"Document A is more relevant — it discusses gene expression signatures linked to prognosis and could include markers like ALDH1 affecting breast cancer outcomes. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692418Z"}
{"comparison_id":"23321b34-ec20-4801-a01d-bdf4814523ca","query_id":"51","doc_a_id":"4455466","doc_b_id":"4418878","presented_order":["4418878","4455466"],"winner_id":"4455466","reasoning":"Document B is more relevant — it discusses a specific gene's expression linked to breast cancer prognosis, which is closer to the claim about ALDH1 expression and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692424Z"}
{"comparison_id":"fffc7f15-5c09-4d5a-bf3b-aefc8f38fd09","query_id":"51","doc_a_id":"2931832","doc_b_id":"4418878","presented_order":["4418878","2931832"],"winner_id":"4418878","reasoning":"Document A is about gene expression signatures and their links to prognosis in cancers, which is directly relevant to a claim about expression of a specific marker (ALDH1). Document B concerns platelet metrics and is unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692431Z"}
{"comparison_id":"cca80c6f-dc1e-48df-8dec-f81b34670a61","query_id":"51","doc_a_id":"20127522","doc_b_id":"4418878","presented_order":["4418878","20127522"],"winner_id":"4418878","reasoning":"Reason: Document A concerns gene expression signatures and their links to prognosis in cancers, which is directly relevant to a claim about ALDH1 expression and breast cancer outcomes; Document B focuses on circulating tumor cells and treatment monitoring, not gene expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692439Z"}
{"comparison_id":"61e074f5-5b53-4c44-a5b4-e92dd409e530","query_id":"51","doc_a_id":"22975806","doc_b_id":"4418878","presented_order":["4418878","22975806"],"winner_id":"4418878","reasoning":"Document A is more relevant — it discusses gene expression signatures and their links to cancer prognosis and outcomes, which relates to ALDH1 expression as a prognostic marker. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692445Z"}
{"comparison_id":"70099308-0c91-4124-b56f-479d4ade49cd","query_id":"51","doc_a_id":"21033230","doc_b_id":"4418878","presented_order":["21033230","4418878"],"winner_id":"21033230","reasoning":"Document A is more relevant — it deals with molecular profiling and prognostic markers specifically in breast cancer, whereas B is a general methods paper. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692452Z"}
{"comparison_id":"0b2e8d17-724a-4bd6-918d-e94da07fd909","query_id":"51","doc_a_id":"34066665","doc_b_id":"4418878","presented_order":["34066665","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it discusses gene expression signatures and their links to cancer prognosis and therapy response, which directly relates to whether ALDH1 expression (a gene marker) associates with breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692460Z"}
{"comparison_id":"5b95b4c9-da62-4fce-99c4-d30f5c1f1960","query_id":"51","doc_a_id":"16086778","doc_b_id":"4418878","presented_order":["4418878","16086778"],"winner_id":"4418878","reasoning":"Document A is more relevant — it discusses gene expression signatures and their links to cancer prognosis, which pertains to whether a marker like ALDH1 correlates with breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692467Z"}
{"comparison_id":"0e9a70f9-3c1a-4c5f-ac5e-8fecb5356910","query_id":"51","doc_a_id":"24834968","doc_b_id":"4418878","presented_order":["24834968","4418878"],"winner_id":"4418878","reasoning":"Document B — it discusses gene expression signatures and prognosis in cancers, which is more relevant to a claim about a specific marker's association with breast cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692473Z"}
{"comparison_id":"d20df9ca-dffb-4039-a8af-26700e99f859","query_id":"51","doc_a_id":"20183360","doc_b_id":"4418878","presented_order":["4418878","20183360"],"winner_id":"4418878","reasoning":"Document A is more relevant — it discusses gene expression signatures and prognosis in cancers, which relates to ALDH1 expression and breast cancer outcomes. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692480Z"}
{"comparison_id":"b0787a2e-5648-4bee-ad43-9566f0ac8492","query_id":"51","doc_a_id":"5500086","doc_b_id":"4418878","presented_order":["5500086","4418878"],"winner_id":"4418878","reasoning":"B is more relevant — it addresses gene-expression signatures and their links to prognosis (which could include ALDH1), whereas A focuses on type I interferon signaling and chemotherapy response, not ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692487Z"}
{"comparison_id":"40f932d2-0f14-43d1-8401-ed1b27e0a3c8","query_id":"51","doc_a_id":"4889228","doc_b_id":"4418878","presented_order":["4889228","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it discusses gene expression signatures and their links to prognosis and treatment in cancers, which aligns with evaluating how a marker's (like ALDH1) expression associates with outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692495Z"}
{"comparison_id":"65b1992f-4253-451e-87ed-16a2b0ec3b82","query_id":"51","doc_a_id":"16691520","doc_b_id":"4418878","presented_order":["16691520","4418878"],"winner_id":"4418878","reasoning":"Document B — it concerns gene expression signatures and links pathway deregulation to prognosis and therapy response, so it's more likely to address ALDH1 expression and its association with breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692502Z"}
{"comparison_id":"086ae3eb-08d7-4516-848f-b051b1a12a20","query_id":"51","doc_a_id":"8891333","doc_b_id":"4418878","presented_order":["8891333","4418878"],"winner_id":"8891333","reasoning":"Document A is more focused on cancer stem cells in breast cancer (where ALDH1 is a known stem-cell marker) and therapy implications; Document B is a broad methods paper on pathway signatures. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692511Z"}
{"comparison_id":"d313e3e1-6b84-4645-963f-681e19e4fbe1","query_id":"51","doc_a_id":"2014909","doc_b_id":"4418878","presented_order":["2014909","4418878"],"winner_id":"2014909","reasoning":"Document A is more relevant — it analyzes tumor-initiating cells and primary breast cancers (ALDH1 is a tumor-initiating/cancer stem cell marker), so it’s more likely to address ALDH1 associations with outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692519Z"}
{"comparison_id":"e26ba821-746a-459f-8d15-030acef2b000","query_id":"51","doc_a_id":"20333864","doc_b_id":"4418878","presented_order":["20333864","4418878"],"winner_id":"4418878","reasoning":"Document B is more relevant — it discusses gene expression signatures and their link to prognosis, which is directly related to whether ALDH1 expression associates with breast cancer outcomes. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692526Z"}
{"comparison_id":"d01c02e6-274f-4c1b-a6d9-e82aae3573a7","query_id":"51","doc_a_id":"11484808","doc_b_id":"4418878","presented_order":["11484808","4418878"],"winner_id":"4418878","reasoning":"Reason: The query concerns a specific gene expression marker (ALDH1) and its association with breast cancer outcomes; Document B focuses on gene expression signatures and prognosis, making it more likely to address ALDH1's prognostic relevance than Document A, which centers on non-coding RNAs.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692534Z"}
{"comparison_id":"887c56b4-05e9-4bc9-8a5b-8fe41b9e7717","query_id":"51","doc_a_id":"22712546","doc_b_id":"4418878","presented_order":["22712546","4418878"],"winner_id":"22712546","reasoning":"Document A is more relevant — it focuses on in situ enzymatic activities and metabolic interactions in breast cancer tissue, which is more likely to address ALDH1 expression and outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692545Z"}
{"comparison_id":"7ac07f8e-1b29-4912-9655-e6fdeaea58e5","query_id":"51","doc_a_id":"825728","doc_b_id":"4418878","presented_order":["4418878","825728"],"winner_id":"825728","reasoning":"Document B is more directly about EMT, cancer stem‑cell properties and links to patient survival, which is more relevant to ALDH1 (a stem cell marker) and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:32:57.692552Z"}
{"comparison_id":"6654b5a0-1b4b-4cfd-9d2e-cc989b75fabb","query_id":"51","doc_a_id":"45638119","doc_b_id":"5579368","presented_order":["5579368","45638119"],"winner_id":"45638119","reasoning":"Document B is directly about ALDH1 in breast cancer and states it predicts poor clinical outcome, directly addressing the claim. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:07.679806Z"}
{"comparison_id":"35067d90-9649-4b1b-90b8-8983e60ce3f0","query_id":"51","doc_a_id":"8963413","doc_b_id":"5579368","presented_order":["8963413","5579368"],"winner_id":"8963413","reasoning":"Document A is more relevant — it discusses protein expression linked to clinical outcomes in breast cancer (though for PD-L1 rather than ALDH1), whereas B is a methods paper about methylation analysis without direct outcome evidence.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:07.679828Z"}
{"comparison_id":"c8e13c01-728c-47c6-914c-4ce3d3142987","query_id":"51","doc_a_id":"12762485","doc_b_id":"5579368","presented_order":["12762485","5579368"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses stem cell phenotypes in breast cancer (which relate to ALDH1 as a stem cell marker) and clinical correlations, while Document B is a methods paper on methylation analysis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:07.679837Z"}
{"comparison_id":"ad24643e-0b72-4905-9715-dde6f3d35952","query_id":"51","doc_a_id":"43385013","doc_b_id":"5579368","presented_order":["5579368","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it discusses stem cell/progenitor properties in breast cell subpopulations, which relates to ALDH1 as a stem cell marker; Document A describes a methylation analysis tool without direct evidence about ALDH1 or outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:07.679845Z"}
{"comparison_id":"bec7b6cd-1036-49ec-b1db-8e01870b5cdc","query_id":"51","doc_a_id":"18953920","doc_b_id":"5579368","presented_order":["5579368","18953920"],"winner_id":"18953920","reasoning":"Document B is more relevant — it discusses breast epithelial stem-cell markers and tumorigenic potential, which relates directly to ALDH1 as a stem-cell marker and its implications for breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:07.679852Z"}
{"comparison_id":"a2cf9186-6629-4ad2-bc6c-9c22ac711204","query_id":"51","doc_a_id":"825728","doc_b_id":"5579368","presented_order":["5579368","825728"],"winner_id":"5579368","reasoning":"Reason: Document A deals with breast cancer biomarkers and gene expression analysis, making it more likely to address ALDH1 expression and outcomes than Document B, which focuses on Prrx1 and metastasis mechanisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:07.679859Z"}
{"comparison_id":"42b5e7c7-6d60-41dd-b1e6-788f8cd3457f","query_id":"51","doc_a_id":"4455466","doc_b_id":"5579368","presented_order":["4455466","5579368"],"winner_id":"4455466","reasoning":"Document A is more relevant — it directly links gene expression level to breast cancer prognosis (though for ZMYND11, not ALDH1), whereas B describes a methylation analysis tool without direct prognosis findings. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:07.679867Z"}
{"comparison_id":"916ee393-90c4-4be5-a2e5-cb7001bd571a","query_id":"51","doc_a_id":"21033230","doc_b_id":"5579368","presented_order":["5579368","21033230"],"winner_id":"5579368","reasoning":"Document A is more relevant — it deals with gene expression and breast cancer biomarkers (integration of methylation and expression), which is more directly related to ALDH1 expression than the CTC marker study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:07.679874Z"}
{"comparison_id":"1f143eef-0c85-4ced-a9cc-08bd57d92c38","query_id":"51","doc_a_id":"8891333","doc_b_id":"5579368","presented_order":["5579368","8891333"],"winner_id":"8891333","reasoning":"Document B is more relevant — it discusses breast cancer stem cells and markers tied to treatment resistance and prognosis, which relates to ALDH1 as a stem-cell marker. Document A is a methods paper without direct evidence about ALDH1 or clinical outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:07.679881Z"}
{"comparison_id":"b858e970-2b3a-4526-a0ac-35efac871226","query_id":"51","doc_a_id":"2014909","doc_b_id":"5579368","presented_order":["5579368","2014909"],"winner_id":"5579368","reasoning":"Document A is more relevant — it deals with correlating gene expression and breast cancer biomarkers (useful for assessing markers like ALDH1). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:07.679888Z"}
{"comparison_id":"6d630db8-1aed-4662-bc78-830a9fdd8236","query_id":"51","doc_a_id":"22712546","doc_b_id":"5579368","presented_order":["5579368","22712546"],"winner_id":"5579368","reasoning":"Document A is more directly about breast cancer gene expression and biomarkers, including tools to correlate expression with outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:07.679894Z"}
{"comparison_id":"ee54e307-54fa-4bbd-851a-76cc8951dfa6","query_id":"51","doc_a_id":"45638119","doc_b_id":"43385013","presented_order":["43385013","45638119"],"winner_id":"45638119","reasoning":"Document B — it directly studies ALDH1 and reports it predicts poor clinical outcome in breast cancer, which directly addresses the claim. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:15.692568Z"}
{"comparison_id":"c2a80916-4b32-43d5-a100-09d485c6f599","query_id":"51","doc_a_id":"8963413","doc_b_id":"43385013","presented_order":["8963413","43385013"],"winner_id":"43385013","reasoning":"Document B — it discusses stem cell/progenitor properties in breast epithelial subpopulations (related to ALDH1 as a stem cell marker), whereas Document A is about PD-L1, not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:15.692590Z"}
{"comparison_id":"754247db-dfc1-44ed-a586-5828a2502c3a","query_id":"51","doc_a_id":"12762485","doc_b_id":"43385013","presented_order":["12762485","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it discusses stem cell/progenitor properties in breast cell subpopulations (ALDH1 is a stem cell marker), while A focuses on p53/ER status without addressing ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:15.692599Z"}
{"comparison_id":"0fa3b954-592d-4293-9c76-5f6660ccfec8","query_id":"51","doc_a_id":"8891333","doc_b_id":"43385013","presented_order":["43385013","8891333"],"winner_id":"8891333","reasoning":"Document B — it addresses cancer stem cells in breast cancer and their impact on therapy/resistance, which is more directly relevant to prognostic implications of a stem-cell marker like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:15.692606Z"}
{"comparison_id":"78ccd420-ae19-4c80-b1c1-bc48b621356a","query_id":"51","doc_a_id":"18953920","doc_b_id":"43385013","presented_order":["18953920","43385013"],"winner_id":"18953920","reasoning":"Document A — it links acquisition of stem-cell markers (like ALDH1) with increased tumorigenic potential, which is directly relevant to whether ALDH1 predicts outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:15.692614Z"}
{"comparison_id":"65099980-6f43-4847-b0f3-68347c3e51dd","query_id":"51","doc_a_id":"4455466","doc_b_id":"43385013","presented_order":["4455466","43385013"],"winner_id":"4455466","reasoning":"Document A is more relevant — it directly links gene expression levels to breast cancer prognosis, while B focuses on cell subpopulations/EMT without discussing clinical outcomes or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:15.692621Z"}
{"comparison_id":"925a941a-4a22-4004-9ca1-3b4687d015e1","query_id":"51","doc_a_id":"45638119","doc_b_id":"8891333","presented_order":["45638119","8891333"],"winner_id":"45638119","reasoning":"Document A is more relevant — it directly discusses ALDH1 expression and states it predicts poor clinical outcome in breast cancer, which directly addresses the query. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:22.320162Z"}
{"comparison_id":"dde026eb-e379-4f1f-8672-99f9d11aa30f","query_id":"51","doc_a_id":"4455466","doc_b_id":"8891333","presented_order":["8891333","4455466"],"winner_id":"8891333","reasoning":"Document A is more relevant — it discusses cancer stem cells in breast cancer (ALDH1 is a common cancer stem cell marker), whereas Document B focuses on ZMYND11 and not ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:22.320184Z"}
{"comparison_id":"9f12bd3e-66e2-4cb0-858d-46b7cfe99efb","query_id":"51","doc_a_id":"18953920","doc_b_id":"8891333","presented_order":["18953920","8891333"],"winner_id":"18953920","reasoning":"Document A is more relevant — it discusses breast (mammary) epithelial stem-cell markers and tumorigenic potential, which is closer to ALDH1 as a stem-cell marker and its link to outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:22.320192Z"}
{"comparison_id":"b0feda9a-36b7-459a-90c6-962b1f854a5c","query_id":"51","doc_a_id":"45638119","doc_b_id":"18953920","presented_order":["18953920","45638119"],"winner_id":"45638119","reasoning":"Document B — it directly addresses ALDH1 and states it predicts poor (not better) clinical outcome, which is directly relevant to the claim. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:25.284311Z"}
{"comparison_id":"7ff3f5e3-7e7b-4ef1-80e7-2bfaa43d8c70","query_id":"51","doc_a_id":"8963413","doc_b_id":"12762485","presented_order":["12762485","8963413"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses stem-cell phenotypes in breast cancer (ALDH1 is a known stem-cell marker), whereas Document B focuses on PD-L1, not ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:33.155179Z"}
{"comparison_id":"6a194fa2-a7ef-4690-b9c4-6f68d88e5311","query_id":"51","doc_a_id":"825728","doc_b_id":"21033230","presented_order":["21033230","825728"],"winner_id":"21033230","reasoning":"Document A is more relevant — it concerns molecular markers and prognosis in metastatic breast cancer, whereas Document B addresses EMT/Prrx1 and metastatic colonization without a clear link to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:44.235423Z"}
{"comparison_id":"1a923035-655a-49b3-921f-23a3fde39113","query_id":"51","doc_a_id":"22712546","doc_b_id":"21033230","presented_order":["21033230","22712546"],"winner_id":"22712546","reasoning":"Document B is more relevant — it focuses on in situ enzymatic/metabolic activity in breast cancer tissue, which is directly related to ALDH1 (an enzyme) expression, whereas A discusses CTC markers (EpCAM, MUC1, HER2) and not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:44.235444Z"}
{"comparison_id":"51ed4037-ab24-4c7e-b3ab-be0c1d6942b6","query_id":"51","doc_a_id":"2014909","doc_b_id":"21033230","presented_order":["2014909","21033230"],"winner_id":"2014909","reasoning":"Document A — it discusses tumor-initiating cells and analyses of primary breast cancers (ALDH1 is a tumor stem-cell marker), whereas B focuses on CTC markers (EpCAM, MUC1, HER2) and does not relate to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:44.235452Z"}
{"comparison_id":"24e42c8b-75b7-4497-a614-36ac1d4c6cbc","query_id":"51","doc_a_id":"22712546","doc_b_id":"2014909","presented_order":["22712546","2014909"],"winner_id":"22712546","reasoning":"Document A is more relevant — it profiles enzymatic activities in breast cancer tissue (potentially including ALDH1) and metabolic interactions linked to tumor cells, whereas B focuses on mTOR and immune recruitment without ALDH1 or outcomes. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:33:49.175905Z"}
{"comparison_id":"c425bf0c-8afd-493e-904b-c2637dc7994c","query_id":"51","doc_a_id":"22401720","doc_b_id":"20454006","presented_order":["20454006","22401720"],"winner_id":"22401720","reasoning":"Document B is more relevant — it examines tumor marker expression and links markers to prognosis, which is closer to the claim about ALDH1 and outcomes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206354Z"}
{"comparison_id":"765f9677-55dc-40b3-bacf-61d6d18bbdd4","query_id":"51","doc_a_id":"7821634","doc_b_id":"20454006","presented_order":["20454006","7821634"],"winner_id":"7821634","reasoning":"Document B is more relevant — it links a tumor biomarker (DUSP4) to chemotherapy response and outcomes in breast cancer, whereas Document A focuses on tamoxifen metabolism and does not address prognostic biomarkers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206387Z"}
{"comparison_id":"f199935e-b24e-45ca-ab25-5529765f4b2c","query_id":"51","doc_a_id":"4429932","doc_b_id":"20454006","presented_order":["4429932","20454006"],"winner_id":"4429932","reasoning":"Document A is more relevant — it discusses a biomarker (LOX) linked to breast cancer patient outcomes, which is closer to evaluating associations between marker expression and prognosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206400Z"}
{"comparison_id":"7d096395-3902-4d23-92dc-7eee115e8603","query_id":"51","doc_a_id":"24341590","doc_b_id":"20454006","presented_order":["24341590","20454006"],"winner_id":"24341590","reasoning":"Document A is more relevant — it links a biological marker (CYP2D6 activity) directly to breast cancer outcomes, whereas B reports metabolic effects of a supplement without outcome data. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206409Z"}
{"comparison_id":"cf3b2b21-8e69-4ac7-8de9-a6a643a327a6","query_id":"51","doc_a_id":"32001951","doc_b_id":"20454006","presented_order":["20454006","32001951"],"winner_id":"32001951","reasoning":"Document B — it's about regulation of enzyme expression in breast cancer cells, which is more closely related to a claim about a protein's expression and cancer outcomes than a trial of an estrogen-modulating supplement. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206418Z"}
{"comparison_id":"112450aa-5856-40f6-8653-88988e4376c8","query_id":"51","doc_a_id":"7583725","doc_b_id":"20454006","presented_order":["7583725","20454006"],"winner_id":"7583725","reasoning":"Reason: Document A addresses the association between a tumor marker's expression and breast cancer outcomes (though for TRPM7, not ALDH1), while Document B discusses a metabolic intervention and not expression-outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206427Z"}
{"comparison_id":"2e53aeaf-5ffc-4837-8cc3-f440561605f2","query_id":"51","doc_a_id":"15113221","doc_b_id":"20454006","presented_order":["20454006","15113221"],"winner_id":"15113221","reasoning":"Reason: Document B discusses gene expression signatures linked to prognosis in carcinoma, which is directly relevant to associations between marker expression and cancer outcomes; Document A is a treatment biomarker trial not addressing prognostic marker expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206436Z"}
{"comparison_id":"7db2be29-60fb-494f-b6fc-12ceb61cb2cf","query_id":"51","doc_a_id":"27240667","doc_b_id":"20454006","presented_order":["27240667","20454006"],"winner_id":"20454006","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it addresses biomarker modulation in breast cancer, whereas A covers mortality trends by ER status and age. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206444Z"}
{"comparison_id":"e1728ca2-a2de-405a-b638-948495fcc9d5","query_id":"51","doc_a_id":"16734530","doc_b_id":"20454006","presented_order":["20454006","16734530"],"winner_id":"16734530","reasoning":"Document B is more relevant — it examines associations between genetic biomarkers and breast cancer characteristics/outcomes, which is methodologically closer to an ALDH1 expression–outcome association than the intervention trial in Document A. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206453Z"}
{"comparison_id":"8e1a981a-c968-4ae4-92e0-30d49dce5801","query_id":"51","doc_a_id":"3285322","doc_b_id":"20454006","presented_order":["20454006","3285322"],"winner_id":"3285322","reasoning":"Document B — it addresses clinical and pathologic features and outcomes in breast cancer patients, which is more relevant to a claim about prognostic markers than a trial of a metabolic supplement. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206462Z"}
{"comparison_id":"1b497125-5fda-46a5-938a-260828d7e329","query_id":"51","doc_a_id":"20839751","doc_b_id":"20454006","presented_order":["20839751","20454006"],"winner_id":"20839751","reasoning":"Document A is more relevant — it addresses prognostic markers and their relationship to breast cancer outcomes, whereas B focuses on a metabolic intervention trial unrelated to ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206470Z"}
{"comparison_id":"3b07b946-dda8-4755-89cf-085febb06886","query_id":"51","doc_a_id":"13030852","doc_b_id":"20454006","presented_order":["13030852","20454006"],"winner_id":"20454006","reasoning":"Neither document mentions ALDH1 or its association with outcomes. Both are unrelated, but Document B is slightly more relevant since it addresses breast cancer biomarker modulation. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206478Z"}
{"comparison_id":"d91ff8a5-d06f-48ee-868d-222b1b6001fe","query_id":"51","doc_a_id":"9600826","doc_b_id":"20454006","presented_order":["9600826","20454006"],"winner_id":"9600826","reasoning":"Document A is more focused on molecular expression and pathways tied to breast cancer behavior and outcomes, while Document B deals with tamoxifen-related metabolic biomarkers unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206486Z"}
{"comparison_id":"8154c79e-7a3a-4b94-a326-ab8cd4836fc0","query_id":"51","doc_a_id":"1171121","doc_b_id":"20454006","presented_order":["20454006","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant — it examines prognostic biomarkers and associations with disease-free survival, whereas A addresses tamoxifen metabolism and BR-DIM without prognostic biomarker data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206495Z"}
{"comparison_id":"d86d54df-4a75-4321-a813-078dec25cb62","query_id":"51","doc_a_id":"25732836","doc_b_id":"20454006","presented_order":["20454006","25732836"],"winner_id":"25732836","reasoning":"Document B is more relevant — it addresses prognostic markers and outcome prediction in breast cancer, whereas Document A focuses on an intervention's effects on estrogen metabolism and tamoxifen metabolites. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206503Z"}
{"comparison_id":"287af6e8-6944-4edf-ac8a-5610c6de88cd","query_id":"51","doc_a_id":"25973484","doc_b_id":"20454006","presented_order":["20454006","25973484"],"winner_id":"25973484","reasoning":"Reason: Document B discusses breast cancer prognosis and tumor phenotypes (factors affecting outcomes), so it's more likely to address biomarkers related to outcomes than Document A, which focuses on a tamoxifen–DIM trial and estrogen metabolism.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206512Z"}
{"comparison_id":"b4dab5c9-cdf9-47dc-9fbc-e5b1db8b17f6","query_id":"51","doc_a_id":"24249915","doc_b_id":"20454006","presented_order":["24249915","20454006"],"winner_id":"24249915","reasoning":"Document A is more relevant — it addresses changes in receptor expression between normal and invasive breast cancer (expression linked to disease state), whereas Document B concerns a supplement trial and estrogen metabolism, not ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206521Z"}
{"comparison_id":"1b3f6c08-8995-4c48-a0e5-bba6b01af124","query_id":"51","doc_a_id":"313403","doc_b_id":"20454006","presented_order":["313403","20454006"],"winner_id":"313403","reasoning":"Document A is more relevant — it discusses a biomarker (TAM infiltration) linked to breast cancer prognosis, whereas Document B is a trial of a metabolic agent and tamoxifen unrelated to ALDH1 expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206530Z"}
{"comparison_id":"f89286b3-893b-4cbb-9e2c-66c9311672b0","query_id":"51","doc_a_id":"1389264","doc_b_id":"20454006","presented_order":["1389264","20454006"],"winner_id":"20454006","reasoning":"Document B is more relevant — it addresses biomarker modulation in breast cancer patients, whereas A focuses on preclinical therapy for HER2-positive brain metastases and not biomarker expression like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206538Z"}
{"comparison_id":"b7a9bff0-2ecf-4f93-b59a-03fa1a87e975","query_id":"51","doc_a_id":"22509015","doc_b_id":"20454006","presented_order":["20454006","22509015"],"winner_id":"20454006","reasoning":"Document A is more relevant because it directly studies breast cancer biomarkers, whereas Document B focuses on WNT signaling and metastasis; neither specifically mentions ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206545Z"}
{"comparison_id":"81567b1a-2292-481e-8cf4-2d4b612d5d8d","query_id":"51","doc_a_id":"11484808","doc_b_id":"20454006","presented_order":["20454006","11484808"],"winner_id":"11484808","reasoning":"Document B is more relevant — it reviews molecular biomarkers and their clinical implications in endocrine cancers, making it more likely to address associations like ALDH1 and outcomes; Document A focuses on a DIM/tamoxifen trial without ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206555Z"}
{"comparison_id":"0cff6a8a-5e09-41ae-9177-c56fb720c1f7","query_id":"51","doc_a_id":"27123743","doc_b_id":"20454006","presented_order":["27123743","20454006"],"winner_id":"27123743","reasoning":"Document A is more relevant — it discusses birthweight-linked mechanisms involving stem cells in breast cancer etiology, which is closer to ALDH1 (a stem cell marker) than the tamoxifen/DIM metabolism trial in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206564Z"}
{"comparison_id":"dfafa651-0d78-454b-848f-d052316176cd","query_id":"51","doc_a_id":"22482820","doc_b_id":"20454006","presented_order":["20454006","22482820"],"winner_id":"22482820","reasoning":"Document B is more relevant — it's a broad review of breast cancer classifications and therapies (more likely to discuss biomarkers like ALDH1 and their outcome associations), whereas A focuses narrowly on tamoxifen metabolism and doesn't mention ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206573Z"}
{"comparison_id":"d4c334fe-1251-446e-ba86-adc9bce9a84b","query_id":"51","doc_a_id":"19358586","doc_b_id":"20454006","presented_order":["19358586","20454006"],"winner_id":"19358586","reasoning":"Document A links protein expression signatures to survival in breast cancer, so it's more relevant to a claim about marker expression and outcomes. Document B concerns a DIM–tamoxifen trial unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206581Z"}
{"comparison_id":"106ff2c4-68e2-4cd6-8de6-77a8bb7a10c5","query_id":"51","doc_a_id":"1866911","doc_b_id":"20454006","presented_order":["1866911","20454006"],"winner_id":"1866911","reasoning":"Document A is more relevant — it discusses mammary progenitor cell populations and markers related to tumor origin, which is closer to ALDH1's role as a stem/progenitor marker. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206589Z"}
{"comparison_id":"6a52be3d-68fe-4263-9258-0a90da265dd6","query_id":"51","doc_a_id":"31311495","doc_b_id":"20454006","presented_order":["20454006","31311495"],"winner_id":"31311495","reasoning":"Document B is more relevant — it discusses tumor aggressiveness and markers linked to prognosis (EMT and tamoxifen resistance), whereas A focuses on estrogen metabolism and tamoxifen metabolites without biomarker/outcome markers like ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206597Z"}
{"comparison_id":"a5d74491-a736-4a11-8b81-ea4917bffabe","query_id":"51","doc_a_id":"12438901","doc_b_id":"20454006","presented_order":["20454006","12438901"],"winner_id":"20454006","reasoning":"Document A is more relevant — it deals with breast cancer biomarkers and their modulation, whereas Document B focuses on treatment duration outcomes without addressing biomarker expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206604Z"}
{"comparison_id":"4bcf1495-6f29-47dc-804d-a3f8ddbe98bd","query_id":"51","doc_a_id":"15946643","doc_b_id":"20454006","presented_order":["15946643","20454006"],"winner_id":"15946643","reasoning":"Document A is more relevant — it addresses tumor biology, chemoresistance and metastasis which are directly related to markers tied to breast cancer outcomes; Document B focuses on tamoxifen metabolism and not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206613Z"}
{"comparison_id":"49e18885-2a80-4199-875c-ff8b5cf29c04","query_id":"51","doc_a_id":"4702639","doc_b_id":"20454006","presented_order":["20454006","4702639"],"winner_id":"4702639","reasoning":"Document B is more relevant — it addresses tumour stemness and markers related to cancer stem cells, which is directly related to ALDH1's role as a stem-cell marker; Document A is about tamoxifen/DIM and estrogen metabolism and does not mention ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206622Z"}
{"comparison_id":"c80c34da-9bc7-4a8b-a906-4b6fbbbb6c94","query_id":"51","doc_a_id":"19673227","doc_b_id":"20454006","presented_order":["20454006","19673227"],"winner_id":"19673227","reasoning":"Document B is more relevant — it addresses prognostic/predictive biomarkers and correlations with disease-free survival and time to progression, which relate to associations between marker expression and breast cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206630Z"}
{"comparison_id":"d04fc598-b150-4ec1-9740-bd64945c9bee","query_id":"51","doc_a_id":"2931832","doc_b_id":"20454006","presented_order":["2931832","20454006"],"winner_id":"2931832","reasoning":"Document A is more relevant because it addresses prognostic biomarkers and associations with disease-free survival in breast cancer, which is closer to the claim about marker-expression and outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206638Z"}
{"comparison_id":"d0b4aeac-dd6a-42b0-ad4c-384f86664e97","query_id":"51","doc_a_id":"20127522","doc_b_id":"20454006","presented_order":["20127522","20454006"],"winner_id":"20127522","reasoning":"Document A is more relevant — it examines a cancer biomarker (CTC levels) linked to patient outcomes, which is more closely related to testing whether a marker like ALDH1 associates with prognosis than Document B's metabolic/tamoxifen biomarker trial.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206646Z"}
{"comparison_id":"030b8f87-043a-4c3c-822b-00a11aa014c2","query_id":"51","doc_a_id":"22975806","doc_b_id":"20454006","presented_order":["22975806","20454006"],"winner_id":"20454006","reasoning":"Document B is more relevant — it addresses biomarker modulation and treatment effects in breast cancer patients, whereas A focuses on BRCA allele loss in tumorigenesis and does not concern biomarker expression or outcomes like ALDH1.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206655Z"}
{"comparison_id":"1b93af7e-54c5-46d4-89b9-d81852f2bbcc","query_id":"51","doc_a_id":"34066665","doc_b_id":"20454006","presented_order":["34066665","20454006"],"winner_id":"34066665","reasoning":"Neither document mentions ALDH1. Document A is slightly more relevant because it discusses molecular markers and signaling pathways related to breast cancer outcomes and therapy resistance, whereas Document B focuses narrowly on a tamoxifen + DIM biomarker trial.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206664Z"}
{"comparison_id":"a4a3f50b-fef5-452f-afa5-ddec4a9441f2","query_id":"51","doc_a_id":"16086778","doc_b_id":"20454006","presented_order":["20454006","16086778"],"winner_id":"16086778","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it addresses pathways (Numb/Notch) tied to tumor progression and prognosis, whereas A focuses on tamoxifen metabolism.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206672Z"}
{"comparison_id":"53bcfb22-f8bc-4609-8b6c-49b745e13557","query_id":"51","doc_a_id":"24834968","doc_b_id":"20454006","presented_order":["20454006","24834968"],"winner_id":"24834968","reasoning":"Document B is more relevant — it evaluates biological markers in breast cancer (where ALDH1 would be categorized), whereas Document A focuses on a supplement's effect on estrogen metabolism and tamoxifen metabolites. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206680Z"}
{"comparison_id":"c0fb2f98-9534-4bce-a4c3-110fa4729059","query_id":"51","doc_a_id":"20183360","doc_b_id":"20454006","presented_order":["20454006","20183360"],"winner_id":"20183360","reasoning":"Document B is more relevant — it addresses mechanisms (invasion, factors influencing tumor progression) tied to breast cancer prognosis, whereas A focuses on tamoxifen metabolism and biomarkers unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206688Z"}
{"comparison_id":"d7d77b65-5d57-451f-8192-fe42db44bf43","query_id":"51","doc_a_id":"5500086","doc_b_id":"20454006","presented_order":["5500086","20454006"],"winner_id":"5500086","reasoning":"Reason: Neither abstract mentions ALDH1, but Document A discusses a biomarker signature linked to better breast cancer outcomes, making it more relevant than B (which focuses on tamoxifen metabolism).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206696Z"}
{"comparison_id":"238cd0ce-d5bb-404c-b112-b03852e5e2a2","query_id":"51","doc_a_id":"4889228","doc_b_id":"20454006","presented_order":["4889228","20454006"],"winner_id":"4889228","reasoning":"Document A — it discusses expression of a molecular marker correlated with prognosis in breast cancer, which is more on-topic than the tamoxifen biomarker trial in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206704Z"}
{"comparison_id":"b254db53-dfe6-4de7-b170-ca86c464aa85","query_id":"51","doc_a_id":"16691520","doc_b_id":"20454006","presented_order":["20454006","16691520"],"winner_id":"16691520","reasoning":"Document B is more relevant — a genome-wide study of estrogen receptor target genes is more likely to address gene expression (including ALDH1) and its links to breast cancer outcomes than a tamoxifen/DIM metabolism trial. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206712Z"}
{"comparison_id":"9fc28cfc-e9d3-4c4e-a49a-6e5583d441e0","query_id":"51","doc_a_id":"20333864","doc_b_id":"20454006","presented_order":["20333864","20454006"],"winner_id":"20333864","reasoning":"Document A is more relevant — it addresses tumor progression and factors affecting invasive behavior and prognosis, whereas Document B focuses on a drug trial and estrogen metabolism without relating to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:13.206720Z"}
{"comparison_id":"3dc3f358-0f67-4a86-b014-a937bf228b09","query_id":"51","doc_a_id":"22401720","doc_b_id":"27123743","presented_order":["22401720","27123743"],"winner_id":"22401720","reasoning":"Reason: Document A discusses molecular markers expressed in breast tumors and their relation to prognosis, making it more relevant to a claim about a tumor marker's association with outcomes than a paper on birthweight and risk.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234107Z"}
{"comparison_id":"70e82730-8249-4d88-8fdb-00034c215fca","query_id":"51","doc_a_id":"7821634","doc_b_id":"27123743","presented_order":["7821634","27123743"],"winner_id":"7821634","reasoning":"Document A is more relevant — it discusses factors (DUSP4, chemotherapy response) tied to breast cancer outcomes, whereas Document B addresses birthweight and cancer risk rather than prognosis or biomarkers like ALDH1.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234130Z"}
{"comparison_id":"15b4a61f-23ba-42a7-8680-652c63b13eba","query_id":"51","doc_a_id":"4429932","doc_b_id":"27123743","presented_order":["27123743","4429932"],"winner_id":"27123743","reasoning":"Document A is slightly more relevant — it discusses breast cancer risk and stem-cell–related mechanisms, whereas Document B focuses on LOX and metastasis without relation to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234138Z"}
{"comparison_id":"921586c7-1b16-4801-b2cc-5755f20304eb","query_id":"51","doc_a_id":"24341590","doc_b_id":"27123743","presented_order":["27123743","24341590"],"winner_id":"24341590","reasoning":"Document B is more relevant — it deals with genetic markers linked to breast cancer outcomes, whereas A discusses birthweight and risk, not biomarker expression or outcome associations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234146Z"}
{"comparison_id":"afadebdc-a096-4945-b351-dae2f73a1148","query_id":"51","doc_a_id":"32001951","doc_b_id":"27123743","presented_order":["27123743","32001951"],"winner_id":"32001951","reasoning":"Document B — it concerns regulation of enzyme expression in breast cancer cells (more related to marker-expression and outcomes) while Document A discusses birthweight and cancer risk, which is unrelated. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234153Z"}
{"comparison_id":"07748d0f-fba7-4959-9366-8a67ff0312f3","query_id":"51","doc_a_id":"7583725","doc_b_id":"27123743","presented_order":["27123743","7583725"],"winner_id":"7583725","reasoning":"Document B — it discusses how expression of a specific protein (TRPM7) relates to breast cancer outcomes, which is conceptually closer to a claim about ALDH1 expression and outcomes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234160Z"}
{"comparison_id":"abf11063-e6e4-4fe0-bfcf-ad360a171ddc","query_id":"51","doc_a_id":"15113221","doc_b_id":"27123743","presented_order":["27123743","15113221"],"winner_id":"15113221","reasoning":"Document B — it concerns gene expression signatures linked to prognosis, which is more relevant to a claim about a marker's association with breast cancer outcomes than a paper about birthweight and risk.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234168Z"}
{"comparison_id":"3348b69b-ee30-4b3b-b9d5-db48957965ff","query_id":"51","doc_a_id":"16734530","doc_b_id":"27123743","presented_order":["16734530","27123743"],"winner_id":"16734530","reasoning":"Document A discusses genetic/molecular factors and clinicopathologic features of breast cancer (ER status, nodal involvement), which is closer to biomarker-associated outcomes than B's focus on birthweight and risk. Neither mentions ALDH1, but A is more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234176Z"}
{"comparison_id":"948aaf49-8047-41a1-b749-4663a9a1e1c0","query_id":"51","doc_a_id":"3285322","doc_b_id":"27123743","presented_order":["27123743","3285322"],"winner_id":"27123743","reasoning":"Document A is marginally more relevant because it discusses stem cells and growth-factor mechanisms linked to breast cancer, which relates to ALDH1 as a stem-cell marker. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234183Z"}
{"comparison_id":"9262dc8c-99c1-4fab-9936-4683d5f6a935","query_id":"51","doc_a_id":"20839751","doc_b_id":"27123743","presented_order":["27123743","20839751"],"winner_id":"20839751","reasoning":"Document B — it discusses pathological markers and prognosis in breast cancer, so it's nearer to a claim about factors associated with outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234190Z"}
{"comparison_id":"58083cf0-948f-4a44-accf-f278f613f025","query_id":"51","doc_a_id":"9600826","doc_b_id":"27123743","presented_order":["27123743","9600826"],"winner_id":"9600826","reasoning":"Document B — it discusses molecular pathways tied to breast cancer invasion and progression (more related to outcomes), whereas A addresses birthweight and risk rather than prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234197Z"}
{"comparison_id":"2dfdd643-7aa9-47d4-a365-972283424832","query_id":"51","doc_a_id":"1171121","doc_b_id":"27123743","presented_order":["27123743","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant — it examines tumor biomarker expression and associations with disease-free survival in breast cancer, which is closer to the claim about a marker (ALDH1) and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234205Z"}
{"comparison_id":"9dae68b4-7c0a-4334-935c-edb1a43127c0","query_id":"51","doc_a_id":"25732836","doc_b_id":"27123743","presented_order":["25732836","27123743"],"winner_id":"27123743","reasoning":"Document B — it discusses birthweight, growth factors and effects on stem cells in breast cancer etiology, which is more related to ALDH1 (a stem-cell marker) than the imaging/CTC prognostic focus of Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234212Z"}
{"comparison_id":"ee8a317a-2237-49bf-9aee-e10fc4606ddc","query_id":"51","doc_a_id":"25973484","doc_b_id":"27123743","presented_order":["27123743","25973484"],"winner_id":"25973484","reasoning":"Neither document discusses ALDH1. DOCUMENT B is slightly more relevant because it addresses breast cancer prognosis and tumor phenotypes, which relate to outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234219Z"}
{"comparison_id":"f92d19e5-2f37-4064-8cf3-2ef3809abd34","query_id":"51","doc_a_id":"24249915","doc_b_id":"27123743","presented_order":["24249915","27123743"],"winner_id":"24249915","reasoning":"Document A is more relevant — it discusses expression of a molecular marker in breast cancer, whereas B addresses birthweight-related risk factors not marker expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234225Z"}
{"comparison_id":"30bd02b8-e24e-4ff4-bde3-71ec560122c7","query_id":"51","doc_a_id":"313403","doc_b_id":"27123743","presented_order":["313403","27123743"],"winner_id":"313403","reasoning":"Document A is more relevant — it addresses prognostic markers in breast cancer (tumor microenvironment and outcomes), whereas Document B discusses birthweight and cancer risk mechanisms unrelated to ALDH1 expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234233Z"}
{"comparison_id":"172cd1f4-3977-433e-8d00-592df0be106d","query_id":"51","doc_a_id":"11484808","doc_b_id":"27123743","presented_order":["11484808","27123743"],"winner_id":"11484808","reasoning":"Document A is more relevant — it discusses biomarkers and clinical implications in endocrine-related cancers (including breast cancer), which is closer to evidence about ALDH1 expression and outcomes than a paper on birthweight. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234240Z"}
{"comparison_id":"df530cdc-8d83-4010-9037-2fcd0508aa7f","query_id":"51","doc_a_id":"20333864","doc_b_id":"27123743","presented_order":["20333864","27123743"],"winner_id":"20333864","reasoning":"Document A discusses mechanisms of breast cancer progression and factors influencing invasive behavior, which is more directly related to outcomes than Document B's focus on birthweight risk. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234247Z"}
{"comparison_id":"5029ed40-db7d-4122-94ec-fe3d12638730","query_id":"51","doc_a_id":"22482820","doc_b_id":"27123743","presented_order":["27123743","22482820"],"winner_id":"22482820","reasoning":"Document B is more relevant — it discusses breast cancer classification and biomarkers related to treatment response, which is closer to a claim about a marker's prognostic association than a paper on birthweight. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234254Z"}
{"comparison_id":"074922a3-2160-44d3-80fd-8427f572e0f4","query_id":"51","doc_a_id":"19358586","doc_b_id":"27123743","presented_order":["19358586","27123743"],"winner_id":"19358586","reasoning":"Document A — it discusses protein signatures and survival in breast cancer, which is more related to marker expression and outcomes than the birthweight etiology review.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234261Z"}
{"comparison_id":"d7d46c70-22a3-4fe2-b07e-2930f528e3ee","query_id":"51","doc_a_id":"1866911","doc_b_id":"27123743","presented_order":["1866911","27123743"],"winner_id":"1866911","reasoning":"Document A is more related — it discusses breast epithelial progenitor cell populations and tumor markers relevant to ALDH1's role in cancer, whereas Document B concerns birthweight and cancer risk mechanisms. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234268Z"}
{"comparison_id":"b5a50f0e-36cc-4fcf-b65e-6d8098bdb941","query_id":"51","doc_a_id":"31311495","doc_b_id":"27123743","presented_order":["31311495","27123743"],"winner_id":"31311495","reasoning":"Document A is more relevant — it addresses molecular changes and tumor aggressiveness in breast cancer (markers/EMT-related pathways), whereas Document B covers birthweight and epidemiology; neither mentions ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234275Z"}
{"comparison_id":"8db1fd92-4d50-4cd6-a2b7-04e5199cdeb7","query_id":"51","doc_a_id":"15946643","doc_b_id":"27123743","presented_order":["15946643","27123743"],"winner_id":"15946643","reasoning":"Document A is more relevant — it addresses molecular mechanisms and chemoresistance/metastasis in breast cancer, which is closer to discussions of biomarkers like ALDH1 than a birthweight–risk review.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234282Z"}
{"comparison_id":"814a8582-205d-4c2e-b4e8-d5525e088156","query_id":"51","doc_a_id":"4702639","doc_b_id":"27123743","presented_order":["27123743","4702639"],"winner_id":"4702639","reasoning":"Document B — it addresses tumor stemness and markers related to cancer stem cells and therapy resistance, which is more relevant to ALDH1's role in breast cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234289Z"}
{"comparison_id":"1cf0ed65-8389-4366-814e-5f80074ce405","query_id":"51","doc_a_id":"19673227","doc_b_id":"27123743","presented_order":["19673227","27123743"],"winner_id":"19673227","reasoning":"Document A is more relevant — it concerns prognostic/predictive biomarkers and outcomes in cancer, whereas B focuses on birthweight and breast cancer risk mechanisms unrelated to ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234296Z"}
{"comparison_id":"763dd129-54a0-4926-827e-033cb8b9ed3a","query_id":"51","doc_a_id":"2931832","doc_b_id":"27123743","presented_order":["2931832","27123743"],"winner_id":"2931832","reasoning":"Document A is more relevant — it discusses prognostic biomarkers and outcomes in breast cancer, which relates to ALDH1's proposed association with outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234303Z"}
{"comparison_id":"ee522fbb-3a24-4f83-85be-c24696506c56","query_id":"51","doc_a_id":"20127522","doc_b_id":"27123743","presented_order":["20127522","27123743"],"winner_id":"20127522","reasoning":"Document A is more relevant — it addresses biomarkers and breast cancer outcomes, whereas Document B discusses birthweight and risk mechanisms unrelated to ALDH1 or outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234310Z"}
{"comparison_id":"a7092d2d-6916-4c2b-8c27-0121738c70e2","query_id":"51","doc_a_id":"34066665","doc_b_id":"27123743","presented_order":["34066665","27123743"],"winner_id":"34066665","reasoning":"Document A is more relevant — it discusses breast cancer molecular signaling and therapy resistance, which is closer to biomarkers like ALDH1 and outcomes than birthweight etiology.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234317Z"}
{"comparison_id":"012ee2f9-f833-4681-9de0-15f6fefc1d04","query_id":"51","doc_a_id":"16086778","doc_b_id":"27123743","presented_order":["16086778","27123743"],"winner_id":"16086778","reasoning":"Document A is more relevant — it addresses molecular pathways (Notch/Numb) involved in breast cancer biology that could relate to markers like ALDH1, whereas Document B discusses birthweight epidemiology with only indirect mention of stem cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234324Z"}
{"comparison_id":"eaac8b00-7ff8-427d-a2f3-65d8ec0887ca","query_id":"51","doc_a_id":"24834968","doc_b_id":"27123743","presented_order":["27123743","24834968"],"winner_id":"24834968","reasoning":"Document B is more relevant — it examines biological markers and treatment response in breast cancer, whereas A addresses birthweight and cancer risk mechanisms. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234331Z"}
{"comparison_id":"196483d2-6472-43b1-bd41-6276cf85bb6d","query_id":"51","doc_a_id":"20183360","doc_b_id":"27123743","presented_order":["27123743","20183360"],"winner_id":"20183360","reasoning":"Document B is more relevant — it addresses molecular mechanisms and tumour cell behavior related to breast cancer outcomes, whereas Document A focuses on birthweight and epidemiology. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234338Z"}
{"comparison_id":"9fbf8321-6608-4e00-b1e6-472622f3b336","query_id":"51","doc_a_id":"5500086","doc_b_id":"27123743","presented_order":["27123743","5500086"],"winner_id":"5500086","reasoning":"Document B is more relevant — it discusses molecular signals and a tumor signature that correlate with breast cancer outcomes, whereas Document A focuses on birthweight and cancer risk without molecular markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234346Z"}
{"comparison_id":"d1c92394-c650-4b18-ae48-d30d5cb24a86","query_id":"51","doc_a_id":"4889228","doc_b_id":"27123743","presented_order":["27123743","4889228"],"winner_id":"27123743","reasoning":"Reason: Document A discusses stem-cell–related mechanisms in breast cancer etiology (more related to ALDH1, a stem cell marker), while Document B focuses on splicing factors in TNBC with no link to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234354Z"}
{"comparison_id":"cbf27844-57a6-4474-8204-a85dae1cbb24","query_id":"51","doc_a_id":"16691520","doc_b_id":"27123743","presented_order":["27123743","16691520"],"winner_id":"27123743","reasoning":"Reason: Document A discusses stem cells and growth-factor–related mechanisms in breast cancer etiology, which is more related to ALDH1 (a stem cell marker) than Document B's focus on estrogen receptor binding sites.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:31.234361Z"}
{"comparison_id":"3f6d6f5c-1f7d-4419-ab6c-007e9e7bb272","query_id":"51","doc_a_id":"22401720","doc_b_id":"20333864","presented_order":["20333864","22401720"],"winner_id":"22401720","reasoning":"Document B discusses expression of factors and their links to prognosis in breast cancer, so it's more relevant to a claim about marker expression and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590185Z"}
{"comparison_id":"34d7e161-70af-40bc-9af8-9bcd8043376f","query_id":"51","doc_a_id":"7821634","doc_b_id":"20333864","presented_order":["7821634","20333864"],"winner_id":"7821634","reasoning":"Document A is more relevant — it examines how expression levels (DUSP4) correlate with treatment response and outcomes in breast cancer, which is closer to the claim about ALDH1 expression and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590209Z"}
{"comparison_id":"8972a2a1-5ce4-40dc-87be-045b382604ac","query_id":"51","doc_a_id":"24341590","doc_b_id":"20333864","presented_order":["24341590","20333864"],"winner_id":"20333864","reasoning":"Document B is more relevant — it addresses cellular and molecular factors in tumor progression and cell differentiation, which is closer to ALDH1's role as a cancer/stem cell marker than a tamoxifen metabolism pharmacogenetics study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590218Z"}
{"comparison_id":"5bbdb38c-4ece-4c1d-ae90-b661695c5056","query_id":"51","doc_a_id":"32001951","doc_b_id":"20333864","presented_order":["32001951","20333864"],"winner_id":"20333864","reasoning":"Document B — it addresses factors affecting tumor progression and invasion (which relate to clinical outcomes), whereas Document A only studies alkaline phosphatase regulation in a cell line and is unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590226Z"}
{"comparison_id":"b3119cae-cd49-4d98-97b8-f8cb3e6a28d7","query_id":"51","doc_a_id":"7583725","doc_b_id":"20333864","presented_order":["7583725","20333864"],"winner_id":"7583725","reasoning":"Document A is more relevant — it discusses a molecular marker (TRPM7) that predicts patient outcomes, so it relates to the claim about marker expression and breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590233Z"}
{"comparison_id":"8e5c0f78-5e81-4cdf-8ec2-b61863a56c1b","query_id":"51","doc_a_id":"15113221","doc_b_id":"20333864","presented_order":["15113221","20333864"],"winner_id":"20333864","reasoning":"Document B — it discusses cellular markers and tumor cell differentiation relevant to markers like ALDH1 and tumor behavior, whereas A focuses on PTEN pathway signatures unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590242Z"}
{"comparison_id":"950e7218-bdc1-4d76-9f95-08662a79cd3a","query_id":"51","doc_a_id":"16734530","doc_b_id":"20333864","presented_order":["16734530","20333864"],"winner_id":"20333864","reasoning":"Document B is more relevant — it discusses cellular and molecular factors influencing tumor progression and outcome (invasion), which is closer to biomarker–outcome relationships than a paper on ORAI1 SNPs.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590249Z"}
{"comparison_id":"63918ba5-6f96-400f-a895-0c9ecdd2cfaf","query_id":"51","doc_a_id":"20839751","doc_b_id":"20333864","presented_order":["20839751","20333864"],"winner_id":"20839751","reasoning":"Document A — it discusses prognostic associations in breast cancer (outcomes), whereas Document B focuses on cellular mechanisms of invasion and doesn't address prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590256Z"}
{"comparison_id":"d6cbf94e-6947-461f-a06c-a6a3341cbf16","query_id":"51","doc_a_id":"9600826","doc_b_id":"20333864","presented_order":["9600826","20333864"],"winner_id":"20333864","reasoning":"Document B is more relevant — it discusses cellular and molecular factors controlling progression and prognosis in breast cancer (more likely to relate to biomarkers like ALDH1), while Document A focuses on a VEGFR2-activated angiogenesis pathway unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590264Z"}
{"comparison_id":"98be6520-99d7-48d2-93cf-86a88d821d38","query_id":"51","doc_a_id":"1171121","doc_b_id":"20333864","presented_order":["20333864","1171121"],"winner_id":"1171121","reasoning":"Document B — it addresses prognostic factors and clinical outcomes in breast cancer, which is more directly relevant to a claim about ALDH1 and patient outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590271Z"}
{"comparison_id":"b71e28e3-69e6-4f3c-8373-a9fa7a17dcab","query_id":"51","doc_a_id":"25973484","doc_b_id":"20333864","presented_order":["25973484","20333864"],"winner_id":"20333864","reasoning":"Document B — it discusses molecular markers and cellular regulators of tumor progression, which is more relevant to a claim about ALDH1 expression and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590278Z"}
{"comparison_id":"d557b07f-bc2e-4cc7-b4bd-be0eccf3f0e8","query_id":"51","doc_a_id":"24249915","doc_b_id":"20333864","presented_order":["20333864","24249915"],"winner_id":"20333864","reasoning":"Neither document mentions ALDH1. Document A is slightly more relevant because it addresses factors driving progression/invasion and tumor outcome, whereas B only discusses ERβ methylation. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590285Z"}
{"comparison_id":"09aab41a-87e8-43fc-a71b-e9f30c1f3798","query_id":"51","doc_a_id":"313403","doc_b_id":"20333864","presented_order":["313403","20333864"],"winner_id":"313403","reasoning":"Document A is more relevant — it discusses clinical outcomes and prognostic markers in breast cancer, whereas Document B focuses on mechanisms of DCIS-to-invasive transition and not on prognosis or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590292Z"}
{"comparison_id":"c6889400-8af6-4239-8628-dfd99d2d2e19","query_id":"51","doc_a_id":"11484808","doc_b_id":"20333864","presented_order":["20333864","11484808"],"winner_id":"20333864","reasoning":"Document A is more directly about breast cancer biology and progression, whereas Document B focuses on ncRNAs across endocrine-related cancers and is less specific to breast cancer markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590300Z"}
{"comparison_id":"735da537-d881-4128-a48f-e14033c91da1","query_id":"51","doc_a_id":"5500086","doc_b_id":"20333864","presented_order":["20333864","5500086"],"winner_id":"5500086","reasoning":"Document B — it links a molecular signature to positive clinical outcomes in breast cancer, whereas Document A focuses on cellular roles in DCIS-to-invasive transition and doesn't address clinical outcome markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590307Z"}
{"comparison_id":"e6328abe-9964-424a-a1d6-26d9b4b15c8c","query_id":"51","doc_a_id":"22482820","doc_b_id":"20333864","presented_order":["20333864","22482820"],"winner_id":"20333864","reasoning":"Neither document addresses ALDH1 or its association with outcomes. Document A is slightly more relevant because it discusses molecular factors in tumor progression, whereas B focuses on treatment strategies.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590315Z"}
{"comparison_id":"c751f7e6-907f-4fb9-91c4-7bfd56980c67","query_id":"51","doc_a_id":"19358586","doc_b_id":"20333864","presented_order":["19358586","20333864"],"winner_id":"19358586","reasoning":"Document A is more relevant — it discusses protein signatures linked to survival in breast cancer, so it's closer to the claim about ALDH1 and outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590321Z"}
{"comparison_id":"d28db14d-865b-4e12-9026-fd7740a0ed19","query_id":"51","doc_a_id":"1866911","doc_b_id":"20333864","presented_order":["1866911","20333864"],"winner_id":"1866911","reasoning":"Document A is more relevant — it discusses luminal progenitors and stem/progenitor cell markers in breast cancer, which relates to ALDH1 as a stem cell marker and its prognostic implications.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590329Z"}
{"comparison_id":"5ead648f-93fc-4d6c-9f49-4fb6fcd16a84","query_id":"51","doc_a_id":"31311495","doc_b_id":"20333864","presented_order":["31311495","20333864"],"winner_id":"20333864","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it addresses factors influencing progression from in situ to invasive breast cancer (ties to outcomes), while A focuses on tamoxifen resistance mechanisms in a cell line.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590337Z"}
{"comparison_id":"bdaa42aa-d78b-4405-b9f2-94bf5471d85b","query_id":"51","doc_a_id":"15946643","doc_b_id":"20333864","presented_order":["20333864","15946643"],"winner_id":"20333864","reasoning":"Neither document mentions ALDH1 or directly addresses its association with breast cancer outcomes, so both are irrelevant. Document A is marginally more related to tumor progression and biomarkers than B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590344Z"}
{"comparison_id":"90447526-542b-44e0-9ff4-f8b5e491345c","query_id":"51","doc_a_id":"4702639","doc_b_id":"20333864","presented_order":["4702639","20333864"],"winner_id":"20333864","reasoning":"Document B is more relevant — it specifically addresses breast carcinoma progression, while Document A discusses stemness and drug resistance in other carcinomas and does not focus on breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590352Z"}
{"comparison_id":"b8424270-0d47-4dc8-ac6e-716b05cc4c2a","query_id":"51","doc_a_id":"19673227","doc_b_id":"20333864","presented_order":["19673227","20333864"],"winner_id":"19673227","reasoning":"Document A is more relevant — it links tumor cell markers/profiles to chemotherapy response and disease-free survival, which relates to outcomes, whereas Document B focuses on cellular mechanisms of invasion without outcome data.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590360Z"}
{"comparison_id":"40f1f531-faef-4ecc-9f7e-5cb096883812","query_id":"51","doc_a_id":"2931832","doc_b_id":"20333864","presented_order":["2931832","20333864"],"winner_id":"20333864","reasoning":"Document B is more relevant — it discusses molecular and cellular factors in tumor progression (potentially relating to marker expression), whereas A only covers a platelet-based prognostic ratio. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590368Z"}
{"comparison_id":"2ef7f310-ff67-4833-ab92-136572fc2b73","query_id":"51","doc_a_id":"20127522","doc_b_id":"20333864","presented_order":["20127522","20333864"],"winner_id":"20127522","reasoning":"Document A is more relevant — it addresses biomarkers linked to patient outcomes (CTC levels and prognosis), whereas Document B focuses on cellular mechanisms of invasion without discussing ALDH1 or outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590375Z"}
{"comparison_id":"a914659e-faf5-4441-9e3d-eecb24574efc","query_id":"51","doc_a_id":"34066665","doc_b_id":"20333864","presented_order":["34066665","20333864"],"winner_id":"20333864","reasoning":"Document B is more focused on cellular mechanisms of progression from in situ to invasive disease (cell types and molecular pathways) and is therefore more relevant to markers like ALDH1 and their impact on outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590383Z"}
{"comparison_id":"8b78a2bc-5bf4-43f8-a3c2-57d4f54546cb","query_id":"51","doc_a_id":"16086778","doc_b_id":"20333864","presented_order":["20333864","16086778"],"winner_id":"20333864","reasoning":"Neither document mentions ALDH1. Document A is slightly more relevant because it addresses factors influencing progression from in situ to invasive disease and thus breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590390Z"}
{"comparison_id":"d423b550-1620-4297-976f-2084bf419430","query_id":"51","doc_a_id":"24834968","doc_b_id":"20333864","presented_order":["24834968","20333864"],"winner_id":"24834968","reasoning":"Document A is more relevant — it evaluates biological markers as predictors of breast cancer treatment response, whereas Document B focuses on cell-type interactions in DCIS-to-invasive transition and does not address marker expression like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590398Z"}
{"comparison_id":"2eb5031a-6524-42d7-858f-cb3228f223cf","query_id":"51","doc_a_id":"20183360","doc_b_id":"20333864","presented_order":["20183360","20333864"],"winner_id":"20183360","reasoning":"Document A is more relevant — it discusses GATA3's role in reducing invasiveness and tumor progression, which is more directly connected to factors influencing breast cancer outcomes than the microenvironment-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:34:51.590406Z"}
{"comparison_id":"f813e723-4ca1-4004-b7ad-0d56a27f3e01","query_id":"51","doc_a_id":"22401720","doc_b_id":"5500086","presented_order":["5500086","22401720"],"winner_id":"5500086","reasoning":"Document A is more relevant — it discusses a molecular signature that correlates with positive breast cancer outcomes, which is closer to the claim about marker expression and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:01.484327Z"}
{"comparison_id":"781ed21e-bf0a-43e1-a776-5e7c7651861c","query_id":"51","doc_a_id":"7821634","doc_b_id":"5500086","presented_order":["7821634","5500086"],"winner_id":"5500086","reasoning":"Reason: Neither mentions ALDH1, but Document B discusses a gene expression/immune signature that correlates with positive breast cancer outcomes, making it slightly more relevant to the query about expression linked to better outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:01.484348Z"}
{"comparison_id":"2bfb8ef3-05de-415b-9b7e-16befe8653f8","query_id":"51","doc_a_id":"7583725","doc_b_id":"5500086","presented_order":["7583725","5500086"],"winner_id":"5500086","reasoning":"Reason: Document B discusses an expression signature (type I IFN) that correlates with positive clinical outcomes in breast cancer, which is closer in topic to a claim about a biomarker’s association with better outcomes than Document A (which links high TRPM7 to worse outcomes).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:01.484357Z"}
{"comparison_id":"e1e2a436-bee6-4eec-8a23-982a984fa6cb","query_id":"51","doc_a_id":"20839751","doc_b_id":"5500086","presented_order":["20839751","5500086"],"winner_id":"5500086","reasoning":"Document B is more relevant — it discusses molecular signatures that correlate with clinical outcomes in breast cancer, whereas Document A focuses on apoptosis and does not address ALDH1 or outcome associations. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:01.484364Z"}
{"comparison_id":"154ddbb0-1dec-4199-9e7a-ebe04f9c4c6f","query_id":"51","doc_a_id":"1171121","doc_b_id":"5500086","presented_order":["1171121","5500086"],"winner_id":"5500086","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it links a molecular signature (type I IFN) to breast cancer outcomes, whereas A focuses on MVD and p53 only. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:01.484372Z"}
{"comparison_id":"986e978d-d7a6-4f88-8229-d3a54ce9c1a4","query_id":"51","doc_a_id":"313403","doc_b_id":"5500086","presented_order":["5500086","313403"],"winner_id":"5500086","reasoning":"Document A is more relevant — it links a molecular/immune signature to positive clinical outcomes in breast cancer, which is closer to the claim about a biomarker being associated with better outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:01.484379Z"}
{"comparison_id":"c8115620-c380-4169-a3a3-df46d8b45392","query_id":"51","doc_a_id":"20183360","doc_b_id":"5500086","presented_order":["5500086","20183360"],"winner_id":"5500086","reasoning":"Document A is more relevant because it discusses molecular expression signatures that correlate with positive clinical outcomes in breast cancer, whereas Document B focuses on invasion mechanisms without outcome correlations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:01.484387Z"}
{"comparison_id":"649672c1-81ae-49cf-982b-c4000d6ff84d","query_id":"51","doc_a_id":"19358586","doc_b_id":"5500086","presented_order":["19358586","5500086"],"winner_id":"5500086","reasoning":"Document B — it links a molecular signature to positive breast cancer outcomes, which is closer to the claim about a marker-outcome association. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:01.484393Z"}
{"comparison_id":"20aee1d7-332d-4342-9565-a9bc6b81abbf","query_id":"51","doc_a_id":"1866911","doc_b_id":"5500086","presented_order":["5500086","1866911"],"winner_id":"5500086","reasoning":"Document A — it discusses a molecular signature that correlates with positive breast cancer outcomes, which is closer to the claim about marker expression and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:01.484400Z"}
{"comparison_id":"03427338-ec70-4e6d-b31d-131af699339a","query_id":"51","doc_a_id":"19673227","doc_b_id":"5500086","presented_order":["19673227","5500086"],"winner_id":"5500086","reasoning":"Document B is more relevant — it discusses molecular signatures tied to better clinical outcomes in breast cancer, whereas A focuses on CTC chemosensitivity without addressing ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:01.484408Z"}
{"comparison_id":"5bc87909-b6f0-4619-9956-2867492cd35b","query_id":"51","doc_a_id":"20127522","doc_b_id":"5500086","presented_order":["20127522","5500086"],"winner_id":"5500086","reasoning":"Reason: Document B discusses tumor cell molecular signatures that correlate with clinical outcomes in breast cancer, making it more relevant to a claim about a biomarker's association with outcomes than Document A, which only addresses circulating tumor cell counts.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:01.484415Z"}
{"comparison_id":"3b47974c-4b7a-468e-b441-e4033f76d656","query_id":"51","doc_a_id":"24834968","doc_b_id":"5500086","presented_order":["24834968","5500086"],"winner_id":"5500086","reasoning":"Document B — it discusses a molecular signature that correlates with positive clinical outcomes in breast cancer, which is more closely related to the claim about marker expression and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:01.484422Z"}
{"comparison_id":"98d45678-fe1a-4a11-b931-996e540d55f5","query_id":"51","doc_a_id":"22401720","doc_b_id":"313403","presented_order":["22401720","313403"],"winner_id":"22401720","reasoning":"Document A is more relevant — it examines expression of tumor proteins and their relation to breast cancer prognosis, which is closer to a claim about ALDH1 expression and outcome. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:12.494585Z"}
{"comparison_id":"43b3bab3-c464-4354-8b14-d8c9ab49563e","query_id":"51","doc_a_id":"7821634","doc_b_id":"313403","presented_order":["7821634","313403"],"winner_id":"7821634","reasoning":"Document A is more relevant — it links expression level of a tumor gene (DUSP4) to chemotherapy response and patient outcomes, which parallels the claim about a marker's expression being associated with better breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:12.494605Z"}
{"comparison_id":"6fc87fc0-b59e-4398-8f15-980286922ad6","query_id":"51","doc_a_id":"7583725","doc_b_id":"313403","presented_order":["7583725","313403"],"winner_id":"7583725","reasoning":"Reason: Document A discusses how expression of a specific tumor cell protein predicts patient outcomes, which is more directly analogous to a claim about ALDH1 expression and prognosis than Document B's focus on macrophage infiltration.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:12.494615Z"}
{"comparison_id":"28f9b752-9ef2-49e6-94b2-cf8f7261705f","query_id":"51","doc_a_id":"20839751","doc_b_id":"313403","presented_order":["20839751","313403"],"winner_id":"20839751","reasoning":"Document A is more relevant — it discusses associations between a molecular/pathological marker and breast cancer prognosis, whereas B focuses specifically on tumor-associated macrophages and not on ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:12.494622Z"}
{"comparison_id":"3d0350fc-898f-49e0-9f3c-a97d3ce7aa82","query_id":"51","doc_a_id":"1171121","doc_b_id":"313403","presented_order":["313403","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant — it evaluates how protein/molecular marker status (p53) and microvessel density relate to breast cancer outcomes, which is analogous to assessing ALDH1 expression as a prognostic marker.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:12.494630Z"}
{"comparison_id":"e2f8b766-461c-49c0-9169-6066b906f986","query_id":"51","doc_a_id":"24834968","doc_b_id":"313403","presented_order":["313403","24834968"],"winner_id":"24834968","reasoning":"Neither abstract mentions ALDH1. Document B is slightly more relevant because it evaluates molecular/biological markers as predictors of treatment response, whereas A focuses on tumor-associated macrophages unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:12.494637Z"}
{"comparison_id":"6c7f9141-61d9-4ac4-9a5b-ce9f9227894a","query_id":"51","doc_a_id":"20183360","doc_b_id":"313403","presented_order":["20183360","313403"],"winner_id":"20183360","reasoning":"Document A is more relevant — it addresses molecular factors and pathways linked to breast cancer invasiveness and prognosis, which is closer to a claim about a molecular marker (ALDH1) and outcomes than the immune infiltration focus in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:12.494644Z"}
{"comparison_id":"aaf5039d-5b6f-4819-aa58-05c37418b0af","query_id":"51","doc_a_id":"19358586","doc_b_id":"313403","presented_order":["19358586","313403"],"winner_id":"313403","reasoning":"Document B is more relevant — it directly addresses prognostic markers and clinical outcomes in breast cancer, whereas A focuses on miRNA regulation and a Myc/p27/phospho-Rb signature without discussing ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:12.494651Z"}
{"comparison_id":"0827d89c-9ecb-41b3-801a-1c058db2bcd2","query_id":"51","doc_a_id":"1866911","doc_b_id":"313403","presented_order":["1866911","313403"],"winner_id":"1866911","reasoning":"Document A is more relevant — it discusses breast epithelial progenitor cell markers and tumor origins (closer to ALDH1, a stem/progenitor marker), whereas B concerns macrophage infiltration unrelated to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:12.494658Z"}
{"comparison_id":"7a8a924f-c717-46fa-9a12-dce58dd77c6b","query_id":"51","doc_a_id":"19673227","doc_b_id":"313403","presented_order":["19673227","313403"],"winner_id":"313403","reasoning":"Document B is more relevant — it directly addresses predictors of breast cancer outcomes, while Document A discusses a general CTC chemosensitivity assay without mention of ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:12.494665Z"}
{"comparison_id":"ab56d22a-f81b-452c-ba02-ebca81fef2e9","query_id":"51","doc_a_id":"20127522","doc_b_id":"313403","presented_order":["20127522","313403"],"winner_id":"313403","reasoning":"Document B — it examines a tumor-tissue marker (TAM infiltration) as a prognostic factor in breast cancer, which is more directly comparable to ALDH1 expression than circulating tumor cell counts. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:12.494671Z"}
{"comparison_id":"ca61c2a8-cd9a-4ab8-bbec-13cbba8d0928","query_id":"51","doc_a_id":"22401720","doc_b_id":"20839751","presented_order":["22401720","20839751"],"winner_id":"20839751","reasoning":"Document B — it examines pathological markers and their association with prognosis in breast cancer, so it's more directly relevant to whether a marker (like ALDH1) correlates with outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:20.330981Z"}
{"comparison_id":"e913357d-7082-4c4a-a61f-a8322a02fdf7","query_id":"51","doc_a_id":"7821634","doc_b_id":"20839751","presented_order":["20839751","7821634"],"winner_id":"20839751","reasoning":"Document A is more relevant — it addresses prognostic associations in breast cancer, whereas Document B focuses on DUSP4 and chemotherapy resistance, not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:20.331001Z"}
{"comparison_id":"1faf3081-c22d-4b50-9742-ebf41f9bfd5f","query_id":"51","doc_a_id":"7583725","doc_b_id":"20839751","presented_order":["20839751","7583725"],"winner_id":"7583725","reasoning":"Document B is more relevant — it directly addresses how expression of a specific protein (TRPM7) predicts breast cancer outcomes, whereas Document A discusses apoptotic index not marker expression. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:20.331009Z"}
{"comparison_id":"e200fb06-0ae5-4085-ae5f-8934a019b4f6","query_id":"51","doc_a_id":"1866911","doc_b_id":"20839751","presented_order":["1866911","20839751"],"winner_id":"1866911","reasoning":"Document A is more relevant — it discusses breast epithelial progenitor cell populations and markers related to tumor origin, which is closer to ALDH1's role as a stem/progenitor marker. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:20.331017Z"}
{"comparison_id":"21b8c8ce-adb6-4479-888a-53435638d76d","query_id":"51","doc_a_id":"1171121","doc_b_id":"20839751","presented_order":["20839751","1171121"],"winner_id":"1171121","reasoning":"Document B — it examines protein marker status (p53) and its association with prognosis, which is analogous to assessing ALDH1 expression and outcomes; Document A focuses on apoptotic index rather than marker expression. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:20.331024Z"}
{"comparison_id":"953dba13-37c3-4ffb-a036-aa9ad313bc82","query_id":"51","doc_a_id":"24834968","doc_b_id":"20839751","presented_order":["24834968","20839751"],"winner_id":"20839751","reasoning":"Reason: Document B discusses how a biomarker (apoptotic index) relates to pathological features and prognosis in breast cancer, so it is more relevant to evaluating associations between marker expression and outcomes than Document A, which focuses on HER-2/chemotherapy response.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:20.331033Z"}
{"comparison_id":"216c0a96-f2fe-4350-a224-dec30d7a1bbc","query_id":"51","doc_a_id":"20183360","doc_b_id":"20839751","presented_order":["20183360","20839751"],"winner_id":"20839751","reasoning":"Document B is more relevant — it discusses relationships between biomarkers and breast cancer prognosis, while A focuses on GATA3/Smad4-mediated invasion mechanisms without addressing ALDH1 or outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:20.331040Z"}
{"comparison_id":"f8a91217-0821-47a8-98c0-2088d28a9343","query_id":"51","doc_a_id":"7583725","doc_b_id":"1866911","presented_order":["7583725","1866911"],"winner_id":"7583725","reasoning":"Document A — it discusses how expression level of a molecular marker (TRPM7) predicts patient outcomes, which is more directly related to a claim about marker expression and prognosis than Document B's focus on progenitor cell origin. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:27.321085Z"}
{"comparison_id":"23c21bd9-5f77-46b8-9eb6-b38966075ddb","query_id":"51","doc_a_id":"1171121","doc_b_id":"1866911","presented_order":["1866911","1171121"],"winner_id":"1866911","reasoning":"Document A is more relevant — it deals with cellular markers and progenitor populations in breast cancer (closer to ALDH1-related stem/progenitor marker context), whereas Document B focuses on MVD and p53 with no relation to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:27.321107Z"}
{"comparison_id":"6945d6af-80fd-4d0e-82c2-5213e9f6cb18","query_id":"51","doc_a_id":"22401720","doc_b_id":"7821634","presented_order":["22401720","7821634"],"winner_id":"22401720","reasoning":"Neither document mentions ALDH1. Document A is slightly more relevant because it examines tumor marker expression and links markers to prognosis in primary breast cancer, whereas B focuses on DUSP4 and chemo resistance.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:35.803147Z"}
{"comparison_id":"ad16ec68-5ffa-486b-be0e-0ef01b29ca3c","query_id":"51","doc_a_id":"20183360","doc_b_id":"7821634","presented_order":["7821634","20183360"],"winner_id":"7821634","reasoning":"Document A is more relevant — it discusses correlations between a molecular marker and breast cancer outcomes, while Document B focuses on transcriptional regulation of invasion without outcome data.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:35.803169Z"}
{"comparison_id":"429c43bd-6603-48c7-915e-bc4fc07e7939","query_id":"51","doc_a_id":"24834968","doc_b_id":"7821634","presented_order":["7821634","24834968"],"winner_id":"7821634","reasoning":"DOCUMENT A — it directly links a biomarker's expression level to prognosis and chemotherapy response in breast cancer, whereas B focuses on HER2 and response prediction without addressing marker–outcome associations like ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:35.803177Z"}
{"comparison_id":"0924c561-162e-4f21-a9f4-7767e5482898","query_id":"51","doc_a_id":"20183360","doc_b_id":"24834968","presented_order":["24834968","20183360"],"winner_id":"20183360","reasoning":"Neither abstract mentions ALDH1. B is marginally more relevant because it addresses molecular regulators of invasion and tumor progression (which relate to outcomes), whereas A focuses on chemo dose-response predictors. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:42.076147Z"}
{"comparison_id":"a58c8950-1f8c-4a14-a43e-c23a8e528e12","query_id":"51","doc_a_id":"19358586","doc_b_id":"19673227","presented_order":["19358586","19673227"],"winner_id":"19358586","reasoning":"A is more relevant — it addresses breast cancer patient survival and protein signatures related to outcome; B focuses on CTC chemosensitivity across epithelial tumors and doesn't pertain to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:46.902153Z"}
{"comparison_id":"d3ec9dfe-6b20-40f3-856d-b819a69e4243","query_id":"51","doc_a_id":"20127522","doc_b_id":"19673227","presented_order":["20127522","19673227"],"winner_id":"20127522","reasoning":"Document A directly addresses breast cancer outcomes (progression-free survival) while Document B covers multiple epithelial tumors generally. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:46.902174Z"}
{"comparison_id":"1233a1e9-a77d-45a7-b8e1-523d422ca60d","query_id":"51","doc_a_id":"19358586","doc_b_id":"20127522","presented_order":["20127522","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant — it discusses molecular markers and their association with survival outcomes in breast cancer, whereas Document A focuses on circulating tumor cells and treatment monitoring without addressing ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:35:50.653429Z"}
{"comparison_id":"699a24a9-856b-4df8-bc30-2868036519b7","query_id":"51","doc_a_id":"24341590","doc_b_id":"11484808","presented_order":["11484808","24341590"],"winner_id":"11484808","reasoning":"Document A is more relevant — it discusses biomarkers and clinical implications in endocrine-related (including breast) cancers, which is closer to a claim about ALDH1 expression and outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:03.139133Z"}
{"comparison_id":"e974eca1-2257-426c-9815-b8525a6856fe","query_id":"51","doc_a_id":"32001951","doc_b_id":"11484808","presented_order":["32001951","11484808"],"winner_id":"11484808","reasoning":"Document B is more relevant because it addresses biomarkers and clinical outcomes in endocrine-related cancers (including breast cancer), whereas Document A focuses on alkaline phosphatase regulation in a cell line and not ALDH1.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:03.139156Z"}
{"comparison_id":"6c72ca4f-23f4-4dba-84c0-6e304b9936d0","query_id":"51","doc_a_id":"15113221","doc_b_id":"11484808","presented_order":["11484808","15113221"],"winner_id":"15113221","reasoning":"Brief reason: Document B addresses gene expression signatures linked to prognosis in carcinomas (directly relevant to expression–outcome associations), while Document A focuses on non-coding RNAs broadly and is less directly related to ALDH1 expression and breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:03.139165Z"}
{"comparison_id":"e4b309f4-2b3c-4d62-a789-59b274a7b856","query_id":"51","doc_a_id":"16734530","doc_b_id":"11484808","presented_order":["16734530","11484808"],"winner_id":"11484808","reasoning":"Document B is more relevant — it covers biomarkers and factors affecting survival in endocrine-related cancers (including breast), whereas Document A focuses on ORAI1 SNPs unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:03.139173Z"}
{"comparison_id":"5b483c4d-213f-42b0-acb7-5395a3cf8f0e","query_id":"51","doc_a_id":"9600826","doc_b_id":"11484808","presented_order":["11484808","9600826"],"winner_id":"11484808","reasoning":"Document A is more likely to discuss biomarkers and their associations with clinical outcomes in endocrine-related cancers, whereas Document B focuses on a specific invasion/angiogenesis pathway without addressing ALDH1 or clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:03.139180Z"}
{"comparison_id":"5025d183-b88c-4269-b9b7-c7eb2527dd34","query_id":"51","doc_a_id":"25973484","doc_b_id":"11484808","presented_order":["11484808","25973484"],"winner_id":"25973484","reasoning":"Document B is more relevant — it specifically discusses breast cancer risk and prognosis (outcomes), whereas Document A focuses on non-coding RNAs broadly in endocrine cancers and is less directly about breast cancer outcome markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:03.139187Z"}
{"comparison_id":"d7cd23c6-6111-44d6-b1cd-accd6e2cbf69","query_id":"51","doc_a_id":"24249915","doc_b_id":"11484808","presented_order":["11484808","24249915"],"winner_id":"24249915","reasoning":"Reason: Document B directly studies protein expression changes in breast cancer tissue and clinical implications, whereas Document A is a general review of ncRNAs and less directly related to ALDH1 expression or outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:03.139194Z"}
{"comparison_id":"ccc8c828-1b31-420c-be15-0e15af8dc45e","query_id":"51","doc_a_id":"16086778","doc_b_id":"11484808","presented_order":["11484808","16086778"],"winner_id":"11484808","reasoning":"Document A is more likely to address biomarkers and clinical outcomes (covers ncRNAs and clinical implications in endocrine-related cancers) and thus more relevant to ALDH1 expression than the Numb/Notch-focused study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:03.139201Z"}
{"comparison_id":"e8f679d5-511a-4bbc-97ea-f9563267ea66","query_id":"51","doc_a_id":"22482820","doc_b_id":"11484808","presented_order":["11484808","22482820"],"winner_id":"11484808","reasoning":"Document A is more likely to address biomarker–outcome associations (clinical implications, diagnostics, survival) relevant to ALDH1; Document B focuses on therapy delivery strategies. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:03.139207Z"}
{"comparison_id":"e3a0baf3-075d-46f2-8b77-bab7fea7cd1b","query_id":"51","doc_a_id":"31311495","doc_b_id":"11484808","presented_order":["31311495","11484808"],"winner_id":"11484808","reasoning":"Reason: Document B reviews clinical biomarkers and outcomes in endocrine-related cancers, so it's more likely to address associations between marker expression and prognosis. Document A is a cell-line mechanistic study not mentioning ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:03.139214Z"}
{"comparison_id":"51d450ca-3e40-4a2e-bae8-e618bac173e2","query_id":"51","doc_a_id":"15946643","doc_b_id":"11484808","presented_order":["11484808","15946643"],"winner_id":"15946643","reasoning":"Document B is more relevant — it directly addresses breast cancer behavior (chemoresistance/metastasis) and is more likely to discuss clinical markers linked to outcomes, whereas A focuses on ncRNAs generally in endocrine cancers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:03.139221Z"}
{"comparison_id":"872be274-72e5-46a7-9adf-f3bdfdc6722b","query_id":"51","doc_a_id":"4702639","doc_b_id":"11484808","presented_order":["11484808","4702639"],"winner_id":"4702639","reasoning":"Document B is more relevant — it addresses tumor stemness and treatment outcomes (contexts where ALDH1, a stem-cell marker, is typically studied), while A is a general review of ncRNAs not specifically about ALDH1 or clinical outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:03.139229Z"}
{"comparison_id":"b99f9fc8-903b-4783-9458-f64982936ccd","query_id":"51","doc_a_id":"2931832","doc_b_id":"11484808","presented_order":["11484808","2931832"],"winner_id":"11484808","reasoning":"Doc A is a review of biomarkers and clinical implications in endocrine-related cancers (including breast cancer) and is more likely to address markers like ALDH1 than a study focused solely on platelet indices.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:03.139236Z"}
{"comparison_id":"f9adfe93-9c58-4db9-882b-eec34405c600","query_id":"51","doc_a_id":"34066665","doc_b_id":"11484808","presented_order":["11484808","34066665"],"winner_id":"11484808","reasoning":"Document A is more likely to discuss biomarkers and clinical implications (including markers like ALDH1) in endocrine-related cancers, whereas Document B focuses specifically on ER–HER signaling and therapy resistance.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:03.139244Z"}
{"comparison_id":"2d4e6ec5-2548-463a-acb1-9b870d5703c0","query_id":"51","doc_a_id":"15113221","doc_b_id":"24249915","presented_order":["15113221","24249915"],"winner_id":"15113221","reasoning":"Reason: Document A discusses gene-expression signatures tied to prognosis in carcinoma, which is more directly related to outcome associations than Document B's focus on ERβ expression and methylation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:12.252898Z"}
{"comparison_id":"c8482e6b-c3a1-436c-abdc-ae55ff9af819","query_id":"51","doc_a_id":"25973484","doc_b_id":"24249915","presented_order":["24249915","25973484"],"winner_id":"24249915","reasoning":"Document A — it discusses expression changes of a breast cancer marker and mechanisms of altered expression, which is more relevant to a claim about a molecular marker (ALDH1) than the obesity–breast cancer review. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:12.252919Z"}
{"comparison_id":"66845b02-8c7c-49f2-ba8a-5e081ffb3d46","query_id":"51","doc_a_id":"4702639","doc_b_id":"24249915","presented_order":["24249915","4702639"],"winner_id":"4702639","reasoning":"Document B — it addresses tumour stemness and markers linked to prognosis and therapy resistance, which is more directly related to ALDH1's role than Document A's focus on ERβ methylation. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:12.252927Z"}
{"comparison_id":"bdd2b7c1-2148-48d6-8c3c-0ce4236a4d1c","query_id":"51","doc_a_id":"15946643","doc_b_id":"24249915","presented_order":["24249915","15946643"],"winner_id":"15946643","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it discusses factors (chemoresistance and metastasis) that directly affect breast cancer outcomes, while A focuses on ERβ expression and methylation. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:12.252934Z"}
{"comparison_id":"eae0c474-b037-410b-a9a6-7e0697479de9","query_id":"51","doc_a_id":"15113221","doc_b_id":"4702639","presented_order":["15113221","4702639"],"winner_id":"4702639","reasoning":"Document B is more relevant — it addresses tumor stemness markers and their impact on prognosis and therapy resistance, which is conceptually closer to ALDH1 (a cancer stem-cell marker) than the PTEN-focused prognostic signature in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:19.687689Z"}
{"comparison_id":"629d2c9d-58ec-4a7b-a170-f309fef60a2e","query_id":"51","doc_a_id":"15946643","doc_b_id":"4702639","presented_order":["4702639","15946643"],"winner_id":"15946643","reasoning":"Reason: Document B specifically addresses breast cancer chemoresistance and metastasis (clinical outcomes), so it's more likely to contain evidence relevant to ALDH1 and breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:19.687711Z"}
{"comparison_id":"14599992-d092-4bc0-9893-5cba054f9f03","query_id":"51","doc_a_id":"24341590","doc_b_id":"16086778","presented_order":["16086778","24341590"],"winner_id":"16086778","reasoning":"Document A is more relevant — it addresses breast cancer tumor biology and pathways linked to prognosis, whereas Document B focuses on tamoxifen pharmacogenetics unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:27.645406Z"}
{"comparison_id":"addb8abc-f519-480b-9f02-3286ec999d3e","query_id":"51","doc_a_id":"32001951","doc_b_id":"16086778","presented_order":["16086778","32001951"],"winner_id":"16086778","reasoning":"Document A is more relevant — it addresses breast cancer biology and factors affecting tumor behavior/outcomes, whereas Document B discusses alkaline phosphatase regulation in a cell line (unrelated to ALDH1).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:27.645427Z"}
{"comparison_id":"3fe49f70-7952-4893-b871-137452564e23","query_id":"51","doc_a_id":"16734530","doc_b_id":"16086778","presented_order":["16086778","16734530"],"winner_id":"16086778","reasoning":"Document A is more relevant — it addresses breast cancer biology and factors affecting tumor behavior/prognosis, whereas Document B only reports ORAI1 SNP associations and doesn't relate to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:27.645435Z"}
{"comparison_id":"9873ae43-df68-4004-a242-e3878b2b80dd","query_id":"51","doc_a_id":"9600826","doc_b_id":"16086778","presented_order":["16086778","9600826"],"winner_id":"16086778","reasoning":"Document A is more relevant — it directly addresses mechanisms affecting breast tumor behavior and patient-relevant cancer progression, whereas B focuses on angiogenesis pathways not directly tied to ALDH1 or clinical outcomes.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:27.645443Z"}
{"comparison_id":"a44ece13-9533-4c41-97fc-8072d6993160","query_id":"51","doc_a_id":"34066665","doc_b_id":"16086778","presented_order":["34066665","16086778"],"winner_id":"34066665","reasoning":"Reason: Neither abstract mentions ALDH1, but Document A discusses clinical implications and treatment outcomes in breast cancer, making it slightly more relevant to a claim about prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:27.645451Z"}
{"comparison_id":"3189a4bf-f9ed-42ba-b6d4-2d278edb96a0","query_id":"51","doc_a_id":"22482820","doc_b_id":"16086778","presented_order":["16086778","22482820"],"winner_id":"16086778","reasoning":"Neither document addresses ALDH1. Document A is marginally more relevant because it concerns breast tumor biology and factors affecting tumor proliferation and outcome, whereas Document B focuses on treatment delivery strategies.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:27.645458Z"}
{"comparison_id":"df313486-60e5-4be1-9c4b-aa0109563ae6","query_id":"51","doc_a_id":"31311495","doc_b_id":"16086778","presented_order":["31311495","16086778"],"winner_id":"16086778","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it addresses mechanisms in human breast carcinogenesis and tumor proliferation (possible links to prognostic markers), whereas A is an in vitro study of tamoxifen-resistant MCF7 cells. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:27.645466Z"}
{"comparison_id":"d552e046-35aa-4832-a396-2994fefc7933","query_id":"51","doc_a_id":"2931832","doc_b_id":"16086778","presented_order":["2931832","16086778"],"winner_id":"16086778","reasoning":"Document B is more relevant — it discusses molecular pathways and tumor suppressors in breast cancer (closer to biomarker/prognostic context) whereas A covers a platelet-based prognostic ratio unrelated to ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:27.645472Z"}
{"comparison_id":"eaaa1931-4d86-487c-9326-13b202a83076","query_id":"51","doc_a_id":"24341590","doc_b_id":"9600826","presented_order":["9600826","24341590"],"winner_id":"24341590","reasoning":"Document B is more relevant — it examines how a biomarker/genetic variation relates to clinical outcomes in breast cancer, which is closer to the claim about marker expression and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:37.171630Z"}
{"comparison_id":"90e5dfc2-52f7-4720-940b-2f13d64fa05b","query_id":"51","doc_a_id":"32001951","doc_b_id":"9600826","presented_order":["32001951","9600826"],"winner_id":"32001951","reasoning":"Reason: Neither abstract mentions ALDH1 or clinical outcomes; Document A at least deals with expression of an enzyme in breast cancer cells, so it's marginally closer to the query.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:37.171652Z"}
{"comparison_id":"3ea29eaa-a9ee-4a73-a386-056644e74e51","query_id":"51","doc_a_id":"16734530","doc_b_id":"9600826","presented_order":["16734530","9600826"],"winner_id":"16734530","reasoning":"Document A is more relevant — it links genetic markers to breast cancer clinical features (ER status, lymph node involvement), which relate to outcomes; Document B focuses on invasion/angiogenesis mechanisms rather than outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:37.171661Z"}
{"comparison_id":"1ff26109-5fb3-4c94-81f1-6c22fc8ceb21","query_id":"51","doc_a_id":"2931832","doc_b_id":"9600826","presented_order":["2931832","9600826"],"winner_id":"2931832","reasoning":"Document A is more relevant — it deals with prognostic factors and breast cancer outcomes, whereas Document B focuses on a signaling pathway and angiogenesis rather than clinical outcome markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:37.171669Z"}
{"comparison_id":"aeb4de8d-67f7-4c6c-a582-cf50a886d310","query_id":"51","doc_a_id":"22482820","doc_b_id":"9600826","presented_order":["9600826","22482820"],"winner_id":"22482820","reasoning":"Neither mentions ALDH1. Document B is slightly more relevant because it addresses breast cancer classification and treatment implications of marker expression. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:37.171676Z"}
{"comparison_id":"7a572752-0bd8-4b45-9477-95239d07809c","query_id":"51","doc_a_id":"31311495","doc_b_id":"9600826","presented_order":["9600826","31311495"],"winner_id":"31311495","reasoning":"Document B is slightly more relevant because it discusses treatment resistance and EMT-related aggressiveness that affect outcomes; neither document mentions ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:37.171683Z"}
{"comparison_id":"c7103b77-fe6f-4f38-8efd-4445fbcb1eed","query_id":"51","doc_a_id":"24341590","doc_b_id":"16734530","presented_order":["16734530","24341590"],"winner_id":"16734530","reasoning":"Document A is marginally more relevant because it addresses genetic markers associated with breast cancer characteristics, whereas Document B focuses specifically on tamoxifen metabolism and treatment outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:43.145840Z"}
{"comparison_id":"47ede2d0-6428-45dc-85ca-e2b67bfcda97","query_id":"51","doc_a_id":"32001951","doc_b_id":"16734530","presented_order":["32001951","16734530"],"winner_id":"32001951","reasoning":"Document A is more relevant — it concerns expression regulation in a breast cancer cell line (though of alkaline phosphatase, not ALDH1), whereas B focuses on ORAI1 SNPs unrelated to ALDH1 expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:43.145866Z"}
{"comparison_id":"bde6fedb-24bf-4e16-bc50-8e3a966e0f00","query_id":"51","doc_a_id":"31311495","doc_b_id":"16734530","presented_order":["31311495","16734530"],"winner_id":"16734530","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it reports clinical genetic associations with breast cancer features (ER status and nodal involvement), whereas A is an in vitro study of tamoxifen resistance.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:43.145877Z"}
{"comparison_id":"26e50b4c-7d51-4601-9994-653c3b7d6fdc","query_id":"51","doc_a_id":"2931832","doc_b_id":"16734530","presented_order":["2931832","16734530"],"winner_id":"2931832","reasoning":"Document A is more relevant — it addresses prognostic biomarkers and outcomes in breast cancer, which is closer to a claim about ALDH1 expression and patient outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:43.145886Z"}
{"comparison_id":"95b6f1fe-5d52-4a4c-88d1-c209b96f68f8","query_id":"51","doc_a_id":"22482820","doc_b_id":"16734530","presented_order":["16734530","22482820"],"winner_id":"16734530","reasoning":"Document A is more relevant — it addresses genetic/biomarker associations with breast cancer outcomes, whereas B focuses on treatment strategies rather than prognostic marker expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:43.145895Z"}
{"comparison_id":"6f0bba07-9e62-415d-88e1-9176940febbd","query_id":"51","doc_a_id":"32001951","doc_b_id":"2931832","presented_order":["2931832","32001951"],"winner_id":"32001951","reasoning":"Document B is slightly more relevant because it discusses regulation of an enzyme's expression in a breast cancer cell line, whereas Document A focuses on a platelet-based prognostic ratio and not gene/protein expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:47.298965Z"}
{"comparison_id":"4c9c2c0d-83b9-481d-ab00-9628b4a3d567","query_id":"51","doc_a_id":"24341590","doc_b_id":"31311495","presented_order":["31311495","24341590"],"winner_id":"31311495","reasoning":"Document A is more relevant — it discusses cellular markers and tumor aggressiveness/EMT in breast cancer, which is closer to linking marker expression (like ALDH1) with outcomes than a pharmacogenetic study of CYP2D6.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:54.457404Z"}
{"comparison_id":"7a75f278-e53c-4e53-a22b-992d599400f4","query_id":"51","doc_a_id":"22482820","doc_b_id":"31311495","presented_order":["22482820","31311495"],"winner_id":"31311495","reasoning":"Document B is more relevant — it discusses molecular changes linked to tumor aggressiveness and treatment resistance (factors related to prognosis), while Document A focuses on therapy delivery strategies and not prognostic markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:36:54.457424Z"}
{"comparison_id":"4e01eefa-a37b-42b9-af15-773d5c3af4f8","query_id":"51","doc_a_id":"24341590","doc_b_id":"22482820","presented_order":["22482820","24341590"],"winner_id":"22482820","reasoning":"Document A is more relevant — it covers breast cancer classification and biomarkers/therapeutic strategies, making it more likely to address ALDH1 expression than the CYP2D6/tamoxifen-specific study in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:37:02.218675Z"}
{"comparison_id":"742c59a0-fe63-4411-8507-f7680a7bd3d7","query_id":"51","doc_a_id":"4429932","doc_b_id":"25732836","presented_order":["25732836","4429932"],"winner_id":"25732836","reasoning":"Document A is more relevant — it evaluates prognostic biomarkers and outcome prediction in breast cancer, while Document B focuses on LOX-mediated metastasis and not on ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:37:13.240951Z"}
{"comparison_id":"04946853-0080-4fd0-86fe-eaa5d33828e6","query_id":"51","doc_a_id":"3285322","doc_b_id":"25732836","presented_order":["25732836","3285322"],"winner_id":"25732836","reasoning":"Document A is more relevant because it addresses prognostic markers and outcome prediction in breast cancer, whereas Document B focuses on BRCA mutation clinical/pathologic differences and not prognostic marker expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:37:13.240972Z"}
{"comparison_id":"b1e4f901-5ad6-48f2-af77-d6726714384f","query_id":"51","doc_a_id":"16691520","doc_b_id":"25732836","presented_order":["25732836","16691520"],"winner_id":"25732836","reasoning":"Document A is more relevant — it addresses prognostic markers and outcome prediction in breast cancer, whereas Document B focuses on estrogen receptor binding sites and gene regulation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:37:13.240981Z"}
{"comparison_id":"23eb586c-54c4-4eac-86ce-0f498b12c9b7","query_id":"51","doc_a_id":"4889228","doc_b_id":"25732836","presented_order":["4889228","25732836"],"winner_id":"25732836","reasoning":"Document B is more relevant — it directly studies prognostic biomarkers and outcome prediction in breast cancer, whereas A focuses on a specific splicing regulator (TDP43) and TNBC mechanisms.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:37:13.240989Z"}
{"comparison_id":"6c41fe08-77f0-4ddb-95bd-0c2dc6746ca1","query_id":"51","doc_a_id":"4429932","doc_b_id":"3285322","presented_order":["3285322","4429932"],"winner_id":"3285322","reasoning":"Document A is more relevant — it discusses breast cancer clinical/pathologic features and outcomes, whereas Document B focuses on LOX and metastasis, not ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:37:21.455360Z"}
{"comparison_id":"c8e189ed-e63b-4485-b631-54d1e936ea26","query_id":"51","doc_a_id":"4889228","doc_b_id":"3285322","presented_order":["4889228","3285322"],"winner_id":"4889228","reasoning":"Document A is more relevant — it links gene/protein expression to breast cancer prognosis, whereas Document B focuses on BRCA status and clinical features without discussing marker expression. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:37:21.455382Z"}
{"comparison_id":"e348b4d4-3b2c-4134-b2f3-5918cf6f5d88","query_id":"51","doc_a_id":"16691520","doc_b_id":"3285322","presented_order":["16691520","3285322"],"winner_id":"3285322","reasoning":"Document B is more relevant — it addresses clinical and pathological features and outcomes in breast cancer patients, which is closer to a claim about marker expression and prognosis than a study of estrogen receptor binding.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:37:21.455390Z"}
{"comparison_id":"452e0b7c-405d-4462-aa7c-b59bf3b053e6","query_id":"51","doc_a_id":"4429932","doc_b_id":"16691520","presented_order":["16691520","4429932"],"winner_id":"16691520","reasoning":"Document A deals with gene expression/regulation in breast cancer and is therefore more relevant to a claim about ALDH1 expression and outcomes than Document B, which focuses on LOX and metastasis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:37:27.749444Z"}
{"comparison_id":"ad3f96f1-5c0c-4290-92bd-e4d3ea441241","query_id":"51","doc_a_id":"27240667","doc_b_id":"1389264","presented_order":["27240667","1389264"],"winner_id":"27240667","reasoning":"Document A is more relevant — it addresses breast cancer outcomes directly, while Document B focuses on a specific therapy in HER2+ brain metastases and not on ALDH1 or general outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:37:34.530998Z"}
{"comparison_id":"ac596f31-af11-4ee0-951a-2c1a4416753f","query_id":"51","doc_a_id":"13030852","doc_b_id":"1389264","presented_order":["13030852","1389264"],"winner_id":"1389264","reasoning":"Reason: Document B discusses biomarkers and treatment-related tumor responses in breast cancer (biomarker-driven trials), which is more conceptually related to studies of marker expression and outcomes than Document A's focus on alkaline phosphatase for metastasis detection.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:37:34.531018Z"}
{"comparison_id":"0d2ba737-8bb5-4143-bbe4-76734079c487","query_id":"51","doc_a_id":"22975806","doc_b_id":"1389264","presented_order":["22975806","1389264"],"winner_id":"22975806","reasoning":"Document A is more relevant — it addresses breast tumorigenesis and clinical implications, whereas B focuses narrowly on targeted therapy for HER2+ brain metastases and not general prognostic biomarkers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:37:34.531027Z"}
{"comparison_id":"ba0508f4-b16a-418d-9b96-5fac59ceeecd","query_id":"51","doc_a_id":"22509015","doc_b_id":"1389264","presented_order":["22509015","1389264"],"winner_id":"22509015","reasoning":"Document A is slightly more relevant — neither abstract mentions ALDH1, but A addresses tumor biology and metastasis/prognosis context, which is closer to outcome associations than the therapy-focused B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:37:34.531034Z"}
{"comparison_id":"8b0f4247-c938-4db9-88a3-c4bfa6651803","query_id":"51","doc_a_id":"12438901","doc_b_id":"1389264","presented_order":["12438901","1389264"],"winner_id":"1389264","reasoning":"Document B is slightly more related because it discusses biomarker-linked therapeutic responses in breast cancer, whereas Document A addresses tamoxifen duration and not biomarker expression. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:37:34.531041Z"}
{"comparison_id":"3d96a251-b1ee-45b3-bce6-6dd543932339","query_id":"51","doc_a_id":"27240667","doc_b_id":"22975806","presented_order":["22975806","27240667"],"winner_id":"22975806","reasoning":"Document A is more focused on molecular mechanisms in breast tumors (closer to biomarkers), whereas B addresses population mortality trends unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:37:41.090258Z"}
{"comparison_id":"8c9cd916-190d-4295-9c20-3aaf7dda4409","query_id":"51","doc_a_id":"22509015","doc_b_id":"22975806","presented_order":["22975806","22509015"],"winner_id":"22975806","reasoning":"Document A is more relevant — it discusses breast tumorigenesis and clinical/ outcome implications, whereas Document B focuses narrowly on WNT signaling and brain metastasis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:37:41.090280Z"}
{"comparison_id":"780aa10c-1e12-4c90-986c-80be00fa073e","query_id":"51","doc_a_id":"27240667","doc_b_id":"22509015","presented_order":["22509015","27240667"],"winner_id":"27240667","reasoning":"Document B is more relevant — it addresses breast cancer outcomes/mortality, whereas Document A focuses on WNT signaling and metastasis mechanisms, not ALDH1 or outcomes.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:37:46.264234Z"}
{"comparison_id":"a0f0264a-929f-4287-8015-50085fe072fa","query_id":"51","doc_a_id":"13030852","doc_b_id":"12438901","presented_order":["13030852","12438901"],"winner_id":"12438901","reasoning":"Document B is more relevant — it concerns breast cancer outcomes (recurrence and mortality), whereas Document A discusses alkaline phosphatase for metastasis detection and does not relate to ALDH1 or prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:37:50.617417Z"}
{"comparison_id":"3482f3cd-d4bf-442e-968d-546bc3b67255","query_id":"51","doc_a_id":"21439640","doc_b_id":"6550579","presented_order":["21439640","6550579"],"winner_id":"21439640","reasoning":"Document A is more relevant — it addresses tumor biology and pathways linked to progression and prognostic factors in breast cancer, whereas Document B focuses specifically on HER2/HER3-targeted therapy and not prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:06.628366Z"}
{"comparison_id":"aec94522-34c1-463c-9fbc-f0e9e8e6122a","query_id":"51","doc_a_id":"13007205","doc_b_id":"6550579","presented_order":["13007205","6550579"],"winner_id":"13007205","reasoning":"Document A is more relevant — it addresses tumor invasion and progression factors affecting prognosis, whereas B focuses on HER2/HER3-targeted therapy rather than prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:06.628386Z"}
{"comparison_id":"08206321-f6d5-48bd-9a36-c4043751b5df","query_id":"51","doc_a_id":"4820792","doc_b_id":"6550579","presented_order":["6550579","4820792"],"winner_id":"4820792","reasoning":"Document B is marginally more relevant because it addresses survival/resistance pathways in breast cancer cells (which relates to prognostic markers like ALDH1), whereas Document A focuses on HER3-targeted therapy without linking to prognostic markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:06.628396Z"}
{"comparison_id":"1c176493-46f5-42ba-a855-eed840819ee3","query_id":"51","doc_a_id":"2140497","doc_b_id":"6550579","presented_order":["2140497","6550579"],"winner_id":"6550579","reasoning":"Neither document mentions ALDH1; both are unrelated. Document B is marginally more relevant because it deals with molecular markers and treatment outcomes in breast cancer, whereas A addresses mammographic density and lobular involution.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:06.628404Z"}
{"comparison_id":"88d58e9b-fb54-42dd-a260-1c2816d90591","query_id":"51","doc_a_id":"13069283","doc_b_id":"6550579","presented_order":["6550579","13069283"],"winner_id":"6550579","reasoning":"Neither document discusses ALDH1. Document A is slightly more relevant because it addresses breast cancer biology and treatment outcomes, whereas B focuses on tamoxifen metabolism/genetics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:06.628411Z"}
{"comparison_id":"3677931d-ba8b-4abc-a812-4ee3c76381f5","query_id":"51","doc_a_id":"195680777","doc_b_id":"6550579","presented_order":["6550579","195680777"],"winner_id":"6550579","reasoning":"Document A is more relevant — it discusses molecular marker-driven outcomes and targeted therapy in breast cancer, whereas B focuses on chemotherapy regimens; neither mentions ALDH1 but A is closer to biomarker-related outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:06.628418Z"}
{"comparison_id":"b4f282cd-39c4-4fb8-952f-6bd36653b1bc","query_id":"51","doc_a_id":"18340282","doc_b_id":"6550579","presented_order":["18340282","6550579"],"winner_id":"6550579","reasoning":"Neither paper mentions ALDH1. Document B is marginally more relevant because it addresses tumor marker-driven biology and treatment outcomes in breast cancer, whereas A focuses on gene–environment interactions for risk. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:06.628427Z"}
{"comparison_id":"e2b237a2-185c-4533-abed-3152e0c3a59c","query_id":"51","doc_a_id":"5864770","doc_b_id":"6550579","presented_order":["6550579","5864770"],"winner_id":"6550579","reasoning":"Document A is more focused on tumor biomarkers and therapeutic outcomes in breast cancer, making it marginally more relevant to a claim about a prognostic marker like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:06.628434Z"}
{"comparison_id":"d0cba0d0-1e3e-4128-b052-3e374d67f3e6","query_id":"51","doc_a_id":"17088791","doc_b_id":"6550579","presented_order":["17088791","6550579"],"winner_id":"6550579","reasoning":"Document B is more relevant — it addresses tumor protein expression and treatment outcomes in breast cancer, which is closer to a claim about a marker's association with prognosis than a study of BRCA1 population variants.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:06.628441Z"}
{"comparison_id":"7dd684fc-81cd-4199-98eb-4727fbec9a8a","query_id":"51","doc_a_id":"885056","doc_b_id":"6550579","presented_order":["885056","6550579"],"winner_id":"6550579","reasoning":"Document B is more relevant — it addresses HER2-amplified breast cancer and therapeutic outcomes, which is closer to clinical outcome associations than Document A's molecular/mitochondrial focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:06.628448Z"}
{"comparison_id":"5629f2f8-ff56-495a-a46d-25c861cb2ff7","query_id":"51","doc_a_id":"164985","doc_b_id":"6550579","presented_order":["6550579","164985"],"winner_id":"164985","reasoning":"Neither document discusses ALDH1. Document B is slightly more related to tumor progression and prognosis (tumor-supporting M2d macrophages), so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:06.628455Z"}
{"comparison_id":"0fb86663-272a-48a8-b9b0-cf557a29eeac","query_id":"51","doc_a_id":"5649538","doc_b_id":"6550579","presented_order":["6550579","5649538"],"winner_id":"5649538","reasoning":"Neither abstract mentions ALDH1. Document B is slightly more relevant because it deals with gene expression markers in breast cancer, whereas A focuses on HER3/HER2 targeted therapy.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:06.628463Z"}
{"comparison_id":"9091b5b5-8e37-4c08-9dd0-47f94b509877","query_id":"51","doc_a_id":"2061878","doc_b_id":"6550579","presented_order":["2061878","6550579"],"winner_id":"2061878","reasoning":"Document A is slightly more relevant — it discusses how expression of a molecular marker correlates with prognosis, which is closer to the claim about ALDH1 and outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:06.628470Z"}
{"comparison_id":"81d619a8-03b3-4ff5-9af5-f22efa1f47ad","query_id":"51","doc_a_id":"21902400","doc_b_id":"6550579","presented_order":["6550579","21902400"],"winner_id":"21902400","reasoning":"Reason: Document B discusses prognostic markers and clinical outcomes in cancer, which is more directly related to a claim about a biomarker (ALDH1) and breast cancer outcomes than Document A's focus on HER3-targeted therapy.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:06.628477Z"}
{"comparison_id":"9e9bd33d-b6d4-4943-a76c-6cdda9bf861b","query_id":"51","doc_a_id":"7046487","doc_b_id":"6550579","presented_order":["6550579","7046487"],"winner_id":"6550579","reasoning":"Document A is specific to breast cancer biology and treatment, so it is more likely to be relevant to a claim about ALDH1 and breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:06.628484Z"}
{"comparison_id":"a72e2bda-a6e4-4600-9bcf-251d2774ead3","query_id":"51","doc_a_id":"8774475","doc_b_id":"6550579","presented_order":["6550579","8774475"],"winner_id":"8774475","reasoning":"Neither document mentions ALDH1, so both are largely irrelevant. Document B is slightly more relevant because it addresses mechanisms of tumorigenesis and cell-state changes that could relate to stem/progenitor markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:06.628491Z"}
{"comparison_id":"f7a1162c-c8a7-49c0-93dc-c52b137ebaf4","query_id":"51","doc_a_id":"19541444","doc_b_id":"6550579","presented_order":["19541444","6550579"],"winner_id":"19541444","reasoning":"Neither document mentions ALDH1 or provides evidence about its association with breast cancer outcomes, so neither is relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:06.628498Z"}
{"comparison_id":"7e1d0d82-cb72-461d-bb6a-c5fed4ee9335","query_id":"51","doc_a_id":"5270265","doc_b_id":"6550579","presented_order":["6550579","5270265"],"winner_id":"5270265","reasoning":"Neither document discusses ALDH1; both are irrelevant. Document B is marginally more relevant because it focuses on mechanisms affecting treatment outcomes (trastuzumab resistance), which is closer to the claim about prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:06.628505Z"}
{"comparison_id":"1f3fa1f1-abed-4661-aa2d-45d228b0bce1","query_id":"51","doc_a_id":"32423829","doc_b_id":"6550579","presented_order":["32423829","6550579"],"winner_id":"6550579","reasoning":"Document B discusses molecular biomarkers and their impact on treatment outcomes, which is more related to biomarker–outcome associations than a screening trial. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:06.628511Z"}
{"comparison_id":"c7b46085-e1dd-483b-b423-d23503721fd8","query_id":"51","doc_a_id":"10279084","doc_b_id":"6550579","presented_order":["10279084","6550579"],"winner_id":"6550579","reasoning":"Document B — it directly addresses drivers and therapeutic outcomes in breast cancer, whereas Document A focuses on a MAP kinase phosphatase splice variant with only passing mention of breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:06.628518Z"}
{"comparison_id":"6bba6be4-ea76-49ac-9fb3-f17ac02e50ed","query_id":"51","doc_a_id":"42106119","doc_b_id":"6550579","presented_order":["6550579","42106119"],"winner_id":"6550579","reasoning":"Document A is more relevant — it concerns breast cancer biology and therapeutic outcomes, while Document B focuses on embryonic stem cell Oct4 networks unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:06.628525Z"}
{"comparison_id":"1e715714-aeb4-40f8-83e8-0c9b9b8caa39","query_id":"51","doc_a_id":"21439640","doc_b_id":"5649538","presented_order":["5649538","21439640"],"winner_id":"5649538","reasoning":"Document A is more relevant — it concerns genomic markers and patient-selection/outcomes in breast cancer, whereas B focuses on macrophage-induced COX-2 signaling mechanisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:12.751688Z"}
{"comparison_id":"64da69f5-b21b-44e7-b8ce-7b3495c8bb66","query_id":"51","doc_a_id":"13007205","doc_b_id":"5649538","presented_order":["5649538","13007205"],"winner_id":"5649538","reasoning":"Document A is more relevant — it deals with gene expression markers in breast cancer, whereas Document B focuses on fibroblast MMP-3 genotype and invasion, not tumor marker expression or outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:12.751708Z"}
{"comparison_id":"9b6cfd5f-8449-4957-8a07-136f2518d565","query_id":"51","doc_a_id":"4820792","doc_b_id":"5649538","presented_order":["5649538","4820792"],"winner_id":"5649538","reasoning":"Document A is more relevant — it discusses gene expression markers and clinical prediction in breast cancer, which is closer to a claim about expression correlating with outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:12.751717Z"}
{"comparison_id":"96555f4a-88ce-4d43-ba45-4b306e127ead","query_id":"51","doc_a_id":"164985","doc_b_id":"5649538","presented_order":["164985","5649538"],"winner_id":"5649538","reasoning":"Document B is more relevant — it concerns gene-expression markers in breast cancer (potentially including prognostic markers), whereas Document A focuses on macrophage IL-6 regulation and tumor-promoting macrophages, not ALDH1 or clinical outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:12.751725Z"}
{"comparison_id":"7f7b9d6f-8428-4abb-8693-f17ba7ac72c9","query_id":"51","doc_a_id":"5270265","doc_b_id":"5649538","presented_order":["5270265","5649538"],"winner_id":"5649538","reasoning":"Reason: Neither document mentions ALDH1, but Document B deals with gene expression–based markers and clinical outcome prediction in breast cancer, so it's marginally more relevant to a claim about expression being linked to outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:12.751733Z"}
{"comparison_id":"2a5a927d-27e6-45a7-9ba1-e5093103dd51","query_id":"51","doc_a_id":"2061878","doc_b_id":"5649538","presented_order":["5649538","2061878"],"winner_id":"5649538","reasoning":"Document A is more relevant — it discusses gene expression markers in breast cancer, whereas Document B focuses on NEAT1 in various cancers and not on ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:12.751740Z"}
{"comparison_id":"0105cfe1-1e71-4508-a160-8798da9cded1","query_id":"51","doc_a_id":"21902400","doc_b_id":"5649538","presented_order":["5649538","21902400"],"winner_id":"5649538","reasoning":"Document A is more relevant — it deals with gene expression markers in breast cancer, whereas Document B addresses tumor hypoxia generally and doesn't pertain to ALDH1 or breast cancer markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:12.751747Z"}
{"comparison_id":"f9e869bb-4922-4768-ac90-95ea15855ceb","query_id":"51","doc_a_id":"8774475","doc_b_id":"5649538","presented_order":["8774475","5649538"],"winner_id":"5649538","reasoning":"Document B is more relevant — it deals with gene expression predictors and clinical outcomes/therapy response, which is closer to evaluating a biomarker like ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:12.751754Z"}
{"comparison_id":"7f13ed0f-1c2c-40e5-b719-90ed8b99ead0","query_id":"51","doc_a_id":"19541444","doc_b_id":"5649538","presented_order":["19541444","5649538"],"winner_id":"5649538","reasoning":"Document B is more relevant — it focuses on gene expression markers in breast cancer, which is closer to assessing associations between specific markers (like ALDH1) and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:12.751761Z"}
{"comparison_id":"a02f784c-3e95-4350-b440-5e630f2521bc","query_id":"51","doc_a_id":"21439640","doc_b_id":"5270265","presented_order":["21439640","5270265"],"winner_id":"5270265","reasoning":"Neither document mentions ALDH1; neither provides evidence for or against the claim. Document B is slightly more related to breast cancer outcomes (treatment resistance), so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:23.247203Z"}
{"comparison_id":"652e3f7f-5787-48ea-b58b-4fffa6dc1101","query_id":"51","doc_a_id":"13007205","doc_b_id":"5270265","presented_order":["13007205","5270265"],"winner_id":"5270265","reasoning":"Document B is more relevant — it discusses treatment resistance and strategies to improve outcomes in breast cancer, which is closer to the claim about prognostic associations. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:23.247226Z"}
{"comparison_id":"07b5892c-1e15-4fe9-b098-69ca05460cd4","query_id":"51","doc_a_id":"4820792","doc_b_id":"5270265","presented_order":["4820792","5270265"],"winner_id":"5270265","reasoning":"Neither document mentions ALDH1. Both are unrelated, but Document B is marginally more relevant because it addresses improving treatment outcomes in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:23.247235Z"}
{"comparison_id":"9e06809f-b5c2-4fdd-9781-2af5b3e30c08","query_id":"51","doc_a_id":"164985","doc_b_id":"5270265","presented_order":["5270265","164985"],"winner_id":"5270265","reasoning":"Reason: Document A addresses treatment resistance and outcome-related pathways in breast cancer, so it is more directly related to clinical outcomes than Document B, which focuses on macrophage behavior.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:23.247242Z"}
{"comparison_id":"10b42688-e80b-4ced-a688-184e15e49f19","query_id":"51","doc_a_id":"19541444","doc_b_id":"5270265","presented_order":["19541444","5270265"],"winner_id":"5270265","reasoning":"Document B is more directly about breast cancer treatment/outcomes (trastuzumab resistance), while Document A discusses MEG3 in tumorigenesis generally and doesn't address breast cancer outcomes or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:23.247249Z"}
{"comparison_id":"786d08e9-1486-451d-a18d-786f9e8b8f7f","query_id":"51","doc_a_id":"2061878","doc_b_id":"5270265","presented_order":["2061878","5270265"],"winner_id":"2061878","reasoning":"Document A is slightly more relevant because it discusses gene expression correlated with prognosis, whereas Document B focuses on trastuzumab resistance mechanisms and does not address prognostic markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:23.247256Z"}
{"comparison_id":"167c6c5a-5a08-4e39-8a00-f00d37cf0e9a","query_id":"51","doc_a_id":"21902400","doc_b_id":"5270265","presented_order":["21902400","5270265"],"winner_id":"21902400","reasoning":"Document A is more about prognostic factors and clinical outcome, which is directly relevant to a claim about a biomarker's association with outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:23.247263Z"}
{"comparison_id":"c49bc842-7fcc-4b4e-a42b-e0d273c8c916","query_id":"51","doc_a_id":"8774475","doc_b_id":"5270265","presented_order":["5270265","8774475"],"winner_id":"5270265","reasoning":"Document A is more relevant — it discusses mechanisms of treatment resistance and improving outcomes in breast cancer, which is closer to prognosis-related evidence than Document B's focus on cell polarity and tumor initiation. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:23.247271Z"}
{"comparison_id":"9f54633c-0bc4-43aa-a69e-257b9e09a557","query_id":"51","doc_a_id":"2061878","doc_b_id":"21902400","presented_order":["2061878","21902400"],"winner_id":"2061878","reasoning":"Document A is more relevant — it discusses biomarker expression and correlations with prognosis, which is closer to the claim about ALDH1 and breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:26.824610Z"}
{"comparison_id":"fabc0bbf-8bb4-41bc-a8b9-da46d9f8c266","query_id":"51","doc_a_id":"21439640","doc_b_id":"4820792","presented_order":["4820792","21439640"],"winner_id":"4820792","reasoning":"Document A is slightly more relevant — it addresses tumor cell survival and therapy resistance (factors tied to outcomes), whereas Document B focuses on macrophage-driven COX-2 signaling and is less directly related to prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:35.482696Z"}
{"comparison_id":"6d5ff71a-e3c4-48ba-8c28-f3dfa76a2a8c","query_id":"51","doc_a_id":"13007205","doc_b_id":"4820792","presented_order":["4820792","13007205"],"winner_id":"4820792","reasoning":"Document A is slightly more relevant because it addresses breast cancer cell survival and therapeutic outcomes, whereas Document B focuses on fibroblast genotypes and invasion without linking to clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:35.482717Z"}
{"comparison_id":"f9dafe42-2719-4f33-a0d4-6836b50b29d7","query_id":"51","doc_a_id":"8774475","doc_b_id":"4820792","presented_order":["4820792","8774475"],"winner_id":"8774475","reasoning":"Neither abstract mentions ALDH1 directly; Document B is slightly more relevant because it addresses mechanisms of tumorigenesis and progression (more closely tied to outcome associations) while A focuses on drug resistance pathways. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:35.482727Z"}
{"comparison_id":"3d1d9f3f-8e3e-44c4-a70a-2c68e0117941","query_id":"51","doc_a_id":"164985","doc_b_id":"4820792","presented_order":["164985","4820792"],"winner_id":"164985","reasoning":"Document A is slightly more relevant because it discusses factors (tumor-promoting macrophages and IL-6) that relate to tumor progression and outcomes; Document B focuses on drug-resistance mechanisms rather than prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:35.482735Z"}
{"comparison_id":"4f038264-53ad-472d-b9c6-ec8456d584fe","query_id":"51","doc_a_id":"19541444","doc_b_id":"4820792","presented_order":["19541444","4820792"],"winner_id":"4820792","reasoning":"Document B is more directly about breast cancer biology and therapeutic outcomes (drug resistance and cell survival), so it is more relevant to a claim about breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:35.482742Z"}
{"comparison_id":"e83d81d9-c467-40a6-9ebd-45c680343aaa","query_id":"51","doc_a_id":"8774475","doc_b_id":"164985","presented_order":["8774475","164985"],"winner_id":"8774475","reasoning":"Document A is more relevant — it deals with mammary tumorigenesis and pathways affecting breast cancer development, which is closer to a claim about breast cancer outcomes than a macrophage-focused study. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:38.809072Z"}
{"comparison_id":"dc9b6c2d-3d71-4a96-a84a-7d6066c27efa","query_id":"51","doc_a_id":"21439640","doc_b_id":"13007205","presented_order":["13007205","21439640"],"winner_id":"13007205","reasoning":"Neither document mentions ALDH1, but Document A discusses factors (fibroblast genotype and increased invasion) more directly related to breast cancer aggressiveness and outcomes than Document B's signaling-focused COX-2 study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:46.312904Z"}
{"comparison_id":"97781a55-36b6-43bd-9019-47b72a1ff99e","query_id":"51","doc_a_id":"19541444","doc_b_id":"13007205","presented_order":["19541444","13007205"],"winner_id":"19541444","reasoning":"Document A is slightly more relevant because it discusses gene expression and tumorigenesis (biomarker-related biology), whereas Document B focuses on fibroblast genotype and invasion without addressing tumor-marker expression or clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:46.312926Z"}
{"comparison_id":"7ea287ff-3197-4554-bf34-fa4d03ea98d5","query_id":"51","doc_a_id":"2140497","doc_b_id":"17088791","presented_order":["17088791","2140497"],"winner_id":"17088791","reasoning":"Document A is more relevant — it addresses genetic/molecular factors related to breast cancer susceptibility, which is closer to a question about a molecular marker (ALDH1) and outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:54.270823Z"}
{"comparison_id":"59c36bd5-534a-40cf-a753-3741f755abc3","query_id":"51","doc_a_id":"13069283","doc_b_id":"17088791","presented_order":["17088791","13069283"],"winner_id":"17088791","reasoning":"Document A is more relevant — it discusses genetic variation linked to breast cancer susceptibility and a potentially protective allele, which is closer to a prognostic biomarker question than B’s tamoxifen metabolism focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:54.270843Z"}
{"comparison_id":"5c709a09-55d7-49bf-9a50-75a52383a24b","query_id":"51","doc_a_id":"195680777","doc_b_id":"17088791","presented_order":["195680777","17088791"],"winner_id":"17088791","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it deals with genetic markers and associations with breast cancer risk/outcomes. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:54.270852Z"}
{"comparison_id":"e3d904f1-09e9-4a70-ab9d-55e464cbfae5","query_id":"51","doc_a_id":"18340282","doc_b_id":"17088791","presented_order":["18340282","17088791"],"winner_id":"18340282","reasoning":"Document A — it reports a large prospective breast cancer cohort (gene–environment effects), which is closer to clinical outcomes than Document B’s focus on BRCA1 susceptibility. Neither document mentions ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:54.270860Z"}
{"comparison_id":"49b1a7c9-cb7c-438a-b761-97dfb63241e7","query_id":"51","doc_a_id":"5864770","doc_b_id":"17088791","presented_order":["17088791","5864770"],"winner_id":"5864770","reasoning":"Document B is more relevant — it discusses breast cancer biology and factors influencing tumor behavior and risk, whereas A only addresses BRCA1 genetic variants unrelated to ALDH1 expression. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:54.270867Z"}
{"comparison_id":"96fd2e09-3e74-4c64-80bd-ba01c97678e3","query_id":"51","doc_a_id":"42106119","doc_b_id":"17088791","presented_order":["42106119","17088791"],"winner_id":"42106119","reasoning":"Document A — it addresses stem cell factors and proteins linked to cancer (ALDH1 is a stem/progenitor cell marker), while Document B focuses on BRCA1 variants unrelated to ALDH1 or outcomes.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:54.270874Z"}
{"comparison_id":"59d848af-46ad-4dd5-93b1-57c960573d95","query_id":"51","doc_a_id":"885056","doc_b_id":"17088791","presented_order":["885056","17088791"],"winner_id":"17088791","reasoning":"Document B is more relevant — it concerns breast cancer genetic factors and outcomes, whereas A discusses SLIRP and mitochondrial/RNA regulation with no link to ALDH1 or clinical outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:54.270881Z"}
{"comparison_id":"b79ffc9e-4241-48e2-be0c-e8efd53b0e43","query_id":"51","doc_a_id":"7046487","doc_b_id":"17088791","presented_order":["7046487","17088791"],"winner_id":"17088791","reasoning":"Document B is more relevant — it addresses genetic factors and breast cancer risk/outcomes, whereas A focuses on NF-κB/inflammation broadly and not on ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:54.270888Z"}
{"comparison_id":"4b2b9fc5-8153-4647-9806-ee458a1d890d","query_id":"51","doc_a_id":"32423829","doc_b_id":"17088791","presented_order":["32423829","17088791"],"winner_id":"17088791","reasoning":"Document B is more relevant — it addresses molecular/genetic factors associated with breast cancer outcomes, whereas Document A is about screening logistics and outcomes unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:54.270895Z"}
{"comparison_id":"85efdb16-8e02-47ab-8c52-a25387a7377b","query_id":"51","doc_a_id":"10279084","doc_b_id":"17088791","presented_order":["10279084","17088791"],"winner_id":"17088791","reasoning":"Document B is more relevant — it discusses genetic variants associated with breast cancer risk and mentions a potentially protective allele, which is closer to the claim about factors linked to better breast cancer outcomes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:54.270902Z"}
{"comparison_id":"7c7ef6ba-1ae5-4905-bcdc-758492f9df4b","query_id":"51","doc_a_id":"18340282","doc_b_id":"5864770","presented_order":["5864770","18340282"],"winner_id":"18340282","reasoning":"Document B is more directly about molecular markers and breast cancer outcomes (large genetic study), which is closer to a claim about a marker's association with outcome than general hormone/proliferation discussion in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:59.926862Z"}
{"comparison_id":"cdb95bfd-f765-418b-a93f-0e56290b23b4","query_id":"51","doc_a_id":"42106119","doc_b_id":"5864770","presented_order":["5864770","42106119"],"winner_id":"5864770","reasoning":"Document A is more related to breast cancer biology and outcomes, whereas Document B focuses on embryonic stem cell Oct4 networks not specifically tied to ALDH1 or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:38:59.926882Z"}
{"comparison_id":"74f172cb-144e-47b7-b0ed-dd3d5b86185c","query_id":"51","doc_a_id":"2140497","doc_b_id":"885056","presented_order":["885056","2140497"],"winner_id":"2140497","reasoning":"Document B is more relevant — it concerns breast pathology and cancer risk/outcomes, whereas Document A discusses an unrelated RNA-binding protein (SLIRP). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:08.352267Z"}
{"comparison_id":"08b407e7-738e-42bb-8f63-c3e86004200b","query_id":"51","doc_a_id":"13069283","doc_b_id":"885056","presented_order":["885056","13069283"],"winner_id":"13069283","reasoning":"Document B is more relevant — neither mentions ALDH1, but B addresses factors (tamoxifen metabolism/genetics) directly related to breast cancer treatment outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:08.352288Z"}
{"comparison_id":"6cd0e221-a54d-420c-a27d-befbbdcdd7c9","query_id":"51","doc_a_id":"195680777","doc_b_id":"885056","presented_order":["195680777","885056"],"winner_id":"195680777","reasoning":"Document A — it addresses breast cancer outcomes (treatment effects on mortality), while Document B discusses SLIRP biology not clinical outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:08.352298Z"}
{"comparison_id":"01fd0e3b-2d2d-44e1-b363-3c4153066b5f","query_id":"51","doc_a_id":"10279084","doc_b_id":"885056","presented_order":["10279084","885056"],"winner_id":"10279084","reasoning":"Document A — it discusses molecular findings in breast cancer (mentions dysregulation in breast), whereas Document B focuses on SLIRP/mitochondria and tamoxifen with no breast cancer marker mention. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:08.352306Z"}
{"comparison_id":"ff70bed0-1ae6-4baf-be4d-f3d856abbc3a","query_id":"51","doc_a_id":"7046487","doc_b_id":"885056","presented_order":["885056","7046487"],"winner_id":"885056","reasoning":"Document A is more relevant — it discusses factors (SLIRP, Tamoxifen, nuclear receptor modulation) directly tied to breast cancer biology and treatment, whereas Document B is a general review of NF-κB in inflammation and cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:08.352313Z"}
{"comparison_id":"caa7ee8f-3694-4176-916a-79df3d392733","query_id":"51","doc_a_id":"32423829","doc_b_id":"885056","presented_order":["885056","32423829"],"winner_id":"32423829","reasoning":"Document B is more relevant — it concerns breast cancer outcomes (screening and treatment results), whereas Document A discusses SLIRP and mitochondrial function, not ALDH1 or clinical outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:08.352320Z"}
{"comparison_id":"ff38e4c5-f044-4004-8717-e53fb4bdd551","query_id":"51","doc_a_id":"2140497","doc_b_id":"195680777","presented_order":["2140497","195680777"],"winner_id":"2140497","reasoning":"Document A is more relevant — it discusses factors associated with breast cancer risk/outcomes, whereas Document B focuses on chemotherapy regimens and mortality unrelated to ALDH1 expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:12.593985Z"}
{"comparison_id":"b4a4ac5d-a7fe-4606-98f1-e47cd1f5e97c","query_id":"51","doc_a_id":"13069283","doc_b_id":"195680777","presented_order":["195680777","13069283"],"winner_id":"13069283","reasoning":"Neither abstract mentions ALDH1. Document B is slightly more relevant because it addresses molecular biomarkers and treatment outcomes in breast cancer, whereas A focuses on chemotherapy regimens.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:12.594005Z"}
{"comparison_id":"cc4b9746-37bf-4a25-baa6-f0df997fc34a","query_id":"51","doc_a_id":"32423829","doc_b_id":"195680777","presented_order":["32423829","195680777"],"winner_id":"195680777","reasoning":"Neither document mentions ALDH1. Both are irrelevant, but Document B is marginally more related because it addresses breast cancer treatment outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:12.594014Z"}
{"comparison_id":"cb13a0fa-53f6-435e-95c7-f4f1827ba34f","query_id":"51","doc_a_id":"10279084","doc_b_id":"195680777","presented_order":["10279084","195680777"],"winner_id":"10279084","reasoning":"Document A is more relevant — it addresses molecular markers and breast cancer biology (while B focuses on chemotherapy regimens and outcomes, not biomarker expression). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:12.594022Z"}
{"comparison_id":"1cec0eb0-aa0b-4129-be81-a04d3b7c21b6","query_id":"51","doc_a_id":"2140497","doc_b_id":"13069283","presented_order":["2140497","13069283"],"winner_id":"2140497","reasoning":"Document A is more relevant because it addresses tissue features linked to breast cancer risk/outcomes, whereas Document B focuses on tamoxifen metabolism genetics, unrelated to ALDH1 expression. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:21.793066Z"}
{"comparison_id":"4f08dcb8-d03b-4e5e-938b-25fde6e2f89a","query_id":"51","doc_a_id":"10279084","doc_b_id":"13069283","presented_order":["13069283","10279084"],"winner_id":"10279084","reasoning":"Document B is more relevant — it discusses expression and functional effects of a molecular marker in breast cancer, whereas A focuses on CYP2D6 pharmacogenetics unrelated to ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:21.793088Z"}
{"comparison_id":"afab9716-23fa-4026-8ff8-5de1db462975","query_id":"51","doc_a_id":"2140497","doc_b_id":"10279084","presented_order":["10279084","2140497"],"winner_id":"10279084","reasoning":"Document A — it discusses molecular alterations in cancer cells including breast cancer (though neither mentions ALDH1), so it’s slightly more relevant to a claim about a molecular marker and breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:27.473403Z"}
{"comparison_id":"7852b6b7-ab77-46d7-86ad-9907e743c225","query_id":"51","doc_a_id":"17648235","doc_b_id":"30226988","presented_order":["17648235","30226988"],"winner_id":"30226988","reasoning":"Document B is more relevant — it discusses breast cancer survival/outcomes (though it doesn't mention ALDH1), whereas Document A focuses on WNT signaling with no outcome data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:35.058944Z"}
{"comparison_id":"b98ffbfd-5a0c-475d-b65d-67ce307757be","query_id":"51","doc_a_id":"4999633","doc_b_id":"30226988","presented_order":["30226988","4999633"],"winner_id":"30226988","reasoning":"Document A is more relevant — it discusses breast cancer survival/outcomes, whereas Document B is an in vitro signaling study not about ALDH1 or clinical outcomes.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:35.058965Z"}
{"comparison_id":"2f32800a-4e8a-478b-a28a-4326784c9b08","query_id":"51","doc_a_id":"38551172","doc_b_id":"30226988","presented_order":["30226988","38551172"],"winner_id":"30226988","reasoning":"Document A is more relevant — it discusses breast cancer survival/outcomes broadly, while Document B focuses on risk factors (mammographic density and vitamin D) not outcomes or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:35.058973Z"}
{"comparison_id":"04020be7-23ae-4a89-aeda-83fd637e4301","query_id":"51","doc_a_id":"4828631","doc_b_id":"30226988","presented_order":["4828631","30226988"],"winner_id":"30226988","reasoning":"Document B is more relevant — it concerns breast cancer survival/outcomes, whereas A addresses BMI and cancer risk, not marker expression or outcomes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:35.058981Z"}
{"comparison_id":"76002030-7a9c-4854-8e2d-c090cb4b0f6e","query_id":"51","doc_a_id":"16322674","doc_b_id":"30226988","presented_order":["30226988","16322674"],"winner_id":"30226988","reasoning":"Document A is more relevant — it discusses breast cancer survival/outcomes, whereas Document B addresses birth size and cancer risk and doesn't pertain to outcomes or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:35.058989Z"}
{"comparison_id":"1ef1c780-3baf-4434-87f0-33e8c9f4597f","query_id":"51","doc_a_id":"2576811","doc_b_id":"30226988","presented_order":["30226988","2576811"],"winner_id":"30226988","reasoning":"Document A is more relevant — it discusses breast cancer survival/outcomes, whereas Document B focuses on actin assembly (FMNL2) in epithelial cells and doesn't address clinical outcomes or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:35.058996Z"}
{"comparison_id":"60ee8385-91c0-4450-8696-e1a6dce997e6","query_id":"51","doc_a_id":"52188256","doc_b_id":"30226988","presented_order":["30226988","52188256"],"winner_id":"30226988","reasoning":"Document A is slightly more relevant because it discusses breast cancer survival outcomes, whereas Document B focuses on global incidence and mortality without outcome details specific to breast cancer biomarkers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:35.059005Z"}
{"comparison_id":"cf01dcee-f441-4c36-aac2-522de1fc110d","query_id":"51","doc_a_id":"13765757","doc_b_id":"30226988","presented_order":["13765757","30226988"],"winner_id":"30226988","reasoning":"Document B — it discusses breast cancer survival/outcomes (though not ALDH1 specifically), whereas A addresses reproductive risk factors rather than outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:35.059011Z"}
{"comparison_id":"4c3de5ba-1b25-4af4-90de-64dbdd6a5b50","query_id":"51","doc_a_id":"25488034","doc_b_id":"30226988","presented_order":["30226988","25488034"],"winner_id":"30226988","reasoning":"Document A is more relevant — it addresses breast cancer survival/outcomes broadly, whereas Document B discusses glutathione-related enzymes and oxidative stress without relating to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:35.059018Z"}
{"comparison_id":"f33dba46-2793-46a9-8eff-9ff1d17674f7","query_id":"51","doc_a_id":"14241418","doc_b_id":"30226988","presented_order":["30226988","14241418"],"winner_id":"30226988","reasoning":"Document A — it discusses breast cancer survival/outcomes generally; Document B focuses on a PI3K/mTOR inhibitor and not on ALDH1 or outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:35.059024Z"}
{"comparison_id":"c5425eec-9920-4979-b6d3-712c3c3b8c36","query_id":"51","doc_a_id":"22267225","doc_b_id":"30226988","presented_order":["30226988","22267225"],"winner_id":"30226988","reasoning":"Document A is more relevant — it discusses breast cancer survival/outcomes, whereas Document B focuses on chemoprevention and not on biomarkers or outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:35.059031Z"}
{"comparison_id":"d33454fd-3a43-47df-9447-27de64bff039","query_id":"51","doc_a_id":"17648235","doc_b_id":"2576811","presented_order":["2576811","17648235"],"winner_id":"17648235","reasoning":"Document B is more relevant — it discusses breast cancer cell proliferation and pathways affecting tumor behavior, whereas A focuses on epithelial junction assembly unrelated to ALDH1 or clinical outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:41.912612Z"}
{"comparison_id":"558bd35c-aff2-400b-8493-568a33f9db6c","query_id":"51","doc_a_id":"4999633","doc_b_id":"2576811","presented_order":["4999633","2576811"],"winner_id":"4999633","reasoning":"Document A is more relevant because it directly studies breast cancer (MCF-7) cell behavior, whereas Document B focuses on actin assembly in epithelial cells and does not relate to breast cancer biomarkers like ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:41.912634Z"}
{"comparison_id":"25c4322a-b193-4e53-9e10-1d7c25667719","query_id":"51","doc_a_id":"38551172","doc_b_id":"2576811","presented_order":["38551172","2576811"],"winner_id":"38551172","reasoning":"Document A is more relevant because it addresses breast cancer risk/outcomes, while Document B focuses on cellular actin assembly unrelated to ALDH1 or clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:41.912643Z"}
{"comparison_id":"bbec0896-c803-4569-94e6-d6b3ffa5982e","query_id":"51","doc_a_id":"4828631","doc_b_id":"2576811","presented_order":["2576811","4828631"],"winner_id":"2576811","reasoning":"Neither document addresses ALDH1 or clinical breast cancer outcomes. Document A is slightly more relevant because it concerns breast epithelial cell biology, whereas B focuses on BMI and cancer risk generally.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:41.912650Z"}
{"comparison_id":"079cda83-5fe7-479d-99ff-c75dccaaa9ad","query_id":"51","doc_a_id":"16322674","doc_b_id":"2576811","presented_order":["2576811","16322674"],"winner_id":"2576811","reasoning":"Document A is more relevant — it deals with molecular/cellular biology in breast epithelial cells (closer to ALDH1 expression and tumor biology) while Document B is about birth size and epidemiology; neither mentions ALDH1 or clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:41.912658Z"}
{"comparison_id":"819f3048-ac7a-44e5-a9ce-b4123ab9d986","query_id":"51","doc_a_id":"22267225","doc_b_id":"2576811","presented_order":["22267225","2576811"],"winner_id":"22267225","reasoning":"Document A is more relevant because it discusses breast cancer outcomes and prevention, whereas Document B focuses on actin assembly machinery in epithelial cells and does not address ALDH1 or clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:41.912666Z"}
{"comparison_id":"a85d4ced-fb60-45a3-ba9c-446de8160d9b","query_id":"51","doc_a_id":"52188256","doc_b_id":"2576811","presented_order":["52188256","2576811"],"winner_id":"52188256","reasoning":"Document A is more relevant — it discusses breast cancer incidence/outcomes, whereas Document B focuses on a cellular cytoskeleton protein unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:41.912673Z"}
{"comparison_id":"7a4d798b-7735-47de-8a34-1b07febe8bd1","query_id":"51","doc_a_id":"13765757","doc_b_id":"2576811","presented_order":["13765757","2576811"],"winner_id":"13765757","reasoning":"Document A is more relevant — it concerns breast cancer risk and tumor characteristics, whereas Document B addresses cytoskeletal regulation in epithelial cells and not clinical outcomes or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:41.912680Z"}
{"comparison_id":"eb5e409a-298e-4f46-ab5d-2db92d2a7228","query_id":"51","doc_a_id":"25488034","doc_b_id":"2576811","presented_order":["2576811","25488034"],"winner_id":"25488034","reasoning":"Reason: Document B discusses detoxifying enzymes and chemoresistance related to oxidative stress, which is conceptually closer to ALDH1's role in cancer than Document A's focus on FMNL2 and junctional actin.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:41.912687Z"}
{"comparison_id":"ca122296-bddc-4b44-8a66-28785e4a309d","query_id":"51","doc_a_id":"14241418","doc_b_id":"2576811","presented_order":["14241418","2576811"],"winner_id":"14241418","reasoning":"Document A is more relevant because it addresses cancer therapy and tumor growth (including trastuzumab-resistant cells), which relates to breast cancer outcomes; Document B focuses on basic epithelial cell biology rather than clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:41.912694Z"}
{"comparison_id":"4a915edb-03c0-4ab2-a08c-a78e6ee7ea7f","query_id":"51","doc_a_id":"17648235","doc_b_id":"22267225","presented_order":["22267225","17648235"],"winner_id":"22267225","reasoning":"Document A is more relevant — it addresses breast cancer clinical outcomes and prevention strategies, whereas Document B focuses on WNT signaling in cell lines and not on ALDH1 or clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:47.849985Z"}
{"comparison_id":"8a01ac79-508d-45a1-9543-a1c921fa275d","query_id":"51","doc_a_id":"4999633","doc_b_id":"22267225","presented_order":["22267225","4999633"],"winner_id":"4999633","reasoning":"Document B — it addresses how expression level of a breast cancer cell marker (mER-α) predicts cellular responses and proliferation, which is more directly related to the claim about marker expression and outcomes than the general chemoprevention overview in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:47.850008Z"}
{"comparison_id":"fa117720-4f7a-47e5-9d36-5f78f1ed1aef","query_id":"51","doc_a_id":"38551172","doc_b_id":"22267225","presented_order":["22267225","38551172"],"winner_id":"22267225","reasoning":"Document A is slightly more relevant because it discusses breast cancer topics broadly (prevention and outcomes), whereas Document B focuses narrowly on mammographic density and vitamin D with no relation to molecular markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:47.850017Z"}
{"comparison_id":"176dd281-ffbf-495a-820d-287321c04043","query_id":"51","doc_a_id":"14241418","doc_b_id":"22267225","presented_order":["22267225","14241418"],"winner_id":"22267225","reasoning":"Document A is more focused on breast cancer prevention and outcomes generally and is therefore more likely to address prognostic markers; Document B is specific to a PI3K/mTOR inhibitor and tumor signaling, not ALDH1 expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:47.850025Z"}
{"comparison_id":"953d32ee-608f-4240-b96d-ff8eb614e117","query_id":"51","doc_a_id":"52188256","doc_b_id":"22267225","presented_order":["22267225","52188256"],"winner_id":"22267225","reasoning":"Document A is more relevant — it discusses breast cancer and clinical outcomes/strategies, whereas Document B is broad epidemiology and does not address molecular markers or outcomes. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:47.850033Z"}
{"comparison_id":"6e62629c-039b-4f89-bf71-41a883938a91","query_id":"51","doc_a_id":"13765757","doc_b_id":"22267225","presented_order":["13765757","22267225"],"winner_id":"13765757","reasoning":"Document A is more relevant — it specifically addresses breast cancer risk and tumor characteristics, whereas B is a general chemoprevention review not focused on biomarkers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:47.850040Z"}
{"comparison_id":"1d2fb8a3-7faa-49d9-9ae1-d5b092bb1ea2","query_id":"51","doc_a_id":"25488034","doc_b_id":"22267225","presented_order":["22267225","25488034"],"winner_id":"22267225","reasoning":"Document A is more relevant — it mentions breast cancer outcomes and chemoprevention topics, which are closer to clinical associations with markers like ALDH1 than a biochemical review of glutathione enzymes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:47.850047Z"}
{"comparison_id":"e83460ba-505e-4db7-b5cc-9c4117bdcd40","query_id":"51","doc_a_id":"4999633","doc_b_id":"13765757","presented_order":["4999633","13765757"],"winner_id":"4999633","reasoning":"Neither document mentions ALDH1. Document A is slightly more relevant because it deals with molecular marker expression and cellular outcomes in breast cancer, whereas B is epidemiological. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:39:54.061245Z"}
{"comparison_id":"21e0b1a2-ae3c-49c6-b219-e46d789b10b5","query_id":"51","doc_a_id":"17648235","doc_b_id":"14241418","presented_order":["17648235","14241418"],"winner_id":"17648235","reasoning":"Neither document mentions ALDH1. Document A is marginally more relevant because it discusses breast cancer signaling and effects on proliferation/outcomes, whereas B focuses on a PI3K/mTOR inhibitor. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:00.116547Z"}
{"comparison_id":"5aeaedc8-ca30-4019-b0b0-8484434c5136","query_id":"51","doc_a_id":"38551172","doc_b_id":"14241418","presented_order":["14241418","38551172"],"winner_id":"14241418","reasoning":"Document A is more relevant — it discusses cancer cell biology and treatment response (trastuzumab resistance) which is closer to biomarker-associated outcomes than an epidemiologic study of vitamin D and mammographic density. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:00.116571Z"}
{"comparison_id":"67fbe24f-f0a7-43fb-a2b6-447351ac995f","query_id":"51","doc_a_id":"25488034","doc_b_id":"14241418","presented_order":["25488034","14241418"],"winner_id":"25488034","reasoning":"Document A is marginally more relevant because it discusses detoxifying/oxidative-stress enzymes (related to metabolic enzyme roles), whereas Document B focuses on a PI3K/mTOR inhibitor and cancer signaling without addressing ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:00.116579Z"}
{"comparison_id":"6ca6267a-e0f3-4e3d-8452-1ade2cfb084d","query_id":"51","doc_a_id":"52188256","doc_b_id":"14241418","presented_order":["52188256","14241418"],"winner_id":"52188256","reasoning":"Document A is more relevant — it addresses breast cancer incidence and outcomes broadly, whereas Document B focuses on a specific PI3K/mTOR inhibitor unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:00.116586Z"}
{"comparison_id":"78444692-2b42-4eef-8b11-98e1f7e1b606","query_id":"51","doc_a_id":"17648235","doc_b_id":"25488034","presented_order":["17648235","25488034"],"winner_id":"17648235","reasoning":"Document A is more relevant — it directly addresses breast cancer biology and signaling pathways, whereas Document B covers general oxidative stress mechanisms not specific to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:03.839171Z"}
{"comparison_id":"426fc283-2a3e-4716-bb0f-6bbad35bd6d6","query_id":"51","doc_a_id":"52188256","doc_b_id":"25488034","presented_order":["52188256","25488034"],"winner_id":"25488034","reasoning":"Document B is more relevant — it discusses detoxifying enzymes and oxidative stress pathways related to enzyme expression in cancer, which is closer to ALDH1's biological role than global cancer incidence data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:03.839191Z"}
{"comparison_id":"d6be008d-0734-4c64-bce9-7024e527f1cd","query_id":"51","doc_a_id":"4828631","doc_b_id":"16322674","presented_order":["4828631","16322674"],"winner_id":"16322674","reasoning":"Document B is more directly about breast cancer-specific risk factors, whereas A addresses BMI and many cancers. Neither mentions ALDH1 or prognosis, but B is more relevant to breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:08.821262Z"}
{"comparison_id":"f27c9cf6-3e93-472c-ad89-e9bc1fa09269","query_id":"51","doc_a_id":"20886584","doc_b_id":"24144677","presented_order":["20886584","24144677"],"winner_id":"24144677","reasoning":"Document B is slightly more relevant because it addresses genetic associations with breast cancer risk/outcomes, whereas A focuses on treatment-related neurotoxicity unrelated to ALDH1 expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.539964Z"}
{"comparison_id":"92ade27b-8577-479a-abf8-8f8d4e0d0081","query_id":"51","doc_a_id":"15721252","doc_b_id":"24144677","presented_order":["24144677","15721252"],"winner_id":"15721252","reasoning":"Neither paper discusses ALDH1. Document B is marginally more relevant because it examines molecular markers and treatment response in breast cancer, which is closer to outcome associations than a study of ATM germline risk. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.539986Z"}
{"comparison_id":"d2d20fd9-5308-4c1e-9e99-e8726fab30af","query_id":"51","doc_a_id":"15081770","doc_b_id":"24144677","presented_order":["24144677","15081770"],"winner_id":"24144677","reasoning":"Document A is more relevant — it deals with breast cancer (the same disease as the claim), whereas Document B concerns lymphoma, not breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.539996Z"}
{"comparison_id":"47da6ca1-2dd0-4a4a-8af2-70db21216e05","query_id":"51","doc_a_id":"16701509","doc_b_id":"24144677","presented_order":["24144677","16701509"],"winner_id":"16701509","reasoning":"Document B is more relevant — neither mentions ALDH1, but B addresses a biomarker (HDL-C) and its association with breast cancer risk/outcomes, which is closer to the claim than A's ATM mutation risk study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540004Z"}
{"comparison_id":"8ddd2aa9-9be2-489c-b66a-76ca2082bff6","query_id":"51","doc_a_id":"37480103","doc_b_id":"24144677","presented_order":["24144677","37480103"],"winner_id":"24144677","reasoning":"Document A is more related to molecular markers and genetic associations with breast cancer risk, making it closer in topic to ALDH1 expression than pregnancy characteristics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540011Z"}
{"comparison_id":"a3c0b7be-c8fa-4b14-be13-e74227f0cca0","query_id":"51","doc_a_id":"15335331","doc_b_id":"24144677","presented_order":["24144677","15335331"],"winner_id":"24144677","reasoning":"Document A is about breast cancer (genetic risk) while Document B concerns oral squamous cell carcinoma; neither mentions ALDH1, but A is more relevant to breast cancer outcomes.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540018Z"}
{"comparison_id":"35c9ed94-b503-4bad-afa7-3ef6c967386d","query_id":"51","doc_a_id":"29366489","doc_b_id":"24144677","presented_order":["29366489","24144677"],"winner_id":"29366489","reasoning":"Document A is slightly more relevant — it discusses a tumor suppressor and the use of molecular markers for cancer prognosis, which is closer to a claim about marker expression and outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540025Z"}
{"comparison_id":"3e37bdfd-570e-4e37-a115-804355cc3b5e","query_id":"51","doc_a_id":"4414547","doc_b_id":"24144677","presented_order":["24144677","4414547"],"winner_id":"24144677","reasoning":"Document A is slightly more relevant — it reports an association study linking a genetic variant to breast cancer risk, which is closer to clinical outcome associations than the PPM1D mechanistic study. Neither mentions ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540032Z"}
{"comparison_id":"fd4c295c-1ec3-4faf-a1c3-29be6739fb73","query_id":"51","doc_a_id":"52180874","doc_b_id":"24144677","presented_order":["52180874","24144677"],"winner_id":"24144677","reasoning":"Document B is more relevant — it specifically concerns breast cancer (genetic risk), whereas A focuses on PD-1/PD-L1 immunotherapy across cancers and doesn't address ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540039Z"}
{"comparison_id":"eec4dffd-a56b-40f1-b439-072cb9f05493","query_id":"51","doc_a_id":"17450673","doc_b_id":"24144677","presented_order":["24144677","17450673"],"winner_id":"24144677","reasoning":"Document A is more relevant. It discusses a molecular/genetic marker related to breast cancer risk, which is closer to the query about a protein marker (ALDH1) and outcomes; Document B focuses on perinatal epidemiology and is less related.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540047Z"}
{"comparison_id":"ddd4d672-5582-4f48-806b-8f76c5a3dc92","query_id":"51","doc_a_id":"2130391","doc_b_id":"24144677","presented_order":["2130391","24144677"],"winner_id":"2130391","reasoning":"Reason: Neither abstract mentions ALDH1, but Document A addresses tumor progression and factors affecting breast cancer outcomes, so it's more relevant than a paper on ATM germline variants and cancer risk.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540054Z"}
{"comparison_id":"9203200b-1339-4a61-bbda-6c2c1cfbf7fa","query_id":"51","doc_a_id":"8671456","doc_b_id":"24144677","presented_order":["8671456","24144677"],"winner_id":"8671456","reasoning":"Document A is more relevant — it reports effects on tumor growth and survival in breast cancer models (outcomes), whereas Document B addresses ATM mutation risk and not ALDH1 expression or clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540061Z"}
{"comparison_id":"f65fbc81-da9d-4109-9b7b-4c9c2a4b2b4f","query_id":"51","doc_a_id":"1554348","doc_b_id":"24144677","presented_order":["1554348","24144677"],"winner_id":"1554348","reasoning":"Document A is more relevant — it discusses expression changes of enzymes/proteins in breast cancer cells, whereas Document B concerns ATM germline mutations and cancer risk, not marker expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540068Z"}
{"comparison_id":"9a38df25-f8e4-435a-b234-d98b48a5233b","query_id":"51","doc_a_id":"20280410","doc_b_id":"24144677","presented_order":["20280410","24144677"],"winner_id":"24144677","reasoning":"Document B is more focused on genetic associations with breast cancer risk, making it slightly closer to the query about biomarkers and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540074Z"}
{"comparison_id":"1decc6ee-8a7d-4845-be9c-2bdd09a93f71","query_id":"51","doc_a_id":"67045088","doc_b_id":"24144677","presented_order":["67045088","24144677"],"winner_id":"67045088","reasoning":"Document A discusses mechanisms affecting tumor growth and therapy responses in breast cancer, which is more related to outcomes than Document B's focus on ATM germline risk. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540081Z"}
{"comparison_id":"6868ef5d-8db1-40ef-b6e0-a205fe8d2eb8","query_id":"51","doc_a_id":"23863551","doc_b_id":"24144677","presented_order":["24144677","23863551"],"winner_id":"23863551","reasoning":"Document B is slightly more relevant — it discusses expression of a receptor (HER3) and therapy response in breast cancer, which is closer to outcome-related expression than a germline ATM risk study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540088Z"}
{"comparison_id":"f0c2b022-1ba2-48e3-a4f2-3b45a654267b","query_id":"51","doc_a_id":"3329824","doc_b_id":"24144677","presented_order":["24144677","3329824"],"winner_id":"3329824","reasoning":"Document B is more relevant — it concerns outcomes (recurrence/metastasis risk) in breast cancer patients, whereas A addresses genetic susceptibility to developing breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540095Z"}
{"comparison_id":"a7942575-7fa4-4ffa-80f7-e2eb89a53cde","query_id":"51","doc_a_id":"9394119","doc_b_id":"24144677","presented_order":["9394119","24144677"],"winner_id":"9394119","reasoning":"Neither document addresses ALDH1 expression or its association with outcomes. If one must be chosen, Document A is slightly more relevant because it deals broadly with breast cancer risk and gene associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540101Z"}
{"comparison_id":"04513728-a411-4b91-a501-8ab0120a726d","query_id":"51","doc_a_id":"13831842","doc_b_id":"24144677","presented_order":["13831842","24144677"],"winner_id":"24144677","reasoning":"Document B is slightly more relevant because it addresses a molecular/genetic marker's association with breast cancer risk, whereas A focuses on anthropometric risk factors unrelated to ALDH1 expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540108Z"}
{"comparison_id":"a8030ed0-559b-424c-9610-40df294f6da0","query_id":"51","doc_a_id":"5222182","doc_b_id":"24144677","presented_order":["24144677","5222182"],"winner_id":"24144677","reasoning":"Document A is more relevant — it discusses a molecular/genetic marker associated with breast cancer risk, which is closer to ALDH1 expression and outcomes than mammographic density predictors.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540115Z"}
{"comparison_id":"e4b9f4bf-f0fc-4822-8f6f-96efba99dcc8","query_id":"51","doc_a_id":"13831558","doc_b_id":"24144677","presented_order":["24144677","13831558"],"winner_id":"13831558","reasoning":"Neither document mentions ALDH1 expression. Document B is slightly more related to breast cancer outcomes (risk/detection) than A, which only addresses a specific genetic susceptibility.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540122Z"}
{"comparison_id":"a49945d6-5755-46bb-a5b0-dc48056edd68","query_id":"51","doc_a_id":"13791206","doc_b_id":"24144677","presented_order":["13791206","24144677"],"winner_id":"24144677","reasoning":"Document B is more relevant — it deals with genetic associations and breast cancer risk/outcomes, whereas A focuses on molecular DNA-repair mechanisms in BRCA1-deficient cells and not clinical markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540148Z"}
{"comparison_id":"914a9282-095d-4640-8348-c3666312625d","query_id":"51","doc_a_id":"4886637","doc_b_id":"24144677","presented_order":["24144677","4886637"],"winner_id":"24144677","reasoning":"Reason: Neither document addresses ALDH1; both are off-topic. Document A is slightly more related to molecular/genetic markers in breast cancer, so it's marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540163Z"}
{"comparison_id":"f22587d1-08fe-4b0f-b72f-b27849f91834","query_id":"51","doc_a_id":"16098747","doc_b_id":"24144677","presented_order":["24144677","16098747"],"winner_id":"24144677","reasoning":"Neither document discusses ALDH1. Document A is slightly more relevant because it addresses a molecular/genetic marker associated with breast cancer risk, whereas B focuses on epidemiologic factors and breast density.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540172Z"}
{"comparison_id":"4644a90a-9933-4b61-b6b5-b3026b06130a","query_id":"51","doc_a_id":"38623601","doc_b_id":"24144677","presented_order":["38623601","24144677"],"winner_id":"38623601","reasoning":"Neither document mentions ALDH1. Document A is slightly more relevant because it discusses protein expression in breast tumors and therapeutic outcomes, while B concerns ATM germline mutations and cancer risk. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540179Z"}
{"comparison_id":"1e2f115c-d2d3-4821-9716-aba1d4bd1c8b","query_id":"51","doc_a_id":"22007333","doc_b_id":"24144677","presented_order":["22007333","24144677"],"winner_id":"24144677","reasoning":"Document B is more relevant — it addresses molecular/genetic factors related to breast cancer risk, whereas A focuses on reproductive factors and mammographic density. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540186Z"}
{"comparison_id":"453b70be-3156-4b4b-8ccb-02c6bd778fd5","query_id":"51","doc_a_id":"3067015","doc_b_id":"24144677","presented_order":["24144677","3067015"],"winner_id":"24144677","reasoning":"Document A is more relevant because it concerns breast cancer (though not ALDH1 specifically), while Document B discusses ALDH2 and blood pressure, unrelated to breast cancer outcomes.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540193Z"}
{"comparison_id":"d4a69da7-2a56-4e95-8374-d3b568e1450e","query_id":"51","doc_a_id":"3727986","doc_b_id":"24144677","presented_order":["3727986","24144677"],"winner_id":"24144677","reasoning":"Document B is more relevant — it addresses genetic associations with breast cancer risk/outcomes, whereas Document A focuses on cell adhesion mechanisms and invasion and does not discuss clinical markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540200Z"}
{"comparison_id":"a82dbf88-05b6-48bb-90b6-0561f70c2f8d","query_id":"51","doc_a_id":"2015126","doc_b_id":"24144677","presented_order":["2015126","24144677"],"winner_id":"2015126","reasoning":"Document A is slightly more relevant because it discusses breast cancer management and outcomes in genetically predisposed women, whereas Document B focuses narrowly on ATM mutations and cancer risk. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540207Z"}
{"comparison_id":"5c8380c8-57b6-439d-a75b-1fd1d8ebddbf","query_id":"51","doc_a_id":"23557241","doc_b_id":"24144677","presented_order":["24144677","23557241"],"winner_id":"24144677","reasoning":"Document A is more related to molecular markers and breast cancer biology (though it doesn't mention ALDH1), while B focuses on birth/intrauterine epidemiology. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540214Z"}
{"comparison_id":"e29f810a-66d8-4a22-a7d8-72a9894544a3","query_id":"51","doc_a_id":"878526","doc_b_id":"24144677","presented_order":["24144677","878526"],"winner_id":"878526","reasoning":"Document B is more relevant — it addresses metastasis-initiating breast cancer cells and factors affecting metastatic outcome, which is closer to prognostic markers like ALDH1. Document A focuses on an ATM mutation and breast cancer risk. (Neither document mentions ALDH1.)\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540221Z"}
{"comparison_id":"69ba89f1-3c17-4ab2-bc93-b4972cf7ee4c","query_id":"51","doc_a_id":"36432234","doc_b_id":"24144677","presented_order":["36432234","24144677"],"winner_id":"24144677","reasoning":"Neither document discusses ALDH1 expression or its association with breast cancer outcomes; both are irrelevant. Document B is marginally closer since it addresses breast cancer risk associations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540228Z"}
{"comparison_id":"123179a4-f8ed-40d3-b0f0-bd5d214aeb1b","query_id":"51","doc_a_id":"3222187","doc_b_id":"24144677","presented_order":["3222187","24144677"],"winner_id":"24144677","reasoning":"Neither abstract mentions ALDH1. Document B is more directly about genetic factors linked to breast cancer risk/outcomes, so it's slightly more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540235Z"}
{"comparison_id":"7c53b1d1-bc35-4740-9317-4c19e5d48283","query_id":"51","doc_a_id":"7875158","doc_b_id":"24144677","presented_order":["24144677","7875158"],"winner_id":"24144677","reasoning":"Document A is more relevant — it addresses breast cancer risk/associations, whereas B is an in vitro study on oxidative stress in resistant cells and does not relate to ALDH1 or clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540242Z"}
{"comparison_id":"541b92b3-813b-42e7-817e-c04cf20f9593","query_id":"51","doc_a_id":"32534305","doc_b_id":"24144677","presented_order":["24144677","32534305"],"winner_id":"24144677","reasoning":"Neither document addresses ALDH1 expression. Document A is slightly more relevant because it studies a molecular genetic marker's association with breast cancer risk, which is closer to marker–outcome research than B's diabetes–incidence focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540249Z"}
{"comparison_id":"fe56b277-bd93-44c2-8c67-3e5f2f512d57","query_id":"51","doc_a_id":"17163294","doc_b_id":"24144677","presented_order":["17163294","24144677"],"winner_id":"24144677","reasoning":"Document B is more directly about breast cancer (molecular genetics and risk), while A only distinguishes cancer types by plasma metabolites and doesn't address markers tied to outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540256Z"}
{"comparison_id":"80b66d6b-8e00-442b-92c1-3a63cb8974e2","query_id":"51","doc_a_id":"16390264","doc_b_id":"24144677","presented_order":["24144677","16390264"],"winner_id":"16390264","reasoning":"Document B is more relevant — it concerns breast cancer patient care and outcomes, whereas Document A addresses a germline ATM mutation and risk. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540263Z"}
{"comparison_id":"92fe60b5-ac26-40fb-b86a-56e55b762092","query_id":"51","doc_a_id":"3524352","doc_b_id":"24144677","presented_order":["24144677","3524352"],"winner_id":"24144677","reasoning":"Document A is more relevant — it deals with molecular/genetic associations with breast cancer (closer to biomarker–outcome relationships), while B is about geographic mortality patterns unrelated to ALDH1 expression.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540270Z"}
{"comparison_id":"1b6eb558-e681-482a-986c-d4b6110ba2b4","query_id":"51","doc_a_id":"3559136","doc_b_id":"24144677","presented_order":["3559136","24144677"],"winner_id":"3559136","reasoning":"Neither document mentions ALDH1, but Document A (tumor microenvironment/CAF effects) is slightly more related to tumor biology and outcomes than a germline ATM mutation study. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540277Z"}
{"comparison_id":"f4258ece-0139-42a1-9d20-c084bdf655cc","query_id":"51","doc_a_id":"15600979","doc_b_id":"24144677","presented_order":["15600979","24144677"],"winner_id":"15600979","reasoning":"Document A is more relevant — it discusses gene overexpression and its impact on breast cancer biology and clinical implications, which is closer to a claim about a marker's association with outcomes than Document B's focus on a germline risk mutation. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540284Z"}
{"comparison_id":"06a2c88e-39d2-41a6-8c7c-bba192041f4c","query_id":"51","doc_a_id":"1065627","doc_b_id":"24144677","presented_order":["1065627","24144677"],"winner_id":"1065627","reasoning":"Document A is more relevant — it addresses treatment response and factors affecting therapeutic efficacy in breast cancer, which is more closely related to outcomes than a genetic susceptibility study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540292Z"}
{"comparison_id":"14543929-a094-4583-826e-766ccfadfd9c","query_id":"51","doc_a_id":"13519661","doc_b_id":"24144677","presented_order":["13519661","24144677"],"winner_id":"24144677","reasoning":"Reason: Both documents discuss genetic associations with breast cancer risk, but Document B reports a specific association (ATM missense mutation linked to increased breast cancer risk), making it slightly more relevant to an association claim than Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540299Z"}
{"comparison_id":"496651f6-5ada-4886-899a-b33df68c2829","query_id":"51","doc_a_id":"38784540","doc_b_id":"24144677","presented_order":["24144677","38784540"],"winner_id":"24144677","reasoning":"Neither document mentions ALDH1 or outcomes; both are irrelevant. Document A is slightly more related because it deals directly with breast cancer genetic risk, whereas B focuses on mammographic density and life-course factors. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540308Z"}
{"comparison_id":"70710970-0fff-4058-855f-992caa007ae1","query_id":"51","doc_a_id":"23078022","doc_b_id":"24144677","presented_order":["23078022","24144677"],"winner_id":"24144677","reasoning":"Document B is more directly related to breast cancer clinical associations (risk/outcomes), while A describes a general oncogenic signaling mechanism not connected to ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540315Z"}
{"comparison_id":"55ce8698-5bd7-433b-b2c7-395bd37223d4","query_id":"51","doc_a_id":"5487448","doc_b_id":"24144677","presented_order":["24144677","5487448"],"winner_id":"24144677","reasoning":"Neither document mentions ALDH1 or breast cancer outcomes. Document A is slightly more relevant because it deals with a molecular/genetic marker linked to breast cancer risk, whereas B addresses birth weight and mammographic density. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540326Z"}
{"comparison_id":"fdd750c4-b84b-490e-8aa5-420a80587c5c","query_id":"51","doc_a_id":"3848469","doc_b_id":"24144677","presented_order":["24144677","3848469"],"winner_id":"3848469","reasoning":"Document B — it addresses stem cell marker expression (which includes ALDH1) and tumour behavior, whereas Document A is about ATM mutations and breast cancer risk and does not relate to ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540333Z"}
{"comparison_id":"4da5e19f-b8bf-4565-ae70-01b29c905af5","query_id":"51","doc_a_id":"15832146","doc_b_id":"24144677","presented_order":["15832146","24144677"],"winner_id":"15832146","reasoning":"Document A is more relevant — it addresses tumor growth and progression (which relate to outcomes), whereas Document B focuses on ATM mutation risk and not on ALDH1 or clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540340Z"}
{"comparison_id":"f025f43f-65a7-4cc8-b359-ec2523ca5cea","query_id":"51","doc_a_id":"9171913","doc_b_id":"24144677","presented_order":["9171913","24144677"],"winner_id":"24144677","reasoning":"Reason: Both documents do not discuss ALDH1, but Document B deals with a molecular/genetic marker related to breast cancer risk, which is closer in topic to biomarker–outcome associations than the lipid–risk study in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540347Z"}
{"comparison_id":"04c9360c-7a7d-4018-b68a-224730664a04","query_id":"51","doc_a_id":"54561709","doc_b_id":"24144677","presented_order":["24144677","54561709"],"winner_id":"24144677","reasoning":"Document A is more relevant — it deals with breast cancer patient data and genetic risk, whereas Document B concerns cell-line variability and not clinical expression or outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540354Z"}
{"comparison_id":"b6dac94e-5b0c-4772-986d-bd9d42c79a79","query_id":"51","doc_a_id":"40735046","doc_b_id":"24144677","presented_order":["24144677","40735046"],"winner_id":"40735046","reasoning":"Document B is more relevant — it addresses breast cancer outcomes (mortality), whereas A concerns a genetic susceptibility variant, not outcome or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540387Z"}
{"comparison_id":"9b93b321-1c30-4b85-ae3d-6f9f4d09d34e","query_id":"51","doc_a_id":"6259170","doc_b_id":"24144677","presented_order":["24144677","6259170"],"winner_id":"24144677","reasoning":"Document A is more relevant — it directly addresses breast cancer (genetic risk), whereas B discusses Nrf2/mitochondria pathways without specific focus on ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540397Z"}
{"comparison_id":"828f4785-c24f-4c6d-90c7-1483af18d88f","query_id":"51","doc_a_id":"31851367","doc_b_id":"24144677","presented_order":["31851367","24144677"],"winner_id":"31851367","reasoning":"Document A is more relevant — it discusses molecular regulators in estrogen receptor–positive breast cancer, which is closer to expression markers like ALDH1 than a paper on ATM germline mutations. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540405Z"}
{"comparison_id":"c90ce730-220b-43b7-8fd1-32bc1fad2feb","query_id":"51","doc_a_id":"15512462","doc_b_id":"24144677","presented_order":["24144677","15512462"],"winner_id":"15512462","reasoning":"Document B is more relevant — it addresses breast cancer incidence/outcomes in a cohort, whereas Document A focuses on an unrelated ATM mutation. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540413Z"}
{"comparison_id":"7c792e63-a543-471b-a48c-64e451bf51a2","query_id":"51","doc_a_id":"831167","doc_b_id":"24144677","presented_order":["24144677","831167"],"winner_id":"24144677","reasoning":"Document A is about breast cancer genetics and risk, so it's more relevant to a claim about breast cancer outcomes than a glioblastoma study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540420Z"}
{"comparison_id":"3974b18f-7548-410b-8fd0-43f3996ef722","query_id":"51","doc_a_id":"219475","doc_b_id":"24144677","presented_order":["219475","24144677"],"winner_id":"219475","reasoning":"Document A is slightly more relevant because it concerns tumor progression and metastasis (clinical outcomes), whereas Document B discusses germline ATM mutations and cancer risk; neither mentions ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:40:41.540427Z"}
{"comparison_id":"5e92ddea-d1f4-4dde-a4de-7e4f8559865e","query_id":"51","doc_a_id":"15721252","doc_b_id":"38623601","presented_order":["15721252","38623601"],"winner_id":"15721252","reasoning":"Document A is slightly more relevant because it discusses molecular markers linked to breast cancer response and outcomes, whereas Document B focuses on arginine starvation in ASS1-deficient cells and not marker–outcome associations. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:02.811010Z"}
{"comparison_id":"400561f5-3f8c-4d7b-88c4-20944ec433a6","query_id":"51","doc_a_id":"16701509","doc_b_id":"38623601","presented_order":["16701509","38623601"],"winner_id":"16701509","reasoning":"Document A is more relevant because it examines associations between a biomarker and breast cancer risk/outcomes, whereas Document B focuses on metabolic therapy in ASS1-deficient cells and is unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:02.811031Z"}
{"comparison_id":"a37d3840-62f0-44c4-8661-57a3afc42936","query_id":"51","doc_a_id":"29366489","doc_b_id":"38623601","presented_order":["29366489","38623601"],"winner_id":"38623601","reasoning":"Neither document mentions ALDH1; both fail to provide evidence about its association with outcomes. Document B is marginally more relevant because it focuses specifically on breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:02.811039Z"}
{"comparison_id":"2ddbdf1a-e65a-4d63-af0c-ec27116c069a","query_id":"51","doc_a_id":"2130391","doc_b_id":"38623601","presented_order":["2130391","38623601"],"winner_id":"2130391","reasoning":"Document A is slightly more relevant because it discusses factors affecting breast cancer invasion and progression, which relate to clinical outcomes; Document B focuses on a metabolic therapy unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:02.811047Z"}
{"comparison_id":"ed10787a-0b5c-4ad6-bdab-cb2aa0cac396","query_id":"51","doc_a_id":"8671456","doc_b_id":"38623601","presented_order":["8671456","38623601"],"winner_id":"38623601","reasoning":"Document B is more relevant — it discusses a biomarker (ASS1) linked to therapy sensitivity and patient samples, whereas A describes a therapeutic agent without biomarker/outcome associations. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:02.811055Z"}
{"comparison_id":"39f189d7-0737-47ef-856a-457abba25c79","query_id":"51","doc_a_id":"1554348","doc_b_id":"38623601","presented_order":["38623601","1554348"],"winner_id":"1554348","reasoning":"Neither abstract mentions ALDH1. Document B is marginally more relevant because it examines protein expression changes in MCF-7 breast cancer cells (marker-related study), whereas A focuses on arginine/ASS1 metabolic therapy. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:02.811061Z"}
{"comparison_id":"1ed3c636-6b9a-40aa-bb1e-88849f9aa011","query_id":"51","doc_a_id":"67045088","doc_b_id":"38623601","presented_order":["38623601","67045088"],"winner_id":"67045088","reasoning":"Neither paper mentions ALDH1. Document B is slightly more relevant because it discusses mechanisms affecting breast tumor control/outcomes, whereas A focuses on ASS1-specific metabolic therapy. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:02.811068Z"}
{"comparison_id":"c0f05033-a57f-4fba-8e22-0d9d24dd6109","query_id":"51","doc_a_id":"23863551","doc_b_id":"38623601","presented_order":["38623601","23863551"],"winner_id":"38623601","reasoning":"Document A is slightly more relevant — it discusses biomarker expression in breast cancer and links marker status to therapeutic response, whereas Document B focuses on drug feedback mechanisms unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:02.811075Z"}
{"comparison_id":"ce2755e8-8709-49c8-ad6f-7e6a00ecfc32","query_id":"51","doc_a_id":"3329824","doc_b_id":"38623601","presented_order":["38623601","3329824"],"winner_id":"3329824","reasoning":"Neither document mentions ALDH1, so both are irrelevant to the claim. Document B is slightly more relevant because it addresses clinical outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:02.811082Z"}
{"comparison_id":"85a9cc15-2e77-436c-b638-121747f0a34a","query_id":"51","doc_a_id":"9394119","doc_b_id":"38623601","presented_order":["9394119","38623601"],"winner_id":"38623601","reasoning":"Document B — it discusses expression of a metabolic enzyme (ASS1) and treatment-relevant biology in breast cancer, which is closer to a claim about a biomarker's association with outcomes than Document A's focus on BRCA mutation locations. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:02.811090Z"}
{"comparison_id":"bc02f9bb-c1a5-43e8-b80c-f838da45ec10","query_id":"51","doc_a_id":"13831558","doc_b_id":"38623601","presented_order":["38623601","13831558"],"winner_id":"38623601","reasoning":"Document A is more relevant — it discusses molecular marker expression in breast cancer, whereas Document B is about mammographic density and cancer risk, not ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:02.811097Z"}
{"comparison_id":"a58d5f6b-50c9-43c9-b0d0-d7966d46f398","query_id":"51","doc_a_id":"219475","doc_b_id":"38623601","presented_order":["38623601","219475"],"winner_id":"219475","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it addresses factors (myeloid cells, metastasis) that directly affect breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:02.811104Z"}
{"comparison_id":"9052dbc0-98c5-40e5-b47c-2bb9d09e1adf","query_id":"51","doc_a_id":"2015126","doc_b_id":"38623601","presented_order":["2015126","38623601"],"winner_id":"2015126","reasoning":"Neither abstract mentions ALDH1. Document A is slightly more relevant because it addresses breast cancer management/outcomes generally, while Document B focuses specifically on ASS1 and arginine starvation therapy.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:02.811111Z"}
{"comparison_id":"b9386884-a199-4b89-a412-a4a393027b9c","query_id":"51","doc_a_id":"878526","doc_b_id":"38623601","presented_order":["878526","38623601"],"winner_id":"878526","reasoning":"Document A is slightly more relevant because it discusses mechanisms of metastatic establishment and factors affecting outcomes in breast cancer, whereas Document B focuses on arginine starvation therapy in ASS1-deficient cells and is less related to prognosis markers like ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:02.811118Z"}
{"comparison_id":"6766e1d8-9a64-48d1-8023-06ba0aa3f410","query_id":"51","doc_a_id":"16390264","doc_b_id":"38623601","presented_order":["16390264","38623601"],"winner_id":"16390264","reasoning":"Document A is more relevant because it discusses breast cancer outcomes (access to care and treatment disparities), whereas Document B focuses on ASS1 metabolism in cell lines and not on ALDH1 or clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:02.811125Z"}
{"comparison_id":"729e4553-ec7e-4f6a-a47a-dc193cdabf54","query_id":"51","doc_a_id":"3559136","doc_b_id":"38623601","presented_order":["3559136","38623601"],"winner_id":"38623601","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it studies a breast cancer biomarker (ASS1) and treatment response/outcomes, whereas A focuses on CAF-driven immune infiltration and therapy resistance.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:02.811132Z"}
{"comparison_id":"9dc8668d-c125-4016-9f23-65fa871e4f23","query_id":"51","doc_a_id":"15600979","doc_b_id":"38623601","presented_order":["38623601","15600979"],"winner_id":"38623601","reasoning":"Document A is slightly more relevant because it discusses breast cancer cell behavior and potential treatment implications, whereas B focuses on DNA repair pathway disruption unrelated to ALDH1 or clinical outcomes. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:02.811138Z"}
{"comparison_id":"b534795c-1d84-4084-8e5a-2a24748c03ff","query_id":"51","doc_a_id":"1065627","doc_b_id":"38623601","presented_order":["38623601","1065627"],"winner_id":"38623601","reasoning":"Document A is slightly more relevant because it discusses gene expression in breast cancer and links expression status in patient samples to therapeutic outcomes; Document B focuses on microenvironment-mediated drug resistance unrelated to marker expression like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:02.811145Z"}
{"comparison_id":"76836f67-7a43-47f1-8b49-ffacd14566fc","query_id":"51","doc_a_id":"3848469","doc_b_id":"38623601","presented_order":["38623601","3848469"],"winner_id":"38623601","reasoning":"Document A is more relevant — it addresses breast cancer (the same disease as the query), whereas Document B studies lung cancer and therefore is less directly applicable.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:02.811151Z"}
{"comparison_id":"bb94c592-d406-4b39-8ff2-bf6cab21dc7e","query_id":"51","doc_a_id":"15832146","doc_b_id":"38623601","presented_order":["38623601","15832146"],"winner_id":"15832146","reasoning":"Neither document mentions ALDH1. Document B is marginally more relevant because it addresses factors (tumor growth/angiogenesis) that relate to breast cancer outcomes, while A focuses on arginine metabolism in ASS1-deficient cells.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:02.811158Z"}
{"comparison_id":"26af069c-7d55-4a1a-879b-5005f4a52941","query_id":"51","doc_a_id":"40735046","doc_b_id":"38623601","presented_order":["38623601","40735046"],"winner_id":"38623601","reasoning":"Document A is more relevant — it addresses molecular features and treatments of breast cancer (closer to ALDH1 expression as a biomarker) while Document B is about screening outcomes and unrelated. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:02.811165Z"}
{"comparison_id":"a0511424-9d26-4091-b855-4a6a945304dd","query_id":"51","doc_a_id":"31851367","doc_b_id":"38623601","presented_order":["31851367","38623601"],"winner_id":"31851367","reasoning":"Document A is marginally more relevant because it discusses breast cancer-related biology (estrogen receptor coregulators), though neither document mentions ALDH1 or provides evidence about ALDH1 expression and outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:02.811172Z"}
{"comparison_id":"fa10359d-04ad-4671-a608-cbc77ada44ea","query_id":"51","doc_a_id":"15512462","doc_b_id":"38623601","presented_order":["15512462","38623601"],"winner_id":"38623601","reasoning":"B is more relevant — it discusses molecular features of breast cancer (therapeutic and prognostic implications), whereas A addresses pre-eclampsia and cancer risk unrelated to ALDH1 expression. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:02.811180Z"}
{"comparison_id":"9e6acb88-fbb8-4e82-8348-5402199cbf62","query_id":"51","doc_a_id":"15721252","doc_b_id":"3329824","presented_order":["15721252","3329824"],"winner_id":"15721252","reasoning":"Document A is more relevant — it discusses molecular markers and treatment response in breast cancer, whereas Document B focuses on CNS metastasis risk in HER2+ patients and doesn't address marker expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:12.023891Z"}
{"comparison_id":"18b5a22e-e31f-4d18-a8d0-16d48fe5d7a2","query_id":"51","doc_a_id":"16701509","doc_b_id":"3329824","presented_order":["3329824","16701509"],"winner_id":"3329824","reasoning":"Neither abstract mentions ALDH1. Document A is slightly more relevant because it concerns breast cancer outcomes (recurrence/metastasis), whereas B addresses risk factors for developing cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:12.023912Z"}
{"comparison_id":"7fd21cf3-cdf8-4267-b4d8-20f017408348","query_id":"51","doc_a_id":"2130391","doc_b_id":"3329824","presented_order":["3329824","2130391"],"winner_id":"2130391","reasoning":"Reason: Neither abstract mentions ALDH1, but Document B discusses factors (tumor invasion/progression) more directly related to outcomes than Document A's focus on CNS recurrence with trastuzumab.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:12.023920Z"}
{"comparison_id":"e2ba14d2-7d30-4342-8ca5-5ff985568c12","query_id":"51","doc_a_id":"1554348","doc_b_id":"3329824","presented_order":["3329824","1554348"],"winner_id":"1554348","reasoning":"Document B is slightly more relevant — it studies molecular markers in breast cancer cells (MCF-7), whereas Document A concerns CNS metastasis risk with trastuzumab and doesn't address molecular markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:12.023928Z"}
{"comparison_id":"f5eef57a-4d74-4eee-8cd7-291aea9768ef","query_id":"51","doc_a_id":"67045088","doc_b_id":"3329824","presented_order":["3329824","67045088"],"winner_id":"67045088","reasoning":"Neither document discusses ALDH1. Document B is slightly more relevant because it addresses mechanisms of tumor control in breast cancer, whereas A focuses on CNS metastases after trastuzumab in HER2-positive patients.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:12.023935Z"}
{"comparison_id":"ebb64385-412f-470e-afd2-fc10c0112884","query_id":"51","doc_a_id":"31851367","doc_b_id":"3329824","presented_order":["3329824","31851367"],"winner_id":"31851367","reasoning":"Document B is more relevant — it discusses molecular regulators in breast cancer biology and therapeutic targeting, whereas A focuses on CNS metastases incidence with trastuzumab and doesn't address ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:12.023942Z"}
{"comparison_id":"2d8ea522-6bd6-450b-be8c-7c5d7826e992","query_id":"51","doc_a_id":"219475","doc_b_id":"3329824","presented_order":["219475","3329824"],"winner_id":"3329824","reasoning":"Document B is more relevant — it addresses breast cancer clinical outcomes (recurrence/metastasis), whereas Document A discusses immune cell mechanisms in a mouse model not linked to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:12.023949Z"}
{"comparison_id":"65d301bb-245c-4517-8514-bf16f681261f","query_id":"51","doc_a_id":"2015126","doc_b_id":"3329824","presented_order":["3329824","2015126"],"winner_id":"3329824","reasoning":"Document A is slightly more relevant because it reports on clinical outcomes in a breast cancer subgroup, whereas Document B focuses on management of genetic predisposition and not outcomes related to biomarker expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:12.023956Z"}
{"comparison_id":"fa6b65f9-c788-4176-874e-d98cf997c1df","query_id":"51","doc_a_id":"878526","doc_b_id":"3329824","presented_order":["3329824","878526"],"winner_id":"878526","reasoning":"Document B is more relevant — it discusses metastasis-initiating breast cancer cells (closer to ALDH1's role as a stem-cell/metastasis marker), whereas A focuses on CNS recurrence risk after trastuzumab and does not relate to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:12.023964Z"}
{"comparison_id":"a5719f38-cd41-46de-bb31-16fb4907c573","query_id":"51","doc_a_id":"16390264","doc_b_id":"3329824","presented_order":["16390264","3329824"],"winner_id":"16390264","reasoning":"Neither paper mentions ALDH1. Document A is slightly more relevant because it addresses breast cancer outcomes in general, whereas B focuses narrowly on CNS recurrence with trastuzumab.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:12.023971Z"}
{"comparison_id":"3c11659a-e619-4b65-b504-4195128eaee4","query_id":"51","doc_a_id":"15832146","doc_b_id":"3329824","presented_order":["15832146","3329824"],"winner_id":"15832146","reasoning":"Document A is more relevant — it addresses tumor biology and factors influencing breast cancer progression, which is closer to biomarker–outcome associations than the treatment/metastasis focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:12.023978Z"}
{"comparison_id":"3df596d0-a5f4-418d-b445-9692554e7362","query_id":"51","doc_a_id":"15721252","doc_b_id":"67045088","presented_order":["15721252","67045088"],"winner_id":"67045088","reasoning":"Neither document mentions ALDH1; neither directly supports or refutes the claim. Document B is slightly more relevant because it discusses tumor control and outcomes in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:20.301761Z"}
{"comparison_id":"ae661467-2ea7-469c-8850-a30950d24cc2","query_id":"51","doc_a_id":"2130391","doc_b_id":"67045088","presented_order":["67045088","2130391"],"winner_id":"2130391","reasoning":"Neither document mentions ALDH1. If I must pick the closer match, ANSWER: B — it addresses factors (adipocytes, invasion, tumor progression) more directly related to breast cancer outcomes.","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:20.301783Z"}
{"comparison_id":"d1664819-0174-41c3-a9a2-d3dd8bba822d","query_id":"51","doc_a_id":"1554348","doc_b_id":"67045088","presented_order":["67045088","1554348"],"winner_id":"67045088","reasoning":"Document A is more relevant — it addresses mechanisms affecting tumor control and breast cancer outcomes, while B focuses on cell-line enzyme/protein changes (ALP, srp27) unrelated to ALDH1 or clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:20.301792Z"}
{"comparison_id":"ebc73644-9525-4fd2-bfa2-8889d2b3c941","query_id":"51","doc_a_id":"15832146","doc_b_id":"67045088","presented_order":["15832146","67045088"],"winner_id":"67045088","reasoning":"Document B is more relevant — it discusses mechanisms that influence tumor control and outcomes in breast cancer models, whereas A focuses on fibroblast-driven angiogenesis and tumor growth without addressing biomarkers or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:20.301800Z"}
{"comparison_id":"e47d91ef-a3a7-40e4-970f-8c6b7e8fdca1","query_id":"51","doc_a_id":"31851367","doc_b_id":"67045088","presented_order":["31851367","67045088"],"winner_id":"67045088","reasoning":"Neither document discusses ALDH1. Document B is marginally more relevant because it addresses mechanisms affecting breast cancer tumor outcomes, whereas A focuses on ER coregulators generally. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:20.301807Z"}
{"comparison_id":"4e9816a2-afbc-4de2-aaf4-904e6eff0793","query_id":"51","doc_a_id":"878526","doc_b_id":"67045088","presented_order":["67045088","878526"],"winner_id":"878526","reasoning":"Document B is slightly more relevant because it discusses metastasis-initiating breast cancer cells (ALDH1 is a common marker of such cancer stem-like cells), whereas A focuses on DPP4/eosinophil mechanisms without linking to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:20.301815Z"}
{"comparison_id":"302e3f3d-493b-4de7-a11a-e2b3726fc816","query_id":"51","doc_a_id":"16390264","doc_b_id":"67045088","presented_order":["16390264","67045088"],"winner_id":"67045088","reasoning":"B — Document B discusses biological mechanisms in breast cancer models (closer to a biomarker/outcome topic), whereas A is about hospital access and not molecular markers. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:20.301822Z"}
{"comparison_id":"65af9dcd-0831-40e9-b6fd-c349849c7155","query_id":"51","doc_a_id":"2130391","doc_b_id":"878526","presented_order":["2130391","878526"],"winner_id":"2130391","reasoning":"Document A is more directly about breast cancer tumor biology and factors influencing progression, so it's slightly more relevant to a claim about prognostic markers like ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:28.020669Z"}
{"comparison_id":"d0da3067-ee87-4260-ab21-de56e6574c26","query_id":"51","doc_a_id":"15721252","doc_b_id":"15832146","presented_order":["15832146","15721252"],"winner_id":"15721252","reasoning":"Neither paper mentions ALDH1; both are irrelevant. Document B is marginally more relevant because it discusses molecular markers linked to breast cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:34.347513Z"}
{"comparison_id":"a15f2aae-64c9-42a9-a64b-496cac9b6bb9","query_id":"51","doc_a_id":"1554348","doc_b_id":"15832146","presented_order":["15832146","1554348"],"winner_id":"15832146","reasoning":"Neither abstract mentions ALDH1. Document A is marginally more relevant because it discusses factors influencing breast tumor progression and outcomes, whereas B focuses on cell stress responses in vitro. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:34.347533Z"}
{"comparison_id":"3e7c61c0-ec8f-4506-bb47-54f6d44f90ab","query_id":"51","doc_a_id":"16390264","doc_b_id":"15832146","presented_order":["15832146","16390264"],"winner_id":"15832146","reasoning":"Doc A discusses molecular/tumor biology in breast cancer (microenvironment and signaling), making it more relevant to biomarker associations like ALDH1 than Doc B's health-services analysis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:34.347541Z"}
{"comparison_id":"f05db77f-715c-4753-89ea-0f062a173bb4","query_id":"51","doc_a_id":"31851367","doc_b_id":"15832146","presented_order":["31851367","15832146"],"winner_id":"15832146","reasoning":"Neither document discusses ALDH1, so neither is directly relevant. DOCUMENT B is slightly more relevant because it addresses factors affecting tumor growth and prognosis, whereas DOCUMENT A focuses on estrogen receptor coregulators.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:34.347549Z"}
{"comparison_id":"ed40c10d-3eac-47a0-9d78-6c6c227af721","query_id":"51","doc_a_id":"1554348","doc_b_id":"16390264","presented_order":["16390264","1554348"],"winner_id":"1554348","reasoning":"Document B is more relevant — it deals with molecular markers in breast cancer cells (MCF-7), which is closer to biomarker-expression/outcome relationships than the healthcare access focus of Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:40.149997Z"}
{"comparison_id":"09d5b004-7667-4140-ba39-499e5ce77fc3","query_id":"51","doc_a_id":"31851367","doc_b_id":"16390264","presented_order":["31851367","16390264"],"winner_id":"16390264","reasoning":"Reason: Document B addresses breast cancer outcomes (clinical factors affecting treatment and outcomes), whereas Document A focuses on estrogen receptor coregulators and not clinical outcome markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:40.150019Z"}
{"comparison_id":"5afb7be2-6093-4d2d-abba-b039e7cd19be","query_id":"51","doc_a_id":"16701509","doc_b_id":"219475","presented_order":["219475","16701509"],"winner_id":"219475","reasoning":"Document A is more related to tumor progression and metastasis (outcomes), whereas Document B addresses risk factors (HDL) for developing breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:46.059282Z"}
{"comparison_id":"73009d73-e644-43d2-b9f9-211c556068d3","query_id":"51","doc_a_id":"2015126","doc_b_id":"219475","presented_order":["2015126","219475"],"winner_id":"219475","reasoning":"Document B is more relevant — it concerns tumor biology and factors affecting metastasis/outcomes in mammary tumors, whereas A addresses genetic-risk management (BRCA) not ALDH1 or prognosis.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:46.059303Z"}
{"comparison_id":"8cdbbe2f-28ac-4114-980c-11226fe9132e","query_id":"51","doc_a_id":"16701509","doc_b_id":"2015126","presented_order":["2015126","16701509"],"winner_id":"2015126","reasoning":"Document A is slightly more relevant because it discusses clinical management and outcomes related to breast cancer, whereas Document B focuses on HDL cholesterol and breast cancer risk. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:50.351296Z"}
{"comparison_id":"a9f1d886-a8b4-40e6-9ceb-38c087487f75","query_id":"51","doc_a_id":"29366489","doc_b_id":"3559136","presented_order":["3559136","29366489"],"winner_id":"29366489","reasoning":"Reason: Document B discusses a molecular marker (DLC-1) tied to cancer prognosis, which is more related to claims about markers and outcomes than Document A's focus on CAFs and therapy resistance.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:57.832994Z"}
{"comparison_id":"a81461bc-07a8-44a5-81c5-bb1ea32bfece","query_id":"51","doc_a_id":"8671456","doc_b_id":"3559136","presented_order":["3559136","8671456"],"winner_id":"3559136","reasoning":"Document A is more relevant — it deals with tumor biology and factors that influence tumor progression/outcomes, whereas Document B focuses on a specific therapy and not prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:57.833016Z"}
{"comparison_id":"ed19cb8b-f13d-417f-99fe-da72d2000fd9","query_id":"51","doc_a_id":"23863551","doc_b_id":"3559136","presented_order":["23863551","3559136"],"winner_id":"23863551","reasoning":"Document A is more relevant — it concerns breast cancer molecular markers and treatment resistance, while Document B focuses on CAFs and granulocyte infiltration without breast-cancer-specific markers. Neither mentions ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:57.833025Z"}
{"comparison_id":"99f95787-7ec7-42cb-bb68-431a6be7745d","query_id":"51","doc_a_id":"9394119","doc_b_id":"3559136","presented_order":["9394119","3559136"],"winner_id":"3559136","reasoning":"Doc B is more relevant — neither mentions ALDH1, but B deals with tumor microenvironment and therapy/outcomes, which is closer to expression-related impact than BRCA mutation-location risk.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:57.833033Z"}
{"comparison_id":"a4885498-ea77-413d-b8ea-972f5b0c765d","query_id":"51","doc_a_id":"13831558","doc_b_id":"3559136","presented_order":["13831558","3559136"],"winner_id":"3559136","reasoning":"Neither document mentions ALDH1 or links its expression to breast cancer outcomes, so both are irrelevant. If forced to choose, B is slightly more relevant because it addresses tumor biology and microenvironment.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:57.833040Z"}
{"comparison_id":"1c700219-a8fe-4a1d-8133-6b28aedfa785","query_id":"51","doc_a_id":"15512462","doc_b_id":"3559136","presented_order":["3559136","15512462"],"winner_id":"15512462","reasoning":"Document B is more relevant — it specifically discusses breast cancer risk/outcomes, whereas Document A focuses on CAFs and CSF1R blockade without addressing ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:57.833048Z"}
{"comparison_id":"f1bfddd6-f6c1-481c-ad67-c7ec21b44bc8","query_id":"51","doc_a_id":"15600979","doc_b_id":"3559136","presented_order":["3559136","15600979"],"winner_id":"15600979","reasoning":"Document B is more relevant — it discusses mechanisms directly tied to breast cancer (BRCA2/EMSY), whereas Document A focuses on tumor microenvironment/CSF1R inhibition without mentioning ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:57.833055Z"}
{"comparison_id":"fabd86d5-bd6b-457b-90df-2e224764923f","query_id":"51","doc_a_id":"1065627","doc_b_id":"3559136","presented_order":["1065627","3559136"],"winner_id":"1065627","reasoning":"Document A is more relevant — it specifically studies HER2+ breast cancer and factors affecting therapeutic response, whereas B focuses on CAF-mediated immune effects in tumors and is less directly related to breast cancer outcomes or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:57.833063Z"}
{"comparison_id":"75c9d7d2-5898-4d72-8d61-932c5a60b89f","query_id":"51","doc_a_id":"3848469","doc_b_id":"3559136","presented_order":["3559136","3848469"],"winner_id":"3848469","reasoning":"Document B is more relevant — it examines stem cell marker expression (linked to ALDH1-type markers and stemness), whereas A focuses on CAFs/immune infiltration and not on ALDH1 or cancer stem cell markers. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:57.833070Z"}
{"comparison_id":"05c3b1a4-0df3-40bc-b7de-a5f5dea183dd","query_id":"51","doc_a_id":"40735046","doc_b_id":"3559136","presented_order":["3559136","40735046"],"winner_id":"3559136","reasoning":"Document A is more related to tumor biology and potential prognostic markers, while Document B addresses population screening outcomes and not biomarker expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:41:57.833076Z"}
{"comparison_id":"891ee5b9-f533-4ffe-ba36-cbd92a182220","query_id":"51","doc_a_id":"29366489","doc_b_id":"15512462","presented_order":["29366489","15512462"],"winner_id":"15512462","reasoning":"Document B is more relevant — it mentions breast cancer risk/outcomes, whereas Document A discusses DLC-1 and not breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:05.890528Z"}
{"comparison_id":"69951b37-89f1-46cf-9a54-a60d705498ff","query_id":"51","doc_a_id":"23863551","doc_b_id":"15512462","presented_order":["23863551","15512462"],"winner_id":"23863551","reasoning":"Document A is more relevant — it deals with breast cancer molecular biology and therapy, whereas Document B addresses pre-eclampsia and long-term cancer risk and does not pertain to ALDH1 or tumor markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:05.890547Z"}
{"comparison_id":"8c4ec035-f9af-448f-9033-6a1ebb538848","query_id":"51","doc_a_id":"3848469","doc_b_id":"15512462","presented_order":["15512462","3848469"],"winner_id":"3848469","reasoning":"Document B is more relevant — it investigates cancer stem cell markers and stemness (which often involve ALDH1), whereas A only addresses cancer risk after pre-eclampsia and not ALDH1 or outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:05.890556Z"}
{"comparison_id":"fe1f99c3-bbc6-40ea-aaf9-7b2d313e99c4","query_id":"51","doc_a_id":"15600979","doc_b_id":"15512462","presented_order":["15512462","15600979"],"winner_id":"15600979","reasoning":"Document B is more relevant — it discusses molecular mechanisms in breast cancer (DNA-damage/BRCA2 pathway), which is closer to biomarker/outcome studies than the epidemiologic pre-eclampsia/cancer risk topic in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:05.890564Z"}
{"comparison_id":"b4be122a-1513-4d17-bc7b-229e87b8d420","query_id":"51","doc_a_id":"1065627","doc_b_id":"15512462","presented_order":["15512462","1065627"],"winner_id":"1065627","reasoning":"Document B is more relevant — it concerns breast cancer biology and treatment response, whereas A addresses cancer risk after pre-eclampsia and not ALDH1 or outcomes. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:05.890571Z"}
{"comparison_id":"958708e0-7e04-4c0c-85c2-8c263f98428d","query_id":"51","doc_a_id":"23863551","doc_b_id":"3848469","presented_order":["23863551","3848469"],"winner_id":"23863551","reasoning":"Document A — it concerns breast cancer biology (treatment and signaling), whereas Document B is about EMT and stemness in lung cancer, so A is more relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:12.261215Z"}
{"comparison_id":"a37bd72f-a8dc-4894-b3fd-44e21b803336","query_id":"51","doc_a_id":"1065627","doc_b_id":"3848469","presented_order":["3848469","1065627"],"winner_id":"1065627","reasoning":"Document B is more relevant — it studies mechanisms in breast cancer (where ALDH1 prognostic associations are assessed), whereas Document A focuses on lung cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:12.261235Z"}
{"comparison_id":"df2ccb77-cc3b-4724-b869-4e707a63c9ea","query_id":"51","doc_a_id":"15600979","doc_b_id":"3848469","presented_order":["15600979","3848469"],"winner_id":"3848469","reasoning":"Document B — it discusses stem-cell markers (likely including ALDH1) and expression changes related to cancer stemness, whereas Document A focuses on EMSY/BRCA2 pathways and does not address ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:12.261244Z"}
{"comparison_id":"18347413-6400-4f25-bca5-1ece2b3a60e3","query_id":"51","doc_a_id":"23863551","doc_b_id":"1065627","presented_order":["23863551","1065627"],"winner_id":"1065627","reasoning":"Relevant document: B — it addresses YAP/TAZ and mechanisms affecting HER2 therapy response, which is closer to pathways linked with stemness markers like ALDH1 than document A. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:17.134849Z"}
{"comparison_id":"bbb295db-2499-4d64-ab6a-224f197e3687","query_id":"51","doc_a_id":"8671456","doc_b_id":"9394119","presented_order":["9394119","8671456"],"winner_id":"8671456","reasoning":"Document B is slightly more relevant because it reports effects on breast cancer growth and survival (outcomes), whereas Document A focuses on BRCA mutation risks, not prognostic markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:23.860841Z"}
{"comparison_id":"7bcc4021-80f7-4a06-8f4b-16f3676c805d","query_id":"51","doc_a_id":"40735046","doc_b_id":"9394119","presented_order":["40735046","9394119"],"winner_id":"9394119","reasoning":"Document B — it deals with molecular/genetic associations related to breast cancer risk, which is closer to a biomarker–outcome question than a screening trial. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:23.860864Z"}
{"comparison_id":"dca371f6-4ff4-4d43-adb0-37725f8c0ddb","query_id":"51","doc_a_id":"13831558","doc_b_id":"9394119","presented_order":["9394119","13831558"],"winner_id":"9394119","reasoning":"Reason: Document A concerns molecular/genetic markers and cancer risk correlations, which is closer to a claim about a molecular marker (ALDH1) and outcomes than Document B's focus on mammographic density and detection.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:23.860873Z"}
{"comparison_id":"436d1f3c-b284-42d1-86ad-0d255ab16f03","query_id":"51","doc_a_id":"40735046","doc_b_id":"13831558","presented_order":["40735046","13831558"],"winner_id":"40735046","reasoning":"Document A is more relevant — it addresses breast cancer outcomes (mortality), whereas Document B focuses on risk and detection (mammographic density) rather than outcomes or biomarker expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:27.677748Z"}
{"comparison_id":"604f4ba9-25bb-4e3f-b0ff-ad8939844d9b","query_id":"51","doc_a_id":"20886584","doc_b_id":"3727986","presented_order":["20886584","3727986"],"winner_id":"20886584","reasoning":"Document A is slightly more relevant because it concerns breast cancer patient data and clinical outcomes (treatment-related toxicity) while Document B focuses on fibroblast-cancer cell adhesion mechanisms; neither mentions ALDH1 but A is in the clinical breast cancer context. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380486Z"}
{"comparison_id":"bef3183e-73bf-4aa2-bbcc-24db655b5276","query_id":"51","doc_a_id":"15081770","doc_b_id":"3727986","presented_order":["3727986","15081770"],"winner_id":"15081770","reasoning":"Reason: Document B discusses expression of a specific enzyme and its association with patient outcomes/prognosis, which is more thematically related to a claim about biomarker expression and breast cancer outcomes than Document A's mechanistic adhesion study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380506Z"}
{"comparison_id":"b1b312c0-6cae-468f-8aec-7f3c991a9454","query_id":"51","doc_a_id":"37480103","doc_b_id":"3727986","presented_order":["37480103","3727986"],"winner_id":"3727986","reasoning":"Document B is more relevant — it discusses molecular mechanisms of cancer cell behavior and tumor invasion, which is closer to biomarkers and outcomes than a pregnancy–breast cancer risk epidemiology paper. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380516Z"}
{"comparison_id":"16b4b698-5a3b-467e-8fca-8d0cde976b0c","query_id":"51","doc_a_id":"15335331","doc_b_id":"3727986","presented_order":["15335331","3727986"],"winner_id":"15335331","reasoning":"Document A is slightly more relevant — it discusses tumor markers and their association with clinicopathological features and patient outcomes (though in OSCC, not breast cancer, and it does not mention ALDH1). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380523Z"}
{"comparison_id":"72f1bc37-a200-4700-973d-fb0e2a8c263a","query_id":"51","doc_a_id":"4414547","doc_b_id":"3727986","presented_order":["3727986","4414547"],"winner_id":"3727986","reasoning":"Document A is more related to tumor cell behavior and mechanisms affecting invasion/outcomes, whereas Document B is about genetic predisposition unrelated to ALDH1 expression or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380531Z"}
{"comparison_id":"1ec5ca6c-2237-4771-816f-9f1bdbdc9349","query_id":"51","doc_a_id":"52180874","doc_b_id":"3727986","presented_order":["52180874","3727986"],"winner_id":"3727986","reasoning":"Document B is more relevant — it addresses mechanisms of cancer cell invasion and tumor microenvironment interactions, which is closer to tumor biology and prognosis than a meta-analysis of PD-1/PD-L1 inhibitors.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380538Z"}
{"comparison_id":"8dae7207-9249-4b54-ad9f-71f6bab0c3ed","query_id":"51","doc_a_id":"17450673","doc_b_id":"3727986","presented_order":["3727986","17450673"],"winner_id":"3727986","reasoning":"Document A is more relevant — it addresses cancer cell behavior and mechanisms tied to tumor aggressiveness/outcomes, whereas B focuses on perinatal risk factors unrelated to prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380545Z"}
{"comparison_id":"16ce47cb-194e-4f1b-b9f9-9ff50e9f92e9","query_id":"51","doc_a_id":"20280410","doc_b_id":"3727986","presented_order":["20280410","3727986"],"winner_id":"3727986","reasoning":"Document B is more relevant — it concerns mechanisms of cancer cell behavior and tumor microenvironment, which is closer to biomarkers and outcomes than a BRCA2 prenatal-viability study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380552Z"}
{"comparison_id":"bf591647-d76f-4b8b-8c96-45dc91ad651e","query_id":"51","doc_a_id":"13831842","doc_b_id":"3727986","presented_order":["13831842","3727986"],"winner_id":"3727986","reasoning":"Neither document mentions ALDH1 or directly addresses breast cancer outcomes. Document B is marginally more relevant because it concerns tumor invasion mechanisms that can affect outcomes, whereas A focuses on height/weight and cancer risk.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380559Z"}
{"comparison_id":"0179dd29-0508-4891-a8a2-21d6815c0a05","query_id":"51","doc_a_id":"5222182","doc_b_id":"3727986","presented_order":["5222182","3727986"],"winner_id":"3727986","reasoning":"Document B is more relevant — it addresses tumor cell behavior and mechanisms affecting invasion and progression, which relate more directly to cancer outcomes than mammographic density.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380566Z"}
{"comparison_id":"172d2f7c-c7c1-4efc-a5ba-1bc6219a3fcb","query_id":"51","doc_a_id":"13791206","doc_b_id":"3727986","presented_order":["13791206","3727986"],"winner_id":"3727986","reasoning":"Document B — it addresses cancer cell behavior and invasion, which is more related to markers of tumor aggressiveness and outcomes than the DNA-repair–focused Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380574Z"}
{"comparison_id":"df5776f9-8bf8-4812-b964-1f41e30d7a91","query_id":"51","doc_a_id":"4886637","doc_b_id":"3727986","presented_order":["3727986","4886637"],"winner_id":"3727986","reasoning":"Document A is more relevant — it addresses cellular/molecular mechanisms of tumor invasion that relate to biomarkers and outcomes, whereas Document B is epidemiological and not about molecular markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380581Z"}
{"comparison_id":"f3ca13c1-5baf-4ad2-afd6-afb4dc0af3cf","query_id":"51","doc_a_id":"16098747","doc_b_id":"3727986","presented_order":["16098747","3727986"],"winner_id":"16098747","reasoning":"Document A is slightly more relevant because it directly concerns breast cancer characteristics and patient outcomes factors; neither document mentions ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380588Z"}
{"comparison_id":"9bf384dd-1fdc-4ee1-8725-19e29dc3cb1d","query_id":"51","doc_a_id":"22007333","doc_b_id":"3727986","presented_order":["22007333","3727986"],"winner_id":"3727986","reasoning":"Document B is more relevant — it concerns mechanisms of tumor invasion and cancer progression, which relate to outcomes; Document A addresses mammographic density and reproductive factors and does not pertain to markers like ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380595Z"}
{"comparison_id":"2af50794-7a08-4991-95cd-d04095326ca7","query_id":"51","doc_a_id":"3067015","doc_b_id":"3727986","presented_order":["3727986","3067015"],"winner_id":"3727986","reasoning":"Document A. It relates to cancer biology and tumor invasion (closer to breast cancer outcomes), whereas Document B concerns ALDH2, alcohol metabolism, and blood pressure—unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380602Z"}
{"comparison_id":"cefb595d-64c3-4b1f-afca-72be05fbe1b1","query_id":"51","doc_a_id":"831167","doc_b_id":"3727986","presented_order":["831167","3727986"],"winner_id":"831167","reasoning":"Document A is more relevant — it concerns gene associations with survival prognosis (though in glioblastoma), whereas Document B focuses on adhesion/mechanism of invasion and not gene expression linked to outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380609Z"}
{"comparison_id":"2f1b8b91-f457-40f4-9701-f2bb8542a013","query_id":"51","doc_a_id":"23557241","doc_b_id":"3727986","presented_order":["23557241","3727986"],"winner_id":"23557241","reasoning":"Document A is more relevant — it addresses breast cancer epidemiology (risk factors/outcomes-related data), whereas Document B focuses on a cellular adhesion mechanism unrelated to ALDH1 or clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380616Z"}
{"comparison_id":"7470a2a4-438e-4b36-8dba-92d487291028","query_id":"51","doc_a_id":"36432234","doc_b_id":"3727986","presented_order":["3727986","36432234"],"winner_id":"3727986","reasoning":"Document A is more relevant — it concerns mechanisms of cancer cell invasion and tumor behavior that relate to outcomes, whereas Document B focuses narrowly on a compound activating estrogen signaling in ER+ cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380623Z"}
{"comparison_id":"77a4845c-9abd-47d8-8b8d-09e812223dce","query_id":"51","doc_a_id":"3222187","doc_b_id":"3727986","presented_order":["3727986","3222187"],"winner_id":"3727986","reasoning":"Document A is more relevant — it addresses tumor invasion and cancer cell behavior tied to outcomes, whereas Document B focuses on vitamin D genetics and levels unrelated to ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380631Z"}
{"comparison_id":"18f4bd2c-c9ac-425f-9d25-e2df3ca0dc86","query_id":"51","doc_a_id":"7875158","doc_b_id":"3727986","presented_order":["3727986","7875158"],"winner_id":"3727986","reasoning":"Document A is slightly more related since it addresses tumor invasion and mechanisms tied to cancer progression/outcomes, whereas Document B focuses on metabolic stress in drug-resistant cell lines with no clear link to clinical outcomes or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380638Z"}
{"comparison_id":"38f729cf-ede0-4c34-9c5b-3bf528023da7","query_id":"51","doc_a_id":"32534305","doc_b_id":"3727986","presented_order":["3727986","32534305"],"winner_id":"3727986","reasoning":"Document A is more directly about tumor biology and cancer cell behavior, which is more relevant to biomarkers and outcomes than an epidemiologic study of diabetes and breast cancer incidence.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380645Z"}
{"comparison_id":"8a2854ac-f557-40c2-9ea2-a5a00a84a8b4","query_id":"51","doc_a_id":"17163294","doc_b_id":"3727986","presented_order":["17163294","3727986"],"winner_id":"17163294","reasoning":"Document A is more relevant — it specifically addresses breast cancer (though neither mentions ALDH1 or outcomes). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380651Z"}
{"comparison_id":"78fb9aee-450c-4d28-864c-71bed02280c7","query_id":"51","doc_a_id":"3524352","doc_b_id":"3727986","presented_order":["3524352","3727986"],"winner_id":"3524352","reasoning":"Document A is more relevant: it concerns breast cancer outcomes (mortality), whereas Document B addresses cell–cell adhesion and invasion mechanisms unrelated to clinical outcomes or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380658Z"}
{"comparison_id":"f04f7932-4a25-428f-9f5b-51da76b2df80","query_id":"51","doc_a_id":"13519661","doc_b_id":"3727986","presented_order":["3727986","13519661"],"winner_id":"3727986","reasoning":"Document A is more relevant — it addresses tumor invasion and mechanisms tied to cancer progression/outcomes, whereas Document B concerns CHEK2 genetic risk and not tumor markers or outcomes. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380665Z"}
{"comparison_id":"b0d60cd7-69f8-49be-84c8-db5a8b8cf97b","query_id":"51","doc_a_id":"38784540","doc_b_id":"3727986","presented_order":["38784540","3727986"],"winner_id":"3727986","reasoning":"Document B is more relevant — it addresses tumor invasion mechanisms and cancer cell behavior, which relate to cancer outcomes, whereas Document A focuses on breast density and life-course risk factors without molecular markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380672Z"}
{"comparison_id":"ed569b11-81f5-4b2c-a0a6-2202d9170b32","query_id":"51","doc_a_id":"23078022","doc_b_id":"3727986","presented_order":["23078022","3727986"],"winner_id":"23078022","reasoning":"Neither document mentions ALDH1. Document A is slightly more relevant because it discusses oncogenic signaling in human carcinomas (which can relate to prognosis), whereas B focuses on adhesion mechanics and invasion. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380678Z"}
{"comparison_id":"388277bb-a265-498a-b134-12f2588d3ef1","query_id":"51","doc_a_id":"5487448","doc_b_id":"3727986","presented_order":["5487448","3727986"],"winner_id":"5487448","reasoning":"Document A is more related to breast cancer (mammographic density and risk factors); Document B focuses on fibroblast–cancer cell adhesion mechanisms not specific to ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380685Z"}
{"comparison_id":"ba07be57-fb5e-4e3a-b355-1c5207c3f8c9","query_id":"51","doc_a_id":"9171913","doc_b_id":"3727986","presented_order":["9171913","3727986"],"winner_id":"3727986","reasoning":"Document B is more relevant — it discusses mechanisms of tumor invasion and progression (closer to outcomes), whereas A addresses blood lipids and cancer risk, not ALDH1 or outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380692Z"}
{"comparison_id":"31e2e9b0-2022-4712-b541-eb7bcf302ec6","query_id":"51","doc_a_id":"54561709","doc_b_id":"3727986","presented_order":["3727986","54561709"],"winner_id":"3727986","reasoning":"Neither document discusses ALDH1 or clinical outcomes, but Document A addresses tumor invasion and cancer biology more directly, so it's marginally more relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380698Z"}
{"comparison_id":"a2715f50-53cd-415d-bc66-7a4f03b1132c","query_id":"51","doc_a_id":"6259170","doc_b_id":"3727986","presented_order":["6259170","3727986"],"winner_id":"3727986","reasoning":"Document B — it directly concerns mechanisms of cancer cell invasion and tumor behavior, making it more relevant to a claim about breast cancer outcomes than Document A, which focuses on Nrf2 and mitochondria.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:44.380705Z"}
{"comparison_id":"fffae1ca-618d-4976-88b1-1a3e5a26069d","query_id":"51","doc_a_id":"20886584","doc_b_id":"831167","presented_order":["20886584","831167"],"winner_id":"20886584","reasoning":"Document A is more relevant — it concerns breast cancer clinical outcomes (treatment-related effects) while Document B addresses glioblastoma, not breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:51.166200Z"}
{"comparison_id":"214bc3aa-0ff6-4ea5-b917-a177e757d2bc","query_id":"51","doc_a_id":"15081770","doc_b_id":"831167","presented_order":["831167","15081770"],"winner_id":"15081770","reasoning":"Document B — it discusses expression of a specific tumor-associated enzyme linked to prognosis in cancers (though in lymphomas), whereas A focuses on glioblastoma network analysis and not marker expression or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:51.166221Z"}
{"comparison_id":"96830dec-db88-4d79-b64c-8bd241c1d494","query_id":"51","doc_a_id":"15335331","doc_b_id":"831167","presented_order":["15335331","831167"],"winner_id":"831167","reasoning":"Neither document addresses ALDH1 or breast cancer directly, but Document B examines gene–survival associations (albeit in glioblastoma), making it more relevant to a claim about gene expression and outcomes than Document A, which focuses on TAMs and EMT in oral SCC.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:51.166230Z"}
{"comparison_id":"e0f3a903-4452-4dfe-99d6-5d05f7de819b","query_id":"51","doc_a_id":"16098747","doc_b_id":"831167","presented_order":["16098747","831167"],"winner_id":"16098747","reasoning":"Document A is more relevant because it concerns breast cancer (the same disease as the query), whereas Document B focuses on glioblastoma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:51.166246Z"}
{"comparison_id":"62531fcb-677a-43c5-8521-e55f71cba0e0","query_id":"51","doc_a_id":"5487448","doc_b_id":"831167","presented_order":["5487448","831167"],"winner_id":"5487448","reasoning":"Document A is more relevant because it addresses breast cancer risk factors (mammographic density) in the breast cancer context, whereas Document B concerns gene networks in glioblastoma (a different cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:51.166258Z"}
{"comparison_id":"2495a424-45b6-40dd-8667-3cdf1a137e4d","query_id":"51","doc_a_id":"23557241","doc_b_id":"831167","presented_order":["23557241","831167"],"winner_id":"23557241","reasoning":"Document A is more relevant because it concerns breast cancer (though about risk factors rather than ALDH1 expression or outcomes). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:51.166264Z"}
{"comparison_id":"58b65f20-4bd6-44cb-811d-2ec97c597bd2","query_id":"51","doc_a_id":"17163294","doc_b_id":"831167","presented_order":["831167","17163294"],"winner_id":"17163294","reasoning":"Document B is more relevant — it concerns breast cancer (though not ALDH1 specifically), while A focuses on glioblastoma. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:51.166271Z"}
{"comparison_id":"a1280ef7-31c4-46fb-a596-a9be5ebb5919","query_id":"51","doc_a_id":"3524352","doc_b_id":"831167","presented_order":["3524352","831167"],"winner_id":"3524352","reasoning":"Document A is more relevant — it concerns breast cancer outcomes (mortality), whereas Document B addresses glioblastoma and gene networks, not breast cancer.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:51.166277Z"}
{"comparison_id":"41f08728-bccd-402c-b46f-7220ac3b16e3","query_id":"51","doc_a_id":"23078022","doc_b_id":"831167","presented_order":["23078022","831167"],"winner_id":"23078022","reasoning":"Document A is slightly more relevant — it addresses oncogenic signaling in human carcinomas (more related to breast cancer biology) while B focuses on glioblastoma.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:51.166284Z"}
{"comparison_id":"9563bd40-05a6-47ca-a085-d2b04549351d","query_id":"51","doc_a_id":"20886584","doc_b_id":"5487448","presented_order":["5487448","20886584"],"winner_id":"20886584","reasoning":"Document B — it concerns molecular/genetic markers in breast cancer (closer to ALDH1 as a biomarker) while A is an epidemiologic birth-weight/mammographic-density study unrelated to ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:58.733433Z"}
{"comparison_id":"ccd9a6cb-14d4-4eb2-a65e-e9f939beb1b3","query_id":"51","doc_a_id":"15081770","doc_b_id":"5487448","presented_order":["5487448","15081770"],"winner_id":"15081770","reasoning":"B — Document B discusses expression of a tumor-associated enzyme and its link to clinical outcomes (though in lymphomas), which is more relevant to a claim about biomarker expression and cancer outcomes than Document A's focus on birth weight and mammographic density. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:58.733455Z"}
{"comparison_id":"23b501ea-1156-4382-94da-27cf1cebca27","query_id":"51","doc_a_id":"16098747","doc_b_id":"5487448","presented_order":["5487448","16098747"],"winner_id":"16098747","reasoning":"Neither abstract mentions ALDH1 or tumor biomarkers; both are only about mammographic density and risk factors. Document B is slightly more relevant because it broadly examines breast cancer risk factors (larger, more generalizable), so ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:58.733464Z"}
{"comparison_id":"4b34d178-1e1d-4523-b302-e0e79d9a3d34","query_id":"51","doc_a_id":"23078022","doc_b_id":"5487448","presented_order":["23078022","5487448"],"winner_id":"23078022","reasoning":"Document A — it discusses molecular cancer signaling (oncoprotein/IKK–NF-κB) and is more related to biomarkers and tumor biology than the epidemiologic birth-weight study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:58.733472Z"}
{"comparison_id":"a3a1aa16-280c-4e82-906a-0f4c6714737d","query_id":"51","doc_a_id":"23557241","doc_b_id":"5487448","presented_order":["5487448","23557241"],"winner_id":"23557241","reasoning":"Neither document discusses ALDH1 or tumor marker expression. Document B is slightly more relevant because it's a broader review of breast cancer risk factors and mechanisms. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:58.733479Z"}
{"comparison_id":"8a2ce0ab-5d76-4aa3-beee-f7051bf4a1e7","query_id":"51","doc_a_id":"17163294","doc_b_id":"5487448","presented_order":["17163294","5487448"],"winner_id":"5487448","reasoning":"Document B is more directly related to breast cancer (mammographic density as a risk factor), whereas A focuses on metabolic differences between cancer types generally. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:58.733486Z"}
{"comparison_id":"303f6eed-6943-470c-b181-c3a6df14abb5","query_id":"51","doc_a_id":"3524352","doc_b_id":"5487448","presented_order":["5487448","3524352"],"winner_id":"5487448","reasoning":"Neither document mentions ALDH1. Document A is slightly more related because it discusses breast cancer risk factors and mammographic density, while B focuses on geographic mortality patterns.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:42:58.733493Z"}
{"comparison_id":"cd1d8147-0a47-4590-b8bd-a0dc3a4c96b6","query_id":"51","doc_a_id":"20886584","doc_b_id":"16098747","presented_order":["16098747","20886584"],"winner_id":"20886584","reasoning":"Neither document mentions ALDH1, but Document B (genetic predictors of treatment toxicity) is slightly closer to molecular biomarkers and clinical outcomes than Document A (breast density risk factors). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:03.989520Z"}
{"comparison_id":"a56e8271-506c-4efa-b5bd-2a35d2524d6b","query_id":"51","doc_a_id":"15081770","doc_b_id":"16098747","presented_order":["16098747","15081770"],"winner_id":"15081770","reasoning":"Document B is more relevant — it discusses tumor marker expression linked to prognosis (better outcomes) in cancer, whereas A addresses breast density risk factors not marker expression or outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:03.989544Z"}
{"comparison_id":"301438b2-d13f-4484-b383-57eccc889d2b","query_id":"51","doc_a_id":"23557241","doc_b_id":"16098747","presented_order":["23557241","16098747"],"winner_id":"23557241","reasoning":"Neither document discusses ALDH1 or tumor marker expression. Both are irrelevant; Document A is marginally more relevant only because it addresses breast cancer risk broadly. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:03.989552Z"}
{"comparison_id":"8ff5e3d4-c031-498a-a63c-d789c9e89d43","query_id":"51","doc_a_id":"23078022","doc_b_id":"16098747","presented_order":["23078022","16098747"],"winner_id":"23078022","reasoning":"Document A is about molecular oncogene signaling in cancer (closer to biomarker/expression studies), while Document B covers epidemiologic breast density risk factors unrelated to ALDH1 expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:03.989560Z"}
{"comparison_id":"d347c2f1-3c49-4488-a992-cde6806f73ca","query_id":"51","doc_a_id":"20886584","doc_b_id":"15081770","presented_order":["15081770","20886584"],"winner_id":"20886584","reasoning":"Document B — it concerns breast cancer (though not ALDH1), while A is about lymphoma and IL4I1, so B is more topically relevant to the query. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:10.385311Z"}
{"comparison_id":"71159079-852b-401f-a0a9-927bf458be1d","query_id":"51","doc_a_id":"23078022","doc_b_id":"15081770","presented_order":["15081770","23078022"],"winner_id":"15081770","reasoning":"Document A is more relevant because it discusses expression of an enzyme tied to prognostic outcomes in cancer (including a link to better outcomes), whereas Document B describes a molecular signaling mechanism not related to prognostic expression. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:10.385332Z"}
{"comparison_id":"311b6783-6960-46ea-b2ab-fd6d05d6fa6e","query_id":"51","doc_a_id":"23557241","doc_b_id":"15081770","presented_order":["15081770","23557241"],"winner_id":"15081770","reasoning":"Document A — it discusses protein expression linked to cancer prognosis (better outcomes), whereas B covers intrauterine risk factors for breast cancer risk, not ALDH1 expression or outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:10.385341Z"}
{"comparison_id":"acc0e9c9-b97f-42b0-b9fb-ceea4a81853e","query_id":"51","doc_a_id":"23078022","doc_b_id":"23557241","presented_order":["23557241","23078022"],"winner_id":"23078022","reasoning":"Reason: Neither document mentions ALDH1. Document B is slightly more relevant because it addresses molecular oncoprotein expression and cancer signaling, whereas A deals with birth factors and cancer risk.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:17.306401Z"}
{"comparison_id":"51608298-0d64-4441-abf0-c3c594ba3a91","query_id":"51","doc_a_id":"17163294","doc_b_id":"3524352","presented_order":["3524352","17163294"],"winner_id":"3524352","reasoning":"Document A is more relevant — it discusses breast cancer mortality/outcomes, whereas B focuses on metabolite-based cancer classification and not ALDH1 or outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:22.545372Z"}
{"comparison_id":"1a27baed-dde9-407a-8d11-045c55aba6d4","query_id":"51","doc_a_id":"37480103","doc_b_id":"22007333","presented_order":["37480103","22007333"],"winner_id":"22007333","reasoning":"Reason: Neither abstract mentions ALDH1, but Document B deals with breast cancer–related biological risk factors (mammographic density and reproductive factors), making it marginally more relevant than Document A's pregnancy/placental-weight focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:34.135261Z"}
{"comparison_id":"76e9aebe-6ebe-4fe9-b7cc-a03827c2f8f1","query_id":"51","doc_a_id":"4414547","doc_b_id":"22007333","presented_order":["4414547","22007333"],"winner_id":"4414547","reasoning":"Neither document mentions ALDH1. Document A is marginally more relevant because it concerns molecular/genetic factors linked to breast cancer risk, whereas B focuses on reproductive factors and mammographic density. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:34.135282Z"}
{"comparison_id":"3209a47b-badd-46c4-b784-7302daee293b","query_id":"51","doc_a_id":"52180874","doc_b_id":"22007333","presented_order":["52180874","22007333"],"winner_id":"22007333","reasoning":"Document B — it concerns breast cancer-related factors (mammographic density and reproductive history), which is closer to the claim about breast cancer outcomes than Document A on PD-1/PD-L1 across cancers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:34.135291Z"}
{"comparison_id":"6fca3030-215d-46c5-80f2-0a7f69d37ea0","query_id":"51","doc_a_id":"17450673","doc_b_id":"22007333","presented_order":["22007333","17450673"],"winner_id":"22007333","reasoning":"Reason: Neither document addresses ALDH1 or molecular markers; Document A is slightly more directly related to breast cancer characteristics and risk factors.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:34.135299Z"}
{"comparison_id":"03245cba-dc38-4ddb-8535-ca30e87e4b8a","query_id":"51","doc_a_id":"20280410","doc_b_id":"22007333","presented_order":["22007333","20280410"],"winner_id":"20280410","reasoning":"Document B is more relevant — it discusses a specific molecular/genetic factor associated with breast cancer risk, which is closer to ALDH1 expression and outcomes than epidemiologic mammographic-density factors.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:34.135307Z"}
{"comparison_id":"4bdf1085-046c-49f1-9f20-bfa4323138e2","query_id":"51","doc_a_id":"13831842","doc_b_id":"22007333","presented_order":["22007333","13831842"],"winner_id":"22007333","reasoning":"Neither abstract mentions ALDH1 or molecular markers. Both are irrelevant, but Document A is slightly more related to breast cancer biology (mammographic density and mechanisms), so it's marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:34.135314Z"}
{"comparison_id":"f14a9a46-7ae2-4bec-8256-454c96715cd2","query_id":"51","doc_a_id":"5222182","doc_b_id":"22007333","presented_order":["22007333","5222182"],"winner_id":"22007333","reasoning":"Neither abstract mentions ALDH1 or clinical outcomes; Document A is slightly more relevant because it explicitly links factors to breast cancer risk. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:34.135321Z"}
{"comparison_id":"1faa3669-e8d0-4b67-a1cb-f91bb924815b","query_id":"51","doc_a_id":"13791206","doc_b_id":"22007333","presented_order":["22007333","13791206"],"winner_id":"22007333","reasoning":"Document A is more relevant. Neither abstract mentions ALDH1, but A concerns breast cancer–related clinical risk/outcome factors (mammographic density and reproductive history), which is closer to the claim than B's molecular DNA-repair focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:34.135328Z"}
{"comparison_id":"8ff76d41-97eb-4236-99ab-c2772b01e189","query_id":"51","doc_a_id":"4886637","doc_b_id":"22007333","presented_order":["22007333","4886637"],"winner_id":"4886637","reasoning":"Neither document discusses ALDH1 or its prognostic association. Document B is slightly more relevant because it addresses breast cancer risk and metabolic factors, which is closer to outcomes than mammographic density.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:34.135335Z"}
{"comparison_id":"cbc5e7d2-e637-48bd-80da-a821d8432e69","query_id":"51","doc_a_id":"6259170","doc_b_id":"22007333","presented_order":["6259170","22007333"],"winner_id":"6259170","reasoning":"Document A is more relevant — it discusses cancer-related pathways (growth advantages, chemoresistance) whereas Document B focuses on reproductive factors and mammographic density, not ALDH1 or cancer outcomes.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:34.135342Z"}
{"comparison_id":"7c4845d0-7754-4d6e-acd3-9f71c7b5323f","query_id":"51","doc_a_id":"3067015","doc_b_id":"22007333","presented_order":["22007333","3067015"],"winner_id":"22007333","reasoning":"Document A is more relevant — it relates to breast cancer risk (via mammographic density), whereas Document B concerns ALDH2 and blood pressure, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:34.135349Z"}
{"comparison_id":"79cad7b9-65fe-4dff-abac-45091e16989b","query_id":"51","doc_a_id":"36432234","doc_b_id":"22007333","presented_order":["22007333","36432234"],"winner_id":"36432234","reasoning":"Document B is more relevant — it addresses molecular biology and tumor cell behavior in breast cancer, which is closer to studies of biomarker expression than A's focus on mammographic density and reproductive factors. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:34.135356Z"}
{"comparison_id":"0dbca971-4c33-4037-8353-d435cb572786","query_id":"51","doc_a_id":"3222187","doc_b_id":"22007333","presented_order":["3222187","22007333"],"winner_id":"22007333","reasoning":"Document B is slightly more relevant because it addresses factors linked to breast cancer risk and outcomes (mammographic density and reproductive history), whereas Document A focuses on vitamin D genetics and levels without addressing cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:34.135364Z"}
{"comparison_id":"18f44430-f404-4eda-8c41-def7f5070f77","query_id":"51","doc_a_id":"7875158","doc_b_id":"22007333","presented_order":["22007333","7875158"],"winner_id":"7875158","reasoning":"Document B is more relevant — it deals with molecular behavior of breast cancer cells, while A addresses reproductive factors and mammographic density (not molecular markers or outcomes).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:34.135371Z"}
{"comparison_id":"4e0444a8-5305-4a75-ab05-a2cb0929a641","query_id":"51","doc_a_id":"32534305","doc_b_id":"22007333","presented_order":["22007333","32534305"],"winner_id":"32534305","reasoning":"Document B is more directly about breast cancer incidence/outcomes, while A discusses mammographic density and reproductive factors unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:34.135377Z"}
{"comparison_id":"8c4e6997-4b9d-43af-9ab3-f587532beae3","query_id":"51","doc_a_id":"13519661","doc_b_id":"22007333","presented_order":["13519661","22007333"],"winner_id":"22007333","reasoning":"Neither abstract mentions ALDH1, so both are irrelevant. B is marginally more relevant because it addresses breast cancer–related factors (mammographic density), whereas A focuses narrowly on CHEK2 variants and risk.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:34.135384Z"}
{"comparison_id":"f233fd2f-c874-4fee-ae65-d3112f2330d6","query_id":"51","doc_a_id":"38784540","doc_b_id":"22007333","presented_order":["22007333","38784540"],"winner_id":"22007333","reasoning":"Document A — it explicitly links reproductive factors (parity) to mammographic density and potential breast cancer risk mechanisms, so it's slightly more relevant to breast cancer outcomes than B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:34.135391Z"}
{"comparison_id":"98cbfacd-d0c7-4e66-8b84-7a7a510c70ee","query_id":"51","doc_a_id":"9171913","doc_b_id":"22007333","presented_order":["22007333","9171913"],"winner_id":"22007333","reasoning":"Neither document mentions ALDH1, but Document A deals with breast cancer–related factors (mammographic density/reproductive history) so is marginally more relevant than a blood-lipid study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:34.135398Z"}
{"comparison_id":"d50ff735-7b71-4cc8-98d5-93a99599c4ef","query_id":"51","doc_a_id":"54561709","doc_b_id":"22007333","presented_order":["54561709","22007333"],"winner_id":"54561709","reasoning":"Document A is more relevant — it concerns breast cancer cell line variability and cell function, which is closer to molecular markers like ALDH1 than a population study of mammographic density. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:34.135408Z"}
{"comparison_id":"35e2e31b-8e1a-4d29-8f4e-b30768b817f1","query_id":"51","doc_a_id":"4414547","doc_b_id":"6259170","presented_order":["6259170","4414547"],"winner_id":"4414547","reasoning":"Document B is more relevant — it directly addresses breast cancer genetics and outcomes, whereas Document A focuses on Nrf2/mitochondria and not breast cancer markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:40.853367Z"}
{"comparison_id":"82c0aa33-5f8a-49b8-8ef4-4e7a7fff1ec2","query_id":"51","doc_a_id":"20280410","doc_b_id":"6259170","presented_order":["20280410","6259170"],"winner_id":"20280410","reasoning":"Document A is more relevant — it directly concerns breast cancer (risk/outcomes), whereas B discusses Nrf2/mitochondria without relation to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:40.853390Z"}
{"comparison_id":"9dcdcbce-5cd4-4a39-8a98-899c3d519f98","query_id":"51","doc_a_id":"4886637","doc_b_id":"6259170","presented_order":["6259170","4886637"],"winner_id":"4886637","reasoning":"Document B is more relevant because it discusses breast cancer (while Document A focuses on Nrf2-mitochondria biology unrelated to ALDH1 or breast cancer outcomes).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:40.853400Z"}
{"comparison_id":"2a5d58d7-af0a-4e7c-9433-941187304a0c","query_id":"51","doc_a_id":"54561709","doc_b_id":"6259170","presented_order":["54561709","6259170"],"winner_id":"54561709","reasoning":"Document A is more relevant — it concerns breast cancer (MCF-7) cell biology and factors that could affect marker expression and outcomes; Document B focuses on Nrf2/mitochondria and does not address ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:40.853408Z"}
{"comparison_id":"209a652f-dde3-43ef-b8de-3ddd54f0075c","query_id":"51","doc_a_id":"36432234","doc_b_id":"6259170","presented_order":["6259170","36432234"],"winner_id":"36432234","reasoning":"Doc B — it directly concerns breast cancer biology (estrogen receptor–driven growth), whereas Doc A focuses on Nrf2/mitochondria and not breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:40.853415Z"}
{"comparison_id":"b1290a59-44de-4b69-ae98-06e1ba91d042","query_id":"51","doc_a_id":"7875158","doc_b_id":"6259170","presented_order":["6259170","7875158"],"winner_id":"7875158","reasoning":"Document B — it specifically studies human breast carcinoma cells and oxidative stress pathways, so it's more related to breast cancer outcomes than Document A. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:40.853423Z"}
{"comparison_id":"8ca798a3-65ae-4f85-ba50-f59f885e0747","query_id":"51","doc_a_id":"32534305","doc_b_id":"6259170","presented_order":["32534305","6259170"],"winner_id":"6259170","reasoning":"Document B is more relevant — it discusses molecular stress-response and detoxification pathways (Keap1-Nrf2) that are mechanistically closer to ALDH1's role in cellular detoxification and chemoresistance, whereas Document A is an epidemiologic study on diabetes and breast cancer risk. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:40.853430Z"}
{"comparison_id":"fb2b7142-5f31-4d2c-9013-9a47fa98adc8","query_id":"51","doc_a_id":"4414547","doc_b_id":"4886637","presented_order":["4886637","4414547"],"winner_id":"4414547","reasoning":"Document B is more relevant — it addresses molecular/genetic factors linked to breast cancer, which is closer to a claim about a specific protein marker (ALDH1) than a diabetes/metabolic risk review.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:48.373611Z"}
{"comparison_id":"5c9e4f53-a5bf-4b9e-ad66-e1e845b652ec","query_id":"51","doc_a_id":"20280410","doc_b_id":"4886637","presented_order":["20280410","4886637"],"winner_id":"4886637","reasoning":"Neither document discusses ALDH1 expression. Document B is more relevant because it broadly reviews metabolic factors and breast cancer, whereas A focuses on a BRCA2 polymorphism and prenatal viability rather than outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:48.373633Z"}
{"comparison_id":"9c2485b0-58f9-445c-a6c9-2729cf3b9554","query_id":"51","doc_a_id":"7875158","doc_b_id":"4886637","presented_order":["4886637","7875158"],"winner_id":"4886637","reasoning":"Document A is more relevant because it discusses breast cancer outcomes and risk factors, whereas Document B focuses on in vitro glucose-deprivation mechanisms unrelated to ALDH1 or clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:48.373641Z"}
{"comparison_id":"20ee03ea-b5bb-4661-8f66-7ac66fdaeb0b","query_id":"51","doc_a_id":"54561709","doc_b_id":"4886637","presented_order":["54561709","4886637"],"winner_id":"54561709","reasoning":"Document A is more relevant — it concerns breast cancer cell-line behavior and experimental factors that could affect measurements of markers like ALDH1, whereas B discusses diabetes/metabolic syndrome and is unrelated to ALDH1 expression. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:48.373649Z"}
{"comparison_id":"8880de52-303c-4847-a647-99b6ba756b97","query_id":"51","doc_a_id":"36432234","doc_b_id":"4886637","presented_order":["36432234","4886637"],"winner_id":"36432234","reasoning":"Neither abstract mentions ALDH1. Document A is slightly more relevant because it addresses molecular markers and signaling in breast cancer, whereas B is an epidemiologic review of diabetes/metabolic syndrome.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:48.373656Z"}
{"comparison_id":"9c8a800f-0215-4534-8490-1e327280bc26","query_id":"51","doc_a_id":"4414547","doc_b_id":"54561709","presented_order":["54561709","4414547"],"winner_id":"54561709","reasoning":"Both documents are irrelevant to ALDH1 expression and breast cancer outcomes, but A is marginally more related because it concerns breast cancer cell-line research (MCF-7). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:55.093526Z"}
{"comparison_id":"3ccb92b7-d15d-4bd0-9522-96260c2b5933","query_id":"51","doc_a_id":"36432234","doc_b_id":"54561709","presented_order":["54561709","36432234"],"winner_id":"54561709","reasoning":"Neither document addresses ALDH1 or clinical outcomes; Document A is slightly more related because it concerns breast cancer cell lines and factors that could affect marker studies. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:43:55.093547Z"}
{"comparison_id":"5a36859c-8e62-4c37-8b0f-78216b3c505d","query_id":"51","doc_a_id":"4414547","doc_b_id":"36432234","presented_order":["4414547","36432234"],"winner_id":"36432234","reasoning":"Neither document discusses ALDH1. Document B is marginally more relevant because it addresses breast cancer cell behavior and signaling, whereas A focuses on PPM1D germline mosaic mutations and cancer predisposition.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:01.890424Z"}
{"comparison_id":"9f72b380-2c2f-4d69-bad4-12f9054609ed","query_id":"51","doc_a_id":"20280410","doc_b_id":"7875158","presented_order":["7875158","20280410"],"winner_id":"7875158","reasoning":"Document A is more relevant — it deals with breast cancer cell biology (drug-resistant MCF-7 cells and metabolic/oxidative factors), which is closer to ALDH1 expression and tumor outcome context than B's BRCA2 polymorphism/prenatal viability focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:07.589293Z"}
{"comparison_id":"a1a1a1c6-1d34-424c-bbe6-7aff38683242","query_id":"51","doc_a_id":"37480103","doc_b_id":"13791206","presented_order":["37480103","13791206"],"winner_id":"37480103","reasoning":"Document A is more relevant — it addresses breast cancer risk/outcomes in a human population, whereas Document B is a molecular study of DNA repair unrelated to ALDH1 or clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:17.177659Z"}
{"comparison_id":"a914f935-cf21-42c7-b1bb-b8ee49643afc","query_id":"51","doc_a_id":"52180874","doc_b_id":"13791206","presented_order":["13791206","52180874"],"winner_id":"13791206","reasoning":"Document A is more relevant — it discusses BRCA1-deficient cells, which are directly related to breast cancer biology; Document B addresses immunotherapy across cancers and is less specific to breast cancer markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:17.177681Z"}
{"comparison_id":"fa927b1b-4140-4814-8341-e2943b00ab4d","query_id":"51","doc_a_id":"17450673","doc_b_id":"13791206","presented_order":["13791206","17450673"],"winner_id":"13791206","reasoning":"Document A is more related to molecular markers and mechanisms in breast cancer (more likely to discuss protein expression implications) than a perinatal epidemiology review.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:17.177696Z"}
{"comparison_id":"4cc176fa-c8ac-4a93-8d30-97e4a57e7bfe","query_id":"51","doc_a_id":"13831842","doc_b_id":"13791206","presented_order":["13791206","13831842"],"winner_id":"13791206","reasoning":"Document A is more closely related to tumor molecular markers and breast cancer biology, whereas Document B addresses height/weight risk factors and not marker expression or outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:17.177704Z"}
{"comparison_id":"6738d27b-103d-4ede-b3d4-d1b63c8504b4","query_id":"51","doc_a_id":"5222182","doc_b_id":"13791206","presented_order":["5222182","13791206"],"winner_id":"5222182","reasoning":"Neither paper discusses ALDH1. Both are irrelevant, but A is marginally more related to clinical breast cancer factors (mammographic density) than B, which focuses on BRCA1/53BP1 DNA repair mechanisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:17.177711Z"}
{"comparison_id":"17c09d6e-4dd9-4954-91f8-5a1f16e43566","query_id":"51","doc_a_id":"9171913","doc_b_id":"13791206","presented_order":["9171913","13791206"],"winner_id":"9171913","reasoning":"Reason: Neither document mentions ALDH1, but Document A concerns breast cancer risk/outcomes, making it slightly more relevant than a paper on DNA-repair mechanisms in BRCA1-deficient cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:17.177718Z"}
{"comparison_id":"a0e2d72f-7842-4518-9e60-737540c71e1b","query_id":"51","doc_a_id":"3067015","doc_b_id":"13791206","presented_order":["3067015","13791206"],"winner_id":"13791206","reasoning":"Document B is more relevant — it addresses cancer-related biology (BRCA1/repair mechanisms) while Document A discusses ALDH2 and blood pressure, not ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:17.177725Z"}
{"comparison_id":"9b16b276-4ff6-4303-8da0-aeeac3ba75ed","query_id":"51","doc_a_id":"3222187","doc_b_id":"13791206","presented_order":["3222187","13791206"],"winner_id":"3222187","reasoning":"Document A is within a breast cancer epidemiology study (more likely to address biomarkers and outcomes) while Document B focuses on DNA repair in BRCA1-deficient cells and is unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:17.177732Z"}
{"comparison_id":"b683b423-8ef8-4645-83b6-629b54a46060","query_id":"51","doc_a_id":"13519661","doc_b_id":"13791206","presented_order":["13791206","13519661"],"winner_id":"13519661","reasoning":"Document B is more relevant because it addresses breast cancer association in human subjects, whereas Document A focuses on DNA repair mechanisms in BRCA1-deficient cells and not clinical outcomes or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:17.177739Z"}
{"comparison_id":"4d15bbfb-080f-448a-8b49-6bb22a6c9ffa","query_id":"51","doc_a_id":"38784540","doc_b_id":"13791206","presented_order":["38784540","13791206"],"winner_id":"38784540","reasoning":"Document A is more relevant because it addresses breast cancer risk and factors related to outcomes, whereas Document B focuses on DNA repair mechanisms in BRCA1-deficient cells and does not pertain to ALDH1 or clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:17.177748Z"}
{"comparison_id":"28007b19-12aa-47a3-8c5e-943f76c6363b","query_id":"51","doc_a_id":"37480103","doc_b_id":"9171913","presented_order":["37480103","9171913"],"winner_id":"37480103","reasoning":"Neither document mentions ALDH1 or reports outcomes after breast cancer diagnosis; both address risk factors. Both are irrelevant, but Document A is marginally more directly about breast cancer risk.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:29.527595Z"}
{"comparison_id":"58c6fd60-b17c-4033-bcd8-daaffdb77421","query_id":"51","doc_a_id":"5222182","doc_b_id":"9171913","presented_order":["5222182","9171913"],"winner_id":"5222182","reasoning":"Neither document mentions ALDH1. Both are irrelevant, but Document A is slightly more related to breast cancer biology (mammographic density) than Document B (blood lipids).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:29.527620Z"}
{"comparison_id":"13e4f364-69b5-403a-84ec-c568d4c172f9","query_id":"51","doc_a_id":"38784540","doc_b_id":"9171913","presented_order":["38784540","9171913"],"winner_id":"38784540","reasoning":"Document A is more relevant — it covers breast cancer–related factors (mammographic density and reproductive/anthropometric influences) which are closer to prognosis than a study of blood lipid levels.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:29.527635Z"}
{"comparison_id":"bdca76bc-04d1-4910-b698-9f6227677112","query_id":"51","doc_a_id":"3222187","doc_b_id":"9171913","presented_order":["3222187","9171913"],"winner_id":"3222187","reasoning":"Document A is slightly more relevant because it concerns a breast cancer cohort and factors that may influence prognosis, whereas Document B addresses lipid levels and breast cancer risk rather than outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:29.527645Z"}
{"comparison_id":"7e31c850-31ae-4a47-88f6-6d2cf85e7bc1","query_id":"51","doc_a_id":"13519661","doc_b_id":"9171913","presented_order":["9171913","13519661"],"winner_id":"13519661","reasoning":"Neither document discusses ALDH1 or tumor marker expression. Document B is slightly more relevant because it addresses molecular/genetic factors in breast cancer, whereas A focuses on blood lipids.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:29.527652Z"}
{"comparison_id":"75c1be39-3ac4-420e-a457-89c09fab3e79","query_id":"51","doc_a_id":"37480103","doc_b_id":"38784540","presented_order":["38784540","37480103"],"winner_id":"38784540","reasoning":"Document A is more relevant — it addresses breast cancer–related factors and outcomes (mammographic density and risk), whereas B focuses on placental weight and pregnancy-related risk only.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:38.906440Z"}
{"comparison_id":"7ea07969-9f6c-494b-bd45-003fd25a5cd8","query_id":"51","doc_a_id":"5222182","doc_b_id":"38784540","presented_order":["38784540","5222182"],"winner_id":"38784540","reasoning":"Neither document mentions ALDH1 or breast cancer outcomes; both are irrelevant. Document A is slightly more relevant because it discusses breast cancer risk factors broadly.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:38.906461Z"}
{"comparison_id":"1c5545fd-8cd9-4599-8dbb-06c7c904f9ad","query_id":"51","doc_a_id":"13519661","doc_b_id":"38784540","presented_order":["38784540","13519661"],"winner_id":"13519661","reasoning":"Neither document addresses ALDH1. Document B is slightly more relevant because it examines a gene-based association with breast cancer risk (molecular focus), whereas A concerns life-course risk factors and breast density.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:38.906470Z"}
{"comparison_id":"79e46849-ed1a-4cd8-a908-93109c25b7d1","query_id":"51","doc_a_id":"3222187","doc_b_id":"38784540","presented_order":["38784540","3222187"],"winner_id":"38784540","reasoning":"Document A is more related (addresses breast cancer risk/density), while Document B focuses on vitamin D genetics unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:38.906476Z"}
{"comparison_id":"0e10a3c7-a391-4120-9799-37071c141422","query_id":"51","doc_a_id":"37480103","doc_b_id":"5222182","presented_order":["37480103","5222182"],"winner_id":"5222182","reasoning":"Neither document mentions ALDH1 or breast cancer outcomes. Document B is marginally more relevant because it addresses breast cancer–related biomarkers (mammographic density), whereas A focuses on pregnancy/placental weight. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:45.263278Z"}
{"comparison_id":"cb1a4813-5b87-4b6d-a837-9165cdf143e3","query_id":"51","doc_a_id":"3222187","doc_b_id":"5222182","presented_order":["3222187","5222182"],"winner_id":"5222182","reasoning":"Neither paper mentions ALDH1. Both are irrelevant, but Document B is slightly more relevant because it addresses breast cancer–related phenotypes (mammographic density) and predictors that could relate to outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:45.263298Z"}
{"comparison_id":"c7c2ac41-b791-44e2-8d90-1fd72c1ba4e7","query_id":"51","doc_a_id":"37480103","doc_b_id":"3222187","presented_order":["37480103","3222187"],"winner_id":"37480103","reasoning":"Document A is slightly more relevant because it directly concerns breast cancer risk/outcomes, whereas Document B focuses on vitamin D genetics not breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:49.415471Z"}
{"comparison_id":"95a75966-00a0-4324-8a41-c2abef0c4436","query_id":"51","doc_a_id":"52180874","doc_b_id":"17450673","presented_order":["52180874","17450673"],"winner_id":"52180874","reasoning":"Both documents are irrelevant to ALDH1 and its association with breast cancer outcomes, but A is marginally more relevant because it addresses biomarker expression and cancer treatment outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:54.485773Z"}
{"comparison_id":"9d4ba34c-8e86-4593-b4e6-201af7c2dd2c","query_id":"51","doc_a_id":"3067015","doc_b_id":"17450673","presented_order":["17450673","3067015"],"winner_id":"17450673","reasoning":"Document A is more relevant — it addresses breast cancer (where ALDH1 expression would be relevant), while Document B concerns ALDH2 and blood pressure, not breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:54.485794Z"}
{"comparison_id":"73b394e1-eaee-4f2a-84ca-6667cb78878c","query_id":"51","doc_a_id":"13831842","doc_b_id":"17450673","presented_order":["13831842","17450673"],"winner_id":"13831842","reasoning":"Reason: Neither abstract mentions ALDH1 or tumor biomarkers, but Document A (adult anthropometric factors and breast cancer risk) is slightly closer to outcomes in breast cancer than the perinatal focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:44:54.485803Z"}
{"comparison_id":"0e0ea0c6-a12f-4057-ab16-0a6e0527023e","query_id":"51","doc_a_id":"52180874","doc_b_id":"13831842","presented_order":["52180874","13831842"],"winner_id":"13831842","reasoning":"Document B is more relevant — it directly addresses breast cancer (risk/outcomes), whereas Document A is about PD-1/PD-L1 immunotherapy across cancers and unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:45:03.622442Z"}
{"comparison_id":"c1a8c4cc-c6c5-4936-8d70-08c664594025","query_id":"51","doc_a_id":"23830488","doc_b_id":"1285713","presented_order":["23830488","1285713"],"winner_id":"23830488","reasoning":"Document A is more relevant — it relates gene expression to cancer outcomes (though in colorectal cancer and different genes), whereas B covers drug pharmacology unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320547Z"}
{"comparison_id":"5a226035-168f-467e-bb50-aeaa7f29437d","query_id":"51","doc_a_id":"24349992","doc_b_id":"1285713","presented_order":["1285713","24349992"],"winner_id":"24349992","reasoning":"Document B is more relevant — it addresses tumor biology and factors influencing cancer behavior and prognosis, whereas A focuses on a PI3K inhibitor's pharmacology and not on ALDH1 or clinical outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320568Z"}
{"comparison_id":"653e29ad-2fb5-4b1b-a416-b94920110600","query_id":"51","doc_a_id":"29124963","doc_b_id":"1285713","presented_order":["1285713","29124963"],"winner_id":"1285713","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes; Document A is slightly more relevant only because it concerns cancer biology/therapeutics generally. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320578Z"}
{"comparison_id":"15cf18a9-2811-48da-9b65-3c102ac0be95","query_id":"51","doc_a_id":"9486930","doc_b_id":"1285713","presented_order":["1285713","9486930"],"winner_id":"9486930","reasoning":"Document B is more relevant — it discusses a stem cell-related signature (ALDH1 is a stem/progenitor marker), whereas Document A focuses on a PI3K inhibitor unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320585Z"}
{"comparison_id":"e802e67d-15b0-429c-acc9-7a80e61d1caa","query_id":"51","doc_a_id":"22963769","doc_b_id":"1285713","presented_order":["1285713","22963769"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant—it's about cancer therapeutics (general breast cancer relevance), whereas Document B focuses on oral squamous cell carcinoma unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320592Z"}
{"comparison_id":"5402c750-1492-4b02-ae75-b68fbf54e09b","query_id":"51","doc_a_id":"42731834","doc_b_id":"1285713","presented_order":["42731834","1285713"],"winner_id":"42731834","reasoning":"Document A is more relevant — it discusses tumor marker expression linked to patient survival outcomes (though in a different marker and cancer type), whereas B focuses on a PI3K inhibitor's pharmacology.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320599Z"}
{"comparison_id":"cfe2d73f-c53f-408b-8d07-c24f7a0d57be","query_id":"51","doc_a_id":"25832301","doc_b_id":"1285713","presented_order":["1285713","25832301"],"winner_id":"25832301","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it examines a gene's expression linked to better outcomes (though in multiple myeloma, not breast cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320607Z"}
{"comparison_id":"0932b817-d577-4b5a-9d37-f38d78c51ca6","query_id":"51","doc_a_id":"8037453","doc_b_id":"1285713","presented_order":["8037453","1285713"],"winner_id":"8037453","reasoning":"Document A is more relevant — it discusses biomarkers linked to cancer patient outcomes and prognosis, which is closer to the claim about a biomarker (ALDH1) and breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320614Z"}
{"comparison_id":"86b509e3-01fb-47c4-b3e8-12010b78aa72","query_id":"51","doc_a_id":"31591262","doc_b_id":"1285713","presented_order":["1285713","31591262"],"winner_id":"31591262","reasoning":"Document B — it discusses gene expression's association with cancer outcomes, which is more similar to the query about ALDH1 expression and breast cancer prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320622Z"}
{"comparison_id":"17f50704-a8d6-4f62-8146-e5e355b8c114","query_id":"51","doc_a_id":"8512633","doc_b_id":"1285713","presented_order":["8512633","1285713"],"winner_id":"8512633","reasoning":"Document A is more relevant — it discusses biomarker associations with cancer outcomes (though in prostate cancer), while B focuses on PI3K inhibitor pharmacology and not biomarker-outcome links.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320629Z"}
{"comparison_id":"1fbac063-8c3a-4577-a9f8-f805da390a54","query_id":"51","doc_a_id":"13906581","doc_b_id":"1285713","presented_order":["13906581","1285713"],"winner_id":"13906581","reasoning":"Reason: The query concerns associations with patient outcomes; Document A discusses patient outcomes (even though not breast cancer-specific), while Document B focuses on a PI3K inhibitor and drug pharmacology.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320636Z"}
{"comparison_id":"b59aca62-88dc-4bfb-ac7c-04892b0b83de","query_id":"51","doc_a_id":"23304931","doc_b_id":"1285713","presented_order":["23304931","1285713"],"winner_id":"23304931","reasoning":"Document A is more relevant — it discusses associations between marker expression and patient outcomes (albeit in DLBCL), whereas Document B is a pharmacologic study unrelated to marker-outcome correlations. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320644Z"}
{"comparison_id":"6f4f4c98-61f9-4d8c-adf0-c76559fbb2a0","query_id":"51","doc_a_id":"7795952","doc_b_id":"1285713","presented_order":["7795952","1285713"],"winner_id":"7795952","reasoning":"Document A is more relevant — it discusses a protein linked directly to cancer prognosis, whereas B focuses on a PI3K inhibitor's pharmacology and not on prognostic markers or outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320651Z"}
{"comparison_id":"3a0d8c62-9387-4943-9b7c-1bacaa1d1d20","query_id":"51","doc_a_id":"23665162","doc_b_id":"1285713","presented_order":["1285713","23665162"],"winner_id":"1285713","reasoning":"Document A is marginally more relevant because it concerns cancer biology/therapy, whereas Document B focuses on LINE-1 methylation and hepatocellular carcinoma (not breast cancer). Neither mentions ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320660Z"}
{"comparison_id":"2748996d-aad7-4168-aedb-55bc0dd3a950","query_id":"51","doc_a_id":"24205118","doc_b_id":"1285713","presented_order":["1285713","24205118"],"winner_id":"24205118","reasoning":"Reason: The query asks about a prognostic marker association; Document B reports clinicopathological and prognostic significance of a marker (Bmi-1), matching study type. Document A is a pharmacologic study of a PI3K inhibitor, not a prognostic marker or breast-cancer outcome study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320672Z"}
{"comparison_id":"19b4af34-d08b-46c4-8901-567bde0fd688","query_id":"51","doc_a_id":"19047331","doc_b_id":"1285713","presented_order":["19047331","1285713"],"winner_id":"19047331","reasoning":"Document A is slightly more relevant because it discusses cancer biomarkers and clinical outcomes (though in ovarian cancer), whereas Document B focuses on a PI3K inhibitor's pharmacology and not on biomarkers or outcomes. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320685Z"}
{"comparison_id":"69453983-8acd-437d-bd5e-e39b201cb8d2","query_id":"51","doc_a_id":"7165938","doc_b_id":"1285713","presented_order":["1285713","7165938"],"winner_id":"7165938","reasoning":"Document B is more relevant — it discusses gene expression linked to patient survival and prognosis (though in colorectal cancer), which is closer to a claim about a biomarker's association with cancer outcomes than a pharmacologic PI3K inhibitor study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320703Z"}
{"comparison_id":"06e4de8c-4c4e-4280-aba4-710240eea409","query_id":"51","doc_a_id":"2727303","doc_b_id":"1285713","presented_order":["2727303","1285713"],"winner_id":"2727303","reasoning":"Neither abstract mentions ALDH1. Document A is slightly more relevant because it addresses regulators of malignant cell behavior and potential therapeutic/ prognostic factors, while B focuses on PI3K inhibitor pharmacology. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320720Z"}
{"comparison_id":"b241a908-2542-4dcc-b125-128eadbb170a","query_id":"51","doc_a_id":"10169908","doc_b_id":"1285713","presented_order":["10169908","1285713"],"winner_id":"1285713","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes; both are irrelevant. Document B is marginally more relevant because it concerns a cancer-targeted therapy with broader tumor-type implications, whereas A is specific to lung cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320730Z"}
{"comparison_id":"e0dd704d-92f5-4bc2-aa07-3b9382ae239d","query_id":"51","doc_a_id":"1782201","doc_b_id":"1285713","presented_order":["1782201","1285713"],"winner_id":"1782201","reasoning":"Document A is slightly more relevant because it discusses tumor progression and prognostic features of carcinomas, whereas B focuses on PI3K inhibitor pharmacology and not on biomarkers or outcomes. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320738Z"}
{"comparison_id":"5dc935eb-53b6-4adf-9338-057ce1030c91","query_id":"51","doc_a_id":"8677721","doc_b_id":"1285713","presented_order":["1285713","8677721"],"winner_id":"1285713","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes. Document A is slightly more relevant because it deals broadly with cancer therapeutics (PI3K inhibition), whereas Document B focuses specifically on hepatocellular carcinoma mechanisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320746Z"}
{"comparison_id":"b18fa281-563c-49fe-ba25-2ced772a09c9","query_id":"51","doc_a_id":"39580129","doc_b_id":"1285713","presented_order":["1285713","39580129"],"winner_id":"39580129","reasoning":"Document B — it discusses expression levels of a biomarker linked to patient outcomes, making it more relevant to a claim about marker expression and cancer prognosis than a pharmacologic study of a PI3K inhibitor.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320754Z"}
{"comparison_id":"93588a71-dcd4-483c-ab2d-3aaf3d8afe5b","query_id":"51","doc_a_id":"7736860","doc_b_id":"1285713","presented_order":["1285713","7736860"],"winner_id":"1285713","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is slightly more relevant only because it addresses cancer therapeutics generally, while B is specific to cervical cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320761Z"}
{"comparison_id":"3cb59357-d781-4528-a87a-c4ad45c330ec","query_id":"51","doc_a_id":"36950726","doc_b_id":"1285713","presented_order":["36950726","1285713"],"winner_id":"1285713","reasoning":"Document B is slightly more relevant because it addresses cancer therapeutics (potentially applicable to breast cancer), whereas Document A focuses on melanoma-specific epigenetic changes not related to ALDH1 or breast cancer.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320769Z"}
{"comparison_id":"9a79eab6-a837-4dea-8efa-7cb913b7971c","query_id":"51","doc_a_id":"3684342","doc_b_id":"1285713","presented_order":["1285713","3684342"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant because it discusses a cancer therapeutic agent and cancer outcomes generally, whereas Document B is specific to LIN28B in lung cancer and unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320776Z"}
{"comparison_id":"e7b754c4-973b-4ec4-9250-919f2b33507e","query_id":"51","doc_a_id":"2389574","doc_b_id":"1285713","presented_order":["2389574","1285713"],"winner_id":"2389574","reasoning":"Document A is more relevant — it discusses prognostic marker expression in cancer (though in endometrial cancer, not breast or ALDH1), whereas Document B focuses on a PI3K inhibitor pharmacology unrelated to ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320784Z"}
{"comparison_id":"4beb0feb-7be8-4139-854f-4a862a3c6bd1","query_id":"51","doc_a_id":"10024681","doc_b_id":"1285713","presented_order":["1285713","10024681"],"winner_id":"1285713","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes; both are irrelevant. Document A is marginally more relevant because it addresses cancer therapeutics broadly (whereas B is specific to prostate cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320793Z"}
{"comparison_id":"ec390758-cc66-4b36-b0fa-68f6877ca67f","query_id":"51","doc_a_id":"24980622","doc_b_id":"1285713","presented_order":["1285713","24980622"],"winner_id":"1285713","reasoning":"Document A is marginally more relevant — it concerns molecular cancer biology/therapeutics (more likely to discuss markers in cancers such as breast) while Document B focuses on colorectal liver metastases and hypoxia markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320801Z"}
{"comparison_id":"a5f97f64-8018-4556-bf4c-8d7351fddfa1","query_id":"51","doc_a_id":"25576204","doc_b_id":"1285713","presented_order":["1285713","25576204"],"winner_id":"25576204","reasoning":"Neither document mentions ALDH1. Document B is marginally more relevant because it addresses cancer tumorigenesis and genes affecting tumor suppression, which is closer to factors influencing cancer outcomes than a pharmacologic PI3K inhibitor study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320809Z"}
{"comparison_id":"5408a8a1-eaa3-4e79-8a08-3740abac8d90","query_id":"51","doc_a_id":"25523969","doc_b_id":"1285713","presented_order":["25523969","1285713"],"winner_id":"25523969","reasoning":"Document A is slightly more relevant because it deals with cancer marker expression and immunohistochemical analysis, which is closer to a claim about ALDH1 expression and outcomes than a pharmacologic study. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320817Z"}
{"comparison_id":"75c230ad-3858-41b8-ab76-8b4ac52ff321","query_id":"51","doc_a_id":"14471161","doc_b_id":"1285713","presented_order":["14471161","1285713"],"winner_id":"1285713","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes; both are irrelevant. If one must be chosen, B is marginally more relevant because it focuses on molecular cancer biology rather than a diet/timing intervention in pancreatic cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320824Z"}
{"comparison_id":"f51cf262-fe02-4f45-b9fb-c7e5818ad062","query_id":"51","doc_a_id":"9239963","doc_b_id":"1285713","presented_order":["1285713","9239963"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant because it discusses cancer biology/therapeutics generally, whereas Document B focuses on endometrial steroidogenesis unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320831Z"}
{"comparison_id":"e86f2a63-791f-4eb7-aadc-dbbd96971b14","query_id":"51","doc_a_id":"5774746","doc_b_id":"1285713","presented_order":["5774746","1285713"],"winner_id":"5774746","reasoning":"Doc A is more relevant — it discusses how protein expression levels correlate with patient survival in cancer (even though it's colorectal, not breast), while Document B focuses on a PI3K inhibitor's pharmacology. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320838Z"}
{"comparison_id":"6ba7ca9a-be54-49c8-b088-cd7fa3e4bada","query_id":"51","doc_a_id":"11271123","doc_b_id":"1285713","presented_order":["1285713","11271123"],"winner_id":"11271123","reasoning":"Document B is more relevant — it involves molecular marker expression and clinical correlations (though in endometrial, not breast, cancer), whereas A focuses on a PI3K inhibitor pharmacology unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320845Z"}
{"comparison_id":"c7e5a91d-7a05-4e78-97e5-576680ecc07b","query_id":"51","doc_a_id":"6790197","doc_b_id":"1285713","presented_order":["1285713","6790197"],"winner_id":"6790197","reasoning":"Document B — it discusses cancer-associated gene expression and links expression changes to clinical outcomes (though in prostate cancer), which is more relevant to a claim about ALDH1 expression and cancer outcomes than a pharmacologic PI3K inhibitor study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320853Z"}
{"comparison_id":"6cc60b7f-1d74-4362-802c-4afe0e1f93f6","query_id":"51","doc_a_id":"4462079","doc_b_id":"1285713","presented_order":["4462079","1285713"],"winner_id":"4462079","reasoning":"Document A is slightly more relevant because it discusses cancer risk and outcomes in a clinical review context, whereas Document B focuses on a PI3K inhibitor's pharmacology and not on biomarkers or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320859Z"}
{"comparison_id":"ed460fbe-0f63-4c66-82e9-c3c5d4da3519","query_id":"51","doc_a_id":"1507222","doc_b_id":"1285713","presented_order":["1285713","1507222"],"winner_id":"1285713","reasoning":"Document A is more relevant — it concerns cancer therapeutics/outcomes, whereas Document B focuses on cachexia and uncoupling proteins in a mouse model, not ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320866Z"}
{"comparison_id":"0eb92d2d-5b16-483d-9758-9e12153e3524","query_id":"51","doc_a_id":"24349430","doc_b_id":"1285713","presented_order":["24349430","1285713"],"winner_id":"1285713","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer; Document B is more broadly about cancer therapeutics and in vivo anti-cancer activity, so slightly more relevant to outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320873Z"}
{"comparison_id":"749c842e-34fa-4dd4-a340-d25e1e58b72f","query_id":"51","doc_a_id":"31439189","doc_b_id":"1285713","presented_order":["31439189","1285713"],"winner_id":"31439189","reasoning":"Document A is slightly more relevant because it discusses cancer stem cell markers and clonogenicity, which is closer to ALDH1 (a stem cell marker) than pharmacologic PI3K inhibitor data. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320879Z"}
{"comparison_id":"a7264075-3a8c-4a20-80a7-f5259aa23636","query_id":"51","doc_a_id":"13964633","doc_b_id":"1285713","presented_order":["13964633","1285713"],"winner_id":"13964633","reasoning":"Document A is more related to molecular markers and tumor outcome modulation (via miRNA, Rb1, PTEN) than a pharmacologic PI3K inhibitor study; neither mentions ALDH1 but A is closer in topic.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320886Z"}
{"comparison_id":"d5031883-6ba0-4948-8858-9c09e849fa15","query_id":"51","doc_a_id":"31313782","doc_b_id":"1285713","presented_order":["31313782","1285713"],"winner_id":"1285713","reasoning":"DOCUMENT B is slightly more relevant because it concerns cancer biology/therapy, whereas DOCUMENT A discusses TLRs in lung disease unrelated to breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320893Z"}
{"comparison_id":"f7260ec8-af28-4a6a-aaa3-380e1273fc92","query_id":"51","doc_a_id":"21181273","doc_b_id":"1285713","presented_order":["21181273","1285713"],"winner_id":"21181273","reasoning":"Doc A discusses altered enzyme expression in cancer and links reduced expression to tumor progression, making it more relevant to a claim about biomarker expression and outcomes than Doc B (a PI3K inhibitor study).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320920Z"}
{"comparison_id":"000246ed-3aa8-4e2d-bed0-fbd4eaa687f9","query_id":"51","doc_a_id":"12358173","doc_b_id":"1285713","presented_order":["12358173","1285713"],"winner_id":"12358173","reasoning":"Document A is more relevant because it discusses the relationship between a tumor marker's expression and cancer prognosis, which is closer to the claim about ALDH1 expression and breast cancer outcomes than a pharmacologic study of a PI3K inhibitor.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320934Z"}
{"comparison_id":"505bd2ef-d407-413b-939d-e4124fc1c3a3","query_id":"51","doc_a_id":"16630996","doc_b_id":"1285713","presented_order":["16630996","1285713"],"winner_id":"1285713","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes, but B is slightly more relevant because it concerns cancer molecular biology/therapy broadly, whereas A focuses specifically on gemcitabine resistance in pancreatic cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320942Z"}
{"comparison_id":"abc56bea-ddeb-49ba-8c84-141e96f00590","query_id":"51","doc_a_id":"32721137","doc_b_id":"1285713","presented_order":["32721137","1285713"],"winner_id":"32721137","reasoning":"Document A is more relevant — it discusses tumor phenotypes and disease-free survival (prognostic associations), whereas B focuses on PI3K inhibitor pharmacology and not clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320950Z"}
{"comparison_id":"bd83f7f0-bc1e-4fc5-8ad9-014c9121e418","query_id":"51","doc_a_id":"2272614","doc_b_id":"1285713","presented_order":["1285713","2272614"],"winner_id":"1285713","reasoning":"Neither abstract mentions ALDH1 or breast cancer; Document A is marginally more relevant because it addresses cancer therapeutics generally, while B is specific to NF1-mediated resistance in lung cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320957Z"}
{"comparison_id":"a2520cb9-a03e-4187-9f72-e14ee6635034","query_id":"51","doc_a_id":"36212758","doc_b_id":"1285713","presented_order":["36212758","1285713"],"winner_id":"36212758","reasoning":"Document A is more relevant — it addresses cancer genomic profiles and associations with survival outcomes (though in lung cancer), whereas B is pharmacology of a PI3K inhibitor unrelated to ALDH1 or clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320964Z"}
{"comparison_id":"e2d6e53f-b0dc-4cb6-8fb1-14b7e52c3963","query_id":"51","doc_a_id":"3355397","doc_b_id":"1285713","presented_order":["3355397","1285713"],"winner_id":"1285713","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer outcomes, but Document B addresses cancer biology/therapy (more directly related to cancer mechanisms) while Document A focuses on diabetes drug–cancer epidemiology.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320971Z"}
{"comparison_id":"e1c14b4e-fac4-40d0-acb9-7f5c12dd2c07","query_id":"51","doc_a_id":"32852283","doc_b_id":"1285713","presented_order":["1285713","32852283"],"winner_id":"1285713","reasoning":"Document A is more relevant — it addresses cancer therapeutics (broadly applicable to tumor biology), whereas Document B focuses specifically on zoledronic acid in non‑small‑cell lung cancer and neither mentions ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320978Z"}
{"comparison_id":"8aa9a487-f5d0-4746-8e11-86b17cece008","query_id":"51","doc_a_id":"24396137","doc_b_id":"1285713","presented_order":["1285713","24396137"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant because it concerns molecular cancer biology and therapeutics, whereas Document B addresses behavioral intervention outcomes in cancer survivors and not molecular markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320986Z"}
{"comparison_id":"aedcd597-4563-418c-89a3-56a5a8ceaaba","query_id":"51","doc_a_id":"33370","doc_b_id":"1285713","presented_order":["33370","1285713"],"winner_id":"33370","reasoning":"Document A is more relevant — it discusses cancer stem cells, which relates conceptually to ALDH1 as a stem cell marker, while Document B focuses on a PI3K inhibitor and not on ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.320993Z"}
{"comparison_id":"3cdeb9d7-7792-47cf-8d0f-98cfec6b8ad9","query_id":"51","doc_a_id":"39929509","doc_b_id":"1285713","presented_order":["39929509","1285713"],"winner_id":"39929509","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes; both are irrelevant. Document A is marginally more relevant because it addresses protein expression and cancer biology generally.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321000Z"}
{"comparison_id":"ce90aee7-936f-42bb-b520-d5d649a04a51","query_id":"51","doc_a_id":"22521091","doc_b_id":"1285713","presented_order":["22521091","1285713"],"winner_id":"22521091","reasoning":"A is slightly more relevant because it discusses gene expression as a biomarker correlated with cancer outcomes (though in HCC), whereas B is about a PI3K inhibitor and not about biomarker expression or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321007Z"}
{"comparison_id":"70f08cfb-b311-43ce-b62e-984f605479a1","query_id":"51","doc_a_id":"14180565","doc_b_id":"1285713","presented_order":["1285713","14180565"],"winner_id":"1285713","reasoning":"Document A is more relevant — it addresses cancer therapeutics and in vivo anti-cancer activity, whereas Document B focuses on gene changes in glioblastoma cells, which is less related to breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321014Z"}
{"comparison_id":"515546af-1a0f-483e-aece-6f25bd361c7b","query_id":"51","doc_a_id":"38808600","doc_b_id":"1285713","presented_order":["38808600","1285713"],"winner_id":"1285713","reasoning":"Document B is more relevant — it concerns cancer pharmacology (potentially applicable to breast cancer), whereas A is specific to glioma imaging and unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321022Z"}
{"comparison_id":"bb316871-f9a0-48c2-8dd3-e4bd9a77c34f","query_id":"51","doc_a_id":"26079071","doc_b_id":"1285713","presented_order":["26079071","1285713"],"winner_id":"1285713","reasoning":"Document B is more relevant — it discusses a molecular cancer therapeutic (PI3K inhibitor) and cancer biology, which is closer to markers affecting cancer outcomes than a NSCLC-specific drug study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321029Z"}
{"comparison_id":"4cc76c15-31a6-4fc0-a8b7-3b1399d893a3","query_id":"51","doc_a_id":"12869200","doc_b_id":"1285713","presented_order":["1285713","12869200"],"winner_id":"1285713","reasoning":"Neither document addresses ALDH1 or breast cancer specifically. Document A is marginally more relevant because it concerns molecular cancer biology/therapeutics, whereas B focuses on adipokines and endometrial cancer risk.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321036Z"}
{"comparison_id":"7850b316-72fb-4a84-b3f6-2bab22d2c142","query_id":"51","doc_a_id":"52925737","doc_b_id":"1285713","presented_order":["1285713","52925737"],"winner_id":"1285713","reasoning":"Neither abstract mentions ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant because it discusses cancer-related molecular biology/therapy broadly, while B is specific to gastric cancer mechanisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321043Z"}
{"comparison_id":"f89390a3-9193-452a-be8d-e45a6d37d2c4","query_id":"51","doc_a_id":"1032372","doc_b_id":"1285713","presented_order":["1032372","1285713"],"winner_id":"1032372","reasoning":"Document A is more related to cancer outcomes and treatment context, while Document B focuses on a PI3K inhibitor's pharmacology unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321050Z"}
{"comparison_id":"debd25a1-dddb-48df-97b1-0fa461d41c62","query_id":"51","doc_a_id":"5386514","doc_b_id":"1285713","presented_order":["5386514","1285713"],"winner_id":"5386514","reasoning":"Document A is more relevant — it discusses tumor biology and factors affecting anticancer therapy efficacy (closer to prognostic/outcome discussions), whereas B is focused on PI3K inhibitor pharmacology. Neither mentions ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321057Z"}
{"comparison_id":"e078bd89-9ab2-4b7d-98bb-cffbaceab4ad","query_id":"51","doc_a_id":"23509593","doc_b_id":"1285713","presented_order":["23509593","1285713"],"winner_id":"1285713","reasoning":"Document B is more relevant — it concerns cancer therapeutics (PI3K inhibition) whereas Document A is about androgen regulation in prostate stromal cells and unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321065Z"}
{"comparison_id":"1a032839-7284-470b-83f1-39c7276874cb","query_id":"51","doc_a_id":"1976183","doc_b_id":"1285713","presented_order":["1976183","1285713"],"winner_id":"1976183","reasoning":"Neither document discusses ALDH1 or breast cancer; however, Document A is slightly more relevant because it addresses expression of a biomarker linked to cancer invasiveness/outcomes (though in oral cancer), while B focuses on a PI3K inhibitor. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321071Z"}
{"comparison_id":"239ef1b6-660a-49ee-b9c9-aa95a1f81c04","query_id":"51","doc_a_id":"46617075","doc_b_id":"1285713","presented_order":["1285713","46617075"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant because it concerns molecular cancer therapeutics and general cancer biology, whereas Document B focuses specifically on the Rb-p16 pathway in lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321078Z"}
{"comparison_id":"5e89fe60-21e4-41cb-8877-d502f4499b02","query_id":"51","doc_a_id":"25298276","doc_b_id":"1285713","presented_order":["1285713","25298276"],"winner_id":"25298276","reasoning":"Neither abstract mentions ALDH1. Document B is slightly more relevant because it discusses clinical outcomes and survival in cancer, whereas A is focused on a PI3K inhibitor's pharmacology. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321085Z"}
{"comparison_id":"cfc94019-6d9f-450c-aacd-350693c8abe2","query_id":"51","doc_a_id":"53211308","doc_b_id":"1285713","presented_order":["53211308","1285713"],"winner_id":"53211308","reasoning":"Neither document addresses ALDH1 or breast cancer specifically, but Document A (biomarker expression in cancer) is more related to expression–outcome associations than the PI3K inhibitor pharmacology in B. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321092Z"}
{"comparison_id":"1212ec73-16cf-490b-a5c4-abc7420dffdb","query_id":"51","doc_a_id":"9211173","doc_b_id":"1285713","presented_order":["1285713","9211173"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular markers and therapies (general cancer context) while Document B focuses specifically on ARID1A mutations in ovarian cancer, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321100Z"}
{"comparison_id":"d7551062-795e-45f4-9663-40646707f303","query_id":"51","doc_a_id":"27306942","doc_b_id":"1285713","presented_order":["1285713","27306942"],"winner_id":"1285713","reasoning":"Neither abstract mentions ALDH1 or breast cancer. Document A is slightly more relevant because it concerns cancer therapeutics generally, whereas B is specific to pediatric B‑cell ALL. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321107Z"}
{"comparison_id":"08392586-af11-4451-9fe3-766de9e5d0c5","query_id":"51","doc_a_id":"23577867","doc_b_id":"1285713","presented_order":["1285713","23577867"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant because it concerns cancer biology/therapy, whereas Document B addresses endometrial cancer risk factors; neither mentions ALDH1 or breast cancer outcomes. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321113Z"}
{"comparison_id":"a549c4ff-46d9-413d-bcbe-7905c9647770","query_id":"51","doc_a_id":"11880289","doc_b_id":"1285713","presented_order":["1285713","11880289"],"winner_id":"1285713","reasoning":"Document A is more relevant — it's a molecular cancer study (potentially discussing biomarkers/biology), whereas Document B is a screening trial unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321120Z"}
{"comparison_id":"dbff01f8-b4e1-460b-a660-464c67759b1a","query_id":"51","doc_a_id":"5377642","doc_b_id":"1285713","presented_order":["1285713","5377642"],"winner_id":"1285713","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes. Document A is marginally more relevant because it addresses cancer therapeutics and in vivo anti-cancer activity, while Document B focuses on T cell epigenetic regulation. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321127Z"}
{"comparison_id":"429b3542-b8bb-46f2-a61e-6ea9d0f8e4f7","query_id":"51","doc_a_id":"4688340","doc_b_id":"1285713","presented_order":["1285713","4688340"],"winner_id":"1285713","reasoning":"Neither document addresses ALDH1 or breast cancer directly. Document A is slightly more relevant because it discusses molecular cancer biology/therapeutics broadly, whereas B is specific to head and neck cancer sphere cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321134Z"}
{"comparison_id":"46409843-182b-4719-9ea5-88d9148c8019","query_id":"51","doc_a_id":"33638477","doc_b_id":"1285713","presented_order":["1285713","33638477"],"winner_id":"33638477","reasoning":"B is more relevant — it addresses gene expression effects on tumor progression and outcomes, which is closer to a claim about a biomarker (ALDH1) and breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321141Z"}
{"comparison_id":"5729f845-0d49-40a0-9d35-d1b0785f1caf","query_id":"51","doc_a_id":"20738970","doc_b_id":"1285713","presented_order":["1285713","20738970"],"winner_id":"1285713","reasoning":"Doc A is more general to cancer biology and therapeutics (potentially relevant to breast cancer mechanisms), while Doc B focuses narrowly on small cell lung cancer apoptosis and not breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321147Z"}
{"comparison_id":"e4e76e26-617c-4453-8669-a0021c0f0a2b","query_id":"51","doc_a_id":"3210545","doc_b_id":"1285713","presented_order":["1285713","3210545"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant because it discusses a cancer therapeutic and general cancer biology, while Document B focuses on KRAS in endometrial cancer (unrelated to ALDH1 or breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321154Z"}
{"comparison_id":"5a5d2146-eb16-405f-a0ac-cff24d2b62a2","query_id":"51","doc_a_id":"39758684","doc_b_id":"1285713","presented_order":["39758684","1285713"],"winner_id":"39758684","reasoning":"Neither document mentions ALDH1 or breast cancer outcomes. Document A (tumorigenesis mechanism) is marginally more relevant to cancer biomarkers than Document B (PI3K inhibitor pharmacology).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321161Z"}
{"comparison_id":"2f7f5392-98e4-4c9e-b6f5-a25df629b32e","query_id":"51","doc_a_id":"26848994","doc_b_id":"1285713","presented_order":["1285713","26848994"],"winner_id":"1285713","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document A is slightly more relevant because it discusses cancer therapeutics generally, while Document B is specific to hepatocellular carcinoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321168Z"}
{"comparison_id":"57a74358-46c3-4b19-a1d1-ebeeb3d1df7f","query_id":"51","doc_a_id":"25121903","doc_b_id":"1285713","presented_order":["1285713","25121903"],"winner_id":"25121903","reasoning":"Document B is more likely to address cancer outcomes and survivorship data (including breast cancer), while Document A focuses on a PI3K inhibitor pharmacology unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321175Z"}
{"comparison_id":"4b019c8f-91b5-47d4-82f7-7ce185bf25d8","query_id":"51","doc_a_id":"21502234","doc_b_id":"1285713","presented_order":["21502234","1285713"],"winner_id":"21502234","reasoning":"Document A is more relevant because it deals with the association between a biomarker status and clinical outcomes (though in endometrial cancer), whereas Document B is preclinical pharmacology unrelated to biomarker-outcome associations. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321182Z"}
{"comparison_id":"8076fa6f-1e25-4771-91c6-c0dca8ad1f16","query_id":"51","doc_a_id":"14938990","doc_b_id":"1285713","presented_order":["1285713","14938990"],"winner_id":"1285713","reasoning":"Document A is more relevant — it deals with cancer biology/therapy (where ALDH1's role in cancer outcomes would be discussed), while Document B concerns PD-1 in SLE and is unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321189Z"}
{"comparison_id":"e7eae8fe-5631-489a-b576-2d4d4a6a72ce","query_id":"51","doc_a_id":"25628793","doc_b_id":"1285713","presented_order":["1285713","25628793"],"winner_id":"1285713","reasoning":"Document A is somewhat more relevant because it concerns cancer biology/therapy, while Document B focuses on endometriosis enzyme expression unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321195Z"}
{"comparison_id":"88015034-6e0f-4afe-b732-058ccb0001cc","query_id":"51","doc_a_id":"26735905","doc_b_id":"1285713","presented_order":["26735905","1285713"],"winner_id":"26735905","reasoning":"Document A is more relevant — it discusses tumor biology and microenvironmental factors linked to cancer progression (though in prostate), which is closer to a biomarker/outcome topic than a pharmacologic PI3K inhibitor study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321202Z"}
{"comparison_id":"c7c6d1d1-73f0-4220-9820-ae02e2cee7b6","query_id":"51","doc_a_id":"17876040","doc_b_id":"1285713","presented_order":["17876040","1285713"],"winner_id":"1285713","reasoning":"Reason: Neither abstract addresses ALDH1 or breast cancer directly, but Document B (PI3K inhibitor) is more broadly related to pathways relevant in breast cancer than Document A (AML-focused PLK inhibitor).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321209Z"}
{"comparison_id":"fdbf3c80-d128-43ff-93c7-91e04e76200f","query_id":"51","doc_a_id":"3052213","doc_b_id":"1285713","presented_order":["1285713","3052213"],"winner_id":"1285713","reasoning":"Document A is more relevant — it discusses cancer therapeutics and tumor biology, whereas Document B concerns adipocyte epigenetics unrelated to breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321216Z"}
{"comparison_id":"669a2abf-4cce-40f4-bc20-c87b501dac7b","query_id":"51","doc_a_id":"26902591","doc_b_id":"1285713","presented_order":["26902591","1285713"],"winner_id":"1285713","reasoning":"Document B is more relevant — it discusses a cancer-targeted therapeutic and cancer outcomes context, whereas Document A focuses on adipose browning in cachexia, unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321223Z"}
{"comparison_id":"6d10bf56-403c-4d42-8bd3-9ec83b2c5c68","query_id":"51","doc_a_id":"6517763","doc_b_id":"1285713","presented_order":["1285713","6517763"],"winner_id":"1285713","reasoning":"Document A is more relevant — it discusses cancer therapeutics and PI3K activity across cancer models (potentially including breast), whereas Document B focuses on glioblastoma and IDH1/2, not ALDH1 or breast cancer outcomes.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321230Z"}
{"comparison_id":"49ae76f9-1a77-4daa-9d5a-9d30645066f6","query_id":"51","doc_a_id":"293661","doc_b_id":"1285713","presented_order":["1285713","293661"],"winner_id":"1285713","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes. Document A is slightly more relevant because it focuses on a cancer therapeutic agent (potentially including breast cancer models), whereas B is specific to arginine-dependent tumors.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321237Z"}
{"comparison_id":"3d639244-c33b-4a4d-8162-427063543021","query_id":"51","doc_a_id":"16532419","doc_b_id":"1285713","presented_order":["16532419","1285713"],"winner_id":"16532419","reasoning":"Document A is more relevant — it discusses induction of stem-like cells and identifies stem cell markers (which can include ALDH1), whereas Document B is focused on a PI3K inhibitor unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321244Z"}
{"comparison_id":"10066801-3626-4cec-bf2f-903cc303e3d7","query_id":"51","doc_a_id":"26488879","doc_b_id":"1285713","presented_order":["26488879","1285713"],"winner_id":"1285713","reasoning":"Document B is more relevant — it concerns cancer biology and therapeutics, whereas Document A is about Helicobacter pylori and gastric inflammation, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321251Z"}
{"comparison_id":"410a11d9-b199-419f-b38c-1284a8e8393b","query_id":"51","doc_a_id":"2360905","doc_b_id":"1285713","presented_order":["1285713","2360905"],"winner_id":"1285713","reasoning":"Document A is more related to cancer biology/therapy and thus more likely relevant to biomarkers in cancer outcomes; Document B focuses on pediatric gliomas, not breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321258Z"}
{"comparison_id":"f83975fc-70a5-4941-8783-b15a4270a99b","query_id":"51","doc_a_id":"515489","doc_b_id":"1285713","presented_order":["1285713","515489"],"winner_id":"515489","reasoning":"Document B — it discusses cancer \"stem cell-like\" properties (related to ALDH1 as a stem cell marker), whereas Document A focuses on a PI3K inhibitor and not stem-cell markers or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321265Z"}
{"comparison_id":"f1d601a9-efdb-47bc-960a-da32da9ddc08","query_id":"51","doc_a_id":"663464","doc_b_id":"1285713","presented_order":["1285713","663464"],"winner_id":"1285713","reasoning":"Document A is cancer-focused (therapeutic agent) and thus more related to breast cancer biology than Document B, which concerns aging and microRNAs.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321271Z"}
{"comparison_id":"4e53a7dc-6954-4214-bd08-c924de0e82f7","query_id":"51","doc_a_id":"7228140","doc_b_id":"1285713","presented_order":["7228140","1285713"],"winner_id":"7228140","reasoning":"Document A is more relevant — it discusses tumor gene-expression subtypes and prognostic associations (though in pancreatic cancer), which is closer to a claim about marker expression and outcomes than a PI3K inhibitor pharmacology paper.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321279Z"}
{"comparison_id":"b09d8ea2-272f-4a2c-9335-b640abb59d3c","query_id":"51","doc_a_id":"520579","doc_b_id":"1285713","presented_order":["520579","1285713"],"winner_id":"1285713","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document B is slightly more relevant because it discusses molecular cancer biology/therapeutics, whereas A focuses on vitamin D and colorectal cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321285Z"}
{"comparison_id":"1b08f99f-76a9-4c97-ae5c-47bb00730c1b","query_id":"51","doc_a_id":"24873253","doc_b_id":"1285713","presented_order":["24873253","1285713"],"winner_id":"24873253","reasoning":"Document A is more clinically focused on cancer outcomes (survival/quality of life), while Document B is a preclinical pharmacology study unrelated to prognostic markers like ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321292Z"}
{"comparison_id":"075ac28f-f9cc-4089-a97c-bc735a44ff77","query_id":"51","doc_a_id":"17755060","doc_b_id":"1285713","presented_order":["17755060","1285713"],"winner_id":"17755060","reasoning":"Document A is more relevant — it discusses tumorigenesis and prognosis in human cancers (links between metabolic marker expression and outcomes), whereas Document B focuses on PI3K inhibitor pharmacology with no link to ALDH1 or breast cancer outcomes.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321299Z"}
{"comparison_id":"6cf333e9-48f0-41a8-bde5-342818d29c6a","query_id":"51","doc_a_id":"4729644","doc_b_id":"1285713","presented_order":["1285713","4729644"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant because it addresses a cancer therapeutic with in vivo anti-cancer activity (potentially applicable to breast cancer), whereas Document B focuses on lncRNA-mediated cisplatin resistance in nasopharyngeal carcinoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321306Z"}
{"comparison_id":"6a20d3ee-0ec4-4411-9590-02f4461d4f9f","query_id":"51","doc_a_id":"3805841","doc_b_id":"1285713","presented_order":["3805841","1285713"],"winner_id":"3805841","reasoning":"Document A is slightly more relevant because it discusses cancer biology and links gene expression to clinical outcomes, whereas Document B focuses on a PI3K inhibitor's pharmacology without relevance to ALDH1 or prognosis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321313Z"}
{"comparison_id":"524760e4-3aea-4a0b-b387-e3c8ff5c71b9","query_id":"51","doc_a_id":"3376731","doc_b_id":"1285713","presented_order":["3376731","1285713"],"winner_id":"3376731","reasoning":"Document A is more relevant — it deals with tumor biology and treatment outcomes (chemoresistance), which is closer to a claim about marker expression and cancer outcomes than a pharmacologic profiling study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321320Z"}
{"comparison_id":"b23af516-48cb-4c0b-95dc-3c66079af341","query_id":"51","doc_a_id":"21551568","doc_b_id":"1285713","presented_order":["21551568","1285713"],"winner_id":"21551568","reasoning":"Document A is more relevant — it discusses cancer-related genetic alterations and their relationship to tumor progression/outcomes, whereas Document B focuses on PI3K inhibitor pharmacology, not biomarkers or clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321327Z"}
{"comparison_id":"d95389af-038e-42ef-9db5-934bef6ffc5e","query_id":"51","doc_a_id":"11968641","doc_b_id":"1285713","presented_order":["11968641","1285713"],"winner_id":"11968641","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant because it discusses tumor cell biology and growth/outcomes generally. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321334Z"}
{"comparison_id":"d9287274-5063-4ba7-907f-b8b2c620cda8","query_id":"51","doc_a_id":"38243984","doc_b_id":"1285713","presented_order":["1285713","38243984"],"winner_id":"38243984","reasoning":"Document B is more relevant — it deals with tumor biomarkers and clinical outcomes (though in pancreatic cancer), whereas A describes a PI3K inhibitor and not biomarker–outcome associations. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321341Z"}
{"comparison_id":"fa9d1cf9-8b23-40f7-ab39-10e1c916c2bf","query_id":"51","doc_a_id":"4468861","doc_b_id":"1285713","presented_order":["1285713","4468861"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant because it concerns cancer therapeutics broadly (potentially including breast cancer), while Document B focuses on melanoma immunotherapy and is less related to breast cancer biomarkers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321347Z"}
{"comparison_id":"27575b06-c352-4277-8008-eff164b8cc23","query_id":"51","doc_a_id":"29806339","doc_b_id":"1285713","presented_order":["29806339","1285713"],"winner_id":"29806339","reasoning":"Document A is slightly more relevant because it discusses tumor regression and factors affecting tumor cell fate, which is closer to cancer outcomes than a pharmacologic profiling study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321355Z"}
{"comparison_id":"faa37e3a-121d-4d0c-bc9b-6cf49d8c2cfe","query_id":"51","doc_a_id":"33030946","doc_b_id":"1285713","presented_order":["1285713","33030946"],"winner_id":"1285713","reasoning":"Neither document directly addresses ALDH1 or breast cancer prognosis. Document A is slightly more relevant because it concerns cancer therapeutics, while Document B focuses on macrophage/osteoclast biology unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321362Z"}
{"comparison_id":"66c9d057-f3e9-460f-bf08-d6f90ac1dbba","query_id":"51","doc_a_id":"38355793","doc_b_id":"1285713","presented_order":["1285713","38355793"],"winner_id":"1285713","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it concerns cancer biology/therapy generally, whereas Document B is specific to A20 in glioma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321369Z"}
{"comparison_id":"c1417e7d-b790-4080-9fb1-9c2be36f0131","query_id":"51","doc_a_id":"24974080","doc_b_id":"1285713","presented_order":["1285713","24974080"],"winner_id":"24974080","reasoning":"Neither document mentions ALDH1 or breast cancer outcomes; both are irrelevant. Document B is slightly more related because it discusses tumor pathways and clinical outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321376Z"}
{"comparison_id":"d5392c48-3dcc-43fd-8e73-45a663ca42c0","query_id":"51","doc_a_id":"9648896","doc_b_id":"1285713","presented_order":["9648896","1285713"],"winner_id":"1285713","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes. Document B is slightly more relevant because it addresses a cancer-targeted therapy (PI3K inhibition), which is more broadly related to cancer prognostic markers and treatment than the lung-specific CAF study in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321383Z"}
{"comparison_id":"aa2f1307-d9d0-4ef0-9564-2391d22d52a2","query_id":"51","doc_a_id":"16016673","doc_b_id":"1285713","presented_order":["16016673","1285713"],"winner_id":"1285713","reasoning":"Document B is more relevant — it deals with cancer biology and therapeutics (potentially applicable to breast cancer), while Document A focuses on bladder cancer detection and unrelated methylation markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321389Z"}
{"comparison_id":"aa2b14f6-aeb2-4712-a15b-cad98503a82b","query_id":"51","doc_a_id":"23934390","doc_b_id":"1285713","presented_order":["23934390","1285713"],"winner_id":"1285713","reasoning":"Neither document mentions ALDH1 or breast cancer outcomes; Document B is slightly more relevant because it addresses cancer therapeutics broadly, whereas A is specific to NSCLC. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321396Z"}
{"comparison_id":"0e84b49c-25b6-4e5d-915b-7cbb388a2bbc","query_id":"51","doc_a_id":"4841908","doc_b_id":"1285713","presented_order":["1285713","4841908"],"winner_id":"1285713","reasoning":"Document A — it deals with cancer biology/therapy and is more likely to touch on markers affecting breast cancer outcomes; Document B focuses on longevity/metabolites and explicitly notes no link to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321403Z"}
{"comparison_id":"7bd908d0-4ff7-42a3-a406-08465e44777e","query_id":"51","doc_a_id":"1780819","doc_b_id":"1285713","presented_order":["1780819","1285713"],"winner_id":"1285713","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document B is slightly more relevant because it concerns cancer therapeutics generally, while A is specific to HAND2 in endometrial cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321409Z"}
{"comparison_id":"ba22e421-2e6c-4544-8956-85a515cbbb85","query_id":"51","doc_a_id":"16806763","doc_b_id":"1285713","presented_order":["1285713","16806763"],"winner_id":"16806763","reasoning":"Document B is more relevant — it deals with molecular expression signatures and associations with patient prognosis, whereas A focuses on a PI3K inhibitor's pharmacology and not prognostic markers. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321416Z"}
{"comparison_id":"b343c1ad-1d64-4112-910c-1a0e1f43ffd3","query_id":"51","doc_a_id":"4387494","doc_b_id":"1285713","presented_order":["4387494","1285713"],"winner_id":"1285713","reasoning":"Document B — it addresses a cancer therapeutic (PI3K inhibitor) broadly relevant to cancer outcomes, whereas Document A focuses specifically on an AML histone demethylase inhibitor. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321423Z"}
{"comparison_id":"c792da78-155f-4752-ac40-9c7d9ecbcb21","query_id":"51","doc_a_id":"8496132","doc_b_id":"1285713","presented_order":["1285713","8496132"],"winner_id":"8496132","reasoning":"Document B deals with regulation of gene expression in carcinoma cells (closer to markers and cancer biology), whereas A is a PI3K inhibitor pharmacology study unrelated to ALDH1 or outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321429Z"}
{"comparison_id":"21de65a9-ce8a-455c-a3ad-d948a56e7cec","query_id":"51","doc_a_id":"21414718","doc_b_id":"1285713","presented_order":["1285713","21414718"],"winner_id":"1285713","reasoning":"Document A is marginally more relevant because it concerns cancer therapeutics and molecular cancer biology, whereas Document B focuses on gastric cancer cell mobility unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321436Z"}
{"comparison_id":"d868112f-a09f-4edd-8dde-3bf000be62d6","query_id":"51","doc_a_id":"23601616","doc_b_id":"1285713","presented_order":["23601616","1285713"],"winner_id":"1285713","reasoning":"Document B is more relevant — it addresses a cancer therapeutic and signaling pathways pertinent to tumor biology, whereas Document A concerns hippocampal effects of liraglutide in obese mice and is unrelated to cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321442Z"}
{"comparison_id":"eee533ce-84fd-45a3-9c61-3344ea513567","query_id":"51","doc_a_id":"18987782","doc_b_id":"1285713","presented_order":["18987782","1285713"],"winner_id":"18987782","reasoning":"Document A is more relevant because it discusses cancer-related molecular markers and effects on tumor progression/outcomes, whereas Document B focuses on a PI3K inhibitor's pharmacology without relevance to ALDH1 or clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321449Z"}
{"comparison_id":"885a4995-6586-4d9b-9e3d-7a8ac6dc256f","query_id":"51","doc_a_id":"14663842","doc_b_id":"1285713","presented_order":["14663842","1285713"],"winner_id":"14663842","reasoning":"Neither document directly addresses ALDH1 expression or breast cancer outcomes. Document A is slightly more relevant because it discusses a dehydrogenase (IDH1) in a cancer context, whereas B focuses on a PI3K inhibitor.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321455Z"}
{"comparison_id":"aba8a0f3-2b9a-4df0-94b3-f722f7784633","query_id":"51","doc_a_id":"5278233","doc_b_id":"1285713","presented_order":["1285713","5278233"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant because it concerns cancer therapeutics and tumor biology, whereas Document B addresses imprinting in Beckwith-Wiedemann syndrome, unrelated to breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321463Z"}
{"comparison_id":"839fce94-378a-4bbd-8778-dd4b850870ba","query_id":"51","doc_a_id":"6807122","doc_b_id":"1285713","presented_order":["1285713","6807122"],"winner_id":"1285713","reasoning":"Document A is more directly about cancer biology and therapeutic implications, whereas Document B focuses on stromal cell origins (EndMT) and not on biomarkers or clinical outcomes related to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321469Z"}
{"comparison_id":"f457dd94-f712-4500-86f9-f5ac73bee9a6","query_id":"51","doc_a_id":"20568364","doc_b_id":"1285713","presented_order":["1285713","20568364"],"winner_id":"1285713","reasoning":"Neither abstract discusses ALDH1 or breast cancer directly. Document A is marginally more relevant because it addresses a cancer-targeted therapy (PI3K inhibition) with broader relevance to multiple cancers including breast cancer, whereas Document B focuses specifically on HNSCC angiogenesis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321476Z"}
{"comparison_id":"9afcfe96-ea7c-4346-a8a2-f29f1993aa1c","query_id":"51","doc_a_id":"11481946","doc_b_id":"1285713","presented_order":["11481946","1285713"],"winner_id":"11481946","reasoning":"Document A is more relevant — it addresses cancer risk and outcomes generally, while Document B focuses on a specific PI3K inhibitor and not on ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321483Z"}
{"comparison_id":"dfc5da70-7246-4fa6-b988-69a57dde5571","query_id":"51","doc_a_id":"21382907","doc_b_id":"1285713","presented_order":["21382907","1285713"],"winner_id":"21382907","reasoning":"Document A is more relevant — it discusses a biomarker linked to patient survival (though in head and neck cancer), whereas B focuses on a PI3K inhibitor's pharmacology and not biomarker–outcome associations. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321490Z"}
{"comparison_id":"a84f836e-79cd-407f-b9a4-2162c4ff2257","query_id":"51","doc_a_id":"23269537","doc_b_id":"1285713","presented_order":["1285713","23269537"],"winner_id":"1285713","reasoning":"Document A is more broadly about cancer biology/therapy (potentially relevant to breast cancer contexts), while Document B focuses on cyclin D1 in B‑cell malignancies, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321497Z"}
{"comparison_id":"1c9ef6cb-af4d-462e-81ad-2183e8697801","query_id":"51","doc_a_id":"23013317","doc_b_id":"1285713","presented_order":["23013317","1285713"],"winner_id":"1285713","reasoning":"Document B is more relevant — it discusses a cancer therapeutic (PI3K inhibitor), whereas Document A concerns hypoalbuminemia in acute illness and is unrelated to breast cancer markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321504Z"}
{"comparison_id":"98d02b26-062d-4a0e-8cf3-a7a9482c32c0","query_id":"51","doc_a_id":"43334921","doc_b_id":"1285713","presented_order":["1285713","43334921"],"winner_id":"1285713","reasoning":"Neither document addresses ALDH1 expression or breast cancer outcomes; both are irrelevant. Document A is slightly more relevant only because it concerns cancer biology/therapy broadly, whereas B focuses on colorectal cancer and NSAID genetics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321511Z"}
{"comparison_id":"f859d5ab-094a-473c-87d9-b04b17fc481b","query_id":"51","doc_a_id":"13070316","doc_b_id":"1285713","presented_order":["1285713","13070316"],"winner_id":"13070316","reasoning":"Neither document mentions ALDH1 or provides evidence about its association with breast cancer outcomes; both are irrelevant. If one must be chosen, B is marginally more related to cancer prognosis (tumor microenvironment/angiogenesis).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321518Z"}
{"comparison_id":"2f8d0f5b-a817-4295-8b4b-3086b4a7b714","query_id":"51","doc_a_id":"57783564","doc_b_id":"1285713","presented_order":["57783564","1285713"],"winner_id":"1285713","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is slightly more relevant because it discusses a cancer therapeutic (PI3K inhibitor) with broader applicability, whereas A is specific to colon cancer biology.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321525Z"}
{"comparison_id":"1afeac23-056c-4990-a24a-41ed03f3624e","query_id":"51","doc_a_id":"6363093","doc_b_id":"1285713","presented_order":["1285713","6363093"],"winner_id":"1285713","reasoning":"Neither abstract mentions ALDH1 or breast cancer; Document A is marginally more relevant because it concerns cancer therapeutics broadly, whereas B is specific to glioblastoma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321531Z"}
{"comparison_id":"fe9e332e-5ce1-436e-9f2a-164eb88cee75","query_id":"51","doc_a_id":"40234452","doc_b_id":"1285713","presented_order":["40234452","1285713"],"winner_id":"1285713","reasoning":"B is more relevant — it concerns cancer biology/therapy, whereas A is about hematopoietic stem cells and unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321538Z"}
{"comparison_id":"7b935120-7884-4a1f-b5a1-d646aa7dc131","query_id":"51","doc_a_id":"2328272","doc_b_id":"1285713","presented_order":["1285713","2328272"],"winner_id":"1285713","reasoning":"Document A is more relevant — it addresses molecular cancer biology/therapeutics (closer to biomarker–outcome topics), while Document B concerns trial recruitment/survivorship and not biomarkers or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321545Z"}
{"comparison_id":"0e282b19-879e-48f2-a7b5-689d1a666e1e","query_id":"51","doc_a_id":"9558539","doc_b_id":"1285713","presented_order":["1285713","9558539"],"winner_id":"9558539","reasoning":"Document B is more relevant — it discusses cancer stem-cell markers (like CD44v6) and their clinical/therapeutic implications, which is conceptually closer to ALDH1's role as a stem-cell marker in cancer outcomes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321551Z"}
{"comparison_id":"a8b1d448-db34-4ffe-8b7e-42687c63da96","query_id":"51","doc_a_id":"3590806","doc_b_id":"1285713","presented_order":["1285713","3590806"],"winner_id":"3590806","reasoning":"Doc B — it discusses cancer-initiating (stem-like) cells and Wnt pathway regulation, which is conceptually related to ALDH1 as a stem-cell marker; Document A focuses on PI3K inhibitor pharmacology and is less relevant. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321559Z"}
{"comparison_id":"547ad5bf-73a6-4f25-85ba-3d8f82139f16","query_id":"51","doc_a_id":"9095394","doc_b_id":"1285713","presented_order":["1285713","9095394"],"winner_id":"1285713","reasoning":"Document A is more relevant — it discusses cancer biology and therapeutic markers/targets, whereas Document B focuses on keratin expression in oral neoplasms unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321566Z"}
{"comparison_id":"0f7e81b6-6141-4fd7-88b3-a3a6c828742a","query_id":"51","doc_a_id":"3710557","doc_b_id":"1285713","presented_order":["1285713","3710557"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant because it discusses cancer therapeutics generally, whereas Document B focuses on β-catenin in liver-specific contexts and not breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321573Z"}
{"comparison_id":"3a734d2b-27a8-4b41-8366-e439fd544d17","query_id":"51","doc_a_id":"4429118","doc_b_id":"1285713","presented_order":["4429118","1285713"],"winner_id":"4429118","reasoning":"Document A is more relevant — it discusses tumor microenvironment and factors affecting prognosis, whereas B focuses on a PI3K inhibitor and not on prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321579Z"}
{"comparison_id":"b7ded76f-d00b-465d-bb0c-948c8d28b196","query_id":"51","doc_a_id":"7639744","doc_b_id":"1285713","presented_order":["1285713","7639744"],"winner_id":"1285713","reasoning":"Document A is more related to molecular cancer biology and potential biomarkers/therapeutics, whereas Document B concerns smoking cessation and lung cancer outcomes, so A is closer to the claim context.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321586Z"}
{"comparison_id":"c7d01bf9-bf1c-4ec0-b3d9-a7daeb87ed23","query_id":"51","doc_a_id":"8764879","doc_b_id":"1285713","presented_order":["8764879","1285713"],"winner_id":"1285713","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer outcomes, but Document B deals with cancer therapeutics broadly, whereas A is specific to AML leukemia stem cells — B is marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321595Z"}
{"comparison_id":"877126bb-0202-4b63-8020-c619fe922585","query_id":"51","doc_a_id":"12337611","doc_b_id":"1285713","presented_order":["12337611","1285713"],"winner_id":"12337611","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes; both are irrelevant. If forced to pick the closer match (discusses cancer biology and outcomes), ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321602Z"}
{"comparison_id":"666e7cd9-99b9-48fd-a6ee-3dd06dc121af","query_id":"51","doc_a_id":"38485364","doc_b_id":"1285713","presented_order":["38485364","1285713"],"winner_id":"38485364","reasoning":"Document A is slightly more relevant — it discusses a protein affecting cancer cell invasion, which relates to tumor aggressiveness and outcomes; Document B focuses on a PI3K inhibitor and is less directly related. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321609Z"}
{"comparison_id":"b5d12d6f-3f20-4015-8103-bb203b34a6fc","query_id":"51","doc_a_id":"2494748","doc_b_id":"1285713","presented_order":["1285713","2494748"],"winner_id":"1285713","reasoning":"Document A is more relevant — it discusses cancer biology and therapeutics (though not ALDH1 or breast cancer specifically), whereas Document B focuses on methylation in gastric carcinoma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321616Z"}
{"comparison_id":"a9dbbb04-43f2-4ee1-8c6d-f08bb94af305","query_id":"51","doc_a_id":"12903921","doc_b_id":"1285713","presented_order":["12903921","1285713"],"winner_id":"1285713","reasoning":"Document B is marginally more relevant because it concerns cancer therapeutics, whereas A addresses leukemia-related oxidative stress in rats and not breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321622Z"}
{"comparison_id":"ef4d95ee-2344-442f-9442-7a869c6431f5","query_id":"51","doc_a_id":"26561572","doc_b_id":"1285713","presented_order":["26561572","1285713"],"winner_id":"26561572","reasoning":"Neither abstract mentions ALDH1 or breast cancer; Document A is slightly more relevant because it includes biomarker–outcome analysis (though in lung cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321629Z"}
{"comparison_id":"f08ab812-7a9e-4b90-b73d-2ffa483efe86","query_id":"51","doc_a_id":"12650610","doc_b_id":"1285713","presented_order":["12650610","1285713"],"winner_id":"1285713","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it addresses a cancer therapeutic with broader applicability, while A is specific to oral cancer signaling. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321636Z"}
{"comparison_id":"31626a5f-ab83-4c38-ad24-2dd3753581b6","query_id":"51","doc_a_id":"9196472","doc_b_id":"1285713","presented_order":["1285713","9196472"],"winner_id":"1285713","reasoning":"Doc A is cancer-focused (therapeutics), making it more relevant to a claim about breast cancer outcomes than Doc B's monocyte/atherosclerosis transcriptome study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321643Z"}
{"comparison_id":"116a9f9d-7e5f-460e-97f9-f5cff632f4ae","query_id":"51","doc_a_id":"41548287","doc_b_id":"1285713","presented_order":["1285713","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant — it addresses cancer stem cell biology and outcomes (though in pancreatic cancer), which is closer to ALDH1's role as a CSC marker than a pharmacologic PI3K inhibitor study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321650Z"}
{"comparison_id":"48c50d27-d623-4580-97fa-dc65ece3d305","query_id":"51","doc_a_id":"6121668","doc_b_id":"1285713","presented_order":["1285713","6121668"],"winner_id":"6121668","reasoning":"Document B — it examines marker expression and links to survival/prognostic factors (though in endometrial cancer), whereas A is a pharmacologic study of a PI3K inhibitor and does not address marker expression or outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321657Z"}
{"comparison_id":"2db621b9-2e22-4fb9-9493-1725dc80f193","query_id":"51","doc_a_id":"7808055","doc_b_id":"1285713","presented_order":["1285713","7808055"],"winner_id":"7808055","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer outcomes; Document B is slightly more relevant because it deals with cancer-related biomarkers and prognosis-related measures, while A focuses on a PI3K inhibitor's pharmacology.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321664Z"}
{"comparison_id":"8d3a5295-e3a2-40eb-b699-33db6b2236ab","query_id":"51","doc_a_id":"6121555","doc_b_id":"1285713","presented_order":["1285713","6121555"],"winner_id":"1285713","reasoning":"Document A is marginally more relevant because it addresses cancer therapeutics generally (whereas B focuses on glioma-specific signaling), though neither mentions ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321670Z"}
{"comparison_id":"ab2d2072-5f76-45af-ab6e-b135a588808f","query_id":"51","doc_a_id":"5406411","doc_b_id":"1285713","presented_order":["1285713","5406411"],"winner_id":"1285713","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes; both are irrelevant. Document A is slightly more cancer-focused (therapeutic activity), so it's marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321677Z"}
{"comparison_id":"9aafbf33-9871-4d95-a905-05ad953cde77","query_id":"51","doc_a_id":"85665741","doc_b_id":"1285713","presented_order":["85665741","1285713"],"winner_id":"1285713","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is slightly more relevant because it discusses a cancer therapeutic that could affect outcomes generally; Document A is specific to BRAF in NSCLC.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321683Z"}
{"comparison_id":"058ac23e-9673-495a-a91d-d68518b617ca","query_id":"51","doc_a_id":"13400643","doc_b_id":"1285713","presented_order":["1285713","13400643"],"winner_id":"13400643","reasoning":"Neither abstract mentions ALDH1 or breast cancer outcomes; both are irrelevant. Document B is slightly more related because it discusses modulation of transcription and tumor behavior, which could more plausibly relate to marker expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321690Z"}
{"comparison_id":"cd77930d-45e0-4d4e-8462-702711e093da","query_id":"51","doc_a_id":"24624992","doc_b_id":"1285713","presented_order":["1285713","24624992"],"winner_id":"1285713","reasoning":"Document A — it concerns cancer therapeutics (more broadly relevant to cancer outcomes) while Document B focuses on leukemia cell lines unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321697Z"}
{"comparison_id":"4fdb7711-2b33-471b-9431-e64a0490e854","query_id":"51","doc_a_id":"16346504","doc_b_id":"1285713","presented_order":["1285713","16346504"],"winner_id":"1285713","reasoning":"Neither abstract discusses ALDH1 or breast cancer outcomes; Document A is marginally more relevant because it deals broadly with cancer therapeutics. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321703Z"}
{"comparison_id":"7048a1f5-9ca7-4811-badc-79183fa2ce3a","query_id":"51","doc_a_id":"4583180","doc_b_id":"1285713","presented_order":["1285713","4583180"],"winner_id":"4583180","reasoning":"Document B is more relevant — it links gene expression changes to tumor progression and patient survival, which is related to associations between marker expression and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321710Z"}
{"comparison_id":"05fdc954-a31c-4513-a952-f25fff962e6f","query_id":"51","doc_a_id":"14315749","doc_b_id":"1285713","presented_order":["1285713","14315749"],"winner_id":"14315749","reasoning":"Document B is more relevant — it examines gene expression correlations with cancer aggressiveness, which is closer to a claim about marker expression and outcomes; Document A is pharmacology of a PI3K inhibitor and unrelated. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321717Z"}
{"comparison_id":"d1c5004b-2d10-4d25-bdf0-cf786f0df7fd","query_id":"51","doc_a_id":"29190724","doc_b_id":"1285713","presented_order":["1285713","29190724"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant — it concerns cancer biology and therapeutics, whereas Document B focuses specifically on DNA methylation in gastric cancer; neither directly addresses ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321724Z"}
{"comparison_id":"569ebd3e-771d-40e8-bbd1-37212cdcf6aa","query_id":"51","doc_a_id":"24916604","doc_b_id":"1285713","presented_order":["24916604","1285713"],"winner_id":"1285713","reasoning":"Neither document discusses ALDH1 or its association with breast cancer outcomes. Document B is slightly more relevant because it addresses molecular cancer therapeutics (biologic mechanisms), whereas A focuses on treatment policy and bisphosphonate use.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321731Z"}
{"comparison_id":"17c01c77-33c7-43f9-aaab-db5481ab5643","query_id":"51","doc_a_id":"33677323","doc_b_id":"1285713","presented_order":["1285713","33677323"],"winner_id":"1285713","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer, but Document A discusses a cancer therapeutic relevant to solid tumors (more likely to relate to breast cancer) while Document B focuses on hematopoietic malignancies.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321738Z"}
{"comparison_id":"929d9d47-cc04-49b3-8b60-dd923aa24db9","query_id":"51","doc_a_id":"1456068","doc_b_id":"1285713","presented_order":["1285713","1456068"],"winner_id":"1285713","reasoning":"Document A is more relevant — it deals with cancer biology/therapeutics and is more likely to pertain to molecular markers and cancer outcomes, whereas Document B focuses on lifestyle and general mortality, not ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321744Z"}
{"comparison_id":"96b9c75c-3639-4ec8-a249-fce89855d906","query_id":"51","doc_a_id":"25738896","doc_b_id":"1285713","presented_order":["1285713","25738896"],"winner_id":"1285713","reasoning":"Reason: Neither abstract addresses ALDH1 or breast cancer prognosis, but Document A at least concerns cancer therapeutics (general cancer context) while B is specific to melanoma immunology.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321751Z"}
{"comparison_id":"d22437e1-7edf-4f9b-83d2-372d4e4e005f","query_id":"51","doc_a_id":"16853734","doc_b_id":"1285713","presented_order":["1285713","16853734"],"winner_id":"1285713","reasoning":"Document A is more relevant — it concerns cancer molecular therapeutics (potentially relevant to tumor markers/outcomes), whereas Document B focuses on MMP1-mediated MSC migration to glioma and doesn't relate to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321758Z"}
{"comparison_id":"0c34f438-2155-409f-a43a-8dea26a68529","query_id":"51","doc_a_id":"28334217","doc_b_id":"1285713","presented_order":["28334217","1285713"],"winner_id":"1285713","reasoning":"Neither document mentions ALDH1 or breast cancer outcomes; both are unrelated. Document B is marginally more relevant because PI3K signaling is more commonly studied in breast cancer contexts than tumor-specific glutaminase.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321765Z"}
{"comparison_id":"e37a07b0-63aa-4280-b3a6-88fe1942a6eb","query_id":"51","doc_a_id":"9226649","doc_b_id":"1285713","presented_order":["9226649","1285713"],"winner_id":"1285713","reasoning":"Neither paper mentions ALDH1 or breast cancer outcomes. Document B is slightly more relevant because it addresses cancer biology/therapy in general, whereas A is specific to colon inflammation and tumorigenesis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321772Z"}
{"comparison_id":"df1b6dfc-609b-4609-8ff2-2840ae4e1254","query_id":"51","doc_a_id":"3545805","doc_b_id":"1285713","presented_order":["1285713","3545805"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant because it discusses a cancer therapeutic agent (PI3K inhibitor) potentially applicable across tumor types, whereas Document B focuses specifically on melanoma immunotherapy and not breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321778Z"}
{"comparison_id":"d7ac164c-61be-48a7-aadd-676b63d7a519","query_id":"51","doc_a_id":"5372432","doc_b_id":"1285713","presented_order":["1285713","5372432"],"winner_id":"1285713","reasoning":"Reason: Document A discusses molecular cancer therapeutics and tumor biology, which is closer to biomarker expression and outcomes than Document B's focus on healthcare access and post-mortem diagnosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321785Z"}
{"comparison_id":"e7eaa471-338a-4ec4-86c0-44b8282e829a","query_id":"51","doc_a_id":"8702697","doc_b_id":"1285713","presented_order":["1285713","8702697"],"winner_id":"1285713","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it addresses cancer therapeutics broadly, whereas Document B is specific to prostate cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321791Z"}
{"comparison_id":"ca650ee6-70f0-43d0-8181-ae6b75062804","query_id":"51","doc_a_id":"4959368","doc_b_id":"1285713","presented_order":["1285713","4959368"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant because it discusses cancer therapeutics and tumor biology, whereas Document B focuses specifically on branched-chain amino acids and pancreatic cancer, not ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321798Z"}
{"comparison_id":"a2bfd007-bf33-4e36-95a3-b0e55ee006d1","query_id":"51","doc_a_id":"6948886","doc_b_id":"1285713","presented_order":["6948886","1285713"],"winner_id":"1285713","reasoning":"Both documents are irrelevant to ALDH1 and breast cancer outcomes, but Document B is slightly more related to cancer therapeutics (may include breast cancer models), so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321805Z"}
{"comparison_id":"4785f380-6b12-462b-9555-621e80e29437","query_id":"51","doc_a_id":"27167110","doc_b_id":"1285713","presented_order":["27167110","1285713"],"winner_id":"1285713","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is slightly more relevant because it addresses a broadly applicable cancer pathway (PI3K) and therapeutic effects that could pertain to breast cancer, whereas A is specific to androgen-regulated miRNAs in prostate cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321812Z"}
{"comparison_id":"14c10117-743d-4918-b361-402c4d747516","query_id":"51","doc_a_id":"25513319","doc_b_id":"1285713","presented_order":["1285713","25513319"],"winner_id":"1285713","reasoning":"Reason: Neither abstract mentions ALDH1 or breast cancer, but Document A relates to general cancer therapeutics while Document B is specific to prostate cancer, so A is slightly more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321818Z"}
{"comparison_id":"0a61fa25-6e55-473a-b7e2-dace388608ae","query_id":"51","doc_a_id":"34189936","doc_b_id":"1285713","presented_order":["34189936","1285713"],"winner_id":"1285713","reasoning":"Neither document discusses ALDH1 or breast cancer directly; Document B is slightly more relevant because it addresses a molecular cancer therapeutic with broader applicability (potential relevance to breast cancer), whereas A is specific to mesothelioma. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321825Z"}
{"comparison_id":"c8dbc6fd-5587-4f7d-96c2-4e7d72910973","query_id":"51","doc_a_id":"15928989","doc_b_id":"1285713","presented_order":["15928989","1285713"],"winner_id":"1285713","reasoning":"Document B is more relevant — it addresses cancer pharmacology, whereas Document A concerns pregnancy and is unrelated to breast cancer markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321831Z"}
{"comparison_id":"1b384923-ec7e-4b56-a648-17ff8dcd0322","query_id":"51","doc_a_id":"29473081","doc_b_id":"1285713","presented_order":["29473081","1285713"],"winner_id":"29473081","reasoning":"Document A is slightly more relevant because it discusses a gene expression marker linked to survival outcomes in cancer, whereas Document B focuses on a PI3K inhibitor's pharmacology and not marker-outcome associations. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321837Z"}
{"comparison_id":"cb91c0d5-e82e-4004-999d-c2cce85928cc","query_id":"51","doc_a_id":"17671145","doc_b_id":"1285713","presented_order":["1285713","17671145"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant — it discusses cancer therapeutics and PI3K biology that could relate to breast cancer contexts, whereas Document B focuses specifically on androgen receptor regulation in castration‑resistant prostate cancer and is unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321845Z"}
{"comparison_id":"a6610a73-61aa-49a2-b61d-4d36fb2038cb","query_id":"51","doc_a_id":"22914228","doc_b_id":"1285713","presented_order":["22914228","1285713"],"winner_id":"22914228","reasoning":"Document A is slightly more relevant because it involves proteomic expression analysis (albeit in pancreatic cancer), which is closer to a claim about marker expression and outcomes than a pharmacologic study of a PI3K inhibitor.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321851Z"}
{"comparison_id":"4e2d217d-03c7-4b81-9bb2-d991f50abca1","query_id":"51","doc_a_id":"654735","doc_b_id":"1285713","presented_order":["654735","1285713"],"winner_id":"654735","reasoning":"Document A is more relevant — it studies a biomarker associated with cancer prognosis (similar topic of marker–outcome association), whereas Document B focuses on PI3K inhibitor pharmacology unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321858Z"}
{"comparison_id":"a12ff7fc-8866-418d-957e-6a8ec8ebe74b","query_id":"51","doc_a_id":"25452937","doc_b_id":"1285713","presented_order":["1285713","25452937"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant because it concerns cancer biomarkers/therapeutics, whereas Document B focuses on macrophages in thyroid cancer (unrelated to ALDH1 or breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321864Z"}
{"comparison_id":"c077cc97-e288-43e1-ae1e-8685d05f4fa9","query_id":"51","doc_a_id":"22901758","doc_b_id":"1285713","presented_order":["1285713","22901758"],"winner_id":"22901758","reasoning":"Document B is more relevant — it discusses tumor-initiating (stem-like) cells and clinical outcomes, which is closer to ALDH1 (a stem cell marker) and prognostic associations than a pharmacologic PI3K inhibitor study. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321871Z"}
{"comparison_id":"5d914336-254a-4252-940e-ff0097675ab1","query_id":"51","doc_a_id":"42150015","doc_b_id":"1285713","presented_order":["42150015","1285713"],"winner_id":"1285713","reasoning":"Document B is more relevant because it deals with cancer biology and therapeutic agents, while Document A focuses on reproductive hormone levels in healthy women and not cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321878Z"}
{"comparison_id":"3ecaf109-ef0b-4e3b-bec0-2d05622447da","query_id":"51","doc_a_id":"15215393","doc_b_id":"1285713","presented_order":["15215393","1285713"],"winner_id":"1285713","reasoning":"Document B is marginally more relevant because it addresses a cancer-targeted therapeutic with broad anti-cancer activity, whereas Document A is specific to glioblastoma and unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321885Z"}
{"comparison_id":"0fd8fd5d-1ede-4b18-8f4c-345826d632df","query_id":"51","doc_a_id":"3765739","doc_b_id":"1285713","presented_order":["3765739","1285713"],"winner_id":"1285713","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document B is marginally more relevant because it concerns cancer therapeutics, whereas A is specific to EBV in B‑lymphoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321891Z"}
{"comparison_id":"e13a0de7-6173-4c2d-8560-51ab3ebff95a","query_id":"51","doc_a_id":"21521236","doc_b_id":"1285713","presented_order":["1285713","21521236"],"winner_id":"21521236","reasoning":"Document B — it discusses cancer-related molecular markers and chemosensitivity (more relevant to prognosis/outcomes) while Document A focuses on a PI3K inhibitor pharmacology without link to ALDH1 or breast outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321898Z"}
{"comparison_id":"cea5bc1d-b44d-42ea-909d-caa44986c7ac","query_id":"51","doc_a_id":"12145359","doc_b_id":"1285713","presented_order":["1285713","12145359"],"winner_id":"1285713","reasoning":"Document A is cancer-related (therapeutic research) and thus marginally more relevant than Document B, which concerns lung function and lung cancer risk unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321904Z"}
{"comparison_id":"f0ae8b3e-d406-4ac4-99eb-da69b07d3b24","query_id":"51","doc_a_id":"11359243","doc_b_id":"1285713","presented_order":["1285713","11359243"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant because it concerns cancer biology and therapeutics, whereas Document B focuses on EBV-induced methylation in B-cells (not breast cancer or ALDH1). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321911Z"}
{"comparison_id":"e83bd9d5-b5dd-4c0d-86b6-a035e690980e","query_id":"51","doc_a_id":"21692235","doc_b_id":"1285713","presented_order":["1285713","21692235"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant — it concerns cancer biology/therapeutics, whereas Document B focuses on glioblastoma subtypes and is unrelated to breast cancer or ALDH1. Neither mentions ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321917Z"}
{"comparison_id":"489f1e94-7621-4dfa-8e86-81003a423897","query_id":"51","doc_a_id":"23576165","doc_b_id":"1285713","presented_order":["23576165","1285713"],"winner_id":"23576165","reasoning":"Reason: Neither abstract mentions ALDH1, but Document A (tumor metabolic microenvironment) is marginally more related to metabolic markers and tumor prognosis than the PI3K inhibitor study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321924Z"}
{"comparison_id":"3ea1174f-e3b8-437e-9089-57444983b1de","query_id":"51","doc_a_id":"23286603","doc_b_id":"1285713","presented_order":["1285713","23286603"],"winner_id":"1285713","reasoning":"Document A is cancer-related (PI3K inhibitor) and thus marginally more relevant to breast cancer outcomes than Document B, which addresses macrophage cholesterol efflux/atherosclerosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321930Z"}
{"comparison_id":"5660604f-c310-4fe1-b5c4-8c6111cb03b6","query_id":"51","doc_a_id":"5123516","doc_b_id":"1285713","presented_order":["1285713","5123516"],"winner_id":"1285713","reasoning":"Document A — it discusses a cancer therapeutic agent and general anti-cancer activity, which is marginally more relevant to a claim about cancer biomarkers/outcomes than a paper specific to glioblastoma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321937Z"}
{"comparison_id":"26eaf064-ceca-4497-8e7b-46bb7aa02372","query_id":"51","doc_a_id":"37204802","doc_b_id":"1285713","presented_order":["37204802","1285713"],"winner_id":"37204802","reasoning":"Document A is slightly more relevant because it discusses a cancer biomarker and associations with cancer aggressiveness/outcomes, whereas Document B focuses on a PI3K inhibitor and pharmacology. Neither mentions ALDH1 or breast cancer specifically.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321944Z"}
{"comparison_id":"8d0963ae-0822-4bc3-a602-3a5423c0e2ed","query_id":"51","doc_a_id":"22180793","doc_b_id":"1285713","presented_order":["22180793","1285713"],"winner_id":"1285713","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes; both are irrelevant. If one must be chosen, ANSWER: B — it is at least about a cancer-relevant molecular pathway, whereas A focuses on prostate-specific N-cadherin.","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321951Z"}
{"comparison_id":"0ca4e43e-270d-46ea-968f-348d4d23a3f7","query_id":"51","doc_a_id":"5468807","doc_b_id":"1285713","presented_order":["5468807","1285713"],"winner_id":"1285713","reasoning":"Neither abstract addresses ALDH1 expression or breast cancer outcomes. Document B is slightly more relevant because it deals with cancer therapeutics generally, whereas A is specific to ARID1A‑mutated ovarian cancer and HDAC6.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321957Z"}
{"comparison_id":"a2696e76-c51b-4ac7-ad11-ea59ebcd4e40","query_id":"51","doc_a_id":"10165723","doc_b_id":"1285713","presented_order":["10165723","1285713"],"winner_id":"10165723","reasoning":"Document A is slightly more relevant because it discusses a molecular biomarker's association with cancer progression and outcomes (though in melanoma, not breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321964Z"}
{"comparison_id":"5625d821-9c8f-403d-9fca-f1b8289e0ced","query_id":"51","doc_a_id":"22049489","doc_b_id":"1285713","presented_order":["22049489","1285713"],"winner_id":"22049489","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes, but Document A is slightly more relevant as it discusses cancer-related gene expression and tumor suppressor pathways, whereas B focuses on a PI3K inhibitor pharmacology. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321970Z"}
{"comparison_id":"dfdffcfd-82a4-4819-a2d0-84572907da71","query_id":"51","doc_a_id":"3730196","doc_b_id":"1285713","presented_order":["3730196","1285713"],"winner_id":"3730196","reasoning":"Document A is more relevant — it discusses a cancer prognostic biomarker (though in SCLC), whereas B is purely a pharmacologic study of a PI3K inhibitor and not about biomarkers or outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321977Z"}
{"comparison_id":"ace3645a-60f0-4243-85ee-30f245e8d0a6","query_id":"51","doc_a_id":"22059387","doc_b_id":"1285713","presented_order":["22059387","1285713"],"winner_id":"1285713","reasoning":"Reason: Document B discusses a cancer therapeutic agent and is generally more related to cancer biology and outcomes than Document A, which focuses on parasite-induced DNA damage in hamsters (different cancer type and context).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321983Z"}
{"comparison_id":"66944980-058b-4ff0-a732-32e823cef49e","query_id":"51","doc_a_id":"3619931","doc_b_id":"1285713","presented_order":["1285713","3619931"],"winner_id":"1285713","reasoning":"Document A is oncology-focused (anti-cancer agent) and thus more relevant to a breast cancer biomarker question than Document B, which concerns lung fibrosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321989Z"}
{"comparison_id":"a4c95582-e4d9-4c45-a337-c385d03162d4","query_id":"51","doc_a_id":"6650933","doc_b_id":"1285713","presented_order":["1285713","6650933"],"winner_id":"6650933","reasoning":"Document B is more relevant — it discusses differential oxidative enzyme activity in tumor vs normal epithelial cells, which is more related to ALDH1's role in detoxification than a PI3K inhibitor study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.321996Z"}
{"comparison_id":"846ec7f5-4341-4647-8e56-f7648f15d26f","query_id":"51","doc_a_id":"3899896","doc_b_id":"1285713","presented_order":["1285713","3899896"],"winner_id":"1285713","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer outcomes; Document A is at least about molecular cancer therapeutics, while B focuses on RDW in rectal cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.322002Z"}
{"comparison_id":"98bf8e94-84ce-4b0f-a9c1-69cdcfee96cc","query_id":"51","doc_a_id":"9791313","doc_b_id":"1285713","presented_order":["1285713","9791313"],"winner_id":"9791313","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer; Document B discusses a cancer-related biomarker/epigenetic modifier and tumor outcomes, making it slightly more relevant than a pharmacologic PI3K inhibitor study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.322008Z"}
{"comparison_id":"56b46120-8c3e-46c7-baad-344ff58ddbd4","query_id":"51","doc_a_id":"4434951","doc_b_id":"1285713","presented_order":["1285713","4434951"],"winner_id":"1285713","reasoning":"Document A is more relevant — it addresses cancer biology/therapeutics, while Document B focuses on aging and epigenetics in mice, not breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.322015Z"}
{"comparison_id":"d8eea9f0-9c7f-4e50-81b4-b834baf67b46","query_id":"51","doc_a_id":"3831884","doc_b_id":"1285713","presented_order":["1285713","3831884"],"winner_id":"1285713","reasoning":"Document A is more relevant — it discusses cancer therapeutics and anti-cancer activity broadly, whereas Document B focuses on pancreatic cancer metabolism unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.322022Z"}
{"comparison_id":"3da10915-c06f-4fa7-a3c4-3d41920404a0","query_id":"51","doc_a_id":"38009906","doc_b_id":"1285713","presented_order":["38009906","1285713"],"winner_id":"38009906","reasoning":"Document A is more relevant — it discusses cancer-related molecular mechanisms (tumor suppressor regulation and cell senescence), which are closer to outcomes/biomarkers than a pharmacologic drug characterization. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.322028Z"}
{"comparison_id":"c33f5cf0-60b6-4496-9713-d8d193e59ed0","query_id":"51","doc_a_id":"18810195","doc_b_id":"1285713","presented_order":["1285713","18810195"],"winner_id":"1285713","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes, so neither is relevant. If one must be chosen, pick A because it at least concerns cancer therapeutics generally. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.322034Z"}
{"comparison_id":"56de06d6-a83e-4965-a1b1-02777def3d6d","query_id":"51","doc_a_id":"35993767","doc_b_id":"1285713","presented_order":["35993767","1285713"],"winner_id":"35993767","reasoning":"Document A is more related because it concerns cancer progression and metastasis (which affect outcomes), while Document B focuses on a drug's pharmacology without prognostic markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.322041Z"}
{"comparison_id":"880fd952-fff0-4f70-aedf-972e00aca659","query_id":"51","doc_a_id":"14672919","doc_b_id":"1285713","presented_order":["1285713","14672919"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant — it addresses molecular cancer biology/therapeutics broadly, whereas Document B focuses on platelet metrics in esophageal cancer, not ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.322048Z"}
{"comparison_id":"09170dbd-fb4a-4ce5-9d01-2e879273c914","query_id":"51","doc_a_id":"1686997","doc_b_id":"1285713","presented_order":["1686997","1285713"],"winner_id":"1686997","reasoning":"Neither document mentions ALDH1 or reports on breast cancer outcomes; both are irrelevant. Document A is slightly more relevant only because it addresses tumor growth pathways, whereas B focuses narrowly on a PI3K inhibitor.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.322054Z"}
{"comparison_id":"f7403a60-578d-4669-a756-f164552c6ac5","query_id":"51","doc_a_id":"3756384","doc_b_id":"1285713","presented_order":["1285713","3756384"],"winner_id":"3756384","reasoning":"Document B — it discusses cancer stem cell–like gene signatures and their association with prognosis, which is conceptually related to ALDH1 (a stem cell marker) and outcome. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.322061Z"}
{"comparison_id":"6a95fe30-df7f-4288-ac24-6e33e8c2089a","query_id":"51","doc_a_id":"36838958","doc_b_id":"1285713","presented_order":["1285713","36838958"],"winner_id":"1285713","reasoning":"Document A is marginally more relevant because it discusses cancer-related biology and therapeutics, whereas Document B concerns adipose tissue metabolism unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.322068Z"}
{"comparison_id":"0215738d-b5a4-4924-b490-ff038e43ff96","query_id":"51","doc_a_id":"27647593","doc_b_id":"1285713","presented_order":["1285713","27647593"],"winner_id":"27647593","reasoning":"Document B — discusses tumor metabolism and microenvironment interactions relevant to markers like ALDH1, whereas Document A focuses narrowly on a PI3K inhibitor with no link to ALDH1 or breast outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.322074Z"}
{"comparison_id":"71ca892f-cdd7-4e0f-8a94-812880a26809","query_id":"51","doc_a_id":"13205096","doc_b_id":"1285713","presented_order":["1285713","13205096"],"winner_id":"13205096","reasoning":"Document B is more relevant — it concerns gene-expression profiling and prognostic markers (although in AML, not breast cancer), which is closer to evaluating expression-outcome associations than a pharmacologic study of a PI3K inhibitor.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.322081Z"}
{"comparison_id":"5a7c75fb-51fd-430a-b550-8af0e8d28805","query_id":"51","doc_a_id":"24323369","doc_b_id":"1285713","presented_order":["1285713","24323369"],"winner_id":"1285713","reasoning":"Document A — it's cancer-related and concerns molecular markers/therapy, whereas Document B is about PCOS/ovulation and unrelated to breast cancer biomarkers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.322088Z"}
{"comparison_id":"6d303aeb-05f5-4ccc-a35d-7dd76d2563bc","query_id":"51","doc_a_id":"26231129","doc_b_id":"1285713","presented_order":["1285713","26231129"],"winner_id":"26231129","reasoning":"B is more relevant — the residual-disease framework likely discusses tumor cell subpopulations and biomarkers (e.g., stem-cell markers like ALDH1) and links to outcomes; A focuses on a PI3K inhibitor's pharmacology and is unrelated. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.322095Z"}
{"comparison_id":"bf645f54-bb31-4f00-9e93-a956b50ee8eb","query_id":"51","doc_a_id":"33387953","doc_b_id":"1285713","presented_order":["1285713","33387953"],"winner_id":"33387953","reasoning":"Neither abstract mentions ALDH1 or breast cancer outcomes. Document B is slightly more relevant because it discusses molecular alterations that affect cancer transformation and therapy resistance (which relate to prognosis), whereas A focuses narrowly on a PI3K inhibitor.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.322102Z"}
{"comparison_id":"199b7dd6-0cf0-46bc-a7ca-f2bb9735ba3a","query_id":"51","doc_a_id":"3504761","doc_b_id":"1285713","presented_order":["3504761","1285713"],"winner_id":"1285713","reasoning":"Document B is slightly more relevant because it concerns cancer therapeutics generally, whereas Document A focuses on liver-specific metabolism and tumorigenesis unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323017Z"}
{"comparison_id":"4fc96ba0-1faf-49fb-8bee-5ff46b4ed379","query_id":"51","doc_a_id":"7869794","doc_b_id":"1285713","presented_order":["1285713","7869794"],"winner_id":"1285713","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes, but Document A (a cancer therapeutic study) is slightly more relevant to cancer prognosis than Document B, which focuses on neutrophil calcium signaling.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323031Z"}
{"comparison_id":"b264aecc-9d71-4c8f-a91c-4412a9a7b537","query_id":"51","doc_a_id":"5783785","doc_b_id":"1285713","presented_order":["5783785","1285713"],"winner_id":"1285713","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it addresses cancer therapeutics (potentially applicable across tumor types), whereas A is specific to miR-33b in gastric cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323039Z"}
{"comparison_id":"31dcdbf5-7072-4072-afae-14de294734e1","query_id":"51","doc_a_id":"12685434","doc_b_id":"1285713","presented_order":["12685434","1285713"],"winner_id":"12685434","reasoning":"Document A is slightly more relevant because it studies tumor gene expression and its impact on cancer behavior; Document B is about a PI3K inhibitor. Neither document mentions ALDH1 or breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323046Z"}
{"comparison_id":"9543f5ec-4786-4d07-a25c-4805150df5cf","query_id":"51","doc_a_id":"22478394","doc_b_id":"1285713","presented_order":["1285713","22478394"],"winner_id":"1285713","reasoning":"Document A is more related to cancer research (potential breast cancer therapeutic context) while Document B focuses on liver PPAR-γ in NAFLD; neither mentions ALDH1 or breast outcomes, but A is closer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323054Z"}
{"comparison_id":"7c3cca2f-1dce-47db-a5fa-2c48d589e26b","query_id":"51","doc_a_id":"31803596","doc_b_id":"1285713","presented_order":["31803596","1285713"],"winner_id":"31803596","reasoning":"Document A is slightly more relevant because it discusses gene expression analysis in cancer (though in oral squamous cell carcinoma, not breast cancer or ALDH1 specifically). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323060Z"}
{"comparison_id":"c9e4675f-3511-4f9e-8b5c-462507a5aeff","query_id":"51","doc_a_id":"864491","doc_b_id":"1285713","presented_order":["864491","1285713"],"winner_id":"864491","reasoning":"Reason: Neither abstract mentions ALDH1 or breast cancer outcomes; Document A is marginally more relevant because CDK4/6 inhibition is directly studied for tumor regression (more outcome-focused, often in breast cancer contexts).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323066Z"}
{"comparison_id":"aeb859fd-ff44-4a0c-942c-7bece1db9afd","query_id":"51","doc_a_id":"18358026","doc_b_id":"1285713","presented_order":["18358026","1285713"],"winner_id":"18358026","reasoning":"Neither document mentions ALDH1 or breast cancer outcomes; both are irrelevant. Document A is slightly more related to cancer biology (epigenetic changes) than B, so is marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323073Z"}
{"comparison_id":"bcd9cad1-4811-446d-800e-4b9c5afa03b4","query_id":"51","doc_a_id":"4467129","doc_b_id":"1285713","presented_order":["4467129","1285713"],"winner_id":"4467129","reasoning":"Reason: Neither paper addresses ALDH1 or breast cancer, but Document A discusses cancer prognosis and molecular markers (let-7) whereas B focuses on a PI3K inhibitor—A is slightly more related to outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323080Z"}
{"comparison_id":"3e7f8ce1-25f7-4cd9-ae7c-a6190a3156ac","query_id":"51","doc_a_id":"7028976","doc_b_id":"1285713","presented_order":["7028976","1285713"],"winner_id":"1285713","reasoning":"Document B is more relevant — it discusses a cancer-targeted molecular therapy (PI3K inhibitor) which is more broadly applicable to cancer outcomes, whereas A is specific to glioblastoma and unrelated to breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323086Z"}
{"comparison_id":"988b033a-f032-414d-832e-307d7ee5b5af","query_id":"51","doc_a_id":"10542877","doc_b_id":"1285713","presented_order":["1285713","10542877"],"winner_id":"1285713","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes. Both are irrelevant; if one must be chosen, ANSWER: A — it at least discusses a cancer-targeted agent broadly, whereas B focuses on lymphoma and lung cancer.","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323094Z"}
{"comparison_id":"0c50913f-32d9-4535-af2e-1df5f80495c0","query_id":"51","doc_a_id":"16361581","doc_b_id":"1285713","presented_order":["1285713","16361581"],"winner_id":"1285713","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes; Document A is slightly more relevant because it addresses cancer therapeutics broadly, while B focuses on multiple myeloma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323101Z"}
{"comparison_id":"b06227c7-3b62-46a2-98ab-7eedfb5f56f5","query_id":"51","doc_a_id":"24783597","doc_b_id":"1285713","presented_order":["24783597","1285713"],"winner_id":"1285713","reasoning":"Document B — it discusses a cancer therapeutic and cancer biology, which is more related to breast cancer outcomes than Document A's IBD-focused study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323107Z"}
{"comparison_id":"b1602d23-575f-4f3a-bac5-80156973df03","query_id":"51","doc_a_id":"667451","doc_b_id":"1285713","presented_order":["1285713","667451"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant because it addresses cancer biology/therapeutics broadly, whereas Document B focuses specifically on clonal evolution in chronic lymphocytic leukemia; neither mentions ALDH1 or breast cancer outcomes.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323114Z"}
{"comparison_id":"3597e9a6-1527-4a34-8c17-8ba9885a0520","query_id":"51","doc_a_id":"5691302","doc_b_id":"1285713","presented_order":["5691302","1285713"],"winner_id":"1285713","reasoning":"Document B is more relevant because it concerns cancer biology and therapeutics, while Document A addresses antidepressant risks in older adults and is unrelated to breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323120Z"}
{"comparison_id":"02423c6d-4189-45db-84e0-1787af33a78f","query_id":"51","doc_a_id":"3858268","doc_b_id":"1285713","presented_order":["3858268","1285713"],"winner_id":"3858268","reasoning":"Document A is more relevant — it concerns cancer stem cells and metabolic markers (closely related to ALDH1 as a CSC marker), whereas Document B focuses on a PI3K inhibitor unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323127Z"}
{"comparison_id":"922d7e4b-c8cb-4aa6-9373-e5cf21ff077b","query_id":"51","doc_a_id":"1836154","doc_b_id":"1285713","presented_order":["1285713","1836154"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant because it discusses cancer therapeutics and biomarkers in a cancer context, whereas Document B focuses specifically on glioblastoma genomics unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323133Z"}
{"comparison_id":"5fbb8c29-b541-440b-9991-6d201d597366","query_id":"51","doc_a_id":"24190159","doc_b_id":"1285713","presented_order":["1285713","24190159"],"winner_id":"1285713","reasoning":"Neither document addresses ALDH1 expression or breast cancer outcomes. Document A is marginally more relevant because it concerns cancer therapeutics generally, while B focuses specifically on KRAS in rectal cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323139Z"}
{"comparison_id":"7b846caf-8c90-4503-aba5-ed25e79c3bc5","query_id":"51","doc_a_id":"23599024","doc_b_id":"1285713","presented_order":["1285713","23599024"],"winner_id":"1285713","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it addresses cancer therapeutics in general, while Document B is specific to lung cancer and SP-B. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323146Z"}
{"comparison_id":"028d6db9-4d57-4e17-951e-2777e30831d9","query_id":"51","doc_a_id":"13905670","doc_b_id":"1285713","presented_order":["13905670","1285713"],"winner_id":"1285713","reasoning":"Document B is more relevant because it addresses cancer biology and therapeutics, whereas Document A concerns inflammatory/infectious disease genetics unrelated to breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323152Z"}
{"comparison_id":"5ff1e237-c50a-43cf-a136-c5e1bb543edf","query_id":"51","doc_a_id":"18882947","doc_b_id":"1285713","presented_order":["18882947","1285713"],"winner_id":"1285713","reasoning":"Neither abstract mentions ALDH1 or breast cancer. Document B is marginally more relevant because it addresses cancer therapeutics broadly, while A is specific to T‑cell lymphoma. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323158Z"}
{"comparison_id":"ba160d4e-b631-439e-ae84-b95c5717876d","query_id":"51","doc_a_id":"19427410","doc_b_id":"1285713","presented_order":["19427410","1285713"],"winner_id":"1285713","reasoning":"Document B is slightly more relevant because it relates to cancer biology and therapeutics, whereas Document A is about IL-33 expression in adipocytes and unrelated to cancer markers or outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323165Z"}
{"comparison_id":"b7864902-57a2-4fbc-a093-52b997ec4050","query_id":"51","doc_a_id":"8538916","doc_b_id":"1285713","presented_order":["1285713","8538916"],"winner_id":"8538916","reasoning":"Document B is more relevant — it discusses expression levels of a protein complex in cancer cells and their relation to cancer cell behavior, whereas Document A focuses on a PI3K inhibitor unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323171Z"}
{"comparison_id":"fa741c77-461e-4f4d-aa33-a1b91fed5d98","query_id":"51","doc_a_id":"25036988","doc_b_id":"1285713","presented_order":["25036988","1285713"],"winner_id":"1285713","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document B is marginally more relevant because it concerns cancer therapeutics broadly, whereas A is specific to lamin B1 in colon cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323178Z"}
{"comparison_id":"6050554c-d082-44db-a75b-1bb465b2c74a","query_id":"51","doc_a_id":"19800147","doc_b_id":"1285713","presented_order":["19800147","1285713"],"winner_id":"1285713","reasoning":"Neither abstract addresses ALDH1 or breast cancer outcomes; both are not relevant. Document B is marginally more general to cancer therapeutics, so slightly more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323184Z"}
{"comparison_id":"7af8eb37-e4a5-455b-9c42-1cd67434a614","query_id":"51","doc_a_id":"5573975","doc_b_id":"1285713","presented_order":["5573975","1285713"],"winner_id":"1285713","reasoning":"Document B is more relevant because it relates to cancer biology/therapy, whereas Document A concerns kidney regeneration and fibrosis, not breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323190Z"}
{"comparison_id":"f0476815-462d-494c-8adf-a151861d0b8b","query_id":"51","doc_a_id":"11578459","doc_b_id":"1285713","presented_order":["11578459","1285713"],"winner_id":"11578459","reasoning":"Reason: Document A discusses a stem cell-related signature (HOX) in cancer, which is more closely related to ALDH1 as a stem cell marker than a pharmacologic PI3K inhibitor study in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323196Z"}
{"comparison_id":"8d1fa590-bf88-4442-a83a-e4c726073b86","query_id":"51","doc_a_id":"6290112","doc_b_id":"1285713","presented_order":["6290112","1285713"],"winner_id":"1285713","reasoning":"Reason: Document B concerns cancer pharmacology (related to cancer outcomes), while Document A addresses salivary amylase and obesity with no relation to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323202Z"}
{"comparison_id":"02d37fb9-b937-4034-82ad-14b3bf83d8a3","query_id":"51","doc_a_id":"33740844","doc_b_id":"1285713","presented_order":["1285713","33740844"],"winner_id":"1285713","reasoning":"Document A is more relevant — it concerns cancer biology/therapeutics, whereas Document B is about maternal/infant nutrition and unrelated to breast cancer markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323208Z"}
{"comparison_id":"ea12638a-e3c9-4596-83f1-b2ac321f51de","query_id":"51","doc_a_id":"67787658","doc_b_id":"1285713","presented_order":["1285713","67787658"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant — it discusses a cancer therapeutic agent (general cancer context) while Document B is specific to glioblastoma and temozolomide resistance, neither mentions ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323215Z"}
{"comparison_id":"69a58f90-6420-4fdd-9abb-204e8e5810e5","query_id":"51","doc_a_id":"13398997","doc_b_id":"1285713","presented_order":["1285713","13398997"],"winner_id":"1285713","reasoning":"Document A is more relevant — it concerns cancer therapeutics and tumor biology, whereas Document B is about T cell immunology in transplantation and unrelated to breast cancer markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323221Z"}
{"comparison_id":"e8099164-ae47-472d-9639-bd98d4cf6492","query_id":"51","doc_a_id":"10669939","doc_b_id":"1285713","presented_order":["10669939","1285713"],"winner_id":"1285713","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer outcomes, but Document B concerns cancer therapeutics and outcomes-related research, making it slightly more relevant than Document A (which focuses on gene imaging in glioma).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323228Z"}
{"comparison_id":"5e6e1d96-36ed-4ba5-a580-7c79212db40e","query_id":"51","doc_a_id":"13889430","doc_b_id":"1285713","presented_order":["13889430","1285713"],"winner_id":"13889430","reasoning":"Neither abstract mentions ALDH1. Document A is slightly more relevant because it addresses cancer biology and tumor–stroma interactions that could affect outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323234Z"}
{"comparison_id":"6055ec57-2b41-4725-83be-3743a009fc12","query_id":"51","doc_a_id":"18682109","doc_b_id":"1285713","presented_order":["1285713","18682109"],"winner_id":"1285713","reasoning":"Doc A is at least generally cancer-related (therapeutic/biomarker context); Doc B concerns lung cancer subtypes and RB loss, so is less relevant to ALDH1 in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323240Z"}
{"comparison_id":"bc611d24-d049-4b41-a5af-c86b4d93090a","query_id":"51","doc_a_id":"5254463","doc_b_id":"1285713","presented_order":["1285713","5254463"],"winner_id":"5254463","reasoning":"Document B — it addresses stem cells and tumorigenesis (though in intestine), which is closer to ALDH1 as a stem-cell marker than a pharmacologic PI3K inhibitor study. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323246Z"}
{"comparison_id":"0b6bd6b9-1112-4b56-9de7-bd692dec65ab","query_id":"51","doc_a_id":"20659283","doc_b_id":"1285713","presented_order":["1285713","20659283"],"winner_id":"1285713","reasoning":"Document A is more relevant — it discusses a cancer therapeutic and cancer biology, whereas Document B focuses on species-specific CYP regulation unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323252Z"}
{"comparison_id":"7687e410-b39e-4203-901e-d06d79c1bd53","query_id":"51","doc_a_id":"195689757","doc_b_id":"1285713","presented_order":["195689757","1285713"],"winner_id":"1285713","reasoning":"Document B is slightly more relevant because it discusses a cancer-targeted pharmacologic agent (potentially relevant across tumor types), whereas Document A is specific to glioblastoma metabolism and unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323259Z"}
{"comparison_id":"d59f09f3-bc4d-467c-885c-d64d3285d74d","query_id":"51","doc_a_id":"15727984","doc_b_id":"1285713","presented_order":["15727984","1285713"],"winner_id":"15727984","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer; Document A is slightly more related to cancer cell biology/tumor microenvironment than a PI3K inhibitor pharmacology paper.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323265Z"}
{"comparison_id":"b9a6fec1-8aa7-4949-a6d4-4a5cf73c174b","query_id":"51","doc_a_id":"21063817","doc_b_id":"1285713","presented_order":["21063817","1285713"],"winner_id":"1285713","reasoning":"Document B is slightly more relevant because it concerns cancer biology and therapeutics, whereas Document A focuses on keratin expression in oral squamous cell carcinoma, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323271Z"}
{"comparison_id":"e3003fab-5d90-4a70-a1b3-72a7ea58ede3","query_id":"51","doc_a_id":"7975937","doc_b_id":"1285713","presented_order":["7975937","1285713"],"winner_id":"7975937","reasoning":"Document A is marginally more relevant — it discusses tumor growth and immune-related outcomes in cancers, whereas Document B focuses narrowly on PI3K inhibitor pharmacology and not on markers or clinical outcomes. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323278Z"}
{"comparison_id":"4bf49e15-d07f-478f-be2c-8d10b815f07b","query_id":"51","doc_a_id":"10365787","doc_b_id":"1285713","presented_order":["1285713","10365787"],"winner_id":"10365787","reasoning":"Document B is more relevant — it addresses tumor suppression and genomic stability tied to cancer outcomes, whereas Document A focuses on PI3K inhibitor pharmacology; neither mentions ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323284Z"}
{"comparison_id":"c43d295e-294c-43c1-aae2-90291cf07750","query_id":"51","doc_a_id":"4325398","doc_b_id":"1285713","presented_order":["4325398","1285713"],"winner_id":"4325398","reasoning":"Document A — it discusses cancer genomics (albeit in pancreatic cancer) which is closer to a biomarker/outcome topic than a pharmacologic characterization of a PI3K inhibitor. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323290Z"}
{"comparison_id":"e09cad9a-f7d9-4bba-a67e-8dd3776372db","query_id":"51","doc_a_id":"17717391","doc_b_id":"1285713","presented_order":["17717391","1285713"],"winner_id":"17717391","reasoning":"Document A is more relevant — it discusses tumor marker expression and tumorigenesis, which is closer to a claim about a biomarker's association with cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323296Z"}
{"comparison_id":"23b0e0f9-9ff9-4673-aed1-58b4e0daf6a9","query_id":"51","doc_a_id":"33076846","doc_b_id":"1285713","presented_order":["33076846","1285713"],"winner_id":"1285713","reasoning":"Document B is slightly more relevant because it addresses cancer therapeutics and outcomes, while Document A focuses on megakaryocyte biology unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323303Z"}
{"comparison_id":"8092dc9d-2dc9-4cd0-bf3c-9184012a66f5","query_id":"51","doc_a_id":"13235609","doc_b_id":"1285713","presented_order":["1285713","13235609"],"winner_id":"1285713","reasoning":"Reason: Document A discusses cancer therapeutics and outcomes broadly, whereas Document B focuses on VEGF/MET signaling in GBM (glioblastoma), which is less relevant to ALDH1 and breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323309Z"}
{"comparison_id":"8e260e36-3b20-4808-8d36-fdbe277da04a","query_id":"51","doc_a_id":"2547636","doc_b_id":"1285713","presented_order":["1285713","2547636"],"winner_id":"1285713","reasoning":"Doc A is cancer-focused and more likely to discuss markers linked to cancer outcomes than a study on epidermal stem cell circadian rhythms. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323315Z"}
{"comparison_id":"75dd0feb-2dc5-40f6-8f54-764045aa2181","query_id":"51","doc_a_id":"9478135","doc_b_id":"1285713","presented_order":["9478135","1285713"],"winner_id":"1285713","reasoning":"Neither document mentions ALDH1 or breast cancer outcomes; both are not relevant. Document B is marginally more related (general cancer therapeutic context), so:\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323322Z"}
{"comparison_id":"ccd95887-c3d3-4e52-9c7c-9758ed2fe928","query_id":"51","doc_a_id":"28644298","doc_b_id":"1285713","presented_order":["28644298","1285713"],"winner_id":"1285713","reasoning":"Document B — it discusses cancer therapeutics/PI3K signaling which is more related to cancer outcomes than EBV/NF-kappaB studies in lymphoid cells.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323328Z"}
{"comparison_id":"2f8ae051-9bb8-4cae-b976-bd94d7fdbb04","query_id":"51","doc_a_id":"6374918","doc_b_id":"1285713","presented_order":["1285713","6374918"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant — it discusses a cancer therapeutic (PI3K inhibitor) and cancer outcomes broadly, whereas B is specific to AML and bone marrow niche, unrelated to breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323335Z"}
{"comparison_id":"4182083e-fd84-416c-a4c7-57ccd4cbd915","query_id":"51","doc_a_id":"2374637","doc_b_id":"1285713","presented_order":["2374637","1285713"],"winner_id":"2374637","reasoning":"Document A is about analyzing gene expression in cancer (relevant to ALDH1 expression and outcomes); Document B is about a PI3K inhibitor and unrelated to ALDH1 or breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323341Z"}
{"comparison_id":"b34ef799-c012-4d00-88bf-6522f342b20c","query_id":"51","doc_a_id":"24294572","doc_b_id":"1285713","presented_order":["24294572","1285713"],"winner_id":"24294572","reasoning":"Document A is more relevant because it discusses cancer-related molecular signaling and tumor behavior, whereas Document B focuses on a PI3K inhibitor's pharmacology and is less related to biomarkers or clinical outcomes like ALDH1 expression.  \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323348Z"}
{"comparison_id":"d71fb76d-fe8c-4dca-9cb3-f171c98198da","query_id":"51","doc_a_id":"1727493","doc_b_id":"1285713","presented_order":["1727493","1285713"],"winner_id":"1727493","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes. Document A is slightly more relevant only because it addresses cancer cell biology and treatment resistance, whereas B focuses on a PI3K inhibitor's pharmacology unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323354Z"}
{"comparison_id":"0f146e6a-46cb-4f27-adaa-d8933877a0b1","query_id":"51","doc_a_id":"14972169","doc_b_id":"1285713","presented_order":["1285713","14972169"],"winner_id":"1285713","reasoning":"Document A is more relevant — it discusses cancer therapeutics and tumor biology, whereas Document B concerns embryonic oxidative stress and GAPDH unrelated to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323361Z"}
{"comparison_id":"35668dde-e205-499c-a72a-b974eb24de0a","query_id":"51","doc_a_id":"17973161","doc_b_id":"1285713","presented_order":["1285713","17973161"],"winner_id":"1285713","reasoning":"Document A is more relevant — it concerns cancer biology/therapy, whereas Document B deals with adipocytes and metabolic homeostasis unrelated to breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323367Z"}
{"comparison_id":"345f9053-446a-4802-9ca3-6ebe959cd347","query_id":"51","doc_a_id":"6766459","doc_b_id":"1285713","presented_order":["6766459","1285713"],"winner_id":"1285713","reasoning":"Document B is more relevant — it concerns a cancer therapeutic (PI3K inhibitor) and cancer biology, whereas Document A focuses on fever-related RBM3/thermomiRs with no cancer or ALDH1 content.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323374Z"}
{"comparison_id":"bb82e3b7-d09c-4a69-8d6d-35c6d5ed92dd","query_id":"51","doc_a_id":"16364639","doc_b_id":"1285713","presented_order":["16364639","1285713"],"winner_id":"16364639","reasoning":"Document A is slightly more relevant because it deals with gene expression and oncogenic pathway regulation, whereas Document B focuses on a PI3K inhibitor's pharmacology unrelated to marker expression or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323380Z"}
{"comparison_id":"c73ef8dc-9c6f-4637-8e95-1b94a332ab1a","query_id":"51","doc_a_id":"952111","doc_b_id":"1285713","presented_order":["952111","1285713"],"winner_id":"952111","reasoning":"Document A is more related to tumor biology and cellular markers (like ALDH1) and their impact on cancer behavior and outcomes; Document B focuses on a PI3K inhibitor and is unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323387Z"}
{"comparison_id":"623c5d98-78e4-4bc3-885c-6dae4289169f","query_id":"51","doc_a_id":"27822315","doc_b_id":"1285713","presented_order":["1285713","27822315"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant because it deals with cancer therapeutics and cancer biology, whereas Document B focuses on steroidogenic differentiation unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323393Z"}
{"comparison_id":"91180d5e-9c58-4b39-b50c-ccd8e445b250","query_id":"51","doc_a_id":"1649738","doc_b_id":"1285713","presented_order":["1649738","1285713"],"winner_id":"1649738","reasoning":"Neither document discusses ALDH1 or breast cancer specifically, but Document A is slightly more relevant because it addresses gene expression in a cancer context. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323399Z"}
{"comparison_id":"964a84f1-95fe-4435-aef6-96cf16ce6186","query_id":"51","doc_a_id":"15322518","doc_b_id":"1285713","presented_order":["1285713","15322518"],"winner_id":"1285713","reasoning":"Document A is more relevant — it addresses cancer-associated signaling/therapeutics (PI3K) that are more likely to relate to breast cancer outcomes than a study focused on malignant rhabdoid tumors.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323405Z"}
{"comparison_id":"2e130600-0cd4-4a99-a221-05ca437c7767","query_id":"51","doc_a_id":"14019636","doc_b_id":"1285713","presented_order":["14019636","1285713"],"winner_id":"14019636","reasoning":"Reason: Document A discusses cancer genomic markers linked to sensitivity/outcomes, which is more related to an expression–outcome claim than Document B's drug-activity focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323411Z"}
{"comparison_id":"f2af3437-8597-4ffa-a037-fed0fd7e79a9","query_id":"51","doc_a_id":"4464565","doc_b_id":"1285713","presented_order":["1285713","4464565"],"winner_id":"1285713","reasoning":"Document A is more relevant because it relates to cancer biology/therapy, whereas Document B studies cocoa effects in intestinal Caco-2 cells and does not address ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323417Z"}
{"comparison_id":"ce3a8fd2-46cc-4378-a32b-3bc375b6851d","query_id":"51","doc_a_id":"14768471","doc_b_id":"1285713","presented_order":["14768471","1285713"],"winner_id":"14768471","reasoning":"Reason: Document A discusses cancer stem cells (CSCs), which are commonly associated with ALDH1 as a stem cell marker; Document B focuses on a PI3K inhibitor and is unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323424Z"}
{"comparison_id":"13e800a0-1089-47c8-bfbe-02f97387ff67","query_id":"51","doc_a_id":"3701541","doc_b_id":"1285713","presented_order":["3701541","1285713"],"winner_id":"1285713","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer specifically, but Document B deals with a cancer-relevant signaling pathway (PI3K) and therapeutics, making it slightly more relevant than a study limited to liver fibrosis/cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323432Z"}
{"comparison_id":"8eae360a-e15a-4f06-ad23-eb1f1963c974","query_id":"51","doc_a_id":"9513785","doc_b_id":"1285713","presented_order":["1285713","9513785"],"winner_id":"1285713","reasoning":"Document A discusses a cancer-related therapeutic and PI3K biology, which is closer to breast cancer outcomes than Document B’s focus on maternal protein restriction and lifespan in mice. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323439Z"}
{"comparison_id":"738d9456-f5e8-4262-a255-7940edbc7cec","query_id":"51","doc_a_id":"19408393","doc_b_id":"1285713","presented_order":["1285713","19408393"],"winner_id":"19408393","reasoning":"Document B is slightly more relevant because it reports clinical outcomes data (whereas A is preclinical pharmacology); however neither document mentions ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323445Z"}
{"comparison_id":"5c70f078-fa15-48e8-9aed-b5bb5f61e2be","query_id":"51","doc_a_id":"30543439","doc_b_id":"1285713","presented_order":["30543439","1285713"],"winner_id":"1285713","reasoning":"Reason: Both abstracts don't address ALDH1 or breast cancer outcomes, but Document B relates to cancer therapeutics generally, so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323451Z"}
{"comparison_id":"a666e488-1422-4d82-a7df-bfb377b2327a","query_id":"51","doc_a_id":"2613411","doc_b_id":"1285713","presented_order":["2613411","1285713"],"winner_id":"2613411","reasoning":"Document A is slightly more relevant because it discusses tumor cell biology and prognostic/therapeutic implications, whereas Document B focuses on a specific PI3K inhibitor unrelated to ALDH1 or breast cancer outcomes.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323457Z"}
{"comparison_id":"c93f20f0-acd6-469e-9bd9-ad5f4ba718bf","query_id":"51","doc_a_id":"25725663","doc_b_id":"1285713","presented_order":["25725663","1285713"],"winner_id":"1285713","reasoning":"Document B is more relevant — it relates to cancer therapeutics, whereas Document A concerns lung epithelial protection unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323464Z"}
{"comparison_id":"68d45d9c-1aec-42b7-a223-16c41dc8722e","query_id":"51","doc_a_id":"4993011","doc_b_id":"1285713","presented_order":["4993011","1285713"],"winner_id":"1285713","reasoning":"Neither abstract mentions ALDH1 or breast cancer outcomes. Document B is slightly more relevant because it concerns a cancer therapeutic (PI3K pathway is implicated in breast cancer), whereas A focuses on ATRX-related rDNA instability in ALT-positive cancers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323470Z"}
{"comparison_id":"8bae5aac-9906-4dad-bcfc-ea7886de8caa","query_id":"51","doc_a_id":"15491308","doc_b_id":"1285713","presented_order":["1285713","15491308"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant because it discusses a cancer therapeutic and tumor biology, whereas Document B concerns stem cell senescence and growth, not cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323476Z"}
{"comparison_id":"e2044ba7-6a80-49fd-8b6e-c52fc9112736","query_id":"51","doc_a_id":"21372171","doc_b_id":"1285713","presented_order":["1285713","21372171"],"winner_id":"1285713","reasoning":"Document A is more related because it concerns cancer research/therapeutics, whereas Document B addresses peripheral artery disease unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323482Z"}
{"comparison_id":"7250bddb-d07c-436f-b4af-38a1716fbe9c","query_id":"51","doc_a_id":"15803282","doc_b_id":"1285713","presented_order":["1285713","15803282"],"winner_id":"1285713","reasoning":"Reason: Document A discusses cancer therapeutics and tumor biology, so it's more related to breast cancer outcomes than Document B, which addresses somatic cell nuclear transfer and stem cell derivation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323489Z"}
{"comparison_id":"8e45f522-f5db-400c-8a3c-99f51f71548d","query_id":"51","doc_a_id":"25022826","doc_b_id":"1285713","presented_order":["25022826","1285713"],"winner_id":"1285713","reasoning":"Document B — it's cancer‑focused (therapeutics) and thus more related to breast cancer outcomes than Document A, which concerns MSC osteogenesis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323495Z"}
{"comparison_id":"0f378a35-791f-418e-b1fc-cc90a2105c4f","query_id":"51","doc_a_id":"19644821","doc_b_id":"1285713","presented_order":["19644821","1285713"],"winner_id":"19644821","reasoning":"Document A is slightly more relevant — it discusses a cancer stem cell regulator and tumor maintenance (albeit in liver cancer), whereas Document B focuses on a PI3K inhibitor and not on markers like ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323502Z"}
{"comparison_id":"3a385f7a-2009-44fc-bf22-bfce22de4dd2","query_id":"51","doc_a_id":"36653415","doc_b_id":"1285713","presented_order":["36653415","1285713"],"winner_id":"1285713","reasoning":"Reason: Neither discusses ALDH1 or breast cancer, but B is about a cancer therapeutic (potentially more related to cancer outcomes) while A focuses on lung tumor metabolism.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323508Z"}
{"comparison_id":"58d61493-00e6-4528-8e29-e9400df2573d","query_id":"51","doc_a_id":"32742683","doc_b_id":"1285713","presented_order":["32742683","1285713"],"winner_id":"32742683","reasoning":"Document A is more relevant — it discusses tumor microenvironment and cell markers related to cancer outcomes (more likely to mention ALDH1) while Document B focuses on a PI3K inhibitor unrelated to ALDH1 or clinical outcomes. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323514Z"}
{"comparison_id":"b6384e83-fd83-4ac1-80ce-b63494747953","query_id":"51","doc_a_id":"20501163","doc_b_id":"1285713","presented_order":["20501163","1285713"],"winner_id":"20501163","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer outcomes, but Document A discusses tumor-related factors that affect cancer progression and treatment efficacy, making it slightly more relevant than a pharmacologic profiling of a PI3K inhibitor.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323521Z"}
{"comparison_id":"47da254f-d153-4ed5-87fd-00784746a5b3","query_id":"51","doc_a_id":"8994465","doc_b_id":"1285713","presented_order":["8994465","1285713"],"winner_id":"8994465","reasoning":"Document A is more relevant — it discusses cancer cell subpopulations and marker expression, whereas B covers PI3K inhibitor pharmacology unrelated to marker expression or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323528Z"}
{"comparison_id":"fe4830f3-cbb8-4bde-b71e-7104c00393cd","query_id":"51","doc_a_id":"19343151","doc_b_id":"1285713","presented_order":["19343151","1285713"],"winner_id":"1285713","reasoning":"Document B is more relevant — it deals with cancer pharmacology/therapeutics, which is closer to breast cancer outcomes than a study on skin aging biomarkers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323534Z"}
{"comparison_id":"b073ee9a-8647-4888-8d09-c17b2ae4f9af","query_id":"51","doc_a_id":"8724666","doc_b_id":"1285713","presented_order":["8724666","1285713"],"winner_id":"1285713","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is slightly more relevant because it discusses cancer therapeutics broadly, while A focuses on hematopoiesis and leukemia.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323540Z"}
{"comparison_id":"972ebcae-1c64-456b-91d8-34a8b1dbb93f","query_id":"51","doc_a_id":"31624828","doc_b_id":"1285713","presented_order":["31624828","1285713"],"winner_id":"31624828","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes. Both are irrelevant, but Document A is marginally more relevant because it concerns tumor biology (p53) rather than drug pharmacology.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323547Z"}
{"comparison_id":"f8098ee2-8baa-41e1-8ee0-c83cd34fefd2","query_id":"51","doc_a_id":"20460020","doc_b_id":"1285713","presented_order":["1285713","20460020"],"winner_id":"1285713","reasoning":"Document A is more relevant — it discusses cancer therapeutics and cancer biology, whereas Document B concerns macrophage roles in wound healing, not cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323553Z"}
{"comparison_id":"a977e592-3ab6-426b-9fb8-e63ff5bc805b","query_id":"51","doc_a_id":"32372280","doc_b_id":"1285713","presented_order":["32372280","1285713"],"winner_id":"1285713","reasoning":"B is more relevant — it concerns cancer biology/therapeutics, whereas A is about glaucoma and unrelated to cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323560Z"}
{"comparison_id":"4b481627-a025-4525-ad4f-c3ae4ff22b70","query_id":"51","doc_a_id":"22896384","doc_b_id":"1285713","presented_order":["1285713","22896384"],"winner_id":"1285713","reasoning":"Document A is more relevant because it discusses cancer therapeutics and tumor biology, whereas Document B covers developmental roles of Foxp genes in lung/esophagus unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323566Z"}
{"comparison_id":"0fe7638b-4249-4f49-a939-f721d6b1a60f","query_id":"51","doc_a_id":"38025907","doc_b_id":"1285713","presented_order":["38025907","1285713"],"winner_id":"1285713","reasoning":"Document B — it's cancer-related (drug effects), while A is about liver disease/FGF19 and unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323572Z"}
{"comparison_id":"902b5164-1d1c-4dd8-a94f-31bd9794fd95","query_id":"51","doc_a_id":"14149065","doc_b_id":"1285713","presented_order":["1285713","14149065"],"winner_id":"1285713","reasoning":"Neither abstract mentions ALDH1. Document A is slightly more relevant because it addresses cancer therapeutics/outcomes, whereas B focuses on cell adhesion and proliferation mechanisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323579Z"}
{"comparison_id":"71debcb9-3b59-4965-9c9a-841667bc3f2f","query_id":"51","doc_a_id":"25344732","doc_b_id":"1285713","presented_order":["1285713","25344732"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant because it discusses cancer therapy and tumor studies, while Document B focuses on PHC3 in osteosarcoma (not breast cancer) and neither mentions ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323585Z"}
{"comparison_id":"50aabfd3-346a-4b77-a931-0e4ed7235a6c","query_id":"51","doc_a_id":"26059876","doc_b_id":"1285713","presented_order":["26059876","1285713"],"winner_id":"1285713","reasoning":"Document B is more relevant — it discusses cancer therapeutics broadly, whereas Document A focuses on Ku70 in colorectal cancer and is unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323592Z"}
{"comparison_id":"b8af6efe-ce6c-461f-a6a4-181d4ce4eeb0","query_id":"51","doc_a_id":"8417211","doc_b_id":"1285713","presented_order":["1285713","8417211"],"winner_id":"1285713","reasoning":"Document A is more relevant — it discusses cancer therapeutics and tumor biology, whereas Document B addresses Drosophila heterochromatin/HP1 unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323598Z"}
{"comparison_id":"305bdfb2-9643-4a27-b688-bc7aa66c78fd","query_id":"51","doc_a_id":"23887844","doc_b_id":"1285713","presented_order":["23887844","1285713"],"winner_id":"23887844","reasoning":"Document A is more relevant — it discusses cancer cell metabolic and redox mechanisms that relate to ALDH1's role in cellular metabolism and survival, whereas B focuses narrowly on a PI3K inhibitor. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323604Z"}
{"comparison_id":"ca725207-e5d6-4f47-b154-175364387c43","query_id":"51","doc_a_id":"28249680","doc_b_id":"1285713","presented_order":["1285713","28249680"],"winner_id":"1285713","reasoning":"Neither document mentions ALDH1 or reports breast cancer outcomes, so both are irrelevant. Document A is marginally more relevant because it addresses a cancer therapeutic that could impact outcomes, while B is a mechanistic apoptosis study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323611Z"}
{"comparison_id":"c3181335-547b-41e4-a032-89a1fd32fd79","query_id":"51","doc_a_id":"4920376","doc_b_id":"1285713","presented_order":["1285713","4920376"],"winner_id":"1285713","reasoning":"Neither abstract mentions ALDH1 or breast cancer outcomes. Document A is slightly more relevant only because it broadly addresses cancer therapeutics, whereas B is specific to KRAS‑mutant pancreatic cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323618Z"}
{"comparison_id":"a7211f39-5aed-4410-9050-80e7d2ccc9fb","query_id":"51","doc_a_id":"2919030","doc_b_id":"1285713","presented_order":["1285713","2919030"],"winner_id":"1285713","reasoning":"Neither document mentions ALDH1 or breast cancer outcomes; both are irrelevant. Document A is marginally more relevant because it addresses cancer therapeutics broadly.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323624Z"}
{"comparison_id":"4bb19e73-2772-4dd2-8625-b3e472bf1707","query_id":"51","doc_a_id":"6137330","doc_b_id":"1285713","presented_order":["6137330","1285713"],"winner_id":"1285713","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes; Document B is slightly more relevant because it addresses cancer biology/therapeutics rather than lung nodule management.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323630Z"}
{"comparison_id":"f843f469-8e63-4492-babe-c60be8baf278","query_id":"51","doc_a_id":"17775228","doc_b_id":"1285713","presented_order":["1285713","17775228"],"winner_id":"1285713","reasoning":"Document A is more relevant — it deals with cancer biology and therapeutic response, whereas Document B focuses on colorectal imprinting unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323636Z"}
{"comparison_id":"6601ec05-4ddd-403d-bf42-faabc7286fd9","query_id":"51","doc_a_id":"6828370","doc_b_id":"1285713","presented_order":["1285713","6828370"],"winner_id":"6828370","reasoning":"Document B is more relevant — it discusses tumor biology and gene-expression regulation that could relate to biomarkers and outcomes, whereas A focuses on a PI3K inhibitor unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323643Z"}
{"comparison_id":"4503c732-140a-4ca1-98a6-915ef0c5d5ec","query_id":"51","doc_a_id":"12737132","doc_b_id":"1285713","presented_order":["1285713","12737132"],"winner_id":"12737132","reasoning":"Document B is more relevant — it addresses gene regulation and pathways (YAP/TEAD) related to cancer growth and EMT, which is closer to factors influencing breast cancer outcomes than a PI3K inhibitor pharmacology paper. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323650Z"}
{"comparison_id":"aa81457b-0a8e-4d2e-9544-09ef14a1af94","query_id":"51","doc_a_id":"4641348","doc_b_id":"1285713","presented_order":["4641348","1285713"],"winner_id":"1285713","reasoning":"Document B is slightly more relevant because it concerns cancer therapeutics (breast cancer context possible), whereas A is about liver disease (NAFLD) and unrelated. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323656Z"}
{"comparison_id":"4a6f848b-8d5d-4684-8df8-be72d898ffd3","query_id":"51","doc_a_id":"20179918","doc_b_id":"1285713","presented_order":["1285713","20179918"],"winner_id":"20179918","reasoning":"Document B is more relevant — it deals with transcriptional regulation of stemness (SALL4/STAT3), which is closer to ALDH1 as a stem-cell marker than a PI3K inhibitor study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323662Z"}
{"comparison_id":"68ef804e-59a3-4e14-b2e3-ad27fc173e09","query_id":"51","doc_a_id":"756887","doc_b_id":"1285713","presented_order":["756887","1285713"],"winner_id":"756887","reasoning":"DOCUMENT A is more relevant — it discusses breast cancer screening and survivors (related to breast cancer outcomes), while DOCUMENT B concerns a PI3K inhibitor with no link to ALDH1 or clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323669Z"}
{"comparison_id":"f3fce404-ba22-4985-a6f7-6231878fe24c","query_id":"51","doc_a_id":"2359152","doc_b_id":"1285713","presented_order":["2359152","1285713"],"winner_id":"1285713","reasoning":"Document B is slightly more relevant because it addresses cancer biology/therapy, whereas A focuses on myelodysplastic syndromes and unrelated genetic lesions; neither mentions ALDH1 or breast cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323675Z"}
{"comparison_id":"6fba8db7-6c84-4296-b65c-c57b8d0adc85","query_id":"51","doc_a_id":"36547290","doc_b_id":"1285713","presented_order":["1285713","36547290"],"winner_id":"36547290","reasoning":"Neither paper discusses ALDH1 or breast cancer outcomes; Document B is slightly more relevant because it concerns gene regulation in cancer-related STAT3/IL-6 pathways that could indirectly affect markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323682Z"}
{"comparison_id":"35d9e1d0-23d0-4b82-bb9e-f1f4680755b3","query_id":"51","doc_a_id":"39481265","doc_b_id":"1285713","presented_order":["39481265","1285713"],"winner_id":"1285713","reasoning":"Document B is more relevant — it discusses cancer therapeutics and cancer biology, whereas Document A focuses on lung fibrosis unrelated to ALDH1 or breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323688Z"}
{"comparison_id":"8a9f877d-9cd9-4e1c-a669-ae69bad48553","query_id":"51","doc_a_id":"22483580","doc_b_id":"1285713","presented_order":["1285713","22483580"],"winner_id":"1285713","reasoning":"Document A is more relevant because it discusses cancer therapeutics (though not ALDH1 specifically), whereas Document B concerns sleep and IL-6 in bipolar disorder, unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323695Z"}
{"comparison_id":"44ab28dc-0b04-4b63-9325-d1fdd90bc3c4","query_id":"51","doc_a_id":"8842332","doc_b_id":"1285713","presented_order":["1285713","8842332"],"winner_id":"1285713","reasoning":"Document A is more relevant — it discusses cancer therapeutics and tumor biology, while Document B is unrelated to cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323701Z"}
{"comparison_id":"7264e2e1-20aa-460b-8713-c6dd59b7e893","query_id":"51","doc_a_id":"5765455","doc_b_id":"1285713","presented_order":["1285713","5765455"],"winner_id":"1285713","reasoning":"Document A is more relevant — it concerns cancer therapeutics and signaling pathways potentially related to solid tumors, whereas Document B focuses on myeloid leukemia and genomic instability. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323708Z"}
{"comparison_id":"bfe0c41c-e283-4eb0-b7cc-a8d851735e74","query_id":"51","doc_a_id":"24586989","doc_b_id":"1285713","presented_order":["1285713","24586989"],"winner_id":"1285713","reasoning":"Document A is more relevant — it concerns cancer therapeutics and tumor biology, whereas Document B is about heart failure genetics and unrelated to ALDH1 or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323714Z"}
{"comparison_id":"a3040c30-2620-4dfb-946f-3b63efc7a3ca","query_id":"51","doc_a_id":"12152977","doc_b_id":"1285713","presented_order":["12152977","1285713"],"winner_id":"12152977","reasoning":"Document A is more relevant — it concerns stem cell self-renewal and pluripotency genes (related to ALDH1 as a stem cell marker), whereas B focuses on a PI3K inhibitor unrelated to ALDH1/breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323721Z"}
{"comparison_id":"5065391f-9c62-4e1a-b001-2f0a053981f7","query_id":"51","doc_a_id":"5939172","doc_b_id":"1285713","presented_order":["1285713","5939172"],"winner_id":"1285713","reasoning":"Document A is cancer-focused (pharmacologic characterization of a cancer therapeutic), while Document B concerns alcohol drinking patterns and mortality—unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323727Z"}
{"comparison_id":"a2d2d1b1-2a81-4124-b039-c8063de03bfa","query_id":"51","doc_a_id":"1871499","doc_b_id":"1285713","presented_order":["1871499","1285713"],"winner_id":"1285713","reasoning":"Document B is slightly more relevant because it concerns cancer therapeutics, whereas Document A is about Huntington's disease and unrelated to breast cancer or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323733Z"}
{"comparison_id":"4ecf8dd4-9643-499b-8688-543f7a1e9502","query_id":"51","doc_a_id":"17412260","doc_b_id":"1285713","presented_order":["17412260","1285713"],"winner_id":"17412260","reasoning":"Document A is more relevant — it discusses tumor biology and in vivo effects on tumor suppression/senescence, which is closer to links between markers like ALDH1 and breast cancer outcomes than a PI3K inhibitor pharmacology paper.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323740Z"}
{"comparison_id":"5132335b-b380-4ee2-9c1d-b7aaa6e3c737","query_id":"51","doc_a_id":"12580014","doc_b_id":"1285713","presented_order":["1285713","12580014"],"winner_id":"1285713","reasoning":"Neither abstract addresses ALDH1 or breast cancer directly; both are irrelevant. Document A is marginally more relevant because it discusses cancer therapeutics in general, whereas B focuses on skin keratinocytes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323747Z"}
{"comparison_id":"c09348d5-e276-4c2b-b288-b97fd62c6f67","query_id":"51","doc_a_id":"13048272","doc_b_id":"1285713","presented_order":["1285713","13048272"],"winner_id":"1285713","reasoning":"Document A is more relevant — it deals with cancer therapeutics/oncology, whereas Document B focuses on hematopoietic stem cell transcriptional regulation unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323753Z"}
{"comparison_id":"238eff78-452f-4eb9-8a69-854cca80b70c","query_id":"51","doc_a_id":"8290760","doc_b_id":"1285713","presented_order":["1285713","8290760"],"winner_id":"1285713","reasoning":"Reason: Document A discusses cancer therapeutics and outcomes-related pharmacology, while Document B focuses on cellular reprogramming unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323759Z"}
{"comparison_id":"87d50970-9599-4cc4-b6f8-582289b5eb92","query_id":"51","doc_a_id":"28390999","doc_b_id":"1285713","presented_order":["28390999","1285713"],"winner_id":"1285713","reasoning":"Document B is more relevant — it discusses cancer therapeutics and tumor biology, whereas A is about chicken gonad development and unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323765Z"}
{"comparison_id":"5f6e143e-2b41-45dd-9457-323fdcd6f924","query_id":"51","doc_a_id":"1791714","doc_b_id":"1285713","presented_order":["1791714","1285713"],"winner_id":"1791714","reasoning":"Document A is more relevant — it addresses carcinoma behavior and metastasis mechanisms (closer to prognostic markers in cancer) while Document B focuses on PI3K inhibitor pharmacology and is not related to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323772Z"}
{"comparison_id":"e1d5f75f-1ff6-4417-bea3-488af029a8b3","query_id":"51","doc_a_id":"3202143","doc_b_id":"1285713","presented_order":["3202143","1285713"],"winner_id":"1285713","reasoning":"Document B is cancer-focused (therapeutic effects relevant to cancer outcomes), whereas A concerns aging and memory in C. elegans. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323778Z"}
{"comparison_id":"acba23c0-136b-483f-b57c-4bab30e669c9","query_id":"51","doc_a_id":"2485101","doc_b_id":"1285713","presented_order":["2485101","1285713"],"winner_id":"2485101","reasoning":"Document A is more relevant — it deals with gene expression and linking gene regulatory effects to disease traits, which is closer to a claim about ALDH1 expression and cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323784Z"}
{"comparison_id":"c3f0eb5c-d125-4139-aee2-c121a80c17c7","query_id":"51","doc_a_id":"25748308","doc_b_id":"1285713","presented_order":["25748308","1285713"],"winner_id":"25748308","reasoning":"Document A is more relevant — it discusses enzyme expression and roles in cancer (like GAPDH), which is closer to a claim about ALDH1 expression and cancer outcomes than a pharmacologic PI3K inhibitor study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323791Z"}
{"comparison_id":"2c27250b-87fd-4928-80ef-a432d6686df8","query_id":"51","doc_a_id":"7225911","doc_b_id":"1285713","presented_order":["1285713","7225911"],"winner_id":"7225911","reasoning":"Neither abstract mentions ALDH1 or breast cancer outcomes. Document B is marginally more relevant because it discusses cancer-related regulatory pathways (p53) rather than only drug pharmacology.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323798Z"}
{"comparison_id":"27056ab5-d8c0-4bf2-96f3-6a5e34aaa95b","query_id":"51","doc_a_id":"2356950","doc_b_id":"1285713","presented_order":["2356950","1285713"],"winner_id":"1285713","reasoning":"Document B is more relevant — it concerns cancer pharmacology (potential relevance to breast cancer outcomes), whereas A is about neural stem cells and miR-184 with no link to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323805Z"}
{"comparison_id":"f3cf834b-2103-4ced-801d-fc853eb204a7","query_id":"51","doc_a_id":"20381484","doc_b_id":"1285713","presented_order":["1285713","20381484"],"winner_id":"1285713","reasoning":"Document A is about a cancer therapeutic and its effects in vitro/in vivo, making it marginally more relevant to cancer outcomes; Document B discusses GAPDH nitrosylation unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323812Z"}
{"comparison_id":"37485409-681a-4515-9433-d965f313dab5","query_id":"51","doc_a_id":"13980338","doc_b_id":"1285713","presented_order":["1285713","13980338"],"winner_id":"13980338","reasoning":"Neither document addresses ALDH1 expression or breast cancer outcomes. Document B is slightly more relevant because it links single-cell gene expression to stem-cell function, which is conceptually closer to ALDH1 as a stem-cell marker; Document A is unrelated (drug characterization).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323819Z"}
{"comparison_id":"336c4b76-acd8-4869-89ff-fa072b31182b","query_id":"51","doc_a_id":"4378885","doc_b_id":"1285713","presented_order":["1285713","4378885"],"winner_id":"1285713","reasoning":"Document A is more relevant — it deals with cancer biology/therapy, whereas B focuses on RNA-seq in lymphoblastoid cell lines unrelated to breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323825Z"}
{"comparison_id":"d27fbf0b-aaf0-4991-8dbc-e35966207124","query_id":"51","doc_a_id":"38028419","doc_b_id":"1285713","presented_order":["1285713","38028419"],"winner_id":"1285713","reasoning":"Document A is more relevant because it concerns cancer biology/therapy, while Document B addresses alcohol-induced fatty liver disease and is unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323832Z"}
{"comparison_id":"0f8408a3-8996-43e6-ae95-0b9069bb28cc","query_id":"51","doc_a_id":"11255504","doc_b_id":"1285713","presented_order":["1285713","11255504"],"winner_id":"1285713","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it addresses cancer therapeutics broadly, while Document B is specific to liver cancer genetics. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323838Z"}
{"comparison_id":"377566f4-91f0-408e-a068-a231ae79b969","query_id":"51","doc_a_id":"4795303","doc_b_id":"1285713","presented_order":["1285713","4795303"],"winner_id":"1285713","reasoning":"Document A is cancer-related (therapeutic/biomarker context) while Document B is unrelated to cancer; neither mentions ALDH1 but A is more relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323845Z"}
{"comparison_id":"08f3c16b-8000-423b-9328-11352a5f2b24","query_id":"51","doc_a_id":"3621011","doc_b_id":"1285713","presented_order":["3621011","1285713"],"winner_id":"1285713","reasoning":"Document B is more relevant — it discusses cancer therapeutics (PI3K inhibitor) while Document A is about adipocyte differentiation and obesity, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323852Z"}
{"comparison_id":"42f64632-80ce-4d19-b9f4-2dce41f13d9a","query_id":"51","doc_a_id":"42484543","doc_b_id":"1285713","presented_order":["1285713","42484543"],"winner_id":"1285713","reasoning":"Document A is about cancer therapeutics and tumor biology, making it marginally more relevant to a claim about a cancer marker and outcomes than an embryonic stem cell transcriptome study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323859Z"}
{"comparison_id":"7026cd17-f4ee-451f-af4f-a2059c350aef","query_id":"51","doc_a_id":"9641846","doc_b_id":"1285713","presented_order":["9641846","1285713"],"winner_id":"9641846","reasoning":"Document A is more relevant — it discusses cell differentiation and cell-cycle regulation, concepts more directly related to ALDH1 (a differentiation/stemness marker) and cancer outcomes than a paper on a PI3K inhibitor's pharmacology.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323866Z"}
{"comparison_id":"ce570c71-77e0-4824-b39f-65dfe4aba5db","query_id":"51","doc_a_id":"2829179","doc_b_id":"1285713","presented_order":["1285713","2829179"],"winner_id":"1285713","reasoning":"Document A is more relevant — it concerns cancer biology/therapeutics (potentially applicable to breast cancer), while Document B is about pre-eclampsia unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323873Z"}
{"comparison_id":"2f610c3b-1623-466d-9c27-eeeeb500f7bb","query_id":"51","doc_a_id":"40901687","doc_b_id":"1285713","presented_order":["1285713","40901687"],"winner_id":"1285713","reasoning":"Document A is slightly more relevant because it addresses cancer therapeutics and outcomes broadly, whereas Document B focuses on a specific DNA damage signaling mechanism; neither mentions ALDH1 or breast cancer outcomes. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323879Z"}
{"comparison_id":"7e19e8dc-78a9-439d-9e93-ac068fc21767","query_id":"51","doc_a_id":"21602220","doc_b_id":"1285713","presented_order":["21602220","1285713"],"winner_id":"1285713","reasoning":"Document B is more related to cancer biology and potential clinical outcomes, while Document A concerns bacterial fermentation and is unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323885Z"}
{"comparison_id":"e4b9adce-06bb-40c6-8498-47501008fa81","query_id":"51","doc_a_id":"1982286","doc_b_id":"1285713","presented_order":["1982286","1285713"],"winner_id":"1285713","reasoning":"Document B is more relevant — though neither mentions ALDH1 or breast cancer, A is specific to T‑ALL/RUNX1 while B discusses cancer pharmacology more broadly, making it marginally closer to the query. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323893Z"}
{"comparison_id":"dddc8542-41ec-4862-85a3-cd6391cedf25","query_id":"51","doc_a_id":"14848619","doc_b_id":"1285713","presented_order":["1285713","14848619"],"winner_id":"1285713","reasoning":"Document A is marginally more relevant because it deals with cancer therapeutics and cancer biology, whereas Document B focuses on hypoxia-induced cell death unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:48:30.323900Z"}
{"comparison_id":"32db35d8-0edf-4e5e-ac9b-4c939e88a298","query_id":"51","doc_a_id":"23830488","doc_b_id":"41548287","presented_order":["41548287","23830488"],"winner_id":"41548287","reasoning":"Neither discusses ALDH1 or breast cancer; Document A is slightly more relevant because it addresses cancer stem cells (ALDH1 is a stem cell marker), while B concerns circadian genes in colorectal cancer.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727805Z"}
{"comparison_id":"e1bfb474-3621-4ac5-9bc7-fc93c7f65478","query_id":"51","doc_a_id":"24349992","doc_b_id":"41548287","presented_order":["41548287","24349992"],"winner_id":"41548287","reasoning":"Document A is more relevant — it discusses cancer stem cells (ALDH1 is a stem cell marker), whereas B focuses on stromal fibroblasts and metabolism, not CSC markers or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727826Z"}
{"comparison_id":"872a12ab-3e1b-445d-93dc-04398257219a","query_id":"51","doc_a_id":"9486930","doc_b_id":"41548287","presented_order":["9486930","41548287"],"winner_id":"9486930","reasoning":"Document A — it addresses a stem cell-related \"self-renewal\" signature and clinical outcomes (therapy resistance), which is more thematically related to ALDH1 as a stem-cell marker and outcome associations than Document B's pancreatic DNMT1/miRNA study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727835Z"}
{"comparison_id":"1c1a9bc9-0cd1-4efa-8ce5-d291e859fde5","query_id":"51","doc_a_id":"42731834","doc_b_id":"41548287","presented_order":["41548287","42731834"],"winner_id":"41548287","reasoning":"Reason: Document A addresses cancer stem cell biology and marker-related effects on tumorigenicity (closer to ALDH1's role as a CSC marker), whereas Document B concerns a different marker in colorectal cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727843Z"}
{"comparison_id":"2d3b688b-27d3-44ae-9427-3688c985709f","query_id":"51","doc_a_id":"25832301","doc_b_id":"41548287","presented_order":["41548287","25832301"],"winner_id":"41548287","reasoning":"Document A — it addresses cancer stem cells (ALDH1 is a stem-cell marker), so it's more related to the query than a multiple myeloma TSPAN7 study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727850Z"}
{"comparison_id":"f32e5130-c78d-46f0-8678-6f6e302a829f","query_id":"51","doc_a_id":"8037453","doc_b_id":"41548287","presented_order":["8037453","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant — it concerns cancer stem cell biology (ALDH1 is a CSC marker), whereas Document A discusses bone turnover markers unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727857Z"}
{"comparison_id":"73678ea6-cd9d-432c-8d7f-7a45d0c01955","query_id":"51","doc_a_id":"31591262","doc_b_id":"41548287","presented_order":["31591262","41548287"],"winner_id":"41548287","reasoning":"Document B — it discusses cancer stem cells and therapy-related outcomes (more related to ALDH1, a stem-cell marker) while A concerns different genes in rectal cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727863Z"}
{"comparison_id":"4c52ffdd-dfd4-4398-877c-a61a3521dbed","query_id":"51","doc_a_id":"8512633","doc_b_id":"41548287","presented_order":["41548287","8512633"],"winner_id":"41548287","reasoning":"Doc A is more related because it addresses cancer stem cell biology (where ALDH1 is a common marker) whereas Doc B concerns prostate lncRNAs unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727870Z"}
{"comparison_id":"118ea182-d3da-4f0b-9cdb-beeb99c3c665","query_id":"51","doc_a_id":"13906581","doc_b_id":"41548287","presented_order":["13906581","41548287"],"winner_id":"41548287","reasoning":"Document B — it discusses molecular regulation of cancer stem cells, which is closer to ALDH1 as a stem-cell marker in cancer than hospital teaching status. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727876Z"}
{"comparison_id":"1ae53b00-1e7d-46ab-bbb4-6c05aa2a3ad8","query_id":"51","doc_a_id":"23304931","doc_b_id":"41548287","presented_order":["23304931","41548287"],"winner_id":"23304931","reasoning":"Document A — it discusses associations between marker expression and patient outcomes (though in lymphoma rather than breast cancer), while B focuses on DNMT1 and pancreatic cancer stem cells, not marker-outcome links. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727883Z"}
{"comparison_id":"91dc9975-3d28-4a9b-8b24-5a0135ce5fd9","query_id":"51","doc_a_id":"7795952","doc_b_id":"41548287","presented_order":["41548287","7795952"],"winner_id":"41548287","reasoning":"Reason: Document A addresses cancer stem cell biology (relevant to ALDH1 as a CSC marker), while Document B focuses on fascin-mediated invasion unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727891Z"}
{"comparison_id":"bf106cb9-abf5-4f53-af1d-35bca178826b","query_id":"51","doc_a_id":"24205118","doc_b_id":"41548287","presented_order":["41548287","24205118"],"winner_id":"24205118","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it examines the prognostic significance of a marker in human cancer (though in cervical, not breast). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727898Z"}
{"comparison_id":"62a195a5-4ccb-4a45-80f7-5357fdeaa6a4","query_id":"51","doc_a_id":"19047331","doc_b_id":"41548287","presented_order":["41548287","19047331"],"winner_id":"41548287","reasoning":"Document A is more relevant — it discusses cancer stem cell biology (ALDH1 is a CSC marker), whereas Document B focuses on ovarian cancer and STAT3 unrelated to ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727905Z"}
{"comparison_id":"1dee7bfc-2ead-4559-af17-7d7a45356bf9","query_id":"51","doc_a_id":"7165938","doc_b_id":"41548287","presented_order":["7165938","41548287"],"winner_id":"41548287","reasoning":"Document B — it discusses cancer stem cells (related to ALDH1 as a CSC marker), whereas Document A is about BMAL1 in colorectal cancer and not stem-cell–related nor breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727912Z"}
{"comparison_id":"5be2de70-1f76-450b-877b-225447b8ad81","query_id":"51","doc_a_id":"2727303","doc_b_id":"41548287","presented_order":["2727303","41548287"],"winner_id":"41548287","reasoning":"Document B — it discusses cancer stem cells and outcomes (though in pancreatic cancer), which is more related to ALDH1's role as a CSC marker than Document A's HDAC6/STIM1 focus. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727919Z"}
{"comparison_id":"3888f267-4a62-49c4-8716-d0e355826839","query_id":"51","doc_a_id":"1782201","doc_b_id":"41548287","presented_order":["1782201","41548287"],"winner_id":"41548287","reasoning":"Document B. It addresses cancer stem cell biology and markers-related mechanisms (reprogramming CSCs), which is more related to ALDH1's role as a stem-cell marker than Document A's focus on integrin αvβ3 signaling in pancreatic tumor progression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727927Z"}
{"comparison_id":"bc1db89c-2ae6-4dbf-a00a-dcc5ff40fbd5","query_id":"51","doc_a_id":"39580129","doc_b_id":"41548287","presented_order":["41548287","39580129"],"winner_id":"41548287","reasoning":"Document A is slightly more relevant because it addresses cancer stem cell biology (ALDH1 is a stem cell marker), whereas Document B focuses on a miRNA prognostic marker in colorectal cancer unrelated to ALDH1 or breast cancer.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727934Z"}
{"comparison_id":"cf6f9f67-4fbc-4759-98f7-60824e75fd3e","query_id":"51","doc_a_id":"2389574","doc_b_id":"41548287","presented_order":["2389574","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant — it deals with cancer stem cell biology (closer to ALDH1's role as a CSC marker), whereas A concerns Stathmin in endometrial cancer, which is unrelated. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727941Z"}
{"comparison_id":"2ab0072d-19b5-4005-b7b0-3533f17cc101","query_id":"51","doc_a_id":"25576204","doc_b_id":"41548287","presented_order":["41548287","25576204"],"winner_id":"41548287","reasoning":"Document A is marginally more relevant because it addresses cancer stem cell biology and therapeutic outcomes (though neither document mentions ALDH1 or breast cancer specifically).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727948Z"}
{"comparison_id":"cb69737a-36f5-47f4-8c6b-05e20d4b0b95","query_id":"51","doc_a_id":"25523969","doc_b_id":"41548287","presented_order":["25523969","41548287"],"winner_id":"25523969","reasoning":"Document A is more relevant — it analyzes human metastatic cancers and uses immunohistochemistry to link molecular markers to metastasis, whereas B focuses on pancreatic cancer stem cells and not breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727955Z"}
{"comparison_id":"8c7dd789-c63f-4fa1-b6b1-2e847ed76305","query_id":"51","doc_a_id":"5774746","doc_b_id":"41548287","presented_order":["5774746","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant — it discusses cancer stem cells and factors affecting their tumorigenicity (closer conceptually to ALDH1 as a stem cell marker), whereas A focuses on inflammation/metastasis in colorectal cancer and not on ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727963Z"}
{"comparison_id":"5b1cb06f-6784-4036-82b2-fc3091145a72","query_id":"51","doc_a_id":"11271123","doc_b_id":"41548287","presented_order":["41548287","11271123"],"winner_id":"41548287","reasoning":"Neither paper addresses ALDH1 or breast cancer directly. Document A is slightly more relevant because it discusses cancer stem cells (ALDH1 is a stem-cell marker), while B focuses on endometrial genomic alterations. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727970Z"}
{"comparison_id":"125d638e-d62e-46f1-987a-bdfe0a1c2db6","query_id":"51","doc_a_id":"6790197","doc_b_id":"41548287","presented_order":["6790197","41548287"],"winner_id":"6790197","reasoning":"Document A is more relevant — it addresses tumor gene expression linked to clinical outcomes (relapse risk), which is closer to the query about expression-outcome associations than a pancreatic CSC mechanistic study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727977Z"}
{"comparison_id":"d5466612-b145-4ea2-94a7-21dd32680bd2","query_id":"51","doc_a_id":"4462079","doc_b_id":"41548287","presented_order":["4462079","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant — it addresses cancer stem cell biology (ALDH1 is a CSC marker), whereas A discusses vitamin D levels and is unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727984Z"}
{"comparison_id":"2a9d0beb-7c04-4e57-b703-511c319876ba","query_id":"51","doc_a_id":"31439189","doc_b_id":"41548287","presented_order":["41548287","31439189"],"winner_id":"31439189","reasoning":"Document B is slightly more relevant — both miss ALDH1 and breast cancer, but B examines stem-cell markers (closer in topic) while A is about DNMT1 in pancreatic cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727990Z"}
{"comparison_id":"b3ce60c0-4700-4daf-9513-f3ff17060d43","query_id":"51","doc_a_id":"13964633","doc_b_id":"41548287","presented_order":["41548287","13964633"],"winner_id":"41548287","reasoning":"Document A is slightly more relevant because it discusses cancer stem cells and tumorigenic potential, which relates conceptually to ALDH1 as a stem cell marker; Document B does not address stem cells or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.727997Z"}
{"comparison_id":"a7b717b3-963c-4d39-b384-ae9c8dac6db4","query_id":"51","doc_a_id":"21181273","doc_b_id":"41548287","presented_order":["21181273","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant — it addresses cancer stem cell biology (related to ALDH1 as a stem cell marker), whereas A concerns an unrelated enzyme in colorectal cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728004Z"}
{"comparison_id":"eb7eec1e-c51f-4095-b05f-2a24a1998b90","query_id":"51","doc_a_id":"12358173","doc_b_id":"41548287","presented_order":["41548287","12358173"],"winner_id":"41548287","reasoning":"Document A is slightly more relevant because it addresses cancer stem cell biology (ALDH1 is a stem cell marker), whereas Document B concerns angiogenesis in lung cancer and not stem-cell markers or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728011Z"}
{"comparison_id":"66a0ac10-0c9f-40b8-bd66-ed60d5eb49f6","query_id":"51","doc_a_id":"32721137","doc_b_id":"41548287","presented_order":["32721137","41548287"],"winner_id":"41548287","reasoning":"Document B — it addresses cancer stem cell biology (relevant to ALDH1 as a stem-cell marker) and outcomes, whereas A is about PI3K in endometrial cancer and not related to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728018Z"}
{"comparison_id":"b79c645d-b0ec-4195-b7bd-8940ba0685c6","query_id":"51","doc_a_id":"36212758","doc_b_id":"41548287","presented_order":["36212758","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant — it discusses cancer stem cells and factors affecting their tumorigenic potential and outcomes, which is closer to ALDH1's role as a stem-cell marker in breast cancer than Document A's NSCLC genomic profiling. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728025Z"}
{"comparison_id":"d6cc4f3e-caab-4852-b40e-714ca2ca0e08","query_id":"51","doc_a_id":"33370","doc_b_id":"41548287","presented_order":["41548287","33370"],"winner_id":"41548287","reasoning":"Document A is slightly more relevant because it discusses cancer stem cell biology and links molecular changes to patient outcomes, whereas Document B focuses on glioma stem cells and A20 without relevance to breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728033Z"}
{"comparison_id":"a6314611-64aa-4833-b47b-88946cf9e1cb","query_id":"51","doc_a_id":"39929509","doc_b_id":"41548287","presented_order":["41548287","39929509"],"winner_id":"41548287","reasoning":"Document A is slightly more relevant because it deals with cancer stem cells and tumor outcomes, which is closer to ALDH1 (a stem-cell marker) and breast cancer prognosis than the WT1/ACTN1 mRNA binding study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728039Z"}
{"comparison_id":"3ccff93a-df16-4dcc-955b-f67daab8c9a3","query_id":"51","doc_a_id":"22521091","doc_b_id":"41548287","presented_order":["22521091","41548287"],"winner_id":"41548287","reasoning":"Document B — it discusses cancer stem cells and therapeutic outcomes (though in pancreatic cancer), which is more related to ALDH1's role as a stem-cell marker than Document A's HCC/NRAGE focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728046Z"}
{"comparison_id":"89a2d08f-f74f-4950-b4f1-65a46da6fb55","query_id":"51","doc_a_id":"1032372","doc_b_id":"41548287","presented_order":["41548287","1032372"],"winner_id":"41548287","reasoning":"Document A is slightly more relevant because it discusses cancer stem cell biology (ALDH1 is a cancer stem cell marker), whereas Document B is a general review on epigenetic agents without CSC or ALDH1 focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728052Z"}
{"comparison_id":"215a33ef-293f-49f9-9200-8e1e952b84a5","query_id":"51","doc_a_id":"5386514","doc_b_id":"41548287","presented_order":["41548287","5386514"],"winner_id":"41548287","reasoning":"Document A is more relevant — it addresses cancer stem cell biology (ALDH1 is a stem-cell marker) whereas Document B focuses on inflammasome-driven immunity unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728059Z"}
{"comparison_id":"98fce5d4-e01a-4d39-a072-eabf25cf7a5d","query_id":"51","doc_a_id":"1976183","doc_b_id":"41548287","presented_order":["41548287","1976183"],"winner_id":"41548287","reasoning":"Document A — it discusses cancer stem cells and outcomes, which is more related to ALDH1 (a stem cell marker) and cancer prognosis than the oral-cancer–focused B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728066Z"}
{"comparison_id":"28ef124b-d6fc-4d8a-a580-aa24f48b6f7f","query_id":"51","doc_a_id":"25298276","doc_b_id":"41548287","presented_order":["25298276","41548287"],"winner_id":"25298276","reasoning":"Document A is slightly more relevant because it discusses therapies and outcomes related to bone metastases and survival in cancer patients, including breast cancer contexts; Document B focuses on pancreatic cancer stem cells and is unrelated to breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728073Z"}
{"comparison_id":"6ad4a9aa-c656-4914-a8a4-49e882e3d37a","query_id":"51","doc_a_id":"53211308","doc_b_id":"41548287","presented_order":["41548287","53211308"],"winner_id":"41548287","reasoning":"Document A is more relevant because it discusses cancer stem cells and markers affecting tumorigenicity, which is conceptually closer to ALDH1 as a stem-cell–associated marker in breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728080Z"}
{"comparison_id":"208ae361-b889-4031-8184-5e9eeac0e334","query_id":"51","doc_a_id":"33638477","doc_b_id":"41548287","presented_order":["41548287","33638477"],"winner_id":"41548287","reasoning":"Document A is slightly more relevant because it addresses cancer stem cell biology (ALDH1 is a CSC marker), whereas Document B focuses on BCL9 in other cancer types without CSC context. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728086Z"}
{"comparison_id":"8e1cc4be-8899-472e-bc41-5c011fa00231","query_id":"51","doc_a_id":"39758684","doc_b_id":"41548287","presented_order":["39758684","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant — it addresses cancer stem cells and therapeutic outcomes (ALDH1 is a cancer stem cell marker), whereas Document A focuses on DNA polymerase beta and chromosome instability without relation to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728094Z"}
{"comparison_id":"aa65f948-567d-4ad8-b82a-83404ae6ce60","query_id":"51","doc_a_id":"25121903","doc_b_id":"41548287","presented_order":["25121903","41548287"],"winner_id":"25121903","reasoning":"Document A — it addresses cancer survivors and breast cancer outcomes generally; Document B is about pancreatic cancer stem cells and DNMT1, not ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728101Z"}
{"comparison_id":"bd3181cf-8f3a-4705-9539-d6cde705f350","query_id":"51","doc_a_id":"21502234","doc_b_id":"41548287","presented_order":["41548287","21502234"],"winner_id":"41548287","reasoning":"Document A is more relevant — it concerns cancer stem cells (ALDH1 is a stem-cell marker), whereas Document B addresses mismatch repair in endometrial cancer not related to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728107Z"}
{"comparison_id":"8e46ee4c-5caf-468c-837e-a341ea53e71d","query_id":"51","doc_a_id":"26735905","doc_b_id":"41548287","presented_order":["26735905","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant — it addresses cancer stem cell biology (ALDH1 is a cancer stem cell marker), while A concerns stromal signaling in prostate cancer unrelated to ALDH1 or breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728114Z"}
{"comparison_id":"2373fc09-9e83-435b-a35a-8b1d9a7899e4","query_id":"51","doc_a_id":"16532419","doc_b_id":"41548287","presented_order":["16532419","41548287"],"winner_id":"16532419","reasoning":"Document A — it discusses cancer stem cell markers (more likely to mention ALDH1) while Document B focuses on DNMT1/miR-17-92 in pancreatic CSCs, which is less related to ALDH1 or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728121Z"}
{"comparison_id":"eaeebd0f-2845-4256-80db-37fe65a46186","query_id":"51","doc_a_id":"515489","doc_b_id":"41548287","presented_order":["41548287","515489"],"winner_id":"41548287","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is slightly more relevant because it addresses cancer stem cells and therapeutic outcomes (though in pancreatic cancer), while B focuses on lncRNA-driven HCC proliferation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728128Z"}
{"comparison_id":"aab3f98a-ad63-402a-bfd9-d5fefdf66539","query_id":"51","doc_a_id":"7228140","doc_b_id":"41548287","presented_order":["41548287","7228140"],"winner_id":"7228140","reasoning":"Document B is more relevant — it concerns prognostic associations of tumor subtypes (outcomes), whereas Document A is a mechanistic study in pancreatic CSCs not addressing prognostic markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728135Z"}
{"comparison_id":"5ddb02c5-af84-4dc7-9717-e4bb09f0b9b7","query_id":"51","doc_a_id":"24873253","doc_b_id":"41548287","presented_order":["24873253","41548287"],"winner_id":"41548287","reasoning":"Document B — it discusses cancer stem cell biology and markers/therapeutic targets, which is closer to ALDH1 (a CSC marker) and outcomes than a paper on bisphosphonate treatment for bone disease.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728142Z"}
{"comparison_id":"33275c9c-e863-482e-9fe7-2537e0bd9a25","query_id":"51","doc_a_id":"17755060","doc_b_id":"41548287","presented_order":["41548287","17755060"],"winner_id":"41548287","reasoning":"Document A is more relevant — it discusses cancer stem cells and factors affecting their tumorigenic potential, which relates conceptually to ALDH1 as a stem-cell marker in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728149Z"}
{"comparison_id":"403d1aaf-f4aa-4c2e-b521-d98116e3c23a","query_id":"51","doc_a_id":"3805841","doc_b_id":"41548287","presented_order":["41548287","3805841"],"winner_id":"41548287","reasoning":"Document A is slightly more relevant because it addresses cancer stem cell biology and tumorigenic potential, which relates to ALDH1 as a stem cell marker; Document B concerns MYC/circadian effects unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728155Z"}
{"comparison_id":"6ff51e75-864a-440a-91da-745f008c124f","query_id":"51","doc_a_id":"3376731","doc_b_id":"41548287","presented_order":["3376731","41548287"],"winner_id":"41548287","reasoning":"Document B is slightly more relevant because it addresses cancer stem cell biology (ALDH1 is a CSC marker), whereas Document A concerns IL6/CXCR7 in esophageal cancer unrelated to ALDH1 or breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728162Z"}
{"comparison_id":"6277fd09-6207-4746-b80d-4952d2827990","query_id":"51","doc_a_id":"21551568","doc_b_id":"41548287","presented_order":["21551568","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant — although neither mentions ALDH1 or breast cancer, B discusses cancer stem cells (ALDH1 is a CSC marker), making it marginally closer to the query.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728168Z"}
{"comparison_id":"79e73ef8-474d-4cfe-b6d7-02811171ecfe","query_id":"51","doc_a_id":"11968641","doc_b_id":"41548287","presented_order":["11968641","41548287"],"winner_id":"41548287","reasoning":"Document B — it discusses cancer stem cells (ALDH1 is a stem cell marker), so it's slightly more related to ALDH1-associated outcome than Document A, which focuses on circadian effects in non-breast cancers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728175Z"}
{"comparison_id":"7b431f93-4ac2-414f-8e8b-327e1547c377","query_id":"51","doc_a_id":"38243984","doc_b_id":"41548287","presented_order":["38243984","41548287"],"winner_id":"41548287","reasoning":"Document B. It addresses cancer stem cell biology (reprogramming CSCs), which is more related to ALDH1 as a stem-cell-associated marker than Document A's focus on engraftment and stromal pathways in pancreatic tumors.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728182Z"}
{"comparison_id":"38cf6dab-a40d-4b34-9012-9c8813384e02","query_id":"51","doc_a_id":"29806339","doc_b_id":"41548287","presented_order":["41548287","29806339"],"winner_id":"41548287","reasoning":"Document A is slightly more relevant because it discusses cancer stem cell biology (ALDH1 is a CSC marker), whereas Document B focuses on mitotic exit mechanisms unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728189Z"}
{"comparison_id":"2488e767-bb06-4643-b27c-6c5e74a083cc","query_id":"51","doc_a_id":"24974080","doc_b_id":"41548287","presented_order":["24974080","41548287"],"winner_id":"41548287","reasoning":"Document B — it discusses cancer stem cells and their regulation, which is more related to ALDH1 (a CSC marker) than VEGF/angiogenesis in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728196Z"}
{"comparison_id":"ac75cc69-a972-4b66-a6b6-35c849ca9998","query_id":"51","doc_a_id":"16806763","doc_b_id":"41548287","presented_order":["16806763","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant — it addresses cancer stem cell biology (ALDH1 is a stem-cell marker), whereas A focuses on lncRNA prognostic signature in colorectal cancer unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728203Z"}
{"comparison_id":"1b6724c9-876e-4c5a-9a0a-2182f9fad592","query_id":"51","doc_a_id":"8496132","doc_b_id":"41548287","presented_order":["8496132","41548287"],"winner_id":"8496132","reasoning":"Document A is slightly more relevant because it deals with gene expression regulation in carcinoma cells, whereas Document B focuses on pancreatic CSCs and DNMT1/miR-17-92 with no overlap with ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728210Z"}
{"comparison_id":"04a6e28b-c32e-476c-a0b2-78730316c607","query_id":"51","doc_a_id":"18987782","doc_b_id":"41548287","presented_order":["41548287","18987782"],"winner_id":"41548287","reasoning":"Document A is slightly more relevant because it addresses cancer stem cell biology (ALDH1 is a stem cell marker), whereas Document B focuses on ribosomal protein/Myc effects unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728216Z"}
{"comparison_id":"a80612a9-ffae-4b65-a595-9e09573f9596","query_id":"51","doc_a_id":"14663842","doc_b_id":"41548287","presented_order":["14663842","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant — it addresses cancer stem cells and clinical outcomes (though in pancreatic cancer), while Document A discusses IDH1 metabolic changes unrelated to ALDH1 or breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728223Z"}
{"comparison_id":"187ddce2-d463-446f-99da-3ee6d2a429ec","query_id":"51","doc_a_id":"11481946","doc_b_id":"41548287","presented_order":["11481946","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant — it addresses cancer stem cell biology (ALDH1 is a stem cell marker), whereas A concerns metabolic links to cancer and not markers or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728230Z"}
{"comparison_id":"cd5eef31-ad53-41bc-b5a9-22d5c5477c70","query_id":"51","doc_a_id":"21382907","doc_b_id":"41548287","presented_order":["21382907","41548287"],"winner_id":"41548287","reasoning":"Document B is more related because it concerns cancer stem cell biology (ALDH1 is a CSC marker), whereas Document A concerns integrin-targeting in head and neck cancer unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728237Z"}
{"comparison_id":"53f6dd9d-984e-44db-9987-d8a460ba933d","query_id":"51","doc_a_id":"13070316","doc_b_id":"41548287","presented_order":["41548287","13070316"],"winner_id":"41548287","reasoning":"Document A is more relevant — it concerns cancer stem cell biology (ALDH1 is a cancer stem cell marker), whereas Document B focuses on macrophage-driven angiogenesis unrelated to ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728244Z"}
{"comparison_id":"b4311283-c54f-4ff9-b2fd-e1cb121dfb7a","query_id":"51","doc_a_id":"9558539","doc_b_id":"41548287","presented_order":["41548287","9558539"],"winner_id":"9558539","reasoning":"Document B is more relevant — it discusses a cancer stem cell surface marker (CD44v6) linked to metastasis and outcome implications, which is closer to a claim about a stem-cell marker (ALDH1) and prognosis than a pancreatic epigenetic study. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728251Z"}
{"comparison_id":"8e5007c4-2910-403d-b63b-83538f4a2403","query_id":"51","doc_a_id":"3590806","doc_b_id":"41548287","presented_order":["41548287","3590806"],"winner_id":"41548287","reasoning":"Reason: Neither paper addresses ALDH1 or breast cancer, but Document A discusses cancer stem cells and tumor outcomes, making it slightly more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728257Z"}
{"comparison_id":"8b4c07ef-ffc9-425f-b6a4-0922f4480728","query_id":"51","doc_a_id":"4429118","doc_b_id":"41548287","presented_order":["4429118","41548287"],"winner_id":"41548287","reasoning":"Document B — it discusses cancer stem cell biology and outcomes (though in pancreatic cancer), which is more related to ALDH1's role as a stem-cell marker than the general inflammation overview in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728264Z"}
{"comparison_id":"1fdd7a97-f1f7-468e-85b4-3b75d8337b6c","query_id":"51","doc_a_id":"12337611","doc_b_id":"41548287","presented_order":["12337611","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant — it addresses cancer stem cells and outcomes (ALDH1 is a CSC marker), whereas A focuses on LIN28B in neuroblastoma unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728271Z"}
{"comparison_id":"cb8608ea-721d-4d85-92c3-a93aaf9e7ac3","query_id":"51","doc_a_id":"38485364","doc_b_id":"41548287","presented_order":["41548287","38485364"],"winner_id":"41548287","reasoning":"Reason: Both abstracts don't mention ALDH1 or breast cancer, but Document A addresses cancer stem cell biology (relevant to ALDH1 as a stem cell marker), whereas B focuses on podosome-mediated invasion machinery. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728278Z"}
{"comparison_id":"ac6dbd9c-21fc-4499-8c69-e1bcbd4b0218","query_id":"51","doc_a_id":"26561572","doc_b_id":"41548287","presented_order":["26561572","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant — it addresses cancer stem cell biology (where ALDH1 is a common marker) and mechanisms affecting stemness and outcomes; Document A covers kinase fusions in lung cancer and is unrelated.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728286Z"}
{"comparison_id":"1f202628-bd63-4851-8e32-02e4020cafc4","query_id":"51","doc_a_id":"9641846","doc_b_id":"41548287","presented_order":["9641846","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant — it addresses cancer stem cell biology (ALDH1 is a CSC marker), whereas A focuses on Rb-family and cell cycle unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728293Z"}
{"comparison_id":"3ef9ab4f-3380-45e3-840d-2678eb4cd7d9","query_id":"51","doc_a_id":"6121668","doc_b_id":"41548287","presented_order":["6121668","41548287"],"winner_id":"41548287","reasoning":"Document B — it discusses cancer stem cell biology and factors affecting tumorigenic potential, which is more conceptually related to ALDH1 (a stem cell marker) and outcomes than Document A's focus on COX-2/survivin in endometrial cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728301Z"}
{"comparison_id":"63670fe6-6cda-4350-8935-3fe43f78af60","query_id":"51","doc_a_id":"7808055","doc_b_id":"41548287","presented_order":["41548287","7808055"],"winner_id":"41548287","reasoning":"Document A is more relevant — it addresses cancer stem cells (ALDH1 is a CSC marker), whereas B covers broad DNA methylation age and not ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728309Z"}
{"comparison_id":"a691f802-2b1b-4928-8e9d-bc8f4b7d64aa","query_id":"51","doc_a_id":"13400643","doc_b_id":"41548287","presented_order":["41548287","13400643"],"winner_id":"41548287","reasoning":"Neither abstract mentions ALDH1 or breast cancer, but Document A discusses cancer stem cell biology and reprogramming (ALDH1 is a CSC marker and relevant to prognosis), making it more directly related than B's general small-molecule inhibitor study. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728316Z"}
{"comparison_id":"0f0327ea-4616-4d41-8a6f-7157695445d6","query_id":"51","doc_a_id":"4583180","doc_b_id":"41548287","presented_order":["4583180","41548287"],"winner_id":"4583180","reasoning":"DOCUMENT A is more relevant — it links gene expression to patient survival outcomes in cancer (even though not breast-specific), while DOCUMENT B focuses on pancreatic CSCs and DNMT1, not breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728324Z"}
{"comparison_id":"0236eb5e-cb0c-4570-a6d2-3b3e4b5690a9","query_id":"51","doc_a_id":"14315749","doc_b_id":"41548287","presented_order":["41548287","14315749"],"winner_id":"41548287","reasoning":"Document A is marginally more relevant: it addresses cancer stem cell biology (which relates to ALDH1 as a CSC marker), whereas B deals with a circadian gene in colorectal cancer unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728331Z"}
{"comparison_id":"86b06150-beac-4b03-87fd-a1da936dcb65","query_id":"51","doc_a_id":"29473081","doc_b_id":"41548287","presented_order":["41548287","29473081"],"winner_id":"41548287","reasoning":"Document A is slightly more relevant because it discusses cancer stem cells and factors affecting tumorigenicity, which is closer to ALDH1's role as a stem-cell marker; Document B is about sialylation in multiple myeloma unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728339Z"}
{"comparison_id":"f87e73e1-0788-42b1-9c9a-098a1ae1ba13","query_id":"51","doc_a_id":"22914228","doc_b_id":"41548287","presented_order":["41548287","22914228"],"winner_id":"41548287","reasoning":"Document A is more relevant — it addresses cancer stem cell biology (where ALDH1 is a common marker) and mechanisms affecting CSC behavior, whereas B focuses on metabolic proteomics unrelated to ALDH1 or breast cancer outcomes.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728345Z"}
{"comparison_id":"4714cb97-5062-4f3a-bebd-1068112eaeb6","query_id":"51","doc_a_id":"654735","doc_b_id":"41548287","presented_order":["654735","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant — it addresses cancer stem cell biology and outcome-related reprogramming (closer to ALDH1's role as a stem-cell marker) while A is about glioma miR-21 in CSF and unrelated to breast/ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728352Z"}
{"comparison_id":"559a9156-4043-4564-bcab-6dfb1d814288","query_id":"51","doc_a_id":"22901758","doc_b_id":"41548287","presented_order":["22901758","41548287"],"winner_id":"41548287","reasoning":"Document B — it concerns cancer stem cell biology and factors affecting tumorigenicity/outcomes, which is more related to ALDH1 as a CSC marker than a glioblastoma signaling study. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728359Z"}
{"comparison_id":"d1e688a2-39e4-4a12-8366-c8107949cfd1","query_id":"51","doc_a_id":"21521236","doc_b_id":"41548287","presented_order":["41548287","21521236"],"winner_id":"41548287","reasoning":"Document A is slightly more relevant because it deals with cancer stem cells and pathways (which relate to markers like ALDH1), whereas Document B focuses on NEAT1 and replication stress without connection to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728366Z"}
{"comparison_id":"5b086fa5-111b-47f5-940b-5692dc057ce3","query_id":"51","doc_a_id":"23576165","doc_b_id":"41548287","presented_order":["23576165","41548287"],"winner_id":"41548287","reasoning":"Document B — it addresses cancer stem cell biology and therapeutic outcomes (though in pancreatic cancer), which is more related to ALDH1 as a CSC marker than the general tumor metabolism topic in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728373Z"}
{"comparison_id":"457f9115-221e-4834-86db-0536daebbce9","query_id":"51","doc_a_id":"37204802","doc_b_id":"41548287","presented_order":["41548287","37204802"],"winner_id":"41548287","reasoning":"Document A — it discusses cancer stem cells and treatment effects on tumorigenic potential (closer to ALDH1 as a stem-cell marker), whereas B focuses on JMJD6/p53 in colon cancer; neither directly addresses ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728380Z"}
{"comparison_id":"5014c5ad-0a49-4d98-a753-fdb2aed42e9e","query_id":"51","doc_a_id":"10165723","doc_b_id":"41548287","presented_order":["41548287","10165723"],"winner_id":"41548287","reasoning":"Document A is more relevant — it addresses cancer stem cell biology (ALDH1 is a stem cell marker), whereas B focuses on methylation in melanoma unrelated to ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728387Z"}
{"comparison_id":"08fe8ba4-aec9-422d-b7f3-923c1748b4ba","query_id":"51","doc_a_id":"22049489","doc_b_id":"41548287","presented_order":["41548287","22049489"],"winner_id":"41548287","reasoning":"Document A is more relevant — it addresses cancer stem cells and therapeutic outcomes (closer to ALDH1's role as a stem-cell/prognostic marker) while B focuses on gastric cancer proliferation via miR-675/RUNX1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728394Z"}
{"comparison_id":"a2b02fc0-3462-4f4d-9277-19cf5ceb4640","query_id":"51","doc_a_id":"3730196","doc_b_id":"41548287","presented_order":["41548287","3730196"],"winner_id":"41548287","reasoning":"Document A — it addresses cancer stem cell biology (where ALDH1 is a common marker) while Document B focuses on lncRNA-driven chemoresistance in small cell lung cancer, unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728401Z"}
{"comparison_id":"cd40cd73-a276-42d0-9e2a-41d85996a47d","query_id":"51","doc_a_id":"6650933","doc_b_id":"41548287","presented_order":["41548287","6650933"],"winner_id":"41548287","reasoning":"Document A is more relevant — it addresses cancer stem cell biology (where ALDH1 is a common marker) and therapy-related outcomes, whereas Document B discusses EGCG oxidative effects unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728407Z"}
{"comparison_id":"1a379475-1fe8-4011-ad4d-378e7746fd92","query_id":"51","doc_a_id":"9791313","doc_b_id":"41548287","presented_order":["9791313","41548287"],"winner_id":"41548287","reasoning":"Neither document discusses ALDH1 or breast cancer directly. Document B is slightly more relevant because it addresses cancer stem cells (ALDH1 is a stem-cell marker), whereas A focuses on SETD2 and renal cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728414Z"}
{"comparison_id":"abacb8c8-87e8-4367-ba58-4fc7ab62ffa0","query_id":"51","doc_a_id":"38009906","doc_b_id":"41548287","presented_order":["41548287","38009906"],"winner_id":"41548287","reasoning":"Document A is slightly more relevant because it addresses cancer stem cell biology (ALDH1 is a stem cell marker), whereas B focuses on polycomb-mediated silencing unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728421Z"}
{"comparison_id":"c0c75b7a-4a10-4160-b11a-3e385dc78e5e","query_id":"51","doc_a_id":"35993767","doc_b_id":"41548287","presented_order":["35993767","41548287"],"winner_id":"41548287","reasoning":"Reason: Both abstracts are unrelated to ALDH1 or breast cancer, but B discusses cancer stem cells (ALDH1 is a CSC marker), so it's slightly more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728428Z"}
{"comparison_id":"99b8cb09-b61d-47c4-80eb-30d3e683c797","query_id":"51","doc_a_id":"1686997","doc_b_id":"41548287","presented_order":["1686997","41548287"],"winner_id":"41548287","reasoning":"Document B is slightly more relevant because it addresses cancer stem cell biology (ALDH1 is a CSC marker), whereas Document A focuses on metabolic enzyme 6PGD unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728435Z"}
{"comparison_id":"66966850-ef8f-4476-ad3e-d917c78ccaf9","query_id":"51","doc_a_id":"3756384","doc_b_id":"41548287","presented_order":["3756384","41548287"],"winner_id":"3756384","reasoning":"Document A — it discusses a cancer stem cell-like gene signature and its association with prognosis (though in hepatocellular carcinoma), which is more directly related to ALDH1 as a stem cell marker and outcome than the pancreatic DNMT1 study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728442Z"}
{"comparison_id":"52a55995-7edb-426a-b907-04617bc64f3b","query_id":"51","doc_a_id":"27647593","doc_b_id":"41548287","presented_order":["41548287","27647593"],"winner_id":"41548287","reasoning":"Document A is more relevant — it addresses cancer stem cells (ALDH1 is a CSC marker), whereas B focuses on stromal–epithelial metabolism, not stem cell markers or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728449Z"}
{"comparison_id":"a48347d0-ca6e-4fed-a2ba-40fe9b3e913d","query_id":"51","doc_a_id":"13205096","doc_b_id":"41548287","presented_order":["13205096","41548287"],"winner_id":"41548287","reasoning":"Reason: Both do not address ALDH1 in breast cancer, but Document B deals with cancer stem cell biology (more conceptually related to ALDH1 as a stem-cell marker) while Document A is about AML gene-expression profiling.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728456Z"}
{"comparison_id":"35e6e7ef-8fab-43df-86a1-1f83999c5315","query_id":"51","doc_a_id":"26231129","doc_b_id":"41548287","presented_order":["41548287","26231129"],"winner_id":"41548287","reasoning":"Document A is slightly more relevant because it addresses cancer stem cell biology (ALDH1 is a CSC marker), whereas Document B is a broad framework on residual disease and not specific to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728463Z"}
{"comparison_id":"49a36226-10c4-4b0a-9a9c-bb82442cb2f6","query_id":"51","doc_a_id":"33387953","doc_b_id":"41548287","presented_order":["33387953","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant because it addresses cancer stem cell biology (ALDH1 is a stem cell marker), whereas Document A discusses G protein beta mutations unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728469Z"}
{"comparison_id":"85034821-d042-437c-a460-d6075ebac7cc","query_id":"51","doc_a_id":"12685434","doc_b_id":"41548287","presented_order":["12685434","41548287"],"winner_id":"41548287","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is marginally more relevant because it deals with cancer stem cell biology and marker-related reprogramming, which is closer to ALDH1’s role as a stem cell marker.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728476Z"}
{"comparison_id":"a0820194-f651-45f8-b493-69dae71dc1ab","query_id":"51","doc_a_id":"31803596","doc_b_id":"41548287","presented_order":["41548287","31803596"],"winner_id":"41548287","reasoning":"Document A is more relevant — it discusses cancer stem cell biology (ALDH1 is a CSC marker), whereas Document B focuses on oral squamous carcinoma gene profiling with no CSC or ALDH1 link.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728483Z"}
{"comparison_id":"cccf4b1b-f0a6-4ac9-a532-619d0601e30c","query_id":"51","doc_a_id":"864491","doc_b_id":"41548287","presented_order":["41548287","864491"],"winner_id":"41548287","reasoning":"Document A — it investigates cancer stem cell biology (ALDH1 is a cancer stem cell marker), so it's more related to ALDH1/breast‑cancer outcome connections than B, which focuses on CDK4/6 inhibition. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728490Z"}
{"comparison_id":"66492dce-6b18-48aa-9219-e218e29f7030","query_id":"51","doc_a_id":"18358026","doc_b_id":"41548287","presented_order":["18358026","41548287"],"winner_id":"41548287","reasoning":"Document B — it discusses cancer stem cells and factors affecting their tumorigenic potential, which is more directly related to ALDH1 (a stem cell marker) and outcomes than Document A's mechanistic methylation study. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728497Z"}
{"comparison_id":"9a646f56-95f8-4ade-b937-cf933949dd2f","query_id":"51","doc_a_id":"4467129","doc_b_id":"41548287","presented_order":["4467129","41548287"],"winner_id":"41548287","reasoning":"Document B — it deals with cancer stem cells and outcomes (though in pancreatic cancer), which is marginally more related to ALDH1's role as a CSC marker than the neuroblastoma-focused study in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728504Z"}
{"comparison_id":"e476a3bd-f2bb-4d26-9e6a-1b964727aed5","query_id":"51","doc_a_id":"3858268","doc_b_id":"41548287","presented_order":["3858268","41548287"],"winner_id":"41548287","reasoning":"Both documents are about cancer stem cells but neither mentions ALDH1 or breast cancer. Document B is slightly more relevant because it links CSC reprogramming to changes in tumorigenic potential and patient outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728510Z"}
{"comparison_id":"02720486-d4a8-47c3-93f0-8499a038c978","query_id":"51","doc_a_id":"8538916","doc_b_id":"41548287","presented_order":["41548287","8538916"],"winner_id":"41548287","reasoning":"Reason: Document A addresses cancer stem cells (ALDH1 is a stem-cell marker often used in breast cancer), so it's marginally more relevant than Document B, which focuses on a chaperonin unrelated to ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728517Z"}
{"comparison_id":"f724cf4e-49a0-490b-9720-72c8bc296b73","query_id":"51","doc_a_id":"11578459","doc_b_id":"41548287","presented_order":["11578459","41548287"],"winner_id":"41548287","reasoning":"Document B — it addresses cancer stem cell biology (ALDH1 is a stem-cell marker), whereas A focuses on a glioblastoma-specific HOX signature unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728524Z"}
{"comparison_id":"32488b74-d239-4bbb-9b11-bf16775ea50c","query_id":"51","doc_a_id":"13889430","doc_b_id":"41548287","presented_order":["13889430","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant — it addresses cancer stem cell biology (ALDH1 is a CSC marker), whereas A focuses on exosome-driven fibroblast differentiation unrelated to ALDH1 or breast outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728531Z"}
{"comparison_id":"11a56433-ac55-4855-813f-28c3c5c119bf","query_id":"51","doc_a_id":"5254463","doc_b_id":"41548287","presented_order":["41548287","5254463"],"winner_id":"41548287","reasoning":"Document A is more relevant — it addresses cancer stem cells (though in pancreatic cancer), which is closer to ALDH1's role as a stem cell marker than B's focus on intestinal Wip1/p53. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728538Z"}
{"comparison_id":"61b579f1-00f8-416f-94ee-df5166b5ac58","query_id":"51","doc_a_id":"15727984","doc_b_id":"41548287","presented_order":["41548287","15727984"],"winner_id":"41548287","reasoning":"Document A is more relevant — it addresses cancer stem cell biology (where ALDH1 is a common marker), whereas B focuses on lung cancer stromal secreted proteins unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728546Z"}
{"comparison_id":"28db1a90-66f4-4eb8-a6d7-c1cc0dc605bc","query_id":"51","doc_a_id":"7975937","doc_b_id":"41548287","presented_order":["41548287","7975937"],"winner_id":"41548287","reasoning":"Document A is more relevant — it addresses cancer stem cell biology (where ALDH1 is a common marker) whereas Document B focuses on COX-driven immune evasion unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728554Z"}
{"comparison_id":"03d33d75-0bf7-47be-af22-1008b6d40d09","query_id":"51","doc_a_id":"10365787","doc_b_id":"41548287","presented_order":["10365787","41548287"],"winner_id":"41548287","reasoning":"Document B — it discusses cancer stem cell biology (ALDH1 is a CSC marker), so it's more related than a paper on APC/C cofactor Cdh1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728562Z"}
{"comparison_id":"cb643e5c-c8fe-4094-905f-4d4809c47240","query_id":"51","doc_a_id":"4325398","doc_b_id":"41548287","presented_order":["41548287","4325398"],"winner_id":"41548287","reasoning":"Reason: Document A discusses cancer stem cell biology and therapeutic impact on tumorigenic potential (conceptually related to ALDH1 as a CSC marker), whereas Document B focuses on genomic aberrations unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728570Z"}
{"comparison_id":"d03ae660-caca-4f01-b0e2-ceaa282c8cb3","query_id":"51","doc_a_id":"17717391","doc_b_id":"41548287","presented_order":["17717391","41548287"],"winner_id":"41548287","reasoning":"Document B — it discusses cancer stem cell biology and tumorigenicity (more related to ALDH1 as a CSC marker) whereas A focuses on p16 and aging, not ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728578Z"}
{"comparison_id":"6c66ed42-2d37-4492-b748-d5bd60b10741","query_id":"51","doc_a_id":"2374637","doc_b_id":"41548287","presented_order":["41548287","2374637"],"winner_id":"41548287","reasoning":"Document A is more related because it addresses cancer stem cell biology (where ALDH1 is a common marker) and tumor outcomes, whereas B is a general methodological paper.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728585Z"}
{"comparison_id":"5f3a74e9-6067-48e6-a5c2-412268c2795b","query_id":"51","doc_a_id":"24294572","doc_b_id":"41548287","presented_order":["24294572","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant — it addresses cancer stem cell biology (ALDH1 is a cancer stem cell marker), whereas A focuses on PTEN/PI lipid signaling unrelated to ALDH1 or breast outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728596Z"}
{"comparison_id":"200e2b7c-7b7b-4702-b416-0e86babeaf34","query_id":"51","doc_a_id":"1727493","doc_b_id":"41548287","presented_order":["1727493","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant — it addresses cancer stem cell biology, which is closely related to ALDH1 as a stem-cell marker, whereas Document A concerns miR-21–mediated drug resistance in ovarian cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728603Z"}
{"comparison_id":"895dd9e3-ae01-4fe9-b076-28cea6a8bdbe","query_id":"51","doc_a_id":"16364639","doc_b_id":"41548287","presented_order":["41548287","16364639"],"winner_id":"41548287","reasoning":"Document A is more relevant — it discusses cancer stem cells and therapeutic outcomes (though in pancreatic cancer), whereas B is about miRNA networks in glioblastoma and unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728611Z"}
{"comparison_id":"cfc467f0-d0b3-4f98-8b43-c37eb5509093","query_id":"51","doc_a_id":"952111","doc_b_id":"41548287","presented_order":["952111","41548287"],"winner_id":"952111","reasoning":"Document A is more relevant — it discusses tumor microenvironment and cancer cell interactions broadly (more likely to pertain to markers and outcomes in breast cancer), while Document B focuses on pancreatic CSCs and DNMT1, not ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728618Z"}
{"comparison_id":"1a7ee946-fedd-4de1-8b6c-78fa1f1fafe5","query_id":"51","doc_a_id":"1649738","doc_b_id":"41548287","presented_order":["1649738","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant because it addresses cancer stem cell biology and factors that alter stemness/tumorigenicity (ALDH1 is a CSC marker), whereas Document A concerns genetic risk for therapy-induced second malignancies after Hodgkin's lymphoma. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728627Z"}
{"comparison_id":"7bcda2da-783f-4f74-9fe1-ba405857f116","query_id":"51","doc_a_id":"14019636","doc_b_id":"41548287","presented_order":["41548287","14019636"],"winner_id":"41548287","reasoning":"Document A is slightly more relevant because it addresses cancer stem cell biology (ALDH1 is a CSC marker), whereas Document B discusses ribosomal DNA copy number unrelated to ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728634Z"}
{"comparison_id":"2c463e85-f4f8-4571-9103-b125173734a1","query_id":"51","doc_a_id":"14768471","doc_b_id":"41548287","presented_order":["14768471","41548287"],"winner_id":"14768471","reasoning":"Document A is slightly more relevant because it discusses cancer stem cells and tumor outcomes (though in renal cancer), while Document B focuses on DNMT1 and pancreatic CSCs unrelated to ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728641Z"}
{"comparison_id":"bd3e1ccb-5409-4bfb-a803-7f1b2fab02fb","query_id":"51","doc_a_id":"19408393","doc_b_id":"41548287","presented_order":["19408393","41548287"],"winner_id":"41548287","reasoning":"Document B — it concerns cancer stem cell biology (though in pancreatic cancer), which is more related to ALDH1 as a stem-cell marker than a paper about whole-brain re-irradiation. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728649Z"}
{"comparison_id":"f3b9ade1-5325-4f81-bcf1-55b85ecf839f","query_id":"51","doc_a_id":"2613411","doc_b_id":"41548287","presented_order":["41548287","2613411"],"winner_id":"41548287","reasoning":"Document A is slightly more relevant because it addresses cancer stem cell biology (ALDH1 is a CSC marker), whereas Document B focuses on CDKs and the cell cycle without relation to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728656Z"}
{"comparison_id":"b5612c02-28e6-49a5-84c0-0cf72863d39e","query_id":"51","doc_a_id":"19644821","doc_b_id":"41548287","presented_order":["19644821","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant — although neither mentions ALDH1 or breast cancer, B deals with cancer stem cells and outcomes/therapy, which is closer to ALDH1's role as a stem-cell marker than A's focus on Lin28b in liver cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728664Z"}
{"comparison_id":"291fa261-3f39-4d13-9e3b-7eefd4d13cdd","query_id":"51","doc_a_id":"32742683","doc_b_id":"41548287","presented_order":["32742683","41548287"],"winner_id":"32742683","reasoning":"Document A is more relevant — it discusses tumor microenvironment and cancer biology (more likely to include breast cancer context), whereas Document B is specific to pancreatic cancer stem cells and unrelated to ALDH1 in breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728671Z"}
{"comparison_id":"8d032ce4-2cc6-478c-9575-738af2955411","query_id":"51","doc_a_id":"20501163","doc_b_id":"41548287","presented_order":["41548287","20501163"],"winner_id":"41548287","reasoning":"Document A is more relevant — it addresses cancer stem cell biology and treatment-related outcomes (though in pancreatic cancer), which is closer to ALDH1 (a stem cell marker) associations than Document B's focus on IL-6–driven metabolism and immune suppression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728680Z"}
{"comparison_id":"e83f93c3-67f7-438d-8895-04d5b2d6c663","query_id":"51","doc_a_id":"8994465","doc_b_id":"41548287","presented_order":["8994465","41548287"],"winner_id":"41548287","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer; Document B is marginally more relevant because it addresses cancer stem cells and therapy-related outcomes, which is conceptually closer to ALDH1's role as a CSC marker.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728687Z"}
{"comparison_id":"69ac10d1-7555-488c-86c4-1eb5d5ea0366","query_id":"51","doc_a_id":"31624828","doc_b_id":"41548287","presented_order":["41548287","31624828"],"winner_id":"41548287","reasoning":"Reason: Document A discusses cancer stem cell biology and therapeutic outcomes (though in pancreatic cancer), which is closer to ALDH1 as a CSC marker and outcome associations than Document B's focus on p53-mediated apoptotic cell clearance.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728695Z"}
{"comparison_id":"9775f922-4959-4df0-828c-a57a670441a3","query_id":"51","doc_a_id":"23887844","doc_b_id":"41548287","presented_order":["41548287","23887844"],"winner_id":"41548287","reasoning":"Document A is more relevant — it deals with cancer stem cell biology and tumorigenic potential, which is closer to ALDH1 (a stem cell marker) and clinical outcomes than a metabolic/apoptosis mechanism in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728703Z"}
{"comparison_id":"5af74718-8de7-460c-80db-82fa5b1111e3","query_id":"51","doc_a_id":"6828370","doc_b_id":"41548287","presented_order":["6828370","41548287"],"winner_id":"41548287","reasoning":"Document B. It addresses cancer stem cell biology (relevant to ALDH1 as a CSC marker), whereas A discusses mRNA/pseudogene regulatory roles not specific to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728710Z"}
{"comparison_id":"9f2a3bee-c22b-4a08-8c38-2702ce48564b","query_id":"51","doc_a_id":"12737132","doc_b_id":"41548287","presented_order":["12737132","41548287"],"winner_id":"12737132","reasoning":"Document A is slightly more relevant — it discusses cancer-related gene expression and pathways (oncogenic transformation/EMT) broadly, whereas Document B is specific to pancreatic CSCs and DNMT1, not ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728737Z"}
{"comparison_id":"d74476a7-acba-4149-819d-acc80ad7fe1c","query_id":"51","doc_a_id":"20179918","doc_b_id":"41548287","presented_order":["20179918","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant — it addresses cancer stem cells and tumorigenic outcomes (though in pancreas), whereas A focuses on embryonic stem cell transcriptional regulation, not cancer/ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728749Z"}
{"comparison_id":"33ed4902-3962-4454-8682-bc051e28259a","query_id":"51","doc_a_id":"756887","doc_b_id":"41548287","presented_order":["41548287","756887"],"winner_id":"756887","reasoning":"Document B is more relevant — it mentions breast cancer (screening/outcomes context), while A focuses on pancreatic cancer stem cells and DNMT1, not breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728758Z"}
{"comparison_id":"e71288fd-1962-458d-9609-e48ac2419058","query_id":"51","doc_a_id":"36547290","doc_b_id":"41548287","presented_order":["36547290","41548287"],"winner_id":"41548287","reasoning":"Document B is slightly more relevant because it deals with cancer stem cells and markers related to tumor outcomes, whereas Document A focuses on BRG1/STAT3 chromatin regulation unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728766Z"}
{"comparison_id":"fab2655b-fc8c-4664-9bdd-a0966524f56d","query_id":"51","doc_a_id":"12152977","doc_b_id":"41548287","presented_order":["12152977","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant because it addresses cancer stem cells (CSCs), which is related to ALDH1 as a CSC marker, whereas Document A focuses on embryonic stem cell pluripotency unrelated to breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728774Z"}
{"comparison_id":"1bf0b669-549a-4604-8b86-d3f33d28b809","query_id":"51","doc_a_id":"17412260","doc_b_id":"41548287","presented_order":["41548287","17412260"],"winner_id":"41548287","reasoning":"Document A is more relevant — it discusses cancer stem cells and factors affecting their tumorigenicity, which is closer to ALDH1 (a stem cell marker) and clinical outcomes than the senescence/SASP focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728782Z"}
{"comparison_id":"ec24a17b-e1bf-41a2-be6e-ab2b3e026bc2","query_id":"51","doc_a_id":"1791714","doc_b_id":"41548287","presented_order":["41548287","1791714"],"winner_id":"41548287","reasoning":"Document A — it discusses cancer stem cell biology (though in pancreatic cancer), which is closer to ALDH1 as a stem-cell marker than the EMT/squamous-cell focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728789Z"}
{"comparison_id":"fca171b0-a1be-43a5-a59b-c48e8e40429f","query_id":"51","doc_a_id":"2485101","doc_b_id":"41548287","presented_order":["2485101","41548287"],"winner_id":"41548287","reasoning":"Document B — it discusses cancer stem cells and therapy-related outcomes, which is more related to ALDH1's role in cancer than the eQTL/GWAS methods in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728796Z"}
{"comparison_id":"311e5abd-05ed-4365-aeb1-bf8baf9e3998","query_id":"51","doc_a_id":"25748308","doc_b_id":"41548287","presented_order":["25748308","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant — it discusses cancer stem cells and outcomes (though in pancreatic cancer), which is more closely related to ALDH1's role as a stem-cell marker than a GAPDH-focused review. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728804Z"}
{"comparison_id":"bf530ee5-b0e7-44cf-ad03-99b3202e9d6f","query_id":"51","doc_a_id":"7225911","doc_b_id":"41548287","presented_order":["7225911","41548287"],"winner_id":"7225911","reasoning":"Document A is marginally more relevant because it concerns cancer-related gene regulation (p53) in human cells, whereas Document B focuses specifically on pancreatic cancer and DNMT1 without relation to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728812Z"}
{"comparison_id":"17147a73-9dd6-4467-975b-a3d3696527c3","query_id":"51","doc_a_id":"13980338","doc_b_id":"41548287","presented_order":["13980338","41548287"],"winner_id":"41548287","reasoning":"Document B is more relevant — it addresses cancer stem cell biology and outcome-related mechanisms (though in pancreatic cancer), while A concerns hematopoietic stem cell methods and not ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:04.728819Z"}
{"comparison_id":"3b0d1e11-db1e-4c9f-a7f0-ed07443c3e0e","query_id":"51","doc_a_id":"9486930","doc_b_id":"7228140","presented_order":["9486930","7228140"],"winner_id":"9486930","reasoning":"Document A is more relevant — it discusses a stem cell-related \"self-renewal\" signature, which is conceptually related to ALDH1 as a stem cell marker, whereas Document B focuses on PDAC subtypes and stroma with no stem-cell link. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:33.415306Z"}
{"comparison_id":"30593dc9-a79a-42c2-904f-2bfe793511cf","query_id":"51","doc_a_id":"23304931","doc_b_id":"7228140","presented_order":["7228140","23304931"],"winner_id":"23304931","reasoning":"Document B is more relevant — it examines associations between immunophenotypic marker expression and patient outcomes, which is conceptually closer to a claim about ALDH1 expression and breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:33.415328Z"}
{"comparison_id":"8851f42b-c732-4d87-a2b0-8258c9c59fa4","query_id":"51","doc_a_id":"24205118","doc_b_id":"7228140","presented_order":["7228140","24205118"],"winner_id":"24205118","reasoning":"Document B — it examines the prognostic significance of a specific molecular marker's expression in cancer, which is more analogous to a claim about ALDH1 expression and outcomes than Document A's PDAC subtype analysis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:33.415337Z"}
{"comparison_id":"acb0c107-829e-46bc-ac81-087b59005297","query_id":"51","doc_a_id":"25523969","doc_b_id":"7228140","presented_order":["25523969","7228140"],"winner_id":"25523969","reasoning":"Document A — it examines gene/marker expression in metastatic cancers (using qRT-PCR and IHC), which is closer to evaluating a marker like ALDH1 in cancer outcomes than Document B's focus on pancreatic tumor/stroma subtypes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:33.415344Z"}
{"comparison_id":"fdf83beb-411a-4d93-a127-b01ea402a2e1","query_id":"51","doc_a_id":"6790197","doc_b_id":"7228140","presented_order":["6790197","7228140"],"winner_id":"7228140","reasoning":"Document B is more relevant — it deals with tumor gene-expression subtypes that are independently prognostic (relating expression patterns to outcomes), whereas A focuses on prostate-specific biopsy findings unrelated to breast cancer markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:33.415352Z"}
{"comparison_id":"cc9a0543-13d0-4896-9be2-a3b32a221e38","query_id":"51","doc_a_id":"31439189","doc_b_id":"7228140","presented_order":["7228140","31439189"],"winner_id":"31439189","reasoning":"Reason: Document B addresses stem-cell markers and their association with cancer cell behavior (marker–outcome relevance), which is more conceptually related to ALDH1 as a stem-cell marker than Document A's pancreatic subtype/prognosis study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:33.415360Z"}
{"comparison_id":"383cf569-c799-4d77-a34b-a4879dbc00e4","query_id":"51","doc_a_id":"25298276","doc_b_id":"7228140","presented_order":["25298276","7228140"],"winner_id":"25298276","reasoning":"Document A is slightly more relevant because it concerns cancer treatment and outcomes (including prevention of bone metastases) which could relate to breast cancer prognosis; Document B focuses on pancreatic cancer subtypes. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:33.415368Z"}
{"comparison_id":"04486433-98b2-42c5-b740-c5878fd5299d","query_id":"51","doc_a_id":"25121903","doc_b_id":"7228140","presented_order":["25121903","7228140"],"winner_id":"25121903","reasoning":"Document A is more relevant — it covers cancer survivorship and outcomes including breast cancer at a population level, whereas Document B focuses on pancreatic cancer subtypes, not breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:33.415376Z"}
{"comparison_id":"e4e454ee-6f84-44a3-b471-dfc27696529d","query_id":"51","doc_a_id":"16532419","doc_b_id":"7228140","presented_order":["16532419","7228140"],"winner_id":"16532419","reasoning":"Document A is more relevant — it discusses induction and identification of cancer stem cell markers (which commonly include ALDH1), whereas Document B focuses on pancreatic tumor/stroma subtypes unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:33.415383Z"}
{"comparison_id":"cd11e414-72d3-4892-9fb6-5329f3bb5de7","query_id":"51","doc_a_id":"7225911","doc_b_id":"7228140","presented_order":["7225911","7228140"],"winner_id":"7228140","reasoning":"Document B is more relevant — it deals with cancer prognostic subtypes and outcomes (although in pancreatic cancer), whereas Document A is about lncRNA-RoR/p53 regulation and not prognosis. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:33.415391Z"}
{"comparison_id":"9ed61d13-be70-43ed-9d96-b0e37f836d3b","query_id":"51","doc_a_id":"8496132","doc_b_id":"7228140","presented_order":["7228140","8496132"],"winner_id":"7228140","reasoning":"Document A is more relevant — it addresses tumor subtypes and prognosis associations (clinical outcomes), whereas Document B focuses on molecular regulation of bcl-2 in non-breast cell lines. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:33.415398Z"}
{"comparison_id":"9b0767b1-9a10-46ff-be45-0788153cd2e0","query_id":"51","doc_a_id":"9558539","doc_b_id":"7228140","presented_order":["9558539","7228140"],"winner_id":"9558539","reasoning":"Document A is slightly more relevant — it discusses a cancer stem cell marker (CD44v6), which is conceptually closer to ALDH1 as a stem-cell–associated marker; neither document mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:33.415405Z"}
{"comparison_id":"9b58046a-63cf-41a3-bec3-b57f7f2ab733","query_id":"51","doc_a_id":"4583180","doc_b_id":"7228140","presented_order":["7228140","4583180"],"winner_id":"7228140","reasoning":"Document A — it discusses tumor/stroma expression patterns and prognosis (more related to marker–outcome associations) while B focuses on SREBP2/cholesterol and tumor progression, not marker expression linked to outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:33.415412Z"}
{"comparison_id":"c47e98ae-876d-4a82-84db-5083b2189414","query_id":"51","doc_a_id":"3756384","doc_b_id":"7228140","presented_order":["7228140","3756384"],"winner_id":"3756384","reasoning":"Reason: Document B discusses a cancer stem cell–like gene signature and prognosis, which is more directly related to ALDH1 (a stem cell marker) and prognostic associations than Document A, which focuses on pancreatic tumor/stroma subtypes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:33.415419Z"}
{"comparison_id":"182226b5-5469-415c-b87b-424b249ec4fc","query_id":"51","doc_a_id":"952111","doc_b_id":"7228140","presented_order":["7228140","952111"],"winner_id":"952111","reasoning":"Document B is more general to tumor biology and could cover markers and breast cancer context; Document A focuses on pancreatic cancer subtypes (not breast). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:33.415426Z"}
{"comparison_id":"4f237f6d-10a9-42be-98ba-684e7f5b609c","query_id":"51","doc_a_id":"14768471","doc_b_id":"7228140","presented_order":["7228140","14768471"],"winner_id":"14768471","reasoning":"Document B — it concerns cancer stem cells (ALDH1 is a stem-cell marker) and tumor behavior, which is more related to ALDH1's prognostic implications than a pancreatic subtype study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:33.415434Z"}
{"comparison_id":"188e2a66-2ff2-4215-b36c-e3d4fe08e8c2","query_id":"51","doc_a_id":"32742683","doc_b_id":"7228140","presented_order":["7228140","32742683"],"winner_id":"32742683","reasoning":"Document B is more relevant — it discusses tumor microenvironment and factors (CAFs) that can influence cancer markers and outcomes across cancers, whereas A focuses on pancreatic cancer subtypes, not breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:33.415441Z"}
{"comparison_id":"a1fbd86c-b71f-4ae4-8f1f-793ccf320a3d","query_id":"51","doc_a_id":"12737132","doc_b_id":"7228140","presented_order":["7228140","12737132"],"winner_id":"7228140","reasoning":"Document A is more relevant — it discusses cancer subtype expression profiles and prognostic associations (though in pancreatic cancer), which is closer to a claim about marker expression and outcomes than Document B's molecular/TEAD–YAP focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:33.415449Z"}
{"comparison_id":"c22e80a3-85ec-452f-abd5-ff9baca3ac34","query_id":"51","doc_a_id":"756887","doc_b_id":"7228140","presented_order":["756887","7228140"],"winner_id":"7228140","reasoning":"Document B is more relevant — it deals with tumor gene expression subtypes and their prognostic associations (though in pancreatic cancer), which is closer to a claim about marker expression and outcomes than Document A's screening-rate data. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:33.415456Z"}
{"comparison_id":"09f8f892-d79e-4411-ac27-3f11334730bd","query_id":"51","doc_a_id":"9486930","doc_b_id":"25121903","presented_order":["25121903","9486930"],"winner_id":"9486930","reasoning":"Document B — it discusses stem cell–related gene signatures (conceptually closer to ALDH1 as a stem cell marker), whereas A is general survivorship statistics and not relevant to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:41.483203Z"}
{"comparison_id":"be4c7667-0c9b-425f-8c41-c2959c8043de","query_id":"51","doc_a_id":"23304931","doc_b_id":"25121903","presented_order":["23304931","25121903"],"winner_id":"23304931","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer specifically, but Document A discusses associations between immunophenotypic markers and clinical outcomes, making it slightly more relevant to a claim about a marker's association with cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:41.483224Z"}
{"comparison_id":"4fa01e55-cc65-464c-8c2d-435d2df026ab","query_id":"51","doc_a_id":"24205118","doc_b_id":"25121903","presented_order":["24205118","25121903"],"winner_id":"24205118","reasoning":"Document A is more relevant — it examines a molecular marker's expression and prognostic significance in cancer (though a different marker and cancer type), whereas B is general survivorship statistics. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:41.483233Z"}
{"comparison_id":"c48160c6-943d-438f-9217-a51369ecadc5","query_id":"51","doc_a_id":"25523969","doc_b_id":"25121903","presented_order":["25523969","25121903"],"winner_id":"25523969","reasoning":"Document A is more relevant — it deals with molecular expression profiling and cancer biomarkers (though it doesn't mention ALDH1), whereas Document B is only population survivorship statistics.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:41.483241Z"}
{"comparison_id":"271afb90-0f13-405b-9279-07d6304339a6","query_id":"51","doc_a_id":"31439189","doc_b_id":"25121903","presented_order":["25121903","31439189"],"winner_id":"25121903","reasoning":"Document A is more relevant — it discusses cancer outcomes and survivorship (including breast cancer), whereas Document B focuses on prostate cancer cell lines and different markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:41.483248Z"}
{"comparison_id":"00a74190-936d-4bb4-886e-4521e93bc98d","query_id":"51","doc_a_id":"25298276","doc_b_id":"25121903","presented_order":["25298276","25121903"],"winner_id":"25298276","reasoning":"Document A is more relevant — it discusses tumor progression and effects on survival/outcomes, which is closer to evidence about markers affecting breast cancer prognosis than the general survivorship statistics in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:41.483256Z"}
{"comparison_id":"3f11318a-6782-4311-9484-15f4159db994","query_id":"51","doc_a_id":"32742683","doc_b_id":"25121903","presented_order":["32742683","25121903"],"winner_id":"32742683","reasoning":"Document A is more likely to discuss tumor markers and microenvironment factors (like ALDH1) related to outcomes; Document B is general survivorship statistics and not about molecular markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:41.483263Z"}
{"comparison_id":"70f89c70-5a4d-4148-ac72-c122ad660b45","query_id":"51","doc_a_id":"16532419","doc_b_id":"25121903","presented_order":["16532419","25121903"],"winner_id":"16532419","reasoning":"Document A — it discusses cancer stem cell markers (likely including ALDH1) and tumorigenic properties, which is more relevant to a claim about ALDH1 and cancer outcomes than broad survivorship statistics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:41.483271Z"}
{"comparison_id":"15874579-a08a-4898-ac0b-feece83cbaf4","query_id":"51","doc_a_id":"9558539","doc_b_id":"25121903","presented_order":["9558539","25121903"],"winner_id":"9558539","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document A is slightly more relevant because it discusses cancer stem cell marker expression and metastasis (though in colon cancer), whereas Document B is general survivorship statistics. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:41.483278Z"}
{"comparison_id":"218bf679-e507-4492-9de2-db4603650712","query_id":"51","doc_a_id":"3756384","doc_b_id":"25121903","presented_order":["25121903","3756384"],"winner_id":"3756384","reasoning":"Neither abstract mentions ALDH1 or breast cancer specifically, but Document B is slightly more relevant because it discusses a cancer stem cell–like gene signature and prognosis (ALDH1 is a stem cell marker), whereas A is general survivorship statistics. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:41.483285Z"}
{"comparison_id":"b71c5c3d-69d7-4b0a-911c-908b317f59cc","query_id":"51","doc_a_id":"952111","doc_b_id":"25121903","presented_order":["952111","25121903"],"winner_id":"952111","reasoning":"Doc A is more focused on tumor biology and microenvironment mechanisms that might relate to molecular markers like ALDH1; Document B is general survivor statistics and less relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:41.483291Z"}
{"comparison_id":"a411b7a8-9c2c-407c-a225-5314b113d860","query_id":"51","doc_a_id":"14768471","doc_b_id":"25121903","presented_order":["25121903","14768471"],"winner_id":"25121903","reasoning":"Reason: Neither discusses ALDH1 or breast cancer specifically, but Document A addresses cancer outcomes and survivorship broadly, making it marginally more relevant to a claim about prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:41.483299Z"}
{"comparison_id":"acc2ad78-522e-4bfb-baa2-fc944afd90b7","query_id":"51","doc_a_id":"9486930","doc_b_id":"25298276","presented_order":["9486930","25298276"],"winner_id":"25298276","reasoning":"Neither document addresses ALDH1. Document B is slightly more relevant because it discusses cancer treatments and effects on metastasis and survival (more directly related to cancer outcomes) while A is specific to glioblastoma stem-cell signatures. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:48.602518Z"}
{"comparison_id":"d2a5cf14-c133-466f-ab33-3193e572c1c5","query_id":"51","doc_a_id":"23304931","doc_b_id":"25298276","presented_order":["23304931","25298276"],"winner_id":"23304931","reasoning":"Document A is more relevant — it analyzes immunophenotypic marker expression and associations with patient outcomes, which is conceptually closer to a claim about ALDH1 expression and breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:48.602541Z"}
{"comparison_id":"f52b87f9-45e3-4f64-bbf4-0ec3f78d94fe","query_id":"51","doc_a_id":"24205118","doc_b_id":"25298276","presented_order":["25298276","24205118"],"winner_id":"25298276","reasoning":"Document A is slightly more relevant — it discusses cancer treatments and outcomes (including prevention of metastasis) whereas Document B is specific to Bmi-1 in cervical cancer; neither mentions ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:48.602550Z"}
{"comparison_id":"1b475fb1-14ea-4f08-a655-bf060329cc86","query_id":"51","doc_a_id":"25523969","doc_b_id":"25298276","presented_order":["25523969","25298276"],"winner_id":"25523969","reasoning":"Document A — it discusses molecular expression profiles and markers in metastatic cancer (more relevant to biomarker–outcome associations) while Document B focuses on bisphosphonate therapy. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:48.602558Z"}
{"comparison_id":"f19a2764-8e63-4135-8af9-c21612b0631c","query_id":"51","doc_a_id":"952111","doc_b_id":"25298276","presented_order":["25298276","952111"],"winner_id":"952111","reasoning":"Neither abstract mentions ALDH1, but Document B (CAFs) is slightly more relevant because it discusses tumor microenvironment and factors affecting tumor behavior and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:48.602565Z"}
{"comparison_id":"969c301a-c50f-480f-86b4-a47750902631","query_id":"51","doc_a_id":"32742683","doc_b_id":"25298276","presented_order":["32742683","25298276"],"winner_id":"32742683","reasoning":"Document A is more related to tumor biology and factors affecting cancer outcomes (tumor microenvironment/biomarkers) than a paper on bisphosphonate therapy.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:48.602572Z"}
{"comparison_id":"6592d6dc-4f73-4d8f-9583-a0e9dd5e0f04","query_id":"51","doc_a_id":"16532419","doc_b_id":"25298276","presented_order":["16532419","25298276"],"winner_id":"16532419","reasoning":"Document A — it discusses induction of cancer stem cell–like properties and stem-cell markers (related to ALDH1) whereas Document B focuses on bisphosphonates and bone metastasis, not ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:48.602580Z"}
{"comparison_id":"f5d25726-80ff-42b0-ad1a-4544ece10b4d","query_id":"51","doc_a_id":"9558539","doc_b_id":"25298276","presented_order":["25298276","9558539"],"winner_id":"25298276","reasoning":"Document A is more relevant — although neither mentions ALDH1, A discusses therapies and outcomes related to bone metastases and survival (more connected to breast cancer outcomes) whereas B focuses on CD44v6 in colon cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:48.602587Z"}
{"comparison_id":"9b21d955-5d9e-41d9-8788-158956fa7685","query_id":"51","doc_a_id":"3756384","doc_b_id":"25298276","presented_order":["25298276","3756384"],"winner_id":"3756384","reasoning":"Document B is more relevant — it discusses cancer stem cell–like gene signatures and prognosis (conceptually related to ALDH1 as a stem cell marker), whereas A focuses on bisphosphonates and bone metastasis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:48.602594Z"}
{"comparison_id":"ac5cb67b-f691-4062-beb8-ccbcd2113873","query_id":"51","doc_a_id":"23304931","doc_b_id":"952111","presented_order":["23304931","952111"],"winner_id":"23304931","reasoning":"Document A discusses associations between marker expression and patient outcomes (though in lymphoma rather than breast cancer), making it more relevant than Document B, which focuses on cancer-associated fibroblasts.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:59.361918Z"}
{"comparison_id":"a8782dd7-3ba9-4714-89c4-ab1d96f97756","query_id":"51","doc_a_id":"25523969","doc_b_id":"952111","presented_order":["25523969","952111"],"winner_id":"25523969","reasoning":"Document A is slightly more relevant because it discusses expression profiling and immunohistochemical analysis linking molecular markers to metastatic cancer outcomes, whereas Document B focuses on fibroblasts and the tumor microenvironment more generally.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:59.361938Z"}
{"comparison_id":"3986d04a-4b4f-4125-99e9-248cf5aabca0","query_id":"51","doc_a_id":"3756384","doc_b_id":"952111","presented_order":["3756384","952111"],"winner_id":"3756384","reasoning":"Document A is more relevant — it discusses a cancer stem cell-like gene signature and prognosis (though in HCC), which is more related to ALDH1 and outcome associations than the CAF-focused review.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:59.361949Z"}
{"comparison_id":"1fc19584-4a8d-4d8d-b1ff-dad6f0d5c7e3","query_id":"51","doc_a_id":"32742683","doc_b_id":"952111","presented_order":["952111","32742683"],"winner_id":"952111","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes; both focus on cancer-associated fibroblasts. More directly matches general tumor behavior: ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:59.361956Z"}
{"comparison_id":"068bfdec-5638-4fcf-96c7-8434dfdb1235","query_id":"51","doc_a_id":"16532419","doc_b_id":"952111","presented_order":["16532419","952111"],"winner_id":"16532419","reasoning":"Document A is more relevant because it discusses induction of stem-like cancer cells and identification of stem cell markers (which relate to ALDH1), whereas Document B focuses on fibroblasts in the tumor microenvironment without addressing stem-cell markers or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:50:59.361963Z"}
{"comparison_id":"94dd1293-cdc2-4883-a749-8c63dd285a88","query_id":"51","doc_a_id":"23304931","doc_b_id":"25523969","presented_order":["23304931","25523969"],"winner_id":"23304931","reasoning":"Document A — it examines marker expression linked to survival outcomes (though in DLBCL), which is closer to the claim about expression and breast cancer outcomes than B's focus on miRNA profiles. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:51:04.713903Z"}
{"comparison_id":"e5b70964-915e-4757-bcf0-b6fbc62c9f8b","query_id":"51","doc_a_id":"16532419","doc_b_id":"25523969","presented_order":["16532419","25523969"],"winner_id":"16532419","reasoning":"Document A is more relevant because it discusses induction of cancer stem cell–like cells and stem cell markers (ALDH1 is a stem cell marker), whereas Document B focuses on miRNA profiles and not ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:51:04.713924Z"}
{"comparison_id":"4481a790-33f7-453f-9b52-fb419570a70a","query_id":"51","doc_a_id":"3756384","doc_b_id":"25523969","presented_order":["3756384","25523969"],"winner_id":"25523969","reasoning":"Document B is more relevant — it studies human metastatic tumors and uses miRNA and immunohistochemical analysis related to cancer markers, whereas A focuses on HBV-related hepatocellular carcinoma and EpCAM, not breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:51:04.713933Z"}
{"comparison_id":"274cb119-5f83-4175-a737-5ef733d88d75","query_id":"51","doc_a_id":"23304931","doc_b_id":"16532419","presented_order":["23304931","16532419"],"winner_id":"23304931","reasoning":"Document A — it discusses marker expression linked to survival outcomes (even though in lymphoma rather than breast cancer), whereas Document B is about lung epithelial cells and nanotube-induced stem-like cells and does not address clinical outcome markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:51:09.245559Z"}
{"comparison_id":"d473f66c-bc08-48c0-af1d-30981d4a1e3a","query_id":"51","doc_a_id":"9486930","doc_b_id":"24205118","presented_order":["24205118","9486930"],"winner_id":"9486930","reasoning":"Document B — it discusses a stem cell–related signature and clinical resistance/outcomes, which is conceptually closer to ALDH1 (a stem-cell marker) and outcome associations than a study on Bmi-1 in cervical cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:51:14.771829Z"}
{"comparison_id":"93f6751d-70d0-48b9-a7c3-f46b05d2ad06","query_id":"51","doc_a_id":"9558539","doc_b_id":"24205118","presented_order":["9558539","24205118"],"winner_id":"9558539","reasoning":"Document A is more relevant — it discusses a cancer stem cell marker (CD44v6) and its prognostic/functional role in cancer, which is conceptually closer to ALDH1 as a stem cell marker than a cervical cancer Bmi-1 study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:51:14.771850Z"}
{"comparison_id":"31726ae3-258f-4f09-968a-a1b21cc18660","query_id":"51","doc_a_id":"9486930","doc_b_id":"9558539","presented_order":["9486930","9558539"],"winner_id":"9558539","reasoning":"Document B is more relevant because it studies a specific cancer stem cell marker (CD44v6) and its association with metastatic outcomes, which is more analogous to evaluating ALDH1 expression and clinical outcomes than Document A's glioblastoma resistance signature. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:51:23.033772Z"}
{"comparison_id":"da0420b0-004d-42bb-93c0-775fc1168004","query_id":"51","doc_a_id":"31439189","doc_b_id":"14768471","presented_order":["31439189","14768471"],"winner_id":"31439189","reasoning":"Document A is slightly more relevant because it discusses stem-cell markers in cancer cell lines (similar topic to ALDH1 as a stem-cell marker), whereas Document B focuses on extracellular vesicles from renal CSCs and stromal effects. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:51:26.956154Z"}
{"comparison_id":"736849c7-5e1c-45fe-b48c-fae90f8c4494","query_id":"51","doc_a_id":"6790197","doc_b_id":"8496132","presented_order":["6790197","8496132"],"winner_id":"8496132","reasoning":"Document B is more relevant — it deals with cancer cell molecular markers and regulation of proteins linked to prognosis/outcome, whereas A is prostate-specific and not relevant to ALDH1 or breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:51:35.697805Z"}
{"comparison_id":"af95e7ad-e4b0-4ca1-ab85-f3e9f7879c83","query_id":"51","doc_a_id":"7225911","doc_b_id":"8496132","presented_order":["8496132","7225911"],"winner_id":"7225911","reasoning":"Both documents are unrelated to ALDH1 or breast cancer outcomes, but B (lncRNA-RoR/p53) is slightly more connected to cancer prognosis pathways (p53) than A. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:51:35.697827Z"}
{"comparison_id":"5f7ea465-9175-480b-8dd0-5cd5850d1d71","query_id":"51","doc_a_id":"756887","doc_b_id":"8496132","presented_order":["756887","8496132"],"winner_id":"8496132","reasoning":"Document B is marginally more relevant because it discusses molecular regulation in cancer cells, which is closer to biomarker–outcome relationships than a population screening study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:51:35.697835Z"}
{"comparison_id":"9844f3d0-751d-4564-92e3-388b892d1d23","query_id":"51","doc_a_id":"4583180","doc_b_id":"8496132","presented_order":["8496132","4583180"],"winner_id":"4583180","reasoning":"Document B — it discusses tumor progression and links SREBP2 target genes to reduced survival in cancer patients, which is more related to clinical outcomes than Document A. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:51:35.697842Z"}
{"comparison_id":"956f6d0b-f80f-493c-89a3-511006e8ffd9","query_id":"51","doc_a_id":"12737132","doc_b_id":"8496132","presented_order":["8496132","12737132"],"winner_id":"12737132","reasoning":"Neither abstract mentions ALDH1 or breast cancer outcomes. Document B is marginally more relevant because it addresses oncogenic pathways and epithelial–mesenchymal transition, which relate to cancer progression and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:51:35.697850Z"}
{"comparison_id":"4a65cac1-ae9e-4862-9214-6443795d0833","query_id":"51","doc_a_id":"7225911","doc_b_id":"4583180","presented_order":["7225911","4583180"],"winner_id":"4583180","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is slightly more relevant because it links gene expression to patient survival (an expression–outcome relationship), whereas A focuses on p53 regulation mechanisms. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:51:43.595079Z"}
{"comparison_id":"ca6de6c6-ec24-4fdc-ab3d-ad3e7e0ba992","query_id":"51","doc_a_id":"12737132","doc_b_id":"4583180","presented_order":["4583180","12737132"],"winner_id":"4583180","reasoning":"Document A is slightly more relevant because it discusses gene expression linked to patient survival and tumor progression, which relates to associations between marker expression and outcomes. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:51:43.595101Z"}
{"comparison_id":"589c4962-9032-49ea-bfb9-0fdab0290577","query_id":"51","doc_a_id":"7225911","doc_b_id":"12737132","presented_order":["7225911","12737132"],"winner_id":"12737132","reasoning":"Reason: Document B discusses pathways (YAP/TEAD, EMT) tied to cancer cell state and prognosis, which is more related to ALDH1's role as a cancer/stemness marker than Document A's focus on p53 translation by lncRNA-RoR.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:51:51.794131Z"}
{"comparison_id":"309b284f-f279-44ed-85b1-00b7e233d3ef","query_id":"51","doc_a_id":"6790197","doc_b_id":"756887","presented_order":["756887","6790197"],"winner_id":"756887","reasoning":"Document A is more relevant — it addresses breast cancer (screening and survivors), whereas Document B focuses on prostate cancer gene expression and not breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:51:55.236291Z"}
{"comparison_id":"79c19a5d-db8e-4c81-bd45-daf17776927d","query_id":"51","doc_a_id":"23830488","doc_b_id":"7808055","presented_order":["23830488","7808055"],"winner_id":"23830488","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is marginally more relevant because it links gene expression to cancer outcomes (though in colorectal cancer), whereas B addresses DNA methylation age across tissues. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.200996Z"}
{"comparison_id":"17cd4c4a-54d9-4b92-b79b-25473d0622ad","query_id":"51","doc_a_id":"24349992","doc_b_id":"7808055","presented_order":["24349992","7808055"],"winner_id":"24349992","reasoning":"Document A is more relevant — it discusses tumor biology and microenvironment in cancer (breast cancer context), which is closer to ALDH1 expression and outcome studies than a paper about DNA methylation age. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201019Z"}
{"comparison_id":"e19a11f1-1dc4-45df-a9fb-2c215c5b251f","query_id":"51","doc_a_id":"42731834","doc_b_id":"7808055","presented_order":["42731834","7808055"],"winner_id":"42731834","reasoning":"Document A is more relevant — it reports a link between tumor marker expression and patient survival (though for AIM2 in colorectal cancer), which is conceptually closer to ALDH1 expression and breast cancer outcomes than the methylation-age study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201028Z"}
{"comparison_id":"706f2395-ad45-49df-9f31-f4e4564d1fd9","query_id":"51","doc_a_id":"25832301","doc_b_id":"7808055","presented_order":["25832301","7808055"],"winner_id":"25832301","reasoning":"Document A is more relevant — it reports a protein's expression linked to reduced tumor burden (better outcome) in cancer, which is conceptually closer to the ALDH1–breast cancer outcome claim than the methylation-aging study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201037Z"}
{"comparison_id":"33e86609-83cc-4b14-8cf9-50da45f95dd7","query_id":"51","doc_a_id":"8037453","doc_b_id":"7808055","presented_order":["8037453","7808055"],"winner_id":"8037453","reasoning":"Document A is slightly more relevant because it concerns biomarker expression and associations with cancer patient outcomes, whereas Document B focuses on DNA methylation age across tissues and cancers (less directly about specific gene expression like ALDH1).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201046Z"}
{"comparison_id":"9f606408-9491-4a53-b195-207955485b06","query_id":"51","doc_a_id":"31591262","doc_b_id":"7808055","presented_order":["31591262","7808055"],"winner_id":"31591262","reasoning":"Document A is more relevant — it links specific gene expression to cancer outcomes (though different genes and cancer type), whereas B discusses DNA methylation age broadly and not gene expression or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201053Z"}
{"comparison_id":"193d3c1f-ef01-4d75-8f6e-3839c3dba78f","query_id":"51","doc_a_id":"8512633","doc_b_id":"7808055","presented_order":["7808055","8512633"],"winner_id":"7808055","reasoning":"Document A is at least about cancer-related biomarkers and age-related changes in tumors, whereas Document B concerns prostate-specific lncRNAs unrelated to ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201060Z"}
{"comparison_id":"f58a1088-3f0a-4fda-b568-ebf1e45bc9cc","query_id":"51","doc_a_id":"13906581","doc_b_id":"7808055","presented_order":["7808055","13906581"],"winner_id":"7808055","reasoning":"Document A is more relevant because it discusses cancer-related molecular measures (DNA methylation age) whereas Document B concerns hospital teaching status and is unrelated to ALDH1 or breast cancer biology.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201067Z"}
{"comparison_id":"d7c0795e-2c9c-4822-b821-f39b47ad2d3e","query_id":"51","doc_a_id":"7795952","doc_b_id":"7808055","presented_order":["7795952","7808055"],"winner_id":"7795952","reasoning":"Doc A is about a cancer-related protein and prognosis/ metastasis, which is more relevant to breast cancer outcome associations than a general paper on DNA methylation age. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201074Z"}
{"comparison_id":"13eb8e7c-04c7-468b-874a-31276bf7410c","query_id":"51","doc_a_id":"19047331","doc_b_id":"7808055","presented_order":["19047331","7808055"],"winner_id":"19047331","reasoning":"Neither document addresses ALDH1 or breast cancer specifically. Document A is slightly more relevant because it discusses a molecular marker's expression and its association with cancer outcomes (albeit in ovarian cancer), while Document B deals with DNA methylation age across tissues. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201081Z"}
{"comparison_id":"606bd671-f201-43f4-8c8c-b6d1767aab17","query_id":"51","doc_a_id":"7165938","doc_b_id":"7808055","presented_order":["7165938","7808055"],"winner_id":"7165938","reasoning":"Document A — it discusses gene expression affecting cancer sensitivity and patient survival (a prognostic expression–outcome link), which is more conceptually related than the methylation-age study. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201089Z"}
{"comparison_id":"ba19a1cc-eacf-417b-ab16-6d8647e88d7f","query_id":"51","doc_a_id":"2727303","doc_b_id":"7808055","presented_order":["2727303","7808055"],"winner_id":"2727303","reasoning":"Document A is more relevant — it addresses cancer cell molecular mechanisms (closer to markers and outcomes) while Document B is about DNA methylation age across tissues and not specific to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201096Z"}
{"comparison_id":"0eada55f-05c0-4528-a298-d2614f5b7066","query_id":"51","doc_a_id":"1782201","doc_b_id":"7808055","presented_order":["1782201","7808055"],"winner_id":"1782201","reasoning":"Document A is more relevant — it discusses tumor progression and outcomes in carcinomas (though not ALDH1 specifically), whereas B focuses on DNA methylation age rather than markers or outcomes in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201103Z"}
{"comparison_id":"ade43163-4e28-4a1e-ac25-621e095284a9","query_id":"51","doc_a_id":"39580129","doc_b_id":"7808055","presented_order":["39580129","7808055"],"winner_id":"7808055","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes. Document B is slightly more generally cancer-related (age acceleration in cancers), so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201110Z"}
{"comparison_id":"4f6e80ce-0023-4c2c-b267-6ebc6c734861","query_id":"51","doc_a_id":"2389574","doc_b_id":"7808055","presented_order":["7808055","2389574"],"winner_id":"2389574","reasoning":"Document B is more relevant — it addresses protein expression as a prognostic marker and survival in cancer (though a different marker and cancer type), whereas A focuses on DNA methylation age and not marker expression or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201118Z"}
{"comparison_id":"4c8adddc-d7d9-40fa-a1d7-a38453cb2a76","query_id":"51","doc_a_id":"25576204","doc_b_id":"7808055","presented_order":["25576204","7808055"],"winner_id":"25576204","reasoning":"Document A is more relevant — it deals with tumorigenesis and genes influencing cancer outcomes, whereas Document B focuses on DNA methylation age and is less directly related to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201125Z"}
{"comparison_id":"8f51f390-c0a2-4856-8ce1-8a189a293012","query_id":"51","doc_a_id":"5774746","doc_b_id":"7808055","presented_order":["5774746","7808055"],"winner_id":"5774746","reasoning":"Document A is more relevant — it deals with tumor markers and correlations with patient survival and metastasis (though in colorectal cancer), which is closer to the claim about a biomarker and cancer outcomes than the methylation-age focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201132Z"}
{"comparison_id":"a207f88e-9bcb-470d-a542-e7fb9d47a1e2","query_id":"51","doc_a_id":"11271123","doc_b_id":"7808055","presented_order":["11271123","7808055"],"winner_id":"11271123","reasoning":"Document A is more relevant — it is a molecular tumor marker study (though in endometrial cancer) and thus closer in scope to biomarker–outcome associations than the DNA methylation age paper.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201139Z"}
{"comparison_id":"96b8c8c5-01e8-476e-8860-3232ee546eae","query_id":"51","doc_a_id":"4462079","doc_b_id":"7808055","presented_order":["7808055","4462079"],"winner_id":"7808055","reasoning":"Document A is slightly more relevant because it addresses cancer biology and methylation changes in cancers, whereas Document B focuses on vitamin D levels and general cancer risk. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201146Z"}
{"comparison_id":"ac2df669-da06-4b87-9629-a9e3427d91d3","query_id":"51","doc_a_id":"13964633","doc_b_id":"7808055","presented_order":["13964633","7808055"],"winner_id":"13964633","reasoning":"Document A is more directly related to tumor biology and mechanisms affecting cancer growth and outcomes, whereas Document B focuses on DNA methylation age across tissues and cancer broadly. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201155Z"}
{"comparison_id":"74b88302-dc08-4c3f-afce-5dfd9286eeb1","query_id":"51","doc_a_id":"21181273","doc_b_id":"7808055","presented_order":["7808055","21181273"],"winner_id":"7808055","reasoning":"Document A is marginally more relevant because it discusses cancer-related changes across multiple tissue types (broadly relevant to cancer outcomes), while Document B focuses on a different enzyme in colorectal cancer rather than ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201163Z"}
{"comparison_id":"5795f260-8721-43ba-9fe2-39769dc6d6b2","query_id":"51","doc_a_id":"12358173","doc_b_id":"7808055","presented_order":["12358173","7808055"],"winner_id":"12358173","reasoning":"Document A is more relevant — it discusses how expression of a protein correlates with cancer prognosis (though in lung cancer and a different marker), whereas B is about DNA methylation age and not marker expression or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201170Z"}
{"comparison_id":"dc3e75da-9221-46f3-99fa-50645c11de55","query_id":"51","doc_a_id":"32721137","doc_b_id":"7808055","presented_order":["7808055","32721137"],"winner_id":"7808055","reasoning":"Document A is more relevant — it addresses cancer-related molecular measures across multiple tissues and their associations with cancer, whereas Document B focuses on endometrial carcinoma and PI3K, not breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201178Z"}
{"comparison_id":"bc69233b-5a3e-4ab6-ab5d-f6389bbb42f8","query_id":"51","doc_a_id":"36212758","doc_b_id":"7808055","presented_order":["7808055","36212758"],"winner_id":"7808055","reasoning":"Document A is more relevant — it addresses cancer across multiple tissue types and age-related molecular changes that could relate to cancer biomarkers, whereas Document B focuses specifically on non-small cell lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201185Z"}
{"comparison_id":"a5194263-82be-4953-9a43-682b51ea616e","query_id":"51","doc_a_id":"33370","doc_b_id":"7808055","presented_order":["33370","7808055"],"winner_id":"33370","reasoning":"Document A is more relevant — it discusses a specific gene's expression affecting tumor cell survival and growth (similar topic of marker expression tied to outcomes), whereas B is about DNA methylation age broadly and not marker expression or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201193Z"}
{"comparison_id":"c2f43b82-143c-4c27-a49e-0ea900df6130","query_id":"51","doc_a_id":"39929509","doc_b_id":"7808055","presented_order":["39929509","7808055"],"winner_id":"7808055","reasoning":"Document B is slightly more relevant because it discusses cancer-related biomarkers and age acceleration in cancer types, which is closer to prognostic associations than Document A's focus on WT1/ACTN1 mRNA binding. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201200Z"}
{"comparison_id":"8766e577-7b5d-47d9-b88c-0a3aceab3fde","query_id":"51","doc_a_id":"22521091","doc_b_id":"7808055","presented_order":["22521091","7808055"],"winner_id":"22521091","reasoning":"Neither document directly addresses ALDH1 or breast cancer outcomes. Document A is slightly more relevant because it discusses expression of a tumor biomarker linked to cancer progression and survival (albeit NRAGE in hepatocellular carcinoma), whereas Document B is about DNA methylation age across tissues. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201208Z"}
{"comparison_id":"6442d2a9-82d0-471a-87d8-01005c39d198","query_id":"51","doc_a_id":"1032372","doc_b_id":"7808055","presented_order":["7808055","1032372"],"winner_id":"1032372","reasoning":"Document B is more relevant — it discusses cancer treatment and outcomes and epigenetic regulation, which is closer to the topic of biomarker expression and prognosis than Document A's focus on DNA methylation age. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201215Z"}
{"comparison_id":"89bdd07d-89f3-498f-9624-fb8150536809","query_id":"51","doc_a_id":"5386514","doc_b_id":"7808055","presented_order":["7808055","5386514"],"winner_id":"5386514","reasoning":"Reason: Document B concerns mechanisms that affect antitumor immune responses and therapy efficacy, which is more related to cancer outcomes than Document A's focus on DNA methylation age.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201222Z"}
{"comparison_id":"9adbbfa3-9b85-4964-9044-0de6518d1b04","query_id":"51","doc_a_id":"1976183","doc_b_id":"7808055","presented_order":["7808055","1976183"],"winner_id":"7808055","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes; Document A is slightly more relevant because it discusses cancer broadly (age acceleration in cancer types). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201228Z"}
{"comparison_id":"834f8180-a966-4b7f-8eaf-15064fc235f4","query_id":"51","doc_a_id":"53211308","doc_b_id":"7808055","presented_order":["53211308","7808055"],"winner_id":"7808055","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer outcomes; Document B at least addresses cancer-related biomarkers and prognostic measures (age acceleration in cancers), making it slightly more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201235Z"}
{"comparison_id":"80a893a9-7493-411a-9cba-44d8d1c7a30f","query_id":"51","doc_a_id":"33638477","doc_b_id":"7808055","presented_order":["7808055","33638477"],"winner_id":"33638477","reasoning":"Document B is more relevant — it discusses genes and pathways that influence tumor progression and outcomes, whereas Document A focuses on a DNA methylation age predictor unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201242Z"}
{"comparison_id":"bf7947bf-06e7-4c95-b77c-6ebee96c7e05","query_id":"51","doc_a_id":"39758684","doc_b_id":"7808055","presented_order":["7808055","39758684"],"winner_id":"7808055","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer outcomes; Document A at least addresses cancer-related biomarkers/changes, making it marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201249Z"}
{"comparison_id":"5670292a-364f-4c52-9f8e-5df4f2d916fd","query_id":"51","doc_a_id":"21502234","doc_b_id":"7808055","presented_order":["7808055","21502234"],"winner_id":"21502234","reasoning":"Document B is more relevant — it examines the relationship between a molecular biomarker and clinical outcomes in cancer (though in endometrial, not breast), while A focuses on DNA methylation age prediction rather than biomarker-outcome associations.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201256Z"}
{"comparison_id":"453d847d-2576-467d-bdbb-3917e4394cab","query_id":"51","doc_a_id":"26735905","doc_b_id":"7808055","presented_order":["26735905","7808055"],"winner_id":"7808055","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes; Document B is slightly more relevant because it addresses cancer broadly, whereas A focuses specifically on stromal signaling in prostate cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201264Z"}
{"comparison_id":"a65f6208-faa1-4a63-87bb-a0250a914e43","query_id":"51","doc_a_id":"515489","doc_b_id":"7808055","presented_order":["7808055","515489"],"winner_id":"515489","reasoning":"Document B is slightly more relevant because it addresses cancer prognosis and stem cell-like properties (related to markers like ALDH1), whereas Document A discusses DNA methylation age broadly and not ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201271Z"}
{"comparison_id":"98573d11-85b6-4ba8-82f8-b5739a84ab8f","query_id":"51","doc_a_id":"24873253","doc_b_id":"7808055","presented_order":["7808055","24873253"],"winner_id":"7808055","reasoning":"Both documents are irrelevant to ALDH1 expression, but Document A is slightly more relevant because it discusses cancer-related biomarkers and outcomes broadly.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201278Z"}
{"comparison_id":"bfbf9aa7-5081-42ce-91a2-da9a954c3d5b","query_id":"51","doc_a_id":"17755060","doc_b_id":"7808055","presented_order":["7808055","17755060"],"winner_id":"17755060","reasoning":"Document B is more relevant — it discusses tumorigenesis and prognosis in human cancers (outcomes-related content), whereas A focuses on DNA methylation age and does not address markers like ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201285Z"}
{"comparison_id":"4c53ea4e-551d-4449-b64a-8c07ee7150c4","query_id":"51","doc_a_id":"3805841","doc_b_id":"7808055","presented_order":["3805841","7808055"],"winner_id":"3805841","reasoning":"Document A is slightly more relevant because it discusses cancer metabolism and links oncogenic changes to clinical outcomes, whereas Document B focuses on DNA methylation age across tissues and not on gene expression or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201292Z"}
{"comparison_id":"dd64d4ac-b771-49af-96d1-850a7dc951f1","query_id":"51","doc_a_id":"3376731","doc_b_id":"7808055","presented_order":["7808055","3376731"],"winner_id":"7808055","reasoning":"Document A is marginally more relevant because it discusses cancer-related changes and outcomes broadly, while Document B focuses on IL6-driven chemoresistance in esophageal carcinoma unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201299Z"}
{"comparison_id":"7ded098b-1118-407d-94a2-a09231f57d09","query_id":"51","doc_a_id":"21551568","doc_b_id":"7808055","presented_order":["7808055","21551568"],"winner_id":"7808055","reasoning":"Document A is marginally more relevant because it addresses cancer-related biological markers across tissues and could pertain to breast cancer outcomes; Document B focuses specifically on thyroid cancer and PI3K/Akt pathway, which is less related to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201306Z"}
{"comparison_id":"4f703633-341e-4cfc-b105-e5359dcc70a1","query_id":"51","doc_a_id":"11968641","doc_b_id":"7808055","presented_order":["7808055","11968641"],"winner_id":"7808055","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes, so neither is relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201313Z"}
{"comparison_id":"cf4be29a-e7d0-4cb9-a927-e0a4a7bbf005","query_id":"51","doc_a_id":"38243984","doc_b_id":"7808055","presented_order":["7808055","38243984"],"winner_id":"38243984","reasoning":"Document B — it links tumor molecular/phenotypic features to patient survival and treatment resistance (clinical outcomes), whereas A discusses a methylation age predictor and not ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201321Z"}
{"comparison_id":"4e68753c-5272-4f8c-b63e-cc330e011c0d","query_id":"51","doc_a_id":"29806339","doc_b_id":"7808055","presented_order":["7808055","29806339"],"winner_id":"29806339","reasoning":"Document B is more directly about tumor behavior and outcomes (tumor regression) while A focuses on DNA methylation age and is only tangentially cancer-related. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201327Z"}
{"comparison_id":"c6da230c-02b1-4572-975d-b043314ff0db","query_id":"51","doc_a_id":"24974080","doc_b_id":"7808055","presented_order":["7808055","24974080"],"winner_id":"7808055","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular measures and cancer types, whereas Document B focuses narrowly on the VEGF pathway and therapy. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201334Z"}
{"comparison_id":"4f0309f0-c86a-4721-85ed-7e39cc5d54cc","query_id":"51","doc_a_id":"16806763","doc_b_id":"7808055","presented_order":["7808055","16806763"],"winner_id":"7808055","reasoning":"Document A is more relevant — it discusses cancer-related measures across multiple tissue types (including age acceleration in cancers), whereas Document B focuses specifically on an lncRNA signature in colorectal cancer and not breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201341Z"}
{"comparison_id":"19bfcb52-761e-4b50-a22b-26ea9409ff74","query_id":"51","doc_a_id":"18987782","doc_b_id":"7808055","presented_order":["7808055","18987782"],"winner_id":"7808055","reasoning":"Document A is more relevant — though neither mentions ALDH1 or breast cancer outcomes, A at least discusses cancer-related measures (age acceleration in cancers), whereas B focuses on Myc and ribosomal protein mechanisms in mice. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201349Z"}
{"comparison_id":"897096ee-1f50-4350-b415-a2938367c921","query_id":"51","doc_a_id":"14663842","doc_b_id":"7808055","presented_order":["14663842","7808055"],"winner_id":"7808055","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes; Document B is slightly more relevant because it discusses cancer-related changes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201355Z"}
{"comparison_id":"61043deb-3874-42bb-b101-56036d35a6cb","query_id":"51","doc_a_id":"11481946","doc_b_id":"7808055","presented_order":["7808055","11481946"],"winner_id":"7808055","reasoning":"Reason: Neither abstract addresses ALDH1 or breast cancer prognosis directly, but Document A discusses cancer-related biomarkers and age-associated changes in tumors, making it marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201362Z"}
{"comparison_id":"62286817-dd10-425c-bc58-70f68275f497","query_id":"51","doc_a_id":"21382907","doc_b_id":"7808055","presented_order":["21382907","7808055"],"winner_id":"7808055","reasoning":"Document B is more relevant — it addresses cancer-related biomarkers and tumor biology broadly (including methylation changes in cancers), whereas A is specific to head and neck cancer therapy and not breast cancer or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201369Z"}
{"comparison_id":"d060ced2-3afd-4fd3-bf10-f0fda8f61e58","query_id":"51","doc_a_id":"13070316","doc_b_id":"7808055","presented_order":["7808055","13070316"],"winner_id":"7808055","reasoning":"Reason: Document A mentions cancer-related findings (age acceleration in cancers) and thus is more broadly related to cancer outcomes; Document B focuses on macrophage-driven angiogenesis, not ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201377Z"}
{"comparison_id":"0eb7e39d-e177-45ad-883e-4b996411a2e8","query_id":"51","doc_a_id":"3590806","doc_b_id":"7808055","presented_order":["7808055","3590806"],"winner_id":"3590806","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer. Document B, however, addresses cancer stem cell regulation (though in colorectal cancer), which is more tangentially related to ALDH1's role as a stem cell marker than Document A's focus on DNA methylation age.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201385Z"}
{"comparison_id":"b445d30f-fa41-48c7-ab53-ffc08b6dbab2","query_id":"51","doc_a_id":"4429118","doc_b_id":"7808055","presented_order":["4429118","7808055"],"winner_id":"4429118","reasoning":"Document A is more relevant — it addresses tumor microenvironment and factors influencing cancer progression, which is closer to marker expression and outcomes than a paper on DNA methylation age.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201408Z"}
{"comparison_id":"8bf3fe78-f388-48b7-9fea-a8acf855daa0","query_id":"51","doc_a_id":"12337611","doc_b_id":"7808055","presented_order":["7808055","12337611"],"winner_id":"7808055","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer specifically, but Document A discusses cancer-related molecular measures across cancer types, making it slightly more relevant than a neuroblastoma-specific study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201426Z"}
{"comparison_id":"89b24229-3dd5-4a10-ad3f-7156c9fc20eb","query_id":"51","doc_a_id":"38485364","doc_b_id":"7808055","presented_order":["7808055","38485364"],"winner_id":"7808055","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes. Document A at least mentions cancer broadly (DNA methylation age/age acceleration in cancers), so it's slightly more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201437Z"}
{"comparison_id":"5325bdcd-293f-430a-a790-e2125f1e32ac","query_id":"51","doc_a_id":"26561572","doc_b_id":"7808055","presented_order":["7808055","26561572"],"winner_id":"26561572","reasoning":"Both documents are irrelevant to the specific claim (neither discusses ALDH1 or breast cancer). Document B is slightly more relevant because it addresses cancer molecular markers and outcomes, whereas A focuses on DNA methylation age across tissues.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201446Z"}
{"comparison_id":"650d4ef1-ae8b-471a-96b8-040dd3cc5a18","query_id":"51","doc_a_id":"9641846","doc_b_id":"7808055","presented_order":["7808055","9641846"],"winner_id":"7808055","reasoning":"Document A is slightly more relevant — it discusses cancer-related biomarkers and prognostic patterns across cancer types, whereas B focuses on Rb-mediated cell cycle biology in mice with no link to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201455Z"}
{"comparison_id":"7deebdfb-b834-4f2f-b837-dc7794b7fc3a","query_id":"51","doc_a_id":"6121668","doc_b_id":"7808055","presented_order":["6121668","7808055"],"winner_id":"7808055","reasoning":"Neither document addresses ALDH1 or breast cancer directly. Document B is marginally more relevant because it discusses cancer-related molecular measures across multiple tissues, whereas A focuses on unrelated markers in endometrial carcinoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201462Z"}
{"comparison_id":"000920e0-774a-41b7-9e62-fe4e7fd6265c","query_id":"51","doc_a_id":"13980338","doc_b_id":"7808055","presented_order":["7808055","13980338"],"winner_id":"13980338","reasoning":"Document B is more relevant — it addresses single-cell gene expression and identifies molecules associated with stem cell populations (ALDH1 is a known stem-cell marker), whereas Document A focuses on DNA methylation age and cancer broadly without ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201471Z"}
{"comparison_id":"551a4ca2-7ee7-418c-854c-e20cd17295dd","query_id":"51","doc_a_id":"13400643","doc_b_id":"7808055","presented_order":["7808055","13400643"],"winner_id":"13400643","reasoning":"Neither document mentions ALDH1 or directly addresses breast cancer prognostic markers; both are not directly relevant. Document B is marginally more relevant because it directly concerns cancer growth and potential impact on outcomes, whereas A focuses on DNA methylation age across tissues.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201478Z"}
{"comparison_id":"1fcb79e9-92d7-40b2-a491-d31dbcdc69c1","query_id":"51","doc_a_id":"14315749","doc_b_id":"7808055","presented_order":["14315749","7808055"],"winner_id":"7808055","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document B is slightly more relevant since it discusses cancer across multiple tissues (potentially including breast), whereas A focuses on a different gene in colorectal cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201485Z"}
{"comparison_id":"169d8e12-0195-436b-9691-b3c7da664a29","query_id":"51","doc_a_id":"29473081","doc_b_id":"7808055","presented_order":["29473081","7808055"],"winner_id":"29473081","reasoning":"Document A is more relevant — it discusses gene/protein expression linked to survival outcomes in cancer (though in multiple myeloma, not breast cancer), which is closer to the query about ALDH1 expression and breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201493Z"}
{"comparison_id":"95509f26-b318-4ece-a495-af902182017a","query_id":"51","doc_a_id":"22914228","doc_b_id":"7808055","presented_order":["22914228","7808055"],"winner_id":"7808055","reasoning":"Document B is more relevant — it addresses cancer-related molecular measures across tissues (including age acceleration in cancer), whereas A focuses on pancreatic cell metabolism with no relation to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201500Z"}
{"comparison_id":"cb2478c6-1507-456c-9cea-6f5cf1769b08","query_id":"51","doc_a_id":"654735","doc_b_id":"7808055","presented_order":["7808055","654735"],"winner_id":"7808055","reasoning":"Document A is more relevant — it discusses cancer-related biomarkers and age acceleration across multiple cancer types, which is closer to breast cancer outcome research than a glioma-specific miRNA study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201507Z"}
{"comparison_id":"4c9b29f5-cbb4-4086-856d-88b142247408","query_id":"51","doc_a_id":"22901758","doc_b_id":"7808055","presented_order":["22901758","7808055"],"winner_id":"7808055","reasoning":"B is more relevant — it addresses molecular characteristics across cancers (including age-related changes) while A is specific to glioblastoma signaling and not breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201514Z"}
{"comparison_id":"25f81fc9-c46b-427d-9980-ea2ac6a51682","query_id":"51","doc_a_id":"21521236","doc_b_id":"7808055","presented_order":["7808055","21521236"],"winner_id":"21521236","reasoning":"Neither document mentions ALDH1 or breast cancer prognosis, but Document B (about NEAT1 and chemosensitivity) is more directly related to cancer treatment/outcomes than Document A. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201521Z"}
{"comparison_id":"cf4bf19b-12b4-4417-a411-01affad8064e","query_id":"51","doc_a_id":"23576165","doc_b_id":"7808055","presented_order":["7808055","23576165"],"winner_id":"23576165","reasoning":"Reason: Document B discusses tumor metabolic pathways and metabolic markers relevant to enzymes like ALDH1, while Document A focuses on DNA methylation age and not on ALDH1 or breast outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201529Z"}
{"comparison_id":"ecee27a1-0140-4804-9cdb-ae57a23eeb1e","query_id":"51","doc_a_id":"37204802","doc_b_id":"7808055","presented_order":["7808055","37204802"],"winner_id":"7808055","reasoning":"Document A is more relevant — it discusses cancer-related biomarkers and age acceleration across multiple tissues, which is closer to breast cancer outcome associations than a colon-specific study about JMJD6. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201536Z"}
{"comparison_id":"522f965d-5717-47b5-a3c0-c7c55606cd20","query_id":"51","doc_a_id":"10165723","doc_b_id":"7808055","presented_order":["10165723","7808055"],"winner_id":"10165723","reasoning":"Document A is slightly more relevant because it discusses tumor progression and clinical outcomes (though in melanoma), whereas B focuses on DNA methylation age across tissues and not on ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201543Z"}
{"comparison_id":"82f416e0-919b-463e-ac37-8c173a9c8d90","query_id":"51","doc_a_id":"22049489","doc_b_id":"7808055","presented_order":["22049489","7808055"],"winner_id":"7808055","reasoning":"Document B is slightly more relevant because it discusses cancer-related molecular measures and outcomes across multiple cancer types, whereas Document A focuses on a gastric cancer-specific miRNA pathway unrelated to ALDH1 or breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201550Z"}
{"comparison_id":"66d06b68-dd38-4363-808b-7f1002b86c2a","query_id":"51","doc_a_id":"3730196","doc_b_id":"7808055","presented_order":["3730196","7808055"],"winner_id":"7808055","reasoning":"Reason: Neither abstract mentions ALDH1 or breast cancer specifically; Document B at least addresses cancer broadly, while A concerns HOTTIP in small cell lung cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201557Z"}
{"comparison_id":"e0803eab-53b6-4e91-bbbf-bc301dcca215","query_id":"51","doc_a_id":"6650933","doc_b_id":"7808055","presented_order":["7808055","6650933"],"winner_id":"7808055","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document A is marginally more relevant because it discusses cancer-related biomarkers and outcomes broadly, whereas Document B focuses on EGCG effects on oxidative stress in cells. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201564Z"}
{"comparison_id":"cb4c69af-1e52-4a6e-a44c-8d7c4a5a1fa8","query_id":"51","doc_a_id":"9791313","doc_b_id":"7808055","presented_order":["7808055","9791313"],"winner_id":"7808055","reasoning":"Neither document discusses ALDH1 or breast cancer specifically; Document A mentions age acceleration in multiple cancer types (broader cancer relevance) while B focuses on SETD2 in renal cancer. More relevant: ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201572Z"}
{"comparison_id":"e4e1f852-b292-41d6-aaa4-949bdbc11776","query_id":"51","doc_a_id":"38009906","doc_b_id":"7808055","presented_order":["38009906","7808055"],"winner_id":"7808055","reasoning":"Document B is more relevant — it addresses cancer-related molecular signatures across tissues, whereas A focuses on ANRIL/CBX7 regulation of INK4a (unrelated to ALDH1 or breast cancer outcomes).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201579Z"}
{"comparison_id":"cb01f130-28de-405f-9770-cb8dc21bc6fe","query_id":"51","doc_a_id":"35993767","doc_b_id":"7808055","presented_order":["7808055","35993767"],"winner_id":"7808055","reasoning":"Reason: Neither abstract mentions ALDH1 or breast cancer specifically, but Document A discusses cancer broadly across tissue types while Document B focuses on hepatocellular carcinoma only.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201586Z"}
{"comparison_id":"db1b9da3-c9f2-41ab-b393-4a83011b28fa","query_id":"51","doc_a_id":"1686997","doc_b_id":"7808055","presented_order":["1686997","7808055"],"winner_id":"1686997","reasoning":"Reason: Neither abstract mentions ALDH1 or breast cancer specifically, but Document A discusses cancer tumor growth and pathways affecting outcomes, making it slightly more relevant than the DNA methylation aging study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201592Z"}
{"comparison_id":"e64fb6e6-fc0e-498a-a93c-5c0a5e3cdd1c","query_id":"51","doc_a_id":"27647593","doc_b_id":"7808055","presented_order":["7808055","27647593"],"winner_id":"27647593","reasoning":"Neither abstract mentions ALDH1 or directly addresses breast cancer prognosis, but Document B deals with tumor metabolism and metastasis (more directly related to cancer outcomes) while A focuses on DNA methylation age. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201599Z"}
{"comparison_id":"55a77ec1-18f6-4ae4-a88e-85376375b17b","query_id":"51","doc_a_id":"13205096","doc_b_id":"7808055","presented_order":["13205096","7808055"],"winner_id":"13205096","reasoning":"Document A is more relevant — it concerns gene-expression profiling and prognostic markers (though in AML, not breast cancer), which is closer to a claim about ALDH1 expression and cancer outcomes than Document B's focus on DNA methylation age across tissues.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201606Z"}
{"comparison_id":"7f202b18-75cc-487c-a81f-eb771c92b877","query_id":"51","doc_a_id":"26231129","doc_b_id":"7808055","presented_order":["26231129","7808055"],"winner_id":"26231129","reasoning":"Document A is more relevant — it deals with molecular markers and residual disease in solid cancers (including breast cancer), which is more likely to discuss ALDH1's prognostic role than a paper on DNA methylation age.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201614Z"}
{"comparison_id":"c954d98f-d573-4a1f-832c-2d3555207aa0","query_id":"51","doc_a_id":"33387953","doc_b_id":"7808055","presented_order":["7808055","33387953"],"winner_id":"33387953","reasoning":"Neither document discusses ALDH1. Document B is slightly more relevant because it addresses cancer-related molecular markers and treatment outcomes, which are closer to prognosis than DNA methylation age.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201620Z"}
{"comparison_id":"7e7f3971-15c6-4f0b-9fd7-2310e95c83ad","query_id":"51","doc_a_id":"12685434","doc_b_id":"7808055","presented_order":["12685434","7808055"],"winner_id":"7808055","reasoning":"Document B is slightly more relevant because it addresses cancer-related molecular measures and outcomes, whereas Document A concerns glioblastoma-specific invasion mechanisms unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201627Z"}
{"comparison_id":"77d693df-d1f5-4eab-a091-1ef2bed5adc2","query_id":"51","doc_a_id":"31803596","doc_b_id":"7808055","presented_order":["7808055","31803596"],"winner_id":"31803596","reasoning":"Document B is more relevant — it involves gene expression analysis in cancer (though OSCC, not breast), while A focuses on DNA methylation age rather than specific gene expression like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201634Z"}
{"comparison_id":"fa9ab49d-5eb5-4035-978c-0d08816b3203","query_id":"51","doc_a_id":"864491","doc_b_id":"7808055","presented_order":["7808055","864491"],"winner_id":"864491","reasoning":"B is more relevant — it addresses tumor behavior and treatment effects related to cancer outcomes, while A focuses on DNA methylation age across tissues and is not about prognostic markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201641Z"}
{"comparison_id":"d5e6c31d-2b26-4616-ba1a-6b1f8bddeb89","query_id":"51","doc_a_id":"18358026","doc_b_id":"7808055","presented_order":["18358026","7808055"],"winner_id":"18358026","reasoning":"Document A is more relevant — it discusses cancer-related gene expression and promoter methylation mechanisms that could affect markers like ALDH1, whereas B focuses on DNA methylation age across tissues and is less directly related to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201648Z"}
{"comparison_id":"91b477d4-9ca9-4535-8d76-aa87f9908393","query_id":"51","doc_a_id":"4467129","doc_b_id":"7808055","presented_order":["4467129","7808055"],"winner_id":"7808055","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer outcomes; Document B is marginally more relevant because it addresses cancer broadly, whereas Document A is specific to neuroblastoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201655Z"}
{"comparison_id":"6a24601e-5996-4fc7-b5ef-a28a4d58a030","query_id":"51","doc_a_id":"3858268","doc_b_id":"7808055","presented_order":["3858268","7808055"],"winner_id":"3858268","reasoning":"Document A — it discusses cancer stem cells and markers/biology related to CSCs (ALDH1 is a CSC marker), while B is about DNA methylation age and not ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201661Z"}
{"comparison_id":"e1ebc7e6-0661-4b89-8a32-cf20976539f8","query_id":"51","doc_a_id":"8538916","doc_b_id":"7808055","presented_order":["7808055","8538916"],"winner_id":"8538916","reasoning":"Document B is more focused on protein expression in cancer cells and its impact on cancer behavior, which is closer to a claim about marker expression and outcomes; Document A is about DNA methylation age, not ALDH1 or clinical outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201668Z"}
{"comparison_id":"0505b041-4c81-425d-b4da-4b3b64ad3759","query_id":"51","doc_a_id":"11578459","doc_b_id":"7808055","presented_order":["11578459","7808055"],"winner_id":"11578459","reasoning":"Neither document directly addresses ALDH1 or breast cancer. Document A discusses a stem cell–related expression signature in a tumor (glioblastoma), which is more closely related to ALDH1 (a stem cell marker) than Document B's broad DNA methylation age analysis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201675Z"}
{"comparison_id":"4933e8b8-5f6b-4c1d-a1f9-c7b60e16306c","query_id":"51","doc_a_id":"13889430","doc_b_id":"7808055","presented_order":["7808055","13889430"],"winner_id":"7808055","reasoning":"Document A is more relevant — it addresses cancer-related molecular measures across tumor types (potentially linked to prognosis), whereas Document B focuses on exosome-induced stromal changes unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201682Z"}
{"comparison_id":"38f37f99-2086-4a40-a255-2a77023aef7f","query_id":"51","doc_a_id":"5254463","doc_b_id":"7808055","presented_order":["5254463","7808055"],"winner_id":"7808055","reasoning":"Document B is slightly more related because it addresses cancer broadly and human tissue biomarkers, whereas A focuses on Wip1 in mouse intestinal/colorectal cancer unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201689Z"}
{"comparison_id":"696df0ae-123b-4ecc-bec0-c0b231189c4c","query_id":"51","doc_a_id":"15727984","doc_b_id":"7808055","presented_order":["7808055","15727984"],"winner_id":"7808055","reasoning":"Document A is more relevant because it discusses cancer-related molecular measures and outcomes across multiple cancer types, whereas Document B focuses on secreted proteins in lung cancer microenvironment only. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201695Z"}
{"comparison_id":"3b6691ad-611c-4547-bc3e-abb504e219ab","query_id":"51","doc_a_id":"7975937","doc_b_id":"7808055","presented_order":["7975937","7808055"],"winner_id":"7808055","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document B is slightly more relevant because it discusses cancer-related changes (age acceleration) across cancer types, whereas A focuses on COX-mediated immune evasion in melanoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201702Z"}
{"comparison_id":"c2111594-6d31-4812-bc5f-db7eaadcee26","query_id":"51","doc_a_id":"10365787","doc_b_id":"7808055","presented_order":["7808055","10365787"],"winner_id":"10365787","reasoning":"Neither document addresses ALDH1 or its link to breast cancer outcomes. Document B is slightly more relevant only because it discusses tumor suppression mechanisms affecting cancer prognosis, whereas A focuses on DNA methylation age across tissues.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201709Z"}
{"comparison_id":"ec0f002a-58d9-43a3-8337-1b65cb9357e0","query_id":"51","doc_a_id":"4325398","doc_b_id":"7808055","presented_order":["7808055","4325398"],"winner_id":"7808055","reasoning":"Reason: Document A addresses cancer-related molecular measures across multiple tissues (broad cancer relevance), while Document B focuses specifically on pancreatic cancer genomic aberrations unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201716Z"}
{"comparison_id":"9b2daa78-e501-4331-a81d-ddd41877dd85","query_id":"51","doc_a_id":"17717391","doc_b_id":"7808055","presented_order":["7808055","17717391"],"winner_id":"17717391","reasoning":"Document B is more relevant — it discusses expression of a tumor-related marker and its relationship to tumorigenesis and outcomes, which is closer to the claim about marker (ALDH1) expression and breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201723Z"}
{"comparison_id":"da6eae29-e327-4476-aca4-fc287e335595","query_id":"51","doc_a_id":"2374637","doc_b_id":"7808055","presented_order":["7808055","2374637"],"winner_id":"2374637","reasoning":"Document B is more relevant — it focuses on methods for interpreting gene expression in cancer, which is directly applicable to assessing a gene (ALDH1) and its association with breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201730Z"}
{"comparison_id":"702b65f8-09cf-4d79-b121-efcb3b0d4c49","query_id":"51","doc_a_id":"24294572","doc_b_id":"7808055","presented_order":["24294572","7808055"],"winner_id":"24294572","reasoning":"Document A is more relevant — it addresses cancer signaling and tumor behavior, which is closer to markers affecting breast cancer outcomes than a paper on DNA methylation age. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201737Z"}
{"comparison_id":"97841062-38bb-4a78-a75a-3bf6af9dab86","query_id":"51","doc_a_id":"1727493","doc_b_id":"7808055","presented_order":["7808055","1727493"],"winner_id":"7808055","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer outcomes, but Document A is a broader cancer-related study (mentions cancer types) while Document B is specific to ovarian cancer and miR21, so A is marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201744Z"}
{"comparison_id":"e118bd00-bfa3-4068-bf37-c44d812bad82","query_id":"51","doc_a_id":"16364639","doc_b_id":"7808055","presented_order":["16364639","7808055"],"winner_id":"7808055","reasoning":"Document B is more relevant — it addresses cancer broadly and tissue-level biomarkers, while A focuses specifically on microRNA networks in glioblastoma (brain cancer), not breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201751Z"}
{"comparison_id":"f4a83a1d-bf5c-4427-a4de-070d779255d5","query_id":"51","doc_a_id":"1649738","doc_b_id":"7808055","presented_order":["7808055","1649738"],"winner_id":"7808055","reasoning":"Document A is more relevant — it addresses cancer-related biomarkers and cancer types generally, whereas Document B focuses on PRDM1 variants in Hodgkin's lymphoma and second malignancies, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201759Z"}
{"comparison_id":"697b7e55-b891-4cae-9026-78d8fc8497d2","query_id":"51","doc_a_id":"14019636","doc_b_id":"7808055","presented_order":["7808055","14019636"],"winner_id":"7808055","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes directly; Document A is marginally more relevant because it discusses cancer-related molecular measures across tissues, whereas B focuses specifically on rDNA copy number and DNA-damage sensitivity. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201765Z"}
{"comparison_id":"5eac871f-77fc-4e66-b9c3-59b170906066","query_id":"51","doc_a_id":"19408393","doc_b_id":"7808055","presented_order":["7808055","19408393"],"winner_id":"7808055","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular measures and age acceleration in cancer types, whereas Document B concerns clinical outcomes after whole brain re-irradiation unrelated to ALDH1 or breast cancer biology.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201772Z"}
{"comparison_id":"28cd6118-80aa-44a8-abbb-35861afa0fb0","query_id":"51","doc_a_id":"2613411","doc_b_id":"7808055","presented_order":["7808055","2613411"],"winner_id":"2613411","reasoning":"Neither document discusses ALDH1 or breast cancer prognosis. Document B is marginally more relevant because it addresses cancer cell biology and therapeutic implications, while A focuses on DNA methylation age across tissues.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201778Z"}
{"comparison_id":"50496193-eafa-42a0-be88-7b5c9ba57a8f","query_id":"51","doc_a_id":"19644821","doc_b_id":"7808055","presented_order":["7808055","19644821"],"winner_id":"7808055","reasoning":"Document A is slightly more relevant because it discusses cancer-related biological markers and outcomes, whereas B focuses specifically on Lin28b in murine liver cancer; neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201785Z"}
{"comparison_id":"53183e72-4f9f-4cd0-9b9b-8ab2b6c10241","query_id":"51","doc_a_id":"20501163","doc_b_id":"7808055","presented_order":["7808055","20501163"],"winner_id":"7808055","reasoning":"Reason: Neither document mentions ALDH1, but Document A discusses cancer-related markers (DNA methylation age) across cancer types, so it's marginally more related to tumor biomarkers and outcomes than the metabolism/immune focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201792Z"}
{"comparison_id":"6605475c-fad0-4e65-ba6a-705c10b70a9d","query_id":"51","doc_a_id":"8994465","doc_b_id":"7808055","presented_order":["7808055","8994465"],"winner_id":"8994465","reasoning":"Reason: Document B discusses tumor cell subpopulations defined by marker expression and their impact on tumor behavior, which is more related to claims about biomarker expression and clinical outcomes than Document A's focus on DNA methylation age.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201798Z"}
{"comparison_id":"df4edf95-843f-491f-a716-4c1942e093e4","query_id":"51","doc_a_id":"31624828","doc_b_id":"7808055","presented_order":["31624828","7808055"],"winner_id":"7808055","reasoning":"Document B is more relevant — it discusses cancer-related biomarkers and prognosis/age-acceleration in cancers, which is closer to a claim about a molecular marker (ALDH1) and breast cancer outcomes. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201805Z"}
{"comparison_id":"35db72b1-7f2f-49c1-9d07-98f55d9da84b","query_id":"51","doc_a_id":"23887844","doc_b_id":"7808055","presented_order":["7808055","23887844"],"winner_id":"7808055","reasoning":"Document A is more relevant — it addresses cancer-related biomarkers and outcomes broadly, whereas Document B focuses on metabolic inhibition of apoptosis and not on ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201811Z"}
{"comparison_id":"fd44b944-1784-4336-bd49-a8c3b7edf995","query_id":"51","doc_a_id":"6828370","doc_b_id":"7808055","presented_order":["7808055","6828370"],"winner_id":"6828370","reasoning":"Document B is more relevant — it discusses gene expression regulation and tumor biology, which is closer to a claim about a specific cancer marker (ALDH1) and outcomes than a paper on DNA methylation age. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201818Z"}
{"comparison_id":"7b764f7e-deee-48b7-bfdf-fe25e7e470b3","query_id":"51","doc_a_id":"20179918","doc_b_id":"7808055","presented_order":["7808055","20179918"],"winner_id":"7808055","reasoning":"Document A mentions cancer and cancer-related measures (age acceleration) and is marginally closer to breast cancer outcomes than Document B, which focuses on STAT3 regulation in embryonic stem cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201825Z"}
{"comparison_id":"48dddb31-d300-4ef3-9ecd-4d86e0ad0818","query_id":"51","doc_a_id":"36547290","doc_b_id":"7808055","presented_order":["7808055","36547290"],"winner_id":"7808055","reasoning":"Document A is more relevant — it discusses cancer-related changes (DNA methylation age acceleration) whereas Document B focuses on BRG1/STAT3 at cytokine-inducible genes with no connection to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201832Z"}
{"comparison_id":"4ee686f3-80c3-4f74-8e23-b6ae586f4276","query_id":"51","doc_a_id":"12152977","doc_b_id":"7808055","presented_order":["7808055","12152977"],"winner_id":"7808055","reasoning":"Document A is more relevant — it addresses cancer-related molecular measures and outcomes, whereas Document B focuses on embryonic stem cell pluripotency and does not pertain to cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201838Z"}
{"comparison_id":"bca3fafb-e557-4a18-872c-c420fbc86476","query_id":"51","doc_a_id":"17412260","doc_b_id":"7808055","presented_order":["17412260","7808055"],"winner_id":"17412260","reasoning":"Document A is more relevant — it discusses tumor-related biology (senescence and tumor suppression) that could affect cancer outcomes, whereas B focuses on DNA methylation age across tissues with only broad cancer associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201846Z"}
{"comparison_id":"a3528e80-aa11-4531-8d04-82948832f683","query_id":"51","doc_a_id":"1791714","doc_b_id":"7808055","presented_order":["7808055","1791714"],"winner_id":"1791714","reasoning":"Reason: Neither discusses ALDH1 or breast cancer, but Document B deals with cancer cell traits (EMT/metastasis) more directly related to prognostic markers than the DNA methylation age topic in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201852Z"}
{"comparison_id":"fd598424-9015-4f40-a72f-58287537f7b3","query_id":"51","doc_a_id":"2485101","doc_b_id":"7808055","presented_order":["2485101","7808055"],"winner_id":"2485101","reasoning":"Document A is more relevant — it focuses on integrating gene expression (eQTLs) with disease associations, which relates to evaluating gene expression (like ALDH1) in disease outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201858Z"}
{"comparison_id":"6aac5e71-28cd-4e8d-b338-c88a01111984","query_id":"51","doc_a_id":"25748308","doc_b_id":"7808055","presented_order":["7808055","25748308"],"winner_id":"7808055","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular markers and age acceleration in cancer types, whereas Document B focuses on GAPDH functions unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:06.201865Z"}
{"comparison_id":"26799151-642a-4e56-892c-aaafe52470ab","query_id":"51","doc_a_id":"23830488","doc_b_id":"3590806","presented_order":["3590806","23830488"],"winner_id":"3590806","reasoning":"Document A — it discusses cancer-initiating (stem-like) cells and self-renewal pathways, which is conceptually closer to ALDH1 (a stem cell marker) than Document B's focus on circadian genes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930041Z"}
{"comparison_id":"0080de6b-4446-41f7-85b9-c251b813d41f","query_id":"51","doc_a_id":"24349992","doc_b_id":"3590806","presented_order":["24349992","3590806"],"winner_id":"24349992","reasoning":"Document A is more relevant — it discusses tumor-stroma biology (including breast cancer–related concepts) and cancer outcomes, whereas Document B focuses on colorectal cancer mechanisms unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930063Z"}
{"comparison_id":"4ac1dbaf-927d-4976-a7d5-6fd9a4938cba","query_id":"51","doc_a_id":"42731834","doc_b_id":"3590806","presented_order":["3590806","42731834"],"winner_id":"3590806","reasoning":"Document A — it deals with cancer-initiating cells and stemness/Wnt pathway regulation (concepts related to ALDH1 as a stem cell marker), whereas B addresses an unrelated prognostic marker (AIM2).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930071Z"}
{"comparison_id":"8cbda4f3-ae1d-40a9-9fcd-8ca9bbd4b6a8","query_id":"51","doc_a_id":"25832301","doc_b_id":"3590806","presented_order":["3590806","25832301"],"winner_id":"25832301","reasoning":"Document B — it links expression level to patient/tumor outcomes (though in multiple myeloma), which is more similar to the claim about marker expression and breast cancer outcomes than Document A's mechanistic colorectal study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930079Z"}
{"comparison_id":"5fbc3a76-cc89-4db5-b719-02df43708744","query_id":"51","doc_a_id":"8037453","doc_b_id":"3590806","presented_order":["8037453","3590806"],"winner_id":"8037453","reasoning":"Document A is more relevant — it discusses prognostic biomarkers and clinical outcomes in cancer patients, whereas Document B concerns a colorectal cancer molecular mechanism unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930086Z"}
{"comparison_id":"1512a0f0-fdb3-430a-8415-4ed1895fb1aa","query_id":"51","doc_a_id":"31591262","doc_b_id":"3590806","presented_order":["31591262","3590806"],"winner_id":"31591262","reasoning":"Document A — it addresses gene expression correlated with clinical outcomes (recurrence-free survival), which is more similar to the query about marker expression and breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930093Z"}
{"comparison_id":"82b45130-13db-4911-8dd5-919761b1473f","query_id":"51","doc_a_id":"7795952","doc_b_id":"3590806","presented_order":["3590806","7795952"],"winner_id":"7795952","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more related because it addresses a protein linked to cancer prognosis, while A is specific to colorectal cancer stem cells and Wnt signaling.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930101Z"}
{"comparison_id":"2d36953f-d2ee-4491-973e-9e4212d930a6","query_id":"51","doc_a_id":"19047331","doc_b_id":"3590806","presented_order":["19047331","3590806"],"winner_id":"19047331","reasoning":"Document A is more relevant — it discusses cancer biomarker expression and clinical outcomes (though in ovarian cancer), whereas B focuses on colorectal Wnt signaling and does not address biomarkers or outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930109Z"}
{"comparison_id":"2230d059-3341-4229-9579-378dfbbfe4f0","query_id":"51","doc_a_id":"7165938","doc_b_id":"3590806","presented_order":["3590806","7165938"],"winner_id":"3590806","reasoning":"Doc A is slightly more relevant because it discusses cancer-initiating cells (stem-cell–related biology), which relates to ALDH1 as a stem cell marker; Doc B is about circadian gene effects in colorectal cancer and not related. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930116Z"}
{"comparison_id":"e1dbc3e8-06fc-4856-a366-a1ac91c35c10","query_id":"51","doc_a_id":"2727303","doc_b_id":"3590806","presented_order":["2727303","3590806"],"winner_id":"3590806","reasoning":"Neither abstract mentions ALDH1 or breast cancer. Document B is slightly more relevant because it concerns cancer-initiating cells and stemness pathways (which relate to ALDH1 as a stem cell marker).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930123Z"}
{"comparison_id":"d3972535-6125-47a9-ada1-000d8c012c56","query_id":"51","doc_a_id":"1782201","doc_b_id":"3590806","presented_order":["3590806","1782201"],"winner_id":"3590806","reasoning":"Document A is slightly more relevant because it addresses cancer-initiating (stem-like) cells, a context where ALDH1 is commonly studied as a marker, whereas B focuses on integrin αvβ3 signaling in pancreatic and other carcinomas without connection to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930130Z"}
{"comparison_id":"bb81c1d5-7664-4c16-9959-f40a82bb4220","query_id":"51","doc_a_id":"2389574","doc_b_id":"3590806","presented_order":["2389574","3590806"],"winner_id":"2389574","reasoning":"Document A is more relevant — it discusses a prognostic marker and survival associations in cancer (though endometrial, not breast), whereas B focuses on a colorectal cancer signaling mechanism unrelated to ALDH1 or outcomes. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930138Z"}
{"comparison_id":"7f0128fa-827a-4eb4-8bbc-1080e01a9f16","query_id":"51","doc_a_id":"25576204","doc_b_id":"3590806","presented_order":["25576204","3590806"],"winner_id":"25576204","reasoning":"Document A is marginally more relevant — it addresses cancer tumorigenesis and tumor-suppressor effects (broader cancer outcome context), while B is specific to colorectal Wnt signaling and not related to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930145Z"}
{"comparison_id":"2a666f84-91a8-412b-a80e-fbef0e891c10","query_id":"51","doc_a_id":"5774746","doc_b_id":"3590806","presented_order":["5774746","3590806"],"winner_id":"3590806","reasoning":"Document B is more related because it addresses cancer-initiating (stem-like) cells and pathways affecting self-renewal, which is relevant to ALDH1 as a stem-cell marker; Document A focuses on inflammation/metastasis in colorectal cancer and does not relate to ALDH1 or breast outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930152Z"}
{"comparison_id":"6060fc98-a8df-4e38-8312-ec2fc9e83e62","query_id":"51","doc_a_id":"11271123","doc_b_id":"3590806","presented_order":["3590806","11271123"],"winner_id":"3590806","reasoning":"Neither paper addresses ALDH1 or breast cancer directly. Document A is slightly more relevant because it concerns cancer-initiating (stem-like) cells, which is thematically closer to ALDH1 as a stem-cell marker. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930159Z"}
{"comparison_id":"cd97e83e-e3e6-41ed-a179-433ad127dc76","query_id":"51","doc_a_id":"13964633","doc_b_id":"3590806","presented_order":["3590806","13964633"],"winner_id":"3590806","reasoning":"Neither abstract mentions ALDH1 or breast cancer, but Document A discusses cancer-initiating cells and stemness pathways (more directly related to ALDH1 as a stem cell marker), so it's slightly more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930166Z"}
{"comparison_id":"002b0fc4-4249-42ad-b0b6-2accb7688dae","query_id":"51","doc_a_id":"12358173","doc_b_id":"3590806","presented_order":["12358173","3590806"],"winner_id":"12358173","reasoning":"Document A is more relevant — it discusses expression levels correlating with tumor prognosis (outcomes) in cancer, whereas Document B focuses on a different pathway in colorectal cancer initiating cells and not on prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930174Z"}
{"comparison_id":"8c4e86d1-8b03-4607-844c-b775ef33b364","query_id":"51","doc_a_id":"33370","doc_b_id":"3590806","presented_order":["3590806","33370"],"winner_id":"3590806","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it deals with cancer-initiating (stem-like) cells and signaling pathways, whereas B focuses on glioma and A20. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930181Z"}
{"comparison_id":"00065661-4163-4749-8853-d56958dfd584","query_id":"51","doc_a_id":"22521091","doc_b_id":"3590806","presented_order":["22521091","3590806"],"winner_id":"22521091","reasoning":"Document A is slightly more relevant because it discusses a protein's expression correlating with cancer progression and patient survival, which is closer to the claim about marker expression and outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930188Z"}
{"comparison_id":"bfbec916-5982-4394-9e75-68bcd3a92705","query_id":"51","doc_a_id":"1032372","doc_b_id":"3590806","presented_order":["3590806","1032372"],"winner_id":"3590806","reasoning":"Document A — it discusses cancer-initiating cells (stem-like cells), which is more related to ALDH1 as a stem cell marker than the general immunotherapy/epigenetics focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930196Z"}
{"comparison_id":"40d3885a-f62c-4ef8-b8da-8b6740015528","query_id":"51","doc_a_id":"5386514","doc_b_id":"3590806","presented_order":["5386514","3590806"],"winner_id":"3590806","reasoning":"Document B is more relevant — it addresses cancer-initiating cells and stem-cell pathways (Wnt/RORβ), which relate to ALDH1 as a stem-cell marker; Document A discusses inflammasome/immune responses, not ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930203Z"}
{"comparison_id":"0f281c8c-1ee8-4966-a5a4-00730e056407","query_id":"51","doc_a_id":"33638477","doc_b_id":"3590806","presented_order":["3590806","33638477"],"winner_id":"3590806","reasoning":"Document A is slightly more relevant because it concerns cancer-initiating (stem-like) cells and Wnt signaling, a context more directly related to ALDH1 as a stem cell marker; Document B focuses on BCL9-driven progression in other cancers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930210Z"}
{"comparison_id":"40bddf4a-1a06-4e19-86c5-6fe687c550be","query_id":"51","doc_a_id":"21502234","doc_b_id":"3590806","presented_order":["21502234","3590806"],"winner_id":"3590806","reasoning":"Document B is more relevant — it discusses cancer stem/initiating cell biology and signaling (which relates to markers like ALDH1), whereas Document A concerns MMR status in endometrial cancer and is unrelated.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930218Z"}
{"comparison_id":"7d94e338-4ac1-49b2-b166-7004b89710f4","query_id":"51","doc_a_id":"515489","doc_b_id":"3590806","presented_order":["3590806","515489"],"winner_id":"515489","reasoning":"Document B is slightly more relevant — it links a marker of stem cell–like properties to clinical prognosis (though in HCC, not breast cancer). Neither document mentions ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930224Z"}
{"comparison_id":"5e703390-c261-40a5-a633-fa8785ea9904","query_id":"51","doc_a_id":"17755060","doc_b_id":"3590806","presented_order":["3590806","17755060"],"winner_id":"17755060","reasoning":"Document B is slightly more relevant because it discusses tumor prognosis and human cancers, whereas A is a mechanistic study in colorectal cancer cells unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930232Z"}
{"comparison_id":"cda8bd56-676a-42f8-a119-ec540cb42f04","query_id":"51","doc_a_id":"3805841","doc_b_id":"3590806","presented_order":["3805841","3590806"],"winner_id":"3590806","reasoning":"Document B is more relevant — it deals with cancer-initiating cells and stemness pathways (related to ALDH1's role as a stem/progenitor marker), whereas A focuses on MYC and circadian disruption in neuroblastoma. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930239Z"}
{"comparison_id":"995f2564-7994-4dd7-bd76-ce0bb90407a5","query_id":"51","doc_a_id":"38243984","doc_b_id":"3590806","presented_order":["38243984","3590806"],"winner_id":"3590806","reasoning":"Document B — it addresses cancer-initiating cells and stemness pathways (closer to ALDH1’s role as a stem-cell marker), whereas A concerns pancreatic tumor engraftment and drug resistance unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930247Z"}
{"comparison_id":"40fa3e57-6289-41ab-9052-db17b0e5ac5a","query_id":"51","doc_a_id":"29806339","doc_b_id":"3590806","presented_order":["3590806","29806339"],"winner_id":"3590806","reasoning":"Document A is slightly more relevant because it addresses cancer-initiating (stem-like) cells and pathways tied to self-renewal, which relates to ALDH1 as a stem cell marker; Document B focuses on mitotic exit mechanisms unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930255Z"}
{"comparison_id":"3c80fd26-0005-4be4-bcbb-77542a2a988b","query_id":"51","doc_a_id":"2485101","doc_b_id":"3590806","presented_order":["2485101","3590806"],"winner_id":"2485101","reasoning":"Document A is more relevant — it discusses methods for linking gene expression to disease-associated traits, which is applicable to assessing ALDH1 expression and breast cancer outcomes; Document B focuses on a different gene in colorectal cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930262Z"}
{"comparison_id":"00a00a2e-5804-4759-b6b1-b26030b3d351","query_id":"51","doc_a_id":"4429118","doc_b_id":"3590806","presented_order":["4429118","3590806"],"winner_id":"4429118","reasoning":"Document A is more relevant because it addresses general cancer biology and tumor microenvironment factors that could relate to biomarkers like ALDH1 in breast cancer, while Document B focuses on colorectal cancer and NRIP2. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930269Z"}
{"comparison_id":"aafbccc8-c713-4fb8-85aa-762938ae4f0d","query_id":"51","doc_a_id":"26561572","doc_b_id":"3590806","presented_order":["3590806","26561572"],"winner_id":"3590806","reasoning":"Document A is slightly more relevant because it discusses cancer-initiating (stem-like) cells and pathways linked to stemness, whereas Document B focuses on kinase fusions in lung cancer and is unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930276Z"}
{"comparison_id":"2b454016-7628-49d1-9f17-322c13113ffd","query_id":"51","doc_a_id":"13980338","doc_b_id":"3590806","presented_order":["3590806","13980338"],"winner_id":"13980338","reasoning":"Document B — it concerns single-cell gene expression linked to stem-cell functional markers, which is more relevant to evaluating associations of a stem-cell marker like ALDH1 with cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930283Z"}
{"comparison_id":"4109ea7c-8642-4c1d-963d-948dda5b7410","query_id":"51","doc_a_id":"13400643","doc_b_id":"3590806","presented_order":["13400643","3590806"],"winner_id":"3590806","reasoning":"Document B — it discusses cancer-initiating cells and self-renewal (concepts related to ALDH1 as a stem-cell marker), whereas A focuses on a small-molecule histone demethylase inhibitor unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930290Z"}
{"comparison_id":"eae76d39-eb88-4396-b5ea-2ebf52ec8f52","query_id":"51","doc_a_id":"29473081","doc_b_id":"3590806","presented_order":["3590806","29473081"],"winner_id":"3590806","reasoning":"Document A — it discusses cancer-initiating cells and pathways related to stemness (more conceptually related to ALDH1’s role in cancer), whereas B is focused on multiple myeloma glycosylation unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930297Z"}
{"comparison_id":"acd136fe-4f9d-426a-a2a2-b9d945542250","query_id":"51","doc_a_id":"21521236","doc_b_id":"3590806","presented_order":["21521236","3590806"],"winner_id":"3590806","reasoning":"Document B is more relevant — it addresses cancer-initiating cells and pathways tied to stemness (contexts where ALDH1 is used as a stem cell marker), while Document A focuses on NEAT1/p53 and chemosensitivity without relation to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930304Z"}
{"comparison_id":"5f3adca2-3194-432b-b854-43832ed4f342","query_id":"51","doc_a_id":"23576165","doc_b_id":"3590806","presented_order":["3590806","23576165"],"winner_id":"3590806","reasoning":"Document A is slightly more relevant because it discusses cancer-initiating cells and stem-cell–related pathways (which relate to ALDH1 as a stem cell marker), whereas Document B focuses on tumor metabolism without relation to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930311Z"}
{"comparison_id":"9cabb6ad-d0bd-4974-9cad-fd9fcd85fb77","query_id":"51","doc_a_id":"10165723","doc_b_id":"3590806","presented_order":["10165723","3590806"],"winner_id":"3590806","reasoning":"B is more relevant — it addresses cancer-initiating cells and stemness pathways (closely related to ALDH1 as a stem cell marker), whereas A concerns melanoma methylation unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930319Z"}
{"comparison_id":"c9e5935f-5e81-4b03-bdd6-2105b319365c","query_id":"51","doc_a_id":"1686997","doc_b_id":"3590806","presented_order":["3590806","1686997"],"winner_id":"3590806","reasoning":"Document A — it discusses cancer-initiating cells and stemness pathways (more conceptually related to ALDH1 as a stem-cell marker), whereas B focuses on a metabolic enzyme unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930326Z"}
{"comparison_id":"0174b667-e900-4ac9-91f3-dc2bd5fd03fd","query_id":"51","doc_a_id":"27647593","doc_b_id":"3590806","presented_order":["3590806","27647593"],"winner_id":"27647593","reasoning":"Neither abstract mentions ALDH1 or directly studies breast cancer, but B discusses tumor metabolism and microenvironment mechanisms relevant across cancers (potentially including breast), whereas A is specific to colorectal cancer signaling. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930334Z"}
{"comparison_id":"2dfa0750-fde2-4d10-8c44-122bff70daa6","query_id":"51","doc_a_id":"13205096","doc_b_id":"3590806","presented_order":["3590806","13205096"],"winner_id":"3590806","reasoning":"Document A is slightly more relevant because it discusses cancer initiating cells and pathways related to stemness, whereas Document B is about prognosis in acute myeloid leukemia; neither addresses ALDH1 or breast cancer directly.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930341Z"}
{"comparison_id":"4bea9587-4010-4f97-bc9b-2c315ebc1489","query_id":"51","doc_a_id":"26231129","doc_b_id":"3590806","presented_order":["3590806","26231129"],"winner_id":"26231129","reasoning":"Document B is more relevant — it discusses residual disease and targeting strategies in solid cancers (broader context that could include biomarkers and outcomes), whereas Document A focuses on NRIP2 in colorectal cancer and is not related to ALDH1 or breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930348Z"}
{"comparison_id":"43dd4f5a-d91d-421d-823d-68c7dd8027e5","query_id":"51","doc_a_id":"33387953","doc_b_id":"3590806","presented_order":["3590806","33387953"],"winner_id":"3590806","reasoning":"Document A — it discusses cancer-initiating cells and pathways tied to tumor stemness (more related to ALDH1 as a stem cell marker), while Document B focuses on G protein mutations and drug resistance unrelated to ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930355Z"}
{"comparison_id":"18b43a08-4864-405a-a5e8-7f9173d58ce0","query_id":"51","doc_a_id":"31803596","doc_b_id":"3590806","presented_order":["31803596","3590806"],"winner_id":"31803596","reasoning":"Document A is slightly more relevant because it reports gene expression analysis in cancer (more likely to address marker–outcome associations), whereas Document B focuses on a specific regulator in colorectal cancer unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930362Z"}
{"comparison_id":"64bd324c-3bf2-49a2-bb2b-3370b91c8b4c","query_id":"51","doc_a_id":"864491","doc_b_id":"3590806","presented_order":["3590806","864491"],"winner_id":"3590806","reasoning":"Document A — it discusses cancer-initiating cells and stemness-related pathways (more thematically related to ALDH1 as a stem cell marker). Neither paper mentions ALDH1 or breast cancer outcomes, but A is closer in topic.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930369Z"}
{"comparison_id":"fceb2f78-02f6-481a-b66e-f30736de213d","query_id":"51","doc_a_id":"18358026","doc_b_id":"3590806","presented_order":["3590806","18358026"],"winner_id":"3590806","reasoning":"Document A — it discusses cancer-initiating cells and regulators of stemness (more related to ALDH1 as a CSC marker), while B concerns DNA methylation/oxidative damage unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930376Z"}
{"comparison_id":"878f0f92-db5b-4148-b34c-fe72429a823d","query_id":"51","doc_a_id":"3858268","doc_b_id":"3590806","presented_order":["3858268","3590806"],"winner_id":"3858268","reasoning":"Document A is slightly more relevant — it addresses cancer stem cell markers and tumor outcomes (though in ovarian cancer), whereas B focuses on colorectal cancer and a different pathway. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930383Z"}
{"comparison_id":"d96deed4-e347-4999-920d-308af0b87a9b","query_id":"51","doc_a_id":"8538916","doc_b_id":"3590806","presented_order":["8538916","3590806"],"winner_id":"3590806","reasoning":"Document B is slightly more relevant because it addresses cancer-initiating cells and pathways related to stemness (which ALDH1 is a marker of), whereas A focuses on a chaperonin unrelated to ALDH1 or breast outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930390Z"}
{"comparison_id":"f14b2c64-8d92-4f78-b904-bc6c52e009fe","query_id":"51","doc_a_id":"11578459","doc_b_id":"3590806","presented_order":["3590806","11578459"],"winner_id":"3590806","reasoning":"Both documents are unrelated to ALDH1 or breast cancer, but Document A discusses cancer-initiating (stem-like) cells and pathways affecting self-renewal, making it slightly more relevant to a claim about a stem-cell marker like ALDH1 than Document B (glioblastoma HOX signature). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930398Z"}
{"comparison_id":"43f03157-657f-4026-a655-2bda33233f99","query_id":"51","doc_a_id":"10365787","doc_b_id":"3590806","presented_order":["3590806","10365787"],"winner_id":"3590806","reasoning":"Document A is more relevant — it discusses cancer-initiating cells and pathways affecting self‑renewal (closely related to stem-cell markers like ALDH1), whereas B focuses on cell-cycle/ genomic stability without connection to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930405Z"}
{"comparison_id":"5fb6a748-5ba3-4c42-9b71-4692fe2e6df9","query_id":"51","doc_a_id":"17717391","doc_b_id":"3590806","presented_order":["17717391","3590806"],"winner_id":"17717391","reasoning":"Document A is slightly more relevant because it discusses tumor marker expression and cancer monitoring, whereas Document B focuses on colorectal-specific mechanisms unrelated to ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930412Z"}
{"comparison_id":"9478df92-9def-47bb-b0e3-5629480541a7","query_id":"51","doc_a_id":"2374637","doc_b_id":"3590806","presented_order":["2374637","3590806"],"winner_id":"2374637","reasoning":"Document A is more relevant — it discusses methods for interpreting genome-wide expression in cancer contexts (applicable to ALDH1/breast cancer expression analyses), whereas B concerns NRIP2 in colorectal cancer and is unrelated.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930418Z"}
{"comparison_id":"a70b5091-ba5f-42a8-855b-d3acb53f5733","query_id":"51","doc_a_id":"24294572","doc_b_id":"3590806","presented_order":["24294572","3590806"],"winner_id":"24294572","reasoning":"Document A is more relevant — it addresses cancer signaling and tumor suppressor activity (broader cancer context), whereas Document B is specific to colorectal cancer and unrelated to ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930426Z"}
{"comparison_id":"f49bf522-39c0-4be8-a646-7ebfa3ca4807","query_id":"51","doc_a_id":"2613411","doc_b_id":"3590806","presented_order":["2613411","3590806"],"winner_id":"2613411","reasoning":"Document A is more generally about cancer biology (cell cycle/CDKs) and thus marginally more relevant to a claim about a breast cancer marker than Document B, which is specific to colorectal cancer and NRIP2.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930432Z"}
{"comparison_id":"d73b32ad-3f12-45ef-bbbc-09b6054b4dc5","query_id":"51","doc_a_id":"8994465","doc_b_id":"3590806","presented_order":["3590806","8994465"],"winner_id":"8994465","reasoning":"Document B is more relevant — it discusses a marker-defined tumor cell subpopulation and its impact on tumor maintenance, which is conceptually closer to evaluating how a marker like ALDH1 relates to cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930439Z"}
{"comparison_id":"289c70cb-9782-4e76-8bc2-80e36ab18ec6","query_id":"51","doc_a_id":"6828370","doc_b_id":"3590806","presented_order":["6828370","3590806"],"winner_id":"6828370","reasoning":"Document A is more relevant — it addresses general tumor biology and cancer-related regulatory mechanisms, whereas B focuses specifically on colorectal cancer and NRIP2/RORβ. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930446Z"}
{"comparison_id":"804a5320-93b4-477b-a37b-9271d7a82f4e","query_id":"51","doc_a_id":"17412260","doc_b_id":"3590806","presented_order":["3590806","17412260"],"winner_id":"3590806","reasoning":"Document A is more relevant — it discusses cancer-initiating cells and pathways affecting self-renewal, which is more directly related to stem-cell marker ALDH1 and cancer outcomes than the inflammasome/SASP topic in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930454Z"}
{"comparison_id":"b6c51709-cbd7-436b-8a4b-9ed0008a9953","query_id":"51","doc_a_id":"1791714","doc_b_id":"3590806","presented_order":["1791714","3590806"],"winner_id":"3590806","reasoning":"Document B is more relevant — it addresses cancer-initiating cells and stemness/Wnt signaling, which relate to ALDH1's role as a stem cell marker; Document A focuses on EMT in squamous carcinoma, not stem-cell markers or breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:53:54.930461Z"}
{"comparison_id":"50b8908e-ef1e-428d-a67f-4acd9745b959","query_id":"51","doc_a_id":"24349992","doc_b_id":"2485101","presented_order":["2485101","24349992"],"winner_id":"24349992","reasoning":"Document B is more relevant — it discusses tumor behavior, aggressiveness, and factors affecting cancer outcomes, whereas Document A is a methodological genetics paper not specific to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:13.602031Z"}
{"comparison_id":"76d8feff-89a0-4731-b7c1-5e16b67dce0e","query_id":"51","doc_a_id":"25832301","doc_b_id":"2485101","presented_order":["2485101","25832301"],"winner_id":"25832301","reasoning":"Document B — it reports a protein's expression being linked to better cancer outcomes (although in myeloma, not breast cancer), so it's more relevant than A's methodological focus. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:13.602052Z"}
{"comparison_id":"213a3089-2063-4a45-9ef6-5569b3960a63","query_id":"51","doc_a_id":"8037453","doc_b_id":"2485101","presented_order":["8037453","2485101"],"winner_id":"2485101","reasoning":"Document B deals with linking gene expression to disease traits (eQTL/GWAS integration), which is more relevant to assessing whether ALDH1 expression associates with cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:13.602061Z"}
{"comparison_id":"49947d52-dc42-49e4-8a11-3b1ac3ae1201","query_id":"51","doc_a_id":"31591262","doc_b_id":"2485101","presented_order":["2485101","31591262"],"winner_id":"31591262","reasoning":"Document B is more relevant — it reports gene expression levels correlated with cancer patient outcomes (though in rectal, not breast, and for different genes). \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:13.602068Z"}
{"comparison_id":"77a08ef1-0d6f-491f-ac59-e38cea5fae1c","query_id":"51","doc_a_id":"7795952","doc_b_id":"2485101","presented_order":["2485101","7795952"],"winner_id":"2485101","reasoning":"Document A is slightly more relevant — it discusses linking gene expression to disease traits and outcomes broadly, whereas Document B focuses specifically on fascin and TGFβ-driven invasion with no relevance to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:13.602076Z"}
{"comparison_id":"2870b4c6-f67f-4f78-a860-72e8b61e92cc","query_id":"51","doc_a_id":"19047331","doc_b_id":"2485101","presented_order":["19047331","2485101"],"winner_id":"19047331","reasoning":"Document A is more relevant — it links expression changes to cancer growth and clinical outcomes (even though it's ovarian and not ALDH1/breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:13.602083Z"}
{"comparison_id":"c822b8e6-9f42-4a6b-a4a5-7c3742e882c6","query_id":"51","doc_a_id":"2389574","doc_b_id":"2485101","presented_order":["2485101","2389574"],"winner_id":"2485101","reasoning":"Document A is more relevant — it addresses methods for linking gene expression (eQTLs) to disease traits, which is closer to evaluating associations between a gene like ALDH1 and cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:13.602090Z"}
{"comparison_id":"7653a168-4e2e-4a11-ab9a-b8333fa0807a","query_id":"51","doc_a_id":"25576204","doc_b_id":"2485101","presented_order":["25576204","2485101"],"winner_id":"25576204","reasoning":"Document A is more relevant — it discusses tumorigenesis and cancer gene effects, whereas B is a methods paper unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:13.602097Z"}
{"comparison_id":"7882e379-c3ef-47e8-a5c0-586d6bbc62a3","query_id":"51","doc_a_id":"12358173","doc_b_id":"2485101","presented_order":["12358173","2485101"],"winner_id":"12358173","reasoning":"Document A is more relevant — it links protein expression to cancer prognosis (although in lung cancer), whereas Document B is a methodological genetics paper not addressing ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:13.602105Z"}
{"comparison_id":"875201f3-a504-44f0-bc12-c9ebece6b559","query_id":"51","doc_a_id":"22521091","doc_b_id":"2485101","presented_order":["22521091","2485101"],"winner_id":"22521091","reasoning":"Document A, because it discusses gene expression linked to cancer progression and survival (even though it's a different gene and cancer type), while B is a methods paper not about specific gene–outcome associations.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:13.602112Z"}
{"comparison_id":"0dd22d76-6132-4583-9e16-f6bfcf7d56de","query_id":"51","doc_a_id":"515489","doc_b_id":"2485101","presented_order":["515489","2485101"],"winner_id":"515489","reasoning":"Document A is more relevant — it discusses cancer stem-cell–like properties and prognosis in tumors (though in HCC), which is closer to ALDH1's role in cancer outcomes than the GWAS/eQTL methods paper.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:13.602120Z"}
{"comparison_id":"91806dd7-9e3b-42d9-9194-d696a55bd5cd","query_id":"51","doc_a_id":"17755060","doc_b_id":"2485101","presented_order":["17755060","2485101"],"winner_id":"17755060","reasoning":"Document A is more relevant — it discusses tumorigenesis and prognosis in human cancers (clinical outcomes), whereas Document B is a methodological genetics paper not addressing ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:13.602127Z"}
{"comparison_id":"64a01dff-9b0e-4036-9953-80800c074300","query_id":"51","doc_a_id":"6828370","doc_b_id":"2485101","presented_order":["2485101","6828370"],"winner_id":"6828370","reasoning":"Document B — it addresses tumor biology and gene regulation relevant to cancer, whereas Document A describes a general eQTL–GWAS method without specific relevance to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:13.602135Z"}
{"comparison_id":"9302e74a-2a5e-4f31-88bc-09a7048e9d30","query_id":"51","doc_a_id":"4429118","doc_b_id":"2485101","presented_order":["4429118","2485101"],"winner_id":"4429118","reasoning":"Document A is more relevant — it discusses cancer biology and the tumor microenvironment (where biomarkers like ALDH1 would be implicated), while Document B is a methods paper on eQTL/GWAS integration not specific to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:13.602144Z"}
{"comparison_id":"376f85b5-aa3c-48df-98ce-23f0bf98ac20","query_id":"51","doc_a_id":"13980338","doc_b_id":"2485101","presented_order":["2485101","13980338"],"winner_id":"13980338","reasoning":"B is more relevant — it focuses on single-cell gene expression and stem-cell marker analysis, which relates to ALDH1 expression and its functional/clinical implications. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:13.602151Z"}
{"comparison_id":"c5314fd5-24c0-4a95-93d9-24c77525e861","query_id":"51","doc_a_id":"27647593","doc_b_id":"2485101","presented_order":["27647593","2485101"],"winner_id":"27647593","reasoning":"Document A is more relevant — it addresses cancer metabolism and the tumor microenvironment (topics likely connected to ALDH1 and breast cancer prognosis), while Document B is a general eQTL/GWAS methods paper. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:13.602158Z"}
{"comparison_id":"b728cfc7-5ff1-4426-b6d5-73018f86a7c3","query_id":"51","doc_a_id":"26231129","doc_b_id":"2485101","presented_order":["26231129","2485101"],"winner_id":"26231129","reasoning":"Document A is more relevant — it concerns cancer biology and treatment outcomes in solid tumors, whereas Document B is a methodological genetics paper not specific to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:13.602165Z"}
{"comparison_id":"1cf833cc-3479-41db-80a5-aeb2350eb2bb","query_id":"51","doc_a_id":"31803596","doc_b_id":"2485101","presented_order":["31803596","2485101"],"winner_id":"31803596","reasoning":"Document A is more relevant — it directly examines gene expression in a cancer context (though OSCC rather than breast cancer), whereas Document B is a methodological eQTL/GWAS paper not specific to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:13.602172Z"}
{"comparison_id":"e596c9ca-6cf2-4dd7-b62c-6047bbb635ad","query_id":"51","doc_a_id":"3858268","doc_b_id":"2485101","presented_order":["3858268","2485101"],"winner_id":"3858268","reasoning":"Document A is more relevant — it discusses cancer stem cell markers and outcomes/therapeutic targeting (though in ovarian cancer), which is closer to ALDH1 and cancer prognosis than a methods paper on eQTL/GWAS.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:13.602179Z"}
{"comparison_id":"474f3ec3-47b4-4aca-bc2a-d3f43cda1d4a","query_id":"51","doc_a_id":"17717391","doc_b_id":"2485101","presented_order":["17717391","2485101"],"winner_id":"17717391","reasoning":"Document A is more relevant — it discusses tumor marker expression and tumorigenesis, which is closer to a claim about a biomarker (ALDH1) and cancer outcomes than the GWAS/eQTL methods in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:13.602186Z"}
{"comparison_id":"c86b753d-8cc9-4034-a32f-516d56204acf","query_id":"51","doc_a_id":"2374637","doc_b_id":"2485101","presented_order":["2374637","2485101"],"winner_id":"2374637","reasoning":"Document A is more relevant — it deals with gene expression analysis methods applied to cancer datasets, which is directly related to examining ALDH1 expression and outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:13.602193Z"}
{"comparison_id":"8f217723-5b2c-493b-a656-8a27a28db69e","query_id":"51","doc_a_id":"24294572","doc_b_id":"2485101","presented_order":["24294572","2485101"],"winner_id":"24294572","reasoning":"Document A is cancer-specific (PTEN signaling affects tumor growth/motility) and thus more related to breast cancer outcome biology than Document B's methodological eQTL/GWAS focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:13.602224Z"}
{"comparison_id":"a1314cd8-574c-4e46-bc6b-25c9519a61f6","query_id":"51","doc_a_id":"2613411","doc_b_id":"2485101","presented_order":["2613411","2485101"],"winner_id":"2613411","reasoning":"Doc A is more relevant because it discusses cancer biology and therapeutic implications related to tumor cell proliferation and outcomes, whereas Doc B is a genetics methods paper not focused on cancer biomarkers. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:13.602237Z"}
{"comparison_id":"8e80d867-7bdd-41d7-b13d-8bb110d2bf74","query_id":"51","doc_a_id":"8994465","doc_b_id":"2485101","presented_order":["8994465","2485101"],"winner_id":"8994465","reasoning":"Reason: Both abstracts are unrelated to ALDH1 or breast cancer, but Document A discusses cancer cell subpopulations and marker expression (albeit in melanoma), making it marginally more relevant than the methodological genetics paper.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:13.602246Z"}
{"comparison_id":"28c58803-f714-499a-8bac-730725ba5177","query_id":"51","doc_a_id":"24349992","doc_b_id":"4429118","presented_order":["4429118","24349992"],"winner_id":"4429118","reasoning":"Document A is more relevant — it discusses tumor microenvironment and pathways tied to prognosis and targets for diagnosis/treatment, which is closer to biomarker-related outcomes than the fibroblast metabolism focus in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:26.835982Z"}
{"comparison_id":"6af8315b-a5e0-4b5b-adcd-b6a0115855a1","query_id":"51","doc_a_id":"25832301","doc_b_id":"4429118","presented_order":["4429118","25832301"],"winner_id":"4429118","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular pathways in the tumor microenvironment, whereas Document B is specific to TSPAN7 in multiple myeloma (unrelated cancer and protein).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:26.836005Z"}
{"comparison_id":"0d421720-2de6-4809-a294-7917b2d5eb04","query_id":"51","doc_a_id":"31591262","doc_b_id":"4429118","presented_order":["4429118","31591262"],"winner_id":"31591262","reasoning":"Document B is more relevant — it directly examines associations between gene expression and cancer outcomes, which is closer to the query about ALDH1 expression and breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:26.836015Z"}
{"comparison_id":"2972a7e3-3b01-4648-b3d4-d04697fd1922","query_id":"51","doc_a_id":"19047331","doc_b_id":"4429118","presented_order":["4429118","19047331"],"winner_id":"4429118","reasoning":"Document A is more generally about cancer biology and tumor microenvironment and is more likely to relate to marker expression and outcomes than Document B, which is specific to a miRNA-STAT3 mechanism in ovarian cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:26.836027Z"}
{"comparison_id":"189ebde2-47a9-41b3-8a07-712a23ed40af","query_id":"51","doc_a_id":"25576204","doc_b_id":"4429118","presented_order":["25576204","4429118"],"winner_id":"4429118","reasoning":"Reason: Neither abstract mentions ALDH1 or breast cancer specifically, but Document B broadly addresses tumor progression and factors influencing outcomes (inflammation, metastasis), making it slightly more relevant to a claim about biomarkers and cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:26.836035Z"}
{"comparison_id":"8f1006c5-ea5d-4600-86cf-4fe72cc6dcee","query_id":"51","doc_a_id":"12358173","doc_b_id":"4429118","presented_order":["12358173","4429118"],"winner_id":"4429118","reasoning":"Document B is more relevant — it discusses general cancer biology and tumor microenvironment factors that could relate to prognostic markers, whereas A is specific to a different factor (PD-ECGF) in non-small-cell lung cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:26.836043Z"}
{"comparison_id":"84d2d21b-bbc0-4ed2-98b9-b01f71a281cc","query_id":"51","doc_a_id":"22521091","doc_b_id":"4429118","presented_order":["22521091","4429118"],"winner_id":"4429118","reasoning":"Document B is more relevant — it discusses general cancer biology and tumor microenvironment factors that could relate to prognostic markers like ALDH1, whereas Document A is specific to NRAGE in liver cancer and unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:26.836051Z"}
{"comparison_id":"35949def-aaac-460a-8ae6-124a35aa3903","query_id":"51","doc_a_id":"515489","doc_b_id":"4429118","presented_order":["515489","4429118"],"winner_id":"515489","reasoning":"Document A is slightly more relevant because it discusses cancer stem cell–like properties and prognosis (ALDH1 is a cancer stem cell marker), whereas B is a general review on inflammation. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:26.836058Z"}
{"comparison_id":"5ea37db3-9bcd-45a1-bee5-61be81c98b49","query_id":"51","doc_a_id":"17755060","doc_b_id":"4429118","presented_order":["4429118","17755060"],"winner_id":"17755060","reasoning":"Document B is more relevant — it discusses tumorigenesis and prognosis (cancer outcomes), whereas A is a general overview of inflammation without outcome-specific data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:26.836065Z"}
{"comparison_id":"21d09509-7bbb-4c56-a4c3-45fe6e5ce6f0","query_id":"51","doc_a_id":"6828370","doc_b_id":"4429118","presented_order":["4429118","6828370"],"winner_id":"6828370","reasoning":"Document B is more directly about gene-level regulation and tumor biology, which is closer to evidence about a specific marker's (ALDH1) expression and clinical associations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:26.836073Z"}
{"comparison_id":"f6b1a1e0-4598-49e6-a5f8-607ba6a1fab0","query_id":"51","doc_a_id":"8994465","doc_b_id":"4429118","presented_order":["4429118","8994465"],"winner_id":"4429118","reasoning":"Document A is more relevant — it discusses tumor microenvironment and broad cancer markers, whereas B focuses on melanoma-specific JARID1B and not ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:26.836080Z"}
{"comparison_id":"1860a95c-f205-4c23-b627-97a905449037","query_id":"51","doc_a_id":"13980338","doc_b_id":"4429118","presented_order":["13980338","4429118"],"winner_id":"13980338","reasoning":"Document A is more relevant — it covers single-cell gene expression in stem cell populations (ALDH1 is a stem cell marker), whereas Document B discusses general cancer inflammation unrelated to ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:26.836087Z"}
{"comparison_id":"cf4c5d77-ae0d-473d-8658-d89f4d904afe","query_id":"51","doc_a_id":"27647593","doc_b_id":"4429118","presented_order":["4429118","27647593"],"winner_id":"27647593","reasoning":"Document B is more relevant — it discusses tumor metabolism and stromal–epithelial interactions, which are more directly related to metabolic markers like ALDH1 than the general inflammation focus of A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:26.836095Z"}
{"comparison_id":"12fa0cf0-1e7e-4ad4-8e41-9822ff5e9872","query_id":"51","doc_a_id":"26231129","doc_b_id":"4429118","presented_order":["26231129","4429118"],"winner_id":"26231129","reasoning":"Document A is more relevant — it addresses molecular features and residual disease/therapy resistance in solid tumors, which is closer to linking a marker like ALDH1 to outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:26.836102Z"}
{"comparison_id":"73b5625f-8b31-469c-95db-7ea5a3c7e6fe","query_id":"51","doc_a_id":"31803596","doc_b_id":"4429118","presented_order":["31803596","4429118"],"winner_id":"31803596","reasoning":"Document A is slightly more relevant because it addresses gene expression analysis (though in oral cancer), which is closer to a claim about ALDH1 expression and cancer outcomes than a general review of inflammation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:26.836110Z"}
{"comparison_id":"0c89f7c0-b55d-45bf-be8c-a2c86c8dd8ae","query_id":"51","doc_a_id":"3858268","doc_b_id":"4429118","presented_order":["4429118","3858268"],"winner_id":"3858268","reasoning":"Document B is more relevant — it discusses cancer stem cell markers and outcomes (though in ovarian cancer), which is closer to ALDH1's role as a CSC marker than a general inflammation review.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:26.836118Z"}
{"comparison_id":"a47bb978-391c-4b90-b139-1e1a3c89c07e","query_id":"51","doc_a_id":"17717391","doc_b_id":"4429118","presented_order":["17717391","4429118"],"winner_id":"17717391","reasoning":"Document A is more relevant — it discusses expression of a tumor marker and in vivo monitoring of tumorigenesis, which is closer to gene-expression associations with cancer outcomes than the general inflammation focus in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:26.836125Z"}
{"comparison_id":"37dc777e-d262-486f-80b5-1d69c8d90c87","query_id":"51","doc_a_id":"2374637","doc_b_id":"4429118","presented_order":["2374637","4429118"],"winner_id":"2374637","reasoning":"Document A is more relevant because it discusses methods for interpreting gene expression data (which could include ALDH1) and cancer-related expression profiles, whereas B focuses on inflammation and not gene expression markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:26.836132Z"}
{"comparison_id":"65085d1c-4c08-415b-b0cb-c51f042f7857","query_id":"51","doc_a_id":"24294572","doc_b_id":"4429118","presented_order":["4429118","24294572"],"winner_id":"4429118","reasoning":"Document A is slightly more relevant because it discusses cancer-related processes and tumor outcomes broadly; Document B focuses on PTEN/PI lipid signaling, unrelated to ALDH1 or outcome. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:26.836139Z"}
{"comparison_id":"1e4da1b9-9c82-442d-a113-66583dc6f6c2","query_id":"51","doc_a_id":"2613411","doc_b_id":"4429118","presented_order":["4429118","2613411"],"winner_id":"4429118","reasoning":"Document A is more relevant — it broadly addresses tumor microenvironment and biomarkers tied to diagnosis and outcomes, which is closer to evaluating ALDH1 expression and breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:26.836146Z"}
{"comparison_id":"d3eb606d-de4f-41bd-9021-9f7481c98c30","query_id":"51","doc_a_id":"31591262","doc_b_id":"27647593","presented_order":["27647593","31591262"],"winner_id":"27647593","reasoning":"Document A is more relevant — it discusses tumor biology and the tumor microenvironment in cancers (concepts often linked to stem cell markers like ALDH1 and outcomes), whereas Document B focuses on LKB1/LGR5 in rectal cancer, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:34.909329Z"}
{"comparison_id":"8cf17e45-7f2a-44ea-891b-5cec0dc8c17a","query_id":"51","doc_a_id":"515489","doc_b_id":"27647593","presented_order":["515489","27647593"],"winner_id":"515489","reasoning":"Document A — it discusses stem cell–like properties and clinical prognosis (though in HCC), which is closer to ALDH1’s role as a stem cell marker than the tumor metabolism focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:34.909350Z"}
{"comparison_id":"3afb151d-36b4-414c-9cfd-51df1a390d6b","query_id":"51","doc_a_id":"17755060","doc_b_id":"27647593","presented_order":["17755060","27647593"],"winner_id":"17755060","reasoning":"Neither document mentions ALDH1 or provides evidence about breast cancer outcomes. Document A discusses tumorigenesis and prognosis in human cancers (marginally more related to outcomes) while B focuses on stromal metabolism. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:34.909359Z"}
{"comparison_id":"30be7fb0-46c4-4304-9869-ab963866601c","query_id":"51","doc_a_id":"6828370","doc_b_id":"27647593","presented_order":["27647593","6828370"],"winner_id":"27647593","reasoning":"Document A is more relevant — it addresses tumor cell metabolism and the tumor microenvironment, which is more related to ALDH1's metabolic/stem-cell roles in breast cancer than the mRNA/pseudogene regulatory focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:34.909367Z"}
{"comparison_id":"97f497bf-f3a8-4d48-bc56-5e0ffb0769cf","query_id":"51","doc_a_id":"13980338","doc_b_id":"27647593","presented_order":["27647593","13980338"],"winner_id":"13980338","reasoning":"Document B. It links single-cell gene expression with stem-cell functional outcomes (applicable to stem-cell markers like ALDH1), whereas A discusses tumor-stroma metabolism and not ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:34.909374Z"}
{"comparison_id":"1d229fee-1334-4144-b13e-5dae5e4d574a","query_id":"51","doc_a_id":"2374637","doc_b_id":"27647593","presented_order":["27647593","2374637"],"winner_id":"2374637","reasoning":"Document B is more relevant — it describes gene expression analysis methods (GSEA) that could be used to evaluate ALDH1 expression and its association with outcomes, whereas Document A focuses on stromal–epithelial metabolism without addressing ALDH1 or outcome data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:34.909381Z"}
{"comparison_id":"22f3b052-4838-43e5-bc05-4267d1f0377e","query_id":"51","doc_a_id":"26231129","doc_b_id":"27647593","presented_order":["26231129","27647593"],"winner_id":"26231129","reasoning":"Document A is more focused on clinical outcomes and residual disease in solid tumors, making it more likely to address biomarkers and prognosis than the metabolic/stromal focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:34.909388Z"}
{"comparison_id":"4b6cba33-0a47-4622-8efd-067cd0ce1d7a","query_id":"51","doc_a_id":"31803596","doc_b_id":"27647593","presented_order":["27647593","31803596"],"winner_id":"27647593","reasoning":"Document A is marginally more relevant — it discusses tumor metabolism and microenvironment factors that could relate to markers like ALDH1, whereas Document B focuses on oral squamous cell carcinoma gene profiling unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:34.909395Z"}
{"comparison_id":"7ec8ae87-84e8-41b7-8900-c81cfb4b4cf4","query_id":"51","doc_a_id":"3858268","doc_b_id":"27647593","presented_order":["3858268","27647593"],"winner_id":"3858268","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes directly. Document A is slightly more relevant because it studies cancer stem cell biology (ALDH1 is a CSC marker), whereas B focuses on stromal–epithelial metabolic coupling.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:34.909403Z"}
{"comparison_id":"d3fd5638-5c06-4ae3-9c9c-5764e06aea79","query_id":"51","doc_a_id":"17717391","doc_b_id":"27647593","presented_order":["17717391","27647593"],"winner_id":"17717391","reasoning":"A is more relevant because it addresses tumor marker expression and its relation to cancer development/outcomes, whereas B discusses tumor metabolism and stroma without addressing marker-outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:34.909410Z"}
{"comparison_id":"e7841fce-fadd-41c2-a079-9bc5ab800668","query_id":"51","doc_a_id":"515489","doc_b_id":"2374637","presented_order":["2374637","515489"],"winner_id":"2374637","reasoning":"Document A is more relevant because it discusses gene expression analysis methods applicable to cancer biomarkers like ALDH1, whereas B focuses on a different lncRNA in liver cancer unrelated to ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:40.800913Z"}
{"comparison_id":"ad884e22-2ab7-4325-8d70-492571c59e2a","query_id":"51","doc_a_id":"17755060","doc_b_id":"2374637","presented_order":["2374637","17755060"],"winner_id":"17755060","reasoning":"Document B is slightly more relevant because it discusses tumorigenesis and prognosis in human cancers, while Document A describes a general analysis method without cancer outcome data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:40.800934Z"}
{"comparison_id":"5ebae570-266d-4b82-92d7-9b6bbec4f71a","query_id":"51","doc_a_id":"13980338","doc_b_id":"2374637","presented_order":["2374637","13980338"],"winner_id":"13980338","reasoning":"Document B is more relevant — it links single-cell gene expression to stem cell functional outcomes and methods applicable to cancer stem cell markers like ALDH1, whereas A is a general gene-set analysis methods paper. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:40.800945Z"}
{"comparison_id":"c39b528b-0a8a-486d-ad2d-7a8bf108ff84","query_id":"51","doc_a_id":"17717391","doc_b_id":"2374637","presented_order":["2374637","17717391"],"winner_id":"2374637","reasoning":"Document A. It discusses gene expression analysis methods (GSEA) relevant to studying markers like ALDH1 and their association with outcomes; Document B focuses on a p16 reporter mouse model, unrelated to ALDH1 or breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:40.800953Z"}
{"comparison_id":"ee9c47ce-2c4c-4261-81f2-df446f5b161e","query_id":"51","doc_a_id":"26231129","doc_b_id":"2374637","presented_order":["2374637","26231129"],"winner_id":"2374637","reasoning":"Document A is slightly more relevant because it discusses gene expression analysis methods (GSEA) that pertain to studying expression markers like ALDH1; Document B focuses on therapy/residual disease and is less directly about gene expression or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:40.800961Z"}
{"comparison_id":"e13d2f0f-8f06-4912-8f62-11bd97304774","query_id":"51","doc_a_id":"3858268","doc_b_id":"2374637","presented_order":["2374637","3858268"],"winner_id":"2374637","reasoning":"Document A is more relevant — it concerns gene expression analysis methods applicable to studies of markers like ALDH1, whereas Document B focuses on ovarian cancer lipid metabolism unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:40.800968Z"}
{"comparison_id":"0242d402-388b-447f-86e0-7450d1491a8c","query_id":"51","doc_a_id":"17755060","doc_b_id":"13980338","presented_order":["13980338","17755060"],"winner_id":"17755060","reasoning":"Document B. It discusses tumorigenesis and prognosis in human cancers (metabolic regulators linked to poor outcomes), which is more related to cancer outcomes than Document A's hematopoietic stem-cell methods.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:45.524820Z"}
{"comparison_id":"0d072a14-1dcf-4824-b850-8cf3ce748db9","query_id":"51","doc_a_id":"515489","doc_b_id":"17717391","presented_order":["515489","17717391"],"winner_id":"515489","reasoning":"Document A — it discusses stem cell–like properties and clinical prognosis (though in HCC), which is more related to ALDH1’s role as a stem cell marker than Document B’s p16 model. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:52.826776Z"}
{"comparison_id":"5f3fb7c0-bafc-434d-8759-5867926133e2","query_id":"51","doc_a_id":"3858268","doc_b_id":"17717391","presented_order":["17717391","3858268"],"winner_id":"3858268","reasoning":"Document B — it discusses cancer stem cell markers and behavior (ALDH1 is a CSC marker), so it's more related to ALDH1 and outcomes than Document A, which focuses on p16INK4a.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:52.826796Z"}
{"comparison_id":"1568672d-9305-4ad8-8f00-2c82ecb30d2e","query_id":"51","doc_a_id":"26231129","doc_b_id":"17717391","presented_order":["26231129","17717391"],"winner_id":"26231129","reasoning":"Document A is more relevant — it addresses cancer progression, residual disease, and treatment outcomes, which relate to biomarkers and prognosis; Document B focuses on a p16 reporter mouse model unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:54:52.826806Z"}
{"comparison_id":"af6b25d8-017a-4a71-983e-e54ca4464a03","query_id":"51","doc_a_id":"515489","doc_b_id":"3858268","presented_order":["3858268","515489"],"winner_id":"3858268","reasoning":"Document A — it concerns cancer stem cells (ALDH1 is a stem-cell marker), whereas Document B is about lncRNA in liver cancer and unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:55:10.198628Z"}
{"comparison_id":"d3155840-ac61-4cca-98af-a6fe3efe13aa","query_id":"51","doc_a_id":"26231129","doc_b_id":"3858268","presented_order":["26231129","3858268"],"winner_id":"3858268","reasoning":"Document B — it deals with cancer stem cell markers and biology (closer to ALDH1's role as a CSC marker), whereas A is a general framework for residual disease and doesn't address ALDH1 or breast cancer specifically.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:55:10.198648Z"}
{"comparison_id":"cd238c53-404a-40af-b4bb-60ecd4d2e06f","query_id":"51","doc_a_id":"515489","doc_b_id":"26231129","presented_order":["515489","26231129"],"winner_id":"26231129","reasoning":"Neither document directly addresses ALDH1 in breast cancer. Document A concerns lncRNA PVT1 in hepatocellular carcinoma (different marker and cancer). Document B is a broader framework about residual disease and outcomes in solid cancers and is therefore more generally relevant to biomarker–outcome relationships.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:55:18.048120Z"}
{"comparison_id":"c8d3d774-63d4-4e5b-87b2-db01fcf9cb45","query_id":"51","doc_a_id":"31591262","doc_b_id":"6828370","presented_order":["6828370","31591262"],"winner_id":"6828370","reasoning":"Document A — it discusses gene/pseudogene mRNA regulation and tumor biology (more relevant to gene expression in cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:55:25.127533Z"}
{"comparison_id":"c5b144a9-669b-4600-8792-bff793d74660","query_id":"51","doc_a_id":"31803596","doc_b_id":"6828370","presented_order":["6828370","31803596"],"winner_id":"6828370","reasoning":"Document A is more relevant — it discusses mRNA/pseudogene regulation and broader tumor biology implications, which is closer to mechanisms affecting cancer markers like ALDH1 than a study limited to oral squamous cell carcinoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:55:25.127555Z"}
{"comparison_id":"02b42f47-7a6e-4948-b222-670c57281788","query_id":"51","doc_a_id":"31591262","doc_b_id":"31803596","presented_order":["31803596","31591262"],"winner_id":"31591262","reasoning":"Document B is more relevant — it examines associations between specific gene expression levels and patient outcomes (recurrence-free survival), which is conceptually closer to the claim about ALDH1 expression and breast cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:55:30.672469Z"}
{"comparison_id":"9058da3d-bced-4458-a3cb-4aabea0e2693","query_id":"51","doc_a_id":"24349992","doc_b_id":"12358173","presented_order":["24349992","12358173"],"winner_id":"24349992","reasoning":"Document A is more relevant — it discusses tumor-stroma interactions and breast cancer–related microenvironment concepts, whereas B concerns PD-ECGF in lung cancer and is unrelated to ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:55:37.081751Z"}
{"comparison_id":"9753a47f-7571-4edc-834a-bca497a52c7b","query_id":"51","doc_a_id":"25832301","doc_b_id":"12358173","presented_order":["25832301","12358173"],"winner_id":"25832301","reasoning":"Document A is more relevant — it reports a marker whose higher expression links to reduced tumor burden/better outcome (albeit in myeloma), whereas B links a marker to worse prognosis in lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:55:37.081773Z"}
{"comparison_id":"c00b8d5b-0f05-44bb-a171-f11def0c00ed","query_id":"51","doc_a_id":"19047331","doc_b_id":"12358173","presented_order":["19047331","12358173"],"winner_id":"19047331","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it discusses biomarker expression linked to cancer outcomes, whereas B concerns angiogenesis in lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:55:37.081782Z"}
{"comparison_id":"e40488b6-e002-4bb6-842c-ce0c3b4ada80","query_id":"51","doc_a_id":"25576204","doc_b_id":"12358173","presented_order":["25576204","12358173"],"winner_id":"12358173","reasoning":"Document B — it addresses how expression levels of a factor correlate with tumor prognosis (though in lung cancer), making it more relevant to a claim about marker expression and cancer outcomes than Document A, which concerns beclin 1 and tumorigenesis generally.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:55:37.081790Z"}
{"comparison_id":"1c6b307e-04c0-4516-a01d-4214019cae8f","query_id":"51","doc_a_id":"2613411","doc_b_id":"12358173","presented_order":["2613411","12358173"],"winner_id":"12358173","reasoning":"Neither document addresses ALDH1 or breast cancer specifically, but Document B is slightly more relevant because it links marker expression to prognosis (though in lung, not breast). \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:55:37.081797Z"}
{"comparison_id":"ba6a6c4f-592f-4de4-ab8a-749c13cb99d6","query_id":"51","doc_a_id":"22521091","doc_b_id":"12358173","presented_order":["22521091","12358173"],"winner_id":"22521091","reasoning":"Document A is slightly more relevant — it discusses a biomarker whose expression correlates with disease-specific survival, which is conceptually closer to a claim about expression and cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:55:37.081805Z"}
{"comparison_id":"7cc8e598-a664-49a8-a59c-d01235e85ad8","query_id":"51","doc_a_id":"8994465","doc_b_id":"12358173","presented_order":["8994465","12358173"],"winner_id":"8994465","reasoning":"Neither paper studies ALDH1 or breast cancer; however, Document A discusses tumor cell subpopulations and marker expression (conceptually closer to ALDH1 as a stem-cell marker) while Document B is about angiogenesis in lung cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:55:37.081812Z"}
{"comparison_id":"56682f6f-54f8-44a6-80b3-132b691d6fc3","query_id":"51","doc_a_id":"24294572","doc_b_id":"12358173","presented_order":["12358173","24294572"],"winner_id":"12358173","reasoning":"Document A is more relevant — it addresses marker expression and association with prognosis (though in NSCLC), whereas B is a mechanistic signaling study not about marker expression or breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:55:37.081820Z"}
{"comparison_id":"7ac89dd7-f81b-404f-bca9-a0851afd7e2a","query_id":"51","doc_a_id":"24349992","doc_b_id":"19047331","presented_order":["19047331","24349992"],"winner_id":"24349992","reasoning":"Neither document discusses ALDH1 or its association with breast cancer outcomes; Document B is slightly more relevant because it addresses tumor microenvironment and cancer metabolism broadly (more applicable to breast cancer contexts) — ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:55:47.807486Z"}
{"comparison_id":"faa337c9-b0a1-4eb5-a89d-42ff6588ad33","query_id":"51","doc_a_id":"25832301","doc_b_id":"19047331","presented_order":["19047331","25832301"],"winner_id":"25832301","reasoning":"Document B — it discusses elevated expression linked to better outcomes (though in multiple myeloma), whereas A describes poorer outcomes in ovarian cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:55:47.807507Z"}
{"comparison_id":"e19119c3-0c60-4471-ba4e-f745bc649e51","query_id":"51","doc_a_id":"8994465","doc_b_id":"19047331","presented_order":["19047331","8994465"],"winner_id":"19047331","reasoning":"Document A is slightly more relevant because it discusses a molecular marker linked to clinical outcomes in cancer (though in ovarian cancer), whereas Document B focuses on melanoma cell subpopulations unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:55:47.807517Z"}
{"comparison_id":"636ec90b-21b1-478d-828d-f5c1fc1f4993","query_id":"51","doc_a_id":"22521091","doc_b_id":"19047331","presented_order":["19047331","22521091"],"winner_id":"22521091","reasoning":"Neither paper studies ALDH1 or breast cancer; however, Document B directly links a biomarker (NRAGE) to disease progression and survival, so it is slightly more relevant to a claim about marker–outcome associations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:55:47.807524Z"}
{"comparison_id":"c6d71aa8-c5a4-41b6-8ab3-24a891721d89","query_id":"51","doc_a_id":"24349992","doc_b_id":"25832301","presented_order":["25832301","24349992"],"winner_id":"24349992","reasoning":"Document B is more relevant — it addresses tumor biology and tumor–stroma interactions in solid cancers (more likely to relate to breast cancer outcomes) while Document A concerns TSPAN7 in multiple myeloma, unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:55:55.480714Z"}
{"comparison_id":"07c1395b-110c-4d58-a7d1-b8c65073ef6d","query_id":"51","doc_a_id":"22521091","doc_b_id":"25832301","presented_order":["22521091","25832301"],"winner_id":"25832301","reasoning":"Document B — it reports a gene whose higher expression is linked to better outcomes (though in multiple myeloma, not breast cancer), which matches the query's direction. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:55:55.480734Z"}
{"comparison_id":"1f17e21b-4f8e-4922-bbf3-f950e98c365c","query_id":"51","doc_a_id":"25576204","doc_b_id":"2613411","presented_order":["2613411","25576204"],"winner_id":"25576204","reasoning":"Document B is more related to cancer outcomes (tumorigenesis and progression), whereas A focuses on CDK biology and therapeutic targeting rather than clinical outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:02.347690Z"}
{"comparison_id":"fa196718-fa10-4d9a-bb30-8a549290d747","query_id":"51","doc_a_id":"24294572","doc_b_id":"2613411","presented_order":["24294572","2613411"],"winner_id":"24294572","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes. If one must be chosen, Document A is marginally more relevant because it addresses cancer signaling and factors affecting tumor growth.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:02.347711Z"}
{"comparison_id":"c7fcc624-8cd1-4b4c-898f-f088dde19a3f","query_id":"51","doc_a_id":"25576204","doc_b_id":"24294572","presented_order":["25576204","24294572"],"winner_id":"25576204","reasoning":"Neither abstract mentions ALDH1 or breast cancer outcomes. Both are unrelated, but A is marginally more relevant because it discusses tumorigenesis/tumor suppression broadly.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:13.399447Z"}
{"comparison_id":"a1cdf31f-a304-43a0-a9c1-314bee0055c8","query_id":"51","doc_a_id":"8037453","doc_b_id":"7795952","presented_order":["7795952","8037453"],"winner_id":"7795952","reasoning":"Document A is more relevant — it links tumor protein expression to cancer prognosis, whereas B discusses bone turnover markers in metastatic patients and not tumor marker expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:21.847856Z"}
{"comparison_id":"49a923ec-d8f2-412d-b964-a1e56074a3d2","query_id":"51","doc_a_id":"2389574","doc_b_id":"7795952","presented_order":["2389574","7795952"],"winner_id":"2389574","reasoning":"Document A is marginally more relevant because it addresses expression of a marker and its association with patient outcomes/survival, whereas Document B focuses on a mechanistic role in invasion without outcome data. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:21.847877Z"}
{"comparison_id":"89205309-0871-414e-a4b4-5f838e9afa90","query_id":"51","doc_a_id":"23830488","doc_b_id":"29806339","presented_order":["29806339","23830488"],"winner_id":"23830488","reasoning":"Reason: Document B addresses correlations between gene expression and patient outcomes (though in colorectal cancer), while Document A focuses on mitotic exit mechanisms and therapy, not on marker expression or outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015198Z"}
{"comparison_id":"5ab2f02c-eb88-4a4f-95df-4b6c2facf4ec","query_id":"51","doc_a_id":"42731834","doc_b_id":"29806339","presented_order":["42731834","29806339"],"winner_id":"42731834","reasoning":"Document A — it discusses a tumor marker's expression linked to patient survival (analogous to the claim), whereas B focuses on mitotic exit mechanisms and therapy. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015221Z"}
{"comparison_id":"62a7280d-8aca-44e9-a21c-6b23fdac4ceb","query_id":"51","doc_a_id":"7165938","doc_b_id":"29806339","presented_order":["7165938","29806339"],"winner_id":"29806339","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document B is slightly more related to cancer outcomes/mechanisms in vivo, so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015231Z"}
{"comparison_id":"5777e015-6f32-457e-b264-cd12f0e74af8","query_id":"51","doc_a_id":"2727303","doc_b_id":"29806339","presented_order":["29806339","2727303"],"winner_id":"2727303","reasoning":"Neither document mentions ALDH1 or breast cancer outcomes. B is marginally more relevant because it discusses regulators of malignant cell behavior that could impact prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015238Z"}
{"comparison_id":"af9946f8-f3e7-449e-9307-b7b753243ebf","query_id":"51","doc_a_id":"1782201","doc_b_id":"29806339","presented_order":["1782201","29806339"],"winner_id":"1782201","reasoning":"Document A is more relevant — it discusses how expression of a specific cell-surface protein (integrin αvβ3) affects tumor progression and prognosis, which is closer to a claim about marker expression and cancer outcomes than a study on mitotic-exit therapeutics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015246Z"}
{"comparison_id":"ea9a9844-380e-45ee-ae40-9939f79f0626","query_id":"51","doc_a_id":"5774746","doc_b_id":"29806339","presented_order":["5774746","29806339"],"winner_id":"5774746","reasoning":"Neither paper mentions ALDH1 or breast cancer, but Document A discusses protein expression correlated with patient survival (though in colorectal cancer), so it's slightly more relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015253Z"}
{"comparison_id":"7d0552d4-8e73-4c5c-ba78-22e139a3e303","query_id":"51","doc_a_id":"11271123","doc_b_id":"29806339","presented_order":["11271123","29806339"],"winner_id":"29806339","reasoning":"Both documents are irrelevant to ALDH1 and breast cancer; Document B is slightly more relevant because it addresses tumor regression and cancer therapy, which relates to outcomes more than Document A's focus on endometrial molecular alterations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015261Z"}
{"comparison_id":"d4b56d8c-3896-4825-8ee8-dff9c9285979","query_id":"51","doc_a_id":"13964633","doc_b_id":"29806339","presented_order":["29806339","13964633"],"winner_id":"13964633","reasoning":"Neither paper mentions ALDH1 or breast cancer outcomes. Document B is slightly more relevant because it deals with gene expression effects on tumor growth, whereas A focuses on mitotic exit mechanisms and therapy.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015269Z"}
{"comparison_id":"7ee8a14a-71b2-49e4-909b-25966760865a","query_id":"51","doc_a_id":"33370","doc_b_id":"29806339","presented_order":["33370","29806339"],"winner_id":"33370","reasoning":"Reason: Document A discusses cancer stem cells (though in glioma), which is more conceptually related to ALDH1 (a cancer stem cell marker) and outcome associations than Document B's focus on mitotic exit mechanisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015275Z"}
{"comparison_id":"885451dc-a7ba-407d-8f53-6e3904450ab0","query_id":"51","doc_a_id":"1032372","doc_b_id":"29806339","presented_order":["29806339","1032372"],"winner_id":"1032372","reasoning":"Document B is more related because it discusses treatment approaches and clinical outcomes, which is closer to the claim about associations with breast cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015283Z"}
{"comparison_id":"082604dc-9ef0-4ccb-8a21-57f16cfb517d","query_id":"51","doc_a_id":"5386514","doc_b_id":"29806339","presented_order":["5386514","29806339"],"winner_id":"5386514","reasoning":"Document A is slightly more relevant because it discusses tumor immune responses and therapy efficacy, which relate more to cancer outcomes; neither document mentions ALDH1 or breast cancer specifically.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015290Z"}
{"comparison_id":"25b5999e-d4ac-4d4c-8f4d-2bb6eebc94b5","query_id":"51","doc_a_id":"33638477","doc_b_id":"29806339","presented_order":["33638477","29806339"],"winner_id":"33638477","reasoning":"Document A is slightly more relevant because it discusses tumor progression and prognosis-related features (proliferation, metastasis) in cancers, which is closer to an outcome/biomarker claim than a mechanistic mitotic-exit therapy study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015297Z"}
{"comparison_id":"d8cd3773-e73d-4295-945b-501dba8c460f","query_id":"51","doc_a_id":"21502234","doc_b_id":"29806339","presented_order":["29806339","21502234"],"winner_id":"29806339","reasoning":"Document A is more related to cancer biology and tumor outcomes, whereas Document B concerns mismatch repair in endometrial cancer unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015304Z"}
{"comparison_id":"d72ecc0d-70c9-44c9-ada3-8cf339a5bdf5","query_id":"51","doc_a_id":"3805841","doc_b_id":"29806339","presented_order":["29806339","3805841"],"winner_id":"29806339","reasoning":"Neither mentions ALDH1 or breast cancer, but Document A deals with tumor regression and factors affecting tumor cell fate (more directly about outcomes) while B focuses on MYC and neuroblastoma metabolism. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015311Z"}
{"comparison_id":"780f5f59-baba-463d-a2f5-7809c13ee149","query_id":"51","doc_a_id":"38243984","doc_b_id":"29806339","presented_order":["29806339","38243984"],"winner_id":"29806339","reasoning":"Neither document mentions ALDH1 or breast cancer outcomes. Document A is slightly more relevant because it deals with tumor behavior and therapy in vivo, while B focuses specifically on pancreatic cancer xenografts. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015321Z"}
{"comparison_id":"339ba09c-9f79-499e-b364-d7606496ad14","query_id":"51","doc_a_id":"1791714","doc_b_id":"29806339","presented_order":["1791714","29806339"],"winner_id":"1791714","reasoning":"Both documents are not about ALDH1 or breast cancer; Document A (EMT and metastasis) is slightly closer to prognosis/marker biology than Document B (mitotic exit and therapy).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015328Z"}
{"comparison_id":"7fee3247-ff9f-4fda-baa2-6fcfb63c99a9","query_id":"51","doc_a_id":"26561572","doc_b_id":"29806339","presented_order":["26561572","29806339"],"winner_id":"29806339","reasoning":"Neither document is relevant — neither mentions ALDH1 or breast cancer. If one must be chosen, B is marginally more relevant to cancer outcomes generally. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015334Z"}
{"comparison_id":"89ccc2f9-01b4-484c-9fec-b8aced3f9b46","query_id":"51","doc_a_id":"13400643","doc_b_id":"29806339","presented_order":["29806339","13400643"],"winner_id":"13400643","reasoning":"Neither document mentions ALDH1 or breast cancer outcomes; both are not directly relevant. If one must be chosen, B is marginally more relevant because it addresses tumor growth and survival effects of a cancer-targeting molecule.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015341Z"}
{"comparison_id":"71343928-79f8-45cf-9915-be533b9b1400","query_id":"51","doc_a_id":"29473081","doc_b_id":"29806339","presented_order":["29806339","29473081"],"winner_id":"29806339","reasoning":"Neither abstract mentions ALDH1 or breast cancer. Document A is marginally more relevant because it addresses tumor biology and therapeutic outcomes broadly, while B is specific to multiple myeloma and a different gene.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015348Z"}
{"comparison_id":"b927dacd-3fe3-4f9a-a713-95bba1a125dc","query_id":"51","doc_a_id":"21521236","doc_b_id":"29806339","presented_order":["21521236","29806339"],"winner_id":"21521236","reasoning":"Document A is more relevant — it discusses factors (NEAT1, p53) that modulate cancer chemosensitivity and treatment response, which relates more directly to cancer outcomes than the mitotic-exit/mechanism focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015355Z"}
{"comparison_id":"e44d1994-9e29-489e-ae7c-1ed7d07a71cd","query_id":"51","doc_a_id":"23576165","doc_b_id":"29806339","presented_order":["23576165","29806339"],"winner_id":"23576165","reasoning":"Neither document mentions ALDH1 or breast cancer outcomes; both are irrelevant. Document A is slightly more related by discussing tumor metabolism (ALDH1 is a metabolic enzyme), so choose A.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015361Z"}
{"comparison_id":"b257fe52-e6fe-496a-84bc-b28aa1cce2b6","query_id":"51","doc_a_id":"10165723","doc_b_id":"29806339","presented_order":["10165723","29806339"],"winner_id":"10165723","reasoning":"Doc A is more relevant because it discusses a molecular marker pattern associated with cancer progression and outcomes (even though in melanoma), whereas Doc B focuses on mitotic exit mechanisms and therapy, not marker–outcome associations. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015368Z"}
{"comparison_id":"a297fe47-5def-4832-9048-13f57b1cf9de","query_id":"51","doc_a_id":"1686997","doc_b_id":"29806339","presented_order":["1686997","29806339"],"winner_id":"1686997","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document A is slightly more relevant because it discusses tumor growth pathways, whereas B focuses on mitotic exit mechanisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015375Z"}
{"comparison_id":"57cef70b-7dec-4628-966b-58619523e307","query_id":"51","doc_a_id":"13205096","doc_b_id":"29806339","presented_order":["13205096","29806339"],"winner_id":"13205096","reasoning":"Reason: Document A discusses gene-expression profiling and prognostic associations (outcomes), which is conceptually closer to evaluating a marker like ALDH1 for breast cancer prognosis; Document B focuses on mitotic exit mechanisms and tumor regression, not prognostic marker expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015382Z"}
{"comparison_id":"acbbc9bd-a269-4924-b39d-2769790ae95a","query_id":"51","doc_a_id":"33387953","doc_b_id":"29806339","presented_order":["33387953","29806339"],"winner_id":"29806339","reasoning":"Neither abstract mentions ALDH1. Document B is slightly more relevant because it addresses tumor regression and factors affecting tumor outcome, while A focuses on G protein mutations and drug resistance.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015389Z"}
{"comparison_id":"a428ed30-f984-4455-941d-f14410dd9b55","query_id":"51","doc_a_id":"864491","doc_b_id":"29806339","presented_order":["29806339","864491"],"winner_id":"864491","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it addresses tumor response/therapy (CDK4/6 inhibition) which relates to cancer outcomes, whereas A focuses on mitotic exit mechanisms without outcome markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015395Z"}
{"comparison_id":"4e87e4f5-b699-455a-8938-909aaaad4559","query_id":"51","doc_a_id":"18358026","doc_b_id":"29806339","presented_order":["29806339","18358026"],"winner_id":"29806339","reasoning":"Document A is more relevant — it discusses tumor regression and factors influencing tumor cell fate, which relate to cancer outcomes; Document B focuses on DNA methylation mechanisms unrelated to ALDH1 or clinical outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015403Z"}
{"comparison_id":"a6bb2388-46a8-4d24-a748-be844105c3ca","query_id":"51","doc_a_id":"8538916","doc_b_id":"29806339","presented_order":["29806339","8538916"],"winner_id":"8538916","reasoning":"Document B is more relevant — it discusses expression levels and cancer cell proliferation, which is closer to a claim about a marker's expression and patient outcomes than Document A’s focus on mitotic exit mechanisms. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015409Z"}
{"comparison_id":"c1c2fcf9-ea82-40ea-a9f7-5b2b68e11243","query_id":"51","doc_a_id":"11578459","doc_b_id":"29806339","presented_order":["29806339","11578459"],"winner_id":"11578459","reasoning":"Document B is slightly more relevant because it discusses stem cell–related expression programs (ALDH1 is a stem cell marker), whereas Document A focuses on mitotic exit mechanisms unrelated to ALDH1 or breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015416Z"}
{"comparison_id":"e7ef6187-30eb-498d-a85e-69bbcf8b3121","query_id":"51","doc_a_id":"10365787","doc_b_id":"29806339","presented_order":["29806339","10365787"],"winner_id":"10365787","reasoning":"Document B is slightly more relevant: it discusses tumor suppression and outcomes broadly, whereas Document A focuses on mitotic exit mechanisms without relating to clinical outcomes or biomarkers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015423Z"}
{"comparison_id":"84da4032-5ce2-477a-8096-d5a1378cb46f","query_id":"51","doc_a_id":"17412260","doc_b_id":"29806339","presented_order":["17412260","29806339"],"winner_id":"17412260","reasoning":"Document A is marginally more relevant because it discusses mechanisms (senescence and tumor suppression) that can affect cancer outcomes; neither document mentions ALDH1 or breast cancer prognosis directly.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:56:48.015429Z"}
{"comparison_id":"5af445af-9761-4b55-a299-d5bbf4de48bc","query_id":"51","doc_a_id":"23830488","doc_b_id":"1791714","presented_order":["23830488","1791714"],"winner_id":"23830488","reasoning":"Document A is more relevant — it links specific gene expression to patient outcomes (though in colorectal cancer), which is conceptually closer to the claim about ALDH1 expression and breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:05.984153Z"}
{"comparison_id":"0b257497-c2cc-4b7a-800c-302b5711cb3c","query_id":"51","doc_a_id":"42731834","doc_b_id":"1791714","presented_order":["42731834","1791714"],"winner_id":"42731834","reasoning":"Document A is more relevant — it discusses how expression loss of a tumor marker correlates with patient survival, which is conceptually closer to the claim about marker expression and breast cancer outcomes than Document B's EMT/metastasis focus. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:05.984174Z"}
{"comparison_id":"a2b6cf8c-bed0-47da-880a-3bdaec11abcf","query_id":"51","doc_a_id":"2727303","doc_b_id":"1791714","presented_order":["1791714","2727303"],"winner_id":"1791714","reasoning":"Document A is slightly more relevant — it discusses EMT and metastasis, topics related to cancer stemness (often linked to ALDH1), whereas Document B focuses on HDAC6/STIM1 signaling and not on ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:05.984183Z"}
{"comparison_id":"6fa367a5-966a-47f1-9a76-bf37c96accbb","query_id":"51","doc_a_id":"1782201","doc_b_id":"1791714","presented_order":["1791714","1782201"],"winner_id":"1782201","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it addresses tumor progression across multiple carcinomas, while A focuses specifically on squamous cell carcinoma EMT.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:05.984191Z"}
{"comparison_id":"4dafdef0-3670-4ba7-9ce3-b49bca89ba36","query_id":"51","doc_a_id":"5774746","doc_b_id":"1791714","presented_order":["1791714","5774746"],"winner_id":"1791714","reasoning":"Document A is slightly more relevant — it discusses carcinoma metastasis and EMT, which is more general to cancer prognosis mechanisms than B's focus on colorectal-specific inflammatory effectors. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:05.984198Z"}
{"comparison_id":"2c04fd89-e132-41ce-b73a-ae83edea4dbe","query_id":"51","doc_a_id":"13964633","doc_b_id":"1791714","presented_order":["1791714","13964633"],"winner_id":"13964633","reasoning":"Neither abstract mentions ALDH1 or breast cancer. Document B is marginally more relevant because it addresses tumor growth regulation and molecular pathways affecting cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:05.984206Z"}
{"comparison_id":"a10d4669-7971-461e-8f21-ec042c4b7a3e","query_id":"51","doc_a_id":"33370","doc_b_id":"1791714","presented_order":["1791714","33370"],"winner_id":"33370","reasoning":"Document B is more relevant — it addresses cancer stem cell biology (GSC survival and markers), which is conceptually closer to ALDH1's role as a stem-cell marker in breast cancer; Document A concerns EMT in squamous carcinoma and doesn't relate to ALDH1 or breast cancer outcomes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:05.984214Z"}
{"comparison_id":"8ebdb403-95f3-461e-8139-1835540e7cf8","query_id":"51","doc_a_id":"1032372","doc_b_id":"1791714","presented_order":["1791714","1032372"],"winner_id":"1032372","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it addresses regulation of cancer-related gene expression, which is nearer to marker–outcome relationships. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:05.984221Z"}
{"comparison_id":"ef90ed9c-fc33-47c6-bb66-ae33ee52588b","query_id":"51","doc_a_id":"5386514","doc_b_id":"1791714","presented_order":["1791714","5386514"],"winner_id":"1791714","reasoning":"Document A is more relevant — although neither mentions ALDH1 or breast cancer, A addresses tumor metastasis/EMT and prognosis-related biology, which is more directly tied to cancer outcomes than the immunity-focused B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:05.984228Z"}
{"comparison_id":"ed71b2c9-dad3-469f-8a7b-c4a78e54799c","query_id":"51","doc_a_id":"33638477","doc_b_id":"1791714","presented_order":["33638477","1791714"],"winner_id":"33638477","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer; Document A is marginally more relevant because it addresses tumor progression and metastasis across cancer types.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:05.984235Z"}
{"comparison_id":"c90ef5a3-189b-4dfa-b877-7d14c6b1795d","query_id":"51","doc_a_id":"17412260","doc_b_id":"1791714","presented_order":["17412260","1791714"],"winner_id":"1791714","reasoning":"Reason: Neither mentions ALDH1 or breast cancer, but Document B (EMT and metastasis) is more related to tumor progression and outcomes than Document A (senescence signaling).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:05.984242Z"}
{"comparison_id":"8f514502-0c50-4893-9e91-8e9168780282","query_id":"51","doc_a_id":"13400643","doc_b_id":"1791714","presented_order":["13400643","1791714"],"winner_id":"1791714","reasoning":"Document B is slightly more relevant because it discusses tumor cell dissemination, metastasis, and cellular states (EMT) that are related to stemness markers like ALDH1, whereas Document A focuses on a small-molecule inhibitor unrelated to ALDH1 or breast outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:05.984249Z"}
{"comparison_id":"73048859-00d4-496a-adf0-ad0864f0fb38","query_id":"51","doc_a_id":"21521236","doc_b_id":"1791714","presented_order":["21521236","1791714"],"winner_id":"21521236","reasoning":"Document A is more relevant — it addresses cancer molecular regulators and chemosensitivity (more directly tied to markers affecting breast cancer outcomes), whereas B focuses specifically on EMT in squamous cell carcinoma and is less related to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:05.984257Z"}
{"comparison_id":"5121bd20-5b8c-4159-bacc-61191ddc01d8","query_id":"51","doc_a_id":"23576165","doc_b_id":"1791714","presented_order":["23576165","1791714"],"winner_id":"23576165","reasoning":"Document A is more relevant — it covers tumor metabolic pathways (ALDH1 is a metabolic enzyme), while B focuses on EMT in squamous cell carcinoma and not metabolism or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:05.984264Z"}
{"comparison_id":"312358e9-94e6-40ac-b950-e77421df8bae","query_id":"51","doc_a_id":"10165723","doc_b_id":"1791714","presented_order":["1791714","10165723"],"winner_id":"1791714","reasoning":"Document A is more relevant — it concerns carcinoma biology and processes (EMT/metastasis) more related to breast cancer outcomes than melanoma CIMP in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:05.984271Z"}
{"comparison_id":"1d7c1e70-275e-4cc1-829b-83a6ebb820f4","query_id":"51","doc_a_id":"1686997","doc_b_id":"1791714","presented_order":["1791714","1686997"],"winner_id":"1791714","reasoning":"Neither document mentions ALDH1 or breast cancer; both are only tangentially related to cancer outcomes. Document A is slightly more relevant because it addresses tumor metastasis and mechanisms affecting outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:05.984279Z"}
{"comparison_id":"ec30093b-5198-466a-a0a7-f8cff3b6e304","query_id":"51","doc_a_id":"13205096","doc_b_id":"1791714","presented_order":["1791714","13205096"],"winner_id":"1791714","reasoning":"Document A is slightly more relevant because it concerns cancer biology and metastasis mechanisms (EMT) in solid tumors, which is closer to breast cancer context than a gene-expression study in AML.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:05.984285Z"}
{"comparison_id":"37750523-5e85-453a-9bbc-ad5127d30d0c","query_id":"51","doc_a_id":"864491","doc_b_id":"1791714","presented_order":["864491","1791714"],"winner_id":"864491","reasoning":"Document A is slightly more relevant — it concerns tumor biology and a therapy (CDK4/6 inhibition) with direct relevance to breast cancer contexts, whereas B focuses on EMT in squamous cell carcinoma and not on ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:05.984292Z"}
{"comparison_id":"76169d2c-862a-4634-bd5a-de49e1aeca14","query_id":"51","doc_a_id":"8538916","doc_b_id":"1791714","presented_order":["1791714","8538916"],"winner_id":"1791714","reasoning":"Document A is more relevant — it discusses tumor metastasis and factors affecting cancer progression, which relate to outcomes (Document B focuses on a chaperonin not linked to ALDH1 or breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:05.984299Z"}
{"comparison_id":"9e0a0f7e-2874-4a6b-8d2d-9521cffbb824","query_id":"51","doc_a_id":"11578459","doc_b_id":"1791714","presented_order":["11578459","1791714"],"winner_id":"1791714","reasoning":"Document B is more relevant — it addresses carcinoma biology (EMT and metastasis) which is closer to breast cancer mechanisms than a glioblastoma stem-cell HOX signature.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:05.984306Z"}
{"comparison_id":"a4a21718-d3d5-45ce-b379-5a29ef5e5e66","query_id":"51","doc_a_id":"10365787","doc_b_id":"1791714","presented_order":["1791714","10365787"],"winner_id":"1791714","reasoning":"Document A is slightly more relevant because it discusses tumor cell phenotypes and metastatic behavior (EMT), which is closer to biomarkers like ALDH1 and cancer outcomes than a paper focused on cell-cycle regulator Cdh1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:05.984313Z"}
{"comparison_id":"77dea002-2903-43c5-8bff-6351c9aec03c","query_id":"51","doc_a_id":"23830488","doc_b_id":"33370","presented_order":["33370","23830488"],"winner_id":"23830488","reasoning":"Document B is more relevant — it examines how gene expression correlates with cancer outcomes, which is conceptually closer to the ALDH1–breast cancer outcome claim than a study focused on A20 in glioma. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:19.148225Z"}
{"comparison_id":"305fd56f-c11e-40e4-8e62-e374ed58bc68","query_id":"51","doc_a_id":"42731834","doc_b_id":"33370","presented_order":["33370","42731834"],"winner_id":"42731834","reasoning":"Document B is more relevant — it links expression levels of a tumor-related gene to patient survival outcomes (though in colorectal cancer), which is analogous to the claim about ALDH1 and breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:19.148246Z"}
{"comparison_id":"534e75b8-afd2-4e80-82dc-9025acec5101","query_id":"51","doc_a_id":"1782201","doc_b_id":"33370","presented_order":["1782201","33370"],"winner_id":"1782201","reasoning":"Document A is slightly more relevant because it discusses carcinoma tumor progression (potentially including breast cancers), whereas Document B is specific to glioma; however neither abstract mentions ALDH1 or directly addresses breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:19.148255Z"}
{"comparison_id":"f55a898c-4d06-447a-b6eb-a94e5b5e9fe5","query_id":"51","doc_a_id":"13964633","doc_b_id":"33370","presented_order":["13964633","33370"],"winner_id":"33370","reasoning":"Document B. Neither document mentions ALDH1 or breast cancer, but B's focus on cancer stem cells (glioma stem cells) is more conceptually related to ALDH1 as a stem-cell marker than A's microRNA/3'UTR topic.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:19.148263Z"}
{"comparison_id":"3a4c8f72-2202-4f6a-9e01-13ded19f1e8c","query_id":"51","doc_a_id":"864491","doc_b_id":"33370","presented_order":["33370","864491"],"winner_id":"33370","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A involves cancer stem cells (GSCs), which is marginally closer to ALDH1 (a stem cell marker) than B's focus on a CDK4/6 inhibitor. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:19.148269Z"}
{"comparison_id":"07b6cfc7-3ae0-4082-ad07-f9d89fea7871","query_id":"51","doc_a_id":"1032372","doc_b_id":"33370","presented_order":["33370","1032372"],"winner_id":"1032372","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes. Document B is slightly more relevant because it addresses cancer therapy and outcomes broadly, while A is specific to glioma stem cells.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:19.148276Z"}
{"comparison_id":"57787a4a-1be2-4fa7-b18e-2ace9a7841a5","query_id":"51","doc_a_id":"33638477","doc_b_id":"33370","presented_order":["33370","33638477"],"winner_id":"33370","reasoning":"Document A — it discusses cancer stem cells, which is more closely related to ALDH1 (a stem-cell marker) and cancer outcomes than Document B. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:19.148283Z"}
{"comparison_id":"629e130b-a73d-424b-b0ce-e834a09b2804","query_id":"51","doc_a_id":"21521236","doc_b_id":"33370","presented_order":["33370","21521236"],"winner_id":"21521236","reasoning":"Document B is more relevant — it discusses cancer treatment response and chemosensitivity, which relate to outcomes, whereas Document A is specific to glioma stem cells and A20.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:19.148290Z"}
{"comparison_id":"e7ee53bb-d053-4142-a218-815f3e5edcc4","query_id":"51","doc_a_id":"23576165","doc_b_id":"33370","presented_order":["23576165","33370"],"winner_id":"23576165","reasoning":"Neither document discusses ALDH1 or breast cancer specifically. Document A is slightly more relevant because it addresses tumor metabolism and heterogeneity broadly, whereas Document B focuses on A20 in glioma stem cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:19.148296Z"}
{"comparison_id":"8f0eb7c2-88f7-40da-944c-b64ce55a7593","query_id":"51","doc_a_id":"23830488","doc_b_id":"1782201","presented_order":["23830488","1782201"],"winner_id":"23830488","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer; Document A at least links gene expression to patient outcomes in cancer, so it's marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:32.981854Z"}
{"comparison_id":"17b2f556-5c54-4bdc-b04a-babc227ed7fe","query_id":"51","doc_a_id":"42731834","doc_b_id":"1782201","presented_order":["42731834","1782201"],"winner_id":"42731834","reasoning":"Document A is more relevant — it addresses protein expression linked to patient survival and prognostic biomarker use, which is closer in subject to the claim about a marker's association with cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:32.981877Z"}
{"comparison_id":"cc2a98fc-ad13-45ad-abfe-ea6bcc0af08d","query_id":"51","doc_a_id":"23576165","doc_b_id":"1782201","presented_order":["23576165","1782201"],"winner_id":"23576165","reasoning":"Document A is more relevant — it discusses tumor metabolic enzymes and microenvironmental metabolism, which is closer to ALDH1's metabolic role and cancer outcomes than integrin/c-Src signaling in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:32.981885Z"}
{"comparison_id":"da292b3c-2468-464c-89b6-d08ad545e214","query_id":"51","doc_a_id":"1032372","doc_b_id":"1782201","presented_order":["1782201","1032372"],"winner_id":"1782201","reasoning":"Document A is slightly more relevant because it addresses mechanisms of tumor progression in carcinomas (which relate to outcomes), whereas B focuses on epigenetic therapy and immune response rather than biomarker–outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:32.981893Z"}
{"comparison_id":"6412b074-1209-4208-8c61-27f55b7ecba1","query_id":"51","doc_a_id":"21521236","doc_b_id":"1782201","presented_order":["1782201","21521236"],"winner_id":"1782201","reasoning":"Neither abstract mentions ALDH1 or reports breast cancer outcomes. Document A is marginally more relevant because it discusses tumor progression in carcinomas, whereas B focuses on a p53–NEAT1 pathway and chemosensitivity. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:32.981900Z"}
{"comparison_id":"51197265-a5a3-4c08-afe8-cf0f08c75028","query_id":"51","doc_a_id":"23830488","doc_b_id":"42731834","presented_order":["23830488","42731834"],"winner_id":"23830488","reasoning":"Document A is more relevant because it discusses correlations between specific gene expression levels and patient outcomes (including genes linked to better outcomes), which is conceptually closer to the claim about ALDH1 expression and breast cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:42.087528Z"}
{"comparison_id":"ac560ae1-6b7c-42c2-ae54-c54d491a6f83","query_id":"51","doc_a_id":"23576165","doc_b_id":"42731834","presented_order":["42731834","23576165"],"winner_id":"42731834","reasoning":"Document A is more relevant — it links marker expression to patient survival (though for AIM2 in colorectal cancer), whereas B discusses tumor metabolism generally and doesn't address marker expression or breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:42.087550Z"}
{"comparison_id":"63413e20-6f01-4dc0-9f1f-caf8e51499cf","query_id":"51","doc_a_id":"1032372","doc_b_id":"21521236","presented_order":["1032372","21521236"],"winner_id":"1032372","reasoning":"Document A is slightly more relevant because it discusses cancer treatment approaches and outcomes generally, whereas Document B focuses on NEAT1/paraspeckles and chemosensitivity without connection to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:57:47.828708Z"}
{"comparison_id":"c7a27609-113d-4add-8191-e637600c1354","query_id":"51","doc_a_id":"13964633","doc_b_id":"864491","presented_order":["13964633","864491"],"winner_id":"864491","reasoning":"Neither document discusses ALDH1. Both are irrelevant, but B is slightly more related because it addresses tumor response/therapy (CDK4/6 inhibition) which pertains to cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:04.894658Z"}
{"comparison_id":"6a42f2b5-5629-46c9-b8c6-69e4c7a2ef6e","query_id":"51","doc_a_id":"33638477","doc_b_id":"864491","presented_order":["864491","33638477"],"winner_id":"864491","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is slightly more pertinent because it discusses tumor response/outcomes, whereas B focuses on BCL9 in other cancer types. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:04.894678Z"}
{"comparison_id":"79e94068-d4c7-47d5-afc6-45d4186400ba","query_id":"51","doc_a_id":"13964633","doc_b_id":"33638477","presented_order":["13964633","33638477"],"winner_id":"13964633","reasoning":"Document A is marginally more relevant because it discusses mechanisms that modulate tumor growth and tumor-suppressor pathways (Rb1, PTEN), which could relate to cancer outcomes; Document B focuses on BCL9 in multiple myeloma and colon cancer rather than breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:15.162103Z"}
{"comparison_id":"27e3b825-798c-4ebf-9a9a-6b1e4a395006","query_id":"51","doc_a_id":"2727303","doc_b_id":"10165723","presented_order":["10165723","2727303"],"winner_id":"10165723","reasoning":"Document A — it addresses tumor marker patterns linked to disease progression and outcomes (though in melanoma rather than breast cancer), while B focuses on HDAC6/STIM1 signaling and not clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:24.181564Z"}
{"comparison_id":"e7764733-9398-45cb-80de-2573f11b891f","query_id":"51","doc_a_id":"5774746","doc_b_id":"10165723","presented_order":["10165723","5774746"],"winner_id":"5774746","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is slightly more relevant because it addresses tumor progression and survival correlations (though in colorectal cancer), while A focuses on methylation patterns in melanoma. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:24.181586Z"}
{"comparison_id":"9ecedcb0-5b84-408d-8762-8a1bfd4f5321","query_id":"51","doc_a_id":"5386514","doc_b_id":"10165723","presented_order":["5386514","10165723"],"winner_id":"5386514","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is slightly more relevant because it deals with tumor immune responses and therapy outcomes generally, while B is specific to melanoma methylation patterns. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:24.181595Z"}
{"comparison_id":"12106c32-006c-4596-843b-878a6faa708b","query_id":"51","doc_a_id":"17412260","doc_b_id":"10165723","presented_order":["17412260","10165723"],"winner_id":"17412260","reasoning":"Document A is more relevant — it discusses tumor-suppressive senescence mechanisms in vivo, which is more closely related to cancer outcomes than a melanoma methylation study.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:24.181602Z"}
{"comparison_id":"99bf72f4-aa49-4424-b278-ab3765c7e99f","query_id":"51","doc_a_id":"13400643","doc_b_id":"10165723","presented_order":["13400643","10165723"],"winner_id":"10165723","reasoning":"Document B is more relevant — it studies molecular marker patterns predicting cancer progression and outcomes, which is conceptually closer to a claim about a biomarker's association with cancer prognosis; Document A focuses on a therapeutic molecule, not biomarker-outcome associations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:24.181610Z"}
{"comparison_id":"d8a288de-5e75-47b9-90e1-edbb4a0a1da3","query_id":"51","doc_a_id":"10365787","doc_b_id":"10165723","presented_order":["10365787","10165723"],"winner_id":"10365787","reasoning":"Neither document mentions ALDH1 or breast cancer, but Document A addresses tumor suppression and cancer-related protein regulation, making it marginally more relevant than a melanoma-specific methylation study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:24.181617Z"}
{"comparison_id":"b25e7795-3518-4387-a7f8-586f3fb540e0","query_id":"51","doc_a_id":"1686997","doc_b_id":"10165723","presented_order":["10165723","1686997"],"winner_id":"1686997","reasoning":"Document B is more relevant — it addresses tumor metabolic enzymes and cancer growth mechanisms (though neither document mentions ALDH1 or breast cancer specifically). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:24.181624Z"}
{"comparison_id":"8f125dac-ec8b-4c24-bbaf-45e45f42b89d","query_id":"51","doc_a_id":"13205096","doc_b_id":"10165723","presented_order":["13205096","10165723"],"winner_id":"13205096","reasoning":"Document A is more relevant — it concerns gene-expression profiling and prognostic markers (though in AML, not breast cancer), which is closer to an ALDH1 expression–outcome association than melanoma CIMP. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:24.181631Z"}
{"comparison_id":"7dfddb44-3b3a-461f-bc13-725ff2bbd2e8","query_id":"51","doc_a_id":"8538916","doc_b_id":"10165723","presented_order":["10165723","8538916"],"winner_id":"8538916","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer; Document B deals with protein expression in cancer more generally and is therefore marginally more relevant than a melanoma-specific methylation study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:24.181638Z"}
{"comparison_id":"a8220945-c808-4850-8f86-89dcfb010d9c","query_id":"51","doc_a_id":"11578459","doc_b_id":"10165723","presented_order":["11578459","10165723"],"winner_id":"11578459","reasoning":"Reason: Document A discusses a stem cell–related signature (more directly connected to ALDH1 as a stem cell marker), while Document B focuses on methylation in melanoma and is less related to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:24.181645Z"}
{"comparison_id":"e0a2d4ed-f03e-470c-b804-1ae7d8868ab3","query_id":"51","doc_a_id":"5774746","doc_b_id":"10365787","presented_order":["10365787","5774746"],"winner_id":"5774746","reasoning":"Document B — it links protein expression to metastasis and patient survival (an expression–outcome association), whereas A discusses Cdh1’s role in genomic stability without expression–outcome data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:34.206474Z"}
{"comparison_id":"8f91404d-fb46-4a6e-a4da-2c80f2eded67","query_id":"51","doc_a_id":"5386514","doc_b_id":"10365787","presented_order":["5386514","10365787"],"winner_id":"10365787","reasoning":"Document B — it discusses tumor suppression and factors affecting tumor susceptibility and genomic stability, which are more directly related to cancer outcomes than the immunology-focused Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:34.206495Z"}
{"comparison_id":"853f6c7d-035f-43b5-989e-dfcab1b21f31","query_id":"51","doc_a_id":"17412260","doc_b_id":"10365787","presented_order":["10365787","17412260"],"winner_id":"10365787","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is slightly more relevant because it directly addresses tumor suppression and genomic stability, which relate to cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:34.206504Z"}
{"comparison_id":"b3431a99-260e-438d-832f-30b9c414fe12","query_id":"51","doc_a_id":"11578459","doc_b_id":"10365787","presented_order":["11578459","10365787"],"winner_id":"11578459","reasoning":"Reason: Document A discusses a stem cell–related expression signature (closer to ALDH1's role as a stem cell marker), whereas Document B focuses on cell-cycle regulator Cdh1 unrelated to ALDH1 or breast cancer outcomes.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:34.206511Z"}
{"comparison_id":"f9d1787a-0ec8-47a9-9767-e4ba31fc8930","query_id":"51","doc_a_id":"1686997","doc_b_id":"10365787","presented_order":["1686997","10365787"],"winner_id":"10365787","reasoning":"Reason: Document B discusses tumor suppression and genomic stability, which are more directly related to cancer outcomes than Document A's focus on a metabolic enzyme.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:34.206519Z"}
{"comparison_id":"cfd023c9-5df1-4a6e-9d8c-a4d84b81c34f","query_id":"51","doc_a_id":"13205096","doc_b_id":"10365787","presented_order":["13205096","10365787"],"winner_id":"13205096","reasoning":"Both documents are largely unrelated to ALDH1 or breast cancer, but Document A discusses gene-expression profiling and prognostic markers (though in AML), making it marginally more relevant to a claim about a prognostic marker. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:34.206526Z"}
{"comparison_id":"97846c34-f28a-475b-811e-fadf84d43600","query_id":"51","doc_a_id":"8538916","doc_b_id":"10365787","presented_order":["10365787","8538916"],"winner_id":"8538916","reasoning":"Neither mentions ALDH1 or breast cancer outcomes; Document B is slightly more relevant because it discusses protein expression levels and their relation to cancer cell behavior. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:34.206532Z"}
{"comparison_id":"7c10e83f-0402-49f6-8ccc-3e9dea27cf3c","query_id":"51","doc_a_id":"5774746","doc_b_id":"11578459","presented_order":["5774746","11578459"],"winner_id":"11578459","reasoning":"Document B is slightly more relevant because it discusses a stem cell–related transcriptional program (ALDH1 is a stem cell marker), but neither document mentions ALDH1 or breast cancer outcomes. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:41.568303Z"}
{"comparison_id":"6a57206c-a960-4f44-baaa-06cb204c1e0d","query_id":"51","doc_a_id":"8538916","doc_b_id":"11578459","presented_order":["8538916","11578459"],"winner_id":"11578459","reasoning":"Document B is more relevant — it discusses a stem cell–related transcriptional program (closer to ALDH1 as a stem cell marker), whereas A focuses on a chaperonin unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:41.568327Z"}
{"comparison_id":"38f6e741-a41e-43fd-acf2-9f443f381bee","query_id":"51","doc_a_id":"13205096","doc_b_id":"11578459","presented_order":["11578459","13205096"],"winner_id":"11578459","reasoning":"Document A is slightly more relevant because it discusses stem cell–related expression signatures in cancer (ALDH1 is a cancer stem cell marker), whereas Document B concerns AML prognostic profiling unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:41.568339Z"}
{"comparison_id":"98304178-c8fa-4074-9aec-fc7eb2717f27","query_id":"51","doc_a_id":"5774746","doc_b_id":"8538916","presented_order":["5774746","8538916"],"winner_id":"5774746","reasoning":"Document A is more relevant — it links protein expression to patient survival and metastasis (though in colorectal cancer), which is closer to the claim about marker expression and breast cancer outcomes than the general chaperonin proliferation study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:47.224047Z"}
{"comparison_id":"70afacd0-dd8a-48b1-9a3a-57d0a6bf19c7","query_id":"51","doc_a_id":"13205096","doc_b_id":"8538916","presented_order":["8538916","13205096"],"winner_id":"8538916","reasoning":"Document A is slightly more relevant because it discusses protein expression in cancer cells, whereas Document B focuses on gene-expression profiling in acute myeloid leukemia (not breast cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:47.224068Z"}
{"comparison_id":"86f89b41-4e06-4e5e-b0f8-8bcf79a88726","query_id":"51","doc_a_id":"5386514","doc_b_id":"17412260","presented_order":["5386514","17412260"],"winner_id":"17412260","reasoning":"Reason: Neither abstract mentions ALDH1 or breast cancer outcomes, but Document B discusses tumor suppression and in vivo effects on senescence that more directly relate to tumor progression/outcomes than Document A's focus on dendritic cell–mediated chemotherapy immune responses.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:56.676197Z"}
{"comparison_id":"a1d8ea06-5ef5-41a4-8d98-ac7d1c0e9189","query_id":"51","doc_a_id":"1686997","doc_b_id":"17412260","presented_order":["17412260","1686997"],"winner_id":"17412260","reasoning":"Document A is slightly more relevant — it discusses in vivo tumor suppression and factors that affect tumor behavior/outcomes, whereas B focuses on metabolic enzyme targeting and tumor growth without relevance to ALDH1 or prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:58:56.676219Z"}
{"comparison_id":"bc03d767-bef9-4518-8d51-20b5a6aacbee","query_id":"51","doc_a_id":"5386514","doc_b_id":"1686997","presented_order":["5386514","1686997"],"winner_id":"5386514","reasoning":"Document A is slightly more relevant because it addresses factors (immune response and chemotherapy efficacy) that influence tumor outcomes, whereas Document B focuses on a metabolic enzyme mechanism without direct connection to clinical outcomes. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:59:04.960185Z"}
{"comparison_id":"8154bb45-a202-407c-9328-ddf06e5fdd8f","query_id":"51","doc_a_id":"2727303","doc_b_id":"13400643","presented_order":["2727303","13400643"],"winner_id":"13400643","reasoning":"Document B is more relevant — neither mentions ALDH1, but B discusses effects on tumor burden and survival (clinical outcomes), while A focuses on intracellular signaling mechanisms. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:59:11.929979Z"}
{"comparison_id":"03c54944-d9a0-4215-b731-9d12bdf6866a","query_id":"51","doc_a_id":"7165938","doc_b_id":"38243984","presented_order":["38243984","7165938"],"winner_id":"38243984","reasoning":"B — Neither paper studies ALDH1 or breast cancer, but B is slightly more relevant because it links gene expression to treatment sensitivity and improved patient survival.","model":"gpt-5-mini","timestamp":"2025-12-31T08:59:20.901324Z"}
{"comparison_id":"09dce6c6-523d-4f50-bc15-5ea8542e731c","query_id":"51","doc_a_id":"11271123","doc_b_id":"38243984","presented_order":["38243984","11271123"],"winner_id":"11271123","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it involves molecular marker analysis in cancer (where marker–outcome associations are studied), whereas A focuses on pancreatic xenograft engraftment and drug resistance.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:59:20.901347Z"}
{"comparison_id":"9303bed0-c44d-45aa-814d-3ac50a2e10ff","query_id":"51","doc_a_id":"21502234","doc_b_id":"38243984","presented_order":["38243984","21502234"],"winner_id":"38243984","reasoning":"Neither paper addresses ALDH1 or breast cancer. Document A is marginally more relevant because it discusses tumor markers/gene-pathway associations with survival in cancer, whereas B focuses on MMR status in endometrial cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:59:20.901357Z"}
{"comparison_id":"3b8e8ff4-1304-4311-aa32-49b91a3d5c86","query_id":"51","doc_a_id":"3805841","doc_b_id":"38243984","presented_order":["3805841","38243984"],"winner_id":"3805841","reasoning":"Neither document mentions ALDH1 or breast cancer, so both are irrelevant. Document A is slightly more related because it discusses cancer metabolism and clinical outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:59:20.901364Z"}
{"comparison_id":"3a2f852b-456a-4204-a8ef-3f44df4af733","query_id":"51","doc_a_id":"18358026","doc_b_id":"38243984","presented_order":["18358026","38243984"],"winner_id":"38243984","reasoning":"Document B is more relevant — it addresses associations between tumor features and clinical outcomes/survival, whereas A focuses on epigenetic mechanisms not related to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:59:20.901372Z"}
{"comparison_id":"aa2416c6-aaee-4fc5-b52f-aca81293a498","query_id":"51","doc_a_id":"26561572","doc_b_id":"38243984","presented_order":["38243984","26561572"],"winner_id":"38243984","reasoning":"Document A is more relevant — it addresses tumor gene pathways and patient survival/outcomes (though in pancreatic cancer), whereas Document B focuses on lung kinase fusions and not outcome associations with ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:59:20.901380Z"}
{"comparison_id":"d6e5ad6d-8c0b-4e0a-9e26-6c5ae9727be7","query_id":"51","doc_a_id":"29473081","doc_b_id":"38243984","presented_order":["29473081","38243984"],"winner_id":"38243984","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document B is marginally more related since it addresses tumor outcomes and survival in cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:59:20.901386Z"}
{"comparison_id":"d6c76d86-91a5-44d9-98d4-0ccbdcf17ae7","query_id":"51","doc_a_id":"33387953","doc_b_id":"38243984","presented_order":["33387953","38243984"],"winner_id":"38243984","reasoning":"Document B — it discusses molecular features linked to clinical outcomes and survival (though in pancreatic cancer), which is more related to the query about expression linked to outcomes than the mutation/functional study in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:59:20.901393Z"}
{"comparison_id":"63844eb8-b1a0-4711-b7b6-3cb1405ae274","query_id":"51","doc_a_id":"11271123","doc_b_id":"3805841","presented_order":["11271123","3805841"],"winner_id":"11271123","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it is a molecular cancer study (though on endometrial cancer), whereas B focuses on MYC and circadian disruption. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:59:29.829980Z"}
{"comparison_id":"fb73406f-2723-4fce-b86f-537bcc382994","query_id":"51","doc_a_id":"7165938","doc_b_id":"18358026","presented_order":["7165938","18358026"],"winner_id":"7165938","reasoning":"Doc A is more relevant because it links gene expression to patient survival and cancer outcomes (even though it's colorectal rather than breast), while Doc B focuses on DNA methylation mechanisms without clinical outcome data.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:59:44.109427Z"}
{"comparison_id":"785dd629-4282-4e67-a073-23990898e7cf","query_id":"51","doc_a_id":"21502234","doc_b_id":"18358026","presented_order":["18358026","21502234"],"winner_id":"21502234","reasoning":"Document B is more relevant — it deals with clinical outcomes in cancer (though endometrial and a different biomarker), whereas A is a mechanistic epigenetics study not about ALDH1 or clinical outcomes.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:59:44.109452Z"}
{"comparison_id":"ebb4d6c5-0b2a-4f04-b293-ae9dcd977a63","query_id":"51","doc_a_id":"33387953","doc_b_id":"18358026","presented_order":["33387953","18358026"],"winner_id":"18358026","reasoning":"Document B is more relevant — it discusses cancer-related changes in gene expression and promoter methylation that could affect markers like ALDH1, whereas A focuses on G protein beta subunit mutations unrelated to ALDH1 or breast outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:59:44.109464Z"}
{"comparison_id":"4e0b5ef8-ce81-44eb-9bc3-fa0499b03b29","query_id":"51","doc_a_id":"26561572","doc_b_id":"18358026","presented_order":["18358026","26561572"],"winner_id":"18358026","reasoning":"Document A is slightly more relevant — it discusses cancer-related gene expression and epigenetic changes, whereas B is specific to lung cancer kinase fusions and unrelated to ALDH1 or breast outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:59:44.109474Z"}
{"comparison_id":"b35e041d-2f42-4a08-bf1c-abf4bd067052","query_id":"51","doc_a_id":"29473081","doc_b_id":"18358026","presented_order":["29473081","18358026"],"winner_id":"18358026","reasoning":"Document B is more relevant — it discusses cancer-related gene regulation mechanisms (DNA methylation/transcriptional silencing) that could affect markers like ALDH1, whereas A concerns a myeloma-specific enzyme unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:59:44.109483Z"}
{"comparison_id":"1bc4e928-8d00-42ce-8fdb-b51621bf816a","query_id":"51","doc_a_id":"7165938","doc_b_id":"21502234","presented_order":["21502234","7165938"],"winner_id":"7165938","reasoning":"Both documents are unrelated to ALDH1 in breast cancer, but Document B is slightly more relevant because it discusses how expression of a gene (Bmal1) is associated with improved cancer outcomes, whereas Document A concerns mismatch repair in endometrial cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:59:50.300467Z"}
{"comparison_id":"12728d69-3390-4973-9d76-669db2735497","query_id":"51","doc_a_id":"33387953","doc_b_id":"26561572","presented_order":["33387953","26561572"],"winner_id":"33387953","reasoning":"Document A is slightly more relevant because it discusses molecular alterations across various cancers, whereas Document B focuses on lung-specific kinase fusions and does not pertain to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T08:59:58.549752Z"}
{"comparison_id":"d7894aa6-6b05-4c44-93c7-af32ea4c5bc8","query_id":"51","doc_a_id":"29473081","doc_b_id":"26561572","presented_order":["26561572","29473081"],"winner_id":"29473081","reasoning":"Document B is slightly more relevant — it studies how a gene's expression level relates to cancer patient survival (though in multiple myeloma), while Document A concerns kinase fusions in lung cancer and doesn't address gene expression or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T08:59:58.549774Z"}
{"comparison_id":"4c34bec0-8e20-4e9a-b49e-493ebc1825df","query_id":"51","doc_a_id":"33387953","doc_b_id":"29473081","presented_order":["29473081","33387953"],"winner_id":"29473081","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it discusses gene expression linked to survival outcomes (albeit for ST3GAL6 in multiple myeloma), while Document B focuses on G protein mutations and drug resistance.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:05.576388Z"}
{"comparison_id":"276c6b6b-f85e-47f1-bc61-6dfc632d27bf","query_id":"51","doc_a_id":"8512633","doc_b_id":"22914228","presented_order":["22914228","8512633"],"winner_id":"8512633","reasoning":"Document B is more relevant — it discusses associations between biomarkers and cancer outcomes (though in prostate cancer), whereas A focuses on pancreatic cell metabolism unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004613Z"}
{"comparison_id":"dba87a87-ff44-4604-ad65-12fecfdbc642","query_id":"51","doc_a_id":"13906581","doc_b_id":"22914228","presented_order":["22914228","13906581"],"winner_id":"22914228","reasoning":"Document A — it's cancer-related (proteomics of tumor cells), whereas Document B concerns hospital teaching status and patient outcomes, unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004633Z"}
{"comparison_id":"9c843e1c-83ed-406c-8824-17a40a7f2194","query_id":"51","doc_a_id":"39580129","doc_b_id":"22914228","presented_order":["39580129","22914228"],"winner_id":"39580129","reasoning":"Document A — though about a different marker and cancer type, it addresses expression of a biomarker and its association with patient outcomes; Document B concerns metabolism in pancreatic cells and is less related to prognostic marker–outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004643Z"}
{"comparison_id":"e7faafb5-074b-4185-a523-b3364c7f2364","query_id":"51","doc_a_id":"4462079","doc_b_id":"22914228","presented_order":["4462079","22914228"],"winner_id":"22914228","reasoning":"Document B — it deals with cancer proteomics and altered protein expression, which is closer to a claim about a protein marker (ALDH1) and cancer outcomes than a vitamin D serum-level review. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004651Z"}
{"comparison_id":"164c9444-187b-4dc8-8c79-ea0ac1a5db94","query_id":"51","doc_a_id":"21181273","doc_b_id":"22914228","presented_order":["22914228","21181273"],"winner_id":"22914228","reasoning":"Document A — it’s a cancer proteomics/metabolism study (more likely to address ALDH1 expression) while Document B focuses on a different enzyme in colorectal cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004658Z"}
{"comparison_id":"6a71f6a1-1e56-49a2-9733-2f974dcd52d5","query_id":"51","doc_a_id":"32721137","doc_b_id":"22914228","presented_order":["22914228","32721137"],"winner_id":"32721137","reasoning":"Document B is more relevant — it links molecular alterations to tumor aggressiveness and disease-free survival (prognostic association), which is conceptually closer to a claim about marker expression and cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004665Z"}
{"comparison_id":"deb19965-769f-46fe-9cbd-106ffe4051ab","query_id":"51","doc_a_id":"36212758","doc_b_id":"22914228","presented_order":["22914228","36212758"],"winner_id":"22914228","reasoning":"Document A is more relevant — it reports a proteomic/metabolic study of cancer cells (more likely to discuss enzyme expression like ALDH1) while Document B focuses on genomic profiles in lung cancer unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004672Z"}
{"comparison_id":"6d88191d-f133-413b-ac84-64c28e5e2acf","query_id":"51","doc_a_id":"39929509","doc_b_id":"22914228","presented_order":["22914228","39929509"],"winner_id":"39929509","reasoning":"Document B is slightly more relevant because it discusses a cancer-related protein and its role in gene regulation, whereas Document A focuses on pancreatic metabolism unrelated to ALDH1 or breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004680Z"}
{"comparison_id":"f8653eac-dc60-413c-80c1-827ce11fe56d","query_id":"51","doc_a_id":"1976183","doc_b_id":"22914228","presented_order":["22914228","1976183"],"winner_id":"22914228","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A (a proteomic cancer study) is marginally more relevant than B (oral cancer microRNA work) because it concerns protein expression and cancer biomarkers generally. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004687Z"}
{"comparison_id":"acfd7790-ca4e-4d2d-9e6b-82e8b03cf605","query_id":"51","doc_a_id":"53211308","doc_b_id":"22914228","presented_order":["22914228","53211308"],"winner_id":"22914228","reasoning":"Document A is slightly more relevant because it reports a proteomic analysis of cancer cell protein expression (more likely to address ALDH1 levels), whereas Document B focuses on miRNA in ovarian cancer not protein expression or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004694Z"}
{"comparison_id":"a7fd5e87-ad59-4994-892b-2c2001eefe6c","query_id":"51","doc_a_id":"39758684","doc_b_id":"22914228","presented_order":["22914228","39758684"],"winner_id":"22914228","reasoning":"Document A is more relevant — it's a proteomic study of cancer cell markers/metabolism (closer to biomarker expression and outcome associations) while Document B focuses on DNA polymerase beta and chromosomal instability, which is less related to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004702Z"}
{"comparison_id":"c383dd1a-1522-4a2c-99f9-6fe0dd29ef39","query_id":"51","doc_a_id":"26735905","doc_b_id":"22914228","presented_order":["26735905","22914228"],"winner_id":"26735905","reasoning":"Document A is slightly more relevant—both abstracts don't mention ALDH1 or breast cancer, but A discusses tumor microenvironment and tumorigenesis, which is more related to cancer outcomes than pancreatic metabolic profiling.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004709Z"}
{"comparison_id":"c11aae02-05ff-4994-a2d0-e356358fa13f","query_id":"51","doc_a_id":"24873253","doc_b_id":"22914228","presented_order":["24873253","22914228"],"winner_id":"24873253","reasoning":"Document A is slightly more relevant because it discusses cancer treatment and outcomes, whereas Document B focuses on pancreatic cell metabolism unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004716Z"}
{"comparison_id":"b129ea47-32a1-46be-a358-9ea4d3e83418","query_id":"51","doc_a_id":"3376731","doc_b_id":"22914228","presented_order":["3376731","22914228"],"winner_id":"3376731","reasoning":"Document A is slightly more relevant because it addresses cancer-related markers and chemoresistance (tumor biology), whereas Document B focuses on pancreatic metabolism with no bearing on ALDH1 or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004724Z"}
{"comparison_id":"50b0589b-565e-4bc5-b61b-feb4183aeac5","query_id":"51","doc_a_id":"21551568","doc_b_id":"22914228","presented_order":["22914228","21551568"],"winner_id":"22914228","reasoning":"Document A is slightly more relevant — it deals with cancer proteomics (potentially including metabolic enzymes like ALDH1) versus Document B which focuses on genetic alterations in thyroid cancer unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004731Z"}
{"comparison_id":"3c3f0420-d507-49f4-919b-ff0c9305d8bf","query_id":"51","doc_a_id":"11968641","doc_b_id":"22914228","presented_order":["22914228","11968641"],"winner_id":"11968641","reasoning":"Document B is slightly more relevant because it addresses tumor growth control across cancer types (potentially related to outcomes), whereas A is specific to pancreatic metabolism and unrelated to ALDH1 or breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004738Z"}
{"comparison_id":"e065ee41-6c41-40c3-b50b-0aec93a7074a","query_id":"51","doc_a_id":"24974080","doc_b_id":"22914228","presented_order":["24974080","22914228"],"winner_id":"24974080","reasoning":"Document A is slightly more relevant because it discusses cancer pathways and treatment outcomes, whereas Document B focuses on pancreatic cell metabolism; neither mentions ALDH1 or breast cancer specifically.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004745Z"}
{"comparison_id":"204f2435-8bc8-451d-9461-551711596fc6","query_id":"51","doc_a_id":"16806763","doc_b_id":"22914228","presented_order":["16806763","22914228"],"winner_id":"16806763","reasoning":"Document A is more relevant — it deals with cancer prognosis and biomarkers (though in colorectal cancer), while Document B focuses on pancreatic cancer metabolism and does not address prognosis or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004752Z"}
{"comparison_id":"078ec25b-ea79-4350-bcf1-93a763d823c7","query_id":"51","doc_a_id":"18987782","doc_b_id":"22914228","presented_order":["18987782","22914228"],"winner_id":"18987782","reasoning":"Document A is more related to cancer biology and oncogenic pathways (Myc) than Document B, which focuses on pancreatic metabolism; neither mentions ALDH1 or breast cancer specifically, but A is closer in topic. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004759Z"}
{"comparison_id":"19ac78f9-6d0f-4c0d-8b8c-13c7585130a0","query_id":"51","doc_a_id":"14663842","doc_b_id":"22914228","presented_order":["22914228","14663842"],"winner_id":"22914228","reasoning":"Neither abstract mentions ALDH1 or breast cancer; however, Document A (cancer proteomics/metabolic enzyme expression) is marginally more relevant than B's focus on IDH1 mutations. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004766Z"}
{"comparison_id":"62d61832-05c6-419c-ae8f-7201388514d3","query_id":"51","doc_a_id":"11481946","doc_b_id":"22914228","presented_order":["22914228","11481946"],"winner_id":"11481946","reasoning":"Document B — it discusses cancer risk and mortality and is therefore marginally more related to cancer outcomes than a proteomic study of pancreatic cells. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004773Z"}
{"comparison_id":"3c2551ad-0a34-472e-9e4c-b6b52ac19343","query_id":"51","doc_a_id":"21382907","doc_b_id":"22914228","presented_order":["21382907","22914228"],"winner_id":"21382907","reasoning":"Document A is marginally more relevant because it discusses cancer outcomes and biomarkers (survival markers), while Document B focuses on pancreatic cell metabolism; neither mentions ALDH1 or breast cancer directly.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004780Z"}
{"comparison_id":"b77ba8d1-1b40-4bc8-b03d-948b193a5445","query_id":"51","doc_a_id":"13070316","doc_b_id":"22914228","presented_order":["13070316","22914228"],"winner_id":"13070316","reasoning":"Document A is more relevant — it concerns tumor microenvironment and factors influencing cancer progression, which is closer to breast cancer outcome markers than a pancreatic metabolic proteomics study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004787Z"}
{"comparison_id":"20914df9-c768-48b6-8971-055fadc676d0","query_id":"51","doc_a_id":"12337611","doc_b_id":"22914228","presented_order":["22914228","12337611"],"winner_id":"22914228","reasoning":"Neither document mentions ALDH1 or breast cancer, so neither is relevant. If forced to choose, A is slightly more relevant because it deals with cancer proteomics (general cancer context) whereas B is specific to neuroblastoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004795Z"}
{"comparison_id":"79edd802-e0b4-43eb-8367-35b2207d37d3","query_id":"51","doc_a_id":"38485364","doc_b_id":"22914228","presented_order":["22914228","38485364"],"winner_id":"38485364","reasoning":"Document B is slightly more relevant because it concerns a protein affecting cancer cell behavior (invasion), whereas Document A focuses on pancreatic metabolism not related to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004802Z"}
{"comparison_id":"d2629c7a-b9cd-4d52-b598-f3ca260affed","query_id":"51","doc_a_id":"9641846","doc_b_id":"22914228","presented_order":["9641846","22914228"],"winner_id":"9641846","reasoning":"Document A is slightly more relevant because it discusses cancer-related cell cycle arrest and differentiation, whereas Document B focuses on pancreatic cancer metabolism; neither mentions ALDH1 or breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004809Z"}
{"comparison_id":"e68eb1a9-76c9-4420-9a09-5938d77865cd","query_id":"51","doc_a_id":"6121668","doc_b_id":"22914228","presented_order":["22914228","6121668"],"winner_id":"6121668","reasoning":"Document B is more relevant — it examines expression of biomarkers and their relation to prognostic factors/overall survival, which is closer to the claim about marker expression and cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004816Z"}
{"comparison_id":"e990ac68-6dea-4734-93c8-c2806839ffe3","query_id":"51","doc_a_id":"14315749","doc_b_id":"22914228","presented_order":["14315749","22914228"],"winner_id":"14315749","reasoning":"Document A is more relevant: it addresses gene expression and clinical tumor features (differentiation, metastasis), which is closer to the query about a gene marker and cancer outcomes than a proteomic metabolic study in pancreatic cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004823Z"}
{"comparison_id":"036cff66-78ae-45ed-8aef-cc96f22553a3","query_id":"51","doc_a_id":"25748308","doc_b_id":"22914228","presented_order":["25748308","22914228"],"winner_id":"25748308","reasoning":"Document A is slightly more relevant because it discusses enzyme roles and cancer broadly, whereas Document B focuses specifically on pancreatic cancer metabolism with no link to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004830Z"}
{"comparison_id":"9b7d73c3-978b-4e28-bb19-bf9e66f37aee","query_id":"51","doc_a_id":"654735","doc_b_id":"22914228","presented_order":["654735","22914228"],"winner_id":"654735","reasoning":"Document A is more relevant — it studies a cancer biomarker's association with prognosis, which is conceptually closer to the query about ALDH1 and breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004837Z"}
{"comparison_id":"313eb9c2-61af-44d8-bcdf-679d140e9bc4","query_id":"51","doc_a_id":"22901758","doc_b_id":"22914228","presented_order":["22914228","22901758"],"winner_id":"22901758","reasoning":"Document B — it discusses tumor-initiating (stem-like) cells and patient outcomes, which is conceptually closer to ALDH1 (a stem-cell marker) and prognostic associations than a pancreatic metabolism study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004844Z"}
{"comparison_id":"d3930528-f5e6-4af4-88d5-3873fe4de8bb","query_id":"51","doc_a_id":"37204802","doc_b_id":"22914228","presented_order":["22914228","37204802"],"winner_id":"22914228","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. If forced to choose, Document A is slightly more relevant because it's a proteomic cancer study (may touch on metabolic enzymes), whereas Document B focuses specifically on JMJD6 and colon cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004851Z"}
{"comparison_id":"7533b19e-f85c-4b40-953f-2fd338d256fd","query_id":"51","doc_a_id":"22049489","doc_b_id":"22914228","presented_order":["22914228","22049489"],"winner_id":"22914228","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document A is a proteomic study (more likely to discuss protein expression like ALDH1) while B focuses on lncRNA/miRNA in gastric cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004858Z"}
{"comparison_id":"b2cda9f4-2255-4ee9-a08e-c52a82039d53","query_id":"51","doc_a_id":"3730196","doc_b_id":"22914228","presented_order":["3730196","22914228"],"winner_id":"3730196","reasoning":"Document A is slightly more relevant because it discusses a molecular biomarker and its prognostic significance in cancer, whereas Document B focuses on pancreatic cancer metabolism unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004865Z"}
{"comparison_id":"9d5b30f1-1ae1-4f81-a119-44b93020bbf6","query_id":"51","doc_a_id":"6650933","doc_b_id":"22914228","presented_order":["6650933","22914228"],"winner_id":"6650933","reasoning":"Document A is more relevant — it discusses differences in oxidative enzyme activity between tumor and normal epithelial cells, which is closer to ALDH1's role in cancer than a study focused on pancreatic cancer metabolism. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004871Z"}
{"comparison_id":"f76d4b5e-ad1e-4c9a-a4b2-259e527c0576","query_id":"51","doc_a_id":"9791313","doc_b_id":"22914228","presented_order":["22914228","9791313"],"winner_id":"9791313","reasoning":"Document B is more relevant — it discusses cancer-related molecular markers and tumor suppressor roles, which is closer to biomarker-outcome associations than a pancreatic metabolism proteomics study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004878Z"}
{"comparison_id":"93b7ceac-aa47-4538-84cb-a9f570677e8b","query_id":"51","doc_a_id":"38009906","doc_b_id":"22914228","presented_order":["38009906","22914228"],"winner_id":"38009906","reasoning":"Document A is more relevant — it addresses cancer-related molecular markers and tumor suppression mechanisms (more closely related to cancer outcomes) while Document B focuses on pancreatic cell metabolism. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004885Z"}
{"comparison_id":"98606e0c-e1ce-42e3-b822-0ca30b2e7e41","query_id":"51","doc_a_id":"35993767","doc_b_id":"22914228","presented_order":["35993767","22914228"],"winner_id":"35993767","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer outcomes; Document A is slightly more relevant because it addresses cancer metastasis mechanisms, whereas Document B focuses on pancreatic cell metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004892Z"}
{"comparison_id":"1943eb9f-d4b0-45b6-a84f-733be25ef8f1","query_id":"51","doc_a_id":"12685434","doc_b_id":"22914228","presented_order":["22914228","12685434"],"winner_id":"22914228","reasoning":"Neither document discusses ALDH1 or breast cancer, but Document A deals with cancer proteomics and metabolic enzymes (making it marginally more related to ALDH1's metabolic role).  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004898Z"}
{"comparison_id":"1fc6767c-4280-4564-992c-4f6741ff448b","query_id":"51","doc_a_id":"4467129","doc_b_id":"22914228","presented_order":["22914228","4467129"],"winner_id":"22914228","reasoning":"Document A — it discusses cancer-related protein/metabolic expression (proteomics) which is somewhat closer to ALDH1 expression than a microRNA study in neuroblastoma. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004905Z"}
{"comparison_id":"6e2e05f8-cb12-4655-ab3b-b4922f7c53da","query_id":"51","doc_a_id":"13889430","doc_b_id":"22914228","presented_order":["22914228","13889430"],"winner_id":"22914228","reasoning":"Document A is marginally more relevant—it's a cancer proteomic study (potentially including protein markers like ALDH1), whereas Document B focuses on exosome-driven fibroblast differentiation unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004912Z"}
{"comparison_id":"9dde9163-e25c-4037-98c5-27a7fe740bd7","query_id":"51","doc_a_id":"5254463","doc_b_id":"22914228","presented_order":["22914228","5254463"],"winner_id":"5254463","reasoning":"B — it deals with stem cells and tumorigenesis (ALDH1 is a stem-cell marker), so it's slightly more related than a proteomic study of pancreatic cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004918Z"}
{"comparison_id":"a88cb6a9-60df-4041-82c0-ef60eda75980","query_id":"51","doc_a_id":"15727984","doc_b_id":"22914228","presented_order":["22914228","15727984"],"winner_id":"22914228","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document A is slightly more relevant because a proteomic study is more likely to report expression of intracellular enzymes like ALDH1 than a secretome-focused lung cancer study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004926Z"}
{"comparison_id":"f6a8db8d-dc7c-4c91-9f36-6ee2877b0e4a","query_id":"51","doc_a_id":"7975937","doc_b_id":"22914228","presented_order":["22914228","7975937"],"winner_id":"7975937","reasoning":"Document B is slightly more relevant because it discusses cancer progression and factors affecting tumor outcomes, whereas Document A is limited to pancreatic cell metabolism and not related to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004933Z"}
{"comparison_id":"73ce758f-36a7-4f82-9c4f-19d5fc441586","query_id":"51","doc_a_id":"4325398","doc_b_id":"22914228","presented_order":["22914228","4325398"],"winner_id":"22914228","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it is a proteomic/metabolism study (ALDH1 is a metabolic enzyme), whereas B focuses on genomic/axon-guidance mutations in pancreatic cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004940Z"}
{"comparison_id":"64e75f6c-5d53-4f97-8187-8dd85f39da9c","query_id":"51","doc_a_id":"1727493","doc_b_id":"22914228","presented_order":["1727493","22914228"],"winner_id":"1727493","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it deals with cancer treatment/resistance, whereas B focuses on pancreatic metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004946Z"}
{"comparison_id":"504d34e0-cb09-43be-810f-5560412fe0cf","query_id":"51","doc_a_id":"16364639","doc_b_id":"22914228","presented_order":["22914228","16364639"],"winner_id":"22914228","reasoning":"Document A is slightly more relevant because it's a proteomic study of cancer cell expression (potentially covering metabolic enzymes like ALDH1), whereas Document B focuses on microRNA networks in glioblastoma and not protein expression or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004953Z"}
{"comparison_id":"900a0a59-a9ab-4150-b05f-49c3c88b00e9","query_id":"51","doc_a_id":"1649738","doc_b_id":"22914228","presented_order":["22914228","1649738"],"winner_id":"22914228","reasoning":"Document A is cancer-related proteomics (may include enzyme expression data), while Document B focuses on germline variants in Hodgkin's survivors; neither mentions ALDH1 or breast cancer, but A is marginally more relevant. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004960Z"}
{"comparison_id":"bb433823-d7da-4dd8-9b27-726602331855","query_id":"51","doc_a_id":"14019636","doc_b_id":"22914228","presented_order":["22914228","14019636"],"winner_id":"14019636","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is marginally more relevant because it addresses cancer genomic markers and treatment-related outcomes, while A is specific to pancreatic metabolism. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004967Z"}
{"comparison_id":"d62cacac-3d7f-48a7-8888-2d788776ffda","query_id":"51","doc_a_id":"19408393","doc_b_id":"22914228","presented_order":["22914228","19408393"],"winner_id":"22914228","reasoning":"Document A is at least about cancer molecular profiling (proteomics), whereas B is a clinical radiotherapy study unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004974Z"}
{"comparison_id":"b423c899-7cff-40be-ad5c-2c04d3c327e1","query_id":"51","doc_a_id":"19644821","doc_b_id":"22914228","presented_order":["19644821","22914228"],"winner_id":"19644821","reasoning":"Document A is more relevant — it discusses gene expression driving cancer and effects on tumor burden/survival, which relates to associations between marker expression and outcomes; Document B focuses on pancreatic cell metabolism and is less related to marker-outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.004981Z"}
{"comparison_id":"961d7bcf-6eee-460a-ac53-20bed4d5dcae","query_id":"51","doc_a_id":"20501163","doc_b_id":"22914228","presented_order":["22914228","20501163"],"winner_id":"22914228","reasoning":"Neither document addresses ALDH1 or breast cancer directly; Document A is a proteomic study (which could plausibly mention ALDH enzymes) while Document B focuses on IL-6–driven host metabolism and immunosuppression. Hence A is marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.005059Z"}
{"comparison_id":"105df9a6-cf90-492a-8dd1-b2290c5011f8","query_id":"51","doc_a_id":"31624828","doc_b_id":"22914228","presented_order":["22914228","31624828"],"winner_id":"22914228","reasoning":"Document A is slightly more relevant because it reports proteomic expression in cancer cells (though in pancreatic cancer), whereas Document B discusses p53-mediated apoptotic clearance and not expression markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.005077Z"}
{"comparison_id":"da157585-c793-4629-8664-b3b68c617079","query_id":"51","doc_a_id":"23887844","doc_b_id":"22914228","presented_order":["22914228","23887844"],"winner_id":"23887844","reasoning":"Reason: Neither addresses ALDH1 or breast cancer; Document B discusses cancer cell survival mechanisms more generally, so it's slightly more relevant to outcomes than a PDAC-specific proteomic study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.005090Z"}
{"comparison_id":"2a803ceb-ff06-410a-8eed-8a8c21e56e68","query_id":"51","doc_a_id":"20179918","doc_b_id":"22914228","presented_order":["22914228","20179918"],"winner_id":"20179918","reasoning":"Reason: Document B concerns regulation of a stem-cell–related gene (SALL4) and transcriptional control, which is more tangentially related to ALDH1 as a stem-cell marker in cancers than the pancreatic metabolism focus of Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.005111Z"}
{"comparison_id":"7a979713-9568-4c82-8219-18977c76a091","query_id":"51","doc_a_id":"36547290","doc_b_id":"22914228","presented_order":["22914228","36547290"],"winner_id":"22914228","reasoning":"Neither paper directly addresses ALDH1 or breast cancer outcomes. Document A is marginally more relevant because it's a proteomic cancer study (may assess protein expression), while B focuses on BRG1/STAT3 chromatin regulation unrelated to ALDH1/breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.005119Z"}
{"comparison_id":"c1dad7a6-3422-4bc7-9267-19c1bd4866bf","query_id":"51","doc_a_id":"12152977","doc_b_id":"22914228","presented_order":["22914228","12152977"],"winner_id":"12152977","reasoning":"Document B — it concerns stem cell self-renewal and pluripotency (topics related to stem cell markers like ALDH1), whereas A is about pancreatic cancer metabolism and is unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:00:48.005126Z"}
{"comparison_id":"05674a55-bd78-4df4-8b77-66700840a5be","query_id":"51","doc_a_id":"8512633","doc_b_id":"6121668","presented_order":["6121668","8512633"],"winner_id":"6121668","reasoning":"Neither abstract addresses ALDH1 or breast cancer; both are irrelevant. Document A is slightly closer because it concerns biomarker expression in a gynecologic cancer, whereas B focuses on prostate cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264753Z"}
{"comparison_id":"37145aa2-b7d8-47e5-974e-3cf3f5202e7f","query_id":"51","doc_a_id":"39580129","doc_b_id":"6121668","presented_order":["39580129","6121668"],"winner_id":"39580129","reasoning":"Both documents are irrelevant (neither mentions ALDH1 or breast cancer). Document A is marginally more relevant because it addresses biomarker expression linked to patient outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264773Z"}
{"comparison_id":"6d95de1b-abad-416b-affd-59fdeb00eab6","query_id":"51","doc_a_id":"32721137","doc_b_id":"6121668","presented_order":["6121668","32721137"],"winner_id":"6121668","reasoning":"Reason: Document A directly examines marker expression in relation to survival (finding no link), which is more similar to assessing whether a marker like ALDH1 associates with outcomes. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264782Z"}
{"comparison_id":"b8826d02-75e9-43cd-87e1-f634c47d3661","query_id":"51","doc_a_id":"39929509","doc_b_id":"6121668","presented_order":["6121668","39929509"],"winner_id":"6121668","reasoning":"Document A — it discusses cancer biomarkers and their link to prognostic factors/overall survival (though in endometrial cancer), which is more relevant to a claim about marker expression and outcomes than Document B's molecular interaction in kidney cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264792Z"}
{"comparison_id":"07c1fc3d-4753-4364-a1ef-93958c8d5432","query_id":"51","doc_a_id":"26735905","doc_b_id":"6121668","presented_order":["26735905","6121668"],"winner_id":"6121668","reasoning":"Document B is slightly more relevant because it discusses expression of biomarkers and their relation to prognostic factors/overall survival (though in endometrial cancer), whereas Document A concerns p62 signaling in prostate stromal fibroblasts and inflammation. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264800Z"}
{"comparison_id":"8415613f-7a5f-4441-acb2-0fc888242d60","query_id":"51","doc_a_id":"24873253","doc_b_id":"6121668","presented_order":["24873253","6121668"],"winner_id":"24873253","reasoning":"Document A is more relevant—it's about cancer management including metastatic bone disease often seen in breast cancer, whereas Document B concerns endometrial cancer markers unrelated to ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264807Z"}
{"comparison_id":"b1ba8202-3404-4cf2-89c2-6f396b3ebfba","query_id":"51","doc_a_id":"3376731","doc_b_id":"6121668","presented_order":["3376731","6121668"],"winner_id":"6121668","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document B discusses biomarkers and their (lack of) link to overall survival, making it slightly more relevant to a claim about expression and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264814Z"}
{"comparison_id":"c97b364f-9534-4cfe-bc3b-be2998f2d862","query_id":"51","doc_a_id":"11968641","doc_b_id":"6121668","presented_order":["6121668","11968641"],"winner_id":"11968641","reasoning":"Document B — it discusses tumor-growth modulation mechanisms in cancer cells (relevance to outcomes), whereas A is specific to endometrial markers unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264821Z"}
{"comparison_id":"7cf388d8-476b-4c43-94e4-ae8079a267a5","query_id":"51","doc_a_id":"24974080","doc_b_id":"6121668","presented_order":["24974080","6121668"],"winner_id":"6121668","reasoning":"Document B — it discusses biomarker expression and links (or lack thereof) to prognostic factors and survival, which is more conceptually related to a claim about ALDH1 and breast cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264829Z"}
{"comparison_id":"6ed394e9-94f7-4011-81b0-76f12f283328","query_id":"51","doc_a_id":"16806763","doc_b_id":"6121668","presented_order":["16806763","6121668"],"winner_id":"6121668","reasoning":"Reason: Both documents are about different cancers, but Document B directly addresses marker expression and its (lack of) link to prognostic factors and overall survival, making it slightly more relevant to a claim about a biomarker's association with cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264837Z"}
{"comparison_id":"959eb081-9bbf-40b1-b9e5-350c753b7957","query_id":"51","doc_a_id":"18987782","doc_b_id":"6121668","presented_order":["6121668","18987782"],"winner_id":"6121668","reasoning":"Document A is more relevant — it discusses marker expression and links to prognostic factors and survival in carcinoma, whereas B is a mechanistic Myc/translation study not related to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264844Z"}
{"comparison_id":"0bb4581b-9a6b-44f7-b7cb-23ef00be20f8","query_id":"51","doc_a_id":"11481946","doc_b_id":"6121668","presented_order":["11481946","6121668"],"winner_id":"11481946","reasoning":"Document A is more relevant because it discusses cancer risk and outcomes broadly (whereas B focuses on COX-2/survivin in endometrial carcinoma, unrelated to ALDH1 or breast cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264851Z"}
{"comparison_id":"1a37fa41-dee4-4c17-8b62-a8254d5f7af7","query_id":"51","doc_a_id":"21382907","doc_b_id":"6121668","presented_order":["21382907","6121668"],"winner_id":"21382907","reasoning":"Document A is more relevant — it links biomarker-related ex vivo responses to patient survival (though in HNSCC, not breast cancer); Document B concerns endometrial markers not linked to survival. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264858Z"}
{"comparison_id":"1e2910a2-aa79-4d9e-8d95-f964420c2a65","query_id":"51","doc_a_id":"13070316","doc_b_id":"6121668","presented_order":["6121668","13070316"],"winner_id":"13070316","reasoning":"B — discusses tumor microenvironment and factors affecting tumor progression, which is more related to prognosis in cancer than a study on COX-2/survivin in endometrial carcinoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264865Z"}
{"comparison_id":"6c89b7c9-4342-4069-982f-a5823a3994b0","query_id":"51","doc_a_id":"38485364","doc_b_id":"6121668","presented_order":["38485364","6121668"],"winner_id":"38485364","reasoning":"Document A is slightly more relevant because it discusses a cancer-related protein affecting tumor invasion, whereas Document B addresses unrelated markers in endometrial carcinoma rather than breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264872Z"}
{"comparison_id":"e15e2d94-632e-444b-aa01-b9d084c43954","query_id":"51","doc_a_id":"9641846","doc_b_id":"6121668","presented_order":["6121668","9641846"],"winner_id":"6121668","reasoning":"Document A — it discusses marker expression and links to survival/prognosis in a cancer type, which is more related to the claim about a biomarker and outcomes than the cell-cycle/developmental focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264879Z"}
{"comparison_id":"219c954b-01d1-4622-8d3e-e11e69d5ccfd","query_id":"51","doc_a_id":"12152977","doc_b_id":"6121668","presented_order":["6121668","12152977"],"winner_id":"12152977","reasoning":"Document B — it concerns stem cell pluripotency and regulators of self-renewal, which is more related to ALDH1 as a stem-cell marker than Document A's focus on COX-2/survivin in endometrial cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264886Z"}
{"comparison_id":"f3bc6623-d22d-4641-87d3-9ddf745ef6e5","query_id":"51","doc_a_id":"14315749","doc_b_id":"6121668","presented_order":["6121668","14315749"],"winner_id":"6121668","reasoning":"Document A is slightly more relevant because it discusses biomarker expression in relation to prognostic factors and overall survival (outcomes), whereas Document B focuses on gene expression and angiogenesis in colorectal cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264893Z"}
{"comparison_id":"3f5ce687-3376-48a2-88dd-16e06192be45","query_id":"51","doc_a_id":"25748308","doc_b_id":"6121668","presented_order":["25748308","6121668"],"winner_id":"6121668","reasoning":"Document B — it discusses marker expression and links to survival/prognostic factors in carcinoma (though endometrial, not breast), making it slightly closer to the query than a general GAPDH review. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264900Z"}
{"comparison_id":"dc4b91b5-39b3-4ad9-b515-61878b098969","query_id":"51","doc_a_id":"654735","doc_b_id":"6121668","presented_order":["654735","6121668"],"winner_id":"6121668","reasoning":"Document B is more relevant — although neither discusses ALDH1 or breast cancer, B addresses marker expression and links (or lack thereof) to survival/prognosis in cancer, making it slightly closer to the query. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264907Z"}
{"comparison_id":"90723add-a031-4bac-a84c-12a782b496bc","query_id":"51","doc_a_id":"22901758","doc_b_id":"6121668","presented_order":["6121668","22901758"],"winner_id":"6121668","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is slightly more relevant because it discusses marker expression and clinical outcomes in a carcinoma, whereas B focuses on glioblastoma signaling. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264915Z"}
{"comparison_id":"4b926d5d-2185-469a-b11a-aece89c8d228","query_id":"51","doc_a_id":"3730196","doc_b_id":"6121668","presented_order":["3730196","6121668"],"winner_id":"3730196","reasoning":"Both documents are irrelevant to ALDH1 in breast cancer, but Document A is slightly more relevant because it discusses a biomarker's expression and association with cancer outcomes (chemoresistance/prognosis), whereas Document B focuses on unrelated proteins in endometrial carcinoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264923Z"}
{"comparison_id":"68ec715b-3fc7-4d66-aa79-2bc7c9bfeb9c","query_id":"51","doc_a_id":"6650933","doc_b_id":"6121668","presented_order":["6650933","6121668"],"winner_id":"6650933","reasoning":"Document A is slightly more relevant because it discusses tumor vs. normal epithelial cell behavior in cancer contexts, while Document B focuses on endometrial carcinoma markers unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264930Z"}
{"comparison_id":"f3851625-fff3-443a-83f1-b36dab5e6127","query_id":"51","doc_a_id":"9791313","doc_b_id":"6121668","presented_order":["6121668","9791313"],"winner_id":"6121668","reasoning":"Document A is slightly more relevant because it discusses biomarker expression and associations with cancer outcomes (though in endometrial carcinoma, not breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264937Z"}
{"comparison_id":"92e8791b-b005-4326-8581-d7781018bb63","query_id":"51","doc_a_id":"38009906","doc_b_id":"6121668","presented_order":["38009906","6121668"],"winner_id":"6121668","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document B discusses biomarker expression and links to survival/prognostic factors (albeit in endometrial cancer), so it's slightly more relevant than A's epigenetic mechanism.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264944Z"}
{"comparison_id":"1f1f2ee5-2ebf-4a1e-b4a6-a010a5f102e5","query_id":"51","doc_a_id":"35993767","doc_b_id":"6121668","presented_order":["6121668","35993767"],"winner_id":"6121668","reasoning":"Document A is more relevant — it addresses marker expression and links (or lack thereof) to prognosis/overall survival in a cancer context, whereas B focuses on fibroblast-driven metastasis in liver cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264951Z"}
{"comparison_id":"6ac90197-033f-4019-a61a-0fdb1ad05d0f","query_id":"51","doc_a_id":"5254463","doc_b_id":"6121668","presented_order":["6121668","5254463"],"winner_id":"6121668","reasoning":"Document A is slightly more relevant because it discusses expression of molecular markers and their relation to cancer prognosis, whereas Document B focuses on Wip1 in mouse intestinal tumorigenesis unrelated to ALDH1 or breast cancer.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264958Z"}
{"comparison_id":"fff584bb-43a8-4801-9188-125ae393e934","query_id":"51","doc_a_id":"7975937","doc_b_id":"6121668","presented_order":["6121668","7975937"],"winner_id":"7975937","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is slightly more generally relevant to cancer biology across tumor types, while A is specific to endometrial carcinoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264965Z"}
{"comparison_id":"c4d28c65-7deb-4b82-ac2b-57557c7c7615","query_id":"51","doc_a_id":"1727493","doc_b_id":"6121668","presented_order":["6121668","1727493"],"winner_id":"6121668","reasoning":"Document A — it discusses biomarker expression and links to prognostic factors/overall survival (though in endometrial cancer), whereas Document B is about miR21-mediated drug resistance in ovarian cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264973Z"}
{"comparison_id":"7f024b7d-d819-4e18-ac54-fc4ae61ef825","query_id":"51","doc_a_id":"14019636","doc_b_id":"6121668","presented_order":["14019636","6121668"],"winner_id":"6121668","reasoning":"Document B is more relevant — it discusses expression of tumor markers and their (lack of) association with survival, whereas Document A concerns rDNA copy number and mTOR pathway, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.264980Z"}
{"comparison_id":"c6221277-6b85-452c-9400-3ea5f2ec5b64","query_id":"51","doc_a_id":"19644821","doc_b_id":"6121668","presented_order":["6121668","19644821"],"winner_id":"6121668","reasoning":"Document A is marginally more relevant because it discusses cancer biomarkers and their relation to prognostic factors/survival, whereas Document B focuses on a different oncogene and liver cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.265042Z"}
{"comparison_id":"b08d75f1-d18d-4aab-841a-0bde5c1a7a22","query_id":"51","doc_a_id":"23887844","doc_b_id":"6121668","presented_order":["23887844","6121668"],"winner_id":"6121668","reasoning":"Document B — it addresses expression of markers and their (lack of) link to survival/prognosis in cancer, so it's slightly more related to an outcome-associated claim than Document A. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.265061Z"}
{"comparison_id":"dde4b2df-f302-4473-8f52-e36b8f85961f","query_id":"51","doc_a_id":"20179918","doc_b_id":"6121668","presented_order":["6121668","20179918"],"winner_id":"6121668","reasoning":"Document A is more relevant — it concerns marker expression in carcinoma and explicitly discusses links (or lack thereof) to prognostic factors and overall survival, which is closer to the query about expression and cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:17.265071Z"}
{"comparison_id":"8c85197d-931a-4eb7-a110-a8531f4e07fd","query_id":"51","doc_a_id":"39580129","doc_b_id":"13070316","presented_order":["13070316","39580129"],"winner_id":"13070316","reasoning":"Document A is closer (discusses tumor biology/markers relevant to cancer outcomes), while B is specific to colorectal miR-24-3p. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:31.784782Z"}
{"comparison_id":"ded8bcb3-e13c-4daa-84e1-ba36cb3cd26e","query_id":"51","doc_a_id":"24873253","doc_b_id":"13070316","presented_order":["24873253","13070316"],"winner_id":"13070316","reasoning":"Document B is more relevant — it discusses tumor biology and factors that influence tumor progression and outcomes, whereas A focuses on bisphosphonate treatment for bone metastases and not on biomarkers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:31.784803Z"}
{"comparison_id":"8c9f94d8-3f1c-444f-8ac5-26686cc93507","query_id":"51","doc_a_id":"11968641","doc_b_id":"13070316","presented_order":["11968641","13070316"],"winner_id":"13070316","reasoning":"Document B is more relevant — it discusses tumor microenvironment factors (angiogenesis, macrophages) that influence cancer progression and outcomes, which is closer to prognosis-related topics than Document A's focus on circadian effects in non-breast cancer cell lines.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:31.784812Z"}
{"comparison_id":"8312105f-cebc-4d08-962b-e6366b44b360","query_id":"51","doc_a_id":"11481946","doc_b_id":"13070316","presented_order":["13070316","11481946"],"winner_id":"11481946","reasoning":"Reason: Document B addresses cancer risk and mortality (outcomes), while A focuses on macrophage-driven angiogenesis; neither mentions ALDH1, but B is closer to outcome-related content.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:31.784820Z"}
{"comparison_id":"d5bca65a-a15a-41f9-92fb-7c78a774db49","query_id":"51","doc_a_id":"21382907","doc_b_id":"13070316","presented_order":["21382907","13070316"],"winner_id":"13070316","reasoning":"Document B is more relevant — it discusses tumor microenvironment and factors affecting tumor progression and prognosis, which is closer to breast cancer outcome markers than a head-and-neck drug trial.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:31.784827Z"}
{"comparison_id":"f734b7cd-e8bd-4469-8ac3-2eefddbbc7a0","query_id":"51","doc_a_id":"7975937","doc_b_id":"13070316","presented_order":["13070316","7975937"],"winner_id":"13070316","reasoning":"Document A is slightly more relevant — it discusses tumor biology (angiogenesis, metastasis) linked to cancer progression, which is closer to outcomes in breast cancer than the melanoma/COX-immunity focus in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:31.784834Z"}
{"comparison_id":"eb44eb15-0b72-4757-8737-0531c53f31fe","query_id":"51","doc_a_id":"38485364","doc_b_id":"13070316","presented_order":["38485364","13070316"],"winner_id":"13070316","reasoning":"Neither document mentions ALDH1 or breast cancer outcomes. Document B is slightly more relevant because it discusses tumor-associated macrophages' effects on angiogenesis and metastasis, which relate to cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:31.784842Z"}
{"comparison_id":"24ffba1e-5556-4c1b-a293-c9591ac9addf","query_id":"51","doc_a_id":"12152977","doc_b_id":"13070316","presented_order":["13070316","12152977"],"winner_id":"13070316","reasoning":"Document A is more related to cancer biology and tumor behavior, while Document B focuses on embryonic stem cell chromatin regulation and is unrelated to cancer markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:31.784850Z"}
{"comparison_id":"e04450c1-0a79-4e8d-900c-79ca552b4d44","query_id":"51","doc_a_id":"3730196","doc_b_id":"13070316","presented_order":["3730196","13070316"],"winner_id":"3730196","reasoning":"Document A is slightly more relevant — it discusses a molecular expression linked to prognosis/chemoresistance as a biomarker (albeit in SCLC, not breast cancer). DOCUMENT B is about macrophages/angiogenesis and is less directly related.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:31.784858Z"}
{"comparison_id":"c631dcd2-4fe9-4c8e-885b-481d83ece731","query_id":"51","doc_a_id":"6650933","doc_b_id":"13070316","presented_order":["6650933","13070316"],"winner_id":"13070316","reasoning":"Reason: Document B discusses factors (angiogenesis/lymphangiogenesis) that directly influence tumor progression and prognosis, which is more related to cancer outcomes than Document A's focus on EGCG oxidative effects.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:31.784865Z"}
{"comparison_id":"bec6ef52-3233-4db0-8dd9-a5131bf61058","query_id":"51","doc_a_id":"11481946","doc_b_id":"3730196","presented_order":["11481946","3730196"],"winner_id":"11481946","reasoning":"Document A is marginally more relevant because it discusses cancer risk and outcomes (including factors affecting mortality), whereas Document B focuses on a specific lncRNA in small cell lung cancer unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:39.968631Z"}
{"comparison_id":"1b701ca0-42dc-4233-99f4-f4d692ca7ff1","query_id":"51","doc_a_id":"39580129","doc_b_id":"21382907","presented_order":["39580129","21382907"],"winner_id":"39580129","reasoning":"Document A is slightly more relevant because it examines a biomarker's expression and its association with patient survival (though in colorectal cancer), whereas B addresses integrin-targeted therapy in head and neck cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:50.323288Z"}
{"comparison_id":"8048c1c1-82b7-4b9d-a921-61772f16d8b1","query_id":"51","doc_a_id":"24873253","doc_b_id":"21382907","presented_order":["21382907","24873253"],"winner_id":"24873253","reasoning":"Neither document mentions ALDH1 or directly addresses breast cancer outcomes. Document B is slightly more relevant because it discusses cancer patient outcomes and markers in metastatic disease, whereas A is limited to head and neck cancer and drug assay results. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:50.323309Z"}
{"comparison_id":"f85107d7-90ee-4317-a4e6-d4390da8ed18","query_id":"51","doc_a_id":"11968641","doc_b_id":"21382907","presented_order":["11968641","21382907"],"winner_id":"21382907","reasoning":"Document B is more relevant — it discusses biomarkers associated with patient survival outcomes (though in HNSCC, not breast cancer), whereas A is about circadian effects in melanoma/colon cells and doesn't address ALDH1 or clinical outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:50.323320Z"}
{"comparison_id":"3efd9653-76df-4e90-a937-9a1ebc8abfde","query_id":"51","doc_a_id":"6650933","doc_b_id":"21382907","presented_order":["6650933","21382907"],"winner_id":"6650933","reasoning":"Document A is slightly more relevant — it discusses differential enzyme-related oxidative environments in tumor vs. normal epithelial cells, which is closer to a claim about expression of an enzyme (ALDH1) in cancer than a trial of integrin-targeting drugs in head and neck cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:50.323329Z"}
{"comparison_id":"8b6927be-07a1-4549-aa3c-c9a9d64746e4","query_id":"51","doc_a_id":"7975937","doc_b_id":"21382907","presented_order":["7975937","21382907"],"winner_id":"7975937","reasoning":"Document A is marginally more relevant — it discusses tumor biology and treatment effects across cancer types, whereas B is specific to head and neck cancer; neither mentions ALDH1 or breast cancer.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:50.323336Z"}
{"comparison_id":"0459cc4e-459b-4d9e-b494-4257573e0481","query_id":"51","doc_a_id":"38485364","doc_b_id":"21382907","presented_order":["38485364","21382907"],"winner_id":"38485364","reasoning":"Document A is slightly more relevant — it addresses cancer cell invasion mechanisms (general cancer biology), while B focuses on head-and-neck therapy and cytokine assays. Neither mentions ALDH1 or breast cancer outcomes.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:50.323343Z"}
{"comparison_id":"782aecf3-691f-4b14-a31c-23a369e16a0a","query_id":"51","doc_a_id":"12152977","doc_b_id":"21382907","presented_order":["12152977","21382907"],"winner_id":"21382907","reasoning":"Document B is more relevant because it discusses cancer patient outcomes (though in head and neck cancer), while Document A focuses on embryonic stem cell biology unrelated to ALDH1 or breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:50.323350Z"}
{"comparison_id":"d8df7748-8740-4550-bea3-eebff856da7c","query_id":"51","doc_a_id":"39580129","doc_b_id":"6650933","presented_order":["39580129","6650933"],"winner_id":"39580129","reasoning":"Document A is more relevant because it examines expression of a biomarker and its association with cancer prognosis (though a different marker and cancer type), whereas B discusses a treatment mechanism unrelated to biomarker prognostic associations. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:57.053637Z"}
{"comparison_id":"cb24afc6-823e-42bc-a761-8836ce81ba88","query_id":"51","doc_a_id":"24873253","doc_b_id":"6650933","presented_order":["24873253","6650933"],"winner_id":"6650933","reasoning":"Document B is slightly more relevant — it discusses tumor epithelial cell biology and factors affecting tumor cell survival, whereas Document A addresses bisphosphonate treatment for bone metastases and not biomarkers or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:57.053659Z"}
{"comparison_id":"ebd071eb-45d0-4c33-ae19-c65578a14fa5","query_id":"51","doc_a_id":"38485364","doc_b_id":"6650933","presented_order":["6650933","38485364"],"winner_id":"6650933","reasoning":"Document A is slightly more relevant — it discusses differential enzyme-related oxidative environments in tumor versus normal epithelial cells, which is closer to the enzymatic/biomarker context of ALDH1 than the invasion-specific focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:57.053668Z"}
{"comparison_id":"1d9691c6-2d6c-43b3-b438-e10e86797529","query_id":"51","doc_a_id":"7975937","doc_b_id":"6650933","presented_order":["7975937","6650933"],"winner_id":"6650933","reasoning":"Document B is slightly more relevant because it discusses tumor cell biology and markers that could affect prognosis, whereas Document A focuses on COX-mediated immune evasion unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:01:57.053675Z"}
{"comparison_id":"cb0e044d-b655-442a-ac20-8ff81397a910","query_id":"51","doc_a_id":"24873253","doc_b_id":"38485364","presented_order":["38485364","24873253"],"winner_id":"38485364","reasoning":"Neither abstract mentions ALDH1. Document A is slightly more relevant because it discusses a molecular factor affecting cancer cell invasiveness, whereas B is about bone-targeted therapy. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:04.191722Z"}
{"comparison_id":"94b20b01-5999-4651-9587-95af71919921","query_id":"51","doc_a_id":"7975937","doc_b_id":"38485364","presented_order":["7975937","38485364"],"winner_id":"38485364","reasoning":"Neither document mentions ALDH1 or breast cancer outcomes; both are irrelevant. If one must be chosen, B is slightly more related because it addresses cancer cell invasion, which can affect outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:04.191773Z"}
{"comparison_id":"fc252b4d-f7d8-48ad-9ad5-9842862333c5","query_id":"51","doc_a_id":"24873253","doc_b_id":"7975937","presented_order":["7975937","24873253"],"winner_id":"24873253","reasoning":"Neither abstract mentions ALDH1. Document B is marginally more relevant because it discusses clinical outcomes and survival in cancer patients (including breast cancer metastases), while A focuses on COX-driven immune evasion in melanoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:16.915053Z"}
{"comparison_id":"1587c640-7721-4c39-8ad6-f870042dfb0b","query_id":"51","doc_a_id":"11968641","doc_b_id":"12152977","presented_order":["11968641","12152977"],"winner_id":"11968641","reasoning":"Document A is more relevant — it concerns cancer cell behavior and tumor growth, while Document B is about embryonic stem cell pluripotency and not cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:20.612593Z"}
{"comparison_id":"9da63fad-58d0-4950-a637-f1cbb383ec50","query_id":"51","doc_a_id":"8512633","doc_b_id":"25748308","presented_order":["8512633","25748308"],"winner_id":"25748308","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer outcomes, but Document B discusses cancer-related protein functions broadly, making it marginally more related than a prostate-specific lncRNA study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:37.914314Z"}
{"comparison_id":"89d941e4-e66a-46ae-b3e8-d1f362cedada","query_id":"51","doc_a_id":"32721137","doc_b_id":"25748308","presented_order":["25748308","32721137"],"winner_id":"25748308","reasoning":"Neither document mentions ALDH1 or breast cancer; Document A is slightly more relevant because it discusses a protein's roles in cancer generally. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:37.914334Z"}
{"comparison_id":"1c54db02-b21e-455d-a1ab-34332ad8c106","query_id":"51","doc_a_id":"39929509","doc_b_id":"25748308","presented_order":["25748308","39929509"],"winner_id":"39929509","reasoning":"Neither abstract mentions ALDH1 or breast cancer outcomes, so both are irrelevant; Document B is marginally more relevant because it discusses a cancer-related tumor suppressor, whereas A focuses on GAPDH functions. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:37.914343Z"}
{"comparison_id":"db44b446-82b4-4c81-9f77-41f96aad0bf3","query_id":"51","doc_a_id":"26735905","doc_b_id":"25748308","presented_order":["25748308","26735905"],"winner_id":"25748308","reasoning":"Document A is slightly more relevant because it discusses a metabolic enzyme's roles in cancer broadly, whereas Document B focuses on stromal signaling in prostate (not breast) cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:37.914350Z"}
{"comparison_id":"275d7bc3-b523-4c7d-9c1d-bdc075923c11","query_id":"51","doc_a_id":"3376731","doc_b_id":"25748308","presented_order":["3376731","25748308"],"winner_id":"25748308","reasoning":"Document B is more relevant — it discusses protein roles in cancers generally, whereas Document A focuses on IL6/CXCR7 in esophageal carcinoma, unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:37.914360Z"}
{"comparison_id":"fd25e759-b867-408a-871e-17c67ffe9adb","query_id":"51","doc_a_id":"24974080","doc_b_id":"25748308","presented_order":["25748308","24974080"],"winner_id":"25748308","reasoning":"Document A is marginally more relevant — it discusses a dehydrogenase and its roles in cancer, whereas Document B focuses on VEGF/angiogenesis unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:37.914367Z"}
{"comparison_id":"bceb99e1-11fe-402f-b28d-d0efc25ff048","query_id":"51","doc_a_id":"16806763","doc_b_id":"25748308","presented_order":["25748308","16806763"],"winner_id":"25748308","reasoning":"Document A is slightly more relevant because it discusses a protein's role in cancer biology (though not ALDH1 or breast cancer specifically), whereas Document B focuses on lncRNA in colorectal cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:37.914374Z"}
{"comparison_id":"645d0906-ccb7-4250-a10f-44f6bd7e8693","query_id":"51","doc_a_id":"18987782","doc_b_id":"25748308","presented_order":["18987782","25748308"],"winner_id":"25748308","reasoning":"Document B is more relevant — it discusses protein roles in cancer contexts, whereas A focuses on ribosomal proteins and Myc without relation to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:37.914380Z"}
{"comparison_id":"cf3c131a-8e93-4225-9cd0-acbce4d8ebc6","query_id":"51","doc_a_id":"9641846","doc_b_id":"25748308","presented_order":["25748308","9641846"],"winner_id":"25748308","reasoning":"Document A is slightly more relevant — it discusses enzyme roles and cancer contexts, whereas Document B focuses on Rb-independent cell cycle/differentiation not related to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:37.914387Z"}
{"comparison_id":"106695a0-58f0-46c7-90ad-afe483bcf7bf","query_id":"51","doc_a_id":"14315749","doc_b_id":"25748308","presented_order":["14315749","25748308"],"winner_id":"25748308","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer; Document B at least discusses enzyme roles in cancer broadly, making it slightly more relevant than a colorectal-specific hClock study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:37.914395Z"}
{"comparison_id":"82852052-20e3-4f86-91d4-73d8b4f9eb18","query_id":"51","doc_a_id":"20179918","doc_b_id":"25748308","presented_order":["20179918","25748308"],"winner_id":"20179918","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document A is slightly more relevant because it concerns regulation of stemness-related genes (SALL4/STAT3), which is conceptually closer to ALDH1 as a stem-cell marker. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:37.914408Z"}
{"comparison_id":"711dce06-92cb-417d-956e-5ea3cb83a265","query_id":"51","doc_a_id":"654735","doc_b_id":"25748308","presented_order":["25748308","654735"],"winner_id":"25748308","reasoning":"Document A is slightly more relevant because it discusses an enzyme's roles in cancer contexts, whereas Document B focuses on glioma-specific miR-21 unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:37.914416Z"}
{"comparison_id":"807d9310-def3-419c-82a9-26c71da57ae9","query_id":"51","doc_a_id":"22901758","doc_b_id":"25748308","presented_order":["22901758","25748308"],"winner_id":"25748308","reasoning":"Document B — it discusses protein roles in cancer broadly (more likely to touch on markers affecting outcomes) while Document A is specific to glioblastoma signaling and not breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:37.914423Z"}
{"comparison_id":"d930dc34-573a-4515-8864-b1ddf99b0037","query_id":"51","doc_a_id":"9791313","doc_b_id":"25748308","presented_order":["25748308","9791313"],"winner_id":"25748308","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A at least mentions roles of a cancer-related enzyme (GAPDH) and cancer broadly, so it is slightly more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:37.914431Z"}
{"comparison_id":"23c0739b-3034-4697-a103-86942afedfb6","query_id":"51","doc_a_id":"38009906","doc_b_id":"25748308","presented_order":["25748308","38009906"],"winner_id":"38009906","reasoning":"Document B is slightly more relevant because it discusses cancer-related molecular mechanisms (tumor suppressor silencing), whereas A focuses on GAPDH's general roles; neither mentions ALDH1 or breast cancer outcomes. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:37.914437Z"}
{"comparison_id":"de1e81da-5dd4-4166-9fff-ec65f874b484","query_id":"51","doc_a_id":"35993767","doc_b_id":"25748308","presented_order":["35993767","25748308"],"winner_id":"25748308","reasoning":"Neither document addresses ALDH1 or breast cancer directly. Document B is slightly more relevant because it discusses protein roles in cancers generally, whereas A is specific to hepatocellular carcinoma pathways.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:37.914445Z"}
{"comparison_id":"99a3e0b9-801d-45c9-ba25-8784a912529b","query_id":"51","doc_a_id":"5254463","doc_b_id":"25748308","presented_order":["25748308","5254463"],"winner_id":"5254463","reasoning":"Document B is more relevant — it deals with stem cells and tumorigenesis (context related to ALDH1 as a stem-cell marker), whereas Document A discusses GAPDH's general roles. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:37.914453Z"}
{"comparison_id":"e2ffe01b-c0d2-4566-9b90-28d4f94aa59c","query_id":"51","doc_a_id":"1727493","doc_b_id":"25748308","presented_order":["25748308","1727493"],"winner_id":"25748308","reasoning":"Document A is slightly more relevant because it discusses roles of a metabolic enzyme (GAPDH) in cancer biology, whereas Document B is specific to miR21-mediated chemotherapy resistance in ovarian cancer and unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:37.914460Z"}
{"comparison_id":"dbaf5d7e-1832-436b-9e78-0a2eb78a8d8c","query_id":"51","doc_a_id":"14019636","doc_b_id":"25748308","presented_order":["25748308","14019636"],"winner_id":"25748308","reasoning":"Neither abstract mentions ALDH1 or breast cancer. Document A is marginally more relevant because it discusses an enzyme's roles in cancer, whereas B focuses on rDNA copy number. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:37.914469Z"}
{"comparison_id":"ba8ca534-c67f-497f-8503-55cadf72d01e","query_id":"51","doc_a_id":"19644821","doc_b_id":"25748308","presented_order":["19644821","25748308"],"winner_id":"25748308","reasoning":"Document B. Reason: Neither mentions ALDH1 or breast cancer, but B discusses protein roles in cancers broadly, making it marginally more relevant than a liver-specific Lin28b study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:37.914477Z"}
{"comparison_id":"93192bdc-42c3-4c57-a17d-5de3eb9d7944","query_id":"51","doc_a_id":"23887844","doc_b_id":"25748308","presented_order":["23887844","25748308"],"winner_id":"25748308","reasoning":"Reason: Neither abstract mentions ALDH1 or breast cancer outcomes, but Document B discusses an enzyme's diverse roles and involvement in cancers, making it slightly more relevant to a claim about an enzyme (ALDH1) and cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:37.914485Z"}
{"comparison_id":"9d776c08-b757-4fe1-8abf-cc2892155531","query_id":"51","doc_a_id":"39929509","doc_b_id":"20179918","presented_order":["39929509","20179918"],"winner_id":"20179918","reasoning":"Document B — it discusses stem cell/pluripotency regulation (STAT3 → SALL4), which is more related to ALDH1's role as a cancer stem cell marker than Document A's WT1/ACTN1 mRNA binding. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:46.246089Z"}
{"comparison_id":"c4e2ead9-991c-42ef-838e-7dcd3325ea74","query_id":"51","doc_a_id":"5254463","doc_b_id":"20179918","presented_order":["5254463","20179918"],"winner_id":"5254463","reasoning":"Document A is more relevant — it addresses tumorigenesis and stem cells in a cancer context (though in intestine), whereas B focuses on embryonic stem cell transcriptional regulation unrelated to cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:46.246111Z"}
{"comparison_id":"4f77d4c0-44bd-497b-9fad-1a01ee1a2492","query_id":"51","doc_a_id":"38009906","doc_b_id":"20179918","presented_order":["38009906","20179918"],"winner_id":"38009906","reasoning":"A is more cancer-related (discusses tumor suppressor/oncogenesis), while B concerns stem cell regulation; neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:46.246120Z"}
{"comparison_id":"3ecf0552-e886-4651-9684-b0217fe8c47e","query_id":"51","doc_a_id":"5254463","doc_b_id":"38009906","presented_order":["38009906","5254463"],"winner_id":"5254463","reasoning":"Document B — it addresses stem cells and tumorigenesis (though in intestine), which is closer to ALDH1 as a stem-cell marker than Document A's focus on ANRIL/CBX7 and INK4 repression. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:02:51.376715Z"}
{"comparison_id":"b6197b66-efab-45df-9061-41049b34afaf","query_id":"51","doc_a_id":"8512633","doc_b_id":"14315749","presented_order":["14315749","8512633"],"winner_id":"14315749","reasoning":"Neither document discusses ALDH1 or breast cancer; Document A is slightly more relevant because it addresses gene expression in a cancer context (colorectal) versus Document B's focus on prostate lncRNAs. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:09.511865Z"}
{"comparison_id":"4ca6aa25-eae5-45a0-8223-98cb18fe0d45","query_id":"51","doc_a_id":"32721137","doc_b_id":"14315749","presented_order":["14315749","32721137"],"winner_id":"32721137","reasoning":"Document B — it discusses genomic markers associated with tumor aggressiveness and disease-free survival (prognosis), which is more directly related to a claim about a marker's association with cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:09.511886Z"}
{"comparison_id":"7b11d57a-e6b8-4d77-a147-08d92449aa33","query_id":"51","doc_a_id":"26735905","doc_b_id":"14315749","presented_order":["14315749","26735905"],"winner_id":"14315749","reasoning":"More relevant: Document A — it discusses gene expression linked to tumor differentiation and metastasis (cancer outcomes), whereas Document B focuses on stromal metabolism in prostate cancer and neither mentions ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:09.511896Z"}
{"comparison_id":"a73eef25-f069-42d6-8f99-b4c76e8e2da7","query_id":"51","doc_a_id":"3376731","doc_b_id":"14315749","presented_order":["3376731","14315749"],"winner_id":"3376731","reasoning":"Document A is slightly more relevant because it addresses cancer treatment outcomes (chemoresistance), whereas Document B discusses a different gene in colorectal cancer without outcome implications.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:09.511903Z"}
{"comparison_id":"c3273a27-7bc1-428d-90ac-6b30d26c6ca5","query_id":"51","doc_a_id":"24974080","doc_b_id":"14315749","presented_order":["24974080","14315749"],"winner_id":"14315749","reasoning":"Reason: Document B examines gene expression correlated with tumor aggressiveness/metastasis (an expression–outcome relationship), which is more similar to the claim about ALDH1 expression and breast cancer outcomes than Document A's focus on the VEGF pathway and anti-VEGF therapy.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:09.511912Z"}
{"comparison_id":"a3c90a8f-f5b0-4824-aaa1-dd35dde81edf","query_id":"51","doc_a_id":"16806763","doc_b_id":"14315749","presented_order":["16806763","14315749"],"winner_id":"16806763","reasoning":"Neither document addresses ALDH1 or breast cancer; Document A concerns prognostic markers and survival (albeit in colorectal cancer), so it is marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:09.511918Z"}
{"comparison_id":"8d0c2ded-4fab-4069-b31b-627b6de2fcc9","query_id":"51","doc_a_id":"18987782","doc_b_id":"14315749","presented_order":["18987782","14315749"],"winner_id":"18987782","reasoning":"Neither document addresses ALDH1 or breast cancer specifically. Document A is marginally more relevant because it deals with general cancer oncogenic mechanisms, whereas B focuses on colorectal cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:09.511925Z"}
{"comparison_id":"908188d3-6596-481b-a034-6657d7471c19","query_id":"51","doc_a_id":"9641846","doc_b_id":"14315749","presented_order":["9641846","14315749"],"winner_id":"9641846","reasoning":"Document A is slightly more relevant — it discusses cancer cell differentiation and cell-cycle regulation, which is more closely related to markers like ALDH1 and cancer outcomes than a study of hClock in colorectal cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:09.511932Z"}
{"comparison_id":"7ab9cb83-dedb-45e1-bb8b-5f822a62843c","query_id":"51","doc_a_id":"23887844","doc_b_id":"14315749","presented_order":["14315749","23887844"],"winner_id":"23887844","reasoning":"Document B — it discusses cancer cell metabolism and survival mechanisms, which is more related to enzyme activity in cancer than Document A's unrelated colorectal hClock study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:09.511939Z"}
{"comparison_id":"f3edf6c3-868e-4429-8cce-492f5386327d","query_id":"51","doc_a_id":"654735","doc_b_id":"14315749","presented_order":["654735","14315749"],"winner_id":"14315749","reasoning":"Reason: Both documents are unrelated to ALDH1 or breast cancer, but Document B addresses gene expression in a carcinoma and its link to tumor outcomes, making it slightly more relevant than a glioma miRNA study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:09.511946Z"}
{"comparison_id":"86a8bb3d-d082-4bc0-b8ef-eb5e4234a134","query_id":"51","doc_a_id":"22901758","doc_b_id":"14315749","presented_order":["14315749","22901758"],"winner_id":"22901758","reasoning":"Document B is more relevant — it links molecular signaling/expression to patient survival outcomes (though in GBM), whereas A discusses a different gene in colorectal cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:09.511954Z"}
{"comparison_id":"eaaf61b3-4d72-4c0c-86af-c91acbdf8eb4","query_id":"51","doc_a_id":"9791313","doc_b_id":"14315749","presented_order":["14315749","9791313"],"winner_id":"14315749","reasoning":"Document A is slightly more relevant — it reports a gene's expression correlated with tumor differentiation and metastasis (clinical outcomes), whereas Document B focuses on SETD2 biology in renal cancer and treatment strategies, less directly related to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:09.511962Z"}
{"comparison_id":"b8ded9c0-b879-4188-aeec-8c8df2acc729","query_id":"51","doc_a_id":"35993767","doc_b_id":"14315749","presented_order":["35993767","14315749"],"winner_id":"14315749","reasoning":"Document B is more relevant — both are unrelated to ALDH1 or breast cancer, but B discusses gene expression in carcinoma tissues (expression linked to tumor features), which is closer in topic than A's focus on HCC fibroblast-secreted chemokines.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:09.511969Z"}
{"comparison_id":"bbc4dfcd-7640-446a-9050-f3fdf00949e7","query_id":"51","doc_a_id":"1727493","doc_b_id":"14315749","presented_order":["1727493","14315749"],"winner_id":"14315749","reasoning":"Document B is more relevant — it examines tumor gene expression correlated with clinical outcomes (differentiation, metastasis), which is conceptually closer to a claim about ALDH1 expression and breast cancer outcomes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:09.511977Z"}
{"comparison_id":"d6c870f2-a8ff-4566-9afa-8cddc11f08df","query_id":"51","doc_a_id":"14019636","doc_b_id":"14315749","presented_order":["14019636","14315749"],"winner_id":"14019636","reasoning":"Document A is slightly more relevant because it addresses general cancer genomic markers and outcomes across cancers, whereas Document B focuses specifically on colorectal carcinoma and a different gene. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:09.511984Z"}
{"comparison_id":"bf51c7dd-ccfb-42bf-8200-1290eb72c1c2","query_id":"51","doc_a_id":"19644821","doc_b_id":"14315749","presented_order":["19644821","14315749"],"winner_id":"14315749","reasoning":"Document B — it examines gene expression linked to tumor aggressiveness and outcomes, whereas A focuses on Lin28b in murine liver cancer models unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:09.511991Z"}
{"comparison_id":"bf42c3a1-fcb8-46fc-9867-2de117197e90","query_id":"51","doc_a_id":"32721137","doc_b_id":"18987782","presented_order":["18987782","32721137"],"winner_id":"18987782","reasoning":"Document A is slightly more relevant because it addresses oncogenic mechanisms (Myc) that could pertain to cancer prognosis, whereas Document B focuses specifically on endometrial carcinoma and PI3K without relation to ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:23.573280Z"}
{"comparison_id":"c87e6c31-b697-4178-ae0a-bfc395c812fc","query_id":"51","doc_a_id":"3376731","doc_b_id":"18987782","presented_order":["18987782","3376731"],"winner_id":"18987782","reasoning":"Document A is more relevant — neither discusses ALDH1 or breast cancer directly, but A addresses general cancer-related mechanisms, whereas B is specific to IL6/CXCR7 in esophageal carcinoma. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:23.573303Z"}
{"comparison_id":"4ccce43a-fe9a-42fe-85f9-ae0521110765","query_id":"51","doc_a_id":"16806763","doc_b_id":"18987782","presented_order":["18987782","16806763"],"winner_id":"16806763","reasoning":"Document B is more relevant — it addresses prognostic biomarkers and patient outcomes (though in colorectal cancer, not breast), whereas A is a mechanistic Myc/ribosome study unrelated to ALDH1 or prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:23.573312Z"}
{"comparison_id":"3421c63b-7dc0-457b-9654-ac2bdbade8c3","query_id":"51","doc_a_id":"14019636","doc_b_id":"18987782","presented_order":["18987782","14019636"],"winner_id":"18987782","reasoning":"Neither document discusses ALDH1 or breast cancer specifically. Document A is marginally more relevant because it addresses oncogenic activity and tumor progression mechanisms, which are closer to outcomes than rDNA copy-number variation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:23.573320Z"}
{"comparison_id":"4faeb3aa-5a43-4bb2-b0a6-68b8c75fffc4","query_id":"51","doc_a_id":"9641846","doc_b_id":"18987782","presented_order":["18987782","9641846"],"winner_id":"18987782","reasoning":"Document A is more relevant — it discusses oncogenic activity and mechanisms affecting cancer progression, which is closer to evidence about markers and outcomes than the developmental Rb-family study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:23.573327Z"}
{"comparison_id":"a6b208a6-1e5f-49d3-b119-2f2cc46e7fe9","query_id":"51","doc_a_id":"23887844","doc_b_id":"18987782","presented_order":["18987782","23887844"],"winner_id":"23887844","reasoning":"Neither abstract mentions ALDH1 or breast cancer outcomes. B is slightly more relevant because it discusses cancer cell survival mechanisms that could influence prognosis; A focuses on Myc-specific translational control in mice.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:23.573334Z"}
{"comparison_id":"b0298f05-3c42-4013-9570-709e657904ba","query_id":"51","doc_a_id":"22901758","doc_b_id":"18987782","presented_order":["18987782","22901758"],"winner_id":"22901758","reasoning":"Document B — it discusses tumor-initiating (stem-like) cells and patient outcomes, which is closer to ALDH1's role as a stem cell marker than Document A's ribosomal/Myc focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:23.573341Z"}
{"comparison_id":"a7caf449-8c74-46ed-a718-18ac3be350e9","query_id":"51","doc_a_id":"16806763","doc_b_id":"23887844","presented_order":["16806763","23887844"],"winner_id":"16806763","reasoning":"Document A — it concerns expression-based prognostic markers and clinical outcomes (though in colorectal cancer), so it's more related to a claim about marker expression and cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:33.623615Z"}
{"comparison_id":"7558496f-136c-47c2-aae2-1f7b7144e88d","query_id":"51","doc_a_id":"22901758","doc_b_id":"23887844","presented_order":["23887844","22901758"],"winner_id":"23887844","reasoning":"Document A is a general cancer biology paper discussing metabolic mechanisms in cancer cells, which is marginally more relevant than Document B that focuses specifically on glioblastoma signaling unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:33.623637Z"}
{"comparison_id":"93feceef-630d-47e9-8de2-8c69bb61b769","query_id":"51","doc_a_id":"32721137","doc_b_id":"3376731","presented_order":["3376731","32721137"],"winner_id":"3376731","reasoning":"Document A is slightly more relevant because it discusses mechanisms of chemoresistance and cancer-associated markers, which is closer to ALDH1's role in cancer stemness and treatment outcomes than a genomic study of endometrial carcinoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:44.451565Z"}
{"comparison_id":"68a7fb87-ea4b-40a8-89d6-47a915af4bdf","query_id":"51","doc_a_id":"9641846","doc_b_id":"3376731","presented_order":["9641846","3376731"],"winner_id":"9641846","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document A is marginally more relevant because it relates to cancer cell differentiation and therapy, whereas B focuses on IL6/CXCR7 in esophageal cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:44.451584Z"}
{"comparison_id":"8cceca1b-e579-4e0c-a026-547fb7ab32e2","query_id":"51","doc_a_id":"14019636","doc_b_id":"3376731","presented_order":["14019636","3376731"],"winner_id":"14019636","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes, so both are irrelevant. Document A is marginally more related to general cancer biology, so it's the closer match.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:44.451593Z"}
{"comparison_id":"a6296e6d-46b8-4f4f-bc0f-3b563e8ad2cc","query_id":"51","doc_a_id":"9641846","doc_b_id":"14019636","presented_order":["9641846","14019636"],"winner_id":"9641846","reasoning":"Document A is marginally more relevant — it discusses cell differentiation and cancer cell cycle regulation, which is closer to ALDH1's role as a differentiation/stem-cell marker. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:03:52.056545Z"}
{"comparison_id":"e36da5c3-28cb-4f59-b61a-6602c0cd4dd2","query_id":"51","doc_a_id":"8512633","doc_b_id":"654735","presented_order":["8512633","654735"],"winner_id":"8512633","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer, but Document A deals with expression–outcome associations in cancer (albeit prostate), making it marginally more relevant than Document B (glioma miRNA).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:00.192357Z"}
{"comparison_id":"315659e4-b1ba-4041-bc35-103a0cc56833","query_id":"51","doc_a_id":"26735905","doc_b_id":"654735","presented_order":["654735","26735905"],"winner_id":"26735905","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is slightly more relevant because it addresses tumorigenesis and stromal factors in epithelial cancers, whereas A is specific to glioma miR‑21.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:00.192378Z"}
{"comparison_id":"a4ba8cd5-f546-4731-96fa-797ae60b5771","query_id":"51","doc_a_id":"24974080","doc_b_id":"654735","presented_order":["24974080","654735"],"winner_id":"654735","reasoning":"Document B — it discusses a biomarker (miR-21) whose levels correlate with prognosis, which is more analogous to a claim about ALDH1 expression and breast cancer outcomes than a VEGF/therapy paper. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:00.192386Z"}
{"comparison_id":"1bdcc520-b6e7-4f6d-9604-9c5e071e10af","query_id":"51","doc_a_id":"19644821","doc_b_id":"654735","presented_order":["654735","19644821"],"winner_id":"654735","reasoning":"Both documents are irrelevant to ALDH1 or breast cancer; however, Document A discusses a biomarker linked to prognosis (though in glioma), so it's slightly more related to the claim's focus on expression and outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:00.192394Z"}
{"comparison_id":"935733b2-c1ef-46de-833a-9ce3f9032604","query_id":"51","doc_a_id":"9791313","doc_b_id":"654735","presented_order":["9791313","654735"],"winner_id":"9791313","reasoning":"Document A is more relevant — it discusses cancer-related molecular markers and tumor suppressor function (broadly relevant to cancer outcome markers), whereas Document B focuses specifically on glioma and miR-21. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:00.192402Z"}
{"comparison_id":"d6d2ea49-3fa6-42b0-9d58-e607b8db6028","query_id":"51","doc_a_id":"35993767","doc_b_id":"654735","presented_order":["654735","35993767"],"winner_id":"654735","reasoning":"Document A — it discusses a biomarker's expression level being linked to prognosis (though in glioma, not breast cancer), so it's slightly more relevant than a mechanistic HCC study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:00.192409Z"}
{"comparison_id":"0158dcea-dc43-4af3-88f9-922db7a29eab","query_id":"51","doc_a_id":"1727493","doc_b_id":"654735","presented_order":["1727493","654735"],"winner_id":"1727493","reasoning":"Neither document mentions ALDH1 or breast cancer, so both are irrelevant. If forced to choose, pick A because it addresses an epithelial gynecologic cancer (ovarian) which is slightly more related to breast cancer than glioma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:00.192417Z"}
{"comparison_id":"c8e83c61-2c58-4a47-a9a9-0d593de990c2","query_id":"51","doc_a_id":"8512633","doc_b_id":"26735905","presented_order":["26735905","8512633"],"winner_id":"8512633","reasoning":"Neither document addresses ALDH1 or breast cancer; both focus on prostate cancer. Document B is slightly more relevant because it deals with biomarker–outcome associations (even though different marker/cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:08.474918Z"}
{"comparison_id":"00dfab19-f4a0-481d-8da4-4c25ee810697","query_id":"51","doc_a_id":"1727493","doc_b_id":"26735905","presented_order":["1727493","26735905"],"winner_id":"26735905","reasoning":"Document B is slightly more relevant — although neither mentions ALDH1 or breast cancer, B addresses stromal-tumor interactions and tumorigenesis mechanisms that more directly relate to cancer outcomes than A's ovarian paclitaxel-resistance focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:08.474940Z"}
{"comparison_id":"25496d52-2790-4b8c-acac-3598b2632adb","query_id":"51","doc_a_id":"9791313","doc_b_id":"26735905","presented_order":["9791313","26735905"],"winner_id":"9791313","reasoning":"Document A is slightly more relevant — it discusses cancer-related biomarkers and tumor suppressor roles, whereas Document B focuses on stromal signaling in prostate cancer; neither mentions ALDH1 or breast cancer outcomes. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:08.474949Z"}
{"comparison_id":"ece43944-0afd-4410-96b2-654ea5e0efa9","query_id":"51","doc_a_id":"8512633","doc_b_id":"9791313","presented_order":["9791313","8512633"],"winner_id":"9791313","reasoning":"Document A is more relevant because it discusses cancer-related molecular markers and tumor suppressor function (broader cancer biology) versus Document B which focuses specifically on prostate lncRNAs unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:13.807090Z"}
{"comparison_id":"bc02864c-bc53-4439-a728-d2f24567ffe5","query_id":"51","doc_a_id":"24974080","doc_b_id":"19644821","presented_order":["24974080","19644821"],"winner_id":"24974080","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document A discusses cancer pathways and survival outcomes generally, making it marginally more relevant than Document B's focus on Lin28b in liver cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:29.452476Z"}
{"comparison_id":"6d30498a-ed31-4380-bdf7-96db0aa207ab","query_id":"51","doc_a_id":"35993767","doc_b_id":"19644821","presented_order":["19644821","35993767"],"winner_id":"19644821","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is slightly more generally related to cancer markers/maintenance, so:\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:29.452496Z"}
{"comparison_id":"b0709d2f-7cda-4673-9476-60cbeb9bb0cc","query_id":"51","doc_a_id":"13906581","doc_b_id":"22049489","presented_order":["13906581","22049489"],"winner_id":"22049489","reasoning":"Document B is slightly more relevant because it concerns molecular markers and cancer biology (though in gastric cancer), whereas A discusses hospital teaching status and patient outcomes unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:49.442535Z"}
{"comparison_id":"ebf3e9e7-25d5-41d4-8de1-db604d110be1","query_id":"51","doc_a_id":"4462079","doc_b_id":"22049489","presented_order":["22049489","4462079"],"winner_id":"22049489","reasoning":"Document A is marginally more relevant because it discusses molecular cancer biology; however neither document mentions ALDH1 or breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:49.442555Z"}
{"comparison_id":"237f21df-4ce2-492e-b1db-f35c7900ffb4","query_id":"51","doc_a_id":"21181273","doc_b_id":"22049489","presented_order":["22049489","21181273"],"winner_id":"21181273","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it examines enzyme expression linked to tumor progression, whereas A focuses on a miRNA pathway in gastric cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:49.442564Z"}
{"comparison_id":"c322665b-6dea-4bfb-a706-8e5ec5487005","query_id":"51","doc_a_id":"36212758","doc_b_id":"22049489","presented_order":["36212758","22049489"],"winner_id":"36212758","reasoning":"Document A — it discusses cancer genomic profiles associated with 5-year recurrence-free survival (outcomes), whereas Document B focuses on gastric cancer molecular mechanism unrelated to outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:49.442578Z"}
{"comparison_id":"fa98cef7-5148-4647-b405-df1c6cb0f0cf","query_id":"51","doc_a_id":"1976183","doc_b_id":"22049489","presented_order":["22049489","1976183"],"winner_id":"22049489","reasoning":"Document A is slightly more relevant because it discusses cancer-related gene expression and tumor suppressor interactions, which is closer to prognostic marker studies than the invasion-focused oral cancer study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:49.442585Z"}
{"comparison_id":"a08771af-75ba-4ad4-ada4-7acd52ca111d","query_id":"51","doc_a_id":"53211308","doc_b_id":"22049489","presented_order":["22049489","53211308"],"winner_id":"22049489","reasoning":"Document A is slightly more relevant — it addresses cancer-related molecular markers and tumor suppressor pathways, whereas Document B focuses on an ovarian exosomal miRNA unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:49.442592Z"}
{"comparison_id":"d696a083-a583-4365-a3ab-9e00a784ee10","query_id":"51","doc_a_id":"39758684","doc_b_id":"22049489","presented_order":["22049489","39758684"],"winner_id":"22049489","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document A is marginally more relevant because it discusses expression of a cancer-related RNA affecting tumor cell behavior, whereas B focuses on DNA polymerase beta–driven chromosomal instability.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:49.442600Z"}
{"comparison_id":"4b200918-10c6-4ec1-86e5-0de14aeafc68","query_id":"51","doc_a_id":"21551568","doc_b_id":"22049489","presented_order":["22049489","21551568"],"winner_id":"22049489","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it addresses gene expression and cancer outcomes, whereas B focuses on PI3K/Akt alterations in thyroid cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:49.442608Z"}
{"comparison_id":"76337652-4ae5-4f04-8cac-5e1294cd3a52","query_id":"51","doc_a_id":"14663842","doc_b_id":"22049489","presented_order":["22049489","14663842"],"winner_id":"14663842","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document B is marginally more relevant because it discusses cancer-related enzyme (IDH1) metabolism, while A focuses on a gastric cancer lncRNA.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:49.442615Z"}
{"comparison_id":"0bb032ca-84b0-4b61-8fe7-00d71b352677","query_id":"51","doc_a_id":"12337611","doc_b_id":"22049489","presented_order":["12337611","22049489"],"winner_id":"12337611","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is marginally more relevant because it addresses gene expression linked to cancer outcomes (though in neuroblastoma), while B concerns a different molecule and gastric cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:49.442623Z"}
{"comparison_id":"2bb62926-59e8-44cc-a512-ff96f5b43bd2","query_id":"51","doc_a_id":"37204802","doc_b_id":"22049489","presented_order":["22049489","37204802"],"winner_id":"22049489","reasoning":"Neither paper mentions ALDH1 or breast cancer. Document A is marginally more relevant because it concerns tumor suppressor biology and cancer proliferation (RUNX1), whereas B focuses specifically on JMJD6 in colon cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:49.442630Z"}
{"comparison_id":"374b0c6d-ab58-4c2e-91fc-6634e4a674a6","query_id":"51","doc_a_id":"36547290","doc_b_id":"22049489","presented_order":["22049489","36547290"],"winner_id":"22049489","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes; both are irrelevant. Document A is slightly more related because it addresses cancer gene expression, whereas B focuses on cytokine-driven chromatin remodeling.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:49.442637Z"}
{"comparison_id":"c7dbcdbf-f0b1-4f91-b78d-b0c0ee5e0b96","query_id":"51","doc_a_id":"12685434","doc_b_id":"22049489","presented_order":["22049489","12685434"],"winner_id":"22049489","reasoning":"Document A is slightly more relevant because it discusses gene expression effects in cancer (though gastric, not breast), whereas Document B concerns glioblastoma invasion unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:49.442645Z"}
{"comparison_id":"20207689-d30c-41e0-9379-0a8f768d6882","query_id":"51","doc_a_id":"4467129","doc_b_id":"22049489","presented_order":["22049489","4467129"],"winner_id":"4467129","reasoning":"Reason: Neither discusses ALDH1 or breast cancer, but Document B addresses links between molecular expression (let-7 disruption) and prognosis, so it's slightly more relevant to a claim about marker expression and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:49.442652Z"}
{"comparison_id":"a576cbd1-57cb-4b64-9ab2-83e57f837290","query_id":"51","doc_a_id":"13889430","doc_b_id":"22049489","presented_order":["22049489","13889430"],"winner_id":"22049489","reasoning":"Neither document mentions ALDH1 or breast cancer, so neither provides evidence for the claim. DOCUMENT A and B are both irrelevant; DOCUMENT A is marginally more related because it discusses cancer-related molecular markers/pathways.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:49.442659Z"}
{"comparison_id":"2254a328-5b0e-4e1a-901e-b3ff9d45a975","query_id":"51","doc_a_id":"15727984","doc_b_id":"22049489","presented_order":["15727984","22049489"],"winner_id":"15727984","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes, so both are irrelevant. Document A is marginally closer (cancer microenvironment/prognosis context), but it still doesn't address ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:49.442666Z"}
{"comparison_id":"7f5d8ba2-7937-4e50-b8a6-55122fe73e14","query_id":"51","doc_a_id":"4325398","doc_b_id":"22049489","presented_order":["4325398","22049489"],"winner_id":"4325398","reasoning":"Neither document discusses ALDH1 or breast cancer; however, Document A is marginally more relevant because it deals with cancer genomics and potential biomarkers, whereas Document B focuses on a gastric cancer-specific lncRNA pathway.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:49.442672Z"}
{"comparison_id":"7168f880-5ece-4938-9c21-4fe6d447589e","query_id":"51","doc_a_id":"16364639","doc_b_id":"22049489","presented_order":["16364639","22049489"],"winner_id":"16364639","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is slightly more relevant because it discusses oncogenic pathway regulation (general cancer relevance), while B is specific to gastric cancer and RUNX1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:49.442679Z"}
{"comparison_id":"a6b3c447-f00c-4f90-8f1e-2c87fa55db7e","query_id":"51","doc_a_id":"1649738","doc_b_id":"22049489","presented_order":["1649738","22049489"],"winner_id":"22049489","reasoning":"Document B is slightly more relevant because it addresses cancer-related molecular expression and pathways, whereas Document A concerns genetic risk for therapy-induced secondary malignancies after Hodgkin's lymphoma and doesn't relate to ALDH1 or breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:49.442685Z"}
{"comparison_id":"68747f33-2615-497f-af9e-659e19273eeb","query_id":"51","doc_a_id":"19408393","doc_b_id":"22049489","presented_order":["22049489","19408393"],"winner_id":"22049489","reasoning":"Document A is slightly more relevant because it addresses cancer molecular biology (lncRNA/miRNA and tumor suppressor pathways), whereas Document B focuses on clinical radiotherapy outcomes for brain metastases; neither mentions ALDH1 or breast cancer specifically.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:49.442693Z"}
{"comparison_id":"3e668d39-8c9a-41fe-8eab-7380ea306b17","query_id":"51","doc_a_id":"20501163","doc_b_id":"22049489","presented_order":["20501163","22049489"],"winner_id":"20501163","reasoning":"Neither document mentions ALDH1 or breast cancer; however, Document A discusses tumor-related biology and systemic effects on anti-tumor outcomes, making it marginally more relevant than a gastric cancer–specific molecular study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:49.442700Z"}
{"comparison_id":"e304c214-b27f-462f-85a4-6a6f65201c62","query_id":"51","doc_a_id":"31624828","doc_b_id":"22049489","presented_order":["31624828","22049489"],"winner_id":"31624828","reasoning":"Document A is slightly more relevant — it discusses cancer-related biology (tumor suppressor p53) broadly, whereas Document B focuses on gastric cancer and H19/miR-675. Neither mentions ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:49.442707Z"}
{"comparison_id":"f043a5c2-4450-4a3a-a8a6-1ad7206246fd","query_id":"51","doc_a_id":"21181273","doc_b_id":"4467129","presented_order":["4467129","21181273"],"winner_id":"4467129","reasoning":"Document A is more relevant — both documents are unrelated to ALDH1 or breast cancer, but A at least discusses prognostic associations in cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:58.960770Z"}
{"comparison_id":"f10c9862-76c3-450e-97fd-165e4e193c20","query_id":"51","doc_a_id":"36212758","doc_b_id":"4467129","presented_order":["36212758","4467129"],"winner_id":"36212758","reasoning":"Document A — neither mentions ALDH1 or breast cancer, but A addresses cancer genomic profiles and associations with survival outcomes, making it slightly more relevant than B (which focuses on neuroblastoma miRNA mechanisms).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:58.960793Z"}
{"comparison_id":"0c545e5e-27bc-431d-9da2-ffce91baf809","query_id":"51","doc_a_id":"14663842","doc_b_id":"4467129","presented_order":["14663842","4467129"],"winner_id":"14663842","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes; Document A is slightly more related because it concerns an enzyme (IDH1) and cancer metabolism, whereas B is about microRNA in neuroblastoma. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:58.960803Z"}
{"comparison_id":"0d26ad4d-9098-4c34-b8ed-71f54d76241d","query_id":"51","doc_a_id":"12337611","doc_b_id":"4467129","presented_order":["4467129","12337611"],"winner_id":"4467129","reasoning":"Neither is relevant — both discuss LIN28B/let-7 in neuroblastoma, not ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:58.960810Z"}
{"comparison_id":"dc655b92-99c7-4c1d-8de1-33b051b2d48b","query_id":"51","doc_a_id":"31624828","doc_b_id":"4467129","presented_order":["4467129","31624828"],"winner_id":"4467129","reasoning":"Document A is more relevant — it discusses cancer prognosis mechanisms (though in neuroblastoma, not breast cancer), whereas B focuses on p53-mediated apoptotic clearance unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:58.960818Z"}
{"comparison_id":"890a3413-afa4-44f1-8f80-1cba921d159d","query_id":"51","doc_a_id":"15727984","doc_b_id":"4467129","presented_order":["4467129","15727984"],"winner_id":"4467129","reasoning":"Document A is slightly more relevant because it discusses cancer prognosis mechanisms (though in neuroblastoma, not breast cancer or ALDH1). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:58.960825Z"}
{"comparison_id":"439498d5-c59b-451f-9685-f4d25d3e1363","query_id":"51","doc_a_id":"4325398","doc_b_id":"4467129","presented_order":["4467129","4325398"],"winner_id":"4467129","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is marginally more relevant because it discusses cancer prognosis mechanisms, whereas B focuses on pancreatic genomic aberrations. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:58.960832Z"}
{"comparison_id":"062f907d-50cf-4fe8-9381-e56b450bc3f6","query_id":"51","doc_a_id":"16364639","doc_b_id":"4467129","presented_order":["4467129","16364639"],"winner_id":"4467129","reasoning":"Both documents are irrelevant to ALDH1 or breast cancer. Document A is slightly more relevant only because it discusses prognosis/outcomes in cancer (neuroblastoma), whereas B focuses on microRNA networks in glioblastoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:58.960839Z"}
{"comparison_id":"b86b7adc-be02-4cc7-bf57-29592d0c51ef","query_id":"51","doc_a_id":"20501163","doc_b_id":"4467129","presented_order":["4467129","20501163"],"winner_id":"4467129","reasoning":"Document A is slightly more relevant — it discusses molecular markers and links to prognosis in cancer (even though it's neuroblastoma, not breast cancer). Document B focuses on tumor-driven metabolic/immune effects, not marker expression or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:04:58.960847Z"}
{"comparison_id":"268a7a5f-d116-44d4-991a-b5ab0febeb65","query_id":"51","doc_a_id":"36212758","doc_b_id":"14663842","presented_order":["36212758","14663842"],"winner_id":"36212758","reasoning":"Document A is slightly more relevant because it discusses cancer genomic profiles linked to recurrence-free survival (though in NSCLC), while Document B addresses IDH1 metabolism and not survival or ALDH1/breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:05:04.516325Z"}
{"comparison_id":"dcf52b95-4cf0-4163-8de8-bd7c7e625eb1","query_id":"51","doc_a_id":"21181273","doc_b_id":"15727984","presented_order":["15727984","21181273"],"winner_id":"15727984","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant only because it discusses cancer-related protein expression broadly. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:05:16.286843Z"}
{"comparison_id":"b8fe38cc-6ecc-403c-8401-a102cb7fb2f0","query_id":"51","doc_a_id":"12337611","doc_b_id":"15727984","presented_order":["12337611","15727984"],"winner_id":"12337611","reasoning":"Document A is slightly more relevant because it discusses how expression of a gene (LIN28B) affects cancer outcomes, whereas Document B focuses on stromal secreted proteins in lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:05:16.286863Z"}
{"comparison_id":"51437751-64cb-4ff4-8b19-dad519bbeafd","query_id":"51","doc_a_id":"31624828","doc_b_id":"15727984","presented_order":["31624828","15727984"],"winner_id":"31624828","reasoning":"Neither abstract mentions ALDH1 or breast cancer outcomes. Document A is slightly more relevant because it addresses a tumor-suppressor pathway with broad cancer implications, while B is specific to lung cancer secreted factors. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:05:16.286871Z"}
{"comparison_id":"697f3118-7f54-454c-99e1-06fc2eadfe2a","query_id":"51","doc_a_id":"20501163","doc_b_id":"15727984","presented_order":["15727984","20501163"],"winner_id":"15727984","reasoning":"Document A is more relevant — it addresses tumor cell biology and tumor-stromal interactions (closer to studies of tumor markers like ALDH1), whereas Document B focuses on systemic metabolic effects of IL-6 unrelated to ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:05:16.286880Z"}
{"comparison_id":"d299cd62-aae8-4315-9402-612a757a04f2","query_id":"51","doc_a_id":"4325398","doc_b_id":"15727984","presented_order":["4325398","15727984"],"winner_id":"15727984","reasoning":"Neither document discusses ALDH1 or breast cancer. However, Document B—on tumor cell–stromal interactions and secreted proteins affecting tumorigenicity—relates more to biomarker expression and cancer outcomes than Document A's pancreatic genomics focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:05:16.286888Z"}
{"comparison_id":"fb195c1f-5c63-420c-9282-8bc0a2738db4","query_id":"51","doc_a_id":"16364639","doc_b_id":"15727984","presented_order":["16364639","15727984"],"winner_id":"16364639","reasoning":"Document A is slightly more relevant because it deals with gene expression and oncogenic pathway regulation, which is closer to questions about a cancer marker's expression and outcomes than Document B's focus on lung cancer secreted proteins.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:05:16.286895Z"}
{"comparison_id":"226f38ef-c323-456b-87db-783beb65678c","query_id":"51","doc_a_id":"12337611","doc_b_id":"31624828","presented_order":["12337611","31624828"],"winner_id":"31624828","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it deals with tumor-suppressor–mediated mechanisms that can influence cancer outcomes, whereas A focuses on LIN28B in neuroblastoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:05:25.132862Z"}
{"comparison_id":"a6be2b6c-5ce3-4bd6-8ef2-11e447faeaa3","query_id":"51","doc_a_id":"16364639","doc_b_id":"31624828","presented_order":["16364639","31624828"],"winner_id":"31624828","reasoning":"Reason: Neither abstract mentions ALDH1 or breast cancer; Document B is slightly more related to cancer outcomes (p53’s role in tumor biology) than Document A, which focuses on glioblastoma-specific microRNA networks.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:05:25.132886Z"}
{"comparison_id":"d6466176-2775-408d-8ba5-2277c3c49568","query_id":"51","doc_a_id":"12337611","doc_b_id":"16364639","presented_order":["12337611","16364639"],"winner_id":"16364639","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer; Document B is slightly more relevant because it discusses gene-expression regulation and oncogenic pathway alterations in cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:05:33.774930Z"}
{"comparison_id":"f9578856-b5bd-4373-bb5c-3554610013de","query_id":"51","doc_a_id":"21181273","doc_b_id":"20501163","presented_order":["20501163","21181273"],"winner_id":"20501163","reasoning":"Document A is more relevant — it addresses tumor biology and factors that influence anti-tumor responses and outcomes, whereas Document B concerns a different enzyme in colorectal cancer, not ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:05:40.936267Z"}
{"comparison_id":"4a43f8e9-8a53-4f97-9ef7-5c42a845ad1f","query_id":"51","doc_a_id":"4325398","doc_b_id":"20501163","presented_order":["4325398","20501163"],"winner_id":"4325398","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer; Document A is at least cancer genomics-related, making it slightly more relevant than B's metabolic/immunology focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:05:40.936287Z"}
{"comparison_id":"218f9d6a-ec9c-4f35-89ff-db9926945189","query_id":"51","doc_a_id":"13906581","doc_b_id":"21551568","presented_order":["21551568","13906581"],"winner_id":"21551568","reasoning":"Document A is slightly more relevant because it addresses cancer-related molecular markers/pathways, whereas Document B concerns hospital teaching status and general patient outcomes unrelated to ALDH1 or breast cancer.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:05:52.762232Z"}
{"comparison_id":"c94f158a-b904-42fc-8c9c-edda2508b6c1","query_id":"51","doc_a_id":"4462079","doc_b_id":"21551568","presented_order":["21551568","4462079"],"winner_id":"4462079","reasoning":"Document B — it discusses cancer risk (though not ALDH1 specifically), while A focuses on thyroid PI3K/Akt alterations unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:05:52.762258Z"}
{"comparison_id":"6fda9f74-b316-49f2-b2a4-cc0caca1ecea","query_id":"51","doc_a_id":"1976183","doc_b_id":"21551568","presented_order":["21551568","1976183"],"winner_id":"21551568","reasoning":"Both documents are irrelevant to ALDH1 and breast cancer, but Document A (cancer-related genetic/pathway study) is marginally closer in scope than Document B (microRNA in oral cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:05:52.762269Z"}
{"comparison_id":"451e6db3-7069-4a31-a5e8-f2fd441d4714","query_id":"51","doc_a_id":"53211308","doc_b_id":"21551568","presented_order":["53211308","21551568"],"winner_id":"53211308","reasoning":"Both documents are unrelated to ALDH1 or breast cancer, but Document A at least discusses cancer biomarker expression and patient sera, making it slightly more relevant than a thyroid PI3K/Akt genetics study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:05:52.762279Z"}
{"comparison_id":"c651ba48-8176-43af-9c69-9b5dcdbb2909","query_id":"51","doc_a_id":"39758684","doc_b_id":"21551568","presented_order":["39758684","21551568"],"winner_id":"39758684","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer outcomes; Document A is slightly more relevant since it discusses tumorigenesis generally, while Document B focuses on thyroid cancer genetics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:05:52.762287Z"}
{"comparison_id":"ab5d2850-6b90-4ea2-a30d-da07af048ac9","query_id":"51","doc_a_id":"19408393","doc_b_id":"21551568","presented_order":["21551568","19408393"],"winner_id":"21551568","reasoning":"Document A is slightly more relevant because it discusses genetic markers and cancer pathways related to tumor progression, which is closer to biomarker–outcome associations than a study of repeat brain radiotherapy.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:05:52.762296Z"}
{"comparison_id":"51458e76-f0ba-44b7-8cc0-2395f1b49cc6","query_id":"51","doc_a_id":"37204802","doc_b_id":"21551568","presented_order":["37204802","21551568"],"winner_id":"37204802","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer; Document A at least concerns a cancer biomarker, making it slightly more related than a paper focused on PI3K/Akt alterations in thyroid cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:05:52.762305Z"}
{"comparison_id":"0fe3781e-ef96-4858-9b67-2b19b3dca7cb","query_id":"51","doc_a_id":"36547290","doc_b_id":"21551568","presented_order":["36547290","21551568"],"winner_id":"36547290","reasoning":"Document A is slightly more relevant because it discusses gene regulation and signaling that could relate to cancer biology, whereas Document B focuses specifically on thyroid cancer pathways not related to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:05:52.762314Z"}
{"comparison_id":"aacd0b2e-4631-4717-8b4f-2b439b2e2882","query_id":"51","doc_a_id":"12685434","doc_b_id":"21551568","presented_order":["12685434","21551568"],"winner_id":"21551568","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes; both are irrelevant. Document B is marginally more related because it addresses cancer-related molecular alterations. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:05:52.762321Z"}
{"comparison_id":"9232af40-86eb-409a-a2c8-d6ed12923303","query_id":"51","doc_a_id":"13889430","doc_b_id":"21551568","presented_order":["13889430","21551568"],"winner_id":"13889430","reasoning":"Document A is marginally more relevant because it addresses cancer-related biology (tumor microenvironment) while Document B is specific to thyroid cancer genetics and neither mentions ALDH1 or breast cancer.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:05:52.762341Z"}
{"comparison_id":"8ba83895-825b-49e4-92e6-71e2e8aa69ba","query_id":"51","doc_a_id":"1649738","doc_b_id":"21551568","presented_order":["1649738","21551568"],"winner_id":"1649738","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document A discusses gene expression changes linked to cancer outcomes, making it marginally more related than Document B (thyroid PI3K/Akt alterations).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:05:52.762362Z"}
{"comparison_id":"a7a66523-9c98-43fa-aabf-c464b73d2e7e","query_id":"51","doc_a_id":"4462079","doc_b_id":"37204802","presented_order":["4462079","37204802"],"winner_id":"37204802","reasoning":"Document B is more relevant because it discusses a specific molecular marker and its association with cancer aggressiveness/outcomes, whereas A is about vitamin D levels and general health. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:06:01.051766Z"}
{"comparison_id":"a4231eab-addd-4cfd-a4a9-4b320db3db86","query_id":"51","doc_a_id":"53211308","doc_b_id":"37204802","presented_order":["53211308","37204802"],"winner_id":"53211308","reasoning":"Document A is slightly more relevant because it deals with a cancer biomarker and clinical samples (serum) and thus is closer to evaluating marker–outcome associations than Document B, which focuses on a mechanistic study in colon cancer unrelated to ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:06:01.051789Z"}
{"comparison_id":"2b69ef92-1aaf-4f75-9248-a4df39837d64","query_id":"51","doc_a_id":"39758684","doc_b_id":"37204802","presented_order":["39758684","37204802"],"winner_id":"39758684","reasoning":"Document A is slightly more relevant — it discusses mechanisms of tumorigenesis (general cancer-related biology), whereas Document B is specific to colon cancer and p53; neither addresses ALDH1 or breast cancer directly.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:06:01.051799Z"}
{"comparison_id":"5150a7d3-1f2c-4d7a-8a97-5e54e7a38d94","query_id":"51","doc_a_id":"1649738","doc_b_id":"37204802","presented_order":["37204802","1649738"],"winner_id":"37204802","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer, but Document A discusses a cancer biomarker and tumor progression, making it marginally more relevant to a claim about marker expression and outcomes than Document B, which concerns genetic risk for therapy-induced second malignancies.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:06:01.051807Z"}
{"comparison_id":"978b79b2-a741-47f0-b07a-eb4bbb959f71","query_id":"51","doc_a_id":"36547290","doc_b_id":"37204802","presented_order":["37204802","36547290"],"winner_id":"37204802","reasoning":"Document A — it's about cancer biomarkers and tumorigenesis, whereas Document B focuses on STAT3/BRG1 chromatin regulation unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:06:01.051814Z"}
{"comparison_id":"c634cc16-ed83-4b49-be27-b7ac6e14a0b0","query_id":"51","doc_a_id":"13889430","doc_b_id":"37204802","presented_order":["37204802","13889430"],"winner_id":"37204802","reasoning":"Document A is slightly more relevant because it discusses a cancer biomarker and links protein expression to tumor aggressiveness/outcomes (though in colon cancer, not breast). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:06:01.051820Z"}
{"comparison_id":"8a17b8dc-80ba-4db1-8748-491621a99377","query_id":"51","doc_a_id":"53211308","doc_b_id":"39758684","presented_order":["53211308","39758684"],"winner_id":"53211308","reasoning":"Document A is slightly more relevant because it discusses cancer biomarker expression and its clinical implications (though in ovarian, not breast, cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:06:09.340998Z"}
{"comparison_id":"693a783a-c18c-4dc0-aa48-3d5e17866447","query_id":"51","doc_a_id":"4462079","doc_b_id":"1649738","presented_order":["1649738","4462079"],"winner_id":"1649738","reasoning":"Document A is slightly more relevant because it deals with gene expression and cancer outcomes, whereas Document B concerns vitamin D levels unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:06:18.172896Z"}
{"comparison_id":"e64be603-62d1-45f8-ae4a-53c0434922bc","query_id":"51","doc_a_id":"13889430","doc_b_id":"1649738","presented_order":["13889430","1649738"],"winner_id":"13889430","reasoning":"Document A is more relevant — it discusses cancer-related biology and tumor stroma interactions, whereas B concerns genetic risk for therapy-induced second cancers in Hodgkin's lymphoma (not ALDH1 or breast cancer outcomes).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:06:18.172918Z"}
{"comparison_id":"4484798f-1894-4753-a185-b73cd4f3ae8c","query_id":"51","doc_a_id":"36547290","doc_b_id":"1649738","presented_order":["1649738","36547290"],"winner_id":"1649738","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it concerns cancer risk/outcomes, while Document B is focused on basic STAT3/BRG1 transcriptional mechanisms unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:06:18.172927Z"}
{"comparison_id":"eded2bd1-7d03-4993-87fa-c8523617c79d","query_id":"51","doc_a_id":"4462079","doc_b_id":"36547290","presented_order":["36547290","4462079"],"winner_id":"4462079","reasoning":"Document B is more relevant — it discusses cancer risk and health outcomes (though not ALDH1 specifically), whereas Document A focuses on BRG1/STAT3 chromatin mechanisms unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:06:26.827696Z"}
{"comparison_id":"b22956f7-d728-4b2e-80ce-f2eabca1ad1d","query_id":"51","doc_a_id":"13906581","doc_b_id":"1976183","presented_order":["13906581","1976183"],"winner_id":"1976183","reasoning":"Document B is more relevant — it discusses a molecular marker associated with cancer behavior (though in oral cancer), whereas A is about hospital teaching status and not molecular/cancer markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:06:34.802163Z"}
{"comparison_id":"994c574e-2e31-4132-b850-a356911f206c","query_id":"51","doc_a_id":"12685434","doc_b_id":"1976183","presented_order":["12685434","1976183"],"winner_id":"1976183","reasoning":"Both documents are irrelevant to ALDH1 or breast cancer outcomes; Document B is slightly more relevant because it deals with cancer biomarkers and invasive behavior in an epithelial cancer (oral), closer to breast cancer biology than glioblastoma. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:06:34.802185Z"}
{"comparison_id":"e2600110-09b0-41e6-8e61-1804dc141007","query_id":"51","doc_a_id":"19408393","doc_b_id":"1976183","presented_order":["1976183","19408393"],"winner_id":"1976183","reasoning":"Document A is more relevant — it discusses cancer biomarker expression and tumor behavior (though in oral cancer), whereas B concerns radiotherapy for brain metastases and is unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:06:34.802194Z"}
{"comparison_id":"7df13a41-8855-40bd-a386-951048e97ed8","query_id":"51","doc_a_id":"13906581","doc_b_id":"12685434","presented_order":["13906581","12685434"],"winner_id":"12685434","reasoning":"Document B is more relevant — it discusses protein expression and its impact on cancer behavior, whereas A is about hospital teaching status and not molecular markers or breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:06:42.087570Z"}
{"comparison_id":"aee7d15c-4afb-4410-beec-15f26438b6a5","query_id":"51","doc_a_id":"19408393","doc_b_id":"12685434","presented_order":["12685434","19408393"],"winner_id":"19408393","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document B is marginally more relevant since it addresses cancer clinical outcomes, whereas A is about glioblastoma molecular mechanisms.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:06:42.087593Z"}
{"comparison_id":"3348f201-231d-4e4a-b0d0-c014f325b5d6","query_id":"51","doc_a_id":"29124963","doc_b_id":"11359243","presented_order":["29124963","11359243"],"winner_id":"29124963","reasoning":"Document A is more relevant — it discusses a genetic marker associated with patient outcomes (prognosis/survival) in cancer, whereas Document B addresses EBV-driven methylation changes in B-cells, which is less related to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326197Z"}
{"comparison_id":"0f20ebb5-1b5a-4b8e-badf-da0a3feeec00","query_id":"51","doc_a_id":"22963769","doc_b_id":"11359243","presented_order":["11359243","22963769"],"winner_id":"22963769","reasoning":"Document B is more relevant — it links protein expression/localization to cancer aggressiveness and clinical outcomes (even though it's oral SCC, it directly addresses expression–outcome associations). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326220Z"}
{"comparison_id":"505d0a54-a86c-478e-a4fe-a6e0447017ca","query_id":"51","doc_a_id":"23665162","doc_b_id":"11359243","presented_order":["11359243","23665162"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant — it discusses cancer-related epigenetic changes and tumor biology, whereas B focuses on LINE-1 hypomethylation and risk for hepatocellular carcinoma (not breast cancer or ALDH1). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326229Z"}
{"comparison_id":"16673f76-e4fd-4a6b-8303-26d1e9cf2c4c","query_id":"51","doc_a_id":"10169908","doc_b_id":"11359243","presented_order":["10169908","11359243"],"winner_id":"10169908","reasoning":"Document A is slightly more relevant because it discusses protein expression linked to cancer cell growth and survival, whereas Document B focuses on EBV-driven methylation in B-cells unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326238Z"}
{"comparison_id":"47192bee-361d-4de5-8e3b-ced563b17807","query_id":"51","doc_a_id":"8677721","doc_b_id":"11359243","presented_order":["11359243","8677721"],"winner_id":"11359243","reasoning":"Neither paper discusses ALDH1 or breast cancer. Document A is marginally more relevant because it addresses cancer-related epigenetic changes, whereas B focuses specifically on hepatocellular carcinoma signaling.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326245Z"}
{"comparison_id":"31903af9-4590-4832-9d8a-fd031ff2ab03","query_id":"51","doc_a_id":"7736860","doc_b_id":"11359243","presented_order":["7736860","11359243"],"winner_id":"7736860","reasoning":"Neither document mentions ALDH1 or breast cancer; Document A is marginally more relevant because it discusses a cancer marker's expression linked to survival, while B focuses on EBV-related B‑cell methylation. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326252Z"}
{"comparison_id":"92489a05-7bcd-4c5a-b732-3b1b6390cd19","query_id":"51","doc_a_id":"36950726","doc_b_id":"11359243","presented_order":["36950726","11359243"],"winner_id":"36950726","reasoning":"A is more relevant — it deals with protein expression changes in a solid tumor context and cancer progression, which is closer to breast cancer/ALDH1 expression than EBV-driven B‑cell methylation.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326259Z"}
{"comparison_id":"29c8734b-6f36-46ac-a52a-cebebefd2c9c","query_id":"51","doc_a_id":"3684342","doc_b_id":"11359243","presented_order":["3684342","11359243"],"winner_id":"3684342","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it discusses gene expression and survival outcomes in a cancer context, whereas B focuses on EBV-driven methylation in B-cells. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326266Z"}
{"comparison_id":"f3da8866-5213-4f21-82c0-65638104001b","query_id":"51","doc_a_id":"10024681","doc_b_id":"11359243","presented_order":["10024681","11359243"],"winner_id":"10024681","reasoning":"Document A — it discusses gene expression linked to cancer prognosis (biomarker–outcome association), which is closer to the ALDH1–breast cancer outcome question than EBV-driven B‑cell methylation. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326273Z"}
{"comparison_id":"f68d6003-3412-4312-8fe3-db066043c184","query_id":"51","doc_a_id":"24980622","doc_b_id":"11359243","presented_order":["24980622","11359243"],"winner_id":"24980622","reasoning":"Document A is slightly more relevant because it concerns tumor biology in human cancers (though not breast or ALDH1), while Document B focuses on EBV-driven methylation changes in B-cells unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326280Z"}
{"comparison_id":"e40a09aa-f1a8-48e5-8f75-e091c8644cb4","query_id":"51","doc_a_id":"14471161","doc_b_id":"11359243","presented_order":["11359243","14471161"],"winner_id":"11359243","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A (epigenetic changes and tumor heterogeneity) is marginally more related to molecular markers like ALDH1 than Document B’s focus on meal timing in pancreatic cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326287Z"}
{"comparison_id":"f5b27689-4016-4737-918c-ba6efb538cb5","query_id":"51","doc_a_id":"9239963","doc_b_id":"11359243","presented_order":["9239963","11359243"],"winner_id":"9239963","reasoning":"Document A is more relevant — it discusses gene expression in tumor cells (cancer context), which is closer to a claim about ALDH1 expression and cancer outcomes than a paper on EBV-driven methylation in B-cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326295Z"}
{"comparison_id":"63b4e412-04c0-4ecc-a8d6-a5cf04c93561","query_id":"51","doc_a_id":"1507222","doc_b_id":"11359243","presented_order":["11359243","1507222"],"winner_id":"11359243","reasoning":"DOCUMENT A is slightly more relevant — it discusses DNA methylation changes in human cancers, whereas DOCUMENT B concerns uncoupling proteins in a mouse cachexia model and is unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326302Z"}
{"comparison_id":"fa58851e-7417-49ae-82b3-93d00e783d22","query_id":"51","doc_a_id":"24349430","doc_b_id":"11359243","presented_order":["24349430","11359243"],"winner_id":"11359243","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document B is slightly more relevant because it discusses cancer-related epigenetic changes across human cancers, whereas A is specific to Orai1 in a lung cancer cell line.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326308Z"}
{"comparison_id":"e96bd0f5-7a47-437d-b98f-97593633de9a","query_id":"51","doc_a_id":"31313782","doc_b_id":"11359243","presented_order":["31313782","11359243"],"winner_id":"11359243","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it addresses cancer-related epigenetic changes, whereas A focuses on Toll-like receptors in lung disease. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326316Z"}
{"comparison_id":"ee111f37-86ba-41d4-9a0b-7e1f9b087f8e","query_id":"51","doc_a_id":"16630996","doc_b_id":"11359243","presented_order":["11359243","16630996"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular changes (methylation patterns) in human cancers, whereas Document B focuses on gemcitabine resistance in pancreatic cancer unrelated to ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326324Z"}
{"comparison_id":"3abc5c6c-279b-4f59-9dd2-f179d6339205","query_id":"51","doc_a_id":"2272614","doc_b_id":"11359243","presented_order":["2272614","11359243"],"winner_id":"11359243","reasoning":"Document B is more relevant — though neither mentions ALDH1 or breast cancer, B discusses cancer-related epigenetic changes and malignant transformation, which is closer to breast cancer outcome mechanisms than a lung cancer drug-resistance study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326331Z"}
{"comparison_id":"1acf1203-ed8a-4351-896f-26ee3b28720f","query_id":"51","doc_a_id":"3355397","doc_b_id":"11359243","presented_order":["3355397","11359243"],"winner_id":"11359243","reasoning":"Document B is more relevant — it discusses cancer-related molecular changes and malignant transformation (closer to factors that could affect cancer prognosis), whereas A is an epidemiologic study of a diabetes drug and cancer risk, not ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326338Z"}
{"comparison_id":"38219d68-93bf-4ef2-b2d9-99ee178ef421","query_id":"51","doc_a_id":"32852283","doc_b_id":"11359243","presented_order":["32852283","11359243"],"winner_id":"11359243","reasoning":"Document B is marginally more relevant — neither discusses ALDH1 or breast cancer, but B addresses cancer-related molecular changes while A is specific to lung cancer drug effects. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326345Z"}
{"comparison_id":"a61aba7e-1bfa-42f7-ba6f-54ebe7b43009","query_id":"51","doc_a_id":"24396137","doc_b_id":"11359243","presented_order":["24396137","11359243"],"winner_id":"24396137","reasoning":"Document A is more relevant — it concerns senior female cancer survivors (the population most likely to include breast cancer patients), whereas Document B focuses on EBV-driven changes in B-cells unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326352Z"}
{"comparison_id":"124bd114-f44f-40f0-a76a-624212497a13","query_id":"51","doc_a_id":"14180565","doc_b_id":"11359243","presented_order":["11359243","14180565"],"winner_id":"11359243","reasoning":"Neither document addresses ALDH1 or breast cancer directly. Document A is marginally more relevant because it discusses cancer-related epigenetic changes and tumor heterogeneity, which are more related to prognostic markers than a glioblastoma drug study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326360Z"}
{"comparison_id":"f07273e0-ee27-444b-b997-aa8b051d0c8a","query_id":"51","doc_a_id":"38808600","doc_b_id":"11359243","presented_order":["38808600","11359243"],"winner_id":"11359243","reasoning":"Document B is slightly more relevant because it discusses cancer-related molecular changes (epigenetic alterations seen in human cancers), whereas A is specific to a glioma imaging probe unrelated to ALDH1 or breast cancer outcomes.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326367Z"}
{"comparison_id":"6199a713-64dc-4c02-a63a-325431c25a53","query_id":"51","doc_a_id":"26079071","doc_b_id":"11359243","presented_order":["11359243","26079071"],"winner_id":"11359243","reasoning":"Document A — it discusses cancer-related molecular changes (methylation) and tumor biology, which is more relevant to a claim about a molecular marker and breast cancer outcomes than a lung cancer drug trial. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326374Z"}
{"comparison_id":"857fafbf-7580-43ed-80b4-d27e738d9ee9","query_id":"51","doc_a_id":"12869200","doc_b_id":"11359243","presented_order":["12869200","11359243"],"winner_id":"12869200","reasoning":"Neither document mentions ALDH1 or breast cancer; however, Document A discusses biomarker associations with cancer risk/outcomes (albeit in endometrial cancer), making it marginally more relevant than Document B's EBV/methylation focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326381Z"}
{"comparison_id":"3be7bf6b-3dc4-49a3-a374-bdf2d534a064","query_id":"51","doc_a_id":"52925737","doc_b_id":"11359243","presented_order":["52925737","11359243"],"winner_id":"11359243","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document B is slightly more general to cancer biology (methylation changes across cancers), so it's marginally more related.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326387Z"}
{"comparison_id":"11e16765-1aae-4256-bb2f-e6a68c4bf5d0","query_id":"51","doc_a_id":"23509593","doc_b_id":"11359243","presented_order":["11359243","23509593"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant — it discusses cancer-related epigenetic changes and malignant transformation, whereas B focuses on androgen regulation in prostate stromal cells unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326395Z"}
{"comparison_id":"392abb7b-62e8-49e8-856f-214573a10726","query_id":"51","doc_a_id":"46617075","doc_b_id":"11359243","presented_order":["46617075","11359243"],"winner_id":"11359243","reasoning":"Document B is slightly more relevant because it discusses cancer-related epigenetic changes across human cancers, whereas A focuses specifically on the Rb-p16 pathway in lung cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326402Z"}
{"comparison_id":"abf80b4f-d1ee-4abd-a278-ad1ddc65c52b","query_id":"51","doc_a_id":"9211173","doc_b_id":"11359243","presented_order":["9211173","11359243"],"winner_id":"9211173","reasoning":"Document A is more relevant — it deals with cancer biomarkers and tumor biology (though in ovarian cancer), whereas Document B focuses on EBV-induced methylation changes in B-cells unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326409Z"}
{"comparison_id":"ae55ac67-841b-4159-856f-867a0fad171a","query_id":"51","doc_a_id":"27306942","doc_b_id":"11359243","presented_order":["11359243","27306942"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular changes and tumor outcomes broadly, whereas Document B is specific to pediatric B-ALL and unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326416Z"}
{"comparison_id":"54e7fba0-4908-412d-8474-7dba66af4e97","query_id":"51","doc_a_id":"23577867","doc_b_id":"11359243","presented_order":["23577867","11359243"],"winner_id":"23577867","reasoning":"Document A is more relevant — it discusses cancer biomarkers and clinical risk associations (though for endometrial cancer, not breast), whereas Document B focuses on EBV-driven methylation in B-cells unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326423Z"}
{"comparison_id":"18523df3-5569-4339-923b-08ec46473153","query_id":"51","doc_a_id":"11880289","doc_b_id":"11359243","presented_order":["11359243","11880289"],"winner_id":"11880289","reasoning":"Document B — it addresses breast cancer outcomes (mortality), whereas Document A is about EBV-induced methylation in B-cells and unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326429Z"}
{"comparison_id":"21211e87-781d-4536-8866-314575e0c338","query_id":"51","doc_a_id":"5377642","doc_b_id":"11359243","presented_order":["5377642","11359243"],"winner_id":"5377642","reasoning":"Neither document discusses ALDH1 or breast cancer directly, but A is marginally more relevant because it concerns tumor immune regulation and anti-tumor outcomes, while B focuses on EBV-driven B‑cell methylation unrelated to breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326437Z"}
{"comparison_id":"037ec9ae-6a69-4442-95d4-fb90556a2481","query_id":"51","doc_a_id":"4688340","doc_b_id":"11359243","presented_order":["11359243","4688340"],"winner_id":"4688340","reasoning":"Document B is more relevant — it studies sphere-forming (cancer stem-like) cells, which relate to ALDH1 as a stem cell marker, whereas A concerns EBV-driven methylation in B-cells unrelated to breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326444Z"}
{"comparison_id":"456942d9-9117-40d0-8f90-bd6fd45fad88","query_id":"51","doc_a_id":"20738970","doc_b_id":"11359243","presented_order":["11359243","20738970"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular changes (epigenetic alterations) across human cancers, whereas Document B focuses specifically on small cell lung cancer and Etk. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326450Z"}
{"comparison_id":"6f259e28-2582-4d83-b95b-60208bbde43c","query_id":"51","doc_a_id":"3210545","doc_b_id":"11359243","presented_order":["3210545","11359243"],"winner_id":"3210545","reasoning":"Document A is somewhat closer because it addresses gene expression and clinical outcomes in cancer (though in endometrial, not breast); Document B concerns EBV-driven methylation in B-cells and is less relevant to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326457Z"}
{"comparison_id":"523db962-bb36-4fd7-b085-6f1267dfa385","query_id":"51","doc_a_id":"26848994","doc_b_id":"11359243","presented_order":["26848994","11359243"],"winner_id":"26848994","reasoning":"Document A is more relevant — it discusses cancer biomarker expression and patient survival/chemoresistance (though in HCC, not breast cancer), while Document B focuses on EBV-induced methylation in B-cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326464Z"}
{"comparison_id":"119e1bb1-e889-444a-b9b9-0e7ae5b396e2","query_id":"51","doc_a_id":"14938990","doc_b_id":"11359243","presented_order":["11359243","14938990"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular changes (methylation patterns), whereas Document B concerns PD-1 expression in autoimmune disease (SLE), not cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326472Z"}
{"comparison_id":"2578f51b-8c39-459a-9fd8-eda07606ae34","query_id":"51","doc_a_id":"25628793","doc_b_id":"11359243","presented_order":["11359243","25628793"],"winner_id":"11359243","reasoning":"Document A is more relevant — it discusses cancer-related epigenetic changes and malignant transformation, which are closer to breast cancer outcome mechanisms than B's focus on endometriosis enzyme expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326479Z"}
{"comparison_id":"e6e29e31-5f11-49ef-bdf8-e584c2ebcf79","query_id":"51","doc_a_id":"17876040","doc_b_id":"11359243","presented_order":["11359243","17876040"],"winner_id":"11359243","reasoning":"Document A is slightly more related to cancer biology (epigenetic changes) than B, which focuses on an AML drug and not on ALDH1 or breast cancer. Neither directly addresses ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326486Z"}
{"comparison_id":"85ec108b-15bb-4ea4-9451-b1f534592ecf","query_id":"51","doc_a_id":"3052213","doc_b_id":"11359243","presented_order":["3052213","11359243"],"winner_id":"11359243","reasoning":"Document B is more relevant — it discusses cancer-related epigenetic changes and tumorigenesis, whereas A focuses on adipocyte transcription and metabolic regulation. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326492Z"}
{"comparison_id":"213430e0-e8b0-4f0d-93e2-531ccbe91627","query_id":"51","doc_a_id":"26902591","doc_b_id":"11359243","presented_order":["11359243","26902591"],"winner_id":"11359243","reasoning":"Document A is more related to cancer biology and potential biomarkers, while Document B focuses on cachexia and adipose tissue, so A is slightly more relevant to a claim about breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326500Z"}
{"comparison_id":"ff25e359-11db-4159-9499-47d07c6ec393","query_id":"51","doc_a_id":"6517763","doc_b_id":"11359243","presented_order":["11359243","6517763"],"winner_id":"6517763","reasoning":"Document B is more relevant — it addresses molecular markers associated with patient survival (clinical outcomes), whereas Document A focuses on EBV-induced methylation changes in B-cells and not clinical outcomes or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326507Z"}
{"comparison_id":"3bf92f96-743d-4925-b2ac-f4207c02d5d7","query_id":"51","doc_a_id":"293661","doc_b_id":"11359243","presented_order":["11359243","293661"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular changes (epigenetic patterns) whereas Document B focuses on arginine metabolism and therapy, neither directly addressing ALDH1 or breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326514Z"}
{"comparison_id":"1b197a61-57d7-4951-b29c-a17fb271fb8a","query_id":"51","doc_a_id":"26488879","doc_b_id":"11359243","presented_order":["26488879","11359243"],"winner_id":"11359243","reasoning":"Document B is more relevant — it deals with cancer-related molecular changes (epigenetic patterns) while A is about H. pylori infection and gastric inflammation.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326521Z"}
{"comparison_id":"319758a3-5a1b-4a40-ab35-9f0cca0fc46d","query_id":"51","doc_a_id":"2360905","doc_b_id":"11359243","presented_order":["11359243","2360905"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular changes (methylation patterns) while Document B focuses on pediatric gliomas unrelated to breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326528Z"}
{"comparison_id":"221ca4d8-b77d-422e-98b7-80a81cb75477","query_id":"51","doc_a_id":"663464","doc_b_id":"11359243","presented_order":["663464","11359243"],"winner_id":"11359243","reasoning":"B is more relevant because it addresses cancer-related epigenetic changes (patterns seen in human cancers), whereas A focuses on age-associated microRNAs and non-cancer outcomes. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326535Z"}
{"comparison_id":"8c904e84-5277-4c39-b335-eb04c6ec40c2","query_id":"51","doc_a_id":"520579","doc_b_id":"11359243","presented_order":["11359243","520579"],"winner_id":"11359243","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes; Document A is slightly more relevant because it concerns cancer-related molecular changes, while Document B deals with vitamin D and colorectal cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326543Z"}
{"comparison_id":"b9250e4e-4eb3-47ac-833f-1bc0498709b9","query_id":"51","doc_a_id":"4729644","doc_b_id":"11359243","presented_order":["11359243","4729644"],"winner_id":"11359243","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is slightly more related to cancer biology broadly (methylation changes in cancers), so it's marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326550Z"}
{"comparison_id":"a3a017e7-8e74-45ff-b8e1-0543c917ba10","query_id":"51","doc_a_id":"4468861","doc_b_id":"11359243","presented_order":["4468861","11359243"],"winner_id":"11359243","reasoning":"Document B is more relevant — it discusses cancer-related epigenetic changes (methylation) which are closer to biomarker/outcome studies than the melanoma immunotherapy focus of A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326558Z"}
{"comparison_id":"df7de65e-b34f-48ea-b430-94a8b10ee7f5","query_id":"51","doc_a_id":"33030946","doc_b_id":"11359243","presented_order":["33030946","11359243"],"winner_id":"11359243","reasoning":"Reason: Neither discusses ALDH1 or breast cancer outcomes, but Document B relates to cancer-associated epigenetic changes while A focuses on macrophage/osteoclast biology.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326565Z"}
{"comparison_id":"fe4bb467-1d4f-4594-b90c-734d975bfaad","query_id":"51","doc_a_id":"38355793","doc_b_id":"11359243","presented_order":["11359243","38355793"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular changes, whereas Document B concerns A20 in glioma with no connection to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326575Z"}
{"comparison_id":"17bbd17d-5039-48b6-8607-78af6bad5dbd","query_id":"51","doc_a_id":"9648896","doc_b_id":"11359243","presented_order":["9648896","11359243"],"winner_id":"9648896","reasoning":"Document A is slightly more relevant because it deals with cancer biology and tumor microenvironment/chemoresistance, whereas Document B focuses on EBV-induced methylation in B-cells; neither directly addresses ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326583Z"}
{"comparison_id":"893db5d8-5361-4d4d-b545-da3a895c8370","query_id":"51","doc_a_id":"16016673","doc_b_id":"11359243","presented_order":["16016673","11359243"],"winner_id":"11359243","reasoning":"Document B is more relevant — it discusses cancer-related epigenetic changes and malignant transformation, which is closer to tumor biology than a bladder-cancer urine marker study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326590Z"}
{"comparison_id":"5f93d620-c70d-4b6e-9700-0f376d2aa8c5","query_id":"51","doc_a_id":"23934390","doc_b_id":"11359243","presented_order":["11359243","23934390"],"winner_id":"11359243","reasoning":"Neither document addresses ALDH1 or breast cancer directly. Document A discusses cancer-related epigenetic changes and tumor heterogeneity (more broadly relevant to cancer outcomes) while Document B is specific to miR-203 in lung cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326597Z"}
{"comparison_id":"0add5fea-739b-4f2a-b857-81eaa837dca3","query_id":"51","doc_a_id":"4841908","doc_b_id":"11359243","presented_order":["11359243","4841908"],"winner_id":"11359243","reasoning":"Document A is somewhat related to cancer biology (methylation changes in malignant transformation), whereas Document B focuses on metabolites and longevity with no cancer link. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326604Z"}
{"comparison_id":"4c13b142-52c3-4978-8a85-7813425b23ab","query_id":"51","doc_a_id":"1780819","doc_b_id":"11359243","presented_order":["1780819","11359243"],"winner_id":"1780819","reasoning":"Document A is more relevant — it addresses gene expression and cancer outcomes (though in endometrial cancer), whereas B focuses on EBV-induced methylation in B-cells and is less related to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326611Z"}
{"comparison_id":"9729edf0-0dcb-47f6-837d-fec36e7685f5","query_id":"51","doc_a_id":"4387494","doc_b_id":"11359243","presented_order":["11359243","4387494"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant — it discusses cancer-related epigenetic changes (broadly linked to tumor behavior), whereas Document B focuses on an AML-specific therapy unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326620Z"}
{"comparison_id":"ac29d657-b74b-4d2e-83c0-da146a8e66d1","query_id":"51","doc_a_id":"21414718","doc_b_id":"11359243","presented_order":["11359243","21414718"],"winner_id":"11359243","reasoning":"Document A — it discusses cancer-related molecular changes (epigenetic alterations) more broadly, whereas B is specific to a gastric cancer protein interaction unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326627Z"}
{"comparison_id":"1f1887fd-c223-4dd6-bd9e-288eb88617fe","query_id":"51","doc_a_id":"23601616","doc_b_id":"11359243","presented_order":["23601616","11359243"],"winner_id":"11359243","reasoning":"Document B — it deals with cancer-related epigenetic changes, which is closer to the claim about cancer biomarkers/outcomes than a study on hippocampal effects in mice. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326634Z"}
{"comparison_id":"dacba9e7-f158-4196-8917-29d871ffb216","query_id":"51","doc_a_id":"5278233","doc_b_id":"11359243","presented_order":["5278233","11359243"],"winner_id":"11359243","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more cancer-related (methylation changes in malignant transformation), so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326641Z"}
{"comparison_id":"b43b13ea-6805-4795-84b5-7d49cc4d8c21","query_id":"51","doc_a_id":"6807122","doc_b_id":"11359243","presented_order":["11359243","6807122"],"winner_id":"6807122","reasoning":"Document B is more relevant — it concerns mechanisms in carcinoma progression and the tumor microenvironment, which are more directly related to cancer outcomes than EBV-induced changes in B-cells. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326648Z"}
{"comparison_id":"f37b56ef-985f-4a16-99cf-35c3e0fff26a","query_id":"51","doc_a_id":"20568364","doc_b_id":"11359243","presented_order":["20568364","11359243"],"winner_id":"11359243","reasoning":"Document B is slightly more relevant — it discusses cancer-related molecular changes across human cancers, whereas A is specific to HNSCC angiogenesis and not related to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326655Z"}
{"comparison_id":"ead55362-8394-489d-b91a-cfa83e047e2b","query_id":"51","doc_a_id":"23269537","doc_b_id":"11359243","presented_order":["23269537","11359243"],"winner_id":"23269537","reasoning":"Document A is slightly more relevant — it discusses gene expression changes in cancer (association of gene expression with epigenetic status), whereas Document B focuses on EBV-driven methylation patterns in B-cells; neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326663Z"}
{"comparison_id":"2fa23875-3516-4fa0-baf1-c823e50376cd","query_id":"51","doc_a_id":"23013317","doc_b_id":"11359243","presented_order":["23013317","11359243"],"winner_id":"11359243","reasoning":"Document B — it discusses cancer-related molecular changes (DNA methylation) whereas Document A is about hypoalbuminemia in acute illness and unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326670Z"}
{"comparison_id":"57e85ee8-5500-4c96-b462-b20c205b531d","query_id":"51","doc_a_id":"43334921","doc_b_id":"11359243","presented_order":["11359243","43334921"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular changes, whereas Document B focuses on aspirin/NSAID use and colorectal cancer genetics; neither addresses ALDH1 or breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326677Z"}
{"comparison_id":"16d70931-e5e1-499b-bd58-9d176e13b56e","query_id":"51","doc_a_id":"57783564","doc_b_id":"11359243","presented_order":["57783564","11359243"],"winner_id":"11359243","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes; both are irrelevant. Document B is slightly more generally related to cancer biology (epigenetic changes), so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326684Z"}
{"comparison_id":"e4ac2350-7354-48b0-be6a-f9279473aca6","query_id":"51","doc_a_id":"6363093","doc_b_id":"11359243","presented_order":["6363093","11359243"],"winner_id":"6363093","reasoning":"Document A is more relevant — it discusses tumor protein expression patterns and cancer subclasses, whereas B concerns EBV-driven B-cell methylation unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326691Z"}
{"comparison_id":"aaa7bef4-eb4f-4c61-a264-3a11b45ab333","query_id":"51","doc_a_id":"40234452","doc_b_id":"11359243","presented_order":["40234452","11359243"],"winner_id":"11359243","reasoning":"Neither document addresses ALDH1 or breast cancer directly; Document B is slightly more relevant because it discusses cancer-related epigenetic changes, whereas A focuses on hematopoietic stem cells.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326699Z"}
{"comparison_id":"e7f0ee5d-9d65-41a3-a00f-148a0d64033a","query_id":"51","doc_a_id":"2328272","doc_b_id":"11359243","presented_order":["2328272","11359243"],"winner_id":"2328272","reasoning":"Document A is more relevant — it discusses cancer survivorship and outcomes, whereas Document B focuses on EBV-driven methylation in B-cells, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326706Z"}
{"comparison_id":"ff77532e-5993-45c8-adf6-8b951045612d","query_id":"51","doc_a_id":"9095394","doc_b_id":"11359243","presented_order":["9095394","11359243"],"winner_id":"9095394","reasoning":"Document A is slightly more relevant because it discusses expression of protein markers in epithelial cancers (though oral, not breast), whereas Document B concerns EBV-related methylation in B-cells and is unrelated to ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326714Z"}
{"comparison_id":"f2e632dd-802e-4059-8e7a-175c16a3c061","query_id":"51","doc_a_id":"3710557","doc_b_id":"11359243","presented_order":["11359243","3710557"],"winner_id":"11359243","reasoning":"Reason: Both documents do not address ALDH1 or breast cancer outcomes, but Document A discusses cancer-related epigenetic changes (more broadly relevant to cancer biomarkers) while Document B focuses on liver-specific β-catenin roles.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326721Z"}
{"comparison_id":"15a3cc7e-ce7d-419c-92f9-e852afa3a45a","query_id":"51","doc_a_id":"7639744","doc_b_id":"11359243","presented_order":["11359243","7639744"],"winner_id":"11359243","reasoning":"Document A is more relevant — it discusses cancer-related molecular biology (epigenetic changes in tumor cells), which is closer to ALDH1 expression and breast cancer biology than a lung-cancer smoking cessation study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326728Z"}
{"comparison_id":"6309ba9c-8a05-4c8a-b0b6-6616a526b7f4","query_id":"51","doc_a_id":"8764879","doc_b_id":"11359243","presented_order":["8764879","11359243"],"winner_id":"8764879","reasoning":"Document A is more relevant — it discusses cancer stem cell markers and their impact on disease initiation and treatment, which is conceptually closer to ALDH1 (a stem/progenitor marker) and outcome associations than the EBV methylation study in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326736Z"}
{"comparison_id":"fddcb24b-8159-4c93-9aa5-6eba0a1c9690","query_id":"51","doc_a_id":"2494748","doc_b_id":"11359243","presented_order":["11359243","2494748"],"winner_id":"2494748","reasoning":"Both documents are irrelevant to ALDH1 expression or breast cancer outcomes. Document B is slightly more related because it addresses gene methylation in carcinoma progression. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326767Z"}
{"comparison_id":"3956cb82-6060-4404-8ad0-1859ef156975","query_id":"51","doc_a_id":"12903921","doc_b_id":"11359243","presented_order":["11359243","12903921"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular changes (methylation) versus Document B which is about leukemia and oxidative stress in rats; neither mentions ALDH1 or breast cancer specifically.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326780Z"}
{"comparison_id":"35a4651b-b7d4-41b8-9563-403c59f2322b","query_id":"51","doc_a_id":"12650610","doc_b_id":"11359243","presented_order":["11359243","12650610"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it discusses cancer-related epigenetic changes and tumor heterogeneity, whereas Document B focuses specifically on oral cancer signaling unrelated to ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326788Z"}
{"comparison_id":"8d2c6d67-9b90-4dee-8f6d-aa321d2e81b7","query_id":"51","doc_a_id":"9196472","doc_b_id":"11359243","presented_order":["9196472","11359243"],"winner_id":"11359243","reasoning":"Reason: Document B addresses cancer-related epigenetic changes, making it marginally more relevant to a claim about cancer outcomes than Document A, which focuses on monocytes and atherosclerosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326796Z"}
{"comparison_id":"7898dcc9-ccf9-447e-aed7-d57601dbe8be","query_id":"51","doc_a_id":"6121555","doc_b_id":"11359243","presented_order":["6121555","11359243"],"winner_id":"11359243","reasoning":"Neither document addresses ALDH1 or breast cancer directly. Document B is slightly more relevant because it discusses cancer-related epigenetic changes and tumor heterogeneity, which are more broadly related to prognosis than the glioma-specific apoptosis pathway in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326804Z"}
{"comparison_id":"0fc46700-8a78-494b-98cd-5c5220ded415","query_id":"51","doc_a_id":"5406411","doc_b_id":"11359243","presented_order":["5406411","11359243"],"winner_id":"5406411","reasoning":"Document A is more related to cancer biology and potential prognostic/therapeutic markers, whereas Document B concerns EBV-driven methylation in B-cells unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326811Z"}
{"comparison_id":"7bd7d64f-335c-4a5f-8e56-7068765de7c9","query_id":"51","doc_a_id":"85665741","doc_b_id":"11359243","presented_order":["85665741","11359243"],"winner_id":"11359243","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document B is slightly more relevant because it discusses cancer-associated epigenetic changes across human cancers, whereas A is specific to BRAF in NSCLC. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326818Z"}
{"comparison_id":"f1dbb2a1-d8a3-49a4-9096-b3614d91942b","query_id":"51","doc_a_id":"24624992","doc_b_id":"11359243","presented_order":["24624992","11359243"],"winner_id":"24624992","reasoning":"Document A — it discusses gene expression changes in cancer cells (though in leukemia), which is more related to a claim about a gene's expression and cancer outcomes than Document B's focus on EBV-induced methylation in B-cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326826Z"}
{"comparison_id":"3e3e4fda-c07c-4d3f-a2a8-dcde168001bd","query_id":"51","doc_a_id":"16346504","doc_b_id":"11359243","presented_order":["16346504","11359243"],"winner_id":"16346504","reasoning":"Document A is slightly more relevant — it concerns cancer biomarkers and tumor-suppressor pathways (though in endometrial, not breast, cancer), whereas B focuses on EBV-driven methylation in B-cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326833Z"}
{"comparison_id":"62adff9e-aae2-401d-b2d8-28766aa61fb7","query_id":"51","doc_a_id":"29190724","doc_b_id":"11359243","presented_order":["11359243","29190724"],"winner_id":"29190724","reasoning":"Reason: Neither mentions ALDH1 or breast cancer, but Document B discusses cancer-related gene methylation broadly, making it marginally more relevant than Document A's EBV/B-cell focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326840Z"}
{"comparison_id":"34b58ce1-2ad4-4d00-85e0-4ed83dc6f36b","query_id":"51","doc_a_id":"24916604","doc_b_id":"11359243","presented_order":["24916604","11359243"],"winner_id":"11359243","reasoning":"Document B is more relevant — it deals with molecular/epigenetic changes in cancer biology, whereas A discusses treatment policy and bisphosphonate use unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326847Z"}
{"comparison_id":"236780e3-2b32-4474-9df6-04fb3ee98a91","query_id":"51","doc_a_id":"33677323","doc_b_id":"11359243","presented_order":["11359243","33677323"],"winner_id":"33677323","reasoning":"Reason: Neither discusses ALDH1 or breast cancer; Document B mentions expression correlated with clinical outcomes (though in hematologic malignancy), making it marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326855Z"}
{"comparison_id":"d4f117ef-3061-454a-9a9b-e8a3e69d61df","query_id":"51","doc_a_id":"1456068","doc_b_id":"11359243","presented_order":["11359243","1456068"],"winner_id":"1456068","reasoning":"Document B is more relevant — it discusses cancer mortality/outcomes (though not ALDH1 or breast cancer specifically), whereas Document A is about EBV-induced B-cell methylation and unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326862Z"}
{"comparison_id":"d29f8ef5-6d52-4661-9c22-da03160f6007","query_id":"51","doc_a_id":"25738896","doc_b_id":"11359243","presented_order":["11359243","25738896"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular changes and tumor heterogeneity, whereas Document B focuses on immune rejection of melanoma with no link to ALDH1 or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326868Z"}
{"comparison_id":"343c2644-9906-4eaf-95e8-db7d91615465","query_id":"51","doc_a_id":"16853734","doc_b_id":"11359243","presented_order":["16853734","11359243"],"winner_id":"11359243","reasoning":"Neither document mentions ALDH1 or breast cancer outcomes. Document B is slightly more relevant because it addresses cancer-associated epigenetic changes and tumor biology, whereas A focuses on MMP1-driven MSC migration toward glioma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326876Z"}
{"comparison_id":"6e3d2329-ae41-4779-946c-abff528f2a7e","query_id":"51","doc_a_id":"28334217","doc_b_id":"11359243","presented_order":["28334217","11359243"],"winner_id":"11359243","reasoning":"Document B is slightly more relevant — it discusses cancer-related molecular changes observed across human cancers, whereas A focuses on glutaminase inhibition in liver and B‑cell models. Neither mentions ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326883Z"}
{"comparison_id":"8d794d3b-d7aa-4283-9492-f4ae0330acf4","query_id":"51","doc_a_id":"9226649","doc_b_id":"11359243","presented_order":["9226649","11359243"],"winner_id":"11359243","reasoning":"Document B is slightly more relevant because it addresses cancer-related molecular changes (DNA methylation) across human cancers, whereas Document A is specific to colonic inflammasome regulation and not breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326890Z"}
{"comparison_id":"6f9b15f5-c15d-4898-a79e-881fafe59afe","query_id":"51","doc_a_id":"3545805","doc_b_id":"11359243","presented_order":["3545805","11359243"],"winner_id":"11359243","reasoning":"Document B is slightly more relevant — it addresses cancer-related molecular changes and human cancer biology, whereas Document A focuses on melanoma immunotherapy and not on markers like ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326897Z"}
{"comparison_id":"18c18a50-ba97-4ae9-b1ec-b035bd82fade","query_id":"51","doc_a_id":"5372432","doc_b_id":"11359243","presented_order":["11359243","5372432"],"winner_id":"11359243","reasoning":"Document A — it discusses molecular/epigenetic cancer-related changes (more related to biomarkers/outcomes) whereas B addresses healthcare access and diagnosis, not molecular markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326905Z"}
{"comparison_id":"c5af1f49-2bea-468e-837f-2af5229bbffb","query_id":"51","doc_a_id":"8702697","doc_b_id":"11359243","presented_order":["11359243","8702697"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it discusses cancer-related epigenetic changes across human cancers (broad cancer context), whereas Document B is specific to prostate cancer and unrelated to ALDH1 or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326912Z"}
{"comparison_id":"5f16dd4d-c564-4b70-a245-99063794c245","query_id":"51","doc_a_id":"4959368","doc_b_id":"11359243","presented_order":["11359243","4959368"],"winner_id":"11359243","reasoning":"Reason: Both documents are unrelated to ALDH1 or breast cancer; Document A is at least broadly cancer-related (methylation changes), while Document B focuses on pancreatic cancer biomarkers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326919Z"}
{"comparison_id":"d5181eb0-29f8-40c9-bdcf-53cdcd5cd297","query_id":"51","doc_a_id":"6948886","doc_b_id":"11359243","presented_order":["11359243","6948886"],"winner_id":"11359243","reasoning":"Document A is marginally more relevant — it discusses cancer-related epigenetic changes broadly, whereas Document B focuses specifically on glioblastoma mechanisms unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326927Z"}
{"comparison_id":"a940cdde-7a14-4a29-b92f-270d21625492","query_id":"51","doc_a_id":"27167110","doc_b_id":"11359243","presented_order":["27167110","11359243"],"winner_id":"11359243","reasoning":"Document B — it discusses cancer-related epigenetic changes relevant across human cancers, while A is limited to prostate cancer miRNA and neither mentions ALDH1 or breast outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326933Z"}
{"comparison_id":"d33e6e77-47c7-4f15-b53a-30cb0c2bc406","query_id":"51","doc_a_id":"25513319","doc_b_id":"11359243","presented_order":["25513319","11359243"],"winner_id":"25513319","reasoning":"Document A is slightly more relevant because it addresses cancer survival and metastasis (outcomes), while Document B focuses on EBV-driven methylation in B-cells and not on cancer prognosis or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326940Z"}
{"comparison_id":"0a5b3a02-fc7a-4c48-b133-7e83566fe645","query_id":"51","doc_a_id":"34189936","doc_b_id":"11359243","presented_order":["34189936","11359243"],"winner_id":"34189936","reasoning":"Neither document mentions ALDH1 or breast cancer. Both are largely irrelevant, but Document A is slightly more relevant because it deals with gene expression in a solid tumor context, whereas Document B concerns EBV effects in B cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326947Z"}
{"comparison_id":"0b4dd6c5-7860-41d7-b71f-6042c93d217d","query_id":"51","doc_a_id":"15928989","doc_b_id":"11359243","presented_order":["15928989","11359243"],"winner_id":"11359243","reasoning":"Document B is more relevant — it discusses cancer-related epigenetic changes, whereas Document A is about reproductive biology and unrelated to cancer biomarkers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326954Z"}
{"comparison_id":"7afa38ce-894e-4899-a487-9424ce0dc310","query_id":"51","doc_a_id":"17671145","doc_b_id":"11359243","presented_order":["17671145","11359243"],"winner_id":"11359243","reasoning":"Document B is slightly more relevant because it discusses cancer-related epigenetic changes across human cancers, whereas Document A focuses on androgen receptor regulation in prostate cancer only. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326961Z"}
{"comparison_id":"bd75656b-0ed3-4bc3-b291-54a0c58f0204","query_id":"51","doc_a_id":"25452937","doc_b_id":"11359243","presented_order":["11359243","25452937"],"winner_id":"11359243","reasoning":"Document A — it discusses cancer-related epigenetic changes and broader tumor biology, which is more related to markers like ALDH1 than a study specific to macrophages in thyroid cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326968Z"}
{"comparison_id":"f7f9856e-529b-402b-a51b-ff1dbda57ac6","query_id":"51","doc_a_id":"42150015","doc_b_id":"11359243","presented_order":["42150015","11359243"],"winner_id":"11359243","reasoning":"Document B is more relevant — it discusses epigenetic changes linked to malignant transformation and cancer genomes, whereas A is about AMH and reproductive factors with no relation to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326975Z"}
{"comparison_id":"8f3be4bf-7d98-471d-a91e-8ee31ef5ee90","query_id":"51","doc_a_id":"15215393","doc_b_id":"11359243","presented_order":["11359243","15215393"],"winner_id":"11359243","reasoning":"Document A is more relevant — it discusses cancer-related molecular changes (methylation patterns in malignant transformation), which is closer to breast cancer outcome biomarkers than a glioblastoma therapy study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.326998Z"}
{"comparison_id":"79b7ced5-b604-48eb-b4cf-34d1f05c5010","query_id":"51","doc_a_id":"3765739","doc_b_id":"11359243","presented_order":["3765739","11359243"],"winner_id":"3765739","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is slightly more related to cancer prognostic factors (apoptosis/survivin), so it is marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327005Z"}
{"comparison_id":"5eb16291-5888-47b1-aebc-c059f7e06698","query_id":"51","doc_a_id":"12145359","doc_b_id":"11359243","presented_order":["12145359","11359243"],"winner_id":"11359243","reasoning":"Document B is more relevant because it addresses cancer-related molecular changes (epigenetic alterations) whereas Document A concerns lung function and lung cancer risk, unrelated to ALDH1 or breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327011Z"}
{"comparison_id":"e1680463-2c11-4624-8c36-4425f381295f","query_id":"51","doc_a_id":"14848619","doc_b_id":"11359243","presented_order":["11359243","14848619"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it discusses cancer-related epigenetic changes, whereas Document B focuses on hypoxic cell death unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327018Z"}
{"comparison_id":"536f51b1-0093-4d71-849e-469a2fa4a1e6","query_id":"51","doc_a_id":"21692235","doc_b_id":"11359243","presented_order":["21692235","11359243"],"winner_id":"21692235","reasoning":"DOCUMENT A is slightly more relevant because it discusses cancer gene expression and clinical outcomes (though in glioblastoma, not breast cancer); neither document mentions ALDH1 or breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327025Z"}
{"comparison_id":"e8106fa5-7018-46ba-9ce8-9b5e129e9e4c","query_id":"51","doc_a_id":"23286603","doc_b_id":"11359243","presented_order":["11359243","23286603"],"winner_id":"11359243","reasoning":"Document A is marginally more relevant because it discusses cancer-related molecular changes, whereas Document B focuses on macrophage cholesterol regulation and atherosclerosis, not cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327031Z"}
{"comparison_id":"2e4a4b63-0a85-466e-8ccb-b93f9af920a1","query_id":"51","doc_a_id":"5123516","doc_b_id":"11359243","presented_order":["5123516","11359243"],"winner_id":"11359243","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document B discusses cancer-associated epigenetic changes across human cancers, making it marginally more related than Document A's glioblastoma-specific focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327038Z"}
{"comparison_id":"74f426e6-e438-496d-999e-cbfc727aa9fb","query_id":"51","doc_a_id":"22180793","doc_b_id":"11359243","presented_order":["22180793","11359243"],"winner_id":"22180793","reasoning":"Document A is more relevant — it discusses cancer biomarkers and progression (though in prostate cancer), whereas Document B focuses on EBV-driven methylation in B-cells unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327045Z"}
{"comparison_id":"f04066b3-4deb-4fc6-b62b-452e5b8212c7","query_id":"51","doc_a_id":"5468807","doc_b_id":"11359243","presented_order":["11359243","5468807"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular alterations and broader tumor biology, whereas Document B focuses specifically on ARID1A-mutant ovarian cancer therapy unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327052Z"}
{"comparison_id":"0b6513f3-acde-4b7a-9323-a197614010f8","query_id":"51","doc_a_id":"22059387","doc_b_id":"11359243","presented_order":["11359243","22059387"],"winner_id":"11359243","reasoning":"Document A is more relevant — it discusses cancer-related epigenetic changes and malignant transformation, whereas B concerns parasite-induced cholangiocarcinoma in hamsters, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327059Z"}
{"comparison_id":"6d4c7471-d9b1-4348-9381-0e46625afd14","query_id":"51","doc_a_id":"3619931","doc_b_id":"11359243","presented_order":["3619931","11359243"],"winner_id":"11359243","reasoning":"Document B is more relevant — it discusses cancer-related epigenetic changes (malignant transformation), whereas Document A concerns thyroid hormone effects on lung fibrosis unrelated to breast cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327067Z"}
{"comparison_id":"c03beec3-c9d9-4d5f-aa35-00c265a04082","query_id":"51","doc_a_id":"3899896","doc_b_id":"11359243","presented_order":["11359243","3899896"],"winner_id":"3899896","reasoning":"Document B is more relevant — it addresses cancer prognosis/outcomes (though in rectal cancer, not breast), whereas A discusses EBV-induced methylation in B-cells unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327074Z"}
{"comparison_id":"1c9bce6c-362f-42f1-8d6e-e0b6cd75fb2a","query_id":"51","doc_a_id":"4434951","doc_b_id":"11359243","presented_order":["4434951","11359243"],"winner_id":"11359243","reasoning":"Document B is more relevant — it discusses DNA methylation changes seen in cancerous transformation, which is nearer to breast cancer biology than longevity/aging epigenetics in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327080Z"}
{"comparison_id":"0311d2b0-d3f2-4cec-a8fc-cfa7f1797a5d","query_id":"51","doc_a_id":"3831884","doc_b_id":"11359243","presented_order":["11359243","3831884"],"winner_id":"11359243","reasoning":"Reason: Neither abstract discusses ALDH1 or breast cancer; Document A at least addresses cancer-related epigenetic changes, while B focuses on pancreatic metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327087Z"}
{"comparison_id":"384de7a1-2aa7-470d-9ad0-fc0d1abbc959","query_id":"51","doc_a_id":"18810195","doc_b_id":"11359243","presented_order":["18810195","11359243"],"winner_id":"18810195","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular changes, whereas Document B focuses on EBV-induced methylation in B-cells unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327094Z"}
{"comparison_id":"c7cbfd63-9d91-48dc-ad76-3cbfb97ec085","query_id":"51","doc_a_id":"14672919","doc_b_id":"11359243","presented_order":["11359243","14672919"],"winner_id":"11359243","reasoning":"Document A is marginally more relevant because it addresses cancer-related molecular changes, whereas B focuses on platelet metrics in esophageal cancer and neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327100Z"}
{"comparison_id":"70863461-33e3-418d-86a9-f021c7ecc65f","query_id":"51","doc_a_id":"36838958","doc_b_id":"11359243","presented_order":["36838958","11359243"],"winner_id":"11359243","reasoning":"Document B is more relevant — it discusses cancer-related epigenetic changes and malignant transformation, which is closer to breast cancer outcome topics than Document A's adipose/thermogenesis focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327107Z"}
{"comparison_id":"6dddf3de-c80f-4ccb-a73d-d99175eeb94a","query_id":"51","doc_a_id":"24323369","doc_b_id":"11359243","presented_order":["11359243","24323369"],"winner_id":"11359243","reasoning":"Document A is more relevant — it discusses cancer-related molecular changes (epigenetic alterations in tumor cells), whereas Document B is unrelated to cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327113Z"}
{"comparison_id":"e2d66db0-37b1-4efc-baea-c6ca968c180d","query_id":"51","doc_a_id":"3504761","doc_b_id":"11359243","presented_order":["3504761","11359243"],"winner_id":"11359243","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is slightly more relevant because it addresses cancer-related genomic changes, whereas A focuses on liver-specific metabolic regulation and tumorigenesis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327120Z"}
{"comparison_id":"fc9e6018-2310-4a6b-bfc3-ecdfebb25895","query_id":"51","doc_a_id":"7869794","doc_b_id":"11359243","presented_order":["11359243","7869794"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular changes and tumor heterogeneity, which is closer to studies of prognostic markers like ALDH1 than neutrophil Ca2+ signaling. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327126Z"}
{"comparison_id":"209ca849-2174-4b08-b500-b133839a55b1","query_id":"51","doc_a_id":"5783785","doc_b_id":"11359243","presented_order":["11359243","5783785"],"winner_id":"11359243","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it addresses cancer-related epigenetic changes broadly, while B is specific to gastric cancer miRNA. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327133Z"}
{"comparison_id":"c8457676-9502-4123-8f50-ed12dadb7b1a","query_id":"51","doc_a_id":"22478394","doc_b_id":"11359243","presented_order":["11359243","22478394"],"winner_id":"11359243","reasoning":"Document A — it discusses cancer-related epigenetic changes (more relevant to cancer outcomes) while Document B concerns liver/NAFLD. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327139Z"}
{"comparison_id":"4a3b7d83-6608-4fdd-9251-a2f1afe8b415","query_id":"51","doc_a_id":"7028976","doc_b_id":"11359243","presented_order":["11359243","7028976"],"winner_id":"7028976","reasoning":"Reason: Both are unrelated to ALDH1 or breast cancer; Document B is marginally more relevant because it deals with marker expression in tumor-initiating cells, which is conceptually closer than EBV-driven methylation in B-cells.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327146Z"}
{"comparison_id":"03df9584-abe2-4cb4-a61f-b5ab90b7688f","query_id":"51","doc_a_id":"10542877","doc_b_id":"11359243","presented_order":["10542877","11359243"],"winner_id":"11359243","reasoning":"Document B is slightly more relevant — it discusses cancer-related molecular changes and biomarkers, whereas A focuses on a STAT3 inhibitor in lymphoma and lung cancer, not biomarkers or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327153Z"}
{"comparison_id":"1391b7eb-6459-4d47-a2c2-547750671e62","query_id":"51","doc_a_id":"16361581","doc_b_id":"11359243","presented_order":["16361581","11359243"],"winner_id":"16361581","reasoning":"Neither document mentions ALDH1 or breast cancer. Both are irrelevant, but A is marginally more related since it addresses cancer cell biology (vs. viral methylation in B-cells).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327159Z"}
{"comparison_id":"bd8e6f41-9e08-46da-b8d9-8ff4b19b3f6f","query_id":"51","doc_a_id":"24783597","doc_b_id":"11359243","presented_order":["24783597","11359243"],"winner_id":"11359243","reasoning":"Document B is more relevant — it discusses cancer-related (malignant transformation) epigenetic changes, whereas Document A is about IL-17F in Crohn's disease and unrelated to breast cancer or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327167Z"}
{"comparison_id":"1bfee33b-ed98-408c-92f1-2305eaa2cfe5","query_id":"51","doc_a_id":"667451","doc_b_id":"11359243","presented_order":["11359243","667451"],"winner_id":"11359243","reasoning":"Document A is more relevant — it discusses cancer-related molecular alterations (large-scale hypomethylation) that could relate to biomarkers like ALDH1, whereas Document B focuses specifically on subclonal mutations in CLL, unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327174Z"}
{"comparison_id":"9af156a5-00c0-4bc7-8971-3f3248511abb","query_id":"51","doc_a_id":"5691302","doc_b_id":"11359243","presented_order":["5691302","11359243"],"winner_id":"11359243","reasoning":"Document B is more relevant — it discusses cancer-related molecular changes (epigenetic alterations in tumorigenesis), whereas A is about antidepressant risks in older adults. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327181Z"}
{"comparison_id":"5430b781-9402-4aa4-a796-2ab1e0e7c3f0","query_id":"51","doc_a_id":"1836154","doc_b_id":"11359243","presented_order":["11359243","1836154"],"winner_id":"11359243","reasoning":"Neither document discusses ALDH1 or breast cancer; Document A is marginally more relevant because it addresses cancer-related epigenetic changes rather than a glioblastoma-specific genomic study. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327187Z"}
{"comparison_id":"e69181cc-1d55-41cf-9bca-a5520e328a99","query_id":"51","doc_a_id":"24190159","doc_b_id":"11359243","presented_order":["11359243","24190159"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular changes (epigenetic patterns) across human cancers, whereas Document B focuses specifically on KRAS-mutant rectal carcinoma genes unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327194Z"}
{"comparison_id":"870051e7-65e1-4ffe-bc36-75a08ff4a008","query_id":"51","doc_a_id":"23599024","doc_b_id":"11359243","presented_order":["11359243","23599024"],"winner_id":"23599024","reasoning":"Document B is more relevant — it addresses protein expression linked to cancer progression and outcomes (though in lung cancer, not breast, and not ALDH1). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327201Z"}
{"comparison_id":"1f08a032-3cad-45bd-af4e-658b88e16a55","query_id":"51","doc_a_id":"13905670","doc_b_id":"11359243","presented_order":["11359243","13905670"],"winner_id":"11359243","reasoning":"Document A is more cancer-relevant (epigenetic changes in malignancy), while B focuses on inflammatory/infectious disease genetics; neither mentions ALDH1 or breast cancer outcomes, but A is closer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327207Z"}
{"comparison_id":"d178cc57-a83f-4bf6-ae30-d18461aa9b8f","query_id":"51","doc_a_id":"18882947","doc_b_id":"11359243","presented_order":["11359243","18882947"],"winner_id":"11359243","reasoning":"Document A is more relevant — it discusses cancer-related epigenetic changes (general tumor biology), whereas Document B focuses on T-cell lymphoma mechanisms unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327214Z"}
{"comparison_id":"620aa178-e49c-4702-9205-a2479bae7b61","query_id":"51","doc_a_id":"19427410","doc_b_id":"11359243","presented_order":["19427410","11359243"],"winner_id":"11359243","reasoning":"Document B is slightly more relevant because it addresses cancer-related molecular changes, whereas Document A concerns IL-33 in adipocytes and not cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327221Z"}
{"comparison_id":"e2c6d88a-c490-4544-949b-8310db011832","query_id":"51","doc_a_id":"25036988","doc_b_id":"11359243","presented_order":["25036988","11359243"],"winner_id":"11359243","reasoning":"Document B is slightly more relevant because it addresses cancer-related epigenetic changes and tumor transformation, whereas Document A focuses on lamin B1 effects in colon cancer unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327228Z"}
{"comparison_id":"6f5ad6cd-31de-4cc6-bcf2-6cbb68078644","query_id":"51","doc_a_id":"19800147","doc_b_id":"11359243","presented_order":["11359243","19800147"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular changes across human cancers, whereas Document B is specific to colon cancer and miRNA; neither directly addresses ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327235Z"}
{"comparison_id":"093ae5fc-4b8e-4611-859d-6e67c5ee4e89","query_id":"51","doc_a_id":"5573975","doc_b_id":"11359243","presented_order":["11359243","5573975"],"winner_id":"11359243","reasoning":"Document A is at least cancer-related (epigenetic changes seen in human cancers); Document B concerns kidney regeneration/fibrosis unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327241Z"}
{"comparison_id":"300af2c9-faf2-4161-88bc-0c3b980b7205","query_id":"51","doc_a_id":"6290112","doc_b_id":"11359243","presented_order":["11359243","6290112"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it deals with cancer-related molecular changes (methylation in malignant transformation), whereas Document B is about obesity and AMY1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327248Z"}
{"comparison_id":"14dc0101-841e-47b8-93bc-7a578a776747","query_id":"51","doc_a_id":"33740844","doc_b_id":"11359243","presented_order":["33740844","11359243"],"winner_id":"11359243","reasoning":"Reason: Document B discusses cancer-related molecular changes (methylation patterns) and is more closely related to oncology than Document A, which is about pregnancy nutrition.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327254Z"}
{"comparison_id":"83fde3f0-b549-4660-8dff-f55408493de6","query_id":"51","doc_a_id":"67787658","doc_b_id":"11359243","presented_order":["67787658","11359243"],"winner_id":"11359243","reasoning":"Document B is more relevant — it addresses cancer-related epigenetic changes observed across human cancers, whereas A focuses specifically on glioblastoma microRNA-mediated chemoresistance. Neither mentions ALDH1 or breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327261Z"}
{"comparison_id":"d7488b44-3d84-445e-aadc-74381a0a8d18","query_id":"51","doc_a_id":"13398997","doc_b_id":"11359243","presented_order":["13398997","11359243"],"winner_id":"11359243","reasoning":"Document B — it relates to cancer-related molecular changes and malignant transformation, whereas Document A is about CTLA-4 on Th17 cells in renal transplant context. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327268Z"}
{"comparison_id":"b4b461e1-a494-4bcf-a0c1-b83a007c2c8a","query_id":"51","doc_a_id":"10669939","doc_b_id":"11359243","presented_order":["10669939","11359243"],"winner_id":"10669939","reasoning":"Document A is more relevant — it deals with imaging and detection of gene expression (though in glioma), which is closer to a claim about ALDH1 expression than Document B's focus on EBV-induced methylation in B‑cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327275Z"}
{"comparison_id":"f60db031-4cc7-4d2d-bdbc-f789ca014d76","query_id":"51","doc_a_id":"18682109","doc_b_id":"11359243","presented_order":["11359243","18682109"],"winner_id":"11359243","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document A is marginally more relevant because it discusses cancer-related epigenetic changes broadly, whereas B focuses specifically on lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327281Z"}
{"comparison_id":"8746bd51-4088-4dcf-ba8a-57cec8d1332e","query_id":"51","doc_a_id":"20659283","doc_b_id":"11359243","presented_order":["11359243","20659283"],"winner_id":"11359243","reasoning":"Document A — it deals with cancer-related molecular changes (epigenetic alterations in B-cells), which is closer to breast cancer/biomarker context than Document B's focus on PXR/CYP regulation. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327289Z"}
{"comparison_id":"0db40efc-1562-4b5f-aef3-b5f74c31e9e0","query_id":"51","doc_a_id":"195689757","doc_b_id":"11359243","presented_order":["195689757","11359243"],"winner_id":"195689757","reasoning":"Document A is more relevant — it discusses altered metabolism and metabolic enzymes in cancer (ALDH1 is a metabolic enzyme), whereas Document B focuses on EBV-induced methylation in B-cells, unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327295Z"}
{"comparison_id":"47589190-484a-4a91-9d9c-f69cd004f317","query_id":"51","doc_a_id":"21063817","doc_b_id":"11359243","presented_order":["21063817","11359243"],"winner_id":"21063817","reasoning":"Neither document mentions ALDH1 or breast cancer; Document A is slightly more relevant because it deals with epithelial carcinoma (closer to breast cancer) whereas B focuses on EBV effects in B-cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327302Z"}
{"comparison_id":"5a7c75c5-cba4-4aba-9381-99b0547d18a9","query_id":"51","doc_a_id":"33076846","doc_b_id":"11359243","presented_order":["11359243","33076846"],"winner_id":"11359243","reasoning":"Document A is more relevant — it discusses cancer-related molecular changes (epigenetic patterns seen in human cancers), whereas B focuses on megakaryocyte/platelet biology unrelated to breast cancer or ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327309Z"}
{"comparison_id":"e574ff32-9814-4ee2-8723-ed9a32e5e08b","query_id":"51","doc_a_id":"13235609","doc_b_id":"11359243","presented_order":["13235609","11359243"],"winner_id":"13235609","reasoning":"Document A is slightly more relevant because it addresses tumor cell behavior (invasion/mesenchymal transition) related to cancer prognosis, whereas Document B focuses on EBV-driven methylation in B-cells unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327315Z"}
{"comparison_id":"8af9ca04-874b-4713-9404-32f409be5f62","query_id":"51","doc_a_id":"2547636","doc_b_id":"11359243","presented_order":["2547636","11359243"],"winner_id":"2547636","reasoning":"Document A is more relevant — it concerns stem cell regulation and carcinogenesis, which is closer to ALDH1's role as a cancer stem cell marker than B's focus on EBV-driven B‑cell methylation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327322Z"}
{"comparison_id":"e4896bb5-7d01-4222-83c0-9a2bcf589ee8","query_id":"51","doc_a_id":"9478135","doc_b_id":"11359243","presented_order":["9478135","11359243"],"winner_id":"11359243","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer; Document B is marginally more relevant because it discusses cancer-related epigenetic changes, whereas A is specific to AML genetics.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327328Z"}
{"comparison_id":"eb89df72-1630-4ea3-bb8b-5fa27b147e4a","query_id":"51","doc_a_id":"28644298","doc_b_id":"11359243","presented_order":["28644298","11359243"],"winner_id":"11359243","reasoning":"Document B is more relevant — it addresses large-scale epigenetic changes during viral-driven transformation that relate to cancer biology and prognosis, whereas A focuses narrowly on NF-kappaB in EBV latency.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327335Z"}
{"comparison_id":"810f20c7-ff7c-4b3c-9259-4ccd33bc2878","query_id":"51","doc_a_id":"6374918","doc_b_id":"11359243","presented_order":["6374918","11359243"],"winner_id":"11359243","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it addresses cancer-related epigenetic changes across human cancers, whereas A focuses specifically on AML therapy.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327341Z"}
{"comparison_id":"99785745-26a7-44a0-a25d-e1ea8ae79c30","query_id":"51","doc_a_id":"14972169","doc_b_id":"11359243","presented_order":["11359243","14972169"],"winner_id":"11359243","reasoning":"Document A is more cancer-related (discusses epigenetic changes in malignant transformation), so it's nearer to a claim about cancer outcomes than an embryology/oxidative stress study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327348Z"}
{"comparison_id":"c31dec36-41f9-49a4-b4df-6384dce3aa7a","query_id":"51","doc_a_id":"17973161","doc_b_id":"11359243","presented_order":["17973161","11359243"],"winner_id":"11359243","reasoning":"Document B — it relates to cancer-related epigenetic changes (closer to breast cancer outcomes) while A concerns adipocytes and metabolic effects in mice. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327355Z"}
{"comparison_id":"e6f19444-9487-4e4d-9bab-bd6541416afe","query_id":"51","doc_a_id":"6766459","doc_b_id":"11359243","presented_order":["11359243","6766459"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular changes, whereas Document B concerns fever regulation and immune microRNAs with no connection to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327361Z"}
{"comparison_id":"51e5ab73-8b1d-4c28-8b58-56ef50237d5f","query_id":"51","doc_a_id":"27822315","doc_b_id":"11359243","presented_order":["27822315","11359243"],"winner_id":"27822315","reasoning":"Document A is more relevant — it deals with stem cell differentiation and steroidogenic pathways that are more related to breast cancer biology and stem-cell markers like ALDH1, whereas Document B focuses on EBV-induced changes in B-cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327368Z"}
{"comparison_id":"2d85d362-2b46-48d3-951c-265ec776f6ea","query_id":"51","doc_a_id":"15322518","doc_b_id":"11359243","presented_order":["15322518","11359243"],"winner_id":"11359243","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document B is slightly more relevant because it discusses cancer-related epigenetic changes across human cancers, whereas A focuses on rhabdoid tumor RTK targeting.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327375Z"}
{"comparison_id":"ae2d663d-ebd3-4219-aad9-a4b01794c131","query_id":"51","doc_a_id":"4464565","doc_b_id":"11359243","presented_order":["11359243","4464565"],"winner_id":"11359243","reasoning":"Document A is more cancer-relevant (discusses epigenetic changes in malignant transformation), while B focuses on cocoa effects in intestinal cells and neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327381Z"}
{"comparison_id":"c37738db-11f7-4582-9b02-9dd64dcb68f5","query_id":"51","doc_a_id":"3701541","doc_b_id":"11359243","presented_order":["3701541","11359243"],"winner_id":"3701541","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document A is marginally more relevant because it deals with cancer-related signaling and tumor suppression, whereas B focuses on EBV-induced methylation in B-cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327388Z"}
{"comparison_id":"7aea26bd-559b-47d9-8ed3-87b8beb6e1b7","query_id":"51","doc_a_id":"9513785","doc_b_id":"11359243","presented_order":["9513785","11359243"],"winner_id":"11359243","reasoning":"Document B is slightly more relevant because it addresses cancer-related molecular changes, whereas Document A concerns maternal protein restriction and lifespan in mice and does not relate to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327395Z"}
{"comparison_id":"1b9557eb-5d0f-43f4-b56a-4de815fd0a77","query_id":"51","doc_a_id":"30543439","doc_b_id":"11359243","presented_order":["11359243","30543439"],"winner_id":"11359243","reasoning":"Document A is slightly more related to cancer biology, though neither mentions ALDH1 or breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327402Z"}
{"comparison_id":"47e46569-b165-4884-9954-61db5c2acc5c","query_id":"51","doc_a_id":"25725663","doc_b_id":"11359243","presented_order":["11359243","25725663"],"winner_id":"11359243","reasoning":"Document A is slightly more related (discusses cancer-related epigenetic changes), while B is about lung epithelial protection unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327408Z"}
{"comparison_id":"1adfba95-dd60-461c-8a4a-a54a5060245e","query_id":"51","doc_a_id":"4993011","doc_b_id":"11359243","presented_order":["4993011","11359243"],"winner_id":"4993011","reasoning":"Document A is slightly more relevant because it discusses cancer biology and therapeutic implications, whereas Document B focuses on EBV effects in B-cells, unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327415Z"}
{"comparison_id":"5c67f8fb-c569-4f66-ae84-88311bc77260","query_id":"51","doc_a_id":"15491308","doc_b_id":"11359243","presented_order":["15491308","11359243"],"winner_id":"11359243","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document B is marginally more related because it addresses cancer-associated methylation changes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327422Z"}
{"comparison_id":"116c0979-374b-4291-b959-b03d12c9b870","query_id":"51","doc_a_id":"21372171","doc_b_id":"11359243","presented_order":["21372171","11359243"],"winner_id":"11359243","reasoning":"Document B — it relates to cancer-related epigenetic changes, making it slightly more relevant to a claim about cancer biomarkers/outcomes than a PAD biomarker study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327429Z"}
{"comparison_id":"238f1b24-d368-4f2f-aab6-f26d5b9d103d","query_id":"51","doc_a_id":"15803282","doc_b_id":"11359243","presented_order":["15803282","11359243"],"winner_id":"11359243","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer outcomes; Document B at least discusses cancer-related methylation changes, so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327435Z"}
{"comparison_id":"4df87b08-03fe-4f9f-a0da-335b1b509c5b","query_id":"51","doc_a_id":"25022826","doc_b_id":"11359243","presented_order":["11359243","25022826"],"winner_id":"11359243","reasoning":"Doc A is slightly more relevant because it discusses DNA methylation patterns observed in human cancers and malignant transformation, whereas Document B concerns MSC osteogenic differentiation unrelated to cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327442Z"}
{"comparison_id":"5e4a6b4f-d7a5-4782-9c64-804d8aa73121","query_id":"51","doc_a_id":"36653415","doc_b_id":"11359243","presented_order":["11359243","36653415"],"winner_id":"11359243","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes; both are irrelevant. Document A is marginally more relevant because it relates to cancer-related molecular changes, whereas B focuses on lung tumor metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327449Z"}
{"comparison_id":"eeb87b1a-ea3d-48d6-b465-3606425ed583","query_id":"51","doc_a_id":"19343151","doc_b_id":"11359243","presented_order":["19343151","11359243"],"winner_id":"11359243","reasoning":"Document B is marginally more relevant because it discusses cancer-related epigenetic changes, whereas Document A concerns skin aging and not cancer biomarkers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327455Z"}
{"comparison_id":"59e8ab4e-a0d0-415a-8b40-00c4cdc666b4","query_id":"51","doc_a_id":"8724666","doc_b_id":"11359243","presented_order":["11359243","8724666"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it discusses cancer-related epigenetic changes (general human cancers), whereas Document B focuses specifically on hematopoiesis and leukemia, not breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327462Z"}
{"comparison_id":"b5494e1d-ca6e-4b74-ae43-091e53113444","query_id":"51","doc_a_id":"20460020","doc_b_id":"11359243","presented_order":["11359243","20460020"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it discusses cancer-related epigenetic changes, while Document B concerns wound healing and macrophage activation unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327468Z"}
{"comparison_id":"2bdcff11-185a-4a4d-a4fd-54537b45b968","query_id":"51","doc_a_id":"32372280","doc_b_id":"11359243","presented_order":["11359243","32372280"],"winner_id":"11359243","reasoning":"Document A is more related to cancer biology and malignant transformation (while B concerns glaucoma), so A is more relevant to a claim about breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327475Z"}
{"comparison_id":"f3d90b98-2e9d-4978-9e37-eaad938cf475","query_id":"51","doc_a_id":"22896384","doc_b_id":"11359243","presented_order":["11359243","22896384"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it concerns cancer-related molecular changes, whereas Document B deals with lung/esophagus development unrelated to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327482Z"}
{"comparison_id":"abb326ed-8a32-4ba1-a5a9-d92ce49365c3","query_id":"51","doc_a_id":"38025907","doc_b_id":"11359243","presented_order":["11359243","38025907"],"winner_id":"11359243","reasoning":"Document A is more relevant — it discusses cancer-related epigenetic changes, whereas Document B concerns liver disease unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327488Z"}
{"comparison_id":"4032a6c7-7162-4056-9fa6-bea620f29f10","query_id":"51","doc_a_id":"14149065","doc_b_id":"11359243","presented_order":["11359243","14149065"],"winner_id":"14149065","reasoning":"Neither document addresses ALDH1 or breast cancer prognosis, but Document B (epithelial proliferation via E-cadherin) is marginally more related to epithelial tumors like breast cancer than Document A (EBV effects in B-cells). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327495Z"}
{"comparison_id":"d5b9836b-17b0-4ceb-8739-a934a91b717f","query_id":"51","doc_a_id":"25344732","doc_b_id":"11359243","presented_order":["11359243","25344732"],"winner_id":"11359243","reasoning":"Document A is more relevant — it discusses cancer-related epigenetic changes across human cancers, while Document B focuses on PHC3 loss in osteosarcoma, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327502Z"}
{"comparison_id":"f1b26c10-476c-46f9-a2a9-bb5d58619d6e","query_id":"51","doc_a_id":"26059876","doc_b_id":"11359243","presented_order":["26059876","11359243"],"winner_id":"11359243","reasoning":"Neither document mentions ALDH1 or breast cancer; Document B is slightly more relevant because it addresses cancer-wide epigenetic changes that could affect marker expression across tumor types. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327508Z"}
{"comparison_id":"6701ffc9-7846-447f-aa5e-9ed31311240a","query_id":"51","doc_a_id":"8417211","doc_b_id":"11359243","presented_order":["8417211","11359243"],"winner_id":"11359243","reasoning":"Document B is more relevant — it discusses DNA methylation changes in human cancers and malignant transformation, which is closer to breast cancer outcomes than a Drosophila HP1 phosphorylation study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327516Z"}
{"comparison_id":"42380ee1-135f-4d69-bb4e-b9a069320340","query_id":"51","doc_a_id":"28249680","doc_b_id":"11359243","presented_order":["11359243","28249680"],"winner_id":"28249680","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer outcomes, but Document B concerns epithelial cancer cell biology (more relevant to breast cancer) while A focuses on EBV effects in B-cells.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327522Z"}
{"comparison_id":"b99f7f21-e246-4d2a-9257-53450c620c53","query_id":"51","doc_a_id":"4920376","doc_b_id":"11359243","presented_order":["11359243","4920376"],"winner_id":"11359243","reasoning":"Document A is more relevant. Neither document discusses ALDH1 or breast cancer specifically, but A addresses cancer-related epigenetic changes and tumor heterogeneity, which is closer to the query's focus than a study on ERK inhibition in pancreatic cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327530Z"}
{"comparison_id":"a3039fac-ab09-453a-aa47-d4e1cf17c2e3","query_id":"51","doc_a_id":"2919030","doc_b_id":"11359243","presented_order":["2919030","11359243"],"winner_id":"2919030","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document A is slightly more relevant because it discusses cancer-related metabolic enzymes and pathways; Document B focuses on EBV-induced methylation in B-cells (not breast cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327539Z"}
{"comparison_id":"c28428a8-b7de-44b4-b622-0fa6edfbae4d","query_id":"51","doc_a_id":"6137330","doc_b_id":"11359243","presented_order":["6137330","11359243"],"winner_id":"11359243","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer; Document B is slightly more relevant because it discusses cancer-related molecular/epigenetic changes, while A focuses on lung nodule clinical guidelines.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327547Z"}
{"comparison_id":"48c12018-f1ec-4f07-9fc3-136e7925883a","query_id":"51","doc_a_id":"17775228","doc_b_id":"11359243","presented_order":["17775228","11359243"],"winner_id":"11359243","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is slightly more relevant because it addresses cancer-associated epigenetic changes across human cancers, whereas A focuses specifically on IGF2/H19 imprinting in colorectal cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327555Z"}
{"comparison_id":"0ac1f56b-6a77-4c66-99c0-c21de3c97454","query_id":"51","doc_a_id":"4641348","doc_b_id":"11359243","presented_order":["4641348","11359243"],"winner_id":"11359243","reasoning":"Neither document discusses ALDH1 or breast cancer directly; Document B is slightly more relevant because it addresses cancer-related epigenetic changes, whereas A is about liver disease. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327561Z"}
{"comparison_id":"da33f389-dbfa-45a5-8715-bfe76e6896b9","query_id":"51","doc_a_id":"2359152","doc_b_id":"11359243","presented_order":["2359152","11359243"],"winner_id":"11359243","reasoning":"Document B is slightly more relevant because it deals with cancer-related molecular changes, whereas Document A focuses on myelodysplastic syndromes (not breast cancer) and genetic lesions unrelated to ALDH1.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327568Z"}
{"comparison_id":"263ad550-7fcf-4c32-a342-302614a16a2f","query_id":"51","doc_a_id":"39481265","doc_b_id":"11359243","presented_order":["11359243","39481265"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it discusses cancer-related epigenetic changes (though in EBV-immortalized B-cells), whereas Document B focuses on lung fibrosis rather than cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327575Z"}
{"comparison_id":"5208de31-5d71-4d33-9831-9d818b71c461","query_id":"51","doc_a_id":"22483580","doc_b_id":"11359243","presented_order":["11359243","22483580"],"winner_id":"11359243","reasoning":"Document A — discusses cancer-related epigenetic alterations, making it more relevant to a claim about breast cancer outcomes than the bipolar disorder/sleep study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327582Z"}
{"comparison_id":"ae31919e-b9de-4934-8372-5fbd3ba6f273","query_id":"51","doc_a_id":"8842332","doc_b_id":"11359243","presented_order":["11359243","8842332"],"winner_id":"11359243","reasoning":"Document A is more relevant — it concerns cancer-related molecular changes, whereas Document B is about diabetes in pregnancy and unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327589Z"}
{"comparison_id":"e584f0ce-4de3-4088-8249-2c8489079f52","query_id":"51","doc_a_id":"5765455","doc_b_id":"11359243","presented_order":["5765455","11359243"],"winner_id":"11359243","reasoning":"Document B is more relevant — it addresses cancer-related molecular changes in human cells (epigenetic alterations in cancer), whereas A focuses on myeloid leukemia mechanisms unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327596Z"}
{"comparison_id":"f8ac0bb3-1552-4380-8f8a-8b5863fd618e","query_id":"51","doc_a_id":"24586989","doc_b_id":"11359243","presented_order":["11359243","24586989"],"winner_id":"11359243","reasoning":"Document A is more related because it discusses cancer-associated epigenetic changes, whereas Document B concerns heart failure genetics unrelated to ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327602Z"}
{"comparison_id":"88a64de0-b74b-4b29-b639-aa1b43d0031b","query_id":"51","doc_a_id":"5939172","doc_b_id":"11359243","presented_order":["11359243","5939172"],"winner_id":"11359243","reasoning":"Document A is more relevant — it discusses cancer-related molecular changes (methylation patterns) relevant to tumor biology, whereas B addresses drinking patterns and mortality unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327609Z"}
{"comparison_id":"4521db80-0242-4b5a-98f5-40ee0714a558","query_id":"51","doc_a_id":"1871499","doc_b_id":"11359243","presented_order":["1871499","11359243"],"winner_id":"11359243","reasoning":"Document B is more relevant — it discusses cancer-related epigenetic changes (similar to patterns seen in human cancers), whereas Document A concerns Huntington's disease. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327616Z"}
{"comparison_id":"aa6528b1-6438-45e8-8a0c-8a501b04def4","query_id":"51","doc_a_id":"12580014","doc_b_id":"11359243","presented_order":["11359243","12580014"],"winner_id":"11359243","reasoning":"Document A is more relevant — it addresses cancer-related molecular changes and tumor biology broadly, whereas Document B focuses specifically on keratin/Aire in skin tumor keratinocytes, not ALDH1 or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327623Z"}
{"comparison_id":"6389cc31-86f0-4d8a-a64e-440321e6e394","query_id":"51","doc_a_id":"13048272","doc_b_id":"11359243","presented_order":["11359243","13048272"],"winner_id":"13048272","reasoning":"Document B is slightly more relevant because it concerns stem/progenitor cell biology (ALDH1 is a stem-cell marker), whereas Document A focuses on EBV-induced methylation changes in B-cells unrelated to ALDH1 or breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327629Z"}
{"comparison_id":"2165eb6f-f24b-4293-b82b-7b652231d9f7","query_id":"51","doc_a_id":"8290760","doc_b_id":"11359243","presented_order":["8290760","11359243"],"winner_id":"11359243","reasoning":"Document B is slightly more relevant because it discusses cancer-associated epigenetic changes, whereas Document A focuses on cellular reprogramming and iPSC markers; however, neither mentions ALDH1 or breast cancer outcomes. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327636Z"}
{"comparison_id":"34d3a0c9-0731-417c-9385-cfae6d853f62","query_id":"51","doc_a_id":"28390999","doc_b_id":"11359243","presented_order":["28390999","11359243"],"winner_id":"11359243","reasoning":"Document B is more relevant — it discusses cancer-related epigenetic changes, whereas A is about chicken gonad development and unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327642Z"}
{"comparison_id":"97f42ddc-ce6f-491f-a76b-7252a919d797","query_id":"51","doc_a_id":"3202143","doc_b_id":"11359243","presented_order":["11359243","3202143"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it discusses cancer-related epigenetic changes, whereas Document B is about C. elegans memory and aging. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327648Z"}
{"comparison_id":"3e73b4ac-e1c4-430b-80e9-44e442b040bd","query_id":"51","doc_a_id":"2356950","doc_b_id":"11359243","presented_order":["11359243","2356950"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it discusses cancer-related epigenetic changes, whereas Document B concerns neural stem cell regulation and not breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327655Z"}
{"comparison_id":"4409d7d3-c537-4840-8d46-fc9df841bfda","query_id":"51","doc_a_id":"20381484","doc_b_id":"11359243","presented_order":["11359243","20381484"],"winner_id":"11359243","reasoning":"Document A is more cancer-related (discusses genome-wide methylation changes in malignant transformation), whereas Document B is about GAPDH nitrosylation and not related to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327662Z"}
{"comparison_id":"039c2760-6983-4937-b640-f6ff7a988307","query_id":"51","doc_a_id":"4378885","doc_b_id":"11359243","presented_order":["11359243","4378885"],"winner_id":"4378885","reasoning":"Document B is more relevant because it focuses on gene expression and RNA-seq methods that could address ALDH1 expression, whereas A discusses EBV-related methylation in B-cells not ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327668Z"}
{"comparison_id":"76cdd36b-01e5-424d-9d6b-f586eda33e86","query_id":"51","doc_a_id":"38028419","doc_b_id":"11359243","presented_order":["11359243","38028419"],"winner_id":"11359243","reasoning":"Document A is more relevant — it discusses cancer-related molecular changes (methylation patterns) which are closer to tumor biomarkers and outcomes than a study on alcoholic fatty liver. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327675Z"}
{"comparison_id":"b35543f8-1a77-498c-a013-3661cb5815b1","query_id":"51","doc_a_id":"11255504","doc_b_id":"11359243","presented_order":["11359243","11255504"],"winner_id":"11359243","reasoning":"Document A is more relevant — it discusses cancer-related molecular changes (epigenetic patterns) across human cancers, whereas B focuses on liver-specific mutagenesis unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327681Z"}
{"comparison_id":"a3fde78a-0df2-43cd-809a-ea309d20c72e","query_id":"51","doc_a_id":"4795303","doc_b_id":"11359243","presented_order":["11359243","4795303"],"winner_id":"11359243","reasoning":"Document A is more related to cancer biology (methylation patterns in malignancy), while Document B covers neuroprotection in PC12 cells and is unrelated to breast cancer or ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327688Z"}
{"comparison_id":"96aea9ac-6138-4b1f-ae9b-d724d3f8b719","query_id":"51","doc_a_id":"3621011","doc_b_id":"11359243","presented_order":["3621011","11359243"],"winner_id":"11359243","reasoning":"Document B is more relevant because it addresses cancer-related epigenetic changes, whereas Document A concerns adipocyte biology and insulin sensitivity unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327694Z"}
{"comparison_id":"5a66bd38-f880-4041-abd4-3f23bbd2a4ec","query_id":"51","doc_a_id":"42484543","doc_b_id":"11359243","presented_order":["42484543","11359243"],"winner_id":"42484543","reasoning":"Document A is slightly more relevant because it reports gene expression profiles and stem-cell–related markers (ALDH1 is a stemness-associated gene), whereas Document B focuses on EBV-related methylation in B-cells and not breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327701Z"}
{"comparison_id":"10e753d8-77f1-49e6-8590-253ece4b7fb8","query_id":"51","doc_a_id":"2829179","doc_b_id":"11359243","presented_order":["2829179","11359243"],"winner_id":"11359243","reasoning":"Document B — it discusses cancer-related epigenetic changes and malignant transformation, which is more relevant to a claim about cancer biomarkers/outcomes than a review on pre-eclampsia.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327707Z"}
{"comparison_id":"814d8040-d46e-48ea-9ab4-53ae5def614a","query_id":"51","doc_a_id":"40901687","doc_b_id":"11359243","presented_order":["40901687","11359243"],"winner_id":"40901687","reasoning":"Document A is slightly more relevant because it addresses cancer-related molecular pathways (DNA damage response) while Document B focuses on EBV-driven B-cell methylation, which is less related to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327714Z"}
{"comparison_id":"fd58f62f-5aad-49e5-9b5b-e9ef337d757c","query_id":"51","doc_a_id":"21602220","doc_b_id":"11359243","presented_order":["21602220","11359243"],"winner_id":"11359243","reasoning":"Document B — it concerns cancer-related epigenetic changes, so it's more relevant to a claim about cancer biomarkers/outcomes than a study on E. coli fermentation.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327720Z"}
{"comparison_id":"41b7ddaa-892f-49d9-b6ab-9c5744903dd3","query_id":"51","doc_a_id":"1982286","doc_b_id":"11359243","presented_order":["11359243","1982286"],"winner_id":"11359243","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular changes (epigenetic patterns) across human cancers, whereas Document B focuses specifically on transcriptional networks in T-ALL. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:00.327726Z"}
{"comparison_id":"656a73b5-4fe9-41e1-8892-580e64f54524","query_id":"51","doc_a_id":"29124963","doc_b_id":"24624992","presented_order":["29124963","24624992"],"winner_id":"24624992","reasoning":"Document B is slightly more relevant because it deals with gene expression changes in cancer cells, whereas Document A concerns a specific translocation in lung adenocarcinoma unrelated to ALDH1 or breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324313Z"}
{"comparison_id":"f53b3312-0724-40d2-a237-f495ba14ac00","query_id":"51","doc_a_id":"22963769","doc_b_id":"24624992","presented_order":["22963769","24624992"],"winner_id":"22963769","reasoning":"Document A is marginally more relevant because it links protein expression to cancer aggressiveness/outcomes, whereas B concerns leukemia cell lines and retinoic acid response, unrelated to breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324334Z"}
{"comparison_id":"b9924259-86f0-4165-ad06-10af99d36c69","query_id":"51","doc_a_id":"10169908","doc_b_id":"24624992","presented_order":["10169908","24624992"],"winner_id":"24624992","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes, so both are irrelevant. Document B is slightly more general about cancer gene expression, but neither provides evidence for the claim.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324343Z"}
{"comparison_id":"1f05e012-c2d0-4edb-ac5c-0e109106ec8c","query_id":"51","doc_a_id":"7736860","doc_b_id":"24624992","presented_order":["24624992","7736860"],"winner_id":"7736860","reasoning":"Document B — it discusses cancer progression and survival outcomes (though in cervical cancer), while A is about IEX-1 in leukemia cells and unrelated to ALDH1 or breast cancer.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324353Z"}
{"comparison_id":"8c2f48e4-b618-4db5-92a2-08a7ce221411","query_id":"51","doc_a_id":"36950726","doc_b_id":"24624992","presented_order":["24624992","36950726"],"winner_id":"36950726","reasoning":"Document B is slightly more relevant because it examines protein expression levels and clinical progression in a solid tumor, which is closer in topic to studies linking marker expression with cancer outcomes than a leukemia cell-line differentiation study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324360Z"}
{"comparison_id":"dfd22285-1ed1-4ded-aa66-8104979fce9a","query_id":"51","doc_a_id":"3684342","doc_b_id":"24624992","presented_order":["3684342","24624992"],"winner_id":"3684342","reasoning":"Document A — it addresses tumorigenesis and clinical outcomes in solid tumors (lung cancer) and references TCGA, making it marginally more relevant to a breast cancer/outcome claim than a leukemia cell–line study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324367Z"}
{"comparison_id":"c7172a7d-3494-4925-846d-98933cbfdaa0","query_id":"51","doc_a_id":"10024681","doc_b_id":"24624992","presented_order":["10024681","24624992"],"winner_id":"10024681","reasoning":"Document A — it discusses cancer prognosis and biomarkers (though in prostate cancer), which is marginally closer to a claim about cancer outcomes than the leukemia cell-line study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324373Z"}
{"comparison_id":"4ce4d61d-ede9-4b93-a719-24675dc26348","query_id":"51","doc_a_id":"24980622","doc_b_id":"24624992","presented_order":["24980622","24624992"],"winner_id":"24980622","reasoning":"Both documents are irrelevant to ALDH1 in breast cancer, but Document A is slightly more related because it studies tumor marker expression in cancer tissue (whereas B is a leukemia cell-line study). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324380Z"}
{"comparison_id":"64ec8430-8a4d-4f32-9001-358ab87356b0","query_id":"51","doc_a_id":"9239963","doc_b_id":"24624992","presented_order":["24624992","9239963"],"winner_id":"24624992","reasoning":"Document A is marginally more relevant because it discusses gene expression and cancer cell phenotypes, whereas Document B focuses on endometrial steroidogenesis unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324386Z"}
{"comparison_id":"e827b7f9-c991-4058-81b0-53cc134b1442","query_id":"51","doc_a_id":"24396137","doc_b_id":"24624992","presented_order":["24624992","24396137"],"winner_id":"24396137","reasoning":"Document B — it concerns outcomes in female cancer survivors (more related to breast cancer patient outcomes) whereas A is about a leukemia cell-line gene not ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324393Z"}
{"comparison_id":"7cc7ac1d-5ebc-45d3-a94b-e09b157df99b","query_id":"51","doc_a_id":"12869200","doc_b_id":"24624992","presented_order":["12869200","24624992"],"winner_id":"12869200","reasoning":"Document A is marginally more relevant because it deals with biomarker–cancer outcome associations (though for endometrial cancer, not ALDH1 or breast cancer). Neither document mentions ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324400Z"}
{"comparison_id":"2a763ddf-3c83-465f-b7f2-93395ea10d64","query_id":"51","doc_a_id":"9211173","doc_b_id":"24624992","presented_order":["24624992","9211173"],"winner_id":"24624992","reasoning":"Document A is marginally more relevant because it discusses gene expression in cancer cells (though in leukemia), whereas Document B concerns ARID1A mutations in ovarian cancer and is unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324407Z"}
{"comparison_id":"2c87d658-78e1-4e8d-a1ab-295332693484","query_id":"51","doc_a_id":"23577867","doc_b_id":"24624992","presented_order":["24624992","23577867"],"winner_id":"23577867","reasoning":"Document B is more relevant — it deals with cancer biomarkers and cancer risk, whereas A focuses on a leukemia-specific gene (IEX-1) unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324414Z"}
{"comparison_id":"69418a5a-6256-42fc-a63c-56b97eb53e68","query_id":"51","doc_a_id":"11880289","doc_b_id":"24624992","presented_order":["24624992","11880289"],"winner_id":"11880289","reasoning":"Document B — it concerns breast cancer mortality/outcomes, while Document A studies a leukemia gene unrelated to ALDH1 or breast cancer.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324421Z"}
{"comparison_id":"a9a872e7-622e-485d-a753-da8d4e361f17","query_id":"51","doc_a_id":"5377642","doc_b_id":"24624992","presented_order":["5377642","24624992"],"winner_id":"5377642","reasoning":"Document A is more relevant — it addresses tumor biology and immune regulation in solid tumors, whereas Document B concerns leukemia cell lines and is less related to breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324427Z"}
{"comparison_id":"c58f2c6b-3bea-4bc4-b3e5-0d69a034207f","query_id":"51","doc_a_id":"4688340","doc_b_id":"24624992","presented_order":["4688340","24624992"],"winner_id":"4688340","reasoning":"Document A is slightly more relevant because it deals with tumor sphere-forming cells (a context where ALDH1 is often studied as a stem cell marker), whereas Document B concerns retinoic acid responses in leukemia cell lines unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324435Z"}
{"comparison_id":"3801cd91-69cc-4451-8778-8127b90e5a48","query_id":"51","doc_a_id":"3210545","doc_b_id":"24624992","presented_order":["24624992","3210545"],"winner_id":"3210545","reasoning":"Document B is more relevant — it examines associations between gene expression and cancer outcomes, whereas A discusses IEX-1 regulation in leukemia cell lines, unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324442Z"}
{"comparison_id":"2a3d1318-d866-4174-8c0f-50049797f769","query_id":"51","doc_a_id":"26848994","doc_b_id":"24624992","presented_order":["24624992","26848994"],"winner_id":"26848994","reasoning":"Document B is more relevant — it discusses a biomarker (lncRNA HANR) linked to patient survival and chemoresistance, which is closer to the claim about a molecular marker (ALDH1) and cancer outcomes than Document A's leukemia cell–line mechanistic study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324449Z"}
{"comparison_id":"6d78fed2-196c-4393-80ce-31ea0e46fb98","query_id":"51","doc_a_id":"6517763","doc_b_id":"24624992","presented_order":["24624992","6517763"],"winner_id":"6517763","reasoning":"Document B — it studies gene expression patterns tied to patient survival/outcomes, which is conceptually closer to a claim about marker expression and clinical outcomes; Document A focuses on IEX-1 in leukemia cell lines. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324455Z"}
{"comparison_id":"970e3006-07fe-4cc6-9d92-68f2e2a182fa","query_id":"51","doc_a_id":"9648896","doc_b_id":"24624992","presented_order":["9648896","24624992"],"winner_id":"9648896","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it addresses tumor biology and chemoresistance (in lung cancer), whereas B focuses on retinoic acid responses in leukemia cell lines.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324463Z"}
{"comparison_id":"bdc8219b-1958-45a2-8ed8-75f277a6c265","query_id":"51","doc_a_id":"1780819","doc_b_id":"24624992","presented_order":["1780819","24624992"],"winner_id":"1780819","reasoning":"Document A is slightly more relevant because it discusses cancer gene expression and clinical outcomes (though in endometrial, not breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324469Z"}
{"comparison_id":"80e319b2-fd39-4edf-a3ba-4bd2a9157602","query_id":"51","doc_a_id":"6807122","doc_b_id":"24624992","presented_order":["6807122","24624992"],"winner_id":"6807122","reasoning":"Both documents are unrelated to ALDH1 in breast cancer, but Document A discusses carcinoma-associated processes and tumor progression (more broadly relevant to cancer outcomes) while Document B focuses on leukemia cell lines. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324476Z"}
{"comparison_id":"ac0bc3bb-5a3f-4c83-8c67-cb611727fe5c","query_id":"51","doc_a_id":"23269537","doc_b_id":"24624992","presented_order":["24624992","23269537"],"winner_id":"24624992","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document A is slightly more relevant only because it discusses gene expression linked to cancer cell phenotype and outcome-related processes (differentiation/apoptosis), whereas B focuses on cyclin D1 epigenetic regulation in B-cell malignancy.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324483Z"}
{"comparison_id":"2d19bee1-31b6-40cb-9485-75a4ababf68c","query_id":"51","doc_a_id":"6363093","doc_b_id":"24624992","presented_order":["6363093","24624992"],"winner_id":"24624992","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes, so both are irrelevant. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324489Z"}
{"comparison_id":"d81803f5-2411-4877-b964-eaee88db8a45","query_id":"51","doc_a_id":"2328272","doc_b_id":"24624992","presented_order":["24624992","2328272"],"winner_id":"24624992","reasoning":"Document A is slightly more relevant because it addresses gene expression in cancer cells; Document B is about survivorship recruitment in colorectal cancer and unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324496Z"}
{"comparison_id":"746a9142-e232-426b-886c-b4f0b7afc6df","query_id":"51","doc_a_id":"9095394","doc_b_id":"24624992","presented_order":["24624992","9095394"],"winner_id":"9095394","reasoning":"Document B. It studies marker expression in epithelial carcinomas (oral squamous neoplasms), which is closer to breast cancer marker-expression research than Document A's leukemia cell-line study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324502Z"}
{"comparison_id":"6e4c0294-2e21-4905-9503-bfc2968b3a30","query_id":"51","doc_a_id":"8764879","doc_b_id":"24624992","presented_order":["24624992","8764879"],"winner_id":"8764879","reasoning":"Document B is more relevant — it addresses stem-cell–related marker regulation and disease outcome implications, whereas A focuses on IEX-1 induction in leukemia cell lines; neither mentions ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324509Z"}
{"comparison_id":"1766a224-f9a1-4751-8ecf-f50a0424bc3e","query_id":"51","doc_a_id":"2494748","doc_b_id":"24624992","presented_order":["2494748","24624992"],"winner_id":"2494748","reasoning":"Doc A is about carcinoma-related molecular changes (though gastric, not breast) and is more broadly cancer-relevant; Doc B concerns leukemia cell lines unrelated to breast cancer.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324516Z"}
{"comparison_id":"b19fce19-4e15-464d-b868-c64c5f96b26b","query_id":"51","doc_a_id":"5406411","doc_b_id":"24624992","presented_order":["24624992","5406411"],"winner_id":"5406411","reasoning":"Document B is more relevant — it addresses cancer-related mechanisms (immune regulation/EGFR) while Document A focuses on IEX-1 in leukemia cell lines, not ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324523Z"}
{"comparison_id":"b158ed4e-4279-48d7-8031-a699e8c95ac0","query_id":"51","doc_a_id":"40901687","doc_b_id":"24624992","presented_order":["40901687","24624992"],"winner_id":"40901687","reasoning":"Document A is slightly more relevant because it addresses cancer-related DNA damage response and apoptosis pathways, which more closely relate to cancer outcomes than a leukemia cell–line study focused on IEX-1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324530Z"}
{"comparison_id":"8c318b06-4b46-4273-9c00-26281bda1bb1","query_id":"51","doc_a_id":"16346504","doc_b_id":"24624992","presented_order":["16346504","24624992"],"winner_id":"16346504","reasoning":"Document A is more relevant because it discusses cancer-related expression and tumor-suppressor mechanisms (though in endometrial, not breast) while Document B focuses on leukemia cell lines. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324537Z"}
{"comparison_id":"33dcb1d9-eede-46bf-ba32-28e883f02eee","query_id":"51","doc_a_id":"29190724","doc_b_id":"24624992","presented_order":["24624992","29190724"],"winner_id":"24624992","reasoning":"Document A is slightly more relevant because it discusses gene expression in cancer (though a different gene and leukemia), whereas Document B focuses on methylation in gastric cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324544Z"}
{"comparison_id":"6d9cecb0-35be-41b9-bc43-aed005e09f61","query_id":"51","doc_a_id":"33677323","doc_b_id":"24624992","presented_order":["33677323","24624992"],"winner_id":"33677323","reasoning":"Doc A, because it discusses cancer stem cell–related biology and links gene expression to clinical outcomes, which is more tangentially related to ALDH1 and prognosis than the cell-line retinoic acid study in Doc B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324551Z"}
{"comparison_id":"9cacd047-7180-4368-8597-916dd0d2bc37","query_id":"51","doc_a_id":"1456068","doc_b_id":"24624992","presented_order":["1456068","24624992"],"winner_id":"1456068","reasoning":"Document A is more relevant — it addresses cancer mortality/outcomes in women, whereas Document B concerns gene expression in leukemia cell lines unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324558Z"}
{"comparison_id":"6bdd9951-51e7-48ce-84c0-ed5bd731ef25","query_id":"51","doc_a_id":"25513319","doc_b_id":"24624992","presented_order":["25513319","24624992"],"winner_id":"25513319","reasoning":"Neither paper addresses ALDH1 or breast cancer, but Document A discusses cancer survival and metastasis (albeit in prostate), making it marginally more relevant than Document B's leukemia-focused cell-line study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324565Z"}
{"comparison_id":"c78cb0af-8e98-46eb-b11e-7d94b3ee4aa6","query_id":"51","doc_a_id":"34189936","doc_b_id":"24624992","presented_order":["24624992","34189936"],"winner_id":"24624992","reasoning":"Neither document mentions ALDH1 or breast cancer, so both are irrelevant. Document A is marginally more relevant only because it discusses gene expression and cancer cell phenotypes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324572Z"}
{"comparison_id":"8ea8b71c-b74c-40f5-8daa-b0cd7b3e697b","query_id":"51","doc_a_id":"3765739","doc_b_id":"24624992","presented_order":["24624992","3765739"],"winner_id":"24624992","reasoning":"Document A is slightly more relevant because it addresses differential gene expression in cancer cells, whereas Document B focuses on viral oncogenesis in B-lymphoma unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324579Z"}
{"comparison_id":"fad05442-deb2-4629-bdda-c2aa014398b2","query_id":"51","doc_a_id":"21692235","doc_b_id":"24624992","presented_order":["24624992","21692235"],"winner_id":"24624992","reasoning":"Document A is slightly more relevant because it discusses gene expression in cancer cells (though not ALDH1 or breast cancer), whereas Document B focuses on glioblastoma subtypes unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324586Z"}
{"comparison_id":"709d12d3-483e-4612-a038-8508ebff079a","query_id":"51","doc_a_id":"22180793","doc_b_id":"24624992","presented_order":["24624992","22180793"],"winner_id":"24624992","reasoning":"Document A is slightly more relevant because it discusses gene expression in cancer (though in leukemia), whereas Document B focuses on an antibody therapy in prostate cancer and does not pertain to gene expression or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324592Z"}
{"comparison_id":"ab4deeea-ca8c-4039-86e7-7c0a49f7495d","query_id":"51","doc_a_id":"3899896","doc_b_id":"24624992","presented_order":["3899896","24624992"],"winner_id":"24624992","reasoning":"Document B — it discusses gene expression in cancer cells (though not ALDH1 or breast cancer), so it's slightly closer in topic than A, which is about RDW in rectal cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324599Z"}
{"comparison_id":"b39c885c-f3d1-43f5-9963-5d925e1eecdb","query_id":"51","doc_a_id":"18810195","doc_b_id":"24624992","presented_order":["24624992","18810195"],"winner_id":"18810195","reasoning":"Document B is more relevant — it discusses a cancer-related metabolic mechanism (PGAM1) and tumor proliferation, whereas A is limited to retinoic acid responses in leukemia cell lines and unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324607Z"}
{"comparison_id":"a413e656-7ee7-41f5-a148-7a55bb0c5ba1","query_id":"51","doc_a_id":"7028976","doc_b_id":"24624992","presented_order":["24624992","7028976"],"winner_id":"7028976","reasoning":"Reason: Both are unrelated to ALDH1 or breast cancer, but Document B discusses tumor-initiating cell markers, which is conceptually closer to ALDH1 as a cancer stem cell marker.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324613Z"}
{"comparison_id":"b43d2569-88cd-44be-94a3-7129372d0a9f","query_id":"51","doc_a_id":"16361581","doc_b_id":"24624992","presented_order":["24624992","16361581"],"winner_id":"24624992","reasoning":"Document A is more relevant — it addresses gene expression patterns in cancer cells (though in leukemia, not breast cancer), whereas B focuses on Notch signaling in multiple myeloma and is less related to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324620Z"}
{"comparison_id":"7ca745d2-7f12-40f2-861c-e830517bc675","query_id":"51","doc_a_id":"23599024","doc_b_id":"24624992","presented_order":["24624992","23599024"],"winner_id":"23599024","reasoning":"Neither document addresses ALDH1 or breast cancer; Document B is marginally more relevant because it deals with cancer progression and prognostic marker biology, whereas A is focused on leukemia cell-line responses. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324628Z"}
{"comparison_id":"cb709512-525c-4ddd-bf7f-e07f84bb5633","query_id":"51","doc_a_id":"10669939","doc_b_id":"24624992","presented_order":["24624992","10669939"],"winner_id":"24624992","reasoning":"Reason: Document A discusses gene expression in cancer cells and its effects on phenotype, which is closer to the claim about a cancer biomarker and outcomes than Document B's imaging-methods focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324634Z"}
{"comparison_id":"bd9aa52a-b832-4a37-8c9b-22b56b7ad065","query_id":"51","doc_a_id":"195689757","doc_b_id":"24624992","presented_order":["24624992","195689757"],"winner_id":"195689757","reasoning":"Document B — it discusses altered metabolism and metabolic enzymes in cancer (ALDH1 is a metabolic enzyme), while A focuses on IEX-1 in leukemia and not on ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324641Z"}
{"comparison_id":"1c412be3-eca4-459e-aeae-db39ac524e89","query_id":"51","doc_a_id":"21063817","doc_b_id":"24624992","presented_order":["21063817","24624992"],"winner_id":"21063817","reasoning":"Document A is about epithelial cancer and marker expression (more related to cancer prognostic markers), while Document B concerns leukemia cell lines and retinoic acid response. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324652Z"}
{"comparison_id":"4439b4e8-681d-4db6-a870-0da349a9f25d","query_id":"51","doc_a_id":"13235609","doc_b_id":"24624992","presented_order":["13235609","24624992"],"winner_id":"13235609","reasoning":"Document A is slightly more related to cancer progression mechanisms (invasion/mesenchymal transition), whereas Document B focuses on leukemia cell lines and IEX-1—neither mentions ALDH1 or breast cancer, but A is marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324659Z"}
{"comparison_id":"cd45dc91-a829-4d60-8a1e-977399daeabc","query_id":"51","doc_a_id":"2547636","doc_b_id":"24624992","presented_order":["2547636","24624992"],"winner_id":"2547636","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it discusses stem cell regulation and carcinogenesis, which is more related to cancer outcomes than the leukemia-specific molecular study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324666Z"}
{"comparison_id":"2c1a6504-4056-4ded-9bc8-a13eb576b7ca","query_id":"51","doc_a_id":"27822315","doc_b_id":"24624992","presented_order":["27822315","24624992"],"winner_id":"27822315","reasoning":"Document A is slightly more relevant because it involves mesenchymal stem cell differentiation (ALDH1 is a stem/progenitor marker), whereas Document B focuses on leukemia cell lines and IEX-1 with no connection to ALDH1 or breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324673Z"}
{"comparison_id":"ec909661-e778-41b4-a1c7-cd028ff771bd","query_id":"51","doc_a_id":"3701541","doc_b_id":"24624992","presented_order":["3701541","24624992"],"winner_id":"3701541","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it addresses cancer biology (liver cancer) versus Document B's focus on leukemia cell lines.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324679Z"}
{"comparison_id":"3cbf5493-bff5-4218-9fe8-a1f154bbdfae","query_id":"51","doc_a_id":"4993011","doc_b_id":"24624992","presented_order":["4993011","24624992"],"winner_id":"24624992","reasoning":"Document B is slightly more relevant because it addresses how gene expression relates to cancer cell phenotypes, whereas Document A focuses on ATRX-related ribosomal DNA instability and therapy sensitivity unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324687Z"}
{"comparison_id":"a3c7e137-02cc-4a65-9490-626b76723f19","query_id":"51","doc_a_id":"14149065","doc_b_id":"24624992","presented_order":["14149065","24624992"],"winner_id":"14149065","reasoning":"Document A is marginally more relevant because it discusses epithelial cell behavior (more related to breast epithelium) whereas Document B concerns leukemia cell lines unrelated to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324693Z"}
{"comparison_id":"d338f32c-f2ab-493b-932d-b5f69bc130c2","query_id":"51","doc_a_id":"28249680","doc_b_id":"24624992","presented_order":["24624992","28249680"],"winner_id":"28249680","reasoning":"Document B is more relevant — it discusses mechanisms in epithelial cancer cells (closer to breast cancer context) while A is about leukemia cell lines and unrelated to ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324701Z"}
{"comparison_id":"3ff69c22-7f84-4605-9fe5-f1b6a3bdcc59","query_id":"51","doc_a_id":"2919030","doc_b_id":"24624992","presented_order":["24624992","2919030"],"winner_id":"2919030","reasoning":"Neither abstract mentions ALDH1 or breast cancer. Document B is slightly more related to cancer biology (mentions cancer metabolism in mammalian cells), so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324707Z"}
{"comparison_id":"c6189867-fef8-427d-88a0-15d6fff62fd7","query_id":"51","doc_a_id":"13048272","doc_b_id":"24624992","presented_order":["13048272","24624992"],"winner_id":"13048272","reasoning":"Document A is slightly more relevant because it concerns gene expression in stem/progenitor cells (ALDH1 is a stem-cell–associated marker), whereas Document B focuses on an unrelated immediate early gene in leukemia cell lines. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324715Z"}
{"comparison_id":"7d1a9e8a-2bef-49f4-88b2-3e5109cb990b","query_id":"51","doc_a_id":"4378885","doc_b_id":"24624992","presented_order":["4378885","24624992"],"winner_id":"4378885","reasoning":"Document A is slightly more relevant because it discusses gene expression analysis methods and variation (which could encompass ALDH1), whereas Document B focuses narrowly on IEX-1 in leukemia cell lines, not ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324722Z"}
{"comparison_id":"3f45b0ca-95a2-4230-bbde-a48a7b5fafe4","query_id":"51","doc_a_id":"42484543","doc_b_id":"24624992","presented_order":["42484543","24624992"],"winner_id":"42484543","reasoning":"Document A is slightly more relevant because it deals with stem-cell transcriptome and gene expression, which is tangentially related to ALDH1 as a stem-cell marker; Document B focuses on IEX-1 in leukemia cells and retinoic acid response, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:09:35.324728Z"}
{"comparison_id":"a72540a8-4263-4688-a9b2-ff99ba7dd4c8","query_id":"51","doc_a_id":"22963769","doc_b_id":"2494748","presented_order":["2494748","22963769"],"winner_id":"22963769","reasoning":"Document B — it links protein expression/localization to cancer aggressiveness (an expression–outcome relationship), which is conceptually closer to the ALDH1 expression–outcome claim. Neither document directly addresses ALDH1 or breast cancer.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382411Z"}
{"comparison_id":"d9e64a16-c15d-477b-9c8f-fec13ed438ce","query_id":"51","doc_a_id":"7736860","doc_b_id":"2494748","presented_order":["2494748","7736860"],"winner_id":"7736860","reasoning":"Document B is more relevant — it discusses cancer progression and survival outcomes (though in cervical cancer), while A is about CpG methylation in gastric carcinoma and unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382430Z"}
{"comparison_id":"7533f9d1-959e-4276-a441-24894dcbdb58","query_id":"51","doc_a_id":"36950726","doc_b_id":"2494748","presented_order":["2494748","36950726"],"winner_id":"2494748","reasoning":"Document A is slightly more relevant — it concerns CpG methylation in a carcinoma (epithelial cancer) context, which is closer to breast carcinoma than melanoma. Neither document mentions ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382439Z"}
{"comparison_id":"6c052d5e-4bc2-4df5-b472-9ac2f7d65f80","query_id":"51","doc_a_id":"3684342","doc_b_id":"2494748","presented_order":["3684342","2494748"],"winner_id":"3684342","reasoning":"Document A is slightly more relevant because it discusses gene expression effects on tumorigenesis and survival outcomes (though in lung cancer), whereas Document B focuses on methylation in gastric premalignancy and not on gene expression or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382448Z"}
{"comparison_id":"6963cfb7-4c65-4e85-a450-0795a8ebe078","query_id":"51","doc_a_id":"10024681","doc_b_id":"2494748","presented_order":["2494748","10024681"],"winner_id":"10024681","reasoning":"Document B is slightly more relevant because it addresses biomarker expression and prognosis (outcomes), while Document A focuses on methylation in gastric cancer stages unrelated to prognosis in breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382455Z"}
{"comparison_id":"507deee1-ee23-45d5-93b7-ad39f4738747","query_id":"51","doc_a_id":"24980622","doc_b_id":"2494748","presented_order":["24980622","2494748"],"winner_id":"24980622","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant only because it deals with tumor biology and metastases, whereas B focuses on gastric methylation. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382461Z"}
{"comparison_id":"9f33b668-db4f-49ab-b523-e52a789f058b","query_id":"51","doc_a_id":"24396137","doc_b_id":"2494748","presented_order":["24396137","2494748"],"winner_id":"24396137","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document A is slightly more relevant because it concerns clinical outcomes in female cancer survivors, whereas Document B focuses on CpG methylation in gastric cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382469Z"}
{"comparison_id":"1ac57972-f384-4477-90d1-ce266eb8c81d","query_id":"51","doc_a_id":"12869200","doc_b_id":"2494748","presented_order":["12869200","2494748"],"winner_id":"2494748","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it deals with molecular markers and cancer biology, whereas A is an epidemiologic study of adipokines in endometrial cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382475Z"}
{"comparison_id":"80115be1-24e9-49cc-a510-964e551aeae8","query_id":"51","doc_a_id":"23577867","doc_b_id":"2494748","presented_order":["23577867","2494748"],"winner_id":"23577867","reasoning":"Reason: Document A discusses cancer-related biomarker expression and outcomes (though for endometrial cancer), which is closer in topic to ALDH1 expression and breast cancer prognosis than Document B's focus on gastric CpG methylation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382482Z"}
{"comparison_id":"c828a51b-0a75-45cb-a524-feac8f57c99c","query_id":"51","doc_a_id":"11880289","doc_b_id":"2494748","presented_order":["11880289","2494748"],"winner_id":"11880289","reasoning":"Document A is about breast cancer mortality/outcomes (though not ALDH1), while B concerns gastric carcinoma methylation and is unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382489Z"}
{"comparison_id":"4c1e3aa4-a155-4088-b35c-bfe0d875ab3e","query_id":"51","doc_a_id":"5377642","doc_b_id":"2494748","presented_order":["2494748","5377642"],"winner_id":"5377642","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer, but Document B addresses tumor-related biology (immune regulation) which is marginally more relevant to cancer outcomes than Document A's focus on gastric CpG methylation.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382496Z"}
{"comparison_id":"1c24f139-0235-47ef-ac13-a2b26cb4e39e","query_id":"51","doc_a_id":"4688340","doc_b_id":"2494748","presented_order":["2494748","4688340"],"winner_id":"4688340","reasoning":"Document B — it discusses sphere-forming cancer cells (a stem-like phenotype relevant to ALDH1 studies), whereas A is about CpG methylation in gastric cancer and unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382504Z"}
{"comparison_id":"1e3f91f0-3145-471e-82af-206d846e840d","query_id":"51","doc_a_id":"3210545","doc_b_id":"2494748","presented_order":["2494748","3210545"],"winner_id":"2494748","reasoning":"Document A — it discusses epigenetic markers and gene expression patterns in carcinomas (closer to biomarker-outcome relationships), while Document B focuses specifically on KRAS in endometrial cancer, which is less related to ALDH1 or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382511Z"}
{"comparison_id":"fa246449-ace1-47e7-804e-b322f85b4e92","query_id":"51","doc_a_id":"26848994","doc_b_id":"2494748","presented_order":["26848994","2494748"],"winner_id":"26848994","reasoning":"Document A is more relevant — it links gene expression changes to patient survival and chemoresistance (though in HCC, not breast cancer), which is more conceptually related to ALDH1 expression and outcomes than a study on CpG methylation in gastric cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382519Z"}
{"comparison_id":"29fecf7b-c663-48b7-81bd-ab20a25719c5","query_id":"51","doc_a_id":"6517763","doc_b_id":"2494748","presented_order":["2494748","6517763"],"winner_id":"6517763","reasoning":"Neither discusses ALDH1 or breast cancer; Document B is slightly more relevant because it links gene expression to patient outcomes (survival), whereas A focuses on methylation in gastric cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382526Z"}
{"comparison_id":"36084dc5-8e24-4c78-91bd-89ee7b1b4764","query_id":"51","doc_a_id":"9648896","doc_b_id":"2494748","presented_order":["9648896","2494748"],"winner_id":"2494748","reasoning":"Neither paper addresses ALDH1 or breast cancer. Document B is slightly more relevant because it discusses molecular biomarkers and cancer progression, whereas A focuses on CAFs in lung cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382533Z"}
{"comparison_id":"09c16863-bcf7-4966-8f7f-fed6e2a9711b","query_id":"51","doc_a_id":"1780819","doc_b_id":"2494748","presented_order":["2494748","1780819"],"winner_id":"1780819","reasoning":"Document B is more relevant — it links gene methylation/silencing to clinical outcomes and treatment response in cancer, whereas A focuses on methylation patterns in gastric carcinogenesis without outcome data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382541Z"}
{"comparison_id":"dde85b20-f9c9-4dae-9561-7c91b9c269cb","query_id":"51","doc_a_id":"6807122","doc_b_id":"2494748","presented_order":["2494748","6807122"],"winner_id":"6807122","reasoning":"B is more relevant — it relates to cancer progression and tumor microenvironment, while A is specific to gastric CpG methylation unrelated to ALDH1 or breast cancer.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382548Z"}
{"comparison_id":"53dae65c-9c95-45f4-a99b-6301b0fcaa55","query_id":"51","doc_a_id":"9095394","doc_b_id":"2494748","presented_order":["9095394","2494748"],"winner_id":"9095394","reasoning":"Document A — it discusses expression of tumor markers (keratins) in cancer, which is more related to marker–outcome associations than Document B's focus on gastric methylation. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382558Z"}
{"comparison_id":"216b5737-3faf-46f4-8b33-a96d75223241","query_id":"51","doc_a_id":"8764879","doc_b_id":"2494748","presented_order":["2494748","8764879"],"winner_id":"8764879","reasoning":"Document B is more relevant — it addresses cancer stem cell biology and therapeutic impact (closer to ALDH1's role as a stem-cell marker), whereas A discusses CpG methylation in gastric cancer and not ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382588Z"}
{"comparison_id":"caa389f4-e861-48df-8c2a-8d7dad2b6d42","query_id":"51","doc_a_id":"42484543","doc_b_id":"2494748","presented_order":["2494748","42484543"],"winner_id":"2494748","reasoning":"Reason: Both documents do not discuss ALDH1 or breast cancer; Document A at least addresses cancer-related molecular markers, while B focuses on embryonic stem cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382608Z"}
{"comparison_id":"062d62ed-457c-4ac9-b5ef-bab405490a1f","query_id":"51","doc_a_id":"5406411","doc_b_id":"2494748","presented_order":["2494748","5406411"],"winner_id":"2494748","reasoning":"Document A is slightly more relevant — it discusses cancer biomarker alterations and progression, whereas B focuses on immune regulation unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382624Z"}
{"comparison_id":"86153b73-90b9-4272-98d4-8191f0352ca0","query_id":"51","doc_a_id":"40901687","doc_b_id":"2494748","presented_order":["40901687","2494748"],"winner_id":"40901687","reasoning":"Neither document discusses ALDH1 or breast cancer; Document A is marginally more relevant because it deals with cancer-related DNA damage response pathways, whereas B focuses on gastric carcinoma methylation. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382636Z"}
{"comparison_id":"cea88713-d32a-41a5-9017-7d6ace9954b9","query_id":"51","doc_a_id":"16346504","doc_b_id":"2494748","presented_order":["16346504","2494748"],"winner_id":"16346504","reasoning":"Document A is more relevant — it discusses gene expression regulation in cancer (though in endometrial, not breast, and does not mention ALDH1). It at least concerns cancer-related expression, whereas B focuses on methylation in gastric carcinoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382648Z"}
{"comparison_id":"38bd5926-072f-4c38-9caf-60cba28e5f4f","query_id":"51","doc_a_id":"33677323","doc_b_id":"2494748","presented_order":["2494748","33677323"],"winner_id":"33677323","reasoning":"Neither document is relevant to the claim (neither mentions ALDH1 or breast cancer). If forced to choose the closer match, ANSWER: B — it addresses stem cell biology and clinical outcomes in cancer, which is conceptually closer than gastric CpG methylation.","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382660Z"}
{"comparison_id":"e02750ca-7898-41b0-b953-c7c6c1bbbff8","query_id":"51","doc_a_id":"1456068","doc_b_id":"2494748","presented_order":["1456068","2494748"],"winner_id":"2494748","reasoning":"Document B is more relevant — it deals with molecular biomarkers and cancer-related epigenetic changes, which is closer to a claim about a biomarker's (ALDH1) association with cancer outcomes than a lifestyle-mortality cohort study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382669Z"}
{"comparison_id":"e3e9047f-6121-4afe-a33a-8df114e377f6","query_id":"51","doc_a_id":"25513319","doc_b_id":"2494748","presented_order":["25513319","2494748"],"winner_id":"25513319","reasoning":"Document A is more relevant — it concerns tumor survival and metastasis biology (cancer expression effects), which is closer to a claim about ALDH1 expression and breast cancer outcomes than a study on gastric CpG methylation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382677Z"}
{"comparison_id":"cfaf1625-e261-49f3-9573-4bd575a4c23a","query_id":"51","doc_a_id":"18810195","doc_b_id":"2494748","presented_order":["18810195","2494748"],"winner_id":"18810195","reasoning":"Neither document discusses ALDH1 or breast cancer directly. Document A relates to cancer metabolism and tumor proliferation (general cancer relevance), while B is specific to gastric carcinoma methylation, so A is slightly more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382685Z"}
{"comparison_id":"1ec1baf8-2d8c-49ae-a0ac-ad4c9e53a9ff","query_id":"51","doc_a_id":"7028976","doc_b_id":"2494748","presented_order":["2494748","7028976"],"winner_id":"7028976","reasoning":"Document B is more relevant — it deals with expression of a tumor cell marker and its link to tumor-initiating cells and outcomes in cancer, which is closer to the query about marker expression and breast cancer prognosis than a study on CpG methylation in gastric carcinoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382692Z"}
{"comparison_id":"006c93af-d4e2-4405-804c-d183c5e7db75","query_id":"51","doc_a_id":"23599024","doc_b_id":"2494748","presented_order":["2494748","23599024"],"winner_id":"23599024","reasoning":"Document B is more relevant — it links a protein's expression level to cancer progression/outcomes (though in lung cancer), whereas A discusses CpG methylation in gastric carcinoma unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382699Z"}
{"comparison_id":"223682e0-777b-41d6-b212-f3f667519b35","query_id":"51","doc_a_id":"195689757","doc_b_id":"2494748","presented_order":["2494748","195689757"],"winner_id":"2494748","reasoning":"Neither document mentions ALDH1 or breast cancer; Document A is marginally more relevant because it addresses carcinoma-related molecular markers (vs. GBM metabolism). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382706Z"}
{"comparison_id":"08bfa1d1-46b2-4c49-8136-695dd8a478e9","query_id":"51","doc_a_id":"21063817","doc_b_id":"2494748","presented_order":["21063817","2494748"],"winner_id":"21063817","reasoning":"Document A is slightly more relevant because it studies protein expression patterns in epithelial cancers (marker expression), whereas Document B focuses on methylation in gastric carcinoma, which is less related to ALDH1 expression or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382713Z"}
{"comparison_id":"388e5b17-1e1d-495e-bdf5-367674794023","query_id":"51","doc_a_id":"13235609","doc_b_id":"2494748","presented_order":["13235609","2494748"],"winner_id":"13235609","reasoning":"Document A is slightly more relevant because it discusses tumor invasion, mesenchymal transition, and survival effects (cancer outcomes), whereas B focuses on methylation in gastric carcinoma unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382720Z"}
{"comparison_id":"141612cc-690b-4549-8d68-f93a1c5a4472","query_id":"51","doc_a_id":"2547636","doc_b_id":"2494748","presented_order":["2547636","2494748"],"winner_id":"2547636","reasoning":"Document A is more relevant — it discusses stem cell function and carcinogenesis, which is closer to ALDH1 (a stem cell marker) and cancer outcomes than gastric CpG methylation. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382727Z"}
{"comparison_id":"fcf86c43-80ae-4b7b-9c03-f8b6d2c2b7f2","query_id":"51","doc_a_id":"27822315","doc_b_id":"2494748","presented_order":["27822315","2494748"],"winner_id":"2494748","reasoning":"Document B is slightly more relevant because it addresses cancer-related molecular markers and outcomes (though in gastric cancer), whereas A concerns steroidogenic differentiation unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382734Z"}
{"comparison_id":"d890a402-0f90-49e8-b802-98a59a210519","query_id":"51","doc_a_id":"3701541","doc_b_id":"2494748","presented_order":["2494748","3701541"],"winner_id":"2494748","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes; both are irrelevant. Document A is slightly more relevant only insofar as it concerns cancer biology (gastric) versus Document B (liver).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382740Z"}
{"comparison_id":"36eabd51-65f0-4575-9c20-7f20ad1c762d","query_id":"51","doc_a_id":"14149065","doc_b_id":"2494748","presented_order":["2494748","14149065"],"winner_id":"14149065","reasoning":"Document B is more relevant — it addresses epithelial cell behavior and proliferation mechanisms that are more directly related to breast cancer biology than gastric CpG methylation.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382747Z"}
{"comparison_id":"59d34f75-46a2-4ee6-a978-201f31d182f5","query_id":"51","doc_a_id":"28249680","doc_b_id":"2494748","presented_order":["2494748","28249680"],"winner_id":"2494748","reasoning":"Neither document addresses ALDH1 or breast cancer directly. Document A is slightly more relevant because it discusses cancer-associated molecular markers (methylation patterns), whereas Document B focuses on apoptosis mechanisms unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382754Z"}
{"comparison_id":"7dc2f0a2-4d9b-441b-a6c6-fb391a25ce37","query_id":"51","doc_a_id":"2919030","doc_b_id":"2494748","presented_order":["2919030","2494748"],"winner_id":"2919030","reasoning":"Document A is slightly more relevant because it discusses cancer-related cellular mechanisms in mammalian cells, whereas Document B focuses on CpG methylation in gastric (not breast) cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382761Z"}
{"comparison_id":"fec1170c-4465-4412-b4f5-5709e69599ed","query_id":"51","doc_a_id":"13048272","doc_b_id":"2494748","presented_order":["13048272","2494748"],"winner_id":"13048272","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer directly, but Document A discusses stem/progenitor cell regulators (ALDH1 is a stem cell marker), making it slightly more relevant than a study on gastric CpG methylation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382768Z"}
{"comparison_id":"326dd117-0590-4597-8e41-5f7383f6fa3d","query_id":"51","doc_a_id":"4378885","doc_b_id":"2494748","presented_order":["2494748","4378885"],"winner_id":"4378885","reasoning":"Document B is more relevant — it addresses gene expression variation (which could include ALDH1 expression), whereas A focuses on CpG methylation in gastric carcinoma, not breast cancer or ALDH1.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:04.382775Z"}
{"comparison_id":"5a2477c5-bab8-4f7d-ba5e-56f295995ecd","query_id":"51","doc_a_id":"22963769","doc_b_id":"9095394","presented_order":["22963769","9095394"],"winner_id":"22963769","reasoning":"Document A is more relevant — it links aberrant protein expression to aggressive clinicopathological features and outcomes, which is conceptually closer to the claim about marker expression and cancer prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.389802Z"}
{"comparison_id":"bc2b247d-f6ca-43b6-b818-eb38fe6ba68b","query_id":"51","doc_a_id":"7736860","doc_b_id":"9095394","presented_order":["9095394","7736860"],"winner_id":"9095394","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer; Document A at least addresses marker expression and tumor behavior, which is marginally more related than Document B (STIM1 in cervical cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.389823Z"}
{"comparison_id":"7cb3669e-a3dd-4872-bbd2-fb249843db59","query_id":"51","doc_a_id":"3684342","doc_b_id":"9095394","presented_order":["3684342","9095394"],"winner_id":"3684342","reasoning":"Document A is more relevant — it links gene expression to tumor behavior and survival analysis in cancer, whereas B focuses on keratin patterns in oral neoplasms without outcome or breast/ALDH1 context.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.389833Z"}
{"comparison_id":"3dd36eb4-2318-4c2a-9bf3-8c1775b6cb29","query_id":"51","doc_a_id":"10024681","doc_b_id":"9095394","presented_order":["9095394","10024681"],"winner_id":"10024681","reasoning":"Document B. It examines molecular marker expression linked to prognosis in cancer (marker → outcome), which is thematically closer to a claim about ALDH1 and breast cancer outcomes than a study of keratin patterns in oral lesions.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.389841Z"}
{"comparison_id":"bd0ec575-04b8-4f04-9374-627215999558","query_id":"51","doc_a_id":"24980622","doc_b_id":"9095394","presented_order":["9095394","24980622"],"winner_id":"9095394","reasoning":"Document A is slightly more relevant because it discusses expression of protein markers in a carcinoma context, whereas B focuses on hypoxia markers in colorectal liver metastases which is farther from ALDH1 and breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.389849Z"}
{"comparison_id":"1c20f46a-f619-4289-aafb-d1c891ff14f4","query_id":"51","doc_a_id":"24396137","doc_b_id":"9095394","presented_order":["9095394","24396137"],"winner_id":"24396137","reasoning":"Document B is slightly more relevant because it concerns outcomes in female cancer survivors (closer to breast cancer context) while A discusses keratins in oral cancers, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.389858Z"}
{"comparison_id":"209dbbc9-0199-46ed-a7bd-d8d5e551704c","query_id":"51","doc_a_id":"23577867","doc_b_id":"9095394","presented_order":["23577867","9095394"],"winner_id":"9095394","reasoning":"Document B is slightly more relevant because it addresses expression of protein markers in tumors, whereas Document A concerns metabolic markers and endometrial cancer risk unrelated to marker expression in breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.389866Z"}
{"comparison_id":"f39f9b12-7554-4e8e-a2e4-8f4680633871","query_id":"51","doc_a_id":"11880289","doc_b_id":"9095394","presented_order":["11880289","9095394"],"winner_id":"11880289","reasoning":"Document A mentions breast cancer outcomes (mortality), while Document B concerns oral squamous neoplasms; A is therefore more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.389873Z"}
{"comparison_id":"db9a4941-da21-465c-b995-41cb4c33e742","query_id":"51","doc_a_id":"5377642","doc_b_id":"9095394","presented_order":["9095394","5377642"],"winner_id":"9095394","reasoning":"Document A is more relevant — it deals with expression of tumor markers in neoplasms (closer to a biomarker–outcome question), whereas B is about T‑cell epigenetic regulation of PD‑1, not ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.389882Z"}
{"comparison_id":"45208c30-f7e3-4a20-8ed1-36a6a044d07f","query_id":"51","doc_a_id":"4688340","doc_b_id":"9095394","presented_order":["9095394","4688340"],"winner_id":"9095394","reasoning":"Document A is marginally more relevant because it discusses cancer marker expression correlated with tumor behavior/outcomes, whereas B focuses on targeted therapy in head and neck cancer spheres. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.389890Z"}
{"comparison_id":"1f6b8ad3-ce45-4423-85b2-27d3730959e9","query_id":"51","doc_a_id":"26848994","doc_b_id":"9095394","presented_order":["9095394","26848994"],"winner_id":"9095394","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is slightly more relevant because it discusses expression of protein markers in tumors, whereas B focuses on an lncRNA in liver cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.389898Z"}
{"comparison_id":"6e194efe-5bac-42a2-bb76-2648c00235b8","query_id":"51","doc_a_id":"6517763","doc_b_id":"9095394","presented_order":["6517763","9095394"],"winner_id":"6517763","reasoning":"Document A is marginally more relevant because it links molecular gene expression to patient survival, whereas Document B discusses keratin markers in oral neoplasms; neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.389906Z"}
{"comparison_id":"bf31898b-69d6-4751-b037-d944bbab2870","query_id":"51","doc_a_id":"1780819","doc_b_id":"9095394","presented_order":["1780819","9095394"],"winner_id":"1780819","reasoning":"Document A — it concerns molecular markers and cancer biology (though in endometrial cancer), whereas B focuses on keratin expression in oral neoplasms and is less relevant to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.389914Z"}
{"comparison_id":"46d089f1-f3ec-4d11-885d-5a6640ae40b9","query_id":"51","doc_a_id":"6807122","doc_b_id":"9095394","presented_order":["9095394","6807122"],"winner_id":"9095394","reasoning":"Document A is slightly more relevant because it discusses marker expression patterns and their correlation with tumor behavior, which is closer to a claim about a biomarker's association with cancer outcomes. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.389921Z"}
{"comparison_id":"12303e23-49ab-4a7a-81f6-0ebe7d24dad6","query_id":"51","doc_a_id":"4378885","doc_b_id":"9095394","presented_order":["9095394","4378885"],"winner_id":"9095394","reasoning":"Document A is more related because it discusses protein marker expression in cancer tissues, whereas Document B is a general RNA-seq study in lymphoblastoid cell lines unrelated to cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.389928Z"}
{"comparison_id":"187c07ae-fb44-479a-8e33-188603db9385","query_id":"51","doc_a_id":"8764879","doc_b_id":"9095394","presented_order":["9095394","8764879"],"winner_id":"9095394","reasoning":"Document A — it discusses expression of tumor markers in epithelial cancers (though not ALDH1 or breast cancer), so it's more relevant than the leukemia-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.389935Z"}
{"comparison_id":"6d7ab1f0-448d-4fa1-a303-20307f939a16","query_id":"51","doc_a_id":"40901687","doc_b_id":"9095394","presented_order":["9095394","40901687"],"winner_id":"9095394","reasoning":"Document A is more relevant because it concerns expression of cellular markers in tumors and their relation to tumor behavior/outcomes, which is closer to the query about a biomarker (ALDH1) and cancer prognosis than the DNA damage signaling focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.389942Z"}
{"comparison_id":"a3f24aa5-3c11-4d9a-b4e7-3716aa1ade68","query_id":"51","doc_a_id":"16346504","doc_b_id":"9095394","presented_order":["16346504","9095394"],"winner_id":"16346504","reasoning":"Document A is slightly more relevant — it discusses molecular marker expression and cancer outcomes (albeit in endometrial, not breast, cancer), whereas Document B focuses on keratin patterns in oral neoplasms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.389949Z"}
{"comparison_id":"fb40b75d-f759-4a34-94de-ddc2fbb2b740","query_id":"51","doc_a_id":"33677323","doc_b_id":"9095394","presented_order":["9095394","33677323"],"winner_id":"9095394","reasoning":"Document A is more relevant — although neither mentions ALDH1 or breast cancer, A discusses expression of tumor markers in epithelial neoplasms, which is closer to breast cancer biomarker studies than the hematopoietic focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.389956Z"}
{"comparison_id":"f67cd5fc-efca-4ebe-b310-819b6a3a58cc","query_id":"51","doc_a_id":"25513319","doc_b_id":"9095394","presented_order":["25513319","9095394"],"winner_id":"9095394","reasoning":"Document B is more relevant — it studies marker expression and its correlation with tumor behavior (though in oral cancer, not breast). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.389963Z"}
{"comparison_id":"fb0b260c-f43a-42d7-894f-d51f1a5cb1c2","query_id":"51","doc_a_id":"18810195","doc_b_id":"9095394","presented_order":["18810195","9095394"],"winner_id":"18810195","reasoning":"Document A is slightly more relevant because it discusses tumor metabolic markers in human cancers, whereas Document B focuses on keratins in oral squamous neoplasms unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.389971Z"}
{"comparison_id":"fb539b97-0a50-45a1-aef2-ca93e43e6d15","query_id":"51","doc_a_id":"7028976","doc_b_id":"9095394","presented_order":["9095394","7028976"],"winner_id":"9095394","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant only because it concerns epithelial tumor marker expression, whereas B is about EGFR in glioblastoma (unrelated tissue/marker).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.389978Z"}
{"comparison_id":"a46cb167-980e-4308-80d8-e04343eea84b","query_id":"51","doc_a_id":"23599024","doc_b_id":"9095394","presented_order":["23599024","9095394"],"winner_id":"23599024","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it examines protein expression linked to cancer progression/outcomes, whereas B focuses on keratins in oral neoplasms. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.389985Z"}
{"comparison_id":"1ddfc6f1-4c73-4f09-a76c-0c770d1a9666","query_id":"51","doc_a_id":"21063817","doc_b_id":"9095394","presented_order":["9095394","21063817"],"winner_id":"9095394","reasoning":"Document A is slightly more relevant because it links marker expression to tumor differentiation and invasiveness (outcome-related features), whereas Document B focuses on diagnostic down-regulation of keratins. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.389992Z"}
{"comparison_id":"220b3ff1-e37f-4376-b679-ca8a0313104c","query_id":"51","doc_a_id":"13235609","doc_b_id":"9095394","presented_order":["13235609","9095394"],"winner_id":"13235609","reasoning":"Document A is more relevant — it discusses tumor invasion, mesenchymal transition and effects on survival in cancer models, whereas B focuses on keratin expression in oral squamous neoplasms and is unrelated to ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.389999Z"}
{"comparison_id":"5ea0deb2-46a4-464b-82dd-db7bc2f24934","query_id":"51","doc_a_id":"2547636","doc_b_id":"9095394","presented_order":["2547636","9095394"],"winner_id":"2547636","reasoning":"Document A is more relevant — it discusses stem cell function and links to carcinogenesis, which is closer to ALDH1 (a stem-cell marker) and cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.390006Z"}
{"comparison_id":"00a2bb1f-3cf7-48f6-9535-e177a89d9490","query_id":"51","doc_a_id":"14149065","doc_b_id":"9095394","presented_order":["14149065","9095394"],"winner_id":"14149065","reasoning":"Document A is more relevant — it discusses epithelial cell behavior (E-cadherin–mediated proliferation), which is more broadly related to cancer biology and could pertain to breast cancer mechanisms; Document B focuses on oral keratins unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.390014Z"}
{"comparison_id":"3eb40f2e-29bd-4dbd-8b61-bf7be24ce989","query_id":"51","doc_a_id":"2919030","doc_b_id":"9095394","presented_order":["9095394","2919030"],"winner_id":"9095394","reasoning":"Document A is more relevant — it deals with expression of protein markers in cancers (though in oral SCC, not breast or ALDH1), whereas Document B focuses on SOD1 and metabolism. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.390020Z"}
{"comparison_id":"5b2ea64b-5469-439a-a3e8-fde9ef52ea08","query_id":"51","doc_a_id":"13048272","doc_b_id":"9095394","presented_order":["9095394","13048272"],"winner_id":"13048272","reasoning":"Document B is slightly more relevant because it addresses stem/progenitor cell transcriptional regulation (ALDH1 is a stem cell marker), whereas Document A concerns keratin expression in oral neoplasms unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:23.390027Z"}
{"comparison_id":"6da3694c-e06e-46ab-abcb-1ff4309ffd94","query_id":"51","doc_a_id":"22963769","doc_b_id":"1780819","presented_order":["1780819","22963769"],"winner_id":"22963769","reasoning":"Reason: Document B examines how protein expression patterns relate to cancer aggressiveness and clinical outcomes (though in oral SCC), so it is more relevant to a claim about a marker's expression being associated with cancer outcomes than Document A, which focuses on HAND2 methylation in endometrial cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:30.937062Z"}
{"comparison_id":"57e62244-3618-4d94-ba9c-cc52a2c2a2f5","query_id":"51","doc_a_id":"3684342","doc_b_id":"1780819","presented_order":["1780819","3684342"],"winner_id":"3684342","reasoning":"Both documents are irrelevant to ALDH1 or breast cancer, but Document B (LIN28B in lung cancer) is slightly more relevant because it examines gene expression and tumor outcomes using TCGA data. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:30.937084Z"}
{"comparison_id":"13d974d6-f52e-48db-92ea-0743f863e061","query_id":"51","doc_a_id":"10024681","doc_b_id":"1780819","presented_order":["10024681","1780819"],"winner_id":"10024681","reasoning":"Reason: Document A discusses gene expression linked to prognosis (expression–outcome association), which is conceptually closer to the claim about ALDH1 expression and breast cancer outcomes; Document B focuses on HAND2 methylation in endometrial cancer and early detection.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:30.937096Z"}
{"comparison_id":"3409206a-480e-41f7-af99-0c9c7c4edb1f","query_id":"51","doc_a_id":"24396137","doc_b_id":"1780819","presented_order":["1780819","24396137"],"winner_id":"1780819","reasoning":"Document A — it discusses gene expression and cancer outcomes (though in endometrial cancer), which is closer to the query about a molecular marker and cancer prognosis than the Tai Chi survivor trial. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:30.937104Z"}
{"comparison_id":"53845b2c-d8a9-48cb-bba0-5fb763183afa","query_id":"51","doc_a_id":"11880289","doc_b_id":"1780819","presented_order":["11880289","1780819"],"winner_id":"11880289","reasoning":"Document A is more relevant — it concerns breast cancer outcomes (mortality), while Document B addresses endometrial cancer and is unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:30.937111Z"}
{"comparison_id":"58ab7fb7-c8a0-49bb-93ab-413849d3bfc3","query_id":"51","doc_a_id":"6517763","doc_b_id":"1780819","presented_order":["6517763","1780819"],"winner_id":"1780819","reasoning":"Neither document addresses ALDH1 or breast cancer. Both are irrelevant, but Document B is marginally closer since it examines gene expression/methylation as a cancer biomarker linked to outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:30.937119Z"}
{"comparison_id":"b2c08ba9-b723-4c57-9c04-bc754a3949d8","query_id":"51","doc_a_id":"13048272","doc_b_id":"1780819","presented_order":["1780819","13048272"],"winner_id":"1780819","reasoning":"Document A is more relevant — it's a cancer study (though about endometrial cancer), whereas Document B focuses on blood stem/progenitor transcription factors and is unrelated to ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:30.937127Z"}
{"comparison_id":"74aba016-0ddb-4e49-96ef-f91e34dad937","query_id":"51","doc_a_id":"16346504","doc_b_id":"1780819","presented_order":["16346504","1780819"],"winner_id":"16346504","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document A at least discusses gene expression effects on cancer cell behavior, making it slightly more relevant than B's focus on methylation as a diagnostic marker in endometrial cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:30.937135Z"}
{"comparison_id":"5df14b77-ed46-443f-994f-e5d7aa525be7","query_id":"51","doc_a_id":"18810195","doc_b_id":"1780819","presented_order":["1780819","18810195"],"winner_id":"1780819","reasoning":"Document A is more relevant — it discusses a cancer biomarker and clinical outcomes (though in endometrial cancer), which is closer to a claim about ALDH1 and breast cancer prognosis than B's biochemical mechanism. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:30.937142Z"}
{"comparison_id":"e6a767dd-f495-4c8f-97a5-3ca9dda0a10c","query_id":"51","doc_a_id":"23599024","doc_b_id":"1780819","presented_order":["23599024","1780819"],"winner_id":"23599024","reasoning":"Document A is slightly more relevant because it addresses cancer progression and survival outcomes (though in lung cancer and not about ALDH1 or breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:30.937149Z"}
{"comparison_id":"96772447-b658-4264-b57b-085d711d32da","query_id":"51","doc_a_id":"13235609","doc_b_id":"1780819","presented_order":["1780819","13235609"],"winner_id":"13235609","reasoning":"Reason: Neither paper addresses ALDH1 or breast cancer; Document B discusses tumor invasion and survival mechanisms relevant to cancer outcomes more broadly, so it's slightly more related.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:30.937155Z"}
{"comparison_id":"0c9cde3d-fea0-4370-ba71-f43f6509949f","query_id":"51","doc_a_id":"2547636","doc_b_id":"1780819","presented_order":["1780819","2547636"],"winner_id":"1780819","reasoning":"Document A is more relevant — it involves cancer biology (epigenetic changes in a cancer type), whereas Document B concerns normal epidermal stem cell circadian regulation unrelated to breast cancer markers or outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:30.937163Z"}
{"comparison_id":"87ff2cff-9d5f-41b2-b6ec-4744269f50f1","query_id":"51","doc_a_id":"14149065","doc_b_id":"1780819","presented_order":["14149065","1780819"],"winner_id":"14149065","reasoning":"Document A is slightly more relevant because it discusses epithelial cell proliferation mechanisms (potentially relevant to breast epithelial biology), whereas Document B concerns HAND2 methylation in endometrial cancer, unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:30.937170Z"}
{"comparison_id":"89e5355d-04b7-48fb-a3bf-cff22c80d4bb","query_id":"51","doc_a_id":"22963769","doc_b_id":"11880289","presented_order":["22963769","11880289"],"winner_id":"11880289","reasoning":"Document B is more relevant because it concerns breast cancer outcomes, whereas Document A addresses oral squamous cell carcinoma unrelated to ALDH1 or breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:35.693071Z"}
{"comparison_id":"7b9c225f-03d1-4c9e-bd3a-e4fe0804d404","query_id":"51","doc_a_id":"3684342","doc_b_id":"11880289","presented_order":["11880289","3684342"],"winner_id":"11880289","reasoning":"Document A is more relevant — it concerns breast cancer outcomes (though not ALDH1), while Document B addresses lung cancer and is unrelated to ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:35.693092Z"}
{"comparison_id":"984a222a-c3cd-4331-85e8-a47c324b9179","query_id":"51","doc_a_id":"10024681","doc_b_id":"11880289","presented_order":["11880289","10024681"],"winner_id":"11880289","reasoning":"Document A is more relevant because it concerns breast cancer outcomes (though not ALDH1), while B is about prostate cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:35.693101Z"}
{"comparison_id":"e0b7702e-cb48-4f9a-bf13-e031eb4639b6","query_id":"51","doc_a_id":"14149065","doc_b_id":"11880289","presented_order":["14149065","11880289"],"winner_id":"11880289","reasoning":"Document B is more relevant — it discusses breast cancer outcomes (mortality), while Document A covers E-cadherin–Rac1 cell proliferation mechanisms unrelated to ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:35.693109Z"}
{"comparison_id":"862aa83d-a9cd-4231-a4c2-2d0bb4b96d8d","query_id":"51","doc_a_id":"16346504","doc_b_id":"11880289","presented_order":["11880289","16346504"],"winner_id":"11880289","reasoning":"Document A is more relevant — it addresses breast cancer outcomes (though not ALDH1), while B concerns molecular mechanisms in endometrial cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:35.693117Z"}
{"comparison_id":"abd67b1a-bffe-4e4a-8473-3c385d05ff59","query_id":"51","doc_a_id":"23599024","doc_b_id":"11880289","presented_order":["23599024","11880289"],"winner_id":"11880289","reasoning":"Document B — it concerns breast cancer outcomes (mortality), while Document A is about lung cancer and unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:35.693124Z"}
{"comparison_id":"6a7fe93d-fa1a-4f7d-8b1a-0dd16ed92c6d","query_id":"51","doc_a_id":"13235609","doc_b_id":"11880289","presented_order":["11880289","13235609"],"winner_id":"11880289","reasoning":"Document A is about breast cancer outcomes (mortality), while Document B addresses VEGF/MET signaling in non-breast tumor models and doesn't mention ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:35.693130Z"}
{"comparison_id":"f4458cc7-1cf7-48bd-aa2e-392f43d58184","query_id":"51","doc_a_id":"22963769","doc_b_id":"14149065","presented_order":["14149065","22963769"],"winner_id":"14149065","reasoning":"Document A is slightly more relevant because it discusses epithelial cell behavior (more related to breast epithelium) while Document B focuses on oral squamous cell carcinoma; neither mentions ALDH1 or breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:41.356769Z"}
{"comparison_id":"953fb41b-9030-4a41-9a82-b5c6bf4d4e75","query_id":"51","doc_a_id":"3684342","doc_b_id":"14149065","presented_order":["14149065","3684342"],"winner_id":"14149065","reasoning":"Document A is more relevant — while neither mentions ALDH1 or breast cancer outcomes, A discusses epithelial cell proliferation mechanisms (potentially relevant to breast epithelial tumors), whereas B is specific to LIN28B in lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:41.356792Z"}
{"comparison_id":"5d1ab7e2-68c1-4eb9-9eff-d1041d1561ee","query_id":"51","doc_a_id":"10024681","doc_b_id":"14149065","presented_order":["14149065","10024681"],"winner_id":"10024681","reasoning":"Document B is more relevant — it discusses cancer prognosis and biomarker expression, whereas A addresses E-cadherin–mediated proliferation without prognosis or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:41.356802Z"}
{"comparison_id":"5c666a71-1315-4d0f-80b5-a2a8c23d0fef","query_id":"51","doc_a_id":"13235609","doc_b_id":"14149065","presented_order":["14149065","13235609"],"winner_id":"14149065","reasoning":"Document A is slightly more relevant because it discusses epithelial cell proliferation mechanisms (more directly related to breast epithelial cancer biology) while B focuses on VEGF/MET effects in GBM. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:41.356810Z"}
{"comparison_id":"34ab9bf6-bea6-46d0-86a7-346ad133bfca","query_id":"51","doc_a_id":"16346504","doc_b_id":"14149065","presented_order":["16346504","14149065"],"winner_id":"16346504","reasoning":"Neither directly addresses ALDH1 or breast cancer outcomes; Document A is slightly more relevant because it concerns cancer-related gene expression and prognosis mechanisms. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:41.356817Z"}
{"comparison_id":"7b058900-aca6-4313-9c28-203c8c4325cc","query_id":"51","doc_a_id":"23599024","doc_b_id":"14149065","presented_order":["14149065","23599024"],"winner_id":"14149065","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes; Document A is marginally more relevant because it addresses epithelial cell proliferation mechanisms (more related to breast cancer biology) rather than a lung-specific protein.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:41.356825Z"}
{"comparison_id":"830f32d9-5c82-4575-94c9-da00a3ac86cb","query_id":"51","doc_a_id":"10024681","doc_b_id":"16346504","presented_order":["16346504","10024681"],"winner_id":"10024681","reasoning":"Document B is more relevant — it links gene expression changes to cancer prognosis (though in prostate cancer), whereas A focuses on a mechanistic finding in endometrial cancer unrelated to prognosis or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:47.418183Z"}
{"comparison_id":"4318ecc2-4f89-470d-8fd9-0f893c953f91","query_id":"51","doc_a_id":"22963769","doc_b_id":"3684342","presented_order":["22963769","3684342"],"winner_id":"22963769","reasoning":"Document A is slightly more relevant because it examines associations between protein expression and cancer clinical outcomes (though in oral SCC, not breast cancer). Neither document mentions ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:52.617014Z"}
{"comparison_id":"90a3b4ba-7b7d-4b10-af9f-8ca99d3f10a6","query_id":"51","doc_a_id":"23599024","doc_b_id":"3684342","presented_order":["3684342","23599024"],"winner_id":"3684342","reasoning":"Neither document mentions ALDH1 or breast cancer, so neither provides relevant evidence for the claim. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:52.617034Z"}
{"comparison_id":"ea2af43c-2c14-4ccd-a453-e2a8860c2bd3","query_id":"51","doc_a_id":"13235609","doc_b_id":"3684342","presented_order":["3684342","13235609"],"winner_id":"3684342","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant since it discusses tumorigenesis and survival data, whereas B focuses on VEGF/MET signaling in GBM.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:52.617042Z"}
{"comparison_id":"435ad38e-5b8c-47a9-9437-960c47417527","query_id":"51","doc_a_id":"23599024","doc_b_id":"13235609","presented_order":["13235609","23599024"],"winner_id":"13235609","reasoning":"Document A is slightly more relevant because it addresses tumor invasion and epithelial–mesenchymal transition—processes related to cancer stem cell markers like ALDH1—whereas B focuses on lung-specific SP-B in NSCLC. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:10:58.485524Z"}
{"comparison_id":"58b4a4f3-ad4b-4fa1-ac1b-4df54e1f7097","query_id":"51","doc_a_id":"24396137","doc_b_id":"13048272","presented_order":["13048272","24396137"],"winner_id":"13048272","reasoning":"Document A is more relevant — it discusses stem/progenitor cell transcriptional regulation, which is closer to ALDH1 (a stem-cell marker) and cancer biology than a Tai Chi blood-pressure trial.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:05.019276Z"}
{"comparison_id":"492d0b74-3a03-492d-b653-09d460c896b2","query_id":"51","doc_a_id":"6517763","doc_b_id":"13048272","presented_order":["13048272","6517763"],"winner_id":"13048272","reasoning":"Document A is slightly more relevant because it addresses stem/progenitor cell transcriptional regulation (ALDH1 is a stem cell marker), whereas Document B focuses on glioblastoma and unrelated mutations.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:05.019297Z"}
{"comparison_id":"c247a3fd-864c-45ba-ade6-02b97840873b","query_id":"51","doc_a_id":"2547636","doc_b_id":"13048272","presented_order":["13048272","2547636"],"winner_id":"13048272","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it concerns stem/progenitor cell transcriptional regulation, which is closer to ALDH1's role as a stem-cell marker.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:05.019305Z"}
{"comparison_id":"98db481e-a565-4170-98b3-790ae9377257","query_id":"51","doc_a_id":"18810195","doc_b_id":"13048272","presented_order":["13048272","18810195"],"winner_id":"18810195","reasoning":"Document B is slightly more relevant because it discusses mechanisms in human tumors/cancer cells, whereas A focuses on blood stem/progenitor transcriptional regulation and not cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:05.019313Z"}
{"comparison_id":"67b5d1c6-5882-4a64-8f03-156c967f0450","query_id":"51","doc_a_id":"24396137","doc_b_id":"6517763","presented_order":["6517763","24396137"],"winner_id":"6517763","reasoning":"Document A is a molecular cancer study linking gene expression to survival (more relevant to a marker-outcome claim) while Document B is a Tai Chi trial on vital signs in mixed cancer survivors. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:08.742544Z"}
{"comparison_id":"b64dec3f-c20e-4614-b9b0-e87509ab333e","query_id":"51","doc_a_id":"2547636","doc_b_id":"6517763","presented_order":["2547636","6517763"],"winner_id":"6517763","reasoning":"Reason: Document B discusses molecular markers associated with cancer patient survival and outcomes, which is more related to the claim about a biomarker's association with cancer outcomes than Document A's focus on epidermal circadian regulation.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:08.742564Z"}
{"comparison_id":"e494ed95-5cdc-4b18-a4f2-11b457619ab5","query_id":"51","doc_a_id":"24396137","doc_b_id":"2547636","presented_order":["2547636","24396137"],"winner_id":"24396137","reasoning":"Document B is slightly more relevant because it involves female cancer survivors (potentially including breast cancer) while Document A focuses on epidermal stem cell circadian rhythms unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:12.859795Z"}
{"comparison_id":"8377d8d6-12d1-4758-aa4a-021964971202","query_id":"51","doc_a_id":"7736860","doc_b_id":"4378885","presented_order":["4378885","7736860"],"winner_id":"7736860","reasoning":"Document B is more relevant because it concerns cancer-related expression and outcomes, whereas A is about gene expression in lymphoblastoid cell lines and not cancer-specific. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:23.827998Z"}
{"comparison_id":"1599d05c-009a-494e-8a8d-a3ab0563555c","query_id":"51","doc_a_id":"24980622","doc_b_id":"4378885","presented_order":["24980622","4378885"],"winner_id":"24980622","reasoning":"Document A is slightly more relevant because it concerns tumor biology and clinical cancer specimens, whereas Document B focuses on RNA-seq in non-cancer lymphoblastoid cell lines. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:23.828018Z"}
{"comparison_id":"1795ce6f-bfc4-4685-a3f3-84d1a374f0b0","query_id":"51","doc_a_id":"23577867","doc_b_id":"4378885","presented_order":["23577867","4378885"],"winner_id":"4378885","reasoning":"Document B is more relevant — it concerns gene expression analysis (RNA-seq), which is more directly related to ALDH1 expression than a study of insulin-related biomarkers and endometrial cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:23.828030Z"}
{"comparison_id":"d82ccd49-607f-4ecc-9f68-f8bcc9d44713","query_id":"51","doc_a_id":"5377642","doc_b_id":"4378885","presented_order":["5377642","4378885"],"winner_id":"5377642","reasoning":"Document A is more related to cancer biology and tumor outcomes (immune regulation in tumors), while B is a general gene-expression methods study in cell lines unrelated to cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:23.828037Z"}
{"comparison_id":"e3bdfc62-3862-452b-a12f-ef2eef64300e","query_id":"51","doc_a_id":"4688340","doc_b_id":"4378885","presented_order":["4688340","4378885"],"winner_id":"4688340","reasoning":"Document A is more relevant — it's cancer-focused and studies tumor sphere/CSC biology (where ALDH1 is a common marker), whereas Document B analyzes lymphoblastoid cell lines unrelated to breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:23.828045Z"}
{"comparison_id":"502cb66f-604b-4f72-bcc3-a24141ad9648","query_id":"51","doc_a_id":"26848994","doc_b_id":"4378885","presented_order":["26848994","4378885"],"winner_id":"26848994","reasoning":"Document A is more relevant — it discusses gene expression linked to tumorigenesis and patient survival (cancer outcomes), whereas Document B is a general gene-expression methods study in cell lines unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:23.828052Z"}
{"comparison_id":"eb58bed8-176e-489c-bea8-6399b6ff21d7","query_id":"51","doc_a_id":"6807122","doc_b_id":"4378885","presented_order":["6807122","4378885"],"winner_id":"6807122","reasoning":"Document A is more relevant — it addresses carcinoma biology and tumor progression (cancer microenvironment), whereas Document B studies gene expression in lymphoblastoid cell lines unrelated to breast cancer or ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:23.828059Z"}
{"comparison_id":"4a4ca008-b7fd-40af-8fbc-960fadd06c56","query_id":"51","doc_a_id":"2919030","doc_b_id":"4378885","presented_order":["4378885","2919030"],"winner_id":"4378885","reasoning":"Document A is about human gene expression analysis (RNA-seq), which is more related to gene expression studies than the yeast/mammalian metabolism focus of Document B. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:23.828066Z"}
{"comparison_id":"583c0dea-73f4-43bf-ada2-977910386911","query_id":"51","doc_a_id":"8764879","doc_b_id":"4378885","presented_order":["4378885","8764879"],"winner_id":"4378885","reasoning":"Document A is slightly more relevant because it addresses gene expression analysis (which could pertain to ALDH1), whereas Document B focuses on CSF1R in AML, unrelated to ALDH1 or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:23.828073Z"}
{"comparison_id":"db188748-5468-4396-9084-8b40b8cf438a","query_id":"51","doc_a_id":"40901687","doc_b_id":"4378885","presented_order":["4378885","40901687"],"winner_id":"40901687","reasoning":"Document B is more relevant — it addresses cancer-related DNA damage response and apoptosis, whereas Document A studies gene expression in lymphoblastoid cell lines unrelated to ALDH1 or breast cancer.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:23.828080Z"}
{"comparison_id":"7c02fe8e-a7ca-4960-a0b4-aed43962a066","query_id":"51","doc_a_id":"33677323","doc_b_id":"4378885","presented_order":["33677323","4378885"],"winner_id":"4378885","reasoning":"Document B is more relevant — it addresses gene expression variation using RNA sequencing (more generally applicable to gene-expression–outcome associations) while Document A focuses on miR-22/TET2 in hematopoietic malignancies, not ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:23.828087Z"}
{"comparison_id":"ce38fb88-a9dd-4787-be45-24c8cb9431c2","query_id":"51","doc_a_id":"25513319","doc_b_id":"4378885","presented_order":["4378885","25513319"],"winner_id":"25513319","reasoning":"Neither document provides evidence about ALDH1 or breast cancer outcomes. Document B is slightly more relevant because it addresses cancer survival/metastasis (though in prostate and not about ALDH1). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:23.828094Z"}
{"comparison_id":"73e42aef-8ccf-42b7-99a0-df8152726a1c","query_id":"51","doc_a_id":"7028976","doc_b_id":"4378885","presented_order":["7028976","4378885"],"winner_id":"7028976","reasoning":"Document A is more relevant — it discusses tumor-initiating/cancer stem cell markers and cancer outcomes (though in GBM), whereas B focuses on lymphoblastoid gene variation unrelated to breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:23.828101Z"}
{"comparison_id":"929e576c-6b19-4fe1-b3e7-0d9d9d675223","query_id":"51","doc_a_id":"21063817","doc_b_id":"4378885","presented_order":["4378885","21063817"],"winner_id":"21063817","reasoning":"Document B is more related because it examines gene expression changes in cancer tissue, whereas A studies gene expression in lymphoblastoid cell lines (non-cancer). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:23.828108Z"}
{"comparison_id":"bd57595f-73f1-4091-963f-334b8271b46b","query_id":"51","doc_a_id":"7736860","doc_b_id":"26848994","presented_order":["7736860","26848994"],"winner_id":"7736860","reasoning":"Document A is slightly more relevant because it discusses cancer marker expression linked to survival and metastasis, which is closer to an expression–outcome association than Document B's focus on an lncRNA in hepatocellular carcinoma. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:30.404760Z"}
{"comparison_id":"3fa0f347-ab03-4376-8460-696898ae8b84","query_id":"51","doc_a_id":"24980622","doc_b_id":"26848994","presented_order":["26848994","24980622"],"winner_id":"26848994","reasoning":"Neither document discusses ALDH1 or breast cancer; Document A is slightly more relevant because it addresses biomarker expression and patient survival in cancer, whereas B focuses on hypoxia markers in colorectal liver metastases.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:30.404781Z"}
{"comparison_id":"708a17e8-a965-4db4-9422-3971ffb6da88","query_id":"51","doc_a_id":"5377642","doc_b_id":"26848994","presented_order":["5377642","26848994"],"winner_id":"5377642","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it deals with tumor biology and immune-related mechanisms, whereas Document B is specific to hepatocellular carcinoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:30.404789Z"}
{"comparison_id":"f71e7f2c-2abe-420f-be3e-c6c40c295412","query_id":"51","doc_a_id":"4688340","doc_b_id":"26848994","presented_order":["26848994","4688340"],"winner_id":"4688340","reasoning":"Neither abstract addresses ALDH1 or breast cancer. Document B is slightly more relevant because it studies sphere-forming (stem-like) cancer cells, which are conceptually related to ALDH1 as a stem-cell marker. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:30.404797Z"}
{"comparison_id":"4fba283b-2168-4237-888d-0bb9a2218643","query_id":"51","doc_a_id":"21063817","doc_b_id":"26848994","presented_order":["26848994","21063817"],"winner_id":"26848994","reasoning":"Document A is more relevant — it discusses a cancer biomarker (HANR) linked to patient survival and chemoresistance, which is closer in topic to ALDH1 as an outcome-associated marker than keratin expression in oral cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:30.404804Z"}
{"comparison_id":"51093701-971d-4911-a586-ee6a7aa8e4fa","query_id":"51","doc_a_id":"6807122","doc_b_id":"26848994","presented_order":["6807122","26848994"],"winner_id":"6807122","reasoning":"Document A is slightly more relevant — it concerns tumor progression mechanisms and carcinoma-associated fibroblasts, which are more related to cancer outcomes than a hepatocellular carcinoma lncRNA study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:30.404812Z"}
{"comparison_id":"415d2419-5065-43f5-9abd-5756cc7e878b","query_id":"51","doc_a_id":"40901687","doc_b_id":"26848994","presented_order":["40901687","26848994"],"winner_id":"40901687","reasoning":"Document A is more relevant — it addresses a cancer-related DNA damage/apoptosis pathway that could be more broadly related to tumor outcomes, whereas Document B is specific to an lncRNA in hepatocellular carcinoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:30.404819Z"}
{"comparison_id":"56027c22-a239-4356-b1f3-729976cb33ed","query_id":"51","doc_a_id":"25513319","doc_b_id":"26848994","presented_order":["26848994","25513319"],"winner_id":"26848994","reasoning":"Document A is more relevant — it discusses tumorigenesis, chemoresistance, and patient survival (clinical outcomes), which is closer to the claim about ALDH1 and breast cancer outcomes than a prostate cancer metabolic study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:30.404826Z"}
{"comparison_id":"6ae1a2c0-0339-421f-8b18-c4e3adc978dd","query_id":"51","doc_a_id":"7028976","doc_b_id":"26848994","presented_order":["7028976","26848994"],"winner_id":"7028976","reasoning":"Document A is more relevant — it discusses tumor-initiating cell markers and their impact on tumorigenesis and clinical response, which is conceptually closer to ALDH1 as a cancer stem-cell marker and outcome associations. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:30.404833Z"}
{"comparison_id":"0d815e61-9422-478b-8d38-d1df9b00b3b3","query_id":"51","doc_a_id":"7736860","doc_b_id":"4688340","presented_order":["4688340","7736860"],"winner_id":"4688340","reasoning":"Reason: Document A discusses sphere-forming cancer cells (a cancer stem cell context related to ALDH1), making it slightly more relevant to ALDH1/breast cancer outcome linkage than Document B, which focuses on STIM1 in cervical cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:41.483684Z"}
{"comparison_id":"48759f90-7a3b-44f9-a8b5-a61f8ac4f201","query_id":"51","doc_a_id":"5377642","doc_b_id":"4688340","presented_order":["4688340","5377642"],"winner_id":"4688340","reasoning":"Document A is slightly more relevant because it deals with tumor cell markers and sphere-forming cancer cells (cancer stem–like cells), whereas Document B focuses on T cell epigenetic regulation and PD-1, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:41.483705Z"}
{"comparison_id":"20d8e0a9-4069-44bd-b7d9-fe3d942ee58c","query_id":"51","doc_a_id":"7028976","doc_b_id":"4688340","presented_order":["7028976","4688340"],"winner_id":"7028976","reasoning":"Document A is slightly more relevant — it discusses marker expression in tumor-initiating (cancer stem) cells, which is conceptually closer to ALDH1 as a stem-cell marker. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:41.483714Z"}
{"comparison_id":"a7b23b26-2710-4be2-bf3f-b693141f7ff4","query_id":"51","doc_a_id":"6807122","doc_b_id":"4688340","presented_order":["6807122","4688340"],"winner_id":"6807122","reasoning":"Document A is more related to cancer progression mechanisms (tumor microenvironment) and thus slightly more relevant to a claim about markers and outcomes than Document B, which focuses on head and neck therapy.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:41.483722Z"}
{"comparison_id":"0b1c9786-1a3d-4d64-b7ab-a765464a7bac","query_id":"51","doc_a_id":"40901687","doc_b_id":"4688340","presented_order":["4688340","40901687"],"winner_id":"4688340","reasoning":"Document A is slightly more relevant because it deals with sphere-forming (stem-like) cancer cells, which is tangentially related to ALDH1 as a cancer stem cell marker; neither document addresses ALDH1 or breast cancer outcomes directly. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:41.483730Z"}
{"comparison_id":"90aaf19d-c4aa-4d2b-93fb-e0177d3d40bd","query_id":"51","doc_a_id":"7028976","doc_b_id":"6807122","presented_order":["7028976","6807122"],"winner_id":"7028976","reasoning":"Document A is slightly more relevant because it discusses marker expression in tumor-initiating (cancer stem) cells, which is conceptually closer to ALDH1 as a stem-cell marker; Document B focuses on EndMT and fibroblasts. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:45.592010Z"}
{"comparison_id":"aa7d0b2d-2247-469f-b575-85ef783ad4d1","query_id":"51","doc_a_id":"7736860","doc_b_id":"5377642","presented_order":["7736860","5377642"],"winner_id":"7736860","reasoning":"Document A — it discusses cancer-marker expression linked to metastasis and survival (though in cervical cancer), which is marginally more relevant than immunoregulatory T‑cell data in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:52.035587Z"}
{"comparison_id":"0da3a3a9-337e-4604-ae2a-32e248243490","query_id":"51","doc_a_id":"40901687","doc_b_id":"5377642","presented_order":["40901687","5377642"],"winner_id":"40901687","reasoning":"Document A. It discusses a tumor cell–intrinsic DNA damage pathway, which is closer to cancer cell markers like ALDH1 than the T cell/PD‑1 immune regulation topic in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:52.035608Z"}
{"comparison_id":"30d2915b-9cdc-437d-9b60-4ff00f1b6477","query_id":"51","doc_a_id":"7736860","doc_b_id":"40901687","presented_order":["40901687","7736860"],"winner_id":"7736860","reasoning":"Document B is slightly more relevant because it discusses a protein's expression being linked to cancer outcomes (survival), whereas Document A focuses on a DNA damage pathway without outcome or breast cancer data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:11:57.716337Z"}
{"comparison_id":"75dda574-0a5e-4f1c-9102-ea93e6057940","query_id":"51","doc_a_id":"24980622","doc_b_id":"21063817","presented_order":["24980622","21063817"],"winner_id":"24980622","reasoning":"Document A is slightly more relevant because it deals with cancer biomarker expression and tumor outcomes (metastases) whereas Document B focuses on keratin changes in oral epithelium unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:04.402336Z"}
{"comparison_id":"1c7f3bdf-6708-486a-8158-83399851533d","query_id":"51","doc_a_id":"25513319","doc_b_id":"21063817","presented_order":["25513319","21063817"],"winner_id":"25513319","reasoning":"Document A is more relevant — it addresses cancer biomarkers and tumor outcomes (though in prostate cancer), whereas Document B concerns keratins in oral carcinoma and is unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:04.402357Z"}
{"comparison_id":"0608d992-b2d1-4891-a233-dcaa9e2a11a0","query_id":"51","doc_a_id":"24980622","doc_b_id":"25513319","presented_order":["25513319","24980622"],"winner_id":"24980622","reasoning":"Both documents are unrelated to ALDH1 or breast cancer, but Document B discusses marker expression patterns in tumors (more conceptually related than a prostate-focused metabolic study).  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:11.201005Z"}
{"comparison_id":"ac1d3d29-03ee-4888-b711-d4fa728a5605","query_id":"51","doc_a_id":"23577867","doc_b_id":"2919030","presented_order":["2919030","23577867"],"winner_id":"2919030","reasoning":"Document A is marginally more related because it discusses cancer cell metabolism in mammalian cells; Document B focuses on endometrial cancer and insulin markers. Neither mentions ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:17.826878Z"}
{"comparison_id":"e85505d9-cf1f-4919-a3f2-8e83adf4ee04","query_id":"51","doc_a_id":"33677323","doc_b_id":"2919030","presented_order":["33677323","2919030"],"winner_id":"33677323","reasoning":"Reason: Document A discusses cancer-related gene expression and clinical outcomes, making it marginally more relevant to a claim about a marker's association with breast cancer outcomes than a yeast metabolic study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:17.826898Z"}
{"comparison_id":"77cf09b0-1a70-484b-8243-603c289adc2e","query_id":"51","doc_a_id":"8764879","doc_b_id":"2919030","presented_order":["8764879","2919030"],"winner_id":"2919030","reasoning":"Document B is slightly more relevant — it discusses mechanisms in cancer and mammalian cells, whereas Document A is specific to AML/leukemia stem cells and not applicable to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:17.826907Z"}
{"comparison_id":"7b412bfd-9437-48f3-8bad-0c942aa06765","query_id":"51","doc_a_id":"23577867","doc_b_id":"8764879","presented_order":["23577867","8764879"],"winner_id":"23577867","reasoning":"Document A is more relevant — it concerns cancer biomarkers and cancer risk (though in endometrial cancer), whereas B addresses leukemia stem cells and CSF1R, which is farther from ALDH1 and breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:22.700660Z"}
{"comparison_id":"9cd8d740-171d-49fe-b38c-4e37e8f9f1a5","query_id":"51","doc_a_id":"36950726","doc_b_id":"5406411","presented_order":["5406411","36950726"],"winner_id":"5406411","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is at least about cancer-related biology and therapeutic relevance, while B focuses on melanoma epigenetics, so A is slightly more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:28.917169Z"}
{"comparison_id":"46b5a017-f82a-4218-9c9d-3ac463702d99","query_id":"51","doc_a_id":"12869200","doc_b_id":"5406411","presented_order":["5406411","12869200"],"winner_id":"5406411","reasoning":"Document A is slightly more relevant because it discusses cancer-related biology (immune regulation/EGFR) while Document B concerns adipokines and endometrial cancer, not breast cancer or ALDH1. Neither directly addresses ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:28.917191Z"}
{"comparison_id":"8a6d651c-b248-4076-88ba-f90471f975b1","query_id":"51","doc_a_id":"3210545","doc_b_id":"5406411","presented_order":["3210545","5406411"],"winner_id":"3210545","reasoning":"Document A is marginally more relevant because it discusses gene expression and associations with cancer outcomes, whereas Document B focuses on immune regulation unrelated to ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:28.917199Z"}
{"comparison_id":"8d95e71b-eb38-49a5-977f-a97e54e2a195","query_id":"51","doc_a_id":"9648896","doc_b_id":"5406411","presented_order":["9648896","5406411"],"winner_id":"9648896","reasoning":"Document A is slightly more relevant because it discusses cancer cell proliferation and chemoresistance (tied to clinical outcomes), while Document B focuses on Treg immune function unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:28.917207Z"}
{"comparison_id":"e56ef41a-e20d-4738-897b-cbe0397a25f5","query_id":"51","doc_a_id":"42484543","doc_b_id":"5406411","presented_order":["5406411","42484543"],"winner_id":"5406411","reasoning":"Document A is more relevant — it deals with cancer-related biology (immune regulation/EGFR) and thus is marginally closer to breast cancer outcome studies than an embryonic stem cell transcriptome paper. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:28.917217Z"}
{"comparison_id":"dbdf6d69-3542-436d-9a61-a982281d9bb0","query_id":"51","doc_a_id":"28249680","doc_b_id":"5406411","presented_order":["5406411","28249680"],"winner_id":"5406411","reasoning":"Neither document mentions ALDH1 or breast cancer prognosis, but Document A is slightly more related to cancer biology and potential therapeutic impact, whereas Document B focuses on a specific cell-death mechanism unrelated to prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:28.917224Z"}
{"comparison_id":"bae4efa6-87d3-4f89-bc0f-67a1f23fd258","query_id":"51","doc_a_id":"1456068","doc_b_id":"5406411","presented_order":["1456068","5406411"],"winner_id":"1456068","reasoning":"Document A is more relevant — it discusses cancer mortality/outcomes (though not ALDH1 specifically), whereas B concerns Treg/AREG immunology without linking to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:28.917232Z"}
{"comparison_id":"2f920f90-3396-458d-83e2-c2867555dbbe","query_id":"51","doc_a_id":"195689757","doc_b_id":"5406411","presented_order":["5406411","195689757"],"winner_id":"5406411","reasoning":"Neither document mentions ALDH1 or breast cancer, but A discusses cancer-related immune regulation and therapeutic targets (more broadly relevant) while B focuses specifically on GBM metabolism. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:28.917239Z"}
{"comparison_id":"f0609a86-313f-487b-b45f-82030ac4da26","query_id":"51","doc_a_id":"27822315","doc_b_id":"5406411","presented_order":["5406411","27822315"],"winner_id":"5406411","reasoning":"Document A is slightly more relevant because it addresses cancer-related mechanisms (immune regulation via AREG/EGFR), whereas Document B concerns steroidogenic differentiation unrelated to breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:28.917246Z"}
{"comparison_id":"15674bab-2528-4bea-96ca-18c4af1d4a50","query_id":"51","doc_a_id":"3701541","doc_b_id":"5406411","presented_order":["3701541","5406411"],"winner_id":"5406411","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is marginally more relevant because it addresses cancer-related immune regulation, whereas A focuses on liver fibrosis and HSCs. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:28.917252Z"}
{"comparison_id":"a8012646-d6be-4d4a-b9b6-98847b3cc5c4","query_id":"51","doc_a_id":"3210545","doc_b_id":"9648896","presented_order":["9648896","3210545"],"winner_id":"3210545","reasoning":"Document B — it discusses associations between gene expression/amplification and cancer outcomes, which is conceptually closer to the claim about marker expression and prognosis, whereas A focuses on CAFs/microRNA in lung cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:36.233509Z"}
{"comparison_id":"cb87b818-5dde-4ce1-9d68-fbb52cbd8e81","query_id":"51","doc_a_id":"1456068","doc_b_id":"9648896","presented_order":["1456068","9648896"],"winner_id":"1456068","reasoning":"Doc A is slightly more relevant because it addresses cancer outcomes in a women's cohort (potentially including breast cancer), whereas Doc B focuses on lung cancer and CAFs unrelated to ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:36.233530Z"}
{"comparison_id":"aa4a5c88-349c-4484-99f4-1e0b7f387939","query_id":"51","doc_a_id":"3210545","doc_b_id":"1456068","presented_order":["3210545","1456068"],"winner_id":"3210545","reasoning":"Doc A is more relevant because it discusses gene expression levels and their association with cancer prognosis, which is conceptually closer to a claim about ALDH1 expression and breast cancer outcomes than a lifestyle-mortality cohort study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:48.336772Z"}
{"comparison_id":"16b43d26-7992-4f8d-b7c7-e2cf36999050","query_id":"51","doc_a_id":"36950726","doc_b_id":"28249680","presented_order":["36950726","28249680"],"winner_id":"28249680","reasoning":"Document B is slightly more relevant — it addresses mechanisms in epithelial cancer cells (which include most breast cancers), while Document A is specific to melanoma and unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:53.880387Z"}
{"comparison_id":"d9ed37e1-bdf1-4402-a61a-ec4d1314dafd","query_id":"51","doc_a_id":"12869200","doc_b_id":"28249680","presented_order":["28249680","12869200"],"winner_id":"28249680","reasoning":"Document A is marginally more relevant because it discusses molecular mechanisms in epithelial cancer cells (more likely applicable to breast cancer) while Document B concerns endometrial cancer epidemiology; neither mentions ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:53.880408Z"}
{"comparison_id":"a0b42d6a-c65f-46a8-bd55-44035639cb89","query_id":"51","doc_a_id":"42484543","doc_b_id":"28249680","presented_order":["28249680","42484543"],"winner_id":"28249680","reasoning":"Document A is more relevant because it discusses mechanisms in epithelial cancer cells (breast cancer is an epithelial cancer), while Document B is about embryonic stem cells and unrelated to cancer outcomes. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:53.880417Z"}
{"comparison_id":"f4c3c77c-9722-4881-bd1f-60f8bfef82b5","query_id":"51","doc_a_id":"3701541","doc_b_id":"28249680","presented_order":["3701541","28249680"],"winner_id":"28249680","reasoning":"Neither document discusses ALDH1 or breast cancer; Document B is slightly more relevant because it addresses cancer cell death mechanisms in epithelial tumors (which can include breast), whereas A is specific to liver cells and fibrosis. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:53.880425Z"}
{"comparison_id":"c9c9f1c3-36bb-409e-af78-7875a99622fd","query_id":"51","doc_a_id":"195689757","doc_b_id":"28249680","presented_order":["28249680","195689757"],"winner_id":"28249680","reasoning":"Document A is more relevant — it discusses mechanisms in epithelial cancers (which include most breast cancers), while Document B focuses on glioblastoma, unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:53.880432Z"}
{"comparison_id":"98678c42-accc-4b59-9b19-53e8b85ad012","query_id":"51","doc_a_id":"27822315","doc_b_id":"28249680","presented_order":["27822315","28249680"],"winner_id":"27822315","reasoning":"Document A is more related because it discusses regulation and differentiation of stem cells (ALDH1 is a stem/progenitor cell marker), whereas Document B focuses on proteasome-induced apoptosis unrelated to ALDH1 or breast cancer outcomes.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:53.880439Z"}
{"comparison_id":"7985a882-95e1-49fc-84cc-b95d572ed81d","query_id":"51","doc_a_id":"36950726","doc_b_id":"42484543","presented_order":["42484543","36950726"],"winner_id":"42484543","reasoning":"Document A is slightly more relevant because it concerns gene expression profiles and stem cell–related markers (contextually closer to ALDH1's role) while Document B focuses on melanoma epigenetics unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:58.451921Z"}
{"comparison_id":"056a6f40-c075-41b6-ac39-f07d42c8d2e8","query_id":"51","doc_a_id":"12869200","doc_b_id":"42484543","presented_order":["42484543","12869200"],"winner_id":"42484543","reasoning":"Document A is slightly more relevant because it concerns gene expression profiling (though not ALDH1 or breast cancer), whereas Document B addresses adipokines and endometrial cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:58.451942Z"}
{"comparison_id":"c58ab1f2-5cc4-40c0-95c2-ca9542d511d0","query_id":"51","doc_a_id":"195689757","doc_b_id":"42484543","presented_order":["195689757","42484543"],"winner_id":"195689757","reasoning":"Document A is more relevant — it addresses cancer metabolic enzymes (ALDH1 is a metabolic enzyme) and cancer context, whereas Document B focuses on embryonic stem cell transcriptomes unrelated to breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:58.451952Z"}
{"comparison_id":"f5e48e1b-f715-4905-a9de-edc892edfb8b","query_id":"51","doc_a_id":"3701541","doc_b_id":"42484543","presented_order":["3701541","42484543"],"winner_id":"42484543","reasoning":"Reason: Neither abstract addresses ALDH1 in breast cancer, but Document B deals with gene expression profiling (more likely to mention ALDH1) while Document A focuses on p62/VDR in liver disease.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:12:58.451960Z"}
{"comparison_id":"e1877e6f-168f-4bad-9f9b-1224104338ce","query_id":"51","doc_a_id":"36950726","doc_b_id":"12869200","presented_order":["36950726","12869200"],"winner_id":"36950726","reasoning":"Document A is more relevant — it concerns protein expression levels and cancer progression (though in melanoma rather than breast cancer), which is closer to a claim about ALDH1 expression and cancer outcomes than an epidemiologic study of adipokines in endometrial cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:03.985457Z"}
{"comparison_id":"90b8a9c0-d581-4874-b76c-534a6babb5b7","query_id":"51","doc_a_id":"3701541","doc_b_id":"12869200","presented_order":["12869200","3701541"],"winner_id":"12869200","reasoning":"Reason: Document A discusses biomarkers and cancer risk/outcomes (though in endometrial cancer), making it marginally closer to a claim about biomarker expression and cancer prognosis than Document B, which addresses liver-specific mechanisms.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:03.985479Z"}
{"comparison_id":"a8440e29-0db8-4262-bc92-436ce3a69d29","query_id":"51","doc_a_id":"29124963","doc_b_id":"29190724","presented_order":["29190724","29124963"],"winner_id":"29124963","reasoning":"Document B — it reports a prognostic biomarker (EML4-ALK) linked to patient outcomes, which is more similar in topic (biomarker and cancer prognosis) to the query than a gastric methylation review. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:15.935847Z"}
{"comparison_id":"f798fd70-d878-4068-8511-031a8df32a76","query_id":"51","doc_a_id":"10169908","doc_b_id":"29190724","presented_order":["29190724","10169908"],"winner_id":"29190724","reasoning":"Document A is slightly more relevant because it discusses cancer-related gene expression and biomarkers (epigenetics), whereas Document B focuses on a lung cancer glutamine transporter unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:15.935872Z"}
{"comparison_id":"ca620404-b979-4d5a-bcb6-85debd088721","query_id":"51","doc_a_id":"9239963","doc_b_id":"29190724","presented_order":["29190724","9239963"],"winner_id":"29190724","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer; Document A (gene methylation in cancer) is marginally more relevant because it addresses cancer biomarkers and gene regulation broadly.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:15.935881Z"}
{"comparison_id":"f73b9d93-acbf-4f23-a4cd-b25d8d7f8da7","query_id":"51","doc_a_id":"9211173","doc_b_id":"29190724","presented_order":["9211173","29190724"],"winner_id":"9211173","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it discusses a cancer biomarker (BAF250a) and tumor outcomes, whereas B focuses on DNA methylation in gastric cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:15.935889Z"}
{"comparison_id":"350e7770-1f92-42af-9db5-fffb9f743fe8","query_id":"51","doc_a_id":"23269537","doc_b_id":"29190724","presented_order":["23269537","29190724"],"winner_id":"23269537","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it deals with gene expression changes in cancer, whereas B focuses specifically on DNA methylation in gastric cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:15.935896Z"}
{"comparison_id":"2c7e23af-1975-46cf-a0d0-45b2eb6c1444","query_id":"51","doc_a_id":"6363093","doc_b_id":"29190724","presented_order":["29190724","6363093"],"winner_id":"29190724","reasoning":"Document A is slightly more relevant because it discusses gene-related changes in cancer (epigenetics), whereas Document B focuses on glioblastoma signaling pathways unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:15.935904Z"}
{"comparison_id":"8ef807b4-14b6-45f8-b238-9fb29d813291","query_id":"51","doc_a_id":"2328272","doc_b_id":"29190724","presented_order":["29190724","2328272"],"winner_id":"29190724","reasoning":"Document A is slightly more relevant because it deals with gene-related cancer biology (epigenetics), whereas Document B focuses on survivorship recruitment in colorectal cancer and not gene expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:15.935911Z"}
{"comparison_id":"7b8221d8-4980-4cc1-9bd8-031f2fff2681","query_id":"51","doc_a_id":"4993011","doc_b_id":"29190724","presented_order":["4993011","29190724"],"winner_id":"29190724","reasoning":"Document B is slightly more relevant because it discusses gene methylation and epigenetic regulation in cancer, which is more related to gene expression (like ALDH1) than ATRX-specific ribosomal DNA changes in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:15.935919Z"}
{"comparison_id":"fa50b533-eaa6-49ce-a8c9-a16cee29a0b8","query_id":"51","doc_a_id":"34189936","doc_b_id":"29190724","presented_order":["34189936","29190724"],"winner_id":"29190724","reasoning":"Document B is slightly more relevant because it discusses gene expression regulation in cancer (epigenetics), which is closer to ALDH1 expression and outcomes than a study on BMAL1 in mesothelioma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:15.935925Z"}
{"comparison_id":"0859f346-1006-4e38-8a86-d12765136c94","query_id":"51","doc_a_id":"3765739","doc_b_id":"29190724","presented_order":["29190724","3765739"],"winner_id":"29190724","reasoning":"Document A is slightly more relevant because it discusses gene-level epigenetic changes in cancer (gene expression/methylation), whereas Document B focuses on EBV-related lymphoma and survivin, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:15.935932Z"}
{"comparison_id":"0a59d5c6-a6b8-40e5-977c-c0e58162d301","query_id":"51","doc_a_id":"21692235","doc_b_id":"29190724","presented_order":["21692235","29190724"],"winner_id":"21692235","reasoning":"Document A is more relevant — it discusses cancer gene expression and genomic markers (though in glioblastoma), whereas Document B focuses on methylation in gastric cancer and is less related to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:15.935940Z"}
{"comparison_id":"935a85f9-10d4-491d-81ad-794e70c372a2","query_id":"51","doc_a_id":"22180793","doc_b_id":"29190724","presented_order":["22180793","29190724"],"winner_id":"29190724","reasoning":"Neither document addresses ALDH1 or breast cancer directly. Document B is slightly more relevant because it discusses molecular/epigenetic biomarkers and cancer prognosis, whereas A focuses on an unrelated prostate therapy.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:15.935947Z"}
{"comparison_id":"2a2607ff-1172-4bfe-a925-aa5ac7253b4e","query_id":"51","doc_a_id":"3899896","doc_b_id":"29190724","presented_order":["3899896","29190724"],"winner_id":"29190724","reasoning":"Document B is slightly more relevant — it deals with gene-level cancer mechanisms (epigenetics), which is closer to expression-related claims than a study of RDW in rectal cancer. Neither directly addresses ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:15.935955Z"}
{"comparison_id":"8f5a418f-8000-4a95-95f0-ad07e97b85e9","query_id":"51","doc_a_id":"16361581","doc_b_id":"29190724","presented_order":["16361581","29190724"],"winner_id":"29190724","reasoning":"Document B is more relevant — it discusses cancer-related epigenetic regulation which is more likely to relate to gene expression markers like ALDH1 than a study specific to multiple myeloma. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:15.935962Z"}
{"comparison_id":"86f60abd-e07a-41fb-8853-202e2110c026","query_id":"51","doc_a_id":"10669939","doc_b_id":"29190724","presented_order":["10669939","29190724"],"winner_id":"29190724","reasoning":"Document B is slightly more relevant because it discusses gene regulation and cancer outcomes (epigenetic changes), whereas A focuses on imaging a transfected gene in glioma. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:15.935969Z"}
{"comparison_id":"9d66d317-3875-4828-b9a3-357422d21363","query_id":"51","doc_a_id":"29124963","doc_b_id":"9211173","presented_order":["29124963","9211173"],"winner_id":"29124963","reasoning":"Document A is more relevant because it discusses a biomarker (EML4-ALK translocation) linked to patient outcomes, which is closer in topic (biomarker–prognosis relationship) than Document B on ARID1A in ovarian cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:21.059319Z"}
{"comparison_id":"1ccac516-a83d-4437-9737-7271f29da5ad","query_id":"51","doc_a_id":"21692235","doc_b_id":"9211173","presented_order":["21692235","9211173"],"winner_id":"9211173","reasoning":"Neither abstract discusses ALDH1 or breast cancer. Document B is slightly more relevant because it addresses carcinoma-associated biomarker/mutation findings, whereas A focuses on glioblastoma subtypes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:21.059340Z"}
{"comparison_id":"fce7e22f-5d99-41ce-b6bc-bbc4464b4a32","query_id":"51","doc_a_id":"23269537","doc_b_id":"9211173","presented_order":["23269537","9211173"],"winner_id":"23269537","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is marginally more related (gene expression in cancer), so pick A.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:21.059352Z"}
{"comparison_id":"6d26abc2-890a-4d42-8de6-34774bcccc1a","query_id":"51","doc_a_id":"29124963","doc_b_id":"23269537","presented_order":["29124963","23269537"],"winner_id":"29124963","reasoning":"Document A is more relevant — it reports a biomarker (EML4-ALK) associated with better patient outcomes, which is conceptually similar to the query about ALDH1 and prognosis; Document B focuses on cyclin D1 epigenetics in B-cell malignancy, not outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:26.601917Z"}
{"comparison_id":"cd3701f6-10de-43dd-b508-4529eced83ff","query_id":"51","doc_a_id":"10169908","doc_b_id":"34189936","presented_order":["10169908","34189936"],"winner_id":"10169908","reasoning":"Neither document addresses ALDH1 or breast cancer. Both are irrelevant, but A is marginally closer since it concerns protein expression in cancer generally.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:34.642581Z"}
{"comparison_id":"cadcf269-cddf-438d-b9ff-45855b220a07","query_id":"51","doc_a_id":"9239963","doc_b_id":"34189936","presented_order":["34189936","9239963"],"winner_id":"9239963","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is slightly more relevant because it involves steroid hormone/estradiol biology, which is more related to hormone-driven breast cancer than mesothelioma. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:34.642601Z"}
{"comparison_id":"dff87020-a359-455a-a996-3fd5aeade002","query_id":"51","doc_a_id":"6363093","doc_b_id":"34189936","presented_order":["6363093","34189936"],"winner_id":"6363093","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are irrelevant; Document A is marginally more related because it addresses cancer subclass protein expression, but it does not provide evidence about ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:34.642609Z"}
{"comparison_id":"ba0ef2ca-4870-401e-a0e9-29bcf2c492de","query_id":"51","doc_a_id":"2328272","doc_b_id":"34189936","presented_order":["2328272","34189936"],"winner_id":"2328272","reasoning":"Reason: Document A deals with cancer survivorship and outcomes (clinical trial follow-up), making it slightly closer to a claim about breast cancer outcomes than Document B, which focuses on a different gene in mesothelioma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:34.642616Z"}
{"comparison_id":"0eaacb5c-f578-4c48-9937-eab791b42587","query_id":"51","doc_a_id":"4993011","doc_b_id":"34189936","presented_order":["4993011","34189936"],"winner_id":"4993011","reasoning":"Reason: Neither abstract mentions ALDH1 or breast cancer, but Document A discusses molecular features across cancers and potential therapeutic implications, making it slightly more relevant than a paper focused specifically on mesothelioma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:34.642624Z"}
{"comparison_id":"b161ccc4-e561-4b59-aaf0-df5a0c860e91","query_id":"51","doc_a_id":"10669939","doc_b_id":"34189936","presented_order":["34189936","10669939"],"winner_id":"34189936","reasoning":"Document A is more relevant — it discusses gene expression in a cancer context (though a different gene/cancer), while B is an imaging-method study unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:34.642634Z"}
{"comparison_id":"a58af779-30bb-4e92-b2bd-c42b506961ed","query_id":"51","doc_a_id":"3765739","doc_b_id":"34189936","presented_order":["34189936","3765739"],"winner_id":"34189936","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant only because it addresses gene expression effects on cancer cell proliferation and survival. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:34.642641Z"}
{"comparison_id":"0d4610ff-2e48-46db-8304-01b5b215031c","query_id":"51","doc_a_id":"22180793","doc_b_id":"34189936","presented_order":["22180793","34189936"],"winner_id":"22180793","reasoning":"Document A is slightly more relevant because it discusses cancer biomarkers/targets and outcomes (though in prostate cancer), whereas Document B concerns a circadian gene in mesothelioma unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:34.642648Z"}
{"comparison_id":"ae898f71-38e8-4719-be8c-df238896387c","query_id":"51","doc_a_id":"3899896","doc_b_id":"34189936","presented_order":["34189936","3899896"],"winner_id":"34189936","reasoning":"Document A is slightly more relevant because it discusses a cancer-related gene, whereas Document B addresses a blood marker in rectal cancer; neither directly concerns ALDH1 or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:34.642655Z"}
{"comparison_id":"cd8f3a05-47fa-4fca-98dc-50ae51f3e07c","query_id":"51","doc_a_id":"16361581","doc_b_id":"34189936","presented_order":["34189936","16361581"],"winner_id":"34189936","reasoning":"Neither abstract mentions ALDH1 or breast cancer; both are irrelevant. Document A is slightly more related because it addresses a cancer gene study (though in mesothelioma), not myeloma signaling.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:34.642663Z"}
{"comparison_id":"30be2373-03d8-4d61-9251-bd080f729c5d","query_id":"51","doc_a_id":"10169908","doc_b_id":"6363093","presented_order":["6363093","10169908"],"winner_id":"6363093","reasoning":"Document A is slightly more relevant because it addresses protein expression patterns and cancer subclass outcomes, whereas Document B focuses on a lung-specific transporter unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:40.265534Z"}
{"comparison_id":"b22ee119-27ae-4c0f-b6e3-117df28e3bd2","query_id":"51","doc_a_id":"9239963","doc_b_id":"6363093","presented_order":["6363093","9239963"],"winner_id":"9239963","reasoning":"Neither document mentions ALDH1 or breast cancer, so both are irrelevant. Document B is marginally closer because it concerns a hormone-related cancer type; it’s therefore slightly more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:40.265555Z"}
{"comparison_id":"35687336-764f-4b69-a969-b3b448ebadb6","query_id":"51","doc_a_id":"22180793","doc_b_id":"6363093","presented_order":["6363093","22180793"],"winner_id":"22180793","reasoning":"Document B is slightly more relevant because it addresses cancer progression and metastasis in a carcinoma (prostate), which is closer to breast cancer biology than a glioblastoma study. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:40.265564Z"}
{"comparison_id":"17a77acd-8e76-4f67-8ae0-cdd9c136fe47","query_id":"51","doc_a_id":"2328272","doc_b_id":"6363093","presented_order":["6363093","2328272"],"winner_id":"6363093","reasoning":"Document A is slightly more relevant because it addresses tumor molecular markers and pathway-defined subclasses (closer to biomarker–outcome relationships) whereas B concerns survivorship recruitment in colorectal cancer; neither directly mentions ALDH1 or breast cancer.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:40.265572Z"}
{"comparison_id":"92dbcdb0-6d77-4e89-afac-4b75b17c9e22","query_id":"51","doc_a_id":"4993011","doc_b_id":"6363093","presented_order":["4993011","6363093"],"winner_id":"4993011","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes; both are irrelevant. Document A is slightly more relevant only because it discusses cancer biology broadly rather than a different tumor type.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:40.265579Z"}
{"comparison_id":"4abc5e6f-ea0d-4965-8be5-8478bbc42612","query_id":"51","doc_a_id":"9239963","doc_b_id":"22180793","presented_order":["22180793","9239963"],"winner_id":"9239963","reasoning":"Document B is more relevant — neither discusses ALDH1 or breast cancer, but B relates to steroid/estradiol biology which is more directly connected to breast cancer biology than a prostate-targeted N-cadherin therapy.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:45.484790Z"}
{"comparison_id":"f424cc98-6ced-4336-84a0-e8eeb9ac124c","query_id":"51","doc_a_id":"4993011","doc_b_id":"22180793","presented_order":["22180793","4993011"],"winner_id":"22180793","reasoning":"Document A is marginally more relevant because it discusses cancer biology and therapeutic markers, whereas Document B focuses on ATRX-related rDNA instability unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:45.484812Z"}
{"comparison_id":"c4880e1a-ebf7-4585-b847-0cc847324a9c","query_id":"51","doc_a_id":"10169908","doc_b_id":"2328272","presented_order":["2328272","10169908"],"winner_id":"2328272","reasoning":"Document A is marginally more relevant because it concerns cancer survivorship and outcomes, whereas Document B studies a different protein in lung cancer (not ALDH1 or breast cancer). \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:13:52.887138Z"}
{"comparison_id":"2ae7afc5-55d6-4c34-ad59-557b07bd7f34","query_id":"51","doc_a_id":"10669939","doc_b_id":"3765739","presented_order":["10669939","3765739"],"winner_id":"3765739","reasoning":"Document B is more relevant because it discusses cancer cell biology and factors affecting tumor cell survival, whereas Document A describes a gene-imaging method in glioma and not biomarkers or breast cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:14:00.683234Z"}
{"comparison_id":"d8692a55-4f51-4ee1-8721-cc249383c841","query_id":"51","doc_a_id":"16361581","doc_b_id":"3765739","presented_order":["3765739","16361581"],"winner_id":"16361581","reasoning":"Reason: Neither paper mentions ALDH1 or breast cancer, but Document B (Notch signaling) is marginally closer because Notch relates to cancer stem-cell biology, which is linked to ALDH1, whereas A focuses on EBV-related survivin in B-lymphoma.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:14:00.683254Z"}
{"comparison_id":"67aec659-7b13-45bd-b44e-f8a4789f985d","query_id":"51","doc_a_id":"3899896","doc_b_id":"3765739","presented_order":["3899896","3765739"],"winner_id":"3899896","reasoning":"Document A is more relevant — it discusses prognostic markers and cancer outcomes (though in rectal cancer), whereas Document B concerns EBV mechanisms in B‑lymphoma and not cancer prognosis broadly.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:14:00.683265Z"}
{"comparison_id":"008109ce-8b36-4c8c-a66d-b78d017b37cf","query_id":"51","doc_a_id":"16361581","doc_b_id":"3899896","presented_order":["3899896","16361581"],"winner_id":"16361581","reasoning":"Document B is slightly more relevant because it discusses molecular signaling in cancer cells (closer to marker-expression studies) while Document A concerns a clinical blood parameter in rectal cancer unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:14:05.298509Z"}
{"comparison_id":"e1fb5877-9601-4c0e-9a20-921bdfe44c68","query_id":"51","doc_a_id":"23665162","doc_b_id":"3831884","presented_order":["3831884","23665162"],"winner_id":"3831884","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it addresses tumor biology/metabolism, while B focuses on LINE-1 methylation and liver cancer risk.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991029Z"}
{"comparison_id":"5dfc3896-e895-4b7d-bb07-bde40cec214f","query_id":"51","doc_a_id":"8677721","doc_b_id":"3831884","presented_order":["8677721","3831884"],"winner_id":"8677721","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document A discusses cancer-related signaling and tumor growth (though in hepatocellular carcinoma), which is slightly closer in topic than the metabolic pathway specific to pancreatic cancer in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991049Z"}
{"comparison_id":"1ca6cdaa-b966-4783-a327-18f7bf46aa98","query_id":"51","doc_a_id":"14471161","doc_b_id":"3831884","presented_order":["3831884","14471161"],"winner_id":"14471161","reasoning":"Document B is more relevant — it addresses tumor gene expression changes and links those changes to altered cancer outcomes (growth inhibition), which is closer to a claim about ALDH1 expression and prognosis than a PDAC-specific metabolic pathway.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991060Z"}
{"comparison_id":"1ce506fd-cc1f-423b-8679-dbad0dbf59d2","query_id":"51","doc_a_id":"1507222","doc_b_id":"3831884","presented_order":["3831884","1507222"],"winner_id":"3831884","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it addresses cancer cell metabolic pathways and tumor growth, whereas B focuses on cachexia-related proteins in a murine model.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991068Z"}
{"comparison_id":"eca9e6e5-a4dd-4047-bacd-a554228940b9","query_id":"51","doc_a_id":"24349430","doc_b_id":"3831884","presented_order":["3831884","24349430"],"winner_id":"24349430","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it discusses how expression of a gene affects cancer cell proliferation and signaling, whereas A focuses on a pancreatic-specific metabolic pathway.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991075Z"}
{"comparison_id":"f0ef963f-f3e9-47c1-9b6d-bf5bcafd9444","query_id":"51","doc_a_id":"31313782","doc_b_id":"3831884","presented_order":["31313782","3831884"],"winner_id":"31313782","reasoning":"Document A is slightly more relevant because it deals with gene expression profiles in cancer (though in lung cancer, not breast cancer); Document B focuses on a pancreatic cancer metabolic pathway and is less related to ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991083Z"}
{"comparison_id":"b41c3a4c-0fba-48d3-9040-4379a7349dfb","query_id":"51","doc_a_id":"16630996","doc_b_id":"3831884","presented_order":["16630996","3831884"],"winner_id":"16630996","reasoning":"Neither document discusses ALDH1 or breast cancer, but Document A deals with gene expression and clinical outcome markers (though in pancreatic cancer), so it's slightly more relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991089Z"}
{"comparison_id":"995ec764-a964-4690-bd36-6c3e8f877e85","query_id":"51","doc_a_id":"2272614","doc_b_id":"3831884","presented_order":["2272614","3831884"],"winner_id":"2272614","reasoning":"Document A is more relevant: it addresses gene expression and cancer treatment outcomes (though in lung cancer), whereas Document B focuses on pancreatic cancer metabolism and is less related to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991096Z"}
{"comparison_id":"7b783587-b1fd-4305-a652-e5b5ab09ee9f","query_id":"51","doc_a_id":"3355397","doc_b_id":"3831884","presented_order":["3831884","3355397"],"winner_id":"3355397","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer, but Document B deals with cancer risk associations (clinical outcomes), making it slightly more relevant than a pancreatic metabolic mechanism.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991103Z"}
{"comparison_id":"a2825964-bad6-45ed-8220-cb60c92d32a7","query_id":"51","doc_a_id":"32852283","doc_b_id":"3831884","presented_order":["3831884","32852283"],"winner_id":"32852283","reasoning":"Document B — it discusses tumor growth and survival outcomes (though in NSCLC), which is closer to a claim about cancer outcomes than Document A's PDAC metabolic pathway. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991110Z"}
{"comparison_id":"13d56aa7-eaa8-4473-bd1a-576d50fac801","query_id":"51","doc_a_id":"14180565","doc_b_id":"3831884","presented_order":["3831884","14180565"],"winner_id":"14180565","reasoning":"Document B is slightly more relevant because it addresses gene expression profiling (which could relate to ALDH1 expression), whereas Document A focuses on a metabolic pathway in pancreatic cancer unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991117Z"}
{"comparison_id":"841bd6b7-bc0e-4dc2-b215-62c1ccbbbb05","query_id":"51","doc_a_id":"38808600","doc_b_id":"3831884","presented_order":["38808600","3831884"],"winner_id":"38808600","reasoning":"Document A is slightly more relevant because it discusses a cancer biomarker linked to prognosis, whereas Document B focuses on a metabolic pathway in pancreatic cancer unrelated to prognostic markers in breast cancer.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991124Z"}
{"comparison_id":"99a4977f-c81d-4edf-a0f4-3be0fbcbedf9","query_id":"51","doc_a_id":"26079071","doc_b_id":"3831884","presented_order":["26079071","3831884"],"winner_id":"3831884","reasoning":"Document B is slightly more relevant because it discusses cancer-related metabolic pathways and therapeutic targets (broad cancer biology), whereas Document A is a lung cancer drug trial unrelated to markers like ALDH1 or breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991131Z"}
{"comparison_id":"eca4977c-1878-412a-8662-e5b63161a21b","query_id":"51","doc_a_id":"52925737","doc_b_id":"3831884","presented_order":["52925737","3831884"],"winner_id":"52925737","reasoning":"Document A — it discusses expression-linked prognosis in cancer (though gastric cancer), whereas B is a pancreatic metabolism study unrelated to ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991139Z"}
{"comparison_id":"6463c946-04eb-4056-80a3-303a7948f028","query_id":"51","doc_a_id":"23509593","doc_b_id":"3831884","presented_order":["3831884","23509593"],"winner_id":"3831884","reasoning":"Neither document addresses ALDH1 or breast cancer, but Document A at least concerns cancer biology (tumor metabolism), whereas B is specific to prostate stromal cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991146Z"}
{"comparison_id":"7410c2e0-db38-400d-8645-da69dea2e651","query_id":"51","doc_a_id":"46617075","doc_b_id":"3831884","presented_order":["3831884","46617075"],"winner_id":"3831884","reasoning":"Both documents are unrelated to ALDH1 or breast cancer, but Document A (tumor metabolic pathway) is slightly more relevant because ALDH1 is a metabolic enzyme, whereas Document B focuses on the Rb-p16 pathway in lung cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991153Z"}
{"comparison_id":"ba1dc063-f7f3-4b49-83b4-0197e48ba168","query_id":"51","doc_a_id":"27306942","doc_b_id":"3831884","presented_order":["3831884","27306942"],"winner_id":"27306942","reasoning":"Document B is more relevant — it reports an association between gene expression/rearrangement and patient outcomes (though in leukemia rather than breast cancer), whereas A focuses on pancreatic metabolic pathways unrelated to marker–outcome associations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991161Z"}
{"comparison_id":"6e702412-f97f-4a25-8da2-def5583dcea3","query_id":"51","doc_a_id":"20738970","doc_b_id":"3831884","presented_order":["20738970","3831884"],"winner_id":"20738970","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes; both are irrelevant. Document A is slightly more related to cancer biomarker/expression studies (though in SCLC, not breast).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991167Z"}
{"comparison_id":"82d59b03-caca-40c7-9b0a-bfcccbdf8d7d","query_id":"51","doc_a_id":"14938990","doc_b_id":"3831884","presented_order":["14938990","3831884"],"winner_id":"3831884","reasoning":"Both documents are irrelevant to ALDH1 or breast cancer; Document B is slightly more relevant because it addresses cancer metabolism, whereas A concerns autoimmune disease. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991174Z"}
{"comparison_id":"28fc7d18-0986-4fb6-be02-1f999c0d3b47","query_id":"51","doc_a_id":"25628793","doc_b_id":"3831884","presented_order":["25628793","3831884"],"winner_id":"25628793","reasoning":"Document A is marginally more related because it deals with hormone-related enzyme expression in gynecologic tissues (closer to breast cancer biology) while Document B focuses on KRAS-driven metabolism in pancreatic cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991180Z"}
{"comparison_id":"1db6192f-8837-4c3f-b26e-77d7c8e94eca","query_id":"51","doc_a_id":"17876040","doc_b_id":"3831884","presented_order":["17876040","3831884"],"winner_id":"17876040","reasoning":"Document A is slightly more relevant because it discusses cancer therapy and survival outcomes, which is closer to the claim about prognostic associations in cancer; Document B focuses on pancreatic metabolic pathways rather than clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991187Z"}
{"comparison_id":"5a5006a2-0a62-4cf0-a12d-f3525ad08afa","query_id":"51","doc_a_id":"3052213","doc_b_id":"3831884","presented_order":["3052213","3831884"],"winner_id":"3831884","reasoning":"Document B — it discusses cancer (pancreatic) biology, so it's more related to cancer outcomes than Document A which is about adipocytes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991194Z"}
{"comparison_id":"4594a7f9-7630-4d15-bcf4-dc73e25d0b99","query_id":"51","doc_a_id":"26902591","doc_b_id":"3831884","presented_order":["3831884","26902591"],"winner_id":"26902591","reasoning":"Document B — it discusses cancer-related tissue changes and systemic effects (cachexia), which is slightly more connected to cancer outcomes than a PDAC-specific metabolic pathway. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991200Z"}
{"comparison_id":"fdacabf9-0d9c-40d3-82ed-d2611c6c4243","query_id":"51","doc_a_id":"293661","doc_b_id":"3831884","presented_order":["3831884","293661"],"winner_id":"293661","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is marginally more relevant because it addresses cancer metabolism and treatment outcomes broadly, whereas A is specific to KRAS-driven pancreatic cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991207Z"}
{"comparison_id":"da05d128-a4fb-46dd-9a64-d7c49a1e1bb7","query_id":"51","doc_a_id":"26488879","doc_b_id":"3831884","presented_order":["26488879","3831884"],"winner_id":"3831884","reasoning":"Document B is more relevant — it discusses cancer biology and tumor growth pathways (though in pancreatic cancer), whereas A is about bacterial proteins and gastric inflammation unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991214Z"}
{"comparison_id":"0c1a1096-a972-42e3-b480-39b029f2ac37","query_id":"51","doc_a_id":"2360905","doc_b_id":"3831884","presented_order":["3831884","2360905"],"winner_id":"2360905","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it addresses gene expression and clinical differences in cancers, whereas A focuses on a metabolic pathway in pancreatic cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991221Z"}
{"comparison_id":"487ec6cc-0f3b-4469-8a0c-683028a231e7","query_id":"51","doc_a_id":"663464","doc_b_id":"3831884","presented_order":["663464","3831884"],"winner_id":"3831884","reasoning":"Document B is more relevant because it addresses cancer biology (tumor growth pathways), whereas Document A concerns age-related microRNA expression and general mortality, not cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991228Z"}
{"comparison_id":"83107b79-8bbf-401f-8687-9a57eeba8d96","query_id":"51","doc_a_id":"520579","doc_b_id":"3831884","presented_order":["3831884","520579"],"winner_id":"3831884","reasoning":"Document A is slightly more relevant because it addresses cancer cell biology and molecular pathways, whereas Document B concerns vitamin D and colorectal cancer epidemiology, not ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991235Z"}
{"comparison_id":"68375dbb-8c8e-4d4d-87e1-940fddf62ba7","query_id":"51","doc_a_id":"4729644","doc_b_id":"3831884","presented_order":["4729644","3831884"],"winner_id":"4729644","reasoning":"Document A — it's about gene expression and cancer treatment outcomes (drug resistance), which is closer to a claim about a marker's association with cancer outcomes than Document B's metabolic pathway in pancreatic cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991242Z"}
{"comparison_id":"658acddf-4eed-41f8-a6eb-bccd3f6e6739","query_id":"51","doc_a_id":"4468861","doc_b_id":"3831884","presented_order":["3831884","4468861"],"winner_id":"4468861","reasoning":"Document B — it discusses cancer treatment responses and mechanisms affecting tumor regression, while A is about pancreatic metabolic pathways unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991249Z"}
{"comparison_id":"b923be5b-d021-47d9-9230-e459defbb8ce","query_id":"51","doc_a_id":"33030946","doc_b_id":"3831884","presented_order":["3831884","33030946"],"winner_id":"3831884","reasoning":"Neither document mentions ALDH1 or breast cancer, but Document A is marginally more relevant because it addresses cancer biology (pancreatic cancer) while Document B focuses on macrophage/osteoclast biology. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991255Z"}
{"comparison_id":"3ac905ee-9b24-4e37-af8f-d41bb973cf07","query_id":"51","doc_a_id":"38355793","doc_b_id":"3831884","presented_order":["3831884","38355793"],"winner_id":"3831884","reasoning":"Document A is slightly more relevant — it discusses cancer metabolic pathways and enzyme-mediated tumor support, whereas Document B addresses A20 in glioma; neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991262Z"}
{"comparison_id":"b74a294c-e4e5-42dc-8697-f1ba564b83b9","query_id":"51","doc_a_id":"16016673","doc_b_id":"3831884","presented_order":["3831884","16016673"],"winner_id":"3831884","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document A is marginally more relevant because it discusses tumor biology/metabolic pathways, whereas Document B focuses on bladder cancer methylation markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991269Z"}
{"comparison_id":"7115b5aa-4362-4efa-8a34-218f8ea0bb85","query_id":"51","doc_a_id":"23934390","doc_b_id":"3831884","presented_order":["3831884","23934390"],"winner_id":"23934390","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is marginally more relevant because it discusses cancer-related biomarkers and prognosis-related biology, whereas A focuses on pancreatic cancer metabolism.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991276Z"}
{"comparison_id":"ef0e8733-05af-4443-8ef6-e1ecf208011c","query_id":"51","doc_a_id":"4841908","doc_b_id":"3831884","presented_order":["4841908","3831884"],"winner_id":"4841908","reasoning":"Document A is marginally more relevant because it addresses associations with longevity and explicitly notes lack of association with cancer, whereas B focuses on pancreatic cancer metabolism unrelated to ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991282Z"}
{"comparison_id":"98ba8b54-08e6-42ec-a3e7-78539e969b5d","query_id":"51","doc_a_id":"4387494","doc_b_id":"3831884","presented_order":["4387494","3831884"],"winner_id":"4387494","reasoning":"Both documents are unrelated to ALDH1 or breast cancer; neither addresses ALDH1 expression or breast cancer outcomes. If forced to choose, A is slightly more relevant because it concerns cancer-related gene regulation and therapeutic outcomes, whereas B focuses on pancreatic-specific metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991289Z"}
{"comparison_id":"079f7e55-421b-462a-ae36-048a8d793eca","query_id":"51","doc_a_id":"21414718","doc_b_id":"3831884","presented_order":["3831884","21414718"],"winner_id":"21414718","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document B at least concerns cancer cell behavior and potential prognostic/therapeutic markers, making it slightly more relevant than a pancreatic metabolic pathway.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991296Z"}
{"comparison_id":"00f64a7f-8513-4ee2-9292-acbbc0eb6068","query_id":"51","doc_a_id":"23601616","doc_b_id":"3831884","presented_order":["23601616","3831884"],"winner_id":"23601616","reasoning":"Document A is more relevant — it links increased gene expression to improved outcomes (though in a different gene and disease), whereas B is about pancreatic cancer metabolism with no expression–outcome association.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991304Z"}
{"comparison_id":"6d2f9dab-0c31-48b6-aac1-7b1db944b814","query_id":"51","doc_a_id":"5278233","doc_b_id":"3831884","presented_order":["5278233","3831884"],"winner_id":"3831884","reasoning":"Document B — it discusses cancer biology (tumor metabolic pathways), which is marginally closer to the claim about cancer outcomes than Document A, which concerns imprinting in Beckwith–Wiedemann syndrome. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991311Z"}
{"comparison_id":"4630e08e-e5c9-4118-8d4c-379426d9e14e","query_id":"51","doc_a_id":"20568364","doc_b_id":"3831884","presented_order":["20568364","3831884"],"winner_id":"20568364","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is slightly more relevant because it addresses tumor signaling and growth/angiogenesis (general cancer outcomes), while B is specific to pancreatic metabolic pathways.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991318Z"}
{"comparison_id":"a28fe883-0025-4b82-8b32-74db328dadb2","query_id":"51","doc_a_id":"23013317","doc_b_id":"3831884","presented_order":["23013317","3831884"],"winner_id":"3831884","reasoning":"Document B — it's about cancer biology (tumor metabolic pathways), so it's closer to the query about a cancer marker than Document A, which concerns hypoalbuminemia in acute illness. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991325Z"}
{"comparison_id":"29db3925-df24-4877-871f-11e3bc0da984","query_id":"51","doc_a_id":"43334921","doc_b_id":"3831884","presented_order":["3831884","43334921"],"winner_id":"3831884","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is at least a molecular cancer study (though about pancreatic cancer), so it's marginally more related than B's colorectal epidemiology.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991332Z"}
{"comparison_id":"b22a1597-53a1-473c-9641-5815a5fd8256","query_id":"51","doc_a_id":"57783564","doc_b_id":"3831884","presented_order":["57783564","3831884"],"winner_id":"57783564","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant because it discusses cancer marker-mediated effects on tumor proliferation, whereas B focuses on pancreatic cancer metabolism. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991339Z"}
{"comparison_id":"293138dc-e2ed-4e60-b077-6725fc9c0af8","query_id":"51","doc_a_id":"40234452","doc_b_id":"3831884","presented_order":["3831884","40234452"],"winner_id":"3831884","reasoning":"Reason: Document A discusses cancer biology (tumor metabolism), which is more related to breast cancer outcome questions than Document B's focus on hematopoietic stem cell preservation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991346Z"}
{"comparison_id":"f2fcffdf-0935-4814-8e3d-816601bd9478","query_id":"51","doc_a_id":"3710557","doc_b_id":"3831884","presented_order":["3710557","3831884"],"winner_id":"3710557","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document A is marginally more relevant because it discusses cancer signaling/tumorigenesis (though in liver), whereas B focuses on pancreatic metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991353Z"}
{"comparison_id":"b85ea1cc-18d1-4751-88a2-5f96df30f4a6","query_id":"51","doc_a_id":"7639744","doc_b_id":"3831884","presented_order":["7639744","3831884"],"winner_id":"7639744","reasoning":"Document A is more relevant — it discusses cancer prognosis and survival outcomes (though in lung cancer), while B focuses on metabolic pathways in pancreatic cancer and not on outcomes or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991360Z"}
{"comparison_id":"7573f836-2560-47f1-a50c-f7feb3c03b8e","query_id":"51","doc_a_id":"12903921","doc_b_id":"3831884","presented_order":["12903921","3831884"],"winner_id":"3831884","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it discusses cancer cell metabolism and tumor growth, whereas A is an animal study of leukemia-related oxidative stress.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991367Z"}
{"comparison_id":"f0485602-247c-4fea-bbc9-506ef5b325d5","query_id":"51","doc_a_id":"12650610","doc_b_id":"3831884","presented_order":["12650610","3831884"],"winner_id":"12650610","reasoning":"Neither document discusses ALDH1 or breast cancer; Document A is slightly more relevant because it deals with cancer progression signaling, whereas B focuses on pancreatic metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991373Z"}
{"comparison_id":"20cadc92-c7b6-47d4-8e2f-287ea48f6179","query_id":"51","doc_a_id":"9196472","doc_b_id":"3831884","presented_order":["3831884","9196472"],"winner_id":"9196472","reasoning":"Document B is more relevant — it discusses gene expression and disease associations, which is closer to a claim about ALDH1 expression and cancer outcomes; Document A is specific to pancreatic glutamine metabolism. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991380Z"}
{"comparison_id":"4f37213b-37dc-4475-9463-b10332ace3fb","query_id":"51","doc_a_id":"6121555","doc_b_id":"3831884","presented_order":["6121555","3831884"],"winner_id":"6121555","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant because it addresses protein expression and cancer cell survival mechanisms. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991387Z"}
{"comparison_id":"d28ddb7b-8f2e-4aa6-9270-52b80d70641c","query_id":"51","doc_a_id":"85665741","doc_b_id":"3831884","presented_order":["85665741","3831884"],"winner_id":"85665741","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more related because it addresses a cancer biomarker predicting treatment response/outcome, whereas B focuses on pancreatic cancer metabolism. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991394Z"}
{"comparison_id":"53321d72-b267-46b1-9304-384bdd0a2552","query_id":"51","doc_a_id":"24916604","doc_b_id":"3831884","presented_order":["24916604","3831884"],"winner_id":"24916604","reasoning":"Document A is more relevant — it concerns clinical treatment practices in cancer care (likely including breast cancer contexts), whereas Document B discusses pancreatic cancer metabolism unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991400Z"}
{"comparison_id":"ffa6bdfb-64b7-4cc3-88c9-285b664cd02d","query_id":"51","doc_a_id":"25738896","doc_b_id":"3831884","presented_order":["25738896","3831884"],"winner_id":"25738896","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it concerns cancer immunology, whereas B focuses on pancreatic cancer metabolism. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991407Z"}
{"comparison_id":"f636e838-e63a-4ab0-b600-93d5cdb1536e","query_id":"51","doc_a_id":"16853734","doc_b_id":"3831884","presented_order":["3831884","16853734"],"winner_id":"3831884","reasoning":"Document A is slightly more relevant because it discusses cancer-related molecular pathways and tumor growth, whereas Document B focuses on MSC migration toward glioma; neither mentions ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991414Z"}
{"comparison_id":"e356912c-d737-42ab-911e-df3fd28b30aa","query_id":"51","doc_a_id":"28334217","doc_b_id":"3831884","presented_order":["28334217","3831884"],"winner_id":"28334217","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it addresses tumor growth and survival outcomes, whereas B focuses on pancreatic KRAS-driven metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991421Z"}
{"comparison_id":"531e965e-3378-47b2-8f94-4f8173ff3785","query_id":"51","doc_a_id":"9226649","doc_b_id":"3831884","presented_order":["3831884","9226649"],"winner_id":"3831884","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes; both are irrelevant. Document A is marginally more relevant because it deals with cancer biology (tumor metabolic pathways) rather than immune-regulated colon tumorigenesis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991428Z"}
{"comparison_id":"4e7ca3e4-80a6-44d3-8d3f-605153ded1e0","query_id":"51","doc_a_id":"3545805","doc_b_id":"3831884","presented_order":["3831884","3545805"],"winner_id":"3831884","reasoning":"Document A — it discusses tumor metabolic pathways and enzymes (more related to metabolic markers like ALDH1), while B is melanoma immunotherapy and unrelated to ALDH1 or breast cancer outcomes.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991435Z"}
{"comparison_id":"d99940b6-a233-4243-871e-e7e30e6cade5","query_id":"51","doc_a_id":"5372432","doc_b_id":"3831884","presented_order":["5372432","3831884"],"winner_id":"5372432","reasoning":"Document A is slightly more relevant because it relates to cancer outcomes/diagnosis, whereas Document B concerns a KRAS-regulated metabolic pathway in pancreatic cancer unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991441Z"}
{"comparison_id":"14264f79-b8f3-4cf4-b843-9741e0f6185c","query_id":"51","doc_a_id":"8702697","doc_b_id":"3831884","presented_order":["8702697","3831884"],"winner_id":"8702697","reasoning":"Document A is slightly more relevant — it addresses tumor aggressiveness and EMT (cancer outcome–related processes), whereas Document B focuses on pancreatic metabolic pathways unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991449Z"}
{"comparison_id":"ca53b5ba-0771-483f-90a2-4150dc7a2102","query_id":"51","doc_a_id":"4959368","doc_b_id":"3831884","presented_order":["4959368","3831884"],"winner_id":"4959368","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it examines a biomarker–outcome association in human cancer, whereas B focuses on a KRAS-regulated metabolic pathway in PDAC cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991456Z"}
{"comparison_id":"bb19be51-1c45-4be7-bdec-30eae4a0d555","query_id":"51","doc_a_id":"6948886","doc_b_id":"3831884","presented_order":["3831884","6948886"],"winner_id":"6948886","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are irrelevant, but Document B (glioblastoma epigenetic regulation of tumorigenicity) is slightly more related conceptually to cancer stemness/markers than A. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991492Z"}
{"comparison_id":"79afaf2a-5004-4ce4-83be-28b73aa110f8","query_id":"51","doc_a_id":"27167110","doc_b_id":"3831884","presented_order":["27167110","3831884"],"winner_id":"27167110","reasoning":"Document A is more relevant because it discusses molecular markers and cancer regulation (though in prostate cancer), while Document B focuses on pancreatic metabolism and is further removed from ALDH1 and breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991507Z"}
{"comparison_id":"4353b10c-039f-4c72-a5f7-d826d6336bae","query_id":"51","doc_a_id":"15928989","doc_b_id":"3831884","presented_order":["15928989","3831884"],"winner_id":"3831884","reasoning":"Document B is more relevant — it concerns cancer biology (though pancreatic, not breast), whereas A is about pregnancy and unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991517Z"}
{"comparison_id":"f052550f-9ca4-4f9e-b25b-c15233687964","query_id":"51","doc_a_id":"17671145","doc_b_id":"3831884","presented_order":["17671145","3831884"],"winner_id":"17671145","reasoning":"Both documents are irrelevant (neither mentions ALDH1 or breast cancer). Document A is slightly more relevant only in that it addresses cancer-related gene expression, whereas B focuses on pancreatic metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991524Z"}
{"comparison_id":"af9e2719-6aa8-4043-9cf5-12f26ccc00cb","query_id":"51","doc_a_id":"25452937","doc_b_id":"3831884","presented_order":["3831884","25452937"],"winner_id":"25452937","reasoning":"Document B is slightly more relevant because it addresses associations between a biomarker (TAM density) and cancer outcomes, whereas Document A focuses on pancreatic metabolic pathways unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991531Z"}
{"comparison_id":"e7c19d98-ab4d-45af-9844-4a04fb57980a","query_id":"51","doc_a_id":"42150015","doc_b_id":"3831884","presented_order":["42150015","3831884"],"winner_id":"3831884","reasoning":"Document B is slightly more relevant because it addresses cancer biology (tumor metabolic pathways), whereas Document A concerns reproductive hormone levels in healthy premenopausal women and is unrelated to cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991538Z"}
{"comparison_id":"94b62c55-01de-4972-90b7-ff9e65ffadf5","query_id":"51","doc_a_id":"15215393","doc_b_id":"3831884","presented_order":["3831884","15215393"],"winner_id":"3831884","reasoning":"Neither document discusses ALDH1 or breast cancer, so both are irrelevant to the claim. If forced to choose, Document A is marginally more relevant because it addresses cancer biology broadly, whereas B is specific to glioblastoma therapy.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991545Z"}
{"comparison_id":"3eff8d6b-e9dc-4041-adc6-fb546da96cec","query_id":"51","doc_a_id":"12145359","doc_b_id":"3831884","presented_order":["12145359","3831884"],"winner_id":"3831884","reasoning":"Neither document is relevant — neither mentions ALDH1 or breast cancer outcomes. If forced to pick the slightly more related one, ANSWER: B (it deals with cancer biology, whereas A is about lung function and lung cancer risk).","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991552Z"}
{"comparison_id":"cc518111-e60d-4fb7-bf19-44e634975d9c","query_id":"51","doc_a_id":"14848619","doc_b_id":"3831884","presented_order":["3831884","14848619"],"winner_id":"14848619","reasoning":"Neither document mentions ALDH1 or breast cancer, so neither provides evidence for the claim. Document B is marginally more relevant because it addresses mechanisms of tumor/ cell survival under hypoxia, which can affect cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991559Z"}
{"comparison_id":"ccb6d857-37e2-4dfd-a85b-60720a53f6cf","query_id":"51","doc_a_id":"23286603","doc_b_id":"3831884","presented_order":["23286603","3831884"],"winner_id":"3831884","reasoning":"Doc B is more relevant because it addresses cancer biology (though pancreatic), whereas Doc A concerns macrophage cholesterol efflux/atherosclerosis and not cancer or ALDH1.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991566Z"}
{"comparison_id":"6e2a117b-ec9f-47b7-a3c3-1ea36f334f59","query_id":"51","doc_a_id":"5123516","doc_b_id":"3831884","presented_order":["3831884","5123516"],"winner_id":"5123516","reasoning":"Neither paper addresses ALDH1 or breast cancer; however, Document B (EphA3 and tumorigenicity) is slightly more relevant because it deals with tumor markers and stem-like tumor behavior, whereas A focuses on pancreatic glutamine metabolism.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991572Z"}
{"comparison_id":"81558f23-cfec-4142-b110-6194f5fd95de","query_id":"51","doc_a_id":"5468807","doc_b_id":"3831884","presented_order":["5468807","3831884"],"winner_id":"5468807","reasoning":"Neither document addresses ALDH1 or breast cancer (both are irrelevant); picking A as slightly more related by cancer type proximity. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991579Z"}
{"comparison_id":"c4f1a3af-f785-4a68-91b9-5d5b27a8e224","query_id":"51","doc_a_id":"22059387","doc_b_id":"3831884","presented_order":["22059387","3831884"],"winner_id":"22059387","reasoning":"Document A is marginally more relevant — it discusses expression changes and carcinogenic mechanisms, whereas Document B focuses on pancreatic glutamine metabolism; neither addresses ALDH1 or breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991586Z"}
{"comparison_id":"38263db0-201a-451b-adf0-cb5c29c40aef","query_id":"51","doc_a_id":"3619931","doc_b_id":"3831884","presented_order":["3831884","3619931"],"winner_id":"3831884","reasoning":"Doc A is cancer-related (tumor metabolism) while Doc B is about lung fibrosis; A is therefore somewhat more relevant to a claim about cancer biomarkers/outcomes.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991593Z"}
{"comparison_id":"b83539a6-7c74-4a5e-bce1-b926b8fc9763","query_id":"51","doc_a_id":"4434951","doc_b_id":"3831884","presented_order":["3831884","4434951"],"winner_id":"3831884","reasoning":"Document A is more relevant because it concerns cancer biology (though pancreatic, not breast), whereas Document B is about aging/epigenetics in mice and unrelated to cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991599Z"}
{"comparison_id":"d749126a-1f1b-4f19-a553-abe6711e8c55","query_id":"51","doc_a_id":"1982286","doc_b_id":"3831884","presented_order":["3831884","1982286"],"winner_id":"3831884","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes; both are irrelevant. If one must be chosen, A is marginally more related because it discusses cancer biology (pancreatic) rather than a leukemia-specific transcriptional study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991606Z"}
{"comparison_id":"592aeba8-bc55-4b4a-b902-27708c4d7041","query_id":"51","doc_a_id":"14672919","doc_b_id":"3831884","presented_order":["3831884","14672919"],"winner_id":"14672919","reasoning":"Neither paper discusses ALDH1 or breast cancer. Document B is marginally more relevant because it concerns prognostic biomarkers and cancer outcomes, whereas A addresses pancreatic metabolism.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991613Z"}
{"comparison_id":"41dde466-1a67-4739-b411-dbb93bbe3807","query_id":"51","doc_a_id":"36838958","doc_b_id":"3831884","presented_order":["3831884","36838958"],"winner_id":"3831884","reasoning":"Document A — it at least concerns cancer biology (tumor growth pathways), while Document B is about adipose tissue thermogenesis and unrelated to cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991620Z"}
{"comparison_id":"189593a8-a062-4db4-b871-f7d9df7fecd5","query_id":"51","doc_a_id":"24323369","doc_b_id":"3831884","presented_order":["3831884","24323369"],"winner_id":"3831884","reasoning":"Document A is slightly more relevant because it concerns cancer biology (though pancreatic, not breast, and does not mention ALDH1); Document B is unrelated (PCOS/ovulation). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991628Z"}
{"comparison_id":"c572d23e-8a2e-4a95-896a-ee669e93079b","query_id":"51","doc_a_id":"3504761","doc_b_id":"3831884","presented_order":["3831884","3504761"],"winner_id":"3831884","reasoning":"Neither document addresses ALDH1 or breast cancer; Document A is marginally more relevant because it discusses cancer biology (pancreatic tumor metabolism) versus Document B's focus on liver metabolism. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991636Z"}
{"comparison_id":"0f35d5b1-c139-4af1-b4f2-c45dee6591e0","query_id":"51","doc_a_id":"7869794","doc_b_id":"3831884","presented_order":["7869794","3831884"],"winner_id":"7869794","reasoning":"Document A is marginally more related because it addresses tumor cell biology and immune-mediated tumor responses, whereas Document B focuses on pancreatic cancer metabolism unrelated to ALDH1 or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991644Z"}
{"comparison_id":"12f26e6b-c068-45aa-bd6e-4accc0becdfe","query_id":"51","doc_a_id":"5783785","doc_b_id":"3831884","presented_order":["5783785","3831884"],"winner_id":"5783785","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it concerns cancer progression mechanisms, while B focuses on pancreatic cancer metabolism. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991652Z"}
{"comparison_id":"a0c8998c-22d0-42a6-a2f6-3c385654e39e","query_id":"51","doc_a_id":"22478394","doc_b_id":"3831884","presented_order":["3831884","22478394"],"winner_id":"3831884","reasoning":"Reason: Document A relates to cancer biology (though pancreatic), so it's more relevant to a claim about cancer outcomes than Document B, which focuses on liver obesity/NAFLD.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991658Z"}
{"comparison_id":"b27474b8-8def-4493-b920-fbc0a050943c","query_id":"51","doc_a_id":"10542877","doc_b_id":"3831884","presented_order":["3831884","10542877"],"winner_id":"10542877","reasoning":"Neither document mentions ALDH1 or breast cancer outcomes. Both are irrelevant, but Document B (clinical activity in cancer) is marginally closer to outcomes-related evidence than A (pancreatic metabolic pathway).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991665Z"}
{"comparison_id":"bd976624-db15-459b-949b-db5b093d82bc","query_id":"51","doc_a_id":"24783597","doc_b_id":"3831884","presented_order":["3831884","24783597"],"winner_id":"3831884","reasoning":"Reason: Document A is a cancer study (pancreatic) and thus more related to oncology than Document B, which is about inflammatory bowel disease.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991671Z"}
{"comparison_id":"b518d174-cc0a-4aff-b9a8-9ead860ddde6","query_id":"51","doc_a_id":"667451","doc_b_id":"3831884","presented_order":["667451","3831884"],"winner_id":"667451","reasoning":"Document A is marginally more relevant because it discusses cancer progression and clinical outcomes (though in CLL), whereas Document B focuses on metabolic mechanisms in pancreatic cancer unrelated to ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991677Z"}
{"comparison_id":"3bdcf84e-30a2-4d7f-bd9c-536b92f93113","query_id":"51","doc_a_id":"5691302","doc_b_id":"3831884","presented_order":["5691302","3831884"],"winner_id":"3831884","reasoning":"Document B is more relevant — it concerns cancer biology (tumor metabolic pathways), whereas Document A is about antidepressant risks in older adults and unrelated to cancer biomarkers. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991685Z"}
{"comparison_id":"186a62da-85ac-41e1-879a-030a61c7808f","query_id":"51","doc_a_id":"1836154","doc_b_id":"3831884","presented_order":["1836154","3831884"],"winner_id":"1836154","reasoning":"Document A is slightly more relevant because it covers gene expression and cancer genomics (where ALDH1 expression would be discussed), whereas Document B focuses on pancreatic metabolic pathways unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991691Z"}
{"comparison_id":"eb2e05e4-cfe2-47f6-b495-039563ef0ac4","query_id":"51","doc_a_id":"24190159","doc_b_id":"3831884","presented_order":["3831884","24190159"],"winner_id":"24190159","reasoning":"Neither abstract mentions ALDH1 or breast cancer. Document B is slightly more relevant because it concerns gene expression in carcinomas and treatment outcomes, whereas A focuses on pancreatic metabolism.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991697Z"}
{"comparison_id":"1a8fe14b-1ad7-4e95-bfb0-e18c4b6b16d1","query_id":"51","doc_a_id":"13905670","doc_b_id":"3831884","presented_order":["3831884","13905670"],"winner_id":"13905670","reasoning":"Reason: Document B concerns genetic regulation of disease prognosis (associations with outcomes), which is conceptually closer to a claim about a biomarker's association with cancer outcomes than Document A, which discusses pancreatic metabolic pathways unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991704Z"}
{"comparison_id":"026f8084-1232-437f-a13d-16f33b1e0490","query_id":"51","doc_a_id":"18882947","doc_b_id":"3831884","presented_order":["3831884","18882947"],"winner_id":"18882947","reasoning":"Neither discusses ALDH1 or breast cancer; Document B is slightly more relevant because it addresses cancer biology/tumor suppression, whereas A focuses on pancreatic metabolic pathways. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991712Z"}
{"comparison_id":"8357b442-5c75-49fd-8e37-1f49b8029fa2","query_id":"51","doc_a_id":"19427410","doc_b_id":"3831884","presented_order":["19427410","3831884"],"winner_id":"3831884","reasoning":"Document B is more relevant — it concerns cancer metabolic pathways and tumor biology, while Document A is about IL-33 in adipocytes and unrelated to cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991718Z"}
{"comparison_id":"e3733c51-136c-450d-9451-34cf1f9c748d","query_id":"51","doc_a_id":"25036988","doc_b_id":"3831884","presented_order":["3831884","25036988"],"winner_id":"3831884","reasoning":"Neither document discusses ALDH1 or breast cancer; Document A is slightly more relevant only because it addresses cancer metabolism, which is closer to an enzyme-related claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991725Z"}
{"comparison_id":"e08c8815-5f40-44c2-bade-b50d5f0bbfbf","query_id":"51","doc_a_id":"19800147","doc_b_id":"3831884","presented_order":["19800147","3831884"],"winner_id":"19800147","reasoning":"Document A is more relevant — it discusses marker expression and links to cancer progression and patient samples, whereas B focuses on a metabolic pathway in pancreatic cancer unrelated to ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991733Z"}
{"comparison_id":"1830424b-28ae-4034-8d5b-15e6172020f2","query_id":"51","doc_a_id":"5573975","doc_b_id":"3831884","presented_order":["3831884","5573975"],"winner_id":"3831884","reasoning":"Document A is more related to cancer biology (tumor metabolism and growth), making it closer to a claim about breast cancer markers than Document B, which concerns kidney regeneration. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991740Z"}
{"comparison_id":"bc313111-ae72-4eab-bcb7-2a6fa06b91b6","query_id":"51","doc_a_id":"6290112","doc_b_id":"3831884","presented_order":["3831884","6290112"],"winner_id":"3831884","reasoning":"Document A is more relevant — it concerns cancer biology (though pancreatic), whereas Document B is about AMY1 and obesity, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991747Z"}
{"comparison_id":"1c15557e-579f-4316-8d0d-4109cb38a618","query_id":"51","doc_a_id":"33740844","doc_b_id":"3831884","presented_order":["33740844","3831884"],"winner_id":"3831884","reasoning":"Reason: Both documents don't address ALDH1 or breast cancer outcomes, but Document B discusses cancer biology (tumor metabolic pathways), making it marginally more relevant than a pregnancy nutrition review.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991754Z"}
{"comparison_id":"85896d91-5ba4-4b60-9edb-0dda6e7d148f","query_id":"51","doc_a_id":"67787658","doc_b_id":"3831884","presented_order":["67787658","3831884"],"winner_id":"67787658","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes, so neither is relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991762Z"}
{"comparison_id":"826dcad1-46a3-4a9f-8098-526520d9b763","query_id":"51","doc_a_id":"13398997","doc_b_id":"3831884","presented_order":["13398997","3831884"],"winner_id":"3831884","reasoning":"Document B is more relevant — it deals with cancer biology and tumor metabolic pathways, whereas Document A focuses on T cell immunology in transplantation. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991771Z"}
{"comparison_id":"1f7e0edc-b707-46d7-b445-6b661b2c1e5a","query_id":"51","doc_a_id":"18682109","doc_b_id":"3831884","presented_order":["18682109","3831884"],"winner_id":"18682109","reasoning":"Document A is slightly more relevant because it discusses cancer molecular marker changes, whereas Document B focuses on pancreatic metabolic pathways unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991777Z"}
{"comparison_id":"819ff1f8-e967-4dfb-9653-d6e11b4bc97c","query_id":"51","doc_a_id":"20659283","doc_b_id":"3831884","presented_order":["3831884","20659283"],"winner_id":"3831884","reasoning":"Document A — it deals with cancer biology (tumor metabolism), whereas Document B focuses on species-specific CYP3A regulation; neither mentions ALDH1 or breast cancer, but A is marginally more related.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991785Z"}
{"comparison_id":"fa473170-bb37-49e5-a533-70dbaf957f94","query_id":"51","doc_a_id":"33076846","doc_b_id":"3831884","presented_order":["33076846","3831884"],"winner_id":"3831884","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is marginally more relevant because it directly addresses cancer biology (tumor metabolic pathway), whereas A focuses on megakaryocyte endomitosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991792Z"}
{"comparison_id":"55babb3e-7e5e-440f-94a1-cb606cb306c6","query_id":"51","doc_a_id":"9478135","doc_b_id":"3831884","presented_order":["9478135","3831884"],"winner_id":"9478135","reasoning":"Document A is slightly more relevant because it reports associations between molecular markers and clinical outcomes (though in leukemia, not breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991798Z"}
{"comparison_id":"f1c1c06b-af97-4707-a8d8-05fb0ed88a07","query_id":"51","doc_a_id":"28644298","doc_b_id":"3831884","presented_order":["28644298","3831884"],"winner_id":"3831884","reasoning":"Neither mentions ALDH1 or breast cancer; Document B is marginally more relevant because it addresses cancer biology (pancreatic) while A is focused on EBV/lymphoid cells. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991805Z"}
{"comparison_id":"b9ed4176-b75c-4652-ad2a-fde098dda382","query_id":"51","doc_a_id":"6374918","doc_b_id":"3831884","presented_order":["3831884","6374918"],"winner_id":"6374918","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are irrelevant, but B is slightly more related to treatment outcomes (chemosensitivity), so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991812Z"}
{"comparison_id":"b8489878-0019-4f4b-8853-7028c0d64246","query_id":"51","doc_a_id":"14972169","doc_b_id":"3831884","presented_order":["3831884","14972169"],"winner_id":"3831884","reasoning":"Document A — it's cancer-related (though pancreatic, not breast); Document B concerns embryonic oxidative stress and is unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991819Z"}
{"comparison_id":"b4300449-a71c-4fd6-8763-553312ba87d3","query_id":"51","doc_a_id":"17973161","doc_b_id":"3831884","presented_order":["17973161","3831884"],"winner_id":"3831884","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is marginally more relevant because it deals with cancer metabolism, while A concerns adipocytes and metabolic homeostasis in mice. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991826Z"}
{"comparison_id":"e10591d3-c5de-45e3-ad0b-06aef500ffa2","query_id":"51","doc_a_id":"6766459","doc_b_id":"3831884","presented_order":["3831884","6766459"],"winner_id":"3831884","reasoning":"Document A is slightly more relevant because it concerns cancer biology (tumor metabolism), whereas Document B concerns fever/immune regulation and not cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991832Z"}
{"comparison_id":"9c08727c-0e29-4e01-b207-4ac4b835906d","query_id":"51","doc_a_id":"15322518","doc_b_id":"3831884","presented_order":["15322518","3831884"],"winner_id":"15322518","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant since it concerns cancer biomarkers/therapeutic targets, whereas Document B focuses on pancreatic metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991839Z"}
{"comparison_id":"6040fe05-242c-4c42-b6b5-ba1164660540","query_id":"51","doc_a_id":"4464565","doc_b_id":"3831884","presented_order":["4464565","3831884"],"winner_id":"4464565","reasoning":"Document A is slightly more relevant because it reports modulation of gene expression (potentially including enzymes like ALDH1), whereas Document B focuses on KRAS-driven metabolism in pancreatic cancer, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991845Z"}
{"comparison_id":"c9c17847-0b73-472f-bbb7-89bbee81a327","query_id":"51","doc_a_id":"9513785","doc_b_id":"3831884","presented_order":["3831884","9513785"],"winner_id":"3831884","reasoning":"Document A is more relevant — it discusses cancer metabolism and tumor growth, whereas Document B concerns maternal diet and lifespan in mice, not cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991852Z"}
{"comparison_id":"658990c5-ada1-4341-a3d6-3e1aafb484f6","query_id":"51","doc_a_id":"30543439","doc_b_id":"3831884","presented_order":["30543439","3831884"],"winner_id":"30543439","reasoning":"Neither document discusses ALDH1 or breast cancer; however, Document A at least addresses enzyme function in cancer cells, so it's marginally more relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991859Z"}
{"comparison_id":"bc6e844b-74ce-4913-a2c7-703f6405931d","query_id":"51","doc_a_id":"25725663","doc_b_id":"3831884","presented_order":["25725663","3831884"],"winner_id":"3831884","reasoning":"Document B is more relevant — it concerns cancer biology (tumor metabolic pathways) while A addresses lung epithelial protection from cigarette smoke and not cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991865Z"}
{"comparison_id":"96b4ab9b-b1c2-4020-a3b1-86a26a8fc9d0","query_id":"51","doc_a_id":"15491308","doc_b_id":"3831884","presented_order":["15491308","3831884"],"winner_id":"15491308","reasoning":"Document A is marginally more relevant because it deals with stem cell protein expression and cell growth, whereas Document B focuses on pancreatic cancer metabolism unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991872Z"}
{"comparison_id":"de6ae926-e7a3-4bad-8b69-1747791c65e9","query_id":"51","doc_a_id":"21372171","doc_b_id":"3831884","presented_order":["21372171","3831884"],"winner_id":"3831884","reasoning":"Document B is slightly more relevant because it concerns cancer biology (though pancreatic, not breast, and does not mention ALDH1). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991879Z"}
{"comparison_id":"3ea4ade2-0306-4075-b0d5-0d82e8972112","query_id":"51","doc_a_id":"15803282","doc_b_id":"3831884","presented_order":["15803282","3831884"],"winner_id":"3831884","reasoning":"Document B is slightly more relevant because it addresses cancer biology and tumor survival, whereas Document A concerns stem cell reprogramming unrelated to cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991885Z"}
{"comparison_id":"e96d2534-781d-4069-a4f3-4bfd1874de3d","query_id":"51","doc_a_id":"25022826","doc_b_id":"3831884","presented_order":["25022826","3831884"],"winner_id":"3831884","reasoning":"Document B — it concerns cancer biology and tumor survival pathways, which is closer to a claim about cancer outcomes than Document A's focus on MSC osteogenic differentiation.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991891Z"}
{"comparison_id":"d2bd34ab-ae51-40e9-8331-66190ca793a9","query_id":"51","doc_a_id":"36653415","doc_b_id":"3831884","presented_order":["3831884","36653415"],"winner_id":"36653415","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are irrelevant; DOCUMENT B is slightly more relevant only insofar as it studies metabolism in human tumors. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991898Z"}
{"comparison_id":"e845a925-acd7-4aed-8073-ef17c43ccd7e","query_id":"51","doc_a_id":"19343151","doc_b_id":"3831884","presented_order":["3831884","19343151"],"winner_id":"3831884","reasoning":"Document A is slightly more relevant because it relates to cancer biology (though in pancreatic cancer), whereas Document B is about skin aging and not cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991904Z"}
{"comparison_id":"6f909020-47d9-4411-8c21-40db240690f3","query_id":"51","doc_a_id":"8724666","doc_b_id":"3831884","presented_order":["3831884","8724666"],"winner_id":"8724666","reasoning":"Document B — it discusses stem/progenitor cell states and cancer metabolism (closer to ALDH1’s role as a stem-cell marker) while A is specific to pancreatic KRAS metabolism. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991911Z"}
{"comparison_id":"52c97781-6110-43e4-a7f6-7f9878c2bc60","query_id":"51","doc_a_id":"20460020","doc_b_id":"3831884","presented_order":["3831884","20460020"],"winner_id":"3831884","reasoning":"Reason: Document A concerns cancer biology (tumor metabolism) and is more related to cancer outcomes than Document B, which is about wound healing and macrophage activation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991918Z"}
{"comparison_id":"0d1321a1-109b-4399-89b5-a1b891dee180","query_id":"51","doc_a_id":"32372280","doc_b_id":"3831884","presented_order":["32372280","3831884"],"winner_id":"3831884","reasoning":"Document B — it's about cancer biology (though pancreatic), whereas A is about glaucoma and unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991924Z"}
{"comparison_id":"629e1af8-2252-4fee-8d84-09b00ac0b940","query_id":"51","doc_a_id":"22896384","doc_b_id":"3831884","presented_order":["3831884","22896384"],"winner_id":"3831884","reasoning":"Reason: Document A deals with cancer biology (though pancreatic), making it nearer to a claim about cancer biomarkers/outcomes than Document B, which concerns lung/esophagus development.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991932Z"}
{"comparison_id":"b96b4d40-5a88-4e13-be64-f4e3c3670953","query_id":"51","doc_a_id":"38025907","doc_b_id":"3831884","presented_order":["38025907","3831884"],"winner_id":"3831884","reasoning":"Document B is slightly more relevant because it concerns cancer biology (tumor metabolism), whereas Document A is about liver disease/NAFLD unrelated to cancer markers or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991938Z"}
{"comparison_id":"ea0e4042-541c-4292-b829-009bffc73992","query_id":"51","doc_a_id":"25344732","doc_b_id":"3831884","presented_order":["25344732","3831884"],"winner_id":"25344732","reasoning":"Document A is marginally more relevant because it discusses gene expression changes in tumors (though in osteosarcoma and not ALDH1/breast cancer), while B focuses on pancreatic cancer metabolism unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991945Z"}
{"comparison_id":"7e52bb83-be05-43c3-b100-4c72fa83f10e","query_id":"51","doc_a_id":"26059876","doc_b_id":"3831884","presented_order":["3831884","26059876"],"winner_id":"26059876","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it addresses tumor progression and outcomes (colorectal adenocarcinoma), whereas A focuses on a pancreatic metabolic pathway. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991952Z"}
{"comparison_id":"95c652d4-0d8c-4f7b-9e9a-5a8b175cc6fc","query_id":"51","doc_a_id":"8417211","doc_b_id":"3831884","presented_order":["3831884","8417211"],"winner_id":"3831884","reasoning":"Document A is slightly more relevant because it concerns cancer biology (though pancreatic, not breast, and does not mention ALDH1); Document B is about Drosophila chromatin regulation and unrelated. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991959Z"}
{"comparison_id":"70598809-0191-42de-8c11-2c280cedcd2f","query_id":"51","doc_a_id":"4920376","doc_b_id":"3831884","presented_order":["3831884","4920376"],"winner_id":"3831884","reasoning":"Neither—neither abstract mentions ALDH1 or breast cancer outcomes, so both are irrelevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991966Z"}
{"comparison_id":"a41a0710-13ee-4466-b28c-354ce56cca68","query_id":"51","doc_a_id":"6137330","doc_b_id":"3831884","presented_order":["6137330","3831884"],"winner_id":"3831884","reasoning":"Document B is more relevant — it discusses cancer biology and molecular pathways, which is closer to a claim about a molecular marker (ALDH1) and cancer outcomes than lung nodule management. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991973Z"}
{"comparison_id":"27106f46-c2bc-4a71-88c8-0961a53f659c","query_id":"51","doc_a_id":"17775228","doc_b_id":"3831884","presented_order":["17775228","3831884"],"winner_id":"17775228","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it concerns cancer genetics (colorectal) vs. Document B which is specific to pancreatic metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991980Z"}
{"comparison_id":"a319dc76-dab8-4fd7-b300-ec95ae7c0d69","query_id":"51","doc_a_id":"4641348","doc_b_id":"3831884","presented_order":["4641348","3831884"],"winner_id":"3831884","reasoning":"Document B is more relevant because it discusses cancer biology (tumor metabolic pathways), whereas Document A addresses fatty liver disease unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991987Z"}
{"comparison_id":"d9e32e38-47ed-433d-9a7a-a8337950b1f4","query_id":"51","doc_a_id":"2359152","doc_b_id":"3831884","presented_order":["3831884","2359152"],"winner_id":"2359152","reasoning":"Document B is more relevant — it deals with cancer-associated biomarkers and prognostic models (outcomes associations), whereas Document A focuses on a metabolic pathway in pancreatic cancer unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.991994Z"}
{"comparison_id":"cde7e6f5-da10-4268-873a-07c160bc9787","query_id":"51","doc_a_id":"39481265","doc_b_id":"3831884","presented_order":["39481265","3831884"],"winner_id":"39481265","reasoning":"Document A is slightly more relevant because it discusses biomarkers and prognosis (outcomes), whereas Document B focuses on pancreatic cancer metabolism unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.992001Z"}
{"comparison_id":"1e3705a2-f2b4-4ed3-8916-671c13cd5092","query_id":"51","doc_a_id":"22483580","doc_b_id":"3831884","presented_order":["3831884","22483580"],"winner_id":"3831884","reasoning":"Document A is more relevant — it discusses cancer biology (though pancreatic), while Document B concerns sleep and IL-6 in bipolar disorder, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.992008Z"}
{"comparison_id":"5ad53b37-167f-4d47-b374-b21da5eb8264","query_id":"51","doc_a_id":"8842332","doc_b_id":"3831884","presented_order":["8842332","3831884"],"winner_id":"3831884","reasoning":"Document B — it discusses cancer biology (though pancreatic, not breast), whereas A is unrelated (type 1 diabetes in pregnancy). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.992014Z"}
{"comparison_id":"9fe1ccaf-e871-490b-8cc6-4fda7c24efaf","query_id":"51","doc_a_id":"5765455","doc_b_id":"3831884","presented_order":["3831884","5765455"],"winner_id":"3831884","reasoning":"Neither abstract addresses ALDH1 or breast cancer directly; Document A (solid tumor metabolic study) is marginally more relevant than B (myeloid leukemia focus). \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.992021Z"}
{"comparison_id":"4a147dc8-a752-4b03-ab1a-d6f8bff40104","query_id":"51","doc_a_id":"24586989","doc_b_id":"3831884","presented_order":["3831884","24586989"],"winner_id":"3831884","reasoning":"Document A is more relevant because it discusses cancer biology (though pancreatic, not breast/ALDH1), while Document B is about heart failure genetics and unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.992028Z"}
{"comparison_id":"41e2ecd9-0e69-4c02-be8d-e6d24aaa4e52","query_id":"51","doc_a_id":"5939172","doc_b_id":"3831884","presented_order":["5939172","3831884"],"winner_id":"5939172","reasoning":"Document A is more relevant — it addresses cancer mortality/outcomes, whereas B focuses on a pancreatic cancer metabolic pathway unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.992034Z"}
{"comparison_id":"37823ece-1f7e-457a-acfb-fc203918b05f","query_id":"51","doc_a_id":"1871499","doc_b_id":"3831884","presented_order":["1871499","3831884"],"winner_id":"3831884","reasoning":"Document B — it's cancer-related (pancreatic tumor metabolism), whereas A concerns Huntington's disease and is unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.992042Z"}
{"comparison_id":"d4056204-13ee-41e2-a263-f50b9aab377f","query_id":"51","doc_a_id":"12580014","doc_b_id":"3831884","presented_order":["12580014","3831884"],"winner_id":"12580014","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it concerns gene expression in epithelial tumors, whereas B focuses on pancreatic cancer metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.992055Z"}
{"comparison_id":"1dbcd105-7f62-41d3-b818-eab134195427","query_id":"51","doc_a_id":"8290760","doc_b_id":"3831884","presented_order":["8290760","3831884"],"winner_id":"8290760","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes; both are irrelevant. Document A is slightly more related because it discusses gene expression analyses, whereas B focuses on pancreatic metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.992062Z"}
{"comparison_id":"b8ef92c6-ca25-4549-9b45-30630660ea2e","query_id":"51","doc_a_id":"28390999","doc_b_id":"3831884","presented_order":["3831884","28390999"],"winner_id":"3831884","reasoning":"Document A is more relevant — it's cancer-related (tumor metabolism), while Document B is about chicken gonad development; neither mentions ALDH1 or breast cancer, but A is closer in topic.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.992069Z"}
{"comparison_id":"19fa5614-0f0a-4810-b05c-326dff09e7e1","query_id":"51","doc_a_id":"3202143","doc_b_id":"3831884","presented_order":["3202143","3831884"],"winner_id":"3831884","reasoning":"Document B is more relevant — it concerns cancer biology (metabolic pathways in tumor cells), whereas Document A is about aging and memory in C. elegans and unrelated to cancer or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.992076Z"}
{"comparison_id":"7c068bb0-ce48-4cff-a755-c904ff961850","query_id":"51","doc_a_id":"2356950","doc_b_id":"3831884","presented_order":["3831884","2356950"],"winner_id":"3831884","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer, but Document A deals with cancer metabolism and tumor growth (pancreatic), making it marginally more relevant than Document B's focus on neural stem cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.992083Z"}
{"comparison_id":"2750fd2a-bd72-4ee3-9210-58584d9c0981","query_id":"51","doc_a_id":"20381484","doc_b_id":"3831884","presented_order":["20381484","3831884"],"winner_id":"20381484","reasoning":"Document A — neither discusses ALDH1 or breast cancer, but A at least concerns a dehydrogenase (GAPDH) and nuclear protein regulation, making it marginally more related than a PDAC glutamine-metabolism paper.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.992091Z"}
{"comparison_id":"9c03c987-ac37-42d9-862d-0cf40dae8103","query_id":"51","doc_a_id":"38028419","doc_b_id":"3831884","presented_order":["38028419","3831884"],"winner_id":"3831884","reasoning":"Document B is slightly more relevant because it discusses cancer metabolism (though in pancreatic cancer), whereas Document A is about alcoholic fatty liver disease and unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.992099Z"}
{"comparison_id":"01eb03e9-b4a4-4a41-bf07-2004910cff38","query_id":"51","doc_a_id":"11255504","doc_b_id":"3831884","presented_order":["3831884","11255504"],"winner_id":"3831884","reasoning":"Document A is slightly more relevant — it deals with cancer metabolism, which is more related to ALDH1 (a metabolic enzyme/marker) than a liver mutagenesis screen. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.992106Z"}
{"comparison_id":"d5cd41df-9275-44bf-88a0-bd9492833161","query_id":"51","doc_a_id":"4795303","doc_b_id":"3831884","presented_order":["3831884","4795303"],"winner_id":"3831884","reasoning":"Document A is cancer-focused (tumor metabolism) and thus slightly more relevant to a claim about cancer outcomes than a neuroprotection study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.992112Z"}
{"comparison_id":"67927b5d-d222-4a41-8925-085f13783212","query_id":"51","doc_a_id":"3621011","doc_b_id":"3831884","presented_order":["3831884","3621011"],"winner_id":"3831884","reasoning":"Document A is slightly more relevant because it concerns cancer biology (though pancreatic, not breast); Document B concerns adipose tissue/insulin sensitivity and is unrelated to cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.992119Z"}
{"comparison_id":"28fb6953-d1d5-49e9-be30-f7eb3458a8e5","query_id":"51","doc_a_id":"2829179","doc_b_id":"3831884","presented_order":["3831884","2829179"],"winner_id":"3831884","reasoning":"Document A is more relevant — it concerns cancer biology (though pancreatic, not breast), whereas Document B is about pre-eclampsia and unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.992126Z"}
{"comparison_id":"927dc31a-94bb-4c66-8964-0d62a18f3556","query_id":"51","doc_a_id":"21602220","doc_b_id":"3831884","presented_order":["3831884","21602220"],"winner_id":"3831884","reasoning":"Document A is more relevant because it discusses cancer biology (tumor metabolism), whereas Document B is about E. coli fermentation and unrelated to cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:09.992132Z"}
{"comparison_id":"0e267872-2b29-4307-ba3d-789b4f9e3637","query_id":"51","doc_a_id":"8677721","doc_b_id":"8702697","presented_order":["8677721","8702697"],"winner_id":"8702697","reasoning":"Neither abstract mentions ALDH1 or breast cancer; Document B is slightly more relevant because it addresses tumor aggressiveness and EMT, which relate to cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220231Z"}
{"comparison_id":"9640d222-9316-465f-81df-e039d082dc26","query_id":"51","doc_a_id":"14471161","doc_b_id":"8702697","presented_order":["8702697","14471161"],"winner_id":"8702697","reasoning":"Neither abstract mentions ALDH1 or breast cancer, but Document A discusses tumor cell behavior, EMT and aggressiveness (more related to cancer stem cell markers) whereas B focuses on meal timing in pancreatic cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220252Z"}
{"comparison_id":"0feafa11-3bd7-4cf7-89d2-bf36dc8ad189","query_id":"51","doc_a_id":"24349430","doc_b_id":"8702697","presented_order":["24349430","8702697"],"winner_id":"24349430","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document A is at least about cancer cell biology (lung cancer proliferation), while B is specific to prostate cancer microenvironment, so A is slightly more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220261Z"}
{"comparison_id":"7134a32a-fd3f-4d69-8e86-7bff17ce08e6","query_id":"51","doc_a_id":"31313782","doc_b_id":"8702697","presented_order":["8702697","31313782"],"winner_id":"8702697","reasoning":"Document A is slightly more relevant because it concerns cancer cell aggressiveness and tumor–stroma interactions (though in prostate cancer), whereas Document B focuses on TLR expression in lung disease. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220270Z"}
{"comparison_id":"c0fda1d7-0d1b-4419-b0f4-0368c2e4c8e0","query_id":"51","doc_a_id":"16630996","doc_b_id":"8702697","presented_order":["16630996","8702697"],"winner_id":"16630996","reasoning":"Document A is more relevant — it discusses gene expression markers and therapy response associations in cancer, which is closer to a claim about expression linked to outcomes than Document B's prostate/miR-205 focus. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220278Z"}
{"comparison_id":"8851d1e7-8009-4985-baf2-6057145ab26f","query_id":"51","doc_a_id":"2272614","doc_b_id":"8702697","presented_order":["8702697","2272614"],"winner_id":"8702697","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A is slightly more related to cancer outcomes (tumor aggressiveness), so:\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220285Z"}
{"comparison_id":"78ad18df-3e9f-42b2-a388-48989bcf897e","query_id":"51","doc_a_id":"3355397","doc_b_id":"8702697","presented_order":["3355397","8702697"],"winner_id":"8702697","reasoning":"Document B is more relevant — it addresses molecular expression (miR-205) and tumor aggressiveness, which is closer in scope to a claim about a biomarker's association with cancer outcomes than a pharmacoepidemiology paper. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220293Z"}
{"comparison_id":"d3f343af-ea0f-4b01-8b31-92f1d9033ee7","query_id":"51","doc_a_id":"32852283","doc_b_id":"8702697","presented_order":["8702697","32852283"],"winner_id":"8702697","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is slightly more relevant because it discusses tumor cell behavior and aggressiveness, while B is specific to a drug effect in lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220300Z"}
{"comparison_id":"1c5443f7-a3f1-4f40-8c2b-fb6ba69a5f02","query_id":"51","doc_a_id":"14180565","doc_b_id":"8702697","presented_order":["14180565","8702697"],"winner_id":"8702697","reasoning":"Document B is slightly more relevant — it addresses cancer cell behavior and outcomes (EMT, tumor aggressiveness), which is closer in topic to cancer prognosis than a glioblastoma gene-expression study unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220307Z"}
{"comparison_id":"aae66bc5-356c-4935-84b4-373e6ce16f2b","query_id":"51","doc_a_id":"38808600","doc_b_id":"8702697","presented_order":["38808600","8702697"],"winner_id":"38808600","reasoning":"Document A is slightly more relevant because it discusses a molecular marker linked to prognosis and outcome assessment in cancer (though in glioma), whereas B focuses on miR-205 in prostate cancer without addressing prognostic marker expression. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220314Z"}
{"comparison_id":"36014cab-8841-43b7-a06a-3644c9832a65","query_id":"51","doc_a_id":"52925737","doc_b_id":"8702697","presented_order":["8702697","52925737"],"winner_id":"8702697","reasoning":"Neither document mentions ALDH1 or breast cancer, but Document A discusses tumor aggressiveness and EMT (general cancer outcome–related processes), making it slightly more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220321Z"}
{"comparison_id":"f9763fef-7f00-4b89-a80e-c817b8701041","query_id":"51","doc_a_id":"27306942","doc_b_id":"8702697","presented_order":["27306942","8702697"],"winner_id":"8702697","reasoning":"Document B — it's about cancer cell behavior and markers (though in prostate cancer), whereas Document A concerns leukemia and is unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220328Z"}
{"comparison_id":"c85b8bdb-f43c-4f9f-9d32-26470340a55a","query_id":"51","doc_a_id":"20738970","doc_b_id":"8702697","presented_order":["20738970","8702697"],"winner_id":"20738970","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is slightly more relevant only because it discusses biomarker expression in cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220335Z"}
{"comparison_id":"67a10188-ec7a-4e4c-abf0-2d513e9e530d","query_id":"51","doc_a_id":"25628793","doc_b_id":"8702697","presented_order":["25628793","8702697"],"winner_id":"8702697","reasoning":"Both documents are irrelevant to ALDH1 expression in breast cancer, but Document B is slightly more relevant because it deals with cancer outcomes and tumor aggressiveness (though in prostate cancer, not breast, and it doesn't mention ALDH1). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220342Z"}
{"comparison_id":"ed45cbf0-48d3-41d6-bd9b-ab564be661f6","query_id":"51","doc_a_id":"17876040","doc_b_id":"8702697","presented_order":["17876040","8702697"],"winner_id":"8702697","reasoning":"Document B is slightly more relevant — it discusses tumor aggressiveness, EMT, and markers affecting cancer outcomes (though in prostate cancer, not breast). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220350Z"}
{"comparison_id":"d8b9b867-ed82-455b-aeed-75e61c572ad3","query_id":"51","doc_a_id":"26902591","doc_b_id":"8702697","presented_order":["8702697","26902591"],"winner_id":"8702697","reasoning":"Document A is more relevant — it addresses tumor cell biology and aggressiveness (though in prostate cancer), whereas B concerns cachexia/adipose changes; neither mentions ALDH1 or breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220358Z"}
{"comparison_id":"617c3543-2f7f-4f7b-ab82-e719b44ab471","query_id":"51","doc_a_id":"293661","doc_b_id":"8702697","presented_order":["293661","8702697"],"winner_id":"293661","reasoning":"Both documents are irrelevant to the claim (neither mentions ALDH1 or breast cancer); Document A is slightly more general to cancer biology. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220365Z"}
{"comparison_id":"e6469226-7aa3-47f7-8f8f-6886bdf15194","query_id":"51","doc_a_id":"2360905","doc_b_id":"8702697","presented_order":["8702697","2360905"],"winner_id":"8702697","reasoning":"Document A is more relevant — it concerns tumor aggressiveness and molecular markers in cancer (albeit prostate), whereas Document B focuses on pediatric gliomas unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220373Z"}
{"comparison_id":"4d2c55db-eff5-45dc-966b-4dde0af66dc5","query_id":"51","doc_a_id":"4729644","doc_b_id":"8702697","presented_order":["4729644","8702697"],"winner_id":"8702697","reasoning":"Document B is marginally more relevant — neither mentions ALDH1 or breast cancer, but B addresses tumor aggressiveness and EMT (linked to prognostic markers), whereas A focuses on NEAT1-mediated cisplatin resistance in nasopharyngeal carcinoma. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220382Z"}
{"comparison_id":"c72d56c5-a2b4-4341-9823-40e9342a8246","query_id":"51","doc_a_id":"4468861","doc_b_id":"8702697","presented_order":["4468861","8702697"],"winner_id":"8702697","reasoning":"Document B is slightly more relevant because it addresses cancer cell biology and markers related to tumor aggressiveness and outcomes, whereas Document A focuses on melanoma immunotherapy unrelated to ALDH1 or breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220392Z"}
{"comparison_id":"5ddf6ee4-4dfc-4103-8de9-82b3eb8b46ac","query_id":"51","doc_a_id":"23934390","doc_b_id":"8702697","presented_order":["23934390","8702697"],"winner_id":"23934390","reasoning":"Both documents are irrelevant — neither mentions ALDH1 or breast cancer outcomes. If forced to choose, A is slightly more relevant because it addresses cancer-related marker/function rather than tumor–stroma interactions.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220399Z"}
{"comparison_id":"3506ca72-7ce7-416e-980c-d98e415e3b72","query_id":"51","doc_a_id":"4841908","doc_b_id":"8702697","presented_order":["8702697","4841908"],"winner_id":"8702697","reasoning":"Document A is more relevant because it concerns cancer biology and tumor aggressiveness (though in prostate cancer), whereas Document B is about metabolomics and longevity and states no link to cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220407Z"}
{"comparison_id":"8c6e23ac-bd74-4c80-a9de-ce833adc0be9","query_id":"51","doc_a_id":"4387494","doc_b_id":"8702697","presented_order":["8702697","4387494"],"winner_id":"8702697","reasoning":"Document A is slightly more relevant because it concerns solid tumor biology and tumor aggressiveness, while Document B is about AML; neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220414Z"}
{"comparison_id":"4c9b25c3-00f7-4441-940b-07c9437bd75b","query_id":"51","doc_a_id":"21414718","doc_b_id":"8702697","presented_order":["8702697","21414718"],"winner_id":"8702697","reasoning":"Document A — neither discusses ALDH1 or breast cancer, but A addresses tumor aggressiveness and metastasis (more related to outcomes) while B is specific to gastric cancer cell mobility. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220421Z"}
{"comparison_id":"53a62ad8-af1d-44dd-ae76-ed04fab1935a","query_id":"51","doc_a_id":"23601616","doc_b_id":"8702697","presented_order":["23601616","8702697"],"winner_id":"8702697","reasoning":"Document B — it discusses cancer cell–microenvironment interactions and tumor aggressiveness (though in prostate cancer), so it's more related to cancer outcomes than Document A. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220428Z"}
{"comparison_id":"2706f07f-59fe-464d-be6c-ef2ab1bc8b66","query_id":"51","doc_a_id":"20568364","doc_b_id":"8702697","presented_order":["20568364","8702697"],"winner_id":"20568364","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is slightly more relevant because it concerns tumor signaling and progression, whereas B focuses on prostate-specific miRNA effects. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220435Z"}
{"comparison_id":"1ae77a4b-dfb3-4e3b-9e9c-58f166f615aa","query_id":"51","doc_a_id":"57783564","doc_b_id":"8702697","presented_order":["8702697","57783564"],"winner_id":"8702697","reasoning":"Reason: Both documents do not address ALDH1 or breast cancer; Document A at least discusses tumor aggressiveness and EMT, which relate to cancer outcomes, so it's slightly more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220441Z"}
{"comparison_id":"a589dbd6-2f22-49aa-a9fa-3d772a8a9914","query_id":"51","doc_a_id":"3710557","doc_b_id":"8702697","presented_order":["3710557","8702697"],"winner_id":"3710557","reasoning":"Neither document discusses ALDH1 or breast cancer. If forced to choose, ANSWER: A — it at least addresses cancer signaling/tumorigenesis (though in liver), whereas B focuses specifically on prostate cancer.","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220449Z"}
{"comparison_id":"d3779ebe-3a71-451c-9f34-ecbb33c77c89","query_id":"51","doc_a_id":"7639744","doc_b_id":"8702697","presented_order":["7639744","8702697"],"winner_id":"8702697","reasoning":"Document B is more relevant — both are unrelated to ALDH1 or breast cancer, but B discusses cancer molecular mechanisms and tumor aggressiveness, making it slightly closer in scope. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220456Z"}
{"comparison_id":"818c2474-e5ea-4ef0-a5e6-2732c55fc2f8","query_id":"51","doc_a_id":"12650610","doc_b_id":"8702697","presented_order":["12650610","8702697"],"winner_id":"8702697","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is slightly more relevant because it addresses tumor aggressiveness, EMT, and metastatic potential (topics related to cancer outcomes), while A focuses on oral cancer–specific signaling.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220463Z"}
{"comparison_id":"ca91520f-027a-4572-a3ff-ad01eed14b29","query_id":"51","doc_a_id":"9196472","doc_b_id":"8702697","presented_order":["8702697","9196472"],"winner_id":"9196472","reasoning":"Document B is marginally more relevant because it addresses associations between gene expression and disease outcomes, whereas Document A focuses on miR-205 in prostate cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220470Z"}
{"comparison_id":"28817652-8ff4-4cc5-a587-30aa1e32ac68","query_id":"51","doc_a_id":"6121555","doc_b_id":"8702697","presented_order":["6121555","8702697"],"winner_id":"8702697","reasoning":"B — Document B addresses cancer aggressiveness and tumor–stroma interactions affecting prognosis, whereas A is glioma-specific apoptosis signaling and not relevant to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220477Z"}
{"comparison_id":"cabb1fae-fc52-4383-9038-ea3d1c4d8d07","query_id":"51","doc_a_id":"85665741","doc_b_id":"8702697","presented_order":["8702697","85665741"],"winner_id":"8702697","reasoning":"Neither document mentions ALDH1 or breast cancer, so both are irrelevant. If forced to pick, Document A is marginally more relevant because it discusses tumor biology/cell–stromal interactions versus Document B which is specific to NSCLC genetics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220485Z"}
{"comparison_id":"cc943c9c-26d1-4836-bb80-b5713ec5f224","query_id":"51","doc_a_id":"24916604","doc_b_id":"8702697","presented_order":["8702697","24916604"],"winner_id":"8702697","reasoning":"Document A is slightly more relevant because it discusses molecular markers and tumor biology (though in prostate cancer), whereas Document B addresses treatment guideline adherence and not biomarker or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220492Z"}
{"comparison_id":"7efe00aa-780a-42e7-8325-95678158b7d8","query_id":"51","doc_a_id":"25738896","doc_b_id":"8702697","presented_order":["25738896","8702697"],"winner_id":"8702697","reasoning":"Neither abstract mentions ALDH1 or breast cancer. Document B is marginally more relevant because it addresses tumor aggressiveness and interactions affecting outcomes, while A focuses on melanoma-specific immune tolerance.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220499Z"}
{"comparison_id":"a5472708-87b3-48dc-bffb-7693627ef4dc","query_id":"51","doc_a_id":"28334217","doc_b_id":"8702697","presented_order":["28334217","8702697"],"winner_id":"28334217","reasoning":"Neither document is relevant — neither mentions ALDH1 or breast cancer. Document A is marginally more related to cancer biology broadly, so: ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220506Z"}
{"comparison_id":"a31e25fa-32cc-49f7-a455-b6eee902bd3b","query_id":"51","doc_a_id":"5372432","doc_b_id":"8702697","presented_order":["8702697","5372432"],"winner_id":"8702697","reasoning":"Document A is slightly more relevant because it discusses molecular cancer biology and tumor aggressiveness, whereas Document B is about healthcare access and post-mortem diagnoses. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220513Z"}
{"comparison_id":"73f42f86-b4e7-45a0-8091-e48f8c44f0cd","query_id":"51","doc_a_id":"20381484","doc_b_id":"8702697","presented_order":["8702697","20381484"],"winner_id":"8702697","reasoning":"Document A is slightly more relevant because it discusses cancer-related markers and tumor outcomes (though in prostate cancer), whereas Document B covers a general protein nitrosylation mechanism unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220519Z"}
{"comparison_id":"3c087ccd-7f21-4e96-a956-54dbd9e968ef","query_id":"51","doc_a_id":"4959368","doc_b_id":"8702697","presented_order":["8702697","4959368"],"winner_id":"8702697","reasoning":"Neither document mentions ALDH1 or breast cancer; Document A is more relevant because it addresses tumor cell biology, EMT, and factors affecting tumor aggressiveness (closer to prognostic markers) whereas Document B concerns metabolic risk for pancreatic cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220526Z"}
{"comparison_id":"50fa1049-6e6d-462e-9f14-8d2f374d2987","query_id":"51","doc_a_id":"6948886","doc_b_id":"8702697","presented_order":["6948886","8702697"],"winner_id":"6948886","reasoning":"Document A — it addresses cancer tumorigenicity and stem-like transcriptional programs (more related to markers like ALDH1) whereas B is specific to prostate CAF interactions and miR-205. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220533Z"}
{"comparison_id":"b8ffe2bc-f574-4f27-b35d-919be6c22b5b","query_id":"51","doc_a_id":"27167110","doc_b_id":"8702697","presented_order":["27167110","8702697"],"winner_id":"8702697","reasoning":"Both documents are irrelevant to ALDH1 in breast cancer; Document B is slightly more relevant because it discusses factors that reduce tumor aggressiveness (relating to outcomes).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220540Z"}
{"comparison_id":"364724cd-abc7-45b0-a4a1-0eac2c3efd41","query_id":"51","doc_a_id":"17671145","doc_b_id":"8702697","presented_order":["17671145","8702697"],"winner_id":"8702697","reasoning":"Both documents are irrelevant to ALDH1 in breast cancer, but Document B is slightly more related because it discusses EMT and tumor aggressiveness (themes linked to cancer stemness markers like ALDH1). \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220546Z"}
{"comparison_id":"bcfc74c2-596b-4914-91cd-965847301f31","query_id":"51","doc_a_id":"25452937","doc_b_id":"8702697","presented_order":["25452937","8702697"],"winner_id":"25452937","reasoning":"Document A is more relevant — it studies the association between a tumor-related marker and patient survival (though in thyroid cancer), which is closer to the claim about ALDH1 and breast cancer outcomes than a prostate miR-205 mechanistic study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220554Z"}
{"comparison_id":"846d117f-529d-4ed5-b59a-5815c33d15e2","query_id":"51","doc_a_id":"14848619","doc_b_id":"8702697","presented_order":["14848619","8702697"],"winner_id":"8702697","reasoning":"Document B is slightly more relevant — it discusses tumor aggressiveness and microenvironmental effects on cancer outcomes (though in prostate cancer), while neither document mentions ALDH1 or breast cancer specifically.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220561Z"}
{"comparison_id":"a46ca5c6-077a-449d-8cd3-c988f724f9d4","query_id":"51","doc_a_id":"5123516","doc_b_id":"8702697","presented_order":["5123516","8702697"],"winner_id":"8702697","reasoning":"Neither document mentions ALDH1 or breast cancer. Both are irrelevant; Document B is marginally more related (concerns epithelial tumor behavior/EMT) so slightly closer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220568Z"}
{"comparison_id":"9f49fd66-170a-46e3-90e3-bde619ef8c8a","query_id":"51","doc_a_id":"5468807","doc_b_id":"8702697","presented_order":["8702697","5468807"],"winner_id":"8702697","reasoning":"Both documents are irrelevant to ALDH1 and breast cancer, but A is slightly more relevant because it addresses tumor aggressiveness/EMT (general cancer biology) while B focuses on ARID1A/HDAC6 in ovarian cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220575Z"}
{"comparison_id":"5548128c-13e8-4538-a51c-d65ac8ed0695","query_id":"51","doc_a_id":"22059387","doc_b_id":"8702697","presented_order":["8702697","22059387"],"winner_id":"8702697","reasoning":"Document A is more relevant — it deals with cancer cell behavior and tumor aggressiveness (though in prostate cancer), whereas Document B concerns parasitic infection and cholangiocarcinoma in hamsters; neither mentions ALDH1 or breast cancer, but A is closer in topic.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220583Z"}
{"comparison_id":"5e05cbcc-a4ff-4e69-b6f2-f407c302cec9","query_id":"51","doc_a_id":"14672919","doc_b_id":"8702697","presented_order":["8702697","14672919"],"winner_id":"8702697","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more related because it addresses molecular expression affecting tumor behavior, whereas B is about platelet indices in esophageal cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220591Z"}
{"comparison_id":"c696c795-006d-4b9a-9319-1a07ec74856e","query_id":"51","doc_a_id":"7869794","doc_b_id":"8702697","presented_order":["7869794","8702697"],"winner_id":"7869794","reasoning":"Document A is slightly more relevant because it discusses tumor cell–immune interactions and mechanisms of tumor cell apoptosis, which are more generally related to cancer outcomes than a prostate-specific miR-205 study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220598Z"}
{"comparison_id":"3707694f-8636-4c77-bd26-96e0a16ba378","query_id":"51","doc_a_id":"5783785","doc_b_id":"8702697","presented_order":["8702697","5783785"],"winner_id":"8702697","reasoning":"Document A is slightly more relevant — it addresses cancer cell aggressiveness and tumor biology (though in prostate cancer), whereas Document B focuses on miR-33b in gastric cancer and neither mentions ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220605Z"}
{"comparison_id":"7f8d3ec4-b0a0-420c-afb2-2e78b99339e4","query_id":"51","doc_a_id":"10542877","doc_b_id":"8702697","presented_order":["10542877","8702697"],"winner_id":"10542877","reasoning":"Neither document mentions ALDH1 or breast cancer. Both are irrelevant; A is marginally more relevant because it deals with cancer therapeutics broadly (vs B's prostate-specific focus).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220612Z"}
{"comparison_id":"670a365c-68e6-447a-9b3a-6640e25e0373","query_id":"51","doc_a_id":"667451","doc_b_id":"8702697","presented_order":["667451","8702697"],"winner_id":"8702697","reasoning":"Document B — it discusses cancer cell behavior (EMT, tumor aggressiveness) and pathways more related to breast cancer biology than the CLL-focused Document A. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220619Z"}
{"comparison_id":"dd91a944-f1ff-4f28-9606-a2f83a823e73","query_id":"51","doc_a_id":"1836154","doc_b_id":"8702697","presented_order":["8702697","1836154"],"winner_id":"8702697","reasoning":"Neither document addresses ALDH1 or breast cancer specifically; Document A, however, deals with cancer cell expression affecting tumor aggressiveness, making it marginally more relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220626Z"}
{"comparison_id":"5c1cde17-d65a-44b2-b610-dbfb398e2eea","query_id":"51","doc_a_id":"24190159","doc_b_id":"8702697","presented_order":["8702697","24190159"],"winner_id":"8702697","reasoning":"Document A is slightly more related because it discusses cancer cell markers and tumor aggressiveness/microenvironment, whereas Document B focuses on KRAS-driven changes in rectal cancer unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220633Z"}
{"comparison_id":"7ec3d96d-6bf1-4415-94e2-314b5ef2fe6c","query_id":"51","doc_a_id":"13905670","doc_b_id":"8702697","presented_order":["8702697","13905670"],"winner_id":"8702697","reasoning":"Document A is more related because it addresses cancer biology and tumor aggressiveness, whereas Document B discusses an immune-related SNP and noncancer diseases. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220640Z"}
{"comparison_id":"cefd198a-b0b5-462c-88c8-f80d461590ee","query_id":"51","doc_a_id":"18882947","doc_b_id":"8702697","presented_order":["18882947","8702697"],"winner_id":"8702697","reasoning":"Document B — it discusses cancer cell behavior (EMT, aggressiveness) and tumor microenvironment, which is more relevant to a claim about cancer marker prognostic value than a paper on T-cell lymphoma biology. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220648Z"}
{"comparison_id":"75d8ccf0-df9a-458e-94c5-f7dd636a3ae7","query_id":"51","doc_a_id":"19800147","doc_b_id":"8702697","presented_order":["8702697","19800147"],"winner_id":"8702697","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it discusses tumor aggressiveness and EMT, concepts closer to cancer outcomes, whereas B focuses on exosomal miR-193a in colon cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220654Z"}
{"comparison_id":"e6df9f92-4091-49f4-b772-8906006f6371","query_id":"51","doc_a_id":"67787658","doc_b_id":"8702697","presented_order":["8702697","67787658"],"winner_id":"8702697","reasoning":"Document A is slightly more relevant because it discusses tumor aggressiveness and pathways affecting cancer outcomes (even though it's about prostate cancer), whereas Document B focuses on glioblastoma chemoresistance and cell-cycle regulation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220661Z"}
{"comparison_id":"78e09f92-2f00-49c2-81ad-c28af788528e","query_id":"51","doc_a_id":"18682109","doc_b_id":"8702697","presented_order":["18682109","8702697"],"winner_id":"18682109","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer, but Document A deals with cancer molecular-marker changes and clinical resistance, making it marginally more relevant than Document B on prostate-specific miR-205.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220668Z"}
{"comparison_id":"2e1cc0ed-7619-49cf-a4f6-502e55717be9","query_id":"51","doc_a_id":"9478135","doc_b_id":"8702697","presented_order":["9478135","8702697"],"winner_id":"8702697","reasoning":"Document B is more relevant — though neither discusses ALDH1 or breast cancer, B deals with tumor behavior and markers of aggressiveness, making it closer in topic than a leukemia genetics paper.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220675Z"}
{"comparison_id":"07c0fb7b-b061-420b-86ff-2eb2812af230","query_id":"51","doc_a_id":"6374918","doc_b_id":"8702697","presented_order":["6374918","8702697"],"winner_id":"8702697","reasoning":"Neither paper discusses ALDH1 or breast cancer. Document B is marginally more relevant because it examines epithelial cancer cell–stromal interactions and EMT (more comparable to breast cancer biology) while A concerns AML/leukemia. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220683Z"}
{"comparison_id":"654f6b1e-4de8-4cad-a80d-34b1fe7d0a98","query_id":"51","doc_a_id":"15322518","doc_b_id":"8702697","presented_order":["15322518","8702697"],"winner_id":"8702697","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it addresses cancer aggressiveness and markers affecting outcomes, whereas Document A focuses on receptor targeting in rhabdoid tumors.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220690Z"}
{"comparison_id":"c4ad1ce9-d9c4-4de1-914e-f78ff1bf6bf5","query_id":"51","doc_a_id":"4464565","doc_b_id":"8702697","presented_order":["8702697","4464565"],"winner_id":"8702697","reasoning":"Document A is more relevant — it discusses cancer-related markers and tumor aggressiveness (though in prostate cancer), whereas Document B concerns dietary polyphenols in colon-derived Caco-2 cells, unrelated to cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220697Z"}
{"comparison_id":"213643dc-7214-47c9-9bcf-36ce0387972d","query_id":"51","doc_a_id":"30543439","doc_b_id":"8702697","presented_order":["30543439","8702697"],"winner_id":"8702697","reasoning":"Document B is more relevant — it concerns cancer cell behavior and markers influencing tumor outcomes (though in prostate cancer), whereas A is unrelated enzymology/structural work. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220704Z"}
{"comparison_id":"92fdddde-04a7-4185-a800-4054d28fc027","query_id":"51","doc_a_id":"15491308","doc_b_id":"8702697","presented_order":["8702697","15491308"],"winner_id":"8702697","reasoning":"Document A — it discusses tumor aggressiveness and cancer-related pathways (even though in prostate cancer), so it's closer to the query than B which concerns MSC senescence unrelated to cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220711Z"}
{"comparison_id":"5708def8-395d-4e1d-8266-58bba038506d","query_id":"51","doc_a_id":"36653415","doc_b_id":"8702697","presented_order":["8702697","36653415"],"winner_id":"8702697","reasoning":"Document A is slightly more relevant because it discusses cancer biology (EMT and tumor aggressiveness), whereas Document B focuses on lung tumor metabolism unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220718Z"}
{"comparison_id":"79965552-e5b0-4848-8f2f-fa6f998aeaf8","query_id":"51","doc_a_id":"8724666","doc_b_id":"8702697","presented_order":["8702697","8724666"],"winner_id":"8702697","reasoning":"Document A is more related because it addresses cancer cell behavior and tumor aggressiveness (outcomes), whereas Document B focuses on hematopoiesis/leukemia metabolism; neither mentions ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220724Z"}
{"comparison_id":"aaa8dea2-846f-40c1-8dfb-a3bb5bf4df60","query_id":"51","doc_a_id":"25344732","doc_b_id":"8702697","presented_order":["8702697","25344732"],"winner_id":"8702697","reasoning":"Document A is more related to cancer progression and tumor aggressiveness (EMT/metastasis), which is closer in topic to factors affecting breast cancer outcomes than Document B's focus on PHC3 loss in osteosarcoma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220731Z"}
{"comparison_id":"5a19e70a-8993-4ea7-a161-1b818ef1e247","query_id":"51","doc_a_id":"26059876","doc_b_id":"8702697","presented_order":["26059876","8702697"],"winner_id":"8702697","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document B is slightly more relevant because it concerns markers and tumor aggressiveness (outcomes), whereas A is focused on Ku70 in colorectal tissue.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220738Z"}
{"comparison_id":"d872ad19-fcaf-4039-8b31-7469622540e5","query_id":"51","doc_a_id":"17775228","doc_b_id":"8702697","presented_order":["8702697","17775228"],"winner_id":"8702697","reasoning":"Document A is more relevant — it discusses cancer cell behavior, EMT, and tumor aggressiveness (general cancer outcome–related topics), whereas Document B focuses on colorectal imprinting mechanisms unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220745Z"}
{"comparison_id":"d01c77eb-30e6-4417-8e04-1b7395b6309d","query_id":"51","doc_a_id":"2359152","doc_b_id":"8702697","presented_order":["8702697","2359152"],"winner_id":"8702697","reasoning":"Document A is slightly more relevant because it discusses tumor biomarkers and effects on cancer aggressiveness (though in prostate cancer), whereas Document B concerns genetic lesions in MDS. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220752Z"}
{"comparison_id":"bf65b1fa-24e5-4513-993d-90b60f24faa7","query_id":"51","doc_a_id":"39481265","doc_b_id":"8702697","presented_order":["39481265","8702697"],"winner_id":"8702697","reasoning":"B is more relevant because it discusses cancer biology and markers of tumor aggressiveness, whereas A concerns lung fibrosis and epigenetics unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220758Z"}
{"comparison_id":"8c4a43fb-ab86-4304-99a0-34ce745a730a","query_id":"51","doc_a_id":"5939172","doc_b_id":"8702697","presented_order":["5939172","8702697"],"winner_id":"5939172","reasoning":"Document A is slightly more relevant because it discusses cancer outcomes/mortality, whereas Document B focuses on molecular interactions in prostate cancer unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220764Z"}
{"comparison_id":"ceeae468-27ce-4890-9bef-9121648819e9","query_id":"51","doc_a_id":"12580014","doc_b_id":"8702697","presented_order":["8702697","12580014"],"winner_id":"8702697","reasoning":"Document A is slightly more relevant because it addresses cancer cell behavior, EMT, and tumor aggressiveness (concepts more related to marker-prognosis studies), whereas B focuses on keratin/Aire in skin tumors. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220771Z"}
{"comparison_id":"98cc7839-2c70-4c72-aace-4fe37530c1ff","query_id":"51","doc_a_id":"8290760","doc_b_id":"8702697","presented_order":["8290760","8702697"],"winner_id":"8290760","reasoning":"Reason: Document A discusses single-cell expression and stemness-related markers (reprogramming factors), which is marginally closer to ALDH1 as a stem-cell–associated marker than a prostate-cancer/miR-205 study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:47.220778Z"}
{"comparison_id":"0ba368d1-7d95-454f-afeb-9268ba315a23","query_id":"51","doc_a_id":"24349430","doc_b_id":"9196472","presented_order":["24349430","9196472"],"winner_id":"9196472","reasoning":"Document B is more relevant — it deals with gene expression associations and disease susceptibility (more directly related to expression–outcome links) while A focuses on a calcium channel in lung cancer cell lines, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:56.007976Z"}
{"comparison_id":"8716b4a0-1adc-4e16-a850-ed9f069688fb","query_id":"51","doc_a_id":"16630996","doc_b_id":"9196472","presented_order":["16630996","9196472"],"winner_id":"16630996","reasoning":"Document A is cancer-focused and discusses molecular markers related to therapy and outcomes (though in pancreatic cancer), making it more relevant than a monocyte transcriptome study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:56.007999Z"}
{"comparison_id":"64a8eb85-bdd4-4c33-9ebc-aff17dd5b708","query_id":"51","doc_a_id":"38808600","doc_b_id":"9196472","presented_order":["9196472","38808600"],"winner_id":"9196472","reasoning":"Document A is more relevant — it discusses gene expression and disease associations (where ALDH1 expression would be a gene-expression–outcome link), whereas B is specific to glioma imaging and integrin α5β1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:56.008008Z"}
{"comparison_id":"f5044987-0ef6-402f-be56-df151c14cfc7","query_id":"51","doc_a_id":"20738970","doc_b_id":"9196472","presented_order":["9196472","20738970"],"winner_id":"20738970","reasoning":"B is more relevant because it addresses cancer-related gene/protein expression and tumor cell biology, whereas A focuses on monocyte transcriptomes and non-cancer diseases. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:56.008016Z"}
{"comparison_id":"c9017c2e-9a77-4f1f-b9cd-60a569dd1152","query_id":"51","doc_a_id":"293661","doc_b_id":"9196472","presented_order":["293661","9196472"],"winner_id":"9196472","reasoning":"Document B is more relevant — it deals with gene expression and links between expression traits and disease susceptibility, which is closer to a claim about ALDH1 expression and cancer outcomes. Document A focuses on arginine metabolism therapies and is unrelated.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:56.008024Z"}
{"comparison_id":"576c0d79-08cb-4064-b4d6-04de985af029","query_id":"51","doc_a_id":"23934390","doc_b_id":"9196472","presented_order":["9196472","23934390"],"winner_id":"9196472","reasoning":"Document A is about gene expression and disease associations (more generally relevant to links between gene expression and disease outcomes), while Document B is specific to microRNA in lung cancer and unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:56.008031Z"}
{"comparison_id":"fb135d96-91be-4185-87b6-44da2827389f","query_id":"51","doc_a_id":"20568364","doc_b_id":"9196472","presented_order":["9196472","20568364"],"winner_id":"20568364","reasoning":"Document B — it discusses tumor biology and signaling relevant to cancer progression (though in HNSCC), while Document A focuses on monocyte transcriptomes and atherosclerosis/immunity, not cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:56.008038Z"}
{"comparison_id":"48bf40a2-233c-473b-9731-f6053b09221c","query_id":"51","doc_a_id":"3710557","doc_b_id":"9196472","presented_order":["3710557","9196472"],"winner_id":"9196472","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer, but Document B addresses gene expression and disease associations (more generally relevant to expression-outcome links) while Document A focuses on β-catenin in liver.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:56.008045Z"}
{"comparison_id":"3e8926b2-1735-4c49-bf7b-1572c8d21f05","query_id":"51","doc_a_id":"8290760","doc_b_id":"9196472","presented_order":["8290760","9196472"],"winner_id":"9196472","reasoning":"Document B is slightly more relevant because it discusses gene expression associations with disease susceptibility, whereas Document A focuses on cellular reprogramming and iPSC markers unrelated to cancer or ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:56.008052Z"}
{"comparison_id":"d688b7ea-9e86-4bf2-a906-9d5518103d1e","query_id":"51","doc_a_id":"28334217","doc_b_id":"9196472","presented_order":["28334217","9196472"],"winner_id":"9196472","reasoning":"Document B is more relevant — it studies gene expression patterns and their links to disease susceptibility, which is closer to evaluating whether ALDH1 expression correlates with cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:56.008059Z"}
{"comparison_id":"f9754ee1-2665-472e-bb20-78fda75f3d82","query_id":"51","doc_a_id":"6948886","doc_b_id":"9196472","presented_order":["9196472","6948886"],"winner_id":"9196472","reasoning":"Document A is marginally more relevant — it deals broadly with gene expression and disease associations (while B focuses specifically on glioblastoma epigenetics). Neither mentions ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:56.008066Z"}
{"comparison_id":"875e138f-98ea-4d66-9fb9-e9b9660c9003","query_id":"51","doc_a_id":"25452937","doc_b_id":"9196472","presented_order":["9196472","25452937"],"winner_id":"25452937","reasoning":"B — Document B discusses tumor-associated immune cells and cancer survival, which is closer to a claim about cancer outcomes than Document A about monocyte transcriptomes and atherosclerosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:56.008073Z"}
{"comparison_id":"2429f101-9a28-4f70-b83f-f02d18e0b6a5","query_id":"51","doc_a_id":"7869794","doc_b_id":"9196472","presented_order":["9196472","7869794"],"winner_id":"9196472","reasoning":"Document A is more relevant because it concerns gene expression and its association with disease outcomes, whereas Document B focuses on neutrophil calcium signaling during ADCC and not gene expression in cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:56.008080Z"}
{"comparison_id":"4b2ee122-9eec-4f91-818e-76d27a8d9ccd","query_id":"51","doc_a_id":"10542877","doc_b_id":"9196472","presented_order":["9196472","10542877"],"winner_id":"9196472","reasoning":"Document A is more relevant — it addresses gene expression associations with disease outcomes, whereas Document B focuses on a STAT3-targeting therapy in lymphoma/lung cancer and does not pertain to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:56.008087Z"}
{"comparison_id":"1f05abb2-2902-4353-bdd1-81dfb2ba3b4d","query_id":"51","doc_a_id":"18682109","doc_b_id":"9196472","presented_order":["18682109","9196472"],"winner_id":"9196472","reasoning":"Document B is more relevant — it addresses gene expression and disease associations (transcriptome-level analysis), which is closer to evaluating whether a marker like ALDH1 relates to outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:56.008095Z"}
{"comparison_id":"540d2491-afa9-4755-93ba-40eacc3901d6","query_id":"51","doc_a_id":"5939172","doc_b_id":"9196472","presented_order":["9196472","5939172"],"winner_id":"9196472","reasoning":"Document A is more relevant — it concerns gene expression and disease associations (transcriptome data), which is closer to a claim about ALDH1 expression and cancer outcomes than a study of drinking patterns.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:15:56.008102Z"}
{"comparison_id":"afdc8ee9-23e9-41f3-88d1-074124bd5d84","query_id":"51","doc_a_id":"16630996","doc_b_id":"20738970","presented_order":["20738970","16630996"],"winner_id":"20738970","reasoning":"Document A is slightly more relevant because it discusses expression of a protein linked to cancer cell behavior (apoptosis), whereas Document B focuses on chemotherapy markers in pancreatic cancer unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:01.216726Z"}
{"comparison_id":"0b9bcb65-68ab-49ae-83e1-df4bad598587","query_id":"51","doc_a_id":"25452937","doc_b_id":"20738970","presented_order":["20738970","25452937"],"winner_id":"25452937","reasoning":"Document B — it reports an association between a biomarker density and patient survival (similar outcome measure), whereas A is about Etk in SCLC apoptosis and unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:01.216747Z"}
{"comparison_id":"db28b09b-993f-4b97-95f9-0ab0511c2fe4","query_id":"51","doc_a_id":"20568364","doc_b_id":"20738970","presented_order":["20568364","20738970"],"winner_id":"20568364","reasoning":"Document A is slightly more relevant — it discusses tumor signaling and growth (Notch/angiogenesis), which is more related to cancer behavior and outcomes than a study on apoptosis in small cell lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:01.216756Z"}
{"comparison_id":"0e461e7d-46ac-461c-8d3e-56e6b2dd9856","query_id":"51","doc_a_id":"25452937","doc_b_id":"20568364","presented_order":["20568364","25452937"],"winner_id":"25452937","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is slightly more relevant because it studies an association between a tumor-related marker (TAM density) and patient survival, which is closer to the claim about marker expression and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:07.067991Z"}
{"comparison_id":"ab239577-6fcd-41f9-9fec-469152ccff72","query_id":"51","doc_a_id":"24349430","doc_b_id":"8290760","presented_order":["8290760","24349430"],"winner_id":"24349430","reasoning":"Document B is more relevant — it discusses cancer cell biology (though in lung cancer), whereas Document A is about cellular reprogramming unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:13.560111Z"}
{"comparison_id":"f5b3200c-9425-41b9-83a1-0342bedf5952","query_id":"51","doc_a_id":"38808600","doc_b_id":"8290760","presented_order":["38808600","8290760"],"winner_id":"38808600","reasoning":"Document A is slightly more relevant because it discusses cancer prognosis markers, whereas Document B concerns cellular reprogramming unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:13.560133Z"}
{"comparison_id":"35cee341-6f59-4168-807f-f04f8f00c9ab","query_id":"51","doc_a_id":"293661","doc_b_id":"8290760","presented_order":["293661","8290760"],"winner_id":"293661","reasoning":"Document A is more relevant — it discusses cancer biology and therapies, whereas Document B focuses on iPSC reprogramming unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:13.560141Z"}
{"comparison_id":"437d570b-f1d5-4f2e-b0c6-5004722574a9","query_id":"51","doc_a_id":"23934390","doc_b_id":"8290760","presented_order":["8290760","23934390"],"winner_id":"23934390","reasoning":"Document B is more relevant — it concerns cancer biology and markers related to tumor outcomes, whereas A deals with cellular reprogramming unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:13.560149Z"}
{"comparison_id":"b588af71-9db6-46ad-9361-e3221f2f19bf","query_id":"51","doc_a_id":"3710557","doc_b_id":"8290760","presented_order":["8290760","3710557"],"winner_id":"8290760","reasoning":"Document A is slightly more relevant — it discusses gene expression and stem-cell–related markers (contextually closer to ALDH1 as a stemness marker), whereas B focuses on liver β-catenin signaling unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:13.560157Z"}
{"comparison_id":"8e0488bd-0a7b-41b9-a7ef-cada82364000","query_id":"51","doc_a_id":"5939172","doc_b_id":"8290760","presented_order":["8290760","5939172"],"winner_id":"8290760","reasoning":"Document A is more relevant — it discusses gene expression analyses (though not ALDH1 specifically), whereas B is about drinking patterns and mortality unrelated to breast cancer markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:13.560164Z"}
{"comparison_id":"87913c6a-573c-4f9c-b7f5-ba050bb4d387","query_id":"51","doc_a_id":"28334217","doc_b_id":"8290760","presented_order":["8290760","28334217"],"winner_id":"28334217","reasoning":"Document B is more relevant — it discusses cancer-specific biology and therapeutic outcomes (though not ALDH1 or breast cancer directly), whereas Document A focuses on iPSC reprogramming and unrelated markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:13.560172Z"}
{"comparison_id":"d65d0822-c941-49a9-a5aa-50bc132e1740","query_id":"51","doc_a_id":"6948886","doc_b_id":"8290760","presented_order":["6948886","8290760"],"winner_id":"6948886","reasoning":"Document A is more relevant — it addresses cancer tumorigenicity (though in glioblastoma), whereas B concerns iPSC reprogramming and not cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:13.560179Z"}
{"comparison_id":"145b016d-2a3f-48bd-8395-e78080d1fb68","query_id":"51","doc_a_id":"7869794","doc_b_id":"8290760","presented_order":["8290760","7869794"],"winner_id":"8290760","reasoning":"Neither document discusses ALDH1 or breast cancer directly, but Document A (gene expression analysis) is marginally more related to expression markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:13.560185Z"}
{"comparison_id":"980a6d34-1c47-4a1b-b592-00b55a5a808e","query_id":"51","doc_a_id":"10542877","doc_b_id":"8290760","presented_order":["10542877","8290760"],"winner_id":"10542877","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer, but Document A concerns cancer clinical activity/outcomes, making it slightly more relevant than a study on cellular reprogramming.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:13.560192Z"}
{"comparison_id":"dba72f36-003e-4345-8122-83840a256c72","query_id":"51","doc_a_id":"18682109","doc_b_id":"8290760","presented_order":["18682109","8290760"],"winner_id":"8290760","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is marginally more relevant because it concerns cell‑state marker expression (stemness markers) whereas A focuses on lung cancer transformation. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:13.560198Z"}
{"comparison_id":"866fb7a0-9c70-4c43-8071-a74b3034822c","query_id":"51","doc_a_id":"24349430","doc_b_id":"23934390","presented_order":["23934390","24349430"],"winner_id":"23934390","reasoning":"Reason: Neither paper studies ALDH1 or breast cancer, but Document A addresses Bmi1, a stemness-related factor more conceptually related to ALDH1 and clinical outcomes than the calcium/Orai1 focus in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:18.127342Z"}
{"comparison_id":"f5391519-720b-4603-941c-a57ec09d3e8d","query_id":"51","doc_a_id":"38808600","doc_b_id":"23934390","presented_order":["38808600","23934390"],"winner_id":"38808600","reasoning":"Document A is slightly more relevant because it discusses a cancer biomarker associated with prognosis, whereas Document B is focused on miR-203 in lung cancer and does not address cancer biomarkers or outcomes generally.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:18.127372Z"}
{"comparison_id":"ea3fda44-ead2-474d-9b25-3d9cc3146d44","query_id":"51","doc_a_id":"293661","doc_b_id":"23934390","presented_order":["293661","23934390"],"winner_id":"293661","reasoning":"Document A is slightly more relevant because it addresses cancer biology and therapies broadly, whereas Document B is specific to non-small cell lung cancer and neither mentions ALDH1 or breast cancer.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:18.127383Z"}
{"comparison_id":"301bd884-802a-4df4-896c-31a409e5a6c5","query_id":"51","doc_a_id":"10542877","doc_b_id":"23934390","presented_order":["23934390","10542877"],"winner_id":"23934390","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document A is marginally more relevant because it discusses molecular markers and tumor behavior, while B focuses on a therapeutic agent in lymphoma/lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:18.127392Z"}
{"comparison_id":"4576328d-6a0b-41bd-a293-5a4225fcc5ed","query_id":"51","doc_a_id":"28334217","doc_b_id":"23934390","presented_order":["23934390","28334217"],"winner_id":"23934390","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it concerns cancer marker regulation and tumor-suppressive effects, whereas B focuses on glutaminase inhibition in non-breast cancers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:18.127399Z"}
{"comparison_id":"15640080-73b9-4474-b1bd-124b49d10873","query_id":"51","doc_a_id":"6948886","doc_b_id":"23934390","presented_order":["23934390","6948886"],"winner_id":"23934390","reasoning":"Document A is slightly more relevant — it addresses cancer stemness-related pathways (Bmi1) even though it's in NSCLC, whereas B focuses on glioblastoma epigenetics unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:18.127409Z"}
{"comparison_id":"3a1a020b-989e-4147-96ca-2e8cf7ea55ff","query_id":"51","doc_a_id":"38808600","doc_b_id":"293661","presented_order":["38808600","293661"],"winner_id":"293661","reasoning":"Document B is more relevant — Document A focuses on a glioma imaging probe targeting integrin α5β1, while Document B addresses cancer metabolism and therapies across tumor types (more broadly related to cancer outcomes). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:23.036583Z"}
{"comparison_id":"3f2db87b-ec64-47cf-bf2c-c439e70252b8","query_id":"51","doc_a_id":"24349430","doc_b_id":"10542877","presented_order":["10542877","24349430"],"winner_id":"10542877","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document A discusses clinical outcomes in cancers (lymphoma, lung), which is marginally closer to the query about clinical outcomes than the cell-line mechanistic study in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:29.744051Z"}
{"comparison_id":"36cbd9df-f227-41af-ae3d-dc2e55435f26","query_id":"51","doc_a_id":"6948886","doc_b_id":"10542877","presented_order":["10542877","6948886"],"winner_id":"10542877","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document A is marginally more relevant because it discusses cancer biomarkers/therapy, whereas B focuses specifically on glioblastoma epigenetics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:29.744070Z"}
{"comparison_id":"8b20a45c-0ce3-4b4a-8df2-78385b523590","query_id":"51","doc_a_id":"28334217","doc_b_id":"10542877","presented_order":["10542877","28334217"],"winner_id":"10542877","reasoning":"Neither abstract mentions ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant because it reports clinical activity in cancers (outcomes-related), whereas B is preclinical metabolism-focused. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:29.744079Z"}
{"comparison_id":"11539466-a0ee-45a8-9638-3633e123f62d","query_id":"51","doc_a_id":"24349430","doc_b_id":"6948886","presented_order":["24349430","6948886"],"winner_id":"6948886","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is marginally more relevant because it concerns gene expression and tumorigenicity, whereas A is limited to Orai1 in lung cancer cells. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:34.441919Z"}
{"comparison_id":"5777a519-5fa5-48ed-b090-eac8a0916c95","query_id":"51","doc_a_id":"28334217","doc_b_id":"6948886","presented_order":["28334217","6948886"],"winner_id":"6948886","reasoning":"Neither abstract mentions ALDH1 or breast cancer. Document B is marginally more relevant because it deals with tumorigenicity and stem-like epigenetic regulation, which is conceptually closer to ALDH1's role as a stemness marker.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:34.441939Z"}
{"comparison_id":"8d243cc7-ad40-403d-bc42-0037b0aacde8","query_id":"51","doc_a_id":"24349430","doc_b_id":"28334217","presented_order":["24349430","28334217"],"winner_id":"28334217","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document B discusses tumor progression and survival outcomes, making it marginally more relevant to the claim about cancer outcomes than Document A (a lung cell signaling study).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:38.489267Z"}
{"comparison_id":"dd802aef-af5f-4217-86a2-34899bc8c04e","query_id":"51","doc_a_id":"3710557","doc_b_id":"5939172","presented_order":["3710557","5939172"],"winner_id":"3710557","reasoning":"Document A is more relevant because it discusses cancer signaling and tumorigenesis (though liver-focused), whereas Document B concerns alcohol drinking patterns and mortality unrelated to ALDH1 or breast cancer.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:43.203731Z"}
{"comparison_id":"1e876c02-17e1-4b54-a149-cf230ddfa884","query_id":"51","doc_a_id":"18682109","doc_b_id":"5939172","presented_order":["5939172","18682109"],"winner_id":"5939172","reasoning":"Document A is more relevant — it discusses cancer mortality in a cohort including women (related to cancer outcomes), whereas Document B focuses on molecular changes in EGFR-mutant lung cancers, unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:43.203753Z"}
{"comparison_id":"c30aac0d-aa31-49d7-b297-289c2e8bb2d3","query_id":"51","doc_a_id":"7869794","doc_b_id":"5939172","presented_order":["7869794","5939172"],"winner_id":"7869794","reasoning":"Document A is more relevant — it discusses tumor cell–immune interactions and mechanisms of tumor cell death, which are closer to cancer outcomes than a study about drinking patterns and mortality.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:43.203761Z"}
{"comparison_id":"8d2f397f-317c-4f27-ada0-6edcd1a6eb1a","query_id":"51","doc_a_id":"3710557","doc_b_id":"7869794","presented_order":["7869794","3710557"],"winner_id":"7869794","reasoning":"Neither document mentions ALDH1 or breast cancer outcomes. Document A is slightly more related because it addresses tumor cell–immune interactions, whereas B is focused on liver β‑catenin signaling. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:16:48.437158Z"}
{"comparison_id":"c4abd731-2f8c-49ea-8f41-7e21eed52720","query_id":"51","doc_a_id":"8677721","doc_b_id":"4959368","presented_order":["4959368","8677721"],"winner_id":"8677721","reasoning":"Document B — it's about molecular pathways in cancer (oncogenic signaling), which is closer to a claim about a cancer-related marker and outcomes than Document A's focus on BCAAs and pancreatic cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690159Z"}
{"comparison_id":"29e0caa8-7626-4cdc-989b-4faeec051da3","query_id":"51","doc_a_id":"14471161","doc_b_id":"4959368","presented_order":["4959368","14471161"],"winner_id":"14471161","reasoning":"Reason: Both papers concern pancreatic cancer rather than ALDH1 or breast cancer, but Document B discusses tumor gene expression and its effect on cancer outcomes, making it slightly more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690180Z"}
{"comparison_id":"29853829-828b-4940-a7ae-c409211683cd","query_id":"51","doc_a_id":"31313782","doc_b_id":"4959368","presented_order":["4959368","31313782"],"winner_id":"31313782","reasoning":"Document B — it concerns gene expression patterns in cancer (though in lung cancer), whereas A concerns metabolites in pancreatic cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690188Z"}
{"comparison_id":"26e87c1b-8914-4a74-86ba-7f09cc540bde","query_id":"51","doc_a_id":"2272614","doc_b_id":"4959368","presented_order":["2272614","4959368"],"winner_id":"2272614","reasoning":"Reason: Document A discusses gene expression effects on cancer therapy and outcomes (though in lung cancer), which is closer in topic to ALDH1 expression and cancer prognosis than Document B, which concerns metabolic biomarkers in pancreatic cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690196Z"}
{"comparison_id":"e00374a1-26c9-4b6c-9284-b1adf16b9b84","query_id":"51","doc_a_id":"3355397","doc_b_id":"4959368","presented_order":["4959368","3355397"],"winner_id":"3355397","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document B is slightly more relevant because it examines associations between an exposure and multiple cancer outcomes, whereas A focuses narrowly on pancreatic cancer metabolism. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690204Z"}
{"comparison_id":"866e1bb4-21f6-42e6-bdb7-01149a2a54e6","query_id":"51","doc_a_id":"32852283","doc_b_id":"4959368","presented_order":["32852283","4959368"],"winner_id":"32852283","reasoning":"Document A — it discusses cancer treatment impact on tumor growth and survival (outcomes), whereas Document B is about metabolic biomarkers in pancreatic cancer and neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690211Z"}
{"comparison_id":"838d5d62-4680-488d-bf01-c7408798e861","query_id":"51","doc_a_id":"14180565","doc_b_id":"4959368","presented_order":["4959368","14180565"],"winner_id":"14180565","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it deals with gene expression modulation (though in glioblastoma), whereas A discusses metabolites in pancreatic cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690219Z"}
{"comparison_id":"2de089e7-ca36-4337-abdb-2e71ea8f4423","query_id":"51","doc_a_id":"52925737","doc_b_id":"4959368","presented_order":["4959368","52925737"],"winner_id":"52925737","reasoning":"Document B — it discusses cancer biomarkers and prognosis/ tumor microenvironment, which is more related to ALDH1's prognostic role than a study about BCAAs in pancreatic cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690226Z"}
{"comparison_id":"cb4051e6-2d00-4994-a759-4285f5db87a9","query_id":"51","doc_a_id":"27306942","doc_b_id":"4959368","presented_order":["27306942","4959368"],"winner_id":"27306942","reasoning":"Document A — it discusses gene expression and associations with clinical outcomes in cancer (though a different gene and cancer type), whereas Document B focuses on metabolic markers in pancreatic cancer and is less related to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690233Z"}
{"comparison_id":"79dcf660-626c-489c-926a-703013494542","query_id":"51","doc_a_id":"25628793","doc_b_id":"4959368","presented_order":["25628793","4959368"],"winner_id":"25628793","reasoning":"Neither document discusses ALDH1, breast cancer, or outcomes; both are irrelevant. Document A is marginally more related (hormone/metabolism context), so:\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690240Z"}
{"comparison_id":"d17e8190-a821-468b-8669-3bc6d8fe0450","query_id":"51","doc_a_id":"17876040","doc_b_id":"4959368","presented_order":["17876040","4959368"],"winner_id":"17876040","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is marginally more related because it concerns cancer therapy generally. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690248Z"}
{"comparison_id":"efe50f8b-4f2d-4c3f-9d19-bbb894f3266f","query_id":"51","doc_a_id":"26902591","doc_b_id":"4959368","presented_order":["26902591","4959368"],"winner_id":"26902591","reasoning":"Document A is slightly more relevant because it discusses cancer-associated processes (though neither mentions ALDH1 or breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690254Z"}
{"comparison_id":"2307d689-4c42-4287-86c3-6e10a077cfd0","query_id":"51","doc_a_id":"2360905","doc_b_id":"4959368","presented_order":["2360905","4959368"],"winner_id":"2360905","reasoning":"Document A is more relevant because it discusses tumor gene expression and molecular profiling (closer to ALDH1/breast cancer expression) whereas Document B concerns BCAAs in pancreatic cancer and is unrelated.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690261Z"}
{"comparison_id":"4cf5acd0-facc-42fd-adc7-9c7b6e228c02","query_id":"51","doc_a_id":"4729644","doc_b_id":"4959368","presented_order":["4729644","4959368"],"winner_id":"4729644","reasoning":"Document A is slightly more relevant because it addresses cancer biology (though in nasopharyngeal carcinoma), whereas Document B concerns metabolic changes in pancreatic cancer unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690268Z"}
{"comparison_id":"f90a2102-99ce-4f37-9b64-a9171ebed1ff","query_id":"51","doc_a_id":"4468861","doc_b_id":"4959368","presented_order":["4959368","4468861"],"winner_id":"4468861","reasoning":"Document B — it discusses cancer treatments and outcomes (though in melanoma), whereas Document A concerns pancreatic BCAA levels and is unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690275Z"}
{"comparison_id":"595d3f63-8b76-46af-bfc6-ae6b0203fa43","query_id":"51","doc_a_id":"4841908","doc_b_id":"4959368","presented_order":["4959368","4841908"],"winner_id":"4959368","reasoning":"Reason: Neither discusses ALDH1 or breast cancer; Document A is at least about cancer (pancreatic) whereas B explicitly excludes cancer relevance.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690281Z"}
{"comparison_id":"5e5c1b10-3be3-4517-9547-1b70bd930625","query_id":"51","doc_a_id":"4387494","doc_b_id":"4959368","presented_order":["4959368","4387494"],"winner_id":"4387494","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is marginally more relevant because it deals with cancer-related molecular markers and therapeutic molecular targeting, while A focuses on metabolic changes in pancreatic cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690288Z"}
{"comparison_id":"5627dc5a-0067-40fd-9c9e-294aca629d95","query_id":"51","doc_a_id":"21414718","doc_b_id":"4959368","presented_order":["4959368","21414718"],"winner_id":"21414718","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document B is marginally more related because it concerns cancer cell mobility/metastasis, which relates to outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690295Z"}
{"comparison_id":"56830482-892f-47bf-9dde-38b121774be3","query_id":"51","doc_a_id":"23601616","doc_b_id":"4959368","presented_order":["4959368","23601616"],"winner_id":"4959368","reasoning":"Document A is slightly more relevant because it concerns cancer biology (though pancreatic, not breast) while Document B is about hippocampal effects in obese mice and unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690302Z"}
{"comparison_id":"b6ffc81f-0bad-476f-b95c-909548da7754","query_id":"51","doc_a_id":"57783564","doc_b_id":"4959368","presented_order":["57783564","4959368"],"winner_id":"57783564","reasoning":"Neither abstract mentions ALDH1 or breast cancer; however, Document A (colon cancer proliferation/tumor formation mechanisms) is marginally more relevant to cancer outcome biology than Document B (BCAAs in pancreatic cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690309Z"}
{"comparison_id":"f615defa-76a1-408c-b62d-f95da5347a48","query_id":"51","doc_a_id":"7639744","doc_b_id":"4959368","presented_order":["7639744","4959368"],"winner_id":"7639744","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant only because it addresses cancer prognosis (lung), whereas B concerns pancreatic biomarkers unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690316Z"}
{"comparison_id":"61fa6bbd-8782-4707-b57c-39c679069863","query_id":"51","doc_a_id":"12650610","doc_b_id":"4959368","presented_order":["4959368","12650610"],"winner_id":"12650610","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is marginally more relevant because it deals with cancer progression signaling, whereas A focuses on pancreatic BCAAs unrelated to ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690323Z"}
{"comparison_id":"78195c14-80b7-4126-8a41-3b1e2c39233c","query_id":"51","doc_a_id":"6121555","doc_b_id":"4959368","presented_order":["6121555","4959368"],"winner_id":"6121555","reasoning":"Document A is more relevant — it's a molecular cancer study (though in glioma) versus B which concerns metabolite changes in pancreatic cancer. Neither paper addresses ALDH1 or breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690331Z"}
{"comparison_id":"9e8cf415-3055-482b-bff1-86aa9dbce29d","query_id":"51","doc_a_id":"85665741","doc_b_id":"4959368","presented_order":["85665741","4959368"],"winner_id":"85665741","reasoning":"Document A is marginally more relevant because it discusses cancer-related molecular markers and treatment response; neither document mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690337Z"}
{"comparison_id":"78ae92eb-49e4-4bc6-bb80-49a22e3f0bce","query_id":"51","doc_a_id":"24916604","doc_b_id":"4959368","presented_order":["4959368","24916604"],"winner_id":"24916604","reasoning":"Neither document addresses ALDH1 expression or breast cancer outcomes. If forced to choose, B is slightly more relevant because it concerns cancer treatment practices (A is about pancreatic BCAAs).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690344Z"}
{"comparison_id":"ac6d6dea-4b12-445b-9f7b-a0e4ea5f2533","query_id":"51","doc_a_id":"25738896","doc_b_id":"4959368","presented_order":["4959368","25738896"],"winner_id":"25738896","reasoning":"Neither document addresses ALDH1 or breast cancer. Both are irrelevant; if one must be chosen, B is slightly more related to tumor immune outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690350Z"}
{"comparison_id":"4c290dcb-81cb-4390-bf47-f48f53605d98","query_id":"51","doc_a_id":"5372432","doc_b_id":"4959368","presented_order":["4959368","5372432"],"winner_id":"4959368","reasoning":"Document A is slightly more relevant because it discusses a biomarker–cancer association, whereas Document B concerns healthcare access and post-mortem diagnosis rather than tumor biomarkers or breast cancer outcomes.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690357Z"}
{"comparison_id":"92b3d6ac-d760-4af5-a1c6-2613c8069c4a","query_id":"51","doc_a_id":"20381484","doc_b_id":"4959368","presented_order":["4959368","20381484"],"winner_id":"4959368","reasoning":"Neither document discusses ALDH1 or breast cancer, but Document A is at least cancer-related (clinical biomarker/outcomes), so it's marginally more relevant. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690364Z"}
{"comparison_id":"a2c3ed02-182d-4a16-a70d-459bcb4ae502","query_id":"51","doc_a_id":"12580014","doc_b_id":"4959368","presented_order":["4959368","12580014"],"winner_id":"12580014","reasoning":"Document B — it's about tumor keratinocyte gene regulation and immune-related markers in cancer, which is closer to cancer-related expression studies than a paper on BCAAs in pancreatic cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690371Z"}
{"comparison_id":"c9d88a7a-0795-422c-9b3f-4addf1f56608","query_id":"51","doc_a_id":"27167110","doc_b_id":"4959368","presented_order":["4959368","27167110"],"winner_id":"27167110","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is marginally more relevant because it discusses molecular markers in cancer, whereas A focuses on BCAAs in pancreatic cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690378Z"}
{"comparison_id":"39a06ae9-40ff-4881-91dd-2fefe8bcaa2b","query_id":"51","doc_a_id":"17671145","doc_b_id":"4959368","presented_order":["4959368","17671145"],"winner_id":"17671145","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it deals with receptor-driven tumor biology and hormone-receptor regulation, which is conceptually closer to breast cancer mechanisms than pancreatic metabolic changes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690385Z"}
{"comparison_id":"3d33729d-faf4-437d-a888-db1dd484a077","query_id":"51","doc_a_id":"14848619","doc_b_id":"4959368","presented_order":["14848619","4959368"],"winner_id":"4959368","reasoning":"Document B is slightly more relevant because it addresses cancer biomarkers and clinical outcomes (though in pancreatic cancer), whereas A focuses on a different molecular pathway unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690392Z"}
{"comparison_id":"9bcc4283-e5cd-4dac-abe5-8370cee6fdda","query_id":"51","doc_a_id":"5123516","doc_b_id":"4959368","presented_order":["4959368","5123516"],"winner_id":"4959368","reasoning":"Both documents are unrelated to ALDH1 or breast cancer, but Document A discusses a cancer-related biomarker association, making it marginally more relevant than a GBM therapeutic-target study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690399Z"}
{"comparison_id":"e6b37866-ed8d-47f4-8da5-5927e55e7300","query_id":"51","doc_a_id":"5468807","doc_b_id":"4959368","presented_order":["4959368","5468807"],"winner_id":"5468807","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document B is at least about tumor biology and therapeutic outcome, so marginally more relevant than a metabolic pancreatic cancer study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690406Z"}
{"comparison_id":"34b358bd-4ed7-4e6f-a117-83fef4e33877","query_id":"51","doc_a_id":"22059387","doc_b_id":"4959368","presented_order":["4959368","22059387"],"winner_id":"4959368","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant because it concerns human cancer biomarkers, whereas B focuses on hamster infection-induced cholangiocarcinoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690413Z"}
{"comparison_id":"08b01d29-5cd5-4c25-9b1f-02da7c6621b5","query_id":"51","doc_a_id":"14672919","doc_b_id":"4959368","presented_order":["4959368","14672919"],"winner_id":"14672919","reasoning":"Document B — it concerns prognostic biomarkers in cancer (like ALDH1's prognostic role), whereas Document A is about metabolic changes in pancreatic cancer development. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690420Z"}
{"comparison_id":"24b38361-db78-46eb-9324-f24be540a6ad","query_id":"51","doc_a_id":"5783785","doc_b_id":"4959368","presented_order":["4959368","5783785"],"winner_id":"5783785","reasoning":"Document B — neither document addresses ALDH1 or breast cancer, but B discusses gene expression and cancer progression (molecular regulation), making it marginally more relevant than a metabolic/pancreatic cancer study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690427Z"}
{"comparison_id":"beff6fdb-a358-4289-9734-191dfcdf08e2","query_id":"51","doc_a_id":"667451","doc_b_id":"4959368","presented_order":["667451","4959368"],"winner_id":"667451","reasoning":"Document A is more relevant — it addresses molecular markers and their association with cancer progression and outcomes, whereas Document B concerns BCAAs in pancreatic cancer unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690434Z"}
{"comparison_id":"0ca92967-dfeb-44a7-a5ff-53c60b4b2e10","query_id":"51","doc_a_id":"1836154","doc_b_id":"4959368","presented_order":["4959368","1836154"],"winner_id":"1836154","reasoning":"Neither abstract mentions ALDH1 or breast cancer. Document B is slightly more relevant because it addresses gene expression and clinical implications in cancer, whereas A focuses on metabolism in pancreatic cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690441Z"}
{"comparison_id":"b777c973-0267-4759-93fb-5437e2dd43bb","query_id":"51","doc_a_id":"24190159","doc_b_id":"4959368","presented_order":["4959368","24190159"],"winner_id":"24190159","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document B is slightly more relevant because it discusses gene expression and cancer treatment outcomes in carcinomas, whereas A concerns metabolism in pancreatic cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690448Z"}
{"comparison_id":"d6413140-b6bb-4f69-9bb3-5b2d863507bf","query_id":"51","doc_a_id":"13905670","doc_b_id":"4959368","presented_order":["13905670","4959368"],"winner_id":"4959368","reasoning":"Document B — it concerns cancer biology (pancreatic cancer), which is more closely related to the query about cancer outcomes than Document A's focus on inflammatory/infectious disease. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690455Z"}
{"comparison_id":"7a4c78de-8253-4033-a015-90157bdf460f","query_id":"51","doc_a_id":"18882947","doc_b_id":"4959368","presented_order":["4959368","18882947"],"winner_id":"4959368","reasoning":"Document A is slightly more relevant because it discusses a biomarker association with cancer risk/outcomes, whereas B is specific to T-cell lymphoma genetics and not about biomarker expression or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690462Z"}
{"comparison_id":"18dbf1da-ebec-4ef9-b54c-8297b43fd403","query_id":"51","doc_a_id":"19800147","doc_b_id":"4959368","presented_order":["19800147","4959368"],"winner_id":"19800147","reasoning":"Neither document mentions ALDH1 or breast cancer; both are unrelated. Document A is marginally more relevant because it addresses cancer progression, whereas B focuses on metabolic markers in pancreatic cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690469Z"}
{"comparison_id":"47898896-f46d-496e-af51-5b068d7beb79","query_id":"51","doc_a_id":"67787658","doc_b_id":"4959368","presented_order":["4959368","67787658"],"winner_id":"4959368","reasoning":"Document A is slightly more relevant because it discusses cancer biomarkers and disease outcomes, whereas Document B focuses on glioblastoma drug resistance mechanisms unrelated to ALDH1 or breast cancer.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690477Z"}
{"comparison_id":"f1e3d977-ef38-450b-ade3-306dfb389ebb","query_id":"51","doc_a_id":"9478135","doc_b_id":"4959368","presented_order":["9478135","4959368"],"winner_id":"9478135","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes, so both are irrelevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690483Z"}
{"comparison_id":"8f8fbc37-a00d-4cbd-b71f-74def6a0306a","query_id":"51","doc_a_id":"6374918","doc_b_id":"4959368","presented_order":["6374918","4959368"],"winner_id":"6374918","reasoning":"Document A is slightly more relevant because it addresses cancer treatment and outcomes (survival/chemosensitivity), whereas Document B focuses on metabolic markers for pancreatic cancer risk and not outcomes in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690489Z"}
{"comparison_id":"d05f2376-33f0-4f49-abbd-4ca2a7ce48f4","query_id":"51","doc_a_id":"15322518","doc_b_id":"4959368","presented_order":["4959368","15322518"],"winner_id":"15322518","reasoning":"Document B is more relevant — it concerns tumor biology and therapeutic markers, while A is about BCAAs in pancreatic cancer and unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690496Z"}
{"comparison_id":"61582cce-f1d1-4979-82ff-34c5eca86278","query_id":"51","doc_a_id":"4464565","doc_b_id":"4959368","presented_order":["4464565","4959368"],"winner_id":"4464565","reasoning":"Document A is more relevant — it discusses changes in gene expression (where ALDH1 expression would fall), whereas Document B concerns branched-chain amino acids and pancreatic cancer, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690503Z"}
{"comparison_id":"3817ff1c-ba30-4625-b7bf-35e7be4d60e9","query_id":"51","doc_a_id":"30543439","doc_b_id":"4959368","presented_order":["4959368","30543439"],"winner_id":"30543439","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B deals with molecular enzymes in cancer cells (MTH1/NUDT15), so it's marginally more relevant than A, which is about BCAAs in pancreatic cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690536Z"}
{"comparison_id":"0c3a77a3-bbae-4a4c-8d92-faa618d0c0df","query_id":"51","doc_a_id":"15491308","doc_b_id":"4959368","presented_order":["4959368","15491308"],"winner_id":"15491308","reasoning":"Document B is slightly more relevant — it deals with stem cell biology (SIRT1 in MSCs), which is closer to ALDH1's role as a stem-cell marker than a study about BCAAs and pancreatic cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690549Z"}
{"comparison_id":"e3502c49-82b1-4a5d-bd8f-12ac1426fea0","query_id":"51","doc_a_id":"36653415","doc_b_id":"4959368","presented_order":["36653415","4959368"],"winner_id":"36653415","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant only because it concerns tumor metabolism in human cancers generally, whereas B focuses on pancreatic cancer biomarkers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690562Z"}
{"comparison_id":"68acacdb-8bea-4b67-b74a-1544395470c4","query_id":"51","doc_a_id":"8724666","doc_b_id":"4959368","presented_order":["8724666","4959368"],"winner_id":"8724666","reasoning":"Document A is more relevant — it deals with cancer metabolism and enzyme expression in malignancy, which is closer to ALDH1-related cancer outcome questions than a paper about BCAAs and pancreatic cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690569Z"}
{"comparison_id":"66af7266-2b09-4f72-a2c8-9fef457e2015","query_id":"51","doc_a_id":"25344732","doc_b_id":"4959368","presented_order":["4959368","25344732"],"winner_id":"25344732","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document B is slightly more relevant because it concerns tumor protein expression, whereas A addresses metabolic markers in pancreatic cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690577Z"}
{"comparison_id":"bb392cae-b540-4c80-8f51-e2fe2e206eb1","query_id":"51","doc_a_id":"26059876","doc_b_id":"4959368","presented_order":["26059876","4959368"],"winner_id":"26059876","reasoning":"Document A is more relevant — it discusses cancer-related molecular mechanisms (tumorigenesis and gene expression), whereas Document B concerns metabolic biomarkers in pancreatic cancer and neither mentions ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690584Z"}
{"comparison_id":"56813702-7cf7-4ed2-94cd-31f44fd499f7","query_id":"51","doc_a_id":"17775228","doc_b_id":"4959368","presented_order":["17775228","4959368"],"winner_id":"17775228","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document A discusses gene expression changes in cancer (colorectal), which is marginally more related to expression-outcome questions than Document B's metabolic biomarker focus in pancreatic cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690592Z"}
{"comparison_id":"1b1079bc-457d-4d7c-b42d-3d5d1d9459e0","query_id":"51","doc_a_id":"2359152","doc_b_id":"4959368","presented_order":["2359152","4959368"],"winner_id":"2359152","reasoning":"Document A is slightly more relevant because it discusses genetic markers and prognostic models related to cancer outcomes, whereas Document B concerns metabolic changes in pancreatic cancer unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690599Z"}
{"comparison_id":"2f717e2b-8de0-4df8-ba8e-bf71e68cc863","query_id":"51","doc_a_id":"39481265","doc_b_id":"4959368","presented_order":["4959368","39481265"],"winner_id":"39481265","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document B discusses epigenetic biomarkers and prognosis which is marginally closer to gene-expression–related outcomes than the pancreatic BCAA study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:17.690606Z"}
{"comparison_id":"26a78b3e-cdb8-40ea-93e3-5a8e7f9f9e84","query_id":"51","doc_a_id":"8677721","doc_b_id":"25738896","presented_order":["8677721","25738896"],"winner_id":"8677721","reasoning":"Document A is more related to tumor biology and oncogenic signaling (though neither mentions ALDH1 or breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824134Z"}
{"comparison_id":"42b23258-d858-4086-88fe-6e2dfa7b83b8","query_id":"51","doc_a_id":"14471161","doc_b_id":"25738896","presented_order":["25738896","14471161"],"winner_id":"14471161","reasoning":"Document B is slightly more relevant because it addresses tumor outcomes and gene expression in cancer, whereas Document A concerns thymic tolerance and melanoma-specific immunity unrelated to ALDH1 or breast cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824154Z"}
{"comparison_id":"008ab5b2-c68b-453e-9fd6-842b7a4ca67b","query_id":"51","doc_a_id":"31313782","doc_b_id":"25738896","presented_order":["31313782","25738896"],"winner_id":"31313782","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant because it discusses gene expression profiles in cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824163Z"}
{"comparison_id":"56a4c6f7-e215-4497-b86a-b295676b3ef8","query_id":"51","doc_a_id":"2272614","doc_b_id":"25738896","presented_order":["25738896","2272614"],"winner_id":"2272614","reasoning":"Reason: Both are unrelated to ALDH1 or breast cancer, but Document B discusses how gene expression (NF1) affects cancer treatment outcomes, which is slightly closer in topic (gene expression linked to outcomes) than Document A's melanoma immunology focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824171Z"}
{"comparison_id":"e88242b8-ced0-4d13-8401-8b24fd24d3f1","query_id":"51","doc_a_id":"3355397","doc_b_id":"25738896","presented_order":["25738896","3355397"],"winner_id":"3355397","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer; Document B at least addresses cancer risk/outcomes across multiple cancers, making it slightly more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824178Z"}
{"comparison_id":"a8992fc1-43b7-4275-a96d-f4c27654efdf","query_id":"51","doc_a_id":"32852283","doc_b_id":"25738896","presented_order":["32852283","25738896"],"winner_id":"32852283","reasoning":"Neither document discusses ALDH1 or breast cancer; Document A is slightly more relevant because it addresses cancer growth and survival outcomes (albeit in lung cancer), while B focuses on immune tolerance in melanoma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824185Z"}
{"comparison_id":"4286fc1f-5b85-4f30-8e86-0dceb314f7e4","query_id":"51","doc_a_id":"14180565","doc_b_id":"25738896","presented_order":["25738896","14180565"],"winner_id":"14180565","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are irrelevant; Document B is marginally more relevant because it addresses gene expression changes in cancer cells. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824192Z"}
{"comparison_id":"02d08e47-4537-4af0-9e2d-7a5915803db8","query_id":"51","doc_a_id":"52925737","doc_b_id":"25738896","presented_order":["25738896","52925737"],"winner_id":"52925737","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document B at least discusses tumor prognosis (albeit in gastric cancer), so it's slightly closer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824199Z"}
{"comparison_id":"8be268e9-bcb0-4859-8887-7bd71af7f348","query_id":"51","doc_a_id":"27306942","doc_b_id":"25738896","presented_order":["25738896","27306942"],"winner_id":"27306942","reasoning":"Document B is slightly more relevant because it discusses associations between a molecular marker and clinical outcomes in cancer, whereas Document A concerns immune selection and melanoma. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824206Z"}
{"comparison_id":"97a92f36-8b12-47d9-8e77-059917105a8b","query_id":"51","doc_a_id":"25628793","doc_b_id":"25738896","presented_order":["25738896","25628793"],"winner_id":"25738896","reasoning":"Document A is slightly more relevant because it concerns cancer immunology (melanoma), whereas Document B is about endometriosis and estrogen metabolism; neither addresses ALDH1 or breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824213Z"}
{"comparison_id":"c31b812a-9ef0-4fa7-be83-468c62563847","query_id":"51","doc_a_id":"17876040","doc_b_id":"25738896","presented_order":["17876040","25738896"],"winner_id":"17876040","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document A is slightly more related because it concerns cancer therapy generally, while B focuses on melanoma immunology.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824220Z"}
{"comparison_id":"f1b65fe9-5d6e-46cb-abad-da8490bd4bb8","query_id":"51","doc_a_id":"26902591","doc_b_id":"25738896","presented_order":["26902591","25738896"],"winner_id":"26902591","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it addresses cancer-associated processes and patient outcomes, while B concerns melanoma immunology. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824227Z"}
{"comparison_id":"3c19f285-1e74-40a5-8a73-ac6993eaf952","query_id":"51","doc_a_id":"2360905","doc_b_id":"25738896","presented_order":["25738896","2360905"],"winner_id":"25738896","reasoning":"Document A is slightly more relevant because it discusses tumor antigen expression and immune-related outcomes in cancer, whereas Document B focuses on pediatric glioma genomics unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824235Z"}
{"comparison_id":"a5a1b248-1ac2-48d0-8045-fbc8c8702264","query_id":"51","doc_a_id":"4729644","doc_b_id":"25738896","presented_order":["4729644","25738896"],"winner_id":"4729644","reasoning":"Document A is more relevant — it discusses molecular expression and cancer outcomes/resistance (though in nasopharyngeal carcinoma, not breast), whereas B concerns immune selection in melanoma and is less related to marker expression in tumors.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824244Z"}
{"comparison_id":"7ae45c1f-3d49-40d9-8701-da40ab02392d","query_id":"51","doc_a_id":"4468861","doc_b_id":"25738896","presented_order":["4468861","25738896"],"winner_id":"4468861","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document A is slightly more relevant only because it discusses cancer outcomes/treatment generally. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824251Z"}
{"comparison_id":"169b6ec6-94fd-47d2-94b0-cc27b1a5d4f3","query_id":"51","doc_a_id":"4387494","doc_b_id":"25738896","presented_order":["25738896","4387494"],"winner_id":"25738896","reasoning":"Document A is slightly more relevant because it discusses cancer-related antigen expression and immune outcomes, whereas Document B focuses on AML therapy and histone modification; neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824258Z"}
{"comparison_id":"2068878e-7c32-40ef-9649-d780ac00e667","query_id":"51","doc_a_id":"21414718","doc_b_id":"25738896","presented_order":["25738896","21414718"],"winner_id":"21414718","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes; both are irrelevant. Document B is marginally more relevant because it concerns cancer cell biology (gastric), whereas A focuses on melanoma immunology.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824266Z"}
{"comparison_id":"42b85e5c-2351-40f3-bb0e-97d25d4e7875","query_id":"51","doc_a_id":"57783564","doc_b_id":"25738896","presented_order":["25738896","57783564"],"winner_id":"57783564","reasoning":"Document B is slightly more relevant — it discusses tumor proliferation and molecular markers in cancer, which is closer to evaluating markers linked to cancer outcomes than a melanoma immune-selection study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824273Z"}
{"comparison_id":"e92c53e9-a51b-442e-adea-8b914958ec70","query_id":"51","doc_a_id":"7639744","doc_b_id":"25738896","presented_order":["25738896","7639744"],"winner_id":"25738896","reasoning":"Neither document addresses ALDH1 or breast cancer, but Document A deals with cancer-related antigen expression and immune outcomes (closer topic). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824280Z"}
{"comparison_id":"4100b6b0-ddd0-453e-a559-b4ff6498814a","query_id":"51","doc_a_id":"12650610","doc_b_id":"25738896","presented_order":["12650610","25738896"],"winner_id":"12650610","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is marginally more relevant because it addresses cancer progression pathways, while B focuses on melanoma immune tolerance. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824287Z"}
{"comparison_id":"b9c46579-d280-4853-bf66-eae4997ac00f","query_id":"51","doc_a_id":"6121555","doc_b_id":"25738896","presented_order":["25738896","6121555"],"winner_id":"6121555","reasoning":"Neither paper mentions ALDH1 or breast cancer; both are irrelevant. Document B is marginally more relevant because it addresses cancer cell survival pathways, whereas A focuses on melanoma immune selection.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824294Z"}
{"comparison_id":"b69820a0-7ec4-4b43-a9a3-29a5172a699f","query_id":"51","doc_a_id":"85665741","doc_b_id":"25738896","presented_order":["85665741","25738896"],"winner_id":"85665741","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is marginally closer since it discusses cancer molecular markers predicting outcomes/therapy response. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824302Z"}
{"comparison_id":"465f3efd-a75e-4d9a-9f50-a7e777c807e5","query_id":"51","doc_a_id":"24916604","doc_b_id":"25738896","presented_order":["25738896","24916604"],"winner_id":"24916604","reasoning":"Document B is more relevant — it deals with clinical cancer treatment practices (likely including breast cancer patients), whereas Document A is specific to melanoma immunology and unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824309Z"}
{"comparison_id":"3f9dc042-3445-41ff-884d-68416c1514de","query_id":"51","doc_a_id":"39481265","doc_b_id":"25738896","presented_order":["39481265","25738896"],"winner_id":"39481265","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A — which discusses biomarkers and prognosis (epigenetic marks) — is marginally more relevant than Document B, which focuses on melanoma immunology.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824317Z"}
{"comparison_id":"b7e95979-be50-444f-a261-97f2a7c8e119","query_id":"51","doc_a_id":"12580014","doc_b_id":"25738896","presented_order":["12580014","25738896"],"winner_id":"12580014","reasoning":"Document A is slightly more relevant because it discusses gene expression in tumor keratinocytes (tumor-related gene regulation), whereas Document B focuses on thymic antigen expression and immune rejection of melanoma—both do not address ALDH1 or breast cancer but A is marginally closer to tumor biology.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824325Z"}
{"comparison_id":"801646cc-f568-447c-b2cf-044ee18b4423","query_id":"51","doc_a_id":"27167110","doc_b_id":"25738896","presented_order":["25738896","27167110"],"winner_id":"27167110","reasoning":"Document B is more relevant — both are unrelated to ALDH1/breast cancer, but B deals with cancer-related gene regulation whereas A is focused on melanoma immunology. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824332Z"}
{"comparison_id":"df426a64-fa9c-47ba-acc5-11c7712c23c0","query_id":"51","doc_a_id":"17671145","doc_b_id":"25738896","presented_order":["17671145","25738896"],"winner_id":"17671145","reasoning":"Both documents are unrelated to ALDH1 or breast cancer; however, Document A is marginally more relevant because it discusses gene expression in a cancer context (prostate), whereas Document B focuses specifically on thymic selection and melanoma immune responses.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824339Z"}
{"comparison_id":"4dd82a82-06a2-49c7-aee2-9f3bfb170c50","query_id":"51","doc_a_id":"5468807","doc_b_id":"25738896","presented_order":["5468807","25738896"],"winner_id":"5468807","reasoning":"Neither document mentions ALDH1 or breast cancer; however, Document A discusses cancer survival outcomes (ovarian), so it's marginally more related.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824346Z"}
{"comparison_id":"f5489998-15b9-49b5-9d91-cc3f170c0694","query_id":"51","doc_a_id":"14672919","doc_b_id":"25738896","presented_order":["14672919","25738896"],"winner_id":"14672919","reasoning":"Neither document discusses ALDH1 or breast cancer; Document A is more relevant because it addresses prognostic markers in cancer (whereas B is melanoma immunology). \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824352Z"}
{"comparison_id":"eb76c7cf-df6d-4039-8cb4-e5f74c1b226a","query_id":"51","doc_a_id":"5783785","doc_b_id":"25738896","presented_order":["25738896","5783785"],"winner_id":"5783785","reasoning":"Document B is slightly more relevant because it addresses gene expression and cancer outcomes (though in gastric cancer), whereas Document A concerns melanoma immunology unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824359Z"}
{"comparison_id":"b4f2de97-b4e8-44f6-8ca8-04785f5f5ef2","query_id":"51","doc_a_id":"667451","doc_b_id":"25738896","presented_order":["667451","25738896"],"winner_id":"667451","reasoning":"Document A is slightly more relevant because it discusses cancer progression and clinical outcomes, whereas Document B focuses on melanoma immunology in mice and is less related to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824366Z"}
{"comparison_id":"a21f39d2-054d-40f5-9b28-0cc6fb97c041","query_id":"51","doc_a_id":"1836154","doc_b_id":"25738896","presented_order":["25738896","1836154"],"winner_id":"1836154","reasoning":"Document B is marginally more relevant because it deals with human cancer genomics and clinical outcomes, whereas A addresses immune rejection in melanoma unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824373Z"}
{"comparison_id":"a2d810a8-387b-40ca-a5c1-66e353fbeb9c","query_id":"51","doc_a_id":"24190159","doc_b_id":"25738896","presented_order":["24190159","25738896"],"winner_id":"24190159","reasoning":"Reason: Document A discusses gene expression changes in human carcinomas (cancer outcomes/treatment relevance), which is more related to the claim about a cancer marker than Document B's mouse melanoma immunology.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824380Z"}
{"comparison_id":"bce53d7e-af1d-4b94-8db9-9a4d0af49b25","query_id":"51","doc_a_id":"19800147","doc_b_id":"25738896","presented_order":["25738896","19800147"],"winner_id":"19800147","reasoning":"Document B is marginally more relevant because it addresses cancer progression with human clinical correlations, whereas A focuses on a mouse melanoma immune mechanism unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824387Z"}
{"comparison_id":"6250c130-1cf5-4d08-9bc6-b2c8f3a3346d","query_id":"51","doc_a_id":"9478135","doc_b_id":"25738896","presented_order":["9478135","25738896"],"winner_id":"25738896","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are irrelevant, but B is slightly more related since it addresses tumor immune response (melanoma) versus A which is specific to leukemia genetics.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824394Z"}
{"comparison_id":"695f7bdc-7edf-49fa-99a6-8759eadcd12a","query_id":"51","doc_a_id":"6374918","doc_b_id":"25738896","presented_order":["6374918","25738896"],"winner_id":"6374918","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A is slightly more related because it addresses cancer treatment outcomes/survival.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824401Z"}
{"comparison_id":"c8d6e22e-6764-40cd-ae3f-fdbbbed1eaf2","query_id":"51","doc_a_id":"15322518","doc_b_id":"25738896","presented_order":["25738896","15322518"],"winner_id":"15322518","reasoning":"Document B is slightly more relevant because it concerns tumor biology and therapeutic markers in cancer, whereas Document A is specific to melanoma immune tolerance and not related to ALDH1 or breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824408Z"}
{"comparison_id":"16d98e9f-c25f-4e16-88a0-03fa17ff2e1e","query_id":"51","doc_a_id":"4464565","doc_b_id":"25738896","presented_order":["4464565","25738896"],"winner_id":"4464565","reasoning":"Document A is marginally more relevant because it involves gene expression analysis (where ALDH1 expression would be assessed), whereas Document B concerns Aire and melanoma immunity and is unrelated to ALDH1 or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824415Z"}
{"comparison_id":"1b437beb-c9e5-4dc2-953d-011379141c3c","query_id":"51","doc_a_id":"30543439","doc_b_id":"25738896","presented_order":["30543439","25738896"],"winner_id":"30543439","reasoning":"Document A is slightly more relevant because it discusses enzymes and cancer cell biology, whereas Document B focuses specifically on melanoma immune tolerance unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824421Z"}
{"comparison_id":"a5de8b58-bf6d-433d-b737-c819204fb44f","query_id":"51","doc_a_id":"15491308","doc_b_id":"25738896","presented_order":["15491308","25738896"],"winner_id":"25738896","reasoning":"Reason: Document B concerns tumor immune responses and cancer outcomes (albeit in melanoma), making it marginally more related to a claim about cancer prognosis than Document A, which focuses on MSC senescence.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824428Z"}
{"comparison_id":"bd9842bb-69a3-4b17-8d10-fbb9f0a0d540","query_id":"51","doc_a_id":"36653415","doc_b_id":"25738896","presented_order":["25738896","36653415"],"winner_id":"36653415","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is marginally more relevant because it concerns tumor biology/metabolism, while A is specific to melanoma immune tolerance. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824435Z"}
{"comparison_id":"6f720262-2810-483e-82b5-1e25cc3b88b5","query_id":"51","doc_a_id":"8724666","doc_b_id":"25738896","presented_order":["25738896","8724666"],"winner_id":"8724666","reasoning":"Document B is more relevant — it discusses metabolic enzyme expression and cancer (leukemia), which is closer to the query about an enzyme marker (ALDH1) and cancer outcomes than the melanoma-immunology focus of Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824442Z"}
{"comparison_id":"dd35c2c3-ea7f-4cac-a3ef-a82bed9b09ee","query_id":"51","doc_a_id":"25344732","doc_b_id":"25738896","presented_order":["25738896","25344732"],"winner_id":"25344732","reasoning":"Neither document mentions ALDH1 or breast cancer; Document B is marginally more relevant because it addresses tumor-related gene expression. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824449Z"}
{"comparison_id":"f77c6682-486a-4d2a-b02b-1171cfdfc0dc","query_id":"51","doc_a_id":"26059876","doc_b_id":"25738896","presented_order":["25738896","26059876"],"winner_id":"26059876","reasoning":"Document B is more relevant — it addresses cancer progression and tumorigenic mechanisms (adenocarcinoma development), which is closer to breast cancer outcomes than an immunology/melanoma-focused study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824456Z"}
{"comparison_id":"52f765fd-c7cb-46b7-8749-1720819d7b2e","query_id":"51","doc_a_id":"17775228","doc_b_id":"25738896","presented_order":["25738896","17775228"],"winner_id":"17775228","reasoning":"Document B is more relevant — it concerns gene expression and epigenetic regulation in cancer (colorectal), whereas A is about Aire and melanoma immune responses, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824463Z"}
{"comparison_id":"4d8f7e27-aead-4af0-a3d5-78300c158ce4","query_id":"51","doc_a_id":"2359152","doc_b_id":"25738896","presented_order":["25738896","2359152"],"winner_id":"2359152","reasoning":"Document B is more relevant — it addresses genetic markers and prognostic models related to cancer outcomes, whereas A focuses on melanoma immune mechanisms unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:40.824470Z"}
{"comparison_id":"73004a56-f165-4b58-8d32-a901ffc81d74","query_id":"51","doc_a_id":"8677721","doc_b_id":"39481265","presented_order":["39481265","8677721"],"winner_id":"39481265","reasoning":"Document A is slightly more relevant — it discusses biomarkers and prognosis (though in lung fibrosis), whereas Document B focuses on HCC mechanisms unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839664Z"}
{"comparison_id":"ba882cc2-9fb7-4d57-9773-4d28d32927b9","query_id":"51","doc_a_id":"14471161","doc_b_id":"39481265","presented_order":["39481265","14471161"],"winner_id":"14471161","reasoning":"Document B is more relevant — it studies cancer biology and tumor gene expression (though not breast cancer or ALDH1 specifically), whereas Document A is about lung fibrosis and epigenetics unrelated to breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839686Z"}
{"comparison_id":"fde7e84d-9420-4e8e-a988-3463319d86b8","query_id":"51","doc_a_id":"31313782","doc_b_id":"39481265","presented_order":["31313782","39481265"],"winner_id":"31313782","reasoning":"Document A is more relevant — it deals with gene expression profiling in cancer (albeit NSCLC), which is closer to a claim about ALDH1 expression and cancer outcomes than a review focused on epigenetics in fibrosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839695Z"}
{"comparison_id":"be0cf941-3b0a-4ea5-bfaf-ca5142db8234","query_id":"51","doc_a_id":"2272614","doc_b_id":"39481265","presented_order":["39481265","2272614"],"winner_id":"2272614","reasoning":"Reason: Both documents are unrelated to ALDH1 or breast cancer, but Document B deals with gene expression in cancer (lung), making it marginally more relevant than Document A (non-cancer lung fibrosis).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839703Z"}
{"comparison_id":"510dfcad-0676-4c44-807f-f4715c5d980c","query_id":"51","doc_a_id":"3355397","doc_b_id":"39481265","presented_order":["3355397","39481265"],"winner_id":"3355397","reasoning":"Reason: Document A deals with cancer risk data (even if not breast-specific), while Document B focuses on epigenetics in lung fibrosis, unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839711Z"}
{"comparison_id":"e2da8ae4-a07a-4c62-a53e-a6d536989398","query_id":"51","doc_a_id":"32852283","doc_b_id":"39481265","presented_order":["39481265","32852283"],"winner_id":"39481265","reasoning":"Document A — it discusses biomarkers and prognosis (epigenetic marks) which is more related to expression–outcome associations than B, which is about a drug in NSCLC. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839718Z"}
{"comparison_id":"fa9636f9-92a7-42a1-a817-882217a9618c","query_id":"51","doc_a_id":"14180565","doc_b_id":"39481265","presented_order":["39481265","14180565"],"winner_id":"14180565","reasoning":"Document B is slightly more relevant because it concerns gene expression changes in cancer cells (though in glioblastoma, not breast cancer); Document A focuses on lung fibrosis and epigenetics and does not address ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839726Z"}
{"comparison_id":"1fb3f4f9-10c2-4c92-b3d6-593c8472e911","query_id":"51","doc_a_id":"52925737","doc_b_id":"39481265","presented_order":["52925737","39481265"],"winner_id":"52925737","reasoning":"Reason: Document A discusses cancer-related prognosis (though in gastric cancer), making it slightly more relevant than Document B, which focuses on lung fibrosis and epigenetics unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839733Z"}
{"comparison_id":"bf6ea90d-3299-417e-88fd-3ff2f35ef99f","query_id":"51","doc_a_id":"27306942","doc_b_id":"39481265","presented_order":["39481265","27306942"],"winner_id":"27306942","reasoning":"Document B — it links gene expression and clinical outcomes in cancer, which is more related to the claim about ALDH1 expression and breast cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839741Z"}
{"comparison_id":"2a915f05-08d5-4b00-8002-e4a5da219441","query_id":"51","doc_a_id":"17876040","doc_b_id":"39481265","presented_order":["39481265","17876040"],"winner_id":"17876040","reasoning":"Neither document mentions ALDH1 or breast cancer; Document B is slightly more relevant because it concerns cancer therapy. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839748Z"}
{"comparison_id":"6995ec38-4149-4dd0-acd9-3e1ea21b6794","query_id":"51","doc_a_id":"26902591","doc_b_id":"39481265","presented_order":["39481265","26902591"],"winner_id":"26902591","reasoning":"B is more relevant — it concerns cancer-related biology (cachexia) whereas A focuses on lung fibrosis unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839755Z"}
{"comparison_id":"8b132cfc-fe79-468a-85ba-ab23f59a9791","query_id":"51","doc_a_id":"4729644","doc_b_id":"39481265","presented_order":["4729644","39481265"],"winner_id":"4729644","reasoning":"Document A is more relevant because it addresses cancer-related molecular markers and mechanisms (though in nasopharyngeal carcinoma), whereas Document B focuses on epigenetics in lung fibrosis, not cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839762Z"}
{"comparison_id":"2fa8dd41-6b9d-4afd-a56f-53ce4e45c159","query_id":"51","doc_a_id":"4468861","doc_b_id":"39481265","presented_order":["4468861","39481265"],"winner_id":"4468861","reasoning":"Document A is more related to cancer biology and treatment, whereas Document B concerns lung fibrosis; neither mentions ALDH1 or breast cancer, but A is closer in topic.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839769Z"}
{"comparison_id":"8866fb66-6ba3-4048-9449-d7dfd9ccaf8b","query_id":"51","doc_a_id":"21414718","doc_b_id":"39481265","presented_order":["39481265","21414718"],"winner_id":"21414718","reasoning":"Document B is more relevant because it addresses cancer biology (though gastric cancer), while Document A concerns lung fibrosis and not cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839776Z"}
{"comparison_id":"444e6490-0d3f-47fa-b842-7071eb937dfc","query_id":"51","doc_a_id":"57783564","doc_b_id":"39481265","presented_order":["39481265","57783564"],"winner_id":"57783564","reasoning":"B is more relevant — at least discusses cancer biology (colon cancer), whereas A is about lung fibrosis and epigenetics unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839783Z"}
{"comparison_id":"987c1de7-4956-4177-8fb1-a4d37d38cc20","query_id":"51","doc_a_id":"12650610","doc_b_id":"39481265","presented_order":["12650610","39481265"],"winner_id":"12650610","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it concerns cancer signaling pathways, while Document B focuses on lung fibrosis (non-cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839790Z"}
{"comparison_id":"60fd3bf0-e190-40d3-9491-4744e215105d","query_id":"51","doc_a_id":"6121555","doc_b_id":"39481265","presented_order":["39481265","6121555"],"winner_id":"39481265","reasoning":"DOCUMENT A is slightly more relevant because it discusses biomarkers and prognosis (though in lung fibrosis, not breast cancer). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839797Z"}
{"comparison_id":"108e05a8-2bdc-41b8-bc40-63aea5391397","query_id":"51","doc_a_id":"85665741","doc_b_id":"39481265","presented_order":["39481265","85665741"],"winner_id":"39481265","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it discusses biomarkers/epigenetic regulation (general cancer-related context), while B focuses specifically on BRAF/MEK in NSCLC.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839804Z"}
{"comparison_id":"726b93ae-dcfe-43bd-bb03-41ff41b27001","query_id":"51","doc_a_id":"24916604","doc_b_id":"39481265","presented_order":["39481265","24916604"],"winner_id":"24916604","reasoning":"Document B is slightly more related because it concerns cancer treatment practices, whereas A concerns lung fibrosis with no cancer relevance. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839811Z"}
{"comparison_id":"c36c5146-4b76-49c4-804b-e11fdb5931b3","query_id":"51","doc_a_id":"2359152","doc_b_id":"39481265","presented_order":["39481265","2359152"],"winner_id":"2359152","reasoning":"Document B is more relevant — it addresses genetic lesions and prognostic models relating molecular markers to patient outcomes (though in MDS, not breast cancer). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839817Z"}
{"comparison_id":"14ad8a80-e0c7-4ca1-b206-98025249d4e3","query_id":"51","doc_a_id":"12580014","doc_b_id":"39481265","presented_order":["12580014","39481265"],"winner_id":"12580014","reasoning":"Document A is more relevant — it concerns tumor gene expression and cancer biology (though in skin tumors), whereas Document B focuses on epigenetics in lung fibrosis, unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839824Z"}
{"comparison_id":"7a4806da-d554-40ed-8cd6-962420300bdb","query_id":"51","doc_a_id":"27167110","doc_b_id":"39481265","presented_order":["27167110","39481265"],"winner_id":"27167110","reasoning":"Document A is more relevant — it's about cancer biology (miRNA regulation in prostate cancer), whereas Document B discusses epigenetics in lung fibrosis (non-cancer), so A is closer to the breast cancer claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839832Z"}
{"comparison_id":"8d4ec9a8-0dbc-42a1-adfd-1623febb5efc","query_id":"51","doc_a_id":"17671145","doc_b_id":"39481265","presented_order":["17671145","39481265"],"winner_id":"17671145","reasoning":"Document A is more relevant — it's cancer-focused (though on prostate cancer), while Document B discusses lung fibrosis; neither mentions ALDH1 or breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839839Z"}
{"comparison_id":"488f53d1-7d9b-4a20-a464-ada744fad1c0","query_id":"51","doc_a_id":"5468807","doc_b_id":"39481265","presented_order":["5468807","39481265"],"winner_id":"5468807","reasoning":"Document A is slightly more relevant because it concerns cancer biology and therapeutic outcomes, whereas Document B focuses on lung fibrosis unrelated to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839845Z"}
{"comparison_id":"174cc3d8-8765-4532-9a07-2100c6343911","query_id":"51","doc_a_id":"14672919","doc_b_id":"39481265","presented_order":["39481265","14672919"],"winner_id":"14672919","reasoning":"Document B is more relevant — it deals with cancer prognostic markers and outcomes, whereas A is about lung fibrosis (non-cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839852Z"}
{"comparison_id":"70d42a3e-5abb-4b11-98e0-804de59252ec","query_id":"51","doc_a_id":"5783785","doc_b_id":"39481265","presented_order":["39481265","5783785"],"winner_id":"5783785","reasoning":"Document B is more relevant — it concerns cancer biology (epigenetic regulation in gastric cancer), whereas Document A is about lung fibrosis and not cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839858Z"}
{"comparison_id":"ed5d29e1-f53a-44a2-b462-80cb0157a187","query_id":"51","doc_a_id":"667451","doc_b_id":"39481265","presented_order":["39481265","667451"],"winner_id":"39481265","reasoning":"Document A is slightly more relevant because it discusses biomarkers and prognosis (epigenetic marks) whereas Document B focuses on CLL subclonal mutations unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839865Z"}
{"comparison_id":"28541284-bed9-4b7f-9c6e-9024b1db0508","query_id":"51","doc_a_id":"1836154","doc_b_id":"39481265","presented_order":["1836154","39481265"],"winner_id":"1836154","reasoning":"Reason: Document A concerns cancer genomic characterization (though of glioblastoma), so it's more related to cancer and gene expression than Document B on lung fibrosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839871Z"}
{"comparison_id":"9bdb303d-972e-4319-9e64-d9cd8c834bea","query_id":"51","doc_a_id":"24190159","doc_b_id":"39481265","presented_order":["24190159","39481265"],"winner_id":"24190159","reasoning":"Document A is more relevant — it concerns cancer biology (though rectal cancer), whereas B addresses lung fibrosis unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839877Z"}
{"comparison_id":"fe34541b-586f-46be-93f9-2c31aefcd8ea","query_id":"51","doc_a_id":"19800147","doc_b_id":"39481265","presented_order":["39481265","19800147"],"winner_id":"19800147","reasoning":"Document B is more relevant — it deals with cancer biology (tumor progression mechanisms), whereas Document A focuses on lung fibrosis and not cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839884Z"}
{"comparison_id":"e23353f1-3bec-489b-bea2-ed066cf71fe2","query_id":"51","doc_a_id":"6374918","doc_b_id":"39481265","presented_order":["39481265","6374918"],"winner_id":"6374918","reasoning":"Document B is more relevant — it concerns cancer biology/therapy (AML), whereas A discusses epigenetics in pulmonary fibrosis, not cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839890Z"}
{"comparison_id":"4b51cec1-7a9b-410f-856e-fb4c17e1ea01","query_id":"51","doc_a_id":"15322518","doc_b_id":"39481265","presented_order":["15322518","39481265"],"winner_id":"15322518","reasoning":"Document A is more relevant—it's about cancer biology and targeted markers/pathways, whereas B covers lung fibrosis; neither directly addresses ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839896Z"}
{"comparison_id":"4df0ef1a-21a4-4cb7-9364-8942fa2c37d5","query_id":"51","doc_a_id":"4464565","doc_b_id":"39481265","presented_order":["4464565","39481265"],"winner_id":"4464565","reasoning":"Document A is about gene expression changes in a cancer cell line (Caco-2), which is at least tangentially related to gene expression in cancer; Document B concerns lung fibrosis, not cancer. Neither mentions ALDH1 or breast cancer, but A is more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839903Z"}
{"comparison_id":"570ca5df-48ca-47e9-97eb-99c1ca7ce831","query_id":"51","doc_a_id":"30543439","doc_b_id":"39481265","presented_order":["39481265","30543439"],"winner_id":"30543439","reasoning":"Document B is slightly more relevant because it discusses cancer cell biology, whereas Document A focuses on lung fibrosis and epigenetics unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839910Z"}
{"comparison_id":"e21ae3cb-7769-4535-8a5c-18337da24a2b","query_id":"51","doc_a_id":"36653415","doc_b_id":"39481265","presented_order":["36653415","39481265"],"winner_id":"36653415","reasoning":"Document A is more relevant because it concerns tumor biology (cancer metabolism), whereas Document B discusses non-cancerous lung fibrosis and epigenetics. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839916Z"}
{"comparison_id":"e5b60748-f2e4-45aa-8fab-c17c8a70e9dd","query_id":"51","doc_a_id":"8724666","doc_b_id":"39481265","presented_order":["39481265","8724666"],"winner_id":"8724666","reasoning":"Document B is more relevant — it deals with cancer cell metabolism and hematologic malignancy (closer to cancer biology), whereas A is about lung fibrosis and epigenetics unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839923Z"}
{"comparison_id":"7dc83d09-3fd5-492d-9d5c-1b20ccd8c36b","query_id":"51","doc_a_id":"25344732","doc_b_id":"39481265","presented_order":["25344732","39481265"],"winner_id":"25344732","reasoning":"Document A is more relevant — it's cancer-related and discusses gene expression changes in tumors, whereas Document B is about lung fibrosis and epigenetics unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839930Z"}
{"comparison_id":"9f2a040c-5c9d-4e95-82c6-40de8adbd031","query_id":"51","doc_a_id":"26059876","doc_b_id":"39481265","presented_order":["26059876","39481265"],"winner_id":"26059876","reasoning":"Document A is more relevant because it addresses cancer-related molecular mechanisms (tumorigenesis), while Document B focuses on lung fibrosis and epigenetics unrelated to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839937Z"}
{"comparison_id":"710433fb-1ceb-4143-a71e-c510532f8bfd","query_id":"51","doc_a_id":"17775228","doc_b_id":"39481265","presented_order":["39481265","17775228"],"winner_id":"39481265","reasoning":"Document A is slightly more relevant because it discusses epigenetic biomarkers and prognosis in a cancer-related context, whereas Document B focuses on imprinting in colorectal cancer specifically and not on markers tied to breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:17:55.839944Z"}
{"comparison_id":"bbc888ca-af9b-4a6d-ba08-b53b6d84e041","query_id":"51","doc_a_id":"14471161","doc_b_id":"12580014","presented_order":["12580014","14471161"],"winner_id":"12580014","reasoning":"Document A is marginally more relevant — it deals with tumor gene expression and regulatory mechanisms in epithelial tumors (closer to breast cancer context) while Document B focuses on meal timing effects in pancreatic cancer, unrelated to ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.984818Z"}
{"comparison_id":"eb4b08fd-e562-4a74-bb40-0e1a277938b9","query_id":"51","doc_a_id":"31313782","doc_b_id":"12580014","presented_order":["31313782","12580014"],"winner_id":"12580014","reasoning":"Both documents are unrelated to ALDH1 or breast cancer. Document B is slightly more relevant because it addresses tumor gene expression/regulation, whereas A focuses on Toll-like receptors in lung disease.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.984839Z"}
{"comparison_id":"ab3f2214-b98d-4019-9711-e5d202746338","query_id":"51","doc_a_id":"2272614","doc_b_id":"12580014","presented_order":["2272614","12580014"],"winner_id":"12580014","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is marginally more relevant because it concerns tumor gene expression mechanisms, whereas A focuses on lung-specific drug resistance. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.984848Z"}
{"comparison_id":"3c17f454-5699-4564-b4f4-334b580bae39","query_id":"51","doc_a_id":"3355397","doc_b_id":"12580014","presented_order":["12580014","3355397"],"winner_id":"3355397","reasoning":"B — Document B discusses cancer risk associations in humans (clinical outcomes), while A is a skin-specific molecular study unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.984855Z"}
{"comparison_id":"cb4d4ee7-b3d6-4e9b-ad1c-2c9eee10767c","query_id":"51","doc_a_id":"14180565","doc_b_id":"12580014","presented_order":["12580014","14180565"],"winner_id":"14180565","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it deals with gene expression changes in cancer cells, whereas A focuses on keratin/Aire in skin tumor keratinocytes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.984862Z"}
{"comparison_id":"c93d2cd8-2867-44e6-a401-7cf40e088a04","query_id":"51","doc_a_id":"52925737","doc_b_id":"12580014","presented_order":["52925737","12580014"],"winner_id":"52925737","reasoning":"Document A is slightly more relevant because it discusses cancer prognosis/outcomes (though in gastric cancer), while Document B focuses on keratin regulation in skin tumors and not prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.984869Z"}
{"comparison_id":"9772385d-87aa-4aee-8dcb-ae1df1372dee","query_id":"51","doc_a_id":"27306942","doc_b_id":"12580014","presented_order":["12580014","27306942"],"winner_id":"12580014","reasoning":"Document A is slightly more relevant — it addresses gene expression in epithelial tumors (skin keratinocytes), which is closer to breast cancer biology than a pediatric B‑cell leukemia study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.984876Z"}
{"comparison_id":"f8aa8d23-85ff-4d71-a51e-38fcade3ce82","query_id":"51","doc_a_id":"17876040","doc_b_id":"12580014","presented_order":["17876040","12580014"],"winner_id":"12580014","reasoning":"Document B is slightly more relevant because it concerns tumor gene expression and mechanisms in cancer cells, whereas Document A focuses on a drug for AML and not on tumor biomarkers or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.984883Z"}
{"comparison_id":"0b4bd6b9-6544-442d-a5dd-93e9667330c7","query_id":"51","doc_a_id":"26902591","doc_b_id":"12580014","presented_order":["26902591","12580014"],"winner_id":"12580014","reasoning":"Neither document discusses ALDH1 or breast cancer; Document B is marginally more relevant because it addresses tumor gene expression mechanisms, whereas A focuses on cancer-associated cachexia. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.984890Z"}
{"comparison_id":"6335ba4a-aa7e-479a-b28a-fdcb78c5e487","query_id":"51","doc_a_id":"4729644","doc_b_id":"12580014","presented_order":["12580014","4729644"],"winner_id":"12580014","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes; both are irrelevant. Document A is marginally closer since it concerns tumor gene expression, whereas B is specific to nasopharyngeal carcinoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.984897Z"}
{"comparison_id":"f80924ca-a4b7-48e3-836f-6b55d29fc4b8","query_id":"51","doc_a_id":"4468861","doc_b_id":"12580014","presented_order":["4468861","12580014"],"winner_id":"12580014","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes; both are irrelevant. Document B is marginally more relevant because it addresses tumor gene expression. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.984904Z"}
{"comparison_id":"d7f14d5d-1dd3-4b5c-a76f-1421043409f0","query_id":"51","doc_a_id":"21414718","doc_b_id":"12580014","presented_order":["12580014","21414718"],"winner_id":"12580014","reasoning":"Document A is slightly more relevant — it concerns tumor gene expression and tumor biology (though in skin, not breast, and it does not mention ALDH1). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.984911Z"}
{"comparison_id":"edec1643-c4f5-4fbf-a2d1-c2bb3a10b91d","query_id":"51","doc_a_id":"57783564","doc_b_id":"12580014","presented_order":["12580014","57783564"],"winner_id":"12580014","reasoning":"Document A is slightly more relevant — it discusses gene expression in tumor epithelial cells, whereas Document B concerns colon-specific CDX2/Wnt signaling. Neither mentions ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.984919Z"}
{"comparison_id":"1da18aa1-6fc6-4658-837d-870009158146","query_id":"51","doc_a_id":"12650610","doc_b_id":"12580014","presented_order":["12650610","12580014"],"winner_id":"12650610","reasoning":"Document A is more relevant — it addresses cancer progression and metastasis mechanisms (though in oral cancer), which is closer to breast cancer outcome research than the skin-specific keratin/Aire study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.984926Z"}
{"comparison_id":"697e78e9-b70f-488e-8500-7ea67105490d","query_id":"51","doc_a_id":"24916604","doc_b_id":"12580014","presented_order":["12580014","24916604"],"winner_id":"24916604","reasoning":"Reason: Neither discusses ALDH1 or breast cancer outcomes, but Document B concerns cancer treatment/outcomes/policy (more related than a skin keratin study).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.984933Z"}
{"comparison_id":"d9df7827-648e-419f-ba55-a3ea5c5408f7","query_id":"51","doc_a_id":"2359152","doc_b_id":"12580014","presented_order":["2359152","12580014"],"winner_id":"12580014","reasoning":"Document B is more relevant — it deals with tumor cell gene expression and tumor biology, which is closer to a claim about a tumor marker and breast cancer outcomes than a study of myelodysplastic syndromes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.984940Z"}
{"comparison_id":"bcd0f720-2774-47f9-a168-2969dca67c0b","query_id":"51","doc_a_id":"26059876","doc_b_id":"12580014","presented_order":["26059876","12580014"],"winner_id":"26059876","reasoning":"Neither document addresses ALDH1 or breast cancer, so both are irrelevant. If forced to choose, pick A because it deals with general tumorigenic mechanisms (colorectal) rather than a skin-specific keratin pathway.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.984947Z"}
{"comparison_id":"3670a4f6-59d5-4dd3-8d21-3a498c4e74ca","query_id":"51","doc_a_id":"27167110","doc_b_id":"12580014","presented_order":["12580014","27167110"],"winner_id":"12580014","reasoning":"Document A is slightly more relevant because it deals with tumor gene expression/regulation (though in skin), whereas Document B focuses on prostate-specific miRNA regulation and not ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.984954Z"}
{"comparison_id":"9def74b7-a3c2-443a-b8ee-b72c1cb87ab6","query_id":"51","doc_a_id":"17671145","doc_b_id":"12580014","presented_order":["17671145","12580014"],"winner_id":"12580014","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document B is marginally closer (tumor gene expression context), so:\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.984961Z"}
{"comparison_id":"a376f9ee-cd6e-47aa-858f-a4e41fb98f1d","query_id":"51","doc_a_id":"5468807","doc_b_id":"12580014","presented_order":["5468807","12580014"],"winner_id":"5468807","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant because it addresses cancer survival outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.984967Z"}
{"comparison_id":"b9959535-99b0-4ed3-a4da-2949c783463f","query_id":"51","doc_a_id":"14672919","doc_b_id":"12580014","presented_order":["14672919","12580014"],"winner_id":"14672919","reasoning":"Document A is slightly more relevant because it deals with cancer prognosis, whereas Document B focuses on keratin/Aire in mouse skin tumors and not cancer outcomes or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.984975Z"}
{"comparison_id":"1a2bb7a3-0d36-4014-af89-91f1bf698456","query_id":"51","doc_a_id":"5783785","doc_b_id":"12580014","presented_order":["12580014","5783785"],"winner_id":"5783785","reasoning":"Document B is more relevant — it studies a molecular marker's effect on cancer progression and outcomes (though in gastric cancer), whereas A focuses on keratin/Aire in skin tumors, unrelated to ALDH1 or breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.985040Z"}
{"comparison_id":"46d18396-d4f5-4aa6-b225-838bb921fdc0","query_id":"51","doc_a_id":"1836154","doc_b_id":"12580014","presented_order":["1836154","12580014"],"winner_id":"12580014","reasoning":"Neither document discusses ALDH1 or breast cancer. Doc B is marginally more relevant because it concerns gene expression in tumor epithelial cells, whereas A focuses on glioblastoma genomics.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.985059Z"}
{"comparison_id":"5cfb99a6-69de-4e44-9d30-fb16e08d681a","query_id":"51","doc_a_id":"24190159","doc_b_id":"12580014","presented_order":["12580014","24190159"],"winner_id":"12580014","reasoning":"Document A is slightly more relevant — it discusses tumor gene expression/regulation (though in skin, not breast, and does not mention ALDH1). Document B focuses on KRAS-driven changes in rectal carcinoma and is unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.985071Z"}
{"comparison_id":"51feba0e-1afd-45d6-ade2-495ef8a1151a","query_id":"51","doc_a_id":"19800147","doc_b_id":"12580014","presented_order":["12580014","19800147"],"winner_id":"12580014","reasoning":"Neither document mentions ALDH1 or breast cancer. Both are irrelevant; Document A is marginally closer because it studies tumor epithelial biology rather than a colon-specific mechanism. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.985079Z"}
{"comparison_id":"be023bb7-033c-4910-95b9-0f6dbb51c552","query_id":"51","doc_a_id":"6374918","doc_b_id":"12580014","presented_order":["12580014","6374918"],"winner_id":"12580014","reasoning":"Document A is at least about tumor gene expression in epithelial (skin) tumors, whereas Document B concerns leukemia/chemotherapy and is unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.985086Z"}
{"comparison_id":"e6d84d7b-1946-4ddb-9bc2-78d5b2ebbb85","query_id":"51","doc_a_id":"15322518","doc_b_id":"12580014","presented_order":["12580014","15322518"],"winner_id":"12580014","reasoning":"Neither paper addresses ALDH1 or breast cancer specifically. Document A is marginally more relevant because it concerns gene expression in tumor cells, whereas B focuses on targeted therapy in rhabdoid tumors.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.985093Z"}
{"comparison_id":"6c261bb5-bee5-457d-acbc-73293155df66","query_id":"51","doc_a_id":"4464565","doc_b_id":"12580014","presented_order":["4464565","12580014"],"winner_id":"12580014","reasoning":"Document B is more relevant — it concerns gene regulation in tumor keratinocytes and cancer-related pathways, whereas Document A studies cocoa effects in intestinal Caco-2 cells and not cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.985100Z"}
{"comparison_id":"0b8a57c1-bfcf-430c-923d-0079d7ed4785","query_id":"51","doc_a_id":"30543439","doc_b_id":"12580014","presented_order":["12580014","30543439"],"winner_id":"30543439","reasoning":"Neither document mentions ALDH1 or breast cancer outcomes, so both are irrelevant. If forced to choose, B is marginally more relevant because it discusses enzymes and cancer cell survival broadly.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.985108Z"}
{"comparison_id":"3ca6e391-9543-4c35-87cf-ed255b235e49","query_id":"51","doc_a_id":"36653415","doc_b_id":"12580014","presented_order":["36653415","12580014"],"winner_id":"36653415","reasoning":"Document A is slightly more relevant because it discusses tumor metabolism, which is closer to enzyme expression like ALDH1 and cancer outcomes than the skin-specific keratin/Aire pathway in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.985114Z"}
{"comparison_id":"3bea606d-f2f2-4eda-91ff-474760f3bcc4","query_id":"51","doc_a_id":"8724666","doc_b_id":"12580014","presented_order":["12580014","8724666"],"winner_id":"12580014","reasoning":"Reason: Both abstracts don't mention ALDH1 or breast cancer, but Document A discusses tumor epithelial gene regulation (more related to breast epithelial tumors) while B focuses on hematopoiesis/leukemia.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.985121Z"}
{"comparison_id":"d4c92990-7f3f-4cac-9cc3-956f7753918c","query_id":"51","doc_a_id":"25344732","doc_b_id":"12580014","presented_order":["12580014","25344732"],"winner_id":"12580014","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is marginally more relevant because it deals with tumor gene expression, whereas Document B focuses on PHC3 in osteosarcoma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:13.985129Z"}
{"comparison_id":"ffb3139a-58b7-4c27-82ae-6cc33402876e","query_id":"51","doc_a_id":"3355397","doc_b_id":"26059876","presented_order":["3355397","26059876"],"winner_id":"3355397","reasoning":"Document A is slightly more relevant — it's a cancer risk/outcomes study (covers multiple cancer types), whereas Document B is specific to colorectal mechanisms and unrelated markers. Neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:20.207971Z"}
{"comparison_id":"54a48ca5-ac98-489f-bd85-b57cca84127a","query_id":"51","doc_a_id":"14180565","doc_b_id":"26059876","presented_order":["14180565","26059876"],"winner_id":"14180565","reasoning":"Neither document addresses ALDH1 or breast cancer, but Document A at least concerns gene expression changes in cancer cells, so it's slightly more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:20.207995Z"}
{"comparison_id":"4a0e5002-ae6e-42a4-bdf3-62eca084d947","query_id":"51","doc_a_id":"52925737","doc_b_id":"26059876","presented_order":["52925737","26059876"],"winner_id":"52925737","reasoning":"Document A is slightly more relevant because it discusses tumor prognosis and factors affecting tumor microenvironment/marker expression (though in gastric cancer, not breast/ALDH1).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:20.208003Z"}
{"comparison_id":"a4168bdf-ad9b-43fe-b4ae-b164a2297ec7","query_id":"51","doc_a_id":"12650610","doc_b_id":"26059876","presented_order":["26059876","12650610"],"winner_id":"26059876","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is slightly more relevant because it addresses tumorigenesis mechanisms in an adenocarcinoma context.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:20.208011Z"}
{"comparison_id":"d141ce75-0186-46ff-a242-3e9b0f121ab2","query_id":"51","doc_a_id":"24916604","doc_b_id":"26059876","presented_order":["26059876","24916604"],"winner_id":"26059876","reasoning":"Document A is slightly more relevant because it discusses cancer biology and molecular mechanisms, whereas B is about treatment policy and physician practices; neither mentions ALDH1 or breast cancer specifically.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:20.208018Z"}
{"comparison_id":"d449dbc8-53c4-450a-ad7f-ec63b9fd11de","query_id":"51","doc_a_id":"36653415","doc_b_id":"26059876","presented_order":["26059876","36653415"],"winner_id":"26059876","reasoning":"Document A is slightly more relevant — it deals with tumorigenesis and cancer progression mechanisms, which relate to cancer outcomes; Document B focuses on lung tumor metabolism, less relevant to ALDH1/breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:20.208025Z"}
{"comparison_id":"db5100f7-5dfa-48f3-b053-917c033c590b","query_id":"51","doc_a_id":"5468807","doc_b_id":"26059876","presented_order":["5468807","26059876"],"winner_id":"5468807","reasoning":"Document A is slightly more relevant because it discusses cancer outcomes and treatment effects, whereas Document B concerns colorectal homeostasis and mechanisms unrelated to breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:20.208033Z"}
{"comparison_id":"ce39a505-8782-4158-b54e-dadeb52b1fd4","query_id":"51","doc_a_id":"14672919","doc_b_id":"26059876","presented_order":["26059876","14672919"],"winner_id":"14672919","reasoning":"Document B is more relevant — it addresses a biomarker-based prognostic association with cancer outcomes, whereas A is a mechanistic colorectal study unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:20.208040Z"}
{"comparison_id":"ddc3df72-2a48-498c-953f-d51a4d872b15","query_id":"51","doc_a_id":"5783785","doc_b_id":"26059876","presented_order":["26059876","5783785"],"winner_id":"5783785","reasoning":"Neither document mentions ALDH1 or breast cancer, so both are irrelevant. If forced to choose, B is slightly more relevant because it addresses cancer biomarkers and outcomes (albeit in gastric cancer), whereas A focuses on Ku70 in colorectal homeostasis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:20.208047Z"}
{"comparison_id":"47f941a0-9387-4b4c-8cb9-e074a77ac41b","query_id":"51","doc_a_id":"30543439","doc_b_id":"26059876","presented_order":["30543439","26059876"],"winner_id":"30543439","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document A at least discusses cancer cell biology generally, while B focuses specifically on colorectal homeostasis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:20.208054Z"}
{"comparison_id":"76a5dbfc-811d-423d-95c8-b09dc5f3a6f5","query_id":"51","doc_a_id":"3355397","doc_b_id":"5468807","presented_order":["3355397","5468807"],"winner_id":"3355397","reasoning":"Neither document discusses ALDH1 or breast cancer specifically, but Document A addresses multiple common cancers (more likely to include breast cancer relevance) while Document B focuses on ARID1A-mutated ovarian cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:25.235138Z"}
{"comparison_id":"c4d91165-21f2-4900-9cca-92ae3bd7579a","query_id":"51","doc_a_id":"14180565","doc_b_id":"5468807","presented_order":["14180565","5468807"],"winner_id":"14180565","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it examines gene expression profiles, whereas B focuses on HDAC6 in ovarian cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:25.235166Z"}
{"comparison_id":"b3680ac8-8354-4369-8144-1bcbc578b044","query_id":"51","doc_a_id":"52925737","doc_b_id":"5468807","presented_order":["52925737","5468807"],"winner_id":"52925737","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A mentions prognosis (cancer outcomes), so it's marginally closer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:25.235173Z"}
{"comparison_id":"80d29fd8-db0b-404a-a573-0f926bdba38f","query_id":"51","doc_a_id":"30543439","doc_b_id":"5468807","presented_order":["30543439","5468807"],"winner_id":"30543439","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant only because it addresses cancer cell biology broadly, while B is specific to ARID1A-mutated ovarian cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:25.235181Z"}
{"comparison_id":"6c9341be-e2c3-491e-af3e-163a0132a8e2","query_id":"51","doc_a_id":"14672919","doc_b_id":"5468807","presented_order":["14672919","5468807"],"winner_id":"14672919","reasoning":"Reason: Document A discusses prognostic biomarkers and survival outcomes in cancer (though in esophageal cancer), making it marginally more relevant to a claim about marker expression and breast cancer outcomes than Document B, which focuses on ovarian ARID1A/HDAC6 biology.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:25.235188Z"}
{"comparison_id":"1835977a-464e-4a15-a98a-c8a25a735de9","query_id":"51","doc_a_id":"5783785","doc_b_id":"5468807","presented_order":["5468807","5783785"],"winner_id":"5468807","reasoning":"Document A is slightly more relevant because it discusses cancer survival outcomes (though in ovarian cancer), whereas Document B focuses on gastric cancer microRNA mechanisms unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:25.235195Z"}
{"comparison_id":"393b59ef-3031-4aea-9c31-bfe0f34529d4","query_id":"51","doc_a_id":"3355397","doc_b_id":"52925737","presented_order":["52925737","3355397"],"winner_id":"52925737","reasoning":"Document A is more relevant — it discusses tumor marker expression and prognosis in cancer (though gastric, not breast), whereas B is about drug-related cancer risk unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:30.491775Z"}
{"comparison_id":"79910136-5b9f-4f63-a729-32111a283991","query_id":"51","doc_a_id":"14180565","doc_b_id":"52925737","presented_order":["14180565","52925737"],"winner_id":"52925737","reasoning":"Document B — it discusses a cancer prognostic marker and links marker expression to patient outcomes, while A focuses on gene changes in glioblastoma cells unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:30.491797Z"}
{"comparison_id":"8493e353-c319-422e-aa9f-dc6fe4c4108b","query_id":"51","doc_a_id":"14672919","doc_b_id":"52925737","presented_order":["52925737","14672919"],"winner_id":"52925737","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it links tumor molecular expression to prognosis (though in gastric cancer and a different marker), while B addresses platelet metrics in esophageal cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:30.491806Z"}
{"comparison_id":"780db0aa-cc2a-4863-9bd2-0749588f83d6","query_id":"51","doc_a_id":"30543439","doc_b_id":"52925737","presented_order":["52925737","30543439"],"winner_id":"52925737","reasoning":"Document A is slightly more relevant because it discusses cancer prognosis associations (though in gastric cancer), while Document B is unrelated enzymology. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:30.491813Z"}
{"comparison_id":"bc0ccf7c-c66c-49a2-89d3-c27bff8a5bb9","query_id":"51","doc_a_id":"3355397","doc_b_id":"14180565","presented_order":["14180565","3355397"],"winner_id":"14180565","reasoning":"Neither paper studies ALDH1 or breast cancer; Document A is marginally more relevant because it concerns gene expression in cancer cells, whereas B is an epidemiologic drug–cancer risk study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:37.195236Z"}
{"comparison_id":"1386bc1a-aaae-42f4-9183-2e98f9ef5362","query_id":"51","doc_a_id":"30543439","doc_b_id":"14180565","presented_order":["30543439","14180565"],"winner_id":"14180565","reasoning":"Reason: Neither abstract addresses ALDH1 or breast cancer, but Document B involves gene expression profiling (more likely to mention ALDH1) while A focuses on unrelated nucleotide‑sanitizing enzymes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:37.195258Z"}
{"comparison_id":"ae0915ac-d4c6-40ab-a2db-e7c918269b6d","query_id":"51","doc_a_id":"14672919","doc_b_id":"14180565","presented_order":["14672919","14180565"],"winner_id":"14180565","reasoning":"Document B is slightly more relevant because it deals with gene expression profiling (though in glioblastoma), whereas A concerns platelet measures in esophageal cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:37.195267Z"}
{"comparison_id":"9d2f7093-168f-4861-836d-5f9105201bfc","query_id":"51","doc_a_id":"3355397","doc_b_id":"30543439","presented_order":["30543439","3355397"],"winner_id":"3355397","reasoning":"Document B is more relevant — it concerns cancer outcomes/risks, whereas A addresses unrelated nucleotide‑sanitizing enzymes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:40.633813Z"}
{"comparison_id":"269f92d3-9399-4253-bbec-d3dc2ae16fd4","query_id":"51","doc_a_id":"14672919","doc_b_id":"30543439","presented_order":["30543439","14672919"],"winner_id":"14672919","reasoning":"Document B — it addresses prognostic markers in cancer (though esophageal, not breast), whereas A is structural/biochemical work unrelated to cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:40.633835Z"}
{"comparison_id":"0b09d4bb-4c06-4435-989c-eed19a4be56d","query_id":"51","doc_a_id":"3355397","doc_b_id":"14672919","presented_order":["14672919","3355397"],"winner_id":"14672919","reasoning":"Reason: Both abstracts do not address ALDH1 or breast cancer; Document A concerns a prognostic biomarker in cancer (though esophageal), which is slightly more related to the claim about a prognostic marker than Document B's drug–cancer risk study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:44.470218Z"}
{"comparison_id":"3ef54a91-2366-42ae-b5d7-d52570d96b22","query_id":"51","doc_a_id":"12650610","doc_b_id":"24916604","presented_order":["24916604","12650610"],"winner_id":"24916604","reasoning":"Document A is more relevant — it addresses cancer treatment practices (bisphosphonate use, e.g., clodronate) which are more likely related to breast cancer management, whereas Document B concerns molecular signaling in oral cancer and is unrelated to ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:49.917356Z"}
{"comparison_id":"9840b404-3449-4fe2-a750-5412286c3fc5","query_id":"51","doc_a_id":"36653415","doc_b_id":"24916604","presented_order":["36653415","24916604"],"winner_id":"24916604","reasoning":"Neither document discusses ALDH1 or directly assesses breast cancer outcomes. Document B is slightly more relevant because it concerns cancer treatment practices (bisphosphonate use, which is used in breast cancer), whereas Document A focuses on lactate metabolism in lung tumors.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:49.917377Z"}
{"comparison_id":"f3c0150c-4ba1-488d-8267-810fcb5bfb19","query_id":"51","doc_a_id":"12650610","doc_b_id":"36653415","presented_order":["36653415","12650610"],"winner_id":"12650610","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Both are irrelevant, but Document B is slightly more related because it discusses cancer progression signaling (vs. lung tumor metabolism in A).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:18:54.696829Z"}
{"comparison_id":"e8586977-9028-4ece-9dce-fe634cd48752","query_id":"51","doc_a_id":"14471161","doc_b_id":"2359152","presented_order":["2359152","14471161"],"winner_id":"14471161","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document B is slightly more relevant because it concerns tumor gene expression and cancer biology, whereas A is about genetic lesions in myelodysplastic syndromes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:08.657106Z"}
{"comparison_id":"7fab29e9-4192-4a2f-8770-54f33526ff70","query_id":"51","doc_a_id":"31313782","doc_b_id":"2359152","presented_order":["2359152","31313782"],"winner_id":"2359152","reasoning":"Neither document addresses ALDH1 or breast cancer; Document A is slightly more relevant because it deals with cancer genetic lesions and prognostic models, while B focuses on TLR expression in lung disease.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:08.657126Z"}
{"comparison_id":"3bd0a880-41ab-47c6-a12f-b40544bfe6f7","query_id":"51","doc_a_id":"2272614","doc_b_id":"2359152","presented_order":["2272614","2359152"],"winner_id":"2359152","reasoning":"Document B is more relevant — it discusses genetic markers and prognostic models linking gene alterations to patient outcomes (though in MDS rather than breast cancer), whereas A focuses on NF1 and drug resistance in lung cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:08.657137Z"}
{"comparison_id":"eeb844a4-6ebb-4976-a26e-480b05994792","query_id":"51","doc_a_id":"27306942","doc_b_id":"2359152","presented_order":["2359152","27306942"],"winner_id":"2359152","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant only because it discusses cancer genetic markers and prognostic models, whereas B focuses narrowly on CRLF2 in pediatric ALL. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:08.657144Z"}
{"comparison_id":"9ac69a85-230f-45cb-8725-f71c0434a9cc","query_id":"51","doc_a_id":"17876040","doc_b_id":"2359152","presented_order":["2359152","17876040"],"winner_id":"2359152","reasoning":"Document A is slightly more relevant because it addresses associations between molecular markers/genetic lesions and patient outcomes (prognostic models), whereas Document B focuses on a drug for AML. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:08.657151Z"}
{"comparison_id":"4730f3d2-83d5-4e09-95dd-828f0735d9e3","query_id":"51","doc_a_id":"26902591","doc_b_id":"2359152","presented_order":["2359152","26902591"],"winner_id":"26902591","reasoning":"Document B is slightly more relevant because it concerns cancer-related biology, while A is specific to myelodysplastic syndromes and unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:08.657158Z"}
{"comparison_id":"8a361ca6-f75b-4567-8719-0dc77de448a4","query_id":"51","doc_a_id":"4729644","doc_b_id":"2359152","presented_order":["2359152","4729644"],"winner_id":"2359152","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document A discusses prognostic associations and outcomes (albeit in MDS), making it marginally more relevant than Document B, which focuses on lncRNA-mediated drug resistance in nasopharyngeal carcinoma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:08.657166Z"}
{"comparison_id":"90fe6ed7-cf7b-4119-a8d0-152c6c517149","query_id":"51","doc_a_id":"4468861","doc_b_id":"2359152","presented_order":["2359152","4468861"],"winner_id":"4468861","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it deals with cancer outcomes and treatment mechanisms, whereas A focuses on myelodysplastic syndromes genetics.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:08.657172Z"}
{"comparison_id":"1c4b10b2-9d31-4597-a6ca-8027fc120fb9","query_id":"51","doc_a_id":"21414718","doc_b_id":"2359152","presented_order":["2359152","21414718"],"winner_id":"21414718","reasoning":"Document B is more relevant — it addresses cancer biology and factors influencing tumor invasion/metastasis (closer to outcomes), whereas A covers genetic lesions in myelodysplastic syndromes (unrelated to breast cancer or ALDH1). \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:08.657180Z"}
{"comparison_id":"48092613-9a00-4b43-8bce-f279ff300587","query_id":"51","doc_a_id":"57783564","doc_b_id":"2359152","presented_order":["57783564","2359152"],"winner_id":"57783564","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it deals with solid-tumor cancer biology, whereas B covers genetic lesions in a hematologic disorder (MDS).\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:08.657186Z"}
{"comparison_id":"ec6e0bcd-9a82-45e5-b014-ae197b043205","query_id":"51","doc_a_id":"25344732","doc_b_id":"2359152","presented_order":["2359152","25344732"],"winner_id":"2359152","reasoning":"Document A is more relevant — it discusses prognostic models and outcome stratification in cancer patients (though in MDS, not breast cancer), whereas B focuses on PHC3 biology in osteosarcoma without outcome association.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:08.657193Z"}
{"comparison_id":"cbf9185e-e742-4cf1-9c6f-8e9554e5d1f3","query_id":"51","doc_a_id":"27167110","doc_b_id":"2359152","presented_order":["2359152","27167110"],"winner_id":"27167110","reasoning":"Document B — it discusses cancer-related biomarker regulation and effects on cancer progression (though in prostate cancer), whereas Document A is about genetic lesions in myelodysplastic syndromes and unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:08.657201Z"}
{"comparison_id":"3d7ec366-ddf5-4100-aeb7-09dafc56c51f","query_id":"51","doc_a_id":"17671145","doc_b_id":"2359152","presented_order":["2359152","17671145"],"winner_id":"2359152","reasoning":"Neither abstract mentions ALDH1 or breast cancer; however, Document A discusses prognostic models and outcomes (albeit in MDS), so it is marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:08.657208Z"}
{"comparison_id":"61277233-7b7e-4164-ad7e-4ce1cf2acb44","query_id":"51","doc_a_id":"1836154","doc_b_id":"2359152","presented_order":["1836154","2359152"],"winner_id":"1836154","reasoning":"Document A is slightly more relevant — it's a cancer genomics study involving gene expression (more related to expression-outcome links) while B concerns hematologic MDS not breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:08.657215Z"}
{"comparison_id":"6958659e-7789-4ea9-8820-4c394d986559","query_id":"51","doc_a_id":"24190159","doc_b_id":"2359152","presented_order":["2359152","24190159"],"winner_id":"2359152","reasoning":"Document A — it addresses molecular markers linked to prognosis and outcome models (though in MDS, not breast cancer), so it's slightly closer to the claim than B. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:08.657222Z"}
{"comparison_id":"c28538f7-2794-4f5c-91b7-ef2b6d2ee585","query_id":"51","doc_a_id":"19800147","doc_b_id":"2359152","presented_order":["19800147","2359152"],"winner_id":"19800147","reasoning":"Document A is more relevant — it's cancer-focused (tumor progression mechanisms), whereas Document B covers genetic lesions in MDS, a non-breast malignancy. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:08.657230Z"}
{"comparison_id":"db0e5f2f-4d19-4ea1-94cf-a028f9c6a69d","query_id":"51","doc_a_id":"6374918","doc_b_id":"2359152","presented_order":["2359152","6374918"],"winner_id":"2359152","reasoning":"Document A is more relevant — it addresses biomarkers and prognostic associations (albeit in MDS rather than breast cancer), whereas Document B focuses on AML therapy and microenvironment. Neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:08.657237Z"}
{"comparison_id":"51d01388-7ec6-48e4-84de-15b01ac1c8aa","query_id":"51","doc_a_id":"15322518","doc_b_id":"2359152","presented_order":["15322518","2359152"],"winner_id":"2359152","reasoning":"Document B is slightly more relevant because it concerns prognostic associations in cancer, whereas A focuses on targeted therapy in rhabdoid tumors; neither mentions ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:08.657244Z"}
{"comparison_id":"a77d3f8f-5b4d-46ef-b72c-3c91f4ddf5cf","query_id":"51","doc_a_id":"4464565","doc_b_id":"2359152","presented_order":["4464565","2359152"],"winner_id":"2359152","reasoning":"Document B is more relevant — it addresses genetic markers and prognostic models (outcomes), whereas A reports gene modulation in intestinal cells unrelated to cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:08.657250Z"}
{"comparison_id":"a3e498da-ef2c-4821-84cd-bcf008082cae","query_id":"51","doc_a_id":"8724666","doc_b_id":"2359152","presented_order":["2359152","8724666"],"winner_id":"8724666","reasoning":"Document B — it's cancer-related (hematopoiesis/leukemogenesis) and discusses metabolic markers, making it marginally more relevant than Document A, which focuses on MDS genetics without relation to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:08.657257Z"}
{"comparison_id":"c7b675cf-7219-4758-bde9-d41adb7fabcc","query_id":"51","doc_a_id":"14471161","doc_b_id":"57783564","presented_order":["14471161","57783564"],"winner_id":"14471161","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more general about tumor outcomes and gene expression, so it's marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:15.198041Z"}
{"comparison_id":"bddcc793-faf7-47e5-a949-347c37e38801","query_id":"51","doc_a_id":"26902591","doc_b_id":"57783564","presented_order":["57783564","26902591"],"winner_id":"57783564","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it addresses tumor cell proliferation and molecular markers in cancer, whereas Document B focuses on cachexia and adipose tissue. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:15.198061Z"}
{"comparison_id":"11571721-6ec8-40b7-b15b-1ff7bd5d6c56","query_id":"51","doc_a_id":"4468861","doc_b_id":"57783564","presented_order":["57783564","4468861"],"winner_id":"57783564","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it concerns gene expression affecting tumor cell behavior, while B focuses on immunotherapy in melanoma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:15.198070Z"}
{"comparison_id":"0e933a91-4f43-4fdd-b5fa-87ebfb40de9d","query_id":"51","doc_a_id":"21414718","doc_b_id":"57783564","presented_order":["21414718","57783564"],"winner_id":"21414718","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes; both are irrelevant. Document A is chosen but does not provide evidence about ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:15.198078Z"}
{"comparison_id":"f68f1492-d406-4276-ab58-08f3186f914b","query_id":"51","doc_a_id":"8724666","doc_b_id":"57783564","presented_order":["57783564","8724666"],"winner_id":"8724666","reasoning":"Document B is slightly more relevant — it discusses stem cell–related metabolism and leukemogenesis (ALDH1 is a stem-cell/metabolic marker), whereas A is about a colon-specific transcription factor unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:15.198087Z"}
{"comparison_id":"defb97b1-a77b-43a5-93e6-9237a7840d0a","query_id":"51","doc_a_id":"27167110","doc_b_id":"57783564","presented_order":["57783564","27167110"],"winner_id":"57783564","reasoning":"Document A is slightly more relevant — both discuss tumor biology and factors affecting proliferation/tumor formation (though neither mentions ALDH1 or breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:15.198094Z"}
{"comparison_id":"8a8bd2dc-a93c-421f-b831-248b828256c8","query_id":"51","doc_a_id":"1836154","doc_b_id":"57783564","presented_order":["57783564","1836154"],"winner_id":"57783564","reasoning":"Document A is slightly more relevant — it discusses gene expression affecting cancer cell proliferation and tumor formation (though in colon cancer), whereas Document B is specific to glioblastoma genomics. Neither mentions ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:15.198102Z"}
{"comparison_id":"448ea9ab-b037-4404-a2b4-7090e38b44d9","query_id":"51","doc_a_id":"19800147","doc_b_id":"57783564","presented_order":["19800147","57783564"],"winner_id":"57783564","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document B is marginally more related to tumor proliferation/outcomes, so:\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:15.198109Z"}
{"comparison_id":"d9b25bbb-268b-41d1-8808-6970e2aea58f","query_id":"51","doc_a_id":"14471161","doc_b_id":"21414718","presented_order":["21414718","14471161"],"winner_id":"14471161","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it links tumor gene expression changes to cancer outcomes, whereas A is specific to TFF1-Piezo1 in gastric cancer cell mobility. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:20.902396Z"}
{"comparison_id":"94853008-aa1d-4ad1-b8df-338709b4ede1","query_id":"51","doc_a_id":"8724666","doc_b_id":"21414718","presented_order":["21414718","8724666"],"winner_id":"21414718","reasoning":"Document A is cancer-related (though gastric) and discusses protein expression linked to tumor behavior, making it marginally more relevant than a hematopoiesis/metabolism study. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:20.902416Z"}
{"comparison_id":"f3d6c3ac-f5e0-4d66-b798-5e8601dff41e","query_id":"51","doc_a_id":"26902591","doc_b_id":"27167110","presented_order":["27167110","26902591"],"winner_id":"27167110","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer; Document A (microRNA regulation in prostate cancer) is somewhat closer to tumor molecular markers and progression than the cachexia-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:27.033135Z"}
{"comparison_id":"18c75913-500c-4f90-940f-925a90f37ee4","query_id":"51","doc_a_id":"4468861","doc_b_id":"27167110","presented_order":["27167110","4468861"],"winner_id":"27167110","reasoning":"Document A — it discusses gene expression changes linked to cancer progression (though in prostate, not breast), which is closer to an ALDH1 expression–outcome question than the immunotherapy/melanoma focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:27.033157Z"}
{"comparison_id":"82c37c4f-8091-47bb-bd0e-2019fb61c5c2","query_id":"51","doc_a_id":"19800147","doc_b_id":"27167110","presented_order":["19800147","27167110"],"winner_id":"19800147","reasoning":"Neither paper mentions ALDH1 or breast cancer; both are irrelevant. Document A is marginally more related because it addresses cancer biomarker levels and outcomes, whereas B is limited to androgen-regulated miRNAs in prostate cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:27.033166Z"}
{"comparison_id":"5f288cc7-9b5f-4253-a414-532a7f74aab7","query_id":"51","doc_a_id":"1836154","doc_b_id":"27167110","presented_order":["1836154","27167110"],"winner_id":"1836154","reasoning":"Document A is marginally more relevant — it addresses gene expression and cancer outcomes (though in glioblastoma, not breast cancer). Neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:27.033174Z"}
{"comparison_id":"9cf19560-0c5c-480a-8d5d-0d457fa5aaf7","query_id":"51","doc_a_id":"19800147","doc_b_id":"1836154","presented_order":["1836154","19800147"],"winner_id":"1836154","reasoning":"Reason: Neither discusses ALDH1 or breast cancer, but Document A addresses gene expression and clinical outcomes (cancer genomics) generally, making it marginally more relevant than a colon-specific exosome study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:32.648676Z"}
{"comparison_id":"a3dc270b-e421-465a-bf65-bc8f8f54c4ae","query_id":"51","doc_a_id":"26902591","doc_b_id":"4468861","presented_order":["26902591","4468861"],"winner_id":"26902591","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is marginally more relevant because it discusses cancer-associated changes in adipose tissue (potentially applicable across cancers), while Document B focuses specifically on melanoma immunotherapy. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:38.596666Z"}
{"comparison_id":"2a8b0872-9471-4c6f-97c1-a7f9959bd4b4","query_id":"51","doc_a_id":"31313782","doc_b_id":"25344732","presented_order":["31313782","25344732"],"winner_id":"31313782","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant only because it addresses gene expression profiles in cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:48.729241Z"}
{"comparison_id":"1a19c37f-dac7-4099-bd9d-8c4819800b9f","query_id":"51","doc_a_id":"2272614","doc_b_id":"25344732","presented_order":["2272614","25344732"],"winner_id":"25344732","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer; Document B is marginally more relevant because it addresses gene expression loss in tumors, whereas A focuses on NF1-driven drug resistance in lung cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:48.729260Z"}
{"comparison_id":"b158a8bf-262e-4aee-8cbf-dbfbda284c88","query_id":"51","doc_a_id":"27306942","doc_b_id":"25344732","presented_order":["25344732","27306942"],"winner_id":"25344732","reasoning":"Document A is slightly more relevant — it discusses gene expression changes in solid tumors and tumorigenesis, whereas Document B concerns pediatric leukemia and is less related to breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:48.729271Z"}
{"comparison_id":"f320f5de-4eb5-46f0-9bdf-de0bc6873201","query_id":"51","doc_a_id":"17876040","doc_b_id":"25344732","presented_order":["17876040","25344732"],"winner_id":"25344732","reasoning":"Reason: Document B discusses gene expression changes in tumors (loss of PHC3), which is more related to biomarker–outcome associations than Document A’s AML drug development.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:48.729279Z"}
{"comparison_id":"c58321e4-c1f7-45fe-9eb1-b91b9560e7b2","query_id":"51","doc_a_id":"4729644","doc_b_id":"25344732","presented_order":["4729644","25344732"],"winner_id":"4729644","reasoning":"Document A is slightly more relevant because it discusses tumor growth and treatment resistance, which relate to cancer outcomes; Document B concerns PHC3 loss in osteosarcoma and cell-cycle regulation, unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:48.729286Z"}
{"comparison_id":"d89cd614-0d46-4849-aa2e-e7eedc1c4058","query_id":"51","doc_a_id":"4464565","doc_b_id":"25344732","presented_order":["25344732","4464565"],"winner_id":"25344732","reasoning":"Document A is more relevant because it discusses gene expression changes in cancerous tumors (though in osteosarcoma), whereas Document B concerns dietary effects in intestinal cells and not cancer outcomes. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:48.729293Z"}
{"comparison_id":"ef13f6e7-72fd-4c11-b5de-b6280c9c8d91","query_id":"51","doc_a_id":"17671145","doc_b_id":"25344732","presented_order":["17671145","25344732"],"winner_id":"25344732","reasoning":"Document B is more relevant — although neither mentions ALDH1 or breast cancer, B discusses tumor-associated loss of a gene's expression (PHC3) and its link to tumorigenesis, which is marginally closer to the claim about marker expression and cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:48.729300Z"}
{"comparison_id":"331a91f3-70f4-45ed-ac8f-fde479934e2e","query_id":"51","doc_a_id":"24190159","doc_b_id":"25344732","presented_order":["25344732","24190159"],"winner_id":"25344732","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A is marginally closer because it concerns gene expression changes in tumors. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:48.729307Z"}
{"comparison_id":"87245ea5-e62a-4d30-a3b6-61c04c9781ea","query_id":"51","doc_a_id":"6374918","doc_b_id":"25344732","presented_order":["25344732","6374918"],"winner_id":"25344732","reasoning":"Both documents are irrelevant to ALDH1 or breast cancer; Document A is slightly more related because it discusses gene expression changes in tumors, whereas Document B focuses on AML therapy. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:48.729314Z"}
{"comparison_id":"ee2485f8-6160-46f0-8c51-d1fd658d2b90","query_id":"51","doc_a_id":"15322518","doc_b_id":"25344732","presented_order":["25344732","15322518"],"winner_id":"25344732","reasoning":"Document A is slightly more relevant because it discusses gene expression changes in tumors, whereas Document B focuses on kinase-targeted therapy in malignant rhabdoid tumors and not expression markers or breast cancer outcomes.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:48.729321Z"}
{"comparison_id":"8c939e06-e951-4d8e-bce6-7fb5209987b0","query_id":"51","doc_a_id":"31313782","doc_b_id":"4729644","presented_order":["4729644","31313782"],"winner_id":"4729644","reasoning":"Document A is slightly more relevant because it addresses cancer-related molecular markers and treatment outcomes (though not ALDH1 or breast cancer specifically). \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:19:52.985420Z"}
{"comparison_id":"b59c6200-4181-4c78-9ba6-c006a70e085b","query_id":"51","doc_a_id":"2272614","doc_b_id":"4464565","presented_order":["2272614","4464565"],"winner_id":"2272614","reasoning":"Document A is slightly more relevant because it discusses gene expression effects on cancer treatment outcomes (though in lung cancer and a different gene), while Document B concerns gene modulation in intestinal cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:02.258946Z"}
{"comparison_id":"6596cc97-df2f-45f2-a66b-ffc3d3f9aed2","query_id":"51","doc_a_id":"27306942","doc_b_id":"4464565","presented_order":["27306942","4464565"],"winner_id":"4464565","reasoning":"Document B is more relevant — it concerns modulation of gene expression (which could include markers like ALDH1), whereas Document A concerns CRLF2/JAK alterations in pediatric ALL and is unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:02.258968Z"}
{"comparison_id":"10082831-7d02-4e31-9958-d93475570952","query_id":"51","doc_a_id":"17876040","doc_b_id":"4464565","presented_order":["4464565","17876040"],"winner_id":"4464565","reasoning":"Document A concerns gene expression modulation (more directly related to ALDH1 expression), while Document B is about an AML drug unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:02.258977Z"}
{"comparison_id":"35574124-4f6a-4bf9-96b0-57ee4a4e6e89","query_id":"51","doc_a_id":"15322518","doc_b_id":"4464565","presented_order":["4464565","15322518"],"winner_id":"4464565","reasoning":"Document A is slightly more relevant because it concerns modulation of gene expression (potentially relating to marker expression), whereas Document B focuses on tyrosine-kinase targeting in rhabdoid tumors, not breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:02.258985Z"}
{"comparison_id":"24adb86c-868f-45c5-8bf0-1abc451cda3f","query_id":"51","doc_a_id":"17671145","doc_b_id":"4464565","presented_order":["4464565","17671145"],"winner_id":"17671145","reasoning":"Document B is more relevant — it concerns cancer biology and tumor outcomes, whereas A studies gene effects of cocoa compounds in intestinal (Caco-2) cells and is unrelated to cancer prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:02.258992Z"}
{"comparison_id":"0e20bbf6-6783-4bcb-a904-dadbac60c017","query_id":"51","doc_a_id":"24190159","doc_b_id":"4464565","presented_order":["4464565","24190159"],"winner_id":"24190159","reasoning":"Reason: Neither abstract addresses ALDH1 or breast cancer outcomes; Document B is at least cancer-related (gene expression in rectal carcinoma) while A focuses on cocoa effects in intestinal cells.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:02.258999Z"}
{"comparison_id":"da435b7a-50b7-4106-b661-7285d072fae7","query_id":"51","doc_a_id":"6374918","doc_b_id":"4464565","presented_order":["4464565","6374918"],"winner_id":"4464565","reasoning":"Document A is more relevant — it discusses modulation of gene expression (where ALDH1 would be measured), whereas Document B is about AML therapy and bone marrow niche, not gene expression or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:02.259007Z"}
{"comparison_id":"a4c77961-71ff-41af-a608-38fffb322fed","query_id":"51","doc_a_id":"2272614","doc_b_id":"17671145","presented_order":["17671145","2272614"],"winner_id":"17671145","reasoning":"Document A is slightly more relevant because it concerns gene expression in a hormone-driven cancer (prostate) versus Document B which addresses NF1-related drug resistance in lung cancer; neither discusses ALDH1 or breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:08.618414Z"}
{"comparison_id":"984eeb7c-335f-44ae-8ea9-bb013883ab8b","query_id":"51","doc_a_id":"24190159","doc_b_id":"17671145","presented_order":["17671145","24190159"],"winner_id":"17671145","reasoning":"Neither paper addresses ALDH1 or breast cancer—both are irrelevant. Document A is slightly more relevant only insofar as it discusses cancer-related gene expression and treatment outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:08.618434Z"}
{"comparison_id":"81ffe07e-de0b-4245-a65c-c328b6b6d6a8","query_id":"51","doc_a_id":"2272614","doc_b_id":"24190159","presented_order":["24190159","2272614"],"winner_id":"24190159","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer; Document A is slightly more relevant because it discusses gene expression in a carcinoma context.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:12.273899Z"}
{"comparison_id":"9c1a1085-0a4f-4c32-8469-e19bf9e049d3","query_id":"51","doc_a_id":"27306942","doc_b_id":"17876040","presented_order":["27306942","17876040"],"winner_id":"27306942","reasoning":"Document A is marginally more relevant because it discusses gene expression associated with clinical outcomes (though it concerns CRLF2 in pediatric ALL, not ALDH1 or breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:17.322012Z"}
{"comparison_id":"4491f3f5-af0c-4827-a88b-bc1ec8912918","query_id":"51","doc_a_id":"6374918","doc_b_id":"17876040","presented_order":["17876040","6374918"],"winner_id":"17876040","reasoning":"Neither document addresses ALDH1 or breast cancer; both discuss AML therapies, so neither is relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:17.322032Z"}
{"comparison_id":"0a68e252-329d-445f-b195-fe0e75b87148","query_id":"51","doc_a_id":"15322518","doc_b_id":"17876040","presented_order":["15322518","17876040"],"winner_id":"17876040","reasoning":"Document B. It discusses cancer therapy outcomes and survival, which is marginally closer to the query about associations with cancer outcomes; Document A focuses on RTK targeting in malignant rhabdoid tumors and doesn't address ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:17.322041Z"}
{"comparison_id":"9d5c8569-242b-4205-beed-ff721bb63a7b","query_id":"51","doc_a_id":"6374918","doc_b_id":"15322518","presented_order":["6374918","15322518"],"winner_id":"15322518","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are unrelated, but B is marginally more relevant because it addresses tumor biology and therapeutic outcomes in a solid tumor context, whereas A focuses on leukemia. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:25.583425Z"}
{"comparison_id":"06cc41a8-c3f5-4907-8811-4272234fa281","query_id":"51","doc_a_id":"8677721","doc_b_id":"6121555","presented_order":["8677721","6121555"],"winner_id":"8677721","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document A is slightly more relevant because it concerns epithelial carcinoma progression, whereas B focuses on glioma.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:33.369090Z"}
{"comparison_id":"67fec295-cf66-4fbc-a535-0bfc6d2c58a5","query_id":"51","doc_a_id":"32852283","doc_b_id":"6121555","presented_order":["6121555","32852283"],"winner_id":"6121555","reasoning":"Doc A is more relevant — it discusses cancer molecular pathways and markers (though in glioma) whereas Doc B focuses on a drug effect in lung cancer; neither mentions ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:33.369114Z"}
{"comparison_id":"4f92a6b0-117c-4bb8-bd65-78367476035f","query_id":"51","doc_a_id":"17775228","doc_b_id":"6121555","presented_order":["6121555","17775228"],"winner_id":"6121555","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document A is marginally more relevant because it deals with cancer cell biology (apoptosis pathways), whereas B focuses on colorectal imprinting/epigenetics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:33.369123Z"}
{"comparison_id":"38cb8e20-e6de-4730-9982-0b9dc3608400","query_id":"51","doc_a_id":"85665741","doc_b_id":"6121555","presented_order":["85665741","6121555"],"winner_id":"6121555","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is marginally more relevant because it discusses cancer survival/apoptosis pathways (potentially related to prognosis), whereas A focuses specifically on BRAF/MEK in NSCLC.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:33.369131Z"}
{"comparison_id":"f3fc9ea1-419c-4f06-a04a-d08eca6d0539","query_id":"51","doc_a_id":"667451","doc_b_id":"6121555","presented_order":["667451","6121555"],"winner_id":"6121555","reasoning":"Document B is slightly more relevant — it addresses tumor cell signaling and apoptosis in a solid tumor context, whereas Document A is specific to CLL genetics and clonal evolution, so neither mentions ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:33.369138Z"}
{"comparison_id":"d3aca10d-71c1-428b-9605-dbaf72608a98","query_id":"51","doc_a_id":"32852283","doc_b_id":"17775228","presented_order":["32852283","17775228"],"winner_id":"17775228","reasoning":"Document B is more relevant — it addresses gene expression and cancer biology (though in colorectal cancer), which is closer to ALDH1 expression and outcome associations than a study on a drug effect in lung cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:39.369638Z"}
{"comparison_id":"53964352-6dd5-4c76-93b7-5360bdee929d","query_id":"51","doc_a_id":"667451","doc_b_id":"17775228","presented_order":["17775228","667451"],"winner_id":"17775228","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it deals with gene expression/methylation in a solid tumor (colorectal cancer), whereas B focuses on clonal evolution in leukemia.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:39.369658Z"}
{"comparison_id":"80ebea86-2821-40cf-8a47-42ff10c7390f","query_id":"51","doc_a_id":"85665741","doc_b_id":"17775228","presented_order":["85665741","17775228"],"winner_id":"85665741","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it concerns cancer biomarkers and treatment response, whereas B is specific to colorectal imprinting. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:39.369666Z"}
{"comparison_id":"d7f8d0aa-454f-432e-bbcc-b4ce4287d15c","query_id":"51","doc_a_id":"32852283","doc_b_id":"667451","presented_order":["667451","32852283"],"winner_id":"667451","reasoning":"Neither document addresses ALDH1 or breast cancer specifically. Document A is slightly more relevant because it discusses cancer prognosis and factors associated with outcomes, whereas Document B focuses on a treatment effect in lung cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:43.786530Z"}
{"comparison_id":"82642226-358c-4ed7-9321-50d8d02d1310","query_id":"51","doc_a_id":"25628793","doc_b_id":"4387494","presented_order":["25628793","4387494"],"winner_id":"25628793","reasoning":"Document A is slightly more relevant — it concerns hormone-related enzymes in gynecologic tissues, which is closer to breast cancer biology than an AML therapy study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:51.636780Z"}
{"comparison_id":"fdaff1d9-929d-42b9-b6bd-6adb97dddfe2","query_id":"51","doc_a_id":"2360905","doc_b_id":"4387494","presented_order":["2360905","4387494"],"winner_id":"2360905","reasoning":"Neither abstract mentions ALDH1 or breast cancer; however, Document A involves tumor gene expression profiling (more related to expression–outcome questions) while B focuses on an AML drug. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:51.636800Z"}
{"comparison_id":"2b3eef61-a4e0-48e6-ad9e-0e693a3aa6e3","query_id":"51","doc_a_id":"15491308","doc_b_id":"4387494","presented_order":["15491308","4387494"],"winner_id":"15491308","reasoning":"Reason: Neither abstract addresses ALDH1 or breast cancer, but Document A (mesenchymal stem cell biology) is marginally closer in topic (stem cell marker/context) than Document B (AML drug study).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:51.636809Z"}
{"comparison_id":"41b65b36-2c83-49d8-95d9-5095251285aa","query_id":"51","doc_a_id":"7639744","doc_b_id":"4387494","presented_order":["7639744","4387494"],"winner_id":"7639744","reasoning":"Document A is more relevant — it addresses cancer prognosis and outcomes (though in lung cancer), whereas Document B concerns a treatment for AML and not breast cancer or ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:51.636817Z"}
{"comparison_id":"a1bcc6ae-fac1-492a-9bed-808d10f7ea3d","query_id":"51","doc_a_id":"9478135","doc_b_id":"4387494","presented_order":["9478135","4387494"],"winner_id":"9478135","reasoning":"Neither document addresses ALDH1 or breast cancer; both focus on acute myeloid leukemia. Document A is slightly more relevant because it examines associations between molecular alterations and disease occurrence/outcomes, which is closer in scope to an expression–outcome claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:51.636831Z"}
{"comparison_id":"444192b4-a497-4fab-aa26-a5e9b8545316","query_id":"51","doc_a_id":"25628793","doc_b_id":"15491308","presented_order":["15491308","25628793"],"winner_id":"15491308","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document A is slightly more related conceptually (cell growth/senescence pathways can link to cancer biology), but both are irrelevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:57.110198Z"}
{"comparison_id":"fbdd9afe-d053-4106-a248-018d080ea360","query_id":"51","doc_a_id":"2360905","doc_b_id":"15491308","presented_order":["15491308","2360905"],"winner_id":"15491308","reasoning":"Document A is slightly more related because it discusses stem-cell–related markers/pathways (ALDH1 is a stem cell marker), while Document B focuses on pediatric gliomas, which is less relevant to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:57.110220Z"}
{"comparison_id":"1961fa1a-0234-487a-be3c-bfc9acab9cf8","query_id":"51","doc_a_id":"9478135","doc_b_id":"15491308","presented_order":["9478135","15491308"],"winner_id":"15491308","reasoning":"Document B — it deals with stem cell biology (ALDH1 is a stem/progenitor cell marker), whereas Document A is about AML-specific gene mutations unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:57.110229Z"}
{"comparison_id":"1fcf4e6f-e9d7-4f85-b5d3-1a539d4f6d55","query_id":"51","doc_a_id":"7639744","doc_b_id":"15491308","presented_order":["7639744","15491308"],"winner_id":"7639744","reasoning":"Document A is more relevant because it addresses cancer prognosis (though in lung cancer), whereas Document B focuses on SIRT1 in mesenchymal stem cells and does not pertain to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:20:57.110241Z"}
{"comparison_id":"9154522f-58fc-434f-ac24-fe902e14361c","query_id":"51","doc_a_id":"25628793","doc_b_id":"2360905","presented_order":["2360905","25628793"],"winner_id":"2360905","reasoning":"Document A is more relevant — it's about cancer molecular/genetic profiling (gene expression) whereas Document B concerns enzyme expression in endometriosis, not cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:00.705335Z"}
{"comparison_id":"dfa44db9-1612-405c-9561-b72c3d07620f","query_id":"51","doc_a_id":"9478135","doc_b_id":"2360905","presented_order":["2360905","9478135"],"winner_id":"2360905","reasoning":"Document A is slightly more relevant because it discusses gene expression profiling in cancer (whereas B focuses on specific mutations in leukemia), though neither addresses ALDH1 or breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:00.705358Z"}
{"comparison_id":"6ae6c83c-2ba8-4f21-9c16-4d84e7630d11","query_id":"51","doc_a_id":"25628793","doc_b_id":"9478135","presented_order":["9478135","25628793"],"winner_id":"9478135","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant because it concerns cancer genetics, whereas B concerns endometriosis/estrogen metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:06.812067Z"}
{"comparison_id":"a383c66b-908c-4b60-9dd4-4c424271f2b8","query_id":"51","doc_a_id":"4841908","doc_b_id":"14848619","presented_order":["14848619","4841908"],"winner_id":"14848619","reasoning":"Document A is slightly more relevant because it deals with a tumor-related cell-death pathway, whereas Document B focuses on longevity/metabolomics and explicitly notes no link to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:23.186059Z"}
{"comparison_id":"45bcc22b-96ff-4fa2-8ae0-384b6f693fd2","query_id":"51","doc_a_id":"23601616","doc_b_id":"14848619","presented_order":["23601616","14848619"],"winner_id":"23601616","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A is chosen (no relevance difference).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:23.186080Z"}
{"comparison_id":"8f484964-379b-4084-b2d6-7a20456aae2f","query_id":"51","doc_a_id":"5372432","doc_b_id":"14848619","presented_order":["5372432","14848619"],"winner_id":"5372432","reasoning":"Document A is slightly more relevant because it discusses cancer diagnosis and outcomes (though not ALDH1 or breast cancer specifically), whereas Document B focuses on a molecular hypoxia pathway unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:23.186089Z"}
{"comparison_id":"0818d9da-62d8-4697-bcc4-76e3a5cba523","query_id":"51","doc_a_id":"20381484","doc_b_id":"14848619","presented_order":["14848619","20381484"],"winner_id":"14848619","reasoning":"Neither abstract mentions ALDH1 or breast cancer outcomes; both are irrelevant. Document A is marginally more relevant because it deals with hypoxia/HIF-1α, which relates to tumor biology, whereas B focuses on GAPDH nitrosylation unrelated to cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:23.186098Z"}
{"comparison_id":"140bb217-d4ba-42a0-8b5c-4d44e811cfe5","query_id":"51","doc_a_id":"67787658","doc_b_id":"14848619","presented_order":["14848619","67787658"],"winner_id":"14848619","reasoning":"Document A — it discusses cancer-relevant cell death mechanisms (potentially impacting outcomes/treatment), whereas Document B is specific to glioblastoma chemoresistance and unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:23.186106Z"}
{"comparison_id":"0593f845-6c10-4682-8aae-0c9040b01451","query_id":"51","doc_a_id":"5123516","doc_b_id":"14848619","presented_order":["14848619","5123516"],"winner_id":"14848619","reasoning":"Document A is slightly more relevant — neither mentions ALDH1 or breast cancer, but A discusses general cancer-relevant hypoxia/HIF-1α biology, whereas B is specific to glioblastoma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:23.186114Z"}
{"comparison_id":"59637c65-9286-4493-b346-52b923c9a6ff","query_id":"51","doc_a_id":"22059387","doc_b_id":"14848619","presented_order":["14848619","22059387"],"winner_id":"14848619","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer; Document A addresses cancer-relevant hypoxic cell-death mechanisms, making it marginally more related than Document B (a parasitic cholangiocarcinoma model).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:23.186121Z"}
{"comparison_id":"75ccbdc6-8c2e-466d-81ee-33fff11bbb07","query_id":"51","doc_a_id":"13905670","doc_b_id":"14848619","presented_order":["14848619","13905670"],"winner_id":"14848619","reasoning":"Document A is slightly more relevant because it deals with cancer-related biology (hypoxic cell death), whereas Document B focuses on inflammatory/infectious disease genetics and not cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:23.186128Z"}
{"comparison_id":"a8d8587f-6f4d-493a-88f4-48f6b6c96937","query_id":"51","doc_a_id":"18882947","doc_b_id":"14848619","presented_order":["14848619","18882947"],"winner_id":"14848619","reasoning":"Document A is slightly more related to cancer biology and therapeutic targets, whereas Document B focuses on T-cell lymphoma development unrelated to breast cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:23.186135Z"}
{"comparison_id":"3cd35189-3f24-4517-8bb6-ec933a908025","query_id":"51","doc_a_id":"23601616","doc_b_id":"5372432","presented_order":["23601616","5372432"],"winner_id":"5372432","reasoning":"Document B is more relevant — it concerns cancer diagnosis/outcomes, whereas Document A is unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:27.130566Z"}
{"comparison_id":"135fa342-4780-4db1-8ef0-b3b267b78384","query_id":"51","doc_a_id":"4841908","doc_b_id":"5123516","presented_order":["4841908","5123516"],"winner_id":"5123516","reasoning":"Document B is slightly more relevant because it addresses tumor marker expression and cancer biology, whereas Document A concerns metabolomics and longevity unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:32.187309Z"}
{"comparison_id":"871ad845-d6cf-4e1f-8e80-cf3c0fd8c76a","query_id":"51","doc_a_id":"20381484","doc_b_id":"5123516","presented_order":["20381484","5123516"],"winner_id":"5123516","reasoning":"Reason: Both documents do not address ALDH1 or breast cancer outcomes; Document B discusses tumorigenicity in cancer (glioblastoma), making it slightly more related to cancer outcomes than Document A's biochemical mechanism.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:32.187330Z"}
{"comparison_id":"7656f9e9-c1d7-4a16-9f47-d8db1535ff1a","query_id":"51","doc_a_id":"67787658","doc_b_id":"5123516","presented_order":["67787658","5123516"],"winner_id":"5123516","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it discusses tumorigenicity and potential markers/targets, whereas A focuses narrowly on miRNAs and cell‑cycle in glioblastoma chemoresistance.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:32.187342Z"}
{"comparison_id":"9a22835c-e314-46c5-82dc-141a064d6f1c","query_id":"51","doc_a_id":"18882947","doc_b_id":"5123516","presented_order":["5123516","18882947"],"winner_id":"5123516","reasoning":"Document A is more relevant — it discusses cancer marker expression and tumorigenicity, which is closer to a claim about a marker (ALDH1) and cancer outcomes than B's focus on Tcf1 in T-cell lymphomas.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:32.187351Z"}
{"comparison_id":"faa76a3c-f4e9-4ef4-83d3-41f2a3165f22","query_id":"51","doc_a_id":"22059387","doc_b_id":"5123516","presented_order":["5123516","22059387"],"winner_id":"5123516","reasoning":"Document A is about cancer biology and tumor markers/targets, which is closer to a claim about a cancer marker (ALDH1) and outcomes than a hamster infection model of cholangiocarcinoma. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:32.187359Z"}
{"comparison_id":"f69998fd-dc41-40ad-9b1a-f61da32718f9","query_id":"51","doc_a_id":"13905670","doc_b_id":"5123516","presented_order":["13905670","5123516"],"winner_id":"5123516","reasoning":"Document B is more relevant — it addresses cancer biology and tumor outcomes, while A concerns inflammatory/infectious disease genetics rather than cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:32.187366Z"}
{"comparison_id":"de25f043-d950-43f5-a554-fd246dde0c89","query_id":"51","doc_a_id":"4841908","doc_b_id":"67787658","presented_order":["4841908","67787658"],"winner_id":"4841908","reasoning":"Neither abstract discusses ALDH1 or breast cancer directly; Document A at least mentions cancer in the context of human outcomes, while B is specific to glioblastoma and miRNAs. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:38.039887Z"}
{"comparison_id":"928e8d30-3466-485f-99c5-c5c77b86dbe0","query_id":"51","doc_a_id":"20381484","doc_b_id":"67787658","presented_order":["67787658","20381484"],"winner_id":"67787658","reasoning":"Document A is more relevant — it concerns cancer biology (tumor cell resistance and markers), whereas Document B covers GAPDH nitrosylation unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:38.039913Z"}
{"comparison_id":"fd7159f7-c662-4714-91d8-e973a3e6181b","query_id":"51","doc_a_id":"13905670","doc_b_id":"67787658","presented_order":["13905670","67787658"],"winner_id":"67787658","reasoning":"Document B is more relevant because it deals with cancer-related molecular markers and treatment resistance, whereas Document A concerns inflammatory/infectious disease genetics unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:38.039925Z"}
{"comparison_id":"4f621a03-aa6b-4ff6-9c93-5ba2c8514143","query_id":"51","doc_a_id":"18882947","doc_b_id":"67787658","presented_order":["18882947","67787658"],"winner_id":"18882947","reasoning":"Both documents are unrelated to ALDH1 or breast cancer, but Document A is slightly more relevant because it discusses gene expression and tumor outcomes in cancer (lymphomas), whereas Document B focuses on glioblastoma chemoresistance. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:38.039935Z"}
{"comparison_id":"c43b8f42-39ae-4ae8-90e8-45747bec6e81","query_id":"51","doc_a_id":"22059387","doc_b_id":"67787658","presented_order":["22059387","67787658"],"winner_id":"67787658","reasoning":"Both documents are irrelevant to ALDH1 and breast cancer; however, Document B deals with cancer cell biology and mechanisms (glioblastoma) and is slightly closer in topic than Document A (parasite-driven cholangiocarcinoma). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:38.039945Z"}
{"comparison_id":"c86a6022-0ba5-44c0-9b47-19847eb65f42","query_id":"51","doc_a_id":"4841908","doc_b_id":"18882947","presented_order":["18882947","4841908"],"winner_id":"18882947","reasoning":"Document A is more relevant — it concerns cancer biology (tumor suppressor activity), whereas Document B focuses on metabolomics and longevity and explicitly notes no link to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:41.263257Z"}
{"comparison_id":"71fd63f8-08a9-4716-8310-436525946049","query_id":"51","doc_a_id":"20381484","doc_b_id":"13905670","presented_order":["20381484","13905670"],"winner_id":"13905670","reasoning":"Document B is more relevant — it addresses genetic variation linked to disease prognosis (outcomes), whereas Document A is a biochemical study unrelated to clinical outcomes or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:45.229451Z"}
{"comparison_id":"bcbd6b7d-b0c6-41e1-ab34-3fcc71a54f3f","query_id":"51","doc_a_id":"22059387","doc_b_id":"13905670","presented_order":["22059387","13905670"],"winner_id":"22059387","reasoning":"Document A is slightly more relevant because it discusses mechanisms of carcinogenesis, whereas Document B concerns inflammatory disease genetics unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:21:45.229472Z"}
{"comparison_id":"e0d2490e-cd2b-4dcf-bb9c-3e50c497b867","query_id":"51","doc_a_id":"23665162","doc_b_id":"5573975","presented_order":["23665162","5573975"],"winner_id":"23665162","reasoning":"Reason: Document A concerns a cancer-related biomarker and outcomes (though in liver cancer), making it slightly more relevant than Document B, which addresses kidney regeneration and fibrosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065438Z"}
{"comparison_id":"e9222f21-2df4-41c2-8c73-80f268bbc162","query_id":"51","doc_a_id":"1507222","doc_b_id":"5573975","presented_order":["5573975","1507222"],"winner_id":"1507222","reasoning":"Both documents are irrelevant to ALDH1 and breast cancer outcomes. Document B is slightly more relevant because it deals with cancer biology (cachexia), whereas A concerns kidney regeneration. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065458Z"}
{"comparison_id":"e7e2a525-35f6-4fd5-a13b-12602e2f3ba1","query_id":"51","doc_a_id":"26079071","doc_b_id":"5573975","presented_order":["5573975","26079071"],"winner_id":"5573975","reasoning":"Neither document addresses ALDH1 or breast cancer. Both are irrelevant, but Document A is marginally closer (deals with epithelial biology/regeneration) while B is focused on targeted therapy in lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065466Z"}
{"comparison_id":"f795fd28-55d9-4743-830d-4cda9ae930aa","query_id":"51","doc_a_id":"23509593","doc_b_id":"5573975","presented_order":["23509593","5573975"],"winner_id":"23509593","reasoning":"Both documents are unrelated to ALDH1 or breast cancer, but Document A at least concerns cancer-related signaling (prostate) whereas Document B is about kidney regeneration. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065473Z"}
{"comparison_id":"1313a946-14d7-4c19-b389-d8fdadf7524b","query_id":"51","doc_a_id":"46617075","doc_b_id":"5573975","presented_order":["5573975","46617075"],"winner_id":"46617075","reasoning":"Document B is more related to cancer biology (though it's about lung cancer), whereas A concerns kidney regeneration and fibrosis and is unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065480Z"}
{"comparison_id":"9ab784ea-51d1-4797-a508-f3bd245836d2","query_id":"51","doc_a_id":"14938990","doc_b_id":"5573975","presented_order":["14938990","5573975"],"winner_id":"14938990","reasoning":"Document A is slightly more relevant because it discusses gene expression being associated with disease outcomes/biomarkers, whereas Document B focuses on kidney regeneration and fibrosis unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065488Z"}
{"comparison_id":"d0c673d7-1547-4cac-bea1-5bed502c1416","query_id":"51","doc_a_id":"3052213","doc_b_id":"5573975","presented_order":["5573975","3052213"],"winner_id":"3052213","reasoning":"Document B is slightly more relevant because it deals with genome-wide profiling of gene regulatory marks and transcription factor binding (gene expression context), whereas Document A is about kidney regeneration and fibrosis and is unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065495Z"}
{"comparison_id":"ed10558e-8b84-4d64-b190-ef931e264c54","query_id":"51","doc_a_id":"26488879","doc_b_id":"5573975","presented_order":["5573975","26488879"],"winner_id":"5573975","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it concerns tissue regeneration/signaling (potentially related to stem-cell biology), whereas Document B is focused on H. pylori and gastric inflammation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065503Z"}
{"comparison_id":"16d49d5c-058b-49d3-9bc7-4e28c0849638","query_id":"51","doc_a_id":"663464","doc_b_id":"5573975","presented_order":["5573975","663464"],"winner_id":"663464","reasoning":"Document B is more relevant — it deals with expression of molecular biomarkers and associations with clinical outcomes, which is closer to the claim about ALDH1 expression and breast cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065512Z"}
{"comparison_id":"c58906c5-67b6-4a69-b59a-e3eacea3260e","query_id":"51","doc_a_id":"520579","doc_b_id":"5573975","presented_order":["5573975","520579"],"winner_id":"520579","reasoning":"Document B — it's about cancer (colorectal) whereas A is about kidney regeneration, so B is slightly closer in topic. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065519Z"}
{"comparison_id":"d9de076d-9072-4d92-946e-1fa46c7e4378","query_id":"51","doc_a_id":"33030946","doc_b_id":"5573975","presented_order":["5573975","33030946"],"winner_id":"33030946","reasoning":"Neither mentions ALDH1 or breast cancer; Document B is slightly more related (discusses hypoxia/NF-κB signaling relevant to tumor biology). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065526Z"}
{"comparison_id":"50093dc3-df7e-4c4c-a62f-397725cc9d75","query_id":"51","doc_a_id":"38355793","doc_b_id":"5573975","presented_order":["38355793","5573975"],"winner_id":"38355793","reasoning":"Document A is more relevant — it deals with gene expression in cancerous tissue, whereas B is about kidney regeneration/fibrosis unrelated to cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065534Z"}
{"comparison_id":"7d8a77f0-d775-4c2f-93ac-3e6e21c04262","query_id":"51","doc_a_id":"16016673","doc_b_id":"5573975","presented_order":["5573975","16016673"],"winner_id":"16016673","reasoning":"Document B is more relevant — both documents are unrelated to ALDH1 or breast cancer specifically, but B concerns cancer biomarkers, making it closer in topic.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065541Z"}
{"comparison_id":"91953931-4879-44f0-b618-b47858dca866","query_id":"51","doc_a_id":"5278233","doc_b_id":"5573975","presented_order":["5278233","5573975"],"winner_id":"5278233","reasoning":"Document A is marginally more relevant because it deals with epigenetic alterations linked to tumorigenesis, whereas Document B concerns kidney regeneration/fibrosis and does not relate to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065548Z"}
{"comparison_id":"5cd7104a-14c0-4d70-ad3f-d7db2fbcd3bf","query_id":"51","doc_a_id":"23013317","doc_b_id":"5573975","presented_order":["5573975","23013317"],"winner_id":"23013317","reasoning":"Neither paper addresses ALDH1 or breast cancer. Document B is slightly more relevant because it discusses predictors of patient outcomes, whereas A focuses on kidney regeneration. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065555Z"}
{"comparison_id":"e6f6dabb-8e9d-4388-8096-213ce0c08204","query_id":"51","doc_a_id":"43334921","doc_b_id":"5573975","presented_order":["5573975","43334921"],"winner_id":"43334921","reasoning":"Document B is more relevant — it concerns cancer outcomes/associations (colorectal cancer and genetic markers), whereas A is about kidney regeneration/fibrosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065562Z"}
{"comparison_id":"9035730a-2d37-48b2-aeac-fe9eeb715dd4","query_id":"51","doc_a_id":"40234452","doc_b_id":"5573975","presented_order":["5573975","40234452"],"winner_id":"40234452","reasoning":"Reason: Both are unrelated to ALDH1 or breast cancer, but Document B concerns stem cell biology (more closely related to ALDH1 as a stem-cell marker) while A is about kidney fibrosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065569Z"}
{"comparison_id":"4ffd94b8-65f6-435d-8b59-aa48700206ba","query_id":"51","doc_a_id":"12903921","doc_b_id":"5573975","presented_order":["12903921","5573975"],"winner_id":"12903921","reasoning":"Document A is marginally more relevant because it concerns cancer (leukemia) and oxidative enzymes, whereas Document B is about kidney regeneration; neither discusses ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065576Z"}
{"comparison_id":"81bff132-1949-458a-91e9-fa374b6919ca","query_id":"51","doc_a_id":"16853734","doc_b_id":"5573975","presented_order":["5573975","16853734"],"winner_id":"16853734","reasoning":"Document B is slightly more relevant because it concerns cancer-related biology (cell migration mechanisms), whereas Document A is focused on kidney regeneration and fibrosis; neither mentions ALDH1 or breast cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065583Z"}
{"comparison_id":"bfd2cc97-9c36-4b0c-80f8-e01407195a1d","query_id":"51","doc_a_id":"9226649","doc_b_id":"5573975","presented_order":["5573975","9226649"],"winner_id":"9226649","reasoning":"Document B is more relevant because it addresses mechanisms of tumorigenesis (cancer), whereas A concerns kidney regeneration/fibrosis not cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065589Z"}
{"comparison_id":"5d3b3145-9fe6-4d71-9b6c-e76182ad0469","query_id":"51","doc_a_id":"3545805","doc_b_id":"5573975","presented_order":["5573975","3545805"],"winner_id":"3545805","reasoning":"Document B is more relevant—it's about tumor biology and therapy, whereas A focuses on kidney regeneration/fibrosis. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065596Z"}
{"comparison_id":"9d9c755c-4b9c-4cf6-aea1-227e46372c87","query_id":"51","doc_a_id":"15928989","doc_b_id":"5573975","presented_order":["15928989","5573975"],"winner_id":"15928989","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A is slightly more relevant only because it involves a receptor potentially related to steroid pathways that can influence cancer biology. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065603Z"}
{"comparison_id":"95fc9a87-a5d8-416d-a7d3-5a189f41ed64","query_id":"51","doc_a_id":"42150015","doc_b_id":"5573975","presented_order":["5573975","42150015"],"winner_id":"42150015","reasoning":"Document B is more relevant — it's about reproductive factors in women (potentially related to breast cancer risk/outcomes), while A is about kidney regeneration and unrelated to cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065610Z"}
{"comparison_id":"2bf912bc-3781-4bad-85ce-c28978f7799b","query_id":"51","doc_a_id":"15215393","doc_b_id":"5573975","presented_order":["5573975","15215393"],"winner_id":"15215393","reasoning":"Document B is more relevant because it concerns cancer biology (though in glioblastoma), whereas Document A focuses on kidney regeneration and fibrosis unrelated to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065617Z"}
{"comparison_id":"2cdb026f-58d6-4385-9c9f-639907df4a2c","query_id":"51","doc_a_id":"12145359","doc_b_id":"5573975","presented_order":["5573975","12145359"],"winner_id":"12145359","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document B is marginally more relevant only because it concerns cancer (lung) rather than kidney biology.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065624Z"}
{"comparison_id":"52cc8df4-7ede-49e1-8283-fb1b0aac652f","query_id":"51","doc_a_id":"23286603","doc_b_id":"5573975","presented_order":["23286603","5573975"],"winner_id":"23286603","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes; both are irrelevant. Document A is marginally more relevant only because it addresses molecular expression in mammalian cells (though it doesn't concern ALDH1 or breast cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065631Z"}
{"comparison_id":"17c719b2-6528-4934-8a73-35bb2147b1c0","query_id":"51","doc_a_id":"3619931","doc_b_id":"5573975","presented_order":["5573975","3619931"],"winner_id":"5573975","reasoning":"Neither document discusses ALDH1 or breast cancer, so both are irrelevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065637Z"}
{"comparison_id":"e2233c88-de3a-4626-b19a-38bcbc90c67c","query_id":"51","doc_a_id":"4434951","doc_b_id":"5573975","presented_order":["4434951","5573975"],"winner_id":"4434951","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document A is marginally more relevant because it deals with gene regulatory/epigenetic changes, whereas B focuses on kidney regeneration.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065643Z"}
{"comparison_id":"fa3904d0-a790-41c0-bc51-ce3e0043af18","query_id":"51","doc_a_id":"1982286","doc_b_id":"5573975","presented_order":["1982286","5573975"],"winner_id":"1982286","reasoning":"Document A is more relevant — it concerns cancer transcriptional networks and a tumor suppressor, whereas Document B focuses on kidney regeneration/fibrosis unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065650Z"}
{"comparison_id":"87ccc9e2-94a2-4976-921f-c5407f80c402","query_id":"51","doc_a_id":"36838958","doc_b_id":"5573975","presented_order":["36838958","5573975"],"winner_id":"36838958","reasoning":"Neither document is relevant — neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065655Z"}
{"comparison_id":"70e58f84-37fd-4a60-b039-3741fe0514ae","query_id":"51","doc_a_id":"24323369","doc_b_id":"5573975","presented_order":["5573975","24323369"],"winner_id":"5573975","reasoning":"Document A is slightly more relevant — although neither mentions ALDH1 or breast cancer, A deals with molecular signaling in disease contexts while B is an unrelated PCOS treatment trial.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065662Z"}
{"comparison_id":"21a94b34-0523-4ebb-9ad2-99affdec0b2b","query_id":"51","doc_a_id":"3504761","doc_b_id":"5573975","presented_order":["5573975","3504761"],"winner_id":"3504761","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it addresses tumorigenesis (though in liver), while A focuses on kidney regeneration.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065668Z"}
{"comparison_id":"58fcb7fc-c305-48c5-9387-5658f2e4e12a","query_id":"51","doc_a_id":"22478394","doc_b_id":"5573975","presented_order":["5573975","22478394"],"winner_id":"22478394","reasoning":"Document B — neither paper addresses ALDH1 or breast cancer, but B discusses gene expression changes (PPAR-γ), making it slightly closer in topic than A, which is about kidney Alk3 signaling.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065675Z"}
{"comparison_id":"27f4887e-5ce7-45b8-9548-82c38e016c8b","query_id":"51","doc_a_id":"24783597","doc_b_id":"5573975","presented_order":["5573975","24783597"],"winner_id":"5573975","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it concerns epithelial biology, but neither provides evidence for the claim. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065682Z"}
{"comparison_id":"6f7c79b7-d102-4d5d-a992-085b7f8bfc67","query_id":"51","doc_a_id":"5691302","doc_b_id":"5573975","presented_order":["5691302","5573975"],"winner_id":"5573975","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Of the two, B is marginally more relevant because it deals with molecular signaling/biology rather than antidepressant outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065688Z"}
{"comparison_id":"460010f2-31b0-4c48-af45-f08f8fc0d1fd","query_id":"51","doc_a_id":"19427410","doc_b_id":"5573975","presented_order":["5573975","19427410"],"winner_id":"19427410","reasoning":"Neither document discusses ALDH1 or breast cancer, so neither is relevant. Document B is slightly closer (involving inflammatory signaling that can relate to cancer biology), but still not relevant to the claim.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065695Z"}
{"comparison_id":"abbfa183-103c-41af-84e5-4b2459502e1f","query_id":"51","doc_a_id":"25036988","doc_b_id":"5573975","presented_order":["5573975","25036988"],"winner_id":"25036988","reasoning":"Document B is marginally more relevant because it addresses cancer cell biology, whereas Document A focuses on kidney regeneration unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065702Z"}
{"comparison_id":"59e32847-a872-4726-a72f-3ca55070af48","query_id":"51","doc_a_id":"21602220","doc_b_id":"5573975","presented_order":["21602220","5573975"],"winner_id":"5573975","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is marginally more relevant because it concerns human tissue signaling and disease processes, whereas A is about microbial fermentation.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065709Z"}
{"comparison_id":"af0d3a82-55a1-41ad-9de2-309e92ca0dde","query_id":"51","doc_a_id":"6290112","doc_b_id":"5573975","presented_order":["6290112","5573975"],"winner_id":"5573975","reasoning":"Document B is marginally more related (both involve tissue biology and signaling relevant to disease outcomes), while A concerns obesity genetics unrelated to cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065715Z"}
{"comparison_id":"1e9b1c1d-7673-4572-a3e4-6296efdea615","query_id":"51","doc_a_id":"33740844","doc_b_id":"5573975","presented_order":["5573975","33740844"],"winner_id":"5573975","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document A is slightly more related biologically (molecular signaling) than B (nutrition), so pick A.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065721Z"}
{"comparison_id":"ac2b2f4b-0e26-4a2d-83f8-6cc80f142bb8","query_id":"51","doc_a_id":"13398997","doc_b_id":"5573975","presented_order":["13398997","5573975"],"winner_id":"13398997","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it discusses cell-surface marker expression and clinical outcomes (immune response), whereas B is focused on kidney regeneration and fibrosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065728Z"}
{"comparison_id":"194f9e39-d297-4130-97b6-d27f46aec210","query_id":"51","doc_a_id":"20659283","doc_b_id":"5573975","presented_order":["5573975","20659283"],"winner_id":"20659283","reasoning":"Neither document mentions ALDH1 or breast cancer outcomes, so both are irrelevant. Document B is marginally more related because it deals with human gene expression regulation (vs. kidney biology in A).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065735Z"}
{"comparison_id":"958fc816-e33b-49c8-89ca-65d52b6a2b7e","query_id":"51","doc_a_id":"33076846","doc_b_id":"5573975","presented_order":["33076846","5573975"],"winner_id":"33076846","reasoning":"Document A — it at least mentions cancer-related factors, whereas Document B focuses on kidney regeneration and fibrosis unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065741Z"}
{"comparison_id":"292e8ee6-60d7-40ec-8039-a47e63f8baf5","query_id":"51","doc_a_id":"28644298","doc_b_id":"5573975","presented_order":["5573975","28644298"],"winner_id":"28644298","reasoning":"Document B — it's about cancer cell survival and gene regulation, which is more related to tumor biology than A's kidney/regeneration focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065748Z"}
{"comparison_id":"944c3658-c219-4e15-a97f-39fbf4091545","query_id":"51","doc_a_id":"14972169","doc_b_id":"5573975","presented_order":["5573975","14972169"],"winner_id":"14972169","reasoning":"Neither abstract addresses ALDH1 or breast cancer; both are irrelevant. Document B is slightly closer because it involves aldehyde (4‑HNE)–related protein modification and oxidative stress, which is more related to aldehyde biology than the kidney/ALK3 focus in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065755Z"}
{"comparison_id":"6332ff24-4c5d-4832-82d3-46e9b18c48fd","query_id":"51","doc_a_id":"17973161","doc_b_id":"5573975","presented_order":["5573975","17973161"],"winner_id":"5573975","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are irrelevant; if forced to choose, A is slightly more relevant because it addresses clinical-pathology signaling and tissue outcomes (vs metabolic adipocytes).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065762Z"}
{"comparison_id":"e4217b9e-8be1-45fb-b0a0-a7bd0656afdd","query_id":"51","doc_a_id":"6766459","doc_b_id":"5573975","presented_order":["5573975","6766459"],"winner_id":"5573975","reasoning":"Document A is slightly more related (discusses epithelial signaling and tissue outcomes) though neither addresses ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065769Z"}
{"comparison_id":"04ef5c9c-af41-4dca-a671-5f8ea2ab97dc","query_id":"51","doc_a_id":"9513785","doc_b_id":"5573975","presented_order":["9513785","5573975"],"winner_id":"9513785","reasoning":"Neither document addresses ALDH1 or breast cancer; Document A is slightly more relevant only because it discusses protein expression, whereas B focuses on kidney/Alk3. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065776Z"}
{"comparison_id":"fa3fd13b-2d86-4edc-bc97-3758c67d1110","query_id":"51","doc_a_id":"25725663","doc_b_id":"5573975","presented_order":["5573975","25725663"],"winner_id":"5573975","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is marginally more related because it discusses epithelial tissue/regeneration, whereas B focuses on bronchial oxidative injury.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065883Z"}
{"comparison_id":"d65c31c3-fb4d-4ad5-9527-a340d147d96e","query_id":"51","doc_a_id":"21372171","doc_b_id":"5573975","presented_order":["5573975","21372171"],"winner_id":"21372171","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document B is slightly more relevant only because it concerns a biomarker–outcome association study, which is conceptually closer to the query.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065900Z"}
{"comparison_id":"691bb96e-a264-4549-a54c-0360122b0019","query_id":"51","doc_a_id":"15803282","doc_b_id":"5573975","presented_order":["15803282","5573975"],"winner_id":"15803282","reasoning":"Document A is slightly more relevant because it concerns stem cell markers/processes (ALDH1 is a stem-cell–associated marker), whereas Document B is about kidney regeneration and fibrosis unrelated to breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065909Z"}
{"comparison_id":"dbfa8bc1-4d4c-4b6d-a6cb-25eb0f03d8d9","query_id":"51","doc_a_id":"25022826","doc_b_id":"5573975","presented_order":["5573975","25022826"],"winner_id":"25022826","reasoning":"Document B is slightly more relevant because it concerns stem cell biology (AFF1/AFF4 in MSC osteogenic differentiation), which is closer to topics about stem-cell markers like ALDH1 than the kidney-focused study in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065917Z"}
{"comparison_id":"0b446543-237b-4a0e-a4e5-214413922326","query_id":"51","doc_a_id":"19343151","doc_b_id":"5573975","presented_order":["19343151","5573975"],"winner_id":"19343151","reasoning":"Document A — neither directly addresses ALDH1 or breast cancer, but A discusses gene expression biomarkers (whereas B focuses on Alk3 and kidney fibrosis), so A is slightly more relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065925Z"}
{"comparison_id":"75a0ab92-bf6b-4926-baca-91f256201d61","query_id":"51","doc_a_id":"20460020","doc_b_id":"5573975","presented_order":["20460020","5573975"],"winner_id":"20460020","reasoning":"Document A is marginally more relevant because it involves estrogen receptor signaling, which is more related to breast cancer biology than kidney regeneration. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065931Z"}
{"comparison_id":"87f76df9-86c7-4ebe-8f8f-e330e5cd1f6b","query_id":"51","doc_a_id":"32372280","doc_b_id":"5573975","presented_order":["5573975","32372280"],"winner_id":"5573975","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes, so neither is relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065937Z"}
{"comparison_id":"402b3ae8-956c-42e9-92da-470133bebf17","query_id":"51","doc_a_id":"22896384","doc_b_id":"5573975","presented_order":["22896384","5573975"],"winner_id":"22896384","reasoning":"Neither document discusses ALDH1 or breast cancer, so both are irrelevant. Document A is marginally more related to cancer biology (transcription factors and epithelial tissues) than a kidney regeneration study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065944Z"}
{"comparison_id":"d0c1b71d-3b8e-4351-b811-2ef764e5588e","query_id":"51","doc_a_id":"38025907","doc_b_id":"5573975","presented_order":["38025907","5573975"],"winner_id":"38025907","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A mentions tumorigenesis and cancer-related outcomes (though in liver), so it's slightly more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065952Z"}
{"comparison_id":"61df5fec-06f1-4810-a88b-156f35dfe547","query_id":"51","doc_a_id":"8417211","doc_b_id":"5573975","presented_order":["8417211","5573975"],"winner_id":"5573975","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is marginally more relevant because it concerns mammalian disease signaling, whereas A is about Drosophila chromatin biology.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065961Z"}
{"comparison_id":"33cd366b-0ea2-4e55-8283-b7cb5500016f","query_id":"51","doc_a_id":"4920376","doc_b_id":"5573975","presented_order":["5573975","4920376"],"winner_id":"4920376","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document B is at least cancer-related (though about pancreatic cancer), so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065969Z"}
{"comparison_id":"60623f65-ee07-4d7b-8871-9bf28607b057","query_id":"51","doc_a_id":"6137330","doc_b_id":"5573975","presented_order":["5573975","6137330"],"winner_id":"6137330","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is about cancer management (lung), so it's slightly more relevant to cancer outcomes than Document A, which concerns kidney regeneration.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065978Z"}
{"comparison_id":"f5bb084b-e1a0-45dd-9137-2c77d712ef9f","query_id":"51","doc_a_id":"4641348","doc_b_id":"5573975","presented_order":["5573975","4641348"],"winner_id":"5573975","reasoning":"Neither document mentions ALDH1 or breast cancer, so both are irrelevant. If one must be chosen, ANSWER: A — it relates to epithelial biology which is slightly closer to cancer biology than a study on fatty liver.","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065987Z"}
{"comparison_id":"b3ac76f0-b07c-494e-b74d-feb8e59bc0fa","query_id":"51","doc_a_id":"22483580","doc_b_id":"5573975","presented_order":["5573975","22483580"],"winner_id":"5573975","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it concerns molecular signaling and epithelial tissue biology, which is closer to cancer biology than a psychiatry/IL-6 study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.065995Z"}
{"comparison_id":"b843fbae-13dc-4b84-a5ee-0cfe9412bda3","query_id":"51","doc_a_id":"8842332","doc_b_id":"5573975","presented_order":["5573975","8842332"],"winner_id":"5573975","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it addresses molecular signaling and epithelial biology, whereas B concerns pregnancy outcomes in type 1 diabetes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.066002Z"}
{"comparison_id":"44aeaa1d-2929-41b9-8f34-374f386c7994","query_id":"51","doc_a_id":"5765455","doc_b_id":"5573975","presented_order":["5765455","5573975"],"winner_id":"5765455","reasoning":"Document A — it relates to cancer and oxidative stress (ROS), which is more tangentially connected to ALDH1's role than a kidney regeneration study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.066010Z"}
{"comparison_id":"b9f2e580-829c-4876-bb7a-69627bb9e25c","query_id":"51","doc_a_id":"24586989","doc_b_id":"5573975","presented_order":["24586989","5573975"],"winner_id":"24586989","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it concerns clinical outcomes (though in heart failure, not cancer).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.066017Z"}
{"comparison_id":"1fad67ef-c098-4f2c-ab4e-461f351b0120","query_id":"51","doc_a_id":"1871499","doc_b_id":"5573975","presented_order":["5573975","1871499"],"winner_id":"1871499","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document B is slightly closer conceptually (epigenetics/gene expression) than A (kidney signaling). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.066025Z"}
{"comparison_id":"ae521d9e-c5a8-4ded-8bcc-7cd4a9425dcc","query_id":"51","doc_a_id":"28390999","doc_b_id":"5573975","presented_order":["5573975","28390999"],"winner_id":"28390999","reasoning":"Both documents are irrelevant to ALDH1 or breast cancer; Document B is slightly more relevant because it discusses gene expression (though in chicken gonadogenesis, not cancer). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.066031Z"}
{"comparison_id":"addd4c0b-83f9-4b3e-8a8b-f7464a480d85","query_id":"51","doc_a_id":"3202143","doc_b_id":"5573975","presented_order":["5573975","3202143"],"winner_id":"5573975","reasoning":"Document A is slightly more relevant because it deals with mammalian tissue biology and disease models, whereas Document B is about C. elegans neurobiology; neither addresses ALDH1 or breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.066038Z"}
{"comparison_id":"aeb433fe-bf0e-4729-9479-a8382ef9e30a","query_id":"51","doc_a_id":"2356950","doc_b_id":"5573975","presented_order":["2356950","5573975"],"winner_id":"2356950","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A (miR-184 in neural stem cells) is slightly more relevant conceptually because it concerns stem cell markers and behavior, whereas B is about kidney regeneration and fibrosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.066045Z"}
{"comparison_id":"f5b574e2-d9ee-4eaf-a505-2d9fd8f60eac","query_id":"51","doc_a_id":"38028419","doc_b_id":"5573975","presented_order":["38028419","5573975"],"winner_id":"38028419","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes; both are irrelevant. Pick A as slightly more general disease-related content but it still does not provide evidence about ALDH1 in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.066052Z"}
{"comparison_id":"b6f3d12f-9757-468a-9f7b-731c06403b93","query_id":"51","doc_a_id":"11255504","doc_b_id":"5573975","presented_order":["11255504","5573975"],"winner_id":"11255504","reasoning":"Document A is more relevant because it deals with cancer-related gene functions (tumor suppressors), whereas Document B concerns kidney regeneration/fibrosis and not cancer biomarkers or breast cancer.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.066059Z"}
{"comparison_id":"fb8f8aa9-31ac-4c1d-b8e8-f043740fdef3","query_id":"51","doc_a_id":"4795303","doc_b_id":"5573975","presented_order":["4795303","5573975"],"winner_id":"4795303","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. If one must be chosen, ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.066065Z"}
{"comparison_id":"f588d660-34cf-41a0-8795-5408457d8654","query_id":"51","doc_a_id":"3621011","doc_b_id":"5573975","presented_order":["3621011","5573975"],"winner_id":"3621011","reasoning":"Neither abstract mentions ALDH1 or breast cancer; both are unrelated. Document A is marginally closer (human adipose/tissue biology vs kidney regeneration), so:\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.066072Z"}
{"comparison_id":"12b15c53-abfb-4178-a173-976c03238d30","query_id":"51","doc_a_id":"2829179","doc_b_id":"5573975","presented_order":["2829179","5573975"],"winner_id":"2829179","reasoning":"Document A is slightly more relevant — it discusses metabolic pathways and enzymes, which is marginally closer to ALDH1 (an enzyme) and disease outcomes than a kidney regeneration/BMP signaling study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:22.066079Z"}
{"comparison_id":"e834065b-6130-478d-9dc5-0c800b523087","query_id":"51","doc_a_id":"23665162","doc_b_id":"3504761","presented_order":["23665162","3504761"],"winner_id":"23665162","reasoning":"Document A is slightly more relevant because it addresses cancer-associated biomarkers and outcomes, whereas Document B focuses on hepatic lipid metabolism and mouse liver disease unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694573Z"}
{"comparison_id":"c451fc71-b202-4d60-9403-b92e1c0fe483","query_id":"51","doc_a_id":"1507222","doc_b_id":"3504761","presented_order":["1507222","3504761"],"winner_id":"3504761","reasoning":"Document B — discusses mechanisms preventing tumorigenesis (though in liver), so slightly more related to cancer outcomes than A, which focuses on cachexia and UCPs. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694595Z"}
{"comparison_id":"e10cbaed-63df-4acc-9d79-e6f4c6cb1886","query_id":"51","doc_a_id":"23509593","doc_b_id":"3504761","presented_order":["23509593","3504761"],"winner_id":"3504761","reasoning":"Document B — it discusses tumorigenesis and cancer-related pathways (though in liver), whereas Document A is about androgen regulation in prostate stromal cells and is less related to breast cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694604Z"}
{"comparison_id":"bb19fd55-4900-4e41-8309-afc6420996b7","query_id":"51","doc_a_id":"46617075","doc_b_id":"3504761","presented_order":["46617075","3504761"],"winner_id":"46617075","reasoning":"Document A is slightly more relevant because it discusses cancer regulatory pathways, whereas Document B focuses on liver metabolism; neither mentions ALDH1 or breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694612Z"}
{"comparison_id":"8e98339b-7db9-4b18-8612-98606b383466","query_id":"51","doc_a_id":"14938990","doc_b_id":"3504761","presented_order":["14938990","3504761"],"winner_id":"3504761","reasoning":"Document B is more relevant — it addresses tumorigenesis and cancer-related pathways (though in liver), whereas A concerns PD-1 and SLE (autoimmune) unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694619Z"}
{"comparison_id":"ede4c23a-9b9a-4f0e-95bd-21657ed9d648","query_id":"51","doc_a_id":"3052213","doc_b_id":"3504761","presented_order":["3052213","3504761"],"winner_id":"3504761","reasoning":"Document B is slightly more relevant because it addresses tumorigenesis and cancer-related pathways, whereas Document A focuses on adipocyte transcription and metabolic regulation unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694626Z"}
{"comparison_id":"8cab25b6-1426-4806-a9b4-91b29fabde2a","query_id":"51","doc_a_id":"663464","doc_b_id":"3504761","presented_order":["663464","3504761"],"winner_id":"3504761","reasoning":"Document B is more relevant because it addresses tumorigenesis and cancer-related pathways, whereas Document A focuses on age-associated microRNAs and all-cause mortality, not ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694633Z"}
{"comparison_id":"13c3224f-bb53-4aed-8d0b-738a0ccb655d","query_id":"51","doc_a_id":"520579","doc_b_id":"3504761","presented_order":["520579","3504761"],"winner_id":"3504761","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it addresses cancer-related mechanisms and tumorigenesis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694640Z"}
{"comparison_id":"07fb8ad4-cf3c-4036-b941-6173d71542ac","query_id":"51","doc_a_id":"33030946","doc_b_id":"3504761","presented_order":["33030946","3504761"],"winner_id":"3504761","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer, but Document B discusses tumorigenesis and cancer-relevant pathways, making it slightly more relevant than Document A (which focuses on osteoclastogenesis and inflammation).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694646Z"}
{"comparison_id":"229a2f09-798b-4757-978b-a0b1c516a6b9","query_id":"51","doc_a_id":"38355793","doc_b_id":"3504761","presented_order":["38355793","3504761"],"winner_id":"38355793","reasoning":"Document A is more relevant — it deals with expression of a cancer-associated protein and tumor outcomes, whereas Document B focuses on liver metabolism and hepatosteatosis; neither mentions ALDH1 or breast cancer but A is closer in topic.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694654Z"}
{"comparison_id":"c3152843-7870-48e1-9392-210feb0db5c0","query_id":"51","doc_a_id":"16016673","doc_b_id":"3504761","presented_order":["3504761","16016673"],"winner_id":"3504761","reasoning":"Document A is slightly more relevant because it discusses cancer-related pathways and tumorigenesis, whereas Document B focuses on bladder cancer urine markers; neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694661Z"}
{"comparison_id":"4456b737-06d0-4c89-b47c-08213f1deef4","query_id":"51","doc_a_id":"5278233","doc_b_id":"3504761","presented_order":["3504761","5278233"],"winner_id":"3504761","reasoning":"Document A is slightly more relevant because it deals with tumorigenesis and cancer-related pathways, while Document B concerns imprinting in Beckwith-Wiedemann syndrome and is unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694669Z"}
{"comparison_id":"5bc47391-1e8a-4a12-9528-16197db741f4","query_id":"51","doc_a_id":"23013317","doc_b_id":"3504761","presented_order":["3504761","23013317"],"winner_id":"3504761","reasoning":"Document A — it discusses tumorigenesis and cancer-related pathways (albeit in liver), whereas Document B is about hypoalbuminemia in acute illness and unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694676Z"}
{"comparison_id":"a98b7f39-a784-441d-a47a-29c49b532ca4","query_id":"51","doc_a_id":"43334921","doc_b_id":"3504761","presented_order":["43334921","3504761"],"winner_id":"3504761","reasoning":"Document B is more relevant because it addresses cancer-related mechanisms and tumorigenesis (though in liver), whereas Document A concerns NSAID use and colorectal cancer genetics; neither directly discusses ALDH1 or breast cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694683Z"}
{"comparison_id":"60968ee4-f532-469a-89dc-a4c6ce00a150","query_id":"51","doc_a_id":"40234452","doc_b_id":"3504761","presented_order":["3504761","40234452"],"winner_id":"3504761","reasoning":"Document A is slightly more relevant because it discusses tumorigenesis (though in liver), whereas Document B concerns hematopoietic stem cell preservation and not cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694690Z"}
{"comparison_id":"d6f58ccf-05c0-428c-9588-3b90bef89777","query_id":"51","doc_a_id":"12903921","doc_b_id":"3504761","presented_order":["3504761","12903921"],"winner_id":"3504761","reasoning":"Document A is slightly more relevant because it discusses tumorigenesis pathways, whereas Document B focuses on oxidative stress in leukemia models unrelated to breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694697Z"}
{"comparison_id":"6b627826-068f-4076-bbd1-a61d8a0ac710","query_id":"51","doc_a_id":"16853734","doc_b_id":"3504761","presented_order":["3504761","16853734"],"winner_id":"3504761","reasoning":"Document A is slightly more relevant because it addresses tumorigenesis and cancer-related pathways (though in liver), whereas B focuses on MSC migration toward glioma and is unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694704Z"}
{"comparison_id":"2263f969-f20f-4c12-be9c-6933116379f8","query_id":"51","doc_a_id":"9226649","doc_b_id":"3504761","presented_order":["3504761","9226649"],"winner_id":"9226649","reasoning":"Reason: Neither abstract mentions ALDH1 or breast cancer; both are unrelated. Document B (colon tumorigenesis mechanisms) is marginally closer to cancer outcome relevance than A (hepatic lipid metabolism).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694711Z"}
{"comparison_id":"ee670333-394a-468b-9891-cd2b28e90359","query_id":"51","doc_a_id":"3545805","doc_b_id":"3504761","presented_order":["3504761","3545805"],"winner_id":"3504761","reasoning":"Document A is marginally more relevant because it discusses tumorigenesis and cancer-related pathways, whereas Document B focuses on melanoma immunotherapy; however, neither mentions ALDH1 or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694719Z"}
{"comparison_id":"6cb796d2-2a1c-44a8-9385-c718fe17c41f","query_id":"51","doc_a_id":"15928989","doc_b_id":"3504761","presented_order":["15928989","3504761"],"winner_id":"3504761","reasoning":"Document B is slightly more relevant — it discusses tumorigenesis and molecular pathways related to cancer, whereas Document A addresses pregnancy biology unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694725Z"}
{"comparison_id":"e295b711-026a-45e0-8670-59afa834e13e","query_id":"51","doc_a_id":"42150015","doc_b_id":"3504761","presented_order":["3504761","42150015"],"winner_id":"3504761","reasoning":"Document A is slightly more relevant because it discusses tumorigenesis and cancer-related pathways (though in liver rather than breast), whereas Document B concerns reproductive hormone levels unrelated to ALDH1 or cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694733Z"}
{"comparison_id":"622e8129-2af1-4adc-8044-0558b24d4e9f","query_id":"51","doc_a_id":"15215393","doc_b_id":"3504761","presented_order":["15215393","3504761"],"winner_id":"15215393","reasoning":"Document A is slightly more relevant because it concerns cancer biology (glioblastoma) whereas Document B focuses on hepatic metabolism and liver tumorigenesis; neither addresses ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694739Z"}
{"comparison_id":"642597e0-0eb4-4cc4-bbce-b7b6911c022c","query_id":"51","doc_a_id":"12145359","doc_b_id":"3504761","presented_order":["3504761","12145359"],"winner_id":"3504761","reasoning":"Document A is slightly more relevant because it concerns tumorigenesis and cancer biology, whereas Document B addresses lung function and lung cancer risk unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694746Z"}
{"comparison_id":"ce482398-31b5-4d92-b01a-7d59e54acfb6","query_id":"51","doc_a_id":"23286603","doc_b_id":"3504761","presented_order":["3504761","23286603"],"winner_id":"3504761","reasoning":"Document A is more relevant — it addresses tumorigenesis and cancer-related pathways (though in liver), whereas Document B concerns macrophage cholesterol efflux and atherosclerosis, not cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694753Z"}
{"comparison_id":"d7848717-afd3-4c55-909a-2887b33919f3","query_id":"51","doc_a_id":"4434951","doc_b_id":"3504761","presented_order":["3504761","4434951"],"winner_id":"3504761","reasoning":"Document A discusses tumorigenesis and cancer-related pathways (though in liver), while Document B is about aging/epigenetics and unrelated to cancer or ALDH1. A is therefore slightly more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694760Z"}
{"comparison_id":"72caf36b-7136-4cb8-8c55-5de2614fdc75","query_id":"51","doc_a_id":"1982286","doc_b_id":"3504761","presented_order":["3504761","1982286"],"winner_id":"1982286","reasoning":"Neither abstract discusses ALDH1 or breast cancer; however, Document B is cancer-focused (oncogenic networks) while A is about hepatic metabolism/tumorigenesis, so B is marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694767Z"}
{"comparison_id":"46817d23-1950-4837-a696-0f74b4f423db","query_id":"51","doc_a_id":"36838958","doc_b_id":"3504761","presented_order":["36838958","3504761"],"winner_id":"3504761","reasoning":"Document B is slightly more relevant because it addresses tumorigenesis and cancer-related pathways, whereas Document A concerns brown adipose tissue thermogenesis unrelated to cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694774Z"}
{"comparison_id":"ba7218ea-0334-4c1c-b2ad-fadb2b09d10c","query_id":"51","doc_a_id":"2829179","doc_b_id":"3504761","presented_order":["3504761","2829179"],"winner_id":"3504761","reasoning":"Document A is slightly more relevant because it discusses tumorigenesis (cancer-related processes), whereas Document B concerns pre-eclampsia and is unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694781Z"}
{"comparison_id":"8145bea8-0a4d-49b7-a0ca-df5e99cd952d","query_id":"51","doc_a_id":"22478394","doc_b_id":"3504761","presented_order":["22478394","3504761"],"winner_id":"3504761","reasoning":"Document B is more relevant — it addresses tumorigenesis and pathways affecting cancer-related processes, whereas A focuses only on liver PPAR-γ in NAFLD without cancer context.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694788Z"}
{"comparison_id":"f0edc6b0-120f-4a68-9faa-1a59de0e17df","query_id":"51","doc_a_id":"19427410","doc_b_id":"3504761","presented_order":["3504761","19427410"],"winner_id":"3504761","reasoning":"Document A is slightly more relevant because it discusses tumorigenesis and cancer-related pathways, whereas Document B concerns adipocyte cytokine expression unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694794Z"}
{"comparison_id":"c8c6263f-5814-450e-b70b-fda4b67c4ebf","query_id":"51","doc_a_id":"25036988","doc_b_id":"3504761","presented_order":["3504761","25036988"],"winner_id":"25036988","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document B is slightly more relevant because it deals with cancer cell gene regulation, whereas A focuses on liver-specific metabolism and tumorigenesis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694801Z"}
{"comparison_id":"5e989848-f00f-40b8-9834-8cb4c1ea2880","query_id":"51","doc_a_id":"13398997","doc_b_id":"3504761","presented_order":["13398997","3504761"],"winner_id":"3504761","reasoning":"Document B is slightly more relevant because it addresses tumorigenesis and cancer-related pathways, whereas Document A focuses on transplant immunology and CTLA-4 in T cells. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694808Z"}
{"comparison_id":"598af4ed-3420-4883-8d08-a51978503892","query_id":"51","doc_a_id":"20659283","doc_b_id":"3504761","presented_order":["3504761","20659283"],"winner_id":"3504761","reasoning":"Document A is somewhat related to cancer/tumorigenesis (though hepatic, not breast, and doesn't mention ALDH1); Document B concerns xenobiotic enzyme regulation and is unrelated to cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694815Z"}
{"comparison_id":"12fcb14b-07b5-4edb-b47a-00a4afa011d1","query_id":"51","doc_a_id":"33076846","doc_b_id":"3504761","presented_order":["3504761","33076846"],"winner_id":"33076846","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it discusses expression of proteins in cancer contexts, whereas A is a liver-specific metabolic/tumorigenesis study. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694821Z"}
{"comparison_id":"3852151c-199a-4339-a0a9-dc95df193e42","query_id":"51","doc_a_id":"28644298","doc_b_id":"3504761","presented_order":["28644298","3504761"],"winner_id":"3504761","reasoning":"Document B is slightly more relevant — it addresses tumorigenesis and cancer-related metabolic pathways, whereas Document A focuses on EBV/NF-kappa B in lymphoblastoid cells, unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694829Z"}
{"comparison_id":"e93ff68a-9e6f-4d26-8c94-080f4db65afe","query_id":"51","doc_a_id":"14972169","doc_b_id":"3504761","presented_order":["14972169","3504761"],"winner_id":"3504761","reasoning":"Document B is more relevant — it addresses tumorigenesis and cancer-related pathways (though in liver), while Document A concerns embryonic GAPDH and oxidative stress unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694835Z"}
{"comparison_id":"362a8bc5-af56-4de4-8fbc-d725656229a3","query_id":"51","doc_a_id":"9513785","doc_b_id":"3504761","presented_order":["3504761","9513785"],"winner_id":"3504761","reasoning":"Document A — it discusses tumorigenesis (cancer-related mechanisms), whereas Document B focuses on maternal protein restriction and lifespan without cancer context.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694842Z"}
{"comparison_id":"03bfc195-f21d-45cc-8a11-003a5423f80b","query_id":"51","doc_a_id":"21372171","doc_b_id":"3504761","presented_order":["21372171","3504761"],"winner_id":"3504761","reasoning":"Document B — it discusses mechanisms of tumorigenesis (though in liver), while Document A concerns peripheral artery disease and is unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694849Z"}
{"comparison_id":"0b3d641f-f630-4add-8700-f13d4c6673a1","query_id":"51","doc_a_id":"15803282","doc_b_id":"3504761","presented_order":["15803282","3504761"],"winner_id":"3504761","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document B concerns tumorigenesis (though in liver), making it slightly more relevant to cancer outcomes than Document A's focus on SCNT and stem cell derivation.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694856Z"}
{"comparison_id":"2887f3a2-6af1-4384-9547-a063b3de90e1","query_id":"51","doc_a_id":"25022826","doc_b_id":"3504761","presented_order":["3504761","25022826"],"winner_id":"3504761","reasoning":"Document A mentions tumorigenesis and cancer-related pathways (though in liver), so it's marginally more relevant than Document B, which addresses MSC osteogenesis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694864Z"}
{"comparison_id":"b772bb82-1d74-4cc4-ad36-3d280dcfe01e","query_id":"51","doc_a_id":"19343151","doc_b_id":"3504761","presented_order":["19343151","3504761"],"winner_id":"3504761","reasoning":"Document B — it discusses tumorigenesis and cancer-relevant pathways (though in liver), whereas A is about skin aging and not related to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694871Z"}
{"comparison_id":"27335119-2617-4cdb-9840-f255f8f166da","query_id":"51","doc_a_id":"20460020","doc_b_id":"3504761","presented_order":["20460020","3504761"],"winner_id":"3504761","reasoning":"Document B — it discusses tumorigenesis and cancer-related pathways (albeit in liver), while Document A is about wound healing and macrophage activation and is unrelated to cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694878Z"}
{"comparison_id":"a6955a38-4bf4-4bc6-81ad-fa987934dda8","query_id":"51","doc_a_id":"22896384","doc_b_id":"3504761","presented_order":["22896384","3504761"],"winner_id":"3504761","reasoning":"Document B — it discusses tumorigenesis and cancer-relevant pathways (though in liver), whereas A is about developmental roles of Foxp factors in lung/esophagus and is unrelated to cancer or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694885Z"}
{"comparison_id":"f741f89c-563b-49d4-845e-1d35a43cfca7","query_id":"51","doc_a_id":"38025907","doc_b_id":"3504761","presented_order":["3504761","38025907"],"winner_id":"3504761","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it discusses tumorigenesis mechanisms, whereas Document B focuses on NAFLD therapy. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694892Z"}
{"comparison_id":"2df787ab-3786-4a70-be40-c0f805106935","query_id":"51","doc_a_id":"4920376","doc_b_id":"3504761","presented_order":["3504761","4920376"],"winner_id":"4920376","reasoning":"Document B — neither mentions ALDH1 or breast cancer, but B is slightly more relevant because it addresses cancer treatment/outcomes (growth suppression) whereas A focuses on hepatic lipid metabolism and hepatocarcinogenesis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694899Z"}
{"comparison_id":"a8d8501c-a4ca-4b31-a101-9d32364bd242","query_id":"51","doc_a_id":"6137330","doc_b_id":"3504761","presented_order":["6137330","3504761"],"winner_id":"3504761","reasoning":"Document B — it discusses tumorigenesis and cancer-related molecular pathways (though in liver), whereas Document A covers lung nodule management and is unrelated to ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694905Z"}
{"comparison_id":"8aaad97a-1ebe-4469-ab1e-1055c87ec1d5","query_id":"51","doc_a_id":"5765455","doc_b_id":"3504761","presented_order":["3504761","5765455"],"winner_id":"5765455","reasoning":"Neither abstract mentions ALDH1 or breast cancer; Document B is slightly more relevant because its focus on reactive oxygen species and genomic instability is more related to pathways ALDH1 influences (aldehyde/ROS detoxification) than the liver-specific metabolic/tumorigenesis focus of A. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694913Z"}
{"comparison_id":"5e482171-cd77-4d95-9ac7-839bfa53a60a","query_id":"51","doc_a_id":"24586989","doc_b_id":"3504761","presented_order":["24586989","3504761"],"winner_id":"3504761","reasoning":"Document B is more relevant — it discusses mechanisms of tumorigenesis (though in the liver), whereas Document A focuses on heart failure genetics unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694920Z"}
{"comparison_id":"15459219-fd4e-4b9e-91ab-d2f98978ada2","query_id":"51","doc_a_id":"1871499","doc_b_id":"3504761","presented_order":["1871499","3504761"],"winner_id":"3504761","reasoning":"Document B is more relevant — it discusses tumorigenesis and cancer-related pathways, whereas A is about Huntington's disease and unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694927Z"}
{"comparison_id":"96f3e832-3ab9-42c2-9bc5-a93544b96092","query_id":"51","doc_a_id":"28390999","doc_b_id":"3504761","presented_order":["28390999","3504761"],"winner_id":"3504761","reasoning":"Document B — discusses tumorigenesis and pathways relevant to cancer biology (though in liver), whereas A is about chicken gonad development and unrelated genes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694934Z"}
{"comparison_id":"f9f6fadd-c050-455a-9581-e009557e59ef","query_id":"51","doc_a_id":"2356950","doc_b_id":"3504761","presented_order":["3504761","2356950"],"winner_id":"3504761","reasoning":"Document A is marginally more relevant because it addresses tumorigenesis (albeit in liver), whereas Document B concerns neural stem cell regulation unrelated to cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694941Z"}
{"comparison_id":"a765244a-6ca5-4f7e-9fae-43aaeb9f069a","query_id":"51","doc_a_id":"38028419","doc_b_id":"3504761","presented_order":["3504761","38028419"],"winner_id":"3504761","reasoning":"Document A — it discusses tumorigenesis and cancer-related pathways (more relevant than Document B's focus on alcoholic fatty liver). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694948Z"}
{"comparison_id":"32a2ca29-1cd8-4e94-9b75-a75b2717721b","query_id":"51","doc_a_id":"11255504","doc_b_id":"3504761","presented_order":["3504761","11255504"],"winner_id":"11255504","reasoning":"Neither document mentions ALDH1 or breast cancer. Both are irrelevant, but B is slightly more relevant because it addresses cancer genetics/tumorigenesis (even though in liver). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694954Z"}
{"comparison_id":"f8b8ed6a-5023-4be4-9219-49358fbb8ad8","query_id":"51","doc_a_id":"4795303","doc_b_id":"3504761","presented_order":["4795303","3504761"],"winner_id":"3504761","reasoning":"Document B is more relevant — it addresses tumorigenesis and cancer-related pathways (though in liver), whereas Document A focuses on neuroprotection and PC12 cells, unrelated to cancer markers or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694961Z"}
{"comparison_id":"eb0c59e3-5de4-4ad0-931e-70ec53e41944","query_id":"51","doc_a_id":"3621011","doc_b_id":"3504761","presented_order":["3504761","3621011"],"winner_id":"3504761","reasoning":"Document A is slightly more relevant because it discusses tumorigenesis (though in liver); neither document mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:22:48.694968Z"}
{"comparison_id":"106a0611-51d7-4815-aad3-17b53c9f032a","query_id":"51","doc_a_id":"23665162","doc_b_id":"1982286","presented_order":["1982286","23665162"],"winner_id":"23665162","reasoning":"Both documents are irrelevant to ALDH1 expression in breast cancer, but Document B is slightly more similar (a biomarker–cancer outcome association study) whereas A focuses on transcriptional networks in T-ALL. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:01.387641Z"}
{"comparison_id":"9c10da58-138d-4b0e-b190-5562ac43aee7","query_id":"51","doc_a_id":"46617075","doc_b_id":"1982286","presented_order":["1982286","46617075"],"winner_id":"1982286","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer; both are largely irrelevant. Document A is slightly more relevant because it deals with cancer transcriptional networks and a tumor suppressor gene, whereas B focuses specifically on the Rb-p16 pathway in lung cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:01.387663Z"}
{"comparison_id":"761a281e-3450-4693-a9ed-1e2b356b4a31","query_id":"51","doc_a_id":"38355793","doc_b_id":"1982286","presented_order":["1982286","38355793"],"winner_id":"1982286","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are irrelevant; Document A is marginally more relevant because it addresses oncogenic transcriptional networks broadly, while B is specific to glioma. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:01.387672Z"}
{"comparison_id":"5f9973f9-f002-4d07-97cf-3cd82b8db8d8","query_id":"51","doc_a_id":"9226649","doc_b_id":"1982286","presented_order":["1982286","9226649"],"winner_id":"1982286","reasoning":"Document A is more relevant because it deals with cancer-related transcriptional networks and tumor suppressors, whereas Document B focuses on colon-specific inflammation and inflammasome biology unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:01.387680Z"}
{"comparison_id":"8e2e7c1a-aa3f-4f62-ace2-20e85b8a289f","query_id":"51","doc_a_id":"15215393","doc_b_id":"1982286","presented_order":["15215393","1982286"],"winner_id":"15215393","reasoning":"Document A is slightly more relevant because it deals with cancer biology and expression-related therapeutic responses, whereas Document B focuses on transcriptional networks in T-ALL (unrelated cancer type).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:01.387687Z"}
{"comparison_id":"867b01d9-25c9-4998-ac07-de514b0c77d8","query_id":"51","doc_a_id":"11255504","doc_b_id":"1982286","presented_order":["1982286","11255504"],"winner_id":"1982286","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are unrelated; Document A is marginally more relevant because it addresses cancer transcriptional networks and tumor suppressors, whereas B focuses on liver-specific mutagenesis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:01.387694Z"}
{"comparison_id":"18e3d482-e482-4f24-9a2d-5b3b7949477e","query_id":"51","doc_a_id":"25036988","doc_b_id":"1982286","presented_order":["25036988","1982286"],"winner_id":"25036988","reasoning":"Document A is slightly more relevant because it discusses cancer cell biology and gene expression changes, whereas Document B is specific to T-ALL and RUNX1. Neither addresses ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:01.387700Z"}
{"comparison_id":"33ce6bbd-b29f-4fb3-9d6d-865ccb77a350","query_id":"51","doc_a_id":"33076846","doc_b_id":"1982286","presented_order":["33076846","1982286"],"winner_id":"1982286","reasoning":"Document B — it addresses cancer-related transcriptional networks and tumor suppressors, so it's marginally closer to a claim about cancer outcomes than a study focused on megakaryocyte endomitosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:01.387707Z"}
{"comparison_id":"52b786fa-3cb9-4e9a-b192-8e63609d7bfb","query_id":"51","doc_a_id":"4920376","doc_b_id":"1982286","presented_order":["4920376","1982286"],"winner_id":"4920376","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant as it deals with cancer signaling and outcomes in a solid tumor context.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:01.387715Z"}
{"comparison_id":"6c6db449-833f-4ca1-8940-795ae72bc202","query_id":"51","doc_a_id":"5765455","doc_b_id":"1982286","presented_order":["1982286","5765455"],"winner_id":"5765455","reasoning":"Neither abstract addresses ALDH1 or breast cancer. Document B is marginally more relevant because its focus on reactive oxygen species (which ALDH enzymes help detoxify) is a closer mechanistic link. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:01.387721Z"}
{"comparison_id":"2379de9c-b120-479a-a5ab-3b1dc8dda684","query_id":"51","doc_a_id":"23665162","doc_b_id":"25036988","presented_order":["25036988","23665162"],"winner_id":"25036988","reasoning":"Document A is slightly more relevant because it discusses cancer cell biology, whereas Document B concerns LINE-1 methylation and liver cancer risk; neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:06.919570Z"}
{"comparison_id":"dd212f16-6d79-465b-b90f-0e2166578938","query_id":"51","doc_a_id":"15215393","doc_b_id":"25036988","presented_order":["25036988","15215393"],"winner_id":"25036988","reasoning":"Document A is slightly more relevant because it addresses cancer cell gene expression and genome integrity, whereas Document B focuses on glioblastoma therapy; neither mentions ALDH1 or breast cancer outcomes. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:06.919591Z"}
{"comparison_id":"e3171d2e-fc2a-47f4-be9b-f4dc6ac0eeaa","query_id":"51","doc_a_id":"5765455","doc_b_id":"25036988","presented_order":["25036988","5765455"],"winner_id":"25036988","reasoning":"Neither document mentions ALDH1 or breast cancer; Document A is slightly more relevant because it deals with gene expression changes in a solid tumor (colon cancer) vs. leukemia in B. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:06.919600Z"}
{"comparison_id":"40a4717b-eb3c-45d7-b7f3-4ba0f275a5ca","query_id":"51","doc_a_id":"4920376","doc_b_id":"25036988","presented_order":["4920376","25036988"],"winner_id":"4920376","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it concerns cancer therapy/outcomes, while B focuses on lamin B1 in colon cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:06.919607Z"}
{"comparison_id":"9185d0b3-3e3b-4a6b-b989-4ec76d0faf0d","query_id":"51","doc_a_id":"23665162","doc_b_id":"15215393","presented_order":["15215393","23665162"],"winner_id":"15215393","reasoning":"Document A is slightly more relevant because it discusses enzyme expression and cancer biology, whereas Document B focuses on LINE-1 hypomethylation and hepatocellular carcinoma risk; however, neither addresses ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:13.652037Z"}
{"comparison_id":"e250bfd9-3cd4-438f-a6e0-ef9e3bbe1539","query_id":"51","doc_a_id":"5765455","doc_b_id":"15215393","presented_order":["15215393","5765455"],"winner_id":"15215393","reasoning":"Both documents do not address ALDH1 or breast cancer. Document A is slightly more relevant because it concerns cancer biology in a solid tumor context (glioblastoma) versus a hematologic malignancy in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:13.652075Z"}
{"comparison_id":"30891e5e-e2a3-4bde-ad15-4cfee63dc2fa","query_id":"51","doc_a_id":"23665162","doc_b_id":"5765455","presented_order":["5765455","23665162"],"winner_id":"23665162","reasoning":"Document B is more relevant — it concerns cancer and biomarker associations (though for HCC, not breast cancer or ALDH1). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:17.066630Z"}
{"comparison_id":"77fb1db5-7a42-469a-b662-682c4335cc00","query_id":"51","doc_a_id":"46617075","doc_b_id":"9226649","presented_order":["46617075","9226649"],"winner_id":"9226649","reasoning":"Both documents do not address ALDH1 or breast cancer. Document B is slightly more relevant because it concerns mechanisms of tumorigenesis and factors affecting cancer cell proliferation/apoptosis, whereas A is focused on the Rb-p16 pathway in lung cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:22.392757Z"}
{"comparison_id":"b31dd283-08fb-419a-8df9-5070c5919722","query_id":"51","doc_a_id":"38355793","doc_b_id":"9226649","presented_order":["38355793","9226649"],"winner_id":"38355793","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it discusses expression of a tumor-associated marker, whereas B focuses on inflammasome roles in colon tumorigenesis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:22.392778Z"}
{"comparison_id":"70984bb2-798b-412f-9b15-fb102d2b828f","query_id":"51","doc_a_id":"33076846","doc_b_id":"9226649","presented_order":["33076846","9226649"],"winner_id":"9226649","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is marginally more relevant because it concerns tumorigenesis and cancer biology, whereas A focuses on megakaryocyte polyploidization unrelated to cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:22.392786Z"}
{"comparison_id":"498c7789-dabf-42a8-afd1-6018cfd56286","query_id":"51","doc_a_id":"11255504","doc_b_id":"9226649","presented_order":["9226649","11255504"],"winner_id":"9226649","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document A is marginally more relevant because it discusses epithelial tumorigenesis (cancer biology) rather than a liver-specific mutagenesis screen.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:22.392794Z"}
{"comparison_id":"4adbfcb8-cca8-474f-a1c1-4653dd825acb","query_id":"51","doc_a_id":"46617075","doc_b_id":"33076846","presented_order":["46617075","33076846"],"winner_id":"46617075","reasoning":"Document A is marginally more relevant because it discusses cancer regulatory pathways (though in lung cancer), while Document B focuses on megakaryocyte biology unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:27.580188Z"}
{"comparison_id":"524cb369-a625-4f95-a812-6365a7ad7bee","query_id":"51","doc_a_id":"11255504","doc_b_id":"33076846","presented_order":["33076846","11255504"],"winner_id":"11255504","reasoning":"Document B is more relevant — it directly addresses cancer genetics and tumorigenesis, whereas A focuses on megakaryocyte polyploidization with only a tangential mention of cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:27.580213Z"}
{"comparison_id":"0ae158bc-279a-46c2-9191-50a82bd47059","query_id":"51","doc_a_id":"46617075","doc_b_id":"11255504","presented_order":["46617075","11255504"],"winner_id":"46617075","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant as a general cancer pathway review versus a liver-specific mutagenesis study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:32.938771Z"}
{"comparison_id":"dfcea338-3a51-458c-97f4-ec459683b025","query_id":"51","doc_a_id":"1507222","doc_b_id":"2829179","presented_order":["2829179","1507222"],"winner_id":"1507222","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes, but Document B is more related since it concerns cancer biology (cachexia). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195303Z"}
{"comparison_id":"d5c886be-cdd4-44d9-abf9-c403aa00252b","query_id":"51","doc_a_id":"23509593","doc_b_id":"2829179","presented_order":["2829179","23509593"],"winner_id":"2829179","reasoning":"Document A is slightly more related because it discusses metabolic pathways (ALDH1 is a metabolic enzyme), while Document B concerns androgen regulation in prostate cells unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195323Z"}
{"comparison_id":"6399dead-8589-4cb7-afd9-3e22b0ad3d0a","query_id":"51","doc_a_id":"14938990","doc_b_id":"2829179","presented_order":["2829179","14938990"],"winner_id":"2829179","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it discusses metabolic enzymes/pathways, whereas B concerns PD-1 in SLE. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195332Z"}
{"comparison_id":"5f03d2f5-b7d7-44a9-8c22-4622db544036","query_id":"51","doc_a_id":"3052213","doc_b_id":"2829179","presented_order":["2829179","3052213"],"winner_id":"2829179","reasoning":"Neither abstract mentions ALDH1 or breast cancer; both are irrelevant. Document A is slightly more related only because it discusses metabolic pathways (ALDH1 is a metabolic enzyme). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195339Z"}
{"comparison_id":"15c73e63-af0c-486d-ad85-3b8807bf0701","query_id":"51","doc_a_id":"663464","doc_b_id":"2829179","presented_order":["2829179","663464"],"winner_id":"663464","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it deals with gene expression and associations with clinical outcomes, whereas A focuses on pre-eclampsia mechanisms. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195347Z"}
{"comparison_id":"af93e610-ef99-4c68-ad64-777655d6f1f3","query_id":"51","doc_a_id":"520579","doc_b_id":"2829179","presented_order":["2829179","520579"],"winner_id":"520579","reasoning":"Document B — it's cancer-related (colorectal) while A is about pre-eclampsia and unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195356Z"}
{"comparison_id":"0edb2b5f-baee-4b75-9f39-bb9142b57d9a","query_id":"51","doc_a_id":"33030946","doc_b_id":"2829179","presented_order":["33030946","2829179"],"winner_id":"33030946","reasoning":"Document A is slightly more relevant because it discusses hypoxia and metabolic signaling pathways (E2F1, NF-κB) that are more related to cancer biology than the pre-eclampsia focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195364Z"}
{"comparison_id":"9d5ebbe0-87c9-49ed-97cf-f1788ba408b8","query_id":"51","doc_a_id":"16016673","doc_b_id":"2829179","presented_order":["2829179","16016673"],"winner_id":"16016673","reasoning":"Document B — it's about cancer (bladder), whereas A concerns pre-eclampsia and is unrelated to cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195371Z"}
{"comparison_id":"e32c9ed2-a53c-4e39-adc3-b83f0593210e","query_id":"51","doc_a_id":"5278233","doc_b_id":"2829179","presented_order":["2829179","5278233"],"winner_id":"2829179","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more related because it addresses metabolic pathways and disease outcomes, whereas Document B focuses on imprinting in Beckwith-Wiedemann syndrome. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195378Z"}
{"comparison_id":"93a6fd7f-3de7-4d2b-9d3c-df2413604ff2","query_id":"51","doc_a_id":"23013317","doc_b_id":"2829179","presented_order":["23013317","2829179"],"winner_id":"23013317","reasoning":"Document A — it addresses associations between a biological measure and clinical outcomes, whereas Document B is about pre-eclampsia and unrelated pathways. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195385Z"}
{"comparison_id":"6fa297c6-b26d-456c-b3e7-8b8d3552ec5c","query_id":"51","doc_a_id":"43334921","doc_b_id":"2829179","presented_order":["2829179","43334921"],"winner_id":"2829179","reasoning":"Document A is slightly more relevant because it discusses metabolic pathways and enzymes, which are more likely to involve ALDH1 than a study on aspirin/NSAID use and colorectal cancer genetics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195392Z"}
{"comparison_id":"860ed3fd-7412-4150-92f6-79b37fc710a1","query_id":"51","doc_a_id":"40234452","doc_b_id":"2829179","presented_order":["2829179","40234452"],"winner_id":"40234452","reasoning":"Document B is more relevant — it concerns stem cell markers and behavior (HES-1 and stem cell populations), which is closer to ALDH1's role as a cancer stem-cell marker than a review on pre-eclampsia.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195399Z"}
{"comparison_id":"5d501196-4668-431c-8c29-603ecbedf313","query_id":"51","doc_a_id":"12903921","doc_b_id":"2829179","presented_order":["2829179","12903921"],"winner_id":"2829179","reasoning":"Document A is slightly more relevant because it discusses metabolic pathways and enzymes, which is closer to ALDH1's role than the leukemia/oxidative stress focus of Document B. Neither document directly addresses ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195406Z"}
{"comparison_id":"a21c851e-192c-4d95-9f66-debe8ade6922","query_id":"51","doc_a_id":"16853734","doc_b_id":"2829179","presented_order":["16853734","2829179"],"winner_id":"16853734","reasoning":"Document A is slightly more relevant because it deals with cancer biology, whereas Document B concerns pre-eclampsia and is unrelated to cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195413Z"}
{"comparison_id":"a2894b21-3ece-4332-9809-69dd873fabb2","query_id":"51","doc_a_id":"3545805","doc_b_id":"2829179","presented_order":["2829179","3545805"],"winner_id":"3545805","reasoning":"Document B is more relevant — it concerns cancer biology/immunotherapy (though in melanoma, not breast or ALDH1), whereas Document A is about pre-eclampsia and unrelated to cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195421Z"}
{"comparison_id":"9819bcb6-fb6c-49ef-acd3-1e378048cb74","query_id":"51","doc_a_id":"15928989","doc_b_id":"2829179","presented_order":["15928989","2829179"],"winner_id":"2829179","reasoning":"Document B is more relevant — it discusses metabolic enzymes and pathways (potentially closer to ALDH1-related metabolism) while Document A focuses on a pregnancy-specific nuclear receptor unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195428Z"}
{"comparison_id":"408177cf-a045-4ec2-b39f-689993afc428","query_id":"51","doc_a_id":"42150015","doc_b_id":"2829179","presented_order":["42150015","2829179"],"winner_id":"42150015","reasoning":"Neither document mentions ALDH1 or breast cancer; however, Document A (reproductive factors in premenopausal women) is slightly more related to breast cancer outcomes than a review on pre-eclampsia. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195435Z"}
{"comparison_id":"50d604ae-d810-4497-8d56-75ec5a7849ac","query_id":"51","doc_a_id":"12145359","doc_b_id":"2829179","presented_order":["12145359","2829179"],"winner_id":"12145359","reasoning":"Document A is more relevant because it addresses cancer risk/outcomes (though for lung cancer), whereas Document B is about pre-eclampsia and unrelated to cancer biomarkers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195441Z"}
{"comparison_id":"3780cecc-540d-4896-9e9b-913f23eafa80","query_id":"51","doc_a_id":"23286603","doc_b_id":"2829179","presented_order":["2829179","23286603"],"winner_id":"2829179","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document A is marginally more related to human disease/biomarkers than B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195448Z"}
{"comparison_id":"e57b1820-4cc9-439b-be0c-fab1ba946d72","query_id":"51","doc_a_id":"4434951","doc_b_id":"2829179","presented_order":["2829179","4434951"],"winner_id":"2829179","reasoning":"Reason: Neither abstract addresses ALDH1 or breast cancer, but Document A concerns human pathological/metabolic pathways (more clinically related) while Document B focuses on mouse aging epigenetics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195454Z"}
{"comparison_id":"21282347-6414-466b-9148-4768751f68ed","query_id":"51","doc_a_id":"36838958","doc_b_id":"2829179","presented_order":["36838958","2829179"],"winner_id":"36838958","reasoning":"Document A is slightly more relevant because it discusses protein expression regulation, whereas Document B focuses on pre-eclampsia and is unrelated to cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195461Z"}
{"comparison_id":"f43c93f9-bddc-4bc7-88d1-63207511a9a1","query_id":"51","doc_a_id":"3621011","doc_b_id":"2829179","presented_order":["2829179","3621011"],"winner_id":"2829179","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is slightly more relevant because it discusses angiogenic and metabolic pathways (more related to cancer biology) while B focuses on adipocyte differentiation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195467Z"}
{"comparison_id":"0ee7e636-823e-4dbc-b0ae-340ed7ad6080","query_id":"51","doc_a_id":"22478394","doc_b_id":"2829179","presented_order":["22478394","2829179"],"winner_id":"22478394","reasoning":"Document A is slightly more relevant because it reports gene expression changes and disease association, whereas Document B discusses pre-eclampsia and angiogenic/metabolic pathways unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195475Z"}
{"comparison_id":"e6285355-7797-40b1-abfb-692d4acaf5fb","query_id":"51","doc_a_id":"19427410","doc_b_id":"2829179","presented_order":["19427410","2829179"],"winner_id":"2829179","reasoning":"Neither abstract addresses ALDH1 or breast cancer directly. Document B is slightly more relevant because it discusses metabolic enzymes/pathways (closer to ALDH1's role as a metabolic enzyme), whereas A focuses on IL-33 in adipocytes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195481Z"}
{"comparison_id":"1bc9186b-d0b4-4011-845f-61474fe55801","query_id":"51","doc_a_id":"13398997","doc_b_id":"2829179","presented_order":["2829179","13398997"],"winner_id":"13398997","reasoning":"Neither document addresses ALDH1 or breast cancer, but Document B (immunology/CTLA-4) is marginally closer in topic to cancer-related immune markers than Document A (pre-eclampsia). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195488Z"}
{"comparison_id":"ef2820a3-4fc1-400f-be1b-b4109a764306","query_id":"51","doc_a_id":"20659283","doc_b_id":"2829179","presented_order":["2829179","20659283"],"winner_id":"2829179","reasoning":"Document A is more relevant — it discusses angiogenic and metabolic pathways (closer to enzymatic/biomarker topics like ALDH1), while Document B focuses on CYP3A4 regulation unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195495Z"}
{"comparison_id":"00c97c53-76b0-4315-aa2b-298438c3a52b","query_id":"51","doc_a_id":"28644298","doc_b_id":"2829179","presented_order":["2829179","28644298"],"winner_id":"28644298","reasoning":"Document B is more relevant — it discusses cancer-related cell survival and transcriptional regulation, whereas A concerns pre-eclampsia; neither directly addresses ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195502Z"}
{"comparison_id":"8a2c5971-ab1a-468c-bca1-520704c2e2b4","query_id":"51","doc_a_id":"14972169","doc_b_id":"2829179","presented_order":["2829179","14972169"],"winner_id":"2829179","reasoning":"Document A is marginally more relevant — it discusses metabolic pathways that are more related to ALDH1's metabolic role and disease outcomes; Document B focuses on embryonic GAPDH and teratogen effects. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195509Z"}
{"comparison_id":"e02e8b3c-814e-4f70-abc0-e71d48eee29a","query_id":"51","doc_a_id":"9513785","doc_b_id":"2829179","presented_order":["2829179","9513785"],"winner_id":"9513785","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is slightly more relevant because it addresses changes in protein expression, whereas A focuses on pre-eclampsia and angiogenic/metabolic pathways unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195515Z"}
{"comparison_id":"0bf7ee6a-9ecf-4795-852d-b5de774892f4","query_id":"51","doc_a_id":"21372171","doc_b_id":"2829179","presented_order":["2829179","21372171"],"winner_id":"2829179","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it discusses metabolic enzymes/pathways, which are closer to ALDH1's biological role than a PAD biomarker study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195522Z"}
{"comparison_id":"f3efd93d-10e5-4d3c-9a0a-b1136f0681ef","query_id":"51","doc_a_id":"15803282","doc_b_id":"2829179","presented_order":["2829179","15803282"],"winner_id":"15803282","reasoning":"Document B is marginally more relevant because it deals with gene expression and stem-cell biology, which is closer to ALDH1's role as a stem-cell marker in cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195529Z"}
{"comparison_id":"60cb0850-a8a1-453b-95f3-611572c43ff6","query_id":"51","doc_a_id":"25022826","doc_b_id":"2829179","presented_order":["25022826","2829179"],"winner_id":"25022826","reasoning":"Document A is slightly more relevant because it deals with gene/protein regulation and cell differentiation, which is closer to cancer biology than a review on pre‑eclampsia. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195535Z"}
{"comparison_id":"46a8e5e0-139f-423c-8fb6-3c83b991b3d6","query_id":"51","doc_a_id":"19343151","doc_b_id":"2829179","presented_order":["19343151","2829179"],"winner_id":"19343151","reasoning":"Document A is slightly more relevant because it discusses gene expression and biomarkers (even though in skin), whereas Document B focuses on pre-eclampsia and is unrelated to cancer.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195542Z"}
{"comparison_id":"0aa2473e-3cd9-4e8b-8122-478f4ddde3bb","query_id":"51","doc_a_id":"20460020","doc_b_id":"2829179","presented_order":["2829179","20460020"],"winner_id":"20460020","reasoning":"Document B is slightly more relevant because it involves estrogen receptor α, which is directly relevant to breast cancer biology, whereas Document A concerns pre-eclampsia and metabolic/angiogenic pathways unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195549Z"}
{"comparison_id":"2ee035ff-b85f-43c5-ad62-d5a3916ad822","query_id":"51","doc_a_id":"22896384","doc_b_id":"2829179","presented_order":["22896384","2829179"],"winner_id":"22896384","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are irrelevant; Document A is marginally closer (focuses on transcription factors in tissues). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195555Z"}
{"comparison_id":"c66b3810-2a24-480b-b484-270855cc9f94","query_id":"51","doc_a_id":"38025907","doc_b_id":"2829179","presented_order":["2829179","38025907"],"winner_id":"2829179","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document A is marginally closer (human disease and metabolic pathways) but still not relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195562Z"}
{"comparison_id":"859bd3da-0355-4aa2-9f61-1b761f664c2a","query_id":"51","doc_a_id":"6137330","doc_b_id":"2829179","presented_order":["6137330","2829179"],"winner_id":"6137330","reasoning":"Document A is more relevant because it concerns cancer diagnosis/management, whereas Document B is about pre-eclampsia and unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195569Z"}
{"comparison_id":"45a5152b-a802-4214-99db-c61183eaf1c8","query_id":"51","doc_a_id":"24586989","doc_b_id":"2829179","presented_order":["2829179","24586989"],"winner_id":"2829179","reasoning":"Document A is slightly more relevant because it discusses metabolic pathways (ALDH1 is a metabolic enzyme), whereas Document B focuses on heart failure genetics unrelated to breast cancer. Neither directly addresses ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195576Z"}
{"comparison_id":"7b9b6ca0-682b-4da8-adba-4b3cbbb6cae3","query_id":"51","doc_a_id":"1871499","doc_b_id":"2829179","presented_order":["2829179","1871499"],"winner_id":"2829179","reasoning":"Document A is more relevant—discusses angiogenic and metabolic pathways which are more related to cancer biology than a Huntington's epigenetics study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195582Z"}
{"comparison_id":"cd026d61-5d8a-4021-90e2-17737b8070c2","query_id":"51","doc_a_id":"28390999","doc_b_id":"2829179","presented_order":["28390999","2829179"],"winner_id":"2829179","reasoning":"Neither document mentions ALDH1 or breast cancer, but Document B discusses human disease and metabolic/angiogenic pathways (more related to clinical outcomes) while A is about chicken gonad development. Slightly more relevant: B.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195589Z"}
{"comparison_id":"77298a15-4a4a-459b-8cde-24ad2907f349","query_id":"51","doc_a_id":"2356950","doc_b_id":"2829179","presented_order":["2829179","2356950"],"winner_id":"2356950","reasoning":"Document B is slightly more relevant because it addresses stem cell regulation (ALDH1 is a stem/progenitor marker), whereas Document A is unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195595Z"}
{"comparison_id":"418be141-b8c7-46d0-9b9e-2126a94e1856","query_id":"51","doc_a_id":"38028419","doc_b_id":"2829179","presented_order":["38028419","2829179"],"winner_id":"2829179","reasoning":"Document B is slightly more relevant because it discusses human disease-related metabolic pathways and enzymes, which is closer to ALDH1 (a metabolic enzyme) and clinical outcomes than a mouse liver/leptin study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195602Z"}
{"comparison_id":"7d285157-6642-48f3-83d9-1adc8a86af9d","query_id":"51","doc_a_id":"4795303","doc_b_id":"2829179","presented_order":["2829179","4795303"],"winner_id":"2829179","reasoning":"Both documents are unrelated to ALDH1 expression in breast cancer, but Document A (a review of metabolic/angiogenic pathways in pre-eclampsia) is marginally more likely to discuss metabolic enzymes relevant to ALDH1 than the neuron-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:23:53.195608Z"}
{"comparison_id":"6f0e6d56-8feb-4104-973f-1fa923e40ade","query_id":"51","doc_a_id":"1507222","doc_b_id":"36838958","presented_order":["36838958","1507222"],"winner_id":"36838958","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes (both focus on uncoupling proteins/ROS in adipose or cachexia), so neither is relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:05.498248Z"}
{"comparison_id":"3e18de43-f016-4af3-8cca-fe83dfbfff07","query_id":"51","doc_a_id":"663464","doc_b_id":"36838958","presented_order":["663464","36838958"],"winner_id":"663464","reasoning":"Document A is slightly more relevant because it concerns biomarkers and associations with mortality and disease outcomes, whereas Document B is about adipose tissue metabolism and unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:05.498268Z"}
{"comparison_id":"b3a2f7f7-5326-4ad5-8c99-4ffccc5467d6","query_id":"51","doc_a_id":"520579","doc_b_id":"36838958","presented_order":["36838958","520579"],"winner_id":"520579","reasoning":"Document B is more relevant — it concerns cancer risk/outcomes (colorectal cancer), whereas Document A addresses adipose tissue metabolism unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:05.498279Z"}
{"comparison_id":"7586baba-51b4-4590-b831-4e5ce03224d1","query_id":"51","doc_a_id":"33030946","doc_b_id":"36838958","presented_order":["36838958","33030946"],"winner_id":"33030946","reasoning":"Document B — it deals with hypoxia, signaling and cellular metabolism in human cells (more related to cancer microenvironments) whereas Document A is about adipose thermogenesis and Ucp1, which is less relevant. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:05.498287Z"}
{"comparison_id":"a3a8e41c-3186-4278-8c54-8b12ed2b6bff","query_id":"51","doc_a_id":"16016673","doc_b_id":"36838958","presented_order":["16016673","36838958"],"winner_id":"16016673","reasoning":"Reason: Document A relates to cancer biomarkers and diagnostics (though for bladder cancer), so it's more relevant to a claim about a cancer biomarker and outcomes than Document B, which concerns adipose tissue metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:05.498296Z"}
{"comparison_id":"ad7c8c0e-9322-4c17-8561-fa7524b4d92c","query_id":"51","doc_a_id":"23013317","doc_b_id":"36838958","presented_order":["23013317","36838958"],"winner_id":"23013317","reasoning":"Document A is slightly more relevant because it discusses clinical outcomes, whereas Document B covers adipose tissue biology unrelated to cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:05.498303Z"}
{"comparison_id":"b5dc3424-069d-479f-bffd-6991789baa49","query_id":"51","doc_a_id":"40234452","doc_b_id":"36838958","presented_order":["36838958","40234452"],"winner_id":"40234452","reasoning":"Document B is slightly more relevant because it concerns stem cell markers and stem cell preservation, which is closer to ALDH1's role as a cancer/stem-cell marker; Document A concerns adipose thermogenesis unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:05.498310Z"}
{"comparison_id":"5a8bfb8d-e5b6-4de9-8a5d-a73f0601153b","query_id":"51","doc_a_id":"16853734","doc_b_id":"36838958","presented_order":["36838958","16853734"],"winner_id":"16853734","reasoning":"Document B is slightly more relevant because it concerns cancer (tumor cell/MSC interactions), whereas A focuses on adipose tissue thermogenesis unrelated to cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:05.498317Z"}
{"comparison_id":"75a20180-a736-4018-a9b9-e8f637280ed2","query_id":"51","doc_a_id":"3545805","doc_b_id":"36838958","presented_order":["36838958","3545805"],"winner_id":"3545805","reasoning":"Document B is slightly more relevant because it concerns cancer biology/immunotherapy, whereas A addresses adipose tissue metabolism; however, neither document mentions ALDH1 or breast cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:05.498324Z"}
{"comparison_id":"ec71b705-0db6-4033-8ffe-f89678e1dafb","query_id":"51","doc_a_id":"42150015","doc_b_id":"36838958","presented_order":["36838958","42150015"],"winner_id":"42150015","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes. Document B is marginally more relevant because it concerns human reproductive factors in women (more related to cancer epidemiology) while A is about brown fat metabolism.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:05.498331Z"}
{"comparison_id":"a4aa90c2-9019-4a3e-8dad-b39d11685349","query_id":"51","doc_a_id":"12145359","doc_b_id":"36838958","presented_order":["12145359","36838958"],"winner_id":"12145359","reasoning":"Document A is more relevant — it addresses cancer risk/outcomes (though lung cancer), whereas Document B concerns adipose tissue metabolism and not cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:05.498337Z"}
{"comparison_id":"fae32a77-9e98-4b83-a73a-f15ddc4f9c6a","query_id":"51","doc_a_id":"2356950","doc_b_id":"36838958","presented_order":["2356950","36838958"],"winner_id":"2356950","reasoning":"Reason: Neither abstract addresses ALDH1 or breast cancer, but Document A discusses stem cell proliferation/differentiation (closer in topic to ALDH1 as a stem cell marker) while Document B is about brown adipose tissue metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:05.498360Z"}
{"comparison_id":"53df0fd3-8c61-4c7f-968c-45cc8dec66c0","query_id":"51","doc_a_id":"22478394","doc_b_id":"36838958","presented_order":["36838958","22478394"],"winner_id":"22478394","reasoning":"Neither document discusses ALDH1 or breast cancer; both are unrelated. Document B is slightly more relevant only because it addresses gene expression in a human disease context (liver/obesity) rather than basic adipose thermogenesis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:05.498375Z"}
{"comparison_id":"3bb4c3e0-fb82-4bc9-a117-4ce385e04e89","query_id":"51","doc_a_id":"13398997","doc_b_id":"36838958","presented_order":["36838958","13398997"],"winner_id":"36838958","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant only because it discusses protein expression, whereas B focuses on transplant immunology.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:05.498385Z"}
{"comparison_id":"0f0229af-c591-4d14-8436-732be55a735c","query_id":"51","doc_a_id":"28644298","doc_b_id":"36838958","presented_order":["36838958","28644298"],"winner_id":"28644298","reasoning":"Document B is more relevant — it addresses cell survival and transcriptional regulation in cancer-related (EBV/LMP1) contexts, whereas Document A concerns adipose thermogenesis unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:05.498394Z"}
{"comparison_id":"0dff5996-e6d8-46ce-ae50-87ca9c009140","query_id":"51","doc_a_id":"9513785","doc_b_id":"36838958","presented_order":["9513785","36838958"],"winner_id":"9513785","reasoning":"Document A is slightly more relevant because it discusses changes in protein expression linked to health outcomes, whereas Document B focuses on brown adipose tissue thermogenesis unrelated to cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:05.498401Z"}
{"comparison_id":"1effd3f0-8dd8-4afc-8e7f-bdb62b6180ef","query_id":"51","doc_a_id":"15803282","doc_b_id":"36838958","presented_order":["15803282","36838958"],"winner_id":"15803282","reasoning":"Document A is more relevant — it concerns stem cell-related enzyme expression and cell reprogramming, which is closer to ALDH1's role as a stem/progenitor marker relevant to cancer outcomes; Document B is about brown adipose tissue and thermogenesis and is unrelated. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:05.498409Z"}
{"comparison_id":"ba7a05f3-40ee-4736-a255-c02dc24b8815","query_id":"51","doc_a_id":"25022826","doc_b_id":"36838958","presented_order":["36838958","25022826"],"winner_id":"25022826","reasoning":"Reason: Neither abstract mentions ALDH1 or breast cancer; Document B (AFF1/AFF4 in human MSC differentiation) is slightly closer due to gene regulation in human stem cells.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:05.498415Z"}
{"comparison_id":"84744238-608b-4f06-bcbf-94a4c8110879","query_id":"51","doc_a_id":"19343151","doc_b_id":"36838958","presented_order":["19343151","36838958"],"winner_id":"19343151","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant because it discusses gene expression in human tissue (biomarkers), while B focuses on adipose thermogenesis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:05.498423Z"}
{"comparison_id":"3df0ca48-bad5-47e8-9a45-0e35c6e62357","query_id":"51","doc_a_id":"20460020","doc_b_id":"36838958","presented_order":["36838958","20460020"],"winner_id":"20460020","reasoning":"Reason: Both documents are unrelated to ALDH1 or breast cancer, but Document B involves estrogen receptor α, which is more tangentially related to breast cancer biology than adipose UCP1 in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:05.498431Z"}
{"comparison_id":"afba317a-0461-4d0a-bf49-f302f0071140","query_id":"51","doc_a_id":"22896384","doc_b_id":"36838958","presented_order":["22896384","36838958"],"winner_id":"22896384","reasoning":"Neither document mentions ALDH1 or breast cancer outcomes, so both are irrelevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:05.498437Z"}
{"comparison_id":"e138fd2d-a580-4c98-b052-29480259c505","query_id":"51","doc_a_id":"6137330","doc_b_id":"36838958","presented_order":["6137330","36838958"],"winner_id":"6137330","reasoning":"Reason: Document A is cancer-related (lung cancer management) while Document B concerns adipose tissue metabolism; A is marginally more relevant to a cancer-outcomes claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:05.498444Z"}
{"comparison_id":"e278dcf6-d26e-4c09-b402-6b5fa3e06285","query_id":"51","doc_a_id":"663464","doc_b_id":"12145359","presented_order":["12145359","663464"],"winner_id":"12145359","reasoning":"Document A is more relevant — it at least addresses cancer risk/outcomes, whereas Document B concerns ageing and microRNAs unrelated to breast cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:17.697840Z"}
{"comparison_id":"eeb3ede2-19fd-49a9-95ae-8d5864bf7ef9","query_id":"51","doc_a_id":"520579","doc_b_id":"12145359","presented_order":["12145359","520579"],"winner_id":"520579","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is slightly more relevant because it addresses a biomarker–cancer outcome association, whereas A concerns lung function and lung cancer risk.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:17.697865Z"}
{"comparison_id":"9a0e7803-ad8b-4c2c-9927-f28fe6e9166c","query_id":"51","doc_a_id":"33030946","doc_b_id":"12145359","presented_order":["12145359","33030946"],"winner_id":"33030946","reasoning":"Document B is slightly more relevant because it discusses cellular metabolism and signaling pathways in human cells (molecular mechanisms), which is closer to ALDH1's role in cancer biology than an epidemiologic lung-function study. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:17.697875Z"}
{"comparison_id":"aa41688f-19f6-48a0-887f-710806497e20","query_id":"51","doc_a_id":"16016673","doc_b_id":"12145359","presented_order":["16016673","12145359"],"winner_id":"16016673","reasoning":"Document A is slightly more relevant because it discusses molecular cancer biomarkers (though for bladder cancer), whereas Document B concerns lung function and lung cancer risk and is unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:17.697883Z"}
{"comparison_id":"b7896d95-2330-44a2-9680-d1c264d8ebad","query_id":"51","doc_a_id":"23013317","doc_b_id":"12145359","presented_order":["23013317","12145359"],"winner_id":"23013317","reasoning":"Document A is slightly more relevant — it discusses a biomarker (albumin) and associations with clinical outcomes, whereas Document B concerns lung function and lung cancer risk, unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:17.697890Z"}
{"comparison_id":"8cfca9d5-027b-45dc-9ae5-f35f22fce301","query_id":"51","doc_a_id":"40234452","doc_b_id":"12145359","presented_order":["12145359","40234452"],"winner_id":"40234452","reasoning":"Document B — it concerns stem-cell biology (HES-1 and stem cell preservation), which is closer to ALDH1's role as a cancer/stem-cell marker than Document A's lung-function/lung-cancer epidemiology. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:17.697897Z"}
{"comparison_id":"52933513-7319-41f4-9e11-dc27b97f1952","query_id":"51","doc_a_id":"16853734","doc_b_id":"12145359","presented_order":["12145359","16853734"],"winner_id":"12145359","reasoning":"Both documents are irrelevant to ALDH1 and breast cancer, but Document A discusses cancer risk/outcomes (lung) while Document B focuses on MMP1 in glioma migration, so A is slightly closer in topic.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:17.697905Z"}
{"comparison_id":"99507a5e-6932-465b-97d4-0e3eca34438d","query_id":"51","doc_a_id":"3545805","doc_b_id":"12145359","presented_order":["3545805","12145359"],"winner_id":"3545805","reasoning":"Document A is more relevant — it concerns cancer biology/immunotherapy (though in melanoma), whereas Document B addresses lung function and lung cancer risk, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:17.697913Z"}
{"comparison_id":"4802712d-a6a8-4155-93b8-6a70893cddbb","query_id":"51","doc_a_id":"42150015","doc_b_id":"12145359","presented_order":["42150015","12145359"],"winner_id":"42150015","reasoning":"Reason: Document A concerns female reproductive biomarkers (more related to breast-cancer–relevant biology) while Document B is about lung function and lung cancer risk; neither addresses ALDH1 or breast cancer directly, but A is marginally more related.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:17.697920Z"}
{"comparison_id":"ec2b6c59-b07a-4605-9f33-eccf483c759e","query_id":"51","doc_a_id":"6137330","doc_b_id":"12145359","presented_order":["12145359","6137330"],"winner_id":"12145359","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document A is slightly more relevant because it discusses cancer risk generally, whereas B focuses narrowly on nodule management.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:17.697927Z"}
{"comparison_id":"22dcc7aa-a8a0-4ba4-83ee-448593931e78","query_id":"51","doc_a_id":"2356950","doc_b_id":"12145359","presented_order":["2356950","12145359"],"winner_id":"12145359","reasoning":"Reason: Both documents are unrelated to ALDH1 or breast cancer; Document B is slightly more relevant because it concerns cancer outcomes (lung cancer), whereas Document A concerns neural stem cells.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:17.697934Z"}
{"comparison_id":"dd18480d-b153-45bc-9a70-bd6023674434","query_id":"51","doc_a_id":"22478394","doc_b_id":"12145359","presented_order":["22478394","12145359"],"winner_id":"12145359","reasoning":"Document B is more relevant — it addresses cancer risk/outcomes (though for lung cancer), whereas Document A concerns liver PPAR-γ in NAFLD and is unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:17.697942Z"}
{"comparison_id":"3e19355b-c853-4bc7-b1f0-98da61bd1348","query_id":"51","doc_a_id":"28644298","doc_b_id":"12145359","presented_order":["12145359","28644298"],"winner_id":"28644298","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is marginally more relevant because it's a molecular study of cancer-related cell survival and transcription, while A is an epidemiologic lung-cancer study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:17.697949Z"}
{"comparison_id":"f6d523d4-4229-4a67-90bf-af8cc2112017","query_id":"51","doc_a_id":"9513785","doc_b_id":"12145359","presented_order":["9513785","12145359"],"winner_id":"9513785","reasoning":"Document A is more relevant — it discusses changes in protein expression (though not ALDH1) and biological outcomes, whereas Document B is unrelated (lung function and lung cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:17.697956Z"}
{"comparison_id":"770dc8e2-efb7-468f-afc5-07c2d2cd4910","query_id":"51","doc_a_id":"15803282","doc_b_id":"12145359","presented_order":["15803282","12145359"],"winner_id":"12145359","reasoning":"Neither document mentions ALDH1 or breast cancer, so both are irrelevant. Between them, B is slightly more relevant because it addresses cancer outcomes (lung cancer risk), whereas A concerns stem cell reprogramming.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:17.697963Z"}
{"comparison_id":"4a7fa6c4-8284-43c1-9123-d05aa0d563b7","query_id":"51","doc_a_id":"25022826","doc_b_id":"12145359","presented_order":["12145359","25022826"],"winner_id":"25022826","reasoning":"Document B is slightly more relevant because it discusses gene expression and stem/progenitor cell regulation, which is closer to ALDH1's role as a stem-cell marker than a lung function/cancer risk study. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:17.697970Z"}
{"comparison_id":"c863cf92-1bee-4945-838b-6fe835db3b8c","query_id":"51","doc_a_id":"19343151","doc_b_id":"12145359","presented_order":["19343151","12145359"],"winner_id":"19343151","reasoning":"Document A is slightly more relevant because it discusses gene expression as a biomarker (similar topic to ALDH1 expression), whereas Document B addresses lung function and lung cancer risk, unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:17.697977Z"}
{"comparison_id":"60ee66bc-ee33-4ee4-ae66-9d0263c26583","query_id":"51","doc_a_id":"20460020","doc_b_id":"12145359","presented_order":["12145359","20460020"],"winner_id":"20460020","reasoning":"Neither abstract addresses ALDH1 or breast cancer; Document B is slightly more relevant because it involves estrogen receptor biology, which is related to breast cancer biology, whereas A is about lung function and lung cancer risk.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:17.697985Z"}
{"comparison_id":"5f3b3b81-23f7-4089-bbaa-99728cfb0d6b","query_id":"51","doc_a_id":"22896384","doc_b_id":"12145359","presented_order":["22896384","12145359"],"winner_id":"12145359","reasoning":"Document B is more relevant — it addresses cancer risk/outcomes (though for lung cancer), whereas Document A concerns developmental biology unrelated to cancer or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:17.697992Z"}
{"comparison_id":"aed25739-175a-4a5e-804d-046cffce7570","query_id":"51","doc_a_id":"520579","doc_b_id":"3545805","presented_order":["520579","3545805"],"winner_id":"3545805","reasoning":"Neither abstract mentions ALDH1 or breast cancer; both are irrelevant. Document B is marginally more related (cancer biology/immunotherapy) than A (vitamin D and colorectal cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:24.549806Z"}
{"comparison_id":"8e90563b-9bfa-428e-ba17-8ec06bd5bd8c","query_id":"51","doc_a_id":"33030946","doc_b_id":"3545805","presented_order":["33030946","3545805"],"winner_id":"3545805","reasoning":"Document B — it concerns tumor immunology and cancer therapy, making it slightly more relevant to a claim about cancer outcomes than Document A, which focuses on osteoclastogenesis and macrophage signaling. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:24.549831Z"}
{"comparison_id":"291c5ac0-4564-4679-a764-27358ba13007","query_id":"51","doc_a_id":"16016673","doc_b_id":"3545805","presented_order":["16016673","3545805"],"winner_id":"16016673","reasoning":"Document A is slightly more relevant because it concerns molecular cancer biomarkers, whereas Document B focuses on T-cell therapy for melanoma; neither addresses ALDH1 or breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:24.549840Z"}
{"comparison_id":"3f03e8f0-c7d3-4373-92de-4859cdedaa6f","query_id":"51","doc_a_id":"23013317","doc_b_id":"3545805","presented_order":["3545805","23013317"],"winner_id":"3545805","reasoning":"Document A — it's cancer-related (tumor immunology), whereas B is about hypoalbuminemia in acute illness and unrelated to cancer markers or breast cancer outcomes.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:24.549847Z"}
{"comparison_id":"c29b0565-3bd8-4e28-9ca8-0b86eea718a0","query_id":"51","doc_a_id":"40234452","doc_b_id":"3545805","presented_order":["3545805","40234452"],"winner_id":"40234452","reasoning":"Document B is slightly more relevant because it concerns stem cell markers and stem cell biology (ALDH1 is a stemness marker), whereas Document A focuses on Th17 immunotherapy for melanoma and is unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:24.549855Z"}
{"comparison_id":"3b143ab0-c512-4a5b-885d-98971cf95f5a","query_id":"51","doc_a_id":"20460020","doc_b_id":"3545805","presented_order":["3545805","20460020"],"winner_id":"3545805","reasoning":"Document A is more relevant — it concerns cancer biology/therapy (tumor outcomes), while Document B is about wound healing and macrophage activation with no link to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:24.549862Z"}
{"comparison_id":"d5193b1d-9782-45e0-82de-3881536d4884","query_id":"51","doc_a_id":"42150015","doc_b_id":"3545805","presented_order":["3545805","42150015"],"winner_id":"42150015","reasoning":"Document B — it addresses reproductive and hormonal factors in women (closer to breast cancer context) while Document A is about melanoma immunotherapy and unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:24.549869Z"}
{"comparison_id":"6e73a12a-3328-4fbd-8183-65afe4d243f7","query_id":"51","doc_a_id":"28644298","doc_b_id":"3545805","presented_order":["3545805","28644298"],"winner_id":"3545805","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant since it deals with tumor biology/immunotherapy, whereas B concerns EBV-infected lymphoid cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:24.549875Z"}
{"comparison_id":"1b6776c0-f3ba-4bb9-942a-dacfb1c853fb","query_id":"51","doc_a_id":"9513785","doc_b_id":"3545805","presented_order":["9513785","3545805"],"winner_id":"3545805","reasoning":"Document B — it discusses tumor immunology and cancer treatment, so it's more closely related to cancer outcomes than Document A, which is about maternal protein restriction and lifespan in mice.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:24.549883Z"}
{"comparison_id":"2c3bf228-e8e1-4e3b-ab0a-887b31520f9f","query_id":"51","doc_a_id":"25022826","doc_b_id":"3545805","presented_order":["25022826","3545805"],"winner_id":"3545805","reasoning":"Document B is slightly more relevant because it concerns tumor immunology and cancer outcomes, whereas Document A is about MSC osteogenic differentiation and not cancer-related.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:24.549890Z"}
{"comparison_id":"225e17a0-bdad-45e6-bd35-220002fd60db","query_id":"51","doc_a_id":"19343151","doc_b_id":"3545805","presented_order":["19343151","3545805"],"winner_id":"3545805","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer prognosis, but Document B is cancer-related (tumor therapy), so it's marginally more relevant than a skin-aging biomarker study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:24.549897Z"}
{"comparison_id":"de57e06e-c689-4e5e-8da7-a370921c05f1","query_id":"51","doc_a_id":"16016673","doc_b_id":"40234452","presented_order":["16016673","40234452"],"winner_id":"16016673","reasoning":"Document A is cancer-focused and discusses biomarkers/diagnosis, making it more related to a claim about a cancer biomarker and outcomes; Document B concerns hematopoietic stem cell manipulation unrelated to breast cancer. Neither directly addresses ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:45.852286Z"}
{"comparison_id":"3317c752-2c43-4211-bc55-da16082e77d0","query_id":"51","doc_a_id":"42150015","doc_b_id":"40234452","presented_order":["42150015","40234452"],"winner_id":"40234452","reasoning":"Document B is slightly more relevant because it discusses stem cell markers/behavior (ALDH1 is a stem-cell–associated marker), whereas Document A is about AMH and reproductive factors unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:45.852310Z"}
{"comparison_id":"f28f0870-216f-4aef-941e-9541d3d03b11","query_id":"51","doc_a_id":"520579","doc_b_id":"20460020","presented_order":["520579","20460020"],"winner_id":"20460020","reasoning":"Document B is more relevant — it involves estrogen receptor α, which relates to breast cancer biology; Document A is about vitamin D and colorectal cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:50.031767Z"}
{"comparison_id":"de61fa81-a360-4f5e-ba03-7a9544e943aa","query_id":"51","doc_a_id":"33030946","doc_b_id":"20460020","presented_order":["33030946","20460020"],"winner_id":"33030946","reasoning":"Document A is slightly more related — it deals with hypoxia, cellular metabolism, and signaling in human myeloid cells, topics more relevant to cancer biology than cutaneous wound repair.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:50.031789Z"}
{"comparison_id":"f5d0c48b-5c10-4205-9773-f1530a641830","query_id":"51","doc_a_id":"23013317","doc_b_id":"20460020","presented_order":["23013317","20460020"],"winner_id":"20460020","reasoning":"Reason: Neither document discusses ALDH1 or breast cancer, but Document B involves estrogen receptor-α, a key factor in breast cancer biology, so it's marginally more related.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:50.031798Z"}
{"comparison_id":"b50a7955-4a79-481a-bf7f-c88bba033a61","query_id":"51","doc_a_id":"19343151","doc_b_id":"20460020","presented_order":["20460020","19343151"],"winner_id":"20460020","reasoning":"Document A is slightly more relevant because it involves estrogen receptor signaling, which is related to breast cancer biology; Document B focuses on skin aging and is unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:50.031807Z"}
{"comparison_id":"8c7ea77d-429a-4bcf-82b4-6cef490dad28","query_id":"51","doc_a_id":"28644298","doc_b_id":"20460020","presented_order":["20460020","28644298"],"winner_id":"20460020","reasoning":"Document A is slightly more relevant because it involves estrogen receptor signaling, which is related to breast cancer biology; Document B focuses on EBV/NF-κB in lymphoid cells and is unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:50.031814Z"}
{"comparison_id":"9730bf8f-7f8f-48f0-856c-80dbde95e4e9","query_id":"51","doc_a_id":"9513785","doc_b_id":"20460020","presented_order":["9513785","20460020"],"winner_id":"20460020","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B is marginally more relevant because ERα relates to breast biology, while A concerns maternal protein restriction in mice. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:50.031821Z"}
{"comparison_id":"51ddc2df-e657-46da-b806-8da22ef49aa7","query_id":"51","doc_a_id":"25022826","doc_b_id":"20460020","presented_order":["25022826","20460020"],"winner_id":"20460020","reasoning":"Reason: Neither abstract mentions ALDH1 or breast cancer, but Document B involves estrogen receptor α, which is more directly related to breast cancer biology than AFF1/AFF4 in MSC osteogenesis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:50.031828Z"}
{"comparison_id":"9d926709-f482-4e16-b502-86802b65c53f","query_id":"51","doc_a_id":"520579","doc_b_id":"19343151","presented_order":["19343151","520579"],"winner_id":"520579","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it concerns cancer outcomes (colorectal), whereas A is about skin aging biomarkers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:57.541795Z"}
{"comparison_id":"a7fcc80e-764a-411f-9d34-7950b0587024","query_id":"51","doc_a_id":"23013317","doc_b_id":"19343151","presented_order":["23013317","19343151"],"winner_id":"19343151","reasoning":"Document B is more relevant — it deals with gene expression as a biomarker (closer to ALDH1 expression being a prognostic marker), whereas Document A is about hypoalbuminemia in acute illness and unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:57.541819Z"}
{"comparison_id":"7e2a053f-213f-4405-9fc3-ab5e93590e32","query_id":"51","doc_a_id":"25022826","doc_b_id":"19343151","presented_order":["19343151","25022826"],"winner_id":"25022826","reasoning":"Document B — it discusses regulation of stem cell (MSC) differentiation, which is conceptually closer to ALDH1 as a stem cell marker than Document A's focus on skin aging markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:57.541827Z"}
{"comparison_id":"1742e51b-03f8-495c-88e3-d0cfd4ee3ad4","query_id":"51","doc_a_id":"28644298","doc_b_id":"19343151","presented_order":["19343151","28644298"],"winner_id":"19343151","reasoning":"Document A is slightly more relevant because it discusses expression of cell-cycle and stemness-related markers (p16INK4A, BMI1), which is closer to ALDH1's role as a cancer/stem-cell marker than the EBV/NF-κB topic in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:57.541835Z"}
{"comparison_id":"1e872126-12b3-459b-a04f-6a461c8f1f8e","query_id":"51","doc_a_id":"9513785","doc_b_id":"19343151","presented_order":["9513785","19343151"],"winner_id":"19343151","reasoning":"Neither document discusses ALDH1 or breast cancer, so both are irrelevant to the claim. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:24:57.541842Z"}
{"comparison_id":"fc9d6219-47cd-4763-b725-ad5387dbfacb","query_id":"51","doc_a_id":"520579","doc_b_id":"25022826","presented_order":["25022826","520579"],"winner_id":"25022826","reasoning":"Document A is slightly more relevant because it discusses gene expression and cellular markers, whereas Document B concerns vitamin D levels and colorectal cancer (different marker and cancer type).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:01.162301Z"}
{"comparison_id":"00750d67-404a-4395-83a0-ff372d8218a2","query_id":"51","doc_a_id":"23013317","doc_b_id":"28644298","presented_order":["23013317","28644298"],"winner_id":"23013317","reasoning":"Document A is slightly more relevant because it discusses associations between a biomarker and clinical outcomes, whereas Document B concerns NF-kappa B signaling in EBV-infected lymphoid cells unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:06.157055Z"}
{"comparison_id":"3572671b-a521-4fdb-ae16-7c2aa6c08429","query_id":"51","doc_a_id":"9513785","doc_b_id":"28644298","presented_order":["28644298","9513785"],"winner_id":"28644298","reasoning":"Document A is slightly more relevant because it addresses cancer-related cell survival and transcriptional regulation, whereas Document B concerns maternal protein restriction and metabolic effects in mice, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:06.157077Z"}
{"comparison_id":"4578e042-b71f-42a9-ba57-4ff2e9fe8808","query_id":"51","doc_a_id":"663464","doc_b_id":"2356950","presented_order":["663464","2356950"],"winner_id":"663464","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document A is slightly more relevant because it concerns gene expression and disease outcomes in humans, whereas Document B focuses on neural stem cell regulation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:12.161942Z"}
{"comparison_id":"d84439a3-bbb6-47b1-828d-c994b4e13396","query_id":"51","doc_a_id":"16853734","doc_b_id":"2356950","presented_order":["2356950","16853734"],"winner_id":"16853734","reasoning":"Document B is more relevant — it deals with cancer-related cellular behavior (glioma/MSC migration), whereas A concerns neural stem cell regulation unrelated to cancer or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:12.161964Z"}
{"comparison_id":"873abb15-5c94-4b72-a6ad-8fdd36e6277b","query_id":"51","doc_a_id":"6137330","doc_b_id":"2356950","presented_order":["2356950","6137330"],"winner_id":"2356950","reasoning":"Neither document mentions ALDH1 or breast cancer; however, Document A (neural stem cell regulation) is marginally closer because ALDH1 is a stem‑cell marker, while Document B is about lung nodule management. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:12.161973Z"}
{"comparison_id":"363962b8-86bc-459b-8d80-dd77a7cc6f77","query_id":"51","doc_a_id":"22896384","doc_b_id":"2356950","presented_order":["22896384","2356950"],"winner_id":"2356950","reasoning":"Document B is slightly more relevant because it discusses stem cell regulation (miR-184/MBD1) whereas Document A concerns developmental transcription factors in lung/esophagus and neither mentions ALDH1 or breast cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:12.161982Z"}
{"comparison_id":"7d4a5aa6-4594-4775-b886-d69f024c776c","query_id":"51","doc_a_id":"22478394","doc_b_id":"2356950","presented_order":["2356950","22478394"],"winner_id":"2356950","reasoning":"Document A is slightly more relevant because it discusses molecular regulation of stem-cell-related markers and differentiation (closer conceptually to cancer stem cell markers like ALDH1) whereas Document B focuses on liver PPAR-γ in NAFLD. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:12.161989Z"}
{"comparison_id":"3ab4bddf-9253-404e-959a-eabd3667517f","query_id":"51","doc_a_id":"15803282","doc_b_id":"2356950","presented_order":["2356950","15803282"],"winner_id":"15803282","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer; Document B is slightly more related because it concerns stemness/pluripotency and reprogramming, which is closer to cancer stem cell biology than the neural-development focus of A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:12.161996Z"}
{"comparison_id":"440c5213-fe2d-4a26-975f-57027eeea371","query_id":"51","doc_a_id":"663464","doc_b_id":"16853734","presented_order":["663464","16853734"],"winner_id":"16853734","reasoning":"Document B is more relevant because it concerns cancer-related molecular mechanisms (tumor/MSC migration), whereas A focuses on aging-related microRNA expression and not cancer outcomes. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:16.713053Z"}
{"comparison_id":"f648c2f6-8e09-484a-a6fe-50bc5a008207","query_id":"51","doc_a_id":"15803282","doc_b_id":"16853734","presented_order":["16853734","15803282"],"winner_id":"16853734","reasoning":"Document A — it relates to cancer biology (tumor cell/MSC interactions), whereas Document B concerns SCNT and pluripotency; neither mentions ALDH1 or breast cancer but A is marginally more relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:16.713076Z"}
{"comparison_id":"a07123a4-53ed-4096-80f6-2f29cda879e9","query_id":"51","doc_a_id":"663464","doc_b_id":"15803282","presented_order":["15803282","663464"],"winner_id":"15803282","reasoning":"Document A is slightly more relevant because it discusses factors affecting stem cell properties (ALDH1 is a stem/cancer stem cell marker), whereas Document B concerns circulating microRNAs and aging. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:19.426013Z"}
{"comparison_id":"bca30fe0-a55d-4fd9-bf89-a72ae7bc0fc2","query_id":"51","doc_a_id":"6137330","doc_b_id":"22896384","presented_order":["22896384","6137330"],"winner_id":"6137330","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is slightly more relevant because it concerns cancer diagnosis/management, whereas A addresses developmental transcription factors in lung/esophagus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:29.132091Z"}
{"comparison_id":"5c79b3bf-4c83-45c6-996a-e466c7f4f27a","query_id":"51","doc_a_id":"22478394","doc_b_id":"22896384","presented_order":["22478394","22896384"],"winner_id":"22478394","reasoning":"Document A is slightly more relevant because it reports gene expression changes in a human disease context (liver), whereas Document B focuses on developmental transcription factors in mouse lung/esophagus; neither addresses ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:29.132112Z"}
{"comparison_id":"453c96f1-60e2-423f-9d22-9bdfd5eedf2e","query_id":"51","doc_a_id":"6137330","doc_b_id":"22478394","presented_order":["22478394","6137330"],"winner_id":"6137330","reasoning":"Document B is more relevant because it relates to cancer clinical outcomes/management, whereas Document A concerns liver PPAR-γ expression in obesity and is unrelated to cancer or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:33.575814Z"}
{"comparison_id":"d327a78f-3c4a-448b-a198-e22f71e1a652","query_id":"51","doc_a_id":"1507222","doc_b_id":"13398997","presented_order":["13398997","1507222"],"winner_id":"1507222","reasoning":"Document B is slightly more relevant because it concerns cancer-related gene expression, whereas Document A is about transplant immunology and Th17 cells, unrelated to ALDH1 or breast cancer.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:36.921719Z"}
{"comparison_id":"78d16a92-8409-4436-a3c1-423d99670218","query_id":"51","doc_a_id":"23509593","doc_b_id":"3621011","presented_order":["3621011","23509593"],"winner_id":"3621011","reasoning":"Neither document mentions ALDH1 or breast cancer. Both are irrelevant; Document A is marginally more related to human tissue biology (adipose) versus B's prostate-specific signaling. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:49.214354Z"}
{"comparison_id":"1cc13b16-43aa-4252-8f48-6c5b10c25965","query_id":"51","doc_a_id":"14938990","doc_b_id":"3621011","presented_order":["14938990","3621011"],"winner_id":"14938990","reasoning":"Document A is more relevant — it discusses expression of a biomarker associated with disease activity/outcomes, whereas Document B concerns adipocyte differentiation and metabolic effects, unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:49.214378Z"}
{"comparison_id":"51e679e0-b5d2-445a-9df2-0ad7836d353d","query_id":"51","doc_a_id":"3052213","doc_b_id":"3621011","presented_order":["3052213","3621011"],"winner_id":"3052213","reasoning":"Neither document mentions ALDH1 or breast cancer, but Document A (genome-wide profiling of acetylation and transcription factor binding) is marginally more relevant because it relates to gene expression regulation. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:49.214388Z"}
{"comparison_id":"f9eb8980-275d-46ac-ba1c-6f66a28ddcd7","query_id":"51","doc_a_id":"5278233","doc_b_id":"3621011","presented_order":["3621011","5278233"],"winner_id":"5278233","reasoning":"Neither document discusses ALDH1 or breast cancer. Document B (epigenetic control of gene expression) is marginally more related to gene-expression topics than A (adipocyte differentiation), so B is slightly more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:49.214398Z"}
{"comparison_id":"4ad4f536-6967-48d8-824b-12befdf3a8e2","query_id":"51","doc_a_id":"43334921","doc_b_id":"3621011","presented_order":["3621011","43334921"],"winner_id":"43334921","reasoning":"Document B is more relevant — it addresses cancer outcomes (though colorectal) and thus is closer to the query about cancer biomarkers than Document A, which concerns adipocyte biology and obesity.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:49.214407Z"}
{"comparison_id":"76bb4924-7d06-47c3-9992-703a335f4596","query_id":"51","doc_a_id":"12903921","doc_b_id":"3621011","presented_order":["3621011","12903921"],"winner_id":"3621011","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes; both are irrelevant. Document A is slightly more relevant only because it involves human tissue biology rather than a rat leukemia model.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:49.214416Z"}
{"comparison_id":"7d26b44d-5a5b-4dff-a524-9d2e848a432b","query_id":"51","doc_a_id":"15928989","doc_b_id":"3621011","presented_order":["15928989","3621011"],"winner_id":"15928989","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant to the claim. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:49.214423Z"}
{"comparison_id":"f9f4c369-73df-4e49-b2fc-56805d97a882","query_id":"51","doc_a_id":"23286603","doc_b_id":"3621011","presented_order":["23286603","3621011"],"winner_id":"23286603","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it addresses gene regulation and a protein (PARP‑1) implicated in cancer biology, whereas Document B focuses on adipocyte differentiation and metabolism.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:49.214432Z"}
{"comparison_id":"1a1c6630-0e77-41b2-a755-66d17855a997","query_id":"51","doc_a_id":"4434951","doc_b_id":"3621011","presented_order":["4434951","3621011"],"winner_id":"4434951","reasoning":"Document A is slightly more relevant because it deals with gene regulatory and epigenetic changes affecting gene expression, whereas Document B concerns adipocyte biology unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:49.214441Z"}
{"comparison_id":"2bc2eded-1c8a-4f08-825f-239e9e4baa92","query_id":"51","doc_a_id":"4795303","doc_b_id":"3621011","presented_order":["3621011","4795303"],"winner_id":"3621011","reasoning":"Reason: Neither abstract mentions ALDH1 or breast cancer, but Document A deals with human tissue expression and disease outcomes (closer in scope) while Document B concerns neuroprotection in PC12 cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:49.214449Z"}
{"comparison_id":"3970e2c4-3ada-43c5-a47e-89b3bd4f8935","query_id":"51","doc_a_id":"19427410","doc_b_id":"3621011","presented_order":["3621011","19427410"],"winner_id":"19427410","reasoning":"Neither document mentions ALDH1 or breast cancer, so both are irrelevant. Between them, B is slightly more related to cancer-relevant biology (immune signaling) than A. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:49.214457Z"}
{"comparison_id":"3e7dad3f-2539-4f35-aa0b-39288e8a0d4f","query_id":"51","doc_a_id":"20659283","doc_b_id":"3621011","presented_order":["3621011","20659283"],"winner_id":"20659283","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are irrelevant, but B is marginally more relevant because it concerns regulation of human gene expression. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:49.214465Z"}
{"comparison_id":"bb954667-13b5-4cf0-b31e-0199fb43f683","query_id":"51","doc_a_id":"14972169","doc_b_id":"3621011","presented_order":["3621011","14972169"],"winner_id":"3621011","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it concerns human tissue biology (vs. embryonic mouse oxidative stress), but neither provides evidence for the claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:49.214474Z"}
{"comparison_id":"81b001b3-fa51-46d0-90b7-1eff4fb65a17","query_id":"51","doc_a_id":"21372171","doc_b_id":"3621011","presented_order":["3621011","21372171"],"winner_id":"3621011","reasoning":"Neither paper addresses ALDH1 or breast cancer outcomes. Document A is marginally more relevant because it deals with molecular expression in human tissues, whereas B focuses on HMGB1 in peripheral artery disease. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:49.214482Z"}
{"comparison_id":"7be8384a-5b7c-4674-ba62-1c37ead98daf","query_id":"51","doc_a_id":"38025907","doc_b_id":"3621011","presented_order":["3621011","38025907"],"winner_id":"3621011","reasoning":"Neither document discusses ALDH1 or breast cancer, so both are irrelevant. Document A is marginally more relevant because it involves human tissue differentiation broadly, whereas B focuses on engineered FGF19 in liver disease. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:49.214489Z"}
{"comparison_id":"295c9f81-cd0b-4aa6-96f7-345c26dcfb68","query_id":"51","doc_a_id":"24586989","doc_b_id":"3621011","presented_order":["3621011","24586989"],"winner_id":"3621011","reasoning":"Document A is slightly more relevant because it discusses tissue-level expression and disease outcomes (adipose biology), whereas Document B is specific to heart failure genetics and unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:49.214497Z"}
{"comparison_id":"0209fdbc-63b4-4d0d-9429-23504ef8161b","query_id":"51","doc_a_id":"1871499","doc_b_id":"3621011","presented_order":["3621011","1871499"],"winner_id":"3621011","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it addresses protein expression and disease-related tissue outcomes, whereas Document B focuses on epigenetic changes in Huntington's disease brain tissue. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:49.214506Z"}
{"comparison_id":"2cfd995a-88b8-48c0-9b1c-3b1343343c4b","query_id":"51","doc_a_id":"28390999","doc_b_id":"3621011","presented_order":["28390999","3621011"],"winner_id":"28390999","reasoning":"Document A is slightly more relevant because it discusses gene expression patterns (though in a different tissue/species), whereas Document B concerns adipocyte biology unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:49.214514Z"}
{"comparison_id":"3f8961be-84cb-4913-8313-3a6e3156aea2","query_id":"51","doc_a_id":"38028419","doc_b_id":"3621011","presented_order":["3621011","38028419"],"winner_id":"3621011","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is slightly more relevant because it discusses gene/protein expression and cell differentiation, which is closer to biomarker–outcome relationships than the liver-focused study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:49.214522Z"}
{"comparison_id":"cf58d313-ab2a-49c5-9692-a772cd5ba193","query_id":"51","doc_a_id":"14938990","doc_b_id":"15928989","presented_order":["14938990","15928989"],"winner_id":"14938990","reasoning":"Document A is more relevant because it discusses expression of a biomarker (PD-1) and its association with disease outcomes, which is closer in topic to ALDH1 expression and breast cancer prognosis than the pregnancy-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:54.498888Z"}
{"comparison_id":"debe8544-25fe-43c2-b069-7f3005d78422","query_id":"51","doc_a_id":"3052213","doc_b_id":"15928989","presented_order":["3052213","15928989"],"winner_id":"3052213","reasoning":"Document A is slightly more relevant because it deals with gene expression and transcriptional profiling (closer to ALDH1 expression) whereas Document B focuses on reproductive biology unrelated to ALDH1 or cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:54.498908Z"}
{"comparison_id":"c29065e9-eb3f-4c29-abd7-c7f2f9d5bea1","query_id":"51","doc_a_id":"5278233","doc_b_id":"15928989","presented_order":["5278233","15928989"],"winner_id":"5278233","reasoning":"Document A is slightly more relevant — it discusses epigenetic changes and imprinting linked to cancer biology, whereas Document B is about pregnancy biology and unrelated to breast cancer or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:54.498918Z"}
{"comparison_id":"1eeb4656-7dc2-4574-8f7a-a794f6b2318e","query_id":"51","doc_a_id":"43334921","doc_b_id":"15928989","presented_order":["43334921","15928989"],"winner_id":"43334921","reasoning":"Document A is cancer-related (though colorectal, not breast) and thus more relevant than Document B, which concerns pregnancy biology unrelated to cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:54.498925Z"}
{"comparison_id":"32c0ca15-7f7d-412d-aa6d-c8e68c8db732","query_id":"51","doc_a_id":"28390999","doc_b_id":"15928989","presented_order":["15928989","28390999"],"winner_id":"28390999","reasoning":"Document B — it discusses gene expression patterns (closer to the claim about ALDH1 expression), whereas A addresses Lrh-1 in pregnancy and not gene expression in cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:54.498932Z"}
{"comparison_id":"342e81bc-2520-4006-93ed-d2020beb3b10","query_id":"51","doc_a_id":"23286603","doc_b_id":"15928989","presented_order":["23286603","15928989"],"winner_id":"23286603","reasoning":"Document A — it at least discusses gene regulation and disease-relevant pathways, whereas Document B is about reproductive biology and pregnancy. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:54.498939Z"}
{"comparison_id":"5dff0612-9667-44c1-b188-923de8f8da15","query_id":"51","doc_a_id":"4434951","doc_b_id":"15928989","presented_order":["4434951","15928989"],"winner_id":"4434951","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document A (epigenetic regulation in mice) is marginally closer to gene-expression and disease-outcome topics than the pregnancy-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:54.498946Z"}
{"comparison_id":"b8dd800f-fc77-471d-9bda-eaf5cd39b74d","query_id":"51","doc_a_id":"19427410","doc_b_id":"15928989","presented_order":["19427410","15928989"],"winner_id":"19427410","reasoning":"Document A is slightly more relevant — it discusses gene expression in human tissues (adipocytes), whereas Document B concerns a reproductive nuclear receptor in mice; neither addresses ALDH1 or breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:54.498953Z"}
{"comparison_id":"c9fbc522-2d28-4cfc-bc01-272a4b8a6a36","query_id":"51","doc_a_id":"20659283","doc_b_id":"15928989","presented_order":["20659283","15928989"],"winner_id":"20659283","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it concerns gene expression regulation, whereas B focuses on pregnancy/ovarian function. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:25:54.498959Z"}
{"comparison_id":"18f6fbc7-2d28-4948-ac5e-e04553bd8731","query_id":"51","doc_a_id":"14938990","doc_b_id":"28390999","presented_order":["28390999","14938990"],"winner_id":"14938990","reasoning":"Neither document mentions ALDH1 or breast cancer. Document B is slightly more relevant because it deals with human disease and gene expression as a biomarker, whereas A is about chicken gonad development. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:01.239891Z"}
{"comparison_id":"e36d6731-3867-485e-9c53-529a88638e52","query_id":"51","doc_a_id":"3052213","doc_b_id":"28390999","presented_order":["28390999","3052213"],"winner_id":"3052213","reasoning":"Document B — it concerns human gene regulation (adipocytes) and is marginally closer to human cancer-related gene expression than chicken gonadogenesis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:01.239913Z"}
{"comparison_id":"883897a5-e039-4d98-8c1f-05709cf77beb","query_id":"51","doc_a_id":"5278233","doc_b_id":"28390999","presented_order":["5278233","28390999"],"winner_id":"5278233","reasoning":"Document A is slightly more relevant because it relates to human disease and cancer-related epigenetics, whereas Document B concerns gene expression in chicken gonad development. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:01.239922Z"}
{"comparison_id":"431946cb-24fc-45ce-80de-b617bd685931","query_id":"51","doc_a_id":"43334921","doc_b_id":"28390999","presented_order":["43334921","28390999"],"winner_id":"28390999","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. Document B is slightly more related because it addresses gene expression (though in chicken gonadogenesis, not breast cancer).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:01.239929Z"}
{"comparison_id":"0e51a51d-aeef-4df1-8231-1d6faf47b49b","query_id":"51","doc_a_id":"20659283","doc_b_id":"28390999","presented_order":["28390999","20659283"],"winner_id":"20659283","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes; both are irrelevant. Document B is slightly more relevant only because it concerns human gene regulation, whereas A is about chicken gonad development.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:01.239937Z"}
{"comparison_id":"dd008082-0a8e-4a76-9ec4-d1b158c6c145","query_id":"51","doc_a_id":"23286603","doc_b_id":"28390999","presented_order":["28390999","23286603"],"winner_id":"28390999","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it concerns gene expression (though in chicken gonadogenesis), while B focuses on macrophage cholesterol metabolism. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:01.239944Z"}
{"comparison_id":"7e54941d-0649-4a5c-a698-a4b6415a4b51","query_id":"51","doc_a_id":"4434951","doc_b_id":"28390999","presented_order":["4434951","28390999"],"winner_id":"4434951","reasoning":"Document A is marginally more relevant — neither discusses ALDH1 or breast cancer, but A (mouse epigenetics/aging) is closer in biological context than chicken gonadogenesis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:01.239951Z"}
{"comparison_id":"11d07436-884e-4eff-89b1-acafa54218e2","query_id":"51","doc_a_id":"19427410","doc_b_id":"28390999","presented_order":["19427410","28390999"],"winner_id":"19427410","reasoning":"Document A is slightly more relevant because it reports human gene expression data (though not about ALDH1 or breast cancer), whereas B is about chicken embryonic gonad genes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:01.239959Z"}
{"comparison_id":"ed8a34e4-cc17-4b12-8370-4a07231451a7","query_id":"51","doc_a_id":"14938990","doc_b_id":"5278233","presented_order":["5278233","14938990"],"winner_id":"5278233","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant because it concerns gene expression/epigenetic regulation, whereas B focuses on PD-1 in SLE.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:07.989486Z"}
{"comparison_id":"1c50f18b-f022-4d3b-bb98-120625b5f401","query_id":"51","doc_a_id":"3052213","doc_b_id":"5278233","presented_order":["5278233","3052213"],"winner_id":"5278233","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it deals with gene expression and epigenetic regulation, whereas B focuses on adipocytes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:07.989507Z"}
{"comparison_id":"16166d27-b1fd-4d7b-8c5e-1ed66fc1cca7","query_id":"51","doc_a_id":"19427410","doc_b_id":"5278233","presented_order":["5278233","19427410"],"winner_id":"5278233","reasoning":"Document A is marginally more relevant because it discusses gene expression and epigenetic changes linked to cancer-related pathways (IGF2), whereas Document B focuses on IL-33 in adipocytes unrelated to ALDH1 or breast cancer.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:07.989516Z"}
{"comparison_id":"ca0d3d9c-78bf-4591-9019-45f90771cd1d","query_id":"51","doc_a_id":"20659283","doc_b_id":"5278233","presented_order":["5278233","20659283"],"winner_id":"20659283","reasoning":"Document B is slightly more relevant because it concerns regulation of human gene expression, whereas Document A deals with imprinting in Beckwith-Wiedemann syndrome and is unrelated to ALDH1 or breast cancer.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:07.989523Z"}
{"comparison_id":"709264c5-5482-4e77-9ba1-34087655e37f","query_id":"51","doc_a_id":"4434951","doc_b_id":"5278233","presented_order":["4434951","5278233"],"winner_id":"4434951","reasoning":"Document A is slightly more relevant — it addresses gene-regulatory epigenetic changes that could relate to gene expression patterns (whereas B concerns imprinting in Beckwith–Wiedemann syndrome, unrelated to ALDH1/breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:07.989534Z"}
{"comparison_id":"e125193b-0baf-4df0-a221-33480f8a59df","query_id":"51","doc_a_id":"20659283","doc_b_id":"4434951","presented_order":["4434951","20659283"],"winner_id":"4434951","reasoning":"Neither document addresses ALDH1 or breast cancer; however, Document A (epigenetic regulation at gene regulatory regions) is slightly more related to gene-expression/outcomes than Document B (CYP3A/PXR drug-metabolism study). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:13.055433Z"}
{"comparison_id":"c7b27d9b-a210-47c8-84f8-2473b36f3265","query_id":"51","doc_a_id":"14938990","doc_b_id":"3052213","presented_order":["3052213","14938990"],"winner_id":"3052213","reasoning":"Document A is slightly more related because it addresses gene expression and transcriptional profiling, whereas Document B is focused on PD-1 and lupus (unrelated to ALDH1 or breast cancer). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:18.277025Z"}
{"comparison_id":"9ea6498c-8c12-4a92-ad28-442357766f2a","query_id":"51","doc_a_id":"19427410","doc_b_id":"3052213","presented_order":["3052213","19427410"],"winner_id":"3052213","reasoning":"Document A is slightly more relevant because it involves genome-wide profiling of gene regulation and expression, which is closer to a claim about expression of a specific gene (ALDH1) and outcomes than a study focused narrowly on IL-33 in adipocytes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:18.277050Z"}
{"comparison_id":"d383c523-5d7e-4f98-9e4a-c2b4e2e28256","query_id":"51","doc_a_id":"14938990","doc_b_id":"19427410","presented_order":["19427410","14938990"],"winner_id":"19427410","reasoning":"Document A is slightly more relevant — both are unrelated to ALDH1 or breast cancer, but A discusses gene expression in human tissues (whereas B focuses on PD-1 in SLE).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:22.221751Z"}
{"comparison_id":"fcbed190-4e0f-473b-ad95-51157f70346d","query_id":"51","doc_a_id":"43334921","doc_b_id":"23286603","presented_order":["43334921","23286603"],"winner_id":"43334921","reasoning":"Document A is more relevant — it deals with cancer (colorectal), while Document B addresses macrophage cholesterol regulation/atherosclerosis and is unrelated to cancer biomarkers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:25.223028Z"}
{"comparison_id":"ef6e72ae-4e25-457a-a1eb-2781ab24563e","query_id":"51","doc_a_id":"23509593","doc_b_id":"21372171","presented_order":["21372171","23509593"],"winner_id":"23509593","reasoning":"Document B is more relevant — it relates to cancer and gene expression regulation, whereas Document A deals with peripheral artery disease and HMGB1, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:37.271942Z"}
{"comparison_id":"8be45ea0-4612-4448-a2bb-b36695a6a65e","query_id":"51","doc_a_id":"12903921","doc_b_id":"21372171","presented_order":["21372171","12903921"],"winner_id":"21372171","reasoning":"Neither document addresses ALDH1 or breast cancer, but Document A (human biomarker study) is marginally more related to biomarker expression than Document B (rat leukemia/behavior).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:37.271963Z"}
{"comparison_id":"444c4d6e-3b21-4d82-b035-0b21d899d12e","query_id":"51","doc_a_id":"4795303","doc_b_id":"21372171","presented_order":["21372171","4795303"],"winner_id":"21372171","reasoning":"Neither document addresses ALDH1 or breast cancer; Document A is slightly more relevant only because it concerns a biomarker study (whereas B is a neuroprotection/cell-stress study). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:37.271972Z"}
{"comparison_id":"79661f5f-ca6b-4398-8738-a7f244bfad00","query_id":"51","doc_a_id":"14972169","doc_b_id":"21372171","presented_order":["21372171","14972169"],"winner_id":"21372171","reasoning":"Document A is more relevant — it deals with a protein biomarker and clinical outcome associations (similar topic area), while B is an embryonic oxidative-stress study unrelated to cancer or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:37.271979Z"}
{"comparison_id":"89042df9-f573-469f-a1d6-794a48582da7","query_id":"51","doc_a_id":"38028419","doc_b_id":"21372171","presented_order":["38028419","21372171"],"winner_id":"38028419","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document A is marginally more relevant as it concerns molecular pathology in a disease model. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:37.271986Z"}
{"comparison_id":"f09e8112-bf2f-48ea-8311-a8b3b895186d","query_id":"51","doc_a_id":"38025907","doc_b_id":"21372171","presented_order":["21372171","38025907"],"winner_id":"38025907","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document B at least discusses tumorigenesis and cancer-related outcomes, making it marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:37.271993Z"}
{"comparison_id":"06457c30-426c-40c2-b44c-aaeb3b10d4b8","query_id":"51","doc_a_id":"24586989","doc_b_id":"21372171","presented_order":["24586989","21372171"],"winner_id":"21372171","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is marginally more relevant because it deals with a biomarker study (whereas A focuses on adrenergic polymorphisms in heart failure).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:37.272000Z"}
{"comparison_id":"5d741ad3-978c-4cb8-81e6-b288ccc5a818","query_id":"51","doc_a_id":"1871499","doc_b_id":"21372171","presented_order":["1871499","21372171"],"winner_id":"1871499","reasoning":"Neither document is relevant — neither mentions ALDH1 or breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:37.272006Z"}
{"comparison_id":"1b281964-66e8-4c1c-b428-341b7aa1dbea","query_id":"51","doc_a_id":"23509593","doc_b_id":"38028419","presented_order":["23509593","38028419"],"winner_id":"23509593","reasoning":"Both documents are irrelevant to ALDH1 expression in breast cancer; Document A is marginally closer since it concerns cancer-related regulation (prostate), whereas B is about alcoholic fatty liver disease.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:42.067952Z"}
{"comparison_id":"701146ea-5b31-4ab5-9336-a74929da1104","query_id":"51","doc_a_id":"1871499","doc_b_id":"38028419","presented_order":["1871499","38028419"],"winner_id":"38028419","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes; both are irrelevant. Document B is marginally more relevant only because it involves disease-related metabolic pathways, whereas A focuses on Huntington's epigenetics.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:42.067976Z"}
{"comparison_id":"094fc4d8-6948-443e-b0ff-266881646b53","query_id":"51","doc_a_id":"38025907","doc_b_id":"38028419","presented_order":["38025907","38028419"],"winner_id":"38025907","reasoning":"Both documents are irrelevant to ALDH1 and breast cancer, but Document A at least mentions tumorigenesis, so it is slightly more related.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:42.067986Z"}
{"comparison_id":"0af25ea5-d952-48d6-8c41-4dd4307a91a1","query_id":"51","doc_a_id":"23509593","doc_b_id":"38025907","presented_order":["38025907","23509593"],"winner_id":"23509593","reasoning":"Reason: Neither document mentions ALDH1 or breast cancer, so neither provides direct evidence; Document B is about cancer-related signaling (prostate) and is slightly more related to oncology than Document A (liver disease).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:46.372977Z"}
{"comparison_id":"94f1ff19-3579-45e2-b080-48e3f5d2448c","query_id":"51","doc_a_id":"12903921","doc_b_id":"4795303","presented_order":["4795303","12903921"],"winner_id":"12903921","reasoning":"Document B — it involves cancer (leukemia) and biomarkers/oxidative stress, which is closer to a cancer-outcomes biomarker question than a neuroprotective PC12 cell study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:51.783741Z"}
{"comparison_id":"9e199f12-ca9a-480a-8900-e782412441d5","query_id":"51","doc_a_id":"24586989","doc_b_id":"4795303","presented_order":["4795303","24586989"],"winner_id":"4795303","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it involves protein expression and cellular outcomes, whereas B concerns beta‑adrenergic polymorphisms in heart failure.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:51.783762Z"}
{"comparison_id":"6cc7af7c-7f6c-4739-b6ca-47c769e055cf","query_id":"51","doc_a_id":"14972169","doc_b_id":"4795303","presented_order":["4795303","14972169"],"winner_id":"14972169","reasoning":"Document B is slightly more relevant — it discusses 4-HNE (an aldehyde)–protein adducts and oxidative damage, which is tangentially related to aldehyde metabolism. Neither document addresses ALDH1 or breast cancer outcomes directly.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:51.783770Z"}
{"comparison_id":"95b5eed5-fd98-4f54-8e24-710a143de09d","query_id":"51","doc_a_id":"12903921","doc_b_id":"14972169","presented_order":["14972169","12903921"],"winner_id":"12903921","reasoning":"Document B is more relevant — it addresses cancer and oxidative stress (closer in topic to ALDH1's role in cancer outcomes) while A concerns embryonic oxidative effects unrelated to cancer. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:26:56.582063Z"}
{"comparison_id":"48f70f0a-4d02-44fc-8e12-87bd034545d5","query_id":"51","doc_a_id":"26079071","doc_b_id":"33740844","presented_order":["33740844","26079071"],"winner_id":"26079071","reasoning":"Document B is marginally more relevant because it discusses cancer and molecular markers, whereas Document A concerns pregnancy nutrition. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:06.319317Z"}
{"comparison_id":"8f256c42-11e4-4bf2-9cd7-22f83901cc0d","query_id":"51","doc_a_id":"26488879","doc_b_id":"33740844","presented_order":["33740844","26488879"],"winner_id":"33740844","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is slightly more relevant to human health outcomes (maternal/infant), so choose A.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:06.319338Z"}
{"comparison_id":"7b0d8fdb-a856-4ff0-a25f-751d6fe6cb72","query_id":"51","doc_a_id":"3619931","doc_b_id":"33740844","presented_order":["33740844","3619931"],"winner_id":"3619931","reasoning":"Document B is marginally more relevant because it's a biomedical, mechanistic study (even though neither document mentions ALDH1 or breast cancer). \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:06.319346Z"}
{"comparison_id":"e37c4852-4778-48f4-8371-c80e69f49590","query_id":"51","doc_a_id":"24323369","doc_b_id":"33740844","presented_order":["33740844","24323369"],"winner_id":"33740844","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is marginally more relevant because it addresses women's health outcomes, while Document B focuses on ovulation induction in PCOS. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:06.319354Z"}
{"comparison_id":"76664674-00a0-4362-a58a-2ac05eacd646","query_id":"51","doc_a_id":"24783597","doc_b_id":"33740844","presented_order":["24783597","33740844"],"winner_id":"24783597","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it deals with molecular expression in a disease context, whereas B is about nutrition and pregnancy. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:06.319361Z"}
{"comparison_id":"89a71341-ade0-4176-aef2-6e76fd3a3ca3","query_id":"51","doc_a_id":"5691302","doc_b_id":"33740844","presented_order":["5691302","33740844"],"winner_id":"33740844","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is marginally more relevant only because it concerns women's health outcomes; A is about antidepressants in older adults.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:06.319368Z"}
{"comparison_id":"28a85d59-c13f-46e2-b7f0-7103fa997b7e","query_id":"51","doc_a_id":"21602220","doc_b_id":"33740844","presented_order":["21602220","33740844"],"winner_id":"33740844","reasoning":"Document B is marginally more relevant because it concerns human health and clinical outcomes, whereas Document A is about microbial fermentation unrelated to cancer. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:06.319375Z"}
{"comparison_id":"1e8688d1-af61-46ee-9ab5-5991171cd8ef","query_id":"51","doc_a_id":"6290112","doc_b_id":"33740844","presented_order":["6290112","33740844"],"winner_id":"6290112","reasoning":"Document A is slightly more relevant because it concerns gene copy number and expression, whereas Document B discusses nutrition and pregnancy with no relation to gene expression or breast cancer. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:06.319382Z"}
{"comparison_id":"8f7ce496-e311-48c0-961a-7eab96fcbe73","query_id":"51","doc_a_id":"3202143","doc_b_id":"33740844","presented_order":["3202143","33740844"],"winner_id":"3202143","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it involves gene expression and biological outcomes (though in C. elegans), whereas Document B focuses on maternal/infant nutrition. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:06.319389Z"}
{"comparison_id":"a69da81a-c280-47c3-bdc3-5f898b1e5da5","query_id":"51","doc_a_id":"17973161","doc_b_id":"33740844","presented_order":["17973161","33740844"],"winner_id":"17973161","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document A is slightly more relevant as it deals with cellular marker expression and human tissue biology versus nutrition outcomes in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:06.319395Z"}
{"comparison_id":"10951d55-2716-45b7-8e82-005745527d5c","query_id":"51","doc_a_id":"6766459","doc_b_id":"33740844","presented_order":["33740844","6766459"],"winner_id":"6766459","reasoning":"Neither document addresses ALDH1 or breast cancer. Document B is slightly more relevant because it discusses molecular gene regulation, whereas A is about prenatal nutrition. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:06.319402Z"}
{"comparison_id":"0333d248-26ac-46f1-806d-04dd00995859","query_id":"51","doc_a_id":"25725663","doc_b_id":"33740844","presented_order":["25725663","33740844"],"winner_id":"25725663","reasoning":"Document A is slightly more relevant because it discusses molecular/cellular pathways, whereas Document B is about maternal nutrition and pregnancy outcomes; neither addresses ALDH1 or breast cancer directly.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:06.319410Z"}
{"comparison_id":"1065e394-5805-43a2-a6fa-ca2fb17d6914","query_id":"51","doc_a_id":"32372280","doc_b_id":"33740844","presented_order":["32372280","33740844"],"winner_id":"32372280","reasoning":"Document A is slightly more relevant because it discusses gene expression (though in glaucoma), whereas Document B concerns nutrition in pregnancy and is unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:06.319417Z"}
{"comparison_id":"d8bcf20c-9a56-4f01-bd45-b726c68fde1a","query_id":"51","doc_a_id":"8417211","doc_b_id":"33740844","presented_order":["33740844","8417211"],"winner_id":"8417211","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer; Document B is at least molecular/ protein-focused, closer to gene-expression biology than a pregnancy nutrition review.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:06.319424Z"}
{"comparison_id":"5d9972ba-6772-4990-badf-956b989c3aff","query_id":"51","doc_a_id":"4641348","doc_b_id":"33740844","presented_order":["4641348","33740844"],"winner_id":"4641348","reasoning":"Neither document discusses ALDH1 or breast cancer. Both are irrelevant; Document A is slightly closer (biomedical, gene-related) but still not about ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:06.319431Z"}
{"comparison_id":"c03a6110-6283-4c94-b207-adf010c1980b","query_id":"51","doc_a_id":"22483580","doc_b_id":"33740844","presented_order":["33740844","22483580"],"winner_id":"33740844","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A is slightly more related to women's health outcomes (though not cancer), so it's marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:06.319437Z"}
{"comparison_id":"ca88754c-a9ec-4890-a2e7-77021b549b43","query_id":"51","doc_a_id":"8842332","doc_b_id":"33740844","presented_order":["33740844","8842332"],"winner_id":"33740844","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. DOCUMENT A is chosen (still not relevant).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:06.319444Z"}
{"comparison_id":"eb15ff5d-b2b6-444c-b274-4fa911acf51a","query_id":"51","doc_a_id":"26079071","doc_b_id":"17973161","presented_order":["26079071","17973161"],"winner_id":"26079071","reasoning":"Document A is more relevant — it's about cancer treatment and outcomes (albeit in NSCLC), whereas Document B concerns adipocytes and metabolic homeostasis, unrelated to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:12.162544Z"}
{"comparison_id":"8823192a-f68b-4d03-b1fd-bee592e32c96","query_id":"51","doc_a_id":"3619931","doc_b_id":"17973161","presented_order":["17973161","3619931"],"winner_id":"17973161","reasoning":"Neither abstract addresses ALDH1 or breast cancer directly; Document A is marginally more relevant because it concerns adipocyte biology and systemic metabolic factors that can influence cancer outcomes. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:12.162564Z"}
{"comparison_id":"de45a15e-fedb-4bf1-9358-b00e1714721f","query_id":"51","doc_a_id":"24783597","doc_b_id":"17973161","presented_order":["24783597","17973161"],"winner_id":"24783597","reasoning":"Document A is more relevant — it discusses gene expression correlated with disease activity, which is conceptually closer to a claim about marker expression and clinical outcomes than Document B's metabolic/adipocyte focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:12.162573Z"}
{"comparison_id":"681bf7ea-bd0f-4c36-a143-92cd16f33f0b","query_id":"51","doc_a_id":"6290112","doc_b_id":"17973161","presented_order":["17973161","6290112"],"winner_id":"17973161","reasoning":"Reason: Neither document addresses ALDH1 or breast cancer, but Document A discusses gene expression in human cells (adipocytes), making it marginally closer in topic than the genetics-of-obesity focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:12.162580Z"}
{"comparison_id":"140b9aea-d015-4eca-89d3-bcca683e3bc2","query_id":"51","doc_a_id":"3202143","doc_b_id":"17973161","presented_order":["17973161","3202143"],"winner_id":"17973161","reasoning":"Brief reason: Neither document discusses ALDH1 or breast cancer, but Document A (human adipocytes/metabolic study) is marginally closer to human disease biology than Document B (C. elegans memory/aging), so A is more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:12.162588Z"}
{"comparison_id":"aa8c4419-99dd-4023-a5f7-ed42a8295b25","query_id":"51","doc_a_id":"4641348","doc_b_id":"17973161","presented_order":["17973161","4641348"],"winner_id":"17973161","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes; both are irrelevant. If forced to choose, A is slightly more related to human cell biology. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:12.162595Z"}
{"comparison_id":"d5ffe6e3-010a-4d50-a727-1c9c4a3576c7","query_id":"51","doc_a_id":"6766459","doc_b_id":"17973161","presented_order":["6766459","17973161"],"winner_id":"6766459","reasoning":"Document A is slightly more relevant because it deals with gene expression and regulatory molecules (RBM3/miRNAs) that are more closely related to cancer biology than a study on adipocyte metabolism. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:12.162602Z"}
{"comparison_id":"6ac04a2f-53fe-4028-9e61-aa87b9772933","query_id":"51","doc_a_id":"25725663","doc_b_id":"17973161","presented_order":["25725663","17973161"],"winner_id":"25725663","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A is marginally more related because it studies human epithelial cell biology and cellular pathways, which is closer to cancer biology than adipocyte metabolic studies.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:12.162609Z"}
{"comparison_id":"da40640b-ee70-418c-a740-dc9497185524","query_id":"51","doc_a_id":"32372280","doc_b_id":"17973161","presented_order":["17973161","32372280"],"winner_id":"17973161","reasoning":"Neither document mentions ALDH1 or breast cancer. Document A is slightly more related (general metabolic/tissue biology) while B is specific to glaucoma/optineurin. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:12.162615Z"}
{"comparison_id":"2bf5ba49-6ba3-4997-9ac1-947d6f943617","query_id":"51","doc_a_id":"8417211","doc_b_id":"17973161","presented_order":["17973161","8417211"],"winner_id":"17973161","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes; both are irrelevant. Document A is slightly closer (human adipocyte biology) than Document B (Drosophila HP1 phosphorylation).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:12.162622Z"}
{"comparison_id":"ec727e00-9f14-4666-8fa5-280c75b429fa","query_id":"51","doc_a_id":"26079071","doc_b_id":"24783597","presented_order":["26079071","24783597"],"winner_id":"26079071","reasoning":"Document A is more relevant because it discusses cancer biomarkers/treatment (though in NSCLC), whereas Document B focuses on IBD and is unrelated to cancer or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:18.006533Z"}
{"comparison_id":"82b53758-8fae-4a9f-8105-2306c8512da6","query_id":"51","doc_a_id":"25725663","doc_b_id":"24783597","presented_order":["25725663","24783597"],"winner_id":"25725663","reasoning":"Neither document discusses ALDH1 or breast cancer outcomes; both are irrelevant. Document A is slightly closer (cell biology/molecular pathway focus), so:\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:18.006553Z"}
{"comparison_id":"652a47f3-7cba-47a0-b562-138356a2b36d","query_id":"51","doc_a_id":"6766459","doc_b_id":"24783597","presented_order":["24783597","6766459"],"winner_id":"6766459","reasoning":"Neither document addresses ALDH1 or breast cancer outcomes; both are irrelevant. Document B is marginally closer (gene expression regulation) but still not relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:18.006561Z"}
{"comparison_id":"ec78e014-8c53-4655-b960-00c7de1de760","query_id":"51","doc_a_id":"26079071","doc_b_id":"25725663","presented_order":["26079071","25725663"],"winner_id":"26079071","reasoning":"Document A is slightly more relevant because it addresses cancer outcomes (although in NSCLC, not breast cancer), whereas Document B concerns oxidative-stress protection in bronchial cells.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:23.782761Z"}
{"comparison_id":"3f06ccd0-3bd7-41ed-a4f9-1e6bbb466986","query_id":"51","doc_a_id":"6766459","doc_b_id":"25725663","presented_order":["6766459","25725663"],"winner_id":"6766459","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document A is marginally closer (discusses gene expression regulation), so:\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:23.782781Z"}
{"comparison_id":"c2a87344-eac4-4d25-8728-a7ae795325c8","query_id":"51","doc_a_id":"26079071","doc_b_id":"6766459","presented_order":["26079071","6766459"],"winner_id":"26079071","reasoning":"Document A is slightly more relevant because it discusses cancer (though lung cancer), whereas Document B concerns fever regulation and immune microRNAs unrelated to ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:27.263530Z"}
{"comparison_id":"4e478f43-f908-4228-9686-601b3d731ff0","query_id":"51","doc_a_id":"3619931","doc_b_id":"3202143","presented_order":["3202143","3619931"],"winner_id":"3202143","reasoning":"Neither document addresses ALDH1 or breast cancer; both are irrelevant. Document A is slightly more related conceptually (gene expression linked to outcomes), so it's marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:33.265850Z"}
{"comparison_id":"47febdbf-2c8c-445e-93b6-39bbcba7a3e3","query_id":"51","doc_a_id":"6290112","doc_b_id":"3202143","presented_order":["6290112","3202143"],"winner_id":"6290112","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is marginally more relevant because it concerns human gene copy number and disease association, whereas B is a C. elegans memory/aging study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:33.265872Z"}
{"comparison_id":"7000706b-cfbe-4ca8-b201-0377af9be6c7","query_id":"51","doc_a_id":"8417211","doc_b_id":"3202143","presented_order":["3202143","8417211"],"winner_id":"3202143","reasoning":"Neither document addresses ALDH1 or breast cancer. Document A is slightly more relevant because it discusses gene expression and aging, whereas Document B focuses on Drosophila HP1 phosphorylation unrelated to cancer markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:33.265880Z"}
{"comparison_id":"8c84c3cc-780d-41d3-a43d-5c074a09f557","query_id":"51","doc_a_id":"4641348","doc_b_id":"3202143","presented_order":["3202143","4641348"],"winner_id":"3202143","reasoning":"Document A is more relevant — it discusses gene expression and effects on phenotype, which is closer to a claim about a gene (ALDH1) and clinical outcomes than a study on a plant extract and liver disease.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:33.265891Z"}
{"comparison_id":"af63b922-5263-4ae2-b83b-6f27d8ab376f","query_id":"51","doc_a_id":"32372280","doc_b_id":"3202143","presented_order":["3202143","32372280"],"winner_id":"32372280","reasoning":"Document B is slightly more relevant because it discusses gene expression changes in a disease context, whereas Document A is about C. elegans learning and memory and not disease-related.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:33.265898Z"}
{"comparison_id":"980be7cf-790a-48ed-8e6c-80407b07d331","query_id":"51","doc_a_id":"6290112","doc_b_id":"32372280","presented_order":["32372280","6290112"],"winner_id":"32372280","reasoning":"Document A is slightly more relevant because it discusses gene expression changes in a disease context, whereas Document B is about AMY1 copy number and obesity unrelated to ALDH1 or breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:37.561436Z"}
{"comparison_id":"61991504-1d9a-42a6-888a-ca5c20893c61","query_id":"51","doc_a_id":"3619931","doc_b_id":"8417211","presented_order":["8417211","3619931"],"winner_id":"8417211","reasoning":"Neither document discusses ALDH1 or breast cancer; both are irrelevant. Document A is slightly more related to gene expression mechanisms, so it's marginally more relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:41.267190Z"}
{"comparison_id":"bad0f870-f35b-49aa-adca-545a4746b505","query_id":"51","doc_a_id":"4641348","doc_b_id":"8417211","presented_order":["4641348","8417211"],"winner_id":"4641348","reasoning":"Neither document addresses ALDH1 or breast cancer — both are unrelated. Document A is slightly closer (human disease/therapeutics) than a Drosophila HP1 phosphorylation study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:41.267212Z"}
{"comparison_id":"e2cc516d-e3de-4e3a-ae5d-7c59afbef31a","query_id":"51","doc_a_id":"26488879","doc_b_id":"5691302","presented_order":["5691302","26488879"],"winner_id":"5691302","reasoning":"Neither document is relevant — neither mentions ALDH1 or breast cancer. The antidepressant study (A) is marginally closer because it concerns human clinical outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:46.903694Z"}
{"comparison_id":"4c59471b-7ffd-4980-89b8-bea949cd3c86","query_id":"51","doc_a_id":"24323369","doc_b_id":"5691302","presented_order":["5691302","24323369"],"winner_id":"5691302","reasoning":"Neither document mentions ALDH1 or breast cancer outcomes; both are irrelevant. Document A is chosen but not relevant.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:46.903717Z"}
{"comparison_id":"4c93b6d7-d600-4107-94e2-26652529274a","query_id":"51","doc_a_id":"8842332","doc_b_id":"5691302","presented_order":["8842332","5691302"],"winner_id":"8842332","reasoning":"Neither document mentions ALDH1 or breast cancer; both are irrelevant. If forced to choose, Document A is marginally more relevant because it discusses disease outcomes (whereas B focuses on antidepressant adverse events).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:46.903728Z"}
{"comparison_id":"08d041f1-8139-4763-84a5-bee248928f1b","query_id":"51","doc_a_id":"21602220","doc_b_id":"5691302","presented_order":["21602220","5691302"],"winner_id":"5691302","reasoning":"Neither document mentions ALDH1 or breast cancer. Both are irrelevant; Document B is slightly more related (human clinical outcomes) than A (microbial fermentation).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:46.903737Z"}
{"comparison_id":"8d91434f-6435-47b8-831c-eb2db08819b8","query_id":"51","doc_a_id":"22483580","doc_b_id":"5691302","presented_order":["5691302","22483580"],"winner_id":"5691302","reasoning":"Neither document is relevant — neither mentions ALDH1 or breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:46.903745Z"}
{"comparison_id":"5d5578c5-ceaa-47a2-bd40-b949ba15a309","query_id":"51","doc_a_id":"26488879","doc_b_id":"24323369","presented_order":["26488879","24323369"],"winner_id":"26488879","reasoning":"Document A is slightly more related (disease, host–tissue interactions) while B is unrelated to cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:51.924198Z"}
{"comparison_id":"a6ba66c0-615c-487f-910f-5949e553cd3a","query_id":"51","doc_a_id":"22483580","doc_b_id":"24323369","presented_order":["22483580","24323369"],"winner_id":"22483580","reasoning":"Neither document discusses ALDH1 or breast cancer. Document A is marginally more relevant because it deals with a biomarker/immune marker in disease, whereas B is focused on ovulation induction in PCOS. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:51.924219Z"}
{"comparison_id":"31d4cf78-9125-42c4-8afd-320f34809c5e","query_id":"51","doc_a_id":"21602220","doc_b_id":"24323369","presented_order":["21602220","24323369"],"winner_id":"24323369","reasoning":"Document B is slightly more relevant because it deals with human clinical outcomes, whereas Document A is about bacterial fermentation and unrelated to cancer. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:51.924229Z"}
{"comparison_id":"7ae936ce-b153-4803-9ce4-94235c606bf5","query_id":"51","doc_a_id":"26488879","doc_b_id":"22483580","presented_order":["26488879","22483580"],"winner_id":"26488879","reasoning":"Neither document mentions ALDH1 or breast cancer outcomes; both are irrelevant. Choosing A as it at least discusses protein expression in a disease context.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:27:57.315449Z"}
{"comparison_id":"f5678b22-753d-4a99-995b-9a7a41a75bb9","query_id":"51","doc_a_id":"20839751","doc_b_id":"31311495","presented_order":["31311495","20839751"],"winner_id":"20839751","reasoning":"Document B — it discusses prognostic associations in breast cancer (outcomes-related factors), so it's more relevant to a claim about expression being linked to outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902297Z"}
{"comparison_id":"6d111af7-b015-4b2e-9eda-2dc18bd73b26","query_id":"51","doc_a_id":"20333864","doc_b_id":"45638119","presented_order":["45638119","20333864"],"winner_id":"45638119","reasoning":"Document A is directly about ALDH1 expression and clinical outcomes, reporting it predicts poor prognosis; Document B does not address ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902318Z"}
{"comparison_id":"0196f9cb-0e99-4a1d-be89-124ebad2c808","query_id":"51","doc_a_id":"7583725","doc_b_id":"825728","presented_order":["825728","7583725"],"winner_id":"825728","reasoning":"Document A — it links EMT/stem-cell properties to patient survival and metastasis (more related to stem-cell marker/clinical outcome associations). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902332Z"}
{"comparison_id":"c65a5e45-8b76-4d85-80a5-458d03435fec","query_id":"51","doc_a_id":"22712546","doc_b_id":"4702639","presented_order":["22712546","4702639"],"winner_id":"22712546","reasoning":"Document A is more relevant — it studies enzymatic/metabolic activity in breast cancer tissue (which relates to ALDH1 as a metabolic/stem-cell marker), while Document B focuses on an integrin–KRAS pathway unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902340Z"}
{"comparison_id":"22cd6148-3ce9-40a4-9dba-2ff87449e905","query_id":"51","doc_a_id":"11484808","doc_b_id":"24834968","presented_order":["11484808","24834968"],"winner_id":"24834968","reasoning":"Document B — it directly studies biological markers in breast cancer, so it's more relevant to a claim about ALDH1 expression and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902347Z"}
{"comparison_id":"8f9a4782-4b1b-4d12-a69b-8697ec2cfe43","query_id":"51","doc_a_id":"2931832","doc_b_id":"4889228","presented_order":["4889228","2931832"],"winner_id":"4889228","reasoning":"Document A — it discusses a gene's expression level correlating with breast cancer prognosis, making it more relevant to a claim about marker expression and outcomes than Document B, which is about a platelet ratio.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902355Z"}
{"comparison_id":"ab9abc37-7153-410f-afca-b3f68af0dc7a","query_id":"51","doc_a_id":"11484808","doc_b_id":"19673227","presented_order":["11484808","19673227"],"winner_id":"11484808","reasoning":"Document A is more relevant — it covers biomarkers and clinical implications in endocrine-related (including breast) cancers, so it's likelier to address ALDH1 and outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902362Z"}
{"comparison_id":"f29424cb-9556-4a8b-95a3-240850d43a72","query_id":"51","doc_a_id":"12762485","doc_b_id":"313403","presented_order":["313403","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses stem-cell–like phenotypes and their association with aggressive markers in breast cancer, which is more directly related to ALDH1 (a stem cell marker) than a study about tumor-associated macrophages.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902370Z"}
{"comparison_id":"a54bd9ef-6adc-4605-a0c8-0799a67e516b","query_id":"51","doc_a_id":"22975806","doc_b_id":"2931832","presented_order":["2931832","22975806"],"winner_id":"2931832","reasoning":"Doc A is about a prognostic biomarker in breast cancer (clinicopathologic marker and outcomes), which is more related to a claim linking a biomarker (ALDH1) to outcomes than Doc B's BRCA-allele tumorigenesis focus.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902377Z"}
{"comparison_id":"861fa352-8aa3-4b38-8661-f48dfd6be6ca","query_id":"51","doc_a_id":"22401720","doc_b_id":"4889228","presented_order":["4889228","22401720"],"winner_id":"22401720","reasoning":"Reason: Document B discusses expression of biomarkers in breast cancer and their relation to prognosis, making it more relevant to a claim about a marker's association with outcomes than Document A, which focuses on TDP43/SRSF3 splicing in TNBC.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902385Z"}
{"comparison_id":"da06064c-374b-4ae4-9604-3a986e62e2f8","query_id":"51","doc_a_id":"34066665","doc_b_id":"9600826","presented_order":["34066665","9600826"],"winner_id":"34066665","reasoning":"Document A is more relevant — it discusses clinical implications and outcomes in breast cancer (endocrine therapy resistance), whereas Document B focuses on angiogenesis/invasion pathways and not clinical outcome markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902393Z"}
{"comparison_id":"52906d21-0ac2-448b-9744-6cd90f7ebb6c","query_id":"51","doc_a_id":"12762485","doc_b_id":"32001951","presented_order":["32001951","12762485"],"winner_id":"12762485","reasoning":"Document B. It discusses breast cancer stem-cell phenotypes and clinical correlations (p53, ER/PgR, proliferation) which relate to ALDH1 as a stem-cell marker; Document A is about alkaline phosphatase, not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902400Z"}
{"comparison_id":"d7769d7f-2998-4caf-823e-dd65f81e52dc","query_id":"51","doc_a_id":"16734530","doc_b_id":"5579368","presented_order":["16734530","5579368"],"winner_id":"5579368","reasoning":"Document B is more relevant — it deals with analysis of gene expression and breast cancer biomarkers (useful for assessing genes like ALDH1), while Document A focuses on ORAI1 SNPs unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902408Z"}
{"comparison_id":"cb9e17e5-b9ca-4dd0-8812-147c2e68db21","query_id":"51","doc_a_id":"12762485","doc_b_id":"20333864","presented_order":["20333864","12762485"],"winner_id":"12762485","reasoning":"Document B. It discusses stem-cell phenotypes and prognostic marker correlations in breast cancer (which is relevant to ALDH1 as a stem-cell marker), while A focuses on stromal/myoepithelial regulation and not stem-cell markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902415Z"}
{"comparison_id":"31f39626-77bd-4cb7-8722-11d66158b375","query_id":"51","doc_a_id":"16691520","doc_b_id":"24249915","presented_order":["24249915","16691520"],"winner_id":"24249915","reasoning":"Document A is more relevant — it concerns expression changes of a breast cancer marker and links expression loss to invasive disease, which is closer to a claim about marker expression and clinical outcome than a genome-wide ER binding study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902422Z"}
{"comparison_id":"83db1826-d37a-43d6-ac8f-473cf7652cc6","query_id":"51","doc_a_id":"15113221","doc_b_id":"16734530","presented_order":["15113221","16734530"],"winner_id":"15113221","reasoning":"Document A is more relevant — it discusses a gene expression signature linked to prognosis in carcinoma, whereas Document B concerns ORAI1 SNPs unrelated to ALDH1 expression or outcome. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902430Z"}
{"comparison_id":"5cdc65bf-ec69-48ee-a231-dbd363791061","query_id":"51","doc_a_id":"21033230","doc_b_id":"4429932","presented_order":["4429932","21033230"],"winner_id":"21033230","reasoning":"Document B is more relevant — it deals with molecular marker profiling and associations with patient outcomes in breast cancer, whereas A focuses on LOX/hypoxia and metastasis unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902438Z"}
{"comparison_id":"6d40b4e5-09b6-425c-9f5f-964f4c0b8e1e","query_id":"51","doc_a_id":"1866911","doc_b_id":"24249915","presented_order":["1866911","24249915"],"winner_id":"1866911","reasoning":"Neither abstract mentions ALDH1. Document A is slightly more relevant because it discusses progenitor/stem-cell populations and marker-defined cell origins in breast cancer, which is closer to ALDH1’s role as a stem-cell marker. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902446Z"}
{"comparison_id":"67c657ac-78a9-4e8b-8b40-9b777c440b14","query_id":"51","doc_a_id":"20839751","doc_b_id":"4702639","presented_order":["4702639","20839751"],"winner_id":"4702639","reasoning":"Document A — it addresses tumor stemness and stem-cell–associated markers/pathways (more directly related to ALDH1) while B focuses on apoptosis and general prognostic indices.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902453Z"}
{"comparison_id":"a2c3523c-6b2f-4a68-9edb-1fcbed0e05ea","query_id":"51","doc_a_id":"5500086","doc_b_id":"9600826","presented_order":["9600826","5500086"],"winner_id":"5500086","reasoning":"Document B is more relevant because it discusses factors and signatures correlated with positive clinical outcomes in breast cancer, whereas A focuses on angiogenesis pathways without outcome data. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902460Z"}
{"comparison_id":"478b17a8-caf8-4554-9354-2dd23262c4eb","query_id":"51","doc_a_id":"16734530","doc_b_id":"2014909","presented_order":["2014909","16734530"],"winner_id":"2014909","reasoning":"Document A is more relevant — it analyzes tumor-initiating cells in primary breast cancers (where ALDH1 is a common marker) and tumor outcomes, whereas B concerns ORAI1 SNPs unrelated to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902466Z"}
{"comparison_id":"031031ca-a24e-4509-af26-76d122415e13","query_id":"51","doc_a_id":"34066665","doc_b_id":"8891333","presented_order":["34066665","8891333"],"winner_id":"8891333","reasoning":"Doc B is more relevant — it discusses cancer stem cells in breast cancer (ALDH1 is a stem-cell marker), whereas Doc A focuses on ER/HER signaling and endocrine resistance. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902473Z"}
{"comparison_id":"ce533aaa-7639-43a6-b8f8-3d207622325f","query_id":"51","doc_a_id":"18953920","doc_b_id":"20333864","presented_order":["20333864","18953920"],"winner_id":"18953920","reasoning":"Document B — it discusses acquisition of stem-cell markers in mammary cells (relevant to ALDH1 as a stem-cell marker); Document A does not mention ALDH1 or stem-cell markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902480Z"}
{"comparison_id":"eae77747-946a-461b-bb4b-4e0584b6170a","query_id":"51","doc_a_id":"22712546","doc_b_id":"4429932","presented_order":["4429932","22712546"],"winner_id":"22712546","reasoning":"Document B — it discusses enzymatic activity profiling in breast cancer tissue and could potentially address ALDH1 expression, while Document A is about LOX and unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902487Z"}
{"comparison_id":"19c05b80-514f-439a-9da8-e0c1ad785eda","query_id":"51","doc_a_id":"16734530","doc_b_id":"3285322","presented_order":["16734530","3285322"],"winner_id":"16734530","reasoning":"Document A is more relevant — it addresses molecular markers and their association with breast cancer clinical features, which is closer to a claim about a biomarker (ALDH1) and outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902494Z"}
{"comparison_id":"d6f9a217-9f70-44c7-a1fe-af4a01227d8a","query_id":"51","doc_a_id":"16086778","doc_b_id":"8891333","presented_order":["8891333","16086778"],"winner_id":"8891333","reasoning":"Document A is more relevant — it discusses cancer stem cells in breast cancer (ALDH1 is a stem-cell marker), whereas Document B focuses on Numb/Notch signaling unrelated to ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902500Z"}
{"comparison_id":"58208a9d-bcf4-4436-9ef8-8c9731e0b53d","query_id":"51","doc_a_id":"25732836","doc_b_id":"34066665","presented_order":["25732836","34066665"],"winner_id":"34066665","reasoning":"Document B — it discusses molecular markers/pathways in breast cancer and treatment implications, which is closer to ALDH1's role than the imaging/CTC-focused Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902507Z"}
{"comparison_id":"c3b7c9ce-7159-44b0-8f68-47d56d1e5d9e","query_id":"51","doc_a_id":"32001951","doc_b_id":"7821634","presented_order":["32001951","7821634"],"winner_id":"7821634","reasoning":"Document B is more relevant — it discusses breast cancer outcomes and prognosis, whereas Document A focuses on alkaline phosphatase regulation in a cell line and not clinical outcomes or ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902514Z"}
{"comparison_id":"06fee26a-3703-462f-b9f6-e5bd6392ff03","query_id":"51","doc_a_id":"11484808","doc_b_id":"5500086","presented_order":["11484808","5500086"],"winner_id":"5500086","reasoning":"Document B is more directly about mechanisms linked to clinical outcomes in breast cancer (type I IFN signature correlating with positive outcomes), whereas Document A discusses ncRNAs broadly and not specifically ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902522Z"}
{"comparison_id":"aa25ec0c-d1b1-49e0-8f61-b10b04f5a2fc","query_id":"51","doc_a_id":"20839751","doc_b_id":"22975806","presented_order":["22975806","20839751"],"winner_id":"20839751","reasoning":"Document B is more relevant — it discusses molecular/pathological markers and their association with breast cancer prognosis, whereas A focuses on BRCA allele loss and tumorigenesis mechanisms.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902528Z"}
{"comparison_id":"698e4902-5588-42a5-abc3-98a326c90542","query_id":"51","doc_a_id":"20127522","doc_b_id":"20183360","presented_order":["20183360","20127522"],"winner_id":"20183360","reasoning":"Document A is more relevant — it addresses molecular markers and tumor biology linked to invasiveness and prognosis, which is closer to ALDH1 expression's prognostic role than a study on circulating tumor cell counts.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902535Z"}
{"comparison_id":"b122ab16-f9a2-43a6-b009-ce034ccff044","query_id":"51","doc_a_id":"20183360","doc_b_id":"9600826","presented_order":["20183360","9600826"],"winner_id":"20183360","reasoning":"Neither document mentions ALDH1. Document A is slightly more relevant because it addresses factors (GATA3/TGFβ-Smad4) that influence breast cancer invasiveness and progression, which is more directly related to outcomes than the angiogenesis-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902543Z"}
{"comparison_id":"cb46b37d-dc26-4172-9554-62f7935f5949","query_id":"51","doc_a_id":"15946643","doc_b_id":"16086778","presented_order":["15946643","16086778"],"winner_id":"15946643","reasoning":"Document A is slightly more relevant because it discusses factors (chemoresistance and metastasis) that relate directly to breast cancer outcomes, whereas Document B focuses on a specific molecular regulator without direct outcome data.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902550Z"}
{"comparison_id":"bc2ed715-44cd-473f-8177-0ca146490c04","query_id":"51","doc_a_id":"4429932","doc_b_id":"7583725","presented_order":["4429932","7583725"],"winner_id":"4429932","reasoning":"Document A — it explicitly discusses a marker (LOX) associated with patient outcomes in breast cancer, making it slightly closer to a claim about prognostic marker expression and outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902557Z"}
{"comparison_id":"559a1035-08e2-438f-a68e-e13d52c35982","query_id":"51","doc_a_id":"22712546","doc_b_id":"31311495","presented_order":["22712546","31311495"],"winner_id":"22712546","reasoning":"Document A is more relevant — it addresses metabolic enzyme activity in breast cancer tissue (potentially including markers like ALDH1) and tumor microenvironment interactions, whereas Document B focuses on tamoxifen resistance mechanisms in a cell line and does not pertain to ALDH1 or clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902565Z"}
{"comparison_id":"65eeaa67-3e85-42b3-8773-b471b4886062","query_id":"51","doc_a_id":"11484808","doc_b_id":"825728","presented_order":["825728","11484808"],"winner_id":"825728","reasoning":"Document A is more relevant — it discusses cancer stem cell properties and links to patient survival and metastasis, which is more directly related to ALDH1 (a stem cell marker) and breast cancer outcomes than a general ncRNA review.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902572Z"}
{"comparison_id":"2be086de-9caf-4c95-96cf-6e5438dc8e3b","query_id":"51","doc_a_id":"45638119","doc_b_id":"5500086","presented_order":["45638119","5500086"],"winner_id":"45638119","reasoning":"Document A is more relevant — it directly addresses ALDH1 expression and links it to clinical outcome (reporting association with poor prognosis, which contradicts the claim).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902578Z"}
{"comparison_id":"73ddfe9b-b16f-42e2-8ee0-1bb2711bf741","query_id":"51","doc_a_id":"3285322","doc_b_id":"43385013","presented_order":["3285322","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it addresses breast epithelial/mesenchymal subpopulations and stem/progenitor properties (ALDH1 is a stem cell marker), whereas Document A focuses on BRCA mutation clinical/pathologic features and not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902586Z"}
{"comparison_id":"a58c637c-54e2-4228-8dc8-a484ecf73913","query_id":"51","doc_a_id":"24834968","doc_b_id":"4702639","presented_order":["4702639","24834968"],"winner_id":"24834968","reasoning":"Document B is more relevant — it concerns breast cancer and evaluation of biological markers as outcome predictors, whereas A focuses on integrin-driven stemness and drug resistance in other carcinomas and does not address ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902593Z"}
{"comparison_id":"9791a61d-081a-4cbf-869a-89f1d266abed","query_id":"51","doc_a_id":"11484808","doc_b_id":"12762485","presented_order":["12762485","11484808"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses stem-cell phenotypes in breast cancer (which relate to ALDH1 as a stem-cell marker), whereas Document B focuses on ncRNAs and is less directly related.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902600Z"}
{"comparison_id":"cc601e7f-4737-46ba-87e9-47492b098f6b","query_id":"51","doc_a_id":"15113221","doc_b_id":"22712546","presented_order":["22712546","15113221"],"winner_id":"22712546","reasoning":"Document A is more relevant — it analyzes enzymatic activities and metabolic markers within breast cancer tissue, which is more likely to address ALDH1 expression and its association with outcomes. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902606Z"}
{"comparison_id":"d58a9b4e-3a47-407e-bf82-dc65b6e64122","query_id":"51","doc_a_id":"2014909","doc_b_id":"7821634","presented_order":["2014909","7821634"],"winner_id":"2014909","reasoning":"Document A is more relevant — it analyzes tumor-initiating cells and primary breast cancers (contexts where ALDH1, a stem-cell/tumor-initiating marker, is typically assessed), whereas Document B focuses narrowly on DUSP4 and chemo resistance.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902614Z"}
{"comparison_id":"23ecd634-4c28-4ee6-be81-c357dc4c57b9","query_id":"51","doc_a_id":"27123743","doc_b_id":"8963413","presented_order":["27123743","8963413"],"winner_id":"8963413","reasoning":"Document B is more relevant — it discusses biomarker expression and associations with breast cancer outcomes, whereas A is about birthweight and cancer risk.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902621Z"}
{"comparison_id":"7a335c1c-983c-49bb-b238-17422128af2f","query_id":"51","doc_a_id":"25732836","doc_b_id":"4702639","presented_order":["4702639","25732836"],"winner_id":"25732836","reasoning":"Document B is more relevant — it evaluates prognostic markers and outcome prediction in breast cancer, whereas Document A is a mechanistic study of integrin/KRAS-driven stemness and drug resistance and does not address ALDH1 or clinical outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902628Z"}
{"comparison_id":"00f90eac-d79e-4ee7-809b-4d1286479f6f","query_id":"51","doc_a_id":"15946643","doc_b_id":"7583725","presented_order":["7583725","15946643"],"winner_id":"7583725","reasoning":"Document A is more relevant — it discusses how expression of a specific protein (TRPM7) predicts patient outcomes in breast cancer, which is closer to the query about marker expression and outcome than Document B's focus on a chemokine signaling network.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902635Z"}
{"comparison_id":"2a8ee8d9-88c2-4f87-ab4a-2e18fc5db397","query_id":"51","doc_a_id":"22401720","doc_b_id":"43385013","presented_order":["43385013","22401720"],"winner_id":"43385013","reasoning":"Document A is more relevant — it discusses stem/progenitor properties in breast cell subpopulations (ALDH1 is a stem cell marker), whereas Document B focuses on angiogenic factors unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902642Z"}
{"comparison_id":"6223a241-5dc2-483a-914f-cc3cd5ef5080","query_id":"51","doc_a_id":"4889228","doc_b_id":"5500086","presented_order":["4889228","5500086"],"winner_id":"5500086","reasoning":"Document B is more relevant — it links a molecular signature to breast cancer clinical outcomes, which is closer to the query about a biomarker's association with outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902665Z"}
{"comparison_id":"7eebb8f5-334a-40be-adff-0c7faffbb35e","query_id":"51","doc_a_id":"20183360","doc_b_id":"4702639","presented_order":["4702639","20183360"],"winner_id":"20183360","reasoning":"Document B is more relevant — it specifically addresses breast cancer biology (invasion and regulators in basal-like breast cancer), whereas A focuses on integrin β3–KRAS–RalB in other carcinomas and drug resistance. Neither mentions ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902682Z"}
{"comparison_id":"ec7ce49f-18b4-4d9a-b6d3-29c61d87f700","query_id":"51","doc_a_id":"20454006","doc_b_id":"825728","presented_order":["825728","20454006"],"winner_id":"825728","reasoning":"Document A is more relevant — it discusses cancer cell stemness, EMT, and links to patient survival and metastasis, which is closer to ALDH1 (a stem cell marker) and outcomes than a tamoxifen biomarker trial. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902693Z"}
{"comparison_id":"93c13558-d692-4dc9-b1c0-c44fc6532114","query_id":"51","doc_a_id":"18953920","doc_b_id":"7821634","presented_order":["18953920","7821634"],"winner_id":"18953920","reasoning":"Document A is more relevant — it discusses acquisition of stem-cell markers (such as ALDH1) and their link to tumor behavior in mammary cells, whereas Document B focuses on DUSP4 and chemotherapy resistance without addressing ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902701Z"}
{"comparison_id":"cc92dae4-ffb3-4082-83fb-4c905b2ec0fd","query_id":"51","doc_a_id":"2931832","doc_b_id":"7583725","presented_order":["7583725","2931832"],"winner_id":"7583725","reasoning":"Neither document mentions ALDH1. Document A is more relevant because it links tumor protein expression (TRPM7) with patient outcomes, which is analogous to the claim about ALDH1 expression and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902709Z"}
{"comparison_id":"dfdb386a-5c89-4104-95f5-af4d88c80675","query_id":"51","doc_a_id":"22712546","doc_b_id":"825728","presented_order":["22712546","825728"],"winner_id":"22712546","reasoning":"Document A is more relevant — it addresses enzymatic activities and metabolic interactions in breast cancer tissue, which is related to ALDH1 (an enzyme) expression, whereas Document B focuses on Prrx1/EMT and metastasis with no enzymatic/ALDH1 link.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902716Z"}
{"comparison_id":"841075bf-33a8-41a1-aeed-11e4e4ea70f9","query_id":"51","doc_a_id":"20333864","doc_b_id":"825728","presented_order":["825728","20333864"],"winner_id":"825728","reasoning":"Document A — it links acquisition of stem-cell properties to patient survival and metastasis, which is more directly related to ALDH1 (a stem-cell marker) and outcomes than the microenvironment-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902723Z"}
{"comparison_id":"ba35a934-10bb-4b47-a0b4-1b290e2de069","query_id":"51","doc_a_id":"24834968","doc_b_id":"2931832","presented_order":["2931832","24834968"],"winner_id":"24834968","reasoning":"Document B — it evaluates tumor biological markers as predictors of treatment response/outcomes, which is more related to ALDH1 expression than Document A’s focus on platelet indices. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902730Z"}
{"comparison_id":"99a7ca00-aec8-4e4d-a1c8-9f68e1feec0a","query_id":"51","doc_a_id":"20127522","doc_b_id":"9600826","presented_order":["20127522","9600826"],"winner_id":"20127522","reasoning":"Document A is more relevant — it addresses prognostic markers and patient outcomes in breast cancer, whereas Document B focuses on a molecular angiogenesis pathway without outcome/prognosis data.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902737Z"}
{"comparison_id":"2faba9aa-bb7c-461a-8db8-bc0c2272d981","query_id":"51","doc_a_id":"4429932","doc_b_id":"8891333","presented_order":["4429932","8891333"],"winner_id":"8891333","reasoning":"Document B is more relevant — it discusses cancer stem cells in breast cancer and markers/therapy resistance, which relates to ALDH1 as a stem-cell marker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902744Z"}
{"comparison_id":"f5f45813-2765-4f38-9882-bceca4bc90b8","query_id":"51","doc_a_id":"1866911","doc_b_id":"22482820","presented_order":["1866911","22482820"],"winner_id":"1866911","reasoning":"Document A is more relevant because it discusses breast epithelial cell populations and marker-defined progenitors (closer to ALDH1 expression studies), while Document B focuses on therapy delivery strategies. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902750Z"}
{"comparison_id":"f1f676fe-cacb-460a-a4e0-e522e0671dc5","query_id":"51","doc_a_id":"2014909","doc_b_id":"20183360","presented_order":["2014909","20183360"],"winner_id":"2014909","reasoning":"Document A is more relevant — it discusses tumor-initiating cells and analyses of primary breast cancers (contexts where ALDH1, a stem-cell marker, is typically evaluated), whereas B focuses on invasion signaling without connection to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902758Z"}
{"comparison_id":"520d6d93-949d-43f0-801d-b6083c777b71","query_id":"51","doc_a_id":"12762485","doc_b_id":"22401720","presented_order":["22401720","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses stem-cell–like phenotypes and their prognostic associations in breast cancer, which is more relevant to ALDH1 (a stem cell marker) than angiogenic factor expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902765Z"}
{"comparison_id":"92d7b4be-ea40-4c86-a055-3c48162983ad","query_id":"51","doc_a_id":"25732836","doc_b_id":"5579368","presented_order":["25732836","5579368"],"winner_id":"5579368","reasoning":"Document B is more relevant — it focuses on integrating DNA methylation with gene expression for breast cancer biomarkers, which could address ALDH1 expression; Document A is about CTCs and PET imaging, not ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902772Z"}
{"comparison_id":"f2ac3fa9-1f9b-4fc5-afe2-10548a4b3bb4","query_id":"51","doc_a_id":"20839751","doc_b_id":"4889228","presented_order":["4889228","20839751"],"winner_id":"20839751","reasoning":"Document B — it discusses prognostic markers and outcome associations in breast cancer, which is more relevant to a claim about ALDH1 and outcomes than Document A's focus on TDP43/SRSF3 in TNBC.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902779Z"}
{"comparison_id":"e288309e-90ba-4dbf-b5f4-bf14bc2635b5","query_id":"51","doc_a_id":"19673227","doc_b_id":"22401720","presented_order":["22401720","19673227"],"winner_id":"22401720","reasoning":"Document A is marginally more relevant because it discusses expression of molecular markers in primary breast cancer and their relation to prognosis, whereas Document B focuses on CTC chemosensitivity across epithelial tumors and not marker expression in breast tissue.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902786Z"}
{"comparison_id":"9c315d80-c122-44e8-8dc0-18f514c2bf1f","query_id":"51","doc_a_id":"2014909","doc_b_id":"24249915","presented_order":["2014909","24249915"],"winner_id":"2014909","reasoning":"Document A is more related because it addresses tumor-initiating cells and patient breast cancer analyses (ALDH1 is a tumor-initiating/cancer stem cell marker), whereas Document B focuses on ERβ methylation. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902793Z"}
{"comparison_id":"c253e00a-1f1a-4031-9602-f2d53133750b","query_id":"51","doc_a_id":"4889228","doc_b_id":"825728","presented_order":["4889228","825728"],"winner_id":"825728","reasoning":"Document B — it links stem-cell-like properties and patient survival (ALDH1 is a stemness marker), so its findings on stemness and outcomes are more relevant to the claim about ALDH1 and breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902800Z"}
{"comparison_id":"4db55320-5f6f-4b7f-9f39-f497edbb826b","query_id":"51","doc_a_id":"20839751","doc_b_id":"2931832","presented_order":["2931832","20839751"],"winner_id":"20839751","reasoning":"Reason: Document B discusses tumor-cell–level pathological markers and their relationship with prognosis, which is more closely related to ALDH1 expression than a platelet-based biomarker.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902807Z"}
{"comparison_id":"6b763a06-f2cd-4458-9ce5-61877e43d988","query_id":"51","doc_a_id":"16691520","doc_b_id":"22482820","presented_order":["16691520","22482820"],"winner_id":"22482820","reasoning":"Document B is more relevant — it discusses breast cancer classification by receptor expression and treatment outcomes, which is closer to prognostic associations like ALDH1 expression. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902814Z"}
{"comparison_id":"09d407a7-7d1e-43f7-b0ab-0229e0b8e36d","query_id":"51","doc_a_id":"16691520","doc_b_id":"25973484","presented_order":["25973484","16691520"],"winner_id":"25973484","reasoning":"Document A is more relevant — it discusses breast cancer prognosis and factors affecting outcomes, whereas Document B focuses on estrogen receptor binding without addressing clinical outcomes or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902821Z"}
{"comparison_id":"4e16ab05-56c9-49e8-a0c5-d0ca1f11a196","query_id":"51","doc_a_id":"22482820","doc_b_id":"32001951","presented_order":["22482820","32001951"],"winner_id":"22482820","reasoning":"Document A is more relevant — it discusses breast cancer classification and treatment strategies and is more likely to address prognostic markers like ALDH1, whereas Document B focuses narrowly on alkaline phosphatase regulation unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902828Z"}
{"comparison_id":"1c5961c3-a51f-4feb-b71e-91a692679ba5","query_id":"51","doc_a_id":"18953920","doc_b_id":"22975806","presented_order":["18953920","22975806"],"winner_id":"18953920","reasoning":"Document A is more relevant — it discusses acquisition of stem-cell markers in mammary epithelial cells (ALDH1 is a common breast cancer stem-cell marker) and links stemness to tumorigenic potential. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902835Z"}
{"comparison_id":"1ed8bf5a-088c-4ccd-8000-16b5d72e9a33","query_id":"51","doc_a_id":"20333864","doc_b_id":"43385013","presented_order":["43385013","20333864"],"winner_id":"43385013","reasoning":"Document A is more relevant — it discusses stem cell/progenitor properties in breast cell subpopulations (ALDH1 is a stem cell marker), which relates to ALDH1 and outcome associations. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902841Z"}
{"comparison_id":"f7708379-a35a-4b50-b23c-cdc755759e94","query_id":"51","doc_a_id":"25973484","doc_b_id":"3285322","presented_order":["25973484","3285322"],"winner_id":"25973484","reasoning":"Document A is more relevant — it discusses breast cancer prognosis and factors affecting outcomes, whereas Document B focuses on BRCA mutation characteristics and not tumor markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902848Z"}
{"comparison_id":"d908ec9e-8605-4b31-a7c7-c3ef3e7280cc","query_id":"51","doc_a_id":"34066665","doc_b_id":"43385013","presented_order":["34066665","43385013"],"winner_id":"43385013","reasoning":"Document B — it addresses stem cell/progenitor properties in breast epithelial/mesenchymal subpopulations, which is more directly related to ALDH1 (a stem cell marker) than Document A's focus on ER/HER signaling. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902855Z"}
{"comparison_id":"d663424b-f650-47ff-afef-71f3f8341f93","query_id":"51","doc_a_id":"19673227","doc_b_id":"2014909","presented_order":["19673227","2014909"],"winner_id":"19673227","reasoning":"Doc A is more relevant because it addresses prognostic/predictive markers and correlations with disease-free survival and time to progression, whereas Doc B focuses on mTOR and immune mechanisms without prognosis markers. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902862Z"}
{"comparison_id":"134b8d14-e5fb-47bb-a516-6b377fa568dc","query_id":"51","doc_a_id":"27123743","doc_b_id":"4455466","presented_order":["4455466","27123743"],"winner_id":"4455466","reasoning":"Document A is more relevant — it discusses gene expression levels linked to breast cancer prognosis (expression correlated with outcome). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902869Z"}
{"comparison_id":"da30b82c-89a0-4cad-aeb8-29336f0eb79e","query_id":"51","doc_a_id":"20127522","doc_b_id":"7821634","presented_order":["20127522","7821634"],"winner_id":"7821634","reasoning":"Document B is more relevant — it discusses tumor marker expression (DUSP4) and its association with chemotherapy response and outcomes, which is closer to the claim about ALDH1 expression and prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902875Z"}
{"comparison_id":"9ecad7bf-9983-488b-8ee8-9686d8b6aa4a","query_id":"51","doc_a_id":"22401720","doc_b_id":"22975806","presented_order":["22401720","22975806"],"winner_id":"22401720","reasoning":"Document A is more relevant: it examines expression of tumor markers in primary breast cancer and relates expression levels to prognosis, whereas Document B focuses on BRCA allele loss and not marker expression or outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902882Z"}
{"comparison_id":"69d756a1-eb00-436a-9210-1370c8ec2542","query_id":"51","doc_a_id":"11484808","doc_b_id":"313403","presented_order":["313403","11484808"],"winner_id":"313403","reasoning":"Document A is more relevant — it directly examines prognostic markers and outcomes in breast cancer, whereas Document B focuses on non-coding RNAs in endocrine cancers and is less directly related to ALDH1 expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902889Z"}
{"comparison_id":"eacb493b-5ca2-4aef-bacc-602ce5daf920","query_id":"51","doc_a_id":"34066665","doc_b_id":"5500086","presented_order":["34066665","5500086"],"winner_id":"5500086","reasoning":"Document B — it discusses molecular markers/signatures that correlate with positive clinical outcomes in breast cancer, which is closer to the query about a prognostic marker (ALDH1) than Document A's focus on ER–HER signaling and endocrine resistance.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902897Z"}
{"comparison_id":"f1c38921-4c3a-4334-8aa5-4747288322c0","query_id":"51","doc_a_id":"2014909","doc_b_id":"27123743","presented_order":["27123743","2014909"],"winner_id":"2014909","reasoning":"Document B — it discusses tumor-initiating cells and analyses of primary breast cancers (more likely to address stem-cell markers like ALDH1). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902904Z"}
{"comparison_id":"202ce3f9-0d11-48b2-93d9-3af4438475b2","query_id":"51","doc_a_id":"22712546","doc_b_id":"4455466","presented_order":["4455466","22712546"],"winner_id":"22712546","reasoning":"Reason: Document B addresses enzymatic activity profiling in breast cancer tissue (so is more likely to provide evidence about ALDH1 expression), while Document A focuses on an unrelated gene (ZMYND11).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902910Z"}
{"comparison_id":"c1dcbae2-2fb6-40d0-9fb3-e284359f8460","query_id":"51","doc_a_id":"24834968","doc_b_id":"25732836","presented_order":["25732836","24834968"],"winner_id":"24834968","reasoning":"Reason: Document B evaluates biological markers as predictors of breast cancer response/outcome, making it more relevant to a claim about ALDH1 expression and outcomes than Document A which focuses on CTCs and PET/CT imaging.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902917Z"}
{"comparison_id":"07f82415-c47e-418f-bf7c-97fc0921d9ed","query_id":"51","doc_a_id":"22482820","doc_b_id":"4889228","presented_order":["4889228","22482820"],"winner_id":"4889228","reasoning":"Reason: Document A discusses associations between marker expression and breast cancer prognosis (high TDP43 with poor outcomes), so it's more relevant to a claim about biomarker (ALDH1) expression and outcomes than the therapy-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902924Z"}
{"comparison_id":"1da4dec8-31aa-4575-8170-e6859e08458f","query_id":"51","doc_a_id":"25973484","doc_b_id":"5579368","presented_order":["25973484","5579368"],"winner_id":"5579368","reasoning":"Document B — it concerns genomic/biomarker (gene expression) analysis in breast cancer and could address ALDH1, while Document A discusses obesity-related epidemiology not ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902931Z"}
{"comparison_id":"46e071ee-0add-4271-bece-346e61f3bda9","query_id":"51","doc_a_id":"22401720","doc_b_id":"24834968","presented_order":["22401720","24834968"],"winner_id":"22401720","reasoning":"Document A is more relevant — it examines expression of tumor markers and their relation to prognosis in breast cancer, while B focuses on HER-2/chemotherapy response rather than marker–outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902954Z"}
{"comparison_id":"d7a5e06e-4c11-4532-9bac-b889272f9b53","query_id":"51","doc_a_id":"20127522","doc_b_id":"24341590","presented_order":["20127522","24341590"],"winner_id":"20127522","reasoning":"Reason: Neither abstract mentions ALDH1, but Document A (CTCs and outcomes) is slightly more related because it links tumor cell markers/levels to breast cancer prognosis; Document B focuses on CYP2D6 pharmacogenetics. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902968Z"}
{"comparison_id":"8a83dbaf-5a77-4bec-9b04-eef16d8474cd","query_id":"51","doc_a_id":"11484808","doc_b_id":"4889228","presented_order":["4889228","11484808"],"winner_id":"4889228","reasoning":"Document A is more directly about breast cancer prognosis and markers, whereas B is a general review on ncRNAs in endocrine cancers and doesn't address ALDH1 or breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902976Z"}
{"comparison_id":"a8dc3cb1-0bf0-4a71-a7ff-29f1ba41abd9","query_id":"51","doc_a_id":"18953920","doc_b_id":"22482820","presented_order":["22482820","18953920"],"winner_id":"18953920","reasoning":"Reason: Document B discusses acquisition of stem-cell markers (like ALDH1) and increased tumorigenic potential in mammary cells, which is directly relevant to the claim about ALDH1 and breast cancer outcomes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902983Z"}
{"comparison_id":"dc3ec156-f080-46dd-9fbe-6bdee49d2e70","query_id":"51","doc_a_id":"16691520","doc_b_id":"2931832","presented_order":["2931832","16691520"],"winner_id":"2931832","reasoning":"Document A is more relevant — it concerns prognostic biomarkers and breast cancer outcomes, which relates to the claim about ALDH1's association with prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902991Z"}
{"comparison_id":"ac198b67-b202-407a-879e-08ba73178368","query_id":"51","doc_a_id":"25973484","doc_b_id":"825728","presented_order":["825728","25973484"],"winner_id":"25973484","reasoning":"Document B is more relevant — it discusses breast cancer risk and prognosis directly, whereas A focuses on Prrx1 and metastatic colonization without addressing ALDH1 or breast cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.902998Z"}
{"comparison_id":"a690774d-2bef-4e36-a62f-b25e6e1f823b","query_id":"51","doc_a_id":"24834968","doc_b_id":"3285322","presented_order":["24834968","3285322"],"winner_id":"24834968","reasoning":"Document A is more relevant — it examines biological markers and treatment response/outcomes in breast cancer, which is closer to ALDH1 expression's prognostic role than BRCA-status comparisons.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903004Z"}
{"comparison_id":"7d4fdaf2-e7e6-43c6-a534-62d088f2103d","query_id":"51","doc_a_id":"32001951","doc_b_id":"43385013","presented_order":["32001951","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it addresses stem cell/progenitor properties in breast cell subpopulations (where ALDH1 is a stem cell marker), while Document A concerns alkaline phosphatase regulation, not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903011Z"}
{"comparison_id":"5fc0460f-e1fb-4cda-9ad7-4f7605566a0a","query_id":"51","doc_a_id":"20127522","doc_b_id":"43385013","presented_order":["43385013","20127522"],"winner_id":"43385013","reasoning":"Document A is more relevant — it discusses stem cell/progenitor properties in breast cell subpopulations (ALDH1 is a stem cell marker), whereas Document B concerns circulating tumor cells and treatment monitoring, not ALDH1 or stem-cell markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903017Z"}
{"comparison_id":"61cec545-ad0d-42cc-98d8-02df32dd3c7e","query_id":"51","doc_a_id":"16691520","doc_b_id":"9600826","presented_order":["9600826","16691520"],"winner_id":"9600826","reasoning":"Document A is more relevant — it discusses molecular pathways linked to breast cancer invasion, metastasis, and prognosis, which is closer to expression markers and outcomes than a genome-wide ER binding study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903024Z"}
{"comparison_id":"c92356b2-44c3-4ada-88ef-3a99da7e3180","query_id":"51","doc_a_id":"22482820","doc_b_id":"22975806","presented_order":["22975806","22482820"],"winner_id":"22482820","reasoning":"Reason: Neither abstract mentions ALDH1; Document B is marginally more relevant because it discusses breast cancer classification and biomarkers/therapy contexts where ALDH1 (a stem-cell marker) would be more likely to be addressed than a BRCA-allele loss study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903031Z"}
{"comparison_id":"1f7d5be3-cbd4-408d-b404-a743315408be","query_id":"51","doc_a_id":"16086778","doc_b_id":"19673227","presented_order":["16086778","19673227"],"winner_id":"16086778","reasoning":"Document A is more relevant — it addresses mechanisms in human breast carcinogenesis, whereas B focuses on CTC chemosensitivity across epithelial tumors and not on breast-specific markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903038Z"}
{"comparison_id":"0532806e-ea3d-4665-8797-2bcf009afc93","query_id":"51","doc_a_id":"1866911","doc_b_id":"22975806","presented_order":["1866911","22975806"],"winner_id":"1866911","reasoning":"Document A is more relevant — it discusses breast epithelial progenitor cell populations and marker expression (e.g., c-KIT) linked to tumor subtypes, which is closer to the topic of ALDH1 as a cell marker and prognosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903045Z"}
{"comparison_id":"15d177a8-ffb7-4a8c-9c97-4fd1cab08307","query_id":"51","doc_a_id":"20183360","doc_b_id":"25973484","presented_order":["25973484","20183360"],"winner_id":"25973484","reasoning":"Document A discusses breast cancer risk and prognosis (outcomes), while Document B focuses on GATA3/Smad4 molecular mechanisms unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903052Z"}
{"comparison_id":"b8a2dd0c-a11f-4683-8ab9-261f2a4bb126","query_id":"51","doc_a_id":"20127522","doc_b_id":"22975806","presented_order":["20127522","22975806"],"winner_id":"20127522","reasoning":"Document A is more relevant — it discusses a biomarker (CTCs) linked to breast cancer outcomes, whereas Document B focuses on BRCA allele loss and tumorigenesis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903058Z"}
{"comparison_id":"5db273df-0405-4ab9-9f33-bf0ee64e2c4f","query_id":"51","doc_a_id":"22712546","doc_b_id":"3285322","presented_order":["3285322","22712546"],"winner_id":"22712546","reasoning":"Document B is more relevant because it studies enzymatic activities and metabolic interactions in breast cancer tissue (potentially including ALDH1), whereas Document A focuses on BRCA mutation clinical features and doesn't address ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903066Z"}
{"comparison_id":"75928bcc-5b38-4282-aaeb-cceea502aefe","query_id":"51","doc_a_id":"16086778","doc_b_id":"5500086","presented_order":["16086778","5500086"],"winner_id":"5500086","reasoning":"Neither document mentions ALDH1, but Document B discusses factors correlating with clinical outcomes in breast cancer (type I IFN signature), making it slightly more relevant to the claim about prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903074Z"}
{"comparison_id":"df0221f3-62e3-45ae-b791-7c0cedd3731b","query_id":"51","doc_a_id":"19358586","doc_b_id":"22401720","presented_order":["22401720","19358586"],"winner_id":"22401720","reasoning":"Document A — it directly examines expression of tumor markers in primary breast cancer and relates specific factor levels to prognosis, so it's more relevant to a claim about a marker's association with outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903082Z"}
{"comparison_id":"00e2f243-09d4-45db-b5f5-f1cb7acddfa2","query_id":"51","doc_a_id":"16691520","doc_b_id":"825728","presented_order":["16691520","825728"],"winner_id":"825728","reasoning":"Document B — it discusses EMT, stem cell properties and links to patient survival/metastasis, which is more related to ALDH1's role as a stem-cell marker and clinical outcomes than a study of estrogen receptor binding. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903089Z"}
{"comparison_id":"72ca5a0e-3a57-41d3-805a-7422fae1dcd8","query_id":"51","doc_a_id":"2931832","doc_b_id":"3285322","presented_order":["2931832","3285322"],"winner_id":"2931832","reasoning":"Document A is more relevant — it examines a prognostic biomarker and disease-free survival in breast cancer, which is directly related to claims about expression markers and outcomes. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903096Z"}
{"comparison_id":"b9ae0193-3974-4b35-a200-d84ae83cc307","query_id":"51","doc_a_id":"16691520","doc_b_id":"16734530","presented_order":["16691520","16734530"],"winner_id":"16734530","reasoning":"Document B is more relevant — it studies genetic markers associated with breast cancer clinical features (ER status and nodal involvement), which is closer to assessing associations between molecular markers and outcomes than a basic ER binding-site mapping.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903103Z"}
{"comparison_id":"31ba6444-926a-4f1b-bf28-7caa1669c6d5","query_id":"51","doc_a_id":"16734530","doc_b_id":"1866911","presented_order":["1866911","16734530"],"winner_id":"1866911","reasoning":"Document A is more relevant — it discusses breast epithelial progenitors and stem/progenitor markers related to tumor origin, which is closer to ALDH1 (a stem-cell marker) than the SNP-focused study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903111Z"}
{"comparison_id":"a864963d-b2ff-4ecf-a925-57e7c8ed9463","query_id":"51","doc_a_id":"22401720","doc_b_id":"24249915","presented_order":["22401720","24249915"],"winner_id":"22401720","reasoning":"Document A is more relevant — it examines expression of tumor markers in breast cancer and links specific factor levels to prognosis, whereas Document B focuses on ERβ expression and methylation without relating expression to outcomes. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903118Z"}
{"comparison_id":"fb451ea6-6e7b-4b11-97ca-87da3f91cdfe","query_id":"51","doc_a_id":"31311495","doc_b_id":"4455466","presented_order":["31311495","4455466"],"winner_id":"4455466","reasoning":"Document B is more relevant — it links gene expression to breast cancer prognosis, whereas A focuses on tamoxifen resistance and EMT without relating marker expression to outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903125Z"}
{"comparison_id":"fed4f124-b6fa-4b1d-a963-f75221024f63","query_id":"51","doc_a_id":"1171121","doc_b_id":"31311495","presented_order":["31311495","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant because it examines prognostic biomarkers and associations with breast cancer outcomes, whereas Document A is a cell-line study on tamoxifen resistance and EMT with no prognostic marker data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903131Z"}
{"comparison_id":"ad010e6c-2de9-4179-9b8f-c2c3a2d72aa7","query_id":"51","doc_a_id":"18953920","doc_b_id":"24834968","presented_order":["24834968","18953920"],"winner_id":"18953920","reasoning":"Document B — it discusses EMT-induced stem-cell markers and increased tumorigenicity in mammary cells (relevant to ALDH1 as a stem-cell marker and outcome implications).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903138Z"}
{"comparison_id":"9a6bd726-57c4-448f-92e3-87b6f7061c43","query_id":"51","doc_a_id":"20839751","doc_b_id":"825728","presented_order":["20839751","825728"],"winner_id":"20839751","reasoning":"Document A is more relevant because it discusses prognostic factors and outcomes in breast cancer; Document B focuses on Prrx1 and metastasis, not breast cancer prognostic markers like ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903146Z"}
{"comparison_id":"3cb61c5d-7086-47e3-b0bf-d836a8932e95","query_id":"51","doc_a_id":"19358586","doc_b_id":"7583725","presented_order":["19358586","7583725"],"winner_id":"7583725","reasoning":"Document B — it directly links a protein's expression level to patient outcomes in breast cancer, whereas A focuses on a miRNA/protein signature without addressing marker-outcome associations. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903152Z"}
{"comparison_id":"2177a17f-0721-4e27-8e75-dadbee6122b1","query_id":"51","doc_a_id":"22975806","doc_b_id":"32001951","presented_order":["22975806","32001951"],"winner_id":"32001951","reasoning":"Document B is more relevant — it concerns regulation of an enzyme's expression in breast cancer cells, which is closer to a claim about ALDH1 expression than the BRCA allele focus of A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903159Z"}
{"comparison_id":"f68aa0e2-f66a-4b19-8f33-3c13fee4e5e3","query_id":"51","doc_a_id":"16734530","doc_b_id":"5500086","presented_order":["5500086","16734530"],"winner_id":"5500086","reasoning":"Document A is more relevant — it links a tumor biomarker signature with positive breast cancer outcomes, whereas B concerns ORAI1 SNPs unrelated to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903165Z"}
{"comparison_id":"ba37bc8b-12ab-41bf-af93-f94c4ed4c37f","query_id":"51","doc_a_id":"25732836","doc_b_id":"25973484","presented_order":["25973484","25732836"],"winner_id":"25732836","reasoning":"Reason: Document B addresses prognostic biomarkers and outcome prediction in breast cancer, which is more relevant to a claim about a biomarker (ALDH1) and outcomes than Document A's obesity-focused review.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903172Z"}
{"comparison_id":"787ac9dd-a8d9-4af1-9a9c-6e927ca68c91","query_id":"51","doc_a_id":"20183360","doc_b_id":"4429932","presented_order":["20183360","4429932"],"winner_id":"4429932","reasoning":"Document B — it discusses a molecule whose expression is explicitly linked to patient outcomes in breast cancer, matching the claim's focus on expression–outcome association.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903178Z"}
{"comparison_id":"4a4698ae-1c38-4d33-9001-8fba0096f902","query_id":"51","doc_a_id":"20127522","doc_b_id":"25732836","presented_order":["20127522","25732836"],"winner_id":"20127522","reasoning":"Neither document mentions ALDH1 or its expression; both focus on circulating tumor cells and imaging for metastatic breast cancer, so neither is relevant. If a choice is required: ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903185Z"}
{"comparison_id":"45fb8c98-9964-49bc-ac4e-ed33cbd28385","query_id":"51","doc_a_id":"43385013","doc_b_id":"7583725","presented_order":["43385013","7583725"],"winner_id":"43385013","reasoning":"Document A is more relevant — it addresses breast epithelial vs mesenchymal subpopulations and stem/progenitor properties (contexts where ALDH1 as a stem cell marker and its prognostic implications are discussed), whereas B focuses on TRPM7 and metastasis without relation to ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903192Z"}
{"comparison_id":"f5032785-2776-4194-b980-b5089709f320","query_id":"51","doc_a_id":"19673227","doc_b_id":"24341590","presented_order":["19673227","24341590"],"winner_id":"24341590","reasoning":"Document B is more relevant because it addresses clinical outcomes specifically in breast cancer patients, whereas Document A discusses a general chemosensitivity assay across epithelial tumors and not ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903198Z"}
{"comparison_id":"4a452029-6a62-43e1-8056-2897b1e99fad","query_id":"51","doc_a_id":"19673227","doc_b_id":"22712546","presented_order":["22712546","19673227"],"winner_id":"22712546","reasoning":"Document A is more relevant — it studies enzymatic activities and metabolic interactions in breast cancer tissue, which could include ALDH1-related findings; Document B focuses on CTC chemosensitivity, not ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903205Z"}
{"comparison_id":"6931ed80-d2ee-4644-a3ec-fbecb8725730","query_id":"51","doc_a_id":"20127522","doc_b_id":"22482820","presented_order":["20127522","22482820"],"winner_id":"20127522","reasoning":"Document A is more relevant because it addresses biomarkers and associations with breast cancer outcomes (prognostic correlation), whereas Document B focuses on treatment strategies rather than marker–outcome relationships.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903212Z"}
{"comparison_id":"763629a4-ee76-492e-8274-6a253c049396","query_id":"51","doc_a_id":"20127522","doc_b_id":"22712546","presented_order":["22712546","20127522"],"winner_id":"22712546","reasoning":"Document A is more relevant — it studies enzymatic activities and metabolic interactions in breast cancer tissue, which relates to ALDH1 expression, whereas Document B deals with circulating tumor cells unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903219Z"}
{"comparison_id":"05bc8cbd-a5cc-4ac6-82f8-c60beaade964","query_id":"51","doc_a_id":"15946643","doc_b_id":"22712546","presented_order":["15946643","22712546"],"winner_id":"22712546","reasoning":"Document B is more relevant — it profiles enzymatic (metabolic) activities in breast cancer tissue, which could include ALDH1 activity and its relation to tumor cells, whereas Document A focuses on CXCL1 signaling and chemoresistance without discussing ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903227Z"}
{"comparison_id":"5ad70d2e-146e-4a6b-87a4-c3fcf81b2888","query_id":"51","doc_a_id":"20333864","doc_b_id":"22975806","presented_order":["22975806","20333864"],"winner_id":"20333864","reasoning":"Document B is more relevant — it addresses molecular factors and cellular markers involved in breast tumor progression, which is closer to evidence about prognostic markers like ALDH1 than a study focused on BRCA allele loss.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903234Z"}
{"comparison_id":"d19584bf-507a-4bdd-886c-e7910f62cae6","query_id":"51","doc_a_id":"16086778","doc_b_id":"5579368","presented_order":["5579368","16086778"],"winner_id":"5579368","reasoning":"Document A — it discusses gene expression and breast cancer biomarkers (more directly related to ALDH1 expression) whereas B is about Numb/Notch signaling unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903240Z"}
{"comparison_id":"e5de383c-81f7-4025-8c89-9c3f953558b6","query_id":"51","doc_a_id":"4889228","doc_b_id":"7583725","presented_order":["4889228","7583725"],"winner_id":"7583725","reasoning":"Reason: Neither abstract mentions ALDH1, but Document B explicitly links a biomarker's expression level to patient outcomes, making it slightly more relevant to a claim about marker-expression associations and breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903247Z"}
{"comparison_id":"c609eb12-8773-4762-b1d1-ae35dff4eccf","query_id":"51","doc_a_id":"16086778","doc_b_id":"25732836","presented_order":["25732836","16086778"],"winner_id":"16086778","reasoning":"Document B — it addresses molecular markers and pathways tied to breast cancer biology, which is closer to a claim about a protein marker (ALDH1) than an imaging/CTC prognostic study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903255Z"}
{"comparison_id":"f030da89-2dfc-4152-a78d-2ae15277690e","query_id":"51","doc_a_id":"12762485","doc_b_id":"19358586","presented_order":["12762485","19358586"],"winner_id":"12762485","reasoning":"Document A — it discusses stem-cell versus luminal phenotypes in breast cancer, which is more related to ALDH1 (a cancer stem-cell marker) than the proteomics/miRNA focus of B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903262Z"}
{"comparison_id":"3b3ec415-463a-4934-9cd0-218944c9ce97","query_id":"51","doc_a_id":"43385013","doc_b_id":"4429932","presented_order":["4429932","43385013"],"winner_id":"43385013","reasoning":"Document B — it addresses stem cell/progenitor properties in breast cell subpopulations (more directly related to markers like ALDH1) while A discusses LOX and metastasis with no connection to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903269Z"}
{"comparison_id":"8b536449-a889-45c0-a5cc-62f1be56ba96","query_id":"51","doc_a_id":"22712546","doc_b_id":"45638119","presented_order":["22712546","45638119"],"winner_id":"45638119","reasoning":"Document B is directly about ALDH1 in breast cancer and states it predicts poor clinical outcome, which directly addresses the claim. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903275Z"}
{"comparison_id":"36e6ee3a-23d9-4995-98b0-cb81ee5481d8","query_id":"51","doc_a_id":"8891333","doc_b_id":"9600826","presented_order":["9600826","8891333"],"winner_id":"8891333","reasoning":"B is more relevant — it discusses breast cancer stem cells and markers related to prognosis/therapy, which is closer to ALDH1's role than the angiogenesis-focused Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903282Z"}
{"comparison_id":"c3e4feee-9713-407c-aca3-dcb10c024b86","query_id":"51","doc_a_id":"21033230","doc_b_id":"7821634","presented_order":["7821634","21033230"],"winner_id":"21033230","reasoning":"Reason: Document B discusses molecular marker profiling and associations with patient outcomes/prognosis, which is more directly related to evaluating whether a marker's (like ALDH1) expression correlates with breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903289Z"}
{"comparison_id":"4ee7c066-d51f-4972-b9fa-58f681c6503b","query_id":"51","doc_a_id":"3285322","doc_b_id":"8891333","presented_order":["3285322","8891333"],"winner_id":"8891333","reasoning":"Document B is more relevant because it discusses cancer stem cells and mechanisms in breast cancer (ALDH1 is a stem-cell marker), while A focuses on BRCA mutation clinical features. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903298Z"}
{"comparison_id":"2f4e1d66-a67d-4e83-bc09-2b05679095d5","query_id":"51","doc_a_id":"19358586","doc_b_id":"20183360","presented_order":["20183360","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant — it discusses prognostic protein signatures and survival outcomes in breast cancer, which is closer to assessing associations between marker expression and patient outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903306Z"}
{"comparison_id":"ce8f2c5e-36d8-4b3f-897a-57d1b3ab2edb","query_id":"51","doc_a_id":"825728","doc_b_id":"8963413","presented_order":["8963413","825728"],"winner_id":"8963413","reasoning":"Document A is more relevant because it directly discusses biomarker expression associated with better breast cancer outcomes, whereas Document B focuses on EMT/Prrx1 and metastasis without addressing ALDH1 or breast-specific biomarker outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903313Z"}
{"comparison_id":"ca6ec2bb-c390-4f2e-9172-c44a255d3bf8","query_id":"51","doc_a_id":"25973484","doc_b_id":"4702639","presented_order":["25973484","4702639"],"winner_id":"4702639","reasoning":"Document B — it addresses tumor stemness and stem-cell–related pathways (more relevant to ALDH1, a cancer stem cell marker), whereas A discusses obesity and breast cancer risk without ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903320Z"}
{"comparison_id":"8e93999a-68ff-4c6e-8746-d0839f30ef9b","query_id":"51","doc_a_id":"20183360","doc_b_id":"22401720","presented_order":["22401720","20183360"],"winner_id":"22401720","reasoning":"Document A is slightly more relevant because it discusses prognostic markers and outcome correlations in breast cancer, whereas Document B focuses on transcriptional regulation of invasion without linking to clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903328Z"}
{"comparison_id":"624ce192-b7e3-4e07-8295-f2d7860a8917","query_id":"51","doc_a_id":"24249915","doc_b_id":"7821634","presented_order":["7821634","24249915"],"winner_id":"7821634","reasoning":"Document A is more relevant — it discusses expression of a molecular marker (DUSP4) and its correlation with outcomes/chemotherapy response in breast cancer, which is closer to the ALDH1–outcome topic than Document B's focus on ERβ methylation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903335Z"}
{"comparison_id":"4729633d-9724-43f6-a0a3-ed8c195b1ba7","query_id":"51","doc_a_id":"19358586","doc_b_id":"8891333","presented_order":["8891333","19358586"],"winner_id":"8891333","reasoning":"Document A is more relevant because it discusses cancer stem cells in breast cancer (ALDH1 is a cancer stem cell marker), whereas Document B focuses on a different protein/miRNA signature not related to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903342Z"}
{"comparison_id":"15861382-e21e-4cf9-8d72-ebaafbce4fc8","query_id":"51","doc_a_id":"21033230","doc_b_id":"22975806","presented_order":["21033230","22975806"],"winner_id":"21033230","reasoning":"Document A is more relevant — it discusses molecular profiling and prognostic markers in breast cancer (potentially related to marker-outcome associations), whereas Document B focuses on BRCA allele loss and not marker expression like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903349Z"}
{"comparison_id":"bbe5cc30-c436-454c-abf9-c7c8f352b1ba","query_id":"51","doc_a_id":"313403","doc_b_id":"32001951","presented_order":["313403","32001951"],"winner_id":"313403","reasoning":"Document A is more relevant — it deals with prognostic markers and clinical outcomes in breast cancer, which relates to the claim about ALDH1 and outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903356Z"}
{"comparison_id":"b3dc18f9-f786-4ed3-9c84-02494fa560cf","query_id":"51","doc_a_id":"20183360","doc_b_id":"3285322","presented_order":["3285322","20183360"],"winner_id":"3285322","reasoning":"Document A is more relevant — it discusses clinical/pathologic features and outcomes in breast cancer subtypes (e.g., triple-negative) which is closer to linking a marker like ALDH1 to prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903362Z"}
{"comparison_id":"19085da6-2d2e-4ff1-893b-7b08c0edfbfd","query_id":"51","doc_a_id":"15113221","doc_b_id":"22401720","presented_order":["15113221","22401720"],"winner_id":"22401720","reasoning":"Document B is more relevant — it examines expression of multiple markers in primary breast cancer and relates marker levels to prognosis, whereas Document A focuses on a PTEN-related signature without addressing ALDH1 or similar prognostic markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903369Z"}
{"comparison_id":"87d437c8-0d9b-433f-bcf5-0bcae3048567","query_id":"51","doc_a_id":"21033230","doc_b_id":"4889228","presented_order":["4889228","21033230"],"winner_id":"21033230","reasoning":"Neither document mentions ALDH1. B is marginally more relevant because it discusses molecular markers on circulating tumor cells and their association with prognosis, whereas A focuses on TDP43/SRSF3 splicing in TNBC.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903376Z"}
{"comparison_id":"a3e51955-4921-4a8d-bae9-45579113c0a3","query_id":"51","doc_a_id":"18953920","doc_b_id":"9600826","presented_order":["18953920","9600826"],"winner_id":"18953920","reasoning":"Document A — it links acquisition of stem-cell markers in mammary cells to increased tumorigenicity, which is relevant to ALDH1 (a stem-cell marker) and its association with outcomes. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903383Z"}
{"comparison_id":"63720b52-87bb-40ed-ad2c-8d8e4805ef94","query_id":"51","doc_a_id":"19673227","doc_b_id":"43385013","presented_order":["43385013","19673227"],"winner_id":"43385013","reasoning":"Document A is more relevant — it studies breast epithelial/mesenchymal subpopulations and stem/progenitor properties (closer to ALDH1 as a stem cell marker and outcome studies) while B focuses on CTC chemosensitivity across tumors and not ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903391Z"}
{"comparison_id":"d3865847-77c0-4f5b-a00e-03fd0c8fb407","query_id":"51","doc_a_id":"31311495","doc_b_id":"5579368","presented_order":["31311495","5579368"],"winner_id":"5579368","reasoning":"Document B — it addresses gene expression and breast cancer biomarkers (analysis tools that could evaluate ALDH1 expression), whereas A focuses on tamoxifen resistance/EMT without mentioning ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903398Z"}
{"comparison_id":"c76a5439-633c-482f-b4af-6f666f4cab15","query_id":"51","doc_a_id":"3285322","doc_b_id":"7821634","presented_order":["7821634","3285322"],"winner_id":"7821634","reasoning":"Doc A is more relevant — it links a molecular marker's expression (DUSP4) to chemotherapy response and patient outcomes, which is closer to the claim about a marker (ALDH1) and outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903405Z"}
{"comparison_id":"cfe24dd3-0c72-4636-8fc4-1a46317adac7","query_id":"51","doc_a_id":"20127522","doc_b_id":"31311495","presented_order":["31311495","20127522"],"winner_id":"31311495","reasoning":"Document A is more relevant — it addresses molecular changes and tumor cell behavior linked to prognosis in breast cancer, whereas Document B focuses solely on circulating tumor cell counts. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903412Z"}
{"comparison_id":"4dd88413-63b7-457b-9ccd-d5fd6f89f79a","query_id":"51","doc_a_id":"2014909","doc_b_id":"31311495","presented_order":["2014909","31311495"],"winner_id":"2014909","reasoning":"Document A — it discusses tumor-initiating cells and analyses of primary breast cancers, which is more likely to relate to ALDH1 (a stem/tumor-initiating cell marker). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903418Z"}
{"comparison_id":"082e8c4e-4da2-47ef-b97c-3b880ba95395","query_id":"51","doc_a_id":"15113221","doc_b_id":"5500086","presented_order":["15113221","5500086"],"winner_id":"5500086","reasoning":"Document B — it discusses a molecular signature (type I IFN) that correlates with positive breast cancer outcomes, which is more conceptually related to the claim about a biomarker (ALDH1) and outcomes than Document A's focus on PTEN-associated poor prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903426Z"}
{"comparison_id":"006ee87e-5adb-43a9-902b-f8909013a5d9","query_id":"51","doc_a_id":"25732836","doc_b_id":"4455466","presented_order":["25732836","4455466"],"winner_id":"4455466","reasoning":"Document B — it discusses a molecular marker whose expression level correlates with breast cancer prognosis, which is conceptually relevant to a claim about ALDH1 expression and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903432Z"}
{"comparison_id":"7c5f6f69-23d6-4bac-823f-459d61c36dd6","query_id":"51","doc_a_id":"16734530","doc_b_id":"45638119","presented_order":["16734530","45638119"],"winner_id":"45638119","reasoning":"Document B — it directly studies ALDH1 and reports its association with poor breast cancer prognosis, which is directly relevant (and contradictory) to the claim. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903439Z"}
{"comparison_id":"35d19b1c-0069-4c7a-82d9-c7977e2b68ce","query_id":"51","doc_a_id":"11484808","doc_b_id":"7821634","presented_order":["11484808","7821634"],"winner_id":"11484808","reasoning":"Document A is more likely to discuss biomarkers and their clinical associations in endocrine-related cancers (including breast cancer), whereas Document B focuses specifically on DUSP4 and chemotherapy resistance. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903445Z"}
{"comparison_id":"049b311b-3a25-447f-b24c-e7b1675a0e62","query_id":"51","doc_a_id":"24249915","doc_b_id":"9600826","presented_order":["9600826","24249915"],"winner_id":"24249915","reasoning":"Document B — it discusses changes in expression of a breast cancer marker (ERβ) and its clinical relevance, which is more related to ALDH1 expression/outcomes than the angiogenesis pathway in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903453Z"}
{"comparison_id":"c1b20601-e906-4c00-b547-6ebfe97b146f","query_id":"51","doc_a_id":"21033230","doc_b_id":"24341590","presented_order":["24341590","21033230"],"winner_id":"21033230","reasoning":"Document B — it deals with molecular marker profiling and prognostic associations in breast cancer, which is more closely related to a claim about a marker's (ALDH1) association with outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903459Z"}
{"comparison_id":"d49e1c6c-e70c-4a6b-8b59-d90eaa34545f","query_id":"51","doc_a_id":"22975806","doc_b_id":"4889228","presented_order":["22975806","4889228"],"winner_id":"4889228","reasoning":"Document B is more relevant — it addresses how expression of a protein (TDP43) correlates with prognosis in breast cancer, which is similar to the query about marker expression and outcomes. Document A does not discuss marker expression or outcome associations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903466Z"}
{"comparison_id":"98869325-e551-4c3a-91de-3bb667313651","query_id":"51","doc_a_id":"21033230","doc_b_id":"9600826","presented_order":["9600826","21033230"],"winner_id":"21033230","reasoning":"Document B — it discusses molecular markers and prognostic/predictive associations in breast cancer, which is closer to the claim about a marker (ALDH1) and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903473Z"}
{"comparison_id":"aa91ed84-b82c-42c4-a1c0-03fccbd93c8c","query_id":"51","doc_a_id":"20333864","doc_b_id":"21033230","presented_order":["21033230","20333864"],"winner_id":"21033230","reasoning":"Document A is more focused on prognostic markers and outcomes in breast cancer (predictive value of CTC profiling), which is more relevant to a claim about a marker's association with outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903479Z"}
{"comparison_id":"2a6f4e07-bdbb-4300-84d2-a340eab57a60","query_id":"51","doc_a_id":"15946643","doc_b_id":"20183360","presented_order":["15946643","20183360"],"winner_id":"20183360","reasoning":"Document B is more relevant — it addresses transcriptional regulation of invasiveness and factors (GATA3) linked to prognosis in breast cancer, which is closer to outcome-related markers than the chemoresistance-focused CXCL1 network in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903487Z"}
{"comparison_id":"98201a79-c5b1-41ed-8298-d6af839273db","query_id":"51","doc_a_id":"20127522","doc_b_id":"5579368","presented_order":["20127522","5579368"],"winner_id":"5579368","reasoning":"Document B is more relevant — it concerns genomic/epigenetic analysis and correlating methylation with gene expression for breast cancer biomarkers (more likely to address ALDH1 expression) while Document A focuses on circulating tumor cells and treatment monitoring, not ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903494Z"}
{"comparison_id":"f8f311a0-fa23-4cd1-adbc-85fc3b44f098","query_id":"51","doc_a_id":"16691520","doc_b_id":"43385013","presented_order":["16691520","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it addresses stem cell/progenitor properties in breast cell subpopulations (ALDH1 is a breast stem cell marker), whereas Document A focuses on estrogen receptor binding sites and not stem cell markers or outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903501Z"}
{"comparison_id":"8740f236-eb17-4a86-ad79-07f8a4aa7807","query_id":"51","doc_a_id":"19358586","doc_b_id":"825728","presented_order":["825728","19358586"],"winner_id":"825728","reasoning":"Document A is slightly more relevant because it discusses cancer stem cell properties and links to patient survival, whereas Document B focuses on a Myc/p27/phospho-Rb signature and miRNAs without addressing ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903507Z"}
{"comparison_id":"98fc4a90-178f-4b87-a4bf-36bb8e05fb06","query_id":"51","doc_a_id":"15113221","doc_b_id":"3285322","presented_order":["3285322","15113221"],"winner_id":"15113221","reasoning":"Document B is more relevant — it concerns gene expression signatures linked to prognosis, which is closer to evaluating whether expression of a specific marker (like ALDH1) associates with outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903514Z"}
{"comparison_id":"248a8a6b-403f-4483-b3dc-5ae25ee3fa8d","query_id":"51","doc_a_id":"1171121","doc_b_id":"4455466","presented_order":["1171121","4455466"],"winner_id":"4455466","reasoning":"Document B is more relevant — it discusses gene expression levels linked to breast cancer prognosis, whereas Document A focuses on microvessel density and p53, not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903521Z"}
{"comparison_id":"bf1424b1-67a5-4401-885a-907aebb97b48","query_id":"51","doc_a_id":"22482820","doc_b_id":"45638119","presented_order":["22482820","45638119"],"winner_id":"45638119","reasoning":"Document B is directly about ALDH1 and reports it predicts poor clinical outcome (contradicting the claim); Document A does not discuss ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903527Z"}
{"comparison_id":"9333526c-6f79-4166-8d31-6e61ebbe18b0","query_id":"51","doc_a_id":"5579368","doc_b_id":"9600826","presented_order":["5579368","9600826"],"winner_id":"5579368","reasoning":"Document A is more relevant — it discusses breast cancer biomarkers and correlating gene expression with outcomes, whereas B focuses on a different pathway (GEP100-Arf6-AMAP1-cortactin) unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903534Z"}
{"comparison_id":"d5c0ff37-06dd-4977-a007-44b6796bdcfc","query_id":"51","doc_a_id":"16734530","doc_b_id":"19673227","presented_order":["16734530","19673227"],"winner_id":"16734530","reasoning":"Document A is more relevant — it specifically studies breast cancer (the same disease as the query), whereas Document B addresses chemosensitivity of circulating tumor cells across epithelial tumors and is less directly related to ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903542Z"}
{"comparison_id":"10cc2581-88ef-4b6f-b61b-ba79755dc516","query_id":"51","doc_a_id":"22482820","doc_b_id":"8891333","presented_order":["22482820","8891333"],"winner_id":"8891333","reasoning":"Document B — it discusses cancer stem cells in breast cancer and pathways/markers related to stemness (more directly relevant to ALDH1), while A focuses on drug-delivery combination therapies and doesn't address ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903549Z"}
{"comparison_id":"3b8566bf-27ef-4aa0-b34a-8bf8509ac3f1","query_id":"51","doc_a_id":"20333864","doc_b_id":"3285322","presented_order":["3285322","20333864"],"winner_id":"20333864","reasoning":"Neither abstract mentions ALDH1, but Document B discusses molecular mechanisms of progression and tumor microenvironment relevant to prognostic markers, so it's more related. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903555Z"}
{"comparison_id":"b2d8d164-40ae-435c-b8ab-8a9705fd6204","query_id":"51","doc_a_id":"16734530","doc_b_id":"4702639","presented_order":["4702639","16734530"],"winner_id":"16734530","reasoning":"B is more relevant — it studies clinical associations in breast cancer patients, whereas A focuses on an integrin/KRAS pathway in other carcinomas and does not address ALDH1 or breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903562Z"}
{"comparison_id":"4d81783e-771a-456b-96c7-fadedf11dfb0","query_id":"51","doc_a_id":"16691520","doc_b_id":"5579368","presented_order":["5579368","16691520"],"winner_id":"5579368","reasoning":"Reason: Document A discusses correlating DNA methylation with gene expression in breast cancer biomarkers, which is more directly relevant to evidence about ALDH1 expression and outcomes than Document B's focus on estrogen receptor binding sites.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903569Z"}
{"comparison_id":"2220b47a-296a-4c88-889f-b4b6e127ce39","query_id":"51","doc_a_id":"19358586","doc_b_id":"21033230","presented_order":["21033230","19358586"],"winner_id":"21033230","reasoning":"Document A is more relevant — it discusses molecular marker profiling and prognostic associations in breast cancer, whereas B focuses on a different miRNA/protein signature. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903576Z"}
{"comparison_id":"7536ebd6-37a4-4def-8d84-270b4c7575c1","query_id":"51","doc_a_id":"4889228","doc_b_id":"9600826","presented_order":["4889228","9600826"],"winner_id":"4889228","reasoning":"Document A is more relevant — it discusses prognostic markers and outcomes in breast cancer, whereas Document B focuses on angiogenesis pathways without addressing prognostic markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903583Z"}
{"comparison_id":"23f7c86c-b6b9-49b4-bd7e-66292e21c662","query_id":"51","doc_a_id":"20183360","doc_b_id":"34066665","presented_order":["34066665","20183360"],"winner_id":"34066665","reasoning":"Document A is more relevant — it addresses clinical implications and endocrine therapy resistance in breast cancer, which relate to outcomes; Document B focuses on molecular invasion mechanisms without clinical outcome data.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903590Z"}
{"comparison_id":"d0fcec5d-948f-4ad0-926e-806dfd11263b","query_id":"51","doc_a_id":"20127522","doc_b_id":"2931832","presented_order":["2931832","20127522"],"winner_id":"2931832","reasoning":"Reason: Neither paper mentions ALDH1, but Document A discusses a prognostic biomarker linked to disease-free survival in breast cancer, so it is slightly more relevant to the claim about a marker's association with outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903598Z"}
{"comparison_id":"4f47e555-fcf7-4633-8d5b-36b206bd338e","query_id":"51","doc_a_id":"1171121","doc_b_id":"4429932","presented_order":["1171121","4429932"],"winner_id":"1171121","reasoning":"Document A is more relevant — it discusses prognostic markers in breast cancer (MVD and p53), whereas Document B focuses on LOX and hypoxia-induced metastasis, not on ALDH1 or general prognostic marker associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903605Z"}
{"comparison_id":"9829b1de-9f51-47ab-ba36-242d7a814fb1","query_id":"51","doc_a_id":"2014909","doc_b_id":"22482820","presented_order":["22482820","2014909"],"winner_id":"2014909","reasoning":"Document B is more likely relevant because it analyzes tumor-initiating cells and primary breast cancers (contexts where ALDH1 is often studied), whereas Document A focuses on combination therapy delivery and drug resistance without addressing ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903613Z"}
{"comparison_id":"9591924d-31c8-4614-b4e3-76dce27ba5a4","query_id":"51","doc_a_id":"3285322","doc_b_id":"5579368","presented_order":["3285322","5579368"],"winner_id":"5579368","reasoning":"Document B is more relevant — it concerns analysis of DNA methylation and gene expression in breast cancer biomarkers, which is directly related to evaluating ALDH1 expression and its association with outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903620Z"}
{"comparison_id":"ad7ba1c9-bba9-41e4-b0ec-e84078d3549c","query_id":"51","doc_a_id":"16691520","doc_b_id":"24341590","presented_order":["24341590","16691520"],"winner_id":"24341590","reasoning":"Document A is more relevant — it directly addresses breast cancer clinical outcomes, whereas Document B focuses on transcriptional regulation without outcome data.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903628Z"}
{"comparison_id":"921e2ee7-2542-4256-8a28-fdf218a12068","query_id":"51","doc_a_id":"12762485","doc_b_id":"1866911","presented_order":["1866911","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses stem-cell versus luminal phenotypes and clinical correlations (proliferation, ER/PgR, differentiation), which is more directly relevant to ALDH1 (a stem-cell marker) and outcome than Document A's focus on luminal progenitors and BRCA1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903635Z"}
{"comparison_id":"17505315-a053-47ad-9f9e-b8e5d97bb35f","query_id":"51","doc_a_id":"1866911","doc_b_id":"20127522","presented_order":["1866911","20127522"],"winner_id":"1866911","reasoning":"Document A is more relevant — it discusses breast epithelial progenitor populations and their markers in tumor development, while Document B focuses on circulating tumor cells and treatment monitoring, not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903642Z"}
{"comparison_id":"0d33c78f-0737-4919-8701-489a823d3aa6","query_id":"51","doc_a_id":"20839751","doc_b_id":"5579368","presented_order":["5579368","20839751"],"winner_id":"5579368","reasoning":"Document A is more relevant — it discusses gene expression and breast cancer biomarkers (tools that could address ALDH1 expression associations), while Document B focuses on apoptosis and prognosis without mentioning ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903649Z"}
{"comparison_id":"ebc4df8e-222f-4ea6-afeb-ab1f040b4976","query_id":"51","doc_a_id":"16734530","doc_b_id":"25732836","presented_order":["25732836","16734530"],"winner_id":"25732836","reasoning":"Document A is more relevant — it studies prognostic markers and outcomes in breast cancer, whereas Document B focuses on ORAI1 SNPs unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903655Z"}
{"comparison_id":"8c0905be-0e92-46dc-9fb9-6108ff5776e2","query_id":"51","doc_a_id":"22712546","doc_b_id":"2931832","presented_order":["2931832","22712546"],"winner_id":"22712546","reasoning":"Document B is more relevant — it discusses enzymatic activity and metabolic profiling in breast cancer tissue, which is more likely to address ALDH1 expression than a study on platelet indices. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903662Z"}
{"comparison_id":"23ae926a-4487-4db0-9be0-0a395c3bf065","query_id":"51","doc_a_id":"4702639","doc_b_id":"5500086","presented_order":["4702639","5500086"],"winner_id":"4702639","reasoning":"Document A is more relevant — it addresses tumour stemness and stem-like markers, which relates directly to ALDH1 as a cancer stem cell marker; Document B focuses on type I interferon signaling and chemotherapy response without discussion of ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903669Z"}
{"comparison_id":"05b91339-b6c2-452f-9f7b-7eb9e87e65a3","query_id":"51","doc_a_id":"313403","doc_b_id":"9600826","presented_order":["9600826","313403"],"winner_id":"313403","reasoning":"Document B is more relevant — it addresses prognostic markers and clinical outcomes in breast cancer, whereas A focuses on an angiogenesis/invasion pathway without prognosis data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903676Z"}
{"comparison_id":"4b90e0c6-9675-42e2-9294-dcd628531443","query_id":"51","doc_a_id":"22712546","doc_b_id":"22975806","presented_order":["22975806","22712546"],"winner_id":"22712546","reasoning":"Document B is more relevant — it addresses in situ enzymatic/metabolic profiling in breast cancer tissue (which could include ALDH1 activity), while A focuses on BRCA allele loss unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903683Z"}
{"comparison_id":"e085fcc6-3b7d-43d7-8777-25d2eaaf9d8e","query_id":"51","doc_a_id":"12762485","doc_b_id":"27123743","presented_order":["12762485","27123743"],"winner_id":"12762485","reasoning":"Document A — it discusses stem-cell–like phenotypes and prognostic markers in breast cancer, which is more relevant to ALDH1 (a stem cell marker) than the birthweight/etiology focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903690Z"}
{"comparison_id":"8098df15-590a-468f-b349-e7388fc980c9","query_id":"51","doc_a_id":"5500086","doc_b_id":"8891333","presented_order":["8891333","5500086"],"winner_id":"8891333","reasoning":"Document A is more relevant — it discusses cancer stem cells in breast cancer (where ALDH1 is a stem-cell marker), whereas Document B focuses on type I interferon signaling and chemotherapy without addressing ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903696Z"}
{"comparison_id":"bb59aaf0-abcf-4af1-80ad-cc8b15cde01e","query_id":"51","doc_a_id":"24249915","doc_b_id":"3285322","presented_order":["24249915","3285322"],"winner_id":"24249915","reasoning":"Document A is more relevant — it discusses changes in expression of a breast cancer marker and its relation to cancer invasiveness, which is closer to a question about marker expression and outcomes than the BRCA-focused clinical study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903703Z"}
{"comparison_id":"8cb4bf8a-cc8c-47ec-bddd-db6e4999b124","query_id":"51","doc_a_id":"12762485","doc_b_id":"25732836","presented_order":["25732836","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses stem-cell–like phenotypes and prognostic markers in breast cancer (more relevant to ALDH1, a stem cell marker). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903710Z"}
{"comparison_id":"c68dfe4d-012d-4c75-a931-c7f9444858e6","query_id":"51","doc_a_id":"24249915","doc_b_id":"31311495","presented_order":["24249915","31311495"],"winner_id":"24249915","reasoning":"Document A is more relevant — it addresses marker expression changes in breast cancer and links expression loss to invasive disease, which relates to biomarker–outcome associations. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903717Z"}
{"comparison_id":"2df1c115-0436-46f2-bde3-f40da06182b3","query_id":"51","doc_a_id":"32001951","doc_b_id":"8963413","presented_order":["32001951","8963413"],"winner_id":"8963413","reasoning":"Document B is more relevant — it discusses expression of a marker (PD-L1) and its association with breast cancer outcomes, whereas A concerns alkaline phosphatase regulation and not outcome or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903724Z"}
{"comparison_id":"d1fedb38-66b5-479d-a2b3-ad579721b8d6","query_id":"51","doc_a_id":"22975806","doc_b_id":"7583725","presented_order":["22975806","7583725"],"winner_id":"7583725","reasoning":"Document B — it links a specific protein's expression to patient outcomes (predicts poor prognosis), so it's more relevant to a claim about marker expression being associated with breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903730Z"}
{"comparison_id":"83b7c971-2148-47d4-a4c8-392e3e4e859f","query_id":"51","doc_a_id":"1866911","doc_b_id":"4702639","presented_order":["1866911","4702639"],"winner_id":"1866911","reasoning":"Neither document mentions ALDH1. Document A is more relevant because it specifically addresses breast cancer cell populations and tumor origins, whereas B focuses on integrin/KRAS-driven stemness and drug resistance in other carcinomas.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903737Z"}
{"comparison_id":"a9082950-0bad-4405-a9d6-e0ffa12aa63d","query_id":"51","doc_a_id":"24249915","doc_b_id":"34066665","presented_order":["24249915","34066665"],"winner_id":"24249915","reasoning":"Neither document mentions ALDH1, but Document A (about ERβ expression changes in breast cancer) is slightly more relevant because it addresses marker expression and clinical changes in tumor tissue, whereas B focuses on signaling crosstalk and therapy resistance. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903744Z"}
{"comparison_id":"becf73be-3b7c-4536-a096-481b003cc5ce","query_id":"51","doc_a_id":"19358586","doc_b_id":"20839751","presented_order":["19358586","20839751"],"winner_id":"20839751","reasoning":"Document B is more relevant — it discusses biomarkers and their association with breast cancer prognosis, whereas Document A focuses on a miRNA/protein signature without ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903750Z"}
{"comparison_id":"4b6d2af7-f497-4e0f-859f-2bcfa9226628","query_id":"51","doc_a_id":"22401720","doc_b_id":"4702639","presented_order":["22401720","4702639"],"winner_id":"4702639","reasoning":"Document B is more relevant — it addresses tumour stemness and markers of stem-like cells (closer to ALDH1's role) while A focuses on angiogenic factors unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903757Z"}
{"comparison_id":"a0df0572-c215-4760-9bdd-5dc8b94e8952","query_id":"51","doc_a_id":"16734530","doc_b_id":"34066665","presented_order":["16734530","34066665"],"winner_id":"34066665","reasoning":"Document B is more relevant — it discusses molecular mechanisms affecting clinical outcomes and therapy resistance in breast cancer, which is closer to the claim about a marker (ALDH1) and outcomes than a paper on ORAI1 SNP associations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903763Z"}
{"comparison_id":"d12e4cdd-9f4b-4277-adcf-12a1ed1e7173","query_id":"51","doc_a_id":"16086778","doc_b_id":"22712546","presented_order":["22712546","16086778"],"winner_id":"22712546","reasoning":"Document A is more relevant — it examines enzymatic activities and metabolic markers in breast cancer tissue (more likely to address ALDH1 expression and its clinical associations). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903770Z"}
{"comparison_id":"af78496f-a7e9-495a-8ad6-a857ded3b6de","query_id":"51","doc_a_id":"19358586","doc_b_id":"22482820","presented_order":["19358586","22482820"],"winner_id":"19358586","reasoning":"Reason: Neither document mentions ALDH1, but Document A discusses protein signatures linked to patient survival (outcomes), making it marginally more relevant than Document B which focuses on therapies.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903776Z"}
{"comparison_id":"70c540e5-fe53-47f5-88a0-c2f4f03f4ee5","query_id":"51","doc_a_id":"4455466","doc_b_id":"45638119","presented_order":["4455466","45638119"],"winner_id":"45638119","reasoning":"Document B — it specifically discusses ALDH1 and states it predicts poor clinical outcome in breast cancer, directly addressing the claim. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903782Z"}
{"comparison_id":"8f5d4f4d-0cab-4a2c-b969-030bb55cf7a6","query_id":"51","doc_a_id":"21033230","doc_b_id":"25973484","presented_order":["25973484","21033230"],"winner_id":"21033230","reasoning":"Document B is more relevant — it deals with molecular markers and prognostic profiling in breast cancer, whereas A focuses on obesity and epidemiology. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903789Z"}
{"comparison_id":"762f67f6-f764-41b6-8c85-df951af54f4d","query_id":"51","doc_a_id":"24341590","doc_b_id":"2931832","presented_order":["24341590","2931832"],"winner_id":"2931832","reasoning":"Document B is more relevant — it examines a biomarker's association with breast cancer outcomes, whereas Document A focuses on CYP2D6 pharmacogenetics and tamoxifen response, not expression markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903796Z"}
{"comparison_id":"56710706-a2f3-4fd9-88af-e9474b4a47f9","query_id":"51","doc_a_id":"15946643","doc_b_id":"825728","presented_order":["15946643","825728"],"winner_id":"825728","reasoning":"Document B is more relevant — it links EMT, acquisition of stem-cell properties, and patient survival (likely discussing stem-cell markers such as ALDH1) which pertains to outcomes associated with ALDH1 expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903802Z"}
{"comparison_id":"73bfc2ad-5e79-4aba-813b-9e15f9183b55","query_id":"51","doc_a_id":"15946643","doc_b_id":"5579368","presented_order":["15946643","5579368"],"winner_id":"5579368","reasoning":"Document B is more relevant — it deals with gene expression and breast cancer biomarkers (and tools to correlate methylation with expression), which is closer to evaluating ALDH1 expression and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903809Z"}
{"comparison_id":"9bcd7cf3-d428-495a-95a1-e01369e21fa2","query_id":"51","doc_a_id":"22975806","doc_b_id":"4455466","presented_order":["4455466","22975806"],"winner_id":"4455466","reasoning":"Document A is more relevant — it discusses gene expression linked to breast cancer prognosis, whereas B focuses on BRCA allele loss heterogeneity unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903815Z"}
{"comparison_id":"12c95234-fdff-43bc-8b9f-b68d9414d496","query_id":"51","doc_a_id":"22401720","doc_b_id":"4429932","presented_order":["4429932","22401720"],"winner_id":"22401720","reasoning":"Document B is more relevant — it examines expression of multiple tumor markers in primary breast cancer and relates expression levels to prognosis, which is closer to assessing associations between marker expression and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903821Z"}
{"comparison_id":"a83dbbcb-3106-41ac-acfe-73ac7502eadc","query_id":"51","doc_a_id":"20839751","doc_b_id":"45638119","presented_order":["45638119","20839751"],"winner_id":"45638119","reasoning":"Document A is directly about ALDH1 and links its expression to clinical outcome (specifically poor prognosis), so it is most relevant to the claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903828Z"}
{"comparison_id":"25a1f9f2-ecc4-48c8-84ec-e20dc5ff0191","query_id":"51","doc_a_id":"7583725","doc_b_id":"7821634","presented_order":["7821634","7583725"],"winner_id":"7821634","reasoning":"Neither document mentions ALDH1. Document A is slightly more relevant because it discusses protein expression associated with chemotherapy response and patient outcomes in breast cancer, which is closer to the claim's topic.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903835Z"}
{"comparison_id":"aab17a6f-0594-4e51-aa6d-0534225c3d89","query_id":"51","doc_a_id":"15946643","doc_b_id":"5500086","presented_order":["5500086","15946643"],"winner_id":"5500086","reasoning":"Document A is more relevant — it links a molecular expression signature to positive clinical outcomes in breast cancer, while B focuses on chemoresistance/metastasis without relating marker expression to better outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903842Z"}
{"comparison_id":"6d15f95a-a3fd-4f97-b62d-d512235c693f","query_id":"51","doc_a_id":"1866911","doc_b_id":"8963413","presented_order":["8963413","1866911"],"winner_id":"8963413","reasoning":"Document A is more relevant — it discusses biomarker expression linked to breast cancer clinical outcomes, while B focuses on cell-of-origin biology (c-KIT) without prognosis or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903848Z"}
{"comparison_id":"ab352ec0-af57-4b9c-8b5d-34bab293e44c","query_id":"51","doc_a_id":"22712546","doc_b_id":"24834968","presented_order":["22712546","24834968"],"winner_id":"22712546","reasoning":"Document A is more relevant — it discusses measuring enzymatic activities in breast cancer tissue (likely including markers like ALDH1) and metabolic interactions in the tumor microenvironment. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903854Z"}
{"comparison_id":"314a0a09-4cf5-451e-ae56-3d5333f4f629","query_id":"51","doc_a_id":"18953920","doc_b_id":"4455466","presented_order":["4455466","18953920"],"winner_id":"18953920","reasoning":"Document B — it discusses acquisition of stem-cell markers and increased tumorigenicity in mammary cells (ALDH1 is a known breast cancer stem-cell marker), so it more directly bears on whether ALDH1 expression relates to outcomes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.903862Z"}
{"comparison_id":"2d7b554c-6aa6-4f4b-9143-520eb910612e","query_id":"51","doc_a_id":"18953920","doc_b_id":"31311495","presented_order":["18953920","31311495"],"winner_id":"18953920","reasoning":"Document A — it discusses stem-cell markers and tumorigenic potential in breast epithelial cells (more likely to mention ALDH1 and its clinical associations), whereas Document B focuses on tamoxifen resistance and beta-catenin signaling. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904283Z"}
{"comparison_id":"46426cd5-b19e-4c74-a83d-36d17f030e1a","query_id":"51","doc_a_id":"25973484","doc_b_id":"4455466","presented_order":["4455466","25973484"],"winner_id":"4455466","reasoning":"Document A is more relevant — it discusses gene expression levels linked to breast cancer prognosis, whereas Document B focuses on obesity-related risk factors and not gene expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904291Z"}
{"comparison_id":"f1542bd8-5679-4239-ae19-476e28ab75f8","query_id":"51","doc_a_id":"19358586","doc_b_id":"2931832","presented_order":["2931832","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant — it discusses molecular/protein signatures and their association with survival in breast cancer, which is closer to a claim about a molecular marker like ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904298Z"}
{"comparison_id":"849c756c-dada-4f0c-a82a-71660f723d1f","query_id":"51","doc_a_id":"15946643","doc_b_id":"19673227","presented_order":["15946643","19673227"],"winner_id":"15946643","reasoning":"Document A is more relevant — it focuses on breast cancer biology and factors affecting chemoresistance/metastasis, whereas Document B describes a general chemosensitivity assay across epithelial tumors and does not address ALDH1 or breast-specific markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904305Z"}
{"comparison_id":"21c995f8-e6e8-4c12-996d-396202e3dd03","query_id":"51","doc_a_id":"31311495","doc_b_id":"45638119","presented_order":["31311495","45638119"],"winner_id":"45638119","reasoning":"Document B is directly about ALDH1 and states it predicts poor clinical outcome in breast cancer, which is directly relevant to the claim. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904312Z"}
{"comparison_id":"f68ffaf7-b22d-4c6f-b9ba-dad119312f2a","query_id":"51","doc_a_id":"12762485","doc_b_id":"15946643","presented_order":["12762485","15946643"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses stem-cell–like phenotypes and marker correlations in breast cancer, which is related to ALDH1 as a stem cell marker.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904318Z"}
{"comparison_id":"4f96e30d-ed32-4f54-a531-3e6737c152b3","query_id":"51","doc_a_id":"5500086","doc_b_id":"825728","presented_order":["5500086","825728"],"winner_id":"825728","reasoning":"Document B is more relevant — it discusses acquisition of stem cell properties and links those changes to patient survival and metastasis, which is directly related to ALDH1 as a stem-cell marker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904325Z"}
{"comparison_id":"160ce6ab-450f-4cf5-865b-313700d17be4","query_id":"51","doc_a_id":"15946643","doc_b_id":"20839751","presented_order":["15946643","20839751"],"winner_id":"20839751","reasoning":"Reason: The query asks about a prognostic marker (ALDH1) and outcomes; Document B discusses apoptosis and associations with prognosis in breast cancer, making it more related to outcomes than Document A's focus on CXCL1 signaling and chemoresistance.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904331Z"}
{"comparison_id":"4bb46765-bda0-4512-9fad-56d43651942b","query_id":"51","doc_a_id":"1866911","doc_b_id":"18953920","presented_order":["1866911","18953920"],"winner_id":"18953920","reasoning":"Document B — it discusses acquisition of stem-cell markers and tumorigenic potential in mammary cells, which is more related to ALDH1 (a stem-cell marker) than Document A. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904337Z"}
{"comparison_id":"fec0835d-90df-4118-91e0-75ec62f945fe","query_id":"51","doc_a_id":"22482820","doc_b_id":"25732836","presented_order":["25732836","22482820"],"winner_id":"25732836","reasoning":"Document A is more focused on prognostic biomarkers and outcome prediction in breast cancer, closer to the claim about a marker's association with outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904343Z"}
{"comparison_id":"b79cbbde-b3ce-45a9-bf84-49c6d561df53","query_id":"51","doc_a_id":"16691520","doc_b_id":"22401720","presented_order":["16691520","22401720"],"winner_id":"22401720","reasoning":"Doc B is more relevant because it examines expression of markers in primary breast cancer and relates expression levels to prognosis/outcomes, whereas Doc A focuses on estrogen receptor binding sites without outcome data. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904350Z"}
{"comparison_id":"2abc80fb-59e0-4687-be69-63c65caa6655","query_id":"51","doc_a_id":"24249915","doc_b_id":"25732836","presented_order":["24249915","25732836"],"winner_id":"25732836","reasoning":"Document B is more relevant because it deals with biomarkers and their association with breast cancer outcomes, whereas Document A focuses on ERβ expression and methylation without relating to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904357Z"}
{"comparison_id":"9ba106ee-718a-4f84-aa3d-610cd2bc091a","query_id":"51","doc_a_id":"12762485","doc_b_id":"22482820","presented_order":["12762485","22482820"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses stem-cell–like phenotypes and marker correlations in breast cancer (which relate to prognostic marker studies), whereas Document B focuses on treatment strategies. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904363Z"}
{"comparison_id":"9f4664ac-5dfb-42d7-aad4-eea39403f5d6","query_id":"51","doc_a_id":"25973484","doc_b_id":"7583725","presented_order":["7583725","25973484"],"winner_id":"7583725","reasoning":"Reason: Document A discusses a protein's expression level being linked to breast cancer outcomes, so it's more relevant to a claim about marker expression and prognosis than the obesity-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904369Z"}
{"comparison_id":"3d4a8961-9283-44a5-a998-a9a60bcddf2d","query_id":"51","doc_a_id":"4455466","doc_b_id":"4889228","presented_order":["4889228","4455466"],"winner_id":"4455466","reasoning":"Document B is more relevant — it directly links gene expression levels to breast cancer prognosis, whereas Document A focuses on TDP43/SRSF3 in TNBC without addressing expression–outcome associations like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904375Z"}
{"comparison_id":"f1af5fa6-3019-4c5e-9053-625cdc73ec25","query_id":"51","doc_a_id":"20127522","doc_b_id":"24834968","presented_order":["24834968","20127522"],"winner_id":"24834968","reasoning":"Document A is more relevant — it discusses biological markers as predictors of response/outcomes in primary breast cancer, whereas Document B focuses on circulating tumor cells in metastatic disease. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904382Z"}
{"comparison_id":"dac45bd8-e8f5-4032-b07f-d975743f8b76","query_id":"51","doc_a_id":"16691520","doc_b_id":"18953920","presented_order":["16691520","18953920"],"winner_id":"18953920","reasoning":"Document B is more relevant — it discusses EMT and acquisition of stem-cell markers (like ALDH1) and tumorigenic potential, which is directly related to ALDH1's role in breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904388Z"}
{"comparison_id":"544765c1-f243-4443-92e3-ccff68a50259","query_id":"51","doc_a_id":"15946643","doc_b_id":"4455466","presented_order":["15946643","4455466"],"winner_id":"4455466","reasoning":"Reason: Document B discusses how expression level of a molecular marker (ZMYND11) correlates with breast cancer prognosis, making it more relevant to a claim about marker expression and outcomes than Document A, which focuses on CXCL1-driven chemoresistance/metastasis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904394Z"}
{"comparison_id":"2cf5c8f4-9a82-4923-8d94-1aa996f8d47d","query_id":"51","doc_a_id":"31311495","doc_b_id":"3285322","presented_order":["3285322","31311495"],"winner_id":"31311495","reasoning":"Document B is more relevant — it discusses cellular behavior and therapy resistance (EMT, markers linked to aggressiveness), which is closer to studies of ALDH1 expression and outcomes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904401Z"}
{"comparison_id":"3a162cde-a260-488a-91d0-d5a8f7135772","query_id":"51","doc_a_id":"12762485","doc_b_id":"22975806","presented_order":["12762485","22975806"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses stem-cell–like phenotypes and markers in breast cancer (closer to ALDH1's role as a stem cell marker), whereas Document B focuses on BRCA allele loss unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904408Z"}
{"comparison_id":"5df5da63-82b6-47e3-b997-d29a66500329","query_id":"51","doc_a_id":"16086778","doc_b_id":"4702639","presented_order":["16086778","4702639"],"winner_id":"4702639","reasoning":"Document B — it discusses tumour stemness and marker-driven outcomes (ALDH1 is a cancer stem cell marker), so B is more related to claims about marker expression and prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904414Z"}
{"comparison_id":"22c6ea8c-14ac-49ed-9a45-bd892abca23f","query_id":"51","doc_a_id":"16691520","doc_b_id":"8891333","presented_order":["16691520","8891333"],"winner_id":"8891333","reasoning":"Document B — it discusses cancer stem cells in breast cancer (where ALDH1 is a known stem-cell marker) and therapy implications, making it more directly relevant to ALDH1-related outcomes than the estrogen receptor binding study. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904421Z"}
{"comparison_id":"a3747c82-3a98-4e77-89fa-78eea6a99b31","query_id":"51","doc_a_id":"2014909","doc_b_id":"25732836","presented_order":["25732836","2014909"],"winner_id":"2014909","reasoning":"Document B is more relevant — it studies tumor-initiating cells and analyzes primary breast cancers, which is more directly related to ALDH1 (a tumor-initiating/stem cell marker) than Document A's focus on CTCs and PET/CT.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904427Z"}
{"comparison_id":"767a58ec-076b-4419-9f3d-ca25325a44e2","query_id":"51","doc_a_id":"20333864","doc_b_id":"4889228","presented_order":["20333864","4889228"],"winner_id":"20333864","reasoning":"Neither document mentions ALDH1. Document A is marginally more relevant because it addresses molecular factors in breast cancer progression broadly, whereas B focuses narrowly on a splicing regulator in TNBC.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904434Z"}
{"comparison_id":"02aa1823-beb0-46e9-ad16-502a2252d67e","query_id":"51","doc_a_id":"11484808","doc_b_id":"20183360","presented_order":["20183360","11484808"],"winner_id":"20183360","reasoning":"Document A is more directly about breast cancer biology and tumor behavior, making it more relevant to a claim about a breast cancer marker like ALDH1 than a general review on ncRNAs in endocrine cancers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904440Z"}
{"comparison_id":"e5b26e90-c75d-4f5d-91d6-0541ae25ad80","query_id":"51","doc_a_id":"19673227","doc_b_id":"7583725","presented_order":["19673227","7583725"],"winner_id":"7583725","reasoning":"Document B is more relevant — it directly examines a breast cancer marker and patient outcomes, whereas A discusses chemosensitivity assays across epithelial tumors without addressing ALDH1 or breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904447Z"}
{"comparison_id":"186b19fa-5323-4986-913d-187c47e2bde2","query_id":"51","doc_a_id":"22712546","doc_b_id":"9600826","presented_order":["22712546","9600826"],"winner_id":"22712546","reasoning":"Document A is more relevant — it addresses in situ enzymatic/metabolic profiling in breast cancer tissue, which is more directly related to ALDH1 expression than B's focus on a signaling/angiogenesis pathway. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904453Z"}
{"comparison_id":"05d01611-01ac-443a-be08-a598e7d8c5e1","query_id":"51","doc_a_id":"24249915","doc_b_id":"43385013","presented_order":["24249915","43385013"],"winner_id":"43385013","reasoning":"Document B — it discusses stem/progenitor cell properties in breast epithelial subpopulations (more directly related to ALDH1 as a stem cell marker), while Document A focuses on ERβ expression and methylation, not ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904460Z"}
{"comparison_id":"f99c3a6a-e554-4d35-aef8-51d3b6891149","query_id":"51","doc_a_id":"18953920","doc_b_id":"20839751","presented_order":["18953920","20839751"],"winner_id":"18953920","reasoning":"Document A is more relevant — it links EMT to acquisition of stem-cell markers (like ALDH1) and increased tumorigenicity, which bears on whether ALDH1 predicts better or worse outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904466Z"}
{"comparison_id":"7197c17f-0b0f-4f53-b367-06d374e4e3d5","query_id":"51","doc_a_id":"4455466","doc_b_id":"5500086","presented_order":["4455466","5500086"],"winner_id":"4455466","reasoning":"Document A is more relevant — it directly links a gene's expression level to breast cancer prognosis (low expression -> poor prognosis; overexpression suppresses tumor growth), which parallels the claim about marker expression and outcomes. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904473Z"}
{"comparison_id":"a5abf36c-c44d-407b-8552-b09865cf81c3","query_id":"51","doc_a_id":"2014909","doc_b_id":"5500086","presented_order":["2014909","5500086"],"winner_id":"2014909","reasoning":"Document A — it discusses tumor-initiating cells and primary breast cancer analyses (ALDH1 is a tumor‑initiating/cancer‑stem cell marker), so it's likelier to address ALDH1-related outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904479Z"}
{"comparison_id":"c1ab24e9-c59e-46d1-b54b-84c5d13ee366","query_id":"51","doc_a_id":"20127522","doc_b_id":"22401720","presented_order":["20127522","22401720"],"winner_id":"22401720","reasoning":"Document B is more relevant — it examines tumor marker expression and links marker levels to prognosis, which is closer to a claim about ALDH1 expression and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904485Z"}
{"comparison_id":"01ec5239-de15-4f1c-8f4c-782fcdb41856","query_id":"51","doc_a_id":"31311495","doc_b_id":"5500086","presented_order":["5500086","31311495"],"winner_id":"5500086","reasoning":"Document A — links a molecular signature to positive clinical outcomes in breast cancer; Document B is an in vitro study of tamoxifen resistance without clinical outcome data or mention of ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904491Z"}
{"comparison_id":"acef8325-46eb-400a-b451-9ef49498ac8d","query_id":"51","doc_a_id":"19673227","doc_b_id":"7821634","presented_order":["19673227","7821634"],"winner_id":"7821634","reasoning":"Document B is more relevant — it deals specifically with biomarkers and outcomes in residual breast cancer, whereas Document A focuses on CTC chemosensitivity across epithelial tumors and doesn't address ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904497Z"}
{"comparison_id":"c8bdd302-1c81-400f-a5dd-737618d4ea6e","query_id":"51","doc_a_id":"15946643","doc_b_id":"16734530","presented_order":["15946643","16734530"],"winner_id":"15946643","reasoning":"Document A is more relevant because it discusses breast cancer chemoresistance and metastasis (clinical outcomes-related mechanisms), whereas Document B focuses on ORAI1 SNP associations and not on ALDH1 or clinical outcome markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904504Z"}
{"comparison_id":"e47ec245-38ea-4d83-9b86-9e60cc8d3c43","query_id":"51","doc_a_id":"19358586","doc_b_id":"4429932","presented_order":["19358586","4429932"],"winner_id":"19358586","reasoning":"Document A — it directly addresses biomarker expression patterns linked to breast cancer survival, making it more relevant to a claim about marker–outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904511Z"}
{"comparison_id":"c67becc6-baf6-488e-aeb8-8ac7a89205f9","query_id":"51","doc_a_id":"32001951","doc_b_id":"7583725","presented_order":["7583725","32001951"],"winner_id":"32001951","reasoning":"Document B is more relevant — it addresses regulation of enzyme expression in breast cancer cells (though not ALDH1 specifically), while A concerns TRPM7 and metastasis unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904517Z"}
{"comparison_id":"d0ce99ea-b538-4af1-9af0-aa2c2bbefaa8","query_id":"51","doc_a_id":"16734530","doc_b_id":"21033230","presented_order":["21033230","16734530"],"winner_id":"21033230","reasoning":"Document A discusses molecular profiling and prognostic markers in breast cancer (though not ALDH1 specifically), so it is more relevant to a claim about marker expression and outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904523Z"}
{"comparison_id":"6ed38215-8e83-43e6-9770-7e09762851ce","query_id":"51","doc_a_id":"5579368","doc_b_id":"7583725","presented_order":["5579368","7583725"],"winner_id":"5579368","reasoning":"Document A is more relevant — it discusses correlating gene expression with breast cancer biomarkers (analysis tools that could address ALDH1 expression), whereas Document B focuses on TRPM7, not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904530Z"}
{"comparison_id":"c41862f8-a09e-4eac-8a71-21e879ce4ef5","query_id":"51","doc_a_id":"22712546","doc_b_id":"8891333","presented_order":["22712546","8891333"],"winner_id":"8891333","reasoning":"B — discusses cancer stem cells in breast cancer (relevant to ALDH1 as a stem-cell marker and prognosis), while A is a general metabolic-methods paper without ALDH1-specific evidence.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904536Z"}
{"comparison_id":"a31a2a2e-8921-46a9-b7f4-38b45994c3b3","query_id":"51","doc_a_id":"20127522","doc_b_id":"8891333","presented_order":["20127522","8891333"],"winner_id":"8891333","reasoning":"Document B is more relevant — it discusses cancer stem cells in breast cancer (where ALDH1 is a known stem-cell marker) and pathways/transporters related to stemness and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904542Z"}
{"comparison_id":"d2a05493-755d-46d5-b698-04018391effb","query_id":"51","doc_a_id":"22712546","doc_b_id":"7583725","presented_order":["7583725","22712546"],"winner_id":"22712546","reasoning":"Document B is more relevant — it addresses enzymatic activity and metabolic profiling in breast cancer tissue, which is closer to ALDH1 (an enzyme) and its potential prognostic role.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904549Z"}
{"comparison_id":"6af2e0b2-4bd3-45de-8523-708dbbe0ad3e","query_id":"51","doc_a_id":"32001951","doc_b_id":"8891333","presented_order":["32001951","8891333"],"winner_id":"8891333","reasoning":"Document B — it discusses breast cancer stem cells (which relate to ALDH1 as a stem-cell marker), whereas Document A is about alkaline phosphatase, not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904555Z"}
{"comparison_id":"19a1039d-335f-4a91-9f40-ce317fea5efe","query_id":"51","doc_a_id":"22975806","doc_b_id":"45638119","presented_order":["45638119","22975806"],"winner_id":"45638119","reasoning":"Document A is directly about ALDH1 and states it predicts poor (not better) clinical outcome, so it directly addresses and refutes the claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904562Z"}
{"comparison_id":"65e8561e-7c17-46ef-a0ea-0d2797d6b034","query_id":"51","doc_a_id":"4455466","doc_b_id":"9600826","presented_order":["9600826","4455466"],"winner_id":"4455466","reasoning":"Document B — it links a gene's expression level to breast cancer prognosis (expression correlates with outcomes), whereas A focuses on an angiogenesis/invasion pathway without prognosis data. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904569Z"}
{"comparison_id":"0344d2d6-aed0-4ffe-84a2-9da3ebe5ae08","query_id":"51","doc_a_id":"15946643","doc_b_id":"22975806","presented_order":["22975806","15946643"],"winner_id":"15946643","reasoning":"Document B is more relevant — it addresses signaling networks that affect chemoresistance and metastasis (clinical outcomes), whereas A focuses on BRCA allele loss in tumorigenesis and not outcome markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904576Z"}
{"comparison_id":"3d5ccacb-9652-4d45-8601-d33e07e3d13d","query_id":"51","doc_a_id":"15946643","doc_b_id":"32001951","presented_order":["32001951","15946643"],"winner_id":"15946643","reasoning":"Document B is more relevant — it discusses breast cancer chemoresistance and metastasis (clinical outcomes), whereas Document A addresses alkaline phosphatase regulation (unrelated to ALDH1). \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904582Z"}
{"comparison_id":"229d7301-a701-40c9-bd76-abf7afe1ba6f","query_id":"51","doc_a_id":"20127522","doc_b_id":"24249915","presented_order":["24249915","20127522"],"winner_id":"20127522","reasoning":"Document B — it discusses a biomarker (CTC levels) linked to breast cancer outcomes, so it's slightly more relevant to a claim about a marker's association with outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904589Z"}
{"comparison_id":"122894e2-8487-4079-ad21-861a59960322","query_id":"51","doc_a_id":"22482820","doc_b_id":"7583725","presented_order":["7583725","22482820"],"winner_id":"7583725","reasoning":"Document A — it links a specific gene's expression to patient outcomes, which is directly related to the query about expression–outcome associations. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904594Z"}
{"comparison_id":"b53ce06d-83e4-453b-b1ce-5ef0e2e04303","query_id":"51","doc_a_id":"313403","doc_b_id":"43385013","presented_order":["313403","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it addresses epithelial/mesenchymal subpopulations and stem cell/progenitor properties (ALDH1 is a stem cell marker), while Document A discusses tumor-associated macrophages and prognosis with no link to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904601Z"}
{"comparison_id":"8e813dab-3e93-473b-a2b1-c84a34b7a3a8","query_id":"51","doc_a_id":"24341590","doc_b_id":"4889228","presented_order":["24341590","4889228"],"winner_id":"4889228","reasoning":"Document B. It deals with expression of splicing factors and their correlation with prognosis in breast cancer (similar concept to ALDH1 expression–outcome associations), whereas A focuses on CYP2D6 pharmacogenetics and tamoxifen response, which is unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904608Z"}
{"comparison_id":"eed89fd8-7c7f-4bf5-ad50-4b8265765e35","query_id":"51","doc_a_id":"19673227","doc_b_id":"8963413","presented_order":["19673227","8963413"],"winner_id":"8963413","reasoning":"Document B is more relevant — though neither mentions ALDH1, B discusses a biomarker (PD-L1) that is reported to associate with better breast cancer outcomes, so it is closer to the claim.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904614Z"}
{"comparison_id":"96ff0ceb-9233-4095-96d3-2a723f06cf4e","query_id":"51","doc_a_id":"18953920","doc_b_id":"5500086","presented_order":["5500086","18953920"],"winner_id":"18953920","reasoning":"Document B — it discusses breast epithelial cells acquiring stem-cell markers (including ALDH1-like markers) and increased tumorigenicity, which is directly relevant to claims about ALDH1 and outcomes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904621Z"}
{"comparison_id":"cc5eb95f-5c8a-46db-917d-45a3a31bf0f7","query_id":"51","doc_a_id":"2014909","doc_b_id":"8963413","presented_order":["2014909","8963413"],"winner_id":"2014909","reasoning":"Document A is more relevant — it discusses tumor-initiating cells and analyses of primary breast cancers (ALDH1 is a tumor-initiating/cancer stem cell marker), whereas B focuses on PD-L1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904628Z"}
{"comparison_id":"3ec69c01-3ebb-4450-b4b2-f0b37bddc0b9","query_id":"51","doc_a_id":"4429932","doc_b_id":"4455466","presented_order":["4429932","4455466"],"winner_id":"4455466","reasoning":"Document B — it discusses how expression level of a specific gene (ZMYND11) relates to breast cancer prognosis (low expression → poor prognosis, overexpression suppresses tumors), which is conceptually closer to the query about gene expression and outcomes than Document A about LOX. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904634Z"}
{"comparison_id":"b3e236bc-fafb-4cfa-9123-f49b51ba56a9","query_id":"51","doc_a_id":"34066665","doc_b_id":"45638119","presented_order":["45638119","34066665"],"winner_id":"45638119","reasoning":"Document A directly addresses ALDH1 expression and its clinical prognostic association, reporting it predicts poor breast cancer outcome (thus refuting the claim). Document B is unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904641Z"}
{"comparison_id":"1a7c99eb-99dc-4ffa-b7be-6789df88ccd6","query_id":"51","doc_a_id":"22975806","doc_b_id":"5579368","presented_order":["22975806","5579368"],"winner_id":"5579368","reasoning":"Document B is more relevant — it relates to gene expression and breast cancer biomarkers (tools that could assess ALDH1 expression), whereas A focuses on BRCA allele loss and not ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904647Z"}
{"comparison_id":"e837521f-3269-495c-bb6a-3ba844f3dc72","query_id":"51","doc_a_id":"11484808","doc_b_id":"5579368","presented_order":["5579368","11484808"],"winner_id":"5579368","reasoning":"Document A is more relevant — it specifically addresses gene expression and breast cancer biomarkers, which is directly related to ALDH1 expression and outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904654Z"}
{"comparison_id":"a5d000b7-61dd-41ab-ae83-248b8c4984f3","query_id":"51","doc_a_id":"2014909","doc_b_id":"20333864","presented_order":["2014909","20333864"],"winner_id":"2014909","reasoning":"Document A is more relevant — it addresses tumor-initiating cells and analyses of primary breast cancers (more likely to report on markers like ALDH1 and their outcome associations).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904682Z"}
{"comparison_id":"8e1353dd-f860-4cb3-a6df-b3d07d4f31dc","query_id":"51","doc_a_id":"1171121","doc_b_id":"8963413","presented_order":["8963413","1171121"],"winner_id":"8963413","reasoning":"Document A is more relevant — it discusses expression of a tumor biomarker (PD-L1) and its association with breast cancer outcomes, which is analogous to the claim about ALDH1 expression and outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904693Z"}
{"comparison_id":"68847d02-367f-490c-9f87-26473354c905","query_id":"51","doc_a_id":"2931832","doc_b_id":"8963413","presented_order":["8963413","2931832"],"winner_id":"8963413","reasoning":"Doc A is more relevant — it discusses expression of a biomarker (PD-L1) linked to better breast cancer outcomes, which is conceptually closer to the query about ALDH1 expression and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904701Z"}
{"comparison_id":"63b09b63-4d4b-42df-854c-19240f7f477d","query_id":"51","doc_a_id":"21033230","doc_b_id":"34066665","presented_order":["34066665","21033230"],"winner_id":"21033230","reasoning":"Document B is more relevant — it addresses molecular markers and their prognostic value in breast cancer (even if ALDH1 isn't specifically mentioned), whereas A focuses on ER/HER signaling and endocrine resistance. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904707Z"}
{"comparison_id":"35b67a3f-7ddd-431b-a80e-259d7f806ea1","query_id":"51","doc_a_id":"19673227","doc_b_id":"22975806","presented_order":["22975806","19673227"],"winner_id":"22975806","reasoning":"Doc A deals directly with breast cancer biology and clinical implications, so it is more relevant to a claim about markers and outcomes in breast cancer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904714Z"}
{"comparison_id":"a52e8ccd-954b-4a26-950e-956a0751282e","query_id":"51","doc_a_id":"18953920","doc_b_id":"2014909","presented_order":["2014909","18953920"],"winner_id":"18953920","reasoning":"Document B is more relevant — it discusses acquisition of stem-cell markers in mammary epithelial cells (ALDH1 is a known stem-cell marker) and links those markers to tumorigenic potential, which bears on associations between ALDH1 expression and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904720Z"}
{"comparison_id":"eadc659d-d453-4a9a-9268-deb94f58eed8","query_id":"51","doc_a_id":"22482820","doc_b_id":"24834968","presented_order":["22482820","24834968"],"winner_id":"24834968","reasoning":"Document B is more relevant — it evaluates biological markers as predictors of treatment response in breast cancer, which is closer to assessing associations between marker expression (like ALDH1) and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904727Z"}
{"comparison_id":"323ed98c-c635-46b5-9f09-4bad04082492","query_id":"51","doc_a_id":"11484808","doc_b_id":"4455466","presented_order":["4455466","11484808"],"winner_id":"4455466","reasoning":"Document A is more relevant — it links a specific gene's expression to breast cancer prognosis, which is closer to the query about marker expression and outcomes than the broad ncRNA review.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904734Z"}
{"comparison_id":"45bdf1a0-5b22-421b-9e72-b60c4a99dd21","query_id":"51","doc_a_id":"15113221","doc_b_id":"34066665","presented_order":["15113221","34066665"],"winner_id":"34066665","reasoning":"Document B is more relevant because it specifically addresses breast cancer signaling and clinical implications for outcomes, whereas Document A discusses a PTEN-related signature in carcinomas generally and not ALDH1 or breast-specific outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904740Z"}
{"comparison_id":"9a299084-0d9f-4cd6-9a66-0e58e1fa8ef0","query_id":"51","doc_a_id":"313403","doc_b_id":"4702639","presented_order":["313403","4702639"],"winner_id":"4702639","reasoning":"Document B — it discusses markers and mechanisms of tumor stemness (closer to ALDH1's role as a cancer stem cell marker), whereas A focuses on macrophage infiltration and prognosis unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904746Z"}
{"comparison_id":"4be6a64e-a517-45d2-b428-61be87174072","query_id":"51","doc_a_id":"19673227","doc_b_id":"4429932","presented_order":["4429932","19673227"],"winner_id":"4429932","reasoning":"Document A is more relevant — it discusses markers linked to breast cancer patient outcomes (though not ALDH1), whereas B focuses on CTC chemosensitivity across epithelial tumors.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904753Z"}
{"comparison_id":"8aadf112-5b12-48f0-8be5-a5931822f2ea","query_id":"51","doc_a_id":"24834968","doc_b_id":"4455466","presented_order":["4455466","24834968"],"winner_id":"4455466","reasoning":"Document A is more relevant — it links expression level of a marker to breast cancer prognosis, whereas B focuses on HER-2/chemotherapy response and does not address marker-outcome associations like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904760Z"}
{"comparison_id":"ab484814-e7ec-4f70-905b-c130f6e95a1b","query_id":"51","doc_a_id":"18953920","doc_b_id":"25973484","presented_order":["25973484","18953920"],"winner_id":"18953920","reasoning":"Document B — it discusses stem-cell markers in mammary cells and tumorigenic potential (more related to ALDH1 as a stem-cell marker) while A focuses on obesity and breast cancer without addressing ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904766Z"}
{"comparison_id":"0c7257bc-b763-47d1-9675-e5013db28ea5","query_id":"51","doc_a_id":"20839751","doc_b_id":"21033230","presented_order":["21033230","20839751"],"winner_id":"21033230","reasoning":"Document A is more relevant — it deals with molecular markers in circulating tumor cells and their prognostic value, whereas B focuses on apoptosis and pathological features without molecular marker outcomes. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904774Z"}
{"comparison_id":"6765c345-b225-407d-a45c-9881f0f3820c","query_id":"51","doc_a_id":"1866911","doc_b_id":"43385013","presented_order":["43385013","1866911"],"winner_id":"43385013","reasoning":"Document A is more relevant — it discusses stem cell/progenitor properties in breast epithelial subpopulations (ALDH1 is a stem cell marker), whereas Document B focuses on BRCA1-related luminal progenitors and c-KIT without addressing stem cell markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904781Z"}
{"comparison_id":"db5f1c0b-c940-4b01-abd9-a3582c17886f","query_id":"51","doc_a_id":"20183360","doc_b_id":"5579368","presented_order":["5579368","20183360"],"winner_id":"5579368","reasoning":"Document A is more relevant — it concerns breast cancer biomarkers and correlating gene expression (which could include ALDH1) with outcomes, whereas Document B focuses on GATA3/Smad4 and invasion, not ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904789Z"}
{"comparison_id":"7a5d6238-810a-47f1-852a-d95fbce1e91a","query_id":"51","doc_a_id":"24249915","doc_b_id":"2931832","presented_order":["2931832","24249915"],"winner_id":"24249915","reasoning":"Document B — it discusses expression of a breast cancer–related protein and its clinical relevance, whereas Document A addresses a platelet-based prognostic ratio; neither mentions ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904795Z"}
{"comparison_id":"4697dd01-0914-46dd-b4b2-539e12ce38c8","query_id":"51","doc_a_id":"15946643","doc_b_id":"34066665","presented_order":["15946643","34066665"],"winner_id":"15946643","reasoning":"Document A is more relevant — it addresses chemoresistance and metastasis in breast cancer, topics more likely to involve biomarkers like ALDH1 and links to outcomes. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904802Z"}
{"comparison_id":"190b4e54-26d0-4d64-993a-0883ff41590f","query_id":"51","doc_a_id":"15946643","doc_b_id":"3285322","presented_order":["3285322","15946643"],"winner_id":"15946643","reasoning":"Document B is more relevant — it discusses tumor biology, chemoresistance and metastatic pathways that are more likely to relate to biomarkers like ALDH1; Document A focuses on BRCA mutation clinical features and not ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904809Z"}
{"comparison_id":"461f8200-dd68-4259-96bf-e2411526b0b5","query_id":"51","doc_a_id":"16086778","doc_b_id":"21033230","presented_order":["16086778","21033230"],"winner_id":"21033230","reasoning":"Document B is more relevant — it addresses molecular markers and their association with patient outcomes, whereas A focuses on Numb/Notch signaling and not prognostic marker expression. (Neither document mentions ALDH1 specifically.)\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904815Z"}
{"comparison_id":"75bf756c-b510-41d4-897d-6d54105cca24","query_id":"51","doc_a_id":"1171121","doc_b_id":"5579368","presented_order":["5579368","1171121"],"winner_id":"5579368","reasoning":"Document A — it discusses correlating gene expression with breast cancer biomarkers (more relevant to ALDH1 expression) while B focuses on MVD and p53, not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904822Z"}
{"comparison_id":"d92329c9-cccc-44dd-9292-25bcdbd2b37c","query_id":"51","doc_a_id":"19673227","doc_b_id":"20183360","presented_order":["19673227","20183360"],"winner_id":"19673227","reasoning":"Document A is slightly more relevant — it discusses prognostic/predictive value and associations with disease-free survival/time to progression, while Document B is a mechanistic study on invasiveness and doesn't address prognostic markers like ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904829Z"}
{"comparison_id":"23014dc1-0823-4e19-9572-dabd42fcba9f","query_id":"51","doc_a_id":"15946643","doc_b_id":"20127522","presented_order":["20127522","15946643"],"winner_id":"20127522","reasoning":"Document A is more relevant because it directly addresses a biomarker's association with breast cancer outcomes (prognosis), whereas Document B focuses on CXCL1-driven chemoresistance and metastasis mechanisms unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904836Z"}
{"comparison_id":"999d6589-b71d-42e8-9007-67aa4f65095f","query_id":"51","doc_a_id":"45638119","doc_b_id":"825728","presented_order":["825728","45638119"],"winner_id":"45638119","reasoning":"Document B — it directly studies ALDH1 in breast cancer and reports its association with clinical outcome (specifically poor prognosis), which is directly relevant to the claim. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904843Z"}
{"comparison_id":"2b430fb3-e4d4-4cbc-a460-0dbf2f45882d","query_id":"51","doc_a_id":"2014909","doc_b_id":"4889228","presented_order":["4889228","2014909"],"winner_id":"4889228","reasoning":"Document A is more relevant — it directly discusses prognostic markers and outcome correlations in breast cancer (TNBC), whereas B focuses on mTOR and immune microenvironment without outcome-marker associations. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904850Z"}
{"comparison_id":"94ff235c-0e98-4134-8115-adf7b6c0e5db","query_id":"51","doc_a_id":"19673227","doc_b_id":"825728","presented_order":["19673227","825728"],"winner_id":"825728","reasoning":"Document B is more relevant — it discusses EMT, cancer stem cell properties and links to patient survival, which relates to biomarker expression and prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904857Z"}
{"comparison_id":"85c2203f-b0a6-4513-bcaf-3bd24ede1069","query_id":"51","doc_a_id":"19673227","doc_b_id":"24834968","presented_order":["24834968","19673227"],"winner_id":"24834968","reasoning":"Document A is more relevant — it discusses biological markers in breast cancer outcomes/response, whereas B focuses on CTC chemosensitivity across epithelial tumors and not marker expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904864Z"}
{"comparison_id":"101c96fc-74fc-4449-a7af-82b18340fc29","query_id":"51","doc_a_id":"20183360","doc_b_id":"31311495","presented_order":["20183360","31311495"],"winner_id":"31311495","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it addresses tamoxifen resistance and EMT — processes linked to stem-cell–like features (often associated with ALDH1) and clinical outcome. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904871Z"}
{"comparison_id":"08c52665-7471-4650-bac0-1df48a778c02","query_id":"51","doc_a_id":"16691520","doc_b_id":"4702639","presented_order":["4702639","16691520"],"winner_id":"16691520","reasoning":"Document B is more relevant — it studies genome-wide binding and target genes in breast cancer cells, which is more likely to address gene expression (like ALDH1) and outcome associations than Document A's focus on an integrin–KRAS pathway and drug resistance. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904878Z"}
{"comparison_id":"4bdd6cf0-c029-42f8-be93-62569f8013db","query_id":"51","doc_a_id":"2014909","doc_b_id":"22401720","presented_order":["2014909","22401720"],"winner_id":"2014909","reasoning":"Document A is more relevant — it discusses tumor-initiating cells and analyses of primary breast cancers (ALDH1 is a tumor-initiating/cancer stem cell marker), whereas B focuses on angiogenic factors unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904885Z"}
{"comparison_id":"a1102c03-d83a-47a7-9be6-7f599a31b9d3","query_id":"51","doc_a_id":"16691520","doc_b_id":"5500086","presented_order":["5500086","16691520"],"winner_id":"5500086","reasoning":"Document A is more relevant — it discusses a molecular signature correlated with positive clinical outcomes in breast cancer, whereas Document B focuses on estrogen receptor binding sites without linking markers to patient outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904892Z"}
{"comparison_id":"a63891a2-5787-4720-8ea4-aabc7f79a949","query_id":"51","doc_a_id":"15113221","doc_b_id":"19673227","presented_order":["15113221","19673227"],"winner_id":"15113221","reasoning":"Doc A deals with a gene expression signature tied to prognosis in carcinomas (relevant to claims about a gene marker like ALDH1 and outcomes); Doc B focuses on CTC chemosensitivity assays, less directly related. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904898Z"}
{"comparison_id":"a10dcfc7-44b3-401b-8387-e670aaf34c01","query_id":"51","doc_a_id":"19673227","doc_b_id":"3285322","presented_order":["3285322","19673227"],"winner_id":"3285322","reasoning":"Document A is more directly about breast cancer clinical/pathologic features and outcomes, whereas Document B focuses on CTC chemosensitivity across epithelial tumors and not breast cancer outcomes specifically.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904905Z"}
{"comparison_id":"f1ad2a62-9f09-4afd-8283-b31004d1e017","query_id":"51","doc_a_id":"20127522","doc_b_id":"32001951","presented_order":["20127522","32001951"],"winner_id":"32001951","reasoning":"Document B is more relevant — it discusses regulation of enzyme expression in breast cancer cells (closer to a claim about marker expression) while Document A focuses on circulating tumor cell counts, not ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904911Z"}
{"comparison_id":"90cdbd6b-9eb6-44cf-8980-99c98d97e316","query_id":"51","doc_a_id":"31311495","doc_b_id":"43385013","presented_order":["43385013","31311495"],"winner_id":"43385013","reasoning":"Document A is more relevant — it discusses stem cell/progenitor properties in breast epithelial subpopulations (ALDH1 is a stem cell marker), whereas B focuses on tamoxifen resistance and beta-catenin signaling without addressing stem cell markers. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904918Z"}
{"comparison_id":"1634e424-94d1-40d1-8a86-cfedb9719ff7","query_id":"51","doc_a_id":"15946643","doc_b_id":"31311495","presented_order":["15946643","31311495"],"winner_id":"15946643","reasoning":"Document A addresses chemoresistance and metastasis in breast cancer—topics directly related to ALDH1's role in stemness and therapy resistance—while B focuses narrowly on tamoxifen-induced EMT in a cell line. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904925Z"}
{"comparison_id":"1bee1c62-f36e-405b-a504-61ede9a42eb5","query_id":"51","doc_a_id":"11484808","doc_b_id":"20127522","presented_order":["11484808","20127522"],"winner_id":"20127522","reasoning":"Document B is more relevant — it concerns biomarkers and their association with breast cancer outcomes (treatment efficacy and progression), whereas Document A focuses on non-coding RNAs generally and not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904932Z"}
{"comparison_id":"7dab567f-af82-4417-8f29-ebc58369d468","query_id":"51","doc_a_id":"12762485","doc_b_id":"2014909","presented_order":["2014909","12762485"],"winner_id":"12762485","reasoning":"Document B is more relevant — it examines stem-cell phenotypes and differentiation in breast cancer, which relates to ALDH1 as a stem-cell marker, while A focuses on mTOR and immune microenvironment without ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904939Z"}
{"comparison_id":"b7c34f07-95e5-4039-8f8e-c0897f7ad60f","query_id":"51","doc_a_id":"15113221","doc_b_id":"19358586","presented_order":["19358586","15113221"],"winner_id":"19358586","reasoning":"Document A is more directly about breast cancer and patient survival (links a protein signature to poor survival), making it more relevant to a claim about breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904946Z"}
{"comparison_id":"88a4a65a-c9e8-4bea-be6a-88287777269b","query_id":"51","doc_a_id":"22712546","doc_b_id":"313403","presented_order":["313403","22712546"],"winner_id":"22712546","reasoning":"Document B is more relevant — it focuses on measuring enzymatic activities and metabolic interactions in breast cancer tissue (ALDH1 is an enzyme), whereas Document A addresses tumor-associated macrophages and prognosis, not ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904953Z"}
{"comparison_id":"59418b5b-13cf-4b1b-854d-a9473b2800e6","query_id":"51","doc_a_id":"22975806","doc_b_id":"43385013","presented_order":["43385013","22975806"],"winner_id":"43385013","reasoning":"Document A is more relevant — it concerns stem cell/progenitor properties in breast cell subpopulations (ALDH1 is a stem cell marker), whereas Document B focuses on BRCA allele loss and not ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904959Z"}
{"comparison_id":"a29db240-64c5-48e6-bd58-27e23eff30f3","query_id":"51","doc_a_id":"19673227","doc_b_id":"31311495","presented_order":["31311495","19673227"],"winner_id":"19673227","reasoning":"Document B is more relevant — it addresses prognostic/predictive markers and correlations with disease-free survival, whereas A is a cell-line mechanistic study that doesn't relate to clinical outcome measures.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904966Z"}
{"comparison_id":"df03fcb9-aa9e-4e7d-abe7-fa94eb6c6832","query_id":"51","doc_a_id":"12762485","doc_b_id":"15113221","presented_order":["15113221","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses stem-cell–like phenotypes in breast cancer (ALDH1 is a stem cell marker), so it's more directly related to claims about ALDH1 and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904973Z"}
{"comparison_id":"d64e5be8-0940-4fbf-9d13-dcde44f234bc","query_id":"51","doc_a_id":"19673227","doc_b_id":"9600826","presented_order":["19673227","9600826"],"winner_id":"9600826","reasoning":"Document B is more directly about mechanisms in breast cancer (invasion/angiogenesis) and thus more relevant to associations with breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.904979Z"}
{"comparison_id":"cdd4bd12-5554-4dde-99b1-9266e7a2c7d1","query_id":"51","doc_a_id":"31311495","doc_b_id":"7821634","presented_order":["7821634","31311495"],"winner_id":"7821634","reasoning":"Document A is more relevant because it addresses the relationship between a molecular marker's expression level and breast cancer outcomes, whereas Document B focuses on tamoxifen resistance mechanisms without linking marker expression to outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905036Z"}
{"comparison_id":"f726fcb2-cd5e-46ac-b780-d28613c692e1","query_id":"51","doc_a_id":"12762485","doc_b_id":"34066665","presented_order":["12762485","34066665"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses stem-cell–like vs luminal phenotypes in breast cancer (ALDH1 is a stem-cell marker), whereas B focuses on ER/HER signaling and therapy resistance without relating to stem-cell markers. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905051Z"}
{"comparison_id":"81632b25-4b24-4f3a-8b2b-39d4c912ae51","query_id":"51","doc_a_id":"22401720","doc_b_id":"22482820","presented_order":["22401720","22482820"],"winner_id":"22401720","reasoning":"Document A is more relevant — it examines marker expression in breast tumors and links expression levels to prognosis, whereas B focuses on treatment strategies rather than marker–outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905058Z"}
{"comparison_id":"64985433-edd2-4726-ada9-b344144b5c3e","query_id":"51","doc_a_id":"16086778","doc_b_id":"24834968","presented_order":["16086778","24834968"],"winner_id":"24834968","reasoning":"Document B is more relevant — it evaluates biological markers as predictors of treatment response/outcomes, which is closer to assessing whether a marker's expression (like ALDH1) associates with prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905066Z"}
{"comparison_id":"61886c24-5f65-4ccc-96fb-d7a2e5b79862","query_id":"51","doc_a_id":"34066665","doc_b_id":"5579368","presented_order":["34066665","5579368"],"winner_id":"5579368","reasoning":"Document B is more relevant — it focuses on integrating DNA methylation with gene expression for breast cancer biomarkers, which is directly applicable to studying ALDH1 expression and its association with outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905072Z"}
{"comparison_id":"70585fa5-dc20-454e-957e-c7ed3a60a689","query_id":"51","doc_a_id":"16691520","doc_b_id":"4889228","presented_order":["16691520","4889228"],"winner_id":"4889228","reasoning":"Document B — it discusses gene/protein expression linked to prognosis in breast cancer, which is more relevant to a claim about ALDH1 expression and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905079Z"}
{"comparison_id":"7dcb3e63-b6be-43aa-9788-82b793b8b3c4","query_id":"51","doc_a_id":"15113221","doc_b_id":"5579368","presented_order":["5579368","15113221"],"winner_id":"5579368","reasoning":"Reason: Document A deals with breast cancer biomarkers and methods to correlate gene expression with outcomes, so it's more likely to address ALDH1 expression associations than Document B (PTEN pathway study).\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905086Z"}
{"comparison_id":"7be21a25-19f5-4492-908a-80a74e6a2fa1","query_id":"51","doc_a_id":"22975806","doc_b_id":"8963413","presented_order":["22975806","8963413"],"winner_id":"8963413","reasoning":"Document B is more relevant — it discusses expression of a tumor marker (PD-L1) and its association with clinical outcomes in breast cancer, which is analogous to the claim about ALDH1 expression and outcomes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905093Z"}
{"comparison_id":"a2601eb6-79fd-429b-8572-0b9b7020389b","query_id":"51","doc_a_id":"313403","doc_b_id":"3285322","presented_order":["3285322","313403"],"winner_id":"313403","reasoning":"Document B is more relevant — it discusses how a tumor-associated marker (TAM density) relates to breast cancer prognosis, which is closer to the query about marker expression and outcomes than the BRCA-focused clinical comparison in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905100Z"}
{"comparison_id":"f70487bb-73c3-4642-856f-a9ee8c4e2aad","query_id":"51","doc_a_id":"12762485","doc_b_id":"16691520","presented_order":["16691520","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses a stem cell phenotype in breast cancer (which relates to ALDH1 as a stem cell marker) and clinical correlations; Document A focuses on ER binding sites and not on ALDH1 or outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905107Z"}
{"comparison_id":"acc07f10-d0be-4cc7-8030-25339b67f8a7","query_id":"51","doc_a_id":"15946643","doc_b_id":"21033230","presented_order":["15946643","21033230"],"winner_id":"21033230","reasoning":"Document B is more relevant because it concerns molecular marker profiling and prognostic associations in breast cancer, which is closer to assessing ALDH1 expression and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905115Z"}
{"comparison_id":"4db742aa-4dd0-4281-8197-7667d5f709b3","query_id":"51","doc_a_id":"25973484","doc_b_id":"9600826","presented_order":["9600826","25973484"],"winner_id":"25973484","reasoning":"Document B is more relevant because it discusses breast cancer prognosis and factors affecting outcomes, whereas Document A focuses on a signaling pathway involved in invasion/angiogenesis and does not address clinical outcomes or ALDH1.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905122Z"}
{"comparison_id":"95d68b45-2b45-42f4-bfac-f715bf66d377","query_id":"51","doc_a_id":"22401720","doc_b_id":"24341590","presented_order":["22401720","24341590"],"winner_id":"22401720","reasoning":"Document A is about expression of tumor markers and their relation to prognosis in breast cancer, making it more relevant to a claim about ALDH1 expression and outcomes. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905128Z"}
{"comparison_id":"a1cd0650-e8a0-40d6-a997-85b1ad790114","query_id":"51","doc_a_id":"11484808","doc_b_id":"43385013","presented_order":["11484808","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it examines stem cell/progenitor properties in breast cell subpopulations, which is directly related to ALDH1 as a breast stem cell marker; Document A covers ncRNAs and is unrelated. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905135Z"}
{"comparison_id":"83d5023e-17bb-4675-b5bc-8eccf18de51f","query_id":"51","doc_a_id":"20839751","doc_b_id":"25732836","presented_order":["25732836","20839751"],"winner_id":"20839751","reasoning":"Document B is more relevant — it examines a tumor biomarker (apoptotic index) and its relationship to prognosis, whereas A focuses on CTCs and imaging. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905142Z"}
{"comparison_id":"1bec3866-ad21-4032-aedf-636a73819930","query_id":"51","doc_a_id":"24249915","doc_b_id":"4429932","presented_order":["4429932","24249915"],"winner_id":"4429932","reasoning":"Reason: Document A explicitly links a protein's expression (LOX) to patient outcomes in breast cancer, so it addresses the claim type (marker expression vs outcomes) more directly than Document B, which focuses on ERβ expression changes and methylation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905148Z"}
{"comparison_id":"3b0e5306-116f-450b-8efb-3207c4d77722","query_id":"51","doc_a_id":"15113221","doc_b_id":"7583725","presented_order":["15113221","7583725"],"winner_id":"7583725","reasoning":"Doc B is more directly about a protein's expression predicting outcomes in breast cancer (relevant to prognostic marker claims), whereas A discusses a PTEN-related signature in carcinomas more generally. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905154Z"}
{"comparison_id":"2d01e4a6-e523-4061-9073-80bc8547387d","query_id":"51","doc_a_id":"15946643","doc_b_id":"45638119","presented_order":["45638119","15946643"],"winner_id":"45638119","reasoning":"Document A is directly about ALDH1 and states it predicts poor clinical outcome in breast cancer, which directly addresses the claim. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905160Z"}
{"comparison_id":"dd339698-9cba-41c7-b029-1c0bf80b9179","query_id":"51","doc_a_id":"1171121","doc_b_id":"20127522","presented_order":["20127522","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant — it examines protein expression status (p53) and other tissue markers as prognostic factors in breast cancer, which is closer to the ALDH1 expression–outcome question than a study on circulating tumor cell counts.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905167Z"}
{"comparison_id":"0d23b178-e6b1-4f8b-a4b6-ab79a2a27213","query_id":"51","doc_a_id":"16691520","doc_b_id":"45638119","presented_order":["45638119","16691520"],"winner_id":"45638119","reasoning":"Document A directly studies ALDH1 and links its expression to clinical outcome, reporting it predicts poor prognosis (contradicting the claim). Document B is unrelated.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905173Z"}
{"comparison_id":"ca40113a-cfae-4523-9a83-5cf615faae3a","query_id":"51","doc_a_id":"20183360","doc_b_id":"4889228","presented_order":["20183360","4889228"],"winner_id":"4889228","reasoning":"Document B — it discusses expression of a protein (TDP43) and its correlation with prognosis in breast cancer, so it's more relevant to a claim about marker expression and outcomes than Document A, which focuses on mechanistic invasion pathways. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905180Z"}
{"comparison_id":"d77f2799-7c2d-4195-bcd3-9f15f9f97fb2","query_id":"51","doc_a_id":"1171121","doc_b_id":"24341590","presented_order":["1171121","24341590"],"winner_id":"1171121","reasoning":"Document A is more relevant — it examines tumor marker expression and prognostic outcomes in breast cancer, which is closer to the ALDH1 prognostic question than a pharmacogenetic tamoxifen study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905186Z"}
{"comparison_id":"633db70b-78fc-45fb-abcc-cc87de7bbab0","query_id":"51","doc_a_id":"24249915","doc_b_id":"8891333","presented_order":["8891333","24249915"],"winner_id":"8891333","reasoning":"Document A is more relevant — it discusses cancer stem cells in breast cancer (ALDH1 is a cancer stem cell marker), whereas Document B focuses on ERβ and methylation with no link to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905192Z"}
{"comparison_id":"eb808af2-58bc-423f-bafd-3c54411199a0","query_id":"51","doc_a_id":"16734530","doc_b_id":"43385013","presented_order":["16734530","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it addresses stem cell/progenitor properties in breast cell subpopulations (ALDH1 is a stem cell marker), whereas Document A concerns ORAI1 SNPs unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905199Z"}
{"comparison_id":"58cbfc3c-bac6-4cc8-a400-4b5b972342e2","query_id":"51","doc_a_id":"1171121","doc_b_id":"20183360","presented_order":["20183360","1171121"],"winner_id":"1171121","reasoning":"Document B — it examines prognostic biomarkers and clinical outcomes, which is more directly related to a claim about ALDH1 as a prognostic marker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905205Z"}
{"comparison_id":"383273bc-3530-4622-bd8e-231c6e68a319","query_id":"51","doc_a_id":"34066665","doc_b_id":"4455466","presented_order":["34066665","4455466"],"winner_id":"4455466","reasoning":"Document B is more relevant — it links a specific gene's expression to breast cancer prognosis, which is conceptually similar to the claim about ALDH1 expression and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905211Z"}
{"comparison_id":"cd6bf3f4-fcb3-44ca-94d2-a666d9657ace","query_id":"51","doc_a_id":"20839751","doc_b_id":"9600826","presented_order":["20839751","9600826"],"winner_id":"20839751","reasoning":"Document A is more relevant because it discusses prognostic associations in breast cancer (outcomes), whereas Document B focuses on angiogenesis pathways and not prognosis or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905218Z"}
{"comparison_id":"618ef5d5-dc37-40be-8a99-57c4c0bd08ed","query_id":"51","doc_a_id":"24834968","doc_b_id":"43385013","presented_order":["24834968","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it addresses stem cell/progenitor properties in breast epithelial/mesenchymal subpopulations (ALDH1 is a stem cell marker), whereas Document A focuses on HER-2/neu and chemo response and does not mention ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905225Z"}
{"comparison_id":"74048559-69e9-4fa4-baf4-9eb3edc1405a","query_id":"51","doc_a_id":"11484808","doc_b_id":"22712546","presented_order":["22712546","11484808"],"winner_id":"22712546","reasoning":"Document A is more relevant — it analyzes enzymatic activities and metabolic markers within breast cancer tissue, which is directly related to ALDH1, whereas B focuses on ncRNAs in endocrine cancers.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905232Z"}
{"comparison_id":"3d9fe7df-d166-4286-9989-933392392552","query_id":"51","doc_a_id":"27123743","doc_b_id":"5579368","presented_order":["5579368","27123743"],"winner_id":"5579368","reasoning":"Document A is more relevant because it discusses integrating gene expression with breast cancer biomarkers, which could include ALDH1 expression and its association with outcomes.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905238Z"}
{"comparison_id":"154d20d8-66e4-47bd-96f0-92b13b951325","query_id":"51","doc_a_id":"20127522","doc_b_id":"2014909","presented_order":["2014909","20127522"],"winner_id":"2014909","reasoning":"Document A is more relevant — it discusses tumor-initiating cells and analyses of primary breast cancers, which relate to ALDH1 as a cancer stem cell/tumor-initiating cell marker. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905244Z"}
{"comparison_id":"76184ee1-2841-403a-be89-c95c149b363b","query_id":"51","doc_a_id":"25973484","doc_b_id":"2931832","presented_order":["2931832","25973484"],"winner_id":"2931832","reasoning":"Document A is more relevant — it concerns prognostic biomarkers in breast cancer, whereas Document B focuses on obesity-related risk factors. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905250Z"}
{"comparison_id":"67a2163f-3505-41d2-b33c-24fd12f041d9","query_id":"51","doc_a_id":"18953920","doc_b_id":"313403","presented_order":["18953920","313403"],"winner_id":"18953920","reasoning":"Doc A is more relevant — it discusses acquisition of stem‑cell markers in mammary cells (ALDH1 is a known breast stem-cell marker) and links stemness to tumor behavior. Document B concerns macrophage infiltration, unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905257Z"}
{"comparison_id":"69e99ea4-d053-4c1e-92f1-34161803d7a0","query_id":"51","doc_a_id":"2014909","doc_b_id":"4455466","presented_order":["4455466","2014909"],"winner_id":"4455466","reasoning":"Document A is more relevant — it links expression level of a gene to breast cancer prognosis, which is closer to the claim about marker expression and outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905264Z"}
{"comparison_id":"66eb7223-2d02-4e99-9857-d2e0422670e9","query_id":"51","doc_a_id":"22401720","doc_b_id":"7583725","presented_order":["7583725","22401720"],"winner_id":"7583725","reasoning":"Document A is more relevant — it directly links a specific protein's expression level to breast cancer patient outcomes, which parallels the claim about ALDH1 as a prognostic marker.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905270Z"}
{"comparison_id":"49c60c62-133e-40bb-a2be-5acf8eb0b8e2","query_id":"51","doc_a_id":"43385013","doc_b_id":"7821634","presented_order":["43385013","7821634"],"winner_id":"43385013","reasoning":"Document A is more relevant — it discusses stem cell/progenitor properties in breast cell subpopulations (ALDH1 is a common stem cell marker), whereas Document B focuses on DUSP4 and chemoresistance unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905276Z"}
{"comparison_id":"1cb5a235-8c6a-4510-a6c2-5bd7c913223f","query_id":"51","doc_a_id":"3285322","doc_b_id":"8963413","presented_order":["8963413","3285322"],"winner_id":"8963413","reasoning":"Document A is more relevant — it discusses biomarker expression (PD-L1) linked to breast cancer outcomes, which is conceptually closer to the query about ALDH1 expression and outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905283Z"}
{"comparison_id":"4742f644-e8d7-4aac-a455-e02a6ef99faa","query_id":"51","doc_a_id":"22712546","doc_b_id":"8963413","presented_order":["8963413","22712546"],"winner_id":"22712546","reasoning":"Document B — it describes measuring enzymatic activities in breast cancer tissue (ALDH1 is an enzyme), so it's more likely to provide direct evidence about ALDH1 expression and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905289Z"}
{"comparison_id":"078ba1fd-a706-45f8-9e97-6e89c4cac837","query_id":"51","doc_a_id":"4429932","doc_b_id":"825728","presented_order":["825728","4429932"],"winner_id":"825728","reasoning":"Doc A — it discusses EMT, acquisition of stem-cell properties and links to patient survival/reduced metastasis, which is more directly related to ALDH1 (a stem-cell marker) than the LOX/hypoxia focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905296Z"}
{"comparison_id":"6d68b7ff-9ff5-4405-bbd6-3be8ebb4e95e","query_id":"51","doc_a_id":"20183360","doc_b_id":"45638119","presented_order":["45638119","20183360"],"winner_id":"45638119","reasoning":"Document A — it directly studies ALDH1 and reports its expression predicts poor clinical outcome in breast cancer, which is directly relevant to the claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905302Z"}
{"comparison_id":"0b3c9adc-d1e2-48fb-9138-4feae629cc15","query_id":"51","doc_a_id":"20127522","doc_b_id":"3285322","presented_order":["20127522","3285322"],"winner_id":"20127522","reasoning":"Document A is more relevant — it discusses a biomarker (circulating tumor cells) and its association with breast cancer outcomes, which is closer to the ALDH1 expression–outcome claim than the BRCA mutation focus in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905309Z"}
{"comparison_id":"04b9383d-0e8e-461d-b86a-abdb13f663ed","query_id":"51","doc_a_id":"20127522","doc_b_id":"4455466","presented_order":["20127522","4455466"],"winner_id":"4455466","reasoning":"Document B — it discusses gene expression levels linked to breast cancer prognosis, which is more relevant to a claim about ALDH1 expression and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905316Z"}
{"comparison_id":"81c30c70-8659-4bd8-932d-3c3c5a5c5237","query_id":"51","doc_a_id":"12762485","doc_b_id":"22712546","presented_order":["22712546","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses stem-cell–like phenotypes and clinicopathologic correlations in breast cancer, which is more directly related to ALDH1 (a stem cell marker) than Document A's metabolic-methods focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905323Z"}
{"comparison_id":"095c80b7-ee13-4a5b-bbc0-298009af0921","query_id":"51","doc_a_id":"18953920","doc_b_id":"21033230","presented_order":["21033230","18953920"],"winner_id":"18953920","reasoning":"Document B is more relevant — it discusses acquisition of stem-cell markers and stem-like properties in mammary cells (context for ALDH1 as a stem cell marker). Document A focuses on CTC markers (EpCAM, MUC1, HER2) and does not address ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905329Z"}
{"comparison_id":"76219655-6222-4f8c-b465-0224fedd50a8","query_id":"51","doc_a_id":"12762485","doc_b_id":"24834968","presented_order":["24834968","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses stem-cell phenotype associations (which relate to markers like ALDH1), whereas A focuses on HER-2/neu and chemo response and does not address stem-cell markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905336Z"}
{"comparison_id":"8832c28b-b43a-407c-9f09-3f233332b14c","query_id":"51","doc_a_id":"19358586","doc_b_id":"3285322","presented_order":["3285322","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant — it discusses protein/miRNA biomarkers linked to survival and therapeutic implications, which is closer to a claim about a biomarker (ALDH1) and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905343Z"}
{"comparison_id":"741c4c3d-acdb-417a-bdcb-b0b937ea8286","query_id":"51","doc_a_id":"16734530","doc_b_id":"4455466","presented_order":["4455466","16734530"],"winner_id":"4455466","reasoning":"Document A — it links gene expression levels to breast cancer prognosis (expression vs outcome), which is more directly relevant than B's focus on ORAI1 SNPs.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905350Z"}
{"comparison_id":"e61fdee1-7194-45fd-aa29-f2b589533564","query_id":"51","doc_a_id":"22712546","doc_b_id":"27123743","presented_order":["22712546","27123743"],"winner_id":"22712546","reasoning":"Document A is more relevant — it analyzes enzymatic activities and metabolic interactions in breast cancer tissue, which could address ALDH1 expression and its prognostic associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905356Z"}
{"comparison_id":"1bfa22b1-326a-4a53-992a-ce545cf52a62","query_id":"51","doc_a_id":"15946643","doc_b_id":"18953920","presented_order":["15946643","18953920"],"winner_id":"18953920","reasoning":"Document B is more relevant — it links EMT to acquisition of stem-cell markers (such as ALDH1) and tumorigenic potential, which directly pertains to ALDH1's prognostic associations. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905362Z"}
{"comparison_id":"d8492515-bd90-4021-9980-80b08ad7eafc","query_id":"51","doc_a_id":"16734530","doc_b_id":"25973484","presented_order":["25973484","16734530"],"winner_id":"25973484","reasoning":"Document A is more relevant — it discusses breast cancer prognosis and factors affecting outcomes, whereas Document B focuses on ORAI1 SNPs unrelated to ALDH1. (Neither document mentions ALDH1 specifically.)\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905369Z"}
{"comparison_id":"9000eba5-da1d-46f4-b6e8-52a10d3e4291","query_id":"51","doc_a_id":"7821634","doc_b_id":"9600826","presented_order":["9600826","7821634"],"winner_id":"7821634","reasoning":"Document B is more relevant — it discusses marker expression linked to breast cancer outcomes (DUSP4 and prognosis), whereas A focuses on angiogenesis pathways and not outcome-associated markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905376Z"}
{"comparison_id":"30ea483f-769a-4e9a-bac8-6b5985615ce0","query_id":"51","doc_a_id":"1866911","doc_b_id":"32001951","presented_order":["32001951","1866911"],"winner_id":"1866911","reasoning":"Document B is more relevant — it discusses breast cancer cell populations and marker expression in tumors, whereas Document A concerns alkaline phosphatase regulation in a cell line and does not relate to ALDH1 or clinical outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905383Z"}
{"comparison_id":"eda3f9ec-8708-4197-b6cd-ff6b1abcf4b0","query_id":"51","doc_a_id":"16734530","doc_b_id":"825728","presented_order":["16734530","825728"],"winner_id":"825728","reasoning":"Document B is more relevant — it discusses cancer stem cell properties and links to patient survival and metastasis, which is conceptually related to ALDH1 (a stem cell marker) and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905390Z"}
{"comparison_id":"ecee3e9d-f2ff-4b98-bd0c-5c1af8a76db7","query_id":"51","doc_a_id":"21033230","doc_b_id":"4702639","presented_order":["21033230","4702639"],"winner_id":"21033230","reasoning":"Document A is more relevant — it addresses prognostic markers and patient outcomes in metastatic breast cancer, while B focuses on integrin-driven stemness and drug resistance mechanisms without linking ALDH1 to breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905396Z"}
{"comparison_id":"ad8bc1bb-395f-4695-bcd7-2b9ab2e73721","query_id":"51","doc_a_id":"21033230","doc_b_id":"24834968","presented_order":["24834968","21033230"],"winner_id":"21033230","reasoning":"Document B — it discusses molecular profiling and prognostic markers correlated with survival, whereas Document A focuses on HER2/Ki67 and chemotherapy response without addressing ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905403Z"}
{"comparison_id":"3e364481-4b44-4c26-a939-34d281afeeb7","query_id":"51","doc_a_id":"20454006","doc_b_id":"43385013","presented_order":["20454006","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it examines stem cell/progenitor properties in breast epithelial/mesenchymal subpopulations, which relates to ALDH1 as a stem cell marker; Document A concerns DIM/tamoxifen metabolism and not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905409Z"}
{"comparison_id":"f2be30e2-d231-46a7-a8df-a5c5cd7d536f","query_id":"51","doc_a_id":"15946643","doc_b_id":"2014909","presented_order":["15946643","2014909"],"winner_id":"2014909","reasoning":"Reason: Document B addresses tumor-initiating cells and analyses of primary breast cancers (contexts where ALDH1, a stem/progenitor marker, is commonly studied), so it is more likely to be relevant to ALDH1–outcome associations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905416Z"}
{"comparison_id":"c2cbfcbe-314a-4629-b23e-2185b34cf484","query_id":"51","doc_a_id":"12762485","doc_b_id":"4889228","presented_order":["4889228","12762485"],"winner_id":"12762485","reasoning":"Document B is more relevant — it discusses stem-cell–like phenotypes and prognostic markers in breast cancer, which relates to ALDH1 as a stem cell marker. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905422Z"}
{"comparison_id":"5254437b-ee62-4009-8209-de8a5d3d4087","query_id":"51","doc_a_id":"22482820","doc_b_id":"825728","presented_order":["825728","22482820"],"winner_id":"825728","reasoning":"Document A is more relevant — it links EMT, acquisition of stem-cell properties, and patient survival (ties to markers like ALDH1), while B focuses on therapy delivery strategies rather than marker-outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905429Z"}
{"comparison_id":"1f4bea24-a199-4af0-b5f7-a169766c3bd8","query_id":"51","doc_a_id":"18953920","doc_b_id":"32001951","presented_order":["18953920","32001951"],"winner_id":"18953920","reasoning":"Document A is more relevant — it discusses breast epithelial stem-cell markers and tumorigenic potential (context for ALDH1's role), while Document B concerns alkaline phosphatase regulation and is unrelated.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905436Z"}
{"comparison_id":"82a0e3c7-ec4a-4384-acbc-3c649bfe2a04","query_id":"51","doc_a_id":"22975806","doc_b_id":"27123743","presented_order":["22975806","27123743"],"winner_id":"22975806","reasoning":"Document A is more relevant — it discusses breast tumorigenesis and clinical implications, whereas Document B focuses on birthweight-related risk and not tumor markers or outcomes. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905442Z"}
{"comparison_id":"07ea6e7b-0bee-4191-9e4b-da6e3137c4c3","query_id":"51","doc_a_id":"19358586","doc_b_id":"24834968","presented_order":["24834968","19358586"],"winner_id":"19358586","reasoning":"Document B — it discusses molecular markers and links a protein signature to survival outcomes, so it's more relevant to a claim about marker expression and breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905448Z"}
{"comparison_id":"b3bfeea5-fa55-4583-9203-4241c08816a6","query_id":"51","doc_a_id":"25973484","doc_b_id":"8891333","presented_order":["8891333","25973484"],"winner_id":"8891333","reasoning":"Doc A is more relevant because it discusses cancer stem cells in breast cancer (ALDH1 is a known stem-cell marker), while Doc B focuses on obesity-related risk/prognosis and doesn't address ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905454Z"}
{"comparison_id":"969e9b41-baad-40e4-929b-382f1c03a2c8","query_id":"51","doc_a_id":"18953920","doc_b_id":"20183360","presented_order":["18953920","20183360"],"winner_id":"18953920","reasoning":"Document A is more relevant — it discusses acquisition of stem-cell markers in mammary cells and links them to increased tumorigenicity, which pertains to ALDH1's role as a stem-cell marker. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905460Z"}
{"comparison_id":"df66e919-94b4-456e-852b-1fd71689a5e3","query_id":"51","doc_a_id":"12762485","doc_b_id":"24249915","presented_order":["12762485","24249915"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses a \"stem cell phenotype\" in breast cancer (ALDH1 is a stem cell marker), whereas Document B focuses on ERβ unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905467Z"}
{"comparison_id":"23c67748-4bf1-49da-ae24-2e9b1755c488","query_id":"51","doc_a_id":"20183360","doc_b_id":"825728","presented_order":["20183360","825728"],"winner_id":"825728","reasoning":"Document B is more relevant — it discusses EMT, acquisition of stem-cell properties, and links to patient survival, which relates to ALDH1 as a stem-cell marker tied to outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905473Z"}
{"comparison_id":"c0884d69-d1bf-421e-af9f-2353df616525","query_id":"51","doc_a_id":"19358586","doc_b_id":"25732836","presented_order":["25732836","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant — it links specific protein expression signatures to patient survival, which is closer to the claim about marker expression and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905479Z"}
{"comparison_id":"41c4873e-7259-41ed-82e0-9932f16e54ab","query_id":"51","doc_a_id":"3285322","doc_b_id":"9600826","presented_order":["3285322","9600826"],"winner_id":"3285322","reasoning":"Document A is more relevant — it addresses clinical and pathological features and outcomes in breast cancer, which is closer to evaluating prognostic markers like ALDH1 than the molecular angiogenesis pathway in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905486Z"}
{"comparison_id":"fb9705ce-8471-4173-9811-ed7ec598ef10","query_id":"51","doc_a_id":"11484808","doc_b_id":"8891333","presented_order":["11484808","8891333"],"winner_id":"8891333","reasoning":"Document B is more relevant — it discusses breast cancer stem cells and markers/pathways related to stemness (where ALDH1 is a known marker), whereas A focuses broadly on non-coding RNAs.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905492Z"}
{"comparison_id":"f114ef9f-b708-479b-8540-94f2aa181a9a","query_id":"51","doc_a_id":"22401720","doc_b_id":"8963413","presented_order":["22401720","8963413"],"winner_id":"8963413","reasoning":"Document B — it discusses expression of a specific tumor marker (PD-L1) and its association with clinical outcomes in breast cancer, which is conceptually closer to the claim about ALDH1 and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905499Z"}
{"comparison_id":"17bda24e-6682-4556-9889-36649cf6a6e8","query_id":"51","doc_a_id":"20839751","doc_b_id":"8891333","presented_order":["20839751","8891333"],"winner_id":"8891333","reasoning":"Document B is more relevant — it discusses breast cancer stem cells and related markers/pathways (closer to ALDH1's role) while Document A focuses on apoptosis and prognosis without mentioning ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905505Z"}
{"comparison_id":"5ac02da9-d27d-4294-8200-65a31a4e21af","query_id":"51","doc_a_id":"31311495","doc_b_id":"32001951","presented_order":["31311495","32001951"],"winner_id":"31311495","reasoning":"Document A discusses mechanisms tied to breast cancer aggressiveness and treatment resistance (more directly related to outcomes), while Document B concerns alkaline phosphatase regulation unrelated to ALDH1 or prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905512Z"}
{"comparison_id":"4a9eee14-07f9-4ea8-b231-0a7ba063af44","query_id":"51","doc_a_id":"12762485","doc_b_id":"4429932","presented_order":["4429932","12762485"],"winner_id":"12762485","reasoning":"Document B is more relevant — it discusses stem-cell–like phenotypes and clinical correlations in breast cancer (ALDH1 is a stem cell marker), which relates to the claim about ALDH1 and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905518Z"}
{"comparison_id":"a72b2e78-27bc-4c18-b212-64f1daee1cfd","query_id":"51","doc_a_id":"24834968","doc_b_id":"4889228","presented_order":["24834968","4889228"],"winner_id":"24834968","reasoning":"Document A is more relevant — it evaluates biological markers in breast cancer and their association with treatment response/outcomes, whereas Document B focuses on splicing regulators in TNBC without discussing ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905525Z"}
{"comparison_id":"fc429e53-c55b-4fe5-bc91-96ae5165d0c5","query_id":"51","doc_a_id":"5579368","doc_b_id":"7821634","presented_order":["7821634","5579368"],"winner_id":"5579368","reasoning":"Document B — it concerns methods for correlating gene expression with methylation and applications to breast cancer biomarkers, which is more relevant to a claim about ALDH1 expression than Document A's focus on DUSP4. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905531Z"}
{"comparison_id":"f13af9a8-c4ca-42d8-a2b7-3005c8b24d3a","query_id":"51","doc_a_id":"19673227","doc_b_id":"24249915","presented_order":["19673227","24249915"],"winner_id":"24249915","reasoning":"Document B is more directly about biomarker expression in breast cancer (ERβ) and its relation to invasiveness, so it's more relevant to a claim about a marker's association with breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905538Z"}
{"comparison_id":"de8f5ca4-35f0-4d17-8da3-96b04a07502c","query_id":"51","doc_a_id":"1866911","doc_b_id":"24834968","presented_order":["24834968","1866911"],"winner_id":"1866911","reasoning":"Document B is more relevant — it discusses cell populations and marker expression in breast cancer (luminal progenitors and c-KIT), which is closer to marker–outcome associations than Document A, which focuses on HER-2/neu and treatment response and does not address stem/progenitor markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905545Z"}
{"comparison_id":"49f702ba-602c-43e7-90d8-2c1b427c2eae","query_id":"51","doc_a_id":"25973484","doc_b_id":"5500086","presented_order":["25973484","5500086"],"winner_id":"5500086","reasoning":"Document B is more relevant — it discusses molecular expression signatures (type I IFN) linked to breast cancer outcomes, whereas A focuses on obesity and does not address ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905551Z"}
{"comparison_id":"f96b8e71-94e2-4496-ad7c-cd80fe052ae0","query_id":"51","doc_a_id":"32001951","doc_b_id":"5500086","presented_order":["32001951","5500086"],"winner_id":"32001951","reasoning":"Document A is more relevant — it discusses expression regulation of an enzyme in breast cancer cells (closer to a marker-expression claim), whereas B focuses on interferon signaling and chemotherapy and does not mention ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905557Z"}
{"comparison_id":"7c2c2bf7-634e-45ca-938b-38a7de89a8e1","query_id":"51","doc_a_id":"20839751","doc_b_id":"22712546","presented_order":["22712546","20839751"],"winner_id":"22712546","reasoning":"Document A is more relevant — it deals with measuring enzymatic/metabolic activity in breast cancer tissue, which is closer to ALDH1 (an enzyme) expression and its association with outcomes. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905564Z"}
{"comparison_id":"a391e663-4127-46b5-839f-d5f12f9755ce","query_id":"51","doc_a_id":"19358586","doc_b_id":"31311495","presented_order":["31311495","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant — it discusses prognostic protein signatures and survival outcomes in breast cancer, while Document A focuses on tamoxifen resistance mechanisms without addressing ALDH1 or clinical outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905570Z"}
{"comparison_id":"750af9e6-bce3-44b3-a404-d8681d960d00","query_id":"51","doc_a_id":"313403","doc_b_id":"4429932","presented_order":["4429932","313403"],"winner_id":"313403","reasoning":"Document B is more relevant — it addresses prognostic markers and clinical outcomes in breast cancer, whereas A focuses on LOX and metastasis without discussing ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905577Z"}
{"comparison_id":"b8f4c048-56c9-47d8-b3db-3be99fc2efa7","query_id":"51","doc_a_id":"20127522","doc_b_id":"4429932","presented_order":["4429932","20127522"],"winner_id":"4429932","reasoning":"Document A is more relevant — it discusses a specific protein's expression (LOX) and its association with breast cancer patient outcomes, which is closer to the claim about a molecular marker (ALDH1) and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905584Z"}
{"comparison_id":"a7001218-405f-4ce6-821a-822ac870dd04","query_id":"51","doc_a_id":"2014909","doc_b_id":"32001951","presented_order":["2014909","32001951"],"winner_id":"2014909","reasoning":"Document A is more relevant — it analyzes tumor-initiating cells and primary breast cancers (likely addressing stem-cell markers such as ALDH1), whereas Document B studies alkaline phosphatase regulation unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905591Z"}
{"comparison_id":"721963c0-6f8f-4733-bbc9-67384a873897","query_id":"51","doc_a_id":"1866911","doc_b_id":"25973484","presented_order":["1866911","25973484"],"winner_id":"1866911","reasoning":"Document A is more relevant — it discusses breast epithelial cell populations and marker-defined progenitors related to tumor subtype, which is closer to ALDH1 (a stem/progenitor marker) than the obesity–breast cancer review. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905598Z"}
{"comparison_id":"652c0cf5-ddff-4fd0-a809-bba203ded489","query_id":"51","doc_a_id":"22712546","doc_b_id":"5500086","presented_order":["5500086","22712546"],"winner_id":"22712546","reasoning":"Document B is more likely to address ALDH1 since it quantifies enzymatic activities in breast cancer tissue; Document A focuses on type I interferon signaling and immune response, not ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905605Z"}
{"comparison_id":"99e9d925-edeb-47d8-a031-77e183a1f7ff","query_id":"51","doc_a_id":"12762485","doc_b_id":"25973484","presented_order":["25973484","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses stem‑cell–like phenotypes and markers in breast cancer (related to ALDH1 as a stem cell marker), whereas A covers obesity and prognosis without mentioning ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905612Z"}
{"comparison_id":"c01740f8-4502-4e30-95ea-5d1289871964","query_id":"51","doc_a_id":"22401720","doc_b_id":"45638119","presented_order":["45638119","22401720"],"winner_id":"45638119","reasoning":"Doc A directly addresses ALDH1 and its prognostic association in breast cancer (reports it predicts poor outcome); Doc B is about angiogenic factors and unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905618Z"}
{"comparison_id":"baf8b859-7fdd-4ef3-b885-0be041e8c27e","query_id":"51","doc_a_id":"1866911","doc_b_id":"19673227","presented_order":["19673227","1866911"],"winner_id":"1866911","reasoning":"B is more relevant — it concerns breast epithelial cell populations and markers linked to breast cancer biology, whereas A discusses a general chemosensitivity assay and does not address ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905624Z"}
{"comparison_id":"d02c4f80-9099-4efe-949e-2de5340c19d9","query_id":"51","doc_a_id":"22975806","doc_b_id":"24249915","presented_order":["22975806","24249915"],"winner_id":"24249915","reasoning":"Document B is more relevant — it deals with expression of a breast cancer biomarker and its relation to invasive disease, whereas A focuses on BRCA allele loss unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905631Z"}
{"comparison_id":"b653bbf5-18fe-4520-b915-986a56621070","query_id":"51","doc_a_id":"20127522","doc_b_id":"4702639","presented_order":["4702639","20127522"],"winner_id":"4702639","reasoning":"Document A is more related — it discusses tumour stemness and markers/drivers of stem-like properties, which is closer to ALDH1 (a stem-cell marker) and outcome associations than a study about circulating tumor cell counts.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905638Z"}
{"comparison_id":"09109d2b-b0ad-4918-a965-194c6d722231","query_id":"51","doc_a_id":"18953920","doc_b_id":"2931832","presented_order":["18953920","2931832"],"winner_id":"18953920","reasoning":"Document A is more relevant — it discusses stem-cell markers in mammary epithelial cells and tumorigenic potential, which relates to ALDH1 as a stem-cell marker and breast cancer outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905645Z"}
{"comparison_id":"765eabba-d20c-4810-969e-1ba2d6f8043e","query_id":"51","doc_a_id":"22975806","doc_b_id":"8891333","presented_order":["22975806","8891333"],"winner_id":"8891333","reasoning":"Document B — it discusses breast cancer stem cells and markers/transporters relevant to ALDH1's role, while A focuses on BRCA allele loss unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905651Z"}
{"comparison_id":"379c67fa-4ad8-4777-8446-ff149722b546","query_id":"51","doc_a_id":"19673227","doc_b_id":"21033230","presented_order":["19673227","21033230"],"winner_id":"21033230","reasoning":"Document B — it deals specifically with molecular profiling of circulating tumor cells in metastatic breast cancer and prognostic markers, which is more related to a claim about a molecular marker (ALDH1) and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905658Z"}
{"comparison_id":"69865f29-b72c-4984-bb85-b78b1d35447b","query_id":"51","doc_a_id":"2931832","doc_b_id":"5579368","presented_order":["2931832","5579368"],"winner_id":"5579368","reasoning":"Document B is more relevant — it concerns analysis of DNA methylation and gene expression for breast cancer biomarkers and could be used to assess ALDH1 expression, whereas A focuses on platelet indices unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905665Z"}
{"comparison_id":"0a4eecf7-1ee0-4947-aa06-8a7f88efbdfa","query_id":"51","doc_a_id":"15946643","doc_b_id":"25732836","presented_order":["25732836","15946643"],"winner_id":"25732836","reasoning":"Document A is more relevant — it addresses prognostic factors and outcomes in breast cancer, whereas Document B focuses on chemoresistance signaling and metastasis without directly relating to outcome markers like ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905672Z"}
{"comparison_id":"0333e51a-816e-493f-a59d-5cdfc0f0d7a5","query_id":"51","doc_a_id":"16734530","doc_b_id":"313403","presented_order":["16734530","313403"],"winner_id":"313403","reasoning":"Document B is more relevant — it addresses markers linked to breast cancer prognosis (outcomes), whereas Document A discusses ORAI1 SNPs and receptor/node associations without outcome data. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905679Z"}
{"comparison_id":"ce430117-7785-445d-9766-c8dc03e1ca5a","query_id":"51","doc_a_id":"21033230","doc_b_id":"24249915","presented_order":["24249915","21033230"],"winner_id":"21033230","reasoning":"Document B is more relevant — it examines molecular markers on tumor cells and their association with patient outcomes, which is closer to assessing whether a marker like ALDH1 predicts prognosis. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905724Z"}
{"comparison_id":"9fc363e5-9f4e-42ac-a110-cf84404943d6","query_id":"51","doc_a_id":"31311495","doc_b_id":"7583725","presented_order":["31311495","7583725"],"winner_id":"7583725","reasoning":"Document B — it links expression level of a gene to patient outcomes and metastasis, which is closer to the claim about a marker's association with breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905731Z"}
{"comparison_id":"7a204601-6c96-40fa-8d55-b3bfb3bd204e","query_id":"51","doc_a_id":"12762485","doc_b_id":"31311495","presented_order":["12762485","31311495"],"winner_id":"12762485","reasoning":"Document A — it discusses stem cell vs luminal phenotypes in breast cancer (ALDH1 is a stem-cell marker), so it's more related to ALDH1-associated outcome discussions.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905738Z"}
{"comparison_id":"3858c8ec-fee4-485a-8b16-254f444c9498","query_id":"51","doc_a_id":"16086778","doc_b_id":"20839751","presented_order":["16086778","20839751"],"winner_id":"20839751","reasoning":"Document B is more relevant — it discusses relationships between a biomarker (apoptotic index) and breast cancer prognosis, whereas Document A focuses on Numb/Notch signaling without addressing prognostic marker expression like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905744Z"}
{"comparison_id":"ca1d9ac7-b985-4812-9c6c-52c01be88e51","query_id":"51","doc_a_id":"16086778","doc_b_id":"825728","presented_order":["16086778","825728"],"winner_id":"825728","reasoning":"Document B. It discusses EMT, acquisition of stem-cell properties and links to patient survival and metastasis, which is more directly relevant to a claim about ALDH1 (a breast cancer stem-cell marker) and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905751Z"}
{"comparison_id":"9f739f14-67c3-484a-ad35-69464299d7e7","query_id":"51","doc_a_id":"22975806","doc_b_id":"25973484","presented_order":["25973484","22975806"],"winner_id":"25973484","reasoning":"Document A is more relevant — it discusses breast cancer prognosis and factors affecting outcomes, whereas Document B focuses on BRCA allele loss unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905757Z"}
{"comparison_id":"dc1d7f00-a35c-4519-84d4-b475eb1a2c56","query_id":"51","doc_a_id":"11484808","doc_b_id":"22401720","presented_order":["22401720","11484808"],"winner_id":"22401720","reasoning":"Document A is more directly about biomarkers and prognosis in primary breast cancer, whereas Document B focuses on non-coding RNAs and not on ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905763Z"}
{"comparison_id":"82369747-c698-411a-8a6d-90199c13cb3e","query_id":"51","doc_a_id":"32001951","doc_b_id":"5579368","presented_order":["5579368","32001951"],"winner_id":"5579368","reasoning":"Document A is more relevant — it addresses breast cancer biomarkers and correlates gene expression with methylation, making it more likely to inform ALDH1 expression and outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905770Z"}
{"comparison_id":"1213b31c-1112-4252-bae3-5878fa101498","query_id":"51","doc_a_id":"4429932","doc_b_id":"4702639","presented_order":["4702639","4429932"],"winner_id":"4702639","reasoning":"Reason: Document A discusses tumor stemness markers and stem-like properties (which relate to ALDH1 as a stem cell marker), so it is marginally more relevant to a claim about ALDH1 and breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905776Z"}
{"comparison_id":"47990480-4fa3-4435-8eef-871182240865","query_id":"51","doc_a_id":"25732836","doc_b_id":"45638119","presented_order":["45638119","25732836"],"winner_id":"45638119","reasoning":"Document A is directly about ALDH1 and reports it predicts poor clinical outcome (contradicting the claim). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905781Z"}
{"comparison_id":"89ede40d-f3a8-4d29-a914-d6c6ee389921","query_id":"51","doc_a_id":"12762485","doc_b_id":"16734530","presented_order":["16734530","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses stem-cell–like phenotypes and their association with prognostic markers in breast cancer, which is more directly relevant to ALDH1 (a stem cell marker) than the ORAI1 SNP study in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905788Z"}
{"comparison_id":"b246567c-dcca-4ad0-a810-590dd2b12d43","query_id":"51","doc_a_id":"1171121","doc_b_id":"43385013","presented_order":["1171121","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it addresses stem cell/progenitor properties in breast cells (where ALDH1 is a common marker), whereas Document A focuses on MVD and p53 and doesn't relate to ALDH1 or stem cell markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905795Z"}
{"comparison_id":"68d4d28a-ff90-412f-9737-405e4a1805a5","query_id":"51","doc_a_id":"22482820","doc_b_id":"5500086","presented_order":["5500086","22482820"],"winner_id":"5500086","reasoning":"Document A is more relevant — it reports a molecular expression signature (type I IFN) that correlates with positive breast cancer outcomes, which is closer to the claim about biomarker expression and outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905802Z"}
{"comparison_id":"ab7ecbe4-f9f2-4b2e-ac90-c20537827583","query_id":"51","doc_a_id":"16086778","doc_b_id":"313403","presented_order":["313403","16086778"],"winner_id":"313403","reasoning":"Document A is more relevant — it addresses prognostic markers and clinical outcomes in breast cancer, which relates to whether a marker (like ALDH1) is associated with better or worse outcomes. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905808Z"}
{"comparison_id":"612925a9-5178-4436-a428-db9a4357f997","query_id":"51","doc_a_id":"20183360","doc_b_id":"4455466","presented_order":["20183360","4455466"],"winner_id":"4455466","reasoning":"Document B is more relevant because it discusses gene expression linked to breast cancer prognosis, whereas Document A focuses on GATA3/Smad4-mediated invasion without prognostic markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905814Z"}
{"comparison_id":"3e171ff6-bfd3-4afc-9747-9f4f4c201ba2","query_id":"51","doc_a_id":"19358586","doc_b_id":"32001951","presented_order":["32001951","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant — it discusses protein/miRNA signatures linked to patient survival in breast cancer, whereas A only studies alkaline phosphatase regulation in a cell line. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905821Z"}
{"comparison_id":"dd0dd742-afec-4ec7-9a91-de731ddfb8ea","query_id":"51","doc_a_id":"16086778","doc_b_id":"7583725","presented_order":["7583725","16086778"],"winner_id":"7583725","reasoning":"Document A is more relevant — it discusses a gene's expression level predicting patient outcomes (prognosis), which is closer to an ALDH1–outcome association than the mechanistic Numb/Notch study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905827Z"}
{"comparison_id":"f0394e46-f196-48fd-83f4-02d7be01af2f","query_id":"51","doc_a_id":"11484808","doc_b_id":"19358586","presented_order":["19358586","11484808"],"winner_id":"19358586","reasoning":"Document A is more relevant — it specifically addresses molecular markers and survival outcomes in breast cancer, whereas Document B is a broad review of non-coding RNAs without direct relevance to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905834Z"}
{"comparison_id":"9cb18f69-3d1a-4e34-8e49-dfdb538870a8","query_id":"51","doc_a_id":"16086778","doc_b_id":"18953920","presented_order":["18953920","16086778"],"winner_id":"18953920","reasoning":"Document A is more relevant — it discusses stem-cell markers in mammary cells (context for ALDH1 as a stem-cell marker) and links stemness to increased tumorigenicity, which bears on outcomes. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905840Z"}
{"comparison_id":"0766f933-aee7-4fdb-8675-9d339cff500d","query_id":"51","doc_a_id":"24249915","doc_b_id":"825728","presented_order":["24249915","825728"],"winner_id":"825728","reasoning":"Document B. It discusses EMT, metastatic colonization and acquisition of stem-cell properties linked to patient survival (topics related to ALDH1 as a cancer stem-cell marker), while A focuses on ERβ methylation unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905847Z"}
{"comparison_id":"b1354d66-1e10-4464-8f9d-90527b9f6f1e","query_id":"51","doc_a_id":"4455466","doc_b_id":"825728","presented_order":["4455466","825728"],"winner_id":"4455466","reasoning":"Document A is more relevant — it directly discusses factors linked to breast cancer prognosis, whereas B focuses on EMT/Prrx1 and metastasis without addressing ALDH1 or breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905853Z"}
{"comparison_id":"69d08147-0144-4cf6-b970-1d7d63bcc8bf","query_id":"51","doc_a_id":"16086778","doc_b_id":"4455466","presented_order":["4455466","16086778"],"winner_id":"4455466","reasoning":"Doc A is more relevant because it links gene expression levels to breast cancer prognosis, which relates to the claim about marker expression and outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905859Z"}
{"comparison_id":"0e7a4da7-1f2e-4b27-80b5-6355af9550d1","query_id":"51","doc_a_id":"2931832","doc_b_id":"5500086","presented_order":["2931832","5500086"],"winner_id":"5500086","reasoning":"Document B is more relevant — it discusses a molecular signature (type I IFN) correlated with positive breast cancer outcomes, which is conceptually closer to a claim about a biomarker's association with prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905866Z"}
{"comparison_id":"c0dddbd2-3562-42d1-869b-d8db8607a979","query_id":"51","doc_a_id":"1171121","doc_b_id":"16734530","presented_order":["1171121","16734530"],"winner_id":"1171121","reasoning":"Document A is more relevant — it addresses prognostic factors and survival outcomes in breast cancer, whereas B focuses on ORAI1 SNPs unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905872Z"}
{"comparison_id":"148f17a0-132f-4f5a-81d3-fd8462be40de","query_id":"51","doc_a_id":"4702639","doc_b_id":"9600826","presented_order":["4702639","9600826"],"winner_id":"4702639","reasoning":"Document A is more relevant — it addresses tumor stemness and markers driving stem-like behavior in cancer, which relates to ALDH1's role as a stem-cell marker; Document B focuses on angiogenesis pathways unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905878Z"}
{"comparison_id":"02a4decb-1ebf-44f7-b357-ab8168725a7f","query_id":"51","doc_a_id":"1866911","doc_b_id":"22401720","presented_order":["22401720","1866911"],"winner_id":"1866911","reasoning":"Reason: Document B discusses breast epithelial progenitor/cell population markers and tumor origins, making it more relevant to a claim about a cell marker (ALDH1) and outcomes than Document A, which focuses on angiogenic factors.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905885Z"}
{"comparison_id":"e4c11d9f-2731-4966-a142-ef34bf64f299","query_id":"51","doc_a_id":"4889228","doc_b_id":"8963413","presented_order":["4889228","8963413"],"winner_id":"8963413","reasoning":"Document B is more relevant — it discusses expression of a biomarker (PD-L1) and its association with breast cancer outcomes, which is conceptually related to the query about ALDH1 as a prognostic marker.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905891Z"}
{"comparison_id":"8e4dc167-458a-47e7-b8f2-be596971087c","query_id":"51","doc_a_id":"4429932","doc_b_id":"7821634","presented_order":["7821634","4429932"],"winner_id":"7821634","reasoning":"Document A is more focused on breast cancer biomarkers and patient outcomes; Document B discusses LOX and metastasis broadly. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905897Z"}
{"comparison_id":"c8da4c08-edd5-449a-a996-7696c7a47418","query_id":"51","doc_a_id":"24834968","doc_b_id":"8963413","presented_order":["24834968","8963413"],"winner_id":"8963413","reasoning":"Document B — it discusses marker expression linked to clinical outcomes in breast cancer (mentions better outcomes), whereas Document A focuses on HER-2/neu and chemo response without addressing marker-outcome associations like ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905903Z"}
{"comparison_id":"0b31d2b0-34ef-40de-b4a2-5325f1bc9bad","query_id":"51","doc_a_id":"22401720","doc_b_id":"34066665","presented_order":["34066665","22401720"],"winner_id":"22401720","reasoning":"Document B is more relevant — it examines expression of tumor markers and their correlation with prognosis, which is closer to assessing whether a marker like ALDH1 relates to outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905910Z"}
{"comparison_id":"17d27bb7-5579-4d0a-b809-62cc81c592d4","query_id":"51","doc_a_id":"19673227","doc_b_id":"8891333","presented_order":["8891333","19673227"],"winner_id":"8891333","reasoning":"Document A is more relevant — it discusses cancer stem cells in breast cancer (where ALDH1 is a common stem-cell marker) and therapeutic implications, whereas B focuses on chemosensitivity assays for circulating tumor cells without addressing ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905916Z"}
{"comparison_id":"594b4e8d-fc7a-47f6-854e-608cb6c6757a","query_id":"51","doc_a_id":"22975806","doc_b_id":"4702639","presented_order":["4702639","22975806"],"winner_id":"4702639","reasoning":"Document A is more relevant — it addresses tumour stemness and markers (related to ALDH1 as a stem/progenitor marker), whereas Document B focuses on BRCA allele loss unrelated to ALDH1 expression. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905923Z"}
{"comparison_id":"ee78809d-fea6-4dee-9034-8948b39c9a5b","query_id":"51","doc_a_id":"16734530","doc_b_id":"24834968","presented_order":["16734530","24834968"],"winner_id":"24834968","reasoning":"Document B is more relevant — it evaluates biological markers as predictors of breast cancer treatment response (closer to assessing associations between marker expression and outcomes) while Document A focuses on ORAI1 SNPs unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905929Z"}
{"comparison_id":"8751717f-5b54-427c-ae39-e959cfafacbb","query_id":"51","doc_a_id":"21033230","doc_b_id":"7583725","presented_order":["21033230","7583725"],"winner_id":"21033230","reasoning":"Neither document mentions ALDH1. Document A is slightly more relevant because it discusses molecular markers and prognostic profiling in breast cancer; Document B focuses on TRPM7. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905935Z"}
{"comparison_id":"19e1a82b-2047-4cd2-b1cc-687eedfeefdc","query_id":"51","doc_a_id":"22401720","doc_b_id":"25973484","presented_order":["22401720","25973484"],"winner_id":"22401720","reasoning":"Document A is more relevant — it examines expression of tumor markers and their relation to prognosis in breast cancer, whereas B focuses on obesity-related risk factors and outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905941Z"}
{"comparison_id":"f94edad2-3c1a-4aed-b4fd-1a55a20c7c0f","query_id":"51","doc_a_id":"2014909","doc_b_id":"24341590","presented_order":["2014909","24341590"],"winner_id":"2014909","reasoning":"Document A — it analyzes tumor-initiating cells and primary breast cancers (more likely to address ALDH1 as a stem-cell marker), whereas Document B concerns CYP2D6/tamoxifen and is unrelated.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905947Z"}
{"comparison_id":"7ffba935-1d5b-4c5b-b944-be092fc773d1","query_id":"51","doc_a_id":"12762485","doc_b_id":"4702639","presented_order":["12762485","4702639"],"winner_id":"12762485","reasoning":"Document A — it discusses stem-cell–like phenotypes in breast cancer (which relate to ALDH1 as a stem cell marker), whereas Document B focuses on integrin/KRAS-driven stemness and drug resistance in other carcinomas. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905954Z"}
{"comparison_id":"fff19926-5dec-4b74-b901-42346d8f6882","query_id":"51","doc_a_id":"2014909","doc_b_id":"4702639","presented_order":["4702639","2014909"],"winner_id":"2014909","reasoning":"Document B is more relevant — it links mTOR signaling to tumor-initiating cells and analyzes primary breast cancers, which is more directly related to markers like ALDH1 and breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905960Z"}
{"comparison_id":"68612993-2988-4d10-8ca3-a28a74e46e35","query_id":"51","doc_a_id":"22975806","doc_b_id":"25732836","presented_order":["22975806","25732836"],"winner_id":"25732836","reasoning":"Document B is more relevant because it evaluates biomarkers and their association with survival outcomes in breast cancer, whereas Document A focuses on BRCA allele loss without discussing ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905967Z"}
{"comparison_id":"e7c6cf35-4694-4c45-9ac6-08e8c4c1a280","query_id":"51","doc_a_id":"20839751","doc_b_id":"4455466","presented_order":["4455466","20839751"],"winner_id":"4455466","reasoning":"Document A is more relevant — it discusses how the expression level of a specific marker (ZMYND11) correlates with breast cancer prognosis, which is more directly related to the claim about marker expression and outcomes than Document B's focus on apoptosis indices.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905973Z"}
{"comparison_id":"1b623d61-2282-4f4b-9258-b0e61a565442","query_id":"51","doc_a_id":"11484808","doc_b_id":"2014909","presented_order":["11484808","2014909"],"winner_id":"2014909","reasoning":"Document B is more likely to address markers of tumor-initiating cells (e.g., ALDH1) and clinical correlations in breast cancer, whereas Document A focuses on ncRNAs broadly and is less directly relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905980Z"}
{"comparison_id":"322ff563-b804-4fdf-8b32-e2d2dee2896f","query_id":"51","doc_a_id":"12762485","doc_b_id":"8891333","presented_order":["12762485","8891333"],"winner_id":"12762485","reasoning":"Document A is more relevant — it examines breast cancer phenotypes and their prognostic features (stem‑cell vs luminal), which is closer to a claim about a marker's association with outcomes than the therapy-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905986Z"}
{"comparison_id":"51d77790-3c39-4ff4-af1f-3200f9219978","query_id":"51","doc_a_id":"12762485","doc_b_id":"3285322","presented_order":["3285322","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses stem cell vs luminal phenotypes and their prognostic features, which is more related to ALDH1 (a stem cell marker) than the BRCA-focused Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905992Z"}
{"comparison_id":"81a20080-aef8-4dca-8d16-ac8147b988d8","query_id":"51","doc_a_id":"22712546","doc_b_id":"24341590","presented_order":["24341590","22712546"],"winner_id":"22712546","reasoning":"Document B — it concerns single-cell enzymatic/metabolic profiling in breast cancer tissue (potentially including ALDH1), while A focuses on CYP2D6/tamoxifen and is unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.905998Z"}
{"comparison_id":"53227703-1911-4e91-869d-8e981510752f","query_id":"51","doc_a_id":"16691520","doc_b_id":"31311495","presented_order":["16691520","31311495"],"winner_id":"31311495","reasoning":"Document B — it discusses tamoxifen resistance and EMT-related aggressiveness in breast cancer, which is more related to markers of prognosis than the estrogen receptor binding focus of A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906005Z"}
{"comparison_id":"8fc7c82a-a56b-4ef6-9414-81f2fa654cef","query_id":"51","doc_a_id":"2014909","doc_b_id":"24834968","presented_order":["24834968","2014909"],"winner_id":"2014909","reasoning":"Neither abstract mentions ALDH1, but Document B discusses tumor-initiating cells and analyses of primary breast cancers (more connected to stem-cell marker biology) while A focuses on HER2/Ki67 and chemotherapy response. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906011Z"}
{"comparison_id":"7123483b-b0ec-48eb-938f-db16ddf6f58c","query_id":"51","doc_a_id":"16691520","doc_b_id":"20127522","presented_order":["20127522","16691520"],"winner_id":"20127522","reasoning":"Doc A is more relevant — it deals with prognostic markers and treatment outcomes in breast cancer, whereas Doc B focuses on estrogen receptor genomic binding and not clinical outcome markers like ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906018Z"}
{"comparison_id":"8bf9a122-986e-4c99-8c13-9ce972601c0a","query_id":"51","doc_a_id":"20839751","doc_b_id":"24341590","presented_order":["20839751","24341590"],"winner_id":"20839751","reasoning":"Document A is more relevant — it discusses breast cancer biomarkers and prognosis, whereas Document B focuses on CYP2D6 pharmacogenetics in tamoxifen treatment, unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906025Z"}
{"comparison_id":"5c5ea71a-8624-4e50-a073-287020697a37","query_id":"51","doc_a_id":"16691520","doc_b_id":"8963413","presented_order":["8963413","16691520"],"winner_id":"8963413","reasoning":"Doc A is more relevant — it discusses biomarker expression and associations with breast cancer outcomes, which is closer to the claim about ALDH1 than a genome-wide ER binding study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906031Z"}
{"comparison_id":"c2c2a838-6768-4bf0-a690-5cd7c746eec4","query_id":"51","doc_a_id":"16734530","doc_b_id":"18953920","presented_order":["18953920","16734530"],"winner_id":"18953920","reasoning":"Document A discusses stem-cell markers and tumorigenic properties in mammary epithelial cells, which is more related to ALDH1 (a stem-cell marker) and breast cancer outcomes. Document B addresses ORAI1 SNPs and is unrelated.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906037Z"}
{"comparison_id":"0dfb46be-aeeb-4d70-aa07-71cdaa0c9eff","query_id":"51","doc_a_id":"20839751","doc_b_id":"3285322","presented_order":["3285322","20839751"],"winner_id":"20839751","reasoning":"Document B is more relevant — it discusses pathological markers and their association with prognosis in breast cancer, while A focuses on BRCA mutation status and tumor subtypes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906043Z"}
{"comparison_id":"9a3caa69-fcd9-4855-82b1-a9ed5329e8a3","query_id":"51","doc_a_id":"16086778","doc_b_id":"43385013","presented_order":["16086778","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it examines stem cell/progenitor properties in breast cell subpopulations, which relates to ALDH1 as a stem cell marker; Document A focuses on Numb/Notch and not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906050Z"}
{"comparison_id":"955759a7-1114-47a5-a076-68eaf110a973","query_id":"51","doc_a_id":"16734530","doc_b_id":"22712546","presented_order":["16734530","22712546"],"winner_id":"22712546","reasoning":"Document B — it studies enzymatic activities and metabolic interactions in breast cancer tissue (more directly related to ALDH1, an enzyme), whereas Document A concerns ORAI1 SNPs unrelated to ALDH1 or outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906057Z"}
{"comparison_id":"488533bb-3818-49c1-b784-e92a0b687275","query_id":"51","doc_a_id":"20127522","doc_b_id":"8963413","presented_order":["8963413","20127522"],"winner_id":"8963413","reasoning":"Document A is more relevant — it discusses biomarker expression linked to breast cancer outcomes (though a different marker, PD-L1), which is closer to the query about ALDH1 expression and outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906064Z"}
{"comparison_id":"1ccb82d6-fef8-4a39-9063-fd25ffea4d75","query_id":"51","doc_a_id":"20127522","doc_b_id":"34066665","presented_order":["34066665","20127522"],"winner_id":"34066665","reasoning":"Neither document mentions ALDH1. Document A is slightly more relevant because it addresses molecular markers and clinical outcomes in breast cancer, whereas Document B focuses specifically on circulating tumor cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906070Z"}
{"comparison_id":"7053474c-ce99-4aa6-912c-f0ac70e2c5cc","query_id":"51","doc_a_id":"12762485","doc_b_id":"20839751","presented_order":["12762485","20839751"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses stem-cell–like phenotypes and markers in breast cancer (which relate to ALDH1 as a stem cell marker), while B focuses on apoptosis and prognostic indices and doesn't address stem-cell markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906076Z"}
{"comparison_id":"28f685a3-5c8c-4c36-80a9-2670ea01bba9","query_id":"51","doc_a_id":"1866911","doc_b_id":"31311495","presented_order":["31311495","1866911"],"winner_id":"1866911","reasoning":"Document B — it concerns breast epithelial progenitor populations and marker-defined cell types (more related to ALDH1 as a stem/progenitor marker), whereas A focuses on tamoxifen resistance and beta-catenin signaling without ALDH1 relevance.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906083Z"}
{"comparison_id":"f456097f-7fdf-4665-89c1-98f37c193c90","query_id":"51","doc_a_id":"21033230","doc_b_id":"43385013","presented_order":["21033230","43385013"],"winner_id":"43385013","reasoning":"Document B — it addresses stem cell/progenitor properties in breast cells (relevant to ALDH1 as a stem cell marker), while Document A does not mention ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906089Z"}
{"comparison_id":"7da0be99-1a9d-4d9e-8115-a885c8e7faaf","query_id":"51","doc_a_id":"22401720","doc_b_id":"22712546","presented_order":["22401720","22712546"],"winner_id":"22712546","reasoning":"Document B — it addresses enzymatic/metabolic activities in breast cancer tissue (more likely to cover ALDH1), while A focuses on angiogenic factors, not ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906095Z"}
{"comparison_id":"02b4aba6-7849-499b-86f1-64119e9d7320","query_id":"51","doc_a_id":"19358586","doc_b_id":"25973484","presented_order":["19358586","25973484"],"winner_id":"19358586","reasoning":"Document A is more relevant — it discusses molecular/protein markers and prognostic signatures in breast cancer, which is closer to ALDH1 as a prognostic marker than the obesity-focused review.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906101Z"}
{"comparison_id":"fd83438e-5e2e-40bb-a443-b659c13c4d13","query_id":"51","doc_a_id":"25732836","doc_b_id":"7821634","presented_order":["25732836","7821634"],"winner_id":"7821634","reasoning":"Reason: B addresses molecular marker expression and outcome associations in breast cancer (mechanisms of residual tumor biology), while A focuses on imaging/CTCs and not gene/protein expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906108Z"}
{"comparison_id":"985911d3-31b2-4526-9e4c-9532b9b46a33","query_id":"51","doc_a_id":"25973484","doc_b_id":"7821634","presented_order":["25973484","7821634"],"winner_id":"7821634","reasoning":"Document B — it discusses molecular markers and their association with breast cancer outcomes (drug resistance and prognosis), which is more relevant to a claim about ALDH1 expression than the obesity-focused Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906114Z"}
{"comparison_id":"9b726a5b-4b89-4248-badb-9bbff4e20821","query_id":"51","doc_a_id":"2014909","doc_b_id":"313403","presented_order":["2014909","313403"],"winner_id":"2014909","reasoning":"Document A is more relevant — it discusses tumor-initiating cells (commonly marked by ALDH1) and breast cancer analyses, which relate to ALDH1's prognostic role.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906120Z"}
{"comparison_id":"1da47d56-ce15-46dc-bd91-0ab55dc96e13","query_id":"51","doc_a_id":"4702639","doc_b_id":"7583725","presented_order":["4702639","7583725"],"winner_id":"4702639","reasoning":"Document A is more relevant — it addresses tumour stemness and markers associated with stem-like cells (contextually related to ALDH1 as a stem cell marker), while Document B focuses on TRPM7 and metastasis without linking to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906127Z"}
{"comparison_id":"b1454129-a552-47da-aeb5-6f64e5b20e9c","query_id":"51","doc_a_id":"15946643","doc_b_id":"1866911","presented_order":["1866911","15946643"],"winner_id":"1866911","reasoning":"Document A is more relevant — it discusses breast epithelial cell populations and marker-defined progenitors, which is closer to a claim about ALDH1 (a stem/progenitor marker) and clinical outcomes than a paper on CXCL1-driven chemoresistance.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906134Z"}
{"comparison_id":"402a5bd7-9ef4-44cd-82ad-fa3af48a93b3","query_id":"51","doc_a_id":"15946643","doc_b_id":"16691520","presented_order":["15946643","16691520"],"winner_id":"15946643","reasoning":"Document A is more relevant — it addresses breast cancer chemoresistance and metastasis and thus is more likely to contain information on biomarkers and clinical outcomes such as ALDH1 expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906140Z"}
{"comparison_id":"4d0d87a3-a647-4371-8ae7-f1555b629a43","query_id":"51","doc_a_id":"16691520","doc_b_id":"32001951","presented_order":["16691520","32001951"],"winner_id":"16691520","reasoning":"Document A is more relevant — it addresses genome-wide gene regulation in breast cancer and could cover genes like ALDH1, whereas Document B concerns alkaline phosphatase, a different enzyme. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906147Z"}
{"comparison_id":"1f7e71f0-0540-402b-832e-78961c0ab7ff","query_id":"51","doc_a_id":"12762485","doc_b_id":"4455466","presented_order":["4455466","12762485"],"winner_id":"12762485","reasoning":"Reason: Document B discusses stem-cell–like phenotypes and prognostic markers in breast cancer (which is directly related to ALDH1 as a stem-cell marker), whereas Document A focuses on ZMYND11 and not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906153Z"}
{"comparison_id":"ba4610a3-dfa2-4e8b-9abf-00954dd22f72","query_id":"51","doc_a_id":"19673227","doc_b_id":"32001951","presented_order":["19673227","32001951"],"winner_id":"19673227","reasoning":"Document A — it discusses prognostic/predictive markers and patient outcomes, which is more relevant to a claim about marker expression and breast cancer outcomes than Document B's in vitro study of alkaline phosphatase regulation.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906159Z"}
{"comparison_id":"9b890db1-e753-4ddc-af4f-c4de438962ac","query_id":"51","doc_a_id":"18953920","doc_b_id":"4702639","presented_order":["18953920","4702639"],"winner_id":"18953920","reasoning":"Document A is about EMT generating stem-cell markers in mammary epithelial cells and increased tumorigenic potential, which is more directly related to ALDH1 as a breast cancer stem-cell marker. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906166Z"}
{"comparison_id":"cf4f6b10-bd0f-4af0-9aea-bb6f6a97ae55","query_id":"51","doc_a_id":"16691520","doc_b_id":"313403","presented_order":["313403","16691520"],"winner_id":"313403","reasoning":"Document A is more relevant—it's about prognostic markers and clinical outcomes in breast cancer, whereas Document B focuses on estrogen receptor binding sites and not prognosis or ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906172Z"}
{"comparison_id":"e93f6d2d-ffab-4bc2-88bb-d76e430ca0ca","query_id":"51","doc_a_id":"11484808","doc_b_id":"16691520","presented_order":["11484808","16691520"],"winner_id":"11484808","reasoning":"Document A is more likely to discuss biomarkers and clinical outcome associations in endocrine-related (including breast) cancers, so it is more relevant to a claim about ALDH1 and outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906178Z"}
{"comparison_id":"386d91d1-55be-4e95-a8a3-765e5b916ea0","query_id":"51","doc_a_id":"19358586","doc_b_id":"45638119","presented_order":["45638119","19358586"],"winner_id":"45638119","reasoning":"Doc A directly addresses ALDH1 in breast cancer and reports it predicts poor clinical outcome (contradicting the claim).  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906183Z"}
{"comparison_id":"bde40aa1-b518-4aee-8c08-541941e76332","query_id":"51","doc_a_id":"1866911","doc_b_id":"21033230","presented_order":["1866911","21033230"],"winner_id":"1866911","reasoning":"Document A is slightly more relevant because it discusses breast progenitor/stem-like cell populations (where ALDH1 is commonly studied as a marker), whereas Document B focuses on CTC markers not including ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906190Z"}
{"comparison_id":"23ff3f65-c932-4e44-94c5-28bf0c4e7031","query_id":"51","doc_a_id":"24341590","doc_b_id":"45638119","presented_order":["24341590","45638119"],"winner_id":"45638119","reasoning":"Document B is directly about ALDH1 and reports it predicts poor clinical outcome (contradicting the claim). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906195Z"}
{"comparison_id":"882021ea-224e-4240-a4a1-c63b62605e4c","query_id":"51","doc_a_id":"31311495","doc_b_id":"34066665","presented_order":["34066665","31311495"],"winner_id":"34066665","reasoning":"Document A is more relevant — it's a clinical review about ER/HER signaling and therapy resistance with implications for treatment outcomes, whereas B is a specific cell-line mechanistic study unlikely to address ALDH1 and clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906202Z"}
{"comparison_id":"b88acf37-f67e-46d1-b8aa-de6738824eb7","query_id":"51","doc_a_id":"313403","doc_b_id":"4889228","presented_order":["4889228","313403"],"winner_id":"4889228","reasoning":"Document A is more relevant — it links a specific gene's expression to prognosis in breast cancer, which is similar to the ALDH1–outcome association in the query.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906208Z"}
{"comparison_id":"db4049c9-8f5b-4408-a7a0-f4d7f0089d4d","query_id":"51","doc_a_id":"45638119","doc_b_id":"9600826","presented_order":["45638119","9600826"],"winner_id":"45638119","reasoning":"Doc A directly addresses ALDH1 and links its expression to clinical outcome (reports poor prognosis), whereas Doc B is unrelated to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906213Z"}
{"comparison_id":"a560fcfc-a63c-48ee-a960-3d0e50bb73f2","query_id":"51","doc_a_id":"1171121","doc_b_id":"24834968","presented_order":["24834968","1171121"],"winner_id":"1171121","reasoning":"Document B — it discusses prognostic markers tied to disease-free survival and outcomes, so it's more relevant to a claim about marker expression and breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906219Z"}
{"comparison_id":"33fe3398-8475-4688-9846-4df2d7aff084","query_id":"51","doc_a_id":"1866911","doc_b_id":"9600826","presented_order":["1866911","9600826"],"winner_id":"1866911","reasoning":"Document A is more relevant — it discusses breast epithelial progenitor populations and tumor origins (contexts where ALDH1, a stem/progenitor marker, is typically studied), whereas Document B focuses on angiogenesis pathways unrelated to ALDH1 or clinical outcomes.\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906226Z"}
{"comparison_id":"d9f49f60-6701-49c3-b68e-7a93c9888517","query_id":"51","doc_a_id":"20839751","doc_b_id":"24249915","presented_order":["24249915","20839751"],"winner_id":"24249915","reasoning":"Document A is more relevant — it discusses expression of a tissue marker (ERβ) and its loss in invasive breast cancer, which is closer to evaluating how marker expression relates to outcomes than Document B's focus on apoptosis indices. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906232Z"}
{"comparison_id":"6694f6f1-c3d3-445d-aec4-5e3f324659be","query_id":"51","doc_a_id":"18953920","doc_b_id":"27123743","presented_order":["27123743","18953920"],"winner_id":"18953920","reasoning":"Document B is more relevant — it discusses acquisition of stem-cell markers and increased tumorigenic potential in mammary epithelial cells (ALDH1 is a known stem-cell marker), whereas A is about birthweight and breast cancer risk. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906239Z"}
{"comparison_id":"4ccd72b8-e024-45fc-b167-151f586e8da0","query_id":"51","doc_a_id":"1866911","doc_b_id":"45638119","presented_order":["45638119","1866911"],"winner_id":"45638119","reasoning":"Document A — it directly addresses ALDH1 expression and links it to clinical outcomes (predictor of poor prognosis), which is directly relevant to the query. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906245Z"}
{"comparison_id":"ae20d3ac-22d2-4038-b2f8-b60d584e15b2","query_id":"51","doc_a_id":"15113221","doc_b_id":"31311495","presented_order":["15113221","31311495"],"winner_id":"15113221","reasoning":"Document A is more relevant — it discusses a gene expression signature linked to prognosis in carcinoma, aligning with the claim's focus on expression–outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906251Z"}
{"comparison_id":"9e4ca17e-a342-45e3-babb-f787bcda089a","query_id":"51","doc_a_id":"4429932","doc_b_id":"5500086","presented_order":["4429932","5500086"],"winner_id":"5500086","reasoning":"Document B is more relevant — it links a molecular signature (type I IFN) to positive breast cancer outcomes, which is closer to the claim about a marker being associated with better outcomes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906257Z"}
{"comparison_id":"b6a377c9-3612-432d-adc5-b6d96fa55281","query_id":"51","doc_a_id":"12762485","doc_b_id":"16086778","presented_order":["12762485","16086778"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses stem cell phenotypes in breast cancer (which relate to markers like ALDH1) and clinical correlations. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906264Z"}
{"comparison_id":"79eca14d-65fa-4197-9f3e-297e75663282","query_id":"51","doc_a_id":"22482820","doc_b_id":"7821634","presented_order":["7821634","22482820"],"winner_id":"7821634","reasoning":"Reason: Document A discusses how expression of a tumor biomarker (DUSP4) correlates with outcomes in breast cancer, making it more relevant to a claim about biomarker (ALDH1) and outcomes than the therapy-focused Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906270Z"}
{"comparison_id":"4c41801c-eb8b-4080-af52-21c8628f0d29","query_id":"51","doc_a_id":"24341590","doc_b_id":"8963413","presented_order":["8963413","24341590"],"winner_id":"8963413","reasoning":"Document A is more relevant — it discusses the association between a biomarker's expression and breast cancer outcomes (though for PD-L1, not ALDH1), which is conceptually closer to the claim than the CYP2D6 pharmacogenetics focus in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906277Z"}
{"comparison_id":"171e58bf-0bbb-446f-a59e-bc9488a4ec5b","query_id":"51","doc_a_id":"1171121","doc_b_id":"3285322","presented_order":["1171121","3285322"],"winner_id":"1171121","reasoning":"Document A is more relevant — it evaluates biomarker status (p53, MVD) in relation to breast cancer outcomes, whereas Document B focuses on BRCA mutation clinical features. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906283Z"}
{"comparison_id":"edcce454-b655-4461-8dc1-232b5fdaf2d7","query_id":"51","doc_a_id":"18953920","doc_b_id":"22712546","presented_order":["18953920","22712546"],"winner_id":"18953920","reasoning":"Doc A is more relevant — it discusses acquisition of stem-cell markers in mammary epithelial cells and increased tumorigenic potential, which directly relates to ALDH1 as a stem-cell marker and its prognostic implications. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906291Z"}
{"comparison_id":"3701040a-45ff-4b27-92a3-35278a630173","query_id":"51","doc_a_id":"21033230","doc_b_id":"8891333","presented_order":["21033230","8891333"],"winner_id":"8891333","reasoning":"Document B — it discusses cancer stem cells in breast cancer (ALDH1 is a cancer stem cell marker), so it’s more relevant to a claim about ALDH1 and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906297Z"}
{"comparison_id":"b53b4771-5674-4494-8e34-c9f2084ececf","query_id":"51","doc_a_id":"1866911","doc_b_id":"2014909","presented_order":["2014909","1866911"],"winner_id":"2014909","reasoning":"Relevant: Document A — it analyzes tumor-initiating cells and primary breast cancers (topics related to ALDH1 as a stem/tumor-initiating marker), whereas B focuses on BRCA1-associated luminal progenitors without outcome data.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906308Z"}
{"comparison_id":"c5784636-1346-493b-aa80-236123b146d9","query_id":"51","doc_a_id":"43385013","doc_b_id":"4889228","presented_order":["43385013","4889228"],"winner_id":"43385013","reasoning":"Document A is more relevant — it discusses stem cell/progenitor properties in breast cell subpopulations (ALDH1 is a stem cell marker), whereas Document B focuses on TDP43 in TNBC and does not relate to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906315Z"}
{"comparison_id":"f1ee26ee-39b5-49f2-8425-1933f50216da","query_id":"51","doc_a_id":"4429932","doc_b_id":"9600826","presented_order":["4429932","9600826"],"winner_id":"4429932","reasoning":"Document A is more relevant — it specifically mentions patient outcomes in breast cancer, whereas Document B focuses on angiogenesis pathways without discussing clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906322Z"}
{"comparison_id":"3182afda-f251-49e4-b0c0-9140aa2a952c","query_id":"51","doc_a_id":"24341590","doc_b_id":"24834968","presented_order":["24834968","24341590"],"winner_id":"24834968","reasoning":"Document A is more likely to address tumor biomarker expression and outcomes (it evaluates HER-2/neu and other biological markers), whereas Document B concerns CYP2D6 polymorphisms and tamoxifen metabolism, unrelated to ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906328Z"}
{"comparison_id":"08e8b86b-1458-4877-a27a-8e5d3309bd85","query_id":"51","doc_a_id":"24249915","doc_b_id":"7583725","presented_order":["7583725","24249915"],"winner_id":"24249915","reasoning":"Document B — it discusses loss and potential beneficial re-expression of a protein (ERβ) in invasive breast cancer, which is more conceptually related to a claim about expression being associated with better outcomes than a paper linking TRPM7 to worse outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906335Z"}
{"comparison_id":"19a69ec9-b871-4939-ac25-c746a92e4f49","query_id":"51","doc_a_id":"31311495","doc_b_id":"4429932","presented_order":["31311495","4429932"],"winner_id":"4429932","reasoning":"Document B — it discusses a molecular marker (LOX) with reported associations to patient outcomes in breast cancer, so it's more relevant to a claim about a biomarker's outcome association.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906342Z"}
{"comparison_id":"2c6e6e42-bc34-4d2d-9b46-7949c679f717","query_id":"51","doc_a_id":"4702639","doc_b_id":"5579368","presented_order":["4702639","5579368"],"winner_id":"5579368","reasoning":"Document B — it deals with genomic/biomarker analysis in breast cancer and linking gene expression to clinical markers, which is more relevant to a claim about ALDH1 expression and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906348Z"}
{"comparison_id":"2e8c138c-dab0-4ea4-8123-9474a730d6bf","query_id":"51","doc_a_id":"2014909","doc_b_id":"22975806","presented_order":["2014909","22975806"],"winner_id":"2014909","reasoning":"Document A is more relevant — it analyzes tumor-initiating cells in primary breast cancers (ALDH1 is a common tumor-initiating cell marker), whereas Document B focuses on BRCA allele loss unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906355Z"}
{"comparison_id":"40da04af-b2ae-499b-a3a7-495b3b6b8381","query_id":"51","doc_a_id":"15113221","doc_b_id":"16691520","presented_order":["16691520","15113221"],"winner_id":"15113221","reasoning":"Document B is more relevant — it links gene expression signatures to prognosis in carcinomas, which is closer to the claim about expression being associated with breast cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906361Z"}
{"comparison_id":"2d7060ca-8f47-4213-8162-3c7a3fc5d764","query_id":"51","doc_a_id":"34066665","doc_b_id":"7583725","presented_order":["34066665","7583725"],"winner_id":"7583725","reasoning":"Document B is more relevant — it discusses how expression of a specific protein (TRPM7) predicts patient outcomes in breast cancer, which is directly about marker–outcome associations. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906368Z"}
{"comparison_id":"be2db09e-e273-41c1-930d-8d1197ee9da2","query_id":"51","doc_a_id":"15113221","doc_b_id":"4429932","presented_order":["4429932","15113221"],"winner_id":"15113221","reasoning":"Reason: Neither abstract mentions ALDH1, but Document B discusses a gene expression signature linked to prognosis, so it's slightly more relevant to a claim about a marker's association with outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906374Z"}
{"comparison_id":"30c96dec-7333-4393-904a-530bccdd99a0","query_id":"51","doc_a_id":"1171121","doc_b_id":"19673227","presented_order":["1171121","19673227"],"winner_id":"1171121","reasoning":"Document A is more relevant — it deals with prognostic markers in breast cancer specifically, whereas B focuses on CTC chemosensitivity across epithelial tumors and not breast cancer prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906381Z"}
{"comparison_id":"7fa63077-f3bf-4651-8be1-b9b1a2ee846c","query_id":"51","doc_a_id":"1171121","doc_b_id":"25732836","presented_order":["25732836","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant — it examines tumor biomarker (p53) status and prognostic factors in breast cancer, which is closer to evaluating associations between marker expression and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906387Z"}
{"comparison_id":"a0dc727b-56ed-4549-ac80-a8ef69d670b3","query_id":"51","doc_a_id":"1866911","doc_b_id":"20183360","presented_order":["20183360","1866911"],"winner_id":"1866911","reasoning":"Document B — it discusses progenitor cell populations and marker-defined origins of breast tumors, which is more related to ALDH1 as a stem/progenitor marker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906393Z"}
{"comparison_id":"63a07992-9267-401b-8188-5c05a0d9646a","query_id":"51","doc_a_id":"21033230","doc_b_id":"313403","presented_order":["313403","21033230"],"winner_id":"21033230","reasoning":"Neither document mentions ALDH1. Document B is marginally more relevant because it addresses molecular marker profiling and associations between marker-positive circulating tumor cells and outcomes, whereas A focuses on tumor-associated macrophages.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906400Z"}
{"comparison_id":"5ef10b91-e6bc-42e8-800e-6cfe16991aaa","query_id":"51","doc_a_id":"24341590","doc_b_id":"34066665","presented_order":["24341590","34066665"],"winner_id":"34066665","reasoning":"Document B is more relevant — it discusses molecular markers and signaling in breast cancer which is closer to ALDH1's role as a biomarker than a pharmacogenetic study of CYP2D6.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906407Z"}
{"comparison_id":"d97f59b3-8834-4a9c-8f98-f0cb0f1d8cc4","query_id":"51","doc_a_id":"1171121","doc_b_id":"9600826","presented_order":["1171121","9600826"],"winner_id":"1171121","reasoning":"Document A is more relevant — it discusses prognostic factors and associations with disease-free survival in breast cancer, whereas Document B focuses on a molecular pathway for invasion/angiogenesis and not clinical outcomes or ALDH1.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906413Z"}
{"comparison_id":"7fb74bd4-5aae-4c37-bfff-c4a7fe86fc6d","query_id":"51","doc_a_id":"2931832","doc_b_id":"8891333","presented_order":["8891333","2931832"],"winner_id":"8891333","reasoning":"Document A is more relevant — it discusses cancer stem cells in breast cancer (ALDH1 is a stem-cell marker), whereas Document B concerns platelet indices unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906420Z"}
{"comparison_id":"b70e7ecc-3ad8-44bc-bd4e-c0b6165abda7","query_id":"51","doc_a_id":"16086778","doc_b_id":"19358586","presented_order":["16086778","19358586"],"winner_id":"19358586","reasoning":"Document B — it discusses markers linked to survival and prognosis in breast cancer, so it's more related to a claim about marker expression and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906427Z"}
{"comparison_id":"8d7eeae5-521f-4471-bf9e-b14c25bffda8","query_id":"51","doc_a_id":"2931832","doc_b_id":"4455466","presented_order":["4455466","2931832"],"winner_id":"4455466","reasoning":"Document A is more relevant — it discusses how expression level of a specific gene (ZMYND11) relates to breast cancer prognosis, which is conceptually similar to a claim about ALDH1 expression and outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906433Z"}
{"comparison_id":"c4f80e03-5f7d-487a-8f19-7e83ce46b98b","query_id":"51","doc_a_id":"19673227","doc_b_id":"25732836","presented_order":["19673227","25732836"],"winner_id":"25732836","reasoning":"B is more relevant — it specifically evaluates prognostic markers for breast cancer outcomes (CTCs and PET/CT). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906439Z"}
{"comparison_id":"afd01a2e-906c-489b-b00f-262736cfad65","query_id":"51","doc_a_id":"24341590","doc_b_id":"32001951","presented_order":["32001951","24341590"],"winner_id":"32001951","reasoning":"Document A is more relevant — it addresses expression of an enzyme in breast cancer cells (though not ALDH1), whereas Document B concerns CYP2D6 genetics and tamoxifen outcomes, not marker expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906446Z"}
{"comparison_id":"71dd3ccc-0bcf-4d40-b4a9-5f82b0520ef0","query_id":"51","doc_a_id":"22482820","doc_b_id":"25973484","presented_order":["22482820","25973484"],"winner_id":"25973484","reasoning":"Document B — it discusses breast cancer prognosis and factors affecting outcomes, making it more relevant to a claim about marker-associated outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906453Z"}
{"comparison_id":"d9a2d351-33c5-4ea6-b6fd-8a710fc2e012","query_id":"51","doc_a_id":"16086778","doc_b_id":"20127522","presented_order":["16086778","20127522"],"winner_id":"16086778","reasoning":"Document A — it discusses molecular regulation and tumor biology in breast cancer (more relevant to biomarker expression/prognosis) while B focuses on circulating tumor cells and monitoring, not ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906459Z"}
{"comparison_id":"ebaa9b41-9147-46ab-8659-a399d1835e3c","query_id":"51","doc_a_id":"24249915","doc_b_id":"24341590","presented_order":["24341590","24249915"],"winner_id":"24249915","reasoning":"Document B is more relevant — it addresses expression of a biomarker (ERβ) and its relation to invasive cancer/outcomes, whereas A focuses on CYP2D6 pharmacogenetics unrelated to ALDH1 expression. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906466Z"}
{"comparison_id":"6b3e5f86-e824-42cd-9a07-724ce89abde7","query_id":"51","doc_a_id":"11484808","doc_b_id":"45638119","presented_order":["45638119","11484808"],"winner_id":"45638119","reasoning":"Document A directly addresses ALDH1 in breast cancer and reports it predicts poor clinical outcome (contradicting the claim); Document B is unrelated. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906472Z"}
{"comparison_id":"757294b3-c0e1-4f93-932f-5343e47de126","query_id":"51","doc_a_id":"1171121","doc_b_id":"34066665","presented_order":["34066665","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant — it addresses prognostic markers in breast cancer (MVD, p53), whereas Document A focuses on ER/HER signaling and endocrine resistance with no mention of ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906479Z"}
{"comparison_id":"c5941f53-18f8-4027-9072-0df74c2985a7","query_id":"51","doc_a_id":"15113221","doc_b_id":"8963413","presented_order":["15113221","8963413"],"winner_id":"8963413","reasoning":"Document B is more relevant — it discusses how a biomarker (PD-L1) is associated with clinical outcomes in breast cancer, which is thematically closer to a claim about a biomarker (ALDH1) and breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906485Z"}
{"comparison_id":"73c219d8-1000-4278-babe-7e2f05fa321c","query_id":"51","doc_a_id":"15113221","doc_b_id":"4455466","presented_order":["15113221","4455466"],"winner_id":"4455466","reasoning":"Document B — it specifically links gene expression (ZMYND11) to breast cancer prognosis, so it's more directly relevant to a claim about a marker's association with breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906492Z"}
{"comparison_id":"387a5d8b-5e42-4cd7-b53f-4a004eaec977","query_id":"51","doc_a_id":"2931832","doc_b_id":"7821634","presented_order":["2931832","7821634"],"winner_id":"7821634","reasoning":"Document B is more relevant — it studies a molecular marker (DUSP4) whose expression correlates with tumor behavior and outcomes in breast cancer, whereas A only addresses a platelet-based prognostic ratio unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906499Z"}
{"comparison_id":"1af094dc-8540-4d08-b882-640ff14a4b2c","query_id":"51","doc_a_id":"20454006","doc_b_id":"21033230","presented_order":["20454006","21033230"],"winner_id":"21033230","reasoning":"Document B is more relevant — it examines molecular markers on tumor cells and their association with survival outcomes, whereas Document A discusses a dietary compound's effect on estrogen metabolism and tamoxifen metabolites without biomarker-outcome correlations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906505Z"}
{"comparison_id":"21c00139-50ab-4a64-9054-706df4f68ba5","query_id":"51","doc_a_id":"11484808","doc_b_id":"1866911","presented_order":["1866911","11484808"],"winner_id":"1866911","reasoning":"Document A discusses progenitor cell populations and marker-defined origins of breast tumors, making it more relevant to ALDH1 (a stem/progenitor marker) than a review of ncRNAs.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906511Z"}
{"comparison_id":"937d250a-0362-48ed-8dd7-96d98825765c","query_id":"51","doc_a_id":"1171121","doc_b_id":"18953920","presented_order":["1171121","18953920"],"winner_id":"18953920","reasoning":"Document B — it discusses acquisition of stem-cell markers in mammary cells (ALDH1 is a breast cancer stem-cell marker), whereas Document A focuses on MVD and p53, not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906518Z"}
{"comparison_id":"7b47a88f-96e8-4ff9-a790-e3cd21f65d53","query_id":"51","doc_a_id":"15946643","doc_b_id":"4429932","presented_order":["4429932","15946643"],"winner_id":"15946643","reasoning":"Reason: Neither abstract mentions ALDH1, but Document B discusses chemoresistance and tumor cell survival in breast cancer—topics more related to ALDH1 (a stem-cell/chemoresistance marker) than Document A's focus on LOX and hypoxia-induced metastasis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906525Z"}
{"comparison_id":"53c9c2f8-657f-43ab-bade-dbdb98b00a25","query_id":"51","doc_a_id":"20454006","doc_b_id":"22712546","presented_order":["22712546","20454006"],"winner_id":"22712546","reasoning":"Document A is more relevant — it focuses on measuring enzymatic activities in breast cancer tissue and single-cell metabolic states, which is more likely to address ALDH1 expression and its association with outcomes than a tamoxifen/DIM biomarker trial.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906531Z"}
{"comparison_id":"486f5407-4219-4927-9489-1c249eaacc92","query_id":"51","doc_a_id":"2014909","doc_b_id":"2931832","presented_order":["2014909","2931832"],"winner_id":"2014909","reasoning":"Document A is more relevant — it analyzes tumor-initiating cells in primary breast cancers (ALDH1 is a marker of such cells), whereas Document B concerns platelet metrics unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906538Z"}
{"comparison_id":"fb95fa15-a81e-4b0a-a7b3-bf26d7a34e12","query_id":"51","doc_a_id":"20127522","doc_b_id":"4889228","presented_order":["20127522","4889228"],"winner_id":"4889228","reasoning":"Document B is more relevant — it discusses molecular marker expression and links expression levels to prognosis in breast cancer, which is closer to the claim about ALDH1 and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906544Z"}
{"comparison_id":"a6754d63-1a2f-4a3c-8194-efa4f0b2f25b","query_id":"51","doc_a_id":"16691520","doc_b_id":"19358586","presented_order":["19358586","16691520"],"winner_id":"19358586","reasoning":"Document A is more relevant — it discusses protein signatures linked to breast cancer survival and therapeutic markers, whereas B focuses on estrogen receptor binding sites without outcome data. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906551Z"}
{"comparison_id":"5dde34a6-6096-4f49-a5ee-7baabcb12386","query_id":"51","doc_a_id":"25973484","doc_b_id":"31311495","presented_order":["31311495","25973484"],"winner_id":"31311495","reasoning":"Document A is more relevant — it discusses EMT-like behavior and increased tumor aggressiveness (processes linked to stem-cell markers like ALDH1), while Document B focuses on obesity and epidemiology, not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906557Z"}
{"comparison_id":"84516e67-5760-49c9-8c46-d7818d46cfd7","query_id":"51","doc_a_id":"7583725","doc_b_id":"8891333","presented_order":["7583725","8891333"],"winner_id":"8891333","reasoning":"Document B — it discusses cancer stem cells in breast cancer (ALDH1 is a stem-cell marker), while A focuses on TRPM7 unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906564Z"}
{"comparison_id":"677f5ba6-ef92-4c28-8692-af2621cc8146","query_id":"51","doc_a_id":"16734530","doc_b_id":"20127522","presented_order":["16734530","20127522"],"winner_id":"20127522","reasoning":"Document B is more relevant — it concerns a prognostic biomarker and its association with breast cancer outcomes, which is closer to the claim about ALDH1 expression and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906570Z"}
{"comparison_id":"b682efb6-2940-4dde-ae4e-1a5141ac3a20","query_id":"51","doc_a_id":"20839751","doc_b_id":"4429932","presented_order":["4429932","20839751"],"winner_id":"20839751","reasoning":"Document B is more relevant — it discusses prognostic markers and outcomes in breast cancer, whereas A focuses on LOX and metastasis unrelated to ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906576Z"}
{"comparison_id":"b0c5b560-7ab9-44a8-99c0-2d2594febcb6","query_id":"51","doc_a_id":"20183360","doc_b_id":"21033230","presented_order":["21033230","20183360"],"winner_id":"21033230","reasoning":"Document A is more relevant — it discusses prognostic markers and correlations with survival in breast cancer, whereas Document B focuses on a mechanistic pathway unrelated to clinical outcomes or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906583Z"}
{"comparison_id":"2c05299a-ba13-4503-ab30-a8a3dcce4d59","query_id":"51","doc_a_id":"20333864","doc_b_id":"5579368","presented_order":["5579368","20333864"],"winner_id":"5579368","reasoning":"Document A is more relevant — it focuses on integrating gene expression with breast cancer biomarkers, so it's more likely to address ALDH1 expression and clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906590Z"}
{"comparison_id":"aa9c982b-be96-4fc0-814d-85b9e0b5d7a1","query_id":"51","doc_a_id":"45638119","doc_b_id":"7583725","presented_order":["7583725","45638119"],"winner_id":"45638119","reasoning":"Document B — it specifically addresses ALDH1 and reports that ALDH1 expression predicts poor clinical outcome in breast cancer (contradicting the query). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906596Z"}
{"comparison_id":"101912ed-e5bf-4e5e-86fb-1139be5a3587","query_id":"51","doc_a_id":"20183360","doc_b_id":"22712546","presented_order":["22712546","20183360"],"winner_id":"22712546","reasoning":"Document A is more relevant — it examines enzymatic/metabolic activity in breast cancer tissue (ALDH1 is a metabolic enzyme), whereas Document B focuses on GATA3/Smad4 signaling and invasion without relation to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906603Z"}
{"comparison_id":"2112dd8b-fbb7-43ed-b247-a6c734b820e4","query_id":"51","doc_a_id":"3285322","doc_b_id":"4455466","presented_order":["3285322","4455466"],"winner_id":"4455466","reasoning":"Document B is more relevant — it discusses how expression level of a specific gene (ZMYND11) correlates with breast cancer prognosis, which is conceptually similar to the query about ALDH1 expression and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906609Z"}
{"comparison_id":"9f433e12-bdc2-4d83-9657-58a3c4cf8431","query_id":"51","doc_a_id":"5500086","doc_b_id":"8963413","presented_order":["5500086","8963413"],"winner_id":"8963413","reasoning":"Reason: Document B discusses how expression of a specific marker (PD-L1) relates to clinical outcomes in breast cancer, which is conceptually closer to a claim about ALDH1 expression and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906615Z"}
{"comparison_id":"bbcda09d-5fc2-48f7-bc02-82273df8eef7","query_id":"51","doc_a_id":"15113221","doc_b_id":"16086778","presented_order":["15113221","16086778"],"winner_id":"15113221","reasoning":"Doc A is more relevant because it discusses a gene expression signature linked to prognosis in carcinomas, whereas Doc B focuses on Numb/Notch mechanism without linking gene expression to overall outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906622Z"}
{"comparison_id":"dd36f899-9a5f-40e3-88f3-01c801881910","query_id":"51","doc_a_id":"22401720","doc_b_id":"3285322","presented_order":["3285322","22401720"],"winner_id":"22401720","reasoning":"Document B—it examines tumor marker expression levels and their relation to prognosis, which is conceptually closer to a claim about ALDH1 expression and outcomes.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906628Z"}
{"comparison_id":"c88f6ee0-46f3-4a1a-8aad-47745c1d93db","query_id":"51","doc_a_id":"2014909","doc_b_id":"43385013","presented_order":["2014909","43385013"],"winner_id":"43385013","reasoning":"B is more relevant — it addresses stem/progenitor cell properties in breast epithelial subpopulations (ALDH1 is a stem cell marker), while A focuses on mTOR/MDSCs and doesn't discuss ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906634Z"}
{"comparison_id":"54762e8d-4ca4-454d-909a-a5ca699b45cf","query_id":"51","doc_a_id":"15113221","doc_b_id":"43385013","presented_order":["15113221","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it addresses breast epithelial/mesenchymal subpopulations and stem/progenitor properties (ALDH1 is a stem cell marker), while A concerns PTEN pathway signatures unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906641Z"}
{"comparison_id":"952b1d56-8a0a-414b-ba01-56b0bb1fbac0","query_id":"51","doc_a_id":"22712546","doc_b_id":"43385013","presented_order":["22712546","43385013"],"winner_id":"22712546","reasoning":"Reason: Document A focuses on measuring enzymatic activities in breast cancer tissue (relevant to ALDH1 as an enzyme marker) and metabolic interactions in tumors, making it more directly applicable to ALDH1 expression and outcomes than Document B, which addresses EMT and stem/progenitor properties in cell lines.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906648Z"}
{"comparison_id":"6bb5abc6-4831-4c21-aaea-234ed51b54e1","query_id":"51","doc_a_id":"32001951","doc_b_id":"4455466","presented_order":["32001951","4455466"],"winner_id":"4455466","reasoning":"Document B. It discusses breast cancer prognosis and tumor suppression, which is closer to a claim about expression correlating with outcomes; Document A concerns alkaline phosphatase in a cell line (unrelated to ALDH1).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906654Z"}
{"comparison_id":"7d205bdd-0d0e-4e9e-8c2f-5cac069a6ba8","query_id":"51","doc_a_id":"20839751","doc_b_id":"8963413","presented_order":["8963413","20839751"],"winner_id":"8963413","reasoning":"Reason: Document A discusses expression of a biomarker (PD-L1) being associated with better outcomes in breast cancer, which is conceptually closer to a claim about marker expression and prognosis than Document B's focus on apoptosis indices.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906672Z"}
{"comparison_id":"ffc5a2b0-b794-4ba7-aa59-f62eeba65af6","query_id":"51","doc_a_id":"24834968","doc_b_id":"32001951","presented_order":["32001951","24834968"],"winner_id":"24834968","reasoning":"Document B — it deals with clinical biomarkers and treatment response in breast cancer, so it's more related to outcomes than Document A, which focuses on alkaline phosphatase regulation in a cell line.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906690Z"}
{"comparison_id":"8bb88821-d1b1-4695-8317-91370f103eb4","query_id":"51","doc_a_id":"15113221","doc_b_id":"21033230","presented_order":["15113221","21033230"],"winner_id":"21033230","reasoning":"Document B is more relevant — it deals with molecular markers and prognostic associations in breast cancer, whereas A focuses on PTEN pathway signatures in carcinomas generally. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906699Z"}
{"comparison_id":"eecddf5b-bb24-461b-abea-58b3f191b5b9","query_id":"51","doc_a_id":"15113221","doc_b_id":"32001951","presented_order":["32001951","15113221"],"winner_id":"15113221","reasoning":"Document B — it links gene-expression signatures to prognosis in carcinomas, whereas A discusses alkaline phosphatase regulation in a cell line and not clinical outcomes or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906706Z"}
{"comparison_id":"329cecd0-4d91-4627-b588-f1a3a39ac4aa","query_id":"51","doc_a_id":"20183360","doc_b_id":"32001951","presented_order":["32001951","20183360"],"winner_id":"32001951","reasoning":"Neither paper discusses ALDH1. Document A is slightly more relevant because it concerns expression of an enzyme in breast cancer cells, whereas B focuses on transcriptional regulation of invasion.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906714Z"}
{"comparison_id":"4e05780a-9579-4e7e-86a0-1aedb66a2faf","query_id":"51","doc_a_id":"22482820","doc_b_id":"8963413","presented_order":["22482820","8963413"],"winner_id":"8963413","reasoning":"Document B is more relevant — it discusses biomarker expression (PD-L1) and its association with clinical outcomes in breast cancer, which is conceptually related to the query about a biomarker (ALDH1) and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906720Z"}
{"comparison_id":"6ca71dbf-7bea-459e-aee9-e77a8a4d6645","query_id":"51","doc_a_id":"1171121","doc_b_id":"15113221","presented_order":["15113221","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant — it discusses prognostic markers in breast cancer, whereas A focuses on PTEN pathway signatures in carcinomas generally. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906727Z"}
{"comparison_id":"9b6837da-61f2-4515-8879-ab20d1c7d6e7","query_id":"51","doc_a_id":"22401720","doc_b_id":"8891333","presented_order":["8891333","22401720"],"winner_id":"8891333","reasoning":"Document A is more relevant — it discusses cancer stem cells in breast cancer (ALDH1 is a cancer stem cell marker), whereas Document B focuses on angiogenic factors and prognosis unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906734Z"}
{"comparison_id":"b0214b01-cab7-4de3-996d-26cdf57d86e3","query_id":"51","doc_a_id":"19358586","doc_b_id":"24249915","presented_order":["24249915","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant — it links specific protein/miRNA expression patterns to patient survival and tumor outcomes, which matches the query's focus on marker expression and prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906740Z"}
{"comparison_id":"b65401a2-7fd2-4016-b03b-5e1db275f38a","query_id":"51","doc_a_id":"31311495","doc_b_id":"4889228","presented_order":["31311495","4889228"],"winner_id":"4889228","reasoning":"Document B is more relevant — it links gene expression to patient prognosis, whereas A describes cellular mechanisms (tamoxifen resistance/EMT) without addressing clinical outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906747Z"}
{"comparison_id":"4b1ea7b8-d971-4a06-bff3-f2befa73fbbc","query_id":"51","doc_a_id":"24834968","doc_b_id":"25973484","presented_order":["25973484","24834968"],"winner_id":"24834968","reasoning":"Document B is more relevant — it discusses biological markers in breast cancer (predictors of response), whereas A focuses on obesity and risk/prognosis factors unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906753Z"}
{"comparison_id":"c921598e-7faf-4038-a33c-6f4182a1dac2","query_id":"51","doc_a_id":"1866911","doc_b_id":"4889228","presented_order":["1866911","4889228"],"winner_id":"1866911","reasoning":"Document A is more relevant — it discusses luminal progenitor cells and cell-surface markers related to tumor cell-of-origin (more closely related to ALDH1 as a progenitor/stem-cell marker), whereas Document B focuses on splicing regulator TDP43 and not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906760Z"}
{"comparison_id":"f67903da-e3a5-43ad-b7a7-62d6e4aa2df2","query_id":"51","doc_a_id":"22712546","doc_b_id":"4889228","presented_order":["22712546","4889228"],"winner_id":"22712546","reasoning":"Document A is more relevant — it studies enzymatic activities and metabolic interactions in breast cancer tissue (more likely to address ALDH1 expression), whereas Document B focuses on splicing factors in TNBC and not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906766Z"}
{"comparison_id":"ccb3b4e3-6ae9-493e-8f0e-9e5f338fb7c0","query_id":"51","doc_a_id":"1171121","doc_b_id":"7583725","presented_order":["7583725","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant — it discusses prognostic markers and survival in breast cancer, which is closer to a claim about ALDH1 and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906772Z"}
{"comparison_id":"e1b717d8-3041-4f9b-85d3-5c3bd03c024b","query_id":"51","doc_a_id":"21033230","doc_b_id":"4455466","presented_order":["21033230","4455466"],"winner_id":"4455466","reasoning":"Document B — it discusses gene expression linked to breast cancer prognosis (low expression associates with poor outcome), which is more relevant to a claim about expression and outcomes than Document A's focus on CTC markers. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906779Z"}
{"comparison_id":"78500697-e32b-4a9d-a2a2-53824d3454f9","query_id":"51","doc_a_id":"24834968","doc_b_id":"9600826","presented_order":["9600826","24834968"],"winner_id":"24834968","reasoning":"Document B is more relevant — it evaluates biological markers as predictors of breast cancer response/outcomes, whereas Document A discusses an angiogenesis pathway unrelated to ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906786Z"}
{"comparison_id":"0e4b0652-d483-43b5-b72a-0a67975e3ad6","query_id":"51","doc_a_id":"25973484","doc_b_id":"45638119","presented_order":["45638119","25973484"],"winner_id":"45638119","reasoning":"Document A is directly about ALDH1 and reports it predicts poor (not better) breast cancer outcomes, so it directly addresses and contradicts the claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906792Z"}
{"comparison_id":"bf1c298e-5f13-4d68-a2fe-304812343f04","query_id":"51","doc_a_id":"22712546","doc_b_id":"25973484","presented_order":["25973484","22712546"],"winner_id":"22712546","reasoning":"Document B is more relevant — it deals with in situ enzymatic activities and metabolic interactions in breast cancer tissue, which is directly related to ALDH1 (an enzyme) expression and its functional assessment. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906799Z"}
{"comparison_id":"fa607427-ca01-4914-93e5-acfccdfc49f5","query_id":"51","doc_a_id":"24249915","doc_b_id":"5579368","presented_order":["24249915","5579368"],"winner_id":"5579368","reasoning":"Neither document mentions ALDH1 or provides direct evidence about its association with breast cancer outcomes. Document B is slightly more relevant because it discusses a tool for linking DNA methylation to gene expression in breast cancer biomarkers (which could be applied to ALDH1), whereas Document A focuses specifically on ERβ.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906806Z"}
{"comparison_id":"21cf586b-8a82-41fb-9a60-0b68e0c8f6a3","query_id":"51","doc_a_id":"16691520","doc_b_id":"22975806","presented_order":["16691520","22975806"],"winner_id":"16691520","reasoning":"Doc A — it concerns genome-wide gene regulation in breast cancer (more likely to address expression of markers like ALDH1) while Doc B focuses on BRCA allele loss unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906813Z"}
{"comparison_id":"8f731d37-729f-4750-89a2-fdf5743a2227","query_id":"51","doc_a_id":"20454006","doc_b_id":"45638119","presented_order":["20454006","45638119"],"winner_id":"45638119","reasoning":"Relevant document is B — it directly addresses ALDH1 and links its expression to poor breast cancer prognosis, which is directly relevant to the claim. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906819Z"}
{"comparison_id":"830f4e59-84b5-45ae-b7ae-ba18572ba211","query_id":"51","doc_a_id":"16691520","doc_b_id":"20839751","presented_order":["20839751","16691520"],"winner_id":"20839751","reasoning":"Document A is more relevant — it discusses prognostic factors and outcomes in breast cancer, whereas Document B focuses on estrogen receptor binding sites without direct relevance to ALDH1 or clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906826Z"}
{"comparison_id":"f491bd3b-48c6-46b2-b8d5-6b7b1a5c5f1a","query_id":"51","doc_a_id":"22482820","doc_b_id":"24249915","presented_order":["24249915","22482820"],"winner_id":"24249915","reasoning":"Neither document addresses ALDH1. Document A is marginally more relevant because it discusses expression changes of a breast cancer marker (ERβ), whereas B focuses on therapy delivery. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906832Z"}
{"comparison_id":"44b07850-de69-437f-878b-0bc1c476b636","query_id":"51","doc_a_id":"16086778","doc_b_id":"3285322","presented_order":["3285322","16086778"],"winner_id":"16086778","reasoning":"Document B — discusses cell-fate/ stemness-related Notch/Numb signaling, which is more conceptually related to ALDH1 (a stemness marker) than a BRCA mutation clinical comparison.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906838Z"}
{"comparison_id":"c66c90bc-1e01-4276-bc8d-34e7b8e239bd","query_id":"51","doc_a_id":"19673227","doc_b_id":"5579368","presented_order":["19673227","5579368"],"winner_id":"5579368","reasoning":"Document B — it deals with gene expression and breast cancer biomarkers (methylation-expression analysis), so it's more relevant to a claim about ALDH1 expression and breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906846Z"}
{"comparison_id":"e9afb54b-a399-4e32-af77-ea4fe274da11","query_id":"51","doc_a_id":"22482820","doc_b_id":"34066665","presented_order":["22482820","34066665"],"winner_id":"22482820","reasoning":"Document A is more focused on breast cancer markers, resistance and treatment strategies where ALDH1's prognostic role would be discussed; Document B concentrates on ER–HER signaling and endocrine resistance, less directly relevant. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906852Z"}
{"comparison_id":"5947ef5b-2a72-4853-909b-2b9ac3c1912c","query_id":"51","doc_a_id":"4702639","doc_b_id":"4889228","presented_order":["4889228","4702639"],"winner_id":"4889228","reasoning":"Document A is more relevant because it discusses prognostic marker expression and outcome associations specifically in breast cancer (TNBC), whereas B focuses on integrin-driven stemness and drug resistance in carcinomas more generally.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906859Z"}
{"comparison_id":"9f1c6064-55d8-4a08-aca0-e7dc13d49f28","query_id":"51","doc_a_id":"2931832","doc_b_id":"45638119","presented_order":["2931832","45638119"],"winner_id":"45638119","reasoning":"Document B — it directly addresses ALDH1 and reports it predicts poor clinical outcome (contradicting the claim). \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906865Z"}
{"comparison_id":"a1f659b5-8f94-4beb-b08e-206c16d5d508","query_id":"51","doc_a_id":"15946643","doc_b_id":"43385013","presented_order":["15946643","43385013"],"winner_id":"43385013","reasoning":"Doc B is more related—it examines epithelial/mesenchymal subpopulations and stem/progenitor properties (contexts where ALDH1 is discussed), whereas Doc A focuses on CXCL1-mediated chemoresistance/metastasis without ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906872Z"}
{"comparison_id":"1ecbf43c-043a-42ef-b316-2b182c51577b","query_id":"51","doc_a_id":"31311495","doc_b_id":"8963413","presented_order":["8963413","31311495"],"winner_id":"8963413","reasoning":"Document A — it discusses a biomarker's (PD-L1) association with better breast cancer outcomes, which is closer to the claim about marker expression and prognosis; Document B does not address biomarker–outcome associations. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906879Z"}
{"comparison_id":"be7d92c6-1767-4941-9177-05c5ef85f4c1","query_id":"51","doc_a_id":"12762485","doc_b_id":"2931832","presented_order":["2931832","12762485"],"winner_id":"12762485","reasoning":"Document B is more relevant — it discusses stem-cell–like phenotypes and marker correlations in breast cancer (which relates to ALDH1 as a stem cell marker), while A concerns platelet ratios unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906920Z"}
{"comparison_id":"0a5172e1-1394-416c-9a93-51fa5910cf50","query_id":"51","doc_a_id":"20183360","doc_b_id":"2931832","presented_order":["2931832","20183360"],"winner_id":"2931832","reasoning":"Document A — it concerns prognostic biomarkers and survival outcomes in breast cancer, so it's more directly related to a claim about marker expression and outcomes. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906927Z"}
{"comparison_id":"cd791542-ecfd-4ff2-b594-9e669f54dc20","query_id":"51","doc_a_id":"1866911","doc_b_id":"3285322","presented_order":["3285322","1866911"],"winner_id":"1866911","reasoning":"Document B is more relevant — it discusses luminal progenitor cells and progenitor markers connected to tumor biology, which is closer to ALDH1 (a stem/progenitor marker) than the BRCA clinical comparison in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906934Z"}
{"comparison_id":"52c7d3b3-a3bd-4de0-83cb-68796d38e47b","query_id":"51","doc_a_id":"25732836","doc_b_id":"8891333","presented_order":["8891333","25732836"],"winner_id":"8891333","reasoning":"Document A is more relevant — it discusses cancer stem cells and related markers/pathways pertinent to ALDH1's role in breast cancer. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906941Z"}
{"comparison_id":"b8b8ae22-f773-4d87-b979-48eaa3b03efc","query_id":"51","doc_a_id":"22482820","doc_b_id":"4702639","presented_order":["22482820","4702639"],"winner_id":"4702639","reasoning":"Document B is more relevant — it addresses tumour stemness markers and treatment resistance (concepts linked to ALDH1 as a stem-cell marker), whereas A focuses on combination drug-delivery strategies without discussing ALDH1 or outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906948Z"}
{"comparison_id":"6791f2b8-ae85-4968-b820-58b66f1d58d7","query_id":"51","doc_a_id":"15113221","doc_b_id":"8891333","presented_order":["15113221","8891333"],"winner_id":"8891333","reasoning":"Document B is more relevant — it discusses breast cancer stem cells and markers/transporters related to stemness and prognosis, which is closer to ALDH1's role than the PTEN-focused study in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906955Z"}
{"comparison_id":"23d024f3-fbe6-426f-b478-a6f1c4f3f5ee","query_id":"51","doc_a_id":"12762485","doc_b_id":"7583725","presented_order":["7583725","12762485"],"winner_id":"12762485","reasoning":"Document B is more relevant — it discusses stem-cell–like phenotypes and clinical correlations in breast cancer (which relates to ALDH1 as a stem cell marker), while A concerns TRPM7 and metastasis, unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906962Z"}
{"comparison_id":"94534907-25d9-4e09-9622-6932b7a12814","query_id":"51","doc_a_id":"7583725","doc_b_id":"9600826","presented_order":["7583725","9600826"],"winner_id":"7583725","reasoning":"Document A is more relevant — it explicitly links a gene's expression level to patient outcomes (high TRPM7 predicts poor prognosis), which is directly comparable to the ALDH1–outcome claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906969Z"}
{"comparison_id":"1f54a568-b286-4da5-8798-801746d7e0a7","query_id":"51","doc_a_id":"19673227","doc_b_id":"2931832","presented_order":["19673227","2931832"],"winner_id":"2931832","reasoning":"Document B is more relevant — it studies a prognostic biomarker in breast cancer specifically, whereas A deals with chemosensitivity of circulating tumor cells across epithelial tumors and is less directly related to ALDH1 and breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906976Z"}
{"comparison_id":"9e5151b8-a6dd-418a-9d76-641499967307","query_id":"51","doc_a_id":"20183360","doc_b_id":"7583725","presented_order":["20183360","7583725"],"winner_id":"7583725","reasoning":"Document B is more relevant — it discusses how expression of a specific protein (TRPM7) predicts patient outcomes, which is conceptually closer to the claim about ALDH1 expression and prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906983Z"}
{"comparison_id":"0cd8df94-a342-41f7-8f67-b6ee0b61b23f","query_id":"51","doc_a_id":"20333864","doc_b_id":"4455466","presented_order":["4455466","20333864"],"winner_id":"4455466","reasoning":"Document A is more relevant — it discusses gene expression linked to breast cancer prognosis, while B focuses on cellular interactions in DCIS-to-invasive transition and doesn't address prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906990Z"}
{"comparison_id":"2286b528-7c6e-470f-a22a-a892433c226c","query_id":"51","doc_a_id":"313403","doc_b_id":"8963413","presented_order":["313403","8963413"],"winner_id":"8963413","reasoning":"Document B is more relevant — it discusses biomarker expression (PD-L1) and its association with breast cancer outcomes, which is closer to a claim about ALDH1 as a prognostic marker than Document A's focus on tumor-associated macrophages.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.906996Z"}
{"comparison_id":"ef762541-4afe-43ac-9f07-a65d6fc2b93e","query_id":"51","doc_a_id":"32001951","doc_b_id":"4702639","presented_order":["4702639","32001951"],"winner_id":"4702639","reasoning":"Document A is more relevant — it discusses tumor stemness markers and clinical behavior of stem-like cancer cells, which is related to ALDH1's role as a stem cell marker; Document B focuses on alkaline phosphatase regulation and is unrelated.  \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907004Z"}
{"comparison_id":"f4cdd412-b377-4086-a88f-f9d3028d4d36","query_id":"51","doc_a_id":"2931832","doc_b_id":"313403","presented_order":["313403","2931832"],"winner_id":"313403","reasoning":"Reason: Document A discusses a tumor-related biomarker (TAM density) that predicts breast cancer prognosis, which is more conceptually related to a claim about a biomarker's (ALDH1) association with outcomes than Document B's platelet ratio study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907010Z"}
{"comparison_id":"70c20673-02a3-4e20-b5ce-d8c47cec3976","query_id":"51","doc_a_id":"16734530","doc_b_id":"20839751","presented_order":["16734530","20839751"],"winner_id":"20839751","reasoning":"Document B is more relevant — it discusses prognostic factors and outcomes in breast cancer, whereas Document A focuses on ORAI1 gene SNPs unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907017Z"}
{"comparison_id":"269e8721-d92d-4f42-b1ef-3be5b8c1406e","query_id":"51","doc_a_id":"15946643","doc_b_id":"7821634","presented_order":["7821634","15946643"],"winner_id":"7821634","reasoning":"Document A is more relevant — it directly links a molecular marker (DUSP4) to chemotherapy response and patient outcomes in breast cancer, which is closer to the claim about marker expression and outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907024Z"}
{"comparison_id":"b7f99c81-2543-4d6c-8d72-682b5e0e858f","query_id":"51","doc_a_id":"19358586","doc_b_id":"8963413","presented_order":["19358586","8963413"],"winner_id":"8963413","reasoning":"Document B — it discusses expression levels associated with clinical outcomes in breast cancer (though for PD-L1, not ALDH1), so it's marginally more relevant. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907030Z"}
{"comparison_id":"b63d84da-273c-42bc-96ed-d896cc380450","query_id":"51","doc_a_id":"11484808","doc_b_id":"22975806","presented_order":["11484808","22975806"],"winner_id":"11484808","reasoning":"Document A is more likely to discuss biomarkers and clinical associations in endocrine-related cancers (possible mention of ALDH1), whereas Document B focuses narrowly on BRCA allele loss. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907037Z"}
{"comparison_id":"c9f56948-3bce-4ee2-8750-493c2983d993","query_id":"51","doc_a_id":"20333864","doc_b_id":"25732836","presented_order":["20333864","25732836"],"winner_id":"20333864","reasoning":"Document A is more focused on molecular and cellular factors in breast tumor progression, making it more likely to address biomarker–outcome relationships like ALDH1 expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907043Z"}
{"comparison_id":"d82b8ba9-2c7d-4da1-a75e-6432568b2a4e","query_id":"51","doc_a_id":"16691520","doc_b_id":"20183360","presented_order":["16691520","20183360"],"winner_id":"20183360","reasoning":"Document B is more relevant — it addresses molecular pathways (GATA3/Smad4) that affect tumor invasion and progression, which relate to breast cancer outcomes; Document A focuses on ER binding sites without outcome data. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907050Z"}
{"comparison_id":"22da460d-a544-4c5b-a009-cbc7ccf4dd7c","query_id":"51","doc_a_id":"16691520","doc_b_id":"34066665","presented_order":["34066665","16691520"],"winner_id":"34066665","reasoning":"Document A is more relevant — it discusses clinical implications and treatment outcomes in breast cancer, whereas Document B focuses on genome-wide ER binding without addressing clinical outcome markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907057Z"}
{"comparison_id":"6695ec0c-3b3d-4167-be85-3636c9697859","query_id":"51","doc_a_id":"19673227","doc_b_id":"34066665","presented_order":["34066665","19673227"],"winner_id":"34066665","reasoning":"Document A is more focused on breast cancer molecular markers and therapy response, so it's likelier to discuss ALDH1 expression and its association with outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907064Z"}
{"comparison_id":"c44feed2-0883-4784-ad1c-e857b29e502d","query_id":"51","doc_a_id":"313403","doc_b_id":"4455466","presented_order":["4455466","313403"],"winner_id":"4455466","reasoning":"Document A — it reports a specific gene's expression level being linked to breast cancer prognosis, which is analogous to the claim about ALDH1 expression; Document B discusses macrophage infiltration rather than marker expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907071Z"}
{"comparison_id":"06f572be-14e4-43a9-9be2-57a22a1dc374","query_id":"51","doc_a_id":"1171121","doc_b_id":"12762485","presented_order":["1171121","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses a \"stem cell phenotype\" in breast cancer (relevant to ALDH1, a stem-cell marker), whereas Document A focuses on microvessel density and p53 without stem-cell marker discussion.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907078Z"}
{"comparison_id":"5328a8aa-8966-4309-88cb-8443e9778d71","query_id":"51","doc_a_id":"22482820","doc_b_id":"313403","presented_order":["22482820","313403"],"winner_id":"313403","reasoning":"Document B — it examines how a tumor biomarker (TAM density) relates to breast cancer prognosis, which is closer to evaluating marker–outcome associations like ALDH1 than Document A's focus on therapy delivery. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907084Z"}
{"comparison_id":"39ed6cc5-6835-47fa-b441-9ece62888cdd","query_id":"51","doc_a_id":"20454006","doc_b_id":"8891333","presented_order":["8891333","20454006"],"winner_id":"8891333","reasoning":"Document A is more relevant — it discusses cancer stem cells in breast cancer (ALDH1 is a known stem-cell marker), whereas Document B focuses on a tamoxifen + DIM trial unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907091Z"}
{"comparison_id":"8376f2a0-7c85-4b7c-9edf-77c1c9aefeb5","query_id":"51","doc_a_id":"19358586","doc_b_id":"4702639","presented_order":["4702639","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant — it studies prognostic protein signatures and survival in breast cancer, whereas A focuses on integrin-mediated stemness and drug resistance without addressing ALDH1 or clinical outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907098Z"}
{"comparison_id":"fa2ed12a-7f07-48c1-ad07-6cb861265811","query_id":"51","doc_a_id":"8891333","doc_b_id":"8963413","presented_order":["8963413","8891333"],"winner_id":"8891333","reasoning":"Document B is more relevant — it discusses cancer stem cells in breast cancer (ALDH1 is a stem‑cell marker), whereas A focuses on PD‑L1, not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907104Z"}
{"comparison_id":"550eda1d-515f-429a-b3c4-623063e89a86","query_id":"51","doc_a_id":"12762485","doc_b_id":"20454006","presented_order":["12762485","20454006"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses a stem-cell phenotype in breast cancer (which relates to ALDH1 as a stem cell marker) and its associations with p53, ER/PgR status and proliferation, whereas Document B covers DIM/tamoxifen biomarker changes unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907111Z"}
{"comparison_id":"66bc206f-6b4b-45c9-8148-665d33057adf","query_id":"51","doc_a_id":"22975806","doc_b_id":"4429932","presented_order":["22975806","4429932"],"winner_id":"4429932","reasoning":"Document B is more relevant — it discusses factors linked to breast cancer patient outcomes (though not ALDH1), whereas Document A focuses on BRCA allele loss in tumorigenesis. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907117Z"}
{"comparison_id":"a8f4536c-3f46-4565-be21-53ad7ab3e028","query_id":"51","doc_a_id":"20333864","doc_b_id":"8963413","presented_order":["20333864","8963413"],"winner_id":"8963413","reasoning":"Document B — it discusses biomarker expression (PD-L1) linked to better outcomes in breast cancer, which is more directly relevant to a claim about a biomarker's association with breast cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907124Z"}
{"comparison_id":"c8d44789-1aa2-4cc9-92e2-cea90142e752","query_id":"51","doc_a_id":"43385013","doc_b_id":"825728","presented_order":["43385013","825728"],"winner_id":"43385013","reasoning":"Document A is more relevant — it addresses stem cell/progenitor properties in basal breast cells (ALDH1 is a stem cell marker), whereas Document B focuses on Prrx1 and metastatic colonization more generally.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907131Z"}
{"comparison_id":"be8ac5b8-d66d-4c0b-adde-a63f623266d5","query_id":"51","doc_a_id":"19358586","doc_b_id":"5579368","presented_order":["5579368","19358586"],"winner_id":"5579368","reasoning":"Document A is more relevant — it deals with correlating gene expression and biomarkers in breast cancer (which could include ALDH1), whereas Document B focuses on a different protein/miRNA signature unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907137Z"}
{"comparison_id":"d9a4c02e-4014-440d-b84e-eae27dd570a8","query_id":"51","doc_a_id":"16734530","doc_b_id":"7821634","presented_order":["16734530","7821634"],"winner_id":"7821634","reasoning":"Document B is more relevant — it discusses biomarkers (DUSP4) linked to treatment response and outcomes in breast cancer, whereas Document A focuses on ORAI1 SNPs and not prognosis. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907143Z"}
{"comparison_id":"5df05ba9-d953-4ed6-a314-f3893e9c67b8","query_id":"51","doc_a_id":"22482820","doc_b_id":"5579368","presented_order":["22482820","5579368"],"winner_id":"5579368","reasoning":"Document B is more relevant — it deals with genomic and gene-expression analysis of breast cancer biomarkers, which is directly related to evaluating associations between marker expression (like ALDH1) and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907150Z"}
{"comparison_id":"7cf74bf8-bc3f-423a-a4ba-6526d17ff6a2","query_id":"51","doc_a_id":"11484808","doc_b_id":"18953920","presented_order":["18953920","11484808"],"winner_id":"18953920","reasoning":"Document A discusses stem-cell markers in mammary epithelial cells and their link to tumorigenic potential, which is directly relevant to ALDH1 (a breast cancer stem-cell marker) and clinical outcomes. Document B is about ncRNAs and not specific to ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907157Z"}
{"comparison_id":"b49b3d3c-647f-4c70-9a0b-8a367f3bbe55","query_id":"51","doc_a_id":"3285322","doc_b_id":"45638119","presented_order":["3285322","45638119"],"winner_id":"45638119","reasoning":"Document B is directly about ALDH1 expression and states it predicts poor clinical outcome (contradicting the claim). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907163Z"}
{"comparison_id":"717854d7-1263-46aa-97c0-5182e94b4077","query_id":"51","doc_a_id":"24249915","doc_b_id":"5500086","presented_order":["24249915","5500086"],"winner_id":"5500086","reasoning":"Document B — it links a tumor/intrinsic molecular signature (type I IFN) to clinical outcomes in breast cancer; Document A focuses on ERβ expression and methylation, not outcome associations. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907170Z"}
{"comparison_id":"f47d88bc-f9ad-44ef-a2d0-f8db46caf9d5","query_id":"51","doc_a_id":"1171121","doc_b_id":"825728","presented_order":["825728","1171121"],"winner_id":"825728","reasoning":"Document A is more relevant — it links EMT, stem-cell properties and patient survival, which relates to ALDH1 (a cancer stem-cell marker), whereas B focuses on MVD and p53 without connection to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907176Z"}
{"comparison_id":"9f02b606-5237-4559-8c1e-b8836ceee013","query_id":"51","doc_a_id":"15113221","doc_b_id":"24341590","presented_order":["15113221","24341590"],"winner_id":"15113221","reasoning":"Document A is more relevant — it deals with gene expression signatures linked to prognosis in carcinomas, which is closer to a claim about ALDH1 expression and breast cancer outcomes; Document B concerns CYP2D6/tamoxifen pharmacogenetics and is unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907183Z"}
{"comparison_id":"5f7175ba-18c4-4e11-aa04-f1fd12443f03","query_id":"51","doc_a_id":"24341590","doc_b_id":"313403","presented_order":["24341590","313403"],"winner_id":"313403","reasoning":"Document B is more relevant because it discusses a biomarker (tumor infiltration) linked to breast cancer prognosis, which is closer to the query about ALDH1 expression and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907189Z"}
{"comparison_id":"dadc898d-259b-400c-8de5-00da46860ec0","query_id":"51","doc_a_id":"4889228","doc_b_id":"7821634","presented_order":["7821634","4889228"],"winner_id":"7821634","reasoning":"Document A — it links expression level of a marker (DUSP4) to treatment response and outcomes (higher expression → better response/outscome), which is conceptually relevant to the ALDH1–outcome claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907196Z"}
{"comparison_id":"c8b75989-c8b5-4313-a0ec-f77e2e0cb407","query_id":"51","doc_a_id":"313403","doc_b_id":"34066665","presented_order":["313403","34066665"],"winner_id":"313403","reasoning":"Document A is more relevant — it deals with prognostic markers and clinical outcomes in breast cancer, whereas Document B focuses on ER/HER signaling and endocrine resistance rather than marker expression tied to outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907202Z"}
{"comparison_id":"1214d27b-039e-4e33-8a4d-5b2e82000c7a","query_id":"51","doc_a_id":"7821634","doc_b_id":"825728","presented_order":["7821634","825728"],"winner_id":"7821634","reasoning":"Document A is more relevant — it directly concerns breast cancer clinical outcomes and therapy response, whereas B focuses on EMT/metastasis mechanisms not specific to breast cancer. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907208Z"}
{"comparison_id":"86dd27ff-ab71-4660-986b-f2fbc6ed85aa","query_id":"51","doc_a_id":"16691520","doc_b_id":"7821634","presented_order":["16691520","7821634"],"winner_id":"7821634","reasoning":"Document B — it discusses marker expression (DUSP4) and correlations with outcomes in breast cancer, so it's more relevant to a claim about marker expression and prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907215Z"}
{"comparison_id":"5d24f7e6-5456-4dd2-953f-07977cffd718","query_id":"51","doc_a_id":"12762485","doc_b_id":"825728","presented_order":["12762485","825728"],"winner_id":"12762485","reasoning":"Document A — it addresses breast cancer and stem-cell–like phenotypes (which relate to ALDH1 as a stem cell marker), whereas B focuses on EMT/Prrx1 and metastasis more generally.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907221Z"}
{"comparison_id":"d35dd79a-0824-4ea5-b5fe-c7b1f302af13","query_id":"51","doc_a_id":"32001951","doc_b_id":"4429932","presented_order":["32001951","4429932"],"winner_id":"4429932","reasoning":"Document B is more relevant — it discusses gene expression (LOX) associated with patient outcomes in breast cancer, whereas A focuses on alkaline phosphatase regulation in a cell line and not clinical outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907228Z"}
{"comparison_id":"251b4c9f-e8ea-4d3b-ac32-00823127e095","query_id":"51","doc_a_id":"16734530","doc_b_id":"4429932","presented_order":["16734530","4429932"],"winner_id":"4429932","reasoning":"Document B is more relevant — neither mentions ALDH1, but B addresses factors linked to breast cancer outcomes (metastasis/poor prognosis), which is closer to the claim about outcome associations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907235Z"}
{"comparison_id":"fae46180-2bb4-470c-a061-6620802ea077","query_id":"51","doc_a_id":"22975806","doc_b_id":"313403","presented_order":["22975806","313403"],"winner_id":"313403","reasoning":"Document B is more relevant — it discusses a biomarker (TAM infiltration) linked to breast cancer prognosis, whereas A focuses on BRCA allele loss heterogeneity and not prognostic marker expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907241Z"}
{"comparison_id":"8cc97ce3-776c-4af8-8b75-1af1d674388c","query_id":"51","doc_a_id":"15113221","doc_b_id":"1866911","presented_order":["15113221","1866911"],"winner_id":"1866911","reasoning":"Document B — it discusses progenitor/stem-cell–related populations in breast cancer (more relevant to ALDH1, a stem/progenitor marker), whereas A focuses on PTEN pathway signatures unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907248Z"}
{"comparison_id":"b33613d1-bf0d-4ee7-8c4f-ca2d3c4fd0a1","query_id":"51","doc_a_id":"16691520","doc_b_id":"4455466","presented_order":["4455466","16691520"],"winner_id":"4455466","reasoning":"Document A is slightly more relevant because it discusses gene expression levels linked to breast cancer prognosis, whereas Document B focuses on estrogen receptor binding without outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907254Z"}
{"comparison_id":"0b2e4f03-0412-4a65-b88f-431267473406","query_id":"51","doc_a_id":"12762485","doc_b_id":"45638119","presented_order":["45638119","12762485"],"winner_id":"45638119","reasoning":"Document A is directly about ALDH1 and reports its association with poor clinical outcome, directly addressing the claim. Document B does not address ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907261Z"}
{"comparison_id":"7d4bd268-d460-4e53-8578-4c4c14606934","query_id":"51","doc_a_id":"19358586","doc_b_id":"9600826","presented_order":["9600826","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant — it discusses prognostic protein signatures and survival in breast cancer, whereas A focuses on angiogenesis mechanisms. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907267Z"}
{"comparison_id":"acd4d1b1-336a-43d1-b54a-193174984b45","query_id":"51","doc_a_id":"25973484","doc_b_id":"4429932","presented_order":["4429932","25973484"],"winner_id":"4429932","reasoning":"Document A is more relevant because it discusses a molecular marker (LOX) linked to breast cancer outcomes and metastasis, closer to the query about a biomarker-outcome association. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907273Z"}
{"comparison_id":"78575294-b530-497f-a75e-51cf38cd0845","query_id":"51","doc_a_id":"4702639","doc_b_id":"8963413","presented_order":["8963413","4702639"],"winner_id":"8963413","reasoning":"Document A — it discusses marker expression tied to breast cancer clinical outcomes (though for PD-L1, not ALDH1). Document B focuses on integrin αvβ3 and drug resistance and does not address breast cancer outcomes directly. Neither mentions ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907280Z"}
{"comparison_id":"dd186293-9350-4c88-b0e1-fee5dc6d8b56","query_id":"51","doc_a_id":"27123743","doc_b_id":"45638119","presented_order":["27123743","45638119"],"winner_id":"45638119","reasoning":"Document B — it directly studies ALDH1 in breast cancer and reports its association with poor clinical outcome, which is directly relevant to the claim.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907287Z"}
{"comparison_id":"caee741a-86bd-46cd-84a9-baf1635777b8","query_id":"51","doc_a_id":"32001951","doc_b_id":"45638119","presented_order":["32001951","45638119"],"winner_id":"45638119","reasoning":"Document B — it specifically discusses ALDH1 and states it predicts poor clinical outcome in breast cancer, directly addressing the claim.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907293Z"}
{"comparison_id":"d5b5e0b3-705e-49e0-bb06-446d05361a93","query_id":"51","doc_a_id":"11484808","doc_b_id":"4429932","presented_order":["4429932","11484808"],"winner_id":"4429932","reasoning":"Document A is more relevant — it discusses prognostic markers and patient outcomes in breast cancer, whereas Document B focuses on non-coding RNAs in endocrine cancers and doesn't address ALDH1 or breast cancer outcomes directly.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907299Z"}
{"comparison_id":"a8b1f054-0f4e-4868-a0cb-7ad930526e57","query_id":"51","doc_a_id":"16086778","doc_b_id":"22975806","presented_order":["22975806","16086778"],"winner_id":"16086778","reasoning":"Reason: Neither paper discusses ALDH1, but Document B deals with expression/regulation factors (Numb/Notch) affecting breast cancer behavior and outcomes, making it slightly more conceptually relevant than Document A's focus on BRCA allele loss.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907306Z"}
{"comparison_id":"b44eac48-9fb4-44f1-9374-4e1321ece51d","query_id":"51","doc_a_id":"4702639","doc_b_id":"825728","presented_order":["4702639","825728"],"winner_id":"4702639","reasoning":"Document A is more relevant — it discusses tumor stemness markers and their relationship to therapy resistance/outcomes, which is closer to a claim about a stem-cell marker (ALDH1) and breast cancer prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907312Z"}
{"comparison_id":"66371dfe-cec4-438d-ab51-9d4c796993e5","query_id":"51","doc_a_id":"12762485","doc_b_id":"21033230","presented_order":["12762485","21033230"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses stem-cell phenotypes and phenotypic markers in breast cancer (related to ALDH1 as a stem-cell marker), while B focuses on circulating tumor cells and different markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907319Z"}
{"comparison_id":"bb480b2a-6299-45da-b77f-2d12e05cb7f0","query_id":"51","doc_a_id":"21033230","doc_b_id":"27123743","presented_order":["21033230","27123743"],"winner_id":"21033230","reasoning":"Document A is more relevant — it deals with molecular markers and prognostic profiling in breast cancer, which is closer to ALDH1 expression and outcomes than the birthweight/etiology focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907325Z"}
{"comparison_id":"b7c64c6e-e308-4597-ae16-df82632ca4ad","query_id":"51","doc_a_id":"18953920","doc_b_id":"34066665","presented_order":["34066665","18953920"],"winner_id":"18953920","reasoning":"Document B is more relevant — it discusses acquisition of stem-cell markers in mammary cells (ALDH1 is a stem-cell marker) and links to tumorigenic potential, which bears on ALDH1's association with outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907334Z"}
{"comparison_id":"4d629917-3ee3-4159-b9e4-c089ad9ddba1","query_id":"51","doc_a_id":"22482820","doc_b_id":"3285322","presented_order":["22482820","3285322"],"winner_id":"3285322","reasoning":"Neither mentions ALDH1. Document B is slightly more relevant because it reports clinical and pathologic characteristics and outcomes in breast cancer patients, which is closer to assessing marker–outcome associations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907343Z"}
{"comparison_id":"ebc6a18b-d017-44e8-80cb-2ea259920754","query_id":"51","doc_a_id":"18953920","doc_b_id":"20454006","presented_order":["18953920","20454006"],"winner_id":"18953920","reasoning":"Document A is more relevant — it discusses acquisition of stem-cell markers in mammary epithelial cells and increased tumorigenic potential, which relates to ALDH1 as a stem-cell marker and its outcome implications. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907349Z"}
{"comparison_id":"dba74f90-e01f-44b0-ae88-1191fce7ed40","query_id":"51","doc_a_id":"22401720","doc_b_id":"25732836","presented_order":["22401720","25732836"],"winner_id":"22401720","reasoning":"Document A is more relevant — it examines tumor protein expression in primary breast cancers and relates expression levels to prognosis, which is closer to the claim about a tumor marker (ALDH1) and outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907356Z"}
{"comparison_id":"d4e438fd-d70f-40ba-9552-73c8a90eb092","query_id":"51","doc_a_id":"313403","doc_b_id":"825728","presented_order":["825728","313403"],"winner_id":"825728","reasoning":"Document A is more relevant — it links EMT regulator repression to acquisition of stem-cell properties and patient survival, which is closer to ALDH1 (a stem-cell marker) and clinical outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907362Z"}
{"comparison_id":"e6f5ca04-944c-4345-8c1d-917333d3a4b3","query_id":"51","doc_a_id":"4455466","doc_b_id":"7583725","presented_order":["4455466","7583725"],"winner_id":"4455466","reasoning":"Document A is more relevant — it links gene expression level to breast cancer prognosis and specifically notes that higher expression is associated with tumor suppression/ better outcomes (though for ZMYND11, not ALDH1). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907369Z"}
{"comparison_id":"864facf8-8118-4058-8543-66b01baa6a4c","query_id":"51","doc_a_id":"24834968","doc_b_id":"5579368","presented_order":["5579368","24834968"],"winner_id":"5579368","reasoning":"Document A is more relevant — it discusses a pipeline that correlates DNA methylation with gene expression in breast cancer biomarkers, which is more directly related to evaluating ALDH1 expression than the chemotherapy biomarker study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907375Z"}
{"comparison_id":"3a049e9e-e76c-490c-943c-8801fd0dc086","query_id":"51","doc_a_id":"20839751","doc_b_id":"25973484","presented_order":["20839751","25973484"],"winner_id":"20839751","reasoning":"Doc A is more relevant — it addresses tumor biomarkers and their association with prognosis, whereas Doc B focuses on obesity-related risk factors and does not discuss ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907382Z"}
{"comparison_id":"bfdeb924-7f7e-4b40-aca9-99c19190366c","query_id":"51","doc_a_id":"4455466","doc_b_id":"4702639","presented_order":["4702639","4455466"],"winner_id":"4455466","reasoning":"Document B — it discusses gene expression levels linked to breast cancer prognosis (relevant to claims about biomarkers and outcomes), while Document A focuses on integrin/KRAS-driven stemness and drug resistance and does not address prognostic marker expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907388Z"}
{"comparison_id":"ce5fd694-b7df-4b35-b4c6-d7e27405fe6e","query_id":"51","doc_a_id":"25732836","doc_b_id":"5500086","presented_order":["5500086","25732836"],"winner_id":"5500086","reasoning":"Document A is more relevant — it discusses a molecular (type I IFN) expression signature that correlates with breast cancer outcomes, whereas B focuses on imaging/CTCs and does not address molecular markers like ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907395Z"}
{"comparison_id":"a9143e74-2c9e-40d8-8b57-b1a0ee015045","query_id":"51","doc_a_id":"11484808","doc_b_id":"21033230","presented_order":["11484808","21033230"],"winner_id":"21033230","reasoning":"Document B is more relevant — it concerns molecular markers and prognosis in breast cancer (CTC profiling), which is closer to evidence about marker expression and outcomes than a general review of non-coding RNAs.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907401Z"}
{"comparison_id":"1c38e83c-e842-4c3a-a775-017b1148b467","query_id":"51","doc_a_id":"19673227","doc_b_id":"20839751","presented_order":["20839751","19673227"],"winner_id":"20839751","reasoning":"Document A is more relevant — it discusses breast cancer pathological/prognostic markers (though not ALDH1 specifically), whereas B addresses CTC chemosensitivity across tumor types and not breast prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907408Z"}
{"comparison_id":"1e2aa77a-f42b-4057-bd9d-ed6f5414f045","query_id":"51","doc_a_id":"16734530","doc_b_id":"8963413","presented_order":["8963413","16734530"],"winner_id":"8963413","reasoning":"Document A is more relevant — it discusses expression of a biomarker (PD-L1) and its association with clinical outcomes in breast cancer, which is analogous to the claim about ALDH1 expression and outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907414Z"}
{"comparison_id":"4e7195c8-d682-4f96-afc9-6b13f2723d9a","query_id":"51","doc_a_id":"25732836","doc_b_id":"313403","presented_order":["313403","25732836"],"winner_id":"313403","reasoning":"Document A is more relevant — it deals with a tissue-based prognostic marker (tumor-associated macrophage infiltration) and clinical outcomes in breast cancer, which is closer to ALDH1 expression as a prognostic biomarker than imaging/CTC monitoring in metastatic disease.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907421Z"}
{"comparison_id":"51292cc1-736a-41c4-a0c2-cc398c21e993","query_id":"51","doc_a_id":"22975806","doc_b_id":"24834968","presented_order":["24834968","22975806"],"winner_id":"24834968","reasoning":"Document A is slightly more relevant because it examines biological markers and treatment response in breast cancer, whereas Document B focuses on BRCA allele loss and tumorigenesis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907427Z"}
{"comparison_id":"865fe544-d021-415c-9da7-94d8fdd51fae","query_id":"51","doc_a_id":"4889228","doc_b_id":"8891333","presented_order":["4889228","8891333"],"winner_id":"8891333","reasoning":"Document B — it discusses cancer stem cells in breast cancer (ALDH1 is a stem-cell marker), so it's more relevant to a claim about ALDH1 and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907434Z"}
{"comparison_id":"9580bef3-173c-438a-b1c2-edeeef1ca54c","query_id":"51","doc_a_id":"19673227","doc_b_id":"4889228","presented_order":["19673227","4889228"],"winner_id":"4889228","reasoning":"Document B — it directly addresses prognostic markers in breast cancer (TNBC), whereas A discusses CTC chemosensitivity across tumors and doesn't focus on breast cancer markers. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907440Z"}
{"comparison_id":"62e09c81-3452-4d19-8783-05aaf7fb6a4c","query_id":"51","doc_a_id":"7821634","doc_b_id":"8963413","presented_order":["7821634","8963413"],"winner_id":"8963413","reasoning":"Document B is more relevant — it discusses how expression of a tumor marker (PD-L1) is associated with better outcomes in breast cancer, which is conceptually closer to the ALDH1-outcome claim. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907446Z"}
{"comparison_id":"cf7d6777-2e6a-4484-9344-2e7b488c132b","query_id":"51","doc_a_id":"4429932","doc_b_id":"4889228","presented_order":["4889228","4429932"],"winner_id":"4889228","reasoning":"Reason: Neither abstract mentions ALDH1, but Document A discusses gene expression linked to breast cancer prognosis, making it slightly more relevant to an outcome-related claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907452Z"}
{"comparison_id":"4d4da321-29cf-41c6-bbb1-2508b2d62283","query_id":"51","doc_a_id":"22401720","doc_b_id":"4455466","presented_order":["22401720","4455466"],"winner_id":"4455466","reasoning":"B — it links expression of a specific gene to breast cancer prognosis, whereas A discusses angiogenic factors and does not address ALDH1 or similar prognostic markers.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907458Z"}
{"comparison_id":"d2356930-3484-4931-a5b7-92cfa48043e3","query_id":"51","doc_a_id":"11484808","doc_b_id":"1171121","presented_order":["11484808","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant — it discusses prognostic markers and outcomes in breast cancer, whereas Document A focuses on non-coding RNAs and not ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907464Z"}
{"comparison_id":"fd6401f8-1391-4e19-88ea-20e8f429ba59","query_id":"51","doc_a_id":"21033230","doc_b_id":"5500086","presented_order":["5500086","21033230"],"winner_id":"21033230","reasoning":"Reason: Document B deals with molecular marker profiling and prognostic associations in breast cancer, which is closer to ALDH1 expression–outcome relationships than Document A's focus on interferon-mediated chemo mechanisms.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907471Z"}
{"comparison_id":"ae970d19-bb60-4dd0-ac57-e6cafeff3742","query_id":"51","doc_a_id":"2014909","doc_b_id":"45638119","presented_order":["2014909","45638119"],"winner_id":"45638119","reasoning":"Document B — it directly studies ALDH1 in breast cancer and links ALDH1 expression to clinical outcomes (specifically poor prognosis). \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907477Z"}
{"comparison_id":"0498afdf-3db8-4660-ad17-64576c3d2253","query_id":"51","doc_a_id":"25732836","doc_b_id":"43385013","presented_order":["25732836","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it examines epithelial/mesenchymal subpopulations and stem/progenitor properties in breast cells (context where ALDH1 as a stem cell marker would be discussed), while A concerns CTCs and imaging unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907484Z"}
{"comparison_id":"bf808fa5-f375-47f6-9f25-2b7ede596dce","query_id":"51","doc_a_id":"15113221","doc_b_id":"22482820","presented_order":["22482820","15113221"],"winner_id":"22482820","reasoning":"Document A is more relevant — it focuses on breast cancer treatment and classification, so it's more likely to address biomarkers like ALDH1 than the PTEN-focused carcinoma study in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907490Z"}
{"comparison_id":"58f46cf8-10cc-43ea-91b3-dfc4768206aa","query_id":"51","doc_a_id":"11484808","doc_b_id":"7583725","presented_order":["7583725","11484808"],"winner_id":"7583725","reasoning":"Document A — it specifically discusses expression of a gene (TRPM7) in breast cancer and its relationship to patient outcomes, which is more directly related to the claim than a general ncRNA review. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907497Z"}
{"comparison_id":"672e39f5-8ac7-4378-ad66-547af7e579b8","query_id":"51","doc_a_id":"18953920","doc_b_id":"20127522","presented_order":["18953920","20127522"],"winner_id":"18953920","reasoning":"Document A is more relevant — it discusses mammary stem-cell markers and tumorigenic potential (context for ALDH1 as a stem-cell marker), while B concerns circulating tumor cells and treatment monitoring. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907503Z"}
{"comparison_id":"2680e0e4-2aea-496b-942c-415be16b9139","query_id":"51","doc_a_id":"16086778","doc_b_id":"4889228","presented_order":["16086778","4889228"],"winner_id":"4889228","reasoning":"Document B is slightly more relevant because it discusses marker expression correlated with prognosis in breast cancer, whereas Document A focuses on Numb/Notch signaling without linking marker expression to outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907509Z"}
{"comparison_id":"0f35ed01-c3b2-467e-8c9e-017f95f4c2ce","query_id":"51","doc_a_id":"7583725","doc_b_id":"8963413","presented_order":["7583725","8963413"],"winner_id":"8963413","reasoning":"Document B — it discusses biomarker expression associated with breast cancer outcomes (mentions better outcomes in breast), whereas Document A is about TRPM7 and metastasis and is unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907516Z"}
{"comparison_id":"abb1bee6-4b12-4c81-8df0-5c99f15ad8a5","query_id":"51","doc_a_id":"32001951","doc_b_id":"34066665","presented_order":["34066665","32001951"],"winner_id":"34066665","reasoning":"Document A is more relevant — it reviews molecular mechanisms and clinical implications in breast cancer (likely addressing prognostic markers and outcomes), whereas Document B focuses on alkaline phosphatase regulation in a cell line, not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907523Z"}
{"comparison_id":"96e21e25-eeb3-4db6-8e42-e1dd421025c9","query_id":"51","doc_a_id":"12762485","doc_b_id":"9600826","presented_order":["9600826","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses stem-cell–like phenotypes and clinical correlations (differentiation, proliferation, receptor status), which is more relevant to ALDH1 (a stem-cell marker) and outcome associations. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907529Z"}
{"comparison_id":"67885a08-ba19-4629-baa8-b647da11ee33","query_id":"51","doc_a_id":"4429932","doc_b_id":"5579368","presented_order":["5579368","4429932"],"winner_id":"5579368","reasoning":"Doc A is more relevant — it focuses on gene expression analysis and breast cancer biomarkers (which could include ALDH1), while Doc B discusses LOX, a different gene not related to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907535Z"}
{"comparison_id":"06de6159-c942-4014-8bff-0848b677da54","query_id":"51","doc_a_id":"34066665","doc_b_id":"825728","presented_order":["34066665","825728"],"winner_id":"825728","reasoning":"Document B is more relevant — it addresses EMT, stem-cell properties and links to patient survival/metastasis, which is closer to ALDH1's role as a cancer stem-cell marker affecting outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907541Z"}
{"comparison_id":"f360d71e-8771-4a64-88b1-45c55c5f08f2","query_id":"51","doc_a_id":"12762485","doc_b_id":"24341590","presented_order":["24341590","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses stem-cell–like phenotypes in breast cancer (which relate to ALDH1 as a stem cell marker), whereas A is about CYP2D6 and tamoxifen metabolism. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907548Z"}
{"comparison_id":"1020fc99-ef0c-4c35-af6f-249f8706ced8","query_id":"51","doc_a_id":"313403","doc_b_id":"45638119","presented_order":["313403","45638119"],"winner_id":"45638119","reasoning":"Document B — it directly studies ALDH1 and reports its association with clinical outcome (specifically poor prognosis), whereas Document A concerns tumor-associated macrophages, not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907554Z"}
{"comparison_id":"7dfd803a-0ff2-479d-8aba-016bbcea210c","query_id":"51","doc_a_id":"12762485","doc_b_id":"5500086","presented_order":["12762485","5500086"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses stem-cell–like phenotypes in breast cancer (ALDH1 is a stem cell marker), while Document B focuses on interferon signaling unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907561Z"}
{"comparison_id":"3d47c3f9-c7cb-4f58-9997-4b0723168a02","query_id":"51","doc_a_id":"24834968","doc_b_id":"7583725","presented_order":["24834968","7583725"],"winner_id":"7583725","reasoning":"Document B is more relevant — it links expression of a specific protein to patient outcomes, whereas A does not address marker expression related to prognosis. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907567Z"}
{"comparison_id":"01733cec-1335-4530-8bba-fe795bf1343e","query_id":"51","doc_a_id":"20127522","doc_b_id":"20839751","presented_order":["20127522","20839751"],"winner_id":"20839751","reasoning":"Document B is more relevant — it discusses a tumor marker (apoptotic index) and its association with pathological features and prognosis, which is closer to a claim about ALDH1 expression and outcomes. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907574Z"}
{"comparison_id":"2e381129-af24-44e8-9373-0888ed0d20aa","query_id":"51","doc_a_id":"2014909","doc_b_id":"825728","presented_order":["825728","2014909"],"winner_id":"825728","reasoning":"Document A is more relevant — it links EMT/stem-cell properties to patient survival and metastasis, which relates to ALDH1 as a stem-cell marker.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907580Z"}
{"comparison_id":"e01c19f1-0fea-4cba-b9be-da12ee637f66","query_id":"51","doc_a_id":"24341590","doc_b_id":"25732836","presented_order":["24341590","25732836"],"winner_id":"24341590","reasoning":"Document A is more relevant — it examines a molecular/genetic biomarker's association with treatment outcomes in breast cancer, whereas Document B focuses on imaging and circulating tumor cells. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907587Z"}
{"comparison_id":"60e8a9d9-63a4-4420-a836-c841bdd5b9c4","query_id":"51","doc_a_id":"22975806","doc_b_id":"7821634","presented_order":["22975806","7821634"],"winner_id":"7821634","reasoning":"Document B is more relevant — it examines gene expression (DUSP4) linked to treatment response and outcomes in breast cancer, which is closer to ALDH1 expression–outcome associations than the BRCA-allele focus of Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907593Z"}
{"comparison_id":"bb9f2e5a-f63c-4bf5-9843-7c4dc98acf78","query_id":"51","doc_a_id":"15113221","doc_b_id":"20839751","presented_order":["15113221","20839751"],"winner_id":"15113221","reasoning":"Neither document mentions ALDH1. Document A is slightly more relevant because it addresses gene expression signatures linked to prognosis in carcinomas, which is closer to the claim about a marker's expression and outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907599Z"}
{"comparison_id":"95352a90-8326-4410-aa04-97848d9d1845","query_id":"51","doc_a_id":"34066665","doc_b_id":"8963413","presented_order":["34066665","8963413"],"winner_id":"8963413","reasoning":"Document B is more relevant — it discusses biomarker expression and associations with breast cancer clinical outcomes (though for PD-L1, not ALDH1). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907606Z"}
{"comparison_id":"57c00741-3552-4b52-9602-b2f194fb7ea1","query_id":"51","doc_a_id":"2014909","doc_b_id":"20839751","presented_order":["2014909","20839751"],"winner_id":"2014909","reasoning":"Document A — it addresses tumor-initiating cells and breast cancer patient analyses (more related to stem-cell marker ALDH1) while B focuses on apoptosis and prognosis without connection to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907612Z"}
{"comparison_id":"b3e849d8-c680-4c4d-a4f7-dcea6790228b","query_id":"51","doc_a_id":"16086778","doc_b_id":"4429932","presented_order":["16086778","4429932"],"winner_id":"4429932","reasoning":"Document B is more relevant — it links a molecular factor (LOX) to patient outcomes in breast cancer, whereas A focuses on Numb/Notch signaling without discussing clinical outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907618Z"}
{"comparison_id":"3dfc011d-b2b1-4eda-84e5-95ecb9776b44","query_id":"51","doc_a_id":"16691520","doc_b_id":"2014909","presented_order":["16691520","2014909"],"winner_id":"2014909","reasoning":"Document B — it discusses tumor-initiating cells and analyses of primary breast cancers, which is more directly related to ALDH1 (a cancer stem/tumor-initiating cell marker) and clinical outcomes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907625Z"}
{"comparison_id":"c0fbffb8-9242-49d8-9aae-a8fa7b732773","query_id":"51","doc_a_id":"21033230","doc_b_id":"3285322","presented_order":["3285322","21033230"],"winner_id":"21033230","reasoning":"Document B is more relevant — it covers molecular markers and prognostic associations in breast cancer, which is closer to ALDH1 expression and outcomes than a BRCA-focused clinical comparison. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907632Z"}
{"comparison_id":"e3110fc4-9d5a-4a36-8922-aeb029055c82","query_id":"51","doc_a_id":"4429932","doc_b_id":"45638119","presented_order":["45638119","4429932"],"winner_id":"45638119","reasoning":"Doc A is directly about ALDH1 and its association with clinical outcome in breast cancer (reports poor prognosis), while Doc B discusses LOX and is unrelated. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907638Z"}
{"comparison_id":"8edb7bd0-26d3-422f-b3ea-7b81570bc210","query_id":"51","doc_a_id":"1866911","doc_b_id":"4455466","presented_order":["1866911","4455466"],"winner_id":"4455466","reasoning":"Reason: Document B discusses how expression level of a specific gene (ZMYND11) correlates with breast cancer prognosis, which is directly relevant to claims about marker expression and outcomes; Document A does not address prognostic marker expression.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907645Z"}
{"comparison_id":"87b21f45-7a84-4314-90e5-653e3ffb92e5","query_id":"51","doc_a_id":"1866911","doc_b_id":"825728","presented_order":["1866911","825728"],"winner_id":"825728","reasoning":"Document B is more relevant — it links EMT/stem-cell properties with patient survival and metastasis, which is closer to evidence about markers like ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907652Z"}
{"comparison_id":"fa0da031-9e68-4c09-a290-61011a718fd7","query_id":"51","doc_a_id":"4455466","doc_b_id":"8963413","presented_order":["8963413","4455466"],"winner_id":"8963413","reasoning":"Document A is more relevant — it explicitly discusses a biomarker (PD-L1) whose expression is associated with better outcomes in breast cancer, which parallels the claim about ALDH1 expression and outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907659Z"}
{"comparison_id":"e3891370-04ee-4080-9476-d28a6560be39","query_id":"51","doc_a_id":"19358586","doc_b_id":"34066665","presented_order":["34066665","19358586"],"winner_id":"19358586","reasoning":"Neither document mentions ALDH1, but Document B discusses prognostic molecular signatures and survival associations, so it's more relevant to a claim about marker expression and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907665Z"}
{"comparison_id":"66b87ba2-1c2c-4dd8-bc23-4f7748c09404","query_id":"51","doc_a_id":"20183360","doc_b_id":"43385013","presented_order":["43385013","20183360"],"winner_id":"43385013","reasoning":"Document A is more relevant — it discusses stem/progenitor cell properties in breast cell subpopulations (ALDH1 is a stem cell marker), which relates to ALDH1 expression and clinical outcomes. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907672Z"}
{"comparison_id":"f0d6130c-ab22-4a6f-941b-683949183616","query_id":"51","doc_a_id":"15946643","doc_b_id":"2931832","presented_order":["2931832","15946643"],"winner_id":"15946643","reasoning":"Neither document mentions ALDH1. Document B is marginally more relevant because it discusses molecular pathways and tumor cell behavior in breast cancer, whereas A focuses on a platelet-based clinical ratio. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907678Z"}
{"comparison_id":"406d4127-e240-4b14-b729-342b40712ec9","query_id":"51","doc_a_id":"16691520","doc_b_id":"22712546","presented_order":["22712546","16691520"],"winner_id":"22712546","reasoning":"Document A is more relevant — it focuses on in situ enzymatic activities and metabolic interactions in breast cancer tissue, which is directly related to ALDH1 (a metabolic enzyme) expression and its implications. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907685Z"}
{"comparison_id":"dbaefd6d-abf6-43d0-a1aa-30fe0ed60433","query_id":"51","doc_a_id":"1171121","doc_b_id":"22401720","presented_order":["22401720","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant — it specifically analyzes prognostic markers and their association with survival outcomes in breast cancer, whereas A focuses on angiogenic factor expression without addressing ALDH1 or broader prognostic markers.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907692Z"}
{"comparison_id":"568ff3f8-5ef1-47cc-bec2-4cb2b5e163ab","query_id":"51","doc_a_id":"1171121","doc_b_id":"2931832","presented_order":["2931832","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant — it examines protein marker status (p53) and microvessel density as prognostic factors, which is closer to evaluating ALDH1 protein expression than a platelet-derived ratio. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907699Z"}
{"comparison_id":"d6f838f7-68aa-42b6-adef-74e63b3e6cf7","query_id":"51","doc_a_id":"21033230","doc_b_id":"45638119","presented_order":["21033230","45638119"],"winner_id":"45638119","reasoning":"Document B — it directly addresses ALDH1 and states it correlates with poor (not better) breast cancer outcomes, so it's most relevant to the query.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907705Z"}
{"comparison_id":"8bad8214-1957-4837-b068-f242d10ff324","query_id":"51","doc_a_id":"24249915","doc_b_id":"32001951","presented_order":["24249915","32001951"],"winner_id":"24249915","reasoning":"Document A is more relevant — it discusses changes in expression levels in breast cancer and links to disease progression, whereas Document B concerns alkaline phosphatase regulation unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907712Z"}
{"comparison_id":"256644c2-3d6a-4437-9b02-af938e1378ee","query_id":"51","doc_a_id":"19358586","doc_b_id":"24341590","presented_order":["24341590","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant — it discusses protein/miRNA signatures and associations with survival in breast cancer, whereas A focuses on CYP2D6 pharmacogenetics unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907718Z"}
{"comparison_id":"10307288-71d8-4996-bbb7-da659403afd9","query_id":"51","doc_a_id":"22975806","doc_b_id":"24341590","presented_order":["24341590","22975806"],"winner_id":"24341590","reasoning":"Document A is more relevant — it discusses associations between a biomarker/genetic factor and clinical outcomes in breast cancer, whereas Document B focuses on BRCA allele loss and tumorigenesis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907725Z"}
{"comparison_id":"a04b90cc-8729-4f30-93c7-9cf849619ec6","query_id":"51","doc_a_id":"22401720","doc_b_id":"825728","presented_order":["825728","22401720"],"winner_id":"825728","reasoning":"Document A is more relevant — it links EMT, acquisition of stem-cell properties and patient survival/metastasis, which relates to ALDH1 as a cancer stem-cell marker. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907731Z"}
{"comparison_id":"2b467b04-3706-407d-a9e5-bdfff7a442e6","query_id":"51","doc_a_id":"15946643","doc_b_id":"19358586","presented_order":["19358586","15946643"],"winner_id":"19358586","reasoning":"Document A is more relevant — it discusses protein expression signatures linked to survival in breast cancer, which is closer to the query about marker expression and outcomes. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907737Z"}
{"comparison_id":"97c32702-0343-4277-a4af-a94188a8a7c4","query_id":"51","doc_a_id":"22712546","doc_b_id":"25732836","presented_order":["25732836","22712546"],"winner_id":"22712546","reasoning":"Document B is more relevant — it studies in situ enzymatic activities and metabolic interactions in breast cancer tissue, which pertains to ALDH1 (an enzymatic marker), whereas A focuses on CTCs and PET/CT and does not address ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907744Z"}
{"comparison_id":"a7ca1d8a-5c36-4aac-b2ed-fab1b317706b","query_id":"51","doc_a_id":"1171121","doc_b_id":"22482820","presented_order":["22482820","1171121"],"winner_id":"1171121","reasoning":"Document B — it addresses prognostic markers and associations with patient outcomes, whereas Document A focuses on treatment strategies and drug delivery rather than marker–outcome relationships.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907750Z"}
{"comparison_id":"014ae95e-dc08-45db-8ce6-a355aa62cda4","query_id":"51","doc_a_id":"22712546","doc_b_id":"32001951","presented_order":["32001951","22712546"],"winner_id":"22712546","reasoning":"Document B is more relevant — it addresses metabolic enzyme activities and cancer cell–fibroblast interactions in breast cancer tissue, which is closer to assessing ALDH1 expression's role than Document A (which focuses on alkaline phosphatase). \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907757Z"}
{"comparison_id":"eb5be756-3114-437b-a9fb-42d421a309e9","query_id":"51","doc_a_id":"24249915","doc_b_id":"4455466","presented_order":["24249915","4455466"],"winner_id":"4455466","reasoning":"Document B is more relevant — it links gene expression levels to breast cancer prognosis (expression associated with outcomes), which matches the claim about ALDH1 expression and outcomes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907764Z"}
{"comparison_id":"b45442cd-78a4-40ef-8ea0-fc0aa6079500","query_id":"51","doc_a_id":"24341590","doc_b_id":"4455466","presented_order":["24341590","4455466"],"winner_id":"4455466","reasoning":"Document B — it links gene expression level to breast cancer prognosis (low expression = poor outcome), which is more relevant to a claim about marker expression and outcomes than Document A about CYP2D6 polymorphisms. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907771Z"}
{"comparison_id":"186be801-70e8-426d-970d-3744396e901c","query_id":"51","doc_a_id":"1171121","doc_b_id":"16086778","presented_order":["1171121","16086778"],"winner_id":"1171121","reasoning":"Document A — it addresses prognostic factors and survival outcomes in breast cancer, which is closer to a claim about ALDH1 and outcomes; Document B focuses on Numb/Notch signaling mechanisms. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907777Z"}
{"comparison_id":"54f47c2c-0dcd-4d4d-a0a5-3bce308c1f75","query_id":"51","doc_a_id":"19358586","doc_b_id":"4455466","presented_order":["19358586","4455466"],"winner_id":"4455466","reasoning":"Reason: Document B links gene expression levels to breast cancer prognosis, which is conceptually closer to the query about a marker's expression and outcomes; Document A focuses on miRNA effects and a Myc/p27/phospho-Rb signature, not marker-outcome associations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907784Z"}
{"comparison_id":"abd42f16-f134-4724-bf2c-c028e95f670a","query_id":"51","doc_a_id":"25732836","doc_b_id":"31311495","presented_order":["25732836","31311495"],"winner_id":"25732836","reasoning":"Document A is more relevant — it addresses prognostic markers and outcome prediction in breast cancer, while Document B is a mechanistic study of tamoxifen resistance without focus on clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907791Z"}
{"comparison_id":"1a6ebbfa-27f6-486c-b644-4b5654cfd4d9","query_id":"51","doc_a_id":"19673227","doc_b_id":"4702639","presented_order":["4702639","19673227"],"winner_id":"19673227","reasoning":"Document B is more relevant — it addresses prognostic/predictive value and correlations with disease-free survival, which relates to claims about marker-associated outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907797Z"}
{"comparison_id":"235c1399-a3de-45ed-8125-34baae2da7ef","query_id":"51","doc_a_id":"24249915","doc_b_id":"313403","presented_order":["24249915","313403"],"winner_id":"313403","reasoning":"Document B is more relevant — it directly links a tumor-associated marker's expression (TAM density) to clinical outcomes, whereas Document A focuses on ERβ expression and epigenetic regulation without outcome data. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907803Z"}
{"comparison_id":"8bd9fd48-943a-4c89-88c6-7bddbfae4cee","query_id":"51","doc_a_id":"2014909","doc_b_id":"3285322","presented_order":["3285322","2014909"],"winner_id":"2014909","reasoning":"Document B is more relevant — it studies tumor-initiating cells and primary breast cancers, which are more likely to discuss stem cell markers like ALDH1 than a BRCA-focused clinicopathologic comparison.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907810Z"}
{"comparison_id":"f8ec6010-5c88-48c1-97bf-f17909c60db2","query_id":"51","doc_a_id":"1171121","doc_b_id":"16691520","presented_order":["1171121","16691520"],"winner_id":"1171121","reasoning":"Document A is more relevant because it addresses prognostic factors and survival outcomes in breast cancer, whereas Document B focuses on estrogen receptor binding sites without clinical outcome data. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907817Z"}
{"comparison_id":"704d6ce7-06fb-4571-96b2-e1494dd6b329","query_id":"51","doc_a_id":"45638119","doc_b_id":"8963413","presented_order":["45638119","8963413"],"winner_id":"45638119","reasoning":"Document A directly discusses ALDH1 in breast cancer and reports it predicts poor clinical outcome, so it directly addresses (and contradicts) the claim.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907822Z"}
{"comparison_id":"d960ad1a-d338-473a-8f50-6ed981bf32ce","query_id":"51","doc_a_id":"16086778","doc_b_id":"8963413","presented_order":["16086778","8963413"],"winner_id":"8963413","reasoning":"Document B is more relevant — it discusses how expression of an immune marker (PD-L1) relates to clinical outcomes in breast cancer, which aligns with the query's focus on marker expression and outcome associations. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907829Z"}
{"comparison_id":"ee44a4d5-6bc0-4d5a-b1e7-c44fab669078","query_id":"51","doc_a_id":"18953920","doc_b_id":"7583725","presented_order":["18953920","7583725"],"winner_id":"18953920","reasoning":"Document A is more related — it discusses breast epithelial cells acquiring stem-cell markers (context relevant to ALDH1 as a stem-cell marker), while B addresses TRPM7 and metastasis unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907835Z"}
{"comparison_id":"1fbe0d3f-26e2-42fa-9e22-32c1e7e6ba9e","query_id":"51","doc_a_id":"2014909","doc_b_id":"9600826","presented_order":["9600826","2014909"],"winner_id":"2014909","reasoning":"B is slightly more relevant — it discusses tumor-initiating cells and analyses of primary breast cancers, which relate to ALDH1 as a stem/tumor-initiating marker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907842Z"}
{"comparison_id":"22ceb024-c1c6-49f4-a0dc-55330e8fe663","query_id":"51","doc_a_id":"27123743","doc_b_id":"825728","presented_order":["825728","27123743"],"winner_id":"825728","reasoning":"Doc A is more relevant — it discusses EMT, cancer stem-cell properties and links to patient survival/metastasis, which relate to biomarkers like ALDH1 and clinical outcomes. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907848Z"}
{"comparison_id":"ab5eedfa-7bbe-4a1d-aafa-a4b86d6f8547","query_id":"51","doc_a_id":"22401720","doc_b_id":"5579368","presented_order":["5579368","22401720"],"winner_id":"5579368","reasoning":"Document A is more relevant — it concerns gene expression and biomarker analysis in breast cancer, whereas Document B focuses on angiogenic factors unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907854Z"}
{"comparison_id":"bb137937-0f8c-464b-a0ed-fd9d536da126","query_id":"51","doc_a_id":"16734530","doc_b_id":"8891333","presented_order":["8891333","16734530"],"winner_id":"8891333","reasoning":"Document A is more relevant — it discusses cancer stem cells in breast cancer (ALDH1 is a stem cell marker), whereas Document B focuses on ORAI1 SNPs unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907860Z"}
{"comparison_id":"e40681d3-de17-4705-80b2-e3919d4bc3ff","query_id":"51","doc_a_id":"1866911","doc_b_id":"2931832","presented_order":["2931832","1866911"],"winner_id":"1866911","reasoning":"Document B is more relevant — it discusses progenitor cell populations and marker expression related to tumor origin, which is closer to ALDH1 (a stem/progenitor marker) and its potential prognostic implications.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907867Z"}
{"comparison_id":"94ac7270-0405-4c90-bf94-21f46435d239","query_id":"51","doc_a_id":"27123743","doc_b_id":"43385013","presented_order":["27123743","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it examines stem cell/progenitor properties in breast epithelial subpopulations (topics closely related to ALDH1 as a stem cell marker), while A discusses birthweight and cancer risk without ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907874Z"}
{"comparison_id":"3adfa07d-6df9-4a38-8d95-f2e3321f5cd3","query_id":"51","doc_a_id":"12762485","doc_b_id":"18953920","presented_order":["18953920","12762485"],"winner_id":"18953920","reasoning":"Document A is more relevant — it links acquisition of stem-cell markers in mammary cells to increased tumorigenicity, which addresses the implication of a stem-cell marker like ALDH1 on breast cancer outcomes. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907880Z"}
{"comparison_id":"94db4280-3441-443f-a427-ac95bb25841d","query_id":"51","doc_a_id":"43385013","doc_b_id":"4702639","presented_order":["43385013","4702639"],"winner_id":"43385013","reasoning":"Document A is more relevant — it addresses stem/progenitor properties in breast epithelial subpopulations (context where ALDH1 is commonly discussed as a stem cell marker), whereas Document B focuses on integrin αvβ3–KRAS–RalB signaling and drug resistance. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907887Z"}
{"comparison_id":"62783f71-82f7-4baf-93a5-5ec5d2831ecc","query_id":"51","doc_a_id":"15113221","doc_b_id":"24834968","presented_order":["24834968","15113221"],"winner_id":"15113221","reasoning":"Neither document mentions ALDH1, but Document B discusses a gene expression signature linked to prognosis (closer to outcomes/biomarker evidence) whereas A focuses on HER2/Ki67 and chemo response. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907894Z"}
{"comparison_id":"4ab06418-3f43-48f4-b43e-19973a58a365","query_id":"51","doc_a_id":"32001951","doc_b_id":"4889228","presented_order":["32001951","4889228"],"winner_id":"4889228","reasoning":"Document B is more relevant — it links gene expression levels to breast cancer prognosis (even though it's about TDP43, not ALDH1), whereas A only studies alkaline phosphatase regulation without outcome data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907900Z"}
{"comparison_id":"62c06d97-365a-4ed1-92e7-2ec21fdad559","query_id":"51","doc_a_id":"16086778","doc_b_id":"1866911","presented_order":["1866911","16086778"],"winner_id":"1866911","reasoning":"Document A is more relevant — it discusses progenitor cell populations and markers related to breast cancer cell-of-origin, which is closer to ALDH1's role as a stem/progenitor marker than the Numb/Notch signaling focus in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907907Z"}
{"comparison_id":"79afa52d-ee6e-45d4-ae41-52748633f007","query_id":"51","doc_a_id":"24834968","doc_b_id":"825728","presented_order":["24834968","825728"],"winner_id":"24834968","reasoning":"Document A is more directly about breast cancer biomarkers and treatment response; Document B focuses on EMT/Prrx1 and metastasis mechanisms not specifically on ALDH1 or breast outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907913Z"}
{"comparison_id":"92d55f3b-8b7f-4182-a641-ede205ca422d","query_id":"51","doc_a_id":"11484808","doc_b_id":"3285322","presented_order":["3285322","11484808"],"winner_id":"11484808","reasoning":"Document B is more relevant — it discusses molecular markers and their clinical implications in endocrine-related cancers, which is closer to expression-outcome associations like ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907919Z"}
{"comparison_id":"241767aa-4b95-4ef6-9c5c-0223a2af01e7","query_id":"51","doc_a_id":"12762485","doc_b_id":"20183360","presented_order":["12762485","20183360"],"winner_id":"12762485","reasoning":"Document A is more relevant — it discusses stem cell phenotypes in breast cancer (ALDH1 is a stem cell marker) and associations with prognostic markers. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907926Z"}
{"comparison_id":"1014722e-2edd-41b3-b432-d6cc4ee402c9","query_id":"51","doc_a_id":"43385013","doc_b_id":"5500086","presented_order":["43385013","5500086"],"winner_id":"43385013","reasoning":"Document A is more relevant — it discusses breast epithelial/mesenchymal subpopulations and stem/progenitor properties (contexts where ALDH1 is a common marker), whereas Document B focuses on interferon signaling and chemotherapy, not ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907932Z"}
{"comparison_id":"b62f72ef-4a56-4d37-96dc-3322f34420fe","query_id":"51","doc_a_id":"18953920","doc_b_id":"19673227","presented_order":["19673227","18953920"],"winner_id":"18953920","reasoning":"Document B — it discusses acquisition of stem-cell markers/properties in mammary epithelial cells (related to ALDH1 as a breast cancer stem-cell marker), whereas A does not address ALDH1.  \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907938Z"}
{"comparison_id":"4e6d12bf-ff90-46c6-8019-00ec34d68c33","query_id":"51","doc_a_id":"15113221","doc_b_id":"7821634","presented_order":["15113221","7821634"],"winner_id":"7821634","reasoning":"Document B is more relevant — it examines a biomarker (DUSP4) whose expression level correlates with breast cancer outcomes, whereas A addresses a PTEN-related signature across carcinomas generally. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907944Z"}
{"comparison_id":"7ff7cf22-a111-4e1a-9709-295f4b3c77d2","query_id":"51","doc_a_id":"24249915","doc_b_id":"8963413","presented_order":["24249915","8963413"],"winner_id":"8963413","reasoning":"Document B is more relevant — it discusses marker expression (PD-L1) and its association with clinical outcomes in breast cancer, which is closer to the claim about a marker (ALDH1) and outcomes than Document A (ER beta methylation study). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907951Z"}
{"comparison_id":"8011317b-ed8d-4eab-938a-b6d1b8df8bfb","query_id":"51","doc_a_id":"20454006","doc_b_id":"4455466","presented_order":["4455466","20454006"],"winner_id":"4455466","reasoning":"Document A is more relevant — it discusses gene expression levels linked to breast cancer prognosis, whereas B focuses on a tamoxifen-related metabolic trial unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907958Z"}
{"comparison_id":"c0f520ff-1593-4a3d-b8c2-125291c30b52","query_id":"51","doc_a_id":"15113221","doc_b_id":"9600826","presented_order":["15113221","9600826"],"winner_id":"15113221","reasoning":"Document A — it directly links a gene expression signature to prognosis (outcomes), whereas B focuses on invasion/angiogenesis without relating expression to patient outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907964Z"}
{"comparison_id":"d94d4af4-2b37-43c3-9a27-9291cd9e6f77","query_id":"51","doc_a_id":"19358586","doc_b_id":"7821634","presented_order":["19358586","7821634"],"winner_id":"7821634","reasoning":"Neither paper mentions ALDH1. Both are unrelated, but B is slightly more focused on markers tied to prognosis and treatment response in breast cancer, so it's marginally more relevant.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907970Z"}
{"comparison_id":"ae243240-9a27-438c-a865-9ed60455fe8b","query_id":"51","doc_a_id":"15113221","doc_b_id":"25973484","presented_order":["25973484","15113221"],"winner_id":"15113221","reasoning":"Document B — it discusses gene expression signatures linked to prognosis in carcinomas, which is closer to a claim about a molecular marker (ALDH1) and outcomes than Document A's focus on obesity-related risk. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907977Z"}
{"comparison_id":"f02d8d23-8600-4385-9461-3e15051367b6","query_id":"51","doc_a_id":"22712546","doc_b_id":"34066665","presented_order":["22712546","34066665"],"winner_id":"22712546","reasoning":"Document A is more relevant — it profiles enzymatic activities and metabolic interactions in breast cancer tissue, which is more likely to address ALDH1 expression and its association with outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907984Z"}
{"comparison_id":"70bcee96-372f-4412-b33c-c1674fbcd806","query_id":"51","doc_a_id":"1866911","doc_b_id":"5579368","presented_order":["1866911","5579368"],"winner_id":"5579368","reasoning":"B is more relevant — it covers tools for linking gene expression to breast cancer biomarkers (which could address ALDH1 expression and outcomes), while A focuses on luminal progenitors/BRCA1 without ALDH1 or outcome data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907990Z"}
{"comparison_id":"77389830-5739-4085-a1b4-07302139aa72","query_id":"51","doc_a_id":"24341590","doc_b_id":"3285322","presented_order":["24341590","3285322"],"winner_id":"24341590","reasoning":"Document A is more relevant — it examines a molecular/genetic predictor (CYP2D6) and its association with breast cancer outcomes, closer to the query about biomarker expression and outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.907996Z"}
{"comparison_id":"75947d49-1958-4109-9ef2-9afadb64dd2c","query_id":"51","doc_a_id":"24341590","doc_b_id":"25973484","presented_order":["24341590","25973484"],"winner_id":"25973484","reasoning":"Document B is slightly more relevant because it discusses factors affecting breast cancer prognosis and tumor phenotypes, whereas Document A focuses narrowly on CYP2D6 and tamoxifen metabolism. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908003Z"}
{"comparison_id":"d706c52e-b009-4ebf-9bfa-ad9d2ba8cda2","query_id":"51","doc_a_id":"34066665","doc_b_id":"4702639","presented_order":["4702639","34066665"],"winner_id":"4702639","reasoning":"Document A is more relevant — it discusses tumour stemness and markers related to cancer stem cells, which is more directly related to ALDH1 (a stem cell marker) and clinical outcomes than a review on ER–HER signalling. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908009Z"}
{"comparison_id":"05c2654d-ec61-44ef-b942-9701db3f43b4","query_id":"51","doc_a_id":"18953920","doc_b_id":"8963413","presented_order":["8963413","18953920"],"winner_id":"18953920","reasoning":"B is more relevant — it discusses acquisition of stem-cell markers and increased tumorigenicity in mammary cells (ALDH1 is a breast cancer stem-cell marker), whereas A focuses on PD-L1, not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908016Z"}
{"comparison_id":"49e817e1-538c-442f-99be-501332a7d0b8","query_id":"51","doc_a_id":"2931832","doc_b_id":"34066665","presented_order":["2931832","34066665"],"winner_id":"2931832","reasoning":"Document A is more relevant — it addresses prognostic biomarkers in breast cancer (though not ALDH1 specifically), whereas Document B focuses on ER–HER signaling and therapy resistance. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908022Z"}
{"comparison_id":"517f441b-62df-4bb3-9753-e269ce9dc774","query_id":"51","doc_a_id":"825728","doc_b_id":"9600826","presented_order":["825728","9600826"],"winner_id":"825728","reasoning":"Document A — it links EMT, acquisition of stem‑cell properties and patient survival/reduced metastasis (more related to ALDH1 as a stem‑cell marker and outcomes). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908028Z"}
{"comparison_id":"bf5ae682-79f1-450b-8c09-3b9fa24d2d27","query_id":"51","doc_a_id":"22482820","doc_b_id":"22712546","presented_order":["22712546","22482820"],"winner_id":"22712546","reasoning":"Document A is more relevant — it analyzes enzymatic activities and metabolic interactions in breast cancer tissue, which is directly related to ALDH1 expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908034Z"}
{"comparison_id":"f61e5ac1-ccbf-49c6-87c0-a364e8b631ca","query_id":"51","doc_a_id":"15113221","doc_b_id":"2931832","presented_order":["15113221","2931832"],"winner_id":"15113221","reasoning":"Document A — it discusses a gene expression signature linked to prognosis, which is closer to ALDH1 (a gene marker) than Document B's platelet metric. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908040Z"}
{"comparison_id":"d6a22b0b-79a0-41e2-a923-ab234901e038","query_id":"51","doc_a_id":"34066665","doc_b_id":"7821634","presented_order":["7821634","34066665"],"winner_id":"7821634","reasoning":"Document A is more relevant because it discusses how expression levels of a molecular marker (DUSP4) correlate with breast cancer outcomes, while Document B focuses on ER–HER signaling and endocrine resistance rather than marker–outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908047Z"}
{"comparison_id":"8c9acad7-78dc-4a13-b8b1-7dad5c099f64","query_id":"51","doc_a_id":"16086778","doc_b_id":"7821634","presented_order":["16086778","7821634"],"winner_id":"16086778","reasoning":"Document A is more relevant — it addresses breast cancer tumor biology and signaling (Numb/Notch) linked to tumor behavior and outcomes, which is closer to a marker-outcome association like ALDH1 than the chemotherapy-resistance focus of Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908054Z"}
{"comparison_id":"46a12592-965e-4e9a-80bb-b7fbef850ffc","query_id":"51","doc_a_id":"12762485","doc_b_id":"7821634","presented_order":["7821634","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses a stem cell phenotype (which ALDH1 marks) and links it to more aggressive features and poorer differentiation, making it more relevant to evaluating ALDH1's association with outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908060Z"}
{"comparison_id":"697232c9-e646-407f-bd21-aa9cdb138185","query_id":"51","doc_a_id":"1171121","doc_b_id":"8891333","presented_order":["8891333","1171121"],"winner_id":"8891333","reasoning":"Document A is more relevant — it discusses cancer stem cells in breast cancer (ALDH1 is a cancer stem cell marker), while B focuses on MVD and p53 and not stem-cell markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908096Z"}
{"comparison_id":"e9d131a0-bebc-4c87-acc2-132afb137533","query_id":"51","doc_a_id":"31311495","doc_b_id":"825728","presented_order":["31311495","825728"],"winner_id":"825728","reasoning":"Document B — it links EMT, acquisition of stem-cell properties and patient survival/metastasis, so it's more likely to address ALDH1's prognostic role.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908102Z"}
{"comparison_id":"ee14c2ac-c276-41d8-ae64-e4f3c5a3fc96","query_id":"51","doc_a_id":"22712546","doc_b_id":"24249915","presented_order":["22712546","24249915"],"winner_id":"22712546","reasoning":"Document A is more relevant — it analyzes enzymatic/metabolic activity in breast cancer tissue (which could include ALDH1), whereas Document B concerns estrogen receptor beta and is unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908109Z"}
{"comparison_id":"e34129a1-d422-45b2-b62d-2bf0cbf79388","query_id":"51","doc_a_id":"22401720","doc_b_id":"9600826","presented_order":["22401720","9600826"],"winner_id":"22401720","reasoning":"Document A is more relevant because it discusses expression of markers in breast cancer and links expression levels (e.g., VEGF) to prognosis, which relates to the claim about marker expression and outcomes. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908115Z"}
{"comparison_id":"6bf94251-e8dc-4128-9fbd-e3a7c539c6d9","query_id":"51","doc_a_id":"20839751","doc_b_id":"32001951","presented_order":["20839751","32001951"],"winner_id":"20839751","reasoning":"Document A is more relevant — it discusses prognostic markers and outcomes in breast cancer, whereas Document B focuses on ALP regulation in a cell line and is unrelated to prognosis or ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908121Z"}
{"comparison_id":"4035e987-1a8e-4a9b-af08-40a17ef027d9","query_id":"51","doc_a_id":"2014909","doc_b_id":"25973484","presented_order":["25973484","2014909"],"winner_id":"2014909","reasoning":"Document B — it discusses tumor-initiating cells in breast cancer (ALDH1 is a marker of tumor-initiating/cancer stem cells), while A focuses on obesity and does not mention ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908127Z"}
{"comparison_id":"54fbb80d-1e5a-4967-91fd-48c6dedd47fe","query_id":"51","doc_a_id":"20183360","doc_b_id":"22975806","presented_order":["22975806","20183360"],"winner_id":"20183360","reasoning":"Neither abstract mentions ALDH1. Document B is slightly more relevant because it discusses factors affecting breast cancer invasiveness and outcome-related biology, whereas A focuses on BRCA allele loss without outcome biomarkers. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908134Z"}
{"comparison_id":"655e9cf4-49ce-46c0-9cfe-8138cf07451c","query_id":"51","doc_a_id":"15113221","doc_b_id":"20183360","presented_order":["15113221","20183360"],"winner_id":"15113221","reasoning":"Document A is more relevant — it discusses gene-expression signatures tied to prognosis and outcomes, whereas B focuses on molecular mechanisms of invasion without addressing clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908140Z"}
{"comparison_id":"b292268c-801c-4d6c-a732-dca2d9bfa2a6","query_id":"51","doc_a_id":"22401720","doc_b_id":"32001951","presented_order":["22401720","32001951"],"winner_id":"22401720","reasoning":"Document A is more relevant — it examines expression of markers in primary breast cancers and relates expression levels to prognosis, whereas B studies regulation of alkaline phosphatase in a cell line without clinical outcome data.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908147Z"}
{"comparison_id":"709d3120-0313-45aa-bc87-2316e1685ef6","query_id":"51","doc_a_id":"2931832","doc_b_id":"43385013","presented_order":["2931832","43385013"],"winner_id":"43385013","reasoning":"Document B — it discusses breast epithelial/mesenchymal subpopulations and stem cell/progenitor properties relevant to markers like ALDH1, whereas A concerns platelet metrics and is unrelated. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908153Z"}
{"comparison_id":"1d6d3c8b-603d-4e22-9d25-48a0c3ef3df8","query_id":"51","doc_a_id":"1171121","doc_b_id":"25973484","presented_order":["1171121","25973484"],"winner_id":"1171121","reasoning":"Document A is more relevant — it discusses prognostic biomarkers and survival outcomes in breast cancer, whereas Document B focuses on obesity-related risk factors; neither mentions ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908159Z"}
{"comparison_id":"8ef606dd-4841-42b3-9da1-48397b9b72dd","query_id":"51","doc_a_id":"16086778","doc_b_id":"2014909","presented_order":["2014909","16086778"],"winner_id":"2014909","reasoning":"Document A is more relevant — it discusses tumor-initiating cells and analyses of primary breast cancers/PDXs (contexts where ALDH1, a stem-cell marker, would be evaluated), while B focuses on Numb/Notch without stem-cell marker context.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908166Z"}
{"comparison_id":"c1c90e05-27e7-4fc9-b38a-3675223d3a54","query_id":"51","doc_a_id":"24834968","doc_b_id":"31311495","presented_order":["24834968","31311495"],"winner_id":"24834968","reasoning":"Document A is more relevant — it evaluates biological markers as predictors of treatment response in breast cancer, whereas Document B focuses on tamoxifen-resistant cell-line EMT mechanisms and does not assess clinical marker–outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908172Z"}
{"comparison_id":"d1b85aa6-bcc0-4e85-aa31-c508f3adf259","query_id":"51","doc_a_id":"19358586","doc_b_id":"43385013","presented_order":["19358586","43385013"],"winner_id":"43385013","reasoning":"Document B — it addresses stem cell/progenitor properties in breast cells (context where ALDH1 is a relevant marker), whereas A focuses on a miRNA/p27/Myc signature with no ALDH1-related content.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908178Z"}
{"comparison_id":"5692cdf3-f75c-424f-86f1-6612e82705c7","query_id":"51","doc_a_id":"4429932","doc_b_id":"8963413","presented_order":["4429932","8963413"],"winner_id":"8963413","reasoning":"B is more relevant — it discusses how expression of a tumor marker (PD-L1) relates to clinical outcomes in breast cancer, which is conceptually closer to the claim about ALDH1 than the LOX/metastasis focus in A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908184Z"}
{"comparison_id":"131d0533-24a3-4af7-a8d8-54d3a4a97235","query_id":"51","doc_a_id":"16086778","doc_b_id":"24249915","presented_order":["16086778","24249915"],"winner_id":"24249915","reasoning":"Neither paper mentions ALDH1, so both are irrelevant to the claim. Document B is slightly more relevant because it addresses expression changes of a breast cancer marker and potential clinical implications. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908190Z"}
{"comparison_id":"75922c25-0a23-4e1b-b24d-156d449aee17","query_id":"51","doc_a_id":"22482820","doc_b_id":"2931832","presented_order":["2931832","22482820"],"winner_id":"2931832","reasoning":"Document A is more relevant — it addresses prognostic biomarkers and survival outcomes in breast cancer, whereas B focuses on treatment strategies. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908196Z"}
{"comparison_id":"47816aeb-f814-48d2-9b01-472b1def36bf","query_id":"51","doc_a_id":"22975806","doc_b_id":"3285322","presented_order":["3285322","22975806"],"winner_id":"3285322","reasoning":"Neither document mentions ALDH1. Document A is more relevant because it addresses clinical/pathologic features and treatment response (outcomes) in breast cancer, whereas B focuses on BRCA allele loss mechanisms. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908202Z"}
{"comparison_id":"2c92b3a8-e336-4422-9f46-924416d6ad78","query_id":"51","doc_a_id":"1866911","doc_b_id":"8891333","presented_order":["1866911","8891333"],"winner_id":"8891333","reasoning":"Document B is more relevant because it discusses cancer stem cells in breast cancer (ALDH1 is a stem-cell marker), while Document A focuses on luminal progenitors and BRCA1 without addressing ALDH1. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908208Z"}
{"comparison_id":"5a391b41-3a4c-44d8-a651-20f4ad7d273c","query_id":"51","doc_a_id":"25973484","doc_b_id":"43385013","presented_order":["25973484","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it addresses stem/progenitor cell properties in breast cell subpopulations (the context in which ALDH1 is a stem cell marker), while A discusses obesity and breast cancer risk without mentioning ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908215Z"}
{"comparison_id":"bd2e9af8-31cb-4530-b52b-c25383c517a5","query_id":"51","doc_a_id":"4455466","doc_b_id":"7821634","presented_order":["7821634","4455466"],"winner_id":"4455466","reasoning":"Document B is more relevant — it directly links a gene's expression level (low expression → poor prognosis, overexpression → tumor suppression) to breast cancer outcomes, which is analogous to the claim about ALDH1 expression and prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908221Z"}
{"comparison_id":"b1c8d2ae-0748-4487-9340-59a97f9bf595","query_id":"51","doc_a_id":"24249915","doc_b_id":"45638119","presented_order":["45638119","24249915"],"winner_id":"45638119","reasoning":"Document A — it directly addresses ALDH1 and its association with clinical outcome, reporting it predicts poor (not better) prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908227Z"}
{"comparison_id":"279edaea-8e07-463e-aad3-c150e313eaef","query_id":"51","doc_a_id":"25732836","doc_b_id":"9600826","presented_order":["25732836","9600826"],"winner_id":"25732836","reasoning":"Document A is more related because it discusses prognostic markers and outcome prediction in breast cancer, whereas Document B focuses on a signaling pathway in invasion/angiogenesis unrelated to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908233Z"}
{"comparison_id":"a022ddb2-194a-4f41-87c1-d7e01e8e2dda","query_id":"51","doc_a_id":"22975806","doc_b_id":"9600826","presented_order":["22975806","9600826"],"winner_id":"22975806","reasoning":"Document A is more relevant — it addresses breast tumorigenesis and clinical implications, whereas Document B focuses on an invasion/angiogenesis pathway unrelated to ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908240Z"}
{"comparison_id":"7342588e-19df-4fbe-9cec-7bd25f4025a3","query_id":"51","doc_a_id":"1171121","doc_b_id":"4889228","presented_order":["1171121","4889228"],"winner_id":"1171121","reasoning":"Document A is more relevant — it addresses prognostic markers and breast cancer outcomes, whereas Document B focuses on splicing regulation in TNBC unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908246Z"}
{"comparison_id":"adec969e-2116-43e6-b033-d947d0d9c82a","query_id":"51","doc_a_id":"15946643","doc_b_id":"4889228","presented_order":["15946643","4889228"],"winner_id":"4889228","reasoning":"Document B is more relevant — it addresses expression of a molecular marker (TDP43) and its correlation with prognosis in breast cancer, which is closer to the claim about marker expression and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908253Z"}
{"comparison_id":"d64461ea-00d9-4099-89bd-2829d523d1a9","query_id":"51","doc_a_id":"34066665","doc_b_id":"4889228","presented_order":["34066665","4889228"],"winner_id":"4889228","reasoning":"Document B — it links expression of a specific protein (TDP43) to prognosis in breast cancer, so it's more directly relevant to claims about marker expression and outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908259Z"}
{"comparison_id":"d479f18a-28ca-45ef-a5c5-88bfa46aaa64","query_id":"51","doc_a_id":"24834968","doc_b_id":"8891333","presented_order":["8891333","24834968"],"winner_id":"24834968","reasoning":"Document B is more relevant — it directly evaluates biological markers as predictors of response/outcomes in breast cancer, whereas A discusses stem-cell pathways and transporters without ALDH1 or outcome data.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908265Z"}
{"comparison_id":"32e8ba0f-bd48-4318-a813-8233b9ead364","query_id":"51","doc_a_id":"16086778","doc_b_id":"20183360","presented_order":["20183360","16086778"],"winner_id":"16086778","reasoning":"Neither abstract mentions ALDH1. Document B is slightly more relevant because loss of Numb/increased Notch relates to stem-cell–like behavior (which is linked to ALDH1 as a cancer stem cell marker), whereas A focuses on GATA3/Smad4–driven invasion. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908272Z"}
{"comparison_id":"cfb521fb-6ecd-4513-b050-3078423754cc","query_id":"51","doc_a_id":"32001951","doc_b_id":"825728","presented_order":["825728","32001951"],"winner_id":"825728","reasoning":"Document A is more relevant — it links EMT, stem-cell properties and patient survival (clinical outcomes), whereas Document B only studies alkaline phosphatase regulation in a cell line and does not address ALDH1 or patient outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908279Z"}
{"comparison_id":"c6695c1e-feb7-4914-8a6b-cc51bac9d0be","query_id":"51","doc_a_id":"19358586","doc_b_id":"2014909","presented_order":["19358586","2014909"],"winner_id":"2014909","reasoning":"Document B is more relevant — it discusses tumor-initiating cells and analyses of primary breast cancers (ALDH1 is a tumor-initiating/cancer stem cell marker), whereas Document A focuses on a Myc/p27/phospho-Rb miRNA signature unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908286Z"}
{"comparison_id":"61193054-5c70-4dd2-86ec-c0568d4bb08c","query_id":"51","doc_a_id":"15113221","doc_b_id":"825728","presented_order":["825728","15113221"],"winner_id":"825728","reasoning":"Document A is more relevant — it discusses EMT, cancer stem-cell properties and links to patient survival, which is closer to ALDH1 (a stem-cell marker) and outcomes than the PTEN-focused study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908292Z"}
{"comparison_id":"3bb5e2f7-4d07-4fe6-bd5b-b73e3d1c08ac","query_id":"51","doc_a_id":"20127522","doc_b_id":"21033230","presented_order":["21033230","20127522"],"winner_id":"21033230","reasoning":"Document A is slightly more relevant because it discusses molecular profiling of tumor cells and specific marker expression, which is closer to evaluating ALDH1 expression than Document B's focus on CTC counts alone.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908298Z"}
{"comparison_id":"286b0316-1059-46b5-9ad6-ffa6953252e2","query_id":"51","doc_a_id":"1171121","doc_b_id":"21033230","presented_order":["21033230","1171121"],"winner_id":"21033230","reasoning":"Document A is slightly more relevant because it discusses molecular profiling of tumor cells and marker analysis (even though it doesn't mention ALDH1); Document B focuses on microvessel density and p53, which are less related to ALDH1 expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908305Z"}
{"comparison_id":"809b298c-eaf5-4218-a21d-b07897c70413","query_id":"51","doc_a_id":"16734530","doc_b_id":"22401720","presented_order":["16734530","22401720"],"winner_id":"22401720","reasoning":"Document B examines expression of tumor markers and their relation to prognosis in breast cancer, which is more related to a claim about ALDH1 expression and outcomes than Document A's focus on ORAI1 SNPs. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908312Z"}
{"comparison_id":"40496393-6811-477d-bea5-fcfb6db48e46","query_id":"51","doc_a_id":"21033230","doc_b_id":"8963413","presented_order":["21033230","8963413"],"winner_id":"8963413","reasoning":"Document B — it discusses marker (protein) expression and its associations with clinical outcomes in breast cancer, which is more directly relevant to a claim about ALDH1 expression and outcomes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908318Z"}
{"comparison_id":"c33516b9-c867-4a46-98b9-f89a4f7d1302","query_id":"51","doc_a_id":"15113221","doc_b_id":"313403","presented_order":["313403","15113221"],"winner_id":"313403","reasoning":"Document A is more relevant — it addresses prognostic markers in breast cancer specifically, whereas Document B discusses a broader carcinoma gene-signature unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908324Z"}
{"comparison_id":"fe68b402-a18c-473c-a6a4-23ce7a413073","query_id":"51","doc_a_id":"31311495","doc_b_id":"8891333","presented_order":["8891333","31311495"],"winner_id":"8891333","reasoning":"Document A is more relevant — it discusses breast cancer stem cells and related markers/targets (context for ALDH1 as a stem-cell marker), whereas B focuses on tamoxifen resistance and EMT without addressing ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908331Z"}
{"comparison_id":"feff6983-94f4-4fcc-801d-7bd66fe1cf19","query_id":"51","doc_a_id":"25973484","doc_b_id":"32001951","presented_order":["32001951","25973484"],"winner_id":"25973484","reasoning":"Document B is more relevant — it discusses breast cancer prognosis and factors affecting outcomes, whereas Document A deals with alkaline phosphatase regulation in a cell line (unrelated to ALDH1).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908338Z"}
{"comparison_id":"effbe2e1-92cc-4b2f-87ed-048d723f0fbf","query_id":"51","doc_a_id":"16691520","doc_b_id":"19673227","presented_order":["16691520","19673227"],"winner_id":"16691520","reasoning":"Document A is more relevant because it focuses on molecular markers and gene regulation in breast cancer specifically, whereas B addresses circulating tumor cell chemosensitivity across epithelial tumors without breast-specific molecular markers. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908345Z"}
{"comparison_id":"18f79d52-4f62-4607-a972-3ca01d5ff41d","query_id":"51","doc_a_id":"1171121","doc_b_id":"24249915","presented_order":["24249915","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant — it addresses prognostic markers and their association with breast cancer outcomes, whereas Document A focuses on ERβ expression and methylation, not prognostic outcome markers like ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908352Z"}
{"comparison_id":"0f626987-2c93-42b9-959a-156fe5efd48b","query_id":"51","doc_a_id":"18953920","doc_b_id":"22401720","presented_order":["18953920","22401720"],"winner_id":"18953920","reasoning":"Document A is more relevant — it discusses acquisition of stem-cell markers and increased tumorigenic potential in breast epithelial cells, which relates to ALDH1 as a stem cell marker. Document B focuses on angiogenic factors and prognosis, unrelated to ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908359Z"}
{"comparison_id":"bb89670d-0538-434d-89d8-b5581fe50d78","query_id":"51","doc_a_id":"16734530","doc_b_id":"7583725","presented_order":["7583725","16734530"],"winner_id":"7583725","reasoning":"Document A is more relevant because it links gene expression levels (TRPM7) to patient outcomes in breast cancer, which is analogous to a claim about ALDH1 expression and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908365Z"}
{"comparison_id":"ba4cd15f-abd3-4e8c-8c42-cd7ccb3122f2","query_id":"51","doc_a_id":"25973484","doc_b_id":"8963413","presented_order":["8963413","25973484"],"winner_id":"8963413","reasoning":"Document A — it discusses tumor marker expression and associations with breast cancer outcomes, which is directly related to the query about marker expression (whereas B focuses on obesity-related risk). ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908372Z"}
{"comparison_id":"f0663c60-10eb-4e97-9c6d-1683db59e3eb","query_id":"51","doc_a_id":"22482820","doc_b_id":"43385013","presented_order":["22482820","43385013"],"winner_id":"43385013","reasoning":"Document B is more relevant — it addresses stem cell/progenitor properties in breast epithelial/mesenchymal subpopulations (ALDH1 is a common stem cell marker), whereas Document A focuses on combination therapy strategies and drug delivery. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908379Z"}
{"comparison_id":"de323328-678e-4b30-ab36-c89e5287f1be","query_id":"51","doc_a_id":"15946643","doc_b_id":"22482820","presented_order":["15946643","22482820"],"winner_id":"22482820","reasoning":"Document B — it covers receptor/marker-based classification and treatment response in breast cancer, so it's more likely to discuss associations of markers like ALDH1 with outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908385Z"}
{"comparison_id":"089edc30-eaec-4260-a097-1420c6690568","query_id":"51","doc_a_id":"16734530","doc_b_id":"24249915","presented_order":["24249915","16734530"],"winner_id":"24249915","reasoning":"Reason: Document A deals with expression changes of a breast cancer–related protein and its potential clinical relevance, so it's more closely related to a claim about expression being linked to outcomes than a genetics/SNP association study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908392Z"}
{"comparison_id":"8d10ef46-f31d-4097-bb7d-d71f40fdff7f","query_id":"51","doc_a_id":"3285322","doc_b_id":"5500086","presented_order":["3285322","5500086"],"winner_id":"5500086","reasoning":"Document B is more relevant — it links a molecular signature (type I IFN) to clinical outcomes in breast cancer, which is closer to asking about a biomarker–outcome association than Document A's BRCA-focused clinical/pathologic comparison.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908398Z"}
{"comparison_id":"0a26cfb1-2d62-4311-ae5b-f708fb60061f","query_id":"51","doc_a_id":"2931832","doc_b_id":"4429932","presented_order":["2931832","4429932"],"winner_id":"2931832","reasoning":"Document A is more relevant — it discusses a prognostic biomarker and breast cancer outcomes, whereas Document B focuses on LOX and metastasis mechanisms. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908405Z"}
{"comparison_id":"50c335fd-4620-49ca-a4cc-4bc0b20340cd","query_id":"51","doc_a_id":"15113221","doc_b_id":"15946643","presented_order":["15113221","15946643"],"winner_id":"15946643","reasoning":"Reason: Document B focuses specifically on breast cancer biology and factors affecting metastasis and treatment outcomes; Document A addresses PTEN-related prognosis across carcinomas but is less directly related to breast-cancer outcome markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908411Z"}
{"comparison_id":"299ee946-5a65-48cc-a7a1-243fe7379477","query_id":"51","doc_a_id":"24249915","doc_b_id":"24834968","presented_order":["24834968","24249915"],"winner_id":"24834968","reasoning":"Document A is more relevant — it evaluates biological markers as predictors of treatment response/outcomes in breast cancer, whereas B focuses on ERβ expression and methylation in cell lines. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908417Z"}
{"comparison_id":"ed27b863-23bb-4def-b116-935ac3c5b6fe","query_id":"51","doc_a_id":"15113221","doc_b_id":"2014909","presented_order":["15113221","2014909"],"winner_id":"2014909","reasoning":"Document B — it discusses tumor-initiating cells and breast cancer biology (more directly related to ALDH1, a tumor‑initiating/cancer stem cell marker), while A focuses on PTEN pathway signatures unrelated to ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908424Z"}
{"comparison_id":"3981ec64-6f91-4d73-ac0b-90c34a0fffac","query_id":"51","doc_a_id":"18953920","doc_b_id":"4889228","presented_order":["4889228","18953920"],"winner_id":"18953920","reasoning":"Document B — it discusses acquisition of stem-cell markers (such as ALDH1) and increased tumorigenicity in mammary cells, which is relevant to links between ALDH1 expression and breast cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908430Z"}
{"comparison_id":"7c29f27f-2327-4ffc-9f56-4b22207fe153","query_id":"51","doc_a_id":"825728","doc_b_id":"8891333","presented_order":["8891333","825728"],"winner_id":"8891333","reasoning":"Document A is more relevant — it discusses breast cancer stem cells and markers/pathways related to stemness, which is closer to ALDH1 expression's role in breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908437Z"}
{"comparison_id":"423f7c0c-dc56-4074-ad4c-b8fbd4539b9e","query_id":"51","doc_a_id":"24341590","doc_b_id":"7821634","presented_order":["7821634","24341590"],"winner_id":"7821634","reasoning":"Document A is more relevant — it examines how the expression level of a tumor marker (DUSP4) correlates with breast cancer outcomes, which is analogous to the query about ALDH1 expression and outcomes. Document B concerns CYP2D6 genotypes and tamoxifen response, not marker expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908443Z"}
{"comparison_id":"5a137d10-fd21-40ad-99e6-6f2af125a7e7","query_id":"51","doc_a_id":"1171121","doc_b_id":"19358586","presented_order":["19358586","1171121"],"winner_id":"1171121","reasoning":"Reason: Document B addresses prognostic markers and survival associations in breast cancer, so it's more relevant to a claim about a marker's association with outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908450Z"}
{"comparison_id":"8c28394d-377f-4571-aa85-14c204656446","query_id":"51","doc_a_id":"1866911","doc_b_id":"25732836","presented_order":["1866911","25732836"],"winner_id":"1866911","reasoning":"Document A — it discusses cellular markers and progenitor cell populations in breast cancer (closer to marker-expression studies like ALDH1) while B focuses on imaging/CTCs rather than marker expression. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908456Z"}
{"comparison_id":"3a837875-8f30-432d-9cc3-5bad9576a176","query_id":"51","doc_a_id":"15946643","doc_b_id":"8891333","presented_order":["15946643","8891333"],"winner_id":"8891333","reasoning":"Document B is more relevant — it addresses cancer stem cells in breast cancer (where ALDH1 is a common stem-cell marker) and therapies targeting them, whereas Document A focuses on CXCL1-driven chemoresistance/metastasis and not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908463Z"}
{"comparison_id":"31473a0e-58fc-4a6d-b87f-ebd6ebf158f6","query_id":"51","doc_a_id":"2014909","doc_b_id":"8891333","presented_order":["2014909","8891333"],"winner_id":"8891333","reasoning":"Document B is more relevant — it discusses cancer stem cells and markers in breast cancer (ALDH1 is a stem-cell marker), so it’s more directly related to ALDH1’s prognostic implications.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908469Z"}
{"comparison_id":"76ef3c17-d049-4ad9-a8ed-1d516c91b65a","query_id":"51","doc_a_id":"20333864","doc_b_id":"22712546","presented_order":["20333864","22712546"],"winner_id":"22712546","reasoning":"Document B is more relevant — it focuses on measuring enzymatic activities and metabolic interactions in breast cancer tissue (ALDH1 is an enzyme-related marker), whereas Document A deals with cellular regulators of DCIS-to-invasive transition and doesn't address ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908476Z"}
{"comparison_id":"087eb0f0-bb8b-44ba-b00e-e3733200ba03","query_id":"51","doc_a_id":"24341590","doc_b_id":"4429932","presented_order":["4429932","24341590"],"winner_id":"4429932","reasoning":"Document A — it discusses a protein's expression being associated with patient outcomes in breast cancer, which is more similar to a claim about ALDH1 expression and outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908484Z"}
{"comparison_id":"92b4249e-7c8e-43f0-96b1-742da1e66a3f","query_id":"51","doc_a_id":"20839751","doc_b_id":"34066665","presented_order":["20839751","34066665"],"winner_id":"20839751","reasoning":"Document A is more relevant because it discusses markers correlated with breast cancer prognosis (outcomes), whereas Document B focuses on ER–HER signaling and therapy resistance rather than prognostic marker expression.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908490Z"}
{"comparison_id":"7822b093-e9e1-4707-942d-e898ec6f1063","query_id":"51","doc_a_id":"15946643","doc_b_id":"25973484","presented_order":["25973484","15946643"],"winner_id":"15946643","reasoning":"Neither document mentions ALDH1. Document B is marginally more relevant because it addresses molecular mechanisms of chemoresistance and metastasis that relate to biomarker-linked outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908496Z"}
{"comparison_id":"afb4a1b3-ccec-46d6-a8a8-d5b6404c26d7","query_id":"51","doc_a_id":"24341590","doc_b_id":"7583725","presented_order":["7583725","24341590"],"winner_id":"7583725","reasoning":"Doc A is more relevant — it discusses a tumor protein whose expression predicts patient outcomes (similar question about a biomarker–outcome association).  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908503Z"}
{"comparison_id":"f736bc7e-21d8-4f63-a493-4473c5e29dfa","query_id":"51","doc_a_id":"2014909","doc_b_id":"20454006","presented_order":["20454006","2014909"],"winner_id":"2014909","reasoning":"Document B is more relevant — it analyzes tumor-initiating cells and primary breast cancers, which is more likely to address ALDH1 expression and outcomes; Document A focuses on tamoxifen/DIM biomarkers without ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908509Z"}
{"comparison_id":"634f21e6-37a4-45aa-8124-0ac45bb4559c","query_id":"51","doc_a_id":"20127522","doc_b_id":"45638119","presented_order":["20127522","45638119"],"winner_id":"45638119","reasoning":"Doc B directly addresses ALDH1 in breast cancer and reports it predicts poor clinical outcome, which is directly relevant to the claim.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908515Z"}
{"comparison_id":"90011ba8-f266-453b-9c60-a890207aafcb","query_id":"51","doc_a_id":"15113221","doc_b_id":"25732836","presented_order":["15113221","25732836"],"winner_id":"15113221","reasoning":"Reason: Document A discusses gene expression signatures linked to prognosis, which is more directly related to marker expression and outcomes than Document B's focus on CTCs and imaging.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908521Z"}
{"comparison_id":"bc034cfb-0758-4842-9cf8-bf8f5e3057cc","query_id":"51","doc_a_id":"20183360","doc_b_id":"25732836","presented_order":["20183360","25732836"],"winner_id":"25732836","reasoning":"Document B is more relevant — it deals with prognostic markers and outcome prediction in breast cancer, which is directly related to the claim about associations with outcomes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908527Z"}
{"comparison_id":"61c0282b-5e75-4836-acc6-545bd4422f27","query_id":"51","doc_a_id":"18953920","doc_b_id":"4429932","presented_order":["18953920","4429932"],"winner_id":"18953920","reasoning":"Document A discusses stem-cell markers and tumorigenic properties in mammary epithelial cells (directly relevant to ALDH1 as a breast cancer stem-cell marker), while B focuses on LOX and hypoxia-related metastasis. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908533Z"}
{"comparison_id":"f67c5f61-f418-48da-ac16-0143e907d153","query_id":"51","doc_a_id":"25973484","doc_b_id":"313403","presented_order":["25973484","313403"],"winner_id":"313403","reasoning":"Document B — it discusses a prognostic biomarker and clinical outcomes in breast cancer, which is more relevant to a claim about marker expression and prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908540Z"}
{"comparison_id":"c657dba8-bc59-4e93-b3c9-008236c5f12f","query_id":"51","doc_a_id":"20454006","doc_b_id":"8963413","presented_order":["20454006","8963413"],"winner_id":"8963413","reasoning":"Document B — it discusses associations between marker expression and breast cancer outcomes (though for PD-L1, not ALDH1), whereas Document A focuses on a tamoxifen combination trial and doesn't address marker-outcome associations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908546Z"}
{"comparison_id":"3e85df7c-4f74-40f3-924b-babdf1e8637d","query_id":"51","doc_a_id":"19358586","doc_b_id":"22712546","presented_order":["22712546","19358586"],"winner_id":"22712546","reasoning":"Document A discusses enzyme activity and metabolic features in breast cancer tissue (more likely to address ALDH1), while Document B focuses on a miRNA/protein signature unrelated to ALDH1. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908553Z"}
{"comparison_id":"bc4f905e-bf7f-44e4-aeae-a8044ff5b145","query_id":"51","doc_a_id":"15113221","doc_b_id":"18953920","presented_order":["18953920","15113221"],"winner_id":"18953920","reasoning":"Document A is more relevant — it discusses acquisition of stem-cell markers (like ALDH1) and links them to tumorigenic potential in mammary epithelial cells, which relates to ALDH1's association with breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908559Z"}
{"comparison_id":"67b9578f-819b-4eb3-b077-3c6d81cd3a33","query_id":"51","doc_a_id":"18953920","doc_b_id":"19358586","presented_order":["19358586","18953920"],"winner_id":"18953920","reasoning":"Document B — it discusses acquisition of stem-cell markers/properties in mammary epithelial cells (contexts where ALDH1 is a relevant marker), while A focuses on a p27/Myc/phospho‑Rb signature and miRNAs and does not address ALDH1.  \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908565Z"}
{"comparison_id":"9fe8efc1-a903-4a52-b495-2abce2cffb37","query_id":"51","doc_a_id":"16734530","doc_b_id":"22975806","presented_order":["16734530","22975806"],"winner_id":"16734530","reasoning":"Neither document mentions ALDH1. Document A is slightly more relevant because it addresses genetic markers linked to breast cancer characteristics/outcomes, whereas Document B focuses on BRCA allele loss and tumorigenesis mechanisms. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908572Z"}
{"comparison_id":"dd837f0f-da80-4368-8e87-52d4eca627e5","query_id":"51","doc_a_id":"313403","doc_b_id":"5579368","presented_order":["313403","5579368"],"winner_id":"5579368","reasoning":"Document B — it discusses tools for analyzing gene expression and breast cancer biomarkers, which is more relevant to a claim about ALDH1 expression and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908578Z"}
{"comparison_id":"74235c29-b42c-49b5-8991-122ab71c3849","query_id":"51","doc_a_id":"16086778","doc_b_id":"22401720","presented_order":["16086778","22401720"],"winner_id":"16086778","reasoning":"Document A is more relevant — it discusses Notch/Numb signaling and tumor biology in breast cancer, which is more closely related to cancer stem-cell markers like ALDH1 than Document B's focus on angiogenic factors. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908584Z"}
{"comparison_id":"c4414110-8101-41d5-b10c-ac7d8be3442c","query_id":"51","doc_a_id":"3285322","doc_b_id":"825728","presented_order":["3285322","825728"],"winner_id":"825728","reasoning":"Document B is more relevant — it addresses cancer stem-cell properties, metastasis, and patient survival, which relate to ALDH1's role as a stem-cell marker and prognostic indicator. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908591Z"}
{"comparison_id":"818ebbee-372c-41bf-b865-6de9adbeacfa","query_id":"51","doc_a_id":"2014909","doc_b_id":"7583725","presented_order":["7583725","2014909"],"winner_id":"2014909","reasoning":"Document B — it addresses tumor-initiating cells and analyses of primary breast cancers (ALDH1 is a tumor‑initiating/cancer stem cell marker), while A focuses on TRPM7 unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908597Z"}
{"comparison_id":"96e045ae-76d6-4e64-9e65-9b80a22e1e52","query_id":"51","doc_a_id":"25732836","doc_b_id":"7583725","presented_order":["25732836","7583725"],"winner_id":"7583725","reasoning":"Document B — it links expression of a specific molecular marker (TRPM7) to patient outcomes, which is more analogous to the claim about ALDH1 expression than Document A’s focus on CTCs and imaging. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908603Z"}
{"comparison_id":"030f97ee-3af6-4f9b-8f6c-c751ac326ac9","query_id":"51","doc_a_id":"20183360","doc_b_id":"24249915","presented_order":["20183360","24249915"],"winner_id":"20183360","reasoning":"Document A is slightly more relevant because it addresses molecular drivers of breast cancer invasiveness and progression, which relates to markers tied to outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908609Z"}
{"comparison_id":"e7592cea-0cd1-402e-9775-a5f745d8d548","query_id":"51","doc_a_id":"19673227","doc_b_id":"4455466","presented_order":["19673227","4455466"],"winner_id":"4455466","reasoning":"Document B is more relevant — it discusses a specific gene's expression linked to breast cancer prognosis, whereas Document A is about CTC chemosensitivity assays and not about gene expression or ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908616Z"}
{"comparison_id":"58f9aee4-badc-4b20-ac2a-f3aa8b232e0b","query_id":"51","doc_a_id":"1171121","doc_b_id":"2014909","presented_order":["2014909","1171121"],"winner_id":"2014909","reasoning":"Document A is more relevant — it discusses tumor-initiating cells in breast cancer (where ALDH1 is a common marker) and analyzes primary breast cancers, making it more likely to address ALDH1-related outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908622Z"}
{"comparison_id":"62bc5b72-7730-4e8e-b8c8-20438ee1352c","query_id":"51","doc_a_id":"1171121","doc_b_id":"4702639","presented_order":["4702639","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant — it studies prognostic factors in early breast cancer outcomes; Document A does not address breast cancer prognosis or ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908629Z"}
{"comparison_id":"a5a91aa4-4846-446e-a512-65b4e3761a64","query_id":"51","doc_a_id":"43385013","doc_b_id":"9600826","presented_order":["43385013","9600826"],"winner_id":"43385013","reasoning":"Reason: Document A discusses stem cell/progenitor properties in breast epithelial subpopulations (ALDH1 is a known stem cell marker), so it's closer to evidence about ALDH1 and outcomes than Document B, which focuses on angiogenesis pathways.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908635Z"}
{"comparison_id":"929e5697-986b-4f86-a49c-22434c488a9a","query_id":"51","doc_a_id":"15113221","doc_b_id":"45638119","presented_order":["45638119","15113221"],"winner_id":"45638119","reasoning":"Document A directly discusses ALDH1 and its association with clinical outcome (reporting poor prognosis), which is directly relevant to the claim. Document B is about PTEN and unrelated.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908641Z"}
{"comparison_id":"cb999956-7fb6-44e3-b376-da1c9b3a2288","query_id":"51","doc_a_id":"20839751","doc_b_id":"43385013","presented_order":["20839751","43385013"],"winner_id":"43385013","reasoning":"Document B — it discusses epithelial/mesenchymal subpopulations and stem cell/progenitor properties (more likely to relate to ALDH1 as a stem cell marker), while A focuses on apoptosis and prognosis without ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908647Z"}
{"comparison_id":"47fac108-7392-4567-a1ad-9ab44956e94b","query_id":"51","doc_a_id":"1171121","doc_b_id":"7821634","presented_order":["7821634","1171121"],"winner_id":"1171121","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it discusses prognostic biomarkers in breast cancer, whereas A focuses on DUSP4 and chemotherapy resistance.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908653Z"}
{"comparison_id":"12a37c98-d6cb-4401-8b52-d1db7afd8581","query_id":"51","doc_a_id":"21033230","doc_b_id":"31311495","presented_order":["31311495","21033230"],"winner_id":"21033230","reasoning":"Document B — it addresses molecular markers and their link to patient outcomes, so it's more relevant to a claim about marker expression and breast cancer prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908660Z"}
{"comparison_id":"a5382f6e-d506-41cd-8022-4e23e916f9d4","query_id":"51","doc_a_id":"19358586","doc_b_id":"4889228","presented_order":["4889228","19358586"],"winner_id":"4889228","reasoning":"Document A is more relevant — it discusses expression of a protein and its correlation with breast cancer prognosis, whereas Document B focuses on a different protein/miRNA signature and therapeutic targeting. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908678Z"}
{"comparison_id":"9a2c4028-cb8d-4f53-b62f-f94e187105c4","query_id":"51","doc_a_id":"24341590","doc_b_id":"8891333","presented_order":["8891333","24341590"],"winner_id":"8891333","reasoning":"Document A is more relevant because it discusses cancer stem cells in breast cancer and related markers/mechanisms (more directly related to ALDH1 as a stem cell marker), whereas Document B focuses on CYP2D6 and tamoxifen pharmacogenetics.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908695Z"}
{"comparison_id":"726b128f-409b-4459-a067-9b427af7fad2","query_id":"51","doc_a_id":"34066665","doc_b_id":"4429932","presented_order":["34066665","4429932"],"winner_id":"34066665","reasoning":"Document A is more relevant — it discusses breast cancer molecular markers and clinical outcomes related to therapy resistance, which is closer to a claim about ALDH1 and prognosis. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908704Z"}
{"comparison_id":"41916a4e-716a-48d8-b860-690029a3fc65","query_id":"51","doc_a_id":"1866911","doc_b_id":"34066665","presented_order":["1866911","34066665"],"winner_id":"1866911","reasoning":"Document A — it discusses breast epithelial cell populations and markers related to tumor origin, which is closer to a claim about ALDH1 expression and outcomes; Document B focuses on ER/HER signaling and therapy resistance. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908711Z"}
{"comparison_id":"13d81670-11e6-41a2-a439-0c6d5cce7aae","query_id":"51","doc_a_id":"16691520","doc_b_id":"1866911","presented_order":["1866911","16691520"],"winner_id":"1866911","reasoning":"Document A is more relevant — it discusses cell populations and progenitor/stem-cell markers in breast cancer, which is where ALDH1 (a stem-cell marker) would be discussed. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908717Z"}
{"comparison_id":"0efb9989-adca-43b2-82a6-663d341f7bf3","query_id":"51","doc_a_id":"15113221","doc_b_id":"22975806","presented_order":["22975806","15113221"],"winner_id":"15113221","reasoning":"Document B — it discusses gene expression signatures linked to prognosis, which is more directly related to claims about marker expression and breast cancer outcomes. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908725Z"}
{"comparison_id":"41a441c1-e976-4f7a-9ac9-fcf318c43300","query_id":"51","doc_a_id":"3285322","doc_b_id":"4702639","presented_order":["3285322","4702639"],"winner_id":"4702639","reasoning":"Document B is more relevant — it discusses tumor stemness markers and mechanisms driving stem-like properties, which relates to ALDH1 as a stem-cell marker. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908732Z"}
{"comparison_id":"7d410b4e-0472-4deb-a930-433ba45831ea","query_id":"51","doc_a_id":"22975806","doc_b_id":"5500086","presented_order":["5500086","22975806"],"winner_id":"5500086","reasoning":"Document A is more relevant — it links a tumor molecular signature (type I IFN) to positive breast cancer outcomes, which is closer to the claim about a biomarker (ALDH1) and prognosis. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908738Z"}
{"comparison_id":"605e674c-6cbe-40f2-a97d-9ba34bd0e04f","query_id":"51","doc_a_id":"24249915","doc_b_id":"4889228","presented_order":["4889228","24249915"],"winner_id":"24249915","reasoning":"Document B is more relevant. Neither mentions ALDH1, but B discusses expression of a breast cancer marker (ERβ) being reduced in invasive cancers—i.e., marker expression linked to better outcomes—whereas A links high expression of TDP43 to worse prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908745Z"}
{"comparison_id":"123a7f74-1a2a-4da8-9216-9ea440fb6d0f","query_id":"51","doc_a_id":"21033230","doc_b_id":"25732836","presented_order":["21033230","25732836"],"winner_id":"21033230","reasoning":"Document A — it reports molecular profiling of circulating tumor cells and marker expression (e.g., EpCAM, MUC1, HER2), which is more closely related to a claim about ALDH1 expression than Document B's focus on imaging and CTC counts.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908752Z"}
{"comparison_id":"8f38676e-95e0-47be-9fcc-2e7b0d98bc99","query_id":"51","doc_a_id":"1866911","doc_b_id":"19358586","presented_order":["19358586","1866911"],"winner_id":"1866911","reasoning":"Document B is more relevant — it addresses breast epithelial/progenitor cell populations and markers related to tumor origin, which is more closely related to studies of ALDH1 as a stem/progenitor marker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908759Z"}
{"comparison_id":"6604882e-ee1b-42c2-a906-54f2432879b5","query_id":"51","doc_a_id":"25732836","doc_b_id":"2931832","presented_order":["2931832","25732836"],"winner_id":"25732836","reasoning":"Document B is more relevant — it concerns tumor-cell–based prognostic markers (circulating tumor cells) in breast cancer, which is more closely related to ALDH1 expression than the platelet-based marker in Document A.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908765Z"}
{"comparison_id":"152bc0c3-d73b-4e2b-98a9-d208c6a7dcb3","query_id":"51","doc_a_id":"15946643","doc_b_id":"24834968","presented_order":["15946643","24834968"],"winner_id":"24834968","reasoning":"Document B examines biological markers as predictors of treatment response and outcomes, so it’s more likely to address associations like ALDH1 expression with prognosis. Document A focuses on CXCL1 signaling and chemoresistance, not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908772Z"}
{"comparison_id":"3dedc51d-f18a-436b-b081-8e4e8159637c","query_id":"51","doc_a_id":"18953920","doc_b_id":"825728","presented_order":["825728","18953920"],"winner_id":"18953920","reasoning":"Document B is more relevant — it addresses mammary epithelial cells and acquisition of stem-cell markers (the category ALDH1 belongs to), directly relating to breast cancer stemness and outcomes. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908779Z"}
{"comparison_id":"19b17923-591e-4fc6-bbb3-2b5f71b7e49b","query_id":"51","doc_a_id":"22975806","doc_b_id":"825728","presented_order":["825728","22975806"],"winner_id":"825728","reasoning":"Document A is more relevant — it links EMT, stem-like properties and patient survival/metastasis, which is closer to ALDH1 (a stem cell marker) and outcome associations than a BRCA-LOH study. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908785Z"}
{"comparison_id":"4a5d3164-d592-4e77-8a4d-e001aba79dbe","query_id":"51","doc_a_id":"16691520","doc_b_id":"21033230","presented_order":["21033230","16691520"],"winner_id":"21033230","reasoning":"Document A is more relevant because it discusses molecular profiling and prognostic markers in breast cancer (predictive value of tumor cell markers), whereas Document B focuses on estrogen receptor binding sites and gene regulation rather than clinical marker-outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908792Z"}
{"comparison_id":"1f1a5198-d163-42aa-ad2c-e787ffe1c65e","query_id":"51","doc_a_id":"4889228","doc_b_id":"5579368","presented_order":["5579368","4889228"],"winner_id":"5579368","reasoning":"Document A is more relevant — it addresses breast cancer biomarkers and correlates methylation with gene expression, which is closer to assessing ALDH1 expression associations than the TNBC splicing study in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908799Z"}
{"comparison_id":"cf5cee94-ff6a-4c24-b7c6-cf471585b565","query_id":"51","doc_a_id":"21033230","doc_b_id":"2931832","presented_order":["2931832","21033230"],"winner_id":"21033230","reasoning":"Reason: Document B covers molecular profiling of tumor cells and prognostic markers in breast cancer (closer to ALDH1 expression), while Document A discusses a platelet-based prognostic ratio unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908805Z"}
{"comparison_id":"1808c680-0a68-4db3-a619-f6514f98d638","query_id":"51","doc_a_id":"18953920","doc_b_id":"24249915","presented_order":["24249915","18953920"],"winner_id":"18953920","reasoning":"Document B — it discusses generation of cells with stem-cell markers and tumorigenic potential (which relates to ALDH1 as a stem cell marker). ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908811Z"}
{"comparison_id":"43c14274-933d-408b-a6d7-a4d3a7b7a2b0","query_id":"51","doc_a_id":"24341590","doc_b_id":"5500086","presented_order":["24341590","5500086"],"winner_id":"5500086","reasoning":"Document B is more relevant — it discusses biomarker signatures that correlate with breast cancer outcomes, while Document A concerns CYP2D6 polymorphisms and tamoxifen efficacy, unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908818Z"}
{"comparison_id":"75f12e6f-d15c-4b80-b759-f70125659918","query_id":"51","doc_a_id":"16086778","doc_b_id":"25973484","presented_order":["16086778","25973484"],"winner_id":"16086778","reasoning":"Document A is more relevant — it discusses molecular markers and pathways (tumor biology) linked to breast cancer outcomes, whereas B focuses on obesity/epidemiology. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908824Z"}
{"comparison_id":"29094464-e8ed-4b60-8895-f0e1675e763a","query_id":"51","doc_a_id":"21033230","doc_b_id":"32001951","presented_order":["21033230","32001951"],"winner_id":"21033230","reasoning":"Document A is more relevant — it addresses prognostic markers and associations with survival in breast cancer patients, whereas Document B focuses on regulation of alkaline phosphatase in a cell line and not clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908830Z"}
{"comparison_id":"72d21888-f780-42b6-9b30-2762084eed8b","query_id":"51","doc_a_id":"27123743","doc_b_id":"8891333","presented_order":["27123743","8891333"],"winner_id":"8891333","reasoning":"Document B — it discusses cancer stem cells in breast cancer and related markers/pathways (more directly related to ALDH1, a stem-cell marker). DOCUMENT A is about birthweight, not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908836Z"}
{"comparison_id":"a202fc55-4a3a-457f-ae60-0264a888df7f","query_id":"51","doc_a_id":"24834968","doc_b_id":"34066665","presented_order":["24834968","34066665"],"winner_id":"24834968","reasoning":"Document A — it evaluates biological markers and clinical response/outcomes in breast cancer (more directly relevant to marker–outcome associations than the ER–HER signaling review). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908842Z"}
{"comparison_id":"1ecb7a20-d923-4c1b-a0a7-19ecd8fc540a","query_id":"51","doc_a_id":"11484808","doc_b_id":"20839751","presented_order":["11484808","20839751"],"winner_id":"20839751","reasoning":"Document B — it directly addresses prognostic associations in breast cancer (apoptosis and outcomes), which is closer to evaluating biomarker–outcome links than a review focused on ncRNAs. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908849Z"}
{"comparison_id":"43b75632-2af4-4194-b7b3-a79ec5364561","query_id":"51","doc_a_id":"24834968","doc_b_id":"4429932","presented_order":["24834968","4429932"],"winner_id":"24834968","reasoning":"Document A is more relevant because it addresses biological markers and predictors of breast cancer outcomes/response, while B focuses on LOX and metastasis without discussing ALDH1. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908856Z"}
{"comparison_id":"a585056d-bedf-41f2-875b-50b99c9f34ae","query_id":"51","doc_a_id":"20183360","doc_b_id":"8963413","presented_order":["8963413","20183360"],"winner_id":"8963413","reasoning":"Document A is more relevant — it discusses tumor marker expression (PD-L1) and its association with clinical outcomes in breast cancer, which is closer to the query about marker expression linked to outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908862Z"}
{"comparison_id":"d9d7298a-d885-48a9-9d21-992b63f4893c","query_id":"51","doc_a_id":"20127522","doc_b_id":"825728","presented_order":["20127522","825728"],"winner_id":"20127522","reasoning":"Document A is more relevant because it directly concerns breast cancer outcomes (though it doesn't mention ALDH1), whereas Document B focuses on EMT/Prrx1 and metastasis more generally. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908868Z"}
{"comparison_id":"c8b253ed-caaf-46d2-9d68-aeab42853cee","query_id":"51","doc_a_id":"22482820","doc_b_id":"4429932","presented_order":["4429932","22482820"],"winner_id":"4429932","reasoning":"Doc A is more relevant — it discusses how expression of a specific molecular marker (LOX) is associated with patient outcomes in breast cancer, which is closest to the query about marker expression and outcomes. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908874Z"}
{"comparison_id":"6d0a4593-3357-4b41-9008-86ab117bd2f2","query_id":"51","doc_a_id":"18953920","doc_b_id":"24341590","presented_order":["24341590","18953920"],"winner_id":"18953920","reasoning":"Document B is more relevant — it discusses acquisition of stem-cell markers in mammary cells (which includes markers like ALDH1) and links to tumorigenic potential, whereas Document A focuses on CYP2D6/tamoxifen and not ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908881Z"}
{"comparison_id":"4ad484b2-6b0a-4afc-a350-859217e74060","query_id":"51","doc_a_id":"20127522","doc_b_id":"25973484","presented_order":["25973484","20127522"],"winner_id":"20127522","reasoning":"Document B — it discusses a biomarker (CTCs) and their association with breast cancer outcomes, which is more related to the claim about a marker's prognostic value than Document A's focus on obesity. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908887Z"}
{"comparison_id":"cc84449f-c61f-4f31-9c2a-89b38c5acf3a","query_id":"51","doc_a_id":"22975806","doc_b_id":"31311495","presented_order":["31311495","22975806"],"winner_id":"31311495","reasoning":"Document A is more relevant — it discusses breast cancer cell behavior, EMT, and treatment resistance, which are more directly related to markers like ALDH1 than the BRCA-allele-focused study in Document B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908894Z"}
{"comparison_id":"ff0c3f85-66f7-4512-8cbf-0299038cf66a","query_id":"51","doc_a_id":"2931832","doc_b_id":"825728","presented_order":["2931832","825728"],"winner_id":"825728","reasoning":"Document B is more relevant — it discusses EMT, acquisition of stem cell properties, and links to patient survival, which relates to ALDH1's role as a stem-cell–associated marker. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908900Z"}
{"comparison_id":"02234a66-0620-4823-911e-4428331506ad","query_id":"51","doc_a_id":"1866911","doc_b_id":"7821634","presented_order":["1866911","7821634"],"winner_id":"1866911","reasoning":"Doc A discusses breast epithelial subpopulations and marker-defined progenitors relevant to tumor biology and prognosis, while Doc B focuses narrowly on DUSP4 and chemo resistance; A is closer to ALDH1-related outcome questions.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908907Z"}
{"comparison_id":"6c5fa970-7ac3-4501-b26d-56358ba0be2b","query_id":"51","doc_a_id":"16734530","doc_b_id":"4889228","presented_order":["16734530","4889228"],"winner_id":"4889228","reasoning":"Document B — it discusses how expression levels of a protein (TDP43) correlate with prognosis in breast cancer, which is more directly related to claims about marker expression and outcomes than Document A's SNP-focused study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908914Z"}
{"comparison_id":"60ed0f9b-6e2a-46aa-9fc6-33a2443457b4","query_id":"51","doc_a_id":"25973484","doc_b_id":"34066665","presented_order":["25973484","34066665"],"winner_id":"34066665","reasoning":"Neither document mentions ALDH1. Document B is marginally more relevant because it addresses molecular signaling and markers affecting breast cancer outcomes, whereas A focuses on obesity epidemiology.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908920Z"}
{"comparison_id":"e26f71b4-fea0-4b14-87bd-86f08574f0e3","query_id":"51","doc_a_id":"45638119","doc_b_id":"4702639","presented_order":["45638119","4702639"],"winner_id":"45638119","reasoning":"Doc A directly addresses ALDH1 in breast cancer and states it predicts poor clinical outcome, which is directly relevant to the claim.  \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908926Z"}
{"comparison_id":"b5c97677-b9a7-42c6-96b9-f6a741feabc7","query_id":"51","doc_a_id":"20127522","doc_b_id":"7583725","presented_order":["20127522","7583725"],"winner_id":"7583725","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it discusses how expression level of a specific protein (TRPM7) predicts outcomes, which is closer in topic to a claim about a biomarker's expression being linked to prognosis.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908932Z"}
{"comparison_id":"c35347cb-db33-4d11-9287-a068a126f6f6","query_id":"51","doc_a_id":"1171121","doc_b_id":"15946643","presented_order":["1171121","15946643"],"winner_id":"1171121","reasoning":"Document A is more relevant — it examines prognostic markers in breast cancer (outcomes), whereas B focuses on chemoresistance/metastasis signaling not prognostic marker expression. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908938Z"}
{"comparison_id":"d5631c00-4125-41e2-800b-2c4e55672ae5","query_id":"51","doc_a_id":"20333864","doc_b_id":"8891333","presented_order":["20333864","8891333"],"winner_id":"8891333","reasoning":"Document B — it discusses cancer stem cells and markers/pathways relevant to breast cancer stemness (more likely to address ALDH1) while Document A does not mention ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908945Z"}
{"comparison_id":"52230935-b367-49bf-81ee-5a82b21279f9","query_id":"51","doc_a_id":"313403","doc_b_id":"8891333","presented_order":["8891333","313403"],"winner_id":"8891333","reasoning":"Reason: Document A discusses cancer stem cells in breast cancer (ALDH1 is a cancer stem cell marker), so it is more relevant to claims about ALDH1 and outcomes. Document B concerns tumor-associated macrophages and prognosis, which is unrelated.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908951Z"}
{"comparison_id":"02940b2f-f8d9-4d0c-ae76-f1523942c0fa","query_id":"51","doc_a_id":"12762485","doc_b_id":"19673227","presented_order":["19673227","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses breast cancer phenotypes and stem-cell–related markers linked to prognosis, which is more relevant to ALDH1 as a stem-cell marker. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908957Z"}
{"comparison_id":"ea65ca80-9dda-4407-8844-63a7db8deb6d","query_id":"51","doc_a_id":"18953920","doc_b_id":"25732836","presented_order":["18953920","25732836"],"winner_id":"18953920","reasoning":"Reason: Document A discusses acquisition of stem-cell markers (such as ALDH1) and increased tumorigenic potential in breast cells, which is directly relevant to associations between ALDH1 expression and outcomes. Document B is unrelated.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908963Z"}
{"comparison_id":"08a7efb8-0f21-452d-a07b-ac98c269f25f","query_id":"51","doc_a_id":"32001951","doc_b_id":"3285322","presented_order":["3285322","32001951"],"winner_id":"32001951","reasoning":"Document B is more relevant — it investigates regulation of an enzyme's expression in a breast cancer cell line, which is closer to the query about marker expression than Document A's focus on BRCA mutation clinical features.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908971Z"}
{"comparison_id":"2fb57800-e18b-45e5-92c3-540830b8935e","query_id":"51","doc_a_id":"1171121","doc_b_id":"22975806","presented_order":["22975806","1171121"],"winner_id":"1171121","reasoning":"Document B is more relevant because it examines biomarkers (MVD and p53) as prognostic factors in breast cancer outcomes, whereas Document A focuses on BRCA allele loss mechanisms rather than outcome-associated markers.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908977Z"}
{"comparison_id":"c903e4cd-f5ff-462a-9b64-3245b97561b6","query_id":"51","doc_a_id":"15113221","doc_b_id":"20127522","presented_order":["15113221","20127522"],"winner_id":"15113221","reasoning":"Document A is more relevant — it discusses a gene expression signature linked to prognosis in carcinoma, which is closer to the claim relating marker expression to breast cancer outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908983Z"}
{"comparison_id":"440fb89b-e141-4bb0-86d0-fb6073d51c04","query_id":"51","doc_a_id":"1866911","doc_b_id":"22712546","presented_order":["1866911","22712546"],"winner_id":"22712546","reasoning":"Document B is more relevant — it describes measuring enzymatic activities in breast cancer tissue (which could include ALDH1), whereas A focuses on c-KIT+ luminal progenitors in BRCA1 carriers and doesn't address ALDH1 or outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908989Z"}
{"comparison_id":"feade29a-6b80-4a99-b303-8c63cc251063","query_id":"51","doc_a_id":"21033230","doc_b_id":"22482820","presented_order":["21033230","22482820"],"winner_id":"21033230","reasoning":"Document A is more relevant — it addresses molecular profiling and prognostic markers in breast cancer, which is closer to assessing associations between marker expression and outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.908996Z"}
{"comparison_id":"f0aa0f9c-b589-433b-849c-da9e79ecf173","query_id":"51","doc_a_id":"16086778","doc_b_id":"16691520","presented_order":["16086778","16691520"],"winner_id":"16086778","reasoning":"Document A is more relevant — it discusses molecular mechanisms affecting breast cancer behavior and outcomes, whereas Document B focuses on estrogen receptor binding sites and not prognosis or ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909002Z"}
{"comparison_id":"c20f623c-1795-4b64-9a1b-a4dca3c9551e","query_id":"51","doc_a_id":"15946643","doc_b_id":"9600826","presented_order":["9600826","15946643"],"winner_id":"15946643","reasoning":"Neither document mentions ALDH1. Document B is slightly more relevant because it addresses factors (chemoresistance and metastasis) directly related to breast cancer outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909009Z"}
{"comparison_id":"4024dd42-e342-4378-b7de-fc3c2a1fcef6","query_id":"51","doc_a_id":"1866911","doc_b_id":"24341590","presented_order":["24341590","1866911"],"winner_id":"1866911","reasoning":"Document B is more relevant — it discusses breast epithelial progenitor cell populations and markers related to tumor origin, which is closer to ALDH1 (a stem/progenitor marker) than Document A's focus on CYP2D6 pharmacogenetics.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909015Z"}
{"comparison_id":"44dce205-9cd3-44cb-9e72-a8b30cef7cae","query_id":"51","doc_a_id":"25732836","doc_b_id":"32001951","presented_order":["32001951","25732836"],"winner_id":"32001951","reasoning":"Document A (studies regulation of enzyme expression in breast cancer cells) is more related to claims about marker expression; Document B is about imaging/CTCs and not marker expression. Neither mentions ALDH1 specifically, but A is closer.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909021Z"}
{"comparison_id":"0ab8791e-f6e6-47ac-b410-2d57f6a2f767","query_id":"51","doc_a_id":"24341590","doc_b_id":"825728","presented_order":["24341590","825728"],"winner_id":"825728","reasoning":"Document B — it discusses EMT, cancer stem cell properties and links to patient survival/metastasis, which is more related to ALDH1's role in cancer outcomes than a CYP2D6/tamoxifen pharmacogenetics paper.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909028Z"}
{"comparison_id":"cb213dfd-585d-4eb2-ad65-c3e180fbc062","query_id":"51","doc_a_id":"2931832","doc_b_id":"31311495","presented_order":["31311495","2931832"],"winner_id":"2931832","reasoning":"Document B — it addresses prognostic biomarkers and patient outcomes in breast cancer, so it's more relevant to a claim about associations with outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909034Z"}
{"comparison_id":"00d38ba9-4880-4daa-ab2a-59e1e9ac5171","query_id":"51","doc_a_id":"4702639","doc_b_id":"7821634","presented_order":["7821634","4702639"],"winner_id":"4702639","reasoning":"Document B — it discusses tumour stemness and markers of stem-like cells (related to ALDH1 as a stem-cell marker), whereas A focuses on DUSP4 and chemotherapy resistance without addressing ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909041Z"}
{"comparison_id":"75ca1f7b-ecd3-4b44-94e7-5902c8617616","query_id":"51","doc_a_id":"11484808","doc_b_id":"25732836","presented_order":["25732836","11484808"],"winner_id":"25732836","reasoning":"Document A is more relevant — it directly addresses prognostic biomarkers and outcome prediction in metastatic breast cancer, whereas Document B focuses on non-coding RNAs in endocrine cancers generally.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909047Z"}
{"comparison_id":"da105335-3325-4091-b762-dceee45e7839","query_id":"51","doc_a_id":"45638119","doc_b_id":"4889228","presented_order":["45638119","4889228"],"winner_id":"45638119","reasoning":"Document A directly addresses ALDH1 and its association with clinical outcome (reports poor prognosis), while Document B discusses TDP43 in TNBC and is unrelated to ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909053Z"}
{"comparison_id":"4da8ecb8-8c3d-47e2-a862-338e197d813f","query_id":"51","doc_a_id":"20839751","doc_b_id":"22482820","presented_order":["20839751","22482820"],"winner_id":"20839751","reasoning":"Document A is more relevant because it discusses prognostic markers and outcomes in breast cancer, whereas B focuses on treatment delivery strategies and drug resistance. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909059Z"}
{"comparison_id":"be999d7d-22ca-4859-bdb5-589e3a321821","query_id":"51","doc_a_id":"22401720","doc_b_id":"2931832","presented_order":["2931832","22401720"],"winner_id":"22401720","reasoning":"Reason: Document B examines tumor protein expression and its relation to prognosis in breast cancer, which is directly analogous to assessing ALDH1 expression and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909091Z"}
{"comparison_id":"e905126d-59ae-40a0-bf6e-18342a7af332","query_id":"51","doc_a_id":"15946643","doc_b_id":"313403","presented_order":["15946643","313403"],"winner_id":"313403","reasoning":"Document B is more relevant — it addresses prognostic markers and clinical outcomes in breast cancer, which aligns with evaluating whether a biomarker (like ALDH1) is associated with patient outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909097Z"}
{"comparison_id":"118acd5d-8640-4c3e-92e6-ac442a27ce55","query_id":"51","doc_a_id":"4702639","doc_b_id":"8891333","presented_order":["4702639","8891333"],"winner_id":"8891333","reasoning":"Document B is more relevant — it discusses cancer stem cells in breast cancer (where ALDH1 is a known stem-cell marker) and their clinical implications. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909103Z"}
{"comparison_id":"51b10f7f-f0ef-49c9-9965-55f7a452e9cb","query_id":"51","doc_a_id":"16691520","doc_b_id":"24834968","presented_order":["16691520","24834968"],"winner_id":"24834968","reasoning":"Document B is more relevant — it evaluates biological markers as predictors of treatment response/outcomes in breast cancer, whereas Document A focuses on estrogen receptor binding sites and not prognostic markers like ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909109Z"}
{"comparison_id":"0dd833fc-4a07-47ea-844c-377c7081a77f","query_id":"51","doc_a_id":"2014909","doc_b_id":"4429932","presented_order":["4429932","2014909"],"winner_id":"2014909","reasoning":"Document B is more relevant — it discusses tumor-initiating cells and analyses of primary breast cancers, which is more related to ALDH1 (a tumor‑initiating/stem cell marker) than Document A. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909115Z"}
{"comparison_id":"07f27f69-e7bc-4619-8bf2-1793609400ea","query_id":"51","doc_a_id":"22401720","doc_b_id":"31311495","presented_order":["22401720","31311495"],"winner_id":"31311495","reasoning":"Document B. It discusses EMT and therapy resistance—biologic processes linked to stem-cell markers like ALDH1 and clinical outcome—whereas Document A focuses on angiogenic factors not related to ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909122Z"}
{"comparison_id":"5368e293-743b-4498-9d0a-d26e7652abdb","query_id":"51","doc_a_id":"19673227","doc_b_id":"25973484","presented_order":["25973484","19673227"],"winner_id":"25973484","reasoning":"Document A is more relevant — it discusses breast cancer risk and prognosis specifically, whereas B covers a general CTC chemosensitivity assay across epithelial tumors.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909128Z"}
{"comparison_id":"44c06c9e-2c69-4efe-abe2-ea978e6067a4","query_id":"51","doc_a_id":"25732836","doc_b_id":"825728","presented_order":["825728","25732836"],"winner_id":"825728","reasoning":"Document A is more relevant — it discusses cancer stem-cell properties and links to patient survival and metastasis, which is closer to a biomarker–outcome association than Document B's focus on CTCs and imaging. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909135Z"}
{"comparison_id":"e29b843b-2a33-4d4f-94bd-42e090827869","query_id":"51","doc_a_id":"3285322","doc_b_id":"34066665","presented_order":["3285322","34066665"],"winner_id":"3285322","reasoning":"Document A is more relevant — it focuses on clinical/pathologic features and treatment outcomes in breast cancer, which is more directly related to evaluating associations between a biomarker (like ALDH1) and prognosis.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909141Z"}
{"comparison_id":"a439f6f7-065d-4b09-b82f-b90b302f55f2","query_id":"51","doc_a_id":"16691520","doc_b_id":"20333864","presented_order":["16691520","20333864"],"winner_id":"20333864","reasoning":"Document B is more relevant — it addresses tumor progression and cellular/microenvironmental factors tied to invasiveness and outcomes, which is closer to discussions of markers like ALDH1 than a genome-wide ER binding study.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909147Z"}
{"comparison_id":"616f5391-dc49-4e1e-a815-c3d2ba61319d","query_id":"51","doc_a_id":"19673227","doc_b_id":"45638119","presented_order":["19673227","45638119"],"winner_id":"45638119","reasoning":"Document B — it directly studies ALDH1 in breast tissue and reports that ALDH1 correlates with poor clinical outcome, which is directly relevant to the claim. \nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909153Z"}
{"comparison_id":"8882db89-c5b7-4c45-b336-fdb5e80e4179","query_id":"51","doc_a_id":"22482820","doc_b_id":"4455466","presented_order":["4455466","22482820"],"winner_id":"4455466","reasoning":"Document A is more relevant — it links gene expression levels to breast cancer prognosis (expression correlated with outcomes), whereas B focuses on treatment strategies rather than prognostic markers.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909160Z"}
{"comparison_id":"bcfa133c-6f0d-4c7e-8f6e-10b800a1b2e8","query_id":"51","doc_a_id":"19673227","doc_b_id":"22482820","presented_order":["22482820","19673227"],"winner_id":"19673227","reasoning":"Document B is more relevant — it addresses prognostic/predictive biomarkers (CTC drug-resistance profiles) and correlations with disease-free survival and time to progression, which relates to claims about markers and outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909166Z"}
{"comparison_id":"b2822a5d-57ec-4528-a5ae-a376ae07652a","query_id":"51","doc_a_id":"11484808","doc_b_id":"8963413","presented_order":["11484808","8963413"],"winner_id":"8963413","reasoning":"Document B — it discusses associations between marker expression and breast cancer outcomes, which is closer in topic to the ALDH1 outcome claim than a review of non-coding RNAs.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909172Z"}
{"comparison_id":"e32cfd63-e44e-467c-88de-f472dd25d032","query_id":"51","doc_a_id":"15946643","doc_b_id":"22401720","presented_order":["15946643","22401720"],"winner_id":"22401720","reasoning":"Document B is more relevant — it examines expression of tumor markers and their relation to prognosis in breast cancer, which is directly related to the claim about a marker's association with outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909178Z"}
{"comparison_id":"08f75a68-6c63-453d-af19-f23fbe8f3558","query_id":"51","doc_a_id":"20183360","doc_b_id":"22482820","presented_order":["22482820","20183360"],"winner_id":"20183360","reasoning":"Document B is more relevant — it addresses molecular regulation of invasiveness and tumor behavior (biomarker-related pathways), which is closer to evaluating how a marker's expression might relate to outcomes. Document A focuses on therapy delivery strategies rather than biomarker-outcome associations.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909186Z"}
{"comparison_id":"8df31656-60f8-4233-a38d-94110b17753e","query_id":"51","doc_a_id":"20183360","doc_b_id":"24341590","presented_order":["24341590","20183360"],"winner_id":"20183360","reasoning":"Document B is more relevant — while neither mentions ALDH1, B addresses transcriptional regulation of tumor invasiveness (closer to biomarkers and outcomes) whereas A focuses on CYP2D6 pharmacogenetics unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909193Z"}
{"comparison_id":"62dd047f-9b6d-4f5a-b17e-b934dd539d8c","query_id":"51","doc_a_id":"45638119","doc_b_id":"7821634","presented_order":["7821634","45638119"],"winner_id":"45638119","reasoning":"Doc B is directly about ALDH1 and its association with clinical outcome (reports poor prognosis), while A is unrelated. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909198Z"}
{"comparison_id":"86002a2c-93c6-4cd9-8c23-efac4035ef70","query_id":"51","doc_a_id":"2931832","doc_b_id":"4702639","presented_order":["2931832","4702639"],"winner_id":"4702639","reasoning":"Document B is more relevant — it concerns tumour stemness and stem-like markers in cancer (closer to ALDH1's role as a stem cell marker) whereas Document A addresses platelet metrics unrelated to ALDH1. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909205Z"}
{"comparison_id":"7175dcf1-330b-4ffd-b587-1061d009870b","query_id":"51","doc_a_id":"24341590","doc_b_id":"4702639","presented_order":["24341590","4702639"],"winner_id":"4702639","reasoning":"Document B is more relevant — it addresses tumor stemness and markers/drivers of stem-like properties (which relates to ALDH1 as a stem cell marker), while Document A concerns CYP2D6/tamoxifen pharmacogenetics and is unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909212Z"}
{"comparison_id":"8068abd0-4f19-4b0f-9c81-8a839fb0bf15","query_id":"51","doc_a_id":"19358586","doc_b_id":"22975806","presented_order":["22975806","19358586"],"winner_id":"19358586","reasoning":"Document B is more relevant because it discusses protein signatures linked to survival and potential prognostic/therapeutic markers in breast cancer, whereas Document A focuses on BRCA allele loss without addressing markers like ALDH1 or outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909218Z"}
{"comparison_id":"5fbeeb36-cf3e-43ff-a626-fa898b33425c","query_id":"51","doc_a_id":"3285322","doc_b_id":"7583725","presented_order":["7583725","3285322"],"winner_id":"7583725","reasoning":"Document A is more relevant — it links expression of a tumor marker to patient outcomes, which is similar to the ALDH1 expression–outcome relationship in the query.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909224Z"}
{"comparison_id":"e0137298-2423-457e-bdce-f00c8d52126c","query_id":"51","doc_a_id":"12762485","doc_b_id":"20127522","presented_order":["20127522","12762485"],"winner_id":"12762485","reasoning":"Document B — it discusses stem-cell–like phenotypes in breast cancer (which relates to ALDH1 as a stem cell marker), while A is about circulating tumor cells and not ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909230Z"}
{"comparison_id":"a0906561-b8a3-4677-a38f-cbf5f6bab227","query_id":"51","doc_a_id":"16734530","doc_b_id":"19358586","presented_order":["19358586","16734530"],"winner_id":"19358586","reasoning":"Document A is more relevant — it discusses protein signatures linked to breast cancer survival and therapeutic factors affecting tumor growth, which is closer to the claim about outcomes than a SNP association study.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909236Z"}
{"comparison_id":"ac527448-fb64-4902-8e5e-218cddff5a40","query_id":"51","doc_a_id":"20454006","doc_b_id":"5579368","presented_order":["5579368","20454006"],"winner_id":"5579368","reasoning":"Document A — it covers gene expression and breast cancer biomarkers (more relevant to ALDH1 expression), while Document B concerns DIM/tamoxifen metabolism and not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909243Z"}
{"comparison_id":"58f25fbf-cf53-48b0-b715-815a65362551","query_id":"51","doc_a_id":"16691520","doc_b_id":"7583725","presented_order":["7583725","16691520"],"winner_id":"7583725","reasoning":"Document A is more relevant — it discusses gene expression linked to breast cancer outcomes (though about TRPM7, not ALDH1), while B focuses on estrogen receptor binding sites without outcome data. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909249Z"}
{"comparison_id":"6e0dac25-33d5-4fe2-a756-6be22a63b8df","query_id":"51","doc_a_id":"16086778","doc_b_id":"45638119","presented_order":["16086778","45638119"],"winner_id":"45638119","reasoning":"Document B is more relevant — it directly addresses ALDH1 in breast cancer and states ALDH1 correlates with poor (not better) clinical outcome, which directly refutes the query. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909256Z"}
{"comparison_id":"d9a345b0-fda0-417b-8fee-733ba3e9e724","query_id":"51","doc_a_id":"1171121","doc_b_id":"45638119","presented_order":["1171121","45638119"],"winner_id":"45638119","reasoning":"Document B — it directly studies ALDH1 and reports that ALDH1 expression predicts poor clinical outcome in breast cancer, which is directly relevant to the claim (and contradicts it).\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909262Z"}
{"comparison_id":"ea416299-8720-40f8-98b1-5061557d84fb","query_id":"51","doc_a_id":"25973484","doc_b_id":"4889228","presented_order":["25973484","4889228"],"winner_id":"4889228","reasoning":"Document B is more relevant — it discusses gene/protein expression correlated with breast cancer prognosis (though not ALDH1 specifically), whereas Document A focuses on obesity-related risk and prognosis factors. \n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909268Z"}
{"comparison_id":"3d462f24-a70e-4921-9134-7bc681c1de8a","query_id":"51","doc_a_id":"15946643","doc_b_id":"8963413","presented_order":["15946643","8963413"],"winner_id":"8963413","reasoning":"Document B — it discusses expression of an immune marker (PD-L1) being associated with better outcomes in breast cancer, which is more related to the query about expression linked to breast cancer prognosis than Document A's focus on CXCL1 and chemoresistance.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909275Z"}
{"comparison_id":"c6418fd6-d4ef-4f6b-a295-e4d14a951184","query_id":"51","doc_a_id":"22712546","doc_b_id":"7821634","presented_order":["22712546","7821634"],"winner_id":"22712546","reasoning":"Document A is more relevant — it examines enzymatic/metabolic activities in breast cancer tissue (which could include ALDH1) and in situ metabolic networks, whereas Document B focuses on DUSP4 and chemotherapy resistance, not ALDH1. ANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909282Z"}
{"comparison_id":"f21fca40-e79f-4362-b59a-45171919f40c","query_id":"51","doc_a_id":"20333864","doc_b_id":"4429932","presented_order":["4429932","20333864"],"winner_id":"4429932","reasoning":"Document A is more relevant — it discusses associations with patient outcomes in breast cancer, whereas Document B focuses on cellular mechanisms of DCIS invasion without addressing ALDH1 or clinical outcome associations.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909288Z"}
{"comparison_id":"724ce844-ef91-4215-83b4-405656ca9645","query_id":"51","doc_a_id":"24834968","doc_b_id":"45638119","presented_order":["45638119","24834968"],"winner_id":"45638119","reasoning":"Document A — it directly reports on ALDH1 expression and its association with clinical outcomes (specifically poor prognosis), whereas Document B does not address ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909294Z"}
{"comparison_id":"e4835d68-c317-45b5-9a60-fef7e4adf625","query_id":"51","doc_a_id":"16734530","doc_b_id":"20183360","presented_order":["20183360","16734530"],"winner_id":"20183360","reasoning":"Document A is more relevant — it addresses mechanisms of breast cancer progression and factors affecting invasiveness (which relate to outcomes), whereas Document B focuses on ORAI1 SNPs and does not pertain to ALDH1. Neither mentions ALDH1 directly.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909301Z"}
{"comparison_id":"587f3dbc-4399-4cf9-9f7b-29a646b90cd6","query_id":"51","doc_a_id":"1866911","doc_b_id":"4429932","presented_order":["1866911","4429932"],"winner_id":"1866911","reasoning":"Document A is about breast epithelial progenitor/stem cell populations and marker expression relevant to tumor origin, making it closer to the ALDH1–outcome question than the LOX/metastasis focus in B.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909307Z"}
{"comparison_id":"445d5fd3-5f7b-4de0-bf8c-d0047eb526c7","query_id":"51","doc_a_id":"7821634","doc_b_id":"8891333","presented_order":["7821634","8891333"],"winner_id":"8891333","reasoning":"Document B — it discusses breast cancer stem cells and pathways/markers related to stemness and therapy resistance (contexts where ALDH1 is commonly investigated), while A focuses on DUSP4 and chemotherapy resistance unrelated to ALDH1.\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909313Z"}
{"comparison_id":"73210f8d-f5b1-454e-b8ee-d13d465c63e9","query_id":"51","doc_a_id":"15113221","doc_b_id":"4889228","presented_order":["4889228","15113221"],"winner_id":"4889228","reasoning":"Document A is more relevant — it concerns breast cancer (triple-negative subtype) and prognosis, whereas B addresses a PTEN-related signature across carcinomas generally. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909319Z"}
{"comparison_id":"0728a0f9-8a2d-40db-aff1-5ef70bcc2b6f","query_id":"51","doc_a_id":"22975806","doc_b_id":"34066665","presented_order":["22975806","34066665"],"winner_id":"34066665","reasoning":"Document B is more relevant — it discusses molecular markers and clinical implications for breast cancer outcomes and therapy, whereas A focuses narrowly on BRCA allele loss without addressing ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909326Z"}
{"comparison_id":"f02e0db6-b69e-4ee2-87d0-069ef798972c","query_id":"51","doc_a_id":"5500086","doc_b_id":"5579368","presented_order":["5500086","5579368"],"winner_id":"5579368","reasoning":"Document B — it concerns analysis of gene expression and biomarkers in breast cancer (which could address ALDH1 associations), whereas A discusses interferon signatures unrelated to ALDH1. ANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909332Z"}
{"comparison_id":"f47c899a-9f26-4b59-aff7-3a389bbe2048","query_id":"51","doc_a_id":"15946643","doc_b_id":"24341590","presented_order":["24341590","15946643"],"winner_id":"15946643","reasoning":"Document B is more relevant — it addresses tumor cell survival, chemoresistance and metastasis pathways that are conceptually related to prognostic markers like ALDH1, whereas Document A focuses on CYP2D6 pharmacogenetics and tamoxifen outcomes.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909338Z"}
{"comparison_id":"1b36925b-6742-4ad6-baba-9fce2c083c8e","query_id":"51","doc_a_id":"8963413","doc_b_id":"9600826","presented_order":["9600826","8963413"],"winner_id":"8963413","reasoning":"Document B is more relevant — it discusses expression of a tumor biomarker (PD-L1) and its association with breast cancer outcomes, which is conceptually closer to the ALDH1–outcome claim than Document A's angiogenesis pathway focus.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909345Z"}
{"comparison_id":"df89063c-02a4-42ca-bc5a-fd9b97142e28","query_id":"51","doc_a_id":"2014909","doc_b_id":"34066665","presented_order":["2014909","34066665"],"winner_id":"2014909","reasoning":"Document A is more relevant — it discusses tumor-initiating cells and analyses of primary breast cancers (ALDH1 is a stem/tumor-initiating cell marker), whereas B focuses on ER/HER signaling and endocrine resistance. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909351Z"}
{"comparison_id":"8660b2ce-8895-4b01-abed-b09f02f4560c","query_id":"51","doc_a_id":"18953920","doc_b_id":"3285322","presented_order":["18953920","3285322"],"winner_id":"18953920","reasoning":"Document A is more relevant — it discusses stem-cell markers in mammary cells (context for ALDH1) and links to tumorigenic potential, whereas B is about BRCA mutation clinical features. \nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909357Z"}
{"comparison_id":"e70f68d8-0133-4e9f-8975-26a5ba3e13c7","query_id":"51","doc_a_id":"24341590","doc_b_id":"5579368","presented_order":["24341590","5579368"],"winner_id":"5579368","reasoning":"Document B is more relevant — it addresses methods for correlating DNA methylation with gene expression in breast cancer biomarkers, which could be applied to ALDH1 expression; Document A focuses on CYP2D6/tamoxifen and is unrelated.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909364Z"}
{"comparison_id":"198e3136-2609-4509-a81b-0c01d4e6de6e","query_id":"51","doc_a_id":"31311495","doc_b_id":"4702639","presented_order":["4702639","31311495"],"winner_id":"4702639","reasoning":"Document A is more relevant — it discusses tumor stemness and markers driving prognosis and treatment resistance, which is conceptually closer to ALDH1 as a stem-cell–associated marker. \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909370Z"}
{"comparison_id":"a0a7534b-6472-4ed8-94c0-d14837cd1e47","query_id":"51","doc_a_id":"31311495","doc_b_id":"313403","presented_order":["31311495","313403"],"winner_id":"31311495","reasoning":"Document A is more relevant — it addresses cellular phenotypes (EMT, therapy resistance) and markers related to tumor aggressiveness that are conceptually closer to ALDH1’s role, whereas B focuses on macrophage infiltration and prognosis, not ALDH1.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909376Z"}
{"comparison_id":"2c726998-418e-43e8-ae27-283d8d925073","query_id":"51","doc_a_id":"21033230","doc_b_id":"22401720","presented_order":["21033230","22401720"],"winner_id":"21033230","reasoning":"Document A is more relevant — it discusses molecular markers on circulating tumor cells and their relation to prognosis in breast cancer, whereas Document B focuses on angiogenic factors (no general marker–outcome profiling). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909383Z"}
{"comparison_id":"dfc5f1aa-c29a-4b36-81b9-bbc7e25e4dea","query_id":"51","doc_a_id":"1171121","doc_b_id":"32001951","presented_order":["1171121","32001951"],"winner_id":"1171121","reasoning":"Document A is about prognostic factors and clinical outcomes in breast cancer (more relevant to a claim about markers and outcomes). Document B studies alkaline phosphatase regulation in a cell line and doesn't address ALDH1 or clinical outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909389Z"}
{"comparison_id":"37d11cbb-fe86-48e6-984a-c34ff25d148b","query_id":"51","doc_a_id":"20183360","doc_b_id":"8891333","presented_order":["8891333","20183360"],"winner_id":"8891333","reasoning":"Document A is more relevant — it discusses cancer stem cells in breast cancer and therapies/markers related to stemness (context where ALDH1, a stem cell marker, would be discussed). \n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909395Z"}
{"comparison_id":"9cb0643b-0908-489f-9949-869af30e9500","query_id":"51","doc_a_id":"24341590","doc_b_id":"43385013","presented_order":["24341590","43385013"],"winner_id":"43385013","reasoning":"Document B — it addresses stem cell/progenitor characteristics in breast cell subpopulations (where ALDH1 is commonly discussed as a stem cell marker), while Document A concerns CYP2D6/tamoxifen and is unrelated to ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909402Z"}
{"comparison_id":"7a442bf3-e5a2-4966-818b-777f3e46b923","query_id":"51","doc_a_id":"1171121","doc_b_id":"22712546","presented_order":["1171121","22712546"],"winner_id":"22712546","reasoning":"Document B is more relevant — it addresses enzymatic activities and metabolic profiling in breast cancer tissue, which is directly related to ALDH1 (an enzyme) expression, whereas Document A discusses MVD and p53 without mentioning ALDH1.\n\nANSWER: B","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909408Z"}
{"comparison_id":"2353811d-bcbb-4321-9b23-109e753dc9b8","query_id":"51","doc_a_id":"25732836","doc_b_id":"8963413","presented_order":["8963413","25732836"],"winner_id":"8963413","reasoning":"Document A is more relevant — it discusses expression of a tumor marker (PD-L1) and its association with breast cancer outcomes, which is conceptually closer to a claim about ALDH1 expression and outcomes.\n\nANSWER: A","model":"gpt-5-mini","timestamp":"2025-12-31T09:34:52.909414Z"}
